data_1xo8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xo8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.775 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 116.249 1.259 . . . . 1.0700000000000001 116.249 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.709 ' HB2' HD13 ' A' ' 122' ' ' LEU . 23.9 m -169.51 33.14 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.105 -1.548 . . . . 1.7 107.215 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.06 155.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.338 -1.301 . . . . 1.53 109.051 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -174.92 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.182 0.438 . . . . 1.05 112.182 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 9.1 t70 -152.72 153.84 34.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.773 0.26 . . . . 1.6899999999999999 110.464 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.424 HG22 ' CZ ' ' A' ' 64' ' ' PHE . 85.1 t -141.32 123.11 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.797 -0.446 . . . . 1.8500000000000001 109.797 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 33.0 t70 -113.93 108.72 17.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.757 -0.656 . . . . 1.8300000000000001 111.017 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.3 tm? -83.06 140.05 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 1.46 110.488 -177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.601 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -138.68 -91.59 0.2 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.627 0.973 . . . . 1.9199999999999999 113.627 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.743 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.309 -1.189 0 O-C-N 121.589 -0.694 . . . . 2.8500000000000001 111.952 -152.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.239 0.544 0 N-CA-C 112.926 0.713 . . . . 1.1299999999999999 112.926 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.743 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 61.0 t -75.86 148.85 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.243 -0.89 . . . . 1.48 109.388 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.011 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 61.8 mt-10 -124.05 142.75 50.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.299 -0.96 . . . . 1.1899999999999999 111.209 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.948 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 11.5 p90 -133.51 131.71 40.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.269 -0.972 . . . . 3.9399999999999999 112.365 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 111.95 23.73 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.213 -1.032 . . . . 1.4299999999999999 108.213 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.824 ' HB1' ' HE1' ' A' ' 41' ' ' TYR . . . -97.08 118.67 34.01 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.176 -0.61 . . . . 1.1100000000000001 110.739 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 17.5 tppt? -84.68 116.9 23.47 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.501 -0.925 . . . . 3.1800000000000002 108.501 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 25' ' ' SER . 37.2 t -100.99 145.42 11.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.142 -0.936 . . . . 1.3999999999999999 110.177 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.491 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 3.6 m -129.34 100.21 5.5 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.22 0.533 . . . . 1.1100000000000001 110.05 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -83.02 121.64 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.879 -1.055 . . . . 1.8500000000000001 110.136 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.775 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.3 m -102.63 113.05 26.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.163 -0.68 . . . . 1.1000000000000001 109.163 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.761 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 8.7 t30 -88.36 128.93 51.35 Favored Pre-proline 0 N--CA 1.466 0.347 0 O-C-N 124.533 1.146 . . . . 1.48 109.961 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.58 13.52 2.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.91000000000000003 114.389 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -130.9 142.42 50.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.392 -0.596 . . . . 2.3100000000000001 109.392 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.59 ' HB3' ' HD2' ' A' ' 85' ' ' LYS . 56.8 p -74.88 31.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.881 0.697 . . . . 1.8300000000000001 112.881 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -145.12 128.99 17.37 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.245 -0.284 . . . . 2.0299999999999998 110.738 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -39.88 110.22 0.14 Allowed 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 124.258 1.023 . . . . 1.73 112.412 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.1 pt -79.62 173.31 7.93 Favored Pre-proline 0 C--O 1.201 -1.48 0 N-CA-C 106.111 -1.811 . . . . 1.23 106.111 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.497 ' C ' HD12 ' A' ' 57' ' ' ILE . 9.4 Cg_endo -92.75 -62.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 121.326 1.509 . . . . 0.53000000000000003 114.408 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 79' ' ' PRO . 1.4 mp -134.26 153.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.274 -0.421 . . . . 1.9099999999999999 110.796 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 124' ' ' ILE . 21.0 m -140.76 178.95 6.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.886 0.851 . . . . 1.95 111.503 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.109 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 42.0 tt0 -133.77 115.53 14.65 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.906 -1.497 . . . . 1.3600000000000001 110.249 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.593 HG23 HD13 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.59 110.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 122.533 1.159 . . . . 1.6499999999999999 110.378 169.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.419 ' C ' HD12 ' A' ' 120' ' ' ILE . 14.2 t -113.3 102.74 10.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.196 -1.82 . . . . 1.02 108.636 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.514 ' HE1' HG13 ' A' ' 95' ' ' VAL . 6.6 p90 -113.66 133.44 55.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.418 0.628 . . . . 0.46000000000000002 110.029 -167.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 27.2 m -126.14 104.77 8.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.675 -1.148 . . . . 1.1699999999999999 108.399 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 4.4 m-85 -95.42 143.17 26.99 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.2 -0.454 . . . . 1.1799999999999999 110.191 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 4.0 m170 -132.11 145.63 51.52 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 107.107 -1.442 . . . . 1.72 107.107 175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.9 ' HB3' HD23 ' A' ' 104' ' ' LEU . 19.9 t -103.84 -91.17 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.631 -1.228 . . . . 1.6599999999999999 111.158 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -69.07 0.17 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.1200000000000001 110.159 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.67 15.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.461 -1.456 . . . . 0.39000000000000001 109.461 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.642 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -100.17 -78.31 0.51 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.516 -0.842 . . . . 2.4900000000000002 109.041 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.642 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -171.4 -177.34 2.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.141 -1.059 . . . . 2.6099999999999999 108.141 171.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.567 HG21 ' HB ' ' A' ' 96' ' ' VAL . 1.6 mm -135.18 -35.77 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.363 -0.835 . . . . 1.1100000000000001 109.556 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 160.5 171.98 27.16 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.281 -1.128 . . . . 0.48999999999999999 110.281 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -161.18 166.13 28.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.124 0.962 . . . . 2.3999999999999999 110.766 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.01 166.02 32.19 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.359 -0.696 . . . . 0.52000000000000002 111.359 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -129.33 129.51 44.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.897 -0.409 . . . . 2.3799999999999999 109.897 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.561 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.8 mt -139.23 121.64 10.31 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.782 0.325 . . . . 1.47 110.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.7 115.4 4.32 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.432 2.088 . . . . 0.81000000000000005 110.76 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.13 141.61 39.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.79000000000000004 109.375 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.625 ' HA ' HG13 ' A' ' 57' ' ' ILE . 23.5 Cg_exo -63.88 82.66 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.593 2.195 . . . . 0.91000000000000003 112.052 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.603 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -87.85 41.97 3.09 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.692 -0.685 . . . . 0.47999999999999998 112.14 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.78 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 44.4 t -73.45 133.74 43.77 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.208 -1.034 . . . . 0.85999999999999999 108.208 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.775 HD13 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -152.81 -156.93 0.75 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 118.201 -1.4 . . . . 1.76 114.641 -163.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -63.82 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 2.4300000000000002 112.173 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.4 106.09 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.75 -0.833 . . . . 1.29 108.75 -171.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.761 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 6.5 ptmm? 46.35 46.25 13.65 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.28 0.988 . . . . 2.21 111.348 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.39 -170.68 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.757 -1.11 . . . . 0.64000000000000001 109.545 -173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.491 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 50.1 ttm -112.0 132.17 54.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 2.04 110.947 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -122.94 146.5 47.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.806 -0.633 . . . . 1.3300000000000001 110.049 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.05 137.09 32.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.24 0.543 . . . . 1.1100000000000001 110.696 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.531 HD21 HG12 ' A' ' 45' ' ' VAL . 7.2 tt -137.72 168.35 19.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.41 -0.959 . . . . 1.45 108.41 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -132.39 140.95 48.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.734 0.642 . . . . 1.8100000000000001 112.734 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.679 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 43.4 mm -110.94 143.51 28.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 1.3999999999999999 108.159 172.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 94' ' ' VAL . 87.7 Cg_exo -49.75 -121.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.787 2.991 . . . . 1.0700000000000001 114.147 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.011 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -157.37 88.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.849 -0.532 . . . . 1.1799999999999999 111.891 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 62' ' ' PHE . 12.3 p -127.39 101.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 115.412 1.634 . . . . 1.1699999999999999 115.412 -168.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 71' ' ' ILE . 1.2 p -150.96 98.76 3.13 Favored Pre-proline 0 C--N 1.315 -0.898 0 O-C-N 121.501 -0.749 . . . . 1.71 110.489 164.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.405 ' HB2' HG12 ' A' ' 100' ' ' ILE . 51.9 Cg_exo -52.59 134.02 51.59 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.064 1.842 . . . . 0.65000000000000002 111.418 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -57.2 -33.28 67.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 1.6899999999999999 111.204 -173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 26.5 m -58.04 -32.02 67.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.926 0.343 . . . . 1.49 111.926 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.457 HG22 ' HG2' ' A' ' 70' ' ' GLU . 9.6 mm -76.9 -56.32 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.502 -0.479 . . . . 1.21 110.695 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -51.24 -27.87 10.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.042 -0.981 . . . . 1.6399999999999999 110.563 171.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 63.2 t80 -65.45 -38.67 90.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.09 -1.413 . . . . 1.2 108.803 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.639 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 36.1 m-80 -74.47 -57.77 3.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.935 -0.575 . . . . 0.81999999999999995 111.758 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 66' ' ' SER . 1.2 pp -62.29 -51.42 67.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.56 0.948 . . . . 1.22 113.56 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.418 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.24 -24.43 65.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.797 0.808 . . . . 1.1899999999999999 110.536 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.3 ttm180 -59.1 -52.04 67.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.917 -1.038 . . . . 2.2200000000000002 110.191 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 22.2 t70 -82.83 -51.34 7.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.6 0.714 . . . . 0.80000000000000004 111.948 -173.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 2.7 t -86.87 -27.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 121.872 -0.518 . . . . 1.5 110.425 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.0 -20.43 79.43 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.739 -0.743 . . . . 0.38 111.692 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -48.45 -46.33 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.824 -1.547 . . . . 1.6599999999999999 106.824 163.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 12.0 t70 -67.09 -90.41 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.477 -0.783 . . . . 1.8700000000000001 109.088 160.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 172.44 -45.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.352 0.661 . . . . 1.3500000000000001 111.17 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.55 127.32 42.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 2.1499999999999999 111.246 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 144' ' ' LEU . 2.3 mp -124.78 158.54 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.697 -0.483 . . . . 1.1599999999999999 109.697 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -97.58 155.39 16.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.326 -0.99 . . . . 2.1099999999999999 108.326 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 47.4 m-85 -136.36 121.83 19.45 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.233 -0.654 . . . . 0.96999999999999997 109.233 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.859 ' HG3' ' HG2' ' A' ' 139' ' ' LYS . 7.9 tt0 -113.08 132.66 55.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.128 -0.323 . . . . 0.80000000000000004 110.128 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.739 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 15.8 tp -102.07 128.83 48.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.219 -0.446 . . . . 1.9199999999999999 110.053 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.669 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.18 99.55 8.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.976 -1.12 . . . . 0.63 107.976 168.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.593 HD13 HG23 ' A' ' 60' ' ' ILE . 5.4 tp -113.17 117.79 56.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.321 0.582 . . . . 1.49 111.099 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 120.62 5.27 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.104 -0.798 . . . . 0.26000000000000001 111.104 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 25' ' ' SER . 5.2 mp -97.76 98.55 9.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.123 0.487 . . . . 1.77 111.164 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.109 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.2 m -100.11 121.14 40.95 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.384 -0.969 . . . . 1.0700000000000001 108.384 169.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.7 HG22 ' SG ' ' A' ' 58' ' ' CYS . 11.0 pt -133.68 132.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.538 -0.465 . . . . 1.6699999999999999 110.355 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.26 107.03 11.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.194 -1.039 . . . . 1.52 108.194 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.554 HD23 HG22 ' A' ' 55' ' ' ILE . 11.1 mt -115.73 160.83 33.42 Favored Pre-proline 0 C--O 1.219 -0.522 0 O-C-N 124.715 1.26 . . . . 1.9299999999999999 110.769 -169.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.75 -23.8 16.32 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.89 1.727 . . . . 0.98999999999999999 112.152 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -57.59 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.259 -0.428 . . . . 1.6699999999999999 112.093 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.544 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -109.17 1.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.033 0.921 . . . . 1.9099999999999999 109.897 -175.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.79 -32.49 0.88 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.09 -1.414 . . . . 1.05 111.682 -171.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -175.75 146.29 0.73 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.456 -1.312 . . . . 1.1599999999999999 107.456 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 123' ' ' THR . 14.6 t80 -150.82 146.32 26.29 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.422 -0.511 . . . . 2.2799999999999998 110.004 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 37.4 m -121.27 110.39 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.913 0.387 . . . . 1.8899999999999999 111.221 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.15 133.9 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 1.26 109.355 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 38.3 Cg_endo -91.54 162.29 3.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.873 1.715 . . . . 0.58999999999999997 113.28 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.448 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.17 167.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.245 -1.02 . . . . 1.1399999999999999 108.245 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.727 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -137.81 150.4 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.662 -0.125 . . . . 1.28 110.662 -167.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.7 t -148.6 102.38 3.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.623 -0.51 . . . . 1.3400000000000001 109.623 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.859 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -99.11 144.5 28.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.847 -0.615 . . . . 2.2000000000000002 110.936 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.37 130.42 3.07 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.478 -0.649 . . . . 0.56000000000000005 111.478 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -98.9 125.29 44.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.662 -0.496 . . . . 2.1000000000000001 109.662 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 172.68 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.841 -1.17 . . . . 1.51 107.841 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -67.23 141.29 57.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.883 -0.414 . . . . 3.9300000000000002 109.883 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.733 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.2 pp -60.35 163.83 7.87 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.366 -0.379 . . . . 1.9299999999999999 111.505 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 144' ' ' LEU . 15.9 Cg_endo . . . . . 0 C--N 1.353 0.808 0 C-N-CA 123.504 2.803 . . . . 0.81000000000000005 113.804 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.549 0 N-CA-C 115.881 1.113 . . . . 1.0700000000000001 115.881 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' HG13 ' A' ' 45' ' ' VAL . 93.2 p -166.57 36.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.776 -1.564 . . . . 1.7 106.776 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 46' ' ' SER . 13.4 m -134.52 154.03 36.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.646 -1.615 . . . . 1.53 109.237 -169.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 2.4 t -175.12 -50.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.245 0.461 . . . . 1.05 112.245 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 16.3 t70 -152.19 157.13 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.912 -0.493 . . . . 1.6899999999999999 111.36 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 75.1 t -147.33 124.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.379 -0.373 . . . . 1.8500000000000001 110.719 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -107.13 142.03 37.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 1.8300000000000001 110.454 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 32' ' ' LYS . 3.0 tm? -97.85 141.04 31.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.34 -0.615 . . . . 1.46 109.34 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.728 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -135.45 -115.21 0.19 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 114.366 1.247 . . . . 1.9199999999999999 114.366 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 11.7 m-20 . . . . . 0 C--O 1.203 -1.368 0 O-C-N 121.653 -0.654 . . . . 2.8500000000000001 111.823 -156.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 N--CA 1.441 -0.897 0 CA-C-O 121.15 0.5 . . . . 1.1299999999999999 110.556 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.639 HG21 HD12 ' A' ' 101' ' ' LEU . 41.8 t -87.64 155.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.606 -0.725 . . . . 1.48 109.495 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.952 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 70.6 mt-10 -118.94 151.12 38.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 122.004 -0.435 . . . . 1.1899999999999999 110.457 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.897 ' HE2' ' HB3' ' A' ' 43' ' ' ALA . 24.3 p90 -136.89 131.55 33.3 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.122 -0.631 . . . . 3.9399999999999999 111.833 171.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.32 112.43 20.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.799 -0.815 . . . . 1.4299999999999999 108.799 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.897 ' HB3' ' HE2' ' A' ' 41' ' ' TYR . . . -95.32 115.8 27.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.249 0.547 . . . . 1.1100000000000001 110.936 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 10.8 tppt? -88.39 123.52 33.03 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.518 -0.919 . . . . 3.1800000000000002 108.518 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 25' ' ' SER . 30.9 t -110.5 140.74 28.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.711 -0.677 . . . . 1.3999999999999999 110.544 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 1.6 m -129.15 99.32 5.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.25 0.547 . . . . 1.1100000000000001 110.165 170.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -82.61 125.88 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.308 -0.86 . . . . 1.8500000000000001 110.483 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.729 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.8 m -108.11 113.97 27.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.465 -0.569 . . . . 1.1000000000000001 109.465 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.852 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 p30 -89.76 150.53 44.17 Favored Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 108.132 -1.062 . . . . 1.48 108.132 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.71 -9.34 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.072 2.515 . . . . 0.91000000000000003 114.48 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.707 ' HE1' HG21 ' A' ' 128' ' ' VAL . 14.2 t80 -89.17 -20.27 24.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.88 -0.728 . . . . 2.3100000000000001 112.195 -155.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.653 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 24.0 t 84.16 13.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.987 0.804 . . . . 1.8300000000000001 109.237 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -139.65 130.0 25.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.77 . . . . 2.0299999999999998 109.382 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 14.7 m -41.89 96.7 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 O-C-N 124.102 0.876 . . . . 1.73 112.928 173.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.958 HG22 HD21 ' A' ' 126' ' ' LEU . 6.0 pt -74.75 171.46 11.48 Favored Pre-proline 0 C--O 1.212 -0.889 0 N-CA-C 108.261 -1.015 . . . . 1.23 108.261 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 12.4 Cg_endo -88.91 -59.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.067 1.178 . . . . 0.53000000000000003 113.993 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.736 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 5.9 mt -138.68 162.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.951 -0.7 . . . . 1.9099999999999999 112.125 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.692 ' HB3' HG21 ' A' ' 124' ' ' ILE . 22.0 p -146.72 177.13 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.251 1.024 . . . . 1.95 111.7 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.112 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 31.8 tt0 -126.4 116.18 20.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.286 -1.779 . . . . 1.3600000000000001 109.723 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -98.88 109.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.204 1.002 . . . . 1.6499999999999999 109.975 172.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 5.8 m -112.44 102.89 10.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.597 -1.638 . . . . 1.02 108.465 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 p90 -112.87 127.37 56.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.456 0.646 . . . . 0.46000000000000002 109.82 -169.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 16.4 m -123.28 106.5 10.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.483 -1.235 . . . . 1.1699999999999999 108.289 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.757 ' CZ ' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.34 135.18 39.61 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.646 -0.421 . . . . 1.1799999999999999 110.514 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 2.2 m170 -123.05 144.76 49.07 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.034 -1.469 . . . . 1.72 107.034 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.969 ' HB3' HD22 ' A' ' 104' ' ' LEU . 46.4 t -106.78 -97.53 0.35 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.223 -0.991 . . . . 1.6599999999999999 110.919 174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.2 -58.79 6.9 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.212 -0.662 . . . . 1.1200000000000001 109.212 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 22.41 0.13 Allowed Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.613 -1.395 . . . . 0.39000000000000001 109.613 164.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.2 ptp180 -122.37 -172.57 2.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.643 -0.503 . . . . 2.4900000000000002 109.643 -175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -100.46 87.19 3.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.716 0.77 . . . . 2.6099999999999999 111.46 -161.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.647 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.8 mm -53.74 -45.15 61.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.598 -1.183 . . . . 1.1100000000000001 112.117 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.91 163.62 30.82 Favored Glycine 0 C--O 1.22 -0.74 0 C-N-CA 120.23 -0.986 . . . . 0.48999999999999999 111.383 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.691 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -163.07 157.59 20.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.886 0.843 . . . . 2.3999999999999999 111.871 -177.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.61 28.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.825 -0.51 . . . . 0.52000000000000002 111.825 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 37.9 mttm -127.3 127.11 43.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.902 -0.407 . . . . 2.3799999999999999 109.902 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.463 ' HB ' HD12 ' A' ' 60' ' ' ILE . 78.4 mt -139.95 124.9 11.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 120.695 0.283 . . . . 1.47 110.55 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.54 116.32 4.64 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.431 2.087 . . . . 0.81000000000000005 110.801 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.476 ' HB2' HD13 ' A' ' 60' ' ' ILE . 10.8 t70 -123.08 141.1 34.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.487 -0.56 . . . . 0.79000000000000004 109.487 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.7 89.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.719 2.28 . . . . 0.91000000000000003 112.337 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.736 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -82.69 28.43 3.53 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.47999999999999998 113.102 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.957 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.9 p -74.91 122.88 24.11 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.985 -0.376 . . . . 0.85999999999999999 109.985 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.8 pt? -153.41 -167.19 2.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 118.317 -1.353 . . . . 1.76 114.059 -165.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 84' ' ' ALA . 87.5 mttt -52.57 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.545 0.943 . . . . 2.4300000000000002 113.545 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . -178.08 105.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.636 -0.876 . . . . 1.29 108.636 -174.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.852 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.7 pttt 36.91 62.97 0.73 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.104 0.877 . . . . 2.21 111.185 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 48' ' ' THR . 5.7 t70 -157.51 -179.3 8.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.789 -1.096 . . . . 0.64000000000000001 109.015 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.574 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 40.6 ttm -108.73 120.12 41.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.072 -0.513 . . . . 2.04 110.597 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 46' ' ' SER . 6.0 t -105.76 143.68 33.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.621 -0.718 . . . . 1.3300000000000001 109.917 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.93 26.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.463 0.649 . . . . 1.1100000000000001 110.708 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG12 ' A' ' 45' ' ' VAL . 5.6 tt -116.0 164.58 14.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.982 -1.008 . . . . 1.45 108.985 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.32 132.9 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 1.8100000000000001 110.951 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.65 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 21.7 mm -118.95 140.82 29.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 1.3999999999999999 111.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.94 -169.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.059 3.173 . . . . 1.0700000000000001 113.626 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.952 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 18.0 m -126.8 91.01 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.885 -0.598 . . . . 1.1799999999999999 112.417 -163.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 41' ' ' TYR . 4.9 p -125.29 104.45 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.885 1.439 . . . . 1.1699999999999999 114.885 -163.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.487 HG11 ' HG ' ' A' ' 101' ' ' LEU . 4.8 t -145.79 109.07 4.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.088 -0.382 . . . . 1.71 110.775 170.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.1 Cg_exo -56.87 129.24 33.48 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 120.711 0.94 . . . . 0.65000000000000002 110.55 169.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.55 ' HE1' ' HD2' ' A' ' 102' ' ' PHE . 11.8 t80 -53.59 -32.16 49.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.261 -0.427 . . . . 1.6899999999999999 110.631 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.578 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 2.0 m -57.45 -30.73 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 1.49 112.041 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.647 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -76.05 -55.44 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 1.21 110.52 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 104' ' ' LEU . 42.3 mt -53.49 -27.17 23.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.524 -0.762 . . . . 1.6399999999999999 110.952 172.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 99' ' ' SER . 34.8 t80 -60.77 -46.42 90.54 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.595 -1.184 . . . . 1.2 108.786 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.587 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 30.3 m-80 -73.44 -56.05 5.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.81999999999999995 112.217 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.969 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.9 pp -59.85 -46.68 88.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.46 0.911 . . . . 1.22 113.46 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -61.71 -24.06 66.53 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.918 0.866 . . . . 1.1899999999999999 110.104 178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.587 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.7 ttp180 -68.61 -49.16 61.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.896 -1.047 . . . . 2.2200000000000002 110.82 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.645 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -81.85 -54.82 5.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.122 0.963 . . . . 0.80000000000000004 112.213 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.917 ' HB ' HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -88.72 -20.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 121.348 -0.845 . . . . 1.5 109.883 -176.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.05 -19.93 79.62 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.077 -1.058 . . . . 0.38 110.93 167.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -50.55 -45.86 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.7 -1.222 . . . . 1.6599999999999999 107.7 167.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 4.6 p-10 -81.16 -84.36 0.1 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.026 -1.07 . . . . 1.8700000000000001 110.929 163.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.415 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 5.0 p-90 178.1 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.604 0.638 . . . . 1.3500000000000001 112.665 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.35 121.95 37.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.691 -0.231 . . . . 2.1499999999999999 111.568 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.917 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.4 mp -113.19 154.81 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.447 -0.575 . . . . 1.1599999999999999 109.447 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -100.4 153.53 19.26 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.62 -0.718 . . . . 2.1099999999999999 109.198 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -135.45 151.5 50.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.683 -1.229 . . . . 0.96999999999999997 107.683 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.794 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 38.3 tt0 -146.07 126.63 14.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 110.032 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.757 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 15.0 tp -97.34 137.13 36.81 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.169 0.509 . . . . 1.9199999999999999 110.692 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.687 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -115.84 100.52 8.07 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.344 -0.984 . . . . 0.63 108.344 170.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.811 HD11 HG22 ' A' ' 60' ' ' ILE . 4.6 tp -114.01 118.9 59.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.218 0.533 . . . . 1.49 111.091 -173.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.14 124.18 6.91 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.544 -0.622 . . . . 0.26000000000000001 111.544 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.584 HD13 ' OG ' ' A' ' 25' ' ' SER . 5.5 mp -104.03 100.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.035 0.445 . . . . 1.77 111.108 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.112 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 99.9 m -102.62 96.6 6.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.223 -0.899 . . . . 1.0700000000000001 108.826 172.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.692 HG21 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.94 133.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.528 -0.469 . . . . 1.6699999999999999 110.717 -175.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 1.0 OUTLIER -75.22 105.67 6.36 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.93 -0.767 . . . . 1.52 108.93 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.958 HD21 HG22 ' A' ' 55' ' ' ILE . 19.2 mt -120.2 143.05 34.82 Favored Pre-proline 0 C--O 1.216 -0.675 0 O-C-N 124.706 1.254 . . . . 1.9299999999999999 109.925 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.424 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 78.0 Cg_exo -53.14 -37.47 79.75 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.905 2.403 . . . . 0.98999999999999999 115.361 -171.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.707 HG21 ' HE1' ' A' ' 51' ' ' TYR . 97.7 t -73.64 -56.93 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.747 -0.596 . . . . 1.6699999999999999 112.496 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.668 HG12 ' HB2' ' A' ' 132' ' ' PHE . 14.9 p -92.16 -7.97 10.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 122.32 1.057 . . . . 1.9099999999999999 109.868 -175.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.27 -36.78 2.39 Favored Glycine 0 N--CA 1.462 0.43 0 CA-C-N 114.18 -1.373 . . . . 1.05 112.078 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.5 pt-20 -165.84 122.3 1.36 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.544 -1.28 . . . . 1.1599999999999999 107.544 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.668 ' HB2' HG12 ' A' ' 129' ' ' VAL . 7.9 t80 -111.98 143.28 43.23 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.241 -0.584 . . . . 2.2799999999999998 109.801 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 64.7 m -123.75 102.43 7.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.846 -0.615 . . . . 1.8899999999999999 111.524 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.53 139.19 34.06 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.728 -0.669 . . . . 1.26 110.096 173.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.16 162.26 3.8 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.58999999999999997 112.557 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.448 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -161.5 167.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.29 -1.004 . . . . 1.1399999999999999 108.29 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -137.1 148.78 46.92 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.952 -0.299 . . . . 1.28 110.794 -170.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 t -140.39 107.83 5.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.445 -0.946 . . . . 1.3400000000000001 108.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.794 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.74 143.93 43.81 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.865 -0.334 . . . . 2.2000000000000002 110.789 -175.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.73 132.62 3.75 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.812 -0.915 . . . . 0.56000000000000005 110.812 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 9.3 mt-10 -97.55 126.31 42.76 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.926 -0.768 . . . . 2.1000000000000001 108.926 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.03 173.3 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.173 -0.677 . . . . 1.51 109.173 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 168.22 7.76 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.747 0.647 . . . . 3.9300000000000002 112.747 -173.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.878 HD12 ' HD2' ' A' ' 145' ' ' PRO . 22.9 tp -56.21 130.48 74.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.033 -0.985 . . . . 1.9299999999999999 112.324 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.878 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.8 Cg_endo . . . . . 0 C--N 1.354 0.849 0 C-N-CA 124.24 3.293 . . . . 0.81000000000000005 112.93 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.422 -2.294 0 CA-C-O 119.788 -0.451 . . . . 1.0700000000000001 112.701 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB2' HD21 ' A' ' 122' ' ' LEU . 4.9 m -172.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.829 0.851 . . . . 1.7 109.62 167.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 46' ' ' SER . 7.4 p -134.25 147.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.56 -0.746 . . . . 1.53 110.926 -174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -166.11 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 1.05 110.899 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 33.3 t70 -167.09 164.78 15.83 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.365 -0.235 . . . . 1.6899999999999999 110.365 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG22 ' HZ ' ' A' ' 64' ' ' PHE . 69.0 t -142.91 120.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.992 -0.373 . . . . 1.8500000000000001 109.992 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 9.7 m-20 -92.4 109.86 21.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.8300000000000001 110.648 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.394 -0.595 . . . . 1.46 109.394 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -124.58 -125.95 0.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.195 -0.457 . . . . 1.9199999999999999 109.962 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.93 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 p30 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 121.13 0.491 . . . . 2.8500000000000001 112.1 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.65 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 39.4 t . . . . . 0 C--O 1.212 -0.877 0 N-CA-C 107.132 -1.433 . . . . 1.1299999999999999 107.132 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.985 HG22 HG11 ' A' ' 96' ' ' VAL . 20.4 m -128.69 178.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.377 0.99 . . . . 1.48 111.476 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.945 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 84.4 mt-10 -125.25 151.68 45.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.815 -0.63 . . . . 1.1899999999999999 111.431 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.889 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 13.5 p90 -136.46 123.42 21.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.897 -0.721 . . . . 3.9399999999999999 110.197 165.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.432 ' N ' HG11 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -86.68 110.82 20.13 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.528 -0.915 . . . . 1.4299999999999999 108.528 174.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.758 ' HB1' ' HE1' ' A' ' 41' ' ' TYR . . . -91.09 115.59 28.13 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.816 0.817 . . . . 1.1100000000000001 110.211 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 20.8 ttmt -84.72 117.72 23.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.252 -1.34 . . . . 3.1800000000000002 108.432 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.734 HG23 HG12 ' A' ' 92' ' ' ILE . 39.5 t -111.57 144.9 18.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.435 0.636 . . . . 1.3999999999999999 111.841 -169.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.643 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 24.7 m -133.57 97.5 3.95 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.22 -0.9 . . . . 1.1100000000000001 108.735 163.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -85.95 132.16 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.61 0.719 . . . . 1.8500000000000001 110.893 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -111.33 115.53 29.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.718 -1.128 . . . . 1.1000000000000001 110.032 -174.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.9 t30 -91.53 132.77 32.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.717 1.26 . . . . 1.48 108.409 174.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -89.04 3.31 5.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.129 2.553 . . . . 0.91000000000000003 114.147 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 91.7 t80 -108.33 133.1 53.01 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.152 -0.684 . . . . 2.3100000000000001 109.152 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.807 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 23.8 p -77.08 30.27 0.14 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.496 0.924 . . . . 1.8300000000000001 113.496 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 62.2 m80 -146.15 142.81 28.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 2.0299999999999998 108.597 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -41.01 105.75 0.05 OUTLIER 'General case' 0 C--O 1.208 -1.125 0 O-C-N 123.886 0.741 . . . . 1.73 112.151 171.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.945 ' O ' ' HA ' ' A' ' 81' ' ' SER . 8.4 pt -75.63 171.32 12.26 Favored Pre-proline 0 C--O 1.209 -1.076 0 N-CA-C 107.463 -1.31 . . . . 1.23 107.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.426 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 10.2 Cg_endo -89.46 -62.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 120.301 1.143 . . . . 0.53000000000000003 113.781 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.664 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.4 mm -130.3 154.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.401 -0.52 . . . . 1.9099999999999999 110.919 -167.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.716 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 4.0 m -146.1 -176.52 5.19 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.977 0.894 . . . . 1.95 110.988 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.954 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 43.1 tt0 -138.47 118.14 13.09 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.96 -1.473 . . . . 1.3600000000000001 111.068 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.63 108.22 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.255 1.026 . . . . 1.6499999999999999 109.54 166.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 15.5 p -113.61 102.62 10.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 113.826 -1.533 . . . . 1.02 108.413 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -112.74 126.89 55.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.488 0.661 . . . . 0.46000000000000002 110.012 -165.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 20.9 m -120.86 104.25 9.71 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.83 -1.077 . . . . 1.1699999999999999 108.392 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.806 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.3 130.06 44.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.444 0.64 . . . . 1.1799999999999999 110.809 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -121.1 145.1 48.16 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 107.104 -1.443 . . . . 1.72 107.104 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.786 ' CB ' HD21 ' A' ' 104' ' ' LEU . 33.8 t -101.97 -102.72 0.27 Allowed 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.079 -1.049 . . . . 1.6599999999999999 110.891 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.66 -54.32 47.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.048 -0.723 . . . . 1.1200000000000001 109.048 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.19 17.9 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.093 -1.603 . . . . 0.39000000000000001 109.093 166.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.547 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 5.9 ptp180 -106.08 -147.51 0.4 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.859 -0.67 . . . . 2.4900000000000002 109.561 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -123.82 99.1 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.19 0.45 . . . . 2.6099999999999999 110.349 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.724 ' HA ' HG22 ' A' ' 100' ' ' ILE . 5.5 mm -70.89 -38.95 74.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.544 -0.753 . . . . 1.1100000000000001 110.231 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.49 171.69 32.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.572 -0.823 . . . . 0.48999999999999999 111.846 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -159.42 154.7 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.091 0.446 . . . . 2.3999999999999999 110.367 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.53 155.56 13.6 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.433 -0.667 . . . . 0.52000000000000002 111.433 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 17.3 ptpt -131.38 134.77 46.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.967 0.413 . . . . 2.3799999999999999 110.703 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -140.01 122.67 10.11 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.866 -0.606 . . . . 1.47 109.939 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.94 108.32 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.204 1.936 . . . . 0.81000000000000005 111.033 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -114.92 141.74 27.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.549 -0.537 . . . . 0.79000000000000004 109.549 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.664 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.8 Cg_endo -60.62 87.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.577 2.185 . . . . 0.91000000000000003 112.407 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.716 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -88.7 33.99 4.01 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.47999999999999998 111.905 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.945 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -71.01 118.29 13.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.681 -0.859 . . . . 0.85999999999999999 108.681 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.752 HD23 HD21 ' A' ' 49' ' ' ASN . 1.4 pt? -148.11 -159.98 1.11 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.07 -1.452 . . . . 1.76 114.73 -158.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.498 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 56.2 mttm -52.57 -92.05 0.0 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.131 -0.94 . . . . 2.4300000000000002 112.778 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 167.02 105.76 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.638 -1.245 . . . . 1.29 107.638 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.807 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.0 pttt 41.37 49.47 3.43 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.363 1.039 . . . . 2.21 111.034 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.17 -172.34 3.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.064 -0.971 . . . . 0.64000000000000001 109.757 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.643 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.7 ttm -113.28 118.15 33.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.886 0.374 . . . . 2.04 110.801 -171.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.577 ' CG2' HG13 ' A' ' 47' ' ' VAL . 7.1 t -107.35 143.43 35.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.489 . . . . 1.3300000000000001 110.19 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.54 136.66 36.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.333 0.587 . . . . 1.1100000000000001 109.59 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.718 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 4.2 tt -133.53 170.48 15.45 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.322 -0.992 . . . . 1.45 108.322 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 t70 -135.2 123.5 23.14 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.012 -0.275 . . . . 1.8100000000000001 110.647 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -105.18 138.15 19.45 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.616 0.246 . . . . 1.3999999999999999 110.997 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.401 ' HD2' HG21 ' A' ' 92' ' ' ILE . 72.4 Cg_exo -50.79 168.25 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.543 2.829 . . . . 1.0700000000000001 112.606 174.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.945 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 4.5 m -110.58 88.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.774 -0.648 . . . . 1.1799999999999999 111.364 -166.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.53 HG13 ' HE2' ' A' ' 41' ' ' TYR . 4.1 p -128.46 101.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 114.726 1.38 . . . . 1.1699999999999999 114.726 -165.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.985 HG11 HG22 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.3 115.65 3.96 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 119.882 -0.727 . . . . 1.71 110.208 162.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.1 128.52 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.439 1.426 . . . . 0.65000000000000002 109.746 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.65 ' H ' ' HA ' ' A' ' 38' ' ' SER . 20.5 t80 -57.03 -28.1 62.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.03 0.443 . . . . 1.6899999999999999 110.112 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -52.44 -30.51 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.563 -0.744 . . . . 1.49 111.892 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.724 HG22 ' HA ' ' A' ' 71' ' ' ILE . 28.1 mm -78.2 -54.12 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.409 -0.359 . . . . 1.21 111.209 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 104' ' ' LEU . 22.8 mt -50.44 -27.96 7.39 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.572 0.701 . . . . 1.6399999999999999 110.218 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 16.7 t80 -68.99 -40.73 78.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.661 -1.609 . . . . 1.2 108.506 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 18.6 m-80 -74.42 -56.51 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.816 -0.629 . . . . 0.81999999999999995 112.365 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 101' ' ' LEU . 1.1 pp -56.7 -56.35 22.5 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.992 0.738 . . . . 1.22 112.992 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.502 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.34 -21.99 66.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.886 0.85 . . . . 1.1899999999999999 110.149 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.646 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -61.03 -53.99 50.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.481 -1.236 . . . . 2.2200000000000002 110.147 173.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.2 t70 -85.4 -52.16 6.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.189 0.995 . . . . 0.80000000000000004 111.723 -171.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.985 HG22 HG22 ' A' ' 114' ' ' ILE . 34.3 m -80.03 -31.08 13.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.586 -0.696 . . . . 1.5 110.706 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.03 -16.54 80.67 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.087 -0.961 . . . . 0.38 111.616 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.71 -42.53 13.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.456 -1.683 . . . . 1.6599999999999999 106.456 161.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 42.0 m-20 -75.74 -86.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.57 -0.741 . . . . 1.8700000000000001 110.298 159.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 144' ' ' LEU . 17.0 p-90 176.73 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.743 0.417 . . . . 1.3500000000000001 111.629 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.3 133.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.359 0.599 . . . . 2.1499999999999999 111.511 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.985 HG22 HG22 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -117.95 149.66 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.603 -0.726 . . . . 1.1599999999999999 109.604 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 10.1 p-10 -104.79 154.98 19.31 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.457 -0.942 . . . . 2.1099999999999999 108.457 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 48.1 m-85 -134.61 156.98 47.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.526 -0.916 . . . . 0.96999999999999997 108.526 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.542 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 31.5 tt0 -143.56 129.46 19.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.607 -0.516 . . . . 0.80000000000000004 109.607 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.806 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -103.79 133.99 47.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.769 -0.65 . . . . 1.9199999999999999 109.46 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.735 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.7 100.73 8.01 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.02 -0.733 . . . . 0.63 109.02 172.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.574 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.1 tp -110.23 117.58 55.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.305 0.574 . . . . 1.49 110.706 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.65 124.51 7.28 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.0 -0.84 . . . . 0.26000000000000001 111.0 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 25' ' ' SER . 2.9 mm? -101.1 98.23 8.69 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.529 0.68 . . . . 1.77 111.961 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 0.954 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 96.5 m -95.83 94.78 7.85 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.32 -1.309 . . . . 1.0700000000000001 108.954 169.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.819 HG13 HD23 ' A' ' 126' ' ' LEU . 9.7 pt -107.38 141.63 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 120.414 -0.514 . . . . 1.6699999999999999 109.646 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.55 106.12 18.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 1.52 109.688 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 124' ' ' ILE . 1.5 mm? -103.13 141.62 22.86 Favored Pre-proline 0 C--O 1.213 -0.82 0 O-C-N 124.344 1.028 . . . . 1.9299999999999999 109.586 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.615 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 52.5 Cg_exo -57.9 -24.98 67.47 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.082 1.855 . . . . 0.98999999999999999 113.988 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.82 -58.13 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.984 0.421 . . . . 1.6699999999999999 111.844 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.79 0.67 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.078 0.942 . . . . 1.9099999999999999 110.789 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.33 -39.45 2.9 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 113.86 -1.518 . . . . 1.05 111.41 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 9.6 pt-20 -167.41 155.44 9.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 1.1599999999999999 109.285 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.47 142.11 31.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.229 -0.656 . . . . 2.2799999999999998 109.229 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.7 m -122.66 107.94 12.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.904 0.383 . . . . 1.8899999999999999 111.777 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.0 141.25 40.59 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.26 110.006 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.6 Cg_endo -92.42 165.66 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.07 1.847 . . . . 0.58999999999999997 112.872 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -159.03 158.2 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.712 -1.218 . . . . 1.1399999999999999 107.712 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 76.5 p -131.97 152.41 51.13 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.471 -0.492 . . . . 1.28 111.898 -170.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -139.46 110.73 6.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.835 -0.802 . . . . 1.3400000000000001 108.835 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.542 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.19 140.92 47.53 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.835 -0.346 . . . . 2.2000000000000002 110.548 -179.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.49 139.16 6.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.868 -0.682 . . . . 0.56000000000000005 111.971 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 27.9 mt-10 -99.12 129.39 45.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 2.1000000000000001 109.739 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.437 HD11 ' CE1' ' A' ' 116' ' ' TYR . 2.0 pp -139.54 173.59 10.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.638 -0.504 . . . . 1.51 109.638 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -65.59 172.29 3.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.897 0.703 . . . . 3.9300000000000002 112.897 -171.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.646 HD21 ' HD2' ' A' ' 145' ' ' PRO . 1.7 tm? -61.64 126.59 87.17 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.924 -1.034 . . . . 1.9299999999999999 109.84 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.646 ' HD2' HD21 ' A' ' 144' ' ' LEU . 72.5 Cg_endo . . . . . 0 C--N 1.349 0.57 0 C-N-CA 123.608 2.872 . . . . 0.81000000000000005 113.198 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.434 -1.491 0 N-CA-C 113.798 0.279 . . . . 1.0700000000000001 113.798 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB2' HD12 ' A' ' 122' ' ' LEU . 37.7 m -169.47 34.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.642 -1.244 . . . . 1.7 107.642 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 46' ' ' SER . 32.7 m -134.04 155.33 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.347 -1.297 . . . . 1.53 109.786 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -165.15 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.57 -0.53 . . . . 1.05 109.57 166.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' HD2' ' A' ' 44' ' ' LYS . 4.8 p-10 -167.99 163.0 13.63 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.523 0.677 . . . . 1.6899999999999999 112.652 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.17 132.98 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.821 -1.082 . . . . 1.8500000000000001 109.266 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.64 138.26 53.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.484 -0.326 . . . . 1.8300000000000001 110.796 -173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.488 HD21 ' CG1' ' A' ' 39' ' ' VAL . 3.2 tm? -94.82 138.96 31.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.789 -0.187 . . . . 1.46 111.095 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.698 ' HE3' ' HB2' ' A' ' 42' ' ' LEU . 6.4 ptpt -145.15 -92.53 0.1 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 114.167 1.173 . . . . 1.9199999999999999 114.167 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.204 -1.304 0 O-C-N 121.308 -0.87 . . . . 2.8500000000000001 111.262 -155.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.628 0.727 . . . . 1.1299999999999999 112.579 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.96 HG23 HD12 ' A' ' 101' ' ' LEU . 26.7 t -79.1 155.13 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.967 -1.015 . . . . 1.48 109.216 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 27.4 mt-10 -117.62 131.59 56.63 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.002 -1.079 . . . . 1.1899999999999999 111.867 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.838 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.84 104.97 11.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.137 -0.938 . . . . 3.9399999999999999 110.513 -176.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.698 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -72.47 109.85 6.45 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.919 -1.141 . . . . 1.4299999999999999 107.919 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.572 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -103.99 107.64 18.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.713 0.768 . . . . 1.1100000000000001 110.144 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 13.0 ttmt -83.47 126.14 32.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.88 -1.156 . . . . 3.1800000000000002 107.88 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 90' ' ' LEU . 43.1 t -111.4 141.52 26.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.705 -0.68 . . . . 1.3999999999999999 109.929 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 29.8 m -128.82 99.25 5.24 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.289 -0.564 . . . . 1.1100000000000001 110.225 171.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -81.61 122.82 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 115.63 -0.714 . . . . 1.8500000000000001 109.748 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.644 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 18.9 m -101.43 116.55 33.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.639 -0.709 . . . . 1.1000000000000001 110.168 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.772 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 15.7 t30 -90.26 126.16 57.7 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.127 -0.694 . . . . 1.48 109.127 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -91.84 15.14 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.248 2.632 . . . . 0.91000000000000003 113.832 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -131.5 146.73 52.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.514 -0.921 . . . . 2.3100000000000001 108.514 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.738 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.7 t -80.96 34.47 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.937 0.399 . . . . 1.8300000000000001 111.722 -169.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -145.31 133.01 21.0 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.654 -0.248 . . . . 2.0299999999999998 110.803 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -45.37 100.83 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 124.448 1.099 . . . . 1.73 113.022 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.846 HG22 HD22 ' A' ' 126' ' ' LEU . 5.8 pt -77.34 128.32 80.76 Favored Pre-proline 0 C--O 1.207 -1.182 0 N-CA-C 109.222 -0.659 . . . . 1.23 109.222 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.5 Cg_endo -60.88 -51.97 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.968 1.779 . . . . 0.53000000000000003 113.691 -160.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.788 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 73.9 mt -138.27 157.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 1.9099999999999999 112.853 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.798 ' HB3' HG21 ' A' ' 124' ' ' ILE . 25.6 p -139.92 168.17 20.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.565 1.174 . . . . 1.95 112.245 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.101 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.9 tt0 -120.43 119.37 32.84 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 112.854 -1.976 . . . . 1.3600000000000001 110.18 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 22.2 mm -94.8 110.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.652 -1.158 . . . . 1.6499999999999999 110.336 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 64.8 p -121.22 102.4 8.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.99 -0.744 . . . . 1.02 108.99 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.606 ' HD1' HG21 ' A' ' 60' ' ' ILE . 17.0 p90 -106.9 135.18 48.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.531 0.681 . . . . 0.46000000000000002 110.242 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.0 m -130.75 105.85 8.07 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.47 -1.241 . . . . 1.1699999999999999 108.726 174.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.505 ' CE1' HD23 ' A' ' 118' ' ' LEU . 96.6 m-85 -96.41 140.75 30.61 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.493 -0.558 . . . . 1.1799999999999999 109.493 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.463 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.3 m170 -127.15 144.43 51.04 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.453 -0.943 . . . . 1.72 108.453 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.533 ' HB3' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.29 -109.84 0.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 116.531 -0.304 . . . . 1.6599999999999999 111.457 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB1' ' NH1' ' A' ' 69' ' ' ARG . . . -64.04 -54.3 36.37 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.643 -0.873 . . . . 1.1200000000000001 108.643 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.3 16.12 0.17 Allowed Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 108.466 -1.853 . . . . 0.39000000000000001 108.466 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -111.98 -171.12 1.78 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.341 -0.985 . . . . 2.4900000000000002 108.341 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.88 90.9 3.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.174 0.512 . . . . 2.6099999999999999 111.16 -164.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.961 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.9 mm -47.88 -42.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.987 -1.006 . . . . 1.1100000000000001 111.867 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.12 167.59 39.34 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 119.859 -1.162 . . . . 0.48999999999999999 111.542 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.81 153.89 9.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.355 0.598 . . . . 2.3999999999999999 111.343 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.09 -179.06 41.5 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.869 -0.892 . . . . 0.52000000000000002 110.869 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.71 132.87 26.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.952 0.376 . . . . 2.3799999999999999 111.34 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 79.1 mt -130.87 109.16 15.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.963 -0.562 . . . . 1.47 109.877 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.8 128.27 14.86 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.317 2.011 . . . . 0.81000000000000005 110.401 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -138.96 144.76 42.6 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.758 -0.377 . . . . 0.79000000000000004 110.128 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.2 Cg_exo -57.24 90.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.578 2.185 . . . . 0.91000000000000003 111.571 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.788 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -75.7 13.68 6.5 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.176 -0.92 . . . . 0.47999999999999998 113.557 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.737 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 94.3 p -69.69 118.04 12.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.496 -0.557 . . . . 0.85999999999999999 109.496 -176.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.628 HD23 ' HB2' ' A' ' 49' ' ' ASN . 1.5 pt? -143.83 -167.16 2.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 119.931 -0.708 . . . . 1.76 112.631 -163.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 86' ' ' ASP . 92.4 mttt -45.49 -93.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.083 0.771 . . . . 2.4300000000000002 113.083 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 163.37 107.18 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.307 -0.997 . . . . 1.29 108.307 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptmt 45.43 47.65 10.81 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.218 0.948 . . . . 2.21 111.159 -176.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 5.3 t70 -150.39 -170.03 3.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.226 -0.897 . . . . 0.64000000000000001 109.514 -173.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.6 ttp -119.2 119.39 33.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.986 0.422 . . . . 2.04 110.874 -171.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.8 t -107.3 144.74 33.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.857 -0.611 . . . . 1.3300000000000001 110.501 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.52 112.5 23.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.515 0.674 . . . . 1.1100000000000001 110.887 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 45' ' ' VAL . 4.6 tt -102.72 166.28 10.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.142 -0.936 . . . . 1.45 109.03 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.459 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 22.1 t70 -128.93 117.74 21.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.419 -0.512 . . . . 1.8100000000000001 112.295 -170.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 47.6 mm -110.84 122.72 37.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.738 -0.838 . . . . 1.3999999999999999 108.738 171.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.645 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 84.6 Cg_exo -46.7 -98.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.922 3.081 . . . . 1.0700000000000001 114.874 -171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -162.4 94.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 112.124 0.416 . . . . 1.1799999999999999 112.124 -169.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.442 HG11 ' CE2' ' A' ' 62' ' ' PHE . 7.4 p -127.52 103.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.138 1.162 . . . . 1.1699999999999999 114.138 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.644 HG11 ' HB ' ' A' ' 39' ' ' VAL . 2.1 p -152.36 98.15 2.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 1.71 110.768 162.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 64.8 Cg_exo -51.4 135.89 47.29 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.924 1.749 . . . . 0.65000000000000002 112.12 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.444 ' HA ' HG21 ' A' ' 39' ' ' VAL . 4.7 t80 -55.56 -30.91 61.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.404 -0.817 . . . . 1.6899999999999999 111.094 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.574 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 50.6 m -56.51 -33.75 66.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.39 0.515 . . . . 1.49 112.39 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.961 HG22 ' HA ' ' A' ' 71' ' ' ILE . 9.0 mm -78.66 -53.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 121.852 -0.53 . . . . 1.21 111.84 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 1.037 HD21 HD21 ' A' ' 104' ' ' LEU . 14.5 mt -50.67 -27.47 7.05 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.524 0.678 . . . . 1.6399999999999999 110.124 170.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HB3' ' O ' ' A' ' 99' ' ' SER . 37.4 t80 -63.69 -42.02 98.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.45 -1.25 . . . . 1.2 108.605 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' ARG . 32.9 m-80 -74.05 -57.92 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 0.81999999999999995 111.961 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 1.037 HD21 HD21 ' A' ' 101' ' ' LEU . 3.2 pp -58.2 -51.99 67.45 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.244 0.831 . . . . 1.22 113.244 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.48 -26.58 68.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.479 0.657 . . . . 1.1899999999999999 110.493 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -74.27 -52.5 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.484 -0.78 . . . . 2.2200000000000002 111.064 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.702 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 8.8 t70 -80.51 -52.42 7.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.826 0.822 . . . . 0.80000000000000004 111.183 -173.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -92.42 -18.47 7.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 O-C-N 121.912 -0.493 . . . . 1.5 110.581 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.24 -19.09 79.87 Favored Glycine 0 CA--C 1.509 -0.321 0 C-N-CA 120.262 -0.97 . . . . 0.38 110.917 167.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -54.28 -49.61 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.392 -1.707 . . . . 1.6599999999999999 106.392 164.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 2.5 m-20 -66.58 -102.84 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.991 -1.004 . . . . 1.8700000000000001 109.902 162.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.86 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 1.3500000000000001 111.938 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.7 123.46 38.16 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.361 -0.382 . . . . 2.1499999999999999 110.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.754 HD11 HD11 ' A' ' 144' ' ' LEU . 3.5 mp -112.82 157.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.899 0.38 . . . . 1.1599999999999999 110.636 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.57 152.7 21.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.692 -0.685 . . . . 2.1099999999999999 109.348 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.535 ' HH ' HD13 ' A' ' 104' ' ' LEU . 73.0 m-85 -145.16 159.97 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.156 -0.683 . . . . 0.96999999999999997 109.156 173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.669 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 33.5 tt0 -154.21 136.0 14.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.779 0.323 . . . . 0.80000000000000004 110.153 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -108.26 130.07 55.18 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.013 -0.736 . . . . 1.9199999999999999 109.013 172.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.625 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -118.9 99.68 6.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.151 -0.685 . . . . 0.63 109.151 176.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -112.18 123.46 67.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.349 0.595 . . . . 1.49 110.367 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.14 123.16 6.44 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.595 -0.729 . . . . 0.26000000000000001 111.552 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 25' ' ' SER . 2.2 mp -96.87 118.55 33.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.781 0.324 . . . . 1.77 110.794 -173.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.101 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 95.8 m -124.71 95.71 4.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.596 -0.729 . . . . 1.0700000000000001 109.524 172.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.798 HG21 ' HB3' ' A' ' 58' ' ' CYS . 14.7 pt -110.88 144.32 19.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.6 -0.44 . . . . 1.6699999999999999 110.42 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.7 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.8 m-20 -85.59 105.09 15.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.858 -1.164 . . . . 1.52 107.858 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.846 HD22 HG22 ' A' ' 55' ' ' ILE . 28.1 mt -102.47 167.33 10.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 125.0 1.438 . . . . 1.9299999999999999 110.195 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.17 -29.56 6.35 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 121.825 1.683 . . . . 0.98999999999999999 112.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -74.12 -58.95 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 112.543 0.572 . . . . 1.6699999999999999 112.543 -172.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.532 ' C ' ' H ' ' A' ' 131' ' ' GLU . 41.8 t -105.94 2.95 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.528 1.156 . . . . 1.9099999999999999 109.441 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 74.32 -24.72 1.11 Allowed Glycine 0 C--N 1.318 -0.434 0 CA-C-N 114.217 -1.356 . . . . 1.05 111.945 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 129' ' ' VAL . 13.3 pt-20 -159.1 170.81 21.19 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.668 -0.864 . . . . 1.1599999999999999 108.668 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.736 ' O ' ' HA ' ' A' ' 123' ' ' THR . 7.0 t80 -163.57 132.78 3.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.652 -0.869 . . . . 2.2799999999999998 108.652 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 86.4 m -123.67 95.55 4.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.317 0.58 . . . . 1.8899999999999999 111.398 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.76 139.12 34.41 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.52 -0.764 . . . . 1.26 110.192 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.655 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.7 Cg_endo -89.15 161.97 5.76 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.778 1.652 . . . . 0.58999999999999997 112.65 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -152.75 167.09 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.386 -0.968 . . . . 1.1399999999999999 108.386 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.8 p -137.82 151.09 47.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.355 0.598 . . . . 1.28 112.075 -172.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 t -139.98 103.34 4.61 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.29 -1.374 . . . . 1.3400000000000001 107.29 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.669 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -112.41 152.48 28.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.198 -0.456 . . . . 2.2000000000000002 110.041 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.53 141.96 7.38 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.342 -0.933 . . . . 0.56000000000000005 111.564 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -107.29 123.98 49.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.785 -0.707 . . . . 2.1000000000000001 109.197 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.9 174.39 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.51 108.527 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -56.78 160.37 3.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.868 0.692 . . . . 3.9300000000000002 112.868 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 HD11 ' A' ' 114' ' ' ILE . 19.4 tp -55.84 138.87 70.76 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 114.894 -1.048 . . . . 1.9299999999999999 111.581 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.591 ' HD2' HD11 ' A' ' 144' ' ' LEU . 34.5 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 123.317 2.678 . . . . 0.81000000000000005 111.911 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.57 0 N-CA-C 116.579 1.392 . . . . 1.0700000000000001 116.579 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.675 ' O ' HG12 ' A' ' 45' ' ' VAL . 95.7 p -167.91 36.47 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.268 -1.382 . . . . 1.7 107.268 174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.4 m -133.86 155.66 40.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.365 -1.289 . . . . 1.53 110.037 -170.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' HG2' ' A' ' 44' ' ' LYS . 1.7 t -168.65 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.699 -0.482 . . . . 1.05 109.699 169.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.73 172.36 1.11 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 111.45 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -142.14 145.91 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.079 -0.711 . . . . 1.8500000000000001 109.079 168.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.43 115.59 30.4 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.762 -0.653 . . . . 1.8300000000000001 110.378 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.0 tm? -80.29 120.05 23.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 1.46 111.08 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HD2' ' HA ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -119.81 -127.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.527 -0.545 . . . . 1.9199999999999999 109.527 171.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.906 ' HA ' HG12 ' A' ' 39' ' ' VAL . 3.1 p30 . . . . . 0 N--CA 1.469 0.494 0 CA-C-N 118.604 0.638 . . . . 2.8500000000000001 111.919 -168.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.586 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 48.1 t . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 105.235 -2.135 . . . . 1.1299999999999999 105.235 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.906 HG12 ' HA ' ' A' ' 33' ' ' ASP . 13.4 t -134.63 156.37 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 118.6 0.636 . . . . 1.48 109.743 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 91.8 mt-10 -119.61 147.59 44.33 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.205 -0.598 . . . . 1.1899999999999999 111.175 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.921 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.5 p90 -142.29 133.89 26.72 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.095 -1.042 . . . . 3.9399999999999999 112.039 166.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -79.9 108.99 13.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.189 -0.914 . . . . 1.4299999999999999 108.715 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -91.62 110.16 21.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.585 0.707 . . . . 1.1100000000000001 109.988 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 27' ' ' THR . 35.4 ttmt -84.03 129.77 34.9 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.929 -1.032 . . . . 3.1800000000000002 109.212 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 25' ' ' SER . 52.5 t -113.57 142.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.69 -0.686 . . . . 1.3999999999999999 110.335 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' THR . 18.7 m -131.34 98.08 4.44 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.254 0.55 . . . . 1.1100000000000001 110.077 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.7 t -83.61 128.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.258 -0.883 . . . . 1.8500000000000001 110.825 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.642 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 6.5 m -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 119.07 -0.491 . . . . 1.1000000000000001 109.793 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.704 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.4 p-10 -91.5 135.21 28.19 Favored Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.859 0.724 . . . . 1.48 110.275 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 57.5 Cg_endo -93.63 12.65 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.71 2.94 . . . . 0.91000000000000003 114.426 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 29.8 t80 -98.55 -117.86 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.332 -0.618 . . . . 2.3100000000000001 109.332 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -165.01 19.68 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.8300000000000001 110.258 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.615 ' HD1' ' HE2' ' A' ' 51' ' ' TYR . 42.8 m80 -148.38 151.32 35.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.528 -0.915 . . . . 2.0299999999999998 108.528 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.573 ' HA ' HD21 ' A' ' 82' ' ' LEU . 28.0 t -44.89 105.57 0.06 Allowed 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.382 1.051 . . . . 1.73 112.295 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.72 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.5 pt -78.17 125.34 85.25 Favored Pre-proline 0 CA--C 1.5 -0.951 0 N-CA-C 108.901 -0.777 . . . . 1.23 108.901 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 27.1 Cg_endo -62.49 -54.65 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.777 1.651 . . . . 0.53000000000000003 112.999 -159.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.5 mm -130.01 159.31 42.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.431 -0.507 . . . . 1.9099999999999999 111.016 -173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 124' ' ' ILE . 27.3 p -150.88 174.7 12.79 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.192 0.996 . . . . 1.95 111.697 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.084 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.3 tt0 -130.86 114.05 14.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.362 -1.744 . . . . 1.3600000000000001 109.673 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.652 HG22 HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.72 111.38 28.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.973 -1.012 . . . . 1.6499999999999999 110.989 173.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 1.6 m -113.7 104.24 12.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.811 -1.541 . . . . 1.02 109.153 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 6.3 p90 -111.98 127.7 55.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.949 -0.389 . . . . 0.46000000000000002 109.949 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 7.1 m -126.4 104.6 8.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.29 -0.633 . . . . 1.1699999999999999 109.29 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 94.7 m-85 -98.28 139.23 34.36 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.1 -0.5 . . . . 1.1799999999999999 111.258 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -128.04 145.43 50.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.667 -1.234 . . . . 1.72 107.667 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.668 ' CB ' HD21 ' A' ' 104' ' ' LEU . 41.5 t -107.27 -98.03 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.14 -1.024 . . . . 1.6599999999999999 111.022 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.56 -60.25 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.674 -0.861 . . . . 1.1200000000000001 108.674 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.58 15.66 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.227 -1.949 . . . . 0.39000000000000001 108.227 163.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.94 HH11 ' HB3' ' A' ' 103' ' ' ASN . 10.2 ptp180 -106.09 -175.34 2.77 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.43 -0.952 . . . . 2.4900000000000002 108.43 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -103.09 97.64 7.7 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.605 0.716 . . . . 2.6099999999999999 109.589 -166.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.841 ' HA ' HG22 ' A' ' 100' ' ' ILE . 2.2 mm -59.04 -43.05 88.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.006 -1.452 . . . . 1.1100000000000001 110.728 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.78 160.2 22.39 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.402 -0.904 . . . . 0.48999999999999999 111.179 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -161.77 156.9 23.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.919 0.859 . . . . 2.3999999999999999 111.446 176.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.76 164.88 28.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.758 -0.937 . . . . 0.52000000000000002 110.758 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -142.13 133.68 26.72 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.097 0.475 . . . . 2.3799999999999999 111.089 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -136.1 133.85 19.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.632 -0.713 . . . . 1.47 110.016 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.26 119.04 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.364 2.042 . . . . 0.81000000000000005 110.508 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.59 139.94 36.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.845 -0.428 . . . . 0.79000000000000004 109.845 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.711 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.0 Cg_endo -61.64 90.82 0.11 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.452 2.101 . . . . 0.91000000000000003 112.08 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.447 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -89.02 30.28 5.56 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.47999999999999998 112.029 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.1 p -70.49 118.36 13.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.513 -0.921 . . . . 0.85999999999999999 108.513 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -139.98 -152.11 0.4 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.048 0.759 . . . . 1.76 113.048 -160.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 93.8 mttt -62.35 -96.99 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.937 -0.574 . . . . 2.4300000000000002 112.304 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.35 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.971 -1.122 . . . . 1.29 107.971 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 39.5 pttt 42.41 50.41 4.69 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.879 0.847 . . . . 2.21 111.134 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.2 t70 -153.35 -173.38 4.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.894 -1.048 . . . . 0.64000000000000001 110.726 -169.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.493 ' HG3' ' HG1' ' A' ' 48' ' ' THR . 45.9 ttm -115.77 125.33 52.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 2.04 110.351 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 46' ' ' SER . 3.3 t -116.16 145.05 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.928 -0.578 . . . . 1.3300000000000001 110.718 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.39 117.07 27.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.514 0.673 . . . . 1.1100000000000001 110.742 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.2 tp -115.88 174.86 5.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.775 -1.102 . . . . 1.45 108.106 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.678 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 35.5 m-20 -137.63 130.66 30.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.502 0.592 . . . . 1.8100000000000001 111.232 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 30.1 mm -108.6 123.84 36.11 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.666 -0.864 . . . . 1.3999999999999999 108.666 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 94' ' ' VAL . 24.3 Cg_exo -28.85 -113.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 1 C-N-CA 125.72 4.28 . . . . 1.0700000000000001 116.22 -171.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.01 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -163.08 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 119.586 -0.245 . . . . 1.1799999999999999 111.191 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 95' ' ' VAL . 7.6 p -127.79 101.74 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 115.635 1.717 . . . . 1.1699999999999999 115.635 -164.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -152.77 107.28 2.7 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 121.326 -0.858 . . . . 1.71 111.607 163.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 53.4 Cg_exo -51.32 129.08 27.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.499 1.466 . . . . 0.65000000000000002 111.192 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.586 ' H ' ' HA ' ' A' ' 38' ' ' SER . 16.3 t80 -50.17 -35.99 28.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.182 -0.917 . . . . 1.6899999999999999 111.898 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.8 t -59.9 -27.49 66.77 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.054 0.39 . . . . 1.49 112.054 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.841 HG22 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -77.62 -54.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 121.892 -0.505 . . . . 1.21 111.17 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 1.06 HD21 HD22 ' A' ' 104' ' ' LEU . 53.3 mt -51.89 -30.18 23.0 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.882 0.848 . . . . 1.6399999999999999 110.129 169.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.519 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 30.4 t80 -69.04 -38.56 79.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.625 -1.625 . . . . 1.2 108.787 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.94 ' HB3' HH11 ' A' ' 69' ' ' ARG . 15.7 m-80 -74.17 -55.95 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 111.975 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 1.06 HD22 HD21 ' A' ' 101' ' ' LEU . 2.9 pp -55.04 -50.67 68.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.737 0.643 . . . . 1.22 112.737 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.21 -24.39 67.2 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.884 0.85 . . . . 1.1899999999999999 110.551 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.519 ' NH2' ' HD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -70.99 -54.76 10.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.106 -0.952 . . . . 2.2200000000000002 110.631 175.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 16.3 t70 -83.01 -53.88 5.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.814 0.816 . . . . 0.80000000000000004 111.649 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.671 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.0 t -84.12 -26.94 7.2 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 121.505 -0.747 . . . . 1.5 109.959 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -70.5 -17.52 74.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 119.536 -1.316 . . . . 0.38 111.381 170.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -53.74 -47.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.18 -1.415 . . . . 1.6599999999999999 107.18 166.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -107.89 68.53 0.71 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.648 0.737 . . . . 1.8700000000000001 112.79 164.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 23.15 -57.86 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 118.802 2.89 . . . . 1.3500000000000001 118.802 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' ASP . 13.2 t70 -91.79 122.85 34.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.59 0.632 . . . . 2.1499999999999999 111.84 -167.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.671 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.8 mp -112.49 158.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 1.1599999999999999 110.78 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -104.74 153.87 20.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.934 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 35.3 m-85 -137.51 167.14 22.23 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.957 -0.757 . . . . 0.96999999999999997 108.957 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.6 tt0 -153.4 139.03 17.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.73 0.3 . . . . 0.80000000000000004 110.629 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.725 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 tp -109.92 129.31 55.67 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.933 -0.576 . . . . 1.9199999999999999 110.3 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.606 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -112.84 101.32 9.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.048 -0.723 . . . . 0.63 109.048 173.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.652 HD12 HG22 ' A' ' 60' ' ' ILE . 5.5 tp -112.58 121.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.158 0.504 . . . . 1.49 111.64 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.68 125.41 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.781 -0.528 . . . . 0.26000000000000001 111.781 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.607 HD13 ' OG ' ' A' ' 25' ' ' SER . 5.0 mp -103.88 106.51 17.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 1.77 111.546 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.084 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.8 m -110.16 95.02 5.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.781 -0.645 . . . . 1.0700000000000001 109.441 174.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.658 ' HB ' HD12 ' A' ' 55' ' ' ILE . 10.6 pt -109.53 141.46 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 120.5 -0.48 . . . . 1.6699999999999999 110.87 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.5 m-20 -84.51 107.47 16.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.714 -0.847 . . . . 1.52 108.714 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.605 HD21 HG21 ' A' ' 55' ' ' ILE . 4.5 mt -115.56 139.65 24.97 Favored Pre-proline 0 C--O 1.216 -0.67 0 O-C-N 124.566 1.166 . . . . 1.9299999999999999 110.455 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.74 -16.67 45.23 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.366 2.044 . . . . 0.98999999999999999 114.105 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.66 -56.45 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.326 0.584 . . . . 1.6699999999999999 111.524 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.91 5.92 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.038 0.923 . . . . 1.9099999999999999 110.799 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.55 -34.44 2.71 Favored Glycine 0 C--N 1.31 -0.884 0 CA-C-N 113.797 -1.547 . . . . 1.05 111.781 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.3 pt-20 -171.21 162.13 6.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.641 -0.874 . . . . 1.1599999999999999 108.641 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 123' ' ' THR . 9.3 t80 -159.11 143.13 15.22 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.464 -0.569 . . . . 2.2799999999999998 109.464 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 75.6 m -112.8 110.67 20.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.148 -0.478 . . . . 1.8899999999999999 111.359 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.3 pp -126.16 136.1 28.06 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.59 . . . . 1.26 109.888 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -93.72 162.96 2.28 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.138 1.892 . . . . 0.58999999999999997 113.21 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.436 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -163.92 168.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.811 -1.181 . . . . 1.1399999999999999 107.811 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 90.3 p -142.29 149.19 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.513 -0.475 . . . . 1.28 111.484 -169.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.3 t -140.64 103.76 4.59 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.243 -1.021 . . . . 1.3400000000000001 108.243 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.2 ptmt -123.52 152.49 41.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.676 -0.693 . . . . 2.2000000000000002 110.454 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.2 155.29 24.18 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.896 -0.668 . . . . 0.56000000000000005 111.485 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 2.2 mp0 -111.04 132.52 54.16 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.404 -0.398 . . . . 2.1000000000000001 110.434 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.24 171.98 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.346 -0.613 . . . . 1.51 109.346 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.557 ' HG2' ' H ' ' A' ' 144' ' ' LEU . 35.7 ttmt -64.57 174.58 1.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.495 . . . . 3.9300000000000002 111.653 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 114' ' ' ILE . 16.6 tp -55.96 139.28 71.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.612 -0.722 . . . . 1.9299999999999999 110.901 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.468 ' HD3' HD12 ' A' ' 114' ' ' ILE . 20.3 Cg_endo . . . . . 0 C--N 1.348 0.513 0 C-N-CA 122.785 2.324 . . . . 0.81000000000000005 112.845 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.221 -0.678 0 N-CA-C 116.374 1.309 . . . . 1.0700000000000001 116.374 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 1.006 ' HG ' HD13 ' A' ' 122' ' ' LEU . 51.9 p -163.54 37.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.691 1.597 . . . . 1.7 106.814 173.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' SER . 1.5 p -131.05 147.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 113.955 -1.475 . . . . 1.53 110.679 -167.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.22 -36.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.712 -0.677 . . . . 1.05 110.631 166.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -175.89 160.94 2.42 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 109.85 -0.426 . . . . 1.6899999999999999 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -137.12 145.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.685 -0.857 . . . . 1.8500000000000001 108.685 162.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.1 146.3 46.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.941 0.4 . . . . 1.8300000000000001 111.646 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 32' ' ' LYS . 2.7 tm? -99.98 135.7 41.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.92 -0.582 . . . . 1.46 111.091 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.533 ' H ' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -143.62 -95.95 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.341 0.867 . . . . 1.9199999999999999 113.341 176.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.752 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 1.6 t70 . . . . . 0 C--O 1.208 -1.11 0 O-C-N 121.723 -0.611 . . . . 2.8500000000000001 111.613 -154.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 8.6 t . . . . . 0 C--O 1.241 0.629 0 CA-C-O 121.561 0.696 . . . . 1.1299999999999999 112.822 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 63.8 t -76.17 151.39 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.017 -0.992 . . . . 1.48 109.647 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.867 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 85.1 mt-10 -109.8 133.34 53.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.223 -0.991 . . . . 1.1899999999999999 111.853 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.826 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.12 106.15 9.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.767 -1.106 . . . . 3.9399999999999999 110.555 -176.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.444 HD21 HG11 ' A' ' 94' ' ' VAL . 1.7 tm? -84.78 110.17 18.61 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.821 -0.807 . . . . 1.4299999999999999 108.821 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -89.97 110.02 21.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.844 0.83 . . . . 1.1100000000000001 110.247 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 30.6 ttmt -84.43 125.38 32.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.579 -1.192 . . . . 3.1800000000000002 108.538 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.735 HG23 HD21 ' A' ' 90' ' ' LEU . 63.5 t -111.78 139.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.219 0.533 . . . . 1.3999999999999999 112.086 -170.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 88' ' ' THR . 15.7 m -131.82 97.59 4.23 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.568 -0.742 . . . . 1.1100000000000001 109.276 162.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 2.3 p -84.62 128.1 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.096 -0.956 . . . . 1.8500000000000001 110.744 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 9.8 m -102.25 121.31 42.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.776 -0.647 . . . . 1.1000000000000001 109.946 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.82 ' HB2' HD21 ' A' ' 82' ' ' LEU . 14.0 t30 -87.57 126.67 61.16 Favored Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 124.722 1.264 . . . . 1.48 109.734 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.4 ' HD2' ' OD1' ' A' ' 49' ' ' ASN . 83.4 Cg_endo -83.29 -10.0 10.2 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.951 3.101 . . . . 0.91000000000000003 115.971 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.705 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.0 t80 -96.23 -105.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.595 -0.842 . . . . 2.3100000000000001 111.264 -171.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.467 ' HB2' ' HD3' ' A' ' 85' ' ' LYS . 47.6 t -175.62 26.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.372 0.606 . . . . 1.8300000000000001 109.862 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -150.74 139.28 20.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.138 -0.69 . . . . 2.0299999999999998 109.138 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 43.5 t -52.19 101.47 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.953 0 O-C-N 124.025 0.828 . . . . 1.73 111.93 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.967 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.7 pt -75.24 172.0 10.32 Favored Pre-proline 0 C--O 1.207 -1.173 0 N-CA-C 107.7 -1.222 . . . . 1.23 107.7 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.56 ' HB2' ' CD1' ' A' ' 57' ' ' ILE . 12.0 Cg_endo -90.08 -58.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.508 0 CA-C-N 120.166 1.095 . . . . 0.53000000000000003 114.687 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 1.5 mp -130.37 161.87 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 119.727 -0.789 . . . . 1.9099999999999999 112.768 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.592 ' HB3' HG21 ' A' ' 124' ' ' ILE . 30.1 p -147.64 168.82 21.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.08 0.943 . . . . 1.95 111.77 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.122 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 16.6 tp10 -122.29 118.71 29.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.412 -1.722 . . . . 1.3600000000000001 110.06 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 13.2 mm -94.58 110.16 23.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 114.618 -1.174 . . . . 1.6499999999999999 110.567 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 11.0 p -120.61 102.67 8.57 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.615 -0.434 . . . . 1.02 109.864 173.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.55 ' HD1' HG23 ' A' ' 60' ' ' ILE . 11.8 p90 -110.3 126.39 54.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.159 0.504 . . . . 0.46000000000000002 109.857 -171.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 18.4 m -123.34 112.1 17.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.034 -0.728 . . . . 1.1699999999999999 109.034 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 93.2 m-85 -97.66 140.99 31.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.979 0.419 . . . . 1.1799999999999999 110.606 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.495 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 5.2 m170 -132.93 145.63 51.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.466 -1.309 . . . . 1.72 107.466 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.964 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -111.52 -97.66 0.42 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.183 -1.007 . . . . 1.6599999999999999 111.41 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.43 -60.57 3.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.529 -0.545 . . . . 1.1200000000000001 109.529 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.77 19.63 0.12 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.578 -1.809 . . . . 0.39000000000000001 108.578 167.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 69' ' ' ARG . 8.5 ptp180 -115.75 -177.85 3.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.332 -0.988 . . . . 2.4900000000000002 108.332 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.9 98.0 7.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.072 0.939 . . . . 2.6099999999999999 110.245 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.798 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.4 mm -54.37 -43.51 62.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.352 -1.749 . . . . 1.1100000000000001 111.86 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.23 169.11 42.25 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.077 -1.058 . . . . 0.48999999999999999 111.355 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.27 155.32 11.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.218 0.509 . . . . 2.3999999999999999 110.541 174.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.22 -175.62 46.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.213 -1.155 . . . . 0.52000000000000002 110.213 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 11.1 ptpt -152.09 136.64 16.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.321 0.56 . . . . 2.3799999999999999 112.134 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 68.6 mt -130.78 108.97 15.64 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.289 -0.868 . . . . 1.47 110.312 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 114.34 3.89 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.312 2.008 . . . . 0.81000000000000005 109.975 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -132.01 146.09 60.21 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.035 -0.357 . . . . 0.79000000000000004 110.035 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 81' ' ' SER . 9.4 Cg_endo -54.6 90.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.513 2.142 . . . . 0.91000000000000003 112.17 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.525 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -77.09 29.01 1.63 Allowed Glycine 0 C--O 1.225 -0.455 0 CA-C-N 115.278 -0.874 . . . . 0.47999999999999998 112.493 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.967 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 59.9 p -74.03 119.92 18.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.719 -0.474 . . . . 0.85999999999999999 109.719 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.869 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -157.95 173.89 16.08 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.833 -1.147 . . . . 1.76 113.646 -164.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 88.6 mttt -33.84 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.578 1.325 . . . . 2.4300000000000002 114.578 -167.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 168.34 108.87 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.359 -0.978 . . . . 1.29 108.359 -174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 47.6 pttt 42.05 48.49 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.168 0.918 . . . . 2.21 110.886 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 4.4 t70 -148.9 -174.37 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.64 -1.164 . . . . 0.64000000000000001 109.782 -168.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.538 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.1 ttm -117.22 121.67 41.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.33 0.586 . . . . 2.04 110.596 -173.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -115.53 144.55 43.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.158 -0.928 . . . . 1.3300000000000001 110.743 -175.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -85.92 141.37 29.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.088 0.47 . . . . 1.1100000000000001 110.043 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.789 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.1 tp -139.32 173.54 11.44 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.25 -1.019 . . . . 1.45 108.25 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.789 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 15.9 m-20 -132.6 124.36 28.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.166 0.508 . . . . 1.8100000000000001 111.842 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -112.84 138.15 22.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.442 -0.799 . . . . 1.3999999999999999 109.01 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' HG22 ' A' ' 92' ' ' ILE . 76.6 Cg_exo -51.96 -159.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.83 3.02 . . . . 1.0700000000000001 114.58 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.867 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -124.08 93.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.371 -0.831 . . . . 1.1799999999999999 110.873 -167.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 95' ' ' VAL . 5.7 p -128.3 103.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 113.917 1.08 . . . . 1.1699999999999999 113.917 -168.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.597 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 p -152.41 99.64 2.83 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.71 110.924 161.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.4 Cg_exo -52.86 131.05 40.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.94 1.76 . . . . 0.65000000000000002 111.022 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -57.96 -30.59 66.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 1.6899999999999999 111.559 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.5 m -59.38 -30.57 68.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.783 0.29 . . . . 1.49 111.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.798 HG22 ' HA ' ' A' ' 71' ' ' ILE . 6.8 mm -76.63 -55.15 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.008 -0.677 . . . . 1.21 110.348 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.644 HD21 HD23 ' A' ' 104' ' ' LEU . 25.3 mt -50.55 -27.38 6.61 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.654 -0.703 . . . . 1.6399999999999999 110.665 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.428 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 23.7 t80 -64.67 -43.16 94.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.672 -1.149 . . . . 1.2 108.799 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 33.1 m-80 -74.42 -57.73 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.81999999999999995 112.458 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.964 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -58.24 -49.57 76.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.385 0.883 . . . . 1.22 113.385 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 144' ' ' LEU . . . -64.9 -23.65 67.29 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 121.912 0.863 . . . . 1.1899999999999999 109.806 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.5 ttp180 -68.03 -47.99 66.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.586 -1.188 . . . . 2.2200000000000002 110.408 173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 15.7 t70 -82.59 -55.89 4.19 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.923 0.868 . . . . 0.80000000000000004 111.871 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.2 t -83.65 -29.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 O-C-N 121.66 -0.65 . . . . 1.5 109.625 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.25 -16.54 80.45 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.522 -0.847 . . . . 0.38 111.693 172.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -49.07 -44.21 16.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.473 -1.677 . . . . 1.6599999999999999 106.473 165.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.64 -81.89 0.08 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.539 -0.755 . . . . 1.8700000000000001 109.954 163.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 178.44 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.623 0.601 . . . . 1.3500000000000001 112.623 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.82 128.63 40.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.319 0.58 . . . . 2.1499999999999999 111.434 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.846 HD13 HD13 ' A' ' 144' ' ' LEU . 2.4 mp -113.5 161.57 12.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.695 -0.684 . . . . 1.1599999999999999 109.901 -172.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.551 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 3.4 p-10 -101.85 152.74 20.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 34.5 m-85 -139.52 166.09 25.49 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.637 -0.875 . . . . 0.96999999999999997 108.637 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.68 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.2 tt0 -153.8 135.35 14.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.80000000000000004 110.142 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -107.37 129.6 54.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.528 -0.76 . . . . 1.9199999999999999 109.181 173.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.697 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.817 -0.809 . . . . 0.63 108.817 177.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.1 tp -112.92 120.89 64.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.228 0.537 . . . . 1.49 111.399 -173.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.81 119.89 5.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.362 -0.695 . . . . 0.26000000000000001 111.362 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 1.006 HD13 ' HG ' ' A' ' 25' ' ' SER . 1.3 mp -98.65 96.11 7.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.007 0.432 . . . . 1.77 110.851 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.122 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 63.2 m -95.98 96.41 8.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.811 -0.631 . . . . 1.0700000000000001 109.387 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.592 HG21 ' HB3' ' A' ' 58' ' ' CYS . 5.7 pt -111.28 138.34 40.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 120.171 -0.612 . . . . 1.6699999999999999 111.327 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.51 106.14 14.13 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.306 -0.998 . . . . 1.52 108.306 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 55' ' ' ILE . 35.1 mt -116.52 150.3 45.28 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 124.859 1.35 . . . . 1.9299999999999999 110.344 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.43 -13.98 41.01 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.14 1.894 . . . . 0.98999999999999999 113.292 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.36 -57.37 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.31 0.576 . . . . 1.6699999999999999 111.257 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.422 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -118.42 6.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.854 0.835 . . . . 1.9099999999999999 110.74 -177.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.31 -31.93 2.6 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 114.005 -1.452 . . . . 1.05 111.966 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.4 pt-20 -178.55 154.03 0.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.705 -0.85 . . . . 1.1599999999999999 108.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.71 ' HD2' HG23 ' A' ' 134' ' ' ILE . 11.3 t80 -157.83 144.99 18.17 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.563 -0.455 . . . . 2.2799999999999998 110.292 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.9 m -101.6 99.56 9.87 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.594 0.559 . . . . 1.8899999999999999 110.855 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.71 HG23 ' HD2' ' A' ' 132' ' ' PHE . 2.3 pp -109.1 124.51 33.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.203 -0.666 . . . . 1.26 109.203 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 95.9 Cg_endo -89.12 162.61 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.559 1.506 . . . . 0.58999999999999997 112.536 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.7 161.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.056 -1.09 . . . . 1.1399999999999999 108.056 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -126.84 144.49 50.95 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.168 -0.308 . . . . 1.28 110.168 -171.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 m -136.99 100.82 4.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.338 -0.986 . . . . 1.3400000000000001 108.338 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.68 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 8.9 ptmt -123.72 143.01 50.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.129 -0.487 . . . . 2.2000000000000002 111.242 -170.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.59 153.63 24.31 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.667 -0.777 . . . . 0.56000000000000005 111.961 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.551 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 26.1 mt-10 -106.85 132.62 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.774 -0.454 . . . . 2.1000000000000001 109.774 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.41 174.15 2.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.153 -1.054 . . . . 1.51 108.153 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.23 170.92 1.5 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.302 0.853 . . . . 3.9300000000000002 113.302 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.846 HD13 HD13 ' A' ' 114' ' ' ILE . 15.9 tp -68.51 149.8 97.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.91 -1.041 . . . . 1.9299999999999999 110.739 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HG ' ' A' ' 144' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.35 0.607 0 C-N-CA 122.502 2.135 . . . . 0.81000000000000005 112.091 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.765 0 N-CA-C 114.624 0.61 . . . . 1.0700000000000001 114.624 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.544 ' OG ' HD12 ' A' ' 122' ' ' LEU . 89.6 p -169.5 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.195 -1.039 . . . . 1.7 108.195 172.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.91 155.25 41.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.742 -1.117 . . . . 1.53 109.058 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 44' ' ' LYS . 1.6 t -168.94 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.208 0.447 . . . . 1.05 112.208 164.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 22.8 t70 -158.51 156.68 30.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.633 0.651 . . . . 1.6899999999999999 110.837 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.21 127.07 46.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.573 -0.529 . . . . 1.8500000000000001 109.573 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -112.49 130.8 55.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 1.8300000000000001 111.562 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.03 122.75 32.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 1.46 111.408 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -128.36 -126.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.228 -0.656 . . . . 1.9199999999999999 109.228 167.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 1.028 ' HA ' HG11 ' A' ' 39' ' ' VAL . 7.4 p-10 . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 113.267 0.84 . . . . 2.8500000000000001 113.267 -171.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 121.015 0.436 . . . . 1.1299999999999999 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 1.028 HG11 ' HA ' ' A' ' 33' ' ' ASP . 46.5 t -76.75 164.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.911 -0.774 . . . . 1.48 108.911 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.914 ' HG2' ' HB ' ' A' ' 94' ' ' VAL . 4.0 mt-10 -124.76 141.18 52.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.559 -0.856 . . . . 1.1899999999999999 112.124 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.846 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -122.55 105.4 10.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.106 -0.952 . . . . 3.9399999999999999 111.012 -177.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -77.74 110.23 12.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.377 -0.971 . . . . 1.4299999999999999 108.377 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -101.06 98.65 9.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.426 0.632 . . . . 1.1100000000000001 110.221 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.582 ' CG ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -82.7 106.07 14.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.533 -1.284 . . . . 3.1800000000000002 107.533 176.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 90' ' ' LEU . 2.0 m -110.83 164.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.702 -1.135 . . . . 1.3999999999999999 110.632 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.458 ' C ' ' HA ' ' A' ' 25' ' ' SER . 2.9 m -142.85 105.13 4.44 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.209 0.528 . . . . 1.1100000000000001 111.665 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.5 t -83.02 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.855 . . . . 1.8500000000000001 110.851 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.663 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.6 m -101.23 122.31 43.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.456 -0.338 . . . . 1.1000000000000001 110.77 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.929 ' HB2' HD21 ' A' ' 82' ' ' LEU . 7.6 t-20 -88.2 134.73 34.2 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.382 1.051 . . . . 1.48 108.849 173.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -108.23 9.88 0.13 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.191 2.594 . . . . 0.91000000000000003 115.812 -178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -118.15 -15.43 9.84 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.089 0.859 . . . . 2.3100000000000001 113.254 -169.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CE ' ' A' ' 85' ' ' LYS . 17.8 t 87.82 17.59 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.532 0.733 . . . . 1.8300000000000001 110.412 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -143.43 125.43 15.29 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.163 -0.68 . . . . 2.0299999999999998 109.163 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -38.85 101.79 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 O-C-N 124.298 0.999 . . . . 1.73 112.969 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 124' ' ' ILE . 7.3 pt -77.76 118.73 73.98 Favored Pre-proline 0 C--O 1.208 -1.085 0 N-CA-C 109.173 -0.676 . . . . 1.23 109.173 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.928 ' HB2' HD13 ' A' ' 57' ' ' ILE . 29.3 Cg_endo -60.42 -54.01 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.273 1.982 . . . . 0.53000000000000003 113.651 -157.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.928 HD13 ' HB2' ' A' ' 56' ' ' PRO . 4.6 mp -133.83 159.07 42.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.045 -0.662 . . . . 1.9099999999999999 110.65 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.643 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -145.69 172.41 13.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.158 0.98 . . . . 1.95 111.789 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.0 tt0 -127.26 114.63 17.88 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.109 -1.86 . . . . 1.3600000000000001 108.949 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.704 HG22 HD12 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.91 109.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 122.512 1.148 . . . . 1.6499999999999999 109.78 169.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 13.5 p -112.4 101.64 9.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.216 -1.811 . . . . 1.02 108.184 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 12.0 p90 -114.71 136.56 52.93 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.137 0.494 . . . . 0.46000000000000002 110.285 -166.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 73' ' ' LYS . 16.9 m -132.45 108.57 9.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.788 -1.097 . . . . 1.1699999999999999 109.546 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -97.22 140.97 30.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.808 -0.633 . . . . 1.1799999999999999 109.438 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.4 m170 -128.59 145.62 51.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.467 -1.308 . . . . 1.72 107.467 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.775 ' CB ' HD23 ' A' ' 104' ' ' LEU . 46.8 t -100.99 -102.86 0.25 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.449 -0.9 . . . . 1.6599999999999999 110.199 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . . . -62.6 -57.05 12.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.889 -0.782 . . . . 1.1200000000000001 108.889 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.54 15.2 0.16 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 108.599 -1.8 . . . . 0.39000000000000001 108.599 165.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -109.72 171.86 7.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.368 -0.975 . . . . 2.4900000000000002 108.368 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.85 95.3 8.17 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.112 0.482 . . . . 2.6099999999999999 109.913 -164.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.802 ' HA ' HG23 ' A' ' 100' ' ' ILE . 1.7 mm -48.08 -41.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.639 -1.164 . . . . 1.1100000000000001 111.403 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.26 163.38 29.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.211 -0.995 . . . . 0.48999999999999999 111.608 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.613 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.6 OUTLIER -165.92 155.91 12.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.533 0.667 . . . . 2.3999999999999999 110.998 174.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.66 35.54 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.482 -0.781 . . . . 0.52000000000000002 111.528 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -123.44 131.71 53.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.09 -0.337 . . . . 2.3799999999999999 110.09 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.538 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 86.7 mt -137.89 126.18 14.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.441 -0.345 . . . . 1.47 110.123 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.09 115.72 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.468 2.112 . . . . 0.81000000000000005 111.633 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -125.04 141.29 38.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.084 -0.339 . . . . 0.79000000000000004 110.084 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.75 87.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.792 2.328 . . . . 0.91000000000000003 111.963 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -78.73 19.55 4.98 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.47999999999999998 113.384 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 91.1 p -70.38 119.71 14.97 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.49 -0.559 . . . . 0.85999999999999999 109.49 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 49' ' ' ASN . 2.6 pt? -142.41 -165.95 2.15 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.854 0.687 . . . . 1.76 112.854 -165.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 89.9 mttt -43.2 -91.33 0.0 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.777 -1.101 . . . . 2.4300000000000002 112.949 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . 165.02 105.17 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.31 -0.996 . . . . 1.29 108.31 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.1 ptpt 43.84 50.84 6.9 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.363 1.04 . . . . 2.21 111.166 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 87' ' ' MET . 10.8 t70 -151.56 -169.87 3.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.217 -0.901 . . . . 0.64000000000000001 108.816 -173.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.465 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 48.4 ttm -116.99 121.4 41.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.835 0.35 . . . . 2.04 110.494 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 12.0 t -104.94 143.36 33.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.754 -0.657 . . . . 1.3300000000000001 109.739 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.01 106.8 14.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.379 0.609 . . . . 1.1100000000000001 110.097 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.934 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 7.7 tp -100.48 178.23 4.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.085 -0.961 . . . . 1.45 109.246 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.934 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.2 t70 -146.58 127.8 14.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.578 -0.283 . . . . 1.8100000000000001 111.303 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 1.5 mp -102.61 116.3 62.98 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.645 -1.243 . . . . 1.3999999999999999 107.645 163.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.579 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 33.5 Cg_exo -32.32 -100.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 125.181 3.921 . . . . 1.0700000000000001 115.477 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.914 ' HB ' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -163.43 93.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 O-C-N 122.275 -0.266 . . . . 1.1799999999999999 111.336 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 95' ' ' VAL . 7.6 p -129.03 104.26 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.676 1.361 . . . . 1.1699999999999999 114.676 -170.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.511 ' CG2' ' HG ' ' A' ' 101' ' ' LEU . 3.0 p -153.79 99.83 2.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 121.867 -0.52 . . . . 1.71 111.949 161.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.5 Cg_exo -53.66 131.71 45.34 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.828 1.685 . . . . 0.65000000000000002 111.183 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -53.9 -33.23 55.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 1.6899999999999999 112.356 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -56.17 -32.0 63.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.757 0.313 . . . . 1.49 111.667 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.802 HG23 ' HA ' ' A' ' 71' ' ' ILE . 12.2 mm -76.28 -55.72 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.602 -0.439 . . . . 1.21 110.643 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.606 HD22 HD21 ' A' ' 104' ' ' LEU . 40.3 mt -51.99 -28.11 15.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.565 -0.743 . . . . 1.6399999999999999 110.703 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.12 -44.66 95.0 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.028 -0.987 . . . . 1.2 108.99 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.21 -57.15 4.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.799 -0.637 . . . . 0.81999999999999995 111.889 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.775 HD23 ' CB ' ' A' ' 66' ' ' SER . 1.6 pp -62.07 -53.06 60.82 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.431 0.9 . . . . 1.22 113.431 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.736 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.1 -25.97 68.61 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.842 0.83 . . . . 1.1899999999999999 110.197 -177.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.76 ' O ' HG12 ' A' ' 110' ' ' VAL . 6.7 ttp180 -74.57 -54.7 6.98 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.531 -1.213 . . . . 2.2200000000000002 110.391 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.871 ' O ' HG21 ' A' ' 110' ' ' VAL . 14.4 t70 -74.06 -52.79 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.883 0.849 . . . . 0.80000000000000004 111.057 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 2.3 t -86.93 -17.21 8.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.355 -0.84 . . . . 1.5 109.697 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -67.91 -25.56 74.22 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.736 -0.745 . . . . 0.38 113.712 168.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.871 HG21 ' O ' ' A' ' 107' ' ' ASP . 11.5 m -63.22 -40.83 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.118 -1.438 . . . . 1.6599999999999999 107.118 170.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.6 m-20 -59.56 -58.53 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.63 -0.713 . . . . 1.8700000000000001 110.927 165.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.5 ' CG ' ' N ' ' A' ' 113' ' ' ASP . 3.8 p-90 128.36 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.282 2.233 . . . . 1.3500000000000001 111.641 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 14.9 t70 -94.44 129.44 41.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.475 -0.329 . . . . 2.1499999999999999 110.404 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.74 HD11 HD13 ' A' ' 144' ' ' LEU . 2.5 mp -115.32 151.13 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.026 0.441 . . . . 1.1599999999999999 109.854 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 141' ' ' GLU . 6.1 p-10 -93.73 152.59 18.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.983 -0.747 . . . . 2.1099999999999999 108.983 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 31.9 m-85 -141.9 165.66 26.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.669 -0.863 . . . . 0.96999999999999997 108.669 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.473 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 22.9 tt0 -152.18 139.92 19.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.751 0.31 . . . . 0.80000000000000004 110.345 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.614 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -113.91 129.94 56.55 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.205 -0.665 . . . . 1.9199999999999999 109.205 173.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.614 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -120.59 100.72 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.118 -0.697 . . . . 0.63 109.118 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.704 HD12 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.07 123.18 71.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.51 0.671 . . . . 1.49 110.773 -174.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.33 124.48 7.07 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.458 -0.792 . . . . 0.26000000000000001 111.768 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 120' ' ' ILE . 6.1 mp -97.4 105.91 18.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.966 0.412 . . . . 1.77 111.055 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.051 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 89.2 m -108.11 95.14 5.47 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.439 -0.801 . . . . 1.0700000000000001 109.007 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.643 ' HB ' HD11 ' A' ' 55' ' ' ILE . 7.0 pt -112.23 140.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 120.555 -0.458 . . . . 1.6699999999999999 110.281 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.787 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -85.81 105.8 16.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.33 -0.989 . . . . 1.52 108.33 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -125.03 135.54 26.93 Favored Pre-proline 0 C--O 1.22 -0.464 0 O-C-N 124.049 0.843 . . . . 1.9299999999999999 110.156 178.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 53.9 Cg_exo -52.73 -19.38 10.57 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.496 2.797 . . . . 0.98999999999999999 115.32 -169.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.48 -51.09 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.231 -0.293 . . . . 1.6699999999999999 111.361 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.673 HG13 ' HD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -103.32 -2.38 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.087 0.946 . . . . 1.9099999999999999 109.456 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.72 -36.95 1.22 Allowed Glycine 0 C--N 1.314 -0.669 0 CA-C-N 113.558 -1.655 . . . . 1.05 111.151 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -177.09 150.57 0.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.554 -1.276 . . . . 1.1599999999999999 107.554 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.673 ' HD1' HG13 ' A' ' 129' ' ' VAL . 12.7 t80 -151.97 147.86 27.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.703 -0.399 . . . . 2.2799999999999998 110.158 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 67.8 m -113.82 104.72 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.506 0.504 . . . . 1.8899999999999999 111.477 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.3 pp -124.04 133.09 24.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 1.26 109.608 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 89.6 Cg_endo -87.38 161.28 8.24 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.592 1.528 . . . . 0.58999999999999997 112.836 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.68 164.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.299 -1.0 . . . . 1.1399999999999999 108.299 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -135.4 150.21 49.84 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.901 -0.319 . . . . 1.28 111.203 -168.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.3 t -145.8 102.18 3.63 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.649 -1.241 . . . . 1.3400000000000001 107.649 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 6.0 ptmt -118.12 144.05 45.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.68 -0.489 . . . . 2.2000000000000002 109.68 -172.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.03 149.55 19.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.021 -1.085 . . . . 0.56000000000000005 112.443 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 115' ' ' ASP . 31.0 mt-10 -108.06 126.94 53.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.055 -0.572 . . . . 2.1000000000000001 109.771 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 172.87 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.868 -0.79 . . . . 1.51 108.868 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -54.64 160.81 1.69 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.995 0.739 . . . . 3.9300000000000002 112.995 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 114' ' ' ILE . 25.0 tp -58.88 136.54 87.26 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.056 -0.974 . . . . 1.9299999999999999 110.57 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.623 ' HD2' HD13 ' A' ' 144' ' ' LEU . 38.1 Cg_endo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.798 2.332 . . . . 0.81000000000000005 112.486 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.753 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 116.282 1.273 . . . . 1.0700000000000001 116.282 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.755 ' HG ' HD13 ' A' ' 122' ' ' LEU . 75.5 p -169.01 34.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.47 1.108 . . . . 1.7 108.107 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.21 152.86 36.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 114.48 -1.236 . . . . 1.53 109.701 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 t -168.53 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.135 0.272 . . . . 1.05 110.712 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -174.36 168.08 3.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.554 0.575 . . . . 1.6899999999999999 112.554 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.8 t -142.76 129.36 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.341 -0.845 . . . . 1.8500000000000001 109.497 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.97 128.12 54.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.619 -0.264 . . . . 1.8300000000000001 110.98 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 2.7 tm? -92.97 139.54 30.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.801 0.297 . . . . 1.46 111.801 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -139.1 -94.52 0.17 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.047 1.129 . . . . 1.9199999999999999 114.047 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.725 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.205 -1.272 0 CA-C-N 116.182 -0.463 . . . . 2.8500000000000001 112.182 -153.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.43 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 45.1 t . . . . . 0 C--O 1.24 0.586 0 CA-C-O 121.83 0.824 . . . . 1.1299999999999999 112.289 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 93.3 t -74.01 147.07 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.578 -1.192 . . . . 1.48 110.056 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.918 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -123.55 137.73 54.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.604 -0.838 . . . . 1.1899999999999999 110.337 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.93 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -141.7 139.61 32.96 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 118.671 -1.212 . . . . 3.9399999999999999 113.677 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -83.24 109.0 16.86 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.666 -1.235 . . . . 1.4299999999999999 107.666 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -93.48 107.52 19.35 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.535 -0.913 . . . . 1.1100000000000001 108.535 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 21.5 ttmm -82.7 131.31 35.21 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.927 -0.768 . . . . 3.1800000000000002 108.927 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 25' ' ' SER . 45.2 t -111.2 137.81 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.735 -1.12 . . . . 1.3999999999999999 110.236 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.7 m -126.39 97.87 5.22 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 120.257 -0.577 . . . . 1.1100000000000001 109.632 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 57.8 t -84.0 124.25 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.651 -0.704 . . . . 1.8500000000000001 110.812 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 22.1 m -99.83 121.01 40.66 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.326 -0.991 . . . . 1.1000000000000001 108.326 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.832 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.9 t30 -89.45 124.37 64.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 124.894 1.371 . . . . 1.48 109.652 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.89 11.67 3.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.852 3.035 . . . . 0.91000000000000003 113.945 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 2.7 t80 -125.54 136.38 53.25 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.717 -0.845 . . . . 2.3100000000000001 108.717 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.2 p -76.31 34.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.311 0.577 . . . . 1.8300000000000001 111.161 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' TYR . 52.8 m80 -148.57 132.69 17.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.371 -0.831 . . . . 2.0299999999999998 109.895 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 11.0 m -45.15 102.07 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.186 0.994 . . . . 1.73 113.459 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.915 ' O ' ' HA ' ' A' ' 81' ' ' SER . 11.1 pt -75.47 171.65 11.31 Favored Pre-proline 0 C--O 1.208 -1.112 0 N-CA-C 108.535 -0.913 . . . . 1.23 108.535 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 39.6 Cg_endo -89.12 -63.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.455 1.437 . . . . 0.53000000000000003 114.923 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 79' ' ' PRO . 18.2 mm -133.0 162.26 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 121.967 -0.458 . . . . 1.9099999999999999 111.532 -166.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.806 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.3 p -150.97 -179.85 7.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.165 0.983 . . . . 1.95 111.998 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.056 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.6 tt0 -132.37 116.12 16.44 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.419 -1.719 . . . . 1.3600000000000001 109.933 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -97.21 108.98 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.362 1.077 . . . . 1.6499999999999999 109.454 168.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.524 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 p -114.42 103.03 10.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.454 -1.703 . . . . 1.02 108.807 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 11.8 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.226 0.536 . . . . 0.46000000000000002 110.294 -165.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 m -137.01 108.81 7.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.873 -1.058 . . . . 1.1699999999999999 109.626 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 92.7 m-85 -98.54 146.59 25.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.409 -0.359 . . . . 1.1799999999999999 110.768 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.738 ' HB3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -139.08 128.83 24.75 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 108.098 -1.075 . . . . 1.72 108.098 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD21 ' A' ' 104' ' ' LEU . 38.1 t -94.06 -89.85 0.21 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.408 -0.917 . . . . 1.6599999999999999 110.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.55 -67.86 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.387 -0.597 . . . . 1.1200000000000001 109.387 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.81 18.08 0.17 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.407 -1.077 . . . . 0.39000000000000001 110.407 167.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.738 ' O ' ' HB3' ' A' ' 65' ' ' HIS . 6.7 ptp180 -106.43 -149.47 0.43 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.558 -0.534 . . . . 2.4900000000000002 109.558 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.35 101.24 7.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 119.068 0.849 . . . . 2.6099999999999999 109.539 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -73.62 -44.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.645 -0.707 . . . . 1.1100000000000001 112.417 -171.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.56 140.24 4.43 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.48999999999999999 111.094 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -154.36 159.08 40.97 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 117.568 0.684 . . . . 2.3999999999999999 111.222 -174.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.74 163.72 26.15 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.886 -0.885 . . . . 0.52000000000000002 110.886 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.9 mttt -129.85 128.37 42.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.162 -0.31 . . . . 2.3799999999999999 110.162 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.429 ' HB ' HD13 ' A' ' 60' ' ' ILE . 75.1 mt -135.67 124.37 15.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.608 -0.269 . . . . 1.47 110.667 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.3 103.0 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.155 1.903 . . . . 0.81000000000000005 111.234 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.431 ' HB2' HD11 ' A' ' 60' ' ' ILE . 7.4 t70 -110.43 136.78 20.56 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.79000000000000004 109.541 -172.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' A' ' 57' ' ' ILE . 25.8 Cg_exo -63.44 88.79 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.546 2.164 . . . . 0.91000000000000003 112.716 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' O ' HD23 ' A' ' 82' ' ' LEU . . . -88.24 35.63 3.54 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.885 -0.598 . . . . 0.47999999999999998 112.379 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.915 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -72.78 117.71 14.82 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.146 -0.687 . . . . 0.85999999999999999 109.146 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.568 ' HG ' ' NZ ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -156.41 -155.15 0.52 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.305 -1.358 . . . . 1.76 114.45 -157.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.829 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -57.68 -158.2 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.339 1.066 . . . . 2.4300000000000002 112.305 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.87 80.59 1.72 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.342 -1.355 . . . . 1.29 107.342 -167.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.832 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 8.9 mtpt 64.74 68.28 0.53 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.962 -1.472 . . . . 2.21 110.934 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.718 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 9.4 t70 -162.53 -169.59 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.238 -1.346 . . . . 0.64000000000000001 109.54 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.461 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 41.8 ttp -122.42 118.96 29.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.193 0.521 . . . . 2.04 110.88 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.786 ' HB ' ' CE ' ' A' ' 83' ' ' LYS . 5.6 t -104.04 143.67 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 1.3300000000000001 109.018 -172.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.71 109.4 20.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.703 0.763 . . . . 1.1100000000000001 110.739 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -115.48 175.07 5.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.66 -1.155 . . . . 1.45 108.136 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.609 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 3.1 p30 -144.25 151.22 39.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.011 0.823 . . . . 1.8100000000000001 112.569 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 40.3 mm -110.16 130.45 22.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.683 -1.144 . . . . 1.3999999999999999 108.044 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 94' ' ' VAL . 44.6 Cg_exo -35.86 -103.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.687 3.592 . . . . 1.0700000000000001 115.372 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.93 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -164.0 90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 CA-C-O 119.118 -0.468 . . . . 1.1799999999999999 110.615 -177.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 95' ' ' VAL . 14.9 p -124.35 104.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.646 1.721 . . . . 1.1699999999999999 115.646 -163.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.686 HG12 ' HG ' ' A' ' 101' ' ' LEU . 2.5 t -148.9 119.23 4.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 1.71 110.346 164.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 17.9 Cg_exo -65.47 124.9 13.53 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.08 1.064 . . . . 0.65000000000000002 109.569 164.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.43 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -58.27 -30.85 66.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.6899999999999999 111.594 -171.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 3.2 p -58.76 -26.54 64.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.311 0.486 . . . . 1.49 112.311 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.824 HG22 ' HA ' ' A' ' 71' ' ' ILE . 20.2 mm -76.86 -55.31 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 121.818 -0.551 . . . . 1.21 110.995 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.686 ' HG ' HG12 ' A' ' 96' ' ' VAL . 26.9 mt -52.24 -26.56 12.09 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.555 0.693 . . . . 1.6399999999999999 110.392 171.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 99' ' ' SER . 57.6 t80 -64.4 -40.24 95.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.467 -1.242 . . . . 1.2 108.839 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HA ' HH21 ' A' ' 106' ' ' ARG . 22.0 m-80 -73.79 -58.06 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.845 -0.616 . . . . 0.81999999999999995 112.422 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -61.04 -50.19 74.31 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.423 0.898 . . . . 1.22 113.423 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.51 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.68 -25.05 67.95 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.856 0.836 . . . . 1.1899999999999999 110.037 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.7 ttp180 -68.18 -51.11 49.37 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.145 . . . . 2.2200000000000002 110.728 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.9 -52.07 7.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.545 1.164 . . . . 0.80000000000000004 112.231 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -84.42 -29.06 6.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.859 -1.151 . . . . 1.5 109.982 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.93 -25.59 73.39 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.923 -0.656 . . . . 0.38 113.786 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -57.65 -40.5 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 118.413 -1.315 . . . . 1.6599999999999999 108.04 170.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 30.6 t70 -64.66 -84.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.504 -1.278 . . . . 1.8700000000000001 108.097 161.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.436 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.9 OUTLIER 168.07 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.24 0.83 . . . . 1.3500000000000001 113.24 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.58 123.78 35.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.87 0.322 . . . . 2.1499999999999999 111.87 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.3 mp -117.28 155.55 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.902 0.382 . . . . 1.1599999999999999 110.032 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 141' ' ' GLU . 37.1 t70 -98.91 155.41 17.41 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.067 -0.716 . . . . 2.1099999999999999 109.067 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 72.9 m-85 -139.08 129.57 25.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.217 -0.66 . . . . 0.96999999999999997 109.217 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.5 tt0 -123.78 137.25 54.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.05 0.453 . . . . 0.80000000000000004 110.068 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.679 HD12 ' HB ' ' A' ' 120' ' ' ILE . 0.8 OUTLIER -111.47 129.36 56.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.588 -0.733 . . . . 1.9199999999999999 109.863 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.34 101.29 9.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 176.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.679 ' HB ' HD12 ' A' ' 118' ' ' LEU . 5.9 tp -111.88 123.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.146 0.498 . . . . 1.49 111.204 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.76 125.2 7.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.378 -0.689 . . . . 0.26000000000000001 111.378 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.755 HD13 ' HG ' ' A' ' 25' ' ' SER . 4.3 mp -101.88 94.99 6.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.38 . . . . 1.77 111.131 -174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.056 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 84.9 m -100.17 95.56 6.89 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.629 -0.714 . . . . 1.0700000000000001 109.177 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.827 HG13 HD22 ' A' ' 126' ' ' LEU . 3.0 pt -106.89 149.42 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.9 -0.5 . . . . 1.6699999999999999 109.698 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.5 m-20 -92.88 107.15 18.99 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.827 HD22 HG13 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -109.93 159.74 30.67 Favored Pre-proline 0 C--O 1.217 -0.63 0 O-C-N 123.996 0.81 . . . . 1.9299999999999999 109.997 -176.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 17.3 Cg_exo -69.88 -13.1 33.93 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.884 1.722 . . . . 0.98999999999999999 113.358 174.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.63 -59.93 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.769 0.655 . . . . 1.6699999999999999 112.769 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.466 ' C ' ' H ' ' A' ' 131' ' ' GLU . 34.1 t -118.99 9.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 122.915 1.341 . . . . 1.9099999999999999 109.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.58 -24.78 3.57 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 113.587 -1.642 . . . . 1.05 111.605 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 10.6 pt-20 -172.52 154.77 3.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.628 -0.879 . . . . 1.1599999999999999 108.628 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -150.0 143.64 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.523 -0.547 . . . . 2.2799999999999998 109.523 170.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 53.5 m -116.23 108.85 16.64 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.383 0.427 . . . . 1.8899999999999999 111.352 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.4 pp -124.94 137.38 29.51 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.098 -0.501 . . . . 1.26 109.975 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 73.7 Cg_endo -92.89 159.11 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.047 1.832 . . . . 0.58999999999999997 113.323 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -156.44 165.38 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.601 -0.888 . . . . 1.1399999999999999 108.601 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -136.27 151.36 49.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.64 -0.255 . . . . 1.28 111.072 -168.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t -146.11 103.8 3.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.016 -0.735 . . . . 1.3400000000000001 109.016 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.83 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.8 ptmt -116.11 152.81 32.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 2.2000000000000002 111.309 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.08 147.02 10.03 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.718 -0.753 . . . . 0.56000000000000005 112.049 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.568 ' HG2' ' HB2' ' A' ' 115' ' ' ASP . 31.3 mt-10 -98.67 135.09 40.68 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.607 -0.516 . . . . 2.1000000000000001 109.607 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 116' ' ' TYR . 2.1 pp -141.13 171.04 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.212 -0.662 . . . . 1.51 109.212 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -60.02 167.01 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 3.9300000000000002 112.334 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.801 HD11 ' HD2' ' A' ' 145' ' ' PRO . 42.0 tp -56.26 125.44 64.99 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.928 -1.033 . . . . 1.9299999999999999 109.809 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.801 ' HD2' HD11 ' A' ' 144' ' ' LEU . 28.6 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 123.658 2.905 . . . . 0.81000000000000005 113.197 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.657 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . . . . . . 0 N--CA 1.445 -0.733 0 N-CA-C 113.875 0.31 . . . . 1.0700000000000001 113.875 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.69 ' O ' HG11 ' A' ' 45' ' ' VAL . 83.6 p -169.31 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.338 1.066 . . . . 1.7 108.561 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 136' ' ' ILE . 14.3 m -134.52 152.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 114.297 -1.32 . . . . 1.53 109.707 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -160.28 -51.52 0.05 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.464 -0.569 . . . . 1.05 109.464 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -157.36 166.16 33.83 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.487 -0.56 . . . . 1.6899999999999999 109.487 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -145.53 148.34 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.154 -0.684 . . . . 1.8500000000000001 109.154 165.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -122.37 144.39 49.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.016 0.436 . . . . 1.8300000000000001 111.215 -169.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.12 118.03 32.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 1.46 111.126 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.649 ' HG2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.63 -136.36 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.525 -1.287 . . . . 1.9199999999999999 107.525 167.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.608 ' HB3' HG12 ' A' ' 39' ' ' VAL . 5.3 p-10 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 115.739 1.755 . . . . 2.8500000000000001 115.739 -173.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.464 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 44.1 t . . . . . 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.451 . . . . 1.1299999999999999 112.184 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.608 HG12 ' HB3' ' A' ' 33' ' ' ASP . 44.5 t -70.99 168.48 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.743 -1.206 . . . . 1.48 107.743 168.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 76.0 mt-10 -128.76 136.18 50.2 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.712 0.768 . . . . 1.1899999999999999 111.081 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.62 104.21 8.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.637 -1.165 . . . . 3.9399999999999999 109.886 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.546 ' N ' HG11 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -75.39 109.83 9.24 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.267 -0.973 . . . . 1.4299999999999999 108.613 176.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -94.52 109.58 21.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.396 0.617 . . . . 1.1100000000000001 109.781 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 21.7 ttmt -84.65 130.14 34.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.436 -0.802 . . . . 3.1800000000000002 109.11 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 HD21 ' A' ' 90' ' ' LEU . 69.3 t -111.34 136.12 48.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 116.149 -0.478 . . . . 1.3999999999999999 112.13 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 29.4 m -127.05 95.76 4.4 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.025 -0.731 . . . . 1.1100000000000001 109.025 160.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -89.48 128.51 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.536 0.684 . . . . 1.8500000000000001 110.955 -176.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.657 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.8 m -103.77 117.27 33.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.963 -1.017 . . . . 1.1000000000000001 109.853 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.776 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 6.3 t30 -88.67 128.47 52.46 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 124.146 0.904 . . . . 1.48 108.922 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -91.84 11.34 2.39 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.25 2.634 . . . . 0.91000000000000003 114.218 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -130.49 143.43 50.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.043 -0.725 . . . . 2.3100000000000001 109.043 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 23.1 t -78.07 34.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.946 0.721 . . . . 1.8300000000000001 112.946 -164.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -144.5 132.14 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.277 -0.264 . . . . 2.0299999999999998 110.375 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -39.37 103.6 0.03 OUTLIER 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 124.058 0.943 . . . . 1.73 112.708 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.959 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.32 169.45 19.33 Favored Pre-proline 0 C--O 1.21 -1.0 0 N-CA-C 108.097 -1.075 . . . . 1.23 108.097 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.899 ' HB2' HD13 ' A' ' 57' ' ' ILE . 9.9 Cg_endo -91.56 -66.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.504 1.469 . . . . 0.53000000000000003 114.333 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.899 HD13 ' HB2' ' A' ' 56' ' ' PRO . 3.8 mp -134.65 152.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.299 -0.56 . . . . 1.9099999999999999 111.028 -167.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.711 ' HB3' HG22 ' A' ' 124' ' ' ILE . 16.5 m -144.23 -178.09 5.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.118 0.961 . . . . 1.95 111.92 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 23.8 tt0 -134.27 116.88 15.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.414 -1.721 . . . . 1.3600000000000001 109.997 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.558 ' HA ' HD12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -95.94 108.4 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 115.054 -0.975 . . . . 1.6499999999999999 108.785 164.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.589 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 39.5 p -112.76 101.95 10.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.05 -1.432 . . . . 1.02 108.377 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -116.16 134.3 55.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.415 0.626 . . . . 0.46000000000000002 110.583 -166.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -128.32 111.01 12.9 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.507 -1.224 . . . . 1.1699999999999999 108.819 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 97.8 m-85 -97.31 140.67 31.44 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.584 -0.524 . . . . 1.1799999999999999 109.584 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -128.19 144.55 51.13 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.048 -1.464 . . . . 1.72 107.048 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.725 ' CB ' HD21 ' A' ' 104' ' ' LEU . 39.1 t -105.43 -103.86 0.32 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 118.967 -1.093 . . . . 1.6599999999999999 111.046 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -60.53 -54.31 47.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.115 -0.698 . . . . 1.1200000000000001 109.115 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 21.22 0.12 Allowed Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 109.116 -1.594 . . . . 0.39000000000000001 109.116 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 6.6 ptp180 -115.97 -172.25 2.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.568 -0.816 . . . . 2.4900000000000002 109.014 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -105.11 91.55 3.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.612 0.72 . . . . 2.6099999999999999 110.555 -165.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.803 ' HA ' HG21 ' A' ' 100' ' ' ILE . 6.0 mm -52.07 -44.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.911 -1.041 . . . . 1.1100000000000001 111.067 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.24 170.54 35.48 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.534 -0.841 . . . . 0.48999999999999999 111.41 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.89 163.02 21.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.377 0.589 . . . . 2.3999999999999999 111.043 176.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.83 166.25 35.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.892 -0.595 . . . . 0.52000000000000002 111.637 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 91.3 mttt -135.74 126.42 27.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.613 0.244 . . . . 2.3799999999999999 110.456 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.37 115.41 14.94 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.944 -0.391 . . . . 1.47 109.944 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.24 95.69 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.498 2.132 . . . . 0.81000000000000005 110.553 170.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -112.24 141.84 25.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.374 -0.602 . . . . 0.79000000000000004 109.374 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' HG13 ' A' ' 57' ' ' ILE . 19.5 Cg_endo -59.44 88.97 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.519 2.146 . . . . 0.91000000000000003 112.502 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.688 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -83.21 38.71 2.74 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.261 -0.881 . . . . 0.47999999999999998 112.29 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.959 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 77.4 p -73.58 125.45 28.02 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.506 -0.553 . . . . 0.85999999999999999 109.506 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.826 HD12 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -156.94 0.77 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.893 1.442 . . . . 1.76 114.893 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -101.24 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.49 -0.777 . . . . 2.4300000000000002 112.513 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.23 102.57 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.045 -1.094 . . . . 1.29 108.045 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptpt 43.59 50.43 6.46 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.415 1.072 . . . . 2.21 111.071 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 87' ' ' MET . 8.0 t70 -149.2 -173.64 4.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.189 -0.914 . . . . 0.64000000000000001 109.678 -174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 48.6 ttm -112.59 126.73 55.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.377 -0.374 . . . . 2.04 110.649 -172.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.484 ' CG2' HG11 ' A' ' 47' ' ' VAL . 5.9 t -116.76 144.64 44.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.046 -0.524 . . . . 1.3300000000000001 110.247 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -90.87 111.36 22.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.737 0.779 . . . . 1.1100000000000001 110.527 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.765 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -109.85 176.14 5.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.588 -1.187 . . . . 1.45 108.56 -176.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.765 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.8 t70 -134.78 131.73 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.365 0.529 . . . . 1.8100000000000001 111.909 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.652 HG12 ' CG2' ' A' ' 45' ' ' VAL . 19.1 mm -113.62 139.31 23.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 1.3999999999999999 110.312 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.3 -177.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.899 . . . . 1.0700000000000001 113.597 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.7 m -115.16 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.553 -0.749 . . . . 1.1799999999999999 110.367 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 p -127.2 102.96 10.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 114.269 1.211 . . . . 1.1699999999999999 114.269 -164.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 71' ' ' ILE . 1.5 p -151.72 98.41 3.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.697 -0.683 . . . . 1.71 110.551 161.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.683 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 87.5 Cg_exo -47.67 130.22 18.32 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.994 1.796 . . . . 0.65000000000000002 111.264 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.464 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -57.86 -31.66 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 1.6899999999999999 110.998 -173.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 m -56.6 -28.78 61.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.722 0.296 . . . . 1.49 111.682 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.803 HG21 ' HA ' ' A' ' 71' ' ' ILE . 21.3 mm -76.34 -54.74 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.757 0.313 . . . . 1.21 110.538 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 104' ' ' LEU . 19.9 mt -50.09 -27.84 6.27 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.21 -0.905 . . . . 1.6399999999999999 110.516 171.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 1.8 t80 -65.66 -42.33 91.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.709 -1.132 . . . . 1.2 109.031 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.636 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 50.7 m-80 -73.59 -56.35 5.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.434 . . . . 0.81999999999999995 111.946 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 101' ' ' LEU . 1.6 pp -60.94 -51.16 70.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.442 0.904 . . . . 1.22 113.442 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.4 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.79 -24.35 66.9 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.718 0.77 . . . . 1.1899999999999999 109.706 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.636 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -60.32 -53.27 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.654 -1.157 . . . . 2.2200000000000002 110.143 172.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.98 -53.29 6.26 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.301 0.572 . . . . 0.80000000000000004 112.394 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 113' ' ' ASP . 2.2 t -89.72 -25.26 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.945 -0.702 . . . . 1.5 110.159 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.35 -24.64 72.63 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.181 -1.009 . . . . 0.38 111.07 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -48.6 -44.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.448 -1.316 . . . . 1.6599999999999999 107.448 166.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 7.6 m-20 -68.84 -87.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.78 -0.646 . . . . 1.8700000000000001 110.179 162.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -179.85 -56.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.313 -0.403 . . . . 1.3500000000000001 111.631 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . 0.491 ' O ' HG11 ' A' ' 108' ' ' VAL . 1.6 p-10 -94.42 134.38 37.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.802 0.334 . . . . 2.1499999999999999 110.234 -177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.64 HD13 HD13 ' A' ' 144' ' ' LEU . 2.3 mp -119.38 156.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.916 -0.772 . . . . 1.1599999999999999 108.916 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 1.6 p-10 -98.0 152.81 18.88 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.714 -0.847 . . . . 2.1099999999999999 108.714 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.729 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 44.0 m-85 -138.07 169.33 17.98 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.737 -1.208 . . . . 0.96999999999999997 107.737 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.606 ' HA ' ' CB ' ' A' ' 139' ' ' LYS . 3.7 tt0 -160.06 145.04 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.907 0.384 . . . . 0.80000000000000004 110.224 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.624 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -116.59 128.79 55.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.885 -0.598 . . . . 1.9199999999999999 109.472 174.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.624 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -117.08 100.37 7.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.465 -0.939 . . . . 0.63 108.465 176.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.14 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.334 0.588 . . . . 1.49 110.846 -173.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -86.06 124.15 6.75 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.368 -0.833 . . . . 0.26000000000000001 111.831 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.587 HD11 HD11 ' A' ' 120' ' ' ILE . 5.9 mp -95.34 106.49 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.11 0.481 . . . . 1.77 110.569 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.1 m -112.04 94.35 4.9 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.034 -0.985 . . . . 1.0700000000000001 109.228 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -117.35 126.17 74.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.481 -0.562 . . . . 1.6699999999999999 109.481 -175.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.851 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 33.3 t70 -81.71 106.86 13.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 120.394 -0.523 . . . . 1.52 110.296 -172.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.672 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 4.5 mm? -98.32 -178.76 0.75 Allowed Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 125.201 1.563 . . . . 1.9299999999999999 109.994 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.417 ' CD ' ' HB3' ' A' ' 126' ' ' LEU . 15.6 Cg_endo -90.78 -16.4 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.987 1.791 . . . . 0.98999999999999999 113.445 167.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.8 t -73.53 -59.71 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.481 0.548 . . . . 1.6699999999999999 112.481 -170.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.52 ' H ' ' HE1' ' A' ' 132' ' ' PHE . 2.1 t -113.59 -2.22 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 123.417 1.579 . . . . 1.9099999999999999 107.026 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 86.95 -133.94 12.15 Favored Glycine 0 N--CA 1.422 -2.248 0 CA-C-N 111.636 -2.529 . . . . 1.05 108.52 -167.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.851 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 7.2 pt-20 -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.796 0.808 . . . . 1.1599999999999999 110.869 176.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.787 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.2 m-30 -89.68 145.13 25.44 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.524 -0.917 . . . . 2.2799999999999998 108.524 173.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 21.2 m -129.88 94.16 3.66 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.733 -0.387 . . . . 1.8899999999999999 111.452 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -128.57 136.16 28.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.23 173.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.428 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 83.9 Cg_endo -89.34 158.23 5.53 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.866 1.711 . . . . 0.58999999999999997 112.604 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.56 HD13 HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.3 163.94 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 1.1399999999999999 109.384 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -132.83 139.95 47.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.376 -0.374 . . . . 1.28 110.133 -170.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 50.2 m -147.83 101.02 3.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.715 -0.846 . . . . 1.3400000000000001 108.715 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.729 ' HB2' ' O ' ' A' ' 116' ' ' TYR . 13.9 ptmm? -116.53 163.06 16.64 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.45 -0.796 . . . . 2.2000000000000002 111.66 -171.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.14 138.96 5.61 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.42 -0.895 . . . . 0.56000000000000005 111.329 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 115' ' ' ASP . 5.0 mp0 -106.55 126.76 52.68 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.715 -0.742 . . . . 2.1000000000000001 109.416 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.52 174.99 4.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.073 -0.714 . . . . 1.51 109.073 -171.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -57.08 163.13 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.384 0.513 . . . . 3.9300000000000002 112.384 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.64 HD13 HD13 ' A' ' 114' ' ' ILE . 28.5 tp -56.55 127.41 72.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 115.392 -0.822 . . . . 1.9299999999999999 110.423 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.627 ' HD2' HD13 ' A' ' 144' ' ' LEU . 25.1 Cg_endo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.401 2.734 . . . . 0.81000000000000005 113.155 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.501 -0.808 0 N-CA-C 116.528 1.371 . . . . 1.0700000000000001 116.528 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.809 ' HB2' HD22 ' A' ' 122' ' ' LEU . 58.6 m 179.95 49.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.066 1.747 . . . . 1.7 107.167 -174.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.65 154.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.05 -0.977 . . . . 1.53 109.488 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -175.82 -36.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 O-C-N 123.48 0.487 . . . . 1.05 111.623 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 34.7 t70 -163.73 154.26 15.66 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.078 0.466 . . . . 1.6899999999999999 110.591 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.703 HG13 ' HZ ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -151.25 144.69 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.604 -0.517 . . . . 1.8500000000000001 109.604 164.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.35 142.72 51.05 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.023 -0.732 . . . . 1.8300000000000001 109.023 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.764 HD21 HG13 ' A' ' 96' ' ' VAL . 3.3 tm? -101.17 112.24 24.67 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.713 -0.477 . . . . 1.46 109.713 -170.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.13 147.86 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.03 1.395 . . . . 1.9199999999999999 112.368 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 1.8 t70 . . . . . 0 C--N 1.294 -1.826 0 CA-C-N 111.178 -2.737 . . . . 2.8500000000000001 108.039 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 42.2 t . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 108.274 -1.01 . . . . 1.1299999999999999 108.274 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HB ' HD12 ' A' ' 101' ' ' LEU . 35.9 t -83.95 158.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.533 -1.654 . . . . 1.48 106.533 171.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.024 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 12.5 mt-10 -139.19 165.66 26.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.124 -1.065 . . . . 1.1899999999999999 108.124 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.892 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 30.5 p90 -134.63 126.8 29.91 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.22 -1.392 . . . . 3.9399999999999999 112.691 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.91 115.17 20.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.566 -0.853 . . . . 1.4299999999999999 109.364 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . . . -106.39 119.46 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.092 0.472 . . . . 1.1100000000000001 111.924 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.6 tppt? -87.3 102.31 14.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.216 1.007 . . . . 3.1800000000000002 109.449 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.983 HG21 HD12 ' A' ' 92' ' ' ILE . 12.4 t -96.36 156.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.766 -1.106 . . . . 1.3999999999999999 110.33 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.527 ' C ' ' HA ' ' A' ' 25' ' ' SER . 4.1 m -139.45 112.32 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 120.054 -0.659 . . . . 1.1100000000000001 111.33 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 25.9 t -82.64 124.07 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.975 -1.011 . . . . 1.8500000000000001 110.372 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -104.09 114.29 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.267 -0.642 . . . . 1.1000000000000001 109.267 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 13.0 t30 -89.81 126.26 58.23 Favored Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 124.395 1.059 . . . . 1.48 110.133 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.02 3.88 7.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.594 2.863 . . . . 0.91000000000000003 113.999 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.603 ' HE2' ' HD1' ' A' ' 53' ' ' HIS . 13.0 t80 -122.03 143.72 49.33 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.407 -0.59 . . . . 2.3100000000000001 109.407 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.611 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 19.8 p -79.2 28.53 0.23 Allowed 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.434 0.531 . . . . 1.8300000000000001 112.434 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.603 ' HD1' ' HE2' ' A' ' 51' ' ' TYR . 42.3 m80 -143.11 131.04 21.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.416 -0.357 . . . . 2.0299999999999998 110.075 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.5 m -40.76 100.14 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.985 0 C-N-CA 124.212 1.005 . . . . 1.73 112.846 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.96 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.8 pt -74.51 171.14 12.14 Favored Pre-proline 0 C--O 1.21 -1.014 0 N-CA-C 108.073 -1.084 . . . . 1.23 108.073 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HB2' HG12 ' A' ' 57' ' ' ILE . 13.4 Cg_endo -92.9 -63.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.034 1.156 . . . . 0.53000000000000003 114.261 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 79' ' ' PRO . 23.2 mm -128.38 154.76 39.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 1.9099999999999999 111.797 -165.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 124' ' ' ILE . 28.5 p -151.02 -177.46 6.03 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.075 0.941 . . . . 1.95 111.78 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.009 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 39.4 tt0 -135.36 115.86 13.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.379 -1.737 . . . . 1.3600000000000001 109.809 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -98.3 109.52 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.334 1.064 . . . . 1.6499999999999999 109.619 168.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 33.2 p -114.52 102.73 10.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.273 -1.785 . . . . 1.02 108.782 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 p90 -109.69 133.36 53.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.969 0.414 . . . . 0.46000000000000002 110.116 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 12.2 m -125.53 100.82 6.64 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.185 -0.916 . . . . 1.1699999999999999 109.546 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.836 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 10.4 m-85 -97.57 143.78 27.91 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.869 -0.605 . . . . 1.1799999999999999 109.956 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.743 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -146.16 143.74 29.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.904 -1.147 . . . . 1.72 107.904 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.859 ' HB3' HD22 ' A' ' 104' ' ' LEU . 33.0 t -102.02 -93.97 0.3 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.987 -0.685 . . . . 1.6599999999999999 111.421 -174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.94 10.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.545 -0.539 . . . . 1.1200000000000001 109.545 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.44 16.29 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.763 -1.208 . . . . 0.39000000000000001 110.247 165.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.674 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -99.19 -69.76 0.75 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.998 -0.601 . . . . 2.4900000000000002 110.532 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 28.1 tt0 -175.75 170.58 2.83 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.523 -1.288 . . . . 2.6099999999999999 107.523 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.528 ' HB ' ' C ' ' A' ' 64' ' ' PHE . 2.4 mm -136.78 -40.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.146 -1.057 . . . . 1.1100000000000001 108.146 168.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.42 151.48 6.28 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.783 -0.927 . . . . 0.48999999999999999 110.783 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -151.89 155.27 37.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.521 0.661 . . . . 2.3999999999999999 110.771 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.34 177.28 44.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.787 -0.721 . . . . 0.52000000000000002 112.208 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 69.4 mttt -128.26 132.71 48.72 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.662 0.272 . . . . 2.3799999999999999 110.368 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 75' ' ' LYS . 3.2 mp -131.18 110.73 15.39 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 109.463 -0.569 . . . . 1.47 109.463 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.66 105.95 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.276 1.984 . . . . 0.81000000000000005 110.231 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -120.38 146.27 42.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.653 ' HA ' HD11 ' A' ' 57' ' ' ILE . 39.5 Cg_exo -61.36 91.75 0.1 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.215 1.943 . . . . 0.91000000000000003 111.917 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.09 31.3 2.86 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.47999999999999998 111.82 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.96 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 51.4 p -73.33 119.91 18.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.131 -0.692 . . . . 0.85999999999999999 109.131 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -152.51 -164.91 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 118.847 -1.141 . . . . 1.76 113.328 -162.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 91.3 mttt -51.59 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.312 0.856 . . . . 2.4300000000000002 113.312 -173.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 161.38 111.19 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.752 -1.203 . . . . 1.29 107.752 -169.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.699 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 44.1 pttt 42.6 45.53 4.01 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.271 0.982 . . . . 2.21 111.698 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 87' ' ' MET . 6.7 t70 -151.23 -172.29 4.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.499 -0.773 . . . . 0.64000000000000001 109.871 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.8 ttm -117.65 122.23 43.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.347 0.594 . . . . 2.04 110.469 -171.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -112.13 143.66 42.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 1.3300000000000001 110.338 -176.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.81 130.36 36.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.599 0.714 . . . . 1.1100000000000001 110.819 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 45' ' ' VAL . 2.1 tm? -125.56 147.75 49.16 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.763 -1.569 . . . . 1.45 106.763 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.564 ' N ' HD13 ' A' ' 90' ' ' LEU . 4.8 p-10 -124.04 123.72 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.162 -1.015 . . . . 1.8100000000000001 111.573 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.983 HD12 HG21 ' A' ' 45' ' ' VAL . 1.2 mp -90.55 146.53 34.51 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.788 -1.096 . . . . 1.3999999999999999 109.066 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 94' ' ' VAL . 78.0 Cg_exo -52.69 -118.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.121 3.214 . . . . 1.0700000000000001 113.346 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.024 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.6 m -162.97 93.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-O 119.008 -0.52 . . . . 1.1799999999999999 111.437 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.537 HG11 ' HE1' ' A' ' 62' ' ' PHE . 14.8 p -129.52 103.64 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 119.639 -1.913 . . . . 1.1699999999999999 115.962 -172.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.764 HG13 HD21 ' A' ' 31' ' ' LEU . 2.4 p -152.98 97.12 2.86 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.312 -0.868 . . . . 1.71 112.122 162.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.75 ' HB2' HG12 ' A' ' 100' ' ' ILE . 75.4 Cg_exo -46.63 136.62 16.08 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 121.823 1.682 . . . . 0.65000000000000002 112.13 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.51 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 3.5 t80 -51.58 -39.54 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.157 -0.474 . . . . 1.6899999999999999 110.688 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.7 m -62.78 -25.03 68.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.495 -0.32 . . . . 1.49 111.859 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.75 HG12 ' HB2' ' A' ' 97' ' ' PRO . 21.4 mm -76.87 -56.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.77 -0.581 . . . . 1.21 111.453 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.656 ' HG ' HG22 ' A' ' 96' ' ' VAL . 41.7 mt -53.54 -27.82 28.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.759 0.79 . . . . 1.6399999999999999 109.942 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 99' ' ' SER . 53.9 t80 -62.45 -42.04 99.18 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.841 -1.527 . . . . 1.2 109.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.623 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.2 m-80 -74.24 -57.6 3.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.946 0.35 . . . . 0.81999999999999995 111.946 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -60.62 -49.41 77.65 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.32 0.859 . . . . 1.22 113.32 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 144' ' ' LEU . . . -68.25 -26.18 65.55 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.821 0.819 . . . . 1.1899999999999999 110.088 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.623 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.8 ttp180 -66.0 -46.09 79.23 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.529 -1.214 . . . . 2.2200000000000002 110.484 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.9 t0 -82.21 -53.68 5.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.532 0.682 . . . . 0.80000000000000004 112.317 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.479 ' HB ' HG13 ' A' ' 114' ' ' ILE . 6.8 t -85.36 -28.7 6.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.039 -0.664 . . . . 1.5 109.792 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 144' ' ' LEU . . . -75.17 -21.66 77.66 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.575 -0.821 . . . . 0.38 111.607 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -47.84 -44.51 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.976 -1.491 . . . . 1.6599999999999999 106.976 165.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.61 -82.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.517 -0.765 . . . . 1.8700000000000001 110.284 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 179.94 -58.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.811 0.671 . . . . 1.3500000000000001 112.811 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 122.97 39.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.505 -0.316 . . . . 2.1499999999999999 110.634 -172.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.579 HD13 HD12 ' A' ' 144' ' ' LEU . 2.2 mp -111.21 153.2 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.116 0.484 . . . . 1.1599999999999999 109.941 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.5 p-10 -99.26 154.12 18.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.513 -0.767 . . . . 2.1099999999999999 109.219 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -139.15 154.22 48.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.732 -0.84 . . . . 0.96999999999999997 108.732 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.732 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 35.0 tt0 -142.05 135.74 29.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 0.80000000000000004 110.395 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.836 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -105.31 134.04 49.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.307 -0.86 . . . . 1.9199999999999999 109.502 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.73 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.93 101.19 7.41 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.533 -0.543 . . . . 0.63 109.533 171.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 118' ' ' LEU . 7.2 tp -108.04 118.07 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 1.49 110.63 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.59 129.84 10.05 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.98 -0.848 . . . . 0.26000000000000001 110.98 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.809 HD22 ' HB2' ' A' ' 25' ' ' SER . 2.7 mm? -108.9 105.82 15.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.337 0.589 . . . . 1.77 112.348 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.009 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 77.3 m -100.13 95.6 6.94 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.813 -1.085 . . . . 1.0700000000000001 109.241 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 58' ' ' CYS . 6.3 pt -109.35 138.12 38.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 120.644 -0.422 . . . . 1.6699999999999999 111.732 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.18 108.13 16.21 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.45 -0.945 . . . . 1.52 108.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.744 HD23 HG21 ' A' ' 55' ' ' ILE . 17.7 mt -120.29 156.75 54.87 Favored Pre-proline 0 C--O 1.217 -0.636 0 O-C-N 124.884 1.365 . . . . 1.9299999999999999 110.273 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.0 Cg_exo -70.87 -21.29 28.52 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.123 1.882 . . . . 0.98999999999999999 112.24 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.95 -57.1 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.073 -0.512 . . . . 1.6699999999999999 112.195 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.8 OUTLIER -106.72 -1.63 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 122.007 0.908 . . . . 1.9099999999999999 109.698 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.52 -32.05 1.19 Allowed Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.163 -1.381 . . . . 1.05 111.264 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.8 pt-20 -174.34 141.39 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.116 -1.438 . . . . 1.1599999999999999 107.116 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -146.0 135.44 23.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.39 -0.596 . . . . 2.2799999999999998 109.39 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.3 t -117.38 105.8 12.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.868 0.842 . . . . 1.8899999999999999 111.347 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.49 138.73 33.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.41 -0.813 . . . . 1.26 110.249 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.579 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 94.7 Cg_endo -95.82 165.62 1.36 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.168 1.912 . . . . 0.58999999999999997 113.602 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.472 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -160.89 167.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.55 -1.278 . . . . 1.1399999999999999 107.55 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 83.5 p -140.1 155.83 46.84 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.215 -0.594 . . . . 1.28 112.225 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 t -144.54 103.2 3.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.231 -1.025 . . . . 1.3400000000000001 108.231 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.732 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -108.17 148.63 29.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.549 -0.296 . . . . 2.2000000000000002 110.24 -177.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.94 141.5 7.1 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.809 -0.71 . . . . 0.56000000000000005 111.676 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 1.6 mp0 -104.73 127.82 52.63 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.927 -0.636 . . . . 2.1000000000000001 109.297 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -147.92 173.02 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.724 0.297 . . . . 1.51 110.314 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.85 159.99 1.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.08 0.77 . . . . 3.9300000000000002 113.08 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.587 HD12 ' HD2' ' A' ' 145' ' ' PRO . 25.9 tp -56.82 132.16 78.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.088 -0.96 . . . . 1.9299999999999999 110.333 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.587 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.7 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.055 2.503 . . . . 0.81000000000000005 112.773 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.798 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.432 -1.61 0 N-CA-C 114.091 0.397 . . . . 1.0700000000000001 114.091 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.605 ' OG ' HG23 ' A' ' 47' ' ' VAL . 11.4 m -170.78 36.55 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.795 1.238 . . . . 1.7 108.023 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 46' ' ' SER . 27.6 m -133.12 154.3 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.098 -1.41 . . . . 1.53 109.226 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -168.79 -41.3 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.546 0.529 . . . . 1.05 110.595 168.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 1.046 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 27.2 t70 -173.21 160.18 4.01 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.354 -0.239 . . . . 1.6899999999999999 110.354 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.406 HG11 ' CD1' ' A' ' 41' ' ' TYR . 56.0 t -137.66 135.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.143 -0.317 . . . . 1.8500000000000001 110.143 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 17.6 m-20 -108.18 122.68 47.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.362 -0.381 . . . . 1.8300000000000001 111.311 -173.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.516 . . . . 1.46 110.335 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CG ' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -125.53 -122.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.617 -0.512 . . . . 1.9199999999999999 109.617 169.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.813 ' HA ' HG12 ' A' ' 39' ' ' VAL . 4.0 p30 . . . . . 0 CA--C 1.507 -0.683 0 C-N-CA 122.446 0.298 . . . . 2.8500000000000001 110.296 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.518 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 13.8 t . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 106.453 -1.684 . . . . 1.1299999999999999 106.453 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 33' ' ' ASP . 12.2 t -128.78 162.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.016 -1.105 . . . . 1.48 108.016 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.8 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 63.3 mt-10 -123.58 144.55 49.51 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.767 -0.773 . . . . 1.1899999999999999 112.144 -170.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -126.33 103.91 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.014 -0.994 . . . . 3.9399999999999999 110.672 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -81.05 109.15 15.34 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.075 -1.083 . . . . 1.4299999999999999 108.075 176.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.66 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -111.0 114.61 28.05 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.673 -0.411 . . . . 1.1100000000000001 110.518 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 1.046 ' HD3' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -83.62 134.88 34.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.287 -1.005 . . . . 3.1800000000000002 108.287 173.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 90' ' ' LEU . 40.8 t -113.18 148.47 16.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.052 -0.976 . . . . 1.3999999999999999 110.12 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.604 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 3.6 m -133.6 101.37 5.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.344 0.592 . . . . 1.1100000000000001 110.7 170.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.798 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 59.6 t -83.42 124.79 39.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 114.901 -1.045 . . . . 1.8500000000000001 110.721 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.8 m -108.49 118.28 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.251 -0.431 . . . . 1.1000000000000001 110.206 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 2.8 p30 -96.54 146.21 30.91 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.429 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -90.17 4.51 4.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.921 3.081 . . . . 0.91000000000000003 114.771 -174.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.676 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 3.8 t80 -95.27 -113.52 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 119.514 -0.874 . . . . 2.3100000000000001 110.173 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 50.0 p -165.32 20.09 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.866 -1.061 . . . . 1.8300000000000001 108.468 171.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -146.22 158.33 43.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 2.0299999999999998 110.871 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.677 ' HA ' HD22 ' A' ' 82' ' ' LEU . 31.4 t -55.95 104.11 0.12 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.198 -1.364 . . . . 1.73 111.678 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.892 HG23 HD22 ' A' ' 126' ' ' LEU . 8.8 pt -79.06 123.3 84.99 Favored Pre-proline 0 C--O 1.213 -0.848 0 C-N-CA 120.442 -0.503 . . . . 1.23 109.911 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.1 Cg_endo -63.06 -55.12 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.796 1.664 . . . . 0.53000000000000003 112.942 -159.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 79' ' ' PRO . 23.4 mm -130.73 154.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.218 -0.593 . . . . 1.9099999999999999 111.088 -172.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.59 ' HB3' HG23 ' A' ' 124' ' ' ILE . 26.6 p -147.17 178.19 8.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.106 0.955 . . . . 1.95 111.697 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.025 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 4.5 tm-20 -140.43 112.84 7.91 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.53 -1.668 . . . . 1.3600000000000001 109.442 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.621 HG21 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -99.33 115.09 39.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.536 -1.665 . . . . 1.6499999999999999 111.373 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -110.33 103.09 11.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.697 -1.592 . . . . 1.02 108.51 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.7 p90 -109.46 132.62 53.96 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.482 0.658 . . . . 0.46000000000000002 109.546 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.762 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 29.0 m -128.41 102.06 6.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.074 -0.967 . . . . 1.1699999999999999 109.55 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 118' ' ' LEU . 97.9 m-85 -96.41 139.45 32.51 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.752 -0.833 . . . . 1.1799999999999999 108.752 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.743 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -146.29 138.14 24.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 1.72 109.056 175.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.743 ' CB ' HD23 ' A' ' 104' ' ' LEU . 47.6 t -95.5 -98.77 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.458 -0.497 . . . . 1.6599999999999999 111.384 -173.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -56.78 -60.05 4.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.279 0.562 . . . . 1.1200000000000001 109.564 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.23 18.21 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.269 -1.533 . . . . 0.39000000000000001 109.269 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -103.44 -56.04 2.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.233 -0.484 . . . . 2.4900000000000002 111.069 -173.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 31.1 tt0 171.49 176.96 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.761 -1.57 . . . . 2.6099999999999999 106.761 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 1.078 ' HA ' HG22 ' A' ' 100' ' ' ILE . 4.4 mm -145.4 -47.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 C-N-CA 124.425 1.09 . . . . 1.1100000000000001 108.529 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.33 121.44 0.59 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.229 -0.986 . . . . 0.48999999999999999 112.011 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -124.49 163.92 20.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.687 0.756 . . . . 2.3999999999999999 111.901 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.01 169.66 26.76 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.091 -1.204 . . . . 0.52000000000000002 110.091 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HB2' ' OE2' ' A' ' 59' ' ' GLU . 10.6 ptmm? -144.12 135.02 25.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.632 0.716 . . . . 2.3799999999999999 111.22 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 52.9 mt -139.98 138.22 19.3 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.723 -0.671 . . . . 1.47 110.152 -173.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 4.2 Cg_exo -78.0 125.9 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.484 2.122 . . . . 0.81000000000000005 111.208 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -130.86 146.16 60.86 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.47 -0.567 . . . . 0.79000000000000004 109.47 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.547 ' HA ' HD11 ' A' ' 57' ' ' ILE . 20.0 Cg_exo -66.61 92.31 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.245 1.963 . . . . 0.91000000000000003 111.794 174.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.1 25.39 17.43 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.47999999999999998 112.267 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.729 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 82.6 p -70.39 119.84 15.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.741 -0.837 . . . . 0.85999999999999999 108.741 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.741 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -141.18 -159.5 0.97 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.837 1.051 . . . . 1.76 113.837 -159.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 60.5 mttm -52.16 -95.98 0.0 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.821 -1.081 . . . . 2.4300000000000002 112.801 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 168.84 113.44 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.862 -1.162 . . . . 1.29 107.862 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 7.7 ptmm? 41.02 51.38 3.28 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.029 0.83 . . . . 2.21 112.02 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.1 t70 -161.83 -171.42 2.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.024 -0.535 . . . . 0.64000000000000001 111.008 -169.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.604 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.2 ttm -112.27 118.68 35.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 2.04 111.23 -169.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.741 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.0 t -106.36 144.45 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 1.3300000000000001 110.655 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.87 118.0 24.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 111.032 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 45' ' ' VAL . 6.4 tt -119.58 175.7 5.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.765 -1.198 . . . . 1.45 107.765 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.404 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.5 m-20 -136.57 143.03 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.739 0.7 . . . . 1.8100000000000001 111.799 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 41.8 mm -113.66 130.18 24.01 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.173 -1.417 . . . . 1.3999999999999999 107.173 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 42' ' ' LEU . 62.1 Cg_exo -50.42 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.344 2.696 . . . . 1.0700000000000001 114.36 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -163.4 91.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 O-C-N 122.112 -0.368 . . . . 1.1799999999999999 111.375 -176.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.3 p -127.34 103.19 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.085 1.143 . . . . 1.1699999999999999 114.085 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 101' ' ' LEU . 2.5 p -154.52 99.61 2.45 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 120.718 -0.393 . . . . 1.71 111.473 160.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 5.8 Cg_endo -49.88 137.72 35.15 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.192 1.928 . . . . 0.65000000000000002 112.506 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.518 ' H ' ' HA ' ' A' ' 38' ' ' SER . 21.6 t80 -53.81 -32.03 51.24 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.769 -0.65 . . . . 1.6899999999999999 111.45 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.8 m -53.21 -31.6 43.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 1.49 111.882 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 1.078 HG22 ' HA ' ' A' ' 71' ' ' ILE . 37.5 mm -76.27 -57.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.828 0.823 . . . . 1.21 111.501 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 1.064 HD23 HD21 ' A' ' 104' ' ' LEU . 2.0 mm? -54.23 -26.68 29.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.393 -1.73 . . . . 1.6399999999999999 110.827 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' SER . 79.1 t80 -64.56 -45.76 85.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.239 -1.346 . . . . 1.2 108.568 177.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.05 -56.72 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.708 -0.678 . . . . 0.81999999999999995 111.799 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 1.064 HD21 HD23 ' A' ' 101' ' ' LEU . 2.2 pp -61.08 -52.72 63.75 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.129 0.788 . . . . 1.22 113.129 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.443 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.6 -25.48 67.41 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.852 0.834 . . . . 1.1899999999999999 110.347 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.462 ' HE ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 ttp180 -64.98 -52.15 57.77 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.671 -1.15 . . . . 2.2200000000000002 110.092 174.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.4 t70 -82.88 -52.83 6.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.55 0.691 . . . . 0.80000000000000004 112.342 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -85.34 -28.45 6.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 121.714 -0.616 . . . . 1.5 110.035 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.15 -20.67 80.02 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.705 -0.759 . . . . 0.38 111.499 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -49.35 -47.14 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.049 -1.463 . . . . 1.6599999999999999 107.049 165.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.7 m-20 -66.8 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 1.8700000000000001 109.761 162.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 178.17 -54.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.543 0.527 . . . . 1.3500000000000001 111.545 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.57 128.87 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.175 0.512 . . . . 2.1499999999999999 111.067 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.559 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.7 mp -112.67 155.94 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.668 -0.696 . . . . 1.1599999999999999 110.197 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -98.09 153.43 18.43 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.081 -0.711 . . . . 2.1099999999999999 109.081 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 61.3 m-85 -140.13 166.13 25.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.639 -0.874 . . . . 0.96999999999999997 108.639 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.845 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 28.4 tt0 -157.0 137.45 13.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.871 0.367 . . . . 0.80000000000000004 110.925 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.67 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 14.2 tp -103.65 133.11 49.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.792 -0.64 . . . . 1.9199999999999999 110.018 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.762 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -118.8 100.18 7.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.399 -0.963 . . . . 0.63 108.399 172.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.621 HD11 HG21 ' A' ' 60' ' ' ILE . 7.2 tp -112.21 114.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.195 0.521 . . . . 1.49 111.207 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -91.8 142.53 16.1 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.644 -0.982 . . . . 0.26000000000000001 110.644 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.735 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.8 mm? -121.48 122.32 39.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.3 0.571 . . . . 1.77 112.469 -173.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.025 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.9 m -116.37 96.1 5.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.844 -1.071 . . . . 1.0700000000000001 108.994 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.638 ' HB ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -108.1 140.86 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.367 -0.533 . . . . 1.6699999999999999 110.607 -175.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.63 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.1 m-20 -84.81 105.87 15.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.406 -0.961 . . . . 1.52 108.406 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.892 HD22 HG23 ' A' ' 55' ' ' ILE . 17.5 mt -111.07 143.38 28.23 Favored Pre-proline 0 C--O 1.219 -0.54 0 O-C-N 125.247 1.592 . . . . 1.9299999999999999 109.158 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.4 -25.0 71.38 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.158 1.905 . . . . 0.98999999999999999 114.08 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.527 HG21 ' HE2' ' A' ' 51' ' ' TYR . 60.1 t -74.65 -58.64 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.846 0.684 . . . . 1.6699999999999999 112.846 -174.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 40.1 t -105.37 -2.85 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 122.798 1.285 . . . . 1.9099999999999999 109.523 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.48 -0.84 53.91 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 113.479 -1.691 . . . . 1.05 111.852 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.6 pt-20 -176.49 174.07 1.96 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.523 -0.547 . . . . 1.1599999999999999 109.523 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.519 ' HB2' HD13 ' A' ' 126' ' ' LEU . 8.3 t80 -170.74 124.07 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.337 -0.986 . . . . 2.2799999999999998 108.337 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.8 t -114.16 102.85 10.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.87 0.843 . . . . 1.8899999999999999 111.687 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.5 pp -127.96 144.99 53.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 1.26 110.137 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.684 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 58.6 Cg_endo -96.44 162.43 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.223 1.948 . . . . 0.58999999999999997 113.134 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.479 HG21 HG22 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -160.39 167.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.765 -1.198 . . . . 1.1399999999999999 107.765 179.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.518 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 88.7 p -146.17 159.17 43.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.599 0.592 . . . . 1.28 112.599 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -151.0 109.83 3.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.851 -0.796 . . . . 1.3400000000000001 108.851 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.845 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -107.43 148.0 29.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 2.2000000000000002 110.217 -179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.38 142.59 8.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.701 -0.762 . . . . 0.56000000000000005 111.866 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -113.07 133.99 54.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.125 -0.538 . . . . 2.1000000000000001 110.391 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.49 174.96 7.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.525 -0.917 . . . . 1.51 108.525 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -69.13 175.25 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.87 0.367 . . . . 3.9300000000000002 111.599 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 145' ' ' PRO . 21.9 tp -57.15 136.37 80.72 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 1.9299999999999999 111.694 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.682 ' HD2' HD11 ' A' ' 144' ' ' LEU . 72.5 Cg_endo . . . . . 0 CA--C 1.53 0.293 0 C-N-CA 123.523 2.815 . . . . 0.81000000000000005 112.902 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.55 0 N-CA-C 116.973 1.549 . . . . 1.0700000000000001 116.973 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 45' ' ' VAL . 99.7 p -161.53 35.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.38 -2.082 . . . . 1.7 105.38 170.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.27 154.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.808 -1.996 . . . . 1.53 108.39 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 7.8 t -173.17 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.365 0.416 . . . . 1.05 111.933 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 4.4 t70 -164.41 156.44 16.34 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.117 -0.364 . . . . 1.6899999999999999 110.112 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -143.85 132.7 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.57 -0.53 . . . . 1.8500000000000001 109.57 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.731 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 23.2 m-20 -112.94 124.08 51.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.798 0.333 . . . . 1.8300000000000001 111.121 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.526 HD21 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -87.69 121.04 29.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.045 -0.525 . . . . 1.46 109.737 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HD3' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -133.5 -127.04 0.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.571 -0.529 . . . . 1.9199999999999999 109.571 171.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.663 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.6 p30 . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 112.419 0.526 . . . . 2.8500000000000001 112.419 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.557 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 36.3 t . . . . . 0 N--CA 1.432 -1.362 0 N-CA-C 105.599 -2.0 . . . . 1.1299999999999999 105.599 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 1.056 HG21 HG13 ' A' ' 96' ' ' VAL . 13.8 m -129.29 179.55 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 109.356 -0.609 . . . . 1.48 109.356 164.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.934 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 74.5 mt-10 -123.49 142.44 51.0 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.904 -0.718 . . . . 1.1899999999999999 112.4 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -123.39 104.16 8.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.124 -0.944 . . . . 3.9399999999999999 109.726 176.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.731 ' HB3' ' HB2' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -75.92 111.29 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.971 -1.122 . . . . 1.4299999999999999 107.971 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.726 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.68 109.7 21.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.697 0.76 . . . . 1.1100000000000001 109.944 -175.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.651 ' HZ1' HD11 ' A' ' 42' ' ' LEU . 41.3 mmtm -83.68 123.53 29.92 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.702 -1.136 . . . . 3.1800000000000002 108.934 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 25' ' ' SER . 55.4 t -111.45 138.92 38.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.625 -0.716 . . . . 1.3999999999999999 111.118 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.604 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 3.5 m -133.93 100.0 4.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.368 0.604 . . . . 1.1100000000000001 110.16 168.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.9 t -82.38 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.115 -0.948 . . . . 1.8500000000000001 111.011 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.551 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.2 m -109.59 109.59 20.4 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.318 -0.623 . . . . 1.1000000000000001 109.318 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -96.8 125.44 46.6 Favored Pre-proline 0 C--O 1.24 0.563 0 O-C-N 124.28 0.987 . . . . 1.48 109.404 175.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 18.1 Cg_endo -112.32 39.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.4 3.4 . . . . 0.91000000000000003 116.513 -169.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CZ ' HG23 ' A' ' 128' ' ' VAL . 10.7 t80 -116.32 -10.82 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.03 1.287 . . . . 2.3100000000000001 112.18 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.619 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 54.4 p 86.91 26.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.837 1.655 . . . . 1.8300000000000001 109.401 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -147.46 123.67 10.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.265 -1.334 . . . . 2.0299999999999998 109.297 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.839 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.0 m -49.03 104.69 0.07 Allowed 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 122.926 0.49 . . . . 1.73 112.045 172.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.92 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.65 170.52 14.85 Favored Pre-proline 0 C--O 1.209 -1.07 0 N-CA-C 108.161 -1.051 . . . . 1.23 108.161 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.59 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.3 Cg_endo -92.87 -63.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.731 1.621 . . . . 0.53000000000000003 114.395 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 79' ' ' PRO . 12.4 mm -128.29 160.62 38.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 121.079 -0.248 . . . . 1.9099999999999999 110.721 -167.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.584 ' CB ' HG23 ' A' ' 124' ' ' ILE . 25.6 p -156.58 -177.52 6.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 122.116 0.96 . . . . 1.95 112.772 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.07 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 26.2 tt0 -133.04 117.1 17.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.184 -1.825 . . . . 1.3600000000000001 109.845 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.742 HG23 HD13 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -97.26 109.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 121.997 0.903 . . . . 1.6499999999999999 109.018 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 19.4 p -112.76 102.76 10.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.005 -1.452 . . . . 1.02 108.908 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 4.6 p90 -112.07 124.9 53.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.467 -0.568 . . . . 0.46000000000000002 109.467 -168.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 6.6 m -121.9 106.11 10.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.21 -0.904 . . . . 1.1699999999999999 108.703 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.592 ' CZ ' HD12 ' A' ' 118' ' ' LEU . 86.1 m-85 -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.935 -0.395 . . . . 1.1799999999999999 109.935 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -126.78 144.53 50.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.569 -0.9 . . . . 1.72 108.569 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.453 ' HB3' HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.48 -112.75 0.16 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.156 -0.475 . . . . 1.6599999999999999 111.298 177.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -64.31 -51.18 64.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.684 -0.858 . . . . 1.1200000000000001 108.684 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.427 ' H ' HH11 ' A' ' 69' ' ' ARG . . . -161.58 12.74 0.13 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.405 -1.078 . . . . 0.39000000000000001 110.405 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.583 ' HE ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -112.62 -164.99 0.95 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.715 -0.846 . . . . 2.4900000000000002 108.715 -175.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.92 98.23 7.74 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.259 0.552 . . . . 2.6099999999999999 109.868 -169.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.935 ' HA ' HG22 ' A' ' 100' ' ' ILE . 2.8 mm -52.25 -34.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.145 -0.934 . . . . 1.1100000000000001 110.358 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.74 170.9 27.11 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.823 -0.911 . . . . 0.48999999999999999 110.823 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.09 163.98 23.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.011 0.906 . . . . 2.3999999999999999 111.691 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.72 170.42 34.15 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.318 -0.856 . . . . 0.52000000000000002 110.995 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HB3' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 133.68 27.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.936 0.398 . . . . 2.3799999999999999 110.734 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.69 123.13 17.1 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.049 -0.523 . . . . 1.47 110.457 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.8 116.16 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.427 2.084 . . . . 0.81000000000000005 110.713 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.85 140.48 37.82 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 121.17 -0.212 . . . . 0.79000000000000004 110.501 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.657 ' HA ' HD11 ' A' ' 57' ' ' ILE . 21.1 Cg_endo -61.26 88.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.821 2.347 . . . . 0.91000000000000003 112.46 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.56 43.08 2.77 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.802 -0.636 . . . . 0.47999999999999998 111.801 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.92 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.6 p -74.08 121.9 21.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.878 -0.415 . . . . 0.85999999999999999 109.878 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -164.66 170.69 15.34 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.41 1.633 . . . . 1.76 115.41 -163.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.888 ' HG3' ' HB3' ' A' ' 86' ' ' ASP . 71.4 mmtt 7.57 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.859 1.664 . . . . 2.4300000000000002 114.031 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 172.0 -44.23 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.622 -1.992 . . . . 1.29 105.622 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.6 ttpt -159.65 71.08 0.48 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 112.131 -2.304 . . . . 2.21 110.162 173.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.888 ' HB3' ' HG3' ' A' ' 83' ' ' LYS . 6.9 t70 -162.24 -161.66 0.76 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.011 -1.45 . . . . 0.64000000000000001 108.809 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.586 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 47.9 ttm -121.3 122.16 39.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.858 -0.423 . . . . 2.04 109.858 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 46' ' ' SER . 2.7 t -104.45 143.04 33.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.119 -0.492 . . . . 1.3300000000000001 109.709 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.93 123.35 31.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 1.1100000000000001 110.781 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.591 HD22 HG12 ' A' ' 45' ' ' VAL . 8.7 tt -130.64 164.5 24.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.137 -1.431 . . . . 1.45 107.137 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.65 142.28 32.04 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.173 -1.011 . . . . 1.8100000000000001 111.764 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.726 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 35.3 mm -100.83 143.39 26.49 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.724 -1.213 . . . . 1.3999999999999999 107.724 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.539 ' O ' HD23 ' A' ' 42' ' ' LEU . 81.9 Cg_exo -48.15 -107.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.212 2.608 . . . . 1.0700000000000001 114.0 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.41 94.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 O-C-N 121.617 -0.677 . . . . 1.1799999999999999 111.979 -172.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.4 p -127.49 103.02 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.581 1.326 . . . . 1.1699999999999999 114.581 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 1.056 HG13 HG21 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -151.98 112.89 2.9 Favored Pre-proline 0 C--O 1.219 -0.517 0 O-C-N 121.712 -0.618 . . . . 1.71 110.332 157.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 4.8 Cg_endo -53.98 135.16 62.73 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.38 1.387 . . . . 0.65000000000000002 111.619 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.557 ' H ' ' HA ' ' A' ' 38' ' ' SER . 22.8 t80 -55.58 -30.7 61.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.762 -0.654 . . . . 1.6899999999999999 110.912 -177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.2 p -58.14 -28.78 65.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.995 -0.548 . . . . 1.49 112.32 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.935 HG22 ' HA ' ' A' ' 71' ' ' ILE . 8.3 mm -77.51 -52.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.031 -0.418 . . . . 1.21 111.014 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 1.064 HD22 HD22 ' A' ' 104' ' ' LEU . 21.3 mt -50.75 -27.01 6.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.5 0.666 . . . . 1.6399999999999999 110.185 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.673 ' HB3' ' O ' ' A' ' 99' ' ' SER . 46.9 t80 -63.81 -42.5 97.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.472 -1.24 . . . . 1.2 108.917 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.663 ' HA ' HH21 ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.24 -57.59 3.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.665 -0.698 . . . . 0.81999999999999995 111.789 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 1.064 HD22 HD22 ' A' ' 101' ' ' LEU . 3.2 pp -57.36 -50.13 73.93 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.926 0.714 . . . . 1.22 112.926 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' N ' HD12 ' A' ' 104' ' ' LEU . . . -68.95 -26.72 65.2 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.497 0.665 . . . . 1.1899999999999999 110.274 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.663 HH21 ' HA ' ' A' ' 103' ' ' ASN . 2.7 ttp180 -68.0 -54.49 18.12 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.238 -0.892 . . . . 2.2200000000000002 110.222 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.64 -53.93 6.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.80000000000000004 111.277 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.613 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.6 t -89.05 -28.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.415 -0.514 . . . . 1.5 110.57 -174.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -68.33 -25.29 74.77 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.063 -1.065 . . . . 0.38 111.416 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -53.7 -46.77 62.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.475 -1.305 . . . . 1.6599999999999999 107.475 168.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 15.2 m-20 -68.01 -61.28 1.94 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.712 0.634 . . . . 1.8700000000000001 112.712 169.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER 153.48 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.209 1.004 . . . . 1.3500000000000001 113.593 -173.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.5 128.82 38.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.101 0.56 . . . . 2.1499999999999999 111.006 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 104' ' ' LEU . 3.3 mp -110.69 155.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.842 -0.429 . . . . 1.1599999999999999 109.842 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 15.1 p-10 -98.41 153.05 18.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.988 -0.745 . . . . 2.1099999999999999 108.988 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 74.4 m-85 -143.62 165.44 27.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.96999999999999997 108.696 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.704 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.5 tt0 -153.16 135.94 15.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 0.80000000000000004 110.307 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.592 HD12 ' CZ ' ' A' ' 64' ' ' PHE . 11.4 tp -104.72 130.76 52.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.821 -0.437 . . . . 1.9199999999999999 109.821 171.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -117.16 100.29 7.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.469 -0.937 . . . . 0.63 108.469 176.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.742 HD13 HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -119.94 120.42 63.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.617 0.722 . . . . 1.49 111.137 -171.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.77 129.13 9.47 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.228 -0.896 . . . . 0.26000000000000001 112.101 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.555 HD13 ' OG ' ' A' ' 25' ' ' SER . 4.8 mp -100.84 92.98 5.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 1.77 110.907 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.07 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.5 m -94.18 95.93 9.28 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.942 -0.762 . . . . 1.0700000000000001 108.942 172.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.584 HG23 ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.93 137.84 43.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.148 -0.621 . . . . 1.6699999999999999 110.761 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 7.2 t70 -79.52 106.74 11.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.799 -1.186 . . . . 1.52 107.799 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.471 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 6.7 mt -113.5 166.05 12.07 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.467 -0.788 . . . . 1.9299999999999999 110.648 -171.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.24 -16.76 15.35 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 121.914 1.743 . . . . 0.98999999999999999 111.867 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.407 HG23 ' CZ ' ' A' ' 51' ' ' TYR . 3.0 t -75.18 -59.7 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.433 0.531 . . . . 1.6699999999999999 112.433 -174.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 131' ' ' GLU . 2.8 t -111.7 -0.2 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 122.643 1.211 . . . . 1.9099999999999999 108.891 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 80.48 -28.62 2.68 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 113.453 -1.703 . . . . 1.05 111.267 -170.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.8 pt-20 -175.35 143.69 0.66 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.087 -1.079 . . . . 1.1599999999999999 108.087 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.5 t80 -155.7 145.47 21.28 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.638 -0.504 . . . . 2.2799999999999998 109.638 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.6 t -113.23 107.94 16.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.581 0.705 . . . . 1.8899999999999999 110.922 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.5 pp -115.12 128.29 26.07 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.701 -0.852 . . . . 1.26 108.701 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.575 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 19.6 Cg_endo -89.3 160.02 5.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 121.759 1.64 . . . . 0.58999999999999997 112.735 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.412 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -155.53 166.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.972 -1.122 . . . . 1.1399999999999999 107.972 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.1 m -139.98 153.19 46.81 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.782 -0.367 . . . . 1.28 111.304 -168.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.0 t -143.84 105.72 4.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.269 -1.011 . . . . 1.3400000000000001 108.269 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.704 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.29 149.07 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.627 -0.26 . . . . 2.2000000000000002 110.788 -176.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.04 148.19 16.28 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.517 -0.849 . . . . 0.56000000000000005 112.131 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -106.1 124.48 49.64 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.807 -0.812 . . . . 2.1000000000000001 108.807 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.43 173.07 13.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.238 -0.653 . . . . 1.51 109.238 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -55.39 160.3 2.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.543 0.687 . . . . 3.9300000000000002 112.358 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.681 HD13 ' HD2' ' A' ' 145' ' ' PRO . 24.6 tp -56.29 134.78 75.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.776 -1.102 . . . . 1.9299999999999999 110.658 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.681 ' HD2' HD13 ' A' ' 144' ' ' LEU . 35.5 Cg_endo . . . . . 0 C--N 1.344 0.297 0 C-N-CA 122.787 2.325 . . . . 0.81000000000000005 111.524 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 115.976 1.151 . . . . 1.0700000000000001 115.976 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.663 ' O ' HG11 ' A' ' 45' ' ' VAL . 79.6 p -162.15 31.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.964 -1.495 . . . . 1.7 106.964 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.7 m -132.79 153.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.209 -1.36 . . . . 1.53 109.665 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.46 -43.89 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.782 0.676 . . . . 1.05 110.407 169.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -169.67 145.27 3.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 122.287 -0.258 . . . . 1.6899999999999999 110.518 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 96.5 t -119.05 132.74 68.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.387 -0.597 . . . . 1.8500000000000001 109.387 173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.92 137.19 54.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.87 0.367 . . . . 1.8300000000000001 111.147 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.58 126.06 38.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.853 -0.612 . . . . 1.46 111.532 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -130.66 -131.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.774 -0.825 . . . . 1.9199999999999999 108.774 167.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.957 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.2 p-10 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 119.239 0.927 . . . . 2.8500000000000001 111.83 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.528 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 14.3 m . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 106.33 -1.73 . . . . 1.1299999999999999 106.33 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 33' ' ' ASP . 28.4 t -130.64 165.56 30.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.381 -0.97 . . . . 1.48 108.381 167.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.794 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 2.8 mt-10 -125.25 139.37 53.78 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.381 0.61 . . . . 1.1899999999999999 111.528 -172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.763 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.3 106.57 9.95 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.15 -0.932 . . . . 3.9399999999999999 109.746 -176.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 4.8 tt -88.72 111.8 22.41 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.445 -1.302 . . . . 1.4299999999999999 109.892 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.71 116.82 30.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.201 -0.909 . . . . 1.1100000000000001 109.65 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -83.35 131.62 35.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.453 -0.943 . . . . 3.1800000000000002 108.453 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 25' ' ' SER . 44.5 t -111.17 142.08 24.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.115 -0.948 . . . . 1.3999999999999999 110.92 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.7 m -131.79 99.45 4.77 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.006 0.431 . . . . 1.1100000000000001 109.905 167.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 62.2 t -82.46 127.9 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.576 -0.738 . . . . 1.8500000000000001 110.537 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.68 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.9 m -107.79 113.82 27.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.293 -0.632 . . . . 1.1000000000000001 109.293 176.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.848 ' HB3' HD22 ' A' ' 82' ' ' LEU . 29.3 p-10 -90.54 140.23 26.7 Favored Pre-proline 0 N--CA 1.461 0.117 0 O-C-N 123.864 0.727 . . . . 1.48 110.164 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.49 ' HD2' HD22 ' A' ' 126' ' ' LEU . 66.9 Cg_endo -96.36 6.22 1.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.891 3.061 . . . . 0.91000000000000003 115.399 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 24.4 t80 -97.18 -113.03 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.855 -0.738 . . . . 2.3100000000000001 110.08 -172.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.745 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 77.5 p 179.98 19.66 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 117.964 0.347 . . . . 1.8300000000000001 111.263 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -139.09 19.86 2.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.736 0.643 . . . . 2.0299999999999998 112.736 -168.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.825 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 31.7 t 57.79 96.57 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 111.955 0.354 . . . . 1.73 111.955 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -73.94 170.71 13.36 Favored Pre-proline 0 C--O 1.209 -1.055 0 N-CA-C 108.62 -0.881 . . . . 1.23 108.62 -172.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.54 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.0 Cg_endo -92.79 -61.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.797 1.665 . . . . 0.53000000000000003 113.935 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 79' ' ' PRO . 17.0 mm -125.95 154.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.217 -0.593 . . . . 1.9099999999999999 111.479 -166.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.635 ' SG ' HG21 ' A' ' 124' ' ' ILE . 26.4 m -145.16 176.43 9.52 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.083 0.944 . . . . 1.95 111.475 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.047 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 2.4 tm-20 -141.86 114.39 8.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.565 -1.652 . . . . 1.3600000000000001 109.885 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.516 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -103.31 121.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.387 1.089 . . . . 1.6499999999999999 112.307 173.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.731 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.41 109.66 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.107 -1.861 . . . . 1.02 109.74 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.659 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.0 p90 -114.06 122.82 48.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.141 0.496 . . . . 0.46000000000000002 110.129 -169.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 26.8 m -122.07 109.61 14.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.524 -0.762 . . . . 1.1699999999999999 109.586 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.484 ' CE1' HD23 ' A' ' 118' ' ' LEU . 97.9 m-85 -98.6 141.2 31.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.036 -0.529 . . . . 1.1799999999999999 110.707 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.3 m170 -131.94 145.74 51.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.64 -1.245 . . . . 1.72 107.64 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.901 ' HB3' HD21 ' A' ' 104' ' ' LEU . 47.9 t -109.98 -100.32 0.39 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.196 -1.002 . . . . 1.6599999999999999 111.025 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.71 -56.8 16.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.231 -0.655 . . . . 1.1200000000000001 109.231 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 18.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.589 -1.404 . . . . 0.39000000000000001 109.589 162.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -105.85 -156.56 0.58 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.738 -0.838 . . . . 2.4900000000000002 108.738 -175.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.16 94.98 4.78 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.709 0.686 . . . . 2.6099999999999999 110.098 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.878 ' HA ' HG23 ' A' ' 100' ' ' ILE . 2.8 mm -56.55 -39.25 61.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.904 -1.043 . . . . 1.1100000000000001 110.892 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.58 169.26 34.25 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.328 -0.939 . . . . 0.48999999999999999 111.458 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.08 164.63 15.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.668 0.734 . . . . 2.3999999999999999 111.028 173.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.16 167.89 34.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.885 -0.886 . . . . 0.52000000000000002 110.885 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.3 mtpt -130.43 131.5 45.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.026 -0.361 . . . . 2.3799999999999999 110.026 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.516 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -133.85 105.14 11.65 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.863 0.363 . . . . 1.47 110.483 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 11.9 Cg_exo -71.25 101.62 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.359 2.039 . . . . 0.81000000000000005 110.428 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.28 143.57 29.1 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.606 -0.516 . . . . 0.79000000000000004 109.606 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.708 ' HA ' HD12 ' A' ' 57' ' ' ILE . 32.5 Cg_exo -62.38 78.78 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.308 2.005 . . . . 0.91000000000000003 111.957 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.531 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 46.7 3.58 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.47999999999999998 112.197 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.888 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 92.9 p -73.55 119.23 17.49 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.361 -0.607 . . . . 0.85999999999999999 109.361 173.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.848 HD22 ' HB3' ' A' ' 49' ' ' ASN . 2.2 pt? -153.03 163.9 38.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 119.191 -1.004 . . . . 1.76 113.241 -164.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 54' ' ' SER . 50.5 mttm -16.49 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.756 -1.565 . . . . 2.4300000000000002 114.417 -168.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 165.5 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.608 -1.256 . . . . 1.29 107.608 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.5 pttt 42.32 52.08 4.62 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.197 0.935 . . . . 2.21 110.893 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.5 t70 -152.56 -166.94 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.288 -0.869 . . . . 0.64000000000000001 110.356 -173.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.481 ' HG3' ' HG1' ' A' ' 48' ' ' THR . 47.3 ttm -125.24 117.73 24.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.102 0.477 . . . . 2.04 110.944 -170.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.493 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -105.87 144.68 32.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.394 -0.821 . . . . 1.3300000000000001 110.113 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.75 129.17 35.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.26 0.553 . . . . 1.1100000000000001 110.927 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.604 HD21 HG13 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -135.25 174.18 10.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.246 -1.02 . . . . 1.45 108.246 -176.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.527 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 5.8 p-10 -142.72 139.48 31.12 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.736 0.698 . . . . 1.8100000000000001 112.059 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.5 mm -109.03 115.97 56.18 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.783 -0.821 . . . . 1.3999999999999999 108.783 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.472 ' O ' HG11 ' A' ' 94' ' ' VAL . 24.7 Cg_exo -28.76 -102.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.405 4.07 . . . . 1.0700000000000001 115.534 -173.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.88 95.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 O-C-N 122.266 -0.271 . . . . 1.1799999999999999 111.474 -175.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -128.67 104.8 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.012 1.486 . . . . 1.1699999999999999 115.012 -172.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -154.4 99.57 2.47 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.601 -0.687 . . . . 1.71 111.335 161.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.9 Cg_exo -51.78 134.65 48.32 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.014 1.809 . . . . 0.65000000000000002 111.572 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.528 ' H ' ' HA ' ' A' ' 38' ' ' SER . 52.7 t80 -54.93 -36.9 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 1.6899999999999999 111.635 -172.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -53.88 -30.97 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.377 . . . . 1.49 111.639 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 71' ' ' ILE . 10.1 mm -76.82 -56.0 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.431 -0.508 . . . . 1.21 110.983 -175.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.629 HD21 HD22 ' A' ' 104' ' ' LEU . 30.6 mt -53.84 -28.25 34.66 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.699 0.625 . . . . 1.6399999999999999 110.53 174.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.4 -42.45 99.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.413 -1.267 . . . . 1.2 109.206 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.402 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.6 m-80 -74.66 -58.26 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.171 0.434 . . . . 0.81999999999999995 112.171 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.901 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.8 pp -60.85 -48.83 80.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.665 0.987 . . . . 1.22 113.665 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.529 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -66.6 -25.59 66.69 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.852 0.834 . . . . 1.1899999999999999 109.574 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.1 ttp180 -68.06 -48.82 64.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.554 -1.203 . . . . 2.2200000000000002 110.451 172.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.627 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 30.1 t70 -81.36 -54.31 5.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.649 0.738 . . . . 0.80000000000000004 112.164 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.535 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.9 t -87.33 -25.64 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.726 -0.609 . . . . 1.5 110.069 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.03 -20.84 80.13 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.717 -0.754 . . . . 0.38 111.309 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -49.99 -48.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.732 -1.581 . . . . 1.6599999999999999 106.732 165.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' N ' HG11 ' A' ' 110' ' ' VAL . 30.3 t70 -69.02 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.38 -0.827 . . . . 1.8700000000000001 109.992 164.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 178.41 -48.19 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.187 0.44 . . . . 1.3500000000000001 112.187 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -92.76 124.13 36.54 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.012 -0.366 . . . . 2.1499999999999999 110.012 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -111.7 154.24 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.846 -0.798 . . . . 1.1599999999999999 108.846 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 152.78 19.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.985 -0.746 . . . . 2.1099999999999999 108.985 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 57.4 m-85 -140.52 162.73 34.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.915 -0.772 . . . . 0.96999999999999997 108.915 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.748 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.6 tt0 -151.05 133.57 15.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.947 0.403 . . . . 0.80000000000000004 110.221 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.615 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.6 OUTLIER -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.301 -0.629 . . . . 1.9199999999999999 109.301 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.649 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.75 103.31 10.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.165 -0.68 . . . . 0.63 109.165 176.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 136' ' ' ILE . 8.4 tp -110.01 120.41 61.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 1.49 110.934 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.94 131.03 10.52 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.196 -0.762 . . . . 0.26000000000000001 111.196 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 133' ' ' THR . 7.5 mp -108.23 106.22 16.3 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 120.926 0.393 . . . . 1.77 111.055 -176.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.047 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 81.4 m -109.0 96.6 6.43 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 109.478 173.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.635 HG21 ' SG ' ' A' ' 58' ' ' CYS . 19.5 pt -112.37 131.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.469 -0.492 . . . . 1.6699999999999999 110.918 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.83 105.84 9.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.377 -0.601 . . . . 1.52 109.377 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 55' ' ' ILE . 83.3 mt -106.52 160.63 25.56 Favored Pre-proline 0 C--O 1.22 -0.456 0 O-C-N 124.81 1.318 . . . . 1.9299999999999999 109.971 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.97 -34.34 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.832 1.688 . . . . 0.98999999999999999 113.434 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.34 -57.88 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.316 0.487 . . . . 1.6699999999999999 112.316 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -96.19 -7.21 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 122.046 0.927 . . . . 1.9099999999999999 109.834 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.56 -28.55 2.72 Favored Glycine 0 C--N 1.311 -0.817 0 CA-C-N 113.626 -1.624 . . . . 1.05 111.16 -171.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.667 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.5 pt-20 -162.83 155.83 19.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.473 -0.936 . . . . 1.1599999999999999 108.473 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB2' HD12 ' A' ' 126' ' ' LEU . 31.2 t80 -143.04 122.19 12.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.222 -0.659 . . . . 2.2799999999999998 109.222 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.8 m -115.06 102.09 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.139 0.495 . . . . 1.8899999999999999 111.763 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.08 144.36 50.21 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.805 -0.634 . . . . 1.26 110.015 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.91 164.1 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.885 1.723 . . . . 0.58999999999999997 113.162 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.882 HG23 HG22 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -156.22 158.53 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.734 -1.21 . . . . 1.1399999999999999 107.734 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 83.0 p -140.59 152.58 45.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.627 -0.429 . . . . 1.28 111.827 -172.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -140.84 102.69 4.34 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.553 -1.276 . . . . 1.3400000000000001 107.553 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.748 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -114.6 143.99 44.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.1 -0.5 . . . . 2.2000000000000002 109.986 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.32 151.61 21.62 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.595 -0.812 . . . . 0.56000000000000005 112.017 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -106.3 130.36 54.16 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.941 -0.763 . . . . 2.1000000000000001 108.941 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.89 174.1 4.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.24 -1.022 . . . . 1.51 108.24 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 3.7 mppt? -65.6 163.82 15.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 3.9300000000000002 112.154 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.619 HD12 HD11 ' A' ' 114' ' ' ILE . 22.7 tp -55.49 131.23 70.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 114.903 -1.044 . . . . 1.9299999999999999 111.076 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 144' ' ' LEU . 40.9 Cg_endo . . . . . 0 C--N 1.343 0.261 0 C-N-CA 123.093 2.529 . . . . 0.81000000000000005 112.869 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.674 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.408 -3.174 0 N-CA-C 111.939 -0.465 . . . . 1.0700000000000001 111.939 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.701 ' HB2' HD12 ' A' ' 122' ' ' LEU . 17.3 m -171.1 32.33 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.895 0.855 . . . . 1.7 108.894 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.3 m -133.29 148.29 31.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.863 -1.062 . . . . 1.53 109.969 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -169.76 -44.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.46 0.475 . . . . 1.05 111.793 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -157.4 153.59 27.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.77 -0.372 . . . . 1.6899999999999999 111.183 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.17 120.31 8.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.646 -0.502 . . . . 1.8500000000000001 109.646 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -113.96 112.15 22.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 1.8300000000000001 111.476 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.2 tm? -72.87 139.02 46.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.963 -0.562 . . . . 1.46 109.99 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.554 ' H ' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -141.99 -100.16 0.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.255 0.835 . . . . 1.9199999999999999 113.255 -176.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.528 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 18.1 m-20 . . . . . 0 CA--C 1.493 -1.229 0 O-C-N 121.911 -0.493 . . . . 2.8500000000000001 109.809 -154.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.521 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 6.3 t . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 1.1299999999999999 111.57 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 31' ' ' LEU . 24.2 t -77.65 156.1 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.566 -0.901 . . . . 1.48 108.566 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.893 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -137.17 145.64 43.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 119.516 -0.874 . . . . 1.1899999999999999 109.368 -173.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.923 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.7 p90 -143.11 141.53 31.25 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.306 -0.958 . . . . 3.9399999999999999 112.575 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.1 tm? -82.45 110.88 17.97 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.425 -0.954 . . . . 1.4299999999999999 108.425 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 92' ' ' ILE . . . -91.5 100.33 13.11 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 1.1100000000000001 109.016 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 23.8 ttmm -83.58 126.0 32.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.626 0.727 . . . . 3.1800000000000002 109.109 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.611 HG11 ' CA ' ' A' ' 25' ' ' SER . 37.4 t -109.51 144.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.725 -1.125 . . . . 1.3999999999999999 110.481 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 14.7 m -128.85 97.4 4.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.576 -0.898 . . . . 1.1100000000000001 108.576 165.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.674 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -86.96 130.69 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.676 0.751 . . . . 1.8500000000000001 111.173 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.417 ' H ' ' HA3' ' A' ' 24' ' ' GLY . 32.1 m -116.88 114.99 24.66 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.344 -1.298 . . . . 1.1000000000000001 109.447 -173.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.757 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.3 t30 -90.76 133.21 32.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 108.108 -1.071 . . . . 1.48 108.108 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -90.9 8.29 3.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.103 2.536 . . . . 0.91000000000000003 114.169 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.586 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 49.2 t80 -119.0 139.14 52.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.949 -0.76 . . . . 2.3100000000000001 108.949 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.443 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.7 p -79.13 37.81 0.33 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.659 0.614 . . . . 1.8300000000000001 112.659 -164.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -146.25 130.58 17.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.271 -0.422 . . . . 2.0299999999999998 110.056 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 m -43.5 100.76 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 124.116 0.966 . . . . 1.73 112.719 172.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.983 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.8 pt -75.55 171.97 10.49 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.431 -0.951 . . . . 1.23 108.431 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.503 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 8.0 Cg_endo -87.98 -59.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.498 1.465 . . . . 0.53000000000000003 114.026 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.799 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 80.0 mt -137.38 155.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.669 0.618 . . . . 1.9099999999999999 112.669 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.59 ' HB3' HG23 ' A' ' 124' ' ' ILE . 25.6 p -138.0 -178.99 5.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.731 0.777 . . . . 1.95 111.211 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.076 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.2 tt0 -141.78 115.5 9.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.99 -1.459 . . . . 1.3600000000000001 109.982 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.692 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.1 109.93 23.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.697 -1.592 . . . . 1.6499999999999999 109.951 173.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 8.5 m -110.97 102.58 11.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.87 -1.514 . . . . 1.02 108.586 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.786 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 3.8 p90 -109.79 122.33 47.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.506 . . . . 0.46000000000000002 109.733 -168.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 93.9 m -121.03 104.91 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.511 -0.768 . . . . 1.1699999999999999 109.4 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.523 ' CE1' HD21 ' A' ' 118' ' ' LEU . 98.9 m-85 -98.14 140.99 31.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.952 -0.567 . . . . 1.1799999999999999 111.148 -174.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -132.4 145.23 51.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.636 -1.246 . . . . 1.72 107.636 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.767 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.9 t -110.75 -98.03 0.41 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.317 -0.953 . . . . 1.6599999999999999 111.062 172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.95 -59.75 4.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.386 -0.598 . . . . 1.1200000000000001 109.386 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.87 18.05 0.1 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.478 -1.449 . . . . 0.39000000000000001 109.478 165.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -111.04 -166.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.119 -0.697 . . . . 2.4900000000000002 109.119 -177.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -108.16 98.49 8.03 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.919 0.866 . . . . 2.6099999999999999 109.689 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.951 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.9 mm -64.57 -41.6 92.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.976 -1.465 . . . . 1.1100000000000001 111.276 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 164.75 38.25 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.217 -0.992 . . . . 0.48999999999999999 111.266 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.38 156.84 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.482 0.641 . . . . 2.3999999999999999 110.991 172.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 165.27 160.77 13.02 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.722 -0.951 . . . . 0.52000000000000002 110.722 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 3.7 ptmm? -136.95 130.74 32.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.968 0.414 . . . . 2.3799999999999999 110.0 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.0 mt -134.47 120.13 14.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 1.47 110.375 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.87 115.34 3.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.328 2.019 . . . . 0.81000000000000005 110.537 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.12 143.35 42.33 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.698 -0.852 . . . . 0.79000000000000004 108.698 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -51.86 90.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.804 2.336 . . . . 0.91000000000000003 112.16 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.799 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -81.99 24.66 4.49 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.47999999999999998 112.585 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.983 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 70.7 p -73.81 117.73 15.93 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.438 -0.579 . . . . 0.85999999999999999 109.438 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.631 HD23 HD21 ' A' ' 49' ' ' ASN . 1.2 pt? -149.41 -171.33 3.86 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.096 -1.442 . . . . 1.76 114.264 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 60.5 mttm -44.77 -96.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.912 -1.04 . . . . 2.4300000000000002 113.54 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 175.5 105.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.059 -1.089 . . . . 1.29 108.059 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.9 ptpt 41.77 50.44 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.339 1.024 . . . . 2.21 110.842 -170.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 3.5 t0 -143.63 179.93 6.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 110.122 -170.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 46' ' ' SER . 54.3 ttp -107.74 119.13 38.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.609 -0.723 . . . . 2.04 110.63 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.558 HG22 HG13 ' A' ' 47' ' ' VAL . 5.1 t -106.27 142.82 35.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.05 -0.523 . . . . 1.3300000000000001 109.633 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 123.77 30.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.549 0.69 . . . . 1.1100000000000001 110.608 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 91' ' ' ASP . 9.0 tt -124.61 160.73 27.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.897 -1.149 . . . . 1.45 107.897 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.419 ' N ' HD22 ' A' ' 90' ' ' LEU . 11.0 m-20 -134.05 122.37 22.88 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.627 -0.67 . . . . 1.8100000000000001 111.407 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 43' ' ' ALA . 32.8 mm -92.56 143.27 26.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 1.3999999999999999 109.644 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 92' ' ' ILE . 75.8 Cg_exo -51.91 -172.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.924 2.416 . . . . 1.0700000000000001 113.266 173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 7.1 m -114.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.72 -0.673 . . . . 1.1799999999999999 110.549 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 95' ' ' VAL . 4.7 p -125.76 102.51 10.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.144 1.535 . . . . 1.1699999999999999 115.144 -161.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.675 HG21 ' HG ' ' A' ' 101' ' ' LEU . 2.5 p -152.24 102.74 2.78 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.157 -0.474 . . . . 1.71 111.045 163.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 74.1 Cg_exo -48.89 131.61 25.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.721 1.614 . . . . 0.65000000000000002 111.398 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.521 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 4.7 t80 -49.43 -35.0 17.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.734 -0.666 . . . . 1.6899999999999999 111.081 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 12.1 t -62.92 -30.19 71.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 1.49 112.237 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.951 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.5 mm -76.78 -54.27 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 121.749 -0.594 . . . . 1.21 110.686 -173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 1.003 HD21 HD23 ' A' ' 104' ' ' LEU . 36.6 mt -53.84 -26.91 26.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.439 0.638 . . . . 1.6399999999999999 110.518 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.0 t80 -65.1 -41.45 94.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.466 -1.243 . . . . 1.2 108.877 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.483 ' HA ' HH21 ' A' ' 106' ' ' ARG . 24.8 m-80 -74.27 -57.88 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.81999999999999995 112.263 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 1.003 HD23 HD21 ' A' ' 101' ' ' LEU . 2.1 pp -56.91 -49.66 74.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.23 0.826 . . . . 1.22 113.23 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.55 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.16 -25.7 68.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.883 0.849 . . . . 1.1899999999999999 110.113 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.483 HH21 ' HA ' ' A' ' 103' ' ' ASN . 6.6 ttp180 -69.62 -50.77 41.19 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.655 -1.157 . . . . 2.2200000000000002 110.511 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 13.6 t70 -81.74 -54.83 5.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.78 0.8 . . . . 0.80000000000000004 111.94 -175.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -84.51 -27.67 6.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.594 -0.692 . . . . 1.5 109.964 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.787 ' HA3' HD22 ' A' ' 144' ' ' LEU . . . -73.01 -19.28 79.54 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.308 -0.948 . . . . 0.38 111.457 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.542 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -51.86 -44.89 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.794 -1.558 . . . . 1.6599999999999999 106.794 166.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m-20 -69.77 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.529 -0.76 . . . . 1.8700000000000001 110.025 161.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.788 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.1 p-90 176.91 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.687 0.617 . . . . 1.3500000000000001 111.715 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.06 129.76 42.02 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 122.304 -0.248 . . . . 2.1499999999999999 110.581 -174.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 144' ' ' LEU . 3.0 mp -117.7 159.19 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.834 0.35 . . . . 1.1599999999999999 110.415 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 9.3 p-10 -102.96 153.34 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.982 -0.377 . . . . 2.1099999999999999 109.982 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.8 m-85 -140.09 165.91 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.869 -0.789 . . . . 0.96999999999999997 108.869 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.628 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 35.4 tt0 -156.16 131.98 9.74 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.007 -0.368 . . . . 0.80000000000000004 110.007 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.639 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -103.69 123.85 47.78 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.006 -0.739 . . . . 1.9199999999999999 109.006 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.761 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 8.4 tp60 -108.28 99.32 8.74 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.672 -0.862 . . . . 0.63 108.672 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.692 HD11 HG22 ' A' ' 60' ' ' ILE . 5.3 tp -106.58 119.36 55.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.259 0.552 . . . . 1.49 110.834 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.53 127.05 8.3 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.879 -0.888 . . . . 0.26000000000000001 110.879 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 133' ' ' THR . 0.4 OUTLIER -98.42 104.32 16.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.457 0.303 . . . . 1.77 111.335 -174.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.076 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 57.9 m -109.83 95.12 5.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.044 -0.526 . . . . 1.0700000000000001 109.584 172.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.59 HG23 ' HB3' ' A' ' 58' ' ' CYS . 11.5 pt -112.75 128.61 69.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 120.234 -0.586 . . . . 1.6699999999999999 110.28 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.858 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 22.7 t70 -81.88 106.02 13.47 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.796 -0.816 . . . . 1.52 108.796 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.969 HD23 HG21 ' A' ' 55' ' ' ILE . 29.1 mt -104.82 176.35 1.78 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 114.522 -1.217 . . . . 1.9299999999999999 109.486 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.586 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 9.9 Cg_exo -76.18 -41.93 0.44 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.762 1.642 . . . . 0.98999999999999999 113.206 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.6 t -59.62 -58.93 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.06 0.763 . . . . 1.6699999999999999 113.06 -168.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.8 -8.5 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.894 1.33 . . . . 1.9099999999999999 108.517 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.692 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 88.38 -143.24 17.8 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 112.413 -2.176 . . . . 1.05 108.132 -164.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.858 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 -60.74 128.9 38.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.111 0.482 . . . . 1.1599999999999999 110.02 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 123' ' ' THR . 15.9 t80 -124.31 145.33 49.48 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.826 -0.805 . . . . 2.2799999999999998 108.826 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 63.1 m -121.86 109.42 14.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.917 0.389 . . . . 1.8899999999999999 112.042 -173.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -127.33 144.04 49.34 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.021 -0.733 . . . . 1.26 109.021 171.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 90.0 Cg_endo -93.31 162.45 2.48 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.863 1.709 . . . . 0.58999999999999997 113.341 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.14 167.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.935 -1.135 . . . . 1.1399999999999999 107.935 175.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -133.07 148.67 52.19 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.791 -0.364 . . . . 1.28 111.258 -169.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.1 t -138.34 103.0 4.79 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.683 -1.228 . . . . 1.3400000000000001 107.683 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 14.4 ptmt -126.88 156.25 41.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.048 -0.524 . . . . 2.2000000000000002 111.184 -171.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.92 150.78 17.29 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.594 -0.812 . . . . 0.56000000000000005 111.634 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.5 mt-10 -98.71 124.88 43.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.741 -0.837 . . . . 2.1000000000000001 108.741 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.24 165.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.07 -1.085 . . . . 1.51 108.07 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -67.45 178.2 1.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.496 0.665 . . . . 3.9300000000000002 112.289 -171.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.788 ' HG ' ' O ' ' A' ' 112' ' ' TRP . 5.9 mt -54.05 131.08 59.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.743 -1.117 . . . . 1.9299999999999999 111.231 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 144' ' ' LEU . 32.9 Cg_endo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 123.16 2.573 . . . . 0.81000000000000005 112.021 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.22 -0.753 0 N-CA-C 116.094 1.198 . . . . 1.0700000000000001 116.094 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.644 ' OG ' HD13 ' A' ' 122' ' ' LEU . 96.2 p -168.99 37.26 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.623 1.169 . . . . 1.7 107.979 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' SER . 4.5 m -134.02 151.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.512 -1.222 . . . . 1.53 110.342 -169.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -167.58 -44.33 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.416 0.447 . . . . 1.05 111.96 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -160.88 164.08 31.52 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.324 0.511 . . . . 1.6899999999999999 111.313 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.07 135.62 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.284 -0.635 . . . . 1.8500000000000001 109.284 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -129.0 135.64 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.648 0.261 . . . . 1.8300000000000001 111.249 -169.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.496 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.6 tm? -101.28 139.43 36.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.593 -0.276 . . . . 1.46 111.371 -172.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -144.34 -90.81 0.11 Allowed 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 114.08 1.141 . . . . 1.9199999999999999 114.08 177.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.204 -1.334 0 O-C-N 121.587 -0.696 . . . . 2.8500000000000001 111.404 -155.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 122.364 1.078 . . . . 1.1299999999999999 112.351 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 1.033 HG21 HD13 ' A' ' 101' ' ' LEU . 46.2 t -73.11 155.42 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.636 -1.62 . . . . 1.48 109.08 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.99 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 96.8 mt-10 -116.9 134.25 55.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 118.936 -1.106 . . . . 1.1899999999999999 112.383 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.8 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.36 105.13 10.61 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.905 -1.043 . . . . 3.9399999999999999 110.718 -175.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.489 ' N ' HG13 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -81.44 111.58 17.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.341 -0.985 . . . . 1.4299999999999999 108.341 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -97.98 117.34 32.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.551 0.691 . . . . 1.1100000000000001 110.904 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.681 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -84.8 120.64 26.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.214 -0.903 . . . . 3.1800000000000002 108.711 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 25' ' ' SER . 54.2 t -111.11 137.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.643 -0.708 . . . . 1.3999999999999999 111.033 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.8 m -130.5 100.07 5.21 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.771 -0.372 . . . . 1.1100000000000001 110.158 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 61.0 t -83.47 130.5 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.938 -0.574 . . . . 1.8500000000000001 110.737 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 4.3 m -104.74 122.69 46.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.743 -0.383 . . . . 1.1000000000000001 110.3 176.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.756 HD21 HD22 ' A' ' 82' ' ' LEU . 13.9 t-20 -88.17 133.52 36.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.86 1.35 . . . . 1.48 109.533 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.92 -17.02 2.15 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.105 2.537 . . . . 0.91000000000000003 115.746 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.732 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.2 t80 -98.42 -100.46 0.21 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.915 -1.114 . . . . 2.3100000000000001 111.386 -165.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.459 ' CB ' ' HD2' ' A' ' 85' ' ' LYS . 48.5 t -174.0 29.8 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.551 0.691 . . . . 1.8300000000000001 109.788 171.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -147.92 133.18 18.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 2.0299999999999998 110.823 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -40.68 101.93 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.814 0 O-C-N 124.376 1.047 . . . . 1.73 112.194 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.712 HG22 HD13 ' A' ' 126' ' ' LEU . 7.6 pt -78.93 121.73 83.74 Favored Pre-proline 0 CA--C 1.5 -0.953 0 C-N-CA 120.071 -0.652 . . . . 1.23 109.5 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.921 ' HB2' HD13 ' A' ' 57' ' ' ILE . 28.1 Cg_endo -61.09 -56.5 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.174 1.916 . . . . 0.53000000000000003 113.51 -157.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.921 HD13 ' HB2' ' A' ' 56' ' ' PRO . 4.2 mp -135.02 156.27 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.849 -0.74 . . . . 1.9099999999999999 111.026 -173.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.67 ' HB3' HG21 ' A' ' 124' ' ' ILE . 28.7 p -145.04 178.43 8.05 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.386 1.089 . . . . 1.95 111.856 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.141 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.9 tt0 -131.15 113.84 14.38 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.129 -1.85 . . . . 1.3600000000000001 109.046 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.503 ' CD1' ' HB ' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -98.9 110.62 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.515 1.15 . . . . 1.6499999999999999 110.151 169.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 79.9 p -111.5 107.12 16.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.051 -1.886 . . . . 1.02 108.228 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.1 p90 -113.92 132.6 55.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.6 0.714 . . . . 0.46000000000000002 110.222 -168.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 33.6 m -131.6 109.75 10.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.433 -1.258 . . . . 1.1699999999999999 108.717 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.422 ' CE1' HD23 ' A' ' 118' ' ' LEU . 94.5 m-85 -97.7 143.08 28.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.691 -0.485 . . . . 1.1799999999999999 109.691 -175.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -129.64 143.37 50.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.759 ' CB ' HD21 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -101.3 -114.79 0.19 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.038 -0.528 . . . . 1.6599999999999999 111.471 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.49 65.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.573 -0.899 . . . . 1.1200000000000001 108.573 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.74 20.74 0.15 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.65 -1.38 . . . . 0.39000000000000001 109.65 164.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 6.2 ptp180 -117.86 -169.21 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.232 -0.655 . . . . 2.4900000000000002 109.232 -174.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.422 ' CD ' ' HZ1' ' A' ' 73' ' ' LYS . 32.4 tt0 -107.71 98.33 7.94 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.325 0.583 . . . . 2.6099999999999999 109.741 -166.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.753 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -60.86 -42.96 94.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.404 -1.271 . . . . 1.1100000000000001 112.19 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.38 154.86 13.18 Favored Glycine 0 C--O 1.219 -0.789 0 C-N-CA 120.339 -0.934 . . . . 0.48999999999999999 111.686 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 ptmt -158.75 160.29 36.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.935 0.868 . . . . 2.3999999999999999 112.381 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.02 168.39 34.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.52000000000000002 111.545 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -127.8 133.35 49.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.944 -0.391 . . . . 2.3799999999999999 109.944 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.503 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 73.8 mt -139.14 112.45 8.05 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.502 -0.317 . . . . 1.47 110.884 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.79 113.53 3.68 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.117 1.878 . . . . 0.81000000000000005 110.938 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -133.92 144.97 53.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.47 -0.196 . . . . 0.79000000000000004 110.47 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.72 94.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.3 . . . . 0.91000000000000003 112.677 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.52 21.19 11.22 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.808 -0.633 . . . . 0.47999999999999998 112.586 175.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 96.2 p -70.25 118.98 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.452 -0.573 . . . . 0.85999999999999999 109.452 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.756 HD22 HD21 ' A' ' 49' ' ' ASN . 1.9 pt? -141.98 -164.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 120.145 -0.622 . . . . 1.76 112.393 -164.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 94.4 mttt -45.63 -89.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.038 0.755 . . . . 2.4300000000000002 113.038 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 156.5 111.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.437 -1.319 . . . . 1.29 107.437 -168.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.732 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 8.2 ptmm? 45.54 46.07 10.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.003 0.814 . . . . 2.21 111.5 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.412 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.2 t70 -155.05 -172.01 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.331 -0.849 . . . . 0.64000000000000001 109.501 -173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 43.3 ttp -114.79 127.57 55.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.106 0.479 . . . . 2.04 110.831 -172.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.2 t -109.53 142.41 40.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.472 -0.785 . . . . 1.3300000000000001 110.025 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 108.41 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.38 0.61 . . . . 1.1100000000000001 110.949 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.784 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.7 tp -100.64 174.89 5.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.094 -0.957 . . . . 1.45 109.131 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.784 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 21.4 t70 -141.71 121.6 13.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.769 -0.372 . . . . 1.8100000000000001 110.638 -173.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 24.5 mm -107.88 141.92 24.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.3 -0.409 . . . . 1.3999999999999999 110.324 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD2' HG21 ' A' ' 92' ' ' ILE . 61.0 Cg_exo -54.62 -152.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.815 3.01 . . . . 1.0700000000000001 113.656 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.99 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.5 m -136.76 94.73 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 112.058 0.392 . . . . 1.1799999999999999 112.058 -165.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -125.38 106.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 113.841 1.052 . . . . 1.1699999999999999 113.841 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.668 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 9.6 t -147.17 102.08 3.82 Favored Pre-proline 0 C--O 1.219 -0.52 0 CA-C-N 115.941 -0.572 . . . . 1.71 110.318 168.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 31.9 Cg_exo -57.1 124.38 16.08 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 CA-C-N 120.495 1.212 . . . . 0.65000000000000002 110.757 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -54.03 -29.91 45.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.019 -0.537 . . . . 1.6899999999999999 111.232 -175.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.1 m -53.0 -33.12 50.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 1.49 111.874 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 71' ' ' ILE . 12.6 mm -77.65 -54.58 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.528 -0.305 . . . . 1.21 111.28 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 39' ' ' VAL . 11.3 mt -51.03 -26.92 6.8 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.504 0.669 . . . . 1.6399999999999999 110.848 172.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 99' ' ' SER . 54.8 t80 -63.99 -46.48 84.39 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.391 -1.277 . . . . 1.2 109.056 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 26.1 m-80 -73.27 -55.88 5.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.492 0.553 . . . . 0.81999999999999995 112.492 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.955 HD22 HD22 ' A' ' 101' ' ' LEU . 1.3 pp -55.47 -57.71 10.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.897 0.702 . . . . 1.22 112.897 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.558 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . -61.26 -24.4 66.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.673 0.749 . . . . 1.1899999999999999 110.806 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.4 ttp180 -62.26 -49.62 74.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.781 -1.099 . . . . 2.2200000000000002 109.86 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -85.21 -53.29 5.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.373 1.082 . . . . 0.80000000000000004 111.129 -173.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.95 HG23 HG21 ' A' ' 114' ' ' ILE . 34.4 m -83.93 -30.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.225 -0.898 . . . . 1.5 110.849 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.58 -20.22 78.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.215 -0.902 . . . . 0.38 111.343 174.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -47.79 -45.59 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.386 -1.709 . . . . 1.6599999999999999 106.386 162.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 9.3 m-20 -72.84 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.716 -0.674 . . . . 1.8700000000000001 110.359 162.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 -179.54 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.719 0.408 . . . . 1.3500000000000001 111.852 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.36 137.92 32.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.018 0.437 . . . . 2.1499999999999999 111.47 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.95 HG21 HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -118.36 148.07 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.237 -0.653 . . . . 1.1599999999999999 109.237 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.3 p-10 -102.65 152.69 20.91 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.951 -1.129 . . . . 2.1099999999999999 107.951 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 87.9 m-85 -137.21 171.48 14.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.636 . . . . 0.96999999999999997 109.284 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.614 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 34.2 tt0 -160.2 121.33 3.07 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.364 0.415 . . . . 0.80000000000000004 110.139 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -97.69 137.61 36.33 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.727 -0.471 . . . . 1.9199999999999999 109.727 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.721 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.37 103.17 8.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.884 -0.598 . . . . 0.63 109.51 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.498 HD13 HG23 ' A' ' 60' ' ' ILE . 6.8 tp -113.1 121.42 65.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.115 0.483 . . . . 1.49 110.904 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.17 126.48 8.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.333 -0.707 . . . . 0.26000000000000001 111.333 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.644 HD13 ' OG ' ' A' ' 25' ' ' SER . 4.5 mp -103.77 100.5 10.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.092 0.473 . . . . 1.77 111.393 -172.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.141 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.3 m -104.6 95.59 6.01 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.474 -0.784 . . . . 1.0700000000000001 109.478 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 58' ' ' CYS . 2.3 pt -106.82 149.89 9.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.716 -0.394 . . . . 1.6699999999999999 110.602 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.685 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -91.12 105.35 17.75 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.52 108.492 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.712 HD13 HG22 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -105.09 148.26 35.88 Favored Pre-proline 0 C--O 1.218 -0.567 0 O-C-N 124.684 1.24 . . . . 1.9299999999999999 108.995 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.45 -32.15 93.42 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.909 1.739 . . . . 0.98999999999999999 113.052 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.94 -58.09 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.455 0.539 . . . . 1.6699999999999999 112.455 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.502 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -94.45 -6.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 122.153 0.978 . . . . 1.9099999999999999 109.952 -175.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.82 -31.36 1.27 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 113.716 -1.584 . . . . 1.05 111.59 -171.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.2 pt-20 -171.05 137.15 1.14 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.692 -0.855 . . . . 1.1599999999999999 108.692 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -143.14 139.55 30.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.372 -0.603 . . . . 2.2799999999999998 109.372 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.3 t -121.18 112.94 19.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.688 0.756 . . . . 1.8899999999999999 111.498 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.69 137.05 29.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.205 -0.907 . . . . 1.26 109.66 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 11.1 Cg_endo -91.47 163.64 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.237 1.958 . . . . 0.58999999999999997 112.758 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.8 166.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.468 -0.938 . . . . 1.1399999999999999 108.468 178.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -136.32 147.17 47.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.223 -0.191 . . . . 1.28 110.802 -167.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.5 t -140.58 102.88 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.489 -0.93 . . . . 1.3400000000000001 108.489 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.614 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 13.6 ptmt -118.46 152.31 36.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.732 -0.667 . . . . 2.2000000000000002 111.087 -174.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.11 158.67 30.25 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.6 -0.81 . . . . 0.56000000000000005 112.231 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.4 mt-10 -102.6 132.79 48.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.409 -0.589 . . . . 2.1000000000000001 109.409 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . 0.405 HD12 ' CE1' ' A' ' 116' ' ' TYR . 2.3 pp -138.52 172.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.467 -0.568 . . . . 1.51 109.467 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 143' ' ' LYS . 4.0 mppt? -75.03 167.22 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.006 0.431 . . . . 3.9300000000000002 111.652 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.692 HD13 HD11 ' A' ' 114' ' ' ILE . 17.8 tp -57.1 132.77 80.48 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.676 -0.693 . . . . 1.9299999999999999 111.124 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.559 ' HD2' HD13 ' A' ' 144' ' ' LEU . 56.1 Cg_endo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 122.611 2.207 . . . . 0.81000000000000005 112.221 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.713 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . . . . . . 0 CA--C 1.505 -0.542 0 N-CA-C 118.348 2.099 . . . . 1.0700000000000001 118.348 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.603 ' C ' HG13 ' A' ' 45' ' ' VAL . 39.4 m -178.99 34.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 112.618 -1.791 . . . . 1.7 107.525 -170.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.442 HG11 HG23 ' A' ' 120' ' ' ILE . 16.4 m -135.07 150.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.84 -1.073 . . . . 1.53 109.638 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 46' ' ' SER . 1.3 t -160.28 -51.66 0.05 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.988 -0.375 . . . . 1.05 109.988 168.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -158.54 150.14 21.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.294 0.568 . . . . 1.6899999999999999 112.101 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.13 127.8 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.3 -0.863 . . . . 1.8500000000000001 108.932 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -119.45 135.27 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 111.303 -169.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -97.33 127.16 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 1.46 111.871 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HZ2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -129.72 -113.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 1.9199999999999999 109.679 166.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.796 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.3 p-10 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.05 0.389 . . . . 2.8500000000000001 112.05 -172.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.591 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 23.0 t . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 106.252 -1.758 . . . . 1.1299999999999999 106.252 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.796 HG13 ' HA ' ' A' ' 33' ' ' ASP . 3.1 t -124.51 161.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.39 -0.967 . . . . 1.48 108.39 166.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.92 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 82.0 mt-10 -114.06 131.93 56.2 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.878 -0.729 . . . . 1.1899999999999999 112.13 -170.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.87 103.82 10.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.855 -1.066 . . . . 3.9399999999999999 109.443 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -72.73 109.18 6.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.081 -1.081 . . . . 1.4299999999999999 108.081 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -107.31 102.84 12.11 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.288 0.566 . . . . 1.1100000000000001 109.797 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 18.0 ttpp -83.77 133.55 34.77 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.875 -0.787 . . . . 3.1800000000000002 108.875 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.647 HG12 HD23 ' A' ' 90' ' ' LEU . 24.3 t -109.7 141.75 24.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.806 -1.088 . . . . 1.3999999999999999 110.409 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 88' ' ' THR . 1.8 p -120.1 100.52 7.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 119.531 -0.868 . . . . 1.1100000000000001 109.373 168.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 77.1 t -81.15 112.46 19.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.599 -0.889 . . . . 1.8500000000000001 108.599 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.713 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 2.0 m -102.92 109.89 21.62 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.914 -1.143 . . . . 1.1000000000000001 107.914 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.782 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 5.1 t30 -87.92 122.52 70.08 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.63 1.206 . . . . 1.48 109.85 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 1.3 Cg_endo -85.34 8.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.988 3.126 . . . . 0.91000000000000003 114.423 -171.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 31.4 t80 -96.79 -114.03 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.116 -0.634 . . . . 2.3100000000000001 110.015 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 18.9 p -168.74 18.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.811 0.3 . . . . 1.8300000000000001 111.811 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -148.04 143.18 27.04 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.514 -0.55 . . . . 2.0299999999999998 109.514 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 5.4 m -41.26 98.19 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.256 0.973 . . . . 1.73 112.873 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.926 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.9 pt -74.63 170.54 14.71 Favored Pre-proline 0 C--O 1.21 -0.998 0 N-CA-C 107.685 -1.228 . . . . 1.23 107.685 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.53 ' HB2' HG12 ' A' ' 57' ' ' ILE . 22.9 Cg_endo -91.25 -64.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 120.89 1.06 . . . . 0.53000000000000003 114.435 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 79' ' ' PRO . 17.8 mm -126.4 161.33 32.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.188 -0.605 . . . . 1.9099999999999999 112.009 -166.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.639 ' HB3' HG22 ' A' ' 124' ' ' ILE . 29.8 p -152.04 175.63 12.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.43 1.11 . . . . 1.95 112.318 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.003 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -136.55 114.24 11.12 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.006 -1.907 . . . . 1.3600000000000001 109.336 175.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -98.92 117.74 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.894 -1.048 . . . . 1.6499999999999999 111.61 174.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.1 p -115.09 109.63 18.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.625 -1.625 . . . . 1.02 109.34 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.0 p90 -114.09 126.86 55.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.428 -0.351 . . . . 0.46000000000000002 110.13 -168.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.9 m -119.6 104.64 10.46 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.826 -0.625 . . . . 1.1699999999999999 109.327 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 94.3 m-85 -97.75 136.04 38.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.957 -0.565 . . . . 1.1799999999999999 109.783 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.665 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -146.59 140.3 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.734 -0.469 . . . . 1.72 109.734 176.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.565 ' HB2' HD13 ' A' ' 71' ' ' ILE . 48.2 t -102.64 -96.12 0.3 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.603 -0.271 . . . . 1.6599999999999999 111.588 -173.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.06 5.58 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.546 -0.909 . . . . 1.1200000000000001 108.546 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.11 16.92 0.18 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 106.69 -2.564 . . . . 0.39000000000000001 106.69 163.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.619 HH11 ' HA ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -105.76 163.25 12.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 112.809 -1.696 . . . . 2.4900000000000002 108.834 -171.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -97.57 87.89 4.21 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.488 0.661 . . . . 2.6099999999999999 109.313 -161.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.937 ' HA ' HG21 ' A' ' 100' ' ' ILE . 14.8 mm -44.63 -43.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 113.867 -1.515 . . . . 1.1100000000000001 111.188 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.23 167.46 36.18 Favored Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 119.9 -1.143 . . . . 0.48999999999999999 111.622 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.87 161.97 18.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.685 0.743 . . . . 2.3999999999999999 111.404 173.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.47 -178.88 32.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.804 -0.918 . . . . 0.52000000000000002 110.804 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 61' ' ' SER . 5.1 ptpp? -147.22 141.93 26.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 2.3799999999999999 111.2 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.47 124.44 18.09 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 1.47 110.182 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.7 111.34 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.427 2.085 . . . . 0.81000000000000005 110.678 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.95 144.61 52.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.816 -0.439 . . . . 0.79000000000000004 109.816 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.623 ' HA ' HD11 ' A' ' 57' ' ' ILE . 34.2 Cg_exo -62.44 90.53 0.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.146 1.897 . . . . 0.91000000000000003 112.112 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.51 35.09 2.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.99 -0.55 . . . . 0.47999999999999998 112.294 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.926 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 52.3 p -73.03 123.73 24.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.396 -0.594 . . . . 0.85999999999999999 109.396 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -149.54 -159.78 1.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.727 -1.189 . . . . 1.76 113.499 -164.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.472 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 86.4 mttt -60.6 -93.61 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.485 0.55 . . . . 2.4300000000000002 112.485 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . 162.91 110.32 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.85 -1.167 . . . . 1.29 107.85 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.782 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 45.2 pttt 41.92 49.43 4.05 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.994 0.902 . . . . 2.21 111.195 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.3 t70 -153.3 -177.97 6.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.706 -1.134 . . . . 0.64000000000000001 110.118 -172.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.9 ttm -110.35 127.39 55.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.649 -0.705 . . . . 2.04 109.793 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.56 142.24 50.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 1.3300000000000001 111.151 -175.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.55 114.17 21.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.151 0.501 . . . . 1.1100000000000001 111.656 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.647 HD23 HG12 ' A' ' 45' ' ' VAL . 5.9 tt -117.96 171.33 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.533 -0.914 . . . . 1.45 108.533 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.409 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.0 m-20 -134.7 133.85 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.477 0.58 . . . . 1.8100000000000001 112.286 -172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 46.0 mm -114.06 113.14 46.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.6 -0.889 . . . . 1.3999999999999999 108.6 168.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.637 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.3 Cg_exo -28.87 -102.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 1 C-N-CA 125.725 4.283 . . . . 1.0700000000000001 115.415 -170.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.92 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.3 93.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 122.356 -0.215 . . . . 1.1799999999999999 110.701 -177.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 95' ' ' VAL . 7.7 p -127.75 102.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 114.474 1.287 . . . . 1.1699999999999999 114.474 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.624 HG23 HD11 ' A' ' 101' ' ' LEU . 2.5 p -153.78 103.61 2.5 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 122.152 -0.343 . . . . 1.71 111.49 159.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 94.2 Cg_exo -44.37 136.4 8.51 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.405 2.07 . . . . 0.65000000000000002 113.543 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.591 ' H ' ' HA ' ' A' ' 38' ' ' SER . 2.1 t80 -52.28 -37.84 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.691 -1.141 . . . . 1.6899999999999999 110.881 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -63.29 -25.89 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 1.49 112.651 -176.047 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.937 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.4 mm -71.29 -54.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.694 0.759 . . . . 1.21 110.659 -175.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -54.21 -33.69 58.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.706 -1.588 . . . . 1.6399999999999999 109.325 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 99' ' ' SER . 56.2 t80 -61.0 -39.85 91.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.29 -1.777 . . . . 1.2 109.032 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.508 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -74.98 -57.49 3.87 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.81999999999999995 111.321 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.619 ' HA ' HH11 ' A' ' 69' ' ' ARG . 3.0 pp -57.99 -50.71 72.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.488 0.922 . . . . 1.22 113.488 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.28 -26.97 66.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.1899999999999999 110.521 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -71.2 -51.71 23.21 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.422 -0.808 . . . . 2.2200000000000002 110.944 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.646 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 35.9 t70 -81.38 -51.96 7.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.776 0.798 . . . . 0.80000000000000004 111.791 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.676 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.5 t -91.01 -22.11 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.734 -0.604 . . . . 1.5 110.431 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.24 -20.09 79.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.393 -0.908 . . . . 0.38 111.043 168.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -51.73 -48.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.635 -1.617 . . . . 1.6599999999999999 106.635 165.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.78 -97.34 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.085 -0.962 . . . . 1.8700000000000001 110.345 163.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -178.18 -52.69 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.554 0.576 . . . . 1.3500000000000001 112.554 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -95.65 124.5 39.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.407 -0.361 . . . . 2.1499999999999999 111.447 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.676 HG13 ' HB ' ' A' ' 108' ' ' VAL . 3.0 mp -117.69 155.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.734 0.302 . . . . 1.1599999999999999 110.218 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -96.0 154.55 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.638 -0.875 . . . . 2.1099999999999999 108.638 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' HH ' HD12 ' A' ' 104' ' ' LEU . 60.8 m-85 -140.31 149.36 42.67 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.161 -1.052 . . . . 0.96999999999999997 108.161 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.81 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 10.5 tt0 -146.29 139.39 25.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.369 -0.532 . . . . 0.80000000000000004 111.066 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.65 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 10.2 tp -105.67 127.59 53.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.335 -0.848 . . . . 1.9199999999999999 109.917 170.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.712 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -113.02 100.34 8.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.456 -0.942 . . . . 0.63 108.456 174.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.4 tp -112.88 122.34 66.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.124 0.488 . . . . 1.49 111.497 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.62 128.48 9.43 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.978 -0.849 . . . . 0.26000000000000001 110.978 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.625 HD22 ' HA2' ' A' ' 24' ' ' GLY . 2.2 mp -104.87 97.64 7.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.881 0.372 . . . . 1.77 111.273 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.003 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 78.9 m -97.38 95.37 7.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.93 -0.767 . . . . 1.0700000000000001 108.93 171.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.639 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.86 147.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.032 -0.667 . . . . 1.6699999999999999 110.013 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 4.5 m-20 -87.99 105.88 17.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 109.374 -0.602 . . . . 1.52 109.374 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.611 HD22 HG12 ' A' ' 124' ' ' ILE . 1.5 mm? -103.37 162.11 21.03 Favored Pre-proline 0 C--O 1.22 -0.457 0 O-C-N 124.333 1.021 . . . . 1.9299999999999999 109.611 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.97 -29.83 14.55 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 121.992 1.794 . . . . 0.98999999999999999 113.053 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . 0.417 HG13 ' HE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -75.38 -57.87 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 113.372 0.879 . . . . 1.6699999999999999 113.372 -176.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.489 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -95.1 -3.35 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.976 0.893 . . . . 1.9099999999999999 109.857 -176.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.84 -36.48 1.44 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 113.951 -1.477 . . . . 1.05 111.217 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.7 pt-20 -174.3 140.09 0.64 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.811 -1.181 . . . . 1.1599999999999999 107.811 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -140.98 146.2 36.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.83 -0.348 . . . . 2.2799999999999998 110.113 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.0 t -114.4 112.9 23.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.534 0.683 . . . . 1.8899999999999999 111.584 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.91 138.48 32.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.624 -0.716 . . . . 1.26 109.76 173.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 83.6 Cg_endo -93.15 163.65 2.53 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.019 1.813 . . . . 0.58999999999999997 113.335 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.466 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -163.34 168.09 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.679 -0.86 . . . . 1.1399999999999999 108.679 177.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -138.32 156.04 48.01 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.134 0.42 . . . . 1.28 112.134 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 t -145.94 106.87 4.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.63 -0.878 . . . . 1.3400000000000001 108.63 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.81 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.1 ptmt -120.84 149.69 42.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.629 -0.259 . . . . 2.2000000000000002 111.099 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.66 146.61 11.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.634 -0.793 . . . . 0.56000000000000005 112.403 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -107.7 132.02 53.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.067 -0.567 . . . . 2.1000000000000001 110.797 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.56 172.0 2.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.805 -1.183 . . . . 1.51 107.805 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.6 152.61 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 3.9300000000000002 111.047 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.87 150.03 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 1.9299999999999999 112.388 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.346 0.407 0 C-N-CA 123.447 2.765 . . . . 0.81000000000000005 113.03 -179.61 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.772 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.424 -2.166 0 N-CA-C 111.623 -0.591 . . . . 1.0700000000000001 111.623 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 122' ' ' LEU . 33.3 m -168.91 29.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.384 -0.969 . . . . 1.7 108.384 170.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.47 153.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.865 -1.061 . . . . 1.53 109.723 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -179.5 -46.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.632 0.582 . . . . 1.05 112.099 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 27.2 t70 -155.38 151.89 28.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.69 -0.404 . . . . 1.6899999999999999 111.603 -174.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.61 120.68 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.393 -0.595 . . . . 1.8500000000000001 109.393 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 t70 -113.44 110.86 20.99 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.637 -0.256 . . . . 1.8300000000000001 111.308 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -79.42 130.97 35.93 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.638 -0.134 . . . . 1.46 110.638 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.599 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.52 -88.05 0.24 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 114.138 1.162 . . . . 1.9199999999999999 114.138 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.204 -1.32 0 O-C-N 121.936 -0.478 . . . . 2.8500000000000001 111.995 -152.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.406 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 6.3 t . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.348 0.594 . . . . 1.1299999999999999 111.358 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.829 HG11 HD22 ' A' ' 101' ' ' LEU . 91.4 t -76.89 155.51 5.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.208 -0.905 . . . . 1.48 110.319 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.902 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 48.8 mt-10 -129.35 139.54 51.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.539 -0.864 . . . . 1.1899999999999999 110.515 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.948 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -139.72 134.62 32.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.582 -0.847 . . . . 3.9399999999999999 112.293 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -80.41 111.42 16.79 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.824 -0.806 . . . . 1.4299999999999999 108.824 -174.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.615 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -90.43 99.9 12.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.374 0.607 . . . . 1.1100000000000001 110.001 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -83.5 125.04 31.34 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.82 -0.807 . . . . 3.1800000000000002 108.82 178.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG11 ' C ' ' A' ' 25' ' ' SER . 52.2 t -115.48 139.19 43.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.169 -0.923 . . . . 1.3999999999999999 110.445 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.75 104.52 8.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.19 -0.604 . . . . 1.1100000000000001 109.58 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.772 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 83.2 t -83.05 129.89 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.338 -0.846 . . . . 1.8500000000000001 110.458 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 30.5 m -122.61 113.94 19.95 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.913 -0.585 . . . . 1.1000000000000001 109.837 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.783 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.5 p-10 -94.87 146.19 30.92 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.628 -0.715 . . . . 1.48 109.172 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.92 8.18 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.13 2.553 . . . . 0.91000000000000003 113.044 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.518 ' CE1' ' HG2' ' A' ' 127' ' ' PRO . 6.8 t80 -117.11 131.92 56.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.958 -0.386 . . . . 2.3100000000000001 109.958 -174.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.561 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 38.1 t -87.48 44.7 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.442 0.639 . . . . 1.8300000000000001 110.655 -169.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -144.07 16.88 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.459 0.911 . . . . 2.0299999999999998 113.459 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 26.2 t 61.42 98.28 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 111.885 0.328 . . . . 1.73 111.885 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.893 ' O ' ' HA ' ' A' ' 81' ' ' SER . 9.1 pt -78.79 128.87 75.52 Favored Pre-proline 0 C--O 1.207 -1.149 0 O-C-N 121.698 -0.626 . . . . 1.23 111.115 -170.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 28.6 Cg_endo -66.34 -59.21 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.914 1.743 . . . . 0.53000000000000003 113.106 -163.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 79' ' ' PRO . 10.1 mm -121.65 152.02 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.23 -0.588 . . . . 1.9099999999999999 110.782 -172.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.616 ' HB3' HG23 ' A' ' 124' ' ' ILE . 10.2 m -148.03 178.23 8.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.147 0.975 . . . . 1.95 111.961 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.087 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 34.7 tt0 -136.8 117.63 14.11 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.587 -1.642 . . . . 1.3600000000000001 110.618 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.638 HG21 HD12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -97.89 109.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.783 0.802 . . . . 1.6499999999999999 109.559 170.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.71 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 13.2 p -117.13 102.05 8.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.325 -1.307 . . . . 1.02 109.717 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 p90 -109.92 126.68 54.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.46000000000000002 110.451 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 8.2 m -120.43 105.3 10.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.525 -0.762 . . . . 1.1699999999999999 109.312 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.697 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 81.6 m-85 -98.67 140.56 32.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.28 -0.418 . . . . 1.1799999999999999 111.226 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.54 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 10.9 m170 -134.78 143.9 47.36 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.085 -1.08 . . . . 1.72 108.085 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 33.6 t -107.64 -100.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.67 -0.812 . . . . 1.6599999999999999 111.176 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.53 3.57 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.217 -0.66 . . . . 1.1200000000000001 109.217 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.51 20.94 0.13 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.292 -1.523 . . . . 0.39000000000000001 109.292 167.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 69' ' ' ARG . 7.3 ptp180 -116.46 -176.83 3.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.64 -0.874 . . . . 2.4900000000000002 108.64 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -103.05 96.8 7.04 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.744 0.783 . . . . 2.6099999999999999 108.935 -167.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.926 ' HA ' HG22 ' A' ' 100' ' ' ILE . 5.0 mm -50.77 -42.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 113.762 -1.563 . . . . 1.1100000000000001 111.153 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 170.0 32.76 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.538 -0.839 . . . . 0.48999999999999999 111.288 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.44 163.83 27.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.411 0.606 . . . . 2.3999999999999999 110.396 174.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.72 159.71 23.54 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.231 -0.748 . . . . 0.52000000000000002 111.231 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.71 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 92.3 mttt -133.19 128.53 36.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.238 -0.282 . . . . 2.3799999999999999 110.238 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.601 ' HB ' HD11 ' A' ' 60' ' ' ILE . 70.3 mt -134.31 111.8 11.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.36 -0.382 . . . . 1.47 110.224 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 111.24 3.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.518 2.146 . . . . 0.81000000000000005 110.554 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.88 142.67 46.4 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.738 -0.467 . . . . 0.79000000000000004 109.738 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' HD12 ' A' ' 57' ' ' ILE . 27.8 Cg_endo -63.84 84.61 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.539 2.159 . . . . 0.91000000000000003 112.365 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.14 41.74 3.08 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.47999999999999998 112.147 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.893 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 83.9 p -70.48 113.14 7.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.85999999999999999 109.179 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.717 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -142.74 160.82 39.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.447 0.536 . . . . 1.76 112.447 -164.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -6.25 -96.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 125.243 1.589 . . . . 2.4300000000000002 113.796 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 170.5 108.54 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.097 -1.075 . . . . 1.29 108.097 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 9.6 ptpt 42.57 54.32 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.291 0.995 . . . . 2.21 110.844 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t70 -153.53 -167.29 2.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 0.64000000000000001 110.822 -171.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.49 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 52.5 ttm -118.81 125.07 48.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 2.04 110.883 -170.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.643 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.2 t -113.58 143.28 44.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.319 -0.855 . . . . 1.3300000000000001 109.309 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.86 106.37 16.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.281 0.563 . . . . 1.1100000000000001 111.068 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.515 HD23 HG13 ' A' ' 45' ' ' VAL . 8.5 tt -103.31 160.28 14.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.514 -0.921 . . . . 1.45 108.514 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -136.3 119.56 16.72 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.682 -0.807 . . . . 1.8100000000000001 111.314 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 31.6 mm -103.36 143.59 26.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.231 -0.895 . . . . 1.3999999999999999 109.612 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 92' ' ' ILE . 17.9 Cg_endo -59.79 -155.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.888 2.392 . . . . 1.0700000000000001 113.718 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.948 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 5.1 m -126.35 92.3 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 115.602 -0.727 . . . . 1.1799999999999999 111.411 -162.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 95' ' ' VAL . 7.5 p -126.29 101.65 8.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 115.633 1.716 . . . . 1.1699999999999999 115.633 -162.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 39' ' ' VAL . 4.8 p -153.32 123.95 3.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 121.182 -0.949 . . . . 1.71 111.766 162.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 49.4 Cg_exo -53.59 135.14 60.88 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.616 1.544 . . . . 0.65000000000000002 112.071 172.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.457 ' HA ' HG21 ' A' ' 39' ' ' VAL . 1.2 t80 -50.33 -36.23 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.052 -0.976 . . . . 1.6899999999999999 110.931 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.7 m -65.62 -25.26 67.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.658 0.614 . . . . 1.49 112.658 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.926 HG22 ' HA ' ' A' ' 71' ' ' ILE . 6.5 mm -72.38 -54.46 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 121.73 -0.606 . . . . 1.21 110.043 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.829 HD22 HG11 ' A' ' 39' ' ' VAL . 9.9 mp -60.1 -25.41 65.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.002 -0.999 . . . . 1.6399999999999999 111.161 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.497 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.2 t80 -59.03 -48.49 81.41 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.54 -1.281 . . . . 1.2 107.54 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 91.3 m-20 -75.48 -56.16 4.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.648 -1.16 . . . . 0.81999999999999995 113.15 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.733 ' HG ' ' HA ' ' A' ' 101' ' ' LEU . 2.8 pp -54.36 -49.76 69.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.255 0.835 . . . . 1.22 113.255 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.575 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.92 -24.81 65.24 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 122.066 0.936 . . . . 1.1899999999999999 110.406 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 3.3 ttp180 -69.7 -49.57 52.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.226 -1.352 . . . . 2.2200000000000002 110.238 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.686 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 9.0 t70 -81.89 -53.91 5.77 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.73 0.776 . . . . 0.80000000000000004 111.98 -173.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.73 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.0 t -89.09 -22.69 6.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 1.5 110.1 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.79 -18.68 78.98 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.43 -0.891 . . . . 0.38 111.228 168.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -51.95 -47.1 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.862 -1.533 . . . . 1.6599999999999999 106.862 164.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 19.4 m-20 -68.5 -96.22 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.709 -0.678 . . . . 1.8700000000000001 110.096 159.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -179.34 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.3500000000000001 111.674 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -94.43 123.73 38.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.064 0.459 . . . . 2.1499999999999999 110.923 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.73 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.9 mp -110.64 158.76 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.283 -0.636 . . . . 1.1599999999999999 109.283 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.666 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 4.8 p-10 -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.879 -0.601 . . . . 2.1099999999999999 109.416 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 40.9 m-85 -137.13 157.9 45.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.903 -1.147 . . . . 0.96999999999999997 107.903 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.899 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.7 tt0 -145.86 137.97 25.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.146 0.498 . . . . 0.80000000000000004 109.853 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.697 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -110.51 131.49 55.0 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.484 -0.78 . . . . 1.9199999999999999 109.562 177.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.645 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -117.56 99.59 7.07 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.772 -0.825 . . . . 0.63 108.772 174.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -114.51 121.06 65.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.441 0.639 . . . . 1.49 110.719 -173.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.6 127.75 8.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.26000000000000001 111.999 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 24' ' ' GLY . 1.9 mp -99.05 96.0 7.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.83 0.348 . . . . 1.77 110.624 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.087 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 94.5 m -101.16 95.66 6.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.156 -0.683 . . . . 1.0700000000000001 109.156 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.78 ' HB ' HD11 ' A' ' 55' ' ' ILE . 32.7 pt -117.06 137.73 50.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.392 -0.523 . . . . 1.6699999999999999 110.785 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.668 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -81.66 105.93 13.2 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.224 -0.658 . . . . 1.52 109.224 -176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.529 HD21 HG22 ' A' ' 55' ' ' ILE . 20.0 mt -107.15 141.69 23.45 Favored Pre-proline 0 C--O 1.217 -0.61 0 O-C-N 124.859 1.35 . . . . 1.9299999999999999 109.69 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.518 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 50.3 Cg_exo -55.16 -27.78 57.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.272 1.981 . . . . 0.98999999999999999 113.536 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.48 -58.21 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 112.584 0.587 . . . . 1.6699999999999999 112.584 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.509 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -99.37 -2.09 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 122.14 0.971 . . . . 1.9099999999999999 109.774 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.79 -31.14 1.98 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 113.742 -1.572 . . . . 1.05 110.711 -171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.3 pt-20 -169.07 145.12 3.38 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.809 -1.182 . . . . 1.1599999999999999 107.809 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.451 ' HB2' HD13 ' A' ' 126' ' ' LEU . 6.6 t80 -134.82 134.63 41.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.048 -0.723 . . . . 2.2799999999999998 109.048 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 90.9 m -119.0 105.11 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 1.8899999999999999 111.723 -175.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.3 pp -127.66 132.75 24.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 1.26 109.838 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.674 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 73.6 Cg_endo -84.96 159.29 11.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.682 1.588 . . . . 0.58999999999999997 112.239 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -150.43 164.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.198 -1.038 . . . . 1.1399999999999999 108.198 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -133.42 149.61 51.79 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.854 -0.338 . . . . 1.28 111.528 -168.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.0 t -144.33 103.82 4.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.812 -0.81 . . . . 1.3400000000000001 108.812 173.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.899 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.7 ptmt -113.44 144.61 42.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.958 -0.565 . . . . 2.2000000000000002 110.837 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.22 139.73 6.76 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.684 -0.769 . . . . 0.56000000000000005 111.734 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.666 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 12.1 mt-10 -106.33 126.79 52.67 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.922 -0.77 . . . . 2.1000000000000001 108.922 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.42 173.6 13.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.609 -0.885 . . . . 1.51 108.609 -176.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -68.43 175.83 3.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.03 0.443 . . . . 3.9300000000000002 111.793 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.645 HD13 ' HD2' ' A' ' 145' ' ' PRO . 21.4 tp -58.82 129.07 85.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.575 -0.739 . . . . 1.9299999999999999 112.119 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.645 ' HD2' HD13 ' A' ' 144' ' ' LEU . 36.8 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 124.206 3.27 . . . . 0.81000000000000005 112.85 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.438 -1.22 0 N-CA-C 113.597 0.199 . . . . 1.0700000000000001 113.597 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . 76.7 p -166.6 36.98 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.437 1.113 . . . . 1.7 108.308 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.1 m -133.85 154.89 39.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.295 -1.32 . . . . 1.53 110.463 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 t -168.04 -45.34 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.781 0.676 . . . . 1.05 111.387 168.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -162.84 162.9 26.67 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.915 -0.49 . . . . 1.6899999999999999 111.479 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.49 146.06 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.878 -0.415 . . . . 1.8500000000000001 109.878 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -129.02 134.92 48.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.582 0.229 . . . . 1.8300000000000001 111.004 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . 2.7 tm? -100.85 134.94 43.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.145 -0.317 . . . . 1.46 110.145 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -142.92 -93.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.7 1.0 . . . . 1.9199999999999999 113.7 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.829 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.199 -1.564 0 CA-C-O 118.801 -0.618 . . . . 2.8500000000000001 111.709 -154.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.242 0.673 0 CA-C-O 121.965 0.888 . . . . 1.1299999999999999 112.173 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.829 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 48.7 t -71.88 152.49 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.181 -1.372 . . . . 1.48 109.126 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.995 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.2 mt-10 -114.84 133.83 55.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.957 -1.097 . . . . 1.1899999999999999 112.595 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.18 105.6 11.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.816 -1.084 . . . . 3.9399999999999999 110.681 -176.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -81.28 111.15 17.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.32 -0.993 . . . . 1.4299999999999999 108.32 178.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB1' ' HB ' ' A' ' 92' ' ' ILE . . . -105.32 115.61 30.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.528 0.68 . . . . 1.1100000000000001 110.875 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 39.3 ttmt -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.893 -1.049 . . . . 3.1800000000000002 108.586 177.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 25' ' ' SER . 51.0 t -108.99 143.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.599 -0.728 . . . . 1.3999999999999999 110.984 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 14.2 m -134.59 100.96 4.79 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.227 0.536 . . . . 1.1100000000000001 110.436 167.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 85.4 t -81.99 124.36 39.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.171 -0.922 . . . . 1.8500000000000001 110.617 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.516 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.0 m -103.2 110.67 22.72 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.902 -0.59 . . . . 1.1000000000000001 110.707 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.648 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 9.9 t30 -90.27 128.01 50.95 Favored Pre-proline 0 C--N 1.318 -0.802 0 O-C-N 123.796 0.685 . . . . 1.48 109.748 176.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.31 8.7 3.43 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.51 . . . . 0.91000000000000003 114.116 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.639 ' HE2' ' HD1' ' A' ' 53' ' ' HIS . 23.2 t80 -127.02 147.28 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.588 -0.893 . . . . 2.3100000000000001 108.588 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.702 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.9 t -79.1 31.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.227 0.454 . . . . 1.8300000000000001 112.227 -168.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.639 ' HD1' ' HE2' ' A' ' 51' ' ' TYR . 40.4 m80 -143.11 128.47 18.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.486 -0.324 . . . . 2.0299999999999998 110.789 176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.503 ' HA ' HD23 ' A' ' 82' ' ' LEU . 47.6 t -38.11 105.05 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 124.577 1.151 . . . . 1.73 112.971 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -77.87 125.11 86.02 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 109.242 -0.651 . . . . 1.23 109.242 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.968 ' HB2' HD12 ' A' ' 57' ' ' ILE . 30.3 Cg_endo -63.09 -58.92 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.048 1.832 . . . . 0.53000000000000003 113.544 -159.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.968 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.5 mp -132.18 154.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.899 -0.72 . . . . 1.9099999999999999 110.994 -173.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.575 ' HB3' HG22 ' A' ' 124' ' ' ILE . 31.4 p -145.83 178.11 8.42 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.504 1.145 . . . . 1.95 112.161 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.104 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.0 tt0 -131.95 114.24 14.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.687 -2.052 . . . . 1.3600000000000001 109.25 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.86 110.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.334 1.064 . . . . 1.6499999999999999 110.125 171.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.52 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -109.1 105.25 14.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.256 -1.793 . . . . 1.02 107.951 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 p90 -115.59 130.71 56.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.416 0.627 . . . . 0.46000000000000002 110.369 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 32.5 m -131.92 114.56 14.79 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.743 -1.117 . . . . 1.1699999999999999 109.065 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 71' ' ' ILE . 97.3 m-85 -96.77 146.83 24.53 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.508 -0.552 . . . . 1.1799999999999999 109.508 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -134.09 146.06 49.94 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.392 -1.336 . . . . 1.72 107.392 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 1.082 ' HB3' HD21 ' A' ' 104' ' ' LEU . 47.7 t -112.56 -97.2 0.43 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.177 -1.009 . . . . 1.6599999999999999 110.846 169.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.82 3.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.837 -0.431 . . . . 1.1200000000000001 109.837 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.2 26.37 0.18 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.964 -1.254 . . . . 0.39000000000000001 109.964 167.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 8.1 ptp180 -126.17 -174.22 3.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.552 -0.536 . . . . 2.4900000000000002 109.552 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 100' ' ' ILE . 43.7 mt-10 -101.44 92.06 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.198 0.523 . . . . 2.6099999999999999 110.391 -164.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.755 HD12 HD22 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -56.85 -32.1 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 1.1100000000000001 112.113 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.67 164.94 33.22 Favored Glycine 0 C--O 1.223 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.48999999999999999 111.245 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.28 160.26 18.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.989 0.895 . . . . 2.3999999999999999 112.126 175.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.77 159.1 21.04 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.076 -0.81 . . . . 0.52000000000000002 111.076 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.0 mtpt -126.2 128.1 46.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.196 0.498 . . . . 2.3799999999999999 110.002 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HB ' HD13 ' A' ' 60' ' ' ILE . 75.5 mt -136.63 122.22 13.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.721 0.296 . . . . 1.47 110.644 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.31 114.53 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.579 2.186 . . . . 0.81000000000000005 111.022 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -129.97 146.0 59.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.074 -0.343 . . . . 0.79000000000000004 110.074 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.82 91.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.727 2.285 . . . . 0.91000000000000003 112.17 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.88 19.51 6.31 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.497 -0.774 . . . . 0.47999999999999998 112.82 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 p -70.74 121.32 17.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.006 -0.739 . . . . 0.85999999999999999 109.006 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.555 HD13 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -145.23 -161.38 1.29 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.843 0.682 . . . . 1.76 112.843 -162.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 67.5 mttm -53.79 -94.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.83 0.678 . . . . 2.4300000000000002 112.83 -174.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 164.51 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.583 -0.895 . . . . 1.29 108.583 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.702 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.1 ptmt 46.27 40.86 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.408 1.067 . . . . 2.21 111.088 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.69 -169.75 3.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 109.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 ttm -116.19 124.5 50.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.305 0.574 . . . . 2.04 110.456 -174.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -111.35 143.48 42.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.352 -0.84 . . . . 1.3300000000000001 110.863 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.02 138.89 31.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 110.447 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.58 HD21 HG12 ' A' ' 45' ' ' VAL . 1.2 tt -144.15 175.06 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.612 -1.255 . . . . 1.45 107.612 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.509 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 4.0 p-10 -142.15 146.5 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.061 0.846 . . . . 1.8100000000000001 112.217 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.702 ' HB ' ' HB1' ' A' ' 43' ' ' ALA . 50.4 mm -114.56 143.25 29.57 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 107.895 -1.15 . . . . 1.3999999999999999 107.895 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 85.2 Cg_exo -51.52 -122.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.472 2.781 . . . . 1.0700000000000001 114.072 175.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.995 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -153.82 93.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 O-C-N 121.837 -0.539 . . . . 1.1799999999999999 111.973 -172.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.29 109.03 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.748 1.018 . . . . 1.1699999999999999 113.748 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.709 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 16.9 t -146.86 103.98 3.89 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 115.683 -0.69 . . . . 1.71 109.731 169.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.6 Cg_exo -61.26 123.45 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 CA-C-N 120.792 1.319 . . . . 0.65000000000000002 110.678 171.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.57 -38.34 44.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.56 -0.745 . . . . 1.6899999999999999 112.176 -171.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 m -56.12 -25.52 46.36 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.674 0.25 . . . . 1.49 111.674 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.639 HG23 ' HA ' ' A' ' 71' ' ' ILE . 19.0 mm -76.34 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 120.252 -0.579 . . . . 1.21 111.116 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.823 HD12 HG23 ' A' ' 39' ' ' VAL . 13.1 mt -51.96 -30.05 23.12 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.488 0.661 . . . . 1.6399999999999999 110.427 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -62.89 -40.36 97.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.178 -1.374 . . . . 1.2 108.908 -178.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.38 -56.12 5.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.727 -0.67 . . . . 0.81999999999999995 111.848 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 1.082 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.3 pp -62.14 -51.8 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.57 0.952 . . . . 1.22 113.57 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.434 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -60.3 -25.97 66.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.783 0.801 . . . . 1.1899999999999999 110.361 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.569 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.0 ttp180 -64.28 -50.42 67.96 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.659 -1.155 . . . . 2.2200000000000002 110.131 173.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.5 t70 -83.24 -53.42 5.77 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.781 0.66 . . . . 0.80000000000000004 112.781 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 114' ' ' ILE . 4.2 t -84.35 -27.47 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.498 -0.481 . . . . 1.5 110.001 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.44 -21.28 77.72 Favored Glycine 0 C--N 1.328 0.139 0 C-N-CA 120.631 -0.795 . . . . 0.38 111.573 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.8 -46.69 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.98 -1.489 . . . . 1.6599999999999999 106.98 165.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 6.3 m-20 -67.66 -90.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.434 -0.803 . . . . 1.8700000000000001 109.615 162.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -178.16 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.196 0.443 . . . . 1.3500000000000001 112.196 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -93.63 133.08 37.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.204 0.526 . . . . 2.1499999999999999 110.991 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.571 HD11 HD12 ' A' ' 144' ' ' LEU . 2.7 mp -115.87 159.95 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.367 -0.833 . . . . 1.1599999999999999 109.962 -171.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 114' ' ' ILE . 10.3 p-10 -98.81 152.83 19.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.59 -0.892 . . . . 2.1099999999999999 108.59 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.745 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.1 m-85 -138.02 163.86 30.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.96999999999999997 108.339 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 36.2 tt0 -160.58 128.47 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.80000000000000004 110.624 -177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -99.83 134.51 42.63 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.314 -0.624 . . . . 1.9199999999999999 109.314 174.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -117.21 102.54 9.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.719 -0.673 . . . . 0.63 109.266 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.579 HD13 HG23 ' A' ' 60' ' ' ILE . 6.4 tp -111.62 120.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.087 0.47 . . . . 1.49 111.154 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -90.85 126.98 8.62 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.114 -0.794 . . . . 0.26000000000000001 111.114 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.0 mp -106.89 112.93 26.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.673 0.273 . . . . 1.77 111.241 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.104 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.6 m -114.01 96.68 5.94 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.817 -0.629 . . . . 1.0700000000000001 109.762 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.637 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -111.33 144.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.544 -0.462 . . . . 1.6699999999999999 110.553 -176.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -88.57 107.12 18.73 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.163 -1.051 . . . . 1.52 108.163 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 55' ' ' ILE . 9.7 mt -106.94 168.08 8.56 Favored Pre-proline 0 C--O 1.222 -0.388 0 O-C-N 125.359 1.662 . . . . 1.9299999999999999 110.236 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.31 -41.98 0.78 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.189 1.926 . . . . 0.98999999999999999 112.982 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.02 -57.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.937 0.347 . . . . 1.6699999999999999 111.937 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -89.19 -8.16 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.697 0.761 . . . . 1.9099999999999999 109.949 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.64 -33.78 0.71 Allowed Glycine 0 C--N 1.321 -0.291 0 CA-C-N 114.473 -1.239 . . . . 1.05 112.369 -172.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -171.99 145.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.419 -1.326 . . . . 1.1599999999999999 107.419 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 123' ' ' THR . 4.4 t80 -153.75 146.11 23.94 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.445 -0.502 . . . . 2.2799999999999998 110.125 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 31.9 m -120.31 107.07 12.5 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.386 0.429 . . . . 1.8899999999999999 111.101 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.4 pp -126.37 138.03 31.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.96 -0.564 . . . . 1.26 109.936 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 18.1 Cg_endo -91.69 165.35 3.39 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.386 2.058 . . . . 0.58999999999999997 112.719 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.473 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -164.9 169.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.691 -0.855 . . . . 1.1399999999999999 108.691 178.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.3 p -136.52 154.08 50.83 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.375 0.509 . . . . 1.28 112.375 -169.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.4 t -140.58 105.61 4.99 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.716 -1.216 . . . . 1.3400000000000001 107.716 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.62 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.35 149.7 38.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.577 -0.283 . . . . 2.2000000000000002 110.834 -172.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.78 135.39 3.9 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.294 -0.723 . . . . 0.56000000000000005 111.294 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.14 131.84 44.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.652 -0.499 . . . . 2.1000000000000001 109.652 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.34 172.9 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.512 -0.551 . . . . 1.51 109.512 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 144' ' ' LEU . 0.5 OUTLIER -61.49 167.09 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.172 0.804 . . . . 3.9300000000000002 113.172 -177.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.81 HD12 ' HD2' ' A' ' 145' ' ' PRO . 32.1 tp -59.19 134.3 87.92 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 114.908 -1.042 . . . . 1.9299999999999999 111.641 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.81 ' HD2' HD12 ' A' ' 144' ' ' LEU . 31.9 Cg_endo . . . . . 0 C--N 1.351 0.666 0 C-N-CA 123.103 2.535 . . . . 0.81000000000000005 112.106 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.779 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.437 -1.245 0 CA-C-O 120.368 -0.129 . . . . 1.0700000000000001 113.35 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.658 ' HB2' HD13 ' A' ' 122' ' ' LEU . 40.7 m -172.03 39.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 1.7 108.382 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 m -134.87 155.12 37.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.778 -1.101 . . . . 1.53 109.312 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -175.56 -48.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.369 0.507 . . . . 1.05 112.369 168.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -158.5 147.04 18.65 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.049 -0.407 . . . . 1.6899999999999999 111.128 -174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.855 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.83 138.59 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.954 0.407 . . . . 1.8500000000000001 110.336 166.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.29 135.49 48.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 1.8300000000000001 111.332 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -89.9 137.94 31.91 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 1.46 111.202 -172.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -137.45 -91.78 0.23 Allowed 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 113.865 1.061 . . . . 1.9199999999999999 113.865 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.571 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 6.8 m-20 . . . . . 0 C--O 1.207 -1.178 0 O-C-N 121.452 -0.78 . . . . 2.8500000000000001 111.149 -156.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 35.6 t . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.989 0.423 . . . . 1.1299999999999999 110.206 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.679 ' HB ' HG13 ' A' ' 96' ' ' VAL . 12.0 t -76.28 158.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.008 -0.542 . . . . 1.48 109.581 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.5 mt-10 -136.91 141.33 42.71 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.451 -0.781 . . . . 1.1899999999999999 110.932 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.914 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -140.73 134.45 30.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.167 -1.013 . . . . 3.9399999999999999 113.454 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -80.78 110.93 16.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.132 . . . . 1.4299999999999999 108.624 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.855 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -100.28 106.42 18.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.239 0.542 . . . . 1.1100000000000001 110.697 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.28 116.99 24.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.161 0.981 . . . . 3.1800000000000002 109.786 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.573 HG12 ' C ' ' A' ' 25' ' ' SER . 16.1 t -95.97 149.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.214 -1.357 . . . . 1.3999999999999999 110.069 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.543 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 2.2 m -132.46 104.08 6.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.177 -0.609 . . . . 1.1100000000000001 110.67 168.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.3 t -83.04 128.43 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.731 -1.122 . . . . 1.8500000000000001 111.141 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.776 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 17.5 m -109.62 109.5 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.962 -0.563 . . . . 1.1000000000000001 110.323 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.879 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -92.29 133.52 29.86 Favored Pre-proline 0 N--CA 1.466 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 40.6 Cg_endo -104.76 22.28 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.453 2.768 . . . . 0.91000000000000003 114.656 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.609 ' HD2' ' HE1' ' A' ' 53' ' ' HIS . 4.1 t80 -116.09 -3.45 12.07 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 118.717 -1.193 . . . . 2.3100000000000001 111.358 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' HD3' ' A' ' 85' ' ' LYS . 24.6 p 89.89 15.97 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.26 1.024 . . . . 1.8300000000000001 112.404 161.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.609 ' HE1' ' HD2' ' A' ' 51' ' ' TYR . 48.7 p-80 -147.6 148.43 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.968 -0.753 . . . . 2.0299999999999998 108.968 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.865 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 41.7 t -54.32 107.16 0.25 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.244 0.965 . . . . 1.73 112.054 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.939 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.0 pt -74.71 173.02 7.42 Favored Pre-proline 0 C--O 1.206 -1.204 0 N-CA-C 107.767 -1.197 . . . . 1.23 107.767 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.491 ' HB2' HG12 ' A' ' 57' ' ' ILE . 11.0 Cg_endo -90.13 -62.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 CA-C-N 120.192 1.104 . . . . 0.53000000000000003 114.774 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.726 HD12 ' HA ' ' A' ' 79' ' ' PRO . 16.8 mm -131.22 161.35 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.588 -0.445 . . . . 1.9099999999999999 111.43 -165.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.598 ' CB ' HG23 ' A' ' 124' ' ' ILE . 29.3 p -155.96 -177.3 6.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.38 1.086 . . . . 1.95 111.972 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.5 tt0 -135.96 116.37 13.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.017 -1.902 . . . . 1.3600000000000001 109.774 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG21 HD13 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -97.25 110.09 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.238 1.018 . . . . 1.6499999999999999 109.489 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.469 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.5 p -114.42 102.97 10.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.325 -1.761 . . . . 1.02 108.844 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.3 p90 -113.37 131.65 55.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.517 -0.549 . . . . 0.46000000000000002 109.517 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 17.6 m -127.94 106.01 8.81 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.736 -1.12 . . . . 1.1699999999999999 109.067 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 72.1 m-85 -96.99 142.49 28.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 110.232 -0.284 . . . . 1.1799999999999999 110.232 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.43 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -129.38 144.85 51.41 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.28 -1.378 . . . . 1.72 107.28 176.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.876 ' HB3' HD22 ' A' ' 104' ' ' LEU . 39.1 t -107.77 -96.47 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.902 -1.119 . . . . 1.6599999999999999 111.106 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -63.93 1.1 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.146 -0.687 . . . . 1.1200000000000001 109.146 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.34 17.21 0.18 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 108.511 -1.836 . . . . 0.39000000000000001 108.511 167.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.913 HH11 ' HB3' ' A' ' 103' ' ' ASN . 11.8 ptp180 -114.3 177.47 4.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.303 -0.999 . . . . 2.4900000000000002 108.303 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.13 98.19 8.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.606 0.717 . . . . 2.6099999999999999 109.486 -163.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.4 mm -54.97 -36.43 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 113.979 -1.464 . . . . 1.1100000000000001 111.912 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.2 161.21 12.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.999 -0.84 . . . . 0.48999999999999999 110.999 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -159.99 161.77 34.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 117.875 0.837 . . . . 2.3999999999999999 111.24 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.76 162.43 28.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.753 -0.658 . . . . 0.52000000000000002 111.456 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.7 mttt -123.47 128.62 50.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.649 -0.5 . . . . 2.3799999999999999 109.649 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 60' ' ' ILE . 80.4 mt -133.56 116.8 14.03 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.268 -0.271 . . . . 1.47 110.268 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.68 101.49 1.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.753 2.302 . . . . 0.81000000000000005 111.115 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -112.85 146.13 34.46 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.509 -0.552 . . . . 0.79000000000000004 109.509 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.726 ' HA ' HD12 ' A' ' 57' ' ' ILE . 35.6 Cg_exo -62.3 86.5 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.028 1.819 . . . . 0.91000000000000003 112.168 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.492 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 36.34 2.58 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.926 -0.579 . . . . 0.47999999999999998 112.671 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.939 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.2 p -73.95 120.29 19.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.297 -0.631 . . . . 0.85999999999999999 109.297 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -156.11 161.59 40.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.318 -1.353 . . . . 1.76 114.546 -163.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HG3' ' OG1' ' A' ' 88' ' ' THR . 88.6 mttt -22.28 -97.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.883 1.438 . . . . 2.4300000000000002 114.883 -164.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 171.24 109.55 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.252 -1.018 . . . . 1.29 108.252 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.734 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 39.5 pttt 42.15 46.56 3.79 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.008 0.818 . . . . 2.21 110.936 -175.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.9 t70 -150.04 -171.04 3.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.261 -0.881 . . . . 0.64000000000000001 109.88 -170.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.543 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.9 ttm -119.01 117.93 30.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.514 0.673 . . . . 2.04 110.157 -173.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.639 ' CB ' ' HB2' ' A' ' 82' ' ' LEU . 0.8 OUTLIER -106.12 143.31 34.42 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.839 -1.073 . . . . 1.3300000000000001 111.124 -176.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.0 129.9 34.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.463 0.649 . . . . 1.1100000000000001 110.73 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.43 ' CD2' ' HB ' ' A' ' 45' ' ' VAL . 8.8 tt -135.42 162.05 33.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.398 -1.334 . . . . 1.45 107.398 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.69 138.27 32.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.23 -0.988 . . . . 1.8100000000000001 112.679 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 27.9 mm -100.82 149.92 36.59 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.005 -1.452 . . . . 1.3999999999999999 107.717 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.613 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 11.3 Cg_endo -53.96 -116.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.964 2.443 . . . . 1.0700000000000001 113.686 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 1.05 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.4 m -156.88 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 O-C-N 121.559 -0.713 . . . . 1.1799999999999999 111.729 -169.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' HE2' ' A' ' 62' ' ' PHE . 9.1 p -126.27 101.56 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 116.102 1.89 . . . . 1.1699999999999999 116.102 -163.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.679 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.5 p -152.21 110.66 2.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 121.25 -0.906 . . . . 1.71 111.864 163.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.0 Cg_exo -54.43 131.81 47.44 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.794 1.663 . . . . 0.65000000000000002 110.942 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 24.8 t80 -54.16 -40.64 67.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.53 -0.759 . . . . 1.6899999999999999 111.523 -172.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -55.88 -26.97 49.66 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.229 0.331 . . . . 1.49 111.785 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.855 HG22 ' HA ' ' A' ' 71' ' ' ILE . 13.3 mm -76.11 -55.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.109 -0.636 . . . . 1.21 110.908 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.94 HD23 HD23 ' A' ' 104' ' ' LEU . 37.9 mt -55.49 -28.48 54.82 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.521 0.677 . . . . 1.6399999999999999 110.344 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.49 -39.72 92.25 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.384 -1.28 . . . . 1.2 108.602 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.913 ' HB3' HH11 ' A' ' 69' ' ' ARG . 11.3 m-80 -74.28 -56.56 4.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.936 . . . . 0.81999999999999995 112.307 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.94 HD23 HD23 ' A' ' 101' ' ' LEU . 1.7 pp -60.77 -47.96 83.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.121 0.786 . . . . 1.22 113.121 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 144' ' ' LEU . . . -63.56 -25.02 68.05 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.844 0.83 . . . . 1.1899999999999999 109.833 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.663 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.15 -54.27 36.33 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.529 -1.214 . . . . 2.2200000000000002 110.274 173.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.533 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 18.7 t70 -82.41 -53.19 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.998 0.904 . . . . 0.80000000000000004 111.923 -173.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 3.4 t -87.55 -27.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 121.639 -0.663 . . . . 1.5 110.042 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.16 -19.76 79.76 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.462 -0.875 . . . . 0.38 111.34 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -49.14 -46.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.847 -1.538 . . . . 1.6599999999999999 106.847 164.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 33.3 m-20 -71.32 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.486 -0.779 . . . . 1.8700000000000001 110.077 162.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 179.64 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.192 0.442 . . . . 1.3500000000000001 112.192 174.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -94.89 131.17 41.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 2.1499999999999999 111.821 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 144' ' ' LEU . 2.4 mp -120.62 161.33 20.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.954 -0.566 . . . . 1.1599999999999999 109.89 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.88 154.6 18.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.783 -0.644 . . . . 2.1099999999999999 109.563 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 83.8 m-85 -140.63 132.14 26.99 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.396 -0.964 . . . . 0.96999999999999997 108.396 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.756 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 23.2 tt0 -131.22 137.15 48.79 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.082 0.468 . . . . 0.80000000000000004 110.307 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 14.9 tp -103.16 131.08 50.45 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.775 -0.648 . . . . 1.9199999999999999 110.256 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.509 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.7 99.5 8.21 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.57 -1.27 . . . . 0.63 107.57 170.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD13 HG21 ' A' ' 60' ' ' ILE . 6.3 tp -113.08 114.89 48.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.348 0.594 . . . . 1.49 111.139 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.41 128.62 8.84 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.212 -0.755 . . . . 0.26000000000000001 111.212 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 133' ' ' THR . 5.7 mp -105.91 102.05 11.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.983 0.421 . . . . 1.77 110.936 -174.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.3 m -107.86 95.17 5.5 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.272 -0.877 . . . . 1.0700000000000001 109.514 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.598 HG23 ' CB ' ' A' ' 58' ' ' CYS . 39.3 pt -113.0 141.97 26.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 C-N-CA 120.146 -0.622 . . . . 1.6699999999999999 110.52 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 53.8 m-20 -85.73 106.16 16.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.752 -0.833 . . . . 1.52 108.752 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.758 HD22 HG22 ' A' ' 55' ' ' ILE . 45.3 mt -104.02 164.87 14.45 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 124.53 1.143 . . . . 1.9299999999999999 109.878 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HG3' ' CE1' ' A' ' 53' ' ' HIS . 41.4 Cg_endo -69.91 -40.38 5.15 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.415 1.41 . . . . 0.98999999999999999 113.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.07 -58.41 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.374 0.509 . . . . 1.6699999999999999 112.374 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 132' ' ' PHE . 9.7 p -90.21 -7.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.172 0.987 . . . . 1.9099999999999999 110.05 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.92 -30.9 0.76 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 114.248 -1.342 . . . . 1.05 112.516 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.0 pt-20 -166.86 126.59 1.5 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 1.1599999999999999 108.716 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.669 ' HB2' HG12 ' A' ' 129' ' ' VAL . 13.0 t80 -123.71 135.63 53.98 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.428 -0.582 . . . . 2.2799999999999998 109.428 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.9 t -128.05 103.22 7.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.921 0.867 . . . . 1.8899999999999999 111.844 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.64 143.9 49.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.236 -0.893 . . . . 1.26 110.227 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 80.9 Cg_endo -92.49 162.74 2.95 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.783 1.656 . . . . 0.58999999999999997 113.597 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.74 168.54 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.112 -1.44 . . . . 1.1399999999999999 107.112 178.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 99.1 p -145.64 152.18 39.25 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.335 -0.546 . . . . 1.28 111.845 -168.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -146.98 113.13 5.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.784 -0.821 . . . . 1.3400000000000001 108.784 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.756 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 6.8 ptmm? -123.88 153.37 41.22 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.08 -0.248 . . . . 2.2000000000000002 111.378 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.45 143.57 8.65 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.371 -0.692 . . . . 0.56000000000000005 111.371 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -108.54 132.13 54.14 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.03 -0.585 . . . . 2.1000000000000001 110.418 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.31 173.45 2.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.473 -1.306 . . . . 1.51 107.473 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -63.94 172.63 2.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.217 0.532 . . . . 3.9300000000000002 112.332 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 114' ' ' ILE . 15.7 tp -58.97 139.85 87.07 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.316 -0.856 . . . . 1.9299999999999999 111.306 -175.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.511 ' HD2' HD11 ' A' ' 144' ' ' LEU . 37.3 Cg_endo . . . . . 0 C--N 1.349 0.604 0 C-N-CA 122.973 2.449 . . . . 0.81000000000000005 112.449 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 114.726 0.65 . . . . 1.0700000000000001 114.726 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.693 ' HB2' HD12 ' A' ' 122' ' ' LEU . 22.5 m -169.83 34.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.841 1.256 . . . . 1.7 108.294 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' SER . 23.1 m -134.94 156.31 39.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.369 -1.287 . . . . 1.53 109.191 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -173.47 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.211 0.448 . . . . 1.05 112.211 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 15.6 t70 -160.67 157.01 26.38 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.825 -0.35 . . . . 1.6899999999999999 111.004 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.4 t -142.45 134.97 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.693 -0.855 . . . . 1.8500000000000001 108.693 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 25.0 t70 -125.2 132.22 53.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 111.078 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.42 HD21 ' N ' ' A' ' 32' ' ' LYS . 2.8 tm? -101.17 127.5 47.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 1.46 111.55 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.08 -115.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.613 -0.722 . . . . 1.9199999999999999 110.05 168.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.91 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.4 p-10 . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 110.409 -0.219 . . . . 2.8500000000000001 110.409 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.593 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 29.7 t . . . . . 0 N--CA 1.429 -1.501 0 N-CA-C 105.818 -1.919 . . . . 1.1299999999999999 105.818 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.91 HG13 ' HA ' ' A' ' 33' ' ' ASP . 8.2 t -131.33 159.83 42.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.154 -0.684 . . . . 1.48 109.154 170.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 90.9 mt-10 -114.07 134.55 54.79 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.456 0.646 . . . . 1.1899999999999999 112.386 -169.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.738 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -121.73 106.08 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.841 -1.072 . . . . 3.9399999999999999 110.237 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -74.11 110.34 8.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.144 -1.058 . . . . 1.4299999999999999 108.144 175.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -98.63 110.17 22.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.468 0.651 . . . . 1.1100000000000001 110.182 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 22.8 ttmt -87.99 117.35 26.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.692 -1.14 . . . . 3.1800000000000002 109.342 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 25' ' ' SER . 61.6 t -105.78 143.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.292 -0.867 . . . . 1.3999999999999999 111.038 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.676 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 4.8 m -134.89 97.39 3.74 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.482 -0.562 . . . . 1.1100000000000001 109.482 166.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -86.49 126.68 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.454 0.645 . . . . 1.8500000000000001 110.973 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.673 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.4 m -101.78 118.01 36.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.886 -1.052 . . . . 1.1000000000000001 110.159 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 20.4 t30 -89.5 124.07 65.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 O-C-N 124.669 1.231 . . . . 1.48 109.472 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.29 2.27 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.495 2.797 . . . . 0.91000000000000003 115.34 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.78 ' CE2' ' HB2' ' A' ' 53' ' ' HIS . 7.2 p90 -134.77 163.03 30.72 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.685 -0.634 . . . . 2.3100000000000001 109.774 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.578 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 51.8 p -81.24 21.47 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.848 1.055 . . . . 1.8300000000000001 113.848 -164.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.78 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 37.0 m80 -131.21 129.97 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.967 -0.693 . . . . 2.0299999999999998 111.357 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -39.54 110.62 0.15 Allowed 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 124.512 1.125 . . . . 1.73 113.056 170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.942 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.5 pt -73.03 170.37 13.97 Favored Pre-proline 0 C--O 1.211 -0.934 0 N-CA-C 107.83 -1.174 . . . . 1.23 107.83 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.424 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 7.6 Cg_endo -87.8 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.223 1.282 . . . . 0.53000000000000003 113.327 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.91 HG12 ' HA ' ' A' ' 79' ' ' PRO . 21.7 mt -142.53 155.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.25 0.463 . . . . 1.9099999999999999 112.25 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' CYS . . . . . 0.763 ' HB3' HG23 ' A' ' 124' ' ' ILE . 21.0 p -142.28 -177.4 5.23 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.042 0.925 . . . . 1.95 110.903 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 1.068 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.1 tt0 -136.4 115.05 11.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.744 -1.571 . . . . 1.3600000000000001 109.992 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.726 HG23 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.69 109.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.359 1.076 . . . . 1.6499999999999999 109.738 167.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 28.7 p -113.55 102.71 10.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.674 -1.603 . . . . 1.02 108.799 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 15.8 p90 -115.49 134.91 54.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.353 0.597 . . . . 0.46000000000000002 110.478 -164.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 19.5 m -131.65 111.01 11.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.616 -1.174 . . . . 1.1699999999999999 109.176 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.56 ' CZ ' HD12 ' A' ' 118' ' ' LEU . 92.2 m-85 -97.27 139.66 32.9 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.111 -0.495 . . . . 1.1799999999999999 110.189 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.523 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 7.6 m170 -130.83 145.55 52.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.821 -1.177 . . . . 1.72 107.821 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD21 ' A' ' 104' ' ' LEU . 29.7 t -107.74 -99.5 0.36 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.642 -0.823 . . . . 1.6599999999999999 111.206 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -55.86 25.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.01 -0.737 . . . . 1.1200000000000001 109.01 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.09 18.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.459 -1.856 . . . . 0.39000000000000001 108.459 164.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 104' ' ' LEU . 8.4 ptp180 -114.07 171.02 7.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.17 -1.015 . . . . 2.4900000000000002 108.603 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.72 94.1 7.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.091 0.948 . . . . 2.6099999999999999 110.324 -166.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.725 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.1 mm -48.75 -44.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.389 -1.732 . . . . 1.1100000000000001 112.112 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.81 168.59 41.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.925 -1.131 . . . . 0.48999999999999999 111.718 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.76 155.57 19.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.211 0.506 . . . . 2.3999999999999999 110.862 176.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.14 155.11 19.82 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.593 -1.003 . . . . 0.52000000000000002 110.593 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -132.35 119.71 21.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.496 -0.557 . . . . 2.3799999999999999 109.496 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . 0.609 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.2 mt -133.45 116.05 13.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 1.47 110.986 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.29 111.8 3.29 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.265 1.977 . . . . 0.81000000000000005 110.141 168.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 57' ' ' ILE . 20.8 t70 -115.87 144.75 33.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.771 -0.455 . . . . 0.79000000000000004 109.771 -173.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.91 ' HA ' HG12 ' A' ' 57' ' ' ILE . 17.9 Cg_endo -61.34 73.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.815 2.343 . . . . 0.91000000000000003 111.794 172.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.564 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -76.47 35.45 1.36 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.333 -0.849 . . . . 0.47999999999999998 113.605 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.942 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.7 p -73.67 119.7 18.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.272 -0.64 . . . . 0.85999999999999999 109.272 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.643 HD22 HG12 ' A' ' 55' ' ' ILE . 1.1 pt? -140.18 -164.47 1.72 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.087 -1.445 . . . . 1.76 114.176 -161.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . 0.426 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 90.3 mttt -54.82 -93.89 0.0 OUTLIER 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.735 0.643 . . . . 2.4300000000000002 112.735 -173.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . 162.32 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.929 -1.137 . . . . 1.29 107.929 -171.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 41.8 pttt 42.32 47.46 4.19 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 124.305 1.003 . . . . 2.21 111.338 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 87' ' ' MET . 5.9 t70 -151.1 -170.41 3.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.282 -0.872 . . . . 0.64000000000000001 109.596 -173.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' MET . . . . . 0.676 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 12.0 ttt -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.889 -0.596 . . . . 2.04 110.256 -170.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 46' ' ' SER . 4.7 t -105.31 142.59 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.093 0.473 . . . . 1.3300000000000001 110.659 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -89.41 105.91 18.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.709 0.766 . . . . 1.1100000000000001 110.336 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.598 HD21 HG12 ' A' ' 45' ' ' VAL . 7.6 tt -104.23 168.29 9.2 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.11 -1.441 . . . . 1.45 107.11 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -141.75 143.22 33.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 119.252 0.933 . . . . 1.8100000000000001 111.874 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.727 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 33.5 mm -106.4 120.72 47.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.825 -1.176 . . . . 1.3999999999999999 107.825 170.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.604 ' O ' HD21 ' A' ' 42' ' ' LEU . 46.0 Cg_exo -30.87 -97.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.811 3.674 . . . . 1.0700000000000001 114.753 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.866 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.7 93.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 O-C-N 122.474 -0.141 . . . . 1.1799999999999999 110.669 -179.066 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 95' ' ' VAL . 7.4 p -127.17 103.65 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.448 1.277 . . . . 1.1699999999999999 114.448 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . 0.436 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.8 p -152.14 98.19 2.95 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 122.108 -0.37 . . . . 1.71 110.519 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 69.3 Cg_exo -50.58 128.87 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.265 1.976 . . . . 0.65000000000000002 111.828 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.593 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.2 t80 -48.63 -40.18 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.398 -0.819 . . . . 1.6899999999999999 111.609 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 m -58.92 -28.77 66.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.334 0.494 . . . . 1.49 112.334 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.9 mm -76.32 -55.02 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.095 -0.642 . . . . 1.21 110.001 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.69 HD21 HD12 ' A' ' 104' ' ' LEU . 35.7 mt -50.25 -28.16 7.24 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.97 0.794 . . . . 1.6399999999999999 110.8 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -65.11 -44.68 87.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.93 -1.032 . . . . 1.2 109.274 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.77 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.0 m-80 -73.57 -58.08 3.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 0.81999999999999995 112.197 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -59.38 -54.57 45.16 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.135 0.791 . . . . 1.22 113.135 -178.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.518 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.5 -24.28 67.75 Favored 'General case' 0 C--O 1.217 -0.605 0 CA-C-O 121.753 0.787 . . . . 1.1899999999999999 110.532 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.77 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.2 ttp180 -64.69 -44.27 90.85 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.717 -1.129 . . . . 2.2200000000000002 110.878 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . 0.643 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 31.5 t70 -85.16 -52.29 6.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.99 0.9 . . . . 0.80000000000000004 111.411 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.916 HG22 HG22 ' A' ' 114' ' ' ILE . 28.7 m -76.71 -30.87 19.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.802 -0.635 . . . . 1.5 110.18 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -79.03 -15.87 79.81 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.869 -1.059 . . . . 0.38 111.681 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.99 -42.15 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.253 -1.758 . . . . 1.6599999999999999 106.253 162.098 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 37.3 m-20 -75.53 -85.25 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.8700000000000001 110.289 157.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.463 ' O ' HD21 ' A' ' 144' ' ' LEU . 4.4 p-90 173.9 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.092 0.557 . . . . 1.3500000000000001 112.393 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.39 134.19 35.88 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.408 -0.517 . . . . 2.1499999999999999 111.941 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.916 HG22 HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -116.68 151.68 18.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.097 0.475 . . . . 1.1599999999999999 109.807 178.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -101.35 154.13 19.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.389 -0.823 . . . . 2.1099999999999999 108.878 173.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 51.8 m-85 -140.91 160.04 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.198 -0.668 . . . . 0.96999999999999997 109.198 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 26.4 tt0 -152.08 132.02 13.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.953 -0.388 . . . . 0.80000000000000004 109.953 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.56 HD12 ' CZ ' ' A' ' 64' ' ' PHE . 9.8 tp -101.58 132.35 47.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.184 -0.462 . . . . 1.9199999999999999 110.399 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLN . . . . . 0.587 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -117.89 99.55 6.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.971 -0.752 . . . . 0.63 108.971 175.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.47 121.58 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.557 0.694 . . . . 1.49 110.714 -173.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -89.36 129.23 9.57 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.319 -0.855 . . . . 0.26000000000000001 111.891 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.1 mp -101.01 109.36 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.841 0.353 . . . . 1.77 110.954 -174.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . 1.068 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.0 m -114.87 96.71 5.85 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.731 -0.668 . . . . 1.0700000000000001 109.702 175.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.763 HG23 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.06 134.35 52.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 120.314 -0.554 . . . . 1.6699999999999999 111.482 -176.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.03 106.81 11.33 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.143 -1.058 . . . . 1.52 108.143 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.544 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 19.5 mt -116.04 170.46 5.74 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.457 1.098 . . . . 1.9299999999999999 110.705 -171.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 91.0 Cg_endo -84.7 -23.76 2.54 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 121.915 1.744 . . . . 0.98999999999999999 112.283 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.85 -57.86 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 1.6699999999999999 111.764 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -107.07 -1.58 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.928 0.871 . . . . 1.9099999999999999 109.787 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.75 -28.12 0.91 Allowed Glycine 0 C--O 1.225 -0.463 0 CA-C-N 114.207 -1.36 . . . . 1.05 111.833 -171.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 129' ' ' VAL . 9.6 pt-20 -165.58 138.25 4.25 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.344 -1.354 . . . . 1.1599999999999999 107.344 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.2 t80 -132.41 128.72 38.14 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.664 -0.865 . . . . 2.2799999999999998 108.664 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 14.0 t -120.97 101.04 7.42 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.293 1.044 . . . . 1.8899999999999999 111.367 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.2 pp -127.21 132.8 24.49 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.993 -1.003 . . . . 1.26 109.84 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PRO . . . . . 0.711 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 2.5 Cg_endo -85.66 161.76 10.76 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.9 1.733 . . . . 0.58999999999999997 112.242 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -155.61 166.6 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 108.114 -1.069 . . . . 1.1399999999999999 108.114 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.1 m -134.96 148.04 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.788 -0.365 . . . . 1.28 110.987 -170.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 t -141.65 103.5 4.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.228 -1.027 . . . . 1.3400000000000001 108.228 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -107.99 147.24 31.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.055 -0.52 . . . . 2.2000000000000002 110.599 -175.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.83 135.9 4.45 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.766 -0.73 . . . . 0.56000000000000005 111.326 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.54 130.05 52.54 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.47 -0.566 . . . . 2.1000000000000001 109.47 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 174.81 6.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.462 -0.94 . . . . 1.51 108.462 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -68.69 171.65 7.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.375 0.509 . . . . 3.9300000000000002 112.375 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -56.36 128.93 74.38 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.232 -0.895 . . . . 1.9299999999999999 110.635 -176.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' PRO . . . . . 0.539 ' HD2' HD22 ' A' ' 144' ' ' LEU . 31.7 Cg_endo . . . . . 0 C--N 1.351 0.676 0 C-N-CA 123.544 2.829 . . . . 0.81000000000000005 113.392 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.939 -0.393 . . . . 12.4 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.84 67.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.675 0.621 . . . . 9.4700000000000006 112.675 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -71.31 -15.94 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 7.0899999999999999 111.936 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.04 61.58 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.731 -0.47 . . . . 8.8100000000000005 109.731 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 5' ' ' LEU . 1.2 tm? -84.09 97.79 9.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.682 -0.69 . . . . 10.82 109.622 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.92 131.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.336 -0.847 . . . . 11.69 111.589 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.655 ' HZ1' ' HB3' ' A' ' 7' ' ' LYS . 9.2 mtpm? -88.78 91.07 8.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.026 0.441 . . . . 11.81 110.825 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.59 170.16 8.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.965 -0.561 . . . . 11.779999999999999 110.3 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.4 ' HB3' ' HE3' ' A' ' 9' ' ' LYS . 5.4 mmmt -107.77 -93.61 0.4 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.468 -0.333 . . . . 15.99 110.214 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 57.47 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.638 0.586 . . . . 12.69 112.552 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.83 -31.13 8.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 14.630000000000001 111.048 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.6 m -95.41 172.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.465 0.65 . . . . 8.8900000000000006 112.643 -167.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.62 -56.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.192 -1.367 . . . . 9.1999999999999993 107.907 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.29 -11.9 3.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.89 -1.05 . . . . 8.5999999999999996 109.049 170.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -94.11 133.3 37.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.554 -0.748 . . . . 9.3100000000000005 110.051 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt 69.89 153.08 0.11 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.99 0.806 . . . . 5.9800000000000004 111.606 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -154.87 -57.44 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 2.98 109.58 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.613 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -161.72 -165.58 1.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.8500000000000001 110.543 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.689 HG21 HD12 ' A' ' 126' ' ' LEU . 25.4 pt -90.15 172.21 7.39 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.241 -0.436 . . . . 3.6800000000000002 110.377 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.523 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 21.4 Cg_exo -66.23 -91.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.632 2.221 . . . . 2.52 113.182 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 56.7 tttm 167.43 -45.52 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 122.857 0.463 . . . . 6.79 111.302 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.46 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 17.5 Cg_exo -68.72 58.46 1.1 Allowed 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.501 2.134 . . . . 3.3799999999999999 112.669 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.658 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 5.5 mp0 -129.04 134.6 48.19 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.617 -2.364 . . . . 3.3900000000000001 104.617 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.775 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -110.2 -177.35 20.92 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.66 -1.733 . . . . 1.0700000000000001 116.249 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.709 ' HB2' HD13 ' A' ' 122' ' ' LEU . 23.9 m -169.51 33.14 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.105 -1.548 . . . . 1.7 107.215 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.06 155.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.338 -1.301 . . . . 1.53 109.051 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -174.92 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.182 0.438 . . . . 1.05 112.182 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.565 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 9.1 t70 -152.72 153.84 34.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.773 0.26 . . . . 1.6899999999999999 110.464 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.424 HG22 ' CZ ' ' A' ' 64' ' ' PHE . 85.1 t -141.32 123.11 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.797 -0.446 . . . . 1.8500000000000001 109.797 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.447 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 33.0 t70 -113.93 108.72 17.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.757 -0.656 . . . . 1.8300000000000001 111.017 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.3 tm? -83.06 140.05 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 1.46 110.488 -177.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.601 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -138.68 -91.59 0.2 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.627 0.973 . . . . 1.9199999999999999 113.627 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.743 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -90.94 -178.62 5.26 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.589 -0.694 . . . . 2.8500000000000001 111.952 -152.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.1 p -166.78 -37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 123.708 0.63 . . . . 3.77 110.718 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 8.5 t30 67.16 -81.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.36 -0.836 . . . . 3.3500000000000001 108.805 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.421 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -172.11 14.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.362 0.601 . . . . 6.21 109.636 168.784 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.421 ' OD1' ' HG2' ' A' ' 36' ' ' ARG . 8.6 m-20 -131.33 -39.05 1.17 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.33 -0.85 . . . . 1.9199999999999999 109.905 -172.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.854 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.7 t -152.63 125.4 8.39 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.926 0.713 . . . . 1.1299999999999999 112.926 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.743 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 61.0 t -75.86 148.85 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.243 -0.89 . . . . 1.48 109.388 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.011 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 61.8 mt-10 -124.05 142.75 50.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.299 -0.96 . . . . 1.1899999999999999 111.209 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.948 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 11.5 p90 -133.51 131.71 40.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.269 -0.972 . . . . 3.9399999999999999 112.365 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 111.95 23.73 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.213 -1.032 . . . . 1.4299999999999999 108.213 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.824 ' HB1' ' HE1' ' A' ' 41' ' ' TYR . . . -97.08 118.67 34.01 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.176 -0.61 . . . . 1.1100000000000001 110.739 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.565 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 17.5 tppt? -84.68 116.9 23.47 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.501 -0.925 . . . . 3.1800000000000002 108.501 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.617 HG13 ' O ' ' A' ' 25' ' ' SER . 37.2 t -100.99 145.42 11.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.142 -0.936 . . . . 1.3999999999999999 110.177 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.491 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 3.6 m -129.34 100.21 5.5 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.22 0.533 . . . . 1.1100000000000001 110.05 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -83.02 121.64 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.879 -1.055 . . . . 1.8500000000000001 110.136 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.775 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.3 m -102.63 113.05 26.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.163 -0.68 . . . . 1.1000000000000001 109.163 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.761 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 8.7 t30 -88.36 128.93 51.35 Favored Pre-proline 0 N--CA 1.466 0.347 0 O-C-N 124.533 1.146 . . . . 1.48 109.961 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.658 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 75.7 Cg_endo -87.58 13.52 2.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.91000000000000003 114.389 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -130.9 142.42 50.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.392 -0.596 . . . . 2.3100000000000001 109.392 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.59 ' HB3' ' HD2' ' A' ' 85' ' ' LYS . 56.8 p -74.88 31.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.881 0.697 . . . . 1.8300000000000001 112.881 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -145.12 128.99 17.37 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.245 -0.284 . . . . 2.0299999999999998 110.738 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -39.88 110.22 0.14 Allowed 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 124.258 1.023 . . . . 1.73 112.412 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.1 pt -79.62 173.31 7.93 Favored Pre-proline 0 C--O 1.201 -1.48 0 N-CA-C 106.111 -1.811 . . . . 1.23 106.111 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.497 ' C ' HD12 ' A' ' 57' ' ' ILE . 9.4 Cg_endo -92.75 -62.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 121.326 1.509 . . . . 0.53000000000000003 114.408 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.625 HG13 ' HA ' ' A' ' 79' ' ' PRO . 1.4 mp -134.26 153.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.274 -0.421 . . . . 1.9099999999999999 110.796 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.7 ' SG ' HG22 ' A' ' 124' ' ' ILE . 21.0 m -140.76 178.95 6.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.886 0.851 . . . . 1.95 111.503 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.109 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 42.0 tt0 -133.77 115.53 14.65 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.906 -1.497 . . . . 1.3600000000000001 110.249 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.593 HG23 HD13 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.59 110.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 122.533 1.159 . . . . 1.6499999999999999 110.378 169.81 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.419 ' C ' HD12 ' A' ' 120' ' ' ILE . 14.2 t -113.3 102.74 10.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.196 -1.82 . . . . 1.02 108.636 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.514 ' HE1' HG13 ' A' ' 95' ' ' VAL . 6.6 p90 -113.66 133.44 55.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.418 0.628 . . . . 0.46000000000000002 110.029 -167.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.521 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 27.2 m -126.14 104.77 8.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.675 -1.148 . . . . 1.1699999999999999 108.399 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 4.4 m-85 -95.42 143.17 26.99 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.2 -0.454 . . . . 1.1799999999999999 110.191 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 4.0 m170 -132.11 145.63 51.52 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 107.107 -1.442 . . . . 1.72 107.107 175.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.9 ' HB3' HD23 ' A' ' 104' ' ' LEU . 19.9 t -103.84 -91.17 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.631 -1.228 . . . . 1.6599999999999999 111.158 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -69.07 0.17 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.85 0.357 . . . . 1.1200000000000001 110.159 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.67 15.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.461 -1.456 . . . . 0.39000000000000001 109.461 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.642 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -100.17 -78.31 0.51 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.516 -0.842 . . . . 2.4900000000000002 109.041 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.642 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -171.4 -177.34 2.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.141 -1.059 . . . . 2.6099999999999999 108.141 171.888 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.567 HG21 ' HB ' ' A' ' 96' ' ' VAL . 1.6 mm -135.18 -35.77 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.363 -0.835 . . . . 1.1100000000000001 109.556 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 160.5 171.98 27.16 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.281 -1.128 . . . . 0.48999999999999999 110.281 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.486 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -161.18 166.13 28.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.124 0.962 . . . . 2.3999999999999999 110.766 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.01 166.02 32.19 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.359 -0.696 . . . . 0.52000000000000002 111.359 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -129.33 129.51 44.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.897 -0.409 . . . . 2.3799999999999999 109.897 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.561 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.8 mt -139.23 121.64 10.31 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.782 0.325 . . . . 1.47 110.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.7 115.4 4.32 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.432 2.088 . . . . 0.81000000000000005 110.76 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.13 141.61 39.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.79000000000000004 109.375 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.625 ' HA ' HG13 ' A' ' 57' ' ' ILE . 23.5 Cg_exo -63.88 82.66 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.593 2.195 . . . . 0.91000000000000003 112.052 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.603 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -87.85 41.97 3.09 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.692 -0.685 . . . . 0.47999999999999998 112.14 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.78 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 44.4 t -73.45 133.74 43.77 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.208 -1.034 . . . . 0.85999999999999999 108.208 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.775 HD13 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -152.81 -156.93 0.75 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 118.201 -1.4 . . . . 1.76 114.641 -163.812 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -63.82 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 2.4300000000000002 112.173 -173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.612 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.4 106.09 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.75 -0.833 . . . . 1.29 108.75 -171.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.761 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 6.5 ptmm? 46.35 46.25 13.65 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.28 0.988 . . . . 2.21 111.348 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.39 -170.68 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.757 -1.11 . . . . 0.64000000000000001 109.545 -173.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.491 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 50.1 ttm -112.0 132.17 54.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 2.04 110.947 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.486 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -122.94 146.5 47.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.806 -0.633 . . . . 1.3300000000000001 110.049 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.05 137.09 32.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.24 0.543 . . . . 1.1100000000000001 110.696 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.531 HD21 HG12 ' A' ' 45' ' ' VAL . 7.2 tt -137.72 168.35 19.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.41 -0.959 . . . . 1.45 108.41 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -132.39 140.95 48.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.734 0.642 . . . . 1.8100000000000001 112.734 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.679 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 43.4 mm -110.94 143.51 28.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 1.3999999999999999 108.159 172.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 94' ' ' VAL . 87.7 Cg_exo -49.75 -121.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.787 2.991 . . . . 1.0700000000000001 114.147 176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.011 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -157.37 88.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.849 -0.532 . . . . 1.1799999999999999 111.891 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.514 HG13 ' HE1' ' A' ' 62' ' ' PHE . 12.3 p -127.39 101.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 115.412 1.634 . . . . 1.1699999999999999 115.412 -168.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.567 ' HB ' HG21 ' A' ' 71' ' ' ILE . 1.2 p -150.96 98.76 3.13 Favored Pre-proline 0 C--N 1.315 -0.898 0 O-C-N 121.501 -0.749 . . . . 1.71 110.489 164.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.405 ' HB2' HG12 ' A' ' 100' ' ' ILE . 51.9 Cg_exo -52.59 134.02 51.59 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.064 1.842 . . . . 0.65000000000000002 111.418 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -57.2 -33.28 67.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 1.6899999999999999 111.204 -173.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 26.5 m -58.04 -32.02 67.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.926 0.343 . . . . 1.49 111.926 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.457 HG22 ' HG2' ' A' ' 70' ' ' GLU . 9.6 mm -76.9 -56.32 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.502 -0.479 . . . . 1.21 110.695 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.663 HD21 HD12 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -51.24 -27.87 10.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.042 -0.981 . . . . 1.6399999999999999 110.563 171.463 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.458 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 63.2 t80 -65.45 -38.67 90.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.09 -1.413 . . . . 1.2 108.803 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.639 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 36.1 m-80 -74.47 -57.77 3.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.935 -0.575 . . . . 0.81999999999999995 111.758 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.9 HD23 ' HB3' ' A' ' 66' ' ' SER . 1.2 pp -62.29 -51.42 67.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.56 0.948 . . . . 1.22 113.56 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.418 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.24 -24.43 65.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.797 0.808 . . . . 1.1899999999999999 110.536 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.3 ttm180 -59.1 -52.04 67.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.917 -1.038 . . . . 2.2200000000000002 110.191 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.546 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 22.2 t70 -82.83 -51.34 7.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.6 0.714 . . . . 0.80000000000000004 111.948 -173.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.552 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 2.7 t -86.87 -27.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 121.872 -0.518 . . . . 1.5 110.425 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.418 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.0 -20.43 79.43 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.739 -0.743 . . . . 0.38 111.692 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -48.45 -46.33 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.824 -1.547 . . . . 1.6599999999999999 106.824 163.593 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.552 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 12.0 t70 -67.09 -90.41 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.477 -0.783 . . . . 1.8700000000000001 109.088 160.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 172.44 -45.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.352 0.661 . . . . 1.3500000000000001 111.17 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.55 127.32 42.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 2.1499999999999999 111.246 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.548 ' CD1' ' HB3' ' A' ' 144' ' ' LEU . 2.3 mp -124.78 158.54 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.697 -0.483 . . . . 1.1599999999999999 109.697 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -97.58 155.39 16.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.326 -0.99 . . . . 2.1099999999999999 108.326 178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.716 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 47.4 m-85 -136.36 121.83 19.45 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.233 -0.654 . . . . 0.96999999999999997 109.233 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.859 ' HG3' ' HG2' ' A' ' 139' ' ' LYS . 7.9 tt0 -113.08 132.66 55.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.128 -0.323 . . . . 0.80000000000000004 110.128 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.739 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 15.8 tp -102.07 128.83 48.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.219 -0.446 . . . . 1.9199999999999999 110.053 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.669 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.18 99.55 8.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.976 -1.12 . . . . 0.63 107.976 168.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.593 HD13 HG23 ' A' ' 60' ' ' ILE . 5.4 tp -113.17 117.79 56.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.321 0.582 . . . . 1.49 111.099 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 120.62 5.27 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.104 -0.798 . . . . 0.26000000000000001 111.104 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.709 HD13 ' HB2' ' A' ' 25' ' ' SER . 5.2 mp -97.76 98.55 9.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.123 0.487 . . . . 1.77 111.164 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.109 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.2 m -100.11 121.14 40.95 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.384 -0.969 . . . . 1.0700000000000001 108.384 169.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.7 HG22 ' SG ' ' A' ' 58' ' ' CYS . 11.0 pt -133.68 132.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.538 -0.465 . . . . 1.6699999999999999 110.355 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.26 107.03 11.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.194 -1.039 . . . . 1.52 108.194 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.689 HD12 HG21 ' A' ' 19' ' ' ILE . 11.1 mt -115.73 160.83 33.42 Favored Pre-proline 0 C--O 1.219 -0.522 0 O-C-N 124.715 1.26 . . . . 1.9299999999999999 110.769 -169.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.75 -23.8 16.32 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.89 1.727 . . . . 0.98999999999999999 112.152 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -57.59 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.259 -0.428 . . . . 1.6699999999999999 112.093 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.613 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -109.17 1.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.033 0.921 . . . . 1.9099999999999999 109.897 -175.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.79 -32.49 0.88 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.09 -1.414 . . . . 1.05 111.682 -171.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.544 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -175.75 146.29 0.73 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.456 -1.312 . . . . 1.1599999999999999 107.456 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.619 ' O ' ' HA ' ' A' ' 123' ' ' THR . 14.6 t80 -150.82 146.32 26.29 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.422 -0.511 . . . . 2.2799999999999998 110.004 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.513 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 37.4 m -121.27 110.39 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.913 0.387 . . . . 1.8899999999999999 111.221 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.504 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.15 133.9 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 1.26 109.355 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 38.3 Cg_endo -91.54 162.29 3.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.873 1.715 . . . . 0.58999999999999997 113.28 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.448 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.17 167.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.245 -1.02 . . . . 1.1399999999999999 108.245 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.727 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -137.81 150.4 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.662 -0.125 . . . . 1.28 110.662 -167.844 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.7 t -148.6 102.38 3.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.623 -0.51 . . . . 1.3400000000000001 109.623 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.859 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -99.11 144.5 28.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.847 -0.615 . . . . 2.2000000000000002 110.936 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.37 130.42 3.07 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.478 -0.649 . . . . 0.56000000000000005 111.478 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -98.9 125.29 44.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.662 -0.496 . . . . 2.1000000000000001 109.662 -178.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 172.68 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.841 -1.17 . . . . 1.51 107.841 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -67.23 141.29 57.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.883 -0.414 . . . . 3.9300000000000002 109.883 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.733 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.2 pp -60.35 163.83 7.87 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.366 -0.379 . . . . 1.9299999999999999 111.505 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.733 ' HD2' ' HB2' ' A' ' 144' ' ' LEU . 15.9 Cg_endo -55.89 172.26 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.504 2.803 . . . . 0.81000000000000005 113.804 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.1 t -65.98 133.64 51.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.972 -0.751 . . . . 2.3700000000000001 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -153.81 -175.53 5.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.824 0.821 . . . . 3.1899999999999999 112.36 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -176.55 -50.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.835 -1.53 . . . . 4.1500000000000004 107.534 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -148.45 39.42 0.89 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.491 -1.232 . . . . 4.2800000000000002 108.141 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.418 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 85.2 m-85 -115.24 -43.27 3.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 3.23 110.581 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 89.1 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 117.657 -1.163 . . . . 4.9000000000000004 109.911 -172.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.989 0.423 . . . . 12.4 109.955 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.87 40.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.988 -0.551 . . . . 9.4700000000000006 111.492 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 p -144.52 151.41 39.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.573 -0.74 . . . . 7.0899999999999999 109.568 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.06 103.52 15.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.771 0.319 . . . . 8.8100000000000005 110.819 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.597 HD13 HD12 ' A' ' 19' ' ' ILE . 3.1 mm? -92.66 -38.09 12.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.54 . . . . 10.82 109.596 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.08 94.64 6.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 11.69 109.66 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -129.79 -9.12 4.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.836 -0.62 . . . . 11.81 110.755 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 64.11 27.69 14.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 11.779999999999999 111.305 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -112.79 131.86 55.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.027 -0.533 . . . . 15.99 110.961 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -136.74 126.19 25.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.096 -0.502 . . . . 12.69 109.936 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -142.74 -58.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.676 -0.861 . . . . 14.630000000000001 108.676 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 17.2 m -137.58 150.99 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.995 -1.002 . . . . 8.8900000000000006 108.934 171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.88 -14.45 21.8 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.799 -0.445 . . . . 9.1999999999999993 109.799 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.72 -71.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.282 -0.872 . . . . 8.5999999999999996 111.545 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.528 ' HB3' ' HB2' ' A' ' 50' ' ' PRO . 56.3 mttp -147.19 60.87 1.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.371 . . . . 9.3100000000000005 110.495 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 41.9 tp -81.59 -32.34 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.192 0.52 . . . . 5.9800000000000004 110.4 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.448 HG21 HG12 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -84.62 169.61 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.765 -0.652 . . . . 2.98 111.253 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.584 ' HB1' HG11 ' A' ' 129' ' ' VAL . . . -80.26 6.9 10.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.819 -0.628 . . . . 1.8500000000000001 111.347 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.597 HD12 HD13 ' A' ' 5' ' ' LEU . 39.0 pt -136.08 61.57 40.89 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.745 1.017 . . . . 3.6800000000000002 113.745 -165.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.53 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 5.7 Cg_exo -81.71 -94.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.029 1.819 . . . . 2.52 111.995 170.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 3.2 tppp? 167.22 -54.07 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 122.678 0.391 . . . . 6.79 111.86 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 14.4 Cg_endo -90.75 76.01 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.583 2.188 . . . . 3.3799999999999999 113.116 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 48' ' ' THR . 7.6 mp0 -127.96 139.96 52.27 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.249 -2.5 . . . . 3.3900000000000001 104.249 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.747 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -114.05 -178.63 19.14 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 118.092 -2.004 . . . . 1.0700000000000001 115.881 -165.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.64 ' O ' HG13 ' A' ' 45' ' ' VAL . 93.2 p -166.57 36.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.776 -1.564 . . . . 1.7 106.776 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.428 ' O ' ' HB2' ' A' ' 46' ' ' SER . 13.4 m -134.52 154.03 36.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.646 -1.615 . . . . 1.53 109.237 -169.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.42 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 2.4 t -175.12 -50.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.245 0.461 . . . . 1.05 112.245 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 16.3 t70 -152.19 157.13 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.912 -0.493 . . . . 1.6899999999999999 111.36 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.563 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 75.1 t -147.33 124.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.379 -0.373 . . . . 1.8500000000000001 110.719 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -107.13 142.03 37.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 1.8300000000000001 110.454 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.728 HD12 ' N ' ' A' ' 32' ' ' LYS . 3.0 tm? -97.85 141.04 31.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.34 -0.615 . . . . 1.46 109.34 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.728 ' N ' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -135.45 -115.21 0.19 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 114.366 1.247 . . . . 1.9199999999999999 114.366 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.595 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 11.7 m-20 -94.87 178.71 5.48 Favored 'General case' 0 C--O 1.203 -1.368 0 O-C-N 121.653 -0.654 . . . . 2.8500000000000001 111.823 -156.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.91 ' HB ' HG23 ' A' ' 39' ' ' VAL . 2.7 p -155.49 -34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 112.765 0.654 . . . . 3.77 112.765 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 60.6 m-80 68.34 -77.88 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.285 -0.635 . . . . 3.3500000000000001 109.285 -170.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.6 10.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.984 -0.553 . . . . 6.21 111.029 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -125.45 -42.39 1.97 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.842 0.83 . . . . 1.9199999999999999 110.364 -169.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.67 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.2 t -161.09 131.77 5.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.361 -1.29 . . . . 1.1299999999999999 110.556 -171.427 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.91 HG23 ' HB ' ' A' ' 34' ' ' VAL . 41.8 t -87.64 155.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.606 -0.725 . . . . 1.48 109.495 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.952 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 70.6 mt-10 -118.94 151.12 38.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 122.004 -0.435 . . . . 1.1899999999999999 110.457 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.897 ' HE2' ' HB3' ' A' ' 43' ' ' ALA . 24.3 p90 -136.89 131.55 33.3 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.122 -0.631 . . . . 3.9399999999999999 111.833 171.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.32 112.43 20.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.799 -0.815 . . . . 1.4299999999999999 108.799 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.897 ' HB3' ' HE2' ' A' ' 41' ' ' TYR . . . -95.32 115.8 27.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.249 0.547 . . . . 1.1100000000000001 110.936 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 10.8 tppt? -88.39 123.52 33.03 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.518 -0.919 . . . . 3.1800000000000002 108.518 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 25' ' ' SER . 30.9 t -110.5 140.74 28.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.711 -0.677 . . . . 1.3999999999999999 110.544 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.574 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 1.6 m -129.15 99.32 5.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.25 0.547 . . . . 1.1100000000000001 110.165 170.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.747 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -82.61 125.88 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.308 -0.86 . . . . 1.8500000000000001 110.483 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.729 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.8 m -108.11 113.97 27.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.465 -0.569 . . . . 1.1000000000000001 109.465 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.852 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 p30 -89.76 150.53 44.17 Favored Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 108.132 -1.062 . . . . 1.48 108.132 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.528 ' HB2' ' HB3' ' A' ' 15' ' ' LYS . 54.2 Cg_endo -97.71 -9.34 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.072 2.515 . . . . 0.91000000000000003 114.48 -175.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.707 ' HE1' HG21 ' A' ' 128' ' ' VAL . 14.2 t80 -89.17 -20.27 24.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.88 -0.728 . . . . 2.3100000000000001 112.195 -155.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.653 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 24.0 t 84.16 13.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.987 0.804 . . . . 1.8300000000000001 109.237 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 34.4 m80 -139.65 130.0 25.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.77 . . . . 2.0299999999999998 109.382 178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.56 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 14.7 m -41.89 96.7 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 O-C-N 124.102 0.876 . . . . 1.73 112.928 173.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.958 HG22 HD21 ' A' ' 126' ' ' LEU . 6.0 pt -74.75 171.46 11.48 Favored Pre-proline 0 C--O 1.212 -0.889 0 N-CA-C 108.261 -1.015 . . . . 1.23 108.261 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 12.4 Cg_endo -88.91 -59.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.067 1.178 . . . . 0.53000000000000003 113.993 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.736 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 5.9 mt -138.68 162.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.951 -0.7 . . . . 1.9099999999999999 112.125 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.692 ' HB3' HG21 ' A' ' 124' ' ' ILE . 22.0 p -146.72 177.13 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.251 1.024 . . . . 1.95 111.7 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.112 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 31.8 tt0 -126.4 116.18 20.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.286 -1.779 . . . . 1.3600000000000001 109.723 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.811 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -98.88 109.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.204 1.002 . . . . 1.6499999999999999 109.975 172.171 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 5.8 m -112.44 102.89 10.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.597 -1.638 . . . . 1.02 108.465 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.691 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 p90 -112.87 127.37 56.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.456 0.646 . . . . 0.46000000000000002 109.82 -169.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.553 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 16.4 m -123.28 106.5 10.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.483 -1.235 . . . . 1.1699999999999999 108.289 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.757 ' CZ ' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.34 135.18 39.61 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.646 -0.421 . . . . 1.1799999999999999 110.514 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 2.2 m170 -123.05 144.76 49.07 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.034 -1.469 . . . . 1.72 107.034 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.969 ' HB3' HD22 ' A' ' 104' ' ' LEU . 46.4 t -106.78 -97.53 0.35 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.223 -0.991 . . . . 1.6599999999999999 110.919 174.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.2 -58.79 6.9 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.212 -0.662 . . . . 1.1200000000000001 109.212 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 22.41 0.13 Allowed Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.613 -1.395 . . . . 0.39000000000000001 109.613 164.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.505 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.2 ptp180 -122.37 -172.57 2.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.643 -0.503 . . . . 2.4900000000000002 109.643 -175.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -100.46 87.19 3.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.716 0.77 . . . . 2.6099999999999999 111.46 -161.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.647 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.8 mm -53.74 -45.15 61.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.598 -1.183 . . . . 1.1100000000000001 112.117 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.91 163.62 30.82 Favored Glycine 0 C--O 1.22 -0.74 0 C-N-CA 120.23 -0.986 . . . . 0.48999999999999999 111.383 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.691 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -163.07 157.59 20.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.886 0.843 . . . . 2.3999999999999999 111.871 -177.758 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.61 28.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.825 -0.51 . . . . 0.52000000000000002 111.825 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 37.9 mttm -127.3 127.11 43.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.902 -0.407 . . . . 2.3799999999999999 109.902 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.463 ' HB ' HD12 ' A' ' 60' ' ' ILE . 78.4 mt -139.95 124.9 11.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 120.695 0.283 . . . . 1.47 110.55 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.54 116.32 4.64 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.431 2.087 . . . . 0.81000000000000005 110.801 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.476 ' HB2' HD13 ' A' ' 60' ' ' ILE . 10.8 t70 -123.08 141.1 34.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.487 -0.56 . . . . 0.79000000000000004 109.487 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.7 89.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.719 2.28 . . . . 0.91000000000000003 112.337 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.736 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -82.69 28.43 3.53 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.47999999999999998 113.102 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.957 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.9 p -74.91 122.88 24.11 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.985 -0.376 . . . . 0.85999999999999999 109.985 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.56 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.8 pt? -153.41 -167.19 2.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 118.317 -1.353 . . . . 1.76 114.059 -165.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' HB2' ' H ' ' A' ' 84' ' ' ALA . 87.5 mttt -52.57 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.545 0.943 . . . . 2.4300000000000002 113.545 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . -178.08 105.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.636 -0.876 . . . . 1.29 108.636 -174.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.852 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.7 pttt 36.91 62.97 0.73 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.104 0.877 . . . . 2.21 111.185 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.566 ' O ' ' HA ' ' A' ' 48' ' ' THR . 5.7 t70 -157.51 -179.3 8.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.789 -1.096 . . . . 0.64000000000000001 109.015 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.574 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 40.6 ttm -108.73 120.12 41.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.072 -0.513 . . . . 2.04 110.597 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.533 ' O ' ' HA ' ' A' ' 46' ' ' SER . 6.0 t -105.76 143.68 33.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.621 -0.718 . . . . 1.3300000000000001 109.917 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.93 26.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.463 0.649 . . . . 1.1100000000000001 110.708 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.621 HD21 HG12 ' A' ' 45' ' ' VAL . 5.6 tt -116.0 164.58 14.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.982 -1.008 . . . . 1.45 108.985 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.32 132.9 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 1.8100000000000001 110.951 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.65 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 21.7 mm -118.95 140.82 29.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 1.3999999999999999 111.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.94 -169.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.059 3.173 . . . . 1.0700000000000001 113.626 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.952 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 18.0 m -126.8 91.01 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.885 -0.598 . . . . 1.1799999999999999 112.417 -163.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG13 ' HE1' ' A' ' 41' ' ' TYR . 4.9 p -125.29 104.45 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.885 1.439 . . . . 1.1699999999999999 114.885 -163.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.487 HG11 ' HG ' ' A' ' 101' ' ' LEU . 4.8 t -145.79 109.07 4.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.088 -0.382 . . . . 1.71 110.775 170.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.589 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.1 Cg_exo -56.87 129.24 33.48 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 120.711 0.94 . . . . 0.65000000000000002 110.55 169.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.715 ' HD2' HG23 ' A' ' 34' ' ' VAL . 11.8 t80 -53.59 -32.16 49.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.261 -0.427 . . . . 1.6899999999999999 110.631 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.578 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 2.0 m -57.45 -30.73 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 1.49 112.041 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.647 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -76.05 -55.44 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 1.21 110.52 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.9 HD21 HD23 ' A' ' 104' ' ' LEU . 42.3 mt -53.49 -27.17 23.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.524 -0.762 . . . . 1.6399999999999999 110.952 172.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.578 ' HB3' ' O ' ' A' ' 99' ' ' SER . 34.8 t80 -60.77 -46.42 90.54 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.595 -1.184 . . . . 1.2 108.786 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.587 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 30.3 m-80 -73.44 -56.05 5.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.81999999999999995 112.217 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.969 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.9 pp -59.85 -46.68 88.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.46 0.911 . . . . 1.22 113.46 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.608 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -61.71 -24.06 66.53 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.918 0.866 . . . . 1.1899999999999999 110.104 178.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.587 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.7 ttp180 -68.61 -49.16 61.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.896 -1.047 . . . . 2.2200000000000002 110.82 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.645 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -81.85 -54.82 5.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.122 0.963 . . . . 0.80000000000000004 112.213 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.917 ' HB ' HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -88.72 -20.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 121.348 -0.845 . . . . 1.5 109.883 -176.211 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.608 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.05 -19.93 79.62 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.077 -1.058 . . . . 0.38 110.93 167.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.645 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -50.55 -45.86 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.7 -1.222 . . . . 1.6599999999999999 107.7 167.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.415 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 4.6 p-10 -81.16 -84.36 0.1 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.026 -1.07 . . . . 1.8700000000000001 110.929 163.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.415 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 5.0 p-90 178.1 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.604 0.638 . . . . 1.3500000000000001 112.665 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.35 121.95 37.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.691 -0.231 . . . . 2.1499999999999999 111.568 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.917 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.4 mp -113.19 154.81 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.447 -0.575 . . . . 1.1599999999999999 109.447 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -100.4 153.53 19.26 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.62 -0.718 . . . . 2.1099999999999999 109.198 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.633 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -135.45 151.5 50.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.683 -1.229 . . . . 0.96999999999999997 107.683 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.794 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 38.3 tt0 -146.07 126.63 14.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 110.032 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.757 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 15.0 tp -97.34 137.13 36.81 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.169 0.509 . . . . 1.9199999999999999 110.692 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.687 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -115.84 100.52 8.07 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.344 -0.984 . . . . 0.63 108.344 170.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.811 HD11 HG22 ' A' ' 60' ' ' ILE . 4.6 tp -114.01 118.9 59.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.218 0.533 . . . . 1.49 111.091 -173.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.14 124.18 6.91 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.544 -0.622 . . . . 0.26000000000000001 111.544 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.584 HD13 ' OG ' ' A' ' 25' ' ' SER . 5.5 mp -104.03 100.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.035 0.445 . . . . 1.77 111.108 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.112 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 99.9 m -102.62 96.6 6.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.223 -0.899 . . . . 1.0700000000000001 108.826 172.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.692 HG21 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.94 133.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.528 -0.469 . . . . 1.6699999999999999 110.717 -175.604 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 1.0 OUTLIER -75.22 105.67 6.36 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.93 -0.767 . . . . 1.52 108.93 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.958 HD21 HG22 ' A' ' 55' ' ' ILE . 19.2 mt -120.2 143.05 34.82 Favored Pre-proline 0 C--O 1.216 -0.675 0 O-C-N 124.706 1.254 . . . . 1.9299999999999999 109.925 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.424 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 78.0 Cg_exo -53.14 -37.47 79.75 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.905 2.403 . . . . 0.98999999999999999 115.361 -171.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.707 HG21 ' HE1' ' A' ' 51' ' ' TYR . 97.7 t -73.64 -56.93 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.747 -0.596 . . . . 1.6699999999999999 112.496 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.668 HG12 ' HB2' ' A' ' 132' ' ' PHE . 14.9 p -92.16 -7.97 10.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 122.32 1.057 . . . . 1.9099999999999999 109.868 -175.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.27 -36.78 2.39 Favored Glycine 0 N--CA 1.462 0.43 0 CA-C-N 114.18 -1.373 . . . . 1.05 112.078 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.5 pt-20 -165.84 122.3 1.36 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.544 -1.28 . . . . 1.1599999999999999 107.544 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.668 ' HB2' HG12 ' A' ' 129' ' ' VAL . 7.9 t80 -111.98 143.28 43.23 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.241 -0.584 . . . . 2.2799999999999998 109.801 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 64.7 m -123.75 102.43 7.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.846 -0.615 . . . . 1.8899999999999999 111.524 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.406 HD12 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.53 139.19 34.06 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.728 -0.669 . . . . 1.26 110.096 173.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.16 162.26 3.8 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.58999999999999997 112.557 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.448 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -161.5 167.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.29 -1.004 . . . . 1.1399999999999999 108.29 178.432 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.514 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -137.1 148.78 46.92 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.952 -0.299 . . . . 1.28 110.794 -170.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 t -140.39 107.83 5.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.445 -0.946 . . . . 1.3400000000000001 108.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.794 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.74 143.93 43.81 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.865 -0.334 . . . . 2.2000000000000002 110.789 -175.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.73 132.62 3.75 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.812 -0.915 . . . . 0.56000000000000005 110.812 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 9.3 mt-10 -97.55 126.31 42.76 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.926 -0.768 . . . . 2.1000000000000001 108.926 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.03 173.3 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.173 -0.677 . . . . 1.51 109.173 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.55 168.22 7.76 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.747 0.647 . . . . 3.9300000000000002 112.747 -173.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.878 HD12 ' HD2' ' A' ' 145' ' ' PRO . 22.9 tp -56.21 130.48 74.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.033 -0.985 . . . . 1.9299999999999999 112.324 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.878 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.8 Cg_endo -58.27 170.9 2.02 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.24 3.293 . . . . 0.81000000000000005 112.93 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.4 m -63.58 102.9 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 2.3700000000000001 110.531 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.457 ' CE1' HD22 ' A' ' 144' ' ' LEU . 7.7 p90 -122.87 -26.84 4.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.511 . . . . 3.1899999999999999 111.158 -176.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt 52.09 46.91 25.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.274 0.559 . . . . 4.1500000000000004 111.386 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 67.12 9.06 6.64 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.508 -0.769 . . . . 4.2800000000000002 112.504 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -98.4 -46.03 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 3.23 110.643 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.425 ' HA ' ' HB2' ' A' ' 147' ' ' PHE . 50.0 m-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 114.754 -1.112 . . . . 4.9000000000000004 108.767 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 7.6 tpt . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.232 -0.655 . . . . 12.4 109.232 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.515 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -100.01 24.07 9.04 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.732 0.641 . . . . 9.4700000000000006 112.732 -171.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -86.54 -39.27 16.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.713 -0.477 . . . . 7.0899999999999999 109.713 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.472 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -127.69 22.2 6.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 8.8100000000000005 110.143 173.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.5 mm? 73.34 150.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.738 -1.119 . . . . 10.82 111.861 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.55 34.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.401 -0.818 . . . . 11.69 111.09 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 62.95 26.63 15.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.546 . . . . 11.81 111.242 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.9 142.64 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.652 . . . . 11.779999999999999 109.682 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 50.4 mtpt -130.86 163.45 27.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.466 -0.334 . . . . 15.99 110.94 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 70.93 -56.78 0.61 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.678 0.791 . . . . 12.69 112.432 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -66.12 -35.31 80.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 14.630000000000001 110.284 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.99 131.33 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.802 -0.635 . . . . 8.8900000000000006 110.894 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.69 30.3 2.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.743 -0.662 . . . . 9.1999999999999993 110.863 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 57.58 41.87 25.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.957 -0.565 . . . . 8.5999999999999996 110.731 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -56.77 -59.71 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.691 -0.686 . . . . 9.3100000000000005 110.554 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.33 128.46 39.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.311 -0.404 . . . . 5.9800000000000004 110.064 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 m -142.27 147.69 36.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.691 -0.485 . . . . 2.98 109.691 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.444 ' HA ' HG11 ' A' ' 129' ' ' VAL . . . 69.42 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 O-C-N 123.931 0.769 . . . . 1.8500000000000001 111.003 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.67 HG21 ' HG ' ' A' ' 126' ' ' LEU . 16.9 pt -153.02 170.45 8.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.184 -0.302 . . . . 3.6800000000000002 110.184 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.21 -160.59 0.06 OUTLIER 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.913 2.409 . . . . 2.52 111.946 172.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HE3' ' OE1' ' A' ' 23' ' ' GLU . 33.4 tttp -66.61 105.69 0.91 Allowed Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 110.093 -0.336 . . . . 6.79 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.786 ' HB3' ' HG3' ' A' ' 50' ' ' PRO . 93.6 Cg_endo -100.48 54.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.973 3.115 . . . . 3.3799999999999999 113.847 -168.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HA ' HD13 ' A' ' 134' ' ' ILE . 11.3 pt-20 -123.59 127.48 48.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.46 0.648 . . . . 3.3900000000000001 110.985 -168.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . 170.77 127.38 0.94 Allowed Glycine 0 N--CA 1.422 -2.294 0 C-N-CA 119.606 -1.283 . . . . 1.0700000000000001 112.701 171.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.502 ' HB2' HD21 ' A' ' 122' ' ' LEU . 4.9 m -172.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.829 0.851 . . . . 1.7 109.62 167.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 46' ' ' SER . 7.4 p -134.25 147.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.56 -0.746 . . . . 1.53 110.926 -174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -166.11 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 1.05 110.899 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.564 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 33.3 t70 -167.09 164.78 15.83 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.365 -0.235 . . . . 1.6899999999999999 110.365 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG22 ' HZ ' ' A' ' 64' ' ' PHE . 69.0 t -142.91 120.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.992 -0.373 . . . . 1.8500000000000001 109.992 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.417 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 9.7 m-20 -92.4 109.86 21.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.8300000000000001 110.648 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.394 -0.595 . . . . 1.46 109.394 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.449 ' CG ' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -124.58 -125.95 0.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.195 -0.457 . . . . 1.9199999999999999 109.962 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.93 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 p30 179.76 176.67 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.13 0.491 . . . . 2.8500000000000001 112.1 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG12 ' O ' ' A' ' 38' ' ' SER . 1.2 t -154.59 132.38 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.816 -1.084 . . . . 3.77 109.549 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.7 t30 51.34 -103.37 0.14 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.504 -1.225 . . . . 3.3500000000000001 110.605 163.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -175.87 33.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.92 1.343 . . . . 6.21 108.228 169.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -130.4 -39.92 1.29 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.377 -1.738 . . . . 1.9199999999999999 109.134 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.65 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 39.4 t -143.16 165.4 27.53 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.976 -1.465 . . . . 1.1299999999999999 107.132 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.985 HG22 HG11 ' A' ' 96' ' ' VAL . 20.4 m -128.69 178.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.377 0.99 . . . . 1.48 111.476 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.945 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 84.4 mt-10 -125.25 151.68 45.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.815 -0.63 . . . . 1.1899999999999999 111.431 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.889 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 13.5 p90 -136.46 123.42 21.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.897 -0.721 . . . . 3.9399999999999999 110.197 165.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.432 ' N ' HG11 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -86.68 110.82 20.13 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.528 -0.915 . . . . 1.4299999999999999 108.528 174.511 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.758 ' HB1' ' HE1' ' A' ' 41' ' ' TYR . . . -91.09 115.59 28.13 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.816 0.817 . . . . 1.1100000000000001 110.211 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 20.8 ttmt -84.72 117.72 23.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.252 -1.34 . . . . 3.1800000000000002 108.432 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.734 HG23 HG12 ' A' ' 92' ' ' ILE . 39.5 t -111.57 144.9 18.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.435 0.636 . . . . 1.3999999999999999 111.841 -169.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.643 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 24.7 m -133.57 97.5 3.95 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.22 -0.9 . . . . 1.1100000000000001 108.735 163.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -85.95 132.16 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.61 0.719 . . . . 1.8500000000000001 110.893 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 26.8 m -111.33 115.53 29.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.718 -1.128 . . . . 1.1000000000000001 110.032 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.9 t30 -91.53 132.77 32.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.717 1.26 . . . . 1.48 108.409 174.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.786 ' HG3' ' HB3' ' A' ' 22' ' ' PRO . 42.0 Cg_endo -89.04 3.31 5.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.129 2.553 . . . . 0.91000000000000003 114.147 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 91.7 t80 -108.33 133.1 53.01 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.152 -0.684 . . . . 2.3100000000000001 109.152 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.807 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 23.8 p -77.08 30.27 0.14 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.496 0.924 . . . . 1.8300000000000001 113.496 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.574 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 62.2 m80 -146.15 142.81 28.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 2.0299999999999998 108.597 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -41.01 105.75 0.05 OUTLIER 'General case' 0 C--O 1.208 -1.125 0 O-C-N 123.886 0.741 . . . . 1.73 112.151 171.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.945 ' O ' ' HA ' ' A' ' 81' ' ' SER . 8.4 pt -75.63 171.32 12.26 Favored Pre-proline 0 C--O 1.209 -1.076 0 N-CA-C 107.463 -1.31 . . . . 1.23 107.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.426 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 10.2 Cg_endo -89.46 -62.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 120.301 1.143 . . . . 0.53000000000000003 113.781 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.664 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.4 mm -130.3 154.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.401 -0.52 . . . . 1.9099999999999999 110.919 -167.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.716 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 4.0 m -146.1 -176.52 5.19 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.977 0.894 . . . . 1.95 110.988 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.954 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 43.1 tt0 -138.47 118.14 13.09 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.96 -1.473 . . . . 1.3600000000000001 111.068 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.512 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.63 108.22 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.255 1.026 . . . . 1.6499999999999999 109.54 166.775 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.515 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 15.5 p -113.61 102.62 10.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 113.826 -1.533 . . . . 1.02 108.413 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.592 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -112.74 126.89 55.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.488 0.661 . . . . 0.46000000000000002 110.012 -165.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.612 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 20.9 m -120.86 104.25 9.71 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.83 -1.077 . . . . 1.1699999999999999 108.392 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.806 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.3 130.06 44.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.444 0.64 . . . . 1.1799999999999999 110.809 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -121.1 145.1 48.16 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 107.104 -1.443 . . . . 1.72 107.104 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.786 ' CB ' HD21 ' A' ' 104' ' ' LEU . 33.8 t -101.97 -102.72 0.27 Allowed 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.079 -1.049 . . . . 1.6599999999999999 110.891 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.66 -54.32 47.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.048 -0.723 . . . . 1.1200000000000001 109.048 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.19 17.9 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.093 -1.603 . . . . 0.39000000000000001 109.093 166.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.547 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 5.9 ptp180 -106.08 -147.51 0.4 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.859 -0.67 . . . . 2.4900000000000002 109.561 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -123.82 99.1 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.19 0.45 . . . . 2.6099999999999999 110.349 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.724 ' HA ' HG22 ' A' ' 100' ' ' ILE . 5.5 mm -70.89 -38.95 74.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.544 -0.753 . . . . 1.1100000000000001 110.231 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.49 171.69 32.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.572 -0.823 . . . . 0.48999999999999999 111.846 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -159.42 154.7 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.091 0.446 . . . . 2.3999999999999999 110.367 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.53 155.56 13.6 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.433 -0.667 . . . . 0.52000000000000002 111.433 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 17.3 ptpt -131.38 134.77 46.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.967 0.413 . . . . 2.3799999999999999 110.703 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -140.01 122.67 10.11 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.866 -0.606 . . . . 1.47 109.939 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.94 108.32 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.204 1.936 . . . . 0.81000000000000005 111.033 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -114.92 141.74 27.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.549 -0.537 . . . . 0.79000000000000004 109.549 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.664 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.8 Cg_endo -60.62 87.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.577 2.185 . . . . 0.91000000000000003 112.407 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.716 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -88.7 33.99 4.01 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.47999999999999998 111.905 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.945 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -71.01 118.29 13.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.681 -0.859 . . . . 0.85999999999999999 108.681 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.752 HD23 HD21 ' A' ' 49' ' ' ASN . 1.4 pt? -148.11 -159.98 1.11 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.07 -1.452 . . . . 1.76 114.73 -158.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.498 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 56.2 mttm -52.57 -92.05 0.0 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.131 -0.94 . . . . 2.4300000000000002 112.778 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 167.02 105.76 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.638 -1.245 . . . . 1.29 107.638 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.807 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.0 pttt 41.37 49.47 3.43 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.363 1.039 . . . . 2.21 111.034 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.17 -172.34 3.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.064 -0.971 . . . . 0.64000000000000001 109.757 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.643 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.7 ttm -113.28 118.15 33.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.886 0.374 . . . . 2.04 110.801 -171.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.577 ' CG2' HG13 ' A' ' 47' ' ' VAL . 7.1 t -107.35 143.43 35.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.489 . . . . 1.3300000000000001 110.19 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.54 136.66 36.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.333 0.587 . . . . 1.1100000000000001 109.59 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.718 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 4.2 tt -133.53 170.48 15.45 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.322 -0.992 . . . . 1.45 108.322 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 t70 -135.2 123.5 23.14 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.012 -0.275 . . . . 1.8100000000000001 110.647 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.746 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -105.18 138.15 19.45 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.616 0.246 . . . . 1.3999999999999999 110.997 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.401 ' HD2' HG21 ' A' ' 92' ' ' ILE . 72.4 Cg_exo -50.79 168.25 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.543 2.829 . . . . 1.0700000000000001 112.606 174.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.945 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 4.5 m -110.58 88.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.774 -0.648 . . . . 1.1799999999999999 111.364 -166.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.53 HG13 ' HE2' ' A' ' 41' ' ' TYR . 4.1 p -128.46 101.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 114.726 1.38 . . . . 1.1699999999999999 114.726 -165.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.985 HG11 HG22 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.3 115.65 3.96 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 119.882 -0.727 . . . . 1.71 110.208 162.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.1 128.52 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.439 1.426 . . . . 0.65000000000000002 109.746 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.65 ' H ' ' HA ' ' A' ' 38' ' ' SER . 20.5 t80 -57.03 -28.1 62.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.03 0.443 . . . . 1.6899999999999999 110.112 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -52.44 -30.51 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.563 -0.744 . . . . 1.49 111.892 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.724 HG22 ' HA ' ' A' ' 71' ' ' ILE . 28.1 mm -78.2 -54.12 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.409 -0.359 . . . . 1.21 111.209 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.79 HD21 HD22 ' A' ' 104' ' ' LEU . 22.8 mt -50.44 -27.96 7.39 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.572 0.701 . . . . 1.6399999999999999 110.218 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 16.7 t80 -68.99 -40.73 78.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.661 -1.609 . . . . 1.2 108.506 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.646 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 18.6 m-80 -74.42 -56.51 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.816 -0.629 . . . . 0.81999999999999995 112.365 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.79 HD22 HD21 ' A' ' 101' ' ' LEU . 1.1 pp -56.7 -56.35 22.5 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.992 0.738 . . . . 1.22 112.992 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.502 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.34 -21.99 66.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.886 0.85 . . . . 1.1899999999999999 110.149 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.646 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -61.03 -53.99 50.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.481 -1.236 . . . . 2.2200000000000002 110.147 173.672 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.591 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.2 t70 -85.4 -52.16 6.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.189 0.995 . . . . 0.80000000000000004 111.723 -171.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.985 HG22 HG22 ' A' ' 114' ' ' ILE . 34.3 m -80.03 -31.08 13.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.586 -0.696 . . . . 1.5 110.706 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.502 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.03 -16.54 80.67 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.087 -0.961 . . . . 0.38 111.616 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.71 -42.53 13.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.456 -1.683 . . . . 1.6599999999999999 106.456 161.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 42.0 m-20 -75.74 -86.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.57 -0.741 . . . . 1.8700000000000001 110.298 159.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.409 ' O ' HD23 ' A' ' 144' ' ' LEU . 17.0 p-90 176.73 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.743 0.417 . . . . 1.3500000000000001 111.629 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.3 133.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.359 0.599 . . . . 2.1499999999999999 111.511 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.985 HG22 HG22 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -117.95 149.66 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.603 -0.726 . . . . 1.1599999999999999 109.604 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 10.1 p-10 -104.79 154.98 19.31 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.457 -0.942 . . . . 2.1099999999999999 108.457 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 48.1 m-85 -134.61 156.98 47.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.526 -0.916 . . . . 0.96999999999999997 108.526 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.542 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 31.5 tt0 -143.56 129.46 19.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.607 -0.516 . . . . 0.80000000000000004 109.607 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.806 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -103.79 133.99 47.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.769 -0.65 . . . . 1.9199999999999999 109.46 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.735 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.7 100.73 8.01 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.02 -0.733 . . . . 0.63 109.02 172.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.574 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.1 tp -110.23 117.58 55.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.305 0.574 . . . . 1.49 110.706 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.65 124.51 7.28 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.0 -0.84 . . . . 0.26000000000000001 111.0 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.502 HD21 ' HB2' ' A' ' 25' ' ' SER . 2.9 mm? -101.1 98.23 8.69 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.529 0.68 . . . . 1.77 111.961 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 0.954 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 96.5 m -95.83 94.78 7.85 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.32 -1.309 . . . . 1.0700000000000001 108.954 169.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.819 HG13 HD23 ' A' ' 126' ' ' LEU . 9.7 pt -107.38 141.63 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 120.414 -0.514 . . . . 1.6699999999999999 109.646 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.55 106.12 18.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 1.52 109.688 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.819 HD23 HG13 ' A' ' 124' ' ' ILE . 1.5 mm? -103.13 141.62 22.86 Favored Pre-proline 0 C--O 1.213 -0.82 0 O-C-N 124.344 1.028 . . . . 1.9299999999999999 109.586 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.615 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 52.5 Cg_exo -57.9 -24.98 67.47 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.082 1.855 . . . . 0.98999999999999999 113.988 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.82 -58.13 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.984 0.421 . . . . 1.6699999999999999 111.844 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -102.79 0.67 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.078 0.942 . . . . 1.9099999999999999 110.789 -177.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.33 -39.45 2.9 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 113.86 -1.518 . . . . 1.05 111.41 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 9.6 pt-20 -167.41 155.44 9.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 1.1599999999999999 109.285 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.47 142.11 31.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.229 -0.656 . . . . 2.2799999999999998 109.229 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.7 m -122.66 107.94 12.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.904 0.383 . . . . 1.8899999999999999 111.777 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.672 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.6 pp -128.0 141.25 40.59 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 1.26 110.006 172.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.539 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.6 Cg_endo -92.42 165.66 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.07 1.847 . . . . 0.58999999999999997 112.872 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.535 HG23 ' CG2' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -159.03 158.2 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.712 -1.218 . . . . 1.1399999999999999 107.712 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 76.5 p -131.97 152.41 51.13 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.471 -0.492 . . . . 1.28 111.898 -170.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -139.46 110.73 6.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.835 -0.802 . . . . 1.3400000000000001 108.835 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.542 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.19 140.92 47.53 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.835 -0.346 . . . . 2.2000000000000002 110.548 -179.264 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.49 139.16 6.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.868 -0.682 . . . . 0.56000000000000005 111.971 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 27.9 mt-10 -99.12 129.39 45.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 2.1000000000000001 109.739 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.437 HD11 ' CE1' ' A' ' 116' ' ' TYR . 2.0 pp -139.54 173.59 10.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.638 -0.504 . . . . 1.51 109.638 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -65.59 172.29 3.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.897 0.703 . . . . 3.9300000000000002 112.897 -171.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.646 HD21 ' HD2' ' A' ' 145' ' ' PRO . 1.7 tm? -61.64 126.59 87.17 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.924 -1.034 . . . . 1.9299999999999999 109.84 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.646 ' HD2' HD21 ' A' ' 144' ' ' LEU . 72.5 Cg_endo -74.38 175.37 11.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.608 2.872 . . . . 0.81000000000000005 113.198 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.8 m -55.08 98.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.94 -0.573 . . . . 2.3700000000000001 110.668 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.695 ' HB2' ' HA ' ' A' ' 151' ' ' PHE . 17.7 p90 -106.15 -29.06 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 3.1899999999999999 111.113 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 61.36 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.74 -0.664 . . . . 4.1500000000000004 112.016 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.74 9.17 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.988 0.899 . . . . 4.2800000000000002 109.202 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.444 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 64.9 m-85 -109.67 -45.69 3.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 3.23 111.652 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.695 ' HA ' ' HB2' ' A' ' 147' ' ' PHE . 60.6 m-85 . . . . . 0 C--O 1.246 0.899 0 O-C-N 124.259 0.974 . . . . 4.9000000000000004 109.034 -165.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.939 0.399 . . . . 12.4 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.2 38.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.615 -0.513 . . . . 9.4700000000000006 109.615 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.553 ' HB3' ' HE2' ' A' ' 51' ' ' TYR . 19.5 t -88.25 -76.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.691 -0.404 . . . . 7.0899999999999999 111.1 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 4' ' ' LEU . 38.7 mt -118.05 88.29 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.557 0.694 . . . . 8.8100000000000005 112.539 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.76 -134.45 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.938 -1.134 . . . . 10.82 107.938 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -165.12 164.81 20.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.788 -0.449 . . . . 11.69 109.788 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.78 -37.43 0.23 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.362 -0.381 . . . . 11.81 110.989 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.57 -94.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.718 0.294 . . . . 11.779999999999999 110.927 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -122.42 175.58 6.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.627 -0.508 . . . . 15.99 109.627 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.9 138.25 32.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.101 0.476 . . . . 12.69 109.846 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -151.12 18.18 0.76 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.751 -0.659 . . . . 14.630000000000001 109.47 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG13 ' HB2' ' A' ' 15' ' ' LYS . 15.5 m -125.99 108.05 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.532 -0.758 . . . . 8.8900000000000006 111.353 -176.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.14 -49.31 2.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 9.1999999999999993 109.422 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.4 -20.7 13.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 8.5999999999999996 109.658 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.815 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.3 mmpt? -55.23 -49.94 70.71 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.562 -0.744 . . . . 9.3100000000000005 111.053 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 tp -107.29 100.16 9.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.123 -0.49 . . . . 5.9800000000000004 109.828 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -109.57 113.46 26.26 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.449 -0.574 . . . . 2.98 109.449 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.618 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 66.7 -148.01 0.18 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.497 -0.774 . . . . 1.8500000000000001 111.467 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.582 ' H ' HD11 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -98.48 154.28 37.61 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.826 -0.624 . . . . 3.6800000000000002 110.854 -170.134 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 -12.9 16.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.836 2.357 . . . . 2.52 114.318 -171.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -129.23 138.44 33.18 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.97 -0.105 . . . . 6.79 110.968 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.35 160.58 48.45 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.334 2.023 . . . . 3.3799999999999999 111.005 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.756 ' HG2' HD13 ' A' ' 124' ' ' ILE . 1.4 mp0 -118.27 156.56 28.63 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 105.8 -1.926 . . . . 3.3900000000000001 105.8 -172.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.766 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.24 -177.4 17.03 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 117.653 -2.213 . . . . 1.0700000000000001 113.798 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.655 ' HB2' HD12 ' A' ' 122' ' ' LEU . 37.7 m -169.47 34.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.642 -1.244 . . . . 1.7 107.642 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' O ' ' HB2' ' A' ' 46' ' ' SER . 32.7 m -134.04 155.33 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.347 -1.297 . . . . 1.53 109.786 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -165.15 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.57 -0.53 . . . . 1.05 109.57 166.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.501 ' OD1' ' HD2' ' A' ' 44' ' ' LYS . 4.8 p-10 -167.99 163.0 13.63 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.523 0.677 . . . . 1.6899999999999999 112.652 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.17 132.98 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.821 -1.082 . . . . 1.8500000000000001 109.266 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.64 138.26 53.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.484 -0.326 . . . . 1.8300000000000001 110.796 -173.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.488 HD21 ' CG1' ' A' ' 39' ' ' VAL . 3.2 tm? -94.82 138.96 31.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.789 -0.187 . . . . 1.46 111.095 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.698 ' HE3' ' HB2' ' A' ' 42' ' ' LEU . 6.4 ptpt -145.15 -92.53 0.1 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 114.167 1.173 . . . . 1.9199999999999999 114.167 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.649 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -89.59 178.71 6.21 Favored 'General case' 0 C--O 1.204 -1.304 0 O-C-N 121.308 -0.87 . . . . 2.8500000000000001 111.262 -155.565 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.877 ' HA ' ' O ' ' A' ' 38' ' ' SER . 6.6 p -168.84 -40.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 120.787 0.327 . . . . 3.77 111.276 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.536 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 8.9 t30 67.9 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.756 -1.202 . . . . 3.3500000000000001 107.756 -170.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' HD2' ' OD1' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -177.85 25.44 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.229 1.014 . . . . 6.21 109.027 168.666 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.87 -40.46 1.06 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.745 -1.57 . . . . 1.9199999999999999 109.163 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.877 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 27.1 t -155.75 127.97 7.65 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.628 0.727 . . . . 1.1299999999999999 112.579 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.96 HG23 HD12 ' A' ' 101' ' ' LEU . 26.7 t -79.1 155.13 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.967 -1.015 . . . . 1.48 109.216 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 27.4 mt-10 -117.62 131.59 56.63 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.002 -1.079 . . . . 1.1899999999999999 111.867 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.838 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.84 104.97 11.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.137 -0.938 . . . . 3.9399999999999999 110.513 -176.457 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.698 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -72.47 109.85 6.45 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.919 -1.141 . . . . 1.4299999999999999 107.919 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.572 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -103.99 107.64 18.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.713 0.768 . . . . 1.1100000000000001 110.144 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 13.0 ttmt -83.47 126.14 32.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.88 -1.156 . . . . 3.1800000000000002 107.88 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.696 HG12 HD23 ' A' ' 90' ' ' LEU . 43.1 t -111.4 141.52 26.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.705 -0.68 . . . . 1.3999999999999999 109.929 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.526 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 29.8 m -128.82 99.25 5.24 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.289 -0.564 . . . . 1.1100000000000001 110.225 171.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.766 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -81.61 122.82 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 115.63 -0.714 . . . . 1.8500000000000001 109.748 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.66 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 18.9 m -101.43 116.55 33.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.639 -0.709 . . . . 1.1000000000000001 110.168 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.772 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 15.7 t30 -90.26 126.16 57.7 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.127 -0.694 . . . . 1.48 109.127 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.494 ' CG ' HG13 ' A' ' 19' ' ' ILE . 60.2 Cg_endo -91.84 15.14 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.248 2.632 . . . . 0.91000000000000003 113.832 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.553 ' HE2' ' HB3' ' A' ' 3' ' ' SER . 6.2 t80 -131.5 146.73 52.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.514 -0.921 . . . . 2.3100000000000001 108.514 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.738 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.7 t -80.96 34.47 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.937 0.399 . . . . 1.8300000000000001 111.722 -169.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -145.31 133.01 21.0 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.654 -0.248 . . . . 2.0299999999999998 110.803 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -45.37 100.83 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 124.448 1.099 . . . . 1.73 113.022 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.846 HG22 HD22 ' A' ' 126' ' ' LEU . 5.8 pt -77.34 128.32 80.76 Favored Pre-proline 0 C--O 1.207 -1.182 0 N-CA-C 109.222 -0.659 . . . . 1.23 109.222 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.7 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.5 Cg_endo -60.88 -51.97 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.968 1.779 . . . . 0.53000000000000003 113.691 -160.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.788 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 73.9 mt -138.27 157.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 1.9099999999999999 112.853 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.798 ' HB3' HG21 ' A' ' 124' ' ' ILE . 25.6 p -139.92 168.17 20.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.565 1.174 . . . . 1.95 112.245 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.101 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.9 tt0 -120.43 119.37 32.84 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 112.854 -1.976 . . . . 1.3600000000000001 110.18 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.634 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 22.2 mm -94.8 110.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.652 -1.158 . . . . 1.6499999999999999 110.336 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 64.8 p -121.22 102.4 8.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.99 -0.744 . . . . 1.02 108.99 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.606 ' HD1' HG21 ' A' ' 60' ' ' ILE . 17.0 p90 -106.9 135.18 48.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.531 0.681 . . . . 0.46000000000000002 110.242 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.582 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.0 m -130.75 105.85 8.07 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.47 -1.241 . . . . 1.1699999999999999 108.726 174.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.505 ' CE1' HD23 ' A' ' 118' ' ' LEU . 96.6 m-85 -96.41 140.75 30.61 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.493 -0.558 . . . . 1.1799999999999999 109.493 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.463 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.3 m170 -127.15 144.43 51.04 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.453 -0.943 . . . . 1.72 108.453 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.533 ' HB3' HD23 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.29 -109.84 0.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 116.531 -0.304 . . . . 1.6599999999999999 111.457 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HB1' ' NH1' ' A' ' 69' ' ' ARG . . . -64.04 -54.3 36.37 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.643 -0.873 . . . . 1.1200000000000001 108.643 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.3 16.12 0.17 Allowed Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 108.466 -1.853 . . . . 0.39000000000000001 108.466 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 0.0 OUTLIER -111.98 -171.12 1.78 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.341 -0.985 . . . . 2.4900000000000002 108.341 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.88 90.9 3.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.174 0.512 . . . . 2.6099999999999999 111.16 -164.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.961 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.9 mm -47.88 -42.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.987 -1.006 . . . . 1.1100000000000001 111.867 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.12 167.59 39.34 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 119.859 -1.162 . . . . 0.48999999999999999 111.542 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.579 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.81 153.89 9.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.355 0.598 . . . . 2.3999999999999999 111.343 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.09 -179.06 41.5 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.869 -0.892 . . . . 0.52000000000000002 110.869 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.634 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.71 132.87 26.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.952 0.376 . . . . 2.3799999999999999 111.34 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.42 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 79.1 mt -130.87 109.16 15.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.963 -0.562 . . . . 1.47 109.877 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.8 128.27 14.86 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.317 2.011 . . . . 0.81000000000000005 110.401 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -138.96 144.76 42.6 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.758 -0.377 . . . . 0.79000000000000004 110.128 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.46 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.2 Cg_exo -57.24 90.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.578 2.185 . . . . 0.91000000000000003 111.571 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.788 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -75.7 13.68 6.5 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.176 -0.92 . . . . 0.47999999999999998 113.557 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.737 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 94.3 p -69.69 118.04 12.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.496 -0.557 . . . . 0.85999999999999999 109.496 -176.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.628 HD23 ' HB2' ' A' ' 49' ' ' ASN . 1.5 pt? -143.83 -167.16 2.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 119.931 -0.708 . . . . 1.76 112.631 -163.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' HD2' ' HB3' ' A' ' 86' ' ' ASP . 92.4 mttt -45.49 -93.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.083 0.771 . . . . 2.4300000000000002 113.083 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.535 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 163.37 107.18 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.307 -0.997 . . . . 1.29 108.307 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptmt 45.43 47.65 10.81 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.218 0.948 . . . . 2.21 111.159 -176.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.447 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 5.3 t70 -150.39 -170.03 3.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.226 -0.897 . . . . 0.64000000000000001 109.514 -173.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.45 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.6 ttp -119.2 119.39 33.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.986 0.422 . . . . 2.04 110.874 -171.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.498 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.8 t -107.3 144.74 33.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.857 -0.611 . . . . 1.3300000000000001 110.501 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.52 112.5 23.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.515 0.674 . . . . 1.1100000000000001 110.887 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.696 HD23 HG12 ' A' ' 45' ' ' VAL . 4.6 tt -102.72 166.28 10.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.142 -0.936 . . . . 1.45 109.03 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.459 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 22.1 t70 -128.93 117.74 21.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.419 -0.512 . . . . 1.8100000000000001 112.295 -170.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 47.6 mm -110.84 122.72 37.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.738 -0.838 . . . . 1.3999999999999999 108.738 171.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 84.6 Cg_exo -46.7 -98.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.922 3.081 . . . . 1.0700000000000001 114.874 -171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -162.4 94.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 112.124 0.416 . . . . 1.1799999999999999 112.124 -169.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.442 HG11 ' CE2' ' A' ' 62' ' ' PHE . 7.4 p -127.52 103.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.138 1.162 . . . . 1.1699999999999999 114.138 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.644 HG11 ' HB ' ' A' ' 39' ' ' VAL . 2.1 p -152.36 98.15 2.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 1.71 110.768 162.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.656 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 64.8 Cg_exo -51.4 135.89 47.29 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.924 1.749 . . . . 0.65000000000000002 112.12 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.444 ' HA ' HG21 ' A' ' 39' ' ' VAL . 4.7 t80 -55.56 -30.91 61.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.404 -0.817 . . . . 1.6899999999999999 111.094 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.574 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 50.6 m -56.51 -33.75 66.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.39 0.515 . . . . 1.49 112.39 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.961 HG22 ' HA ' ' A' ' 71' ' ' ILE . 9.0 mm -78.66 -53.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 121.852 -0.53 . . . . 1.21 111.84 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.037 HD21 HD21 ' A' ' 104' ' ' LEU . 14.5 mt -50.67 -27.47 7.05 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.524 0.678 . . . . 1.6399999999999999 110.124 170.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HB3' ' O ' ' A' ' 99' ' ' SER . 37.4 t80 -63.69 -42.02 98.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.45 -1.25 . . . . 1.2 108.605 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' ARG . 32.9 m-80 -74.05 -57.92 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 0.81999999999999995 111.961 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 1.037 HD21 HD21 ' A' ' 101' ' ' LEU . 3.2 pp -58.2 -51.99 67.45 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.244 0.831 . . . . 1.22 113.244 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.643 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.48 -26.58 68.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.479 0.657 . . . . 1.1899999999999999 110.493 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -74.27 -52.5 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.484 -0.78 . . . . 2.2200000000000002 111.064 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.702 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 8.8 t70 -80.51 -52.42 7.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.826 0.822 . . . . 0.80000000000000004 111.183 -173.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.596 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -92.42 -18.47 7.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 O-C-N 121.912 -0.493 . . . . 1.5 110.581 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.643 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.24 -19.09 79.87 Favored Glycine 0 CA--C 1.509 -0.321 0 C-N-CA 120.262 -0.97 . . . . 0.38 110.917 167.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.702 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -54.28 -49.61 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.392 -1.707 . . . . 1.6599999999999999 106.392 164.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 2.5 m-20 -66.58 -102.84 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.991 -1.004 . . . . 1.8700000000000001 109.902 162.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.86 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 1.3500000000000001 111.938 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.7 123.46 38.16 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.361 -0.382 . . . . 2.1499999999999999 110.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.754 HD11 HD11 ' A' ' 144' ' ' LEU . 3.5 mp -112.82 157.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.899 0.38 . . . . 1.1599999999999999 110.636 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -88.57 152.7 21.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.692 -0.685 . . . . 2.1099999999999999 109.348 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.535 ' HH ' HD13 ' A' ' 104' ' ' LEU . 73.0 m-85 -145.16 159.97 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.156 -0.683 . . . . 0.96999999999999997 109.156 173.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.669 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 33.5 tt0 -154.21 136.0 14.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.779 0.323 . . . . 0.80000000000000004 110.153 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.636 ' O ' ' HA ' ' A' ' 137' ' ' SER . 0.5 OUTLIER -108.26 130.07 55.18 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.013 -0.736 . . . . 1.9199999999999999 109.013 172.402 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.625 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -118.9 99.68 6.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.151 -0.685 . . . . 0.63 109.151 176.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.542 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -112.18 123.46 67.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.349 0.595 . . . . 1.49 110.367 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.655 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.14 123.16 6.44 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.595 -0.729 . . . . 0.26000000000000001 111.552 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 25' ' ' SER . 2.2 mp -96.87 118.55 33.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.781 0.324 . . . . 1.77 110.794 -173.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.101 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 95.8 m -124.71 95.71 4.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.596 -0.729 . . . . 1.0700000000000001 109.524 172.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.798 HG21 ' HB3' ' A' ' 58' ' ' CYS . 14.7 pt -110.88 144.32 19.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.6 -0.44 . . . . 1.6699999999999999 110.42 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.7 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.8 m-20 -85.59 105.09 15.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.858 -1.164 . . . . 1.52 107.858 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.846 HD22 HG22 ' A' ' 55' ' ' ILE . 28.1 mt -102.47 167.33 10.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 125.0 1.438 . . . . 1.9299999999999999 110.195 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.17 -29.56 6.35 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 121.825 1.683 . . . . 0.98999999999999999 112.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.406 HG21 HG21 ' A' ' 19' ' ' ILE . 42.4 t -74.12 -58.95 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 112.543 0.572 . . . . 1.6699999999999999 112.543 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.618 HG22 ' HA ' ' A' ' 18' ' ' ALA . 41.8 t -105.94 2.95 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.528 1.156 . . . . 1.9099999999999999 109.441 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.53 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 74.32 -24.72 1.11 Allowed Glycine 0 C--N 1.318 -0.434 0 CA-C-N 114.217 -1.356 . . . . 1.05 111.945 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 129' ' ' VAL . 13.3 pt-20 -159.1 170.81 21.19 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.668 -0.864 . . . . 1.1599999999999999 108.668 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.736 ' O ' ' HA ' ' A' ' 123' ' ' THR . 7.0 t80 -163.57 132.78 3.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.652 -0.869 . . . . 2.2799999999999998 108.652 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 86.4 m -123.67 95.55 4.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.317 0.58 . . . . 1.8899999999999999 111.398 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.76 139.12 34.41 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.52 -0.764 . . . . 1.26 110.192 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.655 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.7 Cg_endo -89.15 161.97 5.76 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.778 1.652 . . . . 0.58999999999999997 112.65 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.4 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -152.75 167.09 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.386 -0.968 . . . . 1.1399999999999999 108.386 179.495 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.636 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.8 p -137.82 151.09 47.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.355 0.598 . . . . 1.28 112.075 -172.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 t -139.98 103.34 4.61 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.29 -1.374 . . . . 1.3400000000000001 107.29 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.669 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -112.41 152.48 28.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.198 -0.456 . . . . 2.2000000000000002 110.041 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.53 141.96 7.38 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.342 -0.933 . . . . 0.56000000000000005 111.564 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -107.29 123.98 49.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.785 -0.707 . . . . 2.1000000000000001 109.197 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.9 174.39 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.51 108.527 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -56.78 160.37 3.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.868 0.692 . . . . 3.9300000000000002 112.868 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.754 HD11 HD11 ' A' ' 114' ' ' ILE . 19.4 tp -55.84 138.87 70.76 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 114.894 -1.048 . . . . 1.9299999999999999 111.581 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.591 ' HD2' HD11 ' A' ' 144' ' ' LEU . 34.5 Cg_endo -63.61 174.25 3.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.317 2.678 . . . . 0.81000000000000005 111.911 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -53.63 130.5 36.44 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.375 0.607 . . . . 2.3700000000000001 110.877 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -146.54 163.93 34.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.706 . . . . 3.1899999999999999 110.044 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.428 ' HE2' ' HB2' ' A' ' 148' ' ' LYS . 12.8 tppt? -174.69 -84.57 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.008 -0.542 . . . . 4.1500000000000004 109.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -98.62 -23.76 15.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.437 -0.801 . . . . 4.2800000000000002 109.887 177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.429 ' HD1' ' OH ' ' A' ' 98' ' ' TYR . 26.6 m-85 -53.43 -66.8 0.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.062 -0.972 . . . . 3.23 110.024 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.431 ' HE2' ' CG ' ' A' ' 102' ' ' PHE . 45.7 m-85 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.568 -0.73 . . . . 4.9000000000000004 109.292 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.726 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 2.9 mmt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.477 -0.194 . . . . 12.4 110.477 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.59 119.12 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 O-C-N 124.046 0.841 . . . . 9.4700000000000006 111.258 -177.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.69 ' HB3' HG21 ' A' ' 128' ' ' VAL . 53.1 m 69.75 20.7 6.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.486 -0.779 . . . . 7.0899999999999999 111.036 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 2.4 tm? -134.51 99.34 4.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.52 -0.919 . . . . 8.8100000000000005 108.52 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.451 ' N ' HD21 ' A' ' 5' ' ' LEU . 1.9 pt? -150.08 95.84 2.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.326 0.584 . . . . 10.82 111.377 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -170.59 -87.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 11.69 110.215 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.619 ' HZ1' ' HB3' ' A' ' 7' ' ' LYS . 9.3 mtpm? 50.58 31.38 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.156 0.582 . . . . 11.81 111.402 -177.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.567 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -91.15 113.94 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.971 0.415 . . . . 11.779999999999999 110.517 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -77.1 96.6 4.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.852 -0.613 . . . . 15.99 110.301 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 70.22 -175.4 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.193 -0.912 . . . . 12.69 111.342 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 73.77 -46.33 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.818 0.847 . . . . 14.630000000000001 113.023 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.567 HG21 ' HB2' ' A' ' 8' ' ' ALA . 11.0 m -74.22 84.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.578 0.704 . . . . 8.8900000000000006 112.601 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -33.12 72.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.661 -0.7 . . . . 9.1999999999999993 110.015 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.92 -61.42 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.717 . . . . 8.5999999999999996 110.231 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.793 ' HZ2' ' HB2' ' A' ' 15' ' ' LYS . 4.6 ttmp? 62.66 93.84 0.05 OUTLIER 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.92 0.762 . . . . 9.3100000000000005 111.534 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.8 tp -70.02 108.29 3.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 5.9800000000000004 109.824 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -113.87 -46.76 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.541 0.571 . . . . 2.98 112.541 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.603 ' HB2' HG11 ' A' ' 129' ' ' VAL . . . -75.8 79.32 2.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.964 0.727 . . . . 1.8500000000000001 112.964 -170.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.968 HG21 HD13 ' A' ' 126' ' ' LEU . 8.4 pt 55.13 -179.02 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.564 1.146 . . . . 3.6800000000000002 113.722 166.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.563 ' CD ' ' HB ' ' A' ' 19' ' ' ILE . 23.9 Cg_exo -65.74 -99.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.485 2.123 . . . . 2.52 112.534 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 20' ' ' PRO . 2.1 ttmm 170.27 -53.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 6.79 112.521 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.29 82.23 2.14 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.404 2.069 . . . . 3.3799999999999999 113.241 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HB3' ' O ' ' A' ' 48' ' ' THR . 7.5 mp0 -133.09 149.49 52.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.75 -2.315 . . . . 3.3900000000000001 104.75 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.731 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.51 -175.93 16.59 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 117.725 -2.179 . . . . 1.0700000000000001 116.579 -162.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.675 ' O ' HG12 ' A' ' 45' ' ' VAL . 95.7 p -167.91 36.47 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.268 -1.382 . . . . 1.7 107.268 174.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.4 m -133.86 155.66 40.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.365 -1.289 . . . . 1.53 110.037 -170.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.405 HG22 ' HG2' ' A' ' 44' ' ' LYS . 1.7 t -168.65 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.699 -0.482 . . . . 1.05 109.699 169.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.73 172.36 1.11 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 111.45 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.711 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -142.14 145.91 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.079 -0.711 . . . . 1.8500000000000001 109.079 168.496 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.43 115.59 30.4 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.762 -0.653 . . . . 1.8300000000000001 110.378 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.0 tm? -80.29 120.05 23.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 1.46 111.08 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.587 ' HD2' ' HA ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -119.81 -127.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.527 -0.545 . . . . 1.9199999999999999 109.527 171.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.906 ' HA ' HG12 ' A' ' 39' ' ' VAL . 3.1 p30 170.51 166.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.604 0.638 . . . . 2.8500000000000001 111.919 -168.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 38' ' ' SER . 3.2 m -158.4 106.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.367 0.877 . . . . 3.77 113.367 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.573 HD21 ' HB2' ' A' ' 37' ' ' ASP . 16.5 t30 70.42 -91.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 3.3500000000000001 110.79 169.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.702 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 171.66 28.85 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.22 -1.4 . . . . 6.21 107.22 169.116 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.573 ' HB2' HD21 ' A' ' 35' ' ' ASN . 0.9 OUTLIER -99.66 -44.77 6.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 106.357 -1.719 . . . . 1.9199999999999999 106.357 -174.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.634 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.1 t -151.97 177.52 10.37 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.669 -2.969 . . . . 1.1299999999999999 105.235 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.906 HG12 ' HA ' ' A' ' 33' ' ' ASP . 13.4 t -134.63 156.37 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 118.6 0.636 . . . . 1.48 109.743 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 91.8 mt-10 -119.61 147.59 44.33 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.205 -0.598 . . . . 1.1899999999999999 111.175 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.921 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.5 p90 -142.29 133.89 26.72 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.095 -1.042 . . . . 3.9399999999999999 112.039 166.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.405 HD21 ' O ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -79.9 108.99 13.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.189 -0.914 . . . . 1.4299999999999999 108.715 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.711 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -91.62 110.16 21.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.585 0.707 . . . . 1.1100000000000001 109.988 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 27' ' ' THR . 35.4 ttmt -84.03 129.77 34.9 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.929 -1.032 . . . . 3.1800000000000002 109.212 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 25' ' ' SER . 52.5 t -113.57 142.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.69 -0.686 . . . . 1.3999999999999999 110.335 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.605 ' HA ' ' O ' ' A' ' 88' ' ' THR . 18.7 m -131.34 98.08 4.44 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.254 0.55 . . . . 1.1100000000000001 110.077 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.731 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.7 t -83.61 128.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.258 -0.883 . . . . 1.8500000000000001 110.825 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.659 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 6.5 m -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 119.07 -0.491 . . . . 1.1000000000000001 109.793 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.704 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.4 p-10 -91.5 135.21 28.19 Favored Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.859 0.724 . . . . 1.48 110.275 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.509 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 57.5 Cg_endo -93.63 12.65 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.71 2.94 . . . . 0.91000000000000003 114.426 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.71 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 29.8 t80 -98.55 -117.86 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.332 -0.618 . . . . 2.3100000000000001 109.332 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -165.01 19.68 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.8300000000000001 110.258 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.615 ' HD1' ' HE2' ' A' ' 51' ' ' TYR . 42.8 m80 -148.38 151.32 35.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.528 -0.915 . . . . 2.0299999999999998 108.528 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.573 ' HA ' HD21 ' A' ' 82' ' ' LEU . 28.0 t -44.89 105.57 0.06 Allowed 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.382 1.051 . . . . 1.73 112.295 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.72 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.5 pt -78.17 125.34 85.25 Favored Pre-proline 0 CA--C 1.5 -0.951 0 N-CA-C 108.901 -0.777 . . . . 1.23 108.901 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 27.1 Cg_endo -62.49 -54.65 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.777 1.651 . . . . 0.53000000000000003 112.999 -159.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.711 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.5 mm -130.01 159.31 42.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.431 -0.507 . . . . 1.9099999999999999 111.016 -173.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 124' ' ' ILE . 27.3 p -150.88 174.7 12.79 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.192 0.996 . . . . 1.95 111.697 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.084 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.3 tt0 -130.86 114.05 14.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.362 -1.744 . . . . 1.3600000000000001 109.673 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.652 HG22 HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.72 111.38 28.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.973 -1.012 . . . . 1.6499999999999999 110.989 173.77 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.621 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 1.6 m -113.7 104.24 12.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.811 -1.541 . . . . 1.02 109.153 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 6.3 p90 -111.98 127.7 55.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.949 -0.389 . . . . 0.46000000000000002 109.949 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.592 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 7.1 m -126.4 104.6 8.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.29 -0.633 . . . . 1.1699999999999999 109.29 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.725 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 94.7 m-85 -98.28 139.23 34.36 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.1 -0.5 . . . . 1.1799999999999999 111.258 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -128.04 145.43 50.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.667 -1.234 . . . . 1.72 107.667 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.668 ' CB ' HD21 ' A' ' 104' ' ' LEU . 41.5 t -107.27 -98.03 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.14 -1.024 . . . . 1.6599999999999999 111.022 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.56 -60.25 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.674 -0.861 . . . . 1.1200000000000001 108.674 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.58 15.66 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.227 -1.949 . . . . 0.39000000000000001 108.227 163.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.94 HH11 ' HB3' ' A' ' 103' ' ' ASN . 10.2 ptp180 -106.09 -175.34 2.77 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.43 -0.952 . . . . 2.4900000000000002 108.43 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -103.09 97.64 7.7 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.605 0.716 . . . . 2.6099999999999999 109.589 -166.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.841 ' HA ' HG22 ' A' ' 100' ' ' ILE . 2.2 mm -59.04 -43.05 88.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.006 -1.452 . . . . 1.1100000000000001 110.728 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.78 160.2 22.39 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.402 -0.904 . . . . 0.48999999999999999 111.179 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.618 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -161.77 156.9 23.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.919 0.859 . . . . 2.3999999999999999 111.446 176.105 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.76 164.88 28.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.758 -0.937 . . . . 0.52000000000000002 110.758 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -142.13 133.68 26.72 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.097 0.475 . . . . 2.3799999999999999 111.089 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 63.3 mt -136.1 133.85 19.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.632 -0.713 . . . . 1.47 110.016 -174.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.5 Cg_exo -74.26 119.04 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.364 2.042 . . . . 0.81000000000000005 110.508 170.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.59 139.94 36.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.845 -0.428 . . . . 0.79000000000000004 109.845 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.711 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.0 Cg_endo -61.64 90.82 0.11 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.452 2.101 . . . . 0.91000000000000003 112.08 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.447 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -89.02 30.28 5.56 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.47999999999999998 112.029 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.72 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.1 p -70.49 118.36 13.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.513 -0.921 . . . . 0.85999999999999999 108.513 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.573 HD21 ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -139.98 -152.11 0.4 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.048 0.759 . . . . 1.76 113.048 -160.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.509 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 93.8 mttt -62.35 -96.99 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.937 -0.574 . . . . 2.4300000000000002 112.304 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.35 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.971 -1.122 . . . . 1.29 107.971 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.71 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 39.5 pttt 42.41 50.41 4.69 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.879 0.847 . . . . 2.21 111.134 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.559 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.2 t70 -153.35 -173.38 4.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.894 -1.048 . . . . 0.64000000000000001 110.726 -169.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.493 ' HG3' ' HG1' ' A' ' 48' ' ' THR . 45.9 ttm -115.77 125.33 52.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 2.04 110.351 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 46' ' ' SER . 3.3 t -116.16 145.05 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.928 -0.578 . . . . 1.3300000000000001 110.718 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.39 117.07 27.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.514 0.673 . . . . 1.1100000000000001 110.742 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.678 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.2 tp -115.88 174.86 5.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.775 -1.102 . . . . 1.45 108.106 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.678 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 35.5 m-20 -137.63 130.66 30.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.502 0.592 . . . . 1.8100000000000001 111.232 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 30.1 mm -108.6 123.84 36.11 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.666 -0.864 . . . . 1.3999999999999999 108.666 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.487 ' O ' HG12 ' A' ' 94' ' ' VAL . 24.3 Cg_exo -28.85 -113.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 1 C-N-CA 125.72 4.28 . . . . 1.0700000000000001 116.22 -171.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.01 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -163.08 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 119.586 -0.245 . . . . 1.1799999999999999 111.191 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.471 ' O ' HG12 ' A' ' 95' ' ' VAL . 7.6 p -127.79 101.74 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 115.635 1.717 . . . . 1.1699999999999999 115.635 -164.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.564 ' HB ' ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -152.77 107.28 2.7 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 121.326 -0.858 . . . . 1.71 111.607 163.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.537 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 53.4 Cg_exo -51.32 129.08 27.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.499 1.466 . . . . 0.65000000000000002 111.192 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.586 ' H ' ' HA ' ' A' ' 38' ' ' SER . 16.3 t80 -50.17 -35.99 28.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.182 -0.917 . . . . 1.6899999999999999 111.898 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.8 t -59.9 -27.49 66.77 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.054 0.39 . . . . 1.49 112.054 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.841 HG22 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -77.62 -54.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 121.892 -0.505 . . . . 1.21 111.17 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.06 HD21 HD22 ' A' ' 104' ' ' LEU . 53.3 mt -51.89 -30.18 23.0 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.882 0.848 . . . . 1.6399999999999999 110.129 169.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.519 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 30.4 t80 -69.04 -38.56 79.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.625 -1.625 . . . . 1.2 108.787 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.94 ' HB3' HH11 ' A' ' 69' ' ' ARG . 15.7 m-80 -74.17 -55.95 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 111.975 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 1.06 HD22 HD21 ' A' ' 101' ' ' LEU . 2.9 pp -55.04 -50.67 68.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.737 0.643 . . . . 1.22 112.737 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.625 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.21 -24.39 67.2 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.884 0.85 . . . . 1.1899999999999999 110.551 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.519 ' NH2' ' HD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -70.99 -54.76 10.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.106 -0.952 . . . . 2.2200000000000002 110.631 175.759 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.457 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 16.3 t70 -83.01 -53.88 5.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.814 0.816 . . . . 0.80000000000000004 111.649 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.671 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.0 t -84.12 -26.94 7.2 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 121.505 -0.747 . . . . 1.5 109.959 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.625 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -70.5 -17.52 74.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 119.536 -1.316 . . . . 0.38 111.381 170.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -53.74 -47.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.18 -1.415 . . . . 1.6599999999999999 107.18 166.001 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -107.89 68.53 0.71 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.648 0.737 . . . . 1.8700000000000001 112.79 164.826 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 23.15 -57.86 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 118.802 2.89 . . . . 1.3500000000000001 118.802 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' ASP . 13.2 t70 -91.79 122.85 34.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.59 0.632 . . . . 2.1499999999999999 111.84 -167.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.671 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.8 mp -112.49 158.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 1.1599999999999999 110.78 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.533 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -104.74 153.87 20.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.934 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.609 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 35.3 m-85 -137.51 167.14 22.23 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.957 -0.757 . . . . 0.96999999999999997 108.957 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.545 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.6 tt0 -153.4 139.03 17.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.73 0.3 . . . . 0.80000000000000004 110.629 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.725 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 tp -109.92 129.31 55.67 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.933 -0.576 . . . . 1.9199999999999999 110.3 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.606 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -112.84 101.32 9.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.048 -0.723 . . . . 0.63 109.048 173.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.652 HD12 HG22 ' A' ' 60' ' ' ILE . 5.5 tp -112.58 121.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.158 0.504 . . . . 1.49 111.64 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.68 125.41 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.781 -0.528 . . . . 0.26000000000000001 111.781 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.607 HD13 ' OG ' ' A' ' 25' ' ' SER . 5.0 mp -103.88 106.51 17.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 1.77 111.546 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.084 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.8 m -110.16 95.02 5.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.781 -0.645 . . . . 1.0700000000000001 109.441 174.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.658 ' HB ' HD12 ' A' ' 55' ' ' ILE . 10.6 pt -109.53 141.46 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 120.5 -0.48 . . . . 1.6699999999999999 110.87 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.5 m-20 -84.51 107.47 16.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.714 -0.847 . . . . 1.52 108.714 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.968 HD13 HG21 ' A' ' 19' ' ' ILE . 4.5 mt -115.56 139.65 24.97 Favored Pre-proline 0 C--O 1.216 -0.67 0 O-C-N 124.566 1.166 . . . . 1.9299999999999999 110.455 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.74 -16.67 45.23 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.366 2.044 . . . . 0.98999999999999999 114.105 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.69 HG21 ' HB3' ' A' ' 3' ' ' SER . 42.4 t -76.66 -56.45 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.326 0.584 . . . . 1.6699999999999999 111.524 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.603 HG11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -116.91 5.92 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.038 0.923 . . . . 1.9099999999999999 110.799 -175.553 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.55 -34.44 2.71 Favored Glycine 0 C--N 1.31 -0.884 0 CA-C-N 113.797 -1.547 . . . . 1.05 111.781 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.469 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.3 pt-20 -171.21 162.13 6.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.641 -0.874 . . . . 1.1599999999999999 108.641 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 123' ' ' THR . 9.3 t80 -159.11 143.13 15.22 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.464 -0.569 . . . . 2.2799999999999998 109.464 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 75.6 m -112.8 110.67 20.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.148 -0.478 . . . . 1.8899999999999999 111.359 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.3 pp -126.16 136.1 28.06 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.59 . . . . 1.26 109.888 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -93.72 162.96 2.28 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.138 1.892 . . . . 0.58999999999999997 113.21 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.436 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -163.92 168.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.811 -1.181 . . . . 1.1399999999999999 107.811 179.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 90.3 p -142.29 149.19 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.513 -0.475 . . . . 1.28 111.484 -169.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.3 t -140.64 103.76 4.59 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.243 -1.021 . . . . 1.3400000000000001 108.243 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.545 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.2 ptmt -123.52 152.49 41.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.676 -0.693 . . . . 2.2000000000000002 110.454 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.2 155.29 24.18 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.896 -0.668 . . . . 0.56000000000000005 111.485 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 2.2 mp0 -111.04 132.52 54.16 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.404 -0.398 . . . . 2.1000000000000001 110.434 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.24 171.98 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.346 -0.613 . . . . 1.51 109.346 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.557 ' HG2' ' H ' ' A' ' 144' ' ' LEU . 35.7 ttmt -64.57 174.58 1.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.495 . . . . 3.9300000000000002 111.653 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.613 HD12 HD11 ' A' ' 114' ' ' ILE . 16.6 tp -55.96 139.28 71.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.612 -0.722 . . . . 1.9299999999999999 110.901 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.468 ' HD3' HD12 ' A' ' 114' ' ' ILE . 20.3 Cg_endo -60.41 170.44 4.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.785 2.324 . . . . 0.81000000000000005 112.845 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.538 ' HB ' ' HG2' ' A' ' 148' ' ' LYS . 1.4 p -69.51 109.92 4.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.573 -0.739 . . . . 2.3700000000000001 111.81 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.742 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -70.39 61.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 3.1899999999999999 110.297 172.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.64 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 28.5 mmtp -93.16 -61.27 1.61 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.597 1.189 . . . . 4.1500000000000004 108.681 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.702 ' HB3' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -79.98 -11.78 59.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.863 -1.971 . . . . 4.2800000000000002 106.919 166.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.742 ' HA ' ' HA ' ' A' ' 147' ' ' PHE . 63.1 m-85 74.57 107.4 0.07 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 112.718 -2.037 . . . . 3.23 112.632 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.481 ' HD1' ' HB3' ' A' ' 105' ' ' ALA . 93.8 m-85 . . . . . 0 C--O 1.248 1.011 0 CA-C-N 112.967 -1.924 . . . . 4.9000000000000004 110.846 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.807 0.337 . . . . 12.4 110.404 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.82 8.45 8.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.124 0.488 . . . . 9.4700000000000006 110.626 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -77.62 -20.3 54.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.642 -0.708 . . . . 7.0899999999999999 111.186 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 35.5 tp -152.11 166.14 32.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.361 . . . . 8.8100000000000005 110.024 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.5 mt -106.86 -163.87 0.95 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.36 -0.382 . . . . 10.82 110.775 -178.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.16 -16.95 48.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.271 0.558 . . . . 11.69 110.211 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -108.66 -155.66 0.56 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.587 -0.733 . . . . 11.81 110.43 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.04 -156.31 0.23 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.609 0.568 . . . . 11.779999999999999 110.179 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.0 149.95 25.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.977 0.418 . . . . 15.99 111.245 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.66 -32.85 68.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 12.69 110.912 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -90.54 128.08 36.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 14.630000000000001 110.738 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.456 ' HB ' ' HB2' ' A' ' 16' ' ' LEU . 26.8 m -113.46 157.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.057 -0.52 . . . . 8.8900000000000006 109.769 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.93 49.98 0.69 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.32 0.489 . . . . 9.1999999999999993 112.32 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 49.42 14.32 0.1 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.131 1.372 . . . . 8.5999999999999996 114.36 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -129.14 -27.56 2.46 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.023 -0.423 . . . . 9.3100000000000005 111.3 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.456 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 7.1 mp -75.68 94.07 3.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 5.9800000000000004 110.207 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -149.92 -20.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.803 -0.635 . . . . 2.98 110.999 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.755 ' HA ' HG13 ' A' ' 129' ' ' VAL . . . -65.92 -99.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.302 0.482 . . . . 1.8500000000000001 112.302 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 1.028 HG21 ' HD3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -164.87 -63.09 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.021 0.749 . . . . 3.6800000000000002 113.021 -174.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 1.028 ' HD3' HG21 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -104.39 -156.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.364 2.043 . . . . 2.52 114.782 -172.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.595 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 20.8 tptm -175.92 -55.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.334 -1.303 . . . . 6.79 110.412 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.595 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 87.8 Cg_endo -82.05 61.87 7.93 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.117 1.878 . . . . 3.3799999999999999 112.933 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.774 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 7.4 mp0 -128.48 142.69 51.01 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 105.042 -2.207 . . . . 3.3900000000000001 105.042 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.704 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.14 -171.09 15.18 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 117.727 -2.178 . . . . 1.0700000000000001 116.374 -161.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 1.006 ' HG ' HD13 ' A' ' 122' ' ' LEU . 51.9 p -163.54 37.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.691 1.597 . . . . 1.7 106.814 173.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 46' ' ' SER . 1.5 p -131.05 147.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 113.955 -1.475 . . . . 1.53 110.679 -167.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.22 -36.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.712 -0.677 . . . . 1.05 110.631 166.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -175.89 160.94 2.42 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 109.85 -0.426 . . . . 1.6899999999999999 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -137.12 145.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.685 -0.857 . . . . 1.8500000000000001 108.685 162.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.1 146.3 46.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.941 0.4 . . . . 1.8300000000000001 111.646 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.533 HD21 ' H ' ' A' ' 32' ' ' LYS . 2.7 tm? -99.98 135.7 41.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.92 -0.582 . . . . 1.46 111.091 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.533 ' H ' HD21 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -143.62 -95.95 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.341 0.867 . . . . 1.9199999999999999 113.341 176.119 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.752 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 1.6 t70 -91.11 -178.46 5.18 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.723 -0.611 . . . . 2.8500000000000001 111.613 -154.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.2 p -166.47 -36.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 O-C-N 123.499 0.499 . . . . 3.77 111.08 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 10.1 t30 67.2 -79.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.414 -0.812 . . . . 3.3500000000000001 109.352 -174.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.81 14.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 6.21 110.009 170.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -140.71 -41.1 0.41 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.928 -0.578 . . . . 1.9199999999999999 110.264 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.841 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.6 t -141.48 119.65 12.12 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.561 0.696 . . . . 1.1299999999999999 112.822 -174.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.752 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 63.8 t -76.17 151.39 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.017 -0.992 . . . . 1.48 109.647 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.867 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 85.1 mt-10 -109.8 133.34 53.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.223 -0.991 . . . . 1.1899999999999999 111.853 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.826 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.12 106.15 9.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.767 -1.106 . . . . 3.9399999999999999 110.555 -176.808 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.444 HD21 HG11 ' A' ' 94' ' ' VAL . 1.7 tm? -84.78 110.17 18.61 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.821 -0.807 . . . . 1.4299999999999999 108.821 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.646 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -89.97 110.02 21.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.844 0.83 . . . . 1.1100000000000001 110.247 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.4 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 30.6 ttmt -84.43 125.38 32.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.579 -1.192 . . . . 3.1800000000000002 108.538 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.735 HG23 HD21 ' A' ' 90' ' ' LEU . 63.5 t -111.78 139.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.219 0.533 . . . . 1.3999999999999999 112.086 -170.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 88' ' ' THR . 15.7 m -131.82 97.59 4.23 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.568 -0.742 . . . . 1.1100000000000001 109.276 162.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.704 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 2.3 p -84.62 128.1 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.096 -0.956 . . . . 1.8500000000000001 110.744 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.677 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 9.8 m -102.25 121.31 42.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.776 -0.647 . . . . 1.1000000000000001 109.946 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.82 ' HB2' HD21 ' A' ' 82' ' ' LEU . 14.0 t30 -87.57 126.67 61.16 Favored Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 124.722 1.264 . . . . 1.48 109.734 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.774 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 83.4 Cg_endo -83.29 -10.0 10.2 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.951 3.101 . . . . 0.91000000000000003 115.971 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.705 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.0 t80 -96.23 -105.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.595 -0.842 . . . . 2.3100000000000001 111.264 -171.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.467 ' HB2' ' HD3' ' A' ' 85' ' ' LYS . 47.6 t -175.62 26.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.372 0.606 . . . . 1.8300000000000001 109.862 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -150.74 139.28 20.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.138 -0.69 . . . . 2.0299999999999998 109.138 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.869 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 43.5 t -52.19 101.47 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.953 0 O-C-N 124.025 0.828 . . . . 1.73 111.93 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.967 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.7 pt -75.24 172.0 10.32 Favored Pre-proline 0 C--O 1.207 -1.173 0 N-CA-C 107.7 -1.222 . . . . 1.23 107.7 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.56 ' HB2' ' CD1' ' A' ' 57' ' ' ILE . 12.0 Cg_endo -90.08 -58.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.508 0 CA-C-N 120.166 1.095 . . . . 0.53000000000000003 114.687 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.56 ' CD1' ' HB2' ' A' ' 56' ' ' PRO . 1.5 mp -130.37 161.87 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 119.727 -0.789 . . . . 1.9099999999999999 112.768 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.592 ' HB3' HG21 ' A' ' 124' ' ' ILE . 30.1 p -147.64 168.82 21.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.08 0.943 . . . . 1.95 111.77 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.122 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 16.6 tp10 -122.29 118.71 29.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.412 -1.722 . . . . 1.3600000000000001 110.06 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.645 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 13.2 mm -94.58 110.16 23.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 114.618 -1.174 . . . . 1.6499999999999999 110.567 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 11.0 p -120.61 102.67 8.57 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.615 -0.434 . . . . 1.02 109.864 173.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.55 ' HD1' HG23 ' A' ' 60' ' ' ILE . 11.8 p90 -110.3 126.39 54.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.159 0.504 . . . . 0.46000000000000002 109.857 -171.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.539 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 18.4 m -123.34 112.1 17.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.034 -0.728 . . . . 1.1699999999999999 109.034 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.483 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 93.2 m-85 -97.66 140.99 31.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.979 0.419 . . . . 1.1799999999999999 110.606 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.495 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 5.2 m170 -132.93 145.63 51.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.466 -1.309 . . . . 1.72 107.466 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.964 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -111.52 -97.66 0.42 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.183 -1.007 . . . . 1.6599999999999999 111.41 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.43 -60.57 3.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.529 -0.545 . . . . 1.1200000000000001 109.529 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.77 19.63 0.12 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.578 -1.809 . . . . 0.39000000000000001 108.578 167.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 69' ' ' ARG . 8.5 ptp180 -115.75 -177.85 3.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.332 -0.988 . . . . 2.4900000000000002 108.332 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.9 98.0 7.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.072 0.939 . . . . 2.6099999999999999 110.245 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.798 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.4 mm -54.37 -43.51 62.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.352 -1.749 . . . . 1.1100000000000001 111.86 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.23 169.11 42.25 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.077 -1.058 . . . . 0.48999999999999999 111.355 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.547 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.27 155.32 11.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.218 0.509 . . . . 2.3999999999999999 110.541 174.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.22 -175.62 46.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.213 -1.155 . . . . 0.52000000000000002 110.213 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.645 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 11.1 ptpt -152.09 136.64 16.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.321 0.56 . . . . 2.3799999999999999 112.134 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 68.6 mt -130.78 108.97 15.64 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.289 -0.868 . . . . 1.47 110.312 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 114.34 3.89 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.312 2.008 . . . . 0.81000000000000005 109.975 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -132.01 146.09 60.21 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.035 -0.357 . . . . 0.79000000000000004 110.035 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.461 ' C ' ' H ' ' A' ' 81' ' ' SER . 9.4 Cg_endo -54.6 90.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.513 2.142 . . . . 0.91000000000000003 112.17 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.525 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -77.09 29.01 1.63 Allowed Glycine 0 C--O 1.225 -0.455 0 CA-C-N 115.278 -0.874 . . . . 0.47999999999999998 112.493 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.967 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 59.9 p -74.03 119.92 18.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.719 -0.474 . . . . 0.85999999999999999 109.719 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.869 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -157.95 173.89 16.08 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.833 -1.147 . . . . 1.76 113.646 -164.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 88.6 mttt -33.84 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.578 1.325 . . . . 2.4300000000000002 114.578 -167.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 168.34 108.87 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.359 -0.978 . . . . 1.29 108.359 -174.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.81 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 47.6 pttt 42.05 48.49 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.168 0.918 . . . . 2.21 110.886 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 4.4 t70 -148.9 -174.37 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.64 -1.164 . . . . 0.64000000000000001 109.782 -168.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.538 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.1 ttm -117.22 121.67 41.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.33 0.586 . . . . 2.04 110.596 -173.197 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.579 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.7 OUTLIER -115.53 144.55 43.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.158 -0.928 . . . . 1.3300000000000001 110.743 -175.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -85.92 141.37 29.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.088 0.47 . . . . 1.1100000000000001 110.043 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.789 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.1 tp -139.32 173.54 11.44 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.25 -1.019 . . . . 1.45 108.25 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.789 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 15.9 m-20 -132.6 124.36 28.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.166 0.508 . . . . 1.8100000000000001 111.842 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.646 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -112.84 138.15 22.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.442 -0.799 . . . . 1.3999999999999999 109.01 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' HG22 ' A' ' 92' ' ' ILE . 76.6 Cg_exo -51.96 -159.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.83 3.02 . . . . 1.0700000000000001 114.58 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.867 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -124.08 93.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.371 -0.831 . . . . 1.1799999999999999 110.873 -167.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG11 ' O ' ' A' ' 95' ' ' VAL . 5.7 p -128.3 103.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 113.917 1.08 . . . . 1.1699999999999999 113.917 -168.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.597 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 p -152.41 99.64 2.83 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.71 110.924 161.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.619 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.4 Cg_exo -52.86 131.05 40.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.94 1.76 . . . . 0.65000000000000002 111.022 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -57.96 -30.59 66.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 1.6899999999999999 111.559 -171.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.5 m -59.38 -30.57 68.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.783 0.29 . . . . 1.49 111.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.798 HG22 ' HA ' ' A' ' 71' ' ' ILE . 6.8 mm -76.63 -55.15 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.008 -0.677 . . . . 1.21 110.348 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.644 HD21 HD23 ' A' ' 104' ' ' LEU . 25.3 mt -50.55 -27.38 6.61 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.654 -0.703 . . . . 1.6399999999999999 110.665 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.428 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 23.7 t80 -64.67 -43.16 94.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.672 -1.149 . . . . 1.2 108.799 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.496 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 33.1 m-80 -74.42 -57.73 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.81999999999999995 112.458 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.964 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -58.24 -49.57 76.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.385 0.883 . . . . 1.22 113.385 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.475 ' HB2' HD11 ' A' ' 144' ' ' LEU . . . -64.9 -23.65 67.29 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 121.912 0.863 . . . . 1.1899999999999999 109.806 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.496 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.5 ttp180 -68.03 -47.99 66.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.586 -1.188 . . . . 2.2200000000000002 110.408 173.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.476 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 15.7 t70 -82.59 -55.89 4.19 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.923 0.868 . . . . 0.80000000000000004 111.871 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.561 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.2 t -83.65 -29.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 O-C-N 121.66 -0.65 . . . . 1.5 109.625 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.25 -16.54 80.45 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.522 -0.847 . . . . 0.38 111.693 172.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.476 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -49.07 -44.21 16.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.473 -1.677 . . . . 1.6599999999999999 106.473 165.107 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.64 -81.89 0.08 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.539 -0.755 . . . . 1.8700000000000001 109.954 163.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 178.44 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.623 0.601 . . . . 1.3500000000000001 112.623 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.82 128.63 40.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.319 0.58 . . . . 2.1499999999999999 111.434 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.846 HD13 HD13 ' A' ' 144' ' ' LEU . 2.4 mp -113.5 161.57 12.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.695 -0.684 . . . . 1.1599999999999999 109.901 -172.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.551 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 3.4 p-10 -101.85 152.74 20.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 34.5 m-85 -139.52 166.09 25.49 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.637 -0.875 . . . . 0.96999999999999997 108.637 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.68 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.2 tt0 -153.8 135.35 14.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.80000000000000004 110.142 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.651 HD23 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -107.37 129.6 54.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.528 -0.76 . . . . 1.9199999999999999 109.181 173.527 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.697 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.817 -0.809 . . . . 0.63 108.817 177.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.585 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.1 tp -112.92 120.89 64.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.228 0.537 . . . . 1.49 111.399 -173.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.461 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.81 119.89 5.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.362 -0.695 . . . . 0.26000000000000001 111.362 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 1.006 HD13 ' HG ' ' A' ' 25' ' ' SER . 1.3 mp -98.65 96.11 7.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.007 0.432 . . . . 1.77 110.851 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.122 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 63.2 m -95.98 96.41 8.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.811 -0.631 . . . . 1.0700000000000001 109.387 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.592 HG21 ' HB3' ' A' ' 58' ' ' CYS . 5.7 pt -111.28 138.34 40.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 120.171 -0.612 . . . . 1.6699999999999999 111.327 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.51 106.14 14.13 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.306 -0.998 . . . . 1.52 108.306 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.9 HD22 HG21 ' A' ' 55' ' ' ILE . 35.1 mt -116.52 150.3 45.28 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 124.859 1.35 . . . . 1.9299999999999999 110.344 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.43 -13.98 41.01 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.14 1.894 . . . . 0.98999999999999999 113.292 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.36 -57.37 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.31 0.576 . . . . 1.6699999999999999 111.257 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.755 HG13 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -118.42 6.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.854 0.835 . . . . 1.9099999999999999 110.74 -177.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.31 -31.93 2.6 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 114.005 -1.452 . . . . 1.05 111.966 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.477 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.4 pt-20 -178.55 154.03 0.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.705 -0.85 . . . . 1.1599999999999999 108.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.71 ' HD2' HG23 ' A' ' 134' ' ' ILE . 11.3 t80 -157.83 144.99 18.17 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.563 -0.455 . . . . 2.2799999999999998 110.292 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.9 m -101.6 99.56 9.87 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.594 0.559 . . . . 1.8899999999999999 110.855 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.71 HG23 ' HD2' ' A' ' 132' ' ' PHE . 2.3 pp -109.1 124.51 33.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.203 -0.666 . . . . 1.26 109.203 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.461 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 95.9 Cg_endo -89.12 162.61 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.559 1.506 . . . . 0.58999999999999997 112.536 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.7 161.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.056 -1.09 . . . . 1.1399999999999999 108.056 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -126.84 144.49 50.95 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.168 -0.308 . . . . 1.28 110.168 -171.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 m -136.99 100.82 4.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.338 -0.986 . . . . 1.3400000000000001 108.338 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.68 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 8.9 ptmt -123.72 143.01 50.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.129 -0.487 . . . . 2.2000000000000002 111.242 -170.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.59 153.63 24.31 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.667 -0.777 . . . . 0.56000000000000005 111.961 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.551 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 26.1 mt-10 -106.85 132.62 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.774 -0.454 . . . . 2.1000000000000001 109.774 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.41 174.15 2.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.153 -1.054 . . . . 1.51 108.153 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.23 170.92 1.5 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.302 0.853 . . . . 3.9300000000000002 113.302 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.846 HD13 HD13 ' A' ' 114' ' ' ILE . 15.9 tp -68.51 149.8 97.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.91 -1.041 . . . . 1.9299999999999999 110.739 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.429 ' HD2' ' HG ' ' A' ' 144' ' ' LEU . 20.3 Cg_endo -62.43 169.19 8.5 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.502 2.135 . . . . 0.81000000000000005 112.091 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.9 m -68.28 104.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 2.3700000000000001 110.737 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.487 ' CD1' HD22 ' A' ' 144' ' ' LEU . 22.0 p90 -111.29 156.79 20.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 3.1899999999999999 111.23 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.2 OUTLIER -178.8 73.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 4.1500000000000004 109.993 179.286 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 67.51 9.24 6.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.021 0.439 . . . . 4.2800000000000002 111.054 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 148' ' ' LYS . 25.1 m-85 -82.59 -41.0 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.163 -0.68 . . . . 3.23 109.163 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.427 ' HE2' ' HB3' ' A' ' 147' ' ' PHE . 4.1 p90 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.21 -0.9 . . . . 4.9000000000000004 109.059 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.524 -0.176 . . . . 12.4 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.22 -145.53 0.61 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.316 -0.402 . . . . 9.4700000000000006 110.431 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 1.044 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 23.3 m 69.73 -77.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.544 0.527 . . . . 7.0899999999999999 111.368 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.652 ' HB2' ' HB1' ' A' ' 8' ' ' ALA . 87.7 mt -70.73 117.85 12.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 8.8100000000000005 110.945 -175.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.97 108.01 10.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.343 -0.614 . . . . 10.82 109.343 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.405 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 9.1 t70 71.6 159.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.13 0.894 . . . . 11.69 110.168 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 26.9 mtpp 69.0 5.27 4.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.926 0.49 . . . . 11.81 111.974 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.652 ' HB1' ' HB2' ' A' ' 4' ' ' LEU . . . -101.34 94.14 5.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.896 0.379 . . . . 11.779999999999999 111.769 -174.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.49 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 14.3 mptt -70.52 -55.99 7.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.87 -0.789 . . . . 15.99 108.87 169.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.74 35.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.963 -1.017 . . . . 12.69 108.779 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.49 ' CE2' ' HB2' ' A' ' 9' ' ' LYS . 91.7 m-85 -94.23 137.93 32.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.477 -0.783 . . . . 14.630000000000001 110.732 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.499 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 31.5 m -89.49 -1.43 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.037 -0.529 . . . . 8.8900000000000006 110.99 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' O ' ' HG2' ' A' ' 15' ' ' LYS . . . 63.66 10.84 5.32 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.6 -0.727 . . . . 9.1999999999999993 112.144 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' H ' HG21 ' A' ' 12' ' ' VAL . 3.4 m-20 61.04 22.11 12.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.104 -0.498 . . . . 8.5999999999999996 111.165 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 47.1 mmtm -117.16 174.65 5.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.057 -0.719 . . . . 9.3100000000000005 109.057 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.08 102.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.54 -1.281 . . . . 5.9800000000000004 107.54 170.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.53 ' O ' ' HB3' ' A' ' 18' ' ' ALA . 1.8 m -77.96 62.46 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.949 0.722 . . . . 2.98 112.949 -166.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.722 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 163.03 -87.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.413 1.071 . . . . 1.8500000000000001 110.87 168.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.422 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 14.2 pt -142.58 139.98 18.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 3.6800000000000002 110.558 -173.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 4.6 Cg_exo -76.45 -72.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.177 2.585 . . . . 2.52 113.066 -175.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 34.0 mmtp -106.68 161.43 22.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.091 -0.504 . . . . 6.79 109.746 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 18.3 Cg_endo -60.48 157.8 34.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.576 2.184 . . . . 3.3799999999999999 112.17 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.71 ' HB3' ' O ' ' A' ' 48' ' ' THR . 1.8 mp0 -123.75 152.53 42.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 104.502 -2.407 . . . . 3.3900000000000001 104.502 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -115.67 179.91 18.15 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 117.55 -2.262 . . . . 1.0700000000000001 114.624 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.544 ' OG ' HD12 ' A' ' 122' ' ' LEU . 89.6 p -169.5 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.195 -1.039 . . . . 1.7 108.195 172.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.91 155.25 41.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.742 -1.117 . . . . 1.53 109.058 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 44' ' ' LYS . 1.6 t -168.94 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.208 0.447 . . . . 1.05 112.208 164.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.582 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 22.8 t70 -158.51 156.68 30.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.633 0.651 . . . . 1.6899999999999999 110.837 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.21 127.07 46.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.573 -0.529 . . . . 1.8500000000000001 109.573 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -112.49 130.8 55.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 1.8300000000000001 111.562 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.03 122.75 32.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 1.46 111.408 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -128.36 -126.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.228 -0.656 . . . . 1.9199999999999999 109.228 167.231 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 1.028 ' HA ' HG11 ' A' ' 39' ' ' VAL . 7.4 p-10 176.24 170.86 0.42 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 113.267 0.84 . . . . 2.8500000000000001 113.267 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 34' ' ' VAL . 1.2 t -155.94 118.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.181 -1.372 . . . . 3.77 109.995 171.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.529 ' OD1' ' HD3' ' A' ' 36' ' ' ARG . 22.9 t30 54.78 -102.68 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.67 -1.15 . . . . 3.3500000000000001 109.708 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.529 ' HD3' ' OD1' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -177.47 34.99 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.988 1.375 . . . . 6.21 107.93 168.028 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.98 -41.47 3.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.559 -2.11 . . . . 1.9199999999999999 108.399 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 t -152.76 107.66 3.21 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.733 -1.121 . . . . 1.1299999999999999 110.57 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 1.028 HG11 ' HA ' ' A' ' 33' ' ' ASP . 46.5 t -76.75 164.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.911 -0.774 . . . . 1.48 108.911 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.914 ' HG2' ' HB ' ' A' ' 94' ' ' VAL . 4.0 mt-10 -124.76 141.18 52.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.559 -0.856 . . . . 1.1899999999999999 112.124 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.846 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -122.55 105.4 10.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.106 -0.952 . . . . 3.9399999999999999 111.012 -177.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.579 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -77.74 110.23 12.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.377 -0.971 . . . . 1.4299999999999999 108.377 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -101.06 98.65 9.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.426 0.632 . . . . 1.1100000000000001 110.221 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.582 ' CG ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -82.7 106.07 14.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.533 -1.284 . . . . 3.1800000000000002 107.533 176.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.593 HG22 ' HB3' ' A' ' 90' ' ' LEU . 2.0 m -110.83 164.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.702 -1.135 . . . . 1.3999999999999999 110.632 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.458 ' C ' ' HA ' ' A' ' 25' ' ' SER . 2.9 m -142.85 105.13 4.44 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.209 0.528 . . . . 1.1100000000000001 111.665 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.5 t -83.02 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.855 . . . . 1.8500000000000001 110.851 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.71 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 5.6 m -101.23 122.31 43.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.456 -0.338 . . . . 1.1000000000000001 110.77 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.929 ' HB2' HD21 ' A' ' 82' ' ' LEU . 7.6 t-20 -88.2 134.73 34.2 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.382 1.051 . . . . 1.48 108.849 173.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.582 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 15.2 Cg_endo -108.23 9.88 0.13 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.191 2.594 . . . . 0.91000000000000003 115.812 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 38.5 t80 -118.15 -15.43 9.84 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.089 0.859 . . . . 2.3100000000000001 113.254 -169.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CE ' ' A' ' 85' ' ' LYS . 17.8 t 87.82 17.59 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.532 0.733 . . . . 1.8300000000000001 110.412 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -143.43 125.43 15.29 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.163 -0.68 . . . . 2.0299999999999998 109.163 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -38.85 101.79 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 O-C-N 124.298 0.999 . . . . 1.73 112.969 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.643 HD11 ' HB ' ' A' ' 124' ' ' ILE . 7.3 pt -77.76 118.73 73.98 Favored Pre-proline 0 C--O 1.208 -1.085 0 N-CA-C 109.173 -0.676 . . . . 1.23 109.173 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.928 ' HB2' HD13 ' A' ' 57' ' ' ILE . 29.3 Cg_endo -60.42 -54.01 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.273 1.982 . . . . 0.53000000000000003 113.651 -157.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.928 HD13 ' HB2' ' A' ' 56' ' ' PRO . 4.6 mp -133.83 159.07 42.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.045 -0.662 . . . . 1.9099999999999999 110.65 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.643 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -145.69 172.41 13.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.158 0.98 . . . . 1.95 111.789 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.0 tt0 -127.26 114.63 17.88 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.109 -1.86 . . . . 1.3600000000000001 108.949 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.704 HG22 HD12 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.91 109.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 122.512 1.148 . . . . 1.6499999999999999 109.78 169.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 13.5 p -112.4 101.64 9.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.216 -1.811 . . . . 1.02 108.184 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 12.0 p90 -114.71 136.56 52.93 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.137 0.494 . . . . 0.46000000000000002 110.285 -166.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.613 HG23 ' HB3' ' A' ' 73' ' ' LYS . 16.9 m -132.45 108.57 9.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.788 -1.097 . . . . 1.1699999999999999 109.546 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -97.22 140.97 30.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.808 -0.633 . . . . 1.1799999999999999 109.438 -178.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.478 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.4 m170 -128.59 145.62 51.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.467 -1.308 . . . . 1.72 107.467 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.775 ' CB ' HD23 ' A' ' 104' ' ' LEU . 46.8 t -100.99 -102.86 0.25 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.449 -0.9 . . . . 1.6599999999999999 110.199 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.449 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . . . -62.6 -57.05 12.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.889 -0.782 . . . . 1.1200000000000001 108.889 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.54 15.2 0.16 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 108.599 -1.8 . . . . 0.39000000000000001 108.599 165.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.449 ' NH1' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -109.72 171.86 7.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.368 -0.975 . . . . 2.4900000000000002 108.368 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.85 95.3 8.17 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.112 0.482 . . . . 2.6099999999999999 109.913 -164.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.802 ' HA ' HG23 ' A' ' 100' ' ' ILE . 1.7 mm -48.08 -41.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.639 -1.164 . . . . 1.1100000000000001 111.403 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.26 163.38 29.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.211 -0.995 . . . . 0.48999999999999999 111.608 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.613 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.6 OUTLIER -165.92 155.91 12.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.533 0.667 . . . . 2.3999999999999999 110.998 174.928 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.66 35.54 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.482 -0.781 . . . . 0.52000000000000002 111.528 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -123.44 131.71 53.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.09 -0.337 . . . . 2.3799999999999999 110.09 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.538 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 86.7 mt -137.89 126.18 14.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.441 -0.345 . . . . 1.47 110.123 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.09 115.72 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.468 2.112 . . . . 0.81000000000000005 111.633 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -125.04 141.29 38.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.084 -0.339 . . . . 0.79000000000000004 110.084 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.75 87.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.792 2.328 . . . . 0.91000000000000003 111.963 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.499 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -78.73 19.55 4.98 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.47999999999999998 113.384 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 91.1 p -70.38 119.71 14.97 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.49 -0.559 . . . . 0.85999999999999999 109.49 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.929 HD21 ' HB2' ' A' ' 49' ' ' ASN . 2.6 pt? -142.41 -165.95 2.15 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.854 0.687 . . . . 1.76 112.854 -165.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.437 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 89.9 mttt -43.2 -91.33 0.0 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.777 -1.101 . . . . 2.4300000000000002 112.949 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 83' ' ' LYS . . . 165.02 105.17 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.31 -0.996 . . . . 1.29 108.31 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.731 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.1 ptpt 43.84 50.84 6.9 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.363 1.04 . . . . 2.21 111.166 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.465 ' CG ' ' H ' ' A' ' 87' ' ' MET . 10.8 t70 -151.56 -169.87 3.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.217 -0.901 . . . . 0.64000000000000001 108.816 -173.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.465 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 48.4 ttm -116.99 121.4 41.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.835 0.35 . . . . 2.04 110.494 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 12.0 t -104.94 143.36 33.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.754 -0.657 . . . . 1.3300000000000001 109.739 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.01 106.8 14.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.379 0.609 . . . . 1.1100000000000001 110.097 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.934 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 7.7 tp -100.48 178.23 4.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.085 -0.961 . . . . 1.45 109.246 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.934 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.2 t70 -146.58 127.8 14.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.578 -0.283 . . . . 1.8100000000000001 111.303 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 1.5 mp -102.61 116.3 62.98 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.645 -1.243 . . . . 1.3999999999999999 107.645 163.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.579 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 33.5 Cg_exo -32.32 -100.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 125.181 3.921 . . . . 1.0700000000000001 115.477 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.914 ' HB ' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -163.43 93.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 O-C-N 122.275 -0.266 . . . . 1.1799999999999999 111.336 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 95' ' ' VAL . 7.6 p -129.03 104.26 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.676 1.361 . . . . 1.1699999999999999 114.676 -170.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.511 ' CG2' ' HG ' ' A' ' 101' ' ' LEU . 3.0 p -153.79 99.83 2.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 121.867 -0.52 . . . . 1.71 111.949 161.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.5 Cg_exo -53.66 131.71 45.34 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.828 1.685 . . . . 0.65000000000000002 111.183 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -53.9 -33.23 55.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 1.6899999999999999 112.356 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -56.17 -32.0 63.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.757 0.313 . . . . 1.49 111.667 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.802 HG23 ' HA ' ' A' ' 71' ' ' ILE . 12.2 mm -76.28 -55.72 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.602 -0.439 . . . . 1.21 110.643 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.606 HD22 HD21 ' A' ' 104' ' ' LEU . 40.3 mt -51.99 -28.11 15.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.565 -0.743 . . . . 1.6399999999999999 110.703 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.12 -44.66 95.0 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.028 -0.987 . . . . 1.2 108.99 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.21 -57.15 4.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.799 -0.637 . . . . 0.81999999999999995 111.889 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.775 HD23 ' CB ' ' A' ' 66' ' ' SER . 1.6 pp -62.07 -53.06 60.82 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.431 0.9 . . . . 1.22 113.431 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.736 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.1 -25.97 68.61 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.842 0.83 . . . . 1.1899999999999999 110.197 -177.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.76 ' O ' HG12 ' A' ' 110' ' ' VAL . 6.7 ttp180 -74.57 -54.7 6.98 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.531 -1.213 . . . . 2.2200000000000002 110.391 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.871 ' O ' HG21 ' A' ' 110' ' ' VAL . 14.4 t70 -74.06 -52.79 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.883 0.849 . . . . 0.80000000000000004 111.057 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.589 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 2.3 t -86.93 -17.21 8.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.355 -0.84 . . . . 1.5 109.697 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.736 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -67.91 -25.56 74.22 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.736 -0.745 . . . . 0.38 113.712 168.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.871 HG21 ' O ' ' A' ' 107' ' ' ASP . 11.5 m -63.22 -40.83 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.118 -1.438 . . . . 1.6599999999999999 107.118 170.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.589 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.6 m-20 -59.56 -58.53 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.63 -0.713 . . . . 1.8700000000000001 110.927 165.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.5 ' CG ' ' N ' ' A' ' 113' ' ' ASP . 3.8 p-90 128.36 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.282 2.233 . . . . 1.3500000000000001 111.641 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 14.9 t70 -94.44 129.44 41.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.475 -0.329 . . . . 2.1499999999999999 110.404 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.74 HD11 HD13 ' A' ' 144' ' ' LEU . 2.5 mp -115.32 151.13 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.026 0.441 . . . . 1.1599999999999999 109.854 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.478 ' HA ' ' HG2' ' A' ' 141' ' ' GLU . 6.1 p-10 -93.73 152.59 18.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.983 -0.747 . . . . 2.1099999999999999 108.983 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.54 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 31.9 m-85 -141.9 165.66 26.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.669 -0.863 . . . . 0.96999999999999997 108.669 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.473 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 22.9 tt0 -152.18 139.92 19.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.751 0.31 . . . . 0.80000000000000004 110.345 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.614 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -113.91 129.94 56.55 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.205 -0.665 . . . . 1.9199999999999999 109.205 173.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.614 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -120.59 100.72 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.118 -0.697 . . . . 0.63 109.118 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.704 HD12 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.07 123.18 71.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.51 0.671 . . . . 1.49 110.773 -174.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.598 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.33 124.48 7.07 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.458 -0.792 . . . . 0.26000000000000001 111.768 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.583 HD11 HD11 ' A' ' 120' ' ' ILE . 6.1 mp -97.4 105.91 18.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.966 0.412 . . . . 1.77 111.055 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.051 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 89.2 m -108.11 95.14 5.47 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.439 -0.801 . . . . 1.0700000000000001 109.007 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.643 ' HB ' HD11 ' A' ' 55' ' ' ILE . 7.0 pt -112.23 140.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 120.555 -0.458 . . . . 1.6699999999999999 110.281 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.787 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -85.81 105.8 16.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.33 -0.989 . . . . 1.52 108.33 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.401 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -125.03 135.54 26.93 Favored Pre-proline 0 C--O 1.22 -0.464 0 O-C-N 124.049 0.843 . . . . 1.9299999999999999 110.156 178.473 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 53.9 Cg_exo -52.73 -19.38 10.57 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.496 2.797 . . . . 0.98999999999999999 115.32 -169.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.48 -51.09 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.231 -0.293 . . . . 1.6699999999999999 111.361 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 1.044 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 0.2 OUTLIER -103.32 -2.38 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.087 0.946 . . . . 1.9099999999999999 109.456 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.72 -36.95 1.22 Allowed Glycine 0 C--N 1.314 -0.669 0 CA-C-N 113.558 -1.655 . . . . 1.05 111.151 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.537 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.1 pt-20 -177.09 150.57 0.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.554 -1.276 . . . . 1.1599999999999999 107.554 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.673 ' HD1' HG13 ' A' ' 129' ' ' VAL . 12.7 t80 -151.97 147.86 27.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.703 -0.399 . . . . 2.2799999999999998 110.158 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.481 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 67.8 m -113.82 104.72 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.506 0.504 . . . . 1.8899999999999999 111.477 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.3 pp -124.04 133.09 24.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 1.26 109.608 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.598 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 89.6 Cg_endo -87.38 161.28 8.24 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.592 1.528 . . . . 0.58999999999999997 112.836 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.68 164.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.299 -1.0 . . . . 1.1399999999999999 108.299 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -135.4 150.21 49.84 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.901 -0.319 . . . . 1.28 111.203 -168.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.3 t -145.8 102.18 3.63 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.649 -1.241 . . . . 1.3400000000000001 107.649 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.473 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 6.0 ptmt -118.12 144.05 45.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.68 -0.489 . . . . 2.2000000000000002 109.68 -172.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.03 149.55 19.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.021 -1.085 . . . . 0.56000000000000005 112.443 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.478 ' HG2' ' HA ' ' A' ' 115' ' ' ASP . 31.0 mt-10 -108.06 126.94 53.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.055 -0.572 . . . . 2.1000000000000001 109.771 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 172.87 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.868 -0.79 . . . . 1.51 108.868 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -54.64 160.81 1.69 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.995 0.739 . . . . 3.9300000000000002 112.995 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 114' ' ' ILE . 25.0 tp -58.88 136.54 87.26 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.056 -0.974 . . . . 1.9299999999999999 110.57 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.623 ' HD2' HD13 ' A' ' 144' ' ' LEU . 38.1 Cg_endo -66.41 172.57 8.86 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.798 2.332 . . . . 0.81000000000000005 112.486 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -59.15 128.18 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.528 . . . . 2.3700000000000001 110.992 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -139.19 145.55 39.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 3.1899999999999999 110.599 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 150' ' ' PHE . 40.5 ttmt -167.32 97.65 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 4.1500000000000004 109.893 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 4.9 m-20 73.6 -20.82 0.28 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.443 0.697 . . . . 4.2800000000000002 111.986 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.469 ' H ' ' C ' ' A' ' 148' ' ' LYS . 24.8 m-85 -68.63 -39.31 80.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 3.23 109.697 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.495 ' CD1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.388 -0.815 . . . . 4.9000000000000004 109.096 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtm . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.874 0.369 . . . . 12.4 110.082 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.519 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -98.83 -171.44 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.939 -0.573 . . . . 9.4700000000000006 111.057 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m 66.29 -78.18 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.778 -0.647 . . . . 7.0899999999999999 111.369 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.3 138.15 6.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 8.8100000000000005 110.269 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.69 -20.69 12.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 10.82 109.63 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.04 97.79 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 11.69 110.051 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE3' ' HB2' ' A' ' 7' ' ' LYS . 40.4 mtmt 65.24 -165.47 0.23 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.662 -0.699 . . . . 11.81 111.018 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -169.38 107.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.798 -0.637 . . . . 11.779999999999999 110.151 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 tttm 66.31 93.29 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.377 0.608 . . . . 15.99 111.245 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.65 -176.47 4.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 12.69 109.519 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.61 90.33 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 14.630000000000001 109.717 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 m -78.13 93.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.531 -0.759 . . . . 8.8900000000000006 111.714 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 23.71 2.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.744 0.783 . . . . 9.1999999999999993 109.2 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.54 -63.92 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.907 -1.042 . . . . 8.5999999999999996 110.339 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 tttp 68.3 108.41 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.058 0.849 . . . . 9.3100000000000005 111.587 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.595 ' H ' HD22 ' A' ' 16' ' ' LEU . 2.4 pt? -69.81 152.15 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.739 -0.664 . . . . 5.9800000000000004 109.42 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.12 135.64 50.61 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 121.185 -0.206 . . . . 2.98 110.947 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 66.84 -151.67 0.2 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.876 0.735 . . . . 1.8500000000000001 111.702 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.604 HD11 ' HG3' ' A' ' 50' ' ' PRO . 19.1 pt -111.06 170.6 5.1 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.876 -0.602 . . . . 3.6800000000000002 110.128 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.519 ' HG2' ' HA ' ' A' ' 2' ' ' ALA . 11.7 Cg_exo -72.54 -148.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.887 2.391 . . . . 2.52 112.488 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.722 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 16.8 ptpt -158.3 -13.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.486 1.291 . . . . 6.79 114.486 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.722 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 14.2 Cg_exo -72.84 45.18 0.86 Allowed 'Trans proline' 0 C--N 1.363 1.337 0 CA-C-N 121.571 1.597 . . . . 3.3799999999999999 111.848 169.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.724 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 10.8 mp0 -134.39 129.98 36.18 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.828 -2.286 . . . . 3.3900000000000001 104.828 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.753 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -122.2 -161.14 11.18 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 118.508 -1.806 . . . . 1.0700000000000001 116.282 -154.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.755 ' HG ' HD13 ' A' ' 122' ' ' LEU . 75.5 p -169.01 34.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.47 1.108 . . . . 1.7 108.107 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.21 152.86 36.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 114.48 -1.236 . . . . 1.53 109.701 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 t -168.53 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.135 0.272 . . . . 1.05 110.712 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -174.36 168.08 3.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.554 0.575 . . . . 1.6899999999999999 112.554 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 67.8 t -142.76 129.36 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.341 -0.845 . . . . 1.8500000000000001 109.497 176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.97 128.12 54.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.619 -0.264 . . . . 1.8300000000000001 110.98 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.617 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 2.7 tm? -92.97 139.54 30.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.801 0.297 . . . . 1.46 111.801 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -139.1 -94.52 0.17 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.047 1.129 . . . . 1.9199999999999999 114.047 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.725 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER -91.11 -174.41 3.97 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 116.182 -0.463 . . . . 2.8500000000000001 112.182 -153.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.8 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.5 p -165.49 -34.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 123.732 0.645 . . . . 3.77 110.517 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 38.0 m-80 67.34 -65.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.175 -0.92 . . . . 3.3500000000000001 108.963 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.566 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 1.2 tpp180 165.73 18.47 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.874 1.27 . . . . 6.21 110.724 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.494 ' O ' ' HB3' ' A' ' 98' ' ' TYR . 30.2 m-20 -136.82 -32.56 0.81 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.652 0.739 . . . . 1.9199999999999999 109.041 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.8 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.1 t -154.39 119.11 4.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.096 -0.956 . . . . 1.1299999999999999 112.289 -173.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.725 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 93.3 t -74.01 147.07 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.578 -1.192 . . . . 1.48 110.056 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.918 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -123.55 137.73 54.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.604 -0.838 . . . . 1.1899999999999999 110.337 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.93 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -141.7 139.61 32.96 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 118.671 -1.212 . . . . 3.9399999999999999 113.677 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -83.24 109.0 16.86 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.666 -1.235 . . . . 1.4299999999999999 107.666 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.655 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -93.48 107.52 19.35 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.535 -0.913 . . . . 1.1100000000000001 108.535 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.418 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 21.5 ttmm -82.7 131.31 35.21 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.927 -0.768 . . . . 3.1800000000000002 108.927 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.632 HG12 ' O ' ' A' ' 25' ' ' SER . 45.2 t -111.2 137.81 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.735 -1.12 . . . . 1.3999999999999999 110.236 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.7 m -126.39 97.87 5.22 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 120.257 -0.577 . . . . 1.1100000000000001 109.632 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.753 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 57.8 t -84.0 124.25 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.651 -0.704 . . . . 1.8500000000000001 110.812 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.68 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 22.1 m -99.83 121.01 40.66 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.326 -0.991 . . . . 1.1000000000000001 108.326 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.832 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.9 t30 -89.45 124.37 64.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 124.894 1.371 . . . . 1.48 109.652 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.724 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 89.3 Cg_endo -82.89 11.67 3.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.852 3.035 . . . . 0.91000000000000003 113.945 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 2.7 t80 -125.54 136.38 53.25 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.717 -0.845 . . . . 2.3100000000000001 108.717 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.2 p -76.31 34.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.311 0.577 . . . . 1.8300000000000001 111.161 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.49 ' H ' ' C ' ' A' ' 51' ' ' TYR . 52.8 m80 -148.57 132.69 17.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.371 -0.831 . . . . 2.0299999999999998 109.895 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 11.0 m -45.15 102.07 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.186 0.994 . . . . 1.73 113.459 173.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.915 ' O ' ' HA ' ' A' ' 81' ' ' SER . 11.1 pt -75.47 171.65 11.31 Favored Pre-proline 0 C--O 1.208 -1.112 0 N-CA-C 108.535 -0.913 . . . . 1.23 108.535 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 39.6 Cg_endo -89.12 -63.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.455 1.437 . . . . 0.53000000000000003 114.923 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.598 HD12 ' HA ' ' A' ' 79' ' ' PRO . 18.2 mm -133.0 162.26 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 121.967 -0.458 . . . . 1.9099999999999999 111.532 -166.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.806 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.3 p -150.97 -179.85 7.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.165 0.983 . . . . 1.95 111.998 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.056 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.6 tt0 -132.37 116.12 16.44 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.419 -1.719 . . . . 1.3600000000000001 109.933 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HD12 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -97.21 108.98 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.362 1.077 . . . . 1.6499999999999999 109.454 168.573 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.524 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 p -114.42 103.03 10.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.454 -1.703 . . . . 1.02 108.807 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.458 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 11.8 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.226 0.536 . . . . 0.46000000000000002 110.294 -165.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 m -137.01 108.81 7.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.873 -1.058 . . . . 1.1699999999999999 109.626 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 92.7 m-85 -98.54 146.59 25.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.409 -0.359 . . . . 1.1799999999999999 110.768 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.738 ' HB3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -139.08 128.83 24.75 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 108.098 -1.075 . . . . 1.72 108.098 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD21 ' A' ' 104' ' ' LEU . 38.1 t -94.06 -89.85 0.21 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.408 -0.917 . . . . 1.6599999999999999 110.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.55 -67.86 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.387 -0.597 . . . . 1.1200000000000001 109.387 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.81 18.08 0.17 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.407 -1.077 . . . . 0.39000000000000001 110.407 167.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.738 ' O ' ' HB3' ' A' ' 65' ' ' HIS . 6.7 ptp180 -106.43 -149.47 0.43 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.558 -0.534 . . . . 2.4900000000000002 109.558 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.35 101.24 7.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 119.068 0.849 . . . . 2.6099999999999999 109.539 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -73.62 -44.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.645 -0.707 . . . . 1.1100000000000001 112.417 -171.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.56 140.24 4.43 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.48999999999999999 111.094 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -154.36 159.08 40.97 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 117.568 0.684 . . . . 2.3999999999999999 111.222 -174.268 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.74 163.72 26.15 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.886 -0.885 . . . . 0.52000000000000002 110.886 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.524 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.9 mttt -129.85 128.37 42.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.162 -0.31 . . . . 2.3799999999999999 110.162 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.429 ' HB ' HD13 ' A' ' 60' ' ' ILE . 75.1 mt -135.67 124.37 15.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.608 -0.269 . . . . 1.47 110.667 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.3 103.0 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.155 1.903 . . . . 0.81000000000000005 111.234 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.431 ' HB2' HD11 ' A' ' 60' ' ' ILE . 7.4 t70 -110.43 136.78 20.56 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.79000000000000004 109.541 -172.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.598 ' HA ' HD12 ' A' ' 57' ' ' ILE . 25.8 Cg_exo -63.44 88.79 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.546 2.164 . . . . 0.91000000000000003 112.716 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' O ' HD23 ' A' ' 82' ' ' LEU . . . -88.24 35.63 3.54 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.885 -0.598 . . . . 0.47999999999999998 112.379 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.915 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -72.78 117.71 14.82 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.146 -0.687 . . . . 0.85999999999999999 109.146 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.568 ' HG ' ' NZ ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -156.41 -155.15 0.52 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.305 -1.358 . . . . 1.76 114.45 -157.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.829 ' HB2' ' HZ2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -57.68 -158.2 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.339 1.066 . . . . 2.4300000000000002 112.305 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.87 80.59 1.72 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.342 -1.355 . . . . 1.29 107.342 -167.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.832 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 8.9 mtpt 64.74 68.28 0.53 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.962 -1.472 . . . . 2.21 110.934 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.718 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 9.4 t70 -162.53 -169.59 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.238 -1.346 . . . . 0.64000000000000001 109.54 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.461 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 41.8 ttp -122.42 118.96 29.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.193 0.521 . . . . 2.04 110.88 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.786 ' HB ' ' CE ' ' A' ' 83' ' ' LYS . 5.6 t -104.04 143.67 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 1.3300000000000001 109.018 -172.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.71 109.4 20.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.703 0.763 . . . . 1.1100000000000001 110.739 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.609 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -115.48 175.07 5.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.66 -1.155 . . . . 1.45 108.136 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.609 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 3.1 p30 -144.25 151.22 39.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.011 0.823 . . . . 1.8100000000000001 112.569 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.655 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 40.3 mm -110.16 130.45 22.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.683 -1.144 . . . . 1.3999999999999999 108.044 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 94' ' ' VAL . 44.6 Cg_exo -35.86 -103.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.687 3.592 . . . . 1.0700000000000001 115.372 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.93 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -164.0 90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 CA-C-O 119.118 -0.468 . . . . 1.1799999999999999 110.615 -177.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.443 ' O ' HG12 ' A' ' 95' ' ' VAL . 14.9 p -124.35 104.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.646 1.721 . . . . 1.1699999999999999 115.646 -163.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.686 HG12 ' HG ' ' A' ' 101' ' ' LEU . 2.5 t -148.9 119.23 4.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 1.71 110.346 164.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.647 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 17.9 Cg_exo -65.47 124.9 13.53 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.08 1.064 . . . . 0.65000000000000002 109.569 164.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.27 -30.85 66.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.6899999999999999 111.594 -171.699 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 3.2 p -58.76 -26.54 64.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.311 0.486 . . . . 1.49 112.311 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.824 HG22 ' HA ' ' A' ' 71' ' ' ILE . 20.2 mm -76.86 -55.31 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 121.818 -0.551 . . . . 1.21 110.995 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.686 ' HG ' HG12 ' A' ' 96' ' ' VAL . 26.9 mt -52.24 -26.56 12.09 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.555 0.693 . . . . 1.6399999999999999 110.392 171.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.453 ' HB3' ' O ' ' A' ' 99' ' ' SER . 57.6 t80 -64.4 -40.24 95.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.467 -1.242 . . . . 1.2 108.839 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.453 ' HA ' HH21 ' A' ' 106' ' ' ARG . 22.0 m-80 -73.79 -58.06 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.845 -0.616 . . . . 0.81999999999999995 112.422 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -61.04 -50.19 74.31 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.423 0.898 . . . . 1.22 113.423 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.51 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.68 -25.05 67.95 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.856 0.836 . . . . 1.1899999999999999 110.037 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 110' ' ' VAL . 2.7 ttp180 -68.18 -51.11 49.37 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.145 . . . . 2.2200000000000002 110.728 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -82.9 -52.07 7.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.545 1.164 . . . . 0.80000000000000004 112.231 -175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.552 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -84.42 -29.06 6.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.859 -1.151 . . . . 1.5 109.982 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.93 -25.59 73.39 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.923 -0.656 . . . . 0.38 113.786 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -57.65 -40.5 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 118.413 -1.315 . . . . 1.6599999999999999 108.04 170.78 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 30.6 t70 -64.66 -84.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.504 -1.278 . . . . 1.8700000000000001 108.097 161.108 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.436 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.9 OUTLIER 168.07 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.24 0.83 . . . . 1.3500000000000001 113.24 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.58 123.78 35.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.87 0.322 . . . . 2.1499999999999999 111.87 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.552 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.3 mp -117.28 155.55 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.902 0.382 . . . . 1.1599999999999999 110.032 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.568 ' HB2' ' HG2' ' A' ' 141' ' ' GLU . 37.1 t70 -98.91 155.41 17.41 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.067 -0.716 . . . . 2.1099999999999999 109.067 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.633 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 72.9 m-85 -139.08 129.57 25.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.217 -0.66 . . . . 0.96999999999999997 109.217 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.83 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.5 tt0 -123.78 137.25 54.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.05 0.453 . . . . 0.80000000000000004 110.068 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.679 HD12 ' HB ' ' A' ' 120' ' ' ILE . 0.8 OUTLIER -111.47 129.36 56.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.588 -0.733 . . . . 1.9199999999999999 109.863 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.688 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.34 101.29 9.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 176.129 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.679 ' HB ' HD12 ' A' ' 118' ' ' LEU . 5.9 tp -111.88 123.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.146 0.498 . . . . 1.49 111.204 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.76 125.2 7.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.378 -0.689 . . . . 0.26000000000000001 111.378 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.755 HD13 ' HG ' ' A' ' 25' ' ' SER . 4.3 mp -101.88 94.99 6.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.38 . . . . 1.77 111.131 -174.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.056 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 84.9 m -100.17 95.56 6.89 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.629 -0.714 . . . . 1.0700000000000001 109.177 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.827 HG13 HD22 ' A' ' 126' ' ' LEU . 3.0 pt -106.89 149.42 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.9 -0.5 . . . . 1.6699999999999999 109.698 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.503 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.5 m-20 -92.88 107.15 18.99 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.827 HD22 HG13 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -109.93 159.74 30.67 Favored Pre-proline 0 C--O 1.217 -0.63 0 O-C-N 123.996 0.81 . . . . 1.9299999999999999 109.997 -176.103 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.497 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 17.3 Cg_exo -69.88 -13.1 33.93 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.884 1.722 . . . . 0.98999999999999999 113.358 174.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.63 -59.93 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.769 0.655 . . . . 1.6699999999999999 112.769 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.54 HG22 ' HA ' ' A' ' 18' ' ' ALA . 34.1 t -118.99 9.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 122.915 1.341 . . . . 1.9099999999999999 109.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.58 -24.78 3.57 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 113.587 -1.642 . . . . 1.05 111.605 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 10.6 pt-20 -172.52 154.77 3.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.628 -0.879 . . . . 1.1599999999999999 108.628 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -150.0 143.64 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.523 -0.547 . . . . 2.2799999999999998 109.523 170.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.492 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 53.5 m -116.23 108.85 16.64 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.383 0.427 . . . . 1.8899999999999999 111.352 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.431 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.4 pp -124.94 137.38 29.51 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.098 -0.501 . . . . 1.26 109.975 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 73.7 Cg_endo -92.89 159.11 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.047 1.832 . . . . 0.58999999999999997 113.323 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.421 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -156.44 165.38 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.601 -0.888 . . . . 1.1399999999999999 108.601 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.591 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -136.27 151.36 49.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.64 -0.255 . . . . 1.28 111.072 -168.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t -146.11 103.8 3.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.016 -0.735 . . . . 1.3400000000000001 109.016 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.83 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.8 ptmt -116.11 152.81 32.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 2.2000000000000002 111.309 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.08 147.02 10.03 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.718 -0.753 . . . . 0.56000000000000005 112.049 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.568 ' HG2' ' HB2' ' A' ' 115' ' ' ASP . 31.3 mt-10 -98.67 135.09 40.68 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.607 -0.516 . . . . 2.1000000000000001 109.607 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.419 HD12 ' CE1' ' A' ' 116' ' ' TYR . 2.1 pp -141.13 171.04 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.212 -0.662 . . . . 1.51 109.212 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -60.02 167.01 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 3.9300000000000002 112.334 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.801 HD11 ' HD2' ' A' ' 145' ' ' PRO . 42.0 tp -56.26 125.44 64.99 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.928 -1.033 . . . . 1.9299999999999999 109.809 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.801 ' HD2' HD11 ' A' ' 144' ' ' LEU . 28.6 Cg_endo -61.81 173.76 2.76 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.658 2.905 . . . . 0.81000000000000005 113.197 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.641 HG22 ' HG2' ' A' ' 148' ' ' LYS . 3.9 m -52.1 118.67 3.65 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.18 -0.464 . . . . 2.3700000000000001 110.003 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.402 ' H ' ' HD1' ' A' ' 147' ' ' PHE . 9.8 m-85 -54.14 -68.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.248 0.342 . . . . 3.1899999999999999 111.427 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.641 ' HG2' HG22 ' A' ' 146' ' ' THR . 31.4 mmtp 39.68 -103.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.496 0.718 . . . . 4.1500000000000004 112.635 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.27 7.77 9.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.175 -0.466 . . . . 4.2800000000000002 110.631 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.474 ' N ' ' HD1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -63.07 -34.93 78.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.834 -0.802 . . . . 3.23 108.834 -174.312 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.644 ' CZ ' HD23 ' A' ' 144' ' ' LEU . 20.9 p90 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 114.545 -1.207 . . . . 4.9000000000000004 109.189 173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 111.422 0.156 . . . . 12.4 111.422 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.61 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.641 0.588 . . . . 9.4700000000000006 110.266 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 p 42.14 -86.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.485 1.114 . . . . 7.0899999999999999 113.685 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -77.39 111.13 12.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.801 0.334 . . . . 8.8100000000000005 110.701 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.493 ' H ' HD22 ' A' ' 5' ' ' LEU . 2.6 mm? -69.54 -61.62 1.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.206 -0.664 . . . . 10.82 109.206 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -171.8 139.49 1.18 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.172 -0.922 . . . . 11.69 109.481 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -170.07 146.56 3.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.943 0.402 . . . . 11.81 111.118 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.92 139.16 55.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.944 -0.571 . . . . 11.779999999999999 110.171 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -87.38 93.19 9.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.319 0.581 . . . . 15.99 111.319 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.09 -58.01 6.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 12.69 109.696 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -175.12 -24.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.796 . . . . 14.630000000000001 110.011 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 8.0 m -69.67 72.91 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.521 0.677 . . . . 8.8900000000000006 112.21 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.33 126.63 34.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 9.1999999999999993 109.946 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.14 10.36 7.78 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.886 0.741 . . . . 8.5999999999999996 111.022 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.415 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 66.8 mttm -109.74 97.89 7.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.952 -0.567 . . . . 9.3100000000000005 110.118 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.07 111.32 21.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.316 -0.402 . . . . 5.9800000000000004 109.917 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -65.74 -26.18 67.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 2.98 111.358 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HB2' HG21 ' A' ' 129' ' ' VAL . . . -74.9 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 1.8500000000000001 111.803 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.475 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 39.8 pt -117.48 135.99 23.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 120.591 -0.444 . . . . 3.6800000000000002 111.551 -171.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 1.2 Cg_endo -84.55 -55.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.964 2.443 . . . . 2.52 112.74 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -140.23 143.6 34.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 6.79 110.043 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -58.15 160.97 14.52 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.404 2.736 . . . . 3.3799999999999999 113.524 -176.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.803 ' HB3' ' O ' ' A' ' 48' ' ' THR . 1.7 mp0 -122.07 158.36 29.42 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.435 -2.061 . . . . 3.3900000000000001 105.435 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.657 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -117.63 -177.07 17.4 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 117.661 -2.209 . . . . 1.0700000000000001 113.875 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.69 ' O ' HG11 ' A' ' 45' ' ' VAL . 83.6 p -169.31 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.338 1.066 . . . . 1.7 108.561 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.56 HG22 HD13 ' A' ' 136' ' ' ILE . 14.3 m -134.52 152.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 114.297 -1.32 . . . . 1.53 109.707 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -160.28 -51.52 0.05 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.464 -0.569 . . . . 1.05 109.464 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -157.36 166.16 33.83 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.487 -0.56 . . . . 1.6899999999999999 109.487 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.617 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -145.53 148.34 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.154 -0.684 . . . . 1.8500000000000001 109.154 165.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -122.37 144.39 49.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.016 0.436 . . . . 1.8300000000000001 111.215 -169.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.12 118.03 32.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 1.46 111.126 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.649 ' HG2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.63 -136.36 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.525 -1.287 . . . . 1.9199999999999999 107.525 167.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.608 ' HB3' HG12 ' A' ' 39' ' ' VAL . 5.3 p-10 169.81 153.84 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.739 1.755 . . . . 2.8500000000000001 115.739 -173.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.691 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER -132.12 -28.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 112.842 -1.981 . . . . 3.77 109.263 167.551 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.429 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 5.0 t30 67.8 -62.24 0.35 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.894 1.072 . . . . 3.3500000000000001 113.894 167.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -49.3 -25.53 2.44 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.021 0.915 . . . . 6.21 111.627 -171.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -134.83 -30.66 1.07 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.811 -1.54 . . . . 1.9199999999999999 107.695 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.464 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 44.1 t -175.3 126.31 0.25 Allowed 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 118.981 -1.088 . . . . 1.1299999999999999 112.184 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.691 ' HA ' ' H ' ' A' ' 34' ' ' VAL . 44.5 t -70.99 168.48 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.743 -1.206 . . . . 1.48 107.743 168.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 76.0 mt-10 -128.76 136.18 50.2 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.712 0.768 . . . . 1.1899999999999999 111.081 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.62 104.21 8.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.637 -1.165 . . . . 3.9399999999999999 109.886 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.546 ' N ' HG11 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -75.39 109.83 9.24 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.267 -0.973 . . . . 1.4299999999999999 108.613 176.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -94.52 109.58 21.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.396 0.617 . . . . 1.1100000000000001 109.781 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 21.7 ttmt -84.65 130.14 34.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.436 -0.802 . . . . 3.1800000000000002 109.11 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.724 HG21 HD21 ' A' ' 90' ' ' LEU . 69.3 t -111.34 136.12 48.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 116.149 -0.478 . . . . 1.3999999999999999 112.13 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.547 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 29.4 m -127.05 95.76 4.4 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.025 -0.731 . . . . 1.1100000000000001 109.025 160.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -89.48 128.51 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.536 0.684 . . . . 1.8500000000000001 110.955 -176.45 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.803 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 5.8 m -103.77 117.27 33.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.963 -1.017 . . . . 1.1000000000000001 109.853 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.776 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 6.3 t30 -88.67 128.47 52.46 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 124.146 0.904 . . . . 1.48 108.922 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -91.84 11.34 2.39 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.25 2.634 . . . . 0.91000000000000003 114.218 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -130.49 143.43 50.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.043 -0.725 . . . . 2.3100000000000001 109.043 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.456 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 23.1 t -78.07 34.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.946 0.721 . . . . 1.8300000000000001 112.946 -164.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -144.5 132.14 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.277 -0.264 . . . . 2.0299999999999998 110.375 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -39.37 103.6 0.03 OUTLIER 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 124.058 0.943 . . . . 1.73 112.708 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.959 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.32 169.45 19.33 Favored Pre-proline 0 C--O 1.21 -1.0 0 N-CA-C 108.097 -1.075 . . . . 1.23 108.097 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.899 ' HB2' HD13 ' A' ' 57' ' ' ILE . 9.9 Cg_endo -91.56 -66.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.504 1.469 . . . . 0.53000000000000003 114.333 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.899 HD13 ' HB2' ' A' ' 56' ' ' PRO . 3.8 mp -134.65 152.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.299 -0.56 . . . . 1.9099999999999999 111.028 -167.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.711 ' HB3' HG22 ' A' ' 124' ' ' ILE . 16.5 m -144.23 -178.09 5.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.118 0.961 . . . . 1.95 111.92 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.073 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 23.8 tt0 -134.27 116.88 15.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.414 -1.721 . . . . 1.3600000000000001 109.997 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.558 ' HA ' HD12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -95.94 108.4 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 115.054 -0.975 . . . . 1.6499999999999999 108.785 164.215 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.589 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 39.5 p -112.76 101.95 10.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.05 -1.432 . . . . 1.02 108.377 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -116.16 134.3 55.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.415 0.626 . . . . 0.46000000000000002 110.583 -166.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -128.32 111.01 12.9 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.507 -1.224 . . . . 1.1699999999999999 108.819 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.502 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 97.8 m-85 -97.31 140.67 31.44 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.584 -0.524 . . . . 1.1799999999999999 109.584 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -128.19 144.55 51.13 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.048 -1.464 . . . . 1.72 107.048 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.725 ' CB ' HD21 ' A' ' 104' ' ' LEU . 39.1 t -105.43 -103.86 0.32 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 118.967 -1.093 . . . . 1.6599999999999999 111.046 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.427 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -60.53 -54.31 47.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.115 -0.698 . . . . 1.1200000000000001 109.115 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 21.22 0.12 Allowed Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 109.116 -1.594 . . . . 0.39000000000000001 109.116 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.448 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 6.6 ptp180 -115.97 -172.25 2.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.568 -0.816 . . . . 2.4900000000000002 109.014 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -105.11 91.55 3.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.612 0.72 . . . . 2.6099999999999999 110.555 -165.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.803 ' HA ' HG21 ' A' ' 100' ' ' ILE . 6.0 mm -52.07 -44.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.911 -1.041 . . . . 1.1100000000000001 111.067 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.24 170.54 35.48 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.534 -0.841 . . . . 0.48999999999999999 111.41 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.576 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.89 163.02 21.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.377 0.589 . . . . 2.3999999999999999 111.043 176.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.83 166.25 35.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.892 -0.595 . . . . 0.52000000000000002 111.637 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.589 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 91.3 mttt -135.74 126.42 27.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.613 0.244 . . . . 2.3799999999999999 110.456 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.37 115.41 14.94 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.944 -0.391 . . . . 1.47 109.944 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -72.24 95.69 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.498 2.132 . . . . 0.81000000000000005 110.553 170.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -112.24 141.84 25.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.374 -0.602 . . . . 0.79000000000000004 109.374 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' HG13 ' A' ' 57' ' ' ILE . 19.5 Cg_endo -59.44 88.97 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.519 2.146 . . . . 0.91000000000000003 112.502 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.688 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -83.21 38.71 2.74 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.261 -0.881 . . . . 0.47999999999999998 112.29 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.959 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 77.4 p -73.58 125.45 28.02 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.506 -0.553 . . . . 0.85999999999999999 109.506 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.826 HD12 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -156.94 0.77 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.893 1.442 . . . . 1.76 114.893 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -62.71 -101.24 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.49 -0.777 . . . . 2.4300000000000002 112.513 -172.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.23 102.57 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.045 -1.094 . . . . 1.29 108.045 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.776 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptpt 43.59 50.43 6.46 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.415 1.072 . . . . 2.21 111.071 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' CG ' ' H ' ' A' ' 87' ' ' MET . 8.0 t70 -149.2 -173.64 4.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.189 -0.914 . . . . 0.64000000000000001 109.678 -174.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.547 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 48.6 ttm -112.59 126.73 55.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.377 -0.374 . . . . 2.04 110.649 -172.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.484 ' CG2' HG11 ' A' ' 47' ' ' VAL . 5.9 t -116.76 144.64 44.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.046 -0.524 . . . . 1.3300000000000001 110.247 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -90.87 111.36 22.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.737 0.779 . . . . 1.1100000000000001 110.527 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.765 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -109.85 176.14 5.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.588 -1.187 . . . . 1.45 108.56 -176.498 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.765 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.8 t70 -134.78 131.73 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.365 0.529 . . . . 1.8100000000000001 111.909 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.652 HG12 ' CG2' ' A' ' 45' ' ' VAL . 19.1 mm -113.62 139.31 23.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 1.3999999999999999 110.312 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -51.3 -177.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.899 . . . . 1.0700000000000001 113.597 175.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.7 m -115.16 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.553 -0.749 . . . . 1.1799999999999999 110.367 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 p -127.2 102.96 10.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 114.269 1.211 . . . . 1.1699999999999999 114.269 -164.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.502 ' HB ' HG21 ' A' ' 71' ' ' ILE . 1.5 p -151.72 98.41 3.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.697 -0.683 . . . . 1.71 110.551 161.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.683 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 87.5 Cg_exo -47.67 130.22 18.32 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.994 1.796 . . . . 0.65000000000000002 111.264 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.464 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -57.86 -31.66 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 1.6899999999999999 110.998 -173.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 14.9 m -56.6 -28.78 61.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.722 0.296 . . . . 1.49 111.682 177.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.803 HG21 ' HA ' ' A' ' 71' ' ' ILE . 21.3 mm -76.34 -54.74 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.757 0.313 . . . . 1.21 110.538 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 104' ' ' LEU . 19.9 mt -50.09 -27.84 6.27 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.21 -0.905 . . . . 1.6399999999999999 110.516 171.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 1.8 t80 -65.66 -42.33 91.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.709 -1.132 . . . . 1.2 109.031 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.636 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 50.7 m-80 -73.59 -56.35 5.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.434 . . . . 0.81999999999999995 111.946 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.789 HD22 HD22 ' A' ' 101' ' ' LEU . 1.6 pp -60.94 -51.16 70.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.442 0.904 . . . . 1.22 113.442 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.4 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.79 -24.35 66.9 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.718 0.77 . . . . 1.1899999999999999 109.706 -178.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.636 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -60.32 -53.27 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.654 -1.157 . . . . 2.2200000000000002 110.143 172.35 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.98 -53.29 6.26 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.301 0.572 . . . . 0.80000000000000004 112.394 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.491 HG11 ' O ' ' A' ' 113' ' ' ASP . 2.2 t -89.72 -25.26 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.945 -0.702 . . . . 1.5 110.159 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.35 -24.64 72.63 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.181 -1.009 . . . . 0.38 111.07 171.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.8 OUTLIER -48.6 -44.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.448 -1.316 . . . . 1.6599999999999999 107.448 166.777 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 7.6 m-20 -68.84 -87.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.78 -0.646 . . . . 1.8700000000000001 110.179 162.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -179.85 -56.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.313 -0.403 . . . . 1.3500000000000001 111.631 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . 0.491 ' O ' HG11 ' A' ' 108' ' ' VAL . 1.6 p-10 -94.42 134.38 37.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.802 0.334 . . . . 2.1499999999999999 110.234 -177.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.64 HD13 HD13 ' A' ' 144' ' ' LEU . 2.3 mp -119.38 156.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.916 -0.772 . . . . 1.1599999999999999 108.916 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.427 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 1.6 p-10 -98.0 152.81 18.88 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.714 -0.847 . . . . 2.1099999999999999 108.714 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.729 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 44.0 m-85 -138.07 169.33 17.98 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.737 -1.208 . . . . 0.96999999999999997 107.737 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.606 ' HA ' ' CB ' ' A' ' 139' ' ' LYS . 3.7 tt0 -160.06 145.04 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.907 0.384 . . . . 0.80000000000000004 110.224 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.624 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -116.59 128.79 55.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.885 -0.598 . . . . 1.9199999999999999 109.472 174.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.624 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -117.08 100.37 7.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.465 -0.939 . . . . 0.63 108.465 176.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.587 HD11 HD11 ' A' ' 122' ' ' LEU . 0.0 OUTLIER -117.14 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.334 0.588 . . . . 1.49 110.846 -173.142 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -86.06 124.15 6.75 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.368 -0.833 . . . . 0.26000000000000001 111.831 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.587 HD11 HD11 ' A' ' 120' ' ' ILE . 5.9 mp -95.34 106.49 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.11 0.481 . . . . 1.77 110.569 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.073 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.1 m -112.04 94.35 4.9 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.034 -0.985 . . . . 1.0700000000000001 109.228 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.711 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -117.35 126.17 74.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.481 -0.562 . . . . 1.6699999999999999 109.481 -175.851 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.851 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 33.3 t70 -81.71 106.86 13.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 120.394 -0.523 . . . . 1.52 110.296 -172.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.672 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 4.5 mm? -98.32 -178.76 0.75 Allowed Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 125.201 1.563 . . . . 1.9299999999999999 109.994 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.417 ' CD ' ' HB3' ' A' ' 126' ' ' LEU . 15.6 Cg_endo -90.78 -16.4 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.987 1.791 . . . . 0.98999999999999999 113.445 167.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.8 t -73.53 -59.71 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.481 0.548 . . . . 1.6699999999999999 112.481 -170.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.654 HG21 ' HB2' ' A' ' 18' ' ' ALA . 2.1 t -113.59 -2.22 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 123.417 1.579 . . . . 1.9099999999999999 107.026 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 86.95 -133.94 12.15 Favored Glycine 0 N--CA 1.422 -2.248 0 CA-C-N 111.636 -2.529 . . . . 1.05 108.52 -167.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.851 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 7.2 pt-20 -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.796 0.808 . . . . 1.1599999999999999 110.869 176.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.787 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.2 m-30 -89.68 145.13 25.44 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.524 -0.917 . . . . 2.2799999999999998 108.524 173.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 21.2 m -129.88 94.16 3.66 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.733 -0.387 . . . . 1.8899999999999999 111.452 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.458 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -128.57 136.16 28.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.23 173.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.428 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 83.9 Cg_endo -89.34 158.23 5.53 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.866 1.711 . . . . 0.58999999999999997 112.604 178.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.56 HD13 HG22 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.3 163.94 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 1.1399999999999999 109.384 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -132.83 139.95 47.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.376 -0.374 . . . . 1.28 110.133 -170.398 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . 0.53 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 50.2 m -147.83 101.02 3.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.715 -0.846 . . . . 1.3400000000000001 108.715 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.729 ' HB2' ' O ' ' A' ' 116' ' ' TYR . 13.9 ptmm? -116.53 163.06 16.64 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.45 -0.796 . . . . 2.2000000000000002 111.66 -171.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.14 138.96 5.61 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.42 -0.895 . . . . 0.56000000000000005 111.329 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.422 ' HG3' ' HA ' ' A' ' 115' ' ' ASP . 5.0 mp0 -106.55 126.76 52.68 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.715 -0.742 . . . . 2.1000000000000001 109.416 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.52 174.99 4.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.073 -0.714 . . . . 1.51 109.073 -171.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -57.08 163.13 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.384 0.513 . . . . 3.9300000000000002 112.384 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.64 HD13 HD13 ' A' ' 114' ' ' ILE . 28.5 tp -56.55 127.41 72.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 115.392 -0.822 . . . . 1.9299999999999999 110.423 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.627 ' HD2' HD13 ' A' ' 144' ' ' LEU . 25.1 Cg_endo -60.74 172.72 2.63 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.401 2.734 . . . . 0.81000000000000005 113.155 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.59 99.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 2.3700000000000001 111.837 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -114.58 148.87 37.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.448 -0.796 . . . . 3.1899999999999999 109.939 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -158.2 80.02 0.83 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.237 -0.438 . . . . 4.1500000000000004 110.032 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 65.62 1.8 1.86 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.892 -0.595 . . . . 4.2800000000000002 111.165 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.07 -33.29 61.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.312 -0.625 . . . . 3.23 109.312 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.403 ' CE1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.039 -0.982 . . . . 4.9000000000000004 109.15 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.286 -0.264 . . . . 12.4 110.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.0 95.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 9.4700000000000006 110.72 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.559 ' HA ' HG11 ' A' ' 128' ' ' VAL . 37.5 m 65.51 -171.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.518 -0.765 . . . . 7.0899999999999999 110.99 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.7 HD23 ' HE1' ' A' ' 51' ' ' TYR . 3.1 mm? -108.03 139.37 42.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.488 -0.324 . . . . 8.8100000000000005 110.24 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.76 61.69 6.93 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.162 -0.681 . . . . 10.82 109.162 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.494 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 15.8 t70 -171.35 77.04 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.071 -0.968 . . . . 11.69 109.623 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 41.3 ttmt 166.89 -68.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.647 0.592 . . . . 11.81 110.777 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.69 107.95 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.415 0.626 . . . . 11.779999999999999 112.564 -168.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -122.27 -20.01 6.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.975 -1.12 . . . . 15.99 107.975 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -110.27 163.41 13.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.685 -1.143 . . . . 12.69 109.527 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 56.16 30.5 16.6 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.637 0.585 . . . . 14.630000000000001 112.018 173.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 m -90.86 140.31 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.506 -0.316 . . . . 8.8900000000000006 110.571 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . -106.92 104.19 13.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 9.1999999999999993 109.815 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 38.4 m-20 72.94 -58.36 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.506 0.722 . . . . 8.5999999999999996 111.687 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -172.53 118.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.016 -0.538 . . . . 9.3100000000000005 109.782 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.7 116.62 17.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.749 -0.834 . . . . 5.9800000000000004 108.749 177.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.1 m -149.08 144.25 26.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.369 -0.378 . . . . 2.98 110.794 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.495 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . 73.68 -162.13 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 124.121 0.888 . . . . 1.8500000000000001 111.642 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.789 HG21 HD11 ' A' ' 126' ' ' LEU . 39.2 pt -93.31 174.29 4.06 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.861 -0.609 . . . . 3.6800000000000002 110.657 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.655 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 48.1 Cg_exo -56.43 -86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.584 2.189 . . . . 2.52 112.515 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.655 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 5.1 tmmm? 162.57 -49.27 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.807 0 O-C-N 123.518 0.511 . . . . 6.79 111.791 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 17.0 Cg_exo -69.21 59.09 1.34 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.542 2.162 . . . . 3.3799999999999999 113.042 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.883 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 8.9 mp0 -134.49 121.04 20.47 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.415 -2.069 . . . . 3.3900000000000001 105.415 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.741 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -132.83 -145.41 5.42 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 118.187 -1.959 . . . . 1.0700000000000001 116.528 -153.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.809 ' HB2' HD22 ' A' ' 122' ' ' LEU . 58.6 m 179.95 49.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.066 1.747 . . . . 1.7 107.167 -174.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.65 154.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.05 -0.977 . . . . 1.53 109.488 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -175.82 -36.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 O-C-N 123.48 0.487 . . . . 1.05 111.623 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 34.7 t70 -163.73 154.26 15.66 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.078 0.466 . . . . 1.6899999999999999 110.591 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.703 HG13 ' HZ ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -151.25 144.69 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.604 -0.517 . . . . 1.8500000000000001 109.604 164.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.35 142.72 51.05 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.023 -0.732 . . . . 1.8300000000000001 109.023 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.764 HD21 HG13 ' A' ' 96' ' ' VAL . 3.3 tm? -101.17 112.24 24.67 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.713 -0.477 . . . . 1.46 109.713 -170.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.623 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.13 147.86 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.03 1.395 . . . . 1.9199999999999999 112.368 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.61 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 1.8 t70 161.65 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.178 -2.737 . . . . 2.8500000000000001 108.039 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -79.75 -175.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-O 122.37 1.081 . . . . 3.77 108.345 -173.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.539 ' H ' HG21 ' A' ' 34' ' ' VAL . 2.6 t30 -129.77 -48.99 1.14 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 114.183 -1.371 . . . . 3.3500000000000001 112.058 -174.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.402 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 31.1 ptt180 -50.91 -19.32 0.97 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.882 0.848 . . . . 6.21 111.699 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.402 ' OD1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 m-20 -111.07 -55.62 2.47 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.307 -1.315 . . . . 1.9199999999999999 107.532 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.51 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 42.2 t 178.05 140.95 0.09 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 114.185 -1.37 . . . . 1.1299999999999999 108.274 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 35.9 t -83.95 158.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.533 -1.654 . . . . 1.48 106.533 171.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.024 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 12.5 mt-10 -139.19 165.66 26.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.124 -1.065 . . . . 1.1899999999999999 108.124 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.892 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 30.5 p90 -134.63 126.8 29.91 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.22 -1.392 . . . . 3.9399999999999999 112.691 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.91 115.17 20.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.566 -0.853 . . . . 1.4299999999999999 109.364 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 41' ' ' TYR . . . -106.39 119.46 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.092 0.472 . . . . 1.1100000000000001 111.924 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.6 tppt? -87.3 102.31 14.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.216 1.007 . . . . 3.1800000000000002 109.449 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.983 HG21 HD12 ' A' ' 92' ' ' ILE . 12.4 t -96.36 156.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.766 -1.106 . . . . 1.3999999999999999 110.33 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.527 ' C ' ' HA ' ' A' ' 25' ' ' SER . 4.1 m -139.45 112.32 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 120.054 -0.659 . . . . 1.1100000000000001 111.33 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.741 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 25.9 t -82.64 124.07 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.975 -1.011 . . . . 1.8500000000000001 110.372 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.482 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 2.4 m -104.09 114.29 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.267 -0.642 . . . . 1.1000000000000001 109.267 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 13.0 t30 -89.81 126.26 58.23 Favored Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 124.395 1.059 . . . . 1.48 110.133 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.883 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 91.2 Cg_endo -83.02 3.88 7.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.594 2.863 . . . . 0.91000000000000003 113.999 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.7 ' HE1' HD23 ' A' ' 4' ' ' LEU . 13.0 t80 -122.03 143.72 49.33 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.407 -0.59 . . . . 2.3100000000000001 109.407 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.611 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 19.8 p -79.2 28.53 0.23 Allowed 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.434 0.531 . . . . 1.8300000000000001 112.434 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.603 ' HD1' ' HE2' ' A' ' 51' ' ' TYR . 42.3 m80 -143.11 131.04 21.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.416 -0.357 . . . . 2.0299999999999998 110.075 177.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.5 m -40.76 100.14 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.985 0 C-N-CA 124.212 1.005 . . . . 1.73 112.846 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.96 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.8 pt -74.51 171.14 12.14 Favored Pre-proline 0 C--O 1.21 -1.014 0 N-CA-C 108.073 -1.084 . . . . 1.23 108.073 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.476 ' HB2' HG12 ' A' ' 57' ' ' ILE . 13.4 Cg_endo -92.9 -63.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.034 1.156 . . . . 0.53000000000000003 114.261 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.653 HD11 ' HA ' ' A' ' 79' ' ' PRO . 23.2 mm -128.38 154.76 39.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 1.9099999999999999 111.797 -165.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 124' ' ' ILE . 28.5 p -151.02 -177.46 6.03 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.075 0.941 . . . . 1.95 111.78 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.009 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 39.4 tt0 -135.36 115.86 13.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.379 -1.737 . . . . 1.3600000000000001 109.809 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.464 HG22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -98.3 109.52 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.334 1.064 . . . . 1.6499999999999999 109.619 168.685 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.627 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 33.2 p -114.52 102.73 10.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.273 -1.785 . . . . 1.02 108.782 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.644 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 p90 -109.69 133.36 53.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.969 0.414 . . . . 0.46000000000000002 110.116 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.574 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 12.2 m -125.53 100.82 6.64 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.185 -0.916 . . . . 1.1699999999999999 109.546 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.836 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 10.4 m-85 -97.57 143.78 27.91 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.869 -0.605 . . . . 1.1799999999999999 109.956 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.743 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -146.16 143.74 29.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.904 -1.147 . . . . 1.72 107.904 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.859 ' HB3' HD22 ' A' ' 104' ' ' LEU . 33.0 t -102.02 -93.97 0.3 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.987 -0.685 . . . . 1.6599999999999999 111.421 -174.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.94 10.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.545 -0.539 . . . . 1.1200000000000001 109.545 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.44 16.29 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.763 -1.208 . . . . 0.39000000000000001 110.247 165.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.674 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -99.19 -69.76 0.75 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.998 -0.601 . . . . 2.4900000000000002 110.532 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 28.1 tt0 -175.75 170.58 2.83 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.523 -1.288 . . . . 2.6099999999999999 107.523 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.528 ' HB ' ' C ' ' A' ' 64' ' ' PHE . 2.4 mm -136.78 -40.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.146 -1.057 . . . . 1.1100000000000001 108.146 168.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.42 151.48 6.28 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.783 -0.927 . . . . 0.48999999999999999 110.783 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.644 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -151.89 155.27 37.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.521 0.661 . . . . 2.3999999999999999 110.771 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.34 177.28 44.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.787 -0.721 . . . . 0.52000000000000002 112.208 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.627 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 69.4 mttt -128.26 132.71 48.72 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.662 0.272 . . . . 2.3799999999999999 110.368 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.4 HD12 ' C ' ' A' ' 75' ' ' LYS . 3.2 mp -131.18 110.73 15.39 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 109.463 -0.569 . . . . 1.47 109.463 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.66 105.95 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.276 1.984 . . . . 0.81000000000000005 110.231 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -120.38 146.27 42.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -172.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.653 ' HA ' HD11 ' A' ' 57' ' ' ILE . 39.5 Cg_exo -61.36 91.75 0.1 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.215 1.943 . . . . 0.91000000000000003 111.917 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.429 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.09 31.3 2.86 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.47999999999999998 111.82 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.96 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 51.4 p -73.33 119.91 18.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.131 -0.692 . . . . 0.85999999999999999 109.131 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.566 HD13 ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -152.51 -164.91 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 118.847 -1.141 . . . . 1.76 113.328 -162.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 91.3 mttt -51.59 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.312 0.856 . . . . 2.4300000000000002 113.312 -173.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 161.38 111.19 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.752 -1.203 . . . . 1.29 107.752 -169.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.699 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 44.1 pttt 42.6 45.53 4.01 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.271 0.982 . . . . 2.21 111.698 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.4 ' CG ' ' H ' ' A' ' 87' ' ' MET . 6.7 t70 -151.23 -172.29 4.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.499 -0.773 . . . . 0.64000000000000001 109.871 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.459 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.8 ttm -117.65 122.23 43.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.347 0.594 . . . . 2.04 110.469 -171.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.566 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -112.13 143.66 42.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 1.3300000000000001 110.338 -176.096 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.81 130.36 36.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.599 0.714 . . . . 1.1100000000000001 110.819 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 45' ' ' VAL . 2.1 tm? -125.56 147.75 49.16 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.763 -1.569 . . . . 1.45 106.763 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.564 ' N ' HD13 ' A' ' 90' ' ' LEU . 4.8 p-10 -124.04 123.72 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.162 -1.015 . . . . 1.8100000000000001 111.573 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.983 HD12 HG21 ' A' ' 45' ' ' VAL . 1.2 mp -90.55 146.53 34.51 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.788 -1.096 . . . . 1.3999999999999999 109.066 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 94' ' ' VAL . 78.0 Cg_exo -52.69 -118.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.121 3.214 . . . . 1.0700000000000001 113.346 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.024 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.6 m -162.97 93.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-O 119.008 -0.52 . . . . 1.1799999999999999 111.437 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.537 HG11 ' HE1' ' A' ' 62' ' ' PHE . 14.8 p -129.52 103.64 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 119.639 -1.913 . . . . 1.1699999999999999 115.962 -172.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.764 HG13 HD21 ' A' ' 31' ' ' LEU . 2.4 p -152.98 97.12 2.86 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.312 -0.868 . . . . 1.71 112.122 162.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.75 ' HB2' HG12 ' A' ' 100' ' ' ILE . 75.4 Cg_exo -46.63 136.62 16.08 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 121.823 1.682 . . . . 0.65000000000000002 112.13 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.51 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 3.5 t80 -51.58 -39.54 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.157 -0.474 . . . . 1.6899999999999999 110.688 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.523 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.7 m -62.78 -25.03 68.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.495 -0.32 . . . . 1.49 111.859 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.75 HG12 ' HB2' ' A' ' 97' ' ' PRO . 21.4 mm -76.87 -56.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.77 -0.581 . . . . 1.21 111.453 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.656 ' HG ' HG22 ' A' ' 96' ' ' VAL . 41.7 mt -53.54 -27.82 28.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.759 0.79 . . . . 1.6399999999999999 109.942 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.523 ' HB3' ' O ' ' A' ' 99' ' ' SER . 53.9 t80 -62.45 -42.04 99.18 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.841 -1.527 . . . . 1.2 109.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.623 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.2 m-80 -74.24 -57.6 3.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.946 0.35 . . . . 0.81999999999999995 111.946 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.859 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -60.62 -49.41 77.65 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.32 0.859 . . . . 1.22 113.32 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.464 ' HB1' HD13 ' A' ' 144' ' ' LEU . . . -68.25 -26.18 65.55 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.821 0.819 . . . . 1.1899999999999999 110.088 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.623 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.8 ttp180 -66.0 -46.09 79.23 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.529 -1.214 . . . . 2.2200000000000002 110.484 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.409 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.9 t0 -82.21 -53.68 5.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.532 0.682 . . . . 0.80000000000000004 112.317 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.479 ' HB ' HG13 ' A' ' 114' ' ' ILE . 6.8 t -85.36 -28.7 6.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.039 -0.664 . . . . 1.5 109.792 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' HD11 ' A' ' 144' ' ' LEU . . . -75.17 -21.66 77.66 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.575 -0.821 . . . . 0.38 111.607 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -47.84 -44.51 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.976 -1.491 . . . . 1.6599999999999999 106.976 165.775 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.61 -82.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.517 -0.765 . . . . 1.8700000000000001 110.284 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 179.94 -58.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.811 0.671 . . . . 1.3500000000000001 112.811 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 122.97 39.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.505 -0.316 . . . . 2.1499999999999999 110.634 -172.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.579 HD13 HD12 ' A' ' 144' ' ' LEU . 2.2 mp -111.21 153.2 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.116 0.484 . . . . 1.1599999999999999 109.941 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.429 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.5 p-10 -99.26 154.12 18.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.513 -0.767 . . . . 2.1099999999999999 109.219 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -139.15 154.22 48.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.732 -0.84 . . . . 0.96999999999999997 108.732 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.732 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 35.0 tt0 -142.05 135.74 29.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 0.80000000000000004 110.395 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.836 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -105.31 134.04 49.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.307 -0.86 . . . . 1.9199999999999999 109.502 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.73 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.93 101.19 7.41 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.533 -0.543 . . . . 0.63 109.533 171.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.482 ' HB ' HD11 ' A' ' 118' ' ' LEU . 7.2 tp -108.04 118.07 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 1.49 110.63 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.59 129.84 10.05 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.98 -0.848 . . . . 0.26000000000000001 110.98 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.809 HD22 ' HB2' ' A' ' 25' ' ' SER . 2.7 mm? -108.9 105.82 15.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.337 0.589 . . . . 1.77 112.348 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.009 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 77.3 m -100.13 95.6 6.94 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.813 -1.085 . . . . 1.0700000000000001 109.241 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.65 HG21 ' HB3' ' A' ' 58' ' ' CYS . 6.3 pt -109.35 138.12 38.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 120.644 -0.422 . . . . 1.6699999999999999 111.732 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.18 108.13 16.21 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.45 -0.945 . . . . 1.52 108.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.789 HD11 HG21 ' A' ' 19' ' ' ILE . 17.7 mt -120.29 156.75 54.87 Favored Pre-proline 0 C--O 1.217 -0.636 0 O-C-N 124.884 1.365 . . . . 1.9299999999999999 110.273 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.429 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.0 Cg_exo -70.87 -21.29 28.52 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.123 1.882 . . . . 0.98999999999999999 112.24 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 3' ' ' SER . 41.2 t -74.95 -57.1 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.073 -0.512 . . . . 1.6699999999999999 112.195 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.559 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.8 OUTLIER -106.72 -1.63 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 122.007 0.908 . . . . 1.9099999999999999 109.698 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.52 -32.05 1.19 Allowed Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.163 -1.381 . . . . 1.05 111.264 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.559 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.8 pt-20 -174.34 141.39 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.116 -1.438 . . . . 1.1599999999999999 107.116 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -146.0 135.44 23.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.39 -0.596 . . . . 2.2799999999999998 109.39 -179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.3 t -117.38 105.8 12.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.868 0.842 . . . . 1.8899999999999999 111.347 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.508 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.49 138.73 33.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.41 -0.813 . . . . 1.26 110.249 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.579 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 94.7 Cg_endo -95.82 165.62 1.36 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.168 1.912 . . . . 0.58999999999999997 113.602 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.472 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -160.89 167.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.55 -1.278 . . . . 1.1399999999999999 107.55 177.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.522 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 83.5 p -140.1 155.83 46.84 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.215 -0.594 . . . . 1.28 112.225 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 t -144.54 103.2 3.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.231 -1.025 . . . . 1.3400000000000001 108.231 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.732 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -108.17 148.63 29.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.549 -0.296 . . . . 2.2000000000000002 110.24 -177.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.94 141.5 7.1 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.809 -0.71 . . . . 0.56000000000000005 111.676 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.429 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 1.6 mp0 -104.73 127.82 52.63 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.927 -0.636 . . . . 2.1000000000000001 109.297 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -147.92 173.02 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.724 0.297 . . . . 1.51 110.314 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.85 159.99 1.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.08 0.77 . . . . 3.9300000000000002 113.08 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.587 HD12 ' HD2' ' A' ' 145' ' ' PRO . 25.9 tp -56.82 132.16 78.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.088 -0.96 . . . . 1.9299999999999999 110.333 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.587 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.7 Cg_endo -59.22 172.42 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.055 2.503 . . . . 0.81000000000000005 112.773 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -49.89 103.84 0.06 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.068 0.461 . . . . 2.3700000000000001 111.67 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.45 ' HD1' ' O ' ' A' ' 145' ' ' PRO . 28.6 p90 -116.75 125.09 51.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.616 . . . . 3.1899999999999999 110.876 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.8 mmtt -142.13 78.85 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.87 -0.604 . . . . 4.1500000000000004 110.086 176.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 t70 70.16 1.28 3.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.85 -0.613 . . . . 4.2800000000000002 111.073 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -82.17 -50.67 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.294 -0.632 . . . . 3.23 109.294 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.139 -0.937 . . . . 4.9000000000000004 109.99 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.667 0.27 . . . . 12.4 110.519 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.36 2.88 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 9.4700000000000006 111.377 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -68.23 -72.73 0.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 7.0899999999999999 110.979 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.652 HD13 ' HB2' ' A' ' 7' ' ' LYS . 45.4 tp -116.81 103.81 10.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.229 -0.441 . . . . 8.8100000000000005 110.393 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 67.0 tp -146.69 -57.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.933 -0.576 . . . . 10.82 110.339 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.99 -11.47 30.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 11.69 111.009 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.652 ' HB2' HD13 ' A' ' 4' ' ' LEU . 13.4 mptt -68.15 130.67 43.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 11.81 110.787 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.56 -160.4 0.76 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.615 . . . . 11.779999999999999 110.147 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -107.15 157.21 18.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.572 -0.285 . . . . 15.99 110.617 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 67.95 -79.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.925 0.765 . . . . 12.69 111.554 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.42 93.65 8.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.234 0.54 . . . . 14.630000000000001 110.763 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -108.07 -1.91 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 8.8900000000000006 110.762 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.13 64.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 9.1999999999999993 110.917 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.62 -30.79 63.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.679 -0.692 . . . . 8.5999999999999996 110.436 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.438 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.11 -42.77 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 9.3100000000000005 111.64 -174.16 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.4 tp 67.8 109.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.906 0.754 . . . . 5.9800000000000004 110.017 -172.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.473 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 89.4 m -60.63 -50.15 74.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.863 -0.608 . . . . 2.98 111.796 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . . . -64.9 157.78 27.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.402 0.62 . . . . 1.8500000000000001 111.721 -176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.762 HG21 HD12 ' A' ' 126' ' ' LEU . 3.1 tp -91.23 109.12 33.49 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.294 -0.866 . . . . 3.6800000000000002 109.891 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 58.1 Cg_endo -112.24 109.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 125.377 4.051 . . . . 2.52 115.596 -166.829 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.634 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 65.1 mttp -153.01 96.26 2.93 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 107.825 -1.176 . . . . 6.79 107.825 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' LYS . 64.8 Cg_exo -18.09 110.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 125.137 3.891 . . . . 3.3799999999999999 113.14 -168.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.509 ' HB2' HD11 ' A' ' 134' ' ' ILE . 51.3 mp0 -103.01 113.31 26.67 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.024 -1.472 . . . . 3.3900000000000001 107.024 -161.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.798 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -92.75 179.25 39.88 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.3 -1.429 . . . . 1.0700000000000001 114.091 -166.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.605 ' OG ' HG23 ' A' ' 47' ' ' VAL . 11.4 m -170.78 36.55 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.795 1.238 . . . . 1.7 108.023 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.549 ' O ' ' HB2' ' A' ' 46' ' ' SER . 27.6 m -133.12 154.3 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.098 -1.41 . . . . 1.53 109.226 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -168.79 -41.3 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.546 0.529 . . . . 1.05 110.595 168.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 1.046 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 27.2 t70 -173.21 160.18 4.01 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.354 -0.239 . . . . 1.6899999999999999 110.354 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.406 HG11 ' CD1' ' A' ' 41' ' ' TYR . 56.0 t -137.66 135.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.143 -0.317 . . . . 1.8500000000000001 110.143 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.413 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 17.6 m-20 -108.18 122.68 47.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.362 -0.381 . . . . 1.8300000000000001 111.311 -173.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.516 . . . . 1.46 110.335 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.401 ' CG ' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -125.53 -122.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.617 -0.512 . . . . 1.9199999999999999 109.617 169.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.813 ' HA ' HG12 ' A' ' 39' ' ' VAL . 4.0 p30 172.28 176.16 0.09 Allowed 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 122.446 0.298 . . . . 2.8500000000000001 110.296 -173.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.7 97.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 122.358 1.075 . . . . 3.77 111.887 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 67.2 -98.96 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.866 -1.061 . . . . 3.3500000000000001 109.097 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -169.85 20.65 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.768 1.27 . . . . 6.21 108.968 173.566 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -101.82 -40.21 7.04 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.875 -1.966 . . . . 1.9199999999999999 107.216 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.518 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 13.8 t -145.58 178.84 7.83 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 112.961 -1.927 . . . . 1.1299999999999999 106.453 170.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.813 HG12 ' HA ' ' A' ' 33' ' ' ASP . 12.2 t -128.78 162.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.016 -1.105 . . . . 1.48 108.016 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.8 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 63.3 mt-10 -123.58 144.55 49.51 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.767 -0.773 . . . . 1.1899999999999999 112.144 -170.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.841 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -126.33 103.91 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.014 -0.994 . . . . 3.9399999999999999 110.672 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.551 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -81.05 109.15 15.34 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.075 -1.083 . . . . 1.4299999999999999 108.075 176.508 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.66 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -111.0 114.61 28.05 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.673 -0.411 . . . . 1.1100000000000001 110.518 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 1.046 ' HD3' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -83.62 134.88 34.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.287 -1.005 . . . . 3.1800000000000002 108.287 173.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.584 HG11 HD21 ' A' ' 90' ' ' LEU . 40.8 t -113.18 148.47 16.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.052 -0.976 . . . . 1.3999999999999999 110.12 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.604 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 3.6 m -133.6 101.37 5.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.344 0.592 . . . . 1.1100000000000001 110.7 170.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.798 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 59.6 t -83.42 124.79 39.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 114.901 -1.045 . . . . 1.8500000000000001 110.721 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.592 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.8 m -108.49 118.28 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.251 -0.431 . . . . 1.1000000000000001 110.206 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.522 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 2.8 p30 -96.54 146.21 30.91 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.429 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.634 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 57.5 Cg_endo -90.17 4.51 4.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.921 3.081 . . . . 0.91000000000000003 114.771 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.676 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 3.8 t80 -95.27 -113.52 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 119.514 -0.874 . . . . 2.3100000000000001 110.173 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 50.0 p -165.32 20.09 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.866 -1.061 . . . . 1.8300000000000001 108.468 171.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -146.22 158.33 43.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 2.0299999999999998 110.871 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.677 ' HA ' HD22 ' A' ' 82' ' ' LEU . 31.4 t -55.95 104.11 0.12 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.198 -1.364 . . . . 1.73 111.678 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.892 HG23 HD22 ' A' ' 126' ' ' LEU . 8.8 pt -79.06 123.3 84.99 Favored Pre-proline 0 C--O 1.213 -0.848 0 C-N-CA 120.442 -0.503 . . . . 1.23 109.911 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.63 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.1 Cg_endo -63.06 -55.12 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.796 1.664 . . . . 0.53000000000000003 112.942 -159.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.547 HD11 ' HA ' ' A' ' 79' ' ' PRO . 23.4 mm -130.73 154.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.218 -0.593 . . . . 1.9099999999999999 111.088 -172.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.59 ' HB3' HG23 ' A' ' 124' ' ' ILE . 26.6 p -147.17 178.19 8.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.106 0.955 . . . . 1.95 111.697 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.025 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 4.5 tm-20 -140.43 112.84 7.91 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.53 -1.668 . . . . 1.3600000000000001 109.442 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG21 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -99.33 115.09 39.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.536 -1.665 . . . . 1.6499999999999999 111.373 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -110.33 103.09 11.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.697 -1.592 . . . . 1.02 108.51 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.7 p90 -109.46 132.62 53.96 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.482 0.658 . . . . 0.46000000000000002 109.546 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.762 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 29.0 m -128.41 102.06 6.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.074 -0.967 . . . . 1.1699999999999999 109.55 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.67 ' CZ ' HD11 ' A' ' 118' ' ' LEU . 97.9 m-85 -96.41 139.45 32.51 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.752 -0.833 . . . . 1.1799999999999999 108.752 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.743 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -146.29 138.14 24.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 1.72 109.056 175.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.743 ' CB ' HD23 ' A' ' 104' ' ' LEU . 47.6 t -95.5 -98.77 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.458 -0.497 . . . . 1.6599999999999999 111.384 -173.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.461 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -56.78 -60.05 4.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.279 0.562 . . . . 1.1200000000000001 109.564 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.23 18.21 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.269 -1.533 . . . . 0.39000000000000001 109.269 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.53 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -103.44 -56.04 2.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.233 -0.484 . . . . 2.4900000000000002 111.069 -173.47 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.743 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 31.1 tt0 171.49 176.96 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.761 -1.57 . . . . 2.6099999999999999 106.761 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 1.078 ' HA ' HG22 ' A' ' 100' ' ' ILE . 4.4 mm -145.4 -47.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 C-N-CA 124.425 1.09 . . . . 1.1100000000000001 108.529 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.33 121.44 0.59 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.229 -0.986 . . . . 0.48999999999999999 112.011 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -124.49 163.92 20.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.687 0.756 . . . . 2.3999999999999999 111.901 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.01 169.66 26.76 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.091 -1.204 . . . . 0.52000000000000002 110.091 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.482 ' HB2' ' OE2' ' A' ' 59' ' ' GLU . 10.6 ptmm? -144.12 135.02 25.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.632 0.716 . . . . 2.3799999999999999 111.22 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.424 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 52.9 mt -139.98 138.22 19.3 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.723 -0.671 . . . . 1.47 110.152 -173.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 4.2 Cg_exo -78.0 125.9 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.484 2.122 . . . . 0.81000000000000005 111.208 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -130.86 146.16 60.86 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.47 -0.567 . . . . 0.79000000000000004 109.47 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.547 ' HA ' HD11 ' A' ' 57' ' ' ILE . 20.0 Cg_exo -66.61 92.31 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.245 1.963 . . . . 0.91000000000000003 111.794 174.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.1 25.39 17.43 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.47999999999999998 112.267 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.729 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 82.6 p -70.39 119.84 15.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.741 -0.837 . . . . 0.85999999999999999 108.741 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.741 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -141.18 -159.5 0.97 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.837 1.051 . . . . 1.76 113.837 -159.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 60.5 mttm -52.16 -95.98 0.0 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.821 -1.081 . . . . 2.4300000000000002 112.801 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.571 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 168.84 113.44 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.862 -1.162 . . . . 1.29 107.862 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.676 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 7.7 ptmm? 41.02 51.38 3.28 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.029 0.83 . . . . 2.21 112.02 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.592 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.1 t70 -161.83 -171.42 2.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.024 -0.535 . . . . 0.64000000000000001 111.008 -169.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.604 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.2 ttm -112.27 118.68 35.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 2.04 111.23 -169.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.741 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.0 t -106.36 144.45 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 1.3300000000000001 110.655 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.87 118.0 24.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.546 0.689 . . . . 1.1100000000000001 111.032 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.584 HD21 HG11 ' A' ' 45' ' ' VAL . 6.4 tt -119.58 175.7 5.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.765 -1.198 . . . . 1.45 107.765 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.404 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.5 m-20 -136.57 143.03 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.739 0.7 . . . . 1.8100000000000001 111.799 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.66 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 41.8 mm -113.66 130.18 24.01 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.173 -1.417 . . . . 1.3999999999999999 107.173 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 42' ' ' LEU . 62.1 Cg_exo -50.42 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.344 2.696 . . . . 1.0700000000000001 114.36 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.841 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -163.4 91.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 O-C-N 122.112 -0.368 . . . . 1.1799999999999999 111.375 -176.028 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.3 p -127.34 103.19 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.085 1.143 . . . . 1.1699999999999999 114.085 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 101' ' ' LEU . 2.5 p -154.52 99.61 2.45 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 120.718 -0.393 . . . . 1.71 111.473 160.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 5.8 Cg_endo -49.88 137.72 35.15 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.192 1.928 . . . . 0.65000000000000002 112.506 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.518 ' H ' ' HA ' ' A' ' 38' ' ' SER . 21.6 t80 -53.81 -32.03 51.24 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.769 -0.65 . . . . 1.6899999999999999 111.45 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.8 m -53.21 -31.6 43.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 1.49 111.882 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 1.078 HG22 ' HA ' ' A' ' 71' ' ' ILE . 37.5 mm -76.27 -57.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.828 0.823 . . . . 1.21 111.501 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.064 HD23 HD21 ' A' ' 104' ' ' LEU . 2.0 mm? -54.23 -26.68 29.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.393 -1.73 . . . . 1.6399999999999999 110.827 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' SER . 79.1 t80 -64.56 -45.76 85.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.239 -1.346 . . . . 1.2 108.568 177.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.05 -56.72 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.708 -0.678 . . . . 0.81999999999999995 111.799 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 1.064 HD21 HD23 ' A' ' 101' ' ' LEU . 2.2 pp -61.08 -52.72 63.75 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.129 0.788 . . . . 1.22 113.129 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.443 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.6 -25.48 67.41 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.852 0.834 . . . . 1.1899999999999999 110.347 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.462 ' HE ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 ttp180 -64.98 -52.15 57.77 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.671 -1.15 . . . . 2.2200000000000002 110.092 174.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.4 t70 -82.88 -52.83 6.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.55 0.691 . . . . 0.80000000000000004 112.342 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -85.34 -28.45 6.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 121.714 -0.616 . . . . 1.5 110.035 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.15 -20.67 80.02 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.705 -0.759 . . . . 0.38 111.499 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -49.35 -47.14 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.049 -1.463 . . . . 1.6599999999999999 107.049 165.17 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.517 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.7 m-20 -66.8 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 1.8700000000000001 109.761 162.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 178.17 -54.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.543 0.527 . . . . 1.3500000000000001 111.545 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.57 128.87 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.175 0.512 . . . . 2.1499999999999999 111.067 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.559 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.7 mp -112.67 155.94 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.668 -0.696 . . . . 1.1599999999999999 110.197 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -98.09 153.43 18.43 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.081 -0.711 . . . . 2.1099999999999999 109.081 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.654 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 61.3 m-85 -140.13 166.13 25.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.639 -0.874 . . . . 0.96999999999999997 108.639 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.845 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 28.4 tt0 -157.0 137.45 13.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.871 0.367 . . . . 0.80000000000000004 110.925 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.67 HD11 ' CZ ' ' A' ' 64' ' ' PHE . 14.2 tp -103.65 133.11 49.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.792 -0.64 . . . . 1.9199999999999999 110.018 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.762 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -118.8 100.18 7.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.399 -0.963 . . . . 0.63 108.399 172.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.621 HD11 HG21 ' A' ' 60' ' ' ILE . 7.2 tp -112.21 114.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.195 0.521 . . . . 1.49 111.207 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -91.8 142.53 16.1 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.644 -0.982 . . . . 0.26000000000000001 110.644 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.735 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.8 mm? -121.48 122.32 39.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.3 0.571 . . . . 1.77 112.469 -173.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.025 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.9 m -116.37 96.1 5.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.844 -1.071 . . . . 1.0700000000000001 108.994 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.638 ' HB ' HD13 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -108.1 140.86 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.367 -0.533 . . . . 1.6699999999999999 110.607 -175.275 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.63 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.1 m-20 -84.81 105.87 15.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.406 -0.961 . . . . 1.52 108.406 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.892 HD22 HG23 ' A' ' 55' ' ' ILE . 17.5 mt -111.07 143.38 28.23 Favored Pre-proline 0 C--O 1.219 -0.54 0 O-C-N 125.247 1.592 . . . . 1.9299999999999999 109.158 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.4 -25.0 71.38 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.158 1.905 . . . . 0.98999999999999999 114.08 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.527 HG21 ' HE2' ' A' ' 51' ' ' TYR . 60.1 t -74.65 -58.64 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.846 0.684 . . . . 1.6699999999999999 112.846 -174.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.42 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 40.1 t -105.37 -2.85 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 122.798 1.285 . . . . 1.9099999999999999 109.523 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.48 -0.84 53.91 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 113.479 -1.691 . . . . 1.05 111.852 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.566 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.6 pt-20 -176.49 174.07 1.96 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.523 -0.547 . . . . 1.1599999999999999 109.523 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.519 ' HB2' HD13 ' A' ' 126' ' ' LEU . 8.3 t80 -170.74 124.07 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.337 -0.986 . . . . 2.2799999999999998 108.337 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.735 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.8 t -114.16 102.85 10.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.87 0.843 . . . . 1.8899999999999999 111.687 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.509 HD11 ' HB2' ' A' ' 23' ' ' GLU . 2.5 pp -127.96 144.99 53.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 1.26 110.137 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.684 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 58.6 Cg_endo -96.44 162.43 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.223 1.948 . . . . 0.58999999999999997 113.134 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.479 HG21 HG22 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -160.39 167.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.765 -1.198 . . . . 1.1399999999999999 107.765 179.239 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.518 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 88.7 p -146.17 159.17 43.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.599 0.592 . . . . 1.28 112.599 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -151.0 109.83 3.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.851 -0.796 . . . . 1.3400000000000001 108.851 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.845 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -107.43 148.0 29.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 2.2000000000000002 110.217 -179.652 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.38 142.59 8.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.701 -0.762 . . . . 0.56000000000000005 111.866 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -113.07 133.99 54.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.125 -0.538 . . . . 2.1000000000000001 110.391 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.49 174.96 7.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.525 -0.917 . . . . 1.51 108.525 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -69.13 175.25 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.87 0.367 . . . . 3.9300000000000002 111.599 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.682 HD11 ' HD2' ' A' ' 145' ' ' PRO . 21.9 tp -57.15 136.37 80.72 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 1.9299999999999999 111.694 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.682 ' HD2' HD11 ' A' ' 144' ' ' LEU . 72.5 Cg_endo -74.21 174.31 12.69 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.523 2.815 . . . . 0.81000000000000005 112.902 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.3 m -55.08 114.99 1.98 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.745 -0.661 . . . . 2.3700000000000001 111.366 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.93 156.23 44.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 3.1899999999999999 110.086 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 38.6 ttmt -177.32 85.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.176 0.297 . . . . 4.1500000000000004 110.633 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.6 t70 64.77 4.72 2.49 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.235 0.614 . . . . 4.2800000000000002 111.6 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.23 -53.24 4.55 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.347 -0.612 . . . . 3.23 109.347 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.04 -0.982 . . . . 4.9000000000000004 109.385 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.671 -0.122 . . . . 12.4 110.671 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.08 -53.06 0.62 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.576 0.954 . . . . 9.4700000000000006 113.576 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.475 ' HA ' ' HB ' ' A' ' 17' ' ' THR . 16.9 t 73.38 -49.96 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.468 0.707 . . . . 7.0899999999999999 110.018 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.76 115.46 30.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.098 -0.704 . . . . 8.8100000000000005 109.098 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.21 -61.18 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.736 0.303 . . . . 10.82 111.222 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.61 141.69 33.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.325 -0.398 . . . . 11.69 110.088 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.58 -28.57 9.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.653 -0.248 . . . . 11.81 111.38 -173.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 61.1 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.766 0.666 . . . . 11.779999999999999 111.731 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -137.15 71.89 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.047 -0.353 . . . . 15.99 110.047 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.16 19.64 10.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.908 -0.587 . . . . 12.69 111.854 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.04 109.77 6.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.815 0.341 . . . . 14.630000000000001 110.531 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.626 HG23 ' HB2' ' A' ' 15' ' ' LYS . 16.5 m -88.51 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.2 -0.455 . . . . 8.8900000000000006 110.419 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.0 -50.81 53.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 9.1999999999999993 109.888 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -150.24 110.31 4.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.446 -0.797 . . . . 8.5999999999999996 109.752 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.626 ' HB2' HG23 ' A' ' 12' ' ' VAL . 28.4 ttpp -91.3 100.65 13.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.288 -0.415 . . . . 9.3100000000000005 110.522 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.2 tp -150.05 -101.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 5.9800000000000004 110.291 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 3' ' ' SER . 24.9 m 57.31 -90.4 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.429 0.456 . . . . 2.98 110.558 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.46 ' O ' HG12 ' A' ' 128' ' ' VAL . . . 47.95 -131.27 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.155 0.798 . . . . 1.8500000000000001 113.155 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.92 HG22 HD12 ' A' ' 126' ' ' LEU . 37.2 pt -130.25 179.56 1.29 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 3.6800000000000002 111.199 -164.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.516 ' CD ' ' HB ' ' A' ' 19' ' ' ILE . 30.2 Cg_exo -64.41 -152.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.061 2.507 . . . . 2.52 112.98 172.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.596 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 60.6 tttm -150.57 -49.38 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.069 0.396 . . . . 6.79 112.069 -172.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 Cg_exo -74.79 63.31 5.79 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 3.3799999999999999 112.855 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.693 ' HG2' ' HG3' ' A' ' 50' ' ' PRO . 2.0 mp0 -130.95 145.03 51.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.365 -2.087 . . . . 3.3900000000000001 105.365 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.758 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -116.36 -177.1 18.13 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 117.956 -2.068 . . . . 1.0700000000000001 116.973 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.654 ' O ' HG13 ' A' ' 45' ' ' VAL . 99.7 p -161.53 35.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.38 -2.082 . . . . 1.7 105.38 170.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 10.5 m -133.27 154.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.808 -1.996 . . . . 1.53 108.39 -170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.604 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 7.8 t -173.17 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.365 0.416 . . . . 1.05 111.933 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 4.4 t70 -164.41 156.44 16.34 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.117 -0.364 . . . . 1.6899999999999999 110.112 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -143.85 132.7 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.57 -0.53 . . . . 1.8500000000000001 109.57 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.731 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 23.2 m-20 -112.94 124.08 51.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.798 0.333 . . . . 1.8300000000000001 111.121 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.526 HD21 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -87.69 121.04 29.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.045 -0.525 . . . . 1.46 109.737 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HD3' HG13 ' A' ' 94' ' ' VAL . 0.0 OUTLIER -133.5 -127.04 0.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.571 -0.529 . . . . 1.9199999999999999 109.571 171.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.663 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.6 p30 175.7 174.83 0.27 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.419 0.526 . . . . 2.8500000000000001 112.419 -169.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.673 HG13 ' O ' ' A' ' 34' ' ' VAL . 14.4 p -160.12 100.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.067 -0.97 . . . . 3.77 111.057 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.425 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 15.5 t30 67.1 -103.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.131 -0.692 . . . . 3.3500000000000001 109.131 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.415 ' H ' ' CG ' ' A' ' 35' ' ' ASN . 0.5 OUTLIER -173.71 30.82 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.391 -1.337 . . . . 6.21 107.391 172.149 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.37 -43.29 6.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 112.758 -2.019 . . . . 1.9199999999999999 106.141 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.557 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 36.3 t -149.62 178.33 8.94 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.409 -2.632 . . . . 1.1299999999999999 105.599 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 1.056 HG21 HG13 ' A' ' 96' ' ' VAL . 13.8 m -129.29 179.55 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 109.356 -0.609 . . . . 1.48 109.356 164.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.934 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 74.5 mt-10 -123.49 142.44 51.0 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.904 -0.718 . . . . 1.1899999999999999 112.4 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -123.39 104.16 8.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.124 -0.944 . . . . 3.9399999999999999 109.726 176.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.731 ' HB3' ' HB2' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -75.92 111.29 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.971 -1.122 . . . . 1.4299999999999999 107.971 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.726 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.68 109.7 21.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.697 0.76 . . . . 1.1100000000000001 109.944 -175.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.651 ' HZ1' HD11 ' A' ' 42' ' ' LEU . 41.3 mmtm -83.68 123.53 29.92 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.702 -1.136 . . . . 3.1800000000000002 108.934 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 25' ' ' SER . 55.4 t -111.45 138.92 38.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.625 -0.716 . . . . 1.3999999999999999 111.118 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.604 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 3.5 m -133.93 100.0 4.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.368 0.604 . . . . 1.1100000000000001 110.16 168.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.758 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.9 t -82.38 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.115 -0.948 . . . . 1.8500000000000001 111.011 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.551 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.2 m -109.59 109.59 20.4 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.318 -0.623 . . . . 1.1000000000000001 109.318 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.689 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -96.8 125.44 46.6 Favored Pre-proline 0 C--O 1.24 0.563 0 O-C-N 124.28 0.987 . . . . 1.48 109.404 175.147 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.693 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 18.1 Cg_endo -112.32 39.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.4 3.4 . . . . 0.91000000000000003 116.513 -169.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.407 ' CZ ' HG23 ' A' ' 128' ' ' VAL . 10.7 t80 -116.32 -10.82 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.03 1.287 . . . . 2.3100000000000001 112.18 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.619 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 54.4 p 86.91 26.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.837 1.655 . . . . 1.8300000000000001 109.401 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -147.46 123.67 10.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.265 -1.334 . . . . 2.0299999999999998 109.297 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.839 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.0 m -49.03 104.69 0.07 Allowed 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 122.926 0.49 . . . . 1.73 112.045 172.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.92 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.65 170.52 14.85 Favored Pre-proline 0 C--O 1.209 -1.07 0 N-CA-C 108.161 -1.051 . . . . 1.23 108.161 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.59 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.3 Cg_endo -92.87 -63.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.731 1.621 . . . . 0.53000000000000003 114.395 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.657 HD11 ' HA ' ' A' ' 79' ' ' PRO . 12.4 mm -128.29 160.62 38.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 121.079 -0.248 . . . . 1.9099999999999999 110.721 -167.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.584 ' CB ' HG23 ' A' ' 124' ' ' ILE . 25.6 p -156.58 -177.52 6.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 122.116 0.96 . . . . 1.95 112.772 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.07 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 26.2 tt0 -133.04 117.1 17.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.184 -1.825 . . . . 1.3600000000000001 109.845 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.742 HG23 HD13 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -97.26 109.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 121.997 0.903 . . . . 1.6499999999999999 109.018 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.623 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 19.4 p -112.76 102.76 10.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.005 -1.452 . . . . 1.02 108.908 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 4.6 p90 -112.07 124.9 53.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.467 -0.568 . . . . 0.46000000000000002 109.467 -168.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.638 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 6.6 m -121.9 106.11 10.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.21 -0.904 . . . . 1.1699999999999999 108.703 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.592 ' CZ ' HD12 ' A' ' 118' ' ' LEU . 86.1 m-85 -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.935 -0.395 . . . . 1.1799999999999999 109.935 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -126.78 144.53 50.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.569 -0.9 . . . . 1.72 108.569 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.453 ' HB3' HD21 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.48 -112.75 0.16 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.156 -0.475 . . . . 1.6599999999999999 111.298 177.237 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.418 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -64.31 -51.18 64.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.684 -0.858 . . . . 1.1200000000000001 108.684 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.427 ' H ' HH11 ' A' ' 69' ' ' ARG . . . -161.58 12.74 0.13 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.405 -1.078 . . . . 0.39000000000000001 110.405 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.583 ' HE ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -112.62 -164.99 0.95 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.715 -0.846 . . . . 2.4900000000000002 108.715 -175.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.92 98.23 7.74 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.259 0.552 . . . . 2.6099999999999999 109.868 -169.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.935 ' HA ' HG22 ' A' ' 100' ' ' ILE . 2.8 mm -52.25 -34.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.145 -0.934 . . . . 1.1100000000000001 110.358 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.74 170.9 27.11 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.823 -0.911 . . . . 0.48999999999999999 110.823 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.09 163.98 23.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.011 0.906 . . . . 2.3999999999999999 111.691 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.72 170.42 34.15 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.318 -0.856 . . . . 0.52000000000000002 110.995 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.47 ' HB3' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 133.68 27.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.936 0.398 . . . . 2.3799999999999999 110.734 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.69 123.13 17.1 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.049 -0.523 . . . . 1.47 110.457 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.8 116.16 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.427 2.084 . . . . 0.81000000000000005 110.713 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.85 140.48 37.82 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 121.17 -0.212 . . . . 0.79000000000000004 110.501 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.657 ' HA ' HD11 ' A' ' 57' ' ' ILE . 21.1 Cg_endo -61.26 88.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.821 2.347 . . . . 0.91000000000000003 112.46 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.534 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.56 43.08 2.77 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.802 -0.636 . . . . 0.47999999999999998 111.801 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.92 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.6 p -74.08 121.9 21.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.878 -0.415 . . . . 0.85999999999999999 109.878 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.839 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -164.66 170.69 15.34 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.41 1.633 . . . . 1.76 115.41 -163.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.888 ' HG3' ' HB3' ' A' ' 86' ' ' ASP . 71.4 mmtt 7.57 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.859 1.664 . . . . 2.4300000000000002 114.031 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 172.0 -44.23 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.622 -1.992 . . . . 1.29 105.622 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.6 ttpt -159.65 71.08 0.48 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 112.131 -2.304 . . . . 2.21 110.162 173.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.888 ' HB3' ' HG3' ' A' ' 83' ' ' LYS . 6.9 t70 -162.24 -161.66 0.76 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.011 -1.45 . . . . 0.64000000000000001 108.809 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.586 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 47.9 ttm -121.3 122.16 39.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.858 -0.423 . . . . 2.04 109.858 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 46' ' ' SER . 2.7 t -104.45 143.04 33.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.119 -0.492 . . . . 1.3300000000000001 109.709 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.93 123.35 31.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 1.1100000000000001 110.781 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.591 HD22 HG12 ' A' ' 45' ' ' VAL . 8.7 tt -130.64 164.5 24.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.137 -1.431 . . . . 1.45 107.137 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.65 142.28 32.04 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.173 -1.011 . . . . 1.8100000000000001 111.764 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.726 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 35.3 mm -100.83 143.39 26.49 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.724 -1.213 . . . . 1.3999999999999999 107.724 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.539 ' O ' HD23 ' A' ' 42' ' ' LEU . 81.9 Cg_exo -48.15 -107.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.212 2.608 . . . . 1.0700000000000001 114.0 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.934 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.41 94.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 O-C-N 121.617 -0.677 . . . . 1.1799999999999999 111.979 -172.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.4 p -127.49 103.02 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.581 1.326 . . . . 1.1699999999999999 114.581 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 1.056 HG13 HG21 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -151.98 112.89 2.9 Favored Pre-proline 0 C--O 1.219 -0.517 0 O-C-N 121.712 -0.618 . . . . 1.71 110.332 157.582 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.736 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 4.8 Cg_endo -53.98 135.16 62.73 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.38 1.387 . . . . 0.65000000000000002 111.619 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.557 ' H ' ' HA ' ' A' ' 38' ' ' SER . 22.8 t80 -55.58 -30.7 61.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.762 -0.654 . . . . 1.6899999999999999 110.912 -177.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.673 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.2 p -58.14 -28.78 65.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.995 -0.548 . . . . 1.49 112.32 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.935 HG22 ' HA ' ' A' ' 71' ' ' ILE . 8.3 mm -77.51 -52.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.031 -0.418 . . . . 1.21 111.014 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.064 HD22 HD22 ' A' ' 104' ' ' LEU . 21.3 mt -50.75 -27.01 6.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.5 0.666 . . . . 1.6399999999999999 110.185 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.713 ' HA ' ' CZ ' ' A' ' 151' ' ' PHE . 46.9 t80 -63.81 -42.5 97.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.472 -1.24 . . . . 1.2 108.917 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.663 ' HA ' HH21 ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.24 -57.59 3.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.665 -0.698 . . . . 0.81999999999999995 111.789 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 1.064 HD22 HD22 ' A' ' 101' ' ' LEU . 3.2 pp -57.36 -50.13 73.93 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.926 0.714 . . . . 1.22 112.926 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' N ' HD12 ' A' ' 104' ' ' LEU . . . -68.95 -26.72 65.2 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.497 0.665 . . . . 1.1899999999999999 110.274 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.663 HH21 ' HA ' ' A' ' 103' ' ' ASN . 2.7 ttp180 -68.0 -54.49 18.12 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.238 -0.892 . . . . 2.2200000000000002 110.222 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.64 -53.93 6.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.80000000000000004 111.277 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.613 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.6 t -89.05 -28.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.415 -0.514 . . . . 1.5 110.57 -174.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.435 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -68.33 -25.29 74.77 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.063 -1.065 . . . . 0.38 111.416 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -53.7 -46.77 62.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.475 -1.305 . . . . 1.6599999999999999 107.475 168.791 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 15.2 m-20 -68.01 -61.28 1.94 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.712 0.634 . . . . 1.8700000000000001 112.712 169.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.438 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER 153.48 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.209 1.004 . . . . 1.3500000000000001 113.593 -173.166 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -92.5 128.82 38.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.101 0.56 . . . . 2.1499999999999999 111.006 -173.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.775 HG21 ' HB2' ' A' ' 104' ' ' LEU . 3.3 mp -110.69 155.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.842 -0.429 . . . . 1.1599999999999999 109.842 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 15.1 p-10 -98.41 153.05 18.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.988 -0.745 . . . . 2.1099999999999999 108.988 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.401 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 74.4 m-85 -143.62 165.44 27.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.96999999999999997 108.696 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.704 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.5 tt0 -153.16 135.94 15.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 0.80000000000000004 110.307 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.592 HD12 ' CZ ' ' A' ' 64' ' ' PHE . 11.4 tp -104.72 130.76 52.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.821 -0.437 . . . . 1.9199999999999999 109.821 171.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.638 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -117.16 100.29 7.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.469 -0.937 . . . . 0.63 108.469 176.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.742 HD13 HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -119.94 120.42 63.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.617 0.722 . . . . 1.49 111.137 -171.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.77 129.13 9.47 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.228 -0.896 . . . . 0.26000000000000001 112.101 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.555 HD13 ' OG ' ' A' ' 25' ' ' SER . 4.8 mp -100.84 92.98 5.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 1.77 110.907 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.07 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.5 m -94.18 95.93 9.28 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.942 -0.762 . . . . 1.0700000000000001 108.942 172.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.584 HG23 ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.93 137.84 43.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.148 -0.621 . . . . 1.6699999999999999 110.761 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.434 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 7.2 t70 -79.52 106.74 11.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.799 -1.186 . . . . 1.52 107.799 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.92 HD12 HG22 ' A' ' 19' ' ' ILE . 6.7 mt -113.5 166.05 12.07 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.467 -0.788 . . . . 1.9299999999999999 110.648 -171.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.24 -16.76 15.35 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 121.914 1.743 . . . . 0.98999999999999999 111.867 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.469 HG21 HG21 ' A' ' 19' ' ' ILE . 3.0 t -75.18 -59.7 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.433 0.531 . . . . 1.6699999999999999 112.433 -174.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.476 ' C ' ' H ' ' A' ' 131' ' ' GLU . 2.8 t -111.7 -0.2 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 122.643 1.211 . . . . 1.9099999999999999 108.891 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 80.48 -28.62 2.68 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 113.453 -1.703 . . . . 1.05 111.267 -170.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.476 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.8 pt-20 -175.35 143.69 0.66 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.087 -1.079 . . . . 1.1599999999999999 108.087 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.5 t80 -155.7 145.47 21.28 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.638 -0.504 . . . . 2.2799999999999998 109.638 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.508 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.6 t -113.23 107.94 16.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.581 0.705 . . . . 1.8899999999999999 110.922 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.467 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.5 pp -115.12 128.29 26.07 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.701 -0.852 . . . . 1.26 108.701 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.575 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 19.6 Cg_endo -89.3 160.02 5.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 121.759 1.64 . . . . 0.58999999999999997 112.735 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.412 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -155.53 166.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.972 -1.122 . . . . 1.1399999999999999 107.972 179.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.1 m -139.98 153.19 46.81 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.782 -0.367 . . . . 1.28 111.304 -168.782 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.0 t -143.84 105.72 4.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.269 -1.011 . . . . 1.3400000000000001 108.269 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.704 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.29 149.07 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.627 -0.26 . . . . 2.2000000000000002 110.788 -176.535 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.04 148.19 16.28 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.517 -0.849 . . . . 0.56000000000000005 112.131 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -106.1 124.48 49.64 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.807 -0.812 . . . . 2.1000000000000001 108.807 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.43 173.07 13.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.238 -0.653 . . . . 1.51 109.238 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -55.39 160.3 2.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.543 0.687 . . . . 3.9300000000000002 112.358 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.681 HD13 ' HD2' ' A' ' 145' ' ' PRO . 24.6 tp -56.29 134.78 75.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.776 -1.102 . . . . 1.9299999999999999 110.658 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.681 ' HD2' HD13 ' A' ' 144' ' ' LEU . 35.5 Cg_endo -63.2 168.19 11.36 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.787 2.325 . . . . 0.81000000000000005 111.524 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -78.32 90.1 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.159 0.429 . . . . 2.3700000000000001 112.159 -172.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.627 ' HB3' ' HB2' ' A' ' 150' ' ' PHE . 96.4 m-85 -137.28 103.78 5.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.305 0.574 . . . . 3.1899999999999999 110.525 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.61 ' HE3' ' HA ' ' A' ' 148' ' ' LYS . 1.3 tpmt? -72.53 -74.86 0.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 4.1500000000000004 110.698 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -115.97 22.93 12.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.323 0.582 . . . . 4.2800000000000002 110.105 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.627 ' HB2' ' HB3' ' A' ' 147' ' ' PHE . 15.4 m-85 -76.99 -47.01 21.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.889 -0.782 . . . . 3.23 108.889 174.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.713 ' CZ ' ' HA ' ' A' ' 102' ' ' PHE . 35.4 m-85 . . . . . 0 C--O 1.243 0.746 0 CA-C-N 115.384 -0.825 . . . . 4.9000000000000004 109.437 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.93 0.395 . . . . 12.4 110.528 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.838 ' HB2' ' HB3' ' A' ' 14' ' ' ASP . . . -74.62 153.81 38.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 9.4700000000000006 110.602 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.7 t -169.38 -58.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.975 -0.38 . . . . 7.0899999999999999 109.975 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.7 tp 178.74 -58.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.345 -0.843 . . . . 8.8100000000000005 109.044 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 56.56 -102.71 0.16 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.245 -0.889 . . . . 10.82 112.106 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -87.82 156.25 19.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.262 -0.426 . . . . 11.69 110.138 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -104.67 -2.4 25.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 11.81 111.142 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -112.17 21.25 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 11.779999999999999 110.987 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.517 ' HD2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -90.43 109.2 20.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.371 0.605 . . . . 15.99 111.139 178.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.75 -16.75 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 12.69 110.432 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -50.41 -65.07 0.62 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.049 0.452 . . . . 14.630000000000001 110.359 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.93 141.46 40.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.481 -0.781 . . . . 8.8900000000000006 109.408 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 71.4 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.959 -0.385 . . . . 9.1999999999999993 109.959 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.838 ' HB3' ' HB2' ' A' ' 2' ' ' ALA . 3.8 m-20 58.32 88.01 0.07 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.958 0.786 . . . . 8.5999999999999996 110.69 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 26.0 mmmt 61.16 -92.7 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.596 -0.729 . . . . 9.3100000000000005 111.152 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.422 ' C ' ' H ' ' A' ' 18' ' ' ALA . 72.0 mt -140.21 35.55 1.9 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.238 -0.653 . . . . 5.9800000000000004 109.238 178.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.403 ' O ' HG13 ' A' ' 128' ' ' VAL . 26.3 m 79.43 -23.28 0.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.092 -0.958 . . . . 2.98 110.487 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' HA ' HG21 ' A' ' 129' ' ' VAL . . . -104.5 153.78 20.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.174 -0.466 . . . . 1.8500000000000001 109.981 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 1.052 HG23 ' HD3' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -99.43 -63.46 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 114.095 1.146 . . . . 3.6800000000000002 114.095 -166.205 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 1.052 ' HD3' HG23 ' A' ' 19' ' ' ILE . 7.5 Cg_endo -101.86 -143.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.491 2.128 . . . . 2.52 114.042 -171.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.721 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 9.7 ttmt -168.13 -55.34 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.734 -0.666 . . . . 6.79 111.393 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.721 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 42.5 Cg_endo -101.02 95.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.056 2.504 . . . . 3.3799999999999999 113.5 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.626 ' HB3' ' O ' ' A' ' 48' ' ' THR . 10.3 mp0 -127.97 154.12 45.95 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.389 -2.448 . . . . 3.3900000000000001 104.389 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.782 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -112.1 173.2 15.31 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 117.057 -2.497 . . . . 1.0700000000000001 115.976 -169.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.663 ' O ' HG11 ' A' ' 45' ' ' VAL . 79.6 p -162.15 31.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.964 -1.495 . . . . 1.7 106.964 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.7 m -132.79 153.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.209 -1.36 . . . . 1.53 109.665 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.46 -43.89 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.782 0.676 . . . . 1.05 110.407 169.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -169.67 145.27 3.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 122.287 -0.258 . . . . 1.6899999999999999 110.518 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.427 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 96.5 t -119.05 132.74 68.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.387 -0.597 . . . . 1.8500000000000001 109.387 173.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.92 137.19 54.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.87 0.367 . . . . 1.8300000000000001 111.147 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.58 126.06 38.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.853 -0.612 . . . . 1.46 111.532 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.507 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -130.66 -131.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.774 -0.825 . . . . 1.9199999999999999 108.774 167.519 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.957 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.2 p-10 171.98 175.76 0.08 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.239 0.927 . . . . 2.8500000000000001 111.83 -171.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.7 p -156.39 92.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.379 0.609 . . . . 3.77 112.031 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.617 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 9.5 t30 67.92 -62.83 0.34 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.003 0.921 . . . . 3.3500000000000001 113.033 174.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.617 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 137.25 18.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.843 1.657 . . . . 6.21 110.511 -168.64 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.44 -45.14 10.21 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 105.112 -2.181 . . . . 1.9199999999999999 105.112 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.528 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 14.3 m -148.78 178.46 8.64 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 110.534 -3.03 . . . . 1.1299999999999999 106.33 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 33' ' ' ASP . 28.4 t -130.64 165.56 30.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.381 -0.97 . . . . 1.48 108.381 167.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.794 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 2.8 mt-10 -125.25 139.37 53.78 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.381 0.61 . . . . 1.1899999999999999 111.528 -172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.763 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.3 106.57 9.95 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.15 -0.932 . . . . 3.9399999999999999 109.746 -176.507 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.469 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 4.8 tt -88.72 111.8 22.41 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.445 -1.302 . . . . 1.4299999999999999 109.892 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.71 116.82 30.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.201 -0.909 . . . . 1.1100000000000001 109.65 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -83.35 131.62 35.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.453 -0.943 . . . . 3.1800000000000002 108.453 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.663 HG11 ' O ' ' A' ' 25' ' ' SER . 44.5 t -111.17 142.08 24.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.115 -0.948 . . . . 1.3999999999999999 110.92 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.7 m -131.79 99.45 4.77 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.006 0.431 . . . . 1.1100000000000001 109.905 167.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.782 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 62.2 t -82.46 127.9 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.576 -0.738 . . . . 1.8500000000000001 110.537 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.68 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.9 m -107.79 113.82 27.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.293 -0.632 . . . . 1.1000000000000001 109.293 176.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.848 ' HB3' HD22 ' A' ' 82' ' ' LEU . 29.3 p-10 -90.54 140.23 26.7 Favored Pre-proline 0 N--CA 1.461 0.117 0 O-C-N 123.864 0.727 . . . . 1.48 110.164 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.569 ' CG ' ' HG3' ' A' ' 20' ' ' PRO . 66.9 Cg_endo -96.36 6.22 1.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.891 3.061 . . . . 0.91000000000000003 115.399 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.717 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 24.4 t80 -97.18 -113.03 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.855 -0.738 . . . . 2.3100000000000001 110.08 -172.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.745 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 77.5 p 179.98 19.66 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 117.964 0.347 . . . . 1.8300000000000001 111.263 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -139.09 19.86 2.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.736 0.643 . . . . 2.0299999999999998 112.736 -168.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.825 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 31.7 t 57.79 96.57 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 111.955 0.354 . . . . 1.73 111.955 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.888 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -73.94 170.71 13.36 Favored Pre-proline 0 C--O 1.209 -1.055 0 N-CA-C 108.62 -0.881 . . . . 1.23 108.62 -172.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.54 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.0 Cg_endo -92.79 -61.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.797 1.665 . . . . 0.53000000000000003 113.935 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 79' ' ' PRO . 17.0 mm -125.95 154.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.217 -0.593 . . . . 1.9099999999999999 111.479 -166.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.635 ' SG ' HG21 ' A' ' 124' ' ' ILE . 26.4 m -145.16 176.43 9.52 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.083 0.944 . . . . 1.95 111.475 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.047 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 2.4 tm-20 -141.86 114.39 8.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.565 -1.652 . . . . 1.3600000000000001 109.885 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.516 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -103.31 121.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.387 1.089 . . . . 1.6499999999999999 112.307 173.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.731 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.41 109.66 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.107 -1.861 . . . . 1.02 109.74 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.659 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.0 p90 -114.06 122.82 48.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.141 0.496 . . . . 0.46000000000000002 110.129 -169.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 26.8 m -122.07 109.61 14.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.524 -0.762 . . . . 1.1699999999999999 109.586 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.484 ' CE1' HD23 ' A' ' 118' ' ' LEU . 97.9 m-85 -98.6 141.2 31.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.036 -0.529 . . . . 1.1799999999999999 110.707 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.414 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.3 m170 -131.94 145.74 51.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.64 -1.245 . . . . 1.72 107.64 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.901 ' HB3' HD21 ' A' ' 104' ' ' LEU . 47.9 t -109.98 -100.32 0.39 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.196 -1.002 . . . . 1.6599999999999999 111.025 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.71 -56.8 16.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.231 -0.655 . . . . 1.1200000000000001 109.231 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 18.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.589 -1.404 . . . . 0.39000000000000001 109.589 162.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -105.85 -156.56 0.58 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.738 -0.838 . . . . 2.4900000000000002 108.738 -175.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.16 94.98 4.78 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.709 0.686 . . . . 2.6099999999999999 110.098 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.878 ' HA ' HG23 ' A' ' 100' ' ' ILE . 2.8 mm -56.55 -39.25 61.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.904 -1.043 . . . . 1.1100000000000001 110.892 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.58 169.26 34.25 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.328 -0.939 . . . . 0.48999999999999999 111.458 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.659 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.08 164.63 15.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.668 0.734 . . . . 2.3999999999999999 111.028 173.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.16 167.89 34.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.885 -0.886 . . . . 0.52000000000000002 110.885 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.731 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.3 mtpt -130.43 131.5 45.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.026 -0.361 . . . . 2.3799999999999999 110.026 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.516 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -133.85 105.14 11.65 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.863 0.363 . . . . 1.47 110.483 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 11.9 Cg_exo -71.25 101.62 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.359 2.039 . . . . 0.81000000000000005 110.428 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.28 143.57 29.1 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.606 -0.516 . . . . 0.79000000000000004 109.606 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.708 ' HA ' HD12 ' A' ' 57' ' ' ILE . 32.5 Cg_exo -62.38 78.78 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.308 2.005 . . . . 0.91000000000000003 111.957 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.531 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 46.7 3.58 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.47999999999999998 112.197 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.888 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 92.9 p -73.55 119.23 17.49 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.361 -0.607 . . . . 0.85999999999999999 109.361 173.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.848 HD22 ' HB3' ' A' ' 49' ' ' ASN . 2.2 pt? -153.03 163.9 38.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 119.191 -1.004 . . . . 1.76 113.241 -164.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 54' ' ' SER . 50.5 mttm -16.49 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.756 -1.565 . . . . 2.4300000000000002 114.417 -168.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 165.5 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.608 -1.256 . . . . 1.29 107.608 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.745 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.5 pttt 42.32 52.08 4.62 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.197 0.935 . . . . 2.21 110.893 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.568 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.5 t70 -152.56 -166.94 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.288 -0.869 . . . . 0.64000000000000001 110.356 -173.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.481 ' HG3' ' HG1' ' A' ' 48' ' ' THR . 47.3 ttm -125.24 117.73 24.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.102 0.477 . . . . 2.04 110.944 -170.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.493 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -105.87 144.68 32.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.394 -0.821 . . . . 1.3300000000000001 110.113 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.75 129.17 35.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.26 0.553 . . . . 1.1100000000000001 110.927 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.604 HD21 HG13 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -135.25 174.18 10.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.246 -1.02 . . . . 1.45 108.246 -176.314 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.527 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 5.8 p-10 -142.72 139.48 31.12 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.736 0.698 . . . . 1.8100000000000001 112.059 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.582 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.5 mm -109.03 115.97 56.18 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.783 -0.821 . . . . 1.3999999999999999 108.783 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.472 ' O ' HG11 ' A' ' 94' ' ' VAL . 24.7 Cg_exo -28.76 -102.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.405 4.07 . . . . 1.0700000000000001 115.534 -173.169 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.794 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.88 95.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 O-C-N 122.266 -0.271 . . . . 1.1799999999999999 111.474 -175.8 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.494 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -128.67 104.8 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.012 1.486 . . . . 1.1699999999999999 115.012 -172.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -154.4 99.57 2.47 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.601 -0.687 . . . . 1.71 111.335 161.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.9 Cg_exo -51.78 134.65 48.32 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.014 1.809 . . . . 0.65000000000000002 111.572 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.528 ' H ' ' HA ' ' A' ' 38' ' ' SER . 52.7 t80 -54.93 -36.9 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 1.6899999999999999 111.635 -172.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 15.0 m -53.88 -30.97 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.377 . . . . 1.49 111.639 -177.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.878 HG23 ' HA ' ' A' ' 71' ' ' ILE . 10.1 mm -76.82 -56.0 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.431 -0.508 . . . . 1.21 110.983 -175.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.629 HD21 HD22 ' A' ' 104' ' ' LEU . 30.6 mt -53.84 -28.25 34.66 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.699 0.625 . . . . 1.6399999999999999 110.53 174.287 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -62.4 -42.45 99.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.413 -1.267 . . . . 1.2 109.206 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.402 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.6 m-80 -74.66 -58.26 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.171 0.434 . . . . 0.81999999999999995 112.171 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.901 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.8 pp -60.85 -48.83 80.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.665 0.987 . . . . 1.22 113.665 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.529 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -66.6 -25.59 66.69 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.852 0.834 . . . . 1.1899999999999999 109.574 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.402 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.1 ttp180 -68.06 -48.82 64.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.554 -1.203 . . . . 2.2200000000000002 110.451 172.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.627 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 30.1 t70 -81.36 -54.31 5.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.649 0.738 . . . . 0.80000000000000004 112.164 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.535 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.9 t -87.33 -25.64 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.726 -0.609 . . . . 1.5 110.069 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.03 -20.84 80.13 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.717 -0.754 . . . . 0.38 111.309 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.627 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -49.99 -48.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.732 -1.581 . . . . 1.6599999999999999 106.732 165.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' N ' HG11 ' A' ' 110' ' ' VAL . 30.3 t70 -69.02 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.38 -0.827 . . . . 1.8700000000000001 109.992 164.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 178.41 -48.19 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.187 0.44 . . . . 1.3500000000000001 112.187 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -92.76 124.13 36.54 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.012 -0.366 . . . . 2.1499999999999999 110.012 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.619 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -111.7 154.24 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.846 -0.798 . . . . 1.1599999999999999 108.846 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 152.78 19.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.985 -0.746 . . . . 2.1099999999999999 108.985 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 57.4 m-85 -140.52 162.73 34.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.915 -0.772 . . . . 0.96999999999999997 108.915 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.748 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.6 tt0 -151.05 133.57 15.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.947 0.403 . . . . 0.80000000000000004 110.221 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.615 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.6 OUTLIER -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.301 -0.629 . . . . 1.9199999999999999 109.301 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.649 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.75 103.31 10.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.165 -0.68 . . . . 0.63 109.165 176.613 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.882 HG22 HG23 ' A' ' 136' ' ' ILE . 8.4 tp -110.01 120.41 61.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 1.49 110.934 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.94 131.03 10.52 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.196 -0.762 . . . . 0.26000000000000001 111.196 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.699 ' O ' ' HA ' ' A' ' 133' ' ' THR . 7.5 mp -108.23 106.22 16.3 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 120.926 0.393 . . . . 1.77 111.055 -176.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.047 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 81.4 m -109.0 96.6 6.43 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.314 -0.857 . . . . 1.0700000000000001 109.478 173.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.635 HG21 ' SG ' ' A' ' 58' ' ' CYS . 19.5 pt -112.37 131.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.469 -0.492 . . . . 1.6699999999999999 110.918 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.83 105.84 9.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.377 -0.601 . . . . 1.52 109.377 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.728 HD23 HG21 ' A' ' 55' ' ' ILE . 83.3 mt -106.52 160.63 25.56 Favored Pre-proline 0 C--O 1.22 -0.456 0 O-C-N 124.81 1.318 . . . . 1.9299999999999999 109.971 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.97 -34.34 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.832 1.688 . . . . 0.98999999999999999 113.434 176.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 17' ' ' THR . 21.5 t -73.34 -57.88 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.316 0.487 . . . . 1.6699999999999999 112.316 -171.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.768 HG21 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -96.19 -7.21 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 122.046 0.927 . . . . 1.9099999999999999 109.834 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.56 -28.55 2.72 Favored Glycine 0 C--N 1.311 -0.817 0 CA-C-N 113.626 -1.624 . . . . 1.05 111.16 -171.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.667 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.5 pt-20 -162.83 155.83 19.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.473 -0.936 . . . . 1.1599999999999999 108.473 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.454 ' HB2' HD12 ' A' ' 126' ' ' LEU . 31.2 t80 -143.04 122.19 12.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.222 -0.659 . . . . 2.2799999999999998 109.222 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.699 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.8 m -115.06 102.09 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.139 0.495 . . . . 1.8899999999999999 111.763 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.08 144.36 50.21 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.805 -0.634 . . . . 1.26 110.015 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.91 164.1 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.885 1.723 . . . . 0.58999999999999997 113.162 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.882 HG23 HG22 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -156.22 158.53 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.734 -1.21 . . . . 1.1399999999999999 107.734 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.593 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 83.0 p -140.59 152.58 45.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.627 -0.429 . . . . 1.28 111.827 -172.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -140.84 102.69 4.34 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.553 -1.276 . . . . 1.3400000000000001 107.553 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.748 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -114.6 143.99 44.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.1 -0.5 . . . . 2.2000000000000002 109.986 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.32 151.61 21.62 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.595 -0.812 . . . . 0.56000000000000005 112.017 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -106.3 130.36 54.16 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.941 -0.763 . . . . 2.1000000000000001 108.941 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.89 174.1 4.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.24 -1.022 . . . . 1.51 108.24 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.422 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 3.7 mppt? -65.6 163.82 15.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 3.9300000000000002 112.154 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.619 HD12 HD11 ' A' ' 114' ' ' ILE . 22.7 tp -55.49 131.23 70.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 114.903 -1.044 . . . . 1.9299999999999999 111.076 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.571 ' HD2' HD12 ' A' ' 144' ' ' LEU . 40.9 Cg_endo -67.11 163.07 35.5 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.093 2.529 . . . . 0.81000000000000005 112.869 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.2 m -57.03 118.31 4.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 2.3700000000000001 110.47 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' HB2' ' H ' ' A' ' 151' ' ' PHE . 8.6 p90 -124.02 -22.45 4.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.158 -0.474 . . . . 3.1899999999999999 112.03 -172.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.415 ' HB2' ' HD2' ' A' ' 150' ' ' PHE . 35.1 mmtp 57.19 29.23 16.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.62 0.247 . . . . 4.1500000000000004 111.311 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 73.33 15.03 4.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.774 0.83 . . . . 4.2800000000000002 111.238 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.486 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 94.1 m-85 -102.23 -48.82 4.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.769 -0.65 . . . . 3.23 110.424 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.495 ' H ' ' HB2' ' A' ' 147' ' ' PHE . 96.2 m-85 . . . . . 0 C--O 1.247 0.949 0 O-C-N 124.931 1.394 . . . . 4.9000000000000004 109.819 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.388 -0.227 . . . . 12.4 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.53 -163.51 0.21 Allowed 'General case' 0 C--O 1.234 0.279 0 O-C-N 123.888 0.743 . . . . 9.4700000000000006 112.087 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.622 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 34.6 t -91.44 154.88 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.727 -0.67 . . . . 7.0899999999999999 109.782 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 158.42 16.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.314 -0.624 . . . . 8.8100000000000005 109.314 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 mp 69.84 -66.35 0.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.641 0.588 . . . . 10.82 111.942 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -91.01 -25.15 19.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.31 -0.244 . . . . 11.69 111.245 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 3' ' ' SER . 68.1 mttm 64.82 5.35 2.79 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.907 0.706 . . . . 11.81 112.907 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.19 15.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.45 0.643 . . . . 11.779999999999999 110.325 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -84.96 -11.48 55.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 15.99 110.661 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -137.15 140.55 41.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.226 -0.443 . . . . 12.69 110.137 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -78.74 94.16 5.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.48 . . . . 14.630000000000001 110.3 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.78 149.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.818 -0.628 . . . . 8.8900000000000006 111.196 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.31 -26.41 3.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.726 -0.67 . . . . 9.1999999999999993 110.25 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.38 -15.9 44.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 8.5999999999999996 110.263 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.59 -176.39 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 9.3100000000000005 109.642 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 1.7 pt? -136.57 91.56 2.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.182 0.515 . . . . 5.9800000000000004 110.339 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 m -74.42 84.75 1.98 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.998 -0.547 . . . . 2.98 109.986 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.54 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . . . -175.24 176.59 2.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.67 -0.695 . . . . 1.8500000000000001 110.598 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.674 HD13 ' HG3' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -84.65 156.15 61.84 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.497 -0.774 . . . . 3.6800000000000002 110.373 -175.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.89 -64.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.696 2.264 . . . . 2.52 112.844 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 24.0 tptm -154.52 102.5 2.37 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 6.79 110.776 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.72 ' HB3' ' HG3' ' A' ' 50' ' ' PRO . 98.6 Cg_endo -93.68 82.01 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.399 2.733 . . . . 3.3799999999999999 112.2 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.617 ' HA ' HD21 ' A' ' 122' ' ' LEU . 8.4 pt-20 -122.17 119.01 30.02 Favored 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 119.453 -0.899 . . . . 3.3900000000000001 110.812 -169.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.674 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . 172.73 119.49 0.53 Allowed Glycine 0 N--CA 1.408 -3.174 0 CA-C-N 114.47 -1.241 . . . . 1.0700000000000001 111.939 170.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.701 ' HB2' HD12 ' A' ' 122' ' ' LEU . 17.3 m -171.1 32.33 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.895 0.855 . . . . 1.7 108.894 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.3 m -133.29 148.29 31.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.863 -1.062 . . . . 1.53 109.969 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -169.76 -44.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.46 0.475 . . . . 1.05 111.793 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -157.4 153.59 27.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.77 -0.372 . . . . 1.6899999999999999 111.183 -174.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.17 120.31 8.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.646 -0.502 . . . . 1.8500000000000001 109.646 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -113.96 112.15 22.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 1.8300000000000001 111.476 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.859 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.2 tm? -72.87 139.02 46.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.963 -0.562 . . . . 1.46 109.99 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.554 ' H ' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -141.99 -100.16 0.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.255 0.835 . . . . 1.9199999999999999 113.255 -176.305 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.528 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 18.1 m-20 -93.22 178.71 5.65 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.911 -0.493 . . . . 2.8500000000000001 109.809 -154.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.783 HG21 HG23 ' A' ' 39' ' ' VAL . 48.8 t -152.97 -38.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.54 0.686 . . . . 3.77 110.455 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.513 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 4.9 t30 71.59 -75.04 0.08 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.142 -1.39 . . . . 3.3500000000000001 108.617 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 174.21 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 123.847 0.717 . . . . 6.21 111.16 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.46 -25.54 1.02 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.408 0.623 . . . . 1.9199999999999999 109.833 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 6.3 t -166.94 128.88 1.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.235 -0.893 . . . . 1.1299999999999999 111.57 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.783 HG23 HG21 ' A' ' 34' ' ' VAL . 24.2 t -77.65 156.1 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.566 -0.901 . . . . 1.48 108.566 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.893 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -137.17 145.64 43.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 119.516 -0.874 . . . . 1.1899999999999999 109.368 -173.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.923 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.7 p90 -143.11 141.53 31.25 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.306 -0.958 . . . . 3.9399999999999999 112.575 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.407 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.1 tm? -82.45 110.88 17.97 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.425 -0.954 . . . . 1.4299999999999999 108.425 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 92' ' ' ILE . . . -91.5 100.33 13.11 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 1.1100000000000001 109.016 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 23.8 ttmm -83.58 126.0 32.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.626 0.727 . . . . 3.1800000000000002 109.109 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.611 HG11 ' CA ' ' A' ' 25' ' ' SER . 37.4 t -109.51 144.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.725 -1.125 . . . . 1.3999999999999999 110.481 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 14.7 m -128.85 97.4 4.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.576 -0.898 . . . . 1.1100000000000001 108.576 165.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.674 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -86.96 130.69 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.676 0.751 . . . . 1.8500000000000001 111.173 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.597 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 32.1 m -116.88 114.99 24.66 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.344 -1.298 . . . . 1.1000000000000001 109.447 -173.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.757 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.3 t30 -90.76 133.21 32.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 108.108 -1.071 . . . . 1.48 108.108 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.72 ' HG3' ' HB3' ' A' ' 22' ' ' PRO . 31.3 Cg_endo -90.9 8.29 3.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.103 2.536 . . . . 0.91000000000000003 114.169 -174.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.586 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 49.2 t80 -119.0 139.14 52.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.949 -0.76 . . . . 2.3100000000000001 108.949 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.443 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.7 p -79.13 37.81 0.33 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.659 0.614 . . . . 1.8300000000000001 112.659 -164.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -146.25 130.58 17.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.271 -0.422 . . . . 2.0299999999999998 110.056 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.559 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 m -43.5 100.76 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 124.116 0.966 . . . . 1.73 112.719 172.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.983 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.8 pt -75.55 171.97 10.49 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.431 -0.951 . . . . 1.23 108.431 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.503 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 8.0 Cg_endo -87.98 -59.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.498 1.465 . . . . 0.53000000000000003 114.026 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.799 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 80.0 mt -137.38 155.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.669 0.618 . . . . 1.9099999999999999 112.669 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.59 ' HB3' HG23 ' A' ' 124' ' ' ILE . 25.6 p -138.0 -178.99 5.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.731 0.777 . . . . 1.95 111.211 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.076 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.2 tt0 -141.78 115.5 9.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.99 -1.459 . . . . 1.3600000000000001 109.982 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.692 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.1 109.93 23.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.697 -1.592 . . . . 1.6499999999999999 109.951 173.542 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 8.5 m -110.97 102.58 11.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.87 -1.514 . . . . 1.02 108.586 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.786 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 3.8 p90 -109.79 122.33 47.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.506 . . . . 0.46000000000000002 109.733 -168.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.761 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 93.9 m -121.03 104.91 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.511 -0.768 . . . . 1.1699999999999999 109.4 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.523 ' CE1' HD21 ' A' ' 118' ' ' LEU . 98.9 m-85 -98.14 140.99 31.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.952 -0.567 . . . . 1.1799999999999999 111.148 -174.075 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -132.4 145.23 51.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.636 -1.246 . . . . 1.72 107.636 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.767 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.9 t -110.75 -98.03 0.41 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.317 -0.953 . . . . 1.6599999999999999 111.062 172.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.95 -59.75 4.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.386 -0.598 . . . . 1.1200000000000001 109.386 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.87 18.05 0.1 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.478 -1.449 . . . . 0.39000000000000001 109.478 165.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.427 ' CZ ' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -111.04 -166.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.119 -0.697 . . . . 2.4900000000000002 109.119 -177.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -108.16 98.49 8.03 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.919 0.866 . . . . 2.6099999999999999 109.689 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.951 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.9 mm -64.57 -41.6 92.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.976 -1.465 . . . . 1.1100000000000001 111.276 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 164.75 38.25 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.217 -0.992 . . . . 0.48999999999999999 111.266 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.786 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.38 156.84 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.482 0.641 . . . . 2.3999999999999999 110.991 172.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 165.27 160.77 13.02 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.722 -0.951 . . . . 0.52000000000000002 110.722 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.402 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 3.7 ptmm? -136.95 130.74 32.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.968 0.414 . . . . 2.3799999999999999 110.0 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.0 mt -134.47 120.13 14.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 1.47 110.375 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.87 115.34 3.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.328 2.019 . . . . 0.81000000000000005 110.537 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.12 143.35 42.33 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.698 -0.852 . . . . 0.79000000000000004 108.698 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -51.86 90.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.804 2.336 . . . . 0.91000000000000003 112.16 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.799 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -81.99 24.66 4.49 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.47999999999999998 112.585 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.983 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 70.7 p -73.81 117.73 15.93 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.438 -0.579 . . . . 0.85999999999999999 109.438 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.631 HD23 HD21 ' A' ' 49' ' ' ASN . 1.2 pt? -149.41 -171.33 3.86 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.096 -1.442 . . . . 1.76 114.264 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 60.5 mttm -44.77 -96.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.912 -1.04 . . . . 2.4300000000000002 113.54 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 175.5 105.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.059 -1.089 . . . . 1.29 108.059 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.757 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.9 ptpt 41.77 50.44 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.339 1.024 . . . . 2.21 110.842 -170.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 3.5 t0 -143.63 179.93 6.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 110.122 -170.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.43 ' CG ' ' HB3' ' A' ' 46' ' ' SER . 54.3 ttp -107.74 119.13 38.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.609 -0.723 . . . . 2.04 110.63 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.558 HG22 HG13 ' A' ' 47' ' ' VAL . 5.1 t -106.27 142.82 35.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.05 -0.523 . . . . 1.3300000000000001 109.633 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 123.77 30.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.549 0.69 . . . . 1.1100000000000001 110.608 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.419 HD22 ' N ' ' A' ' 91' ' ' ASP . 9.0 tt -124.61 160.73 27.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.897 -1.149 . . . . 1.45 107.897 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.419 ' N ' HD22 ' A' ' 90' ' ' LEU . 11.0 m-20 -134.05 122.37 22.88 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.627 -0.67 . . . . 1.8100000000000001 111.407 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 43' ' ' ALA . 32.8 mm -92.56 143.27 26.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 1.3999999999999999 109.644 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.41 ' HD2' HG23 ' A' ' 92' ' ' ILE . 75.8 Cg_exo -51.91 -172.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.924 2.416 . . . . 1.0700000000000001 113.266 173.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.923 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 7.1 m -114.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.72 -0.673 . . . . 1.1799999999999999 110.549 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 95' ' ' VAL . 4.7 p -125.76 102.51 10.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.144 1.535 . . . . 1.1699999999999999 115.144 -161.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.675 HG21 ' HG ' ' A' ' 101' ' ' LEU . 2.5 p -152.24 102.74 2.78 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.157 -0.474 . . . . 1.71 111.045 163.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 74.1 Cg_exo -48.89 131.61 25.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.721 1.614 . . . . 0.65000000000000002 111.398 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.521 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 4.7 t80 -49.43 -35.0 17.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.734 -0.666 . . . . 1.6899999999999999 111.081 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.511 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 12.1 t -62.92 -30.19 71.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 1.49 112.237 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.951 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.5 mm -76.78 -54.27 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 121.749 -0.594 . . . . 1.21 110.686 -173.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.003 HD21 HD23 ' A' ' 104' ' ' LEU . 36.6 mt -53.84 -26.91 26.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.439 0.638 . . . . 1.6399999999999999 110.518 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.511 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.0 t80 -65.1 -41.45 94.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.466 -1.243 . . . . 1.2 108.877 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.483 ' HA ' HH21 ' A' ' 106' ' ' ARG . 24.8 m-80 -74.27 -57.88 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.81999999999999995 112.263 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 1.003 HD23 HD21 ' A' ' 101' ' ' LEU . 2.1 pp -56.91 -49.66 74.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.23 0.826 . . . . 1.22 113.23 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.55 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.16 -25.7 68.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.883 0.849 . . . . 1.1899999999999999 110.113 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.483 HH21 ' HA ' ' A' ' 103' ' ' ASN . 6.6 ttp180 -69.62 -50.77 41.19 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.655 -1.157 . . . . 2.2200000000000002 110.511 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.542 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 13.6 t70 -81.74 -54.83 5.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.78 0.8 . . . . 0.80000000000000004 111.94 -175.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -84.51 -27.67 6.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.594 -0.692 . . . . 1.5 109.964 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.787 ' HA3' HD22 ' A' ' 144' ' ' LEU . . . -73.01 -19.28 79.54 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.308 -0.948 . . . . 0.38 111.457 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.542 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -51.86 -44.89 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.794 -1.558 . . . . 1.6599999999999999 106.794 166.23 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m-20 -69.77 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.529 -0.76 . . . . 1.8700000000000001 110.025 161.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.788 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.1 p-90 176.91 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.687 0.617 . . . . 1.3500000000000001 111.715 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.06 129.76 42.02 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 122.304 -0.248 . . . . 2.1499999999999999 110.581 -174.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.566 HD13 HD23 ' A' ' 144' ' ' LEU . 3.0 mp -117.7 159.19 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.834 0.35 . . . . 1.1599999999999999 110.415 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 9.3 p-10 -102.96 153.34 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.982 -0.377 . . . . 2.1099999999999999 109.982 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.62 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.8 m-85 -140.09 165.91 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.869 -0.789 . . . . 0.96999999999999997 108.869 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.628 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 35.4 tt0 -156.16 131.98 9.74 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.007 -0.368 . . . . 0.80000000000000004 110.007 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.639 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -103.69 123.85 47.78 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.006 -0.739 . . . . 1.9199999999999999 109.006 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.761 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 8.4 tp60 -108.28 99.32 8.74 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.672 -0.862 . . . . 0.63 108.672 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.692 HD11 HG22 ' A' ' 60' ' ' ILE . 5.3 tp -106.58 119.36 55.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.259 0.552 . . . . 1.49 110.834 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.413 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.53 127.05 8.3 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.879 -0.888 . . . . 0.26000000000000001 110.879 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.703 ' O ' ' HA ' ' A' ' 133' ' ' THR . 0.4 OUTLIER -98.42 104.32 16.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.457 0.303 . . . . 1.77 111.335 -174.869 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.076 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 57.9 m -109.83 95.12 5.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.044 -0.526 . . . . 1.0700000000000001 109.584 172.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 22' ' ' PRO . 11.5 pt -112.75 128.61 69.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 120.234 -0.586 . . . . 1.6699999999999999 110.28 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.858 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 22.7 t70 -81.88 106.02 13.47 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.796 -0.816 . . . . 1.52 108.796 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.969 HD23 HG21 ' A' ' 55' ' ' ILE . 29.1 mt -104.82 176.35 1.78 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 114.522 -1.217 . . . . 1.9299999999999999 109.486 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.586 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 9.9 Cg_exo -76.18 -41.93 0.44 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.762 1.642 . . . . 0.98999999999999999 113.206 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.6 t -59.62 -58.93 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.06 0.763 . . . . 1.6699999999999999 113.06 -168.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.54 ' CG2' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t -109.8 -8.5 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.894 1.33 . . . . 1.9099999999999999 108.517 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.692 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 88.38 -143.24 17.8 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 112.413 -2.176 . . . . 1.05 108.132 -164.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.858 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 -60.74 128.9 38.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.111 0.482 . . . . 1.1599999999999999 110.02 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.412 ' O ' ' HA ' ' A' ' 123' ' ' THR . 15.9 t80 -124.31 145.33 49.48 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.826 -0.805 . . . . 2.2799999999999998 108.826 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.703 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 63.1 m -121.86 109.42 14.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.917 0.389 . . . . 1.8899999999999999 112.042 -173.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -127.33 144.04 49.34 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.021 -0.733 . . . . 1.26 109.021 171.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.413 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 90.0 Cg_endo -93.31 162.45 2.48 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.863 1.709 . . . . 0.58999999999999997 113.341 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.427 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.14 167.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.935 -1.135 . . . . 1.1399999999999999 107.935 175.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -133.07 148.67 52.19 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.791 -0.364 . . . . 1.28 111.258 -169.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.1 t -138.34 103.0 4.79 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.683 -1.228 . . . . 1.3400000000000001 107.683 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 14.4 ptmt -126.88 156.25 41.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.048 -0.524 . . . . 2.2000000000000002 111.184 -171.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.92 150.78 17.29 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.594 -0.812 . . . . 0.56000000000000005 111.634 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.623 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.5 mt-10 -98.71 124.88 43.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.741 -0.837 . . . . 2.1000000000000001 108.741 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.24 165.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.07 -1.085 . . . . 1.51 108.07 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -67.45 178.2 1.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.496 0.665 . . . . 3.9300000000000002 112.289 -171.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.788 ' HG ' ' O ' ' A' ' 112' ' ' TRP . 5.9 mt -54.05 131.08 59.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.743 -1.117 . . . . 1.9299999999999999 111.231 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.515 ' HD2' HD23 ' A' ' 144' ' ' LEU . 32.9 Cg_endo -63.72 173.52 4.55 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.16 2.573 . . . . 0.81000000000000005 112.021 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -49.76 98.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.927 0.394 . . . . 2.3700000000000001 111.298 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.484 ' HD1' ' O ' ' A' ' 145' ' ' PRO . 16.0 p90 -124.21 149.28 46.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 3.1899999999999999 110.501 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -172.8 76.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.615 . . . . 4.1500000000000004 109.589 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 69.27 4.8 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.587 -0.733 . . . . 4.2800000000000002 111.355 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -86.34 -38.32 17.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 3.23 108.847 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.7 p90 . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.531 -1.213 . . . . 4.9000000000000004 108.821 174.774 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.815 0.341 . . . . 12.4 110.161 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.922 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . . . -77.84 0.22 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 9.4700000000000006 112.03 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.657 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 3.9 p -60.28 -53.78 53.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.156 -0.475 . . . . 7.0899999999999999 111.04 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.5 -29.6 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 8.8100000000000005 110.551 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.37 19.42 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.412 . . . . 10.82 111.771 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.922 ' HB2' ' HA ' ' A' ' 2' ' ' ALA . 25.9 t70 -90.86 -37.74 13.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.096 0.474 . . . . 11.69 110.576 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.81 176.18 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.862 -0.608 . . . . 11.81 110.156 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 69.2 -63.38 0.37 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.831 0.707 . . . . 11.779999999999999 111.205 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 65.79 15.24 9.97 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.995 0.518 . . . . 15.99 110.965 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -102.21 134.91 44.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.687 -0.688 . . . . 12.69 109.757 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.96 78.13 5.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.959 0.409 . . . . 14.630000000000001 110.308 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.62 -68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 8.8900000000000006 110.722 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.33 31.65 0.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 9.1999999999999993 110.236 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.419 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 24.1 m-20 61.72 21.14 11.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.715 -0.675 . . . . 8.5999999999999996 110.991 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -145.78 142.63 29.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.812 -0.631 . . . . 9.3100000000000005 109.772 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 tp -175.01 -57.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.149 -0.685 . . . . 5.9800000000000004 109.149 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -112.96 -48.07 3.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.858 -0.61 . . . . 2.98 110.237 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.716 ' HA ' HG21 ' A' ' 129' ' ' VAL . . . -141.36 -164.59 1.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.282 -0.417 . . . . 1.8500000000000001 111.196 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.631 HG22 ' HG ' ' A' ' 126' ' ' LEU . 2.4 pp -93.8 168.28 12.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 3.6800000000000002 111.084 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.618 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 17.3 Cg_exo -66.93 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 2.52 113.938 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 64.5 tttp 173.86 -53.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.416 0.525 . . . . 6.79 112.416 -171.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.618 ' HD2' ' HB2' ' A' ' 20' ' ' PRO . 86.9 Cg_endo -78.25 65.08 8.48 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.005 1.803 . . . . 3.3799999999999999 113.298 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.484 ' CG ' ' HB3' ' A' ' 50' ' ' PRO . 5.6 mp0 -125.01 132.26 53.27 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 104.61 -2.367 . . . . 3.3900000000000001 104.61 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -112.14 -172.85 19.1 Favored Glycine 0 C--O 1.22 -0.753 0 C-N-CA 118.578 -1.772 . . . . 1.0700000000000001 116.094 -159.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.644 ' OG ' HD13 ' A' ' 122' ' ' LEU . 96.2 p -168.99 37.26 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.623 1.169 . . . . 1.7 107.979 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' SER . 4.5 m -134.02 151.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.512 -1.222 . . . . 1.53 110.342 -169.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -167.58 -44.33 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.416 0.447 . . . . 1.05 111.96 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -160.88 164.08 31.52 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.324 0.511 . . . . 1.6899999999999999 111.313 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.07 135.62 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.284 -0.635 . . . . 1.8500000000000001 109.284 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -129.0 135.64 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.648 0.261 . . . . 1.8300000000000001 111.249 -169.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.496 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.6 tm? -101.28 139.43 36.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.593 -0.276 . . . . 1.46 111.371 -172.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.492 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -144.34 -90.81 0.11 Allowed 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 114.08 1.141 . . . . 1.9199999999999999 114.08 177.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.818 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.89 179.52 5.96 Favored 'General case' 0 C--O 1.204 -1.334 0 O-C-N 121.587 -0.696 . . . . 2.8500000000000001 111.404 -155.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 38' ' ' SER . 6.2 p -168.16 -43.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 112.164 0.431 . . . . 3.77 112.164 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.401 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 44.2 m-80 67.1 -81.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 3.3500000000000001 109.183 -170.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.12 13.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.652 -0.704 . . . . 6.21 110.178 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.465 ' O ' ' HB3' ' A' ' 98' ' ' TYR . 8.7 p-10 -132.95 -42.3 0.9 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.321 -0.854 . . . . 1.9199999999999999 110.257 -172.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.843 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 t -154.83 117.68 4.37 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.364 1.078 . . . . 1.1299999999999999 112.351 -169.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 1.033 HG21 HD13 ' A' ' 101' ' ' LEU . 46.2 t -73.11 155.42 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.636 -1.62 . . . . 1.48 109.08 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.99 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 96.8 mt-10 -116.9 134.25 55.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 118.936 -1.106 . . . . 1.1899999999999999 112.383 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.8 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.36 105.13 10.61 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.905 -1.043 . . . . 3.9399999999999999 110.718 -175.836 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.489 ' N ' HG13 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -81.44 111.58 17.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.341 -0.985 . . . . 1.4299999999999999 108.341 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.672 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -97.98 117.34 32.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.551 0.691 . . . . 1.1100000000000001 110.904 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.681 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -84.8 120.64 26.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.214 -0.903 . . . . 3.1800000000000002 108.711 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG11 ' O ' ' A' ' 25' ' ' SER . 54.2 t -111.11 137.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.643 -0.708 . . . . 1.3999999999999999 111.033 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.8 m -130.5 100.07 5.21 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.771 -0.372 . . . . 1.1100000000000001 110.158 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 61.0 t -83.47 130.5 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.938 -0.574 . . . . 1.8500000000000001 110.737 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.462 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 4.3 m -104.74 122.69 46.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.743 -0.383 . . . . 1.1000000000000001 110.3 176.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.756 HD21 HD22 ' A' ' 82' ' ' LEU . 13.9 t-20 -88.17 133.52 36.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.86 1.35 . . . . 1.48 109.533 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.484 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 74.5 Cg_endo -88.92 -17.02 2.15 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.105 2.537 . . . . 0.91000000000000003 115.746 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.732 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.2 t80 -98.42 -100.46 0.21 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.915 -1.114 . . . . 2.3100000000000001 111.386 -165.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.459 ' CB ' ' HD2' ' A' ' 85' ' ' LYS . 48.5 t -174.0 29.8 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.551 0.691 . . . . 1.8300000000000001 109.788 171.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -147.92 133.18 18.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 2.0299999999999998 110.823 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -40.68 101.93 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.814 0 O-C-N 124.376 1.047 . . . . 1.73 112.194 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.712 HG22 HD13 ' A' ' 126' ' ' LEU . 7.6 pt -78.93 121.73 83.74 Favored Pre-proline 0 CA--C 1.5 -0.953 0 C-N-CA 120.071 -0.652 . . . . 1.23 109.5 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.921 ' HB2' HD13 ' A' ' 57' ' ' ILE . 28.1 Cg_endo -61.09 -56.5 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.174 1.916 . . . . 0.53000000000000003 113.51 -157.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.921 HD13 ' HB2' ' A' ' 56' ' ' PRO . 4.2 mp -135.02 156.27 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.849 -0.74 . . . . 1.9099999999999999 111.026 -173.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.67 ' HB3' HG21 ' A' ' 124' ' ' ILE . 28.7 p -145.04 178.43 8.05 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.386 1.089 . . . . 1.95 111.856 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.141 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.9 tt0 -131.15 113.84 14.38 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.129 -1.85 . . . . 1.3600000000000001 109.046 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.503 ' CD1' ' HB ' ' A' ' 76' ' ' ILE . 0.8 OUTLIER -98.9 110.62 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.515 1.15 . . . . 1.6499999999999999 110.151 169.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.435 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 79.9 p -111.5 107.12 16.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.051 -1.886 . . . . 1.02 108.228 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.537 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.1 p90 -113.92 132.6 55.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.6 0.714 . . . . 0.46000000000000002 110.222 -168.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.462 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 33.6 m -131.6 109.75 10.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.433 -1.258 . . . . 1.1699999999999999 108.717 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.422 ' CE1' HD23 ' A' ' 118' ' ' LEU . 94.5 m-85 -97.7 143.08 28.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.691 -0.485 . . . . 1.1799999999999999 109.691 -175.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.489 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -129.64 143.37 50.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.903 -0.777 . . . . 1.72 108.903 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.759 ' CB ' HD21 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -101.3 -114.79 0.19 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.038 -0.528 . . . . 1.6599999999999999 111.471 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.98 -52.49 65.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.573 -0.899 . . . . 1.1200000000000001 108.573 -174.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.74 20.74 0.15 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.65 -1.38 . . . . 0.39000000000000001 109.65 164.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 6.2 ptp180 -117.86 -169.21 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.232 -0.655 . . . . 2.4900000000000002 109.232 -174.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.422 ' CD ' ' HZ1' ' A' ' 73' ' ' LYS . 32.4 tt0 -107.71 98.33 7.94 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.325 0.583 . . . . 2.6099999999999999 109.741 -166.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.753 ' HA ' HG22 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -60.86 -42.96 94.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.404 -1.271 . . . . 1.1100000000000001 112.19 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.38 154.86 13.18 Favored Glycine 0 C--O 1.219 -0.789 0 C-N-CA 120.339 -0.934 . . . . 0.48999999999999999 111.686 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.537 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 ptmt -158.75 160.29 36.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.935 0.868 . . . . 2.3999999999999999 112.381 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.02 168.39 34.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.52000000000000002 111.545 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -127.8 133.35 49.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.944 -0.391 . . . . 2.3799999999999999 109.944 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.503 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 73.8 mt -139.14 112.45 8.05 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.502 -0.317 . . . . 1.47 110.884 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.79 113.53 3.68 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.117 1.878 . . . . 0.81000000000000005 110.938 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -133.92 144.97 53.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.47 -0.196 . . . . 0.79000000000000004 110.47 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.72 94.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.3 . . . . 0.91000000000000003 112.677 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -84.52 21.19 11.22 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.808 -0.633 . . . . 0.47999999999999998 112.586 175.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.654 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 96.2 p -70.25 118.98 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.452 -0.573 . . . . 0.85999999999999999 109.452 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.756 HD22 HD21 ' A' ' 49' ' ' ASN . 1.9 pt? -141.98 -164.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 120.145 -0.622 . . . . 1.76 112.393 -164.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.457 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 94.4 mttt -45.63 -89.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.038 0.755 . . . . 2.4300000000000002 113.038 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.65 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 156.5 111.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.437 -1.319 . . . . 1.29 107.437 -168.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.732 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 8.2 ptmm? 45.54 46.07 10.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.003 0.814 . . . . 2.21 111.5 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.412 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.2 t70 -155.05 -172.01 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.331 -0.849 . . . . 0.64000000000000001 109.501 -173.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.429 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 43.3 ttp -114.79 127.57 55.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.106 0.479 . . . . 2.04 110.831 -172.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.2 t -109.53 142.41 40.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.472 -0.785 . . . . 1.3300000000000001 110.025 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 108.41 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.38 0.61 . . . . 1.1100000000000001 110.949 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.784 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.7 tp -100.64 174.89 5.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.094 -0.957 . . . . 1.45 109.131 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.784 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 21.4 t70 -141.71 121.6 13.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.769 -0.372 . . . . 1.8100000000000001 110.638 -173.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.672 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 24.5 mm -107.88 141.92 24.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.3 -0.409 . . . . 1.3999999999999999 110.324 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.452 ' HD2' HG21 ' A' ' 92' ' ' ILE . 61.0 Cg_exo -54.62 -152.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.815 3.01 . . . . 1.0700000000000001 113.656 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.99 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.5 m -136.76 94.73 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 112.058 0.392 . . . . 1.1799999999999999 112.058 -165.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -125.38 106.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 113.841 1.052 . . . . 1.1699999999999999 113.841 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.668 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 9.6 t -147.17 102.08 3.82 Favored Pre-proline 0 C--O 1.219 -0.52 0 CA-C-N 115.941 -0.572 . . . . 1.71 110.318 168.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 31.9 Cg_exo -57.1 124.38 16.08 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 CA-C-N 120.495 1.212 . . . . 0.65000000000000002 110.757 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.508 ' HE1' ' HB3' ' A' ' 150' ' ' PHE . 1.0 OUTLIER -54.03 -29.91 45.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.019 -0.537 . . . . 1.6899999999999999 111.232 -175.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.508 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.1 m -53.0 -33.12 50.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 1.49 111.874 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.753 HG22 ' HA ' ' A' ' 71' ' ' ILE . 12.6 mm -77.65 -54.58 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.528 -0.305 . . . . 1.21 111.28 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 1.033 HD13 HG21 ' A' ' 39' ' ' VAL . 11.3 mt -51.03 -26.92 6.8 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.504 0.669 . . . . 1.6399999999999999 110.848 172.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.508 ' HB3' ' O ' ' A' ' 99' ' ' SER . 54.8 t80 -63.99 -46.48 84.39 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.391 -1.277 . . . . 1.2 109.056 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.54 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 26.1 m-80 -73.27 -55.88 5.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.492 0.553 . . . . 0.81999999999999995 112.492 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.955 HD22 HD22 ' A' ' 101' ' ' LEU . 1.3 pp -55.47 -57.71 10.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.897 0.702 . . . . 1.22 112.897 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.558 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . -61.26 -24.4 66.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.673 0.749 . . . . 1.1899999999999999 110.806 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.54 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.4 ttp180 -62.26 -49.62 74.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.781 -1.099 . . . . 2.2200000000000002 109.86 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.555 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -85.21 -53.29 5.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.373 1.082 . . . . 0.80000000000000004 111.129 -173.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.95 HG23 HG21 ' A' ' 114' ' ' ILE . 34.4 m -83.93 -30.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.225 -0.898 . . . . 1.5 110.849 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.58 -20.22 78.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.215 -0.902 . . . . 0.38 111.343 174.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.555 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -47.79 -45.59 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.386 -1.709 . . . . 1.6599999999999999 106.386 162.385 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.518 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 9.3 m-20 -72.84 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.716 -0.674 . . . . 1.8700000000000001 110.359 162.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 -179.54 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.719 0.408 . . . . 1.3500000000000001 111.852 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.36 137.92 32.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.018 0.437 . . . . 2.1499999999999999 111.47 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.95 HG21 HG23 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -118.36 148.07 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.237 -0.653 . . . . 1.1599999999999999 109.237 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.3 p-10 -102.65 152.69 20.91 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.951 -1.129 . . . . 2.1099999999999999 107.951 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.442 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 87.9 m-85 -137.21 171.48 14.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.636 . . . . 0.96999999999999997 109.284 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.614 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 34.2 tt0 -160.2 121.33 3.07 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.364 0.415 . . . . 0.80000000000000004 110.139 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.637 HD21 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -97.69 137.61 36.33 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.727 -0.471 . . . . 1.9199999999999999 109.727 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.721 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.37 103.17 8.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.884 -0.598 . . . . 0.63 109.51 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.498 HD13 HG23 ' A' ' 60' ' ' ILE . 6.8 tp -113.1 121.42 65.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.115 0.483 . . . . 1.49 110.904 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.17 126.48 8.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.333 -0.707 . . . . 0.26000000000000001 111.333 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD13 ' OG ' ' A' ' 25' ' ' SER . 4.5 mp -103.77 100.5 10.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.092 0.473 . . . . 1.77 111.393 -172.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.141 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.3 m -104.6 95.59 6.01 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.474 -0.784 . . . . 1.0700000000000001 109.478 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.67 HG21 ' HB3' ' A' ' 58' ' ' CYS . 2.3 pt -106.82 149.89 9.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.716 -0.394 . . . . 1.6699999999999999 110.602 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.685 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -91.12 105.35 17.75 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.52 108.492 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.712 HD13 HG22 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -105.09 148.26 35.88 Favored Pre-proline 0 C--O 1.218 -0.567 0 O-C-N 124.684 1.24 . . . . 1.9299999999999999 108.995 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.45 -32.15 93.42 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.909 1.739 . . . . 0.98999999999999999 113.052 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.94 -58.09 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.455 0.539 . . . . 1.6699999999999999 112.455 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.716 HG21 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -94.45 -6.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 122.153 0.978 . . . . 1.9099999999999999 109.952 -175.434 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.82 -31.36 1.27 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 113.716 -1.584 . . . . 1.05 111.59 -171.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.2 pt-20 -171.05 137.15 1.14 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.692 -0.855 . . . . 1.1599999999999999 108.692 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -143.14 139.55 30.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.372 -0.603 . . . . 2.2799999999999998 109.372 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.3 t -121.18 112.94 19.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.688 0.756 . . . . 1.8899999999999999 111.498 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.474 HD11 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.69 137.05 29.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.205 -0.907 . . . . 1.26 109.66 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 11.1 Cg_endo -91.47 163.64 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.237 1.958 . . . . 0.58999999999999997 112.758 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.8 166.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.468 -0.938 . . . . 1.1399999999999999 108.468 178.035 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -136.32 147.17 47.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.223 -0.191 . . . . 1.28 110.802 -167.605 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.5 t -140.58 102.88 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.489 -0.93 . . . . 1.3400000000000001 108.489 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.614 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 13.6 ptmt -118.46 152.31 36.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.732 -0.667 . . . . 2.2000000000000002 111.087 -174.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.11 158.67 30.25 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.6 -0.81 . . . . 0.56000000000000005 112.231 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.4 mt-10 -102.6 132.79 48.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.409 -0.589 . . . . 2.1000000000000001 109.409 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . 0.405 HD12 ' CE1' ' A' ' 116' ' ' TYR . 2.3 pp -138.52 172.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.467 -0.568 . . . . 1.51 109.467 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 143' ' ' LYS . 4.0 mppt? -75.03 167.22 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.006 0.431 . . . . 3.9300000000000002 111.652 -173.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.692 HD13 HD11 ' A' ' 114' ' ' ILE . 17.8 tp -57.1 132.77 80.48 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.676 -0.693 . . . . 1.9299999999999999 111.124 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.559 ' HD2' HD13 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -70.64 172.8 12.8 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.611 2.207 . . . . 0.81000000000000005 112.221 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 m -70.33 107.8 3.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.039 -0.528 . . . . 2.3700000000000001 110.429 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -118.52 151.7 37.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.966 0.412 . . . . 3.1899999999999999 111.102 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 150' ' ' PHE . 40.7 ttmt -172.85 102.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.264 -0.88 . . . . 4.1500000000000004 109.249 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.51 3.89 2.07 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.573 0.546 . . . . 4.2800000000000002 110.576 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.508 ' HB3' ' HE1' ' A' ' 98' ' ' TYR . 21.7 m-85 -86.84 -35.19 19.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.917 -0.771 . . . . 3.23 108.917 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.463 ' CD1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.169 -0.923 . . . . 4.9000000000000004 108.771 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.406 -0.22 . . . . 12.4 110.406 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.85 -12.35 0.22 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.011 1.115 . . . . 9.4700000000000006 114.011 173.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 p -66.06 -65.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 7.0899999999999999 111.625 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.657 ' H ' HD22 ' A' ' 4' ' ' LEU . 2.6 pt? -96.92 -0.21 47.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 8.8100000000000005 110.58 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.4 tp -105.72 29.25 6.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.371 0.605 . . . . 10.82 110.146 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.533 ' CG ' ' HZ1' ' A' ' 15' ' ' LYS . 18.4 t70 -86.79 -45.57 10.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.665 -0.698 . . . . 11.69 109.674 178.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 57.35 67.22 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.302 -0.863 . . . . 11.81 111.492 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.17 143.74 30.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.393 -0.821 . . . . 11.779999999999999 110.213 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -133.24 -31.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.453 -0.339 . . . . 15.99 111.087 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.71 131.76 36.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.691 -0.231 . . . . 12.69 110.848 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 70.91 -67.17 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.069 0.856 . . . . 14.630000000000001 111.22 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.13 137.33 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.344 -0.389 . . . . 8.8900000000000006 110.585 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.98 -12.27 9.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.282 0.563 . . . . 9.1999999999999993 110.064 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -97.78 -79.63 0.46 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.537 -0.756 . . . . 8.5999999999999996 110.212 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.642 ' HG2' ' HG ' ' A' ' 16' ' ' LEU . 35.1 ttpt 68.32 -77.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.866 0.729 . . . . 9.3100000000000005 111.642 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.642 ' HG ' ' HG2' ' A' ' 15' ' ' LYS . 2.8 pp -163.03 163.55 25.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.137 -0.32 . . . . 5.9800000000000004 110.137 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -152.82 21.13 0.6 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 2.98 110.624 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.524 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . -122.92 -103.22 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.487 -0.324 . . . . 1.8500000000000001 111.805 -177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.532 HG23 ' HG ' ' A' ' 126' ' ' LEU . 40.7 pt -147.01 170.5 7.66 Favored Pre-proline 0 N--CA 1.463 0.184 0 C-N-CA 122.145 0.178 . . . . 3.6800000000000002 110.898 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.687 ' HD2' ' HB2' ' A' ' 50' ' ' PRO . 31.7 Cg_exo -61.97 177.24 1.1 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.856 2.371 . . . . 2.52 111.839 169.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.666 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 57.5 mtpt -117.05 -55.25 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.606 0.965 . . . . 6.79 113.606 -171.24 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.666 ' HD3' ' HB2' ' A' ' 21' ' ' LYS . 3.0 Cg_exo -77.85 74.65 5.14 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.018 1.812 . . . . 3.3799999999999999 113.358 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 48' ' ' THR . 32.3 mt-10 -154.41 131.02 10.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.045 -2.206 . . . . 3.3900000000000001 105.045 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.713 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -127.62 -144.07 5.86 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 118.348 2.099 . . . . 1.0700000000000001 118.348 -143.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.603 ' C ' HG13 ' A' ' 45' ' ' VAL . 39.4 m -178.99 34.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 112.618 -1.791 . . . . 1.7 107.525 -170.412 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.442 HG11 HG23 ' A' ' 120' ' ' ILE . 16.4 m -135.07 150.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.84 -1.073 . . . . 1.53 109.638 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.465 ' HB ' ' HB3' ' A' ' 46' ' ' SER . 1.3 t -160.28 -51.66 0.05 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.988 -0.375 . . . . 1.05 109.988 168.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' OD2' ' HB3' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -158.54 150.14 21.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.294 0.568 . . . . 1.6899999999999999 112.101 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.13 127.8 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.3 -0.863 . . . . 1.8500000000000001 108.932 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -119.45 135.27 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 111.303 -169.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -97.33 127.16 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 1.46 111.871 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.433 ' HZ2' ' HB2' ' A' ' 42' ' ' LEU . 0.0 OUTLIER -129.72 -113.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 1.9199999999999999 109.679 166.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.796 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.3 p-10 172.2 176.07 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.05 0.389 . . . . 2.8500000000000001 112.05 -172.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.653 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.4 p -161.7 105.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 122.009 0.909 . . . . 3.77 112.117 174.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t30 59.15 -97.53 0.07 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.149 -0.932 . . . . 3.3500000000000001 111.101 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.96 24.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.383 1.087 . . . . 6.21 108.512 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.74 -35.51 9.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.41 -1.723 . . . . 1.9199999999999999 107.434 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.591 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 23.0 t -157.86 179.82 8.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.648 -2.069 . . . . 1.1299999999999999 106.252 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.796 HG13 ' HA ' ' A' ' 33' ' ' ASP . 3.1 t -124.51 161.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.39 -0.967 . . . . 1.48 108.39 166.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.92 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 82.0 mt-10 -114.06 131.93 56.2 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.878 -0.729 . . . . 1.1899999999999999 112.13 -170.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.785 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.87 103.82 10.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.855 -1.066 . . . . 3.9399999999999999 109.443 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.637 HD23 ' O ' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -72.73 109.18 6.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.081 -1.081 . . . . 1.4299999999999999 108.081 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -107.31 102.84 12.11 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.288 0.566 . . . . 1.1100000000000001 109.797 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 18.0 ttpp -83.77 133.55 34.77 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.875 -0.787 . . . . 3.1800000000000002 108.875 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.647 HG12 HD23 ' A' ' 90' ' ' LEU . 24.3 t -109.7 141.75 24.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.806 -1.088 . . . . 1.3999999999999999 110.409 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 88' ' ' THR . 1.8 p -120.1 100.52 7.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 119.531 -0.868 . . . . 1.1100000000000001 109.373 168.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.675 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 77.1 t -81.15 112.46 19.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.599 -0.889 . . . . 1.8500000000000001 108.599 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.713 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 2.0 m -102.92 109.89 21.62 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.914 -1.143 . . . . 1.1000000000000001 107.914 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.782 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 5.1 t30 -87.92 122.52 70.08 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.63 1.206 . . . . 1.48 109.85 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.687 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 1.3 Cg_endo -85.34 8.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.988 3.126 . . . . 0.91000000000000003 114.423 -171.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.697 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 31.4 t80 -96.79 -114.03 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.116 -0.634 . . . . 2.3100000000000001 110.015 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.423 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 18.9 p -168.74 18.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.811 0.3 . . . . 1.8300000000000001 111.811 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -148.04 143.18 27.04 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.514 -0.55 . . . . 2.0299999999999998 109.514 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 5.4 m -41.26 98.19 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.256 0.973 . . . . 1.73 112.873 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.926 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.9 pt -74.63 170.54 14.71 Favored Pre-proline 0 C--O 1.21 -0.998 0 N-CA-C 107.685 -1.228 . . . . 1.23 107.685 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.53 ' HB2' HG12 ' A' ' 57' ' ' ILE . 22.9 Cg_endo -91.25 -64.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 120.89 1.06 . . . . 0.53000000000000003 114.435 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.623 HD11 ' HA ' ' A' ' 79' ' ' PRO . 17.8 mm -126.4 161.33 32.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.188 -0.605 . . . . 1.9099999999999999 112.009 -166.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.639 ' HB3' HG22 ' A' ' 124' ' ' ILE . 29.8 p -152.04 175.63 12.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.43 1.11 . . . . 1.95 112.318 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.003 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -136.55 114.24 11.12 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.006 -1.907 . . . . 1.3600000000000001 109.336 175.357 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.424 HG21 HD13 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -98.92 117.74 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.894 -1.048 . . . . 1.6499999999999999 111.61 174.1 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.627 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.1 p -115.09 109.63 18.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.625 -1.625 . . . . 1.02 109.34 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.753 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.0 p90 -114.09 126.86 55.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.428 -0.351 . . . . 0.46000000000000002 110.13 -168.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.712 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.9 m -119.6 104.64 10.46 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.826 -0.625 . . . . 1.1699999999999999 109.327 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.65 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 94.3 m-85 -97.75 136.04 38.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.957 -0.565 . . . . 1.1799999999999999 109.783 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.665 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -146.59 140.3 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.734 -0.469 . . . . 1.72 109.734 176.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.565 ' HB2' HD13 ' A' ' 71' ' ' ILE . 48.2 t -102.64 -96.12 0.3 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.603 -0.271 . . . . 1.6599999999999999 111.588 -173.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.06 5.58 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.546 -0.909 . . . . 1.1200000000000001 108.546 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.11 16.92 0.18 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 106.69 -2.564 . . . . 0.39000000000000001 106.69 163.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.619 HH11 ' HA ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -105.76 163.25 12.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 112.809 -1.696 . . . . 2.4900000000000002 108.834 -171.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -97.57 87.89 4.21 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.488 0.661 . . . . 2.6099999999999999 109.313 -161.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.937 ' HA ' HG21 ' A' ' 100' ' ' ILE . 14.8 mm -44.63 -43.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 113.867 -1.515 . . . . 1.1100000000000001 111.188 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.23 167.46 36.18 Favored Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 119.9 -1.143 . . . . 0.48999999999999999 111.622 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.753 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.87 161.97 18.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.685 0.743 . . . . 2.3999999999999999 111.404 173.508 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.47 -178.88 32.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.804 -0.918 . . . . 0.52000000000000002 110.804 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 61' ' ' SER . 5.1 ptpp? -147.22 141.93 26.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 2.3799999999999999 111.2 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 92.0 mt -133.47 124.44 18.09 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 1.47 110.182 -178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.7 111.34 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.427 2.085 . . . . 0.81000000000000005 110.678 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.95 144.61 52.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.816 -0.439 . . . . 0.79000000000000004 109.816 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.623 ' HA ' HD11 ' A' ' 57' ' ' ILE . 34.2 Cg_exo -62.44 90.53 0.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.146 1.897 . . . . 0.91000000000000003 112.112 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.51 35.09 2.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.99 -0.55 . . . . 0.47999999999999998 112.294 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.926 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 52.3 p -73.03 123.73 24.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.396 -0.594 . . . . 0.85999999999999999 109.396 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -149.54 -159.78 1.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.727 -1.189 . . . . 1.76 113.499 -164.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.472 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 86.4 mttt -60.6 -93.61 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.485 0.55 . . . . 2.4300000000000002 112.485 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . 162.91 110.32 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.85 -1.167 . . . . 1.29 107.85 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.782 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 45.2 pttt 41.92 49.43 4.05 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.994 0.902 . . . . 2.21 111.195 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.471 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.3 t70 -153.3 -177.97 6.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.706 -1.134 . . . . 0.64000000000000001 110.118 -172.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.9 ttm -110.35 127.39 55.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.649 -0.705 . . . . 2.04 109.793 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.521 ' HB ' HD11 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.56 142.24 50.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 1.3300000000000001 111.151 -175.062 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.55 114.17 21.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.151 0.501 . . . . 1.1100000000000001 111.656 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.647 HD23 HG12 ' A' ' 45' ' ' VAL . 5.9 tt -117.96 171.33 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.533 -0.914 . . . . 1.45 108.533 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.409 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.0 m-20 -134.7 133.85 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.477 0.58 . . . . 1.8100000000000001 112.286 -172.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.638 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 46.0 mm -114.06 113.14 46.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.6 -0.889 . . . . 1.3999999999999999 108.6 168.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.637 ' O ' HD23 ' A' ' 42' ' ' LEU . 45.3 Cg_exo -28.87 -102.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 1 C-N-CA 125.725 4.283 . . . . 1.0700000000000001 115.415 -170.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.92 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.3 93.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 122.356 -0.215 . . . . 1.1799999999999999 110.701 -177.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 95' ' ' VAL . 7.7 p -127.75 102.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 114.474 1.287 . . . . 1.1699999999999999 114.474 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.624 HG23 HD11 ' A' ' 101' ' ' LEU . 2.5 p -153.78 103.61 2.5 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 122.152 -0.343 . . . . 1.71 111.49 159.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 94.2 Cg_exo -44.37 136.4 8.51 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.405 2.07 . . . . 0.65000000000000002 113.543 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.591 ' H ' ' HA ' ' A' ' 38' ' ' SER . 2.1 t80 -52.28 -37.84 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.691 -1.141 . . . . 1.6899999999999999 110.881 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.469 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -63.29 -25.89 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 1.49 112.651 -176.047 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.937 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.4 mm -71.29 -54.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.694 0.759 . . . . 1.21 110.659 -175.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.624 HD11 HG23 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -54.21 -33.69 58.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.706 -1.588 . . . . 1.6399999999999999 109.325 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.469 ' HB3' ' O ' ' A' ' 99' ' ' SER . 56.2 t80 -61.0 -39.85 91.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.29 -1.777 . . . . 1.2 109.032 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.508 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -74.98 -57.49 3.87 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.81999999999999995 111.321 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.619 ' HA ' HH11 ' A' ' 69' ' ' ARG . 3.0 pp -57.99 -50.71 72.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.488 0.922 . . . . 1.22 113.488 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.28 -26.97 66.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.1899999999999999 110.521 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -71.2 -51.71 23.21 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.422 -0.808 . . . . 2.2200000000000002 110.944 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.646 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 35.9 t70 -81.38 -51.96 7.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.776 0.798 . . . . 0.80000000000000004 111.791 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.676 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.5 t -91.01 -22.11 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.734 -0.604 . . . . 1.5 110.431 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.24 -20.09 79.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.393 -0.908 . . . . 0.38 111.043 168.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -51.73 -48.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.635 -1.617 . . . . 1.6599999999999999 106.635 165.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.78 -97.34 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.085 -0.962 . . . . 1.8700000000000001 110.345 163.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -178.18 -52.69 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.554 0.576 . . . . 1.3500000000000001 112.554 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -95.65 124.5 39.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.407 -0.361 . . . . 2.1499999999999999 111.447 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.676 HG13 ' HB ' ' A' ' 108' ' ' VAL . 3.0 mp -117.69 155.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.734 0.302 . . . . 1.1599999999999999 110.218 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -96.0 154.55 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.638 -0.875 . . . . 2.1099999999999999 108.638 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' HH ' HD12 ' A' ' 104' ' ' LEU . 60.8 m-85 -140.31 149.36 42.67 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.161 -1.052 . . . . 0.96999999999999997 108.161 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.81 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 10.5 tt0 -146.29 139.39 25.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.369 -0.532 . . . . 0.80000000000000004 111.066 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.65 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 10.2 tp -105.67 127.59 53.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.335 -0.848 . . . . 1.9199999999999999 109.917 170.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.712 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -113.02 100.34 8.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.456 -0.942 . . . . 0.63 108.456 174.28 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.568 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.4 tp -112.88 122.34 66.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.124 0.488 . . . . 1.49 111.497 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.412 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.62 128.48 9.43 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.978 -0.849 . . . . 0.26000000000000001 110.978 174.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.625 HD22 ' HA2' ' A' ' 24' ' ' GLY . 2.2 mp -104.87 97.64 7.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.881 0.372 . . . . 1.77 111.273 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.003 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 78.9 m -97.38 95.37 7.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.93 -0.767 . . . . 1.0700000000000001 108.93 171.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.639 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.86 147.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.032 -0.667 . . . . 1.6699999999999999 110.013 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 4.5 m-20 -87.99 105.88 17.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 109.374 -0.602 . . . . 1.52 109.374 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.611 HD22 HG12 ' A' ' 124' ' ' ILE . 1.5 mm? -103.37 162.11 21.03 Favored Pre-proline 0 C--O 1.22 -0.457 0 O-C-N 124.333 1.021 . . . . 1.9299999999999999 109.611 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.97 -29.83 14.55 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 121.992 1.794 . . . . 0.98999999999999999 113.053 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.417 HG13 ' HE1' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -75.38 -57.87 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 113.372 0.879 . . . . 1.6699999999999999 113.372 -176.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.524 HG23 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -95.1 -3.35 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.976 0.893 . . . . 1.9099999999999999 109.857 -176.308 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.84 -36.48 1.44 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 113.951 -1.477 . . . . 1.05 111.217 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.7 pt-20 -174.3 140.09 0.64 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.811 -1.181 . . . . 1.1599999999999999 107.811 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -140.98 146.2 36.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.83 -0.348 . . . . 2.2799999999999998 110.113 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.612 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.0 t -114.4 112.9 23.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.534 0.683 . . . . 1.8899999999999999 111.584 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.429 HD13 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.91 138.48 32.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.624 -0.716 . . . . 1.26 109.76 173.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.412 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 83.6 Cg_endo -93.15 163.65 2.53 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.019 1.813 . . . . 0.58999999999999997 113.335 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.466 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -163.34 168.09 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.679 -0.86 . . . . 1.1399999999999999 108.679 177.318 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -138.32 156.04 48.01 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.134 0.42 . . . . 1.28 112.134 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 t -145.94 106.87 4.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.63 -0.878 . . . . 1.3400000000000001 108.63 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.81 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.1 ptmt -120.84 149.69 42.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.629 -0.259 . . . . 2.2000000000000002 111.099 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.66 146.61 11.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.634 -0.793 . . . . 0.56000000000000005 112.403 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -107.7 132.02 53.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.067 -0.567 . . . . 2.1000000000000001 110.797 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.56 172.0 2.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.805 -1.183 . . . . 1.51 107.805 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.6 152.61 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 3.9300000000000002 111.047 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.87 150.03 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 1.9299999999999999 112.388 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.419 ' HG2' ' O ' ' A' ' 151' ' ' PHE . 35.9 Cg_endo -65.97 174.22 6.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.447 2.765 . . . . 0.81000000000000005 113.03 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -66.54 102.96 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.723 0.773 . . . . 2.3700000000000001 110.957 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 151' ' ' PHE . 29.8 p90 -79.1 26.09 0.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.368 -0.833 . . . . 3.1899999999999999 111.931 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -79.09 81.95 5.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.364 -0.38 . . . . 4.1500000000000004 109.998 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 77.23 -42.55 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.782 0.833 . . . . 4.2800000000000002 110.98 -176.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.462 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 15.8 m-85 -65.04 -49.32 70.6 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.242 0.339 . . . . 3.23 110.483 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.699 ' HA ' ' HA ' ' A' ' 147' ' ' PHE . 47.4 m-85 . . . . . 0 C--O 1.248 1.016 0 O-C-N 124.791 1.307 . . . . 4.9000000000000004 110.266 -171.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.804 0.335 . . . . 12.4 110.855 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.13 80.1 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.219 0.533 . . . . 9.4700000000000006 111.529 -175.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.411 ' HB3' HD21 ' A' ' 4' ' ' LEU . 29.2 t -117.84 -55.01 2.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.768 -0.827 . . . . 7.0899999999999999 108.768 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.659 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 mm? -104.59 11.58 34.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.184 -0.673 . . . . 8.8100000000000005 109.184 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.625 HD21 ' HA ' ' A' ' 51' ' ' TYR . 3.3 mm? 70.3 -67.87 0.22 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.15 -0.932 . . . . 10.82 110.596 -175.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.94 -161.89 1.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.143 -0.688 . . . . 11.69 109.143 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -154.87 101.44 2.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 11.81 111.324 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.22 -103.57 0.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.205 -0.452 . . . . 11.779999999999999 109.839 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 132.06 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.21 -0.292 . . . . 15.99 110.21 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.56 25.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.526 -0.546 . . . . 12.69 109.526 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 61.96 100.11 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.1 -0.955 . . . . 14.630000000000001 112.141 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -84.84 -32.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.932 -1.136 . . . . 8.8900000000000006 107.932 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.6 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.446 -1.252 . . . . 9.1999999999999993 112.388 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -130.09 5.62 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.295 -0.412 . . . . 8.5999999999999996 110.714 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.716 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 46.6 mmtm -95.13 39.23 1.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.022 0.439 . . . . 9.3100000000000005 111.248 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.67 -25.09 64.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.104 -0.498 . . . . 5.9800000000000004 110.232 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 m -128.33 149.4 50.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 2.98 109.87 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.755 ' O ' HG13 ' A' ' 19' ' ' ILE . . . 66.62 35.43 5.32 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.726 0.641 . . . . 1.8500000000000001 111.251 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.755 HG13 ' O ' ' A' ' 18' ' ' ALA . 1.1 pp 66.21 157.52 0.13 Allowed Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.82 1.248 . . . . 3.6800000000000002 112.613 172.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.716 ' HA ' ' HB3' ' A' ' 15' ' ' LYS . 6.3 Cg_exo -77.06 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.826 2.351 . . . . 2.52 112.975 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 12.0 ptpt -142.0 116.39 6.73 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.183 0.516 . . . . 6.79 110.887 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.667 ' HG3' ' HD2' ' A' ' 132' ' ' PHE . 86.5 Cg_endo -100.98 48.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.973 3.115 . . . . 3.3799999999999999 112.25 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.427 ' HA ' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.96 114.86 27.09 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.648 0.737 . . . . 3.3900000000000001 111.253 -168.513 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.772 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . 175.27 108.72 0.23 Allowed Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 114.538 -1.21 . . . . 1.0700000000000001 111.623 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.626 ' HB2' HD12 ' A' ' 122' ' ' LEU . 33.3 m -168.91 29.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.384 -0.969 . . . . 1.7 108.384 170.725 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.47 153.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.865 -1.061 . . . . 1.53 109.723 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -179.5 -46.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.632 0.582 . . . . 1.05 112.099 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.68 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 27.2 t70 -155.38 151.89 28.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.69 -0.404 . . . . 1.6899999999999999 111.603 -174.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.61 120.68 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.393 -0.595 . . . . 1.8500000000000001 109.393 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.498 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 t70 -113.44 110.86 20.99 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.637 -0.256 . . . . 1.8300000000000001 111.308 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.671 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -79.42 130.97 35.93 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.638 -0.134 . . . . 1.46 110.638 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.599 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.52 -88.05 0.24 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 114.138 1.162 . . . . 1.9199999999999999 114.138 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -91.32 -177.35 4.83 Favored 'General case' 0 C--O 1.204 -1.32 0 O-C-N 121.936 -0.478 . . . . 2.8500000000000001 111.995 -152.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.699 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.1 p -164.36 -33.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.973 0.416 . . . . 3.77 111.101 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.71 -69.49 0.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.855 -1.066 . . . . 3.3500000000000001 110.032 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -174.89 -6.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.819 -0.628 . . . . 6.21 112.191 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -128.15 -30.18 2.45 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.306 0.574 . . . . 1.9199999999999999 110.159 -164.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.699 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 6.3 t -165.59 131.94 2.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.154 -0.93 . . . . 1.1299999999999999 111.358 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.829 HG11 HD22 ' A' ' 101' ' ' LEU . 91.4 t -76.89 155.51 5.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.208 -0.905 . . . . 1.48 110.319 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.902 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 48.8 mt-10 -129.35 139.54 51.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.539 -0.864 . . . . 1.1899999999999999 110.515 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.948 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -139.72 134.62 32.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.582 -0.847 . . . . 3.9399999999999999 112.293 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.505 ' N ' HG13 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -80.41 111.42 16.79 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.824 -0.806 . . . . 1.4299999999999999 108.824 -174.621 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.615 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -90.43 99.9 12.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.374 0.607 . . . . 1.1100000000000001 110.001 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -83.5 125.04 31.34 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.82 -0.807 . . . . 3.1800000000000002 108.82 178.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG11 ' C ' ' A' ' 25' ' ' SER . 52.2 t -115.48 139.19 43.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.169 -0.923 . . . . 1.3999999999999999 110.445 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.75 104.52 8.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.19 -0.604 . . . . 1.1100000000000001 109.58 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.772 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 83.2 t -83.05 129.89 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.338 -0.846 . . . . 1.8500000000000001 110.458 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 30.5 m -122.61 113.94 19.95 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.913 -0.585 . . . . 1.1000000000000001 109.837 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.783 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.5 p-10 -94.87 146.19 30.92 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.628 -0.715 . . . . 1.48 109.172 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.556 ' HG3' HD11 ' A' ' 19' ' ' ILE . 47.4 Cg_endo -93.92 8.18 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.13 2.553 . . . . 0.91000000000000003 113.044 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.625 ' HA ' HD21 ' A' ' 5' ' ' LEU . 6.8 t80 -117.11 131.92 56.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.958 -0.386 . . . . 2.3100000000000001 109.958 -174.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.561 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 38.1 t -87.48 44.7 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.442 0.639 . . . . 1.8300000000000001 110.655 -169.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -144.07 16.88 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.459 0.911 . . . . 2.0299999999999998 113.459 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.717 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 26.2 t 61.42 98.28 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 111.885 0.328 . . . . 1.73 111.885 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.893 ' O ' ' HA ' ' A' ' 81' ' ' SER . 9.1 pt -78.79 128.87 75.52 Favored Pre-proline 0 C--O 1.207 -1.149 0 O-C-N 121.698 -0.626 . . . . 1.23 111.115 -170.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.668 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 28.6 Cg_endo -66.34 -59.21 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.914 1.743 . . . . 0.53000000000000003 113.106 -163.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.535 HD12 ' HA ' ' A' ' 79' ' ' PRO . 10.1 mm -121.65 152.02 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.23 -0.588 . . . . 1.9099999999999999 110.782 -172.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.616 ' HB3' HG23 ' A' ' 124' ' ' ILE . 10.2 m -148.03 178.23 8.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.147 0.975 . . . . 1.95 111.961 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.087 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 34.7 tt0 -136.8 117.63 14.11 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.587 -1.642 . . . . 1.3600000000000001 110.618 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.638 HG21 HD12 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -97.89 109.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.783 0.802 . . . . 1.6499999999999999 109.559 170.029 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.71 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 13.2 p -117.13 102.05 8.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.325 -1.307 . . . . 1.02 109.717 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.607 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 p90 -109.92 126.68 54.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.46000000000000002 110.451 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 8.2 m -120.43 105.3 10.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.525 -0.762 . . . . 1.1699999999999999 109.312 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.697 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 81.6 m-85 -98.67 140.56 32.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.28 -0.418 . . . . 1.1799999999999999 111.226 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.54 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 10.9 m170 -134.78 143.9 47.36 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.085 -1.08 . . . . 1.72 108.085 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.591 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 33.6 t -107.64 -100.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.67 -0.812 . . . . 1.6599999999999999 111.176 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.53 3.57 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.217 -0.66 . . . . 1.1200000000000001 109.217 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.51 20.94 0.13 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.292 -1.523 . . . . 0.39000000000000001 109.292 167.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 69' ' ' ARG . 7.3 ptp180 -116.46 -176.83 3.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.64 -0.874 . . . . 2.4900000000000002 108.64 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -103.05 96.8 7.04 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.744 0.783 . . . . 2.6099999999999999 108.935 -167.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.926 ' HA ' HG22 ' A' ' 100' ' ' ILE . 5.0 mm -50.77 -42.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 113.762 -1.563 . . . . 1.1100000000000001 111.153 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 170.0 32.76 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.538 -0.839 . . . . 0.48999999999999999 111.288 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.607 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.44 163.83 27.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.411 0.606 . . . . 2.3999999999999999 110.396 174.812 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.72 159.71 23.54 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.231 -0.748 . . . . 0.52000000000000002 111.231 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.71 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 92.3 mttt -133.19 128.53 36.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.238 -0.282 . . . . 2.3799999999999999 110.238 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.601 ' HB ' HD11 ' A' ' 60' ' ' ILE . 70.3 mt -134.31 111.8 11.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.36 -0.382 . . . . 1.47 110.224 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 111.24 3.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.518 2.146 . . . . 0.81000000000000005 110.554 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -130.88 142.67 46.4 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.738 -0.467 . . . . 0.79000000000000004 109.738 -172.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' HD12 ' A' ' 57' ' ' ILE . 27.8 Cg_endo -63.84 84.61 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.539 2.159 . . . . 0.91000000000000003 112.365 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.14 41.74 3.08 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.47999999999999998 112.147 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.893 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 83.9 p -70.48 113.14 7.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.85999999999999999 109.179 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.717 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -142.74 160.82 39.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.447 0.536 . . . . 1.76 112.447 -164.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 90.9 mttt -6.25 -96.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 125.243 1.589 . . . . 2.4300000000000002 113.796 -172.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.467 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 170.5 108.54 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.097 -1.075 . . . . 1.29 108.097 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.783 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 9.6 ptpt 42.57 54.32 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.291 0.995 . . . . 2.21 110.844 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.642 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t70 -153.53 -167.29 2.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 0.64000000000000001 110.822 -171.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.49 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 52.5 ttm -118.81 125.07 48.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 2.04 110.883 -170.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.643 HG21 ' HB ' ' A' ' 47' ' ' VAL . 1.2 t -113.58 143.28 44.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.319 -0.855 . . . . 1.3300000000000001 109.309 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.86 106.37 16.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.281 0.563 . . . . 1.1100000000000001 111.068 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.515 HD23 HG13 ' A' ' 45' ' ' VAL . 8.5 tt -103.31 160.28 14.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.514 -0.921 . . . . 1.45 108.514 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -136.3 119.56 16.72 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.682 -0.807 . . . . 1.8100000000000001 111.314 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.615 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 31.6 mm -103.36 143.59 26.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.231 -0.895 . . . . 1.3999999999999999 109.612 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.502 ' HD2' HG23 ' A' ' 92' ' ' ILE . 17.9 Cg_endo -59.79 -155.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.888 2.392 . . . . 1.0700000000000001 113.718 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.948 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 5.1 m -126.35 92.3 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 115.602 -0.727 . . . . 1.1799999999999999 111.411 -162.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 95' ' ' VAL . 7.5 p -126.29 101.65 8.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 115.633 1.716 . . . . 1.1699999999999999 115.633 -162.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.641 HG12 ' HB ' ' A' ' 39' ' ' VAL . 4.8 p -153.32 123.95 3.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 121.182 -0.949 . . . . 1.71 111.766 162.439 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.566 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 49.4 Cg_exo -53.59 135.14 60.88 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.616 1.544 . . . . 0.65000000000000002 112.071 172.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.457 ' HA ' HG21 ' A' ' 39' ' ' VAL . 1.2 t80 -50.33 -36.23 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.052 -0.976 . . . . 1.6899999999999999 110.931 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.7 m -65.62 -25.26 67.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.658 0.614 . . . . 1.49 112.658 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.926 HG22 ' HA ' ' A' ' 71' ' ' ILE . 6.5 mm -72.38 -54.46 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 121.73 -0.606 . . . . 1.21 110.043 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.829 HD22 HG11 ' A' ' 39' ' ' VAL . 9.9 mp -60.1 -25.41 65.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.002 -0.999 . . . . 1.6399999999999999 111.161 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.621 ' HA ' ' CD1' ' A' ' 151' ' ' PHE . 77.2 t80 -59.03 -48.49 81.41 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.54 -1.281 . . . . 1.2 107.54 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.502 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 91.3 m-20 -75.48 -56.16 4.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.648 -1.16 . . . . 0.81999999999999995 113.15 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.733 ' HG ' ' HA ' ' A' ' 101' ' ' LEU . 2.8 pp -54.36 -49.76 69.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.255 0.835 . . . . 1.22 113.255 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.635 ' HB1' ' CZ ' ' A' ' 147' ' ' PHE . . . -67.92 -24.81 65.24 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 122.066 0.936 . . . . 1.1899999999999999 110.406 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.502 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 3.3 ttp180 -69.7 -49.57 52.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.226 -1.352 . . . . 2.2200000000000002 110.238 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.686 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 9.0 t70 -81.89 -53.91 5.77 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.73 0.776 . . . . 0.80000000000000004 111.98 -173.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.73 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.0 t -89.09 -22.69 6.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 1.5 110.1 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.79 -18.68 78.98 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.43 -0.891 . . . . 0.38 111.228 168.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.686 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -51.95 -47.1 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.862 -1.533 . . . . 1.6599999999999999 106.862 164.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 19.4 m-20 -68.5 -96.22 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.709 -0.678 . . . . 1.8700000000000001 110.096 159.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -179.34 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.3500000000000001 111.674 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -94.43 123.73 38.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.064 0.459 . . . . 2.1499999999999999 110.923 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.73 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.9 mp -110.64 158.76 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.283 -0.636 . . . . 1.1599999999999999 109.283 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.666 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 4.8 p-10 -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.879 -0.601 . . . . 2.1099999999999999 109.416 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.591 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 40.9 m-85 -137.13 157.9 45.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.903 -1.147 . . . . 0.96999999999999997 107.903 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.899 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.7 tt0 -145.86 137.97 25.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.146 0.498 . . . . 0.80000000000000004 109.853 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.697 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -110.51 131.49 55.0 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.484 -0.78 . . . . 1.9199999999999999 109.562 177.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.645 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -117.56 99.59 7.07 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.772 -0.825 . . . . 0.63 108.772 174.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.672 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -114.51 121.06 65.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.441 0.639 . . . . 1.49 110.719 -173.847 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.674 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.6 127.75 8.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.26000000000000001 111.999 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.705 HD23 ' H ' ' A' ' 24' ' ' GLY . 1.9 mp -99.05 96.0 7.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.83 0.348 . . . . 1.77 110.624 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.087 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 94.5 m -101.16 95.66 6.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.156 -0.683 . . . . 1.0700000000000001 109.156 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.78 ' HB ' HD11 ' A' ' 55' ' ' ILE . 32.7 pt -117.06 137.73 50.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.392 -0.523 . . . . 1.6699999999999999 110.785 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.668 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -81.66 105.93 13.2 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.224 -0.658 . . . . 1.52 109.224 -176.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.529 HD21 HG22 ' A' ' 55' ' ' ILE . 20.0 mt -107.15 141.69 23.45 Favored Pre-proline 0 C--O 1.217 -0.61 0 O-C-N 124.859 1.35 . . . . 1.9299999999999999 109.69 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.518 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 50.3 Cg_exo -55.16 -27.78 57.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.272 1.981 . . . . 0.98999999999999999 113.536 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.48 -58.21 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 112.584 0.587 . . . . 1.6699999999999999 112.584 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -99.37 -2.09 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 122.14 0.971 . . . . 1.9099999999999999 109.774 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.79 -31.14 1.98 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 113.742 -1.572 . . . . 1.05 110.711 -171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.3 pt-20 -169.07 145.12 3.38 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.809 -1.182 . . . . 1.1599999999999999 107.809 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.667 ' HD2' ' HG3' ' A' ' 22' ' ' PRO . 6.6 t80 -134.82 134.63 41.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.048 -0.723 . . . . 2.2799999999999998 109.048 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 90.9 m -119.0 105.11 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 1.8899999999999999 111.723 -175.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.611 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.3 pp -127.66 132.75 24.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 1.26 109.838 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.674 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 73.6 Cg_endo -84.96 159.29 11.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.682 1.588 . . . . 0.58999999999999997 112.239 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.403 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -150.43 164.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.198 -1.038 . . . . 1.1399999999999999 108.198 179.4 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -133.42 149.61 51.79 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.854 -0.338 . . . . 1.28 111.528 -168.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.0 t -144.33 103.82 4.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.812 -0.81 . . . . 1.3400000000000001 108.812 173.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.899 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.7 ptmt -113.44 144.61 42.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.958 -0.565 . . . . 2.2000000000000002 110.837 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.22 139.73 6.76 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.684 -0.769 . . . . 0.56000000000000005 111.734 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.666 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 12.1 mt-10 -106.33 126.79 52.67 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.922 -0.77 . . . . 2.1000000000000001 108.922 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.42 173.6 13.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.609 -0.885 . . . . 1.51 108.609 -176.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -68.43 175.83 3.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.03 0.443 . . . . 3.9300000000000002 111.793 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.645 HD13 ' HD2' ' A' ' 145' ' ' PRO . 21.4 tp -58.82 129.07 85.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.575 -0.739 . . . . 1.9299999999999999 112.119 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.645 ' HD2' HD13 ' A' ' 144' ' ' LEU . 36.8 Cg_endo -65.07 175.86 3.55 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.206 3.27 . . . . 0.81000000000000005 112.85 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 136.94 57.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 2.3700000000000001 112.111 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.635 ' CZ ' ' HB1' ' A' ' 105' ' ' ALA . 17.0 m-85 -125.79 165.74 18.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.145 -0.48 . . . . 3.1899999999999999 110.511 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.529 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 2.5 tppp? 176.71 55.21 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 O-C-N 123.539 0.525 . . . . 4.1500000000000004 109.782 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 64.27 28.19 13.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.695 -0.684 . . . . 4.2800000000000002 110.737 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.529 ' CE2' ' HB3' ' A' ' 148' ' ' LYS . 23.1 m-85 -98.56 -49.86 4.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.682 -0.69 . . . . 3.23 109.387 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.621 ' CD1' ' HA ' ' A' ' 102' ' ' PHE . 6.3 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.993 -1.003 . . . . 4.9000000000000004 109.698 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HE2' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.445 -0.206 . . . . 12.4 110.445 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.96 -8.46 57.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.359 0.503 . . . . 9.4700000000000006 112.359 -172.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.455 ' O ' ' HE2' ' A' ' 1' ' ' MET . 35.4 m -123.39 93.97 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.175 -0.306 . . . . 7.0899999999999999 110.175 175.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.28 -71.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.426 . . . . 8.8100000000000005 110.23 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.446 HD22 ' HA ' ' A' ' 17' ' ' THR . 57.3 tp 59.71 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.856 0.722 . . . . 10.82 111.488 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -114.39 -45.48 3.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.919 -0.582 . . . . 11.69 110.603 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -100.76 124.38 46.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.998 -0.546 . . . . 11.81 110.849 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -153.56 125.14 7.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.603 -0.726 . . . . 11.779999999999999 109.329 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -73.98 -38.29 64.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.907 0.384 . . . . 15.99 110.308 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -93.12 128.81 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.379 -0.6 . . . . 12.69 109.379 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -79.52 178.77 7.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.264 0.554 . . . . 14.630000000000001 111.723 -171.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -120.07 158.17 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.681 -0.69 . . . . 8.8900000000000006 110.51 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.48 -61.01 2.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.125 0.488 . . . . 9.1999999999999993 110.305 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -147.19 -44.8 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 8.5999999999999996 111.163 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.1 tppt? -143.45 127.25 17.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.487 -0.324 . . . . 9.3100000000000005 110.413 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.6 tp -143.12 -78.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.111 -0.329 . . . . 5.9800000000000004 110.111 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.446 ' HA ' HD22 ' A' ' 5' ' ' LEU . 71.6 m 62.4 -85.09 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.575 0.547 . . . . 2.98 110.836 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.527 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 60.46 -88.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.382 0.673 . . . . 1.8500000000000001 112.585 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.417 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.7 pp -137.21 141.44 34.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 3.6800000000000002 110.57 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.56 -12.86 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.825 2.35 . . . . 2.52 113.0 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -145.78 127.25 7.58 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.917 -0.771 . . . . 6.79 108.917 -176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.32 163.85 11.72 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.684 2.256 . . . . 3.3799999999999999 112.217 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.714 ' HG3' ' HD3' ' A' ' 50' ' ' PRO . 31.1 mp0 -115.92 148.62 39.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.784 -1.932 . . . . 3.3900000000000001 105.784 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -113.57 -178.81 19.32 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 118.124 -1.989 . . . . 1.0700000000000001 113.597 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.648 ' O ' HG13 ' A' ' 45' ' ' VAL . 76.7 p -166.6 36.98 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.437 1.113 . . . . 1.7 108.308 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.1 m -133.85 154.89 39.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.295 -1.32 . . . . 1.53 110.463 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 t -168.04 -45.34 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.781 0.676 . . . . 1.05 111.387 168.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -162.84 162.9 26.67 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.915 -0.49 . . . . 1.6899999999999999 111.479 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.49 146.06 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.878 -0.415 . . . . 1.8500000000000001 109.878 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -129.02 134.92 48.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.582 0.229 . . . . 1.8300000000000001 111.004 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' HB2' ' HE1' ' A' ' 41' ' ' TYR . 2.7 tm? -100.85 134.94 43.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.145 -0.317 . . . . 1.46 110.145 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.464 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -142.92 -93.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.7 1.0 . . . . 1.9199999999999999 113.7 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.829 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -91.06 -178.11 5.1 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-O 118.801 -0.618 . . . . 2.8500000000000001 111.709 -154.63 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.805 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.5 p -165.56 -36.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 112.46 0.541 . . . . 3.77 112.46 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 66.49 -66.27 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.05 0.844 . . . . 3.3500000000000001 110.78 -174.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.49 -3.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.663 0.785 . . . . 6.21 109.852 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -127.63 -41.78 1.67 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.349 -0.387 . . . . 1.9199999999999999 110.21 -168.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.805 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 22.6 t -146.92 122.43 10.4 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.965 0.888 . . . . 1.1299999999999999 112.173 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.829 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 48.7 t -71.88 152.49 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.181 -1.372 . . . . 1.48 109.126 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.995 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.2 mt-10 -114.84 133.83 55.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.957 -1.097 . . . . 1.1899999999999999 112.595 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.81 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.18 105.6 11.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.816 -1.084 . . . . 3.9399999999999999 110.681 -176.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.54 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -81.28 111.15 17.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.32 -0.993 . . . . 1.4299999999999999 108.32 178.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB1' ' HB ' ' A' ' 92' ' ' ILE . . . -105.32 115.61 30.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.528 0.68 . . . . 1.1100000000000001 110.875 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 39.3 ttmt -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.893 -1.049 . . . . 3.1800000000000002 108.586 177.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.648 HG13 ' O ' ' A' ' 25' ' ' SER . 51.0 t -108.99 143.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.599 -0.728 . . . . 1.3999999999999999 110.984 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.541 ' HB2' ' O ' ' A' ' 26' ' ' VAL . 14.2 m -134.59 100.96 4.79 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.227 0.536 . . . . 1.1100000000000001 110.436 167.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 85.4 t -81.99 124.36 39.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.171 -0.922 . . . . 1.8500000000000001 110.617 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.516 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.0 m -103.2 110.67 22.72 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.902 -0.59 . . . . 1.1000000000000001 110.707 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.648 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 9.9 t30 -90.27 128.01 50.95 Favored Pre-proline 0 C--N 1.318 -0.802 0 O-C-N 123.796 0.685 . . . . 1.48 109.748 176.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.714 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 57.3 Cg_endo -90.31 8.7 3.43 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.51 . . . . 0.91000000000000003 114.116 -175.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.639 ' HE2' ' HD1' ' A' ' 53' ' ' HIS . 23.2 t80 -127.02 147.28 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.588 -0.893 . . . . 2.3100000000000001 108.588 -176.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.702 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.9 t -79.1 31.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.227 0.454 . . . . 1.8300000000000001 112.227 -168.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.639 ' HD1' ' HE2' ' A' ' 51' ' ' TYR . 40.4 m80 -143.11 128.47 18.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.486 -0.324 . . . . 2.0299999999999998 110.789 176.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.503 ' HA ' HD23 ' A' ' 82' ' ' LEU . 47.6 t -38.11 105.05 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 124.577 1.151 . . . . 1.73 112.971 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.693 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -77.87 125.11 86.02 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 109.242 -0.651 . . . . 1.23 109.242 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.968 ' HB2' HD12 ' A' ' 57' ' ' ILE . 30.3 Cg_endo -63.09 -58.92 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.048 1.832 . . . . 0.53000000000000003 113.544 -159.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.968 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.5 mp -132.18 154.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.899 -0.72 . . . . 1.9099999999999999 110.994 -173.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.575 ' HB3' HG22 ' A' ' 124' ' ' ILE . 31.4 p -145.83 178.11 8.42 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.504 1.145 . . . . 1.95 112.161 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.104 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.0 tt0 -131.95 114.24 14.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.687 -2.052 . . . . 1.3600000000000001 109.25 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.579 HG23 HD13 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.86 110.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.334 1.064 . . . . 1.6499999999999999 110.125 171.415 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.52 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -109.1 105.25 14.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.256 -1.793 . . . . 1.02 107.951 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.655 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 p90 -115.59 130.71 56.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.416 0.627 . . . . 0.46000000000000002 110.369 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.405 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 32.5 m -131.92 114.56 14.79 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.743 -1.117 . . . . 1.1699999999999999 109.065 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.487 ' HB2' HG21 ' A' ' 71' ' ' ILE . 97.3 m-85 -96.77 146.83 24.53 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.508 -0.552 . . . . 1.1799999999999999 109.508 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -134.09 146.06 49.94 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.392 -1.336 . . . . 1.72 107.392 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 1.082 ' HB3' HD21 ' A' ' 104' ' ' LEU . 47.7 t -112.56 -97.2 0.43 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.177 -1.009 . . . . 1.6599999999999999 110.846 169.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.82 3.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.837 -0.431 . . . . 1.1200000000000001 109.837 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.2 26.37 0.18 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.964 -1.254 . . . . 0.39000000000000001 109.964 167.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.494 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 8.1 ptp180 -126.17 -174.22 3.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.552 -0.536 . . . . 2.4900000000000002 109.552 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.402 ' C ' HG23 ' A' ' 100' ' ' ILE . 43.7 mt-10 -101.44 92.06 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.198 0.523 . . . . 2.6099999999999999 110.391 -164.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.755 HD12 HD22 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -56.85 -32.1 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 1.1100000000000001 112.113 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.67 164.94 33.22 Favored Glycine 0 C--O 1.223 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.48999999999999999 111.245 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.655 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.28 160.26 18.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.989 0.895 . . . . 2.3999999999999999 112.126 175.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.77 159.1 21.04 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.076 -0.81 . . . . 0.52000000000000002 111.076 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.0 mtpt -126.2 128.1 46.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.196 0.498 . . . . 2.3799999999999999 110.002 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HB ' HD13 ' A' ' 60' ' ' ILE . 75.5 mt -136.63 122.22 13.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.721 0.296 . . . . 1.47 110.644 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.31 114.53 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.579 2.186 . . . . 0.81000000000000005 111.022 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -129.97 146.0 59.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.074 -0.343 . . . . 0.79000000000000004 110.074 -173.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -56.82 91.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.727 2.285 . . . . 0.91000000000000003 112.17 175.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -79.88 19.51 6.31 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.497 -0.774 . . . . 0.47999999999999998 112.82 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.693 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 p -70.74 121.32 17.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.006 -0.739 . . . . 0.85999999999999999 109.006 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.555 HD13 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -145.23 -161.38 1.29 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.843 0.682 . . . . 1.76 112.843 -162.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.463 ' O ' ' HB3' ' A' ' 84' ' ' ALA . 67.5 mttm -53.79 -94.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.83 0.678 . . . . 2.4300000000000002 112.83 -174.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.619 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 164.51 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.583 -0.895 . . . . 1.29 108.583 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.702 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.1 ptmt 46.27 40.86 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.408 1.067 . . . . 2.21 111.088 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.69 -169.75 3.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 109.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 ttm -116.19 124.5 50.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.305 0.574 . . . . 2.04 110.456 -174.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.555 ' HB ' HD13 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -111.35 143.48 42.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.352 -0.84 . . . . 1.3300000000000001 110.863 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.02 138.89 31.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.026 0.441 . . . . 1.1100000000000001 110.447 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.58 HD21 HG12 ' A' ' 45' ' ' VAL . 1.2 tt -144.15 175.06 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.612 -1.255 . . . . 1.45 107.612 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.509 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 4.0 p-10 -142.15 146.5 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.061 0.846 . . . . 1.8100000000000001 112.217 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.702 ' HB ' ' HB1' ' A' ' 43' ' ' ALA . 50.4 mm -114.56 143.25 29.57 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 107.895 -1.15 . . . . 1.3999999999999999 107.895 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.54 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 85.2 Cg_exo -51.52 -122.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.472 2.781 . . . . 1.0700000000000001 114.072 175.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.995 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -153.82 93.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 O-C-N 121.837 -0.539 . . . . 1.1799999999999999 111.973 -172.081 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -126.29 109.03 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.748 1.018 . . . . 1.1699999999999999 113.748 -169.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.709 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 16.9 t -146.86 103.98 3.89 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 115.683 -0.69 . . . . 1.71 109.731 169.246 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.561 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.6 Cg_exo -61.26 123.45 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 CA-C-N 120.792 1.319 . . . . 0.65000000000000002 110.678 171.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.57 -38.34 44.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.56 -0.745 . . . . 1.6899999999999999 112.176 -171.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 1.9 m -56.12 -25.52 46.36 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.674 0.25 . . . . 1.49 111.674 -177.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.639 HG23 ' HA ' ' A' ' 71' ' ' ILE . 19.0 mm -76.34 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 120.252 -0.579 . . . . 1.21 111.116 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.823 HD12 HG23 ' A' ' 39' ' ' VAL . 13.1 mt -51.96 -30.05 23.12 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.488 0.661 . . . . 1.6399999999999999 110.427 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.461 ' HA ' ' O ' ' A' ' 151' ' ' PHE . 85.3 t80 -62.89 -40.36 97.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.178 -1.374 . . . . 1.2 108.908 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.569 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.38 -56.12 5.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.727 -0.67 . . . . 0.81999999999999995 111.848 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 1.082 HD21 ' HB3' ' A' ' 66' ' ' SER . 1.3 pp -62.14 -51.8 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.57 0.952 . . . . 1.22 113.57 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.434 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -60.3 -25.97 66.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.783 0.801 . . . . 1.1899999999999999 110.361 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.569 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.0 ttp180 -64.28 -50.42 67.96 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.659 -1.155 . . . . 2.2200000000000002 110.131 173.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.49 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.5 t70 -83.24 -53.42 5.77 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.781 0.66 . . . . 0.80000000000000004 112.781 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.484 HG13 ' HA ' ' A' ' 114' ' ' ILE . 4.2 t -84.35 -27.47 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.498 -0.481 . . . . 1.5 110.001 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.44 -21.28 77.72 Favored Glycine 0 C--N 1.328 0.139 0 C-N-CA 120.631 -0.795 . . . . 0.38 111.573 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.49 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.8 -46.69 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.98 -1.489 . . . . 1.6599999999999999 106.98 165.461 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 6.3 m-20 -67.66 -90.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.434 -0.803 . . . . 1.8700000000000001 109.615 162.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -178.16 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.196 0.443 . . . . 1.3500000000000001 112.196 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -93.63 133.08 37.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.204 0.526 . . . . 2.1499999999999999 110.991 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.571 HD11 HD12 ' A' ' 144' ' ' LEU . 2.7 mp -115.87 159.95 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.367 -0.833 . . . . 1.1599999999999999 109.962 -171.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.408 ' N ' HG22 ' A' ' 114' ' ' ILE . 10.3 p-10 -98.81 152.83 19.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.59 -0.892 . . . . 2.1099999999999999 108.59 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.745 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.1 m-85 -138.02 163.86 30.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.96999999999999997 108.339 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 36.2 tt0 -160.58 128.47 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.80000000000000004 110.624 -177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.593 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -99.83 134.51 42.63 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.314 -0.624 . . . . 1.9199999999999999 109.314 174.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.665 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -117.21 102.54 9.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.719 -0.673 . . . . 0.63 109.266 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.579 HD13 HG23 ' A' ' 60' ' ' ILE . 6.4 tp -111.62 120.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.087 0.47 . . . . 1.49 111.154 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.495 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -90.85 126.98 8.62 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.114 -0.794 . . . . 0.26000000000000001 111.114 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.66 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.0 mp -106.89 112.93 26.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.673 0.273 . . . . 1.77 111.241 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.104 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.6 m -114.01 96.68 5.94 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.817 -0.629 . . . . 1.0700000000000001 109.762 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.637 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -111.33 144.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.544 -0.462 . . . . 1.6699999999999999 110.553 -176.853 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -88.57 107.12 18.73 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.163 -1.051 . . . . 1.52 108.163 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.603 HD21 HG22 ' A' ' 55' ' ' ILE . 9.7 mt -106.94 168.08 8.56 Favored Pre-proline 0 C--O 1.222 -0.388 0 O-C-N 125.359 1.662 . . . . 1.9299999999999999 110.236 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.31 -41.98 0.78 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.189 1.926 . . . . 0.98999999999999999 112.982 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.02 -57.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.937 0.347 . . . . 1.6699999999999999 111.937 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.538 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -89.19 -8.16 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.697 0.761 . . . . 1.9099999999999999 109.949 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.504 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.64 -33.78 0.71 Allowed Glycine 0 C--N 1.321 -0.291 0 CA-C-N 114.473 -1.239 . . . . 1.05 112.369 -172.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.538 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -171.99 145.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.419 -1.326 . . . . 1.1599999999999999 107.419 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.611 ' O ' ' HA ' ' A' ' 123' ' ' THR . 4.4 t80 -153.75 146.11 23.94 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.445 -0.502 . . . . 2.2799999999999998 110.125 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.66 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 31.9 m -120.31 107.07 12.5 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.386 0.429 . . . . 1.8899999999999999 111.101 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.433 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.4 pp -126.37 138.03 31.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.96 -0.564 . . . . 1.26 109.936 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.495 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 18.1 Cg_endo -91.69 165.35 3.39 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.386 2.058 . . . . 0.58999999999999997 112.719 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.473 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -164.9 169.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.691 -0.855 . . . . 1.1399999999999999 108.691 178.025 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.3 p -136.52 154.08 50.83 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.375 0.509 . . . . 1.28 112.375 -169.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.4 t -140.58 105.61 4.99 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.716 -1.216 . . . . 1.3400000000000001 107.716 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.62 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.35 149.7 38.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.577 -0.283 . . . . 2.2000000000000002 110.834 -172.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.78 135.39 3.9 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.294 -0.723 . . . . 0.56000000000000005 111.294 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.14 131.84 44.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.652 -0.499 . . . . 2.1000000000000001 109.652 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.34 172.9 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.512 -0.551 . . . . 1.51 109.512 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.414 ' HE3' ' O ' ' A' ' 144' ' ' LEU . 0.5 OUTLIER -61.49 167.09 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.172 0.804 . . . . 3.9300000000000002 113.172 -177.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.81 HD12 ' HD2' ' A' ' 145' ' ' PRO . 32.1 tp -59.19 134.3 87.92 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 114.908 -1.042 . . . . 1.9299999999999999 111.641 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.81 ' HD2' HD12 ' A' ' 144' ' ' LEU . 31.9 Cg_endo -63.56 174.25 3.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.103 2.535 . . . . 0.81000000000000005 112.106 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.3 m -49.78 96.18 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.298 0.571 . . . . 2.3700000000000001 111.326 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -100.0 23.41 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 3.1899999999999999 111.201 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.65 -64.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.282 0.563 . . . . 4.1500000000000004 110.997 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -140.21 3.38 1.96 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.955 0.884 . . . . 4.2800000000000002 109.136 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.52 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 51.3 m-85 -101.0 -70.4 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.087 -0.961 . . . . 3.23 111.508 -168.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 66.0 m-85 . . . . . 0 C--O 1.245 0.847 0 O-C-N 124.387 1.055 . . . . 4.9000000000000004 109.277 -164.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HA ' ' HH ' ' A' ' 51' ' ' TYR . 22.4 ptt? . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.323 -0.251 . . . . 12.4 110.323 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.78 -70.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.07 -0.715 . . . . 9.4700000000000006 109.07 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.798 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 13.3 p 49.78 -88.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.741 1.385 . . . . 7.0899999999999999 114.741 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.02 147.21 25.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 8.8100000000000005 112.14 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.746 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.6 pt? -74.6 -45.63 43.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.56 -0.745 . . . . 10.82 111.126 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.415 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 5.3 m-20 -83.89 83.69 7.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.378 0.609 . . . . 11.69 110.277 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 1.058 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -167.03 128.99 1.68 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.127 -0.942 . . . . 11.81 109.633 -175.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.26 -5.77 3.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.099 -0.5 . . . . 11.779999999999999 111.455 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.21 -18.28 61.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.379 0.609 . . . . 15.99 110.154 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 1.058 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 3.3 t70 -100.77 146.44 27.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.11 -1.07 . . . . 12.69 108.11 169.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.91 12.51 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.287 1.217 . . . . 14.630000000000001 114.287 -163.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.403 HG23 ' OD2' ' A' ' 10' ' ' ASP . 19.7 m -130.11 170.01 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.836 -0.431 . . . . 8.8900000000000006 109.836 171.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.07 -90.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.756 -0.377 . . . . 9.1999999999999993 110.068 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -146.33 69.14 1.19 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.762 0.792 . . . . 8.5999999999999996 110.973 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -86.3 -6.97 58.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.051 -0.522 . . . . 9.3100000000000005 110.435 176.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.9 mt -135.76 107.5 7.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.977 -0.556 . . . . 5.9800000000000004 109.583 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -74.84 -35.35 62.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.523 . . . . 2.98 110.194 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.3 -94.43 0.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 1.8500000000000001 110.906 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.817 HG23 HD13 ' A' ' 126' ' ' LEU . 2.6 pp -146.92 156.33 47.57 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 122.266 -0.271 . . . . 3.6800000000000002 111.096 -177.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -94.86 -13.98 0.73 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.968 2.446 . . . . 2.52 114.699 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 50' ' ' PRO . 61.3 mttp -131.72 145.55 58.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.311 -0.243 . . . . 6.79 111.009 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.38 155.19 55.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.081 2.52 . . . . 3.3799999999999999 111.341 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.639 ' HG2' HD13 ' A' ' 124' ' ' ILE . 2.6 mp0 -119.57 146.05 45.84 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.275 -1.75 . . . . 3.3900000000000001 106.275 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.779 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -110.59 178.52 19.9 Favored Glycine 0 C--N 1.303 -1.29 0 C-N-CA 118.392 -1.861 . . . . 1.0700000000000001 113.35 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.658 ' HB2' HD13 ' A' ' 122' ' ' LEU . 40.7 m -172.03 39.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 1.7 108.382 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 25.1 m -134.87 155.12 37.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.778 -1.101 . . . . 1.53 109.312 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -175.56 -48.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.369 0.507 . . . . 1.05 112.369 168.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -158.5 147.04 18.65 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.049 -0.407 . . . . 1.6899999999999999 111.128 -174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.855 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.83 138.59 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.954 0.407 . . . . 1.8500000000000001 110.336 166.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.29 135.49 48.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 1.8300000000000001 111.332 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.656 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -89.9 137.94 31.91 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 1.46 111.202 -172.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.571 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -137.45 -91.78 0.23 Allowed 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 113.865 1.061 . . . . 1.9199999999999999 113.865 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.571 ' H ' ' HG2' ' A' ' 32' ' ' LYS . 6.8 m-20 -88.48 177.69 6.74 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 121.452 -0.78 . . . . 2.8500000000000001 111.149 -156.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.865 HG23 HG22 ' A' ' 39' ' ' VAL . 4.9 p -165.04 -43.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.787 0.327 . . . . 3.77 111.671 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 5.3 t30 67.33 -10.15 0.36 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.691 0.758 . . . . 3.3500000000000001 110.755 -176.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.61 ' H ' ' C ' ' A' ' 34' ' ' VAL . 10.7 mmt180 82.87 28.73 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.564 1.546 . . . . 6.21 110.313 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -127.75 -33.75 2.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.064 -1.426 . . . . 1.9199999999999999 109.673 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.736 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 35.6 t -168.12 123.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.832 -0.622 . . . . 1.1299999999999999 110.206 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.865 HG22 HG23 ' A' ' 34' ' ' VAL . 12.0 t -76.28 158.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.008 -0.542 . . . . 1.48 109.581 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 1.05 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.5 mt-10 -136.91 141.33 42.71 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.451 -0.781 . . . . 1.1899999999999999 110.932 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.914 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -140.73 134.45 30.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.167 -1.013 . . . . 3.9399999999999999 113.454 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -80.78 110.93 16.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.132 . . . . 1.4299999999999999 108.624 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.855 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -100.28 106.42 18.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.239 0.542 . . . . 1.1100000000000001 110.697 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.28 116.99 24.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.161 0.981 . . . . 3.1800000000000002 109.786 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.573 HG12 ' C ' ' A' ' 25' ' ' SER . 16.1 t -95.97 149.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.214 -1.357 . . . . 1.3999999999999999 110.069 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.543 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 2.2 m -132.46 104.08 6.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.177 -0.609 . . . . 1.1100000000000001 110.67 168.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.3 t -83.04 128.43 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.731 -1.122 . . . . 1.8500000000000001 111.141 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.776 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 17.5 m -109.62 109.5 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.962 -0.563 . . . . 1.1000000000000001 110.323 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.879 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -92.29 133.52 29.86 Favored Pre-proline 0 N--CA 1.466 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.628 ' HG3' ' HG3' ' A' ' 23' ' ' GLU . 40.6 Cg_endo -104.76 22.28 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.453 2.768 . . . . 0.91000000000000003 114.656 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.609 ' HD2' ' HE1' ' A' ' 53' ' ' HIS . 4.1 t80 -116.09 -3.45 12.07 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 118.717 -1.193 . . . . 2.3100000000000001 111.358 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.484 ' CB ' ' HD3' ' A' ' 85' ' ' LYS . 24.6 p 89.89 15.97 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.26 1.024 . . . . 1.8300000000000001 112.404 161.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.609 ' HE1' ' HD2' ' A' ' 51' ' ' TYR . 48.7 p-80 -147.6 148.43 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.968 -0.753 . . . . 2.0299999999999998 108.968 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.865 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 41.7 t -54.32 107.16 0.25 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.244 0.965 . . . . 1.73 112.054 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.939 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.0 pt -74.71 173.02 7.42 Favored Pre-proline 0 C--O 1.206 -1.204 0 N-CA-C 107.767 -1.197 . . . . 1.23 107.767 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.491 ' HB2' HG12 ' A' ' 57' ' ' ILE . 11.0 Cg_endo -90.13 -62.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 CA-C-N 120.192 1.104 . . . . 0.53000000000000003 114.774 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.726 HD12 ' HA ' ' A' ' 79' ' ' PRO . 16.8 mm -131.22 161.35 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.588 -0.445 . . . . 1.9099999999999999 111.43 -165.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.598 ' CB ' HG23 ' A' ' 124' ' ' ILE . 29.3 p -155.96 -177.3 6.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.38 1.086 . . . . 1.95 111.972 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.5 tt0 -135.96 116.37 13.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.017 -1.902 . . . . 1.3600000000000001 109.774 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG21 HD13 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -97.25 110.09 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.238 1.018 . . . . 1.6499999999999999 109.489 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.469 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.5 p -114.42 102.97 10.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.325 -1.761 . . . . 1.02 108.844 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.541 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.3 p90 -113.37 131.65 55.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.517 -0.549 . . . . 0.46000000000000002 109.517 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.478 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 17.6 m -127.94 106.01 8.81 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.736 -1.12 . . . . 1.1699999999999999 109.067 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 72.1 m-85 -96.99 142.49 28.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 110.232 -0.284 . . . . 1.1799999999999999 110.232 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.43 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -129.38 144.85 51.41 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.28 -1.378 . . . . 1.72 107.28 176.737 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.876 ' HB3' HD22 ' A' ' 104' ' ' LEU . 39.1 t -107.77 -96.47 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.902 -1.119 . . . . 1.6599999999999999 111.106 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -63.93 1.1 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.146 -0.687 . . . . 1.1200000000000001 109.146 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.34 17.21 0.18 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 108.511 -1.836 . . . . 0.39000000000000001 108.511 167.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.913 HH11 ' HB3' ' A' ' 103' ' ' ASN . 11.8 ptp180 -114.3 177.47 4.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.303 -0.999 . . . . 2.4900000000000002 108.303 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.13 98.19 8.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.606 0.717 . . . . 2.6099999999999999 109.486 -163.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.855 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.4 mm -54.97 -36.43 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 113.979 -1.464 . . . . 1.1100000000000001 111.912 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.2 161.21 12.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.999 -0.84 . . . . 0.48999999999999999 110.999 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.541 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -159.99 161.77 34.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 117.875 0.837 . . . . 2.3999999999999999 111.24 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.76 162.43 28.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.753 -0.658 . . . . 0.52000000000000002 111.456 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.469 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.7 mttt -123.47 128.62 50.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.649 -0.5 . . . . 2.3799999999999999 109.649 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.466 ' HB ' HD11 ' A' ' 60' ' ' ILE . 80.4 mt -133.56 116.8 14.03 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.268 -0.271 . . . . 1.47 110.268 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.68 101.49 1.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.753 2.302 . . . . 0.81000000000000005 111.115 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -112.85 146.13 34.46 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.509 -0.552 . . . . 0.79000000000000004 109.509 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.726 ' HA ' HD12 ' A' ' 57' ' ' ILE . 35.6 Cg_exo -62.3 86.5 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.028 1.819 . . . . 0.91000000000000003 112.168 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.492 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 36.34 2.58 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.926 -0.579 . . . . 0.47999999999999998 112.671 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.939 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.2 p -73.95 120.29 19.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.297 -0.631 . . . . 0.85999999999999999 109.297 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.879 HD11 ' HB3' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -156.11 161.59 40.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.318 -1.353 . . . . 1.76 114.546 -163.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.51 ' HG3' ' OG1' ' A' ' 88' ' ' THR . 88.6 mttt -22.28 -97.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.883 1.438 . . . . 2.4300000000000002 114.883 -164.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 171.24 109.55 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.252 -1.018 . . . . 1.29 108.252 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.734 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 39.5 pttt 42.15 46.56 3.79 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.008 0.818 . . . . 2.21 110.936 -175.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.574 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.9 t70 -150.04 -171.04 3.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.261 -0.881 . . . . 0.64000000000000001 109.88 -170.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.543 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.9 ttm -119.01 117.93 30.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.514 0.673 . . . . 2.04 110.157 -173.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.639 ' CB ' ' HB2' ' A' ' 82' ' ' LEU . 0.8 OUTLIER -106.12 143.31 34.42 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.839 -1.073 . . . . 1.3300000000000001 111.124 -176.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.0 129.9 34.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.463 0.649 . . . . 1.1100000000000001 110.73 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.43 ' CD2' ' HB ' ' A' ' 45' ' ' VAL . 8.8 tt -135.42 162.05 33.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.398 -1.334 . . . . 1.45 107.398 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.69 138.27 32.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.23 -0.988 . . . . 1.8100000000000001 112.679 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 27.9 mm -100.82 149.92 36.59 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.005 -1.452 . . . . 1.3999999999999999 107.717 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.613 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 11.3 Cg_endo -53.96 -116.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.964 2.443 . . . . 1.0700000000000001 113.686 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 1.05 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.4 m -156.88 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 O-C-N 121.559 -0.713 . . . . 1.1799999999999999 111.729 -169.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' HE2' ' A' ' 62' ' ' PHE . 9.1 p -126.27 101.56 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 116.102 1.89 . . . . 1.1699999999999999 116.102 -163.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.679 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.5 p -152.21 110.66 2.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 121.25 -0.906 . . . . 1.71 111.864 163.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.597 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.0 Cg_exo -54.43 131.81 47.44 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.794 1.663 . . . . 0.65000000000000002 110.942 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.544 ' HE2' ' NH1' ' A' ' 36' ' ' ARG . 24.8 t80 -54.16 -40.64 67.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.53 -0.759 . . . . 1.6899999999999999 111.523 -172.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.4 t -55.88 -26.97 49.66 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.229 0.331 . . . . 1.49 111.785 -176.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.855 HG22 ' HA ' ' A' ' 71' ' ' ILE . 13.3 mm -76.11 -55.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.109 -0.636 . . . . 1.21 110.908 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.94 HD23 HD23 ' A' ' 104' ' ' LEU . 37.9 mt -55.49 -28.48 54.82 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.521 0.677 . . . . 1.6399999999999999 110.344 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.1 t80 -65.49 -39.72 92.25 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.384 -1.28 . . . . 1.2 108.602 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.913 ' HB3' HH11 ' A' ' 69' ' ' ARG . 11.3 m-80 -74.28 -56.56 4.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.936 . . . . 0.81999999999999995 112.307 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.94 HD23 HD23 ' A' ' 101' ' ' LEU . 1.7 pp -60.77 -47.96 83.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.121 0.786 . . . . 1.22 113.121 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.482 ' HB2' HD12 ' A' ' 144' ' ' LEU . . . -63.56 -25.02 68.05 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.844 0.83 . . . . 1.1899999999999999 109.833 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.663 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.15 -54.27 36.33 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.529 -1.214 . . . . 2.2200000000000002 110.274 173.24 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.533 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 18.7 t70 -82.41 -53.19 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.998 0.904 . . . . 0.80000000000000004 111.923 -173.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.43 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 3.4 t -87.55 -27.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 121.639 -0.663 . . . . 1.5 110.042 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.16 -19.76 79.76 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.462 -0.875 . . . . 0.38 111.34 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.533 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -49.14 -46.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.847 -1.538 . . . . 1.6599999999999999 106.847 164.743 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 33.3 m-20 -71.32 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.486 -0.779 . . . . 1.8700000000000001 110.077 162.227 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 179.64 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.192 0.442 . . . . 1.3500000000000001 112.192 174.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -94.89 131.17 41.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 2.1499999999999999 111.821 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.675 HD11 HD11 ' A' ' 144' ' ' LEU . 2.4 mp -120.62 161.33 20.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.954 -0.566 . . . . 1.1599999999999999 109.89 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -99.88 154.6 18.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.783 -0.644 . . . . 2.1099999999999999 109.563 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 83.8 m-85 -140.63 132.14 26.99 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.396 -0.964 . . . . 0.96999999999999997 108.396 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.756 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 23.2 tt0 -131.22 137.15 48.79 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.082 0.468 . . . . 0.80000000000000004 110.307 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 14.9 tp -103.16 131.08 50.45 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.775 -0.648 . . . . 1.9199999999999999 110.256 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.509 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.7 99.5 8.21 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.57 -1.27 . . . . 0.63 107.57 170.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD13 HG21 ' A' ' 60' ' ' ILE . 6.3 tp -113.08 114.89 48.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.348 0.594 . . . . 1.49 111.139 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.511 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.41 128.62 8.84 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.212 -0.755 . . . . 0.26000000000000001 111.212 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.692 ' O ' ' HA ' ' A' ' 133' ' ' THR . 5.7 mp -105.91 102.05 11.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.983 0.421 . . . . 1.77 110.936 -174.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.3 m -107.86 95.17 5.5 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.272 -0.877 . . . . 1.0700000000000001 109.514 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.639 HD13 ' HG2' ' A' ' 23' ' ' GLU . 39.3 pt -113.0 141.97 26.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 C-N-CA 120.146 -0.622 . . . . 1.6699999999999999 110.52 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.477 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 53.8 m-20 -85.73 106.16 16.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.752 -0.833 . . . . 1.52 108.752 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.817 HD13 HG23 ' A' ' 19' ' ' ILE . 45.3 mt -104.02 164.87 14.45 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 124.53 1.143 . . . . 1.9299999999999999 109.878 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HG3' ' CE1' ' A' ' 53' ' ' HIS . 41.4 Cg_endo -69.91 -40.38 5.15 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.415 1.41 . . . . 0.98999999999999999 113.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.798 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 98.9 t -74.07 -58.41 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.374 0.509 . . . . 1.6699999999999999 112.374 -173.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.669 HG12 ' HB2' ' A' ' 132' ' ' PHE . 9.7 p -90.21 -7.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.172 0.987 . . . . 1.9099999999999999 110.05 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.92 -30.9 0.76 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 114.248 -1.342 . . . . 1.05 112.516 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.505 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.0 pt-20 -166.86 126.59 1.5 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 1.1599999999999999 108.716 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.669 ' HB2' HG12 ' A' ' 129' ' ' VAL . 13.0 t80 -123.71 135.63 53.98 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.428 -0.582 . . . . 2.2799999999999998 109.428 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.692 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.9 t -128.05 103.22 7.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.921 0.867 . . . . 1.8899999999999999 111.844 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.64 143.9 49.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.236 -0.893 . . . . 1.26 110.227 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.511 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 80.9 Cg_endo -92.49 162.74 2.95 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.783 1.656 . . . . 0.58999999999999997 113.597 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.426 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.74 168.54 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.112 -1.44 . . . . 1.1399999999999999 107.112 178.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 99.1 p -145.64 152.18 39.25 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.335 -0.546 . . . . 1.28 111.845 -168.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -146.98 113.13 5.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.784 -0.821 . . . . 1.3400000000000001 108.784 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.756 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 6.8 ptmm? -123.88 153.37 41.22 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.08 -0.248 . . . . 2.2000000000000002 111.378 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.45 143.57 8.65 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.371 -0.692 . . . . 0.56000000000000005 111.371 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -108.54 132.13 54.14 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.03 -0.585 . . . . 2.1000000000000001 110.418 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.31 173.45 2.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.473 -1.306 . . . . 1.51 107.473 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -63.94 172.63 2.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.217 0.532 . . . . 3.9300000000000002 112.332 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.675 HD11 HD11 ' A' ' 114' ' ' ILE . 15.7 tp -58.97 139.85 87.07 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.316 -0.856 . . . . 1.9299999999999999 111.306 -175.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.511 ' HD2' HD11 ' A' ' 144' ' ' LEU . 37.3 Cg_endo -65.9 172.87 7.76 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.973 2.449 . . . . 0.81000000000000005 112.449 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 t -60.4 125.12 22.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.506 0.669 . . . . 2.3700000000000001 111.469 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.565 ' CE1' HD21 ' A' ' 144' ' ' LEU . 5.3 p90 -154.11 161.43 41.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 3.1899999999999999 109.602 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -151.04 75.09 1.18 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.569 -0.53 . . . . 4.1500000000000004 109.569 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 66.98 11.27 8.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.434 -0.803 . . . . 4.2800000000000002 110.72 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 26.1 m-85 -108.78 -43.45 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 3.23 110.574 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.42 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 59.6 m-85 . . . . . 0 C--O 1.253 1.252 0 CA-C-O 117.652 -1.166 . . . . 4.9000000000000004 109.122 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . 1.8 mpt? . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.845 0.355 . . . . 12.4 110.269 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.34 145.54 48.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.204 -0.453 . . . . 9.4700000000000006 110.274 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.445 ' HA ' ' HA ' ' A' ' 20' ' ' PRO . 8.9 m -77.26 8.51 3.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.402 -0.363 . . . . 7.0899999999999999 111.353 -177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.5 tp 73.0 -54.5 0.69 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.806 0.842 . . . . 8.8100000000000005 111.36 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.35 -2.69 26.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.174 0.511 . . . . 10.82 110.592 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.82 -20.75 62.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.13 -0.941 . . . . 11.69 111.269 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HG3' ' H ' ' A' ' 8' ' ' ALA . 52.5 pttt -47.55 -63.38 1.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.655 -0.702 . . . . 11.81 112.681 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.494 ' H ' ' HG3' ' A' ' 7' ' ' LYS . . . -178.55 163.06 1.49 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 122.206 0.202 . . . . 11.779999999999999 110.893 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.17 142.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 O-C-N 124.206 0.941 . . . . 15.99 113.427 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 72.43 127.0 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.757 -1.11 . . . . 12.69 112.354 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.564 ' CD2' HG21 ' A' ' 12' ' ' VAL . 4.2 t80 59.64 -156.19 0.34 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.327 -0.851 . . . . 14.630000000000001 109.964 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.637 HG22 ' HB2' ' A' ' 15' ' ' LYS . 31.4 m -80.28 -31.98 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.362 0.125 . . . . 8.8900000000000006 111.222 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.04 -59.87 0.47 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.14 0.793 . . . . 9.1999999999999993 113.14 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -31.56 62.96 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.681 0.277 . . . . 8.5999999999999996 111.095 -174.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.637 ' HB2' HG22 ' A' ' 12' ' ' VAL . 44.9 mmtm -75.52 136.69 40.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.256 -0.646 . . . . 9.3100000000000005 109.256 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.67 88.65 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.239 0.542 . . . . 5.9800000000000004 110.314 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -74.03 -47.88 33.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 2.98 110.139 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.487 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . -139.29 176.09 9.01 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.8500000000000001 110.416 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 126' ' ' LEU . 6.9 tp -83.91 149.34 56.25 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.419 -0.81 . . . . 3.6800000000000002 109.571 -176.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.539 ' HD2' ' CD1' ' A' ' 19' ' ' ILE . 72.4 Cg_exo -43.87 141.66 4.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.849 2.366 . . . . 2.52 113.382 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.577 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 63.7 mttm -70.27 -34.18 3.88 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 114.17 1.174 . . . . 6.79 114.17 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.577 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 33.8 Cg_endo -65.55 75.94 0.28 Allowed 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.46 1.44 . . . . 3.3799999999999999 113.808 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 48' ' ' THR . 8.7 mt-10 -123.08 137.09 55.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.414 -2.81 . . . . 3.3900000000000001 103.414 169.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.714 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -108.01 -179.68 21.93 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 117.648 -2.215 . . . . 1.0700000000000001 114.726 -171.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.693 ' HB2' HD12 ' A' ' 122' ' ' LEU . 22.5 m -169.83 34.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.841 1.256 . . . . 1.7 108.294 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' SER . 23.1 m -134.94 156.31 39.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.369 -1.287 . . . . 1.53 109.191 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -173.47 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.211 0.448 . . . . 1.05 112.211 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.838 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 15.6 t70 -160.67 157.01 26.38 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.825 -0.35 . . . . 1.6899999999999999 111.004 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.4 t -142.45 134.97 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.693 -0.855 . . . . 1.8500000000000001 108.693 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.586 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 25.0 t70 -125.2 132.22 53.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 111.078 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.42 HD21 ' N ' ' A' ' 32' ' ' LYS . 2.8 tm? -101.17 127.5 47.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 1.46 111.55 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.468 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.08 -115.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.613 -0.722 . . . . 1.9199999999999999 110.05 168.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.91 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.4 p-10 171.66 175.31 0.08 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 110.409 -0.219 . . . . 2.8500000000000001 110.409 -173.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.586 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -154.16 96.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.539 0.685 . . . . 3.77 111.105 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . 0.501 HD21 ' HB2' ' A' ' 37' ' ' ASP . 11.0 t30 69.47 -97.35 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.696 -0.683 . . . . 3.3500000000000001 109.267 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.23 32.31 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.246 -1.39 . . . . 6.21 107.246 172.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' HB2' HD21 ' A' ' 35' ' ' ASN . 2.0 t70 -101.6 -44.2 5.65 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 112.595 -2.093 . . . . 1.9199999999999999 105.628 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.593 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 29.7 t -147.61 179.07 7.95 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 110.724 -2.944 . . . . 1.1299999999999999 105.818 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.91 HG13 ' HA ' ' A' ' 33' ' ' ASP . 8.2 t -131.33 159.83 42.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.154 -0.684 . . . . 1.48 109.154 170.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.866 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 90.9 mt-10 -114.07 134.55 54.79 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.456 0.646 . . . . 1.1899999999999999 112.386 -169.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.738 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -121.73 106.08 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.841 -1.072 . . . . 3.9399999999999999 110.237 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.604 HD21 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -74.11 110.34 8.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.144 -1.058 . . . . 1.4299999999999999 108.144 175.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' HB ' ' A' ' 92' ' ' ILE . . . -98.63 110.17 22.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.468 0.651 . . . . 1.1100000000000001 110.182 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 22.8 ttmt -87.99 117.35 26.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.692 -1.14 . . . . 3.1800000000000002 109.342 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.691 HG13 ' O ' ' A' ' 25' ' ' SER . 61.6 t -105.78 143.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.292 -0.867 . . . . 1.3999999999999999 111.038 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.676 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 4.8 m -134.89 97.39 3.74 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.482 -0.562 . . . . 1.1100000000000001 109.482 166.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.714 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -86.49 126.68 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.454 0.645 . . . . 1.8500000000000001 110.973 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.673 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.4 m -101.78 118.01 36.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.886 -1.052 . . . . 1.1000000000000001 110.159 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . 0.694 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 20.4 t30 -89.5 124.07 65.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 O-C-N 124.669 1.231 . . . . 1.48 109.472 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.29 2.27 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.495 2.797 . . . . 0.91000000000000003 115.34 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.78 ' CE2' ' HB2' ' A' ' 53' ' ' HIS . 7.2 p90 -134.77 163.03 30.72 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.685 -0.634 . . . . 2.3100000000000001 109.774 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.578 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 51.8 p -81.24 21.47 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.848 1.055 . . . . 1.8300000000000001 113.848 -164.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.78 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 37.0 m80 -131.21 129.97 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.967 -0.693 . . . . 2.0299999999999998 111.357 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.2 m -39.54 110.62 0.15 Allowed 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 124.512 1.125 . . . . 1.73 113.056 170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.942 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.5 pt -73.03 170.37 13.97 Favored Pre-proline 0 C--O 1.211 -0.934 0 N-CA-C 107.83 -1.174 . . . . 1.23 107.83 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.424 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 7.6 Cg_endo -87.8 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.223 1.282 . . . . 0.53000000000000003 113.327 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.91 HG12 ' HA ' ' A' ' 79' ' ' PRO . 21.7 mt -142.53 155.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.25 0.463 . . . . 1.9099999999999999 112.25 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' CYS . . . . . 0.763 ' HB3' HG23 ' A' ' 124' ' ' ILE . 21.0 p -142.28 -177.4 5.23 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.042 0.925 . . . . 1.95 110.903 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 1.068 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.1 tt0 -136.4 115.05 11.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.744 -1.571 . . . . 1.3600000000000001 109.992 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.726 HG23 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.69 109.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.359 1.076 . . . . 1.6499999999999999 109.738 167.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 28.7 p -113.55 102.71 10.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.674 -1.603 . . . . 1.02 108.799 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.466 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 15.8 p90 -115.49 134.91 54.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.353 0.597 . . . . 0.46000000000000002 110.478 -164.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.424 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 19.5 m -131.65 111.01 11.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.616 -1.174 . . . . 1.1699999999999999 109.176 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.56 ' CZ ' HD12 ' A' ' 118' ' ' LEU . 92.2 m-85 -97.27 139.66 32.9 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.111 -0.495 . . . . 1.1799999999999999 110.189 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.523 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 7.6 m170 -130.83 145.55 52.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.821 -1.177 . . . . 1.72 107.821 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD21 ' A' ' 104' ' ' LEU . 29.7 t -107.74 -99.5 0.36 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.642 -0.823 . . . . 1.6599999999999999 111.206 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -55.86 25.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.01 -0.737 . . . . 1.1200000000000001 109.01 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.09 18.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.459 -1.856 . . . . 0.39000000000000001 108.459 164.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . 0.417 ' HD2' ' HB3' ' A' ' 104' ' ' LEU . 8.4 ptp180 -114.07 171.02 7.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.17 -1.015 . . . . 2.4900000000000002 108.603 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.72 94.1 7.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.091 0.948 . . . . 2.6099999999999999 110.324 -166.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.725 ' HA ' HG22 ' A' ' 100' ' ' ILE . 1.1 mm -48.75 -44.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.389 -1.732 . . . . 1.1100000000000001 112.112 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.81 168.59 41.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.925 -1.131 . . . . 0.48999999999999999 111.718 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.76 155.57 19.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.211 0.506 . . . . 2.3999999999999999 110.862 176.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.14 155.11 19.82 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.593 -1.003 . . . . 0.52000000000000002 110.593 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -132.35 119.71 21.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.496 -0.557 . . . . 2.3799999999999999 109.496 179.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . 0.609 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.2 mt -133.45 116.05 13.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 1.47 110.986 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.29 111.8 3.29 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.265 1.977 . . . . 0.81000000000000005 110.141 168.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.42 ' O ' HG21 ' A' ' 57' ' ' ILE . 20.8 t70 -115.87 144.75 33.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.771 -0.455 . . . . 0.79000000000000004 109.771 -173.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.91 ' HA ' HG12 ' A' ' 57' ' ' ILE . 17.9 Cg_endo -61.34 73.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.815 2.343 . . . . 0.91000000000000003 111.794 172.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.564 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -76.47 35.45 1.36 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.333 -0.849 . . . . 0.47999999999999998 113.605 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.942 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.7 p -73.67 119.7 18.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.272 -0.64 . . . . 0.85999999999999999 109.272 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.643 HD22 HG12 ' A' ' 55' ' ' ILE . 1.1 pt? -140.18 -164.47 1.72 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.087 -1.445 . . . . 1.76 114.176 -161.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.426 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 90.3 mttt -54.82 -93.89 0.0 OUTLIER 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.735 0.643 . . . . 2.4300000000000002 112.735 -173.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 83' ' ' LYS . . . 162.32 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.929 -1.137 . . . . 1.29 107.929 -171.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 41.8 pttt 42.32 47.46 4.19 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 124.305 1.003 . . . . 2.21 111.338 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 87' ' ' MET . 5.9 t70 -151.1 -170.41 3.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.282 -0.872 . . . . 0.64000000000000001 109.596 -173.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.676 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 12.0 ttt -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.889 -0.596 . . . . 2.04 110.256 -170.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.633 ' O ' ' HA ' ' A' ' 46' ' ' SER . 4.7 t -105.31 142.59 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.093 0.473 . . . . 1.3300000000000001 110.659 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -89.41 105.91 18.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.709 0.766 . . . . 1.1100000000000001 110.336 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.598 HD21 HG12 ' A' ' 45' ' ' VAL . 7.6 tt -104.23 168.29 9.2 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.11 -1.441 . . . . 1.45 107.11 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -141.75 143.22 33.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 119.252 0.933 . . . . 1.8100000000000001 111.874 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.727 ' HB ' ' HB2' ' A' ' 43' ' ' ALA . 33.5 mm -106.4 120.72 47.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.825 -1.176 . . . . 1.3999999999999999 107.825 170.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.604 ' O ' HD21 ' A' ' 42' ' ' LEU . 46.0 Cg_exo -30.87 -97.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.811 3.674 . . . . 1.0700000000000001 114.753 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.866 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.7 93.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 O-C-N 122.474 -0.141 . . . . 1.1799999999999999 110.669 -179.066 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.42 ' O ' HG12 ' A' ' 95' ' ' VAL . 7.4 p -127.17 103.65 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.448 1.277 . . . . 1.1699999999999999 114.448 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.436 ' CG2' HD11 ' A' ' 71' ' ' ILE . 1.8 p -152.14 98.19 2.95 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 122.108 -0.37 . . . . 1.71 110.519 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.687 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 69.3 Cg_exo -50.58 128.87 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.265 1.976 . . . . 0.65000000000000002 111.828 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.593 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.2 t80 -48.63 -40.18 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.398 -0.819 . . . . 1.6899999999999999 111.609 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.9 m -58.92 -28.77 66.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.334 0.494 . . . . 1.49 112.334 -175.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.725 HG22 ' HA ' ' A' ' 71' ' ' ILE . 5.9 mm -76.32 -55.02 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.095 -0.642 . . . . 1.21 110.001 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.69 HD21 HD12 ' A' ' 104' ' ' LEU . 35.7 mt -50.25 -28.16 7.24 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.97 0.794 . . . . 1.6399999999999999 110.8 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -65.11 -44.68 87.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.93 -1.032 . . . . 1.2 109.274 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.77 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.0 m-80 -73.57 -58.08 3.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 0.81999999999999995 112.197 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.991 HD21 ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -59.38 -54.57 45.16 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.135 0.791 . . . . 1.22 113.135 -178.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.518 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.5 -24.28 67.75 Favored 'General case' 0 C--O 1.217 -0.605 0 CA-C-O 121.753 0.787 . . . . 1.1899999999999999 110.532 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.77 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.2 ttp180 -64.69 -44.27 90.85 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.717 -1.129 . . . . 2.2200000000000002 110.878 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . 0.643 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 31.5 t70 -85.16 -52.29 6.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.99 0.9 . . . . 0.80000000000000004 111.411 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.916 HG22 HG22 ' A' ' 114' ' ' ILE . 28.7 m -76.71 -30.87 19.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.802 -0.635 . . . . 1.5 110.18 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -79.03 -15.87 79.81 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.869 -1.059 . . . . 0.38 111.681 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.643 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.99 -42.15 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.253 -1.758 . . . . 1.6599999999999999 106.253 162.098 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . 0.5 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 37.3 m-20 -75.53 -85.25 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.8700000000000001 110.289 157.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.463 ' O ' HD21 ' A' ' 144' ' ' LEU . 4.4 p-90 173.9 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.092 0.557 . . . . 1.3500000000000001 112.393 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.39 134.19 35.88 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.408 -0.517 . . . . 2.1499999999999999 111.941 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.916 HG22 HG22 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -116.68 151.68 18.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.097 0.475 . . . . 1.1599999999999999 109.807 178.455 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -101.35 154.13 19.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.389 -0.823 . . . . 2.1099999999999999 108.878 173.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.627 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 51.8 m-85 -140.91 160.04 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.198 -0.668 . . . . 0.96999999999999997 109.198 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.568 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 26.4 tt0 -152.08 132.02 13.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.953 -0.388 . . . . 0.80000000000000004 109.953 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.56 HD12 ' CZ ' ' A' ' 64' ' ' PHE . 9.8 tp -101.58 132.35 47.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.184 -0.462 . . . . 1.9199999999999999 110.399 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLN . . . . . 0.587 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -117.89 99.55 6.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.971 -0.752 . . . . 0.63 108.971 175.182 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.47 121.58 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.557 0.694 . . . . 1.49 110.714 -173.83 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.711 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -89.36 129.23 9.57 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.319 -0.855 . . . . 0.26000000000000001 111.891 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.707 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.1 mp -101.01 109.36 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.841 0.353 . . . . 1.77 110.954 -174.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . 1.068 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.0 m -114.87 96.71 5.85 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.731 -0.668 . . . . 1.0700000000000001 109.702 175.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.763 HG23 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.06 134.35 52.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 120.314 -0.554 . . . . 1.6699999999999999 111.482 -176.677 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.03 106.81 11.33 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.143 -1.058 . . . . 1.52 108.143 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.742 HD11 HG21 ' A' ' 19' ' ' ILE . 19.5 mt -116.04 170.46 5.74 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.457 1.098 . . . . 1.9299999999999999 110.705 -171.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 91.0 Cg_endo -84.7 -23.76 2.54 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 121.915 1.744 . . . . 0.98999999999999999 112.283 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 19' ' ' ILE . 22.8 t -74.85 -57.86 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 1.6699999999999999 111.764 -175.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.543 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -107.07 -1.58 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.928 0.871 . . . . 1.9099999999999999 109.787 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.544 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.75 -28.12 0.91 Allowed Glycine 0 C--O 1.225 -0.463 0 CA-C-N 114.207 -1.36 . . . . 1.05 111.833 -171.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.543 ' H ' ' C ' ' A' ' 129' ' ' VAL . 9.6 pt-20 -165.58 138.25 4.25 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.344 -1.354 . . . . 1.1599999999999999 107.344 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . 0.431 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.2 t80 -132.41 128.72 38.14 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.664 -0.865 . . . . 2.2799999999999998 108.664 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.707 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 14.0 t -120.97 101.04 7.42 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.293 1.044 . . . . 1.8899999999999999 111.367 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.2 pp -127.21 132.8 24.49 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.993 -1.003 . . . . 1.26 109.84 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PRO . . . . . 0.711 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 2.5 Cg_endo -85.66 161.76 10.76 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.9 1.733 . . . . 0.58999999999999997 112.242 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.401 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -155.61 166.6 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 108.114 -1.069 . . . . 1.1399999999999999 108.114 179.74 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.1 m -134.96 148.04 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.788 -0.365 . . . . 1.28 110.987 -170.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 t -141.65 103.5 4.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.228 -1.027 . . . . 1.3400000000000001 108.228 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -107.99 147.24 31.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.055 -0.52 . . . . 2.2000000000000002 110.599 -175.416 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.83 135.9 4.45 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.766 -0.73 . . . . 0.56000000000000005 111.326 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.54 130.05 52.54 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.47 -0.566 . . . . 2.1000000000000001 109.47 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 174.81 6.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.462 -0.94 . . . . 1.51 108.462 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.482 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -68.69 171.65 7.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.375 0.509 . . . . 3.9300000000000002 112.375 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.748 HD22 HD13 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -56.36 128.93 74.38 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.232 -0.895 . . . . 1.9299999999999999 110.635 -176.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' PRO . . . . . 0.539 ' HD2' HD22 ' A' ' 144' ' ' LEU . 31.7 Cg_endo -63.66 173.82 4.22 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.544 2.829 . . . . 0.81000000000000005 113.392 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.7 m -47.92 104.23 0.05 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.464 -0.789 . . . . 2.3700000000000001 111.602 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CD1' HD12 ' A' ' 144' ' ' LEU . 10.5 p90 -130.77 162.15 30.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.405 -0.361 . . . . 3.1899999999999999 110.688 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 23.9 ttmm 174.04 76.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.077 0.861 . . . . 4.1500000000000004 109.653 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 65.39 7.13 4.07 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.884 -0.598 . . . . 4.2800000000000002 111.419 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' HB3' ' HH ' ' A' ' 98' ' ' TYR . 23.2 m-85 -83.78 -48.57 9.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.211 -1.033 . . . . 3.23 108.211 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 9.4 p90 . . . . . 0 C--O 1.246 0.913 0 CA-C-N 114.424 -1.262 . . . . 4.9000000000000004 108.521 172.082 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.718 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 116.249 1.259 . . . . 0.54 116.249 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.746 ' HB2' HD11 ' A' ' 122' ' ' LEU . 23.9 m -169.51 33.14 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.105 -1.548 . . . . 1.2 107.215 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.06 155.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.338 -1.301 . . . . 0.93 109.051 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -174.92 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.182 0.438 . . . . 0.48 112.182 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 9.1 t70 -152.72 153.84 34.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.773 0.26 . . . . 1.69 110.464 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 85.1 t -141.32 123.11 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.797 -0.446 . . . . 1.14 109.797 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 33.0 t70 -113.93 108.72 17.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.757 -0.656 . . . . 1.83 111.017 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.3 tm? -83.06 140.05 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.94 110.488 -177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.605 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -138.68 -91.59 0.2 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.627 0.973 . . . . 1.33 113.627 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.754 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.309 -1.189 0 O-C-N 121.589 -0.694 . . . . 2.85 111.952 -152.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.432 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 5.7 t . . . . . 0 C--O 1.239 0.544 0 N-CA-C 112.926 0.713 . . . . 0.94 112.926 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 61.0 t -75.86 148.85 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.243 -0.89 . . . . 0.86 109.388 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 61.8 mt-10 -124.05 142.75 50.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.299 -0.96 . . . . 1.19 111.209 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.954 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 11.5 p90 -133.51 131.71 40.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.269 -0.972 . . . . 3.73 112.365 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 111.95 23.73 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.213 -1.032 . . . . 0.81 108.213 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.08 118.67 34.01 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.176 -0.61 . . . . 0.42 110.739 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 17.5 tppt? -84.68 116.9 23.47 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.501 -0.925 . . . . 2.63 108.501 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 25' ' ' SER . 37.2 t -100.99 145.42 11.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.82 110.177 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -129.34 100.21 5.5 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.22 0.533 . . . . 0.72 110.05 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -83.02 121.64 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.879 -1.055 . . . . 1.14 110.136 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 87' ' ' MET . 13.3 m -102.63 113.05 26.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.163 -0.68 . . . . 0.41 109.163 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.772 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 8.7 t30 -88.36 128.93 51.35 Favored Pre-proline 0 N--CA 1.466 0.347 0 O-C-N 124.533 1.146 . . . . 1.48 109.961 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.58 13.52 2.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.73 114.389 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -130.9 142.42 50.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.392 -0.596 . . . . 2.08 109.392 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.611 ' HB3' ' HD2' ' A' ' 85' ' ' LYS . 56.8 p -74.88 31.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.881 0.697 . . . . 1.51 112.881 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -145.12 128.99 17.37 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.245 -0.284 . . . . 1.67 110.738 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -39.88 110.22 0.14 Allowed 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 124.258 1.023 . . . . 1.39 112.412 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HD11 ' A' ' 82' ' ' LEU . 4.1 pt -79.62 173.31 7.93 Favored Pre-proline 0 C--O 1.201 -1.48 0 N-CA-C 106.111 -1.811 . . . . 1.03 106.111 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.505 ' C ' HD12 ' A' ' 57' ' ' ILE . 9.4 Cg_endo -92.75 -62.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 121.326 1.509 . . . . 0.37 114.408 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.6 HG13 ' HA ' ' A' ' 79' ' ' PRO . 1.4 mp -134.26 153.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.274 -0.421 . . . . 1.23 110.796 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 124' ' ' ILE . 21.0 m -140.76 178.95 6.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.886 0.851 . . . . 1.15 111.503 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.087 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 42.0 tt0 -133.77 115.53 14.65 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.906 -1.497 . . . . 1.36 110.249 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.621 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.59 110.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 122.533 1.159 . . . . 1.05 110.378 169.81 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 120' ' ' ILE . 14.2 t -113.3 102.74 10.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.196 -1.82 . . . . 0.83 108.636 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.536 ' HE1' HG11 ' A' ' 95' ' ' VAL . 6.6 p90 -113.66 133.44 55.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.418 0.628 . . . . 0.4 110.029 -167.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 27.2 m -126.14 104.77 8.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.675 -1.148 . . . . 0.38 108.399 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 4.4 m-85 -95.42 143.17 26.99 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.2 -0.454 . . . . 0.96 110.191 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -132.11 145.63 51.52 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 107.107 -1.442 . . . . 1.29 107.107 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.936 ' HB3' HD22 ' A' ' 104' ' ' LEU . 19.9 t -103.84 -91.17 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.631 -1.228 . . . . 1.27 111.158 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -69.07 0.17 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.85 0.357 . . . . 0.36 110.159 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.67 15.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.461 -1.456 . . . . 0.39 109.461 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -100.17 -78.31 0.51 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.516 -0.842 . . . . 1.97 109.041 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.664 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -171.4 -177.34 2.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.141 -1.059 . . . . 2.61 108.141 171.888 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 96' ' ' VAL . 1.6 mm -135.18 -35.77 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.363 -0.835 . . . . 0.4 109.556 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 160.5 171.98 27.16 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.281 -1.128 . . . . 0.49 110.281 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -161.18 166.13 28.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.124 0.962 . . . . 1.81 110.766 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.01 166.02 32.19 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.359 -0.696 . . . . 0.43 111.359 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -129.33 129.51 44.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.897 -0.409 . . . . 1.72 109.897 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.8 mt -139.23 121.64 10.31 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.782 0.325 . . . . 0.73 110.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.7 115.4 4.32 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.432 2.088 . . . . 0.57 110.76 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.13 141.61 39.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.79 109.375 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 57' ' ' ILE . 23.5 Cg_exo -63.88 82.66 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.593 2.195 . . . . 0.58 112.052 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -87.85 41.97 3.09 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.692 -0.685 . . . . 0.4 112.14 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.801 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 44.4 t -73.45 133.74 43.77 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.208 -1.034 . . . . 0.62 108.208 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.823 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -152.81 -156.93 0.75 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 118.201 -1.4 . . . . 1.1 114.641 -163.812 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.521 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 64.9 mttm -63.82 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 1.84 112.173 -173.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.4 106.09 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.75 -0.833 . . . . 0.99 108.75 -171.543 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 6.5 ptmm? 46.35 46.25 13.65 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.28 0.988 . . . . 1.84 111.348 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.39 -170.68 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.757 -1.11 . . . . 0.64 109.545 -173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 50.1 ttm -112.0 132.17 54.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 1.35 110.947 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -122.94 146.5 47.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.806 -0.633 . . . . 0.77 110.049 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.05 137.09 32.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.24 0.543 . . . . 0.48 110.696 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 45' ' ' VAL . 7.2 tt -137.72 168.35 19.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.41 -0.959 . . . . 0.77 108.41 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -132.39 140.95 48.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.734 0.642 . . . . 1.81 112.734 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 43.4 mm -110.94 143.51 28.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.65 108.159 172.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.75 -121.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.787 2.991 . . . . 1.07 114.147 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.975 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -157.37 88.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.849 -0.532 . . . . 0.46 111.891 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' HE1' ' A' ' 62' ' ' PHE . 12.3 p -127.39 101.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 115.412 1.634 . . . . 0.48 115.412 -168.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.575 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.2 p -150.96 98.76 3.13 Favored Pre-proline 0 C--N 1.315 -0.898 0 O-C-N 121.501 -0.749 . . . . 1.07 110.489 164.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HB2' HG12 ' A' ' 100' ' ' ILE . 51.9 Cg_exo -52.59 134.02 51.59 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.064 1.842 . . . . 0.48 111.418 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.5 t80 -57.2 -33.28 67.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 1.31 111.204 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 26.5 m -58.04 -32.02 67.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.926 0.343 . . . . 1.2 111.926 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.493 HG21 ' HG2' ' A' ' 70' ' ' GLU . 9.6 mm -76.9 -56.32 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.502 -0.479 . . . . 0.51 110.695 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -51.24 -27.87 10.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.563 171.463 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 63.2 t80 -65.45 -38.67 90.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.09 -1.413 . . . . 0.96 108.803 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.648 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 36.1 m-80 -74.47 -57.77 3.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.935 -0.575 . . . . 0.82 111.758 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.936 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.2 pp -62.29 -51.42 67.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.56 0.948 . . . . 0.65 113.56 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.407 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.24 -24.43 65.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.797 0.808 . . . . 0.43 110.536 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.3 ttm180 -59.1 -52.04 67.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.917 -1.038 . . . . 1.81 110.191 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 22.2 t70 -82.83 -51.34 7.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.6 0.714 . . . . 0.8 111.948 -173.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 2.7 t -86.87 -27.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 121.872 -0.518 . . . . 0.88 110.425 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.0 -20.43 79.43 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.739 -0.743 . . . . 0.38 111.692 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -48.45 -46.33 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.824 -1.547 . . . . 1.09 106.824 163.593 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 12.0 t70 -67.09 -90.41 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.477 -0.783 . . . . 1.87 109.088 160.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 172.44 -45.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.352 0.661 . . . . 1.17 111.17 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.55 127.32 42.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 2.15 111.246 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 144' ' ' LEU . 2.3 mp -124.78 158.54 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.697 -0.483 . . . . 0.39 109.697 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 23.3 t70 -97.58 155.39 16.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.326 -0.99 . . . . 2.11 108.326 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.758 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 47.4 m-85 -136.36 121.83 19.45 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.233 -0.654 . . . . 0.62 109.233 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.868 ' HG3' ' HG2' ' A' ' 139' ' ' LYS . 7.9 tt0 -113.08 132.66 55.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.128 -0.323 . . . . 0.8 110.128 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.739 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 15.8 tp -102.07 128.83 48.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.219 -0.446 . . . . 1.25 110.053 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.3 tp60 -111.18 99.55 8.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.976 -1.12 . . . . 0.63 107.976 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 60' ' ' ILE . 5.4 tp -113.17 117.79 56.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.321 0.582 . . . . 0.81 111.099 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 120.62 5.27 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.104 -0.798 . . . . 0.26 111.104 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 25' ' ' SER . 5.2 mp -97.76 98.55 9.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.123 0.487 . . . . 1.2 111.164 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.087 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.2 m -100.11 121.14 40.95 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.384 -0.969 . . . . 0.32 108.384 169.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.73 HG22 ' SG ' ' A' ' 58' ' ' CYS . 11.0 pt -133.68 132.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.538 -0.465 . . . . 0.98 110.355 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.26 107.03 11.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.194 -1.039 . . . . 1.52 108.194 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.568 HD23 HG21 ' A' ' 55' ' ' ILE . 11.1 mt -115.73 160.83 33.42 Favored Pre-proline 0 C--O 1.219 -0.522 0 O-C-N 124.715 1.26 . . . . 1.28 110.769 -169.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.75 -23.8 16.32 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.89 1.727 . . . . 0.74 112.152 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -57.59 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.259 -0.428 . . . . 1.12 112.093 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -109.17 1.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.033 0.921 . . . . 1.35 109.897 -175.34 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.79 -32.49 0.88 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.09 -1.414 . . . . 1.05 111.682 -171.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -175.75 146.29 0.73 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.456 -1.312 . . . . 1.16 107.456 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 14.6 t80 -150.82 146.32 26.29 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.422 -0.511 . . . . 1.91 110.004 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 37.4 m -121.27 110.39 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.913 0.387 . . . . 1.19 111.221 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.15 133.9 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.5 109.355 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 38.3 Cg_endo -91.54 162.29 3.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.873 1.715 . . . . 0.45 113.28 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.17 167.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.245 -1.02 . . . . 0.44 108.245 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -137.81 150.4 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.662 -0.125 . . . . 0.88 110.662 -167.844 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.7 t -148.6 102.38 3.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.623 -0.51 . . . . 0.96 109.623 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.868 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -99.11 144.5 28.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.847 -0.615 . . . . 1.76 110.936 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.37 130.42 3.07 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.478 -0.649 . . . . 0.5 111.478 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 24.0 mt-10 -98.9 125.29 44.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.662 -0.496 . . . . 2.1 109.662 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 172.68 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.841 -1.17 . . . . 0.76 107.841 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -67.23 141.29 57.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.883 -0.414 . . . . 3.53 109.883 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.2 pp -60.35 163.83 7.87 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.366 -0.379 . . . . 1.23 111.505 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 144' ' ' LEU . 15.9 Cg_endo . . . . . 0 C--N 1.353 0.808 0 C-N-CA 123.504 2.803 . . . . 0.71 113.804 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.549 0 N-CA-C 115.881 1.113 . . . . 0.54 115.881 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG13 ' A' ' 45' ' ' VAL . 93.2 p -166.57 36.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.776 -1.564 . . . . 1.2 106.776 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 46' ' ' SER . 13.4 m -134.52 154.03 36.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.646 -1.615 . . . . 0.93 109.237 -169.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 2.4 t -175.12 -50.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.245 0.461 . . . . 0.48 112.245 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 16.3 t70 -152.19 157.13 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.912 -0.493 . . . . 1.69 111.36 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 75.1 t -147.33 124.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.379 -0.373 . . . . 1.14 110.719 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -107.13 142.03 37.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 1.83 110.454 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.0 tm? -97.85 141.04 31.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.34 -0.615 . . . . 0.94 109.34 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.778 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -135.45 -115.21 0.19 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 114.366 1.247 . . . . 1.33 114.366 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 11.7 m-20 . . . . . 0 C--O 1.203 -1.368 0 O-C-N 121.653 -0.654 . . . . 2.85 111.823 -156.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 7.2 t . . . . . 0 N--CA 1.441 -0.897 0 CA-C-O 121.15 0.5 . . . . 0.94 110.556 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.674 HG21 HD12 ' A' ' 101' ' ' LEU . 41.8 t -87.64 155.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.606 -0.725 . . . . 0.86 109.495 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.947 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 70.6 mt-10 -118.94 151.12 38.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 122.004 -0.435 . . . . 1.19 110.457 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE2' ' HB2' ' A' ' 43' ' ' ALA . 24.3 p90 -136.89 131.55 33.3 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.122 -0.631 . . . . 3.73 111.833 171.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.32 112.43 20.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.799 -0.815 . . . . 0.81 108.799 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HB2' ' HE2' ' A' ' 41' ' ' TYR . . . -95.32 115.8 27.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.249 0.547 . . . . 0.42 110.936 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 10.8 tppt? -88.39 123.52 33.03 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.518 -0.919 . . . . 2.63 108.518 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 25' ' ' SER . 30.9 t -110.5 140.74 28.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.711 -0.677 . . . . 0.82 110.544 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 1.6 m -129.15 99.32 5.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.25 0.547 . . . . 0.72 110.165 170.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -82.61 125.88 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.308 -0.86 . . . . 1.14 110.483 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 5.8 m -108.11 113.97 27.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.465 -0.569 . . . . 0.41 109.465 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.86 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 p30 -89.76 150.53 44.17 Favored Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 108.132 -1.062 . . . . 1.48 108.132 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.71 -9.34 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.072 2.515 . . . . 0.73 114.48 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.719 ' HE1' HG23 ' A' ' 128' ' ' VAL . 14.2 t80 -89.17 -20.27 24.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.88 -0.728 . . . . 2.08 112.195 -155.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.702 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 24.0 t 84.16 13.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.987 0.804 . . . . 1.51 109.237 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HD1' ' HD2' ' A' ' 51' ' ' TYR . 34.4 m80 -139.65 130.0 25.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.77 . . . . 1.67 109.382 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 14.7 m -41.89 96.7 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 O-C-N 124.102 0.876 . . . . 1.39 112.928 173.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.006 HG21 HD23 ' A' ' 126' ' ' LEU . 6.0 pt -74.75 171.46 11.48 Favored Pre-proline 0 C--O 1.212 -0.889 0 N-CA-C 108.261 -1.015 . . . . 1.03 108.261 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 12.4 Cg_endo -88.91 -59.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.067 1.178 . . . . 0.37 113.993 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.799 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 5.9 mt -138.68 162.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.951 -0.7 . . . . 1.23 112.125 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.708 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.0 p -146.72 177.13 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.251 1.024 . . . . 1.15 111.7 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.111 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 31.8 tt0 -126.4 116.18 20.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.286 -1.779 . . . . 1.36 109.723 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.852 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -98.88 109.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.204 1.002 . . . . 1.05 109.975 172.171 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 5.8 m -112.44 102.89 10.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.597 -1.638 . . . . 0.83 108.465 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 p90 -112.87 127.37 56.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.456 0.646 . . . . 0.4 109.82 -169.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 16.4 m -123.28 106.5 10.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.483 -1.235 . . . . 0.38 108.289 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.34 135.18 39.61 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.646 -0.421 . . . . 0.96 110.514 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -123.05 144.76 49.07 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.034 -1.469 . . . . 1.29 107.034 176.051 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.975 ' HB3' HD22 ' A' ' 104' ' ' LEU . 46.4 t -106.78 -97.53 0.35 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.223 -0.991 . . . . 1.27 110.919 174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.2 -58.79 6.9 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.212 -0.662 . . . . 0.36 109.212 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 22.41 0.13 Allowed Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.613 -1.395 . . . . 0.39 109.613 164.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.2 ptp180 -122.37 -172.57 2.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.643 -0.503 . . . . 1.97 109.643 -175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -100.46 87.19 3.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.716 0.77 . . . . 2.61 111.46 -161.175 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.671 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.8 mm -53.74 -45.15 61.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.598 -1.183 . . . . 0.4 112.117 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.91 163.62 30.82 Favored Glycine 0 C--O 1.22 -0.74 0 C-N-CA 120.23 -0.986 . . . . 0.49 111.383 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -163.07 157.59 20.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.886 0.843 . . . . 1.81 111.871 -177.758 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.61 28.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.825 -0.51 . . . . 0.43 111.825 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 37.9 mttm -127.3 127.11 43.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.902 -0.407 . . . . 1.72 109.902 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 60' ' ' ILE . 78.4 mt -139.95 124.9 11.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 120.695 0.283 . . . . 0.73 110.55 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.54 116.32 4.64 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.431 2.087 . . . . 0.57 110.801 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 60' ' ' ILE . 10.8 t70 -123.08 141.1 34.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.487 -0.56 . . . . 0.79 109.487 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.7 89.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.719 2.28 . . . . 0.58 112.337 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.799 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -82.69 28.43 3.53 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.4 113.102 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.959 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.9 p -74.91 122.88 24.11 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.985 -0.376 . . . . 0.62 109.985 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.8 pt? -153.41 -167.19 2.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 118.317 -1.353 . . . . 1.1 114.059 -165.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 87.5 mttt -52.57 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.545 0.943 . . . . 1.84 113.545 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . -178.08 105.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.636 -0.876 . . . . 0.99 108.636 -174.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.86 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.7 pttt 36.91 62.97 0.73 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.104 0.877 . . . . 1.84 111.185 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' THR . 5.7 t70 -157.51 -179.3 8.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.789 -1.096 . . . . 0.64 109.015 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.598 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 40.6 ttm -108.73 120.12 41.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.072 -0.513 . . . . 1.35 110.597 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 46' ' ' SER . 6.0 t -105.76 143.68 33.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.621 -0.718 . . . . 0.77 109.917 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.93 26.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.463 0.649 . . . . 0.48 110.708 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.622 HD22 HG11 ' A' ' 45' ' ' VAL . 5.6 tt -116.0 164.58 14.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.982 -1.008 . . . . 0.77 108.985 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.32 132.9 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 1.81 110.951 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 21.7 mm -118.95 140.82 29.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.65 111.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.94 -169.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.059 3.173 . . . . 1.07 113.626 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 18.0 m -126.8 91.01 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.46 112.417 -163.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.447 HG13 ' HE1' ' A' ' 41' ' ' TYR . 4.9 p -125.29 104.45 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.885 1.439 . . . . 0.48 114.885 -163.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.47 HG13 HG23 ' A' ' 71' ' ' ILE . 4.8 t -145.79 109.07 4.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.088 -0.382 . . . . 1.07 110.775 170.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.1 Cg_exo -56.87 129.24 33.48 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 120.711 0.94 . . . . 0.48 110.55 169.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HE1' ' HD2' ' A' ' 102' ' ' PHE . 11.8 t80 -53.59 -32.16 49.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.261 -0.427 . . . . 1.31 110.631 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 2.0 m -57.45 -30.73 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 1.2 112.041 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.671 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -76.05 -55.44 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.51 110.52 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 104' ' ' LEU . 42.3 mt -53.49 -27.17 23.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.952 172.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.592 ' HB3' ' O ' ' A' ' 99' ' ' SER . 34.8 t80 -60.77 -46.42 90.54 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.595 -1.184 . . . . 0.96 108.786 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.596 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.3 m-80 -73.44 -56.05 5.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.82 112.217 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.975 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.9 pp -59.85 -46.68 88.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.46 0.911 . . . . 0.65 113.46 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -61.71 -24.06 66.53 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.918 0.866 . . . . 0.43 110.104 178.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.596 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.7 ttp180 -68.61 -49.16 61.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.896 -1.047 . . . . 1.81 110.82 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.667 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -81.85 -54.82 5.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.122 0.963 . . . . 0.8 112.213 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.94 ' HB ' HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -88.72 -20.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 121.348 -0.845 . . . . 0.88 109.883 -176.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.05 -19.93 79.62 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.077 -1.058 . . . . 0.38 110.93 167.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -50.55 -45.86 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.7 -1.222 . . . . 1.09 107.7 167.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 4.6 p-10 -81.16 -84.36 0.1 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.026 -1.07 . . . . 1.87 110.929 163.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.428 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 5.0 p-90 178.1 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.604 0.638 . . . . 1.17 112.665 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.35 121.95 37.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.691 -0.231 . . . . 2.15 111.568 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.94 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.4 mp -113.19 154.81 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.447 -0.575 . . . . 0.39 109.447 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -100.4 153.53 19.26 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.62 -0.718 . . . . 2.11 109.198 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -135.45 151.5 50.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.683 -1.229 . . . . 0.62 107.683 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.805 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 38.3 tt0 -146.07 126.63 14.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.865 0.364 . . . . 0.8 110.032 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.765 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 15.0 tp -97.34 137.13 36.81 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.169 0.509 . . . . 1.25 110.692 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.583 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 5.9 tp60 -115.84 100.52 8.07 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.344 -0.984 . . . . 0.63 108.344 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.852 HD11 HG22 ' A' ' 60' ' ' ILE . 4.6 tp -114.01 118.9 59.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.218 0.533 . . . . 0.81 111.091 -173.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.14 124.18 6.91 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.544 -0.622 . . . . 0.26 111.544 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.61 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.5 mp -104.03 100.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.035 0.445 . . . . 1.2 111.108 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 99.9 m -102.62 96.6 6.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.223 -0.899 . . . . 0.32 108.826 172.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.708 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.94 133.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.528 -0.469 . . . . 0.98 110.717 -175.604 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 1.0 OUTLIER -75.22 105.67 6.36 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.93 -0.767 . . . . 1.52 108.93 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 1.006 HD23 HG21 ' A' ' 55' ' ' ILE . 19.2 mt -120.2 143.05 34.82 Favored Pre-proline 0 C--O 1.216 -0.675 0 O-C-N 124.706 1.254 . . . . 1.28 109.925 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 78.0 Cg_exo -53.14 -37.47 79.75 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.905 2.403 . . . . 0.74 115.361 -171.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.719 HG23 ' HE1' ' A' ' 51' ' ' TYR . 97.7 t -73.64 -56.93 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.747 -0.596 . . . . 1.12 112.496 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' ' 132' ' ' PHE . 14.9 p -92.16 -7.97 10.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 122.32 1.057 . . . . 1.35 109.868 -175.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.27 -36.78 2.39 Favored Glycine 0 N--CA 1.462 0.43 0 CA-C-N 114.18 -1.373 . . . . 1.05 112.078 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.5 pt-20 -165.84 122.3 1.36 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.544 -1.28 . . . . 1.16 107.544 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.671 ' HB2' HG11 ' A' ' 129' ' ' VAL . 7.9 t80 -111.98 143.28 43.23 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.241 -0.584 . . . . 1.91 109.801 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 64.7 m -123.75 102.43 7.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.846 -0.615 . . . . 1.19 111.524 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.53 139.19 34.06 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.728 -0.669 . . . . 0.5 110.096 173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.16 162.26 3.8 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.45 112.557 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 167.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.29 -1.004 . . . . 0.44 108.29 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -137.1 148.78 46.92 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.952 -0.299 . . . . 0.88 110.794 -170.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 t -140.39 107.83 5.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.445 -0.946 . . . . 0.96 108.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.805 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.74 143.93 43.81 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.865 -0.334 . . . . 1.76 110.789 -175.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.73 132.62 3.75 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.812 -0.915 . . . . 0.5 110.812 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 9.3 mt-10 -97.55 126.31 42.76 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.926 -0.768 . . . . 2.1 108.926 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.03 173.3 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.173 -0.677 . . . . 0.76 109.173 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -65.55 168.22 7.76 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.747 0.647 . . . . 3.53 112.747 -173.249 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.915 HD12 ' HD2' ' A' ' 145' ' ' PRO . 22.9 tp -56.21 130.48 74.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.033 -0.985 . . . . 1.23 112.324 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.915 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.8 Cg_endo . . . . . 0 C--N 1.354 0.849 0 C-N-CA 124.24 3.293 . . . . 0.71 112.93 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.422 -2.294 0 CA-C-O 119.788 -0.451 . . . . 0.54 112.701 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.493 ' HB2' HD21 ' A' ' 122' ' ' LEU . 4.9 m -172.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.829 0.851 . . . . 1.2 109.62 167.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 46' ' ' SER . 7.4 p -134.25 147.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.56 -0.746 . . . . 0.93 110.926 -174.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -166.11 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.48 110.899 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 33.3 t70 -167.09 164.78 15.83 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.365 -0.235 . . . . 1.69 110.365 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG21 ' HZ ' ' A' ' 64' ' ' PHE . 69.0 t -142.91 120.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.992 -0.373 . . . . 1.14 109.992 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 9.7 m-20 -92.4 109.86 21.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.83 110.648 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.394 -0.595 . . . . 0.94 109.394 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -124.58 -125.95 0.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.195 -0.457 . . . . 1.33 109.962 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.955 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 p30 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 121.13 0.491 . . . . 2.85 112.1 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.723 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 39.4 t . . . . . 0 C--O 1.212 -0.877 0 N-CA-C 107.132 -1.433 . . . . 0.94 107.132 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.105 HG23 HG13 ' A' ' 96' ' ' VAL . 20.4 m -128.69 178.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.377 0.99 . . . . 0.86 111.476 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.949 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 84.4 mt-10 -125.25 151.68 45.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.815 -0.63 . . . . 1.19 111.431 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.884 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 13.5 p90 -136.46 123.42 21.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.897 -0.721 . . . . 3.73 110.197 165.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -86.68 110.82 20.13 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.528 -0.915 . . . . 0.81 108.528 174.511 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.09 115.59 28.13 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.816 0.817 . . . . 0.42 110.211 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 20.8 ttmt -84.72 117.72 23.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.252 -1.34 . . . . 2.63 108.432 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.747 HG21 HG12 ' A' ' 92' ' ' ILE . 39.5 t -111.57 144.9 18.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.435 0.636 . . . . 0.82 111.841 -169.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.672 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 24.7 m -133.57 97.5 3.95 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.22 -0.9 . . . . 0.72 108.735 163.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -85.95 132.16 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.61 0.719 . . . . 1.14 110.893 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.446 ' H ' ' HA3' ' A' ' 24' ' ' GLY . 26.8 m -111.33 115.53 29.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.718 -1.128 . . . . 0.41 110.032 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.9 t30 -91.53 132.77 32.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.717 1.26 . . . . 1.48 108.409 174.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -89.04 3.31 5.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.129 2.553 . . . . 0.73 114.147 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 91.7 t80 -108.33 133.1 53.01 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.152 -0.684 . . . . 2.08 109.152 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.777 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 23.8 p -77.08 30.27 0.14 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.496 0.924 . . . . 1.51 113.496 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 62.2 m80 -146.15 142.81 28.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 1.67 108.597 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -41.01 105.75 0.05 OUTLIER 'General case' 0 C--O 1.208 -1.125 0 O-C-N 123.886 0.741 . . . . 1.39 112.151 171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.947 ' O ' ' HA ' ' A' ' 81' ' ' SER . 8.4 pt -75.63 171.32 12.26 Favored Pre-proline 0 C--O 1.209 -1.076 0 N-CA-C 107.463 -1.31 . . . . 1.03 107.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 10.2 Cg_endo -89.46 -62.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 120.301 1.143 . . . . 0.37 113.781 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.4 mm -130.3 154.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.401 -0.52 . . . . 1.23 110.919 -167.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.717 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 4.0 m -146.1 -176.52 5.19 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.977 0.894 . . . . 1.15 110.988 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.953 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 43.1 tt0 -138.47 118.14 13.09 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.96 -1.473 . . . . 1.36 111.068 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.63 108.22 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.255 1.026 . . . . 1.05 109.54 166.775 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 15.5 p -113.61 102.62 10.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 113.826 -1.533 . . . . 0.83 108.413 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -112.74 126.89 55.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.488 0.661 . . . . 0.4 110.012 -165.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 20.9 m -120.86 104.25 9.71 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.83 -1.077 . . . . 0.38 108.392 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.814 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.3 130.06 44.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.444 0.64 . . . . 0.96 110.809 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -121.1 145.1 48.16 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 107.104 -1.443 . . . . 1.29 107.104 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 104' ' ' LEU . 33.8 t -101.97 -102.72 0.27 Allowed 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.079 -1.049 . . . . 1.27 110.891 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.66 -54.32 47.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.048 -0.723 . . . . 0.36 109.048 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.19 17.9 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.093 -1.603 . . . . 0.39 109.093 166.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 5.9 ptp180 -106.08 -147.51 0.4 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.859 -0.67 . . . . 1.97 109.561 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -123.82 99.1 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.19 0.45 . . . . 2.61 110.349 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.74 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.5 mm -70.89 -38.95 74.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.544 -0.753 . . . . 0.4 110.231 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.49 171.69 32.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.572 -0.823 . . . . 0.49 111.846 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -159.42 154.7 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.091 0.446 . . . . 1.81 110.367 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.53 155.56 13.6 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.433 -0.667 . . . . 0.43 111.433 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 17.3 ptpt -131.38 134.77 46.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.967 0.413 . . . . 1.72 110.703 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -140.01 122.67 10.11 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.73 109.939 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.94 108.32 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.204 1.936 . . . . 0.57 111.033 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -114.92 141.74 27.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.549 -0.537 . . . . 0.79 109.549 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.8 Cg_endo -60.62 87.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.577 2.185 . . . . 0.58 112.407 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.717 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -88.7 33.99 4.01 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.4 111.905 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.947 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -71.01 118.29 13.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.681 -0.859 . . . . 0.62 108.681 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 HD22 ' A' ' 49' ' ' ASN . 1.4 pt? -148.11 -159.98 1.11 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.07 -1.452 . . . . 1.1 114.73 -158.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 56.2 mttm -52.57 -92.05 0.0 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.131 -0.94 . . . . 1.84 112.778 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 167.02 105.76 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.638 -1.245 . . . . 0.99 107.638 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.0 pttt 41.37 49.47 3.43 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.363 1.039 . . . . 1.84 111.034 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.17 -172.34 3.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.064 -0.971 . . . . 0.64 109.757 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.7 ttm -113.28 118.15 33.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.886 0.374 . . . . 1.35 110.801 -171.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.598 ' CG2' HG13 ' A' ' 47' ' ' VAL . 7.1 t -107.35 143.43 35.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.489 . . . . 0.77 110.19 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.54 136.66 36.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.333 0.587 . . . . 0.48 109.59 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 4.2 tt -133.53 170.48 15.45 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.322 -0.992 . . . . 0.77 108.322 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 t70 -135.2 123.5 23.14 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.012 -0.275 . . . . 1.81 110.647 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -105.18 138.15 19.45 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.616 0.246 . . . . 0.65 110.997 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.79 168.25 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.543 2.829 . . . . 1.07 112.606 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.949 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 4.5 m -110.58 88.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.46 111.364 -166.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG13 ' HE2' ' A' ' 41' ' ' TYR . 4.1 p -128.46 101.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 114.726 1.38 . . . . 0.48 114.726 -165.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.105 HG13 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.3 115.65 3.96 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 119.882 -0.727 . . . . 1.07 110.208 162.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.1 128.52 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.439 1.426 . . . . 0.48 109.746 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.723 ' H ' ' HA ' ' A' ' 38' ' ' SER . 20.5 t80 -57.03 -28.1 62.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.03 0.443 . . . . 1.31 110.112 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -52.44 -30.51 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.563 -0.744 . . . . 1.2 111.892 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.74 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.1 mm -78.2 -54.12 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.409 -0.359 . . . . 0.51 111.209 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 104' ' ' LEU . 22.8 mt -50.44 -27.96 7.39 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.572 0.701 . . . . 1.0 110.218 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 16.7 t80 -68.99 -40.73 78.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.661 -1.609 . . . . 0.96 108.506 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.657 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 18.6 m-80 -74.42 -56.51 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.816 -0.629 . . . . 0.82 112.365 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.1 pp -56.7 -56.35 22.5 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.992 0.738 . . . . 0.65 112.992 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.485 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.34 -21.99 66.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.886 0.85 . . . . 0.43 110.149 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -61.03 -53.99 50.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.481 -1.236 . . . . 1.81 110.147 173.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.617 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.2 t70 -85.4 -52.16 6.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.189 0.995 . . . . 0.8 111.723 -171.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 114' ' ' ILE . 34.3 m -80.03 -31.08 13.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.586 -0.696 . . . . 0.88 110.706 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.03 -16.54 80.67 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.087 -0.961 . . . . 0.38 111.616 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.71 -42.53 13.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.456 -1.683 . . . . 1.09 106.456 161.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 42.0 m-20 -75.74 -86.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.57 -0.741 . . . . 1.87 110.298 159.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.443 ' O ' HD23 ' A' ' 144' ' ' LEU . 17.0 p-90 176.73 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.743 0.417 . . . . 1.17 111.629 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.3 133.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.359 0.599 . . . . 2.15 111.511 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.04 HG23 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -117.95 149.66 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.603 -0.726 . . . . 0.39 109.604 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 10.1 p-10 -104.79 154.98 19.31 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.457 -0.942 . . . . 2.11 108.457 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 48.1 m-85 -134.61 156.98 47.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.526 -0.916 . . . . 0.62 108.526 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.526 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 31.5 tt0 -143.56 129.46 19.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.607 -0.516 . . . . 0.8 109.607 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.814 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -103.79 133.99 47.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.769 -0.65 . . . . 1.25 109.46 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.663 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.1 tp60 -116.7 100.73 8.01 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.02 -0.733 . . . . 0.63 109.02 172.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.589 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.1 tp -110.23 117.58 55.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.305 0.574 . . . . 0.81 110.706 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.65 124.51 7.28 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.0 -0.84 . . . . 0.26 111.0 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.9 mm? -101.1 98.23 8.69 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.529 0.68 . . . . 1.2 111.961 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . 0.953 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 96.5 m -95.83 94.78 7.85 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.32 -1.309 . . . . 0.32 108.954 169.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.808 HG13 HD21 ' A' ' 126' ' ' LEU . 9.7 pt -107.38 141.63 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 120.414 -0.514 . . . . 0.98 109.646 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.55 106.12 18.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 1.52 109.688 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.808 HD21 HG13 ' A' ' 124' ' ' ILE . 1.5 mm? -103.13 141.62 22.86 Favored Pre-proline 0 C--O 1.213 -0.82 0 O-C-N 124.344 1.028 . . . . 1.28 109.586 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 52.5 Cg_exo -57.9 -24.98 67.47 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.082 1.855 . . . . 0.74 113.988 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.82 -58.13 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.984 0.421 . . . . 1.12 111.844 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.79 0.67 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.078 0.942 . . . . 1.35 110.789 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.33 -39.45 2.9 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 113.86 -1.518 . . . . 1.05 111.41 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 9.6 pt-20 -167.41 155.44 9.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 1.16 109.285 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.47 142.11 31.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.229 -0.656 . . . . 1.91 109.229 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.7 m -122.66 107.94 12.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.904 0.383 . . . . 1.19 111.777 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.0 141.25 40.59 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.5 110.006 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.6 Cg_endo -92.42 165.66 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.07 1.847 . . . . 0.45 112.872 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.548 HG23 ' CG2' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -159.03 158.2 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.712 -1.218 . . . . 0.44 107.712 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 76.5 p -131.97 152.41 51.13 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.471 -0.492 . . . . 0.88 111.898 -170.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -139.46 110.73 6.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.835 -0.802 . . . . 0.96 108.835 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.526 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.19 140.92 47.53 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.835 -0.346 . . . . 1.76 110.548 -179.264 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.49 139.16 6.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.868 -0.682 . . . . 0.5 111.971 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 27.9 mt-10 -99.12 129.39 45.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 2.1 109.739 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 pp -139.54 173.59 10.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.638 -0.504 . . . . 0.76 109.638 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -65.59 172.29 3.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.897 0.703 . . . . 3.53 112.897 -171.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.694 HD22 ' HD2' ' A' ' 145' ' ' PRO . 1.7 tm? -61.64 126.59 87.17 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.924 -1.034 . . . . 1.23 109.84 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.694 ' HD2' HD22 ' A' ' 144' ' ' LEU . 72.5 Cg_endo . . . . . 0 C--N 1.349 0.57 0 C-N-CA 123.608 2.872 . . . . 0.71 113.198 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.761 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.434 -1.491 0 N-CA-C 113.798 0.279 . . . . 0.54 113.798 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB2' HD11 ' A' ' 122' ' ' LEU . 37.7 m -169.47 34.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.642 -1.244 . . . . 1.2 107.642 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 46' ' ' SER . 32.7 m -134.04 155.33 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.347 -1.297 . . . . 0.93 109.786 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -165.15 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.57 -0.53 . . . . 0.48 109.57 166.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 44' ' ' LYS . 4.8 p-10 -167.99 163.0 13.63 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.523 0.677 . . . . 1.69 112.652 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.17 132.98 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.821 -1.082 . . . . 1.14 109.266 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.64 138.26 53.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.484 -0.326 . . . . 1.83 110.796 -173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 39' ' ' VAL . 3.2 tm? -94.82 138.96 31.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.789 -0.187 . . . . 0.94 111.095 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HE3' ' HB2' ' A' ' 42' ' ' LEU . 6.4 ptpt -145.15 -92.53 0.1 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 114.167 1.173 . . . . 1.33 114.167 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.204 -1.304 0 O-C-N 121.308 -0.87 . . . . 2.85 111.262 -155.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.628 0.727 . . . . 0.94 112.579 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 101' ' ' LEU . 26.7 t -79.1 155.13 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.967 -1.015 . . . . 0.86 109.216 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 27.4 mt-10 -117.62 131.59 56.63 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.002 -1.079 . . . . 1.19 111.867 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.854 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.84 104.97 11.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.137 -0.938 . . . . 3.73 110.513 -176.457 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.703 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -72.47 109.85 6.45 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.919 -1.141 . . . . 0.81 107.919 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -103.99 107.64 18.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.713 0.768 . . . . 0.42 110.144 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 13.0 ttmt -83.47 126.14 32.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.88 -1.156 . . . . 2.63 107.88 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 90' ' ' LEU . 43.1 t -111.4 141.52 26.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.705 -0.68 . . . . 0.82 109.929 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 88' ' ' THR . 29.8 m -128.82 99.25 5.24 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.289 -0.564 . . . . 0.72 110.225 171.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -81.61 122.82 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 115.63 -0.714 . . . . 1.14 109.748 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -101.43 116.55 33.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.639 -0.709 . . . . 0.41 110.168 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 15.7 t30 -90.26 126.16 57.7 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.127 -0.694 . . . . 1.48 109.127 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -91.84 15.14 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.248 2.632 . . . . 0.73 113.832 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -131.5 146.73 52.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.514 -0.921 . . . . 2.08 108.514 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.728 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.7 t -80.96 34.47 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.937 0.399 . . . . 1.51 111.722 -169.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -145.31 133.01 21.0 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.654 -0.248 . . . . 1.67 110.803 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -45.37 100.83 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 124.448 1.099 . . . . 1.39 113.022 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.849 HG21 HD23 ' A' ' 126' ' ' LEU . 5.8 pt -77.34 128.32 80.76 Favored Pre-proline 0 C--O 1.207 -1.182 0 N-CA-C 109.222 -0.659 . . . . 1.03 109.222 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.5 Cg_endo -60.88 -51.97 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.968 1.779 . . . . 0.37 113.691 -160.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.876 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 73.9 mt -138.27 157.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 1.23 112.853 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.837 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -139.92 168.17 20.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.565 1.174 . . . . 1.15 112.245 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.119 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.9 tt0 -120.43 119.37 32.84 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 112.854 -1.976 . . . . 1.36 110.18 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 22.2 mm -94.8 110.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.652 -1.158 . . . . 1.05 110.336 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 64.8 p -121.22 102.4 8.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.99 -0.744 . . . . 0.83 108.99 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' HD1' HG22 ' A' ' 60' ' ' ILE . 17.0 p90 -106.9 135.18 48.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.531 0.681 . . . . 0.4 110.242 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.0 m -130.75 105.85 8.07 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.47 -1.241 . . . . 0.38 108.726 174.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CE1' HD23 ' A' ' 118' ' ' LEU . 96.6 m-85 -96.41 140.75 30.61 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.493 -0.558 . . . . 0.96 109.493 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -127.15 144.43 51.04 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.453 -0.943 . . . . 1.29 108.453 177.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.29 -109.84 0.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 116.531 -0.304 . . . . 1.27 111.457 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.04 -54.3 36.37 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.643 -0.873 . . . . 0.36 108.643 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.3 16.12 0.17 Allowed Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 108.466 -1.853 . . . . 0.39 108.466 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.456 ' NH1' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.98 -171.12 1.78 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.341 -0.985 . . . . 1.97 108.341 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.88 90.9 3.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.174 0.512 . . . . 2.61 111.16 -164.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.986 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -47.88 -42.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.4 111.867 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.12 167.59 39.34 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 119.859 -1.162 . . . . 0.49 111.542 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.81 153.89 9.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.355 0.598 . . . . 1.81 111.343 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.09 -179.06 41.5 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.869 -0.892 . . . . 0.43 110.869 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.71 132.87 26.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.952 0.376 . . . . 1.72 111.34 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.43 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 79.1 mt -130.87 109.16 15.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.963 -0.562 . . . . 0.73 109.877 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.8 128.27 14.86 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.317 2.011 . . . . 0.57 110.401 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -138.96 144.76 42.6 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.758 -0.377 . . . . 0.79 110.128 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.2 Cg_exo -57.24 90.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.578 2.185 . . . . 0.58 111.571 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.876 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -75.7 13.68 6.5 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.176 -0.92 . . . . 0.4 113.557 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 94.3 p -69.69 118.04 12.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.496 -0.557 . . . . 0.62 109.496 -176.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 49' ' ' ASN . 1.5 pt? -143.83 -167.16 2.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 119.931 -0.708 . . . . 1.1 112.631 -163.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 86' ' ' ASP . 92.4 mttt -45.49 -93.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.083 0.771 . . . . 1.84 113.083 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 163.37 107.18 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.307 -0.997 . . . . 0.99 108.307 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptmt 45.43 47.65 10.81 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.218 0.948 . . . . 1.84 111.159 -176.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 5.3 t70 -150.39 -170.03 3.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.226 -0.897 . . . . 0.64 109.514 -173.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.6 ttp -119.2 119.39 33.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.986 0.422 . . . . 1.35 110.874 -171.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.8 t -107.3 144.74 33.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.857 -0.611 . . . . 0.77 110.501 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.52 112.5 23.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.515 0.674 . . . . 0.48 110.887 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 45' ' ' VAL . 4.6 tt -102.72 166.28 10.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.142 -0.936 . . . . 0.77 109.03 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 22.1 t70 -128.93 117.74 21.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.419 -0.512 . . . . 1.81 112.295 -170.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 47.6 mm -110.84 122.72 37.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.738 -0.838 . . . . 0.65 108.738 171.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 84.6 Cg_exo -46.7 -98.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.922 3.081 . . . . 1.07 114.874 -171.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -162.4 94.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 112.124 0.416 . . . . 0.46 112.124 -169.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 62' ' ' PHE . 7.4 p -127.52 103.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.138 1.162 . . . . 0.48 114.138 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.1 p -152.36 98.15 2.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 1.07 110.768 162.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 64.8 Cg_exo -51.4 135.89 47.29 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.924 1.749 . . . . 0.48 112.12 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 102' ' ' PHE . 4.7 t80 -55.56 -30.91 61.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.404 -0.817 . . . . 1.31 111.094 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 50.6 m -56.51 -33.75 66.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.986 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 mm -78.66 -53.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 121.852 -0.53 . . . . 0.51 111.84 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 104' ' ' LEU . 14.5 mt -50.67 -27.47 7.05 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.524 0.678 . . . . 1.0 110.124 170.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' SER . 37.4 t80 -63.69 -42.02 98.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.45 -1.25 . . . . 0.96 108.605 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 69' ' ' ARG . 32.9 m-80 -74.05 -57.92 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 0.82 111.961 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -58.2 -51.99 67.45 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.244 0.831 . . . . 0.65 113.244 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.63 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.48 -26.58 68.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.479 0.657 . . . . 0.43 110.493 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -74.27 -52.5 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.484 -0.78 . . . . 1.81 111.064 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.722 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 8.8 t70 -80.51 -52.42 7.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.826 0.822 . . . . 0.8 111.183 -173.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -92.42 -18.47 7.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 O-C-N 121.912 -0.493 . . . . 0.88 110.581 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.24 -19.09 79.87 Favored Glycine 0 CA--C 1.509 -0.321 0 C-N-CA 120.262 -0.97 . . . . 0.38 110.917 167.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.722 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -54.28 -49.61 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.392 -1.707 . . . . 1.09 106.392 164.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 2.5 m-20 -66.58 -102.84 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.991 -1.004 . . . . 1.87 109.902 162.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.86 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 1.17 111.938 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.7 123.46 38.16 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.361 -0.382 . . . . 2.15 110.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.762 HD11 HD12 ' A' ' 144' ' ' LEU . 3.5 mp -112.82 157.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.899 0.38 . . . . 0.39 110.636 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 114' ' ' ILE . 3.2 m-20 -88.57 152.7 21.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.692 -0.685 . . . . 2.11 109.348 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -145.16 159.97 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.156 -0.683 . . . . 0.62 109.156 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.681 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 33.5 tt0 -154.21 136.0 14.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.779 0.323 . . . . 0.8 110.153 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -108.26 130.07 55.18 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.013 -0.736 . . . . 1.25 109.013 172.402 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.649 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.9 tp60 -118.9 99.68 6.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.151 -0.685 . . . . 0.63 109.151 176.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -112.18 123.46 67.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.349 0.595 . . . . 0.81 110.367 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.14 123.16 6.44 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.595 -0.729 . . . . 0.26 111.552 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 25' ' ' SER . 2.2 mp -96.87 118.55 33.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.781 0.324 . . . . 1.2 110.794 -173.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 95.8 m -124.71 95.71 4.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.596 -0.729 . . . . 0.32 109.524 172.785 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.837 HG22 ' HB3' ' A' ' 58' ' ' CYS . 14.7 pt -110.88 144.32 19.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.6 -0.44 . . . . 0.98 110.42 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.707 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.8 m-20 -85.59 105.09 15.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.858 -1.164 . . . . 1.52 107.858 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.849 HD23 HG21 ' A' ' 55' ' ' ILE . 28.1 mt -102.47 167.33 10.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 125.0 1.438 . . . . 1.28 110.195 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.17 -29.56 6.35 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 121.825 1.683 . . . . 0.74 112.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -74.12 -58.95 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 112.543 0.572 . . . . 1.12 112.543 -172.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 41.8 t -105.94 2.95 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.528 1.156 . . . . 1.35 109.441 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 74.32 -24.72 1.11 Allowed Glycine 0 C--N 1.318 -0.434 0 CA-C-N 114.217 -1.356 . . . . 1.05 111.945 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 13.3 pt-20 -159.1 170.81 21.19 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.668 -0.864 . . . . 1.16 108.668 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.735 ' O ' ' HA ' ' A' ' 123' ' ' THR . 7.0 t80 -163.57 132.78 3.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.652 -0.869 . . . . 1.91 108.652 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 86.4 m -123.67 95.55 4.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.317 0.58 . . . . 1.19 111.398 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.76 139.12 34.41 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.52 -0.764 . . . . 0.5 110.192 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.606 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.7 Cg_endo -89.15 161.97 5.76 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.778 1.652 . . . . 0.45 112.65 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 167.09 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.386 -0.968 . . . . 0.44 108.386 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.8 p -137.82 151.09 47.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.355 0.598 . . . . 0.88 112.075 -172.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 t -139.98 103.34 4.61 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.29 -1.374 . . . . 0.96 107.29 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.681 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -112.41 152.48 28.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.198 -0.456 . . . . 1.76 110.041 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.53 141.96 7.38 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.342 -0.933 . . . . 0.5 111.564 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -107.29 123.98 49.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.785 -0.707 . . . . 2.1 109.197 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.9 174.39 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.527 -0.916 . . . . 0.76 108.527 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -56.78 160.37 3.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.868 0.692 . . . . 3.53 112.868 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.762 HD12 HD11 ' A' ' 114' ' ' ILE . 19.4 tp -55.84 138.87 70.76 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 114.894 -1.048 . . . . 1.23 111.581 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 144' ' ' LEU . 34.5 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 123.317 2.678 . . . . 0.71 111.911 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.57 0 N-CA-C 116.579 1.392 . . . . 0.54 116.579 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 95.7 p -167.91 36.47 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.268 -1.382 . . . . 1.2 107.268 174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.4 m -133.86 155.66 40.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.365 -1.289 . . . . 0.93 110.037 -170.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.4 HG21 ' HG2' ' A' ' 44' ' ' LYS . 1.7 t -168.65 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.699 -0.482 . . . . 0.48 109.699 169.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.73 172.36 1.11 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.283 -0.417 . . . . 1.69 111.45 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.716 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -142.14 145.91 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.079 -0.711 . . . . 1.14 109.079 168.496 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.43 115.59 30.4 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.762 -0.653 . . . . 1.83 110.378 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.0 tm? -80.29 120.05 23.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 0.94 111.08 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -119.81 -127.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.527 -0.545 . . . . 1.33 109.527 171.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.931 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.1 p30 . . . . . 0 N--CA 1.469 0.494 0 CA-C-N 118.604 0.638 . . . . 2.85 111.919 -168.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.689 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 48.1 t . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 105.235 -2.135 . . . . 0.94 105.235 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.931 HG13 ' HA ' ' A' ' 33' ' ' ASP . 13.4 t -134.63 156.37 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 118.6 0.636 . . . . 0.86 109.743 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.982 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 91.8 mt-10 -119.61 147.59 44.33 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.205 -0.598 . . . . 1.19 111.175 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.935 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.5 p90 -142.29 133.89 26.72 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.095 -1.042 . . . . 3.73 112.039 166.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -79.9 108.99 13.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.189 -0.914 . . . . 0.81 108.715 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.749 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.62 110.16 21.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.585 0.707 . . . . 0.42 109.988 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 35.4 ttmt -84.03 129.77 34.9 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.929 -1.032 . . . . 2.63 109.212 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 25' ' ' SER . 52.5 t -113.57 142.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.69 -0.686 . . . . 0.82 110.335 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 88' ' ' THR . 18.7 m -131.34 98.08 4.44 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.254 0.55 . . . . 0.72 110.077 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.7 t -83.61 128.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.258 -0.883 . . . . 1.14 110.825 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.5 m -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 119.07 -0.491 . . . . 0.41 109.793 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.4 p-10 -91.5 135.21 28.19 Favored Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.859 0.724 . . . . 1.48 110.275 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 57.5 Cg_endo -93.63 12.65 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.71 2.94 . . . . 0.73 114.426 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.719 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 29.8 t80 -98.55 -117.86 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.332 -0.618 . . . . 2.08 109.332 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -165.01 19.68 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.51 110.258 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -148.38 151.32 35.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.528 -0.915 . . . . 1.67 108.528 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.61 ' HA ' HD23 ' A' ' 82' ' ' LEU . 28.0 t -44.89 105.57 0.06 Allowed 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.382 1.051 . . . . 1.39 112.295 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.5 pt -78.17 125.34 85.25 Favored Pre-proline 0 CA--C 1.5 -0.951 0 N-CA-C 108.901 -0.777 . . . . 1.03 108.901 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 27.1 Cg_endo -62.49 -54.65 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.777 1.651 . . . . 0.37 112.999 -159.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.5 mm -130.01 159.31 42.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.431 -0.507 . . . . 1.23 111.016 -173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.608 ' HB3' HG22 ' A' ' 124' ' ' ILE . 27.3 p -150.88 174.7 12.79 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.192 0.996 . . . . 1.15 111.697 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.3 tt0 -130.86 114.05 14.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.362 -1.744 . . . . 1.36 109.673 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.72 111.38 28.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.973 -1.012 . . . . 1.05 110.989 173.77 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 1.6 m -113.7 104.24 12.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.811 -1.541 . . . . 0.83 109.153 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 6.3 p90 -111.98 127.7 55.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.949 -0.389 . . . . 0.4 109.949 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 7.1 m -126.4 104.6 8.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.29 -0.633 . . . . 0.38 109.29 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 94.7 m-85 -98.28 139.23 34.36 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.1 -0.5 . . . . 0.96 111.258 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.04 145.43 50.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.667 -1.234 . . . . 1.29 107.667 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.685 ' CB ' HD22 ' A' ' 104' ' ' LEU . 41.5 t -107.27 -98.03 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.14 -1.024 . . . . 1.27 111.022 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.56 -60.25 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.674 -0.861 . . . . 0.36 108.674 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.58 15.66 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.227 -1.949 . . . . 0.39 108.227 163.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.94 HH11 ' HB3' ' A' ' 103' ' ' ASN . 10.2 ptp180 -106.09 -175.34 2.77 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.43 -0.952 . . . . 1.97 108.43 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -103.09 97.64 7.7 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.605 0.716 . . . . 2.61 109.589 -166.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.848 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.2 mm -59.04 -43.05 88.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.006 -1.452 . . . . 0.4 110.728 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.78 160.2 22.39 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.402 -0.904 . . . . 0.49 111.179 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -161.77 156.9 23.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.919 0.859 . . . . 1.81 111.446 176.105 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.76 164.88 28.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.758 -0.937 . . . . 0.43 110.758 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -142.13 133.68 26.72 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.097 0.475 . . . . 1.72 111.089 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 63.3 mt -136.1 133.85 19.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.632 -0.713 . . . . 0.73 110.016 -174.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 7.5 Cg_exo -74.26 119.04 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.364 2.042 . . . . 0.57 110.508 170.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.59 139.94 36.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.845 -0.428 . . . . 0.79 109.845 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.0 Cg_endo -61.64 90.82 0.11 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.452 2.101 . . . . 0.58 112.08 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.456 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -89.02 30.28 5.56 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.4 112.029 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.1 p -70.49 118.36 13.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.513 -0.921 . . . . 0.62 108.513 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.61 HD23 ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -139.98 -152.11 0.4 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.048 0.759 . . . . 1.1 113.048 -160.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 93.8 mttt -62.35 -96.99 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.937 -0.574 . . . . 1.84 112.304 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.35 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.971 -1.122 . . . . 0.99 107.971 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.719 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 39.5 pttt 42.41 50.41 4.69 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.879 0.847 . . . . 1.84 111.134 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.2 t70 -153.35 -173.38 4.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.894 -1.048 . . . . 0.64 110.726 -169.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.9 ttm -115.77 125.33 52.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 1.35 110.351 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 46' ' ' SER . 3.3 t -116.16 145.05 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.928 -0.578 . . . . 0.77 110.718 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.39 117.07 27.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.514 0.673 . . . . 0.48 110.742 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.666 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.2 tp -115.88 174.86 5.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.775 -1.102 . . . . 0.77 108.106 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.666 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 35.5 m-20 -137.63 130.66 30.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.502 0.592 . . . . 1.81 111.232 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.749 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 30.1 mm -108.6 123.84 36.11 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.666 -0.864 . . . . 0.65 108.666 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 94' ' ' VAL . 24.3 Cg_exo -28.85 -113.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 1 C-N-CA 125.72 4.28 . . . . 1.07 116.22 -171.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.982 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -163.08 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 119.586 -0.245 . . . . 0.46 111.191 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -127.79 101.74 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 115.635 1.717 . . . . 0.48 115.635 -164.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -152.77 107.28 2.7 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 121.326 -0.858 . . . . 1.07 111.607 163.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 53.4 Cg_exo -51.32 129.08 27.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.499 1.466 . . . . 0.48 111.192 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.689 ' H ' ' HA ' ' A' ' 38' ' ' SER . 16.3 t80 -50.17 -35.99 28.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.182 -0.917 . . . . 1.31 111.898 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.8 t -59.9 -27.49 66.77 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.054 0.39 . . . . 1.2 112.054 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.848 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -77.62 -54.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 121.892 -0.505 . . . . 0.51 111.17 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.077 HD23 HD21 ' A' ' 104' ' ' LEU . 53.3 mt -51.89 -30.18 23.0 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.882 0.848 . . . . 1.0 110.129 169.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.523 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 30.4 t80 -69.04 -38.56 79.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.625 -1.625 . . . . 0.96 108.787 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.94 ' HB3' HH11 ' A' ' 69' ' ' ARG . 15.7 m-80 -74.17 -55.95 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.543 -0.753 . . . . 0.82 111.975 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.077 HD21 HD23 ' A' ' 101' ' ' LEU . 2.9 pp -55.04 -50.67 68.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.737 0.643 . . . . 0.65 112.737 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.611 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.21 -24.39 67.2 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.884 0.85 . . . . 0.43 110.551 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.523 ' NH2' ' HD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -70.99 -54.76 10.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.106 -0.952 . . . . 1.81 110.631 175.759 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 16.3 t70 -83.01 -53.88 5.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.814 0.816 . . . . 0.8 111.649 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.0 t -84.12 -26.94 7.2 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 121.505 -0.747 . . . . 0.88 109.959 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -70.5 -17.52 74.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 119.536 -1.316 . . . . 0.38 111.381 170.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -53.74 -47.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.18 -1.415 . . . . 1.09 107.18 166.001 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -107.89 68.53 0.71 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.648 0.737 . . . . 1.87 112.79 164.826 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 23.15 -57.86 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 118.802 2.89 . . . . 1.17 118.802 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' ASP . 13.2 t70 -91.79 122.85 34.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.59 0.632 . . . . 2.15 111.84 -167.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.672 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.8 mp -112.49 158.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.39 110.78 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -104.74 153.87 20.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 2.11 109.934 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 35.3 m-85 -137.51 167.14 22.23 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.957 -0.757 . . . . 0.62 108.957 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.6 tt0 -153.4 139.03 17.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.73 0.3 . . . . 0.8 110.629 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 tp -109.92 129.31 55.67 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.933 -0.576 . . . . 1.25 110.3 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.615 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 7.3 tp60 -112.84 101.32 9.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.048 -0.723 . . . . 0.63 109.048 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 60' ' ' ILE . 5.5 tp -112.58 121.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.158 0.504 . . . . 0.81 111.64 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.68 125.41 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.781 -0.528 . . . . 0.26 111.781 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.601 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.0 mp -103.88 106.51 17.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 1.2 111.546 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.8 m -110.16 95.02 5.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.781 -0.645 . . . . 0.32 109.441 174.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 55' ' ' ILE . 10.6 pt -109.53 141.46 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 120.5 -0.48 . . . . 0.98 110.87 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.5 m-20 -84.51 107.47 16.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.714 -0.847 . . . . 1.52 108.714 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 55' ' ' ILE . 4.5 mt -115.56 139.65 24.97 Favored Pre-proline 0 C--O 1.216 -0.67 0 O-C-N 124.566 1.166 . . . . 1.28 110.455 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 32.2 Cg_exo -60.74 -16.67 45.23 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.366 2.044 . . . . 0.74 114.105 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.66 -56.45 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.326 0.584 . . . . 1.12 111.524 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.91 5.92 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.038 0.923 . . . . 1.35 110.799 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.55 -34.44 2.71 Favored Glycine 0 C--N 1.31 -0.884 0 CA-C-N 113.797 -1.547 . . . . 1.05 111.781 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.3 pt-20 -171.21 162.13 6.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.641 -0.874 . . . . 1.16 108.641 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' THR . 9.3 t80 -159.11 143.13 15.22 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.464 -0.569 . . . . 1.91 109.464 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 75.6 m -112.8 110.67 20.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.148 -0.478 . . . . 1.19 111.359 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -126.16 136.1 28.06 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.59 . . . . 0.5 109.888 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -93.72 162.96 2.28 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.138 1.892 . . . . 0.45 113.21 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.92 168.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.811 -1.181 . . . . 0.44 107.811 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 90.3 p -142.29 149.19 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.513 -0.475 . . . . 0.88 111.484 -169.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.3 t -140.64 103.76 4.59 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.243 -1.021 . . . . 0.96 108.243 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.2 ptmt -123.52 152.49 41.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.676 -0.693 . . . . 1.76 110.454 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.2 155.29 24.18 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.896 -0.668 . . . . 0.5 111.485 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 2.2 mp0 -111.04 132.52 54.16 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.404 -0.398 . . . . 2.1 110.434 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.24 171.98 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.346 -0.613 . . . . 0.76 109.346 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' H ' ' A' ' 144' ' ' LEU . 35.7 ttmt -64.57 174.58 1.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.495 . . . . 3.53 111.653 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.646 HD12 HD11 ' A' ' 114' ' ' ILE . 16.6 tp -55.96 139.28 71.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.612 -0.722 . . . . 1.23 110.901 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.348 0.513 0 C-N-CA 122.785 2.324 . . . . 0.71 112.845 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.221 -0.678 0 N-CA-C 116.374 1.309 . . . . 0.54 116.374 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 45' ' ' VAL . 51.9 p -163.54 37.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.691 1.597 . . . . 1.2 106.814 173.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 46' ' ' SER . 1.5 p -131.05 147.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 113.955 -1.475 . . . . 0.93 110.679 -167.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.22 -36.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.712 -0.677 . . . . 0.48 110.631 166.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -175.89 160.94 2.42 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 109.85 -0.426 . . . . 1.69 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -137.12 145.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.685 -0.857 . . . . 1.14 108.685 162.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.1 146.3 46.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.941 0.4 . . . . 1.83 111.646 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.7 tm? -99.98 135.7 41.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.92 -0.582 . . . . 0.94 111.091 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -143.62 -95.95 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.341 0.867 . . . . 1.33 113.341 176.119 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.77 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 1.6 t70 . . . . . 0 C--O 1.208 -1.11 0 O-C-N 121.723 -0.611 . . . . 2.85 111.613 -154.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.434 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 8.6 t . . . . . 0 C--O 1.241 0.629 0 CA-C-O 121.561 0.696 . . . . 0.94 112.822 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 63.8 t -76.17 151.39 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.017 -0.992 . . . . 0.86 109.647 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.84 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 85.1 mt-10 -109.8 133.34 53.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.223 -0.991 . . . . 1.19 111.853 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.843 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.12 106.15 9.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.767 -1.106 . . . . 3.73 110.555 -176.808 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 94' ' ' VAL . 1.7 tm? -84.78 110.17 18.61 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.821 -0.807 . . . . 0.81 108.821 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -89.97 110.02 21.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.844 0.83 . . . . 0.42 110.247 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 30.6 ttmt -84.43 125.38 32.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.579 -1.192 . . . . 2.63 108.538 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 90' ' ' LEU . 63.5 t -111.78 139.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.219 0.533 . . . . 0.82 112.086 -170.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' THR . 15.7 m -131.82 97.59 4.23 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.72 109.276 162.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 2.3 p -84.62 128.1 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.096 -0.956 . . . . 1.14 110.744 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 9.8 m -102.25 121.31 42.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.776 -0.647 . . . . 0.41 109.946 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 14.0 t30 -87.57 126.67 61.16 Favored Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 124.722 1.264 . . . . 1.48 109.734 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 -10.0 10.2 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.951 3.101 . . . . 0.73 115.971 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.0 t80 -96.23 -105.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.595 -0.842 . . . . 2.08 111.264 -171.033 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 85' ' ' LYS . 47.6 t -175.62 26.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.372 0.606 . . . . 1.51 109.862 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -150.74 139.28 20.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.138 -0.69 . . . . 1.67 109.138 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.862 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 43.5 t -52.19 101.47 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.953 0 O-C-N 124.025 0.828 . . . . 1.39 111.93 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.7 pt -75.24 172.0 10.32 Favored Pre-proline 0 C--O 1.207 -1.173 0 N-CA-C 107.7 -1.222 . . . . 1.03 107.7 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HB2' ' CD1' ' A' ' 57' ' ' ILE . 12.0 Cg_endo -90.08 -58.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.508 0 CA-C-N 120.166 1.095 . . . . 0.37 114.687 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 1.5 mp -130.37 161.87 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 119.727 -0.789 . . . . 1.23 112.768 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 30.1 p -147.64 168.82 21.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.08 0.943 . . . . 1.15 111.77 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.103 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 16.6 tp10 -122.29 118.71 29.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.412 -1.722 . . . . 1.36 110.06 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 13.2 mm -94.58 110.16 23.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 114.618 -1.174 . . . . 1.05 110.567 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 11.0 p -120.61 102.67 8.57 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.615 -0.434 . . . . 0.83 109.864 173.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.556 ' HD1' HG22 ' A' ' 60' ' ' ILE . 11.8 p90 -110.3 126.39 54.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.159 0.504 . . . . 0.4 109.857 -171.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 18.4 m -123.34 112.1 17.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.034 -0.728 . . . . 0.38 109.034 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 93.2 m-85 -97.66 140.99 31.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.979 0.419 . . . . 0.96 110.606 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.518 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -132.93 145.63 51.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.466 -1.309 . . . . 1.29 107.466 176.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -111.52 -97.66 0.42 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.183 -1.007 . . . . 1.27 111.41 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.43 -60.57 3.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.529 -0.545 . . . . 0.36 109.529 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.77 19.63 0.12 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.578 -1.809 . . . . 0.39 108.578 167.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 69' ' ' ARG . 8.5 ptp180 -115.75 -177.85 3.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.332 -0.988 . . . . 1.97 108.332 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.9 98.0 7.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.072 0.939 . . . . 2.61 110.245 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.811 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.37 -43.51 62.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.352 -1.749 . . . . 0.4 111.86 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.23 169.11 42.25 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.077 -1.058 . . . . 0.49 111.355 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.27 155.32 11.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.218 0.509 . . . . 1.81 110.541 174.156 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.22 -175.62 46.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.213 -1.155 . . . . 0.43 110.213 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 11.1 ptpt -152.09 136.64 16.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.321 0.56 . . . . 1.72 112.134 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 68.6 mt -130.78 108.97 15.64 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.289 -0.868 . . . . 0.73 110.312 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 114.34 3.89 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.312 2.008 . . . . 0.57 109.975 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -132.01 146.09 60.21 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.035 -0.357 . . . . 0.79 110.035 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 81' ' ' SER . 9.4 Cg_endo -54.6 90.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.513 2.142 . . . . 0.58 112.17 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -77.09 29.01 1.63 Allowed Glycine 0 C--O 1.225 -0.455 0 CA-C-N 115.278 -0.874 . . . . 0.4 112.493 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.969 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 59.9 p -74.03 119.92 18.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.719 -0.474 . . . . 0.62 109.719 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.862 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -157.95 173.89 16.08 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.833 -1.147 . . . . 1.1 113.646 -164.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 88.6 mttt -33.84 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.578 1.325 . . . . 1.84 114.578 -167.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 168.34 108.87 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.359 -0.978 . . . . 0.99 108.359 -174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.822 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 47.6 pttt 42.05 48.49 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.168 0.918 . . . . 1.84 110.886 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 4.4 t70 -148.9 -174.37 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.64 -1.164 . . . . 0.64 109.782 -168.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.57 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.1 ttm -117.22 121.67 41.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.33 0.586 . . . . 1.35 110.596 -173.197 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.644 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -115.53 144.55 43.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.158 -0.928 . . . . 0.77 110.743 -175.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -85.92 141.37 29.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.088 0.47 . . . . 0.48 110.043 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.783 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.1 tp -139.32 173.54 11.44 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.25 -1.019 . . . . 0.77 108.25 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.783 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 15.9 m-20 -132.6 124.36 28.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.166 0.508 . . . . 1.81 111.842 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -112.84 138.15 22.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.442 -0.799 . . . . 0.65 109.01 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 92' ' ' ILE . 76.6 Cg_exo -51.96 -159.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.83 3.02 . . . . 1.07 114.58 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 1.4 m -124.08 93.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.371 -0.831 . . . . 0.46 110.873 -167.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 95' ' ' VAL . 5.7 p -128.3 103.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 113.917 1.08 . . . . 0.48 113.917 -168.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 p -152.41 99.64 2.83 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.07 110.924 161.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.4 Cg_exo -52.86 131.05 40.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.94 1.76 . . . . 0.48 111.022 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.434 ' H ' ' HA ' ' A' ' 38' ' ' SER . 10.9 t80 -57.96 -30.59 66.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 1.31 111.559 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.5 m -59.38 -30.57 68.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.783 0.29 . . . . 1.2 111.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.811 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 mm -76.63 -55.15 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.008 -0.677 . . . . 0.51 110.348 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 39' ' ' VAL . 25.3 mt -50.55 -27.38 6.61 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.665 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.431 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 23.7 t80 -64.67 -43.16 94.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.672 -1.149 . . . . 0.96 108.799 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 33.1 m-80 -74.42 -57.73 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.82 112.458 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.991 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -58.24 -49.57 76.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.385 0.883 . . . . 0.65 113.385 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.9 -23.65 67.29 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 121.912 0.863 . . . . 0.43 109.806 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.5 ttp180 -68.03 -47.99 66.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.586 -1.188 . . . . 1.81 110.408 173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 15.7 t70 -82.59 -55.89 4.19 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.923 0.868 . . . . 0.8 111.871 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.2 t -83.65 -29.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 O-C-N 121.66 -0.65 . . . . 0.88 109.625 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.25 -16.54 80.45 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.522 -0.847 . . . . 0.38 111.693 172.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -49.07 -44.21 16.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.473 -1.677 . . . . 1.09 106.473 165.107 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.64 -81.89 0.08 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.539 -0.755 . . . . 1.87 109.954 163.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 178.44 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.623 0.601 . . . . 1.17 112.623 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.82 128.63 40.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.319 0.58 . . . . 2.15 111.434 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -113.5 161.57 12.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.695 -0.684 . . . . 0.39 109.901 -172.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 3.4 p-10 -101.85 152.74 20.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.768 -0.827 . . . . 2.11 108.768 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 34.5 m-85 -139.52 166.09 25.49 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.637 -0.875 . . . . 0.62 108.637 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.2 tt0 -153.8 135.35 14.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.8 110.142 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -107.37 129.6 54.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.528 -0.76 . . . . 1.25 109.181 173.527 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.698 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.0 tp60 -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.817 -0.809 . . . . 0.63 108.817 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.1 tp -112.92 120.89 64.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.228 0.537 . . . . 0.81 111.399 -173.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.81 119.89 5.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.362 -0.695 . . . . 0.26 111.362 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.617 HD11 ' OG ' ' A' ' 25' ' ' SER . 1.3 mp -98.65 96.11 7.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.007 0.432 . . . . 1.2 110.851 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.103 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 63.2 m -95.98 96.41 8.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.811 -0.631 . . . . 0.32 109.387 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 58' ' ' CYS . 5.7 pt -111.28 138.34 40.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 120.171 -0.612 . . . . 0.98 111.327 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.51 106.14 14.13 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.306 -0.998 . . . . 1.52 108.306 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 55' ' ' ILE . 35.1 mt -116.52 150.3 45.28 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 124.859 1.35 . . . . 1.28 110.344 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.43 -13.98 41.01 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.14 1.894 . . . . 0.74 113.292 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.36 -57.37 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.31 0.576 . . . . 1.12 111.257 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.42 6.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.854 0.835 . . . . 1.35 110.74 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.31 -31.93 2.6 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 114.005 -1.452 . . . . 1.05 111.966 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.4 pt-20 -178.55 154.03 0.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.705 -0.85 . . . . 1.16 108.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.725 ' HD2' HG23 ' A' ' 134' ' ' ILE . 11.3 t80 -157.83 144.99 18.17 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.563 -0.455 . . . . 1.91 110.292 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.9 m -101.6 99.56 9.87 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.594 0.559 . . . . 1.19 110.855 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 132' ' ' PHE . 2.3 pp -109.1 124.51 33.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.203 -0.666 . . . . 0.5 109.203 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 95.9 Cg_endo -89.12 162.61 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.559 1.506 . . . . 0.45 112.536 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.7 161.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.056 -1.09 . . . . 0.44 108.056 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -126.84 144.49 50.95 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.168 -0.308 . . . . 0.88 110.168 -171.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 m -136.99 100.82 4.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.338 -0.986 . . . . 0.96 108.338 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 8.9 ptmt -123.72 143.01 50.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.129 -0.487 . . . . 1.76 111.242 -170.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.59 153.63 24.31 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.667 -0.777 . . . . 0.5 111.961 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.559 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 26.1 mt-10 -106.85 132.62 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.774 -0.454 . . . . 2.1 109.774 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.41 174.15 2.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.153 -1.054 . . . . 0.76 108.153 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.23 170.92 1.5 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.302 0.853 . . . . 3.53 113.302 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -68.51 149.8 97.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.91 -1.041 . . . . 1.23 110.739 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.35 0.607 0 C-N-CA 122.502 2.135 . . . . 0.71 112.091 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.765 0 N-CA-C 114.624 0.61 . . . . 0.54 114.624 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 122' ' ' LEU . 89.6 p -169.5 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.195 -1.039 . . . . 1.2 108.195 172.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.91 155.25 41.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.742 -1.117 . . . . 0.93 109.058 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 44' ' ' LYS . 1.6 t -168.94 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.208 0.447 . . . . 0.48 112.208 164.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 22.8 t70 -158.51 156.68 30.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.633 0.651 . . . . 1.69 110.837 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.21 127.07 46.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.573 -0.529 . . . . 1.14 109.573 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -112.49 130.8 55.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 1.83 111.562 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.03 122.75 32.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.94 111.408 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -128.36 -126.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.228 -0.656 . . . . 1.33 109.228 167.231 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 1.029 ' HA ' HG13 ' A' ' 39' ' ' VAL . 7.4 p-10 . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 113.267 0.84 . . . . 2.85 113.267 -171.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 121.015 0.436 . . . . 0.94 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 33' ' ' ASP . 46.5 t -76.75 164.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.911 -0.774 . . . . 0.86 108.911 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.892 ' HG2' ' HB ' ' A' ' 94' ' ' VAL . 4.0 mt-10 -124.76 141.18 52.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.559 -0.856 . . . . 1.19 112.124 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.869 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -122.55 105.4 10.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.106 -0.952 . . . . 3.73 111.012 -177.019 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -77.74 110.23 12.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.377 -0.971 . . . . 0.81 108.377 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -101.06 98.65 9.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.426 0.632 . . . . 0.42 110.221 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -82.7 106.07 14.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.533 -1.284 . . . . 2.63 107.533 176.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 90' ' ' LEU . 2.0 m -110.83 164.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.702 -1.135 . . . . 0.82 110.632 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.9 m -142.85 105.13 4.44 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.209 0.528 . . . . 0.72 111.665 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.5 t -83.02 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.855 . . . . 1.14 110.851 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -101.23 122.31 43.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.456 -0.338 . . . . 0.41 110.77 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.934 ' HB2' HD21 ' A' ' 82' ' ' LEU . 7.6 t-20 -88.2 134.73 34.2 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.382 1.051 . . . . 1.48 108.849 173.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 15.2 Cg_endo -108.23 9.88 0.13 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.191 2.594 . . . . 0.73 115.812 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 52' ' ' SER . 38.5 t80 -118.15 -15.43 9.84 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.089 0.859 . . . . 2.08 113.254 -169.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CE ' ' A' ' 85' ' ' LYS . 17.8 t 87.82 17.59 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.532 0.733 . . . . 1.51 110.412 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -143.43 125.43 15.29 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.163 -0.68 . . . . 1.67 109.163 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -38.85 101.79 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 O-C-N 124.298 0.999 . . . . 1.39 112.969 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.654 HD12 ' HB ' ' A' ' 124' ' ' ILE . 7.3 pt -77.76 118.73 73.98 Favored Pre-proline 0 C--O 1.208 -1.085 0 N-CA-C 109.173 -0.676 . . . . 1.03 109.173 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.939 ' HB2' HD12 ' A' ' 57' ' ' ILE . 29.3 Cg_endo -60.42 -54.01 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.273 1.982 . . . . 0.37 113.651 -157.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.939 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.6 mp -133.83 159.07 42.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.045 -0.662 . . . . 1.23 110.65 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.678 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -145.69 172.41 13.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.158 0.98 . . . . 1.15 111.789 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.048 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.0 tt0 -127.26 114.63 17.88 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.109 -1.86 . . . . 1.36 108.949 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.91 109.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 122.512 1.148 . . . . 1.05 109.78 169.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 13.5 p -112.4 101.64 9.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.216 -1.811 . . . . 0.83 108.184 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 12.0 p90 -114.71 136.56 52.93 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.137 0.494 . . . . 0.4 110.285 -166.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 73' ' ' LYS . 16.9 m -132.45 108.57 9.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.788 -1.097 . . . . 0.38 109.546 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CZ ' HD23 ' A' ' 118' ' ' LEU . 96.4 m-85 -97.22 140.97 30.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.808 -0.633 . . . . 0.96 109.438 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -128.59 145.62 51.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.467 -1.308 . . . . 1.29 107.467 175.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.792 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.8 t -100.99 -102.86 0.25 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.449 -0.9 . . . . 1.27 110.199 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' HH11 ' A' ' 69' ' ' ARG . . . -62.6 -57.05 12.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.889 -0.782 . . . . 0.36 108.889 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.54 15.2 0.16 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 108.599 -1.8 . . . . 0.39 108.599 165.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -109.72 171.86 7.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.368 -0.975 . . . . 1.97 108.368 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.85 95.3 8.17 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.112 0.482 . . . . 2.61 109.913 -164.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.826 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.7 mm -48.08 -41.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.639 -1.164 . . . . 0.4 111.403 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.26 163.38 29.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.211 -0.995 . . . . 0.49 111.608 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.638 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.6 OUTLIER -165.92 155.91 12.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.533 0.667 . . . . 1.81 110.998 174.928 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.66 35.54 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.482 -0.781 . . . . 0.43 111.528 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -123.44 131.71 53.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.09 -0.337 . . . . 1.72 110.09 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.546 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 86.7 mt -137.89 126.18 14.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.441 -0.345 . . . . 0.73 110.123 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.09 115.72 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.468 2.112 . . . . 0.57 111.633 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -125.04 141.29 38.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.084 -0.339 . . . . 0.79 110.084 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.75 87.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.792 2.328 . . . . 0.58 111.963 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -78.73 19.55 4.98 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.4 113.384 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . 91.1 p -70.38 119.71 14.97 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.49 -0.559 . . . . 0.62 109.49 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 49' ' ' ASN . 2.6 pt? -142.41 -165.95 2.15 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.854 0.687 . . . . 1.1 112.854 -165.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 89.9 mttt -43.2 -91.33 0.0 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.777 -1.101 . . . . 1.84 112.949 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 165.02 105.17 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.31 -0.996 . . . . 0.99 108.31 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.1 ptpt 43.84 50.84 6.9 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.363 1.04 . . . . 1.84 111.166 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 87' ' ' MET . 10.8 t70 -151.56 -169.87 3.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.217 -0.901 . . . . 0.64 108.816 -173.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.411 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 48.4 ttm -116.99 121.4 41.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.835 0.35 . . . . 1.35 110.494 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' SER . 12.0 t -104.94 143.36 33.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.754 -0.657 . . . . 0.77 109.739 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.01 106.8 14.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.379 0.609 . . . . 0.48 110.097 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 7.7 tp -100.48 178.23 4.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.085 -0.961 . . . . 0.77 109.246 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.944 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.2 t70 -146.58 127.8 14.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.578 -0.283 . . . . 1.81 111.303 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 1.5 mp -102.61 116.3 62.98 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.645 -1.243 . . . . 0.65 107.645 163.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 33.5 Cg_exo -32.32 -100.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 125.181 3.921 . . . . 1.07 115.477 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.892 ' HB ' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -163.43 93.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 O-C-N 122.275 -0.266 . . . . 0.46 111.336 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -129.03 104.26 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.676 1.361 . . . . 0.48 114.676 -170.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.509 ' CG2' ' HG ' ' A' ' 101' ' ' LEU . 3.0 p -153.79 99.83 2.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 121.867 -0.52 . . . . 1.07 111.949 161.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.5 Cg_exo -53.66 131.71 45.34 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.828 1.685 . . . . 0.48 111.183 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -53.9 -33.23 55.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 1.31 112.356 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -56.17 -32.0 63.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.757 0.313 . . . . 1.2 111.667 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.826 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 mm -76.28 -55.72 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.602 -0.439 . . . . 0.51 110.643 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 104' ' ' LEU . 40.3 mt -51.99 -28.11 15.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.703 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.12 -44.66 95.0 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.028 -0.987 . . . . 0.96 108.99 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.21 -57.15 4.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.799 -0.637 . . . . 0.82 111.889 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.792 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.6 pp -62.07 -53.06 60.82 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.431 0.9 . . . . 0.65 113.431 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.1 -25.97 68.61 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.842 0.83 . . . . 0.43 110.197 -177.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 110' ' ' VAL . 6.7 ttp180 -74.57 -54.7 6.98 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.531 -1.213 . . . . 1.81 110.391 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.88 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.4 t70 -74.06 -52.79 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.883 0.849 . . . . 0.8 111.057 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.608 HG21 HG23 ' A' ' 114' ' ' ILE . 2.3 t -86.93 -17.21 8.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.355 -0.84 . . . . 0.88 109.697 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.738 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -67.91 -25.56 74.22 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.736 -0.745 . . . . 0.38 113.712 168.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 107' ' ' ASP . 11.5 m -63.22 -40.83 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.118 -1.438 . . . . 1.09 107.118 170.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.6 m-20 -59.56 -58.53 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.63 -0.713 . . . . 1.87 110.927 165.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.5 ' CG ' ' N ' ' A' ' 113' ' ' ASP . 3.8 p-90 128.36 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.282 2.233 . . . . 1.17 111.641 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 14.9 t70 -94.44 129.44 41.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.475 -0.329 . . . . 2.15 110.404 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.738 HD11 HD12 ' A' ' 144' ' ' LEU . 2.5 mp -115.32 151.13 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.026 0.441 . . . . 0.39 109.854 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 141' ' ' GLU . 6.1 p-10 -93.73 152.59 18.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.983 -0.747 . . . . 2.11 108.983 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 31.9 m-85 -141.9 165.66 26.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.669 -0.863 . . . . 0.62 108.669 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 22.9 tt0 -152.18 139.92 19.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.751 0.31 . . . . 0.8 110.345 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -113.91 129.94 56.55 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.205 -0.665 . . . . 1.25 109.205 173.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.648 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.9 tp60 -120.59 100.72 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.118 -0.697 . . . . 0.63 109.118 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.07 123.18 71.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.51 0.671 . . . . 0.81 110.773 -174.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.33 124.48 7.07 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.458 -0.792 . . . . 0.26 111.768 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.564 HD12 HD12 ' A' ' 120' ' ' ILE . 6.1 mp -97.4 105.91 18.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.966 0.412 . . . . 1.2 111.055 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.048 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 89.2 m -108.11 95.14 5.47 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.439 -0.801 . . . . 0.32 109.007 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 58' ' ' CYS . 7.0 pt -112.23 140.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 120.555 -0.458 . . . . 0.98 110.281 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.797 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -85.81 105.8 16.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.33 -0.989 . . . . 1.52 108.33 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -125.03 135.54 26.93 Favored Pre-proline 0 C--O 1.22 -0.464 0 O-C-N 124.049 0.843 . . . . 1.28 110.156 178.473 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 53.9 Cg_exo -52.73 -19.38 10.57 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.496 2.797 . . . . 0.74 115.32 -169.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.48 -51.09 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.231 -0.293 . . . . 1.12 111.361 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.692 HG11 ' HD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -103.32 -2.38 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.087 0.946 . . . . 1.35 109.456 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.72 -36.95 1.22 Allowed Glycine 0 C--N 1.314 -0.669 0 CA-C-N 113.558 -1.655 . . . . 1.05 111.151 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.1 pt-20 -177.09 150.57 0.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.554 -1.276 . . . . 1.16 107.554 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HD1' HG11 ' A' ' 129' ' ' VAL . 12.7 t80 -151.97 147.86 27.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.703 -0.399 . . . . 1.91 110.158 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 67.8 m -113.82 104.72 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.506 0.504 . . . . 1.19 111.477 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -124.04 133.09 24.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 0.5 109.608 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 89.6 Cg_endo -87.38 161.28 8.24 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.592 1.528 . . . . 0.45 112.836 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.68 164.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.299 -1.0 . . . . 0.44 108.299 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -135.4 150.21 49.84 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.901 -0.319 . . . . 0.88 111.203 -168.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.3 t -145.8 102.18 3.63 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.649 -1.241 . . . . 0.96 107.649 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 6.0 ptmt -118.12 144.05 45.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.68 -0.489 . . . . 1.76 109.68 -172.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.03 149.55 19.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.021 -1.085 . . . . 0.5 112.443 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 115' ' ' ASP . 31.0 mt-10 -108.06 126.94 53.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.055 -0.572 . . . . 2.1 109.771 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 172.87 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.868 -0.79 . . . . 0.76 108.868 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -54.64 160.81 1.69 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.995 0.739 . . . . 3.53 112.995 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.738 HD12 HD11 ' A' ' 114' ' ' ILE . 25.0 tp -58.88 136.54 87.26 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.056 -0.974 . . . . 1.23 110.57 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.664 ' HD2' HD12 ' A' ' 144' ' ' LEU . 38.1 Cg_endo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.798 2.332 . . . . 0.71 112.486 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 116.282 1.273 . . . . 0.54 116.282 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 75.5 p -169.01 34.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.47 1.108 . . . . 1.2 108.107 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.21 152.86 36.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 114.48 -1.236 . . . . 0.93 109.701 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 t -168.53 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.135 0.272 . . . . 0.48 110.712 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -174.36 168.08 3.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.554 0.575 . . . . 1.69 112.554 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 67.8 t -142.76 129.36 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.341 -0.845 . . . . 1.14 109.497 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.97 128.12 54.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.619 -0.264 . . . . 1.83 110.98 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 2.7 tm? -92.97 139.54 30.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.801 0.297 . . . . 0.94 111.801 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -139.1 -94.52 0.17 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.047 1.129 . . . . 1.33 114.047 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.205 -1.272 0 CA-C-N 116.182 -0.463 . . . . 2.85 112.182 -153.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 45.1 t . . . . . 0 C--O 1.24 0.586 0 CA-C-O 121.83 0.824 . . . . 0.94 112.289 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 93.3 t -74.01 147.07 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.578 -1.192 . . . . 0.86 110.056 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -123.55 137.73 54.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.604 -0.838 . . . . 1.19 110.337 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.94 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -141.7 139.61 32.96 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 118.671 -1.212 . . . . 3.73 113.677 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -83.24 109.0 16.86 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.666 -1.235 . . . . 0.81 107.666 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -93.48 107.52 19.35 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.535 -0.913 . . . . 0.42 108.535 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 21.5 ttmm -82.7 131.31 35.21 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.927 -0.768 . . . . 2.63 108.927 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 25' ' ' SER . 45.2 t -111.2 137.81 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.735 -1.12 . . . . 0.82 110.236 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.7 m -126.39 97.87 5.22 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 120.257 -0.577 . . . . 0.72 109.632 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 57.8 t -84.0 124.25 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.651 -0.704 . . . . 1.14 110.812 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 22.1 m -99.83 121.01 40.66 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.326 -0.991 . . . . 0.41 108.326 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.844 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.9 t30 -89.45 124.37 64.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 124.894 1.371 . . . . 1.48 109.652 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.89 11.67 3.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.852 3.035 . . . . 0.73 113.945 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 2.7 t80 -125.54 136.38 53.25 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.717 -0.845 . . . . 2.08 108.717 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.2 p -76.31 34.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.311 0.577 . . . . 1.51 111.161 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 51' ' ' TYR . 52.8 m80 -148.57 132.69 17.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.371 -0.831 . . . . 1.67 109.895 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -45.15 102.07 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.186 0.994 . . . . 1.39 113.459 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 81' ' ' SER . 11.1 pt -75.47 171.65 11.31 Favored Pre-proline 0 C--O 1.208 -1.112 0 N-CA-C 108.535 -0.913 . . . . 1.03 108.535 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 39.6 Cg_endo -89.12 -63.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.455 1.437 . . . . 0.37 114.923 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.2 mm -133.0 162.26 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 121.967 -0.458 . . . . 1.23 111.532 -166.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.809 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.3 p -150.97 -179.85 7.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.165 0.983 . . . . 1.15 111.998 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.064 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.6 tt0 -132.37 116.12 16.44 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.419 -1.719 . . . . 1.36 109.933 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -97.21 108.98 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.362 1.077 . . . . 1.05 109.454 168.573 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 p -114.42 103.03 10.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.454 -1.703 . . . . 0.83 108.807 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 11.8 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.226 0.536 . . . . 0.4 110.294 -165.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 m -137.01 108.81 7.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.873 -1.058 . . . . 0.38 109.626 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 92.7 m-85 -98.54 146.59 25.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.409 -0.359 . . . . 0.96 110.768 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.74 ' HB3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -139.08 128.83 24.75 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 108.098 -1.075 . . . . 1.29 108.098 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . 1.035 ' HB3' HD22 ' A' ' 104' ' ' LEU . 38.1 t -94.06 -89.85 0.21 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.408 -0.917 . . . . 1.27 110.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.55 -67.86 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.387 -0.597 . . . . 0.36 109.387 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.81 18.08 0.17 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.407 -1.077 . . . . 0.39 110.407 167.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' O ' ' HB3' ' A' ' 65' ' ' HIS . 6.7 ptp180 -106.43 -149.47 0.43 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.558 -0.534 . . . . 1.97 109.558 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.35 101.24 7.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 119.068 0.849 . . . . 2.61 109.539 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -73.62 -44.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.645 -0.707 . . . . 0.4 112.417 -171.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.56 140.24 4.43 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.49 111.094 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -154.36 159.08 40.97 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 117.568 0.684 . . . . 1.81 111.222 -174.268 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.74 163.72 26.15 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.886 -0.885 . . . . 0.43 110.886 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.9 mttt -129.85 128.37 42.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.162 -0.31 . . . . 1.72 110.162 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.1 mt -135.67 124.37 15.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.608 -0.269 . . . . 0.73 110.667 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.3 103.0 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.155 1.903 . . . . 0.57 111.234 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HB2' HD11 ' A' ' 60' ' ' ILE . 7.4 t70 -110.43 136.78 20.56 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.79 109.541 -172.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' HD13 ' A' ' 57' ' ' ILE . 25.8 Cg_exo -63.44 88.79 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.546 2.164 . . . . 0.58 112.716 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 82' ' ' LEU . . . -88.24 35.63 3.54 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.885 -0.598 . . . . 0.4 112.379 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.943 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -72.78 117.71 14.82 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.146 -0.687 . . . . 0.62 109.146 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HG ' ' NZ ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -156.41 -155.15 0.52 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.305 -1.358 . . . . 1.1 114.45 -157.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.796 ' CE ' ' HB ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -57.68 -158.2 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.339 1.066 . . . . 1.84 112.305 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.87 80.59 1.72 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.342 -1.355 . . . . 0.99 107.342 -167.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 8.9 mtpt 64.74 68.28 0.53 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.962 -1.472 . . . . 1.84 110.934 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.698 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 9.4 t70 -162.53 -169.59 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.238 -1.346 . . . . 0.64 109.54 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.473 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 41.8 ttp -122.42 118.96 29.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.193 0.521 . . . . 1.35 110.88 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.796 ' HB ' ' CE ' ' A' ' 83' ' ' LYS . 5.6 t -104.04 143.67 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.77 109.018 -172.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.71 109.4 20.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.703 0.763 . . . . 0.48 110.739 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -115.48 175.07 5.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.66 -1.155 . . . . 0.77 108.136 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.588 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 3.1 p30 -144.25 151.22 39.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.011 0.823 . . . . 1.81 112.569 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 40.3 mm -110.16 130.45 22.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.683 -1.144 . . . . 0.65 108.044 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.508 ' O ' HG13 ' A' ' 94' ' ' VAL . 44.6 Cg_exo -35.86 -103.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.687 3.592 . . . . 1.07 115.372 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -164.0 90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 CA-C-O 119.118 -0.468 . . . . 0.46 110.615 -177.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.9 p -124.35 104.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.646 1.721 . . . . 0.48 115.646 -163.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 101' ' ' LEU . 2.5 t -148.9 119.23 4.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 1.07 110.346 164.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 17.9 Cg_exo -65.47 124.9 13.53 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.08 1.064 . . . . 0.48 109.569 164.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.471 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -58.27 -30.85 66.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.31 111.594 -171.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 3.2 p -58.76 -26.54 64.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.311 0.486 . . . . 1.2 112.311 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.2 mm -76.86 -55.31 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 121.818 -0.551 . . . . 0.51 110.995 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 96' ' ' VAL . 26.9 mt -52.24 -26.56 12.09 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.555 0.693 . . . . 1.0 110.392 171.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' SER . 57.6 t80 -64.4 -40.24 95.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.467 -1.242 . . . . 0.96 108.839 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HA ' HH21 ' A' ' 106' ' ' ARG . 22.0 m-80 -73.79 -58.06 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.845 -0.616 . . . . 0.82 112.422 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.035 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -61.04 -50.19 74.31 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.423 0.898 . . . . 0.65 113.423 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.68 -25.05 67.95 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.856 0.836 . . . . 0.43 110.037 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 110' ' ' VAL . 2.7 ttp180 -68.18 -51.11 49.37 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.145 . . . . 1.81 110.728 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 110' ' ' VAL . 24.8 t70 -82.9 -52.07 7.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.545 1.164 . . . . 0.8 112.231 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -84.42 -29.06 6.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.859 -1.151 . . . . 0.88 109.982 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.93 -25.59 73.39 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.923 -0.656 . . . . 0.38 113.786 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -57.65 -40.5 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 118.413 -1.315 . . . . 1.09 108.04 170.78 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 30.6 t70 -64.66 -84.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.504 -1.278 . . . . 1.87 108.097 161.108 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.9 OUTLIER 168.07 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.24 0.83 . . . . 1.17 113.24 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.58 123.78 35.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.87 0.322 . . . . 2.15 111.87 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.578 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.3 mp -117.28 155.55 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.902 0.382 . . . . 0.39 110.032 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' A' ' 141' ' ' GLU . 37.1 t70 -98.91 155.41 17.41 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.067 -0.716 . . . . 2.11 109.067 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 72.9 m-85 -139.08 129.57 25.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.217 -0.66 . . . . 0.62 109.217 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.844 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.5 tt0 -123.78 137.25 54.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.05 0.453 . . . . 0.8 110.068 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.699 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -111.47 129.36 56.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.588 -0.733 . . . . 1.25 109.863 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.699 ' N ' HD22 ' A' ' 118' ' ' LEU . 5.6 tp60 -113.34 101.29 9.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.654 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 tp -111.88 123.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.146 0.498 . . . . 0.81 111.204 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.76 125.2 7.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.378 -0.689 . . . . 0.26 111.378 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.583 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.3 mp -101.88 94.99 6.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.38 . . . . 1.2 111.131 -174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.064 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 84.9 m -100.17 95.56 6.89 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.629 -0.714 . . . . 0.32 109.177 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.838 HG13 HD21 ' A' ' 126' ' ' LEU . 3.0 pt -106.89 149.42 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.9 -0.5 . . . . 0.98 109.698 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.527 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.5 m-20 -92.88 107.15 18.99 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -109.93 159.74 30.67 Favored Pre-proline 0 C--O 1.217 -0.63 0 O-C-N 123.996 0.81 . . . . 1.28 109.997 -176.103 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 17.3 Cg_exo -69.88 -13.1 33.93 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.884 1.722 . . . . 0.74 113.358 174.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.63 -59.93 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.769 0.655 . . . . 1.12 112.769 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 129' ' ' VAL . 34.1 t -118.99 9.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 122.915 1.341 . . . . 1.35 109.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.58 -24.78 3.57 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 113.587 -1.642 . . . . 1.05 111.605 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 10.6 pt-20 -172.52 154.77 3.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.628 -0.879 . . . . 1.16 108.628 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -150.0 143.64 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.523 -0.547 . . . . 1.91 109.523 170.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 53.5 m -116.23 108.85 16.64 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.383 0.427 . . . . 1.19 111.352 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.4 pp -124.94 137.38 29.51 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.098 -0.501 . . . . 0.5 109.975 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 73.7 Cg_endo -92.89 159.11 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.047 1.832 . . . . 0.45 113.323 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -156.44 165.38 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.601 -0.888 . . . . 0.44 108.601 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -136.27 151.36 49.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.64 -0.255 . . . . 0.88 111.072 -168.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t -146.11 103.8 3.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.016 -0.735 . . . . 0.96 109.016 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.844 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.8 ptmt -116.11 152.81 32.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 1.76 111.309 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.08 147.02 10.03 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.718 -0.753 . . . . 0.5 112.049 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 115' ' ' ASP . 31.3 mt-10 -98.67 135.09 40.68 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.607 -0.516 . . . . 2.1 109.607 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.13 171.04 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.212 -0.662 . . . . 0.76 109.212 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -60.02 167.01 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 3.53 112.334 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.825 HD12 ' HD2' ' A' ' 145' ' ' PRO . 42.0 tp -56.26 125.44 64.99 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.928 -1.033 . . . . 1.23 109.809 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.825 ' HD2' HD12 ' A' ' 144' ' ' LEU . 28.6 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 123.658 2.905 . . . . 0.71 113.197 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.733 0 N-CA-C 113.875 0.31 . . . . 0.54 113.875 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.701 ' O ' HG13 ' A' ' 45' ' ' VAL . 83.6 p -169.31 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.338 1.066 . . . . 1.2 108.561 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 136' ' ' ILE . 14.3 m -134.52 152.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 114.297 -1.32 . . . . 0.93 109.707 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -160.28 -51.52 0.05 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.464 -0.569 . . . . 0.48 109.464 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -157.36 166.16 33.83 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.487 -0.56 . . . . 1.69 109.487 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -145.53 148.34 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.154 -0.684 . . . . 1.14 109.154 165.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -122.37 144.39 49.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.016 0.436 . . . . 1.83 111.215 -169.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.12 118.03 32.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.94 111.126 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HG2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.63 -136.36 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 167.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.623 ' HB3' HG13 ' A' ' 39' ' ' VAL . 5.3 p-10 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 115.739 1.755 . . . . 2.85 115.739 -173.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 44.1 t . . . . . 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.451 . . . . 0.94 112.184 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.623 HG13 ' HB3' ' A' ' 33' ' ' ASP . 44.5 t -70.99 168.48 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.743 -1.206 . . . . 0.86 107.743 168.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.019 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 76.0 mt-10 -128.76 136.18 50.2 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.712 0.768 . . . . 1.19 111.081 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.62 104.21 8.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.637 -1.165 . . . . 3.73 109.886 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.556 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -75.39 109.83 9.24 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.267 -0.973 . . . . 0.81 108.613 176.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.734 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -94.52 109.58 21.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.396 0.617 . . . . 0.42 109.781 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 21.7 ttmt -84.65 130.14 34.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.436 -0.802 . . . . 2.63 109.11 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 90' ' ' LEU . 69.3 t -111.34 136.12 48.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 116.149 -0.478 . . . . 0.82 112.13 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.561 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 29.4 m -127.05 95.76 4.4 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.025 -0.731 . . . . 0.72 109.025 160.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -89.48 128.51 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.536 0.684 . . . . 1.14 110.955 -176.45 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -103.77 117.27 33.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.963 -1.017 . . . . 0.41 109.853 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 6.3 t30 -88.67 128.47 52.46 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 124.146 0.904 . . . . 1.48 108.922 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -91.84 11.34 2.39 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.25 2.634 . . . . 0.73 114.218 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -130.49 143.43 50.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.043 -0.725 . . . . 2.08 109.043 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 23.1 t -78.07 34.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.946 0.721 . . . . 1.51 112.946 -164.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -144.5 132.14 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.277 -0.264 . . . . 1.67 110.375 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -39.37 103.6 0.03 OUTLIER 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 124.058 0.943 . . . . 1.39 112.708 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.32 169.45 19.33 Favored Pre-proline 0 C--O 1.21 -1.0 0 N-CA-C 108.097 -1.075 . . . . 1.03 108.097 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.923 ' HB2' HD12 ' A' ' 57' ' ' ILE . 9.9 Cg_endo -91.56 -66.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.504 1.469 . . . . 0.37 114.333 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 56' ' ' PRO . 3.8 mp -134.65 152.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.299 -0.56 . . . . 1.23 111.028 -167.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.68 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 16.5 m -144.23 -178.09 5.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.118 0.961 . . . . 1.15 111.92 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 23.8 tt0 -134.27 116.88 15.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.414 -1.721 . . . . 1.36 109.997 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.571 ' HA ' HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -95.94 108.4 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 115.054 -0.975 . . . . 1.05 108.785 164.215 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 39.5 p -112.76 101.95 10.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.05 -1.432 . . . . 0.83 108.377 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -116.16 134.3 55.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.415 0.626 . . . . 0.4 110.583 -166.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -128.32 111.01 12.9 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.507 -1.224 . . . . 0.38 108.819 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 97.8 m-85 -97.31 140.67 31.44 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.584 -0.524 . . . . 0.96 109.584 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -128.19 144.55 51.13 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.048 -1.464 . . . . 1.29 107.048 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 39.1 t -105.43 -103.86 0.32 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 118.967 -1.093 . . . . 1.27 111.046 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -60.53 -54.31 47.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.115 -0.698 . . . . 0.36 109.115 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 21.22 0.12 Allowed Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 109.116 -1.594 . . . . 0.39 109.116 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 6.6 ptp180 -115.97 -172.25 2.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.568 -0.816 . . . . 1.97 109.014 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -105.11 91.55 3.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.612 0.72 . . . . 2.61 110.555 -165.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 100' ' ' ILE . 6.0 mm -52.07 -44.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.911 -1.041 . . . . 0.4 111.067 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.24 170.54 35.48 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.534 -0.841 . . . . 0.49 111.41 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.89 163.02 21.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.377 0.589 . . . . 1.81 111.043 176.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.83 166.25 35.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.892 -0.595 . . . . 0.43 111.637 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 91.3 mttt -135.74 126.42 27.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.613 0.244 . . . . 1.72 110.456 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.37 115.41 14.94 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.944 -0.391 . . . . 0.73 109.944 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 9.8 Cg_exo -72.24 95.69 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.498 2.132 . . . . 0.57 110.553 170.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -112.24 141.84 25.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.374 -0.602 . . . . 0.79 109.374 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HA ' HG13 ' A' ' 57' ' ' ILE . 19.5 Cg_endo -59.44 88.97 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.519 2.146 . . . . 0.58 112.502 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.68 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -83.21 38.71 2.74 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.261 -0.881 . . . . 0.4 112.29 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.973 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 77.4 p -73.58 125.45 28.02 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.506 -0.553 . . . . 0.62 109.506 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.878 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -156.94 0.77 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.893 1.442 . . . . 1.1 114.893 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.545 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 91.5 mttt -62.71 -101.24 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.49 -0.777 . . . . 1.84 112.513 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.23 102.57 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.045 -1.094 . . . . 0.99 108.045 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptpt 43.59 50.43 6.46 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.415 1.072 . . . . 1.84 111.071 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.2 -173.64 4.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.189 -0.914 . . . . 0.64 109.678 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 48.6 ttm -112.59 126.73 55.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.377 -0.374 . . . . 1.35 110.649 -172.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.539 ' CG2' HG13 ' A' ' 47' ' ' VAL . 5.9 t -116.76 144.64 44.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.046 -0.524 . . . . 0.77 110.247 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -90.87 111.36 22.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.737 0.779 . . . . 0.48 110.527 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.746 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -109.85 176.14 5.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.588 -1.187 . . . . 0.77 108.56 -176.498 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.746 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.8 t70 -134.78 131.73 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.365 0.529 . . . . 1.81 111.909 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 19.1 mm -113.62 139.31 23.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.65 110.312 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 92' ' ' ILE . 71.9 Cg_exo -51.3 -177.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.899 . . . . 1.07 113.597 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.019 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.7 m -115.16 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.553 -0.749 . . . . 0.46 110.367 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 p -127.2 102.96 10.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 114.269 1.211 . . . . 0.48 114.269 -164.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.5 p -151.72 98.41 3.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.697 -0.683 . . . . 1.07 110.551 161.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 87.5 Cg_exo -47.67 130.22 18.32 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.994 1.796 . . . . 0.48 111.264 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.513 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -57.86 -31.66 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 1.31 110.998 -173.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 14.9 m -56.6 -28.78 61.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.722 0.296 . . . . 1.2 111.682 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 21.3 mm -76.34 -54.74 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.757 0.313 . . . . 0.51 110.538 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 104' ' ' LEU . 19.9 mt -50.09 -27.84 6.27 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.21 -0.905 . . . . 1.0 110.516 171.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 1.8 t80 -65.66 -42.33 91.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.709 -1.132 . . . . 0.96 109.031 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.649 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 50.7 m-80 -73.59 -56.35 5.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.434 . . . . 0.82 111.946 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 101' ' ' LEU . 1.6 pp -60.94 -51.16 70.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.442 0.904 . . . . 0.65 113.442 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -24.35 66.9 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.718 0.77 . . . . 0.43 109.706 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.649 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -60.32 -53.27 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.654 -1.157 . . . . 1.81 110.143 172.35 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.98 -53.29 6.26 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.301 0.572 . . . . 0.8 112.394 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 2.2 t -89.72 -25.26 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.945 -0.702 . . . . 0.88 110.159 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.35 -24.64 72.63 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.181 -1.009 . . . . 0.38 111.07 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.6 -44.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.448 -1.316 . . . . 1.09 107.448 166.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 7.6 m-20 -68.84 -87.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.78 -0.646 . . . . 1.87 110.179 162.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -179.85 -56.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.313 -0.403 . . . . 1.17 111.631 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 108' ' ' VAL . 1.6 p-10 -94.42 134.38 37.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.802 0.334 . . . . 2.15 110.234 -177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.653 HD11 HD12 ' A' ' 144' ' ' LEU . 2.3 mp -119.38 156.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.916 -0.772 . . . . 0.39 108.916 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 141' ' ' GLU . 1.6 p-10 -98.0 152.81 18.88 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.714 -0.847 . . . . 2.11 108.714 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 44.0 m-85 -138.07 169.33 17.98 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.737 -1.208 . . . . 0.62 107.737 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.617 ' HA ' ' CB ' ' A' ' 139' ' ' LYS . 3.7 tt0 -160.06 145.04 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.907 0.384 . . . . 0.8 110.224 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -116.59 128.79 55.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.885 -0.598 . . . . 1.25 109.472 174.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.635 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.8 tp60 -117.08 100.37 7.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.465 -0.939 . . . . 0.63 108.465 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -117.14 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.334 0.588 . . . . 0.81 110.846 -173.142 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' N ' HD13 ' A' ' 120' ' ' ILE . . . -86.06 124.15 6.75 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.368 -0.833 . . . . 0.26 111.831 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.555 HD12 HD12 ' A' ' 120' ' ' ILE . 5.9 mp -95.34 106.49 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.11 0.481 . . . . 1.2 110.569 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.08 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.1 m -112.04 94.35 4.9 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.034 -0.985 . . . . 0.32 109.228 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.677 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -117.35 126.17 74.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.481 -0.562 . . . . 0.98 109.481 -175.851 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.847 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 33.3 t70 -81.71 106.86 13.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 120.394 -0.523 . . . . 1.52 110.296 -172.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.672 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 4.5 mm? -98.32 -178.76 0.75 Allowed Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 125.201 1.563 . . . . 1.28 109.994 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 126' ' ' LEU . 15.6 Cg_endo -90.78 -16.4 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.987 1.791 . . . . 0.74 113.445 167.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.8 t -73.53 -59.71 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.481 0.548 . . . . 1.12 112.481 -170.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.595 ' H ' ' HE1' ' A' ' 132' ' ' PHE . 2.1 t -113.59 -2.22 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 123.417 1.579 . . . . 1.35 107.026 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 86.95 -133.94 12.15 Favored Glycine 0 N--CA 1.422 -2.248 0 CA-C-N 111.636 -2.529 . . . . 1.05 108.52 -167.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.847 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 7.2 pt-20 -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.796 0.808 . . . . 1.16 110.869 176.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.79 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.2 m-30 -89.68 145.13 25.44 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.524 -0.917 . . . . 1.91 108.524 173.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 21.2 m -129.88 94.16 3.66 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.733 -0.387 . . . . 1.19 111.452 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -128.57 136.16 28.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.23 173.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -89.34 158.23 5.53 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.866 1.711 . . . . 0.45 112.604 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.3 163.94 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.44 109.384 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -132.83 139.95 47.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.376 -0.374 . . . . 0.88 110.133 -170.398 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 50.2 m -147.83 101.02 3.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.715 -0.846 . . . . 0.96 108.715 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 116' ' ' TYR . 13.9 ptmm? -116.53 163.06 16.64 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.45 -0.796 . . . . 1.76 111.66 -171.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.14 138.96 5.61 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.42 -0.895 . . . . 0.5 111.329 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 115' ' ' ASP . 5.0 mp0 -106.55 126.76 52.68 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.715 -0.742 . . . . 2.1 109.416 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.52 174.99 4.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.073 -0.714 . . . . 0.76 109.073 -171.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -57.08 163.13 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.384 0.513 . . . . 3.53 112.384 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.656 HD12 ' HD2' ' A' ' 145' ' ' PRO . 28.5 tp -56.55 127.41 72.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 115.392 -0.822 . . . . 1.23 110.423 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.656 ' HD2' HD12 ' A' ' 144' ' ' LEU . 25.1 Cg_endo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.401 2.734 . . . . 0.71 113.155 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.501 -0.808 0 N-CA-C 116.528 1.371 . . . . 0.54 116.528 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.817 ' HB2' HD21 ' A' ' 122' ' ' LEU . 58.6 m 179.95 49.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.066 1.747 . . . . 1.2 107.167 -174.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.65 154.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.05 -0.977 . . . . 0.93 109.488 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -175.82 -36.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 O-C-N 123.48 0.487 . . . . 0.48 111.623 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 34.7 t70 -163.73 154.26 15.66 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.078 0.466 . . . . 1.69 110.591 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.719 HG11 ' HZ ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -151.25 144.69 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.604 -0.517 . . . . 1.14 109.604 164.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.35 142.72 51.05 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.023 -0.732 . . . . 1.83 109.023 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.776 HD21 HG11 ' A' ' 96' ' ' VAL . 3.3 tm? -101.17 112.24 24.67 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.713 -0.477 . . . . 0.94 109.713 -170.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.13 147.86 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.03 1.395 . . . . 1.33 112.368 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 1.8 t70 . . . . . 0 C--N 1.294 -1.826 0 CA-C-N 111.178 -2.737 . . . . 2.85 108.039 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.534 ' OG ' ' HA ' ' A' ' 97' ' ' PRO . 42.2 t . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 108.274 -1.01 . . . . 0.94 108.274 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HB ' HD12 ' A' ' 101' ' ' LEU . 35.9 t -83.95 158.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.533 -1.654 . . . . 0.86 106.533 171.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 12.5 mt-10 -139.19 165.66 26.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.124 -1.065 . . . . 1.19 108.124 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.899 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 30.5 p90 -134.63 126.8 29.91 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.22 -1.392 . . . . 3.73 112.691 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.91 115.17 20.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.566 -0.853 . . . . 0.81 109.364 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . . . -106.39 119.46 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.092 0.472 . . . . 0.42 111.924 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.6 tppt? -87.3 102.31 14.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.216 1.007 . . . . 2.63 109.449 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.999 HG21 HD13 ' A' ' 92' ' ' ILE . 12.4 t -96.36 156.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.766 -1.106 . . . . 0.82 110.33 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.503 ' C ' ' HA ' ' A' ' 25' ' ' SER . 4.1 m -139.45 112.32 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 120.054 -0.659 . . . . 0.72 111.33 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 25.9 t -82.64 124.07 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.975 -1.011 . . . . 1.14 110.372 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -104.09 114.29 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.41 109.267 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 13.0 t30 -89.81 126.26 58.23 Favored Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 124.395 1.059 . . . . 1.48 110.133 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.02 3.88 7.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.594 2.863 . . . . 0.73 113.999 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 13.0 t80 -122.03 143.72 49.33 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.407 -0.59 . . . . 2.08 109.407 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.624 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 19.8 p -79.2 28.53 0.23 Allowed 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.434 0.531 . . . . 1.51 112.434 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -143.11 131.04 21.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.416 -0.357 . . . . 1.67 110.075 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.5 m -40.76 100.14 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.985 0 C-N-CA 124.212 1.005 . . . . 1.39 112.846 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.957 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.8 pt -74.51 171.14 12.14 Favored Pre-proline 0 C--O 1.21 -1.014 0 N-CA-C 108.073 -1.084 . . . . 1.03 108.073 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 57' ' ' ILE . 13.4 Cg_endo -92.9 -63.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.034 1.156 . . . . 0.37 114.261 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.2 mm -128.38 154.76 39.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 1.23 111.797 -165.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.651 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.5 p -151.02 -177.46 6.03 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.075 0.941 . . . . 1.15 111.78 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.022 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 39.4 tt0 -135.36 115.86 13.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.379 -1.737 . . . . 1.36 109.809 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -98.3 109.52 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.334 1.064 . . . . 1.05 109.619 168.685 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 33.2 p -114.52 102.73 10.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.273 -1.785 . . . . 0.83 108.782 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 p90 -109.69 133.36 53.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.969 0.414 . . . . 0.4 110.116 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 12.2 m -125.53 100.82 6.64 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.185 -0.916 . . . . 0.38 109.546 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.836 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 10.4 m-85 -97.57 143.78 27.91 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.869 -0.605 . . . . 0.96 109.956 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -146.16 143.74 29.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.904 -1.147 . . . . 1.29 107.904 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.882 ' HB3' HD22 ' A' ' 104' ' ' LEU . 33.0 t -102.02 -93.97 0.3 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.987 -0.685 . . . . 1.27 111.421 -174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.94 10.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.36 109.545 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.44 16.29 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.763 -1.208 . . . . 0.39 110.247 165.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.694 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -99.19 -69.76 0.75 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.998 -0.601 . . . . 1.97 110.532 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 28.1 tt0 -175.75 170.58 2.83 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.523 -1.288 . . . . 2.61 107.523 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.54 ' HB ' ' C ' ' A' ' 64' ' ' PHE . 2.4 mm -136.78 -40.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.146 -1.057 . . . . 0.4 108.146 168.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.42 151.48 6.28 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.783 -0.927 . . . . 0.49 110.783 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -151.89 155.27 37.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.521 0.661 . . . . 1.81 110.771 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.34 177.28 44.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.787 -0.721 . . . . 0.43 112.208 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.65 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 69.4 mttt -128.26 132.71 48.72 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.662 0.272 . . . . 1.72 110.368 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 75' ' ' LYS . 3.2 mp -131.18 110.73 15.39 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 109.463 -0.569 . . . . 0.73 109.463 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.66 105.95 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.276 1.984 . . . . 0.57 110.231 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -120.38 146.27 42.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.216 -0.661 . . . . 0.79 109.216 -172.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 57' ' ' ILE . 39.5 Cg_exo -61.36 91.75 0.1 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.215 1.943 . . . . 0.58 111.917 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.09 31.3 2.86 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.4 111.82 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.957 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 51.4 p -73.33 119.91 18.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.131 -0.692 . . . . 0.62 109.131 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -152.51 -164.91 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 118.847 -1.141 . . . . 1.1 113.328 -162.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 91.3 mttt -51.59 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.312 0.856 . . . . 1.84 113.312 -173.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 161.38 111.19 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.752 -1.203 . . . . 0.99 107.752 -169.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 44.1 pttt 42.6 45.53 4.01 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.271 0.982 . . . . 1.84 111.698 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.7 t70 -151.23 -172.29 4.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.499 -0.773 . . . . 0.64 109.871 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.8 ttm -117.65 122.23 43.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.347 0.594 . . . . 1.35 110.469 -171.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.656 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -112.13 143.66 42.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.77 110.338 -176.096 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.81 130.36 36.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.599 0.714 . . . . 0.48 110.819 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 45' ' ' VAL . 2.1 tm? -125.56 147.75 49.16 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.763 -1.569 . . . . 0.77 106.763 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 90' ' ' LEU . 4.8 p-10 -124.04 123.72 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.162 -1.015 . . . . 1.81 111.573 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.999 HD13 HG21 ' A' ' 45' ' ' VAL . 1.2 mp -90.55 146.53 34.51 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.788 -1.096 . . . . 0.65 109.066 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' O ' HG13 ' A' ' 94' ' ' VAL . 78.0 Cg_exo -52.69 -118.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.121 3.214 . . . . 1.07 113.346 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.6 m -162.97 93.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-O 119.008 -0.52 . . . . 0.46 111.437 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.558 HG11 ' HE1' ' A' ' 62' ' ' PHE . 14.8 p -129.52 103.64 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 119.639 -1.913 . . . . 0.48 115.962 -172.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.776 HG11 HD21 ' A' ' 31' ' ' LEU . 2.4 p -152.98 97.12 2.86 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.312 -0.868 . . . . 1.07 112.122 162.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.747 ' HB2' HG12 ' A' ' 100' ' ' ILE . 75.4 Cg_exo -46.63 136.62 16.08 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 121.823 1.682 . . . . 0.48 112.13 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 3.5 t80 -51.58 -39.54 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.157 -0.474 . . . . 1.31 110.688 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.7 m -62.78 -25.03 68.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.495 -0.32 . . . . 1.2 111.859 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.747 HG12 ' HB2' ' A' ' 97' ' ' PRO . 21.4 mm -76.87 -56.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.77 -0.581 . . . . 0.51 111.453 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.642 HD23 HD11 ' A' ' 104' ' ' LEU . 41.7 mt -53.54 -27.82 28.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.759 0.79 . . . . 1.0 109.942 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 99' ' ' SER . 53.9 t80 -62.45 -42.04 99.18 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.841 -1.527 . . . . 0.96 109.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.628 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.2 m-80 -74.24 -57.6 3.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.946 0.35 . . . . 0.82 111.946 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.882 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -60.62 -49.41 77.65 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.32 0.859 . . . . 0.65 113.32 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 144' ' ' LEU . . . -68.25 -26.18 65.55 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.821 0.819 . . . . 0.43 110.088 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.628 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.8 ttp180 -66.0 -46.09 79.23 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.529 -1.214 . . . . 1.81 110.484 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.9 t0 -82.21 -53.68 5.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.532 0.682 . . . . 0.8 112.317 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 114' ' ' ILE . 6.8 t -85.36 -28.7 6.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.039 -0.664 . . . . 0.88 109.792 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 144' ' ' LEU . . . -75.17 -21.66 77.66 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.575 -0.821 . . . . 0.38 111.607 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -47.84 -44.51 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.976 -1.491 . . . . 1.09 106.976 165.775 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.61 -82.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.517 -0.765 . . . . 1.87 110.284 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 179.94 -58.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.811 0.671 . . . . 1.17 112.811 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 122.97 39.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.505 -0.316 . . . . 2.15 110.634 -172.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 144' ' ' LEU . 2.2 mp -111.21 153.2 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.39 109.941 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.5 p-10 -99.26 154.12 18.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.513 -0.767 . . . . 2.11 109.219 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -139.15 154.22 48.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.732 -0.84 . . . . 0.62 108.732 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.732 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 35.0 tt0 -142.05 135.74 29.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 0.8 110.395 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.836 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -105.31 134.04 49.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.307 -0.86 . . . . 1.25 109.502 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.639 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.8 tp60 -121.93 101.19 7.41 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.533 -0.543 . . . . 0.63 109.533 171.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.478 ' HB ' HD11 ' A' ' 118' ' ' LEU . 7.2 tp -108.04 118.07 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 0.81 110.63 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.59 129.84 10.05 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.98 -0.848 . . . . 0.26 110.98 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 25' ' ' SER . 2.7 mm? -108.9 105.82 15.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.337 0.589 . . . . 1.2 112.348 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.022 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 77.3 m -100.13 95.6 6.94 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.813 -1.085 . . . . 0.32 109.241 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.651 HG22 ' HB3' ' A' ' 58' ' ' CYS . 6.3 pt -109.35 138.12 38.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 120.644 -0.422 . . . . 0.98 111.732 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.18 108.13 16.21 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.45 -0.945 . . . . 1.52 108.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 55' ' ' ILE . 17.7 mt -120.29 156.75 54.87 Favored Pre-proline 0 C--O 1.217 -0.636 0 O-C-N 124.884 1.365 . . . . 1.28 110.273 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.0 Cg_exo -70.87 -21.29 28.52 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.123 1.882 . . . . 0.74 112.24 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.95 -57.1 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.073 -0.512 . . . . 1.12 112.195 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.8 OUTLIER -106.72 -1.63 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 122.007 0.908 . . . . 1.35 109.698 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.52 -32.05 1.19 Allowed Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.163 -1.381 . . . . 1.05 111.264 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.8 pt-20 -174.34 141.39 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.116 -1.438 . . . . 1.16 107.116 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.5 t80 -146.0 135.44 23.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.39 -0.596 . . . . 1.91 109.39 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.3 t -117.38 105.8 12.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.868 0.842 . . . . 1.19 111.347 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.49 138.73 33.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.41 -0.813 . . . . 0.5 110.249 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.509 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 94.7 Cg_endo -95.82 165.62 1.36 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.168 1.912 . . . . 0.45 113.602 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.89 167.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.55 -1.278 . . . . 0.44 107.55 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 83.5 p -140.1 155.83 46.84 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.215 -0.594 . . . . 0.88 112.225 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 t -144.54 103.2 3.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.231 -1.025 . . . . 0.96 108.231 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.732 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -108.17 148.63 29.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.549 -0.296 . . . . 1.76 110.24 -177.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.94 141.5 7.1 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.809 -0.71 . . . . 0.5 111.676 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 1.6 mp0 -104.73 127.82 52.63 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.927 -0.636 . . . . 2.1 109.297 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -147.92 173.02 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.724 0.297 . . . . 0.76 110.314 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.85 159.99 1.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.08 0.77 . . . . 3.53 113.08 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' A' ' 145' ' ' PRO . 25.9 tp -56.82 132.16 78.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.088 -0.96 . . . . 1.23 110.333 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.7 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.055 2.503 . . . . 0.71 112.773 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.796 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.432 -1.61 0 N-CA-C 114.091 0.397 . . . . 0.54 114.091 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 47' ' ' VAL . 11.4 m -170.78 36.55 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.795 1.238 . . . . 1.2 108.023 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 46' ' ' SER . 27.6 m -133.12 154.3 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.098 -1.41 . . . . 0.93 109.226 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -168.79 -41.3 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.546 0.529 . . . . 0.48 110.595 168.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 1.016 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 27.2 t70 -173.21 160.18 4.01 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.354 -0.239 . . . . 1.69 110.354 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 41' ' ' TYR . 56.0 t -137.66 135.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.143 -0.317 . . . . 1.14 110.143 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 17.6 m-20 -108.18 122.68 47.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.362 -0.381 . . . . 1.83 111.311 -173.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.94 110.335 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -125.53 -122.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.617 -0.512 . . . . 1.33 109.617 169.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.851 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.0 p30 . . . . . 0 CA--C 1.507 -0.683 0 C-N-CA 122.446 0.298 . . . . 2.85 110.296 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.597 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 13.8 t . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 106.453 -1.684 . . . . 0.94 106.453 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.851 HG13 ' HA ' ' A' ' 33' ' ' ASP . 12.2 t -128.78 162.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.016 -1.105 . . . . 0.86 108.016 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 63.3 mt-10 -123.58 144.55 49.51 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.767 -0.773 . . . . 1.19 112.144 -170.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.855 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -126.33 103.91 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.014 -0.994 . . . . 3.73 110.672 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -81.05 109.15 15.34 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.075 -1.083 . . . . 0.81 108.075 176.508 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -111.0 114.61 28.05 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.673 -0.411 . . . . 0.42 110.518 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 1.016 ' HD3' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -83.62 134.88 34.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.287 -1.005 . . . . 2.63 108.287 173.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.57 ' CG2' HG12 ' A' ' 92' ' ' ILE . 40.8 t -113.18 148.47 16.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.052 -0.976 . . . . 0.82 110.12 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -133.6 101.37 5.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.344 0.592 . . . . 0.72 110.7 170.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 59.6 t -83.42 124.79 39.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 114.901 -1.045 . . . . 1.14 110.721 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.8 m -108.49 118.28 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.251 -0.431 . . . . 0.41 110.206 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 2.8 p30 -96.54 146.21 30.91 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.429 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -90.17 4.51 4.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.921 3.081 . . . . 0.73 114.771 -174.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.69 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 3.8 t80 -95.27 -113.52 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 119.514 -0.874 . . . . 2.08 110.173 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 51' ' ' TYR . 50.0 p -165.32 20.09 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.866 -1.061 . . . . 1.51 108.468 171.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -146.22 158.33 43.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 1.67 110.871 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.707 ' HA ' HD23 ' A' ' 82' ' ' LEU . 31.4 t -55.95 104.11 0.12 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.198 -1.364 . . . . 1.39 111.678 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG21 HD23 ' A' ' 126' ' ' LEU . 8.8 pt -79.06 123.3 84.99 Favored Pre-proline 0 C--O 1.213 -0.848 0 C-N-CA 120.442 -0.503 . . . . 1.03 109.911 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 81' ' ' SER . 29.1 Cg_endo -63.06 -55.12 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.796 1.664 . . . . 0.37 112.942 -159.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.4 mm -130.73 154.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.218 -0.593 . . . . 1.23 111.088 -172.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -147.17 178.19 8.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.106 0.955 . . . . 1.15 111.697 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.045 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 4.5 tm-20 -140.43 112.84 7.91 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.53 -1.668 . . . . 1.36 109.442 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.613 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -99.33 115.09 39.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.536 -1.665 . . . . 1.05 111.373 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -110.33 103.09 11.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.697 -1.592 . . . . 0.83 108.51 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.7 p90 -109.46 132.62 53.96 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.482 0.658 . . . . 0.4 109.546 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 29.0 m -128.41 102.06 6.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.074 -0.967 . . . . 0.38 109.55 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 97.9 m-85 -96.41 139.45 32.51 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.752 -0.833 . . . . 0.96 108.752 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HA ' ' C ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -146.29 138.14 24.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 1.29 109.056 175.357 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.755 ' CB ' HD22 ' A' ' 104' ' ' LEU . 47.6 t -95.5 -98.77 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.458 -0.497 . . . . 1.27 111.384 -173.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -56.78 -60.05 4.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.279 0.562 . . . . 0.36 109.564 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.23 18.21 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.269 -1.533 . . . . 0.39 109.269 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -103.44 -56.04 2.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.233 -0.484 . . . . 1.97 111.069 -173.47 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.734 ' C ' ' HA ' ' A' ' 65' ' ' HIS . 31.1 tt0 171.49 176.96 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.761 -1.57 . . . . 2.61 106.761 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.075 ' HA ' HG21 ' A' ' 100' ' ' ILE . 4.4 mm -145.4 -47.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 C-N-CA 124.425 1.09 . . . . 0.4 108.529 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.33 121.44 0.59 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.229 -0.986 . . . . 0.49 112.011 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -124.49 163.92 20.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.687 0.756 . . . . 1.81 111.901 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.01 169.66 26.76 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.091 -1.204 . . . . 0.43 110.091 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HB2' ' OE2' ' A' ' 59' ' ' GLU . 10.6 ptmm? -144.12 135.02 25.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.632 0.716 . . . . 1.72 111.22 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 52.9 mt -139.98 138.22 19.3 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.723 -0.671 . . . . 0.73 110.152 -173.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 4.2 Cg_exo -78.0 125.9 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.484 2.122 . . . . 0.57 111.208 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -130.86 146.16 60.86 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.47 -0.567 . . . . 0.79 109.47 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' HD13 ' A' ' 57' ' ' ILE . 20.0 Cg_exo -66.61 92.31 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.245 1.963 . . . . 0.58 111.794 174.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.1 25.39 17.43 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.4 112.267 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 82.6 p -70.39 119.84 15.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.741 -0.837 . . . . 0.62 108.741 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -141.18 -159.5 0.97 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.837 1.051 . . . . 1.1 113.837 -159.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 60.5 mttm -52.16 -95.98 0.0 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.821 -1.081 . . . . 1.84 112.801 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 168.84 113.44 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.862 -1.162 . . . . 0.99 107.862 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.69 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 7.7 ptmm? 41.02 51.38 3.28 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.029 0.83 . . . . 1.84 112.02 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.1 t70 -161.83 -171.42 2.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.024 -0.535 . . . . 0.64 111.008 -169.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.635 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.2 ttm -112.27 118.68 35.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 1.35 111.23 -169.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.0 t -106.36 144.45 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 0.77 110.655 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.87 118.0 24.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.546 0.689 . . . . 0.48 111.032 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 45' ' ' VAL . 6.4 tt -119.58 175.7 5.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.765 -1.198 . . . . 0.77 107.765 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.5 m-20 -136.57 143.03 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.739 0.7 . . . . 1.81 111.799 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 41.8 mm -113.66 130.18 24.01 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.173 -1.417 . . . . 0.65 107.173 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.565 ' O ' HD22 ' A' ' 42' ' ' LEU . 62.1 Cg_exo -50.42 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.344 2.696 . . . . 1.07 114.36 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -163.4 91.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 O-C-N 122.112 -0.368 . . . . 0.46 111.375 -176.028 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.3 p -127.34 103.19 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.085 1.143 . . . . 0.48 114.085 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.504 ' CG2' HD23 ' A' ' 101' ' ' LEU . 2.5 p -154.52 99.61 2.45 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 120.718 -0.393 . . . . 1.07 111.473 160.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 5.8 Cg_endo -49.88 137.72 35.15 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.192 1.928 . . . . 0.48 112.506 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.597 ' H ' ' HA ' ' A' ' 38' ' ' SER . 21.6 t80 -53.81 -32.03 51.24 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.769 -0.65 . . . . 1.31 111.45 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.8 m -53.21 -31.6 43.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 1.2 111.882 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 1.075 HG21 ' HA ' ' A' ' 71' ' ' ILE . 37.5 mm -76.27 -57.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.828 0.823 . . . . 0.51 111.501 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.061 HD22 HD21 ' A' ' 104' ' ' LEU . 2.0 mm? -54.23 -26.68 29.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.393 -1.73 . . . . 1.0 110.827 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 99' ' ' SER . 79.1 t80 -64.56 -45.76 85.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.239 -1.346 . . . . 0.96 108.568 177.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.05 -56.72 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.708 -0.678 . . . . 0.82 111.799 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.061 HD21 HD22 ' A' ' 101' ' ' LEU . 2.2 pp -61.08 -52.72 63.75 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.129 0.788 . . . . 0.65 113.129 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.6 -25.48 67.41 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.852 0.834 . . . . 0.43 110.347 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 ttp180 -64.98 -52.15 57.77 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.671 -1.15 . . . . 1.81 110.092 174.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.4 t70 -82.88 -52.83 6.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.55 0.691 . . . . 0.8 112.342 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -85.34 -28.45 6.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 121.714 -0.616 . . . . 0.88 110.035 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.15 -20.67 80.02 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.705 -0.759 . . . . 0.38 111.499 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -49.35 -47.14 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.049 -1.463 . . . . 1.09 107.049 165.17 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.7 m-20 -66.8 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 1.87 109.761 162.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 178.17 -54.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.543 0.527 . . . . 1.17 111.545 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.57 128.87 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.175 0.512 . . . . 2.15 111.067 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.54 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.7 mp -112.67 155.94 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.668 -0.696 . . . . 0.39 110.197 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -98.09 153.43 18.43 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.081 -0.711 . . . . 2.11 109.081 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 61.3 m-85 -140.13 166.13 25.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.639 -0.874 . . . . 0.62 108.639 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.862 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 28.4 tt0 -157.0 137.45 13.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.871 0.367 . . . . 0.8 110.925 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.666 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 14.2 tp -103.65 133.11 49.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.792 -0.64 . . . . 1.25 110.018 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.788 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.9 tp60 -118.8 100.18 7.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.399 -0.963 . . . . 0.63 108.399 172.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 HG22 ' A' ' 60' ' ' ILE . 7.2 tp -112.21 114.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.195 0.521 . . . . 0.81 111.207 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -91.8 142.53 16.1 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.644 -0.982 . . . . 0.26 110.644 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.8 mm? -121.48 122.32 39.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.3 0.571 . . . . 1.2 112.469 -173.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.045 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.9 m -116.37 96.1 5.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.844 -1.071 . . . . 0.32 108.994 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.643 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -108.1 140.86 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.367 -0.533 . . . . 0.98 110.607 -175.275 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.64 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.1 m-20 -84.81 105.87 15.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.406 -0.961 . . . . 1.52 108.406 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.88 HD23 HG21 ' A' ' 55' ' ' ILE . 17.5 mt -111.07 143.38 28.23 Favored Pre-proline 0 C--O 1.219 -0.54 0 O-C-N 125.247 1.592 . . . . 1.28 109.158 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.4 -25.0 71.38 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.158 1.905 . . . . 0.74 114.08 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.524 HG23 ' HE2' ' A' ' 51' ' ' TYR . 60.1 t -74.65 -58.64 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.846 0.684 . . . . 1.12 112.846 -174.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 40.1 t -105.37 -2.85 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 122.798 1.285 . . . . 1.35 109.523 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.48 -0.84 53.91 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 113.479 -1.691 . . . . 1.05 111.852 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.6 pt-20 -176.49 174.07 1.96 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.523 -0.547 . . . . 1.16 109.523 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.549 ' HB2' HD12 ' A' ' 126' ' ' LEU . 8.3 t80 -170.74 124.07 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.337 -0.986 . . . . 1.91 108.337 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.8 t -114.16 102.85 10.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.87 0.843 . . . . 1.19 111.687 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.5 pp -127.96 144.99 53.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 0.5 110.137 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 58.6 Cg_endo -96.44 162.43 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.223 1.948 . . . . 0.45 113.134 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.461 HG23 HG23 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -160.39 167.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.765 -1.198 . . . . 0.44 107.765 179.239 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.7 p -146.17 159.17 43.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.599 0.592 . . . . 0.88 112.599 -168.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -151.0 109.83 3.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.851 -0.796 . . . . 0.96 108.851 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.862 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -107.43 148.0 29.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 1.76 110.217 -179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.38 142.59 8.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.701 -0.762 . . . . 0.5 111.866 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -113.07 133.99 54.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.125 -0.538 . . . . 2.1 110.391 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.49 174.96 7.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.525 -0.917 . . . . 0.76 108.525 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -69.13 175.25 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.87 0.367 . . . . 3.53 111.599 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.704 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.9 tp -57.15 136.37 80.72 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 1.23 111.694 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.704 ' HD2' HD12 ' A' ' 144' ' ' LEU . 72.5 Cg_endo . . . . . 0 CA--C 1.53 0.293 0 C-N-CA 123.523 2.815 . . . . 0.71 112.902 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.55 0 N-CA-C 116.973 1.549 . . . . 0.54 116.973 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.667 ' O ' HG13 ' A' ' 45' ' ' VAL . 99.7 p -161.53 35.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.38 -2.082 . . . . 1.2 105.38 170.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' SER . 10.5 m -133.27 154.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.808 -1.996 . . . . 0.93 108.39 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 7.8 t -173.17 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.365 0.416 . . . . 0.48 111.933 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 4.4 t70 -164.41 156.44 16.34 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.117 -0.364 . . . . 1.69 110.112 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -143.85 132.7 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.57 -0.53 . . . . 1.14 109.57 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 23.2 m-20 -112.94 124.08 51.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.798 0.333 . . . . 1.83 111.121 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -87.69 121.04 29.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.045 -0.525 . . . . 0.94 109.737 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.5 -127.04 0.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.571 -0.529 . . . . 1.33 109.571 171.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.683 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.6 p30 . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 112.419 0.526 . . . . 2.85 112.419 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.647 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 36.3 t . . . . . 0 N--CA 1.432 -1.362 0 N-CA-C 105.599 -2.0 . . . . 0.94 105.599 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.113 HG23 HG13 ' A' ' 96' ' ' VAL . 13.8 m -129.29 179.55 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 109.356 -0.609 . . . . 0.86 109.356 164.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 74.5 mt-10 -123.49 142.44 51.0 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.904 -0.718 . . . . 1.19 112.4 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.808 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -123.39 104.16 8.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.124 -0.944 . . . . 3.73 109.726 176.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -75.92 111.29 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.971 -1.122 . . . . 0.81 107.971 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.68 109.7 21.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.697 0.76 . . . . 0.42 109.944 -175.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 28' ' ' ASP . 41.3 mmtm -83.68 123.53 29.92 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.702 -1.136 . . . . 2.63 108.934 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 25' ' ' SER . 55.4 t -111.45 138.92 38.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.625 -0.716 . . . . 0.82 111.118 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.611 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 3.5 m -133.93 100.0 4.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.368 0.604 . . . . 0.72 110.16 168.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.9 t -82.38 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.115 -0.948 . . . . 1.14 111.011 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 3.2 m -109.59 109.59 20.4 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.318 -0.623 . . . . 0.41 109.318 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -96.8 125.44 46.6 Favored Pre-proline 0 C--O 1.24 0.563 0 O-C-N 124.28 0.987 . . . . 1.48 109.404 175.147 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 18.1 Cg_endo -112.32 39.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.4 3.4 . . . . 0.73 116.513 -169.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 10.7 t80 -116.32 -10.82 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.03 1.287 . . . . 2.08 112.18 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.615 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 54.4 p 86.91 26.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.837 1.655 . . . . 1.51 109.401 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -147.46 123.67 10.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.265 -1.334 . . . . 1.67 109.297 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.816 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.0 m -49.03 104.69 0.07 Allowed 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 122.926 0.49 . . . . 1.39 112.045 172.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.944 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.65 170.52 14.85 Favored Pre-proline 0 C--O 1.209 -1.07 0 N-CA-C 108.161 -1.051 . . . . 1.03 108.161 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.6 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.3 Cg_endo -92.87 -63.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.731 1.621 . . . . 0.37 114.395 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 79' ' ' PRO . 12.4 mm -128.29 160.62 38.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 121.079 -0.248 . . . . 1.23 110.721 -167.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.576 ' CB ' HG22 ' A' ' 124' ' ' ILE . 25.6 p -156.58 -177.52 6.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 122.116 0.96 . . . . 1.15 112.772 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.074 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 26.2 tt0 -133.04 117.1 17.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.184 -1.825 . . . . 1.36 109.845 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.746 HG22 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -97.26 109.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 121.997 0.903 . . . . 1.05 109.018 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 19.4 p -112.76 102.76 10.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.005 -1.452 . . . . 0.83 108.908 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 4.6 p90 -112.07 124.9 53.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.467 -0.568 . . . . 0.4 109.467 -168.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 6.6 m -121.9 106.11 10.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.21 -0.904 . . . . 0.38 108.703 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 86.1 m-85 -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.935 -0.395 . . . . 0.96 109.935 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.406 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -126.78 144.53 50.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.569 -0.9 . . . . 1.29 108.569 178.012 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.489 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.48 -112.75 0.16 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.298 177.237 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.31 -51.18 64.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.684 -0.858 . . . . 0.36 108.684 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' H ' HH11 ' A' ' 69' ' ' ARG . . . -161.58 12.74 0.13 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.405 -1.078 . . . . 0.39 110.405 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.613 ' HE ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -112.62 -164.99 0.95 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 -175.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.92 98.23 7.74 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.259 0.552 . . . . 2.61 109.868 -169.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.938 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -52.25 -34.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.145 -0.934 . . . . 0.4 110.358 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.74 170.9 27.11 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.823 -0.911 . . . . 0.49 110.823 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.09 163.98 23.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.011 0.906 . . . . 1.81 111.691 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.72 170.42 34.15 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.318 -0.856 . . . . 0.43 110.995 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 133.68 27.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.936 0.398 . . . . 1.72 110.734 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.69 123.13 17.1 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.049 -0.523 . . . . 0.73 110.457 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.8 116.16 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.427 2.084 . . . . 0.57 110.713 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.85 140.48 37.82 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 121.17 -0.212 . . . . 0.79 110.501 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HA ' HD13 ' A' ' 57' ' ' ILE . 21.1 Cg_endo -61.26 88.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.821 2.347 . . . . 0.58 112.46 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.56 43.08 2.77 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.802 -0.636 . . . . 0.4 111.801 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.944 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.6 p -74.08 121.9 21.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.878 -0.415 . . . . 0.62 109.878 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.816 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -164.66 170.69 15.34 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.41 1.633 . . . . 1.1 115.41 -163.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.881 ' HG3' ' HB3' ' A' ' 86' ' ' ASP . 71.4 mmtt 7.57 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.859 1.664 . . . . 1.84 114.031 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . 172.0 -44.23 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.622 -1.992 . . . . 0.99 105.622 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.6 ttpt -159.65 71.08 0.48 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 112.131 -2.304 . . . . 1.84 110.162 173.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.881 ' HB3' ' HG3' ' A' ' 83' ' ' LYS . 6.9 t70 -162.24 -161.66 0.76 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.011 -1.45 . . . . 0.64 108.809 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.601 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 47.9 ttm -121.3 122.16 39.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.858 -0.423 . . . . 1.35 109.858 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 46' ' ' SER . 2.7 t -104.45 143.04 33.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.119 -0.492 . . . . 0.77 109.709 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.93 123.35 31.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.48 110.781 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.604 HD22 HG11 ' A' ' 45' ' ' VAL . 8.7 tt -130.64 164.5 24.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.137 -1.431 . . . . 0.77 107.137 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.65 142.28 32.04 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.173 -1.011 . . . . 1.81 111.764 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 35.3 mm -100.83 143.39 26.49 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.724 -1.213 . . . . 0.65 107.724 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 42' ' ' LEU . 81.9 Cg_exo -48.15 -107.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.212 2.608 . . . . 1.07 114.0 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.41 94.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 O-C-N 121.617 -0.677 . . . . 0.46 111.979 -172.875 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.504 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.4 p -127.49 103.02 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.581 1.326 . . . . 0.48 114.581 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 1.113 HG13 HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -151.98 112.89 2.9 Favored Pre-proline 0 C--O 1.219 -0.517 0 O-C-N 121.712 -0.618 . . . . 1.07 110.332 157.582 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 4.8 Cg_endo -53.98 135.16 62.73 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.38 1.387 . . . . 0.48 111.619 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.647 ' H ' ' HA ' ' A' ' 38' ' ' SER . 22.8 t80 -55.58 -30.7 61.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.762 -0.654 . . . . 1.31 110.912 -177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.687 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.2 p -58.14 -28.78 65.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.995 -0.548 . . . . 1.2 112.32 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 mm -77.51 -52.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.031 -0.418 . . . . 0.51 111.014 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.089 HD23 HD21 ' A' ' 104' ' ' LEU . 21.3 mt -50.75 -27.01 6.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.5 0.666 . . . . 1.0 110.185 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.687 ' HB3' ' O ' ' A' ' 99' ' ' SER . 46.9 t80 -63.81 -42.5 97.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.472 -1.24 . . . . 0.96 108.917 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.671 ' HA ' HH21 ' A' ' 106' ' ' ARG . 2.9 m-20 -74.24 -57.59 3.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.665 -0.698 . . . . 0.82 111.789 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.089 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -57.36 -50.13 73.93 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.926 0.714 . . . . 0.65 112.926 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 104' ' ' LEU . . . -68.95 -26.72 65.2 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.497 0.665 . . . . 0.43 110.274 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.671 HH21 ' HA ' ' A' ' 103' ' ' ASN . 2.7 ttp180 -68.0 -54.49 18.12 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.238 -0.892 . . . . 1.81 110.222 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.64 -53.93 6.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.8 111.277 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.632 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.6 t -89.05 -28.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.415 -0.514 . . . . 0.88 110.57 -174.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 144' ' ' LEU . . . -68.33 -25.29 74.77 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.063 -1.065 . . . . 0.38 111.416 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -53.7 -46.77 62.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.475 -1.305 . . . . 1.09 107.475 168.791 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 15.2 m-20 -68.01 -61.28 1.94 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.712 0.634 . . . . 1.87 112.712 169.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.435 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER 153.48 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.209 1.004 . . . . 1.17 113.593 -173.166 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -92.5 128.82 38.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.101 0.56 . . . . 2.15 111.006 -173.598 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' HB2' ' A' ' 104' ' ' LEU . 3.3 mp -110.69 155.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.842 -0.429 . . . . 0.39 109.842 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 15.1 p-10 -98.41 153.05 18.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.988 -0.745 . . . . 2.11 108.988 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 74.4 m-85 -143.62 165.44 27.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.62 108.696 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.715 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.5 tt0 -153.16 135.94 15.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 0.8 110.307 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.601 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 11.4 tp -104.72 130.76 52.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.821 -0.437 . . . . 1.25 109.821 171.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.1 tp60 -117.16 100.29 7.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.469 -0.937 . . . . 0.63 108.469 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -119.94 120.42 63.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.617 0.722 . . . . 0.81 111.137 -171.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.77 129.13 9.47 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.228 -0.896 . . . . 0.26 112.101 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.566 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.8 mp -100.84 92.98 5.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 1.2 110.907 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.074 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.5 m -94.18 95.93 9.28 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.942 -0.762 . . . . 0.32 108.942 172.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.576 HG22 ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.93 137.84 43.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.148 -0.621 . . . . 0.98 110.761 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.467 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 7.2 t70 -79.52 106.74 11.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.799 -1.186 . . . . 1.52 107.799 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.458 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 6.7 mt -113.5 166.05 12.07 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.467 -0.788 . . . . 1.28 110.648 -171.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.24 -16.76 15.35 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 121.914 1.743 . . . . 0.74 111.867 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 3.0 t -75.18 -59.7 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.433 0.531 . . . . 1.12 112.433 -174.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 131' ' ' GLU . 2.8 t -111.7 -0.2 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 122.643 1.211 . . . . 1.35 108.891 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 80.48 -28.62 2.68 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 113.453 -1.703 . . . . 1.05 111.267 -170.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.8 pt-20 -175.35 143.69 0.66 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.087 -1.079 . . . . 1.16 108.087 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.5 t80 -155.7 145.47 21.28 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.638 -0.504 . . . . 1.91 109.638 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.6 t -113.23 107.94 16.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.581 0.705 . . . . 1.19 110.922 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.5 pp -115.12 128.29 26.07 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.701 -0.852 . . . . 0.5 108.701 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 19.6 Cg_endo -89.3 160.02 5.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 121.759 1.64 . . . . 0.45 112.735 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.53 166.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.972 -1.122 . . . . 0.44 107.972 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.1 m -139.98 153.19 46.81 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.782 -0.367 . . . . 0.88 111.304 -168.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.0 t -143.84 105.72 4.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.269 -1.011 . . . . 0.96 108.269 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.29 149.07 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.627 -0.26 . . . . 1.76 110.788 -176.535 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.04 148.19 16.28 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.517 -0.849 . . . . 0.5 112.131 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -106.1 124.48 49.64 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.807 -0.812 . . . . 2.1 108.807 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.43 173.07 13.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.238 -0.653 . . . . 0.76 109.238 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -55.39 160.3 2.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.543 0.687 . . . . 3.53 112.358 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.716 HD12 ' HD2' ' A' ' 145' ' ' PRO . 24.6 tp -56.29 134.78 75.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.776 -1.102 . . . . 1.23 110.658 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.716 ' HD2' HD12 ' A' ' 144' ' ' LEU . 35.5 Cg_endo . . . . . 0 C--N 1.344 0.297 0 C-N-CA 122.787 2.325 . . . . 0.71 111.524 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 115.976 1.151 . . . . 0.54 115.976 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.67 ' OG ' HD11 ' A' ' 122' ' ' LEU . 79.6 p -162.15 31.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.964 -1.495 . . . . 1.2 106.964 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.7 m -132.79 153.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.209 -1.36 . . . . 0.93 109.665 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.46 -43.89 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.782 0.676 . . . . 0.48 110.407 169.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -169.67 145.27 3.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 122.287 -0.258 . . . . 1.69 110.518 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 96.5 t -119.05 132.74 68.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.387 -0.597 . . . . 1.14 109.387 173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.92 137.19 54.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.87 0.367 . . . . 1.83 111.147 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.58 126.06 38.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.853 -0.612 . . . . 0.94 111.532 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -130.66 -131.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.774 -0.825 . . . . 1.33 108.774 167.519 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.938 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.2 p-10 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 119.239 0.927 . . . . 2.85 111.83 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.623 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 14.3 m . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 106.33 -1.73 . . . . 0.94 106.33 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 33' ' ' ASP . 28.4 t -130.64 165.56 30.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.381 -0.97 . . . . 0.86 108.381 167.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.769 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 2.8 mt-10 -125.25 139.37 53.78 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.381 0.61 . . . . 1.19 111.528 -172.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.3 106.57 9.95 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.15 -0.932 . . . . 3.73 109.746 -176.507 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 4.8 tt -88.72 111.8 22.41 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.445 -1.302 . . . . 0.81 109.892 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.71 116.82 30.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.201 -0.909 . . . . 0.42 109.65 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -83.35 131.62 35.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.453 -0.943 . . . . 2.63 108.453 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 25' ' ' SER . 44.5 t -111.17 142.08 24.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.115 -0.948 . . . . 0.82 110.92 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.7 m -131.79 99.45 4.77 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.006 0.431 . . . . 0.72 109.905 167.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 62.2 t -82.46 127.9 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.576 -0.738 . . . . 1.14 110.537 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 5.9 m -107.79 113.82 27.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.293 -0.632 . . . . 0.41 109.293 176.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.868 ' HB3' HD21 ' A' ' 82' ' ' LEU . 29.3 p-10 -90.54 140.23 26.7 Favored Pre-proline 0 N--CA 1.461 0.117 0 O-C-N 123.864 0.727 . . . . 1.48 110.164 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HD2' HD21 ' A' ' 126' ' ' LEU . 66.9 Cg_endo -96.36 6.22 1.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.891 3.061 . . . . 0.73 115.399 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.714 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 24.4 t80 -97.18 -113.03 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.855 -0.738 . . . . 2.08 110.08 -172.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.736 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 77.5 p 179.98 19.66 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 117.964 0.347 . . . . 1.51 111.263 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -139.09 19.86 2.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.736 0.643 . . . . 1.67 112.736 -168.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 31.7 t 57.79 96.57 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 111.955 0.354 . . . . 1.39 111.955 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.917 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -73.94 170.71 13.36 Favored Pre-proline 0 C--O 1.209 -1.055 0 N-CA-C 108.62 -0.881 . . . . 1.03 108.62 -172.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.0 Cg_endo -92.79 -61.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.797 1.665 . . . . 0.37 113.935 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.677 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.0 mm -125.95 154.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.217 -0.593 . . . . 1.23 111.479 -166.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 124' ' ' ILE . 26.4 m -145.16 176.43 9.52 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.083 0.944 . . . . 1.15 111.475 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.066 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 2.4 tm-20 -141.86 114.39 8.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.565 -1.652 . . . . 1.36 109.885 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.521 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -103.31 121.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.387 1.089 . . . . 1.05 112.307 173.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.743 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.41 109.66 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.107 -1.861 . . . . 0.83 109.74 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.0 p90 -114.06 122.82 48.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.141 0.496 . . . . 0.4 110.129 -169.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 26.8 m -122.07 109.61 14.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.524 -0.762 . . . . 0.38 109.586 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 118' ' ' LEU . 97.9 m-85 -98.6 141.2 31.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.036 -0.529 . . . . 0.96 110.707 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.431 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -131.94 145.74 51.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.64 -1.245 . . . . 1.29 107.64 175.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.94 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.9 t -109.98 -100.32 0.39 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.196 -1.002 . . . . 1.27 111.025 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.71 -56.8 16.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.231 -0.655 . . . . 0.36 109.231 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 18.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.589 -1.404 . . . . 0.39 109.589 162.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 7.9 ptp180 -105.85 -156.56 0.58 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.738 -0.838 . . . . 1.97 108.738 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.16 94.98 4.78 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.709 0.686 . . . . 2.61 110.098 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.888 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -56.55 -39.25 61.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.904 -1.043 . . . . 0.4 110.892 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.58 169.26 34.25 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.328 -0.939 . . . . 0.49 111.458 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.08 164.63 15.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.668 0.734 . . . . 1.81 111.028 173.607 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.16 167.89 34.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.885 -0.886 . . . . 0.43 110.885 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.743 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.3 mtpt -130.43 131.5 45.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.026 -0.361 . . . . 1.72 110.026 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -133.85 105.14 11.65 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.863 0.363 . . . . 0.73 110.483 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 11.9 Cg_exo -71.25 101.62 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.359 2.039 . . . . 0.57 110.428 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.28 143.57 29.1 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.606 -0.516 . . . . 0.79 109.606 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HA ' HD13 ' A' ' 57' ' ' ILE . 32.5 Cg_exo -62.38 78.78 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.308 2.005 . . . . 0.58 111.957 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.522 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 46.7 3.58 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.4 112.197 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.917 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 92.9 p -73.55 119.23 17.49 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.361 -0.607 . . . . 0.62 109.361 173.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 49' ' ' ASN . 2.2 pt? -153.03 163.9 38.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 119.191 -1.004 . . . . 1.1 113.241 -164.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 54' ' ' SER . 50.5 mttm -16.49 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.756 -1.565 . . . . 1.84 114.417 -168.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 165.5 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.608 -1.256 . . . . 0.99 107.608 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 37.5 pttt 42.32 52.08 4.62 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.197 0.935 . . . . 1.84 110.893 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.5 t70 -152.56 -166.94 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.288 -0.869 . . . . 0.64 110.356 -173.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 47.3 ttm -125.24 117.73 24.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.102 0.477 . . . . 1.35 110.944 -170.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -105.87 144.68 32.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.394 -0.821 . . . . 0.77 110.113 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.75 129.17 35.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.26 0.553 . . . . 0.48 110.927 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -135.25 174.18 10.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.246 -1.02 . . . . 0.77 108.246 -176.314 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 5.8 p-10 -142.72 139.48 31.12 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.736 0.698 . . . . 1.81 112.059 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.5 mm -109.03 115.97 56.18 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.783 -0.821 . . . . 0.65 108.783 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.7 Cg_exo -28.76 -102.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.405 4.07 . . . . 1.07 115.534 -173.169 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -164.88 95.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 O-C-N 122.266 -0.271 . . . . 0.46 111.474 -175.8 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.541 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.5 p -128.67 104.8 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.012 1.486 . . . . 0.48 115.012 -172.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -154.4 99.57 2.47 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.601 -0.687 . . . . 1.07 111.335 161.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.9 Cg_exo -51.78 134.65 48.32 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.014 1.809 . . . . 0.48 111.572 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.623 ' H ' ' HA ' ' A' ' 38' ' ' SER . 52.7 t80 -54.93 -36.9 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 1.31 111.635 -172.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 15.0 m -53.88 -30.97 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.377 . . . . 1.2 111.639 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.888 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 mm -76.82 -56.0 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.431 -0.508 . . . . 0.51 110.983 -175.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 104' ' ' LEU . 30.6 mt -53.84 -28.25 34.66 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.699 0.625 . . . . 1.0 110.53 174.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.5 t80 -62.4 -42.45 99.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.413 -1.267 . . . . 0.96 109.206 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.414 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.6 m-80 -74.66 -58.26 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.171 0.434 . . . . 0.82 112.171 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.94 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.8 pp -60.85 -48.83 80.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.665 0.987 . . . . 0.65 113.665 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -66.6 -25.59 66.69 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.852 0.834 . . . . 0.43 109.574 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.414 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.1 ttp180 -68.06 -48.82 64.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.554 -1.203 . . . . 1.81 110.451 172.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.646 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 30.1 t70 -81.36 -54.31 5.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.649 0.738 . . . . 0.8 112.164 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.9 t -87.33 -25.64 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.726 -0.609 . . . . 0.88 110.069 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.03 -20.84 80.13 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.717 -0.754 . . . . 0.38 111.309 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -49.99 -48.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.732 -1.581 . . . . 1.09 106.732 165.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' N ' HG12 ' A' ' 110' ' ' VAL . 30.3 t70 -69.02 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.38 -0.827 . . . . 1.87 109.992 164.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 178.41 -48.19 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.187 0.44 . . . . 1.17 112.187 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -92.76 124.13 36.54 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.012 -0.366 . . . . 2.15 110.012 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -111.7 154.24 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.846 -0.798 . . . . 0.39 108.846 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 152.78 19.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.985 -0.746 . . . . 2.11 108.985 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 57.4 m-85 -140.52 162.73 34.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.915 -0.772 . . . . 0.62 108.915 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.767 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.6 tt0 -151.05 133.57 15.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.947 0.403 . . . . 0.8 110.221 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.6 OUTLIER -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.301 -0.629 . . . . 1.25 109.301 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.642 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.8 tp60 -116.75 103.31 10.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.165 -0.68 . . . . 0.63 109.165 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 136' ' ' ILE . 8.4 tp -110.01 120.41 61.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.81 110.934 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.94 131.03 10.52 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.196 -0.762 . . . . 0.26 111.196 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 133' ' ' THR . 7.5 mp -108.23 106.22 16.3 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 120.926 0.393 . . . . 1.2 111.055 -176.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.066 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 81.4 m -109.0 96.6 6.43 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.314 -0.857 . . . . 0.32 109.478 173.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.674 HG22 ' SG ' ' A' ' 58' ' ' CYS . 19.5 pt -112.37 131.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.469 -0.492 . . . . 0.98 110.918 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.83 105.84 9.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.377 -0.601 . . . . 1.52 109.377 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 55' ' ' ILE . 83.3 mt -106.52 160.63 25.56 Favored Pre-proline 0 C--O 1.22 -0.456 0 O-C-N 124.81 1.318 . . . . 1.28 109.971 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.9 Cg_exo -68.97 -34.34 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.832 1.688 . . . . 0.74 113.434 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.34 -57.88 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.316 0.487 . . . . 1.12 112.316 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.677 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -96.19 -7.21 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 122.046 0.927 . . . . 1.35 109.834 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.56 -28.55 2.72 Favored Glycine 0 C--N 1.311 -0.817 0 CA-C-N 113.626 -1.624 . . . . 1.05 111.16 -171.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.677 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.5 pt-20 -162.83 155.83 19.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.473 -0.936 . . . . 1.16 108.473 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.471 ' HB2' HD12 ' A' ' 126' ' ' LEU . 31.2 t80 -143.04 122.19 12.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.222 -0.659 . . . . 1.91 109.222 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.8 m -115.06 102.09 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.139 0.495 . . . . 1.19 111.763 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.08 144.36 50.21 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.015 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.91 164.1 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.885 1.723 . . . . 0.45 113.162 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -156.22 158.53 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.734 -1.21 . . . . 0.44 107.734 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.679 ' H ' HD12 ' A' ' 136' ' ' ILE . 83.0 p -140.59 152.58 45.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.627 -0.429 . . . . 0.88 111.827 -172.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -140.84 102.69 4.34 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.553 -1.276 . . . . 0.96 107.553 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.767 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -114.6 143.99 44.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.1 -0.5 . . . . 1.76 109.986 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.32 151.61 21.62 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.595 -0.812 . . . . 0.5 112.017 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -106.3 130.36 54.16 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.941 -0.763 . . . . 2.1 108.941 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.89 174.1 4.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.24 -1.022 . . . . 0.76 108.24 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 143' ' ' LYS . 3.7 mppt? -65.6 163.82 15.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 3.53 112.154 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' ILE . 22.7 tp -55.49 131.23 70.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 114.903 -1.044 . . . . 1.23 111.076 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 144' ' ' LEU . 40.9 Cg_endo . . . . . 0 C--N 1.343 0.261 0 C-N-CA 123.093 2.529 . . . . 0.71 112.869 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.681 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.408 -3.174 0 N-CA-C 111.939 -0.465 . . . . 0.54 111.939 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 122' ' ' LEU . 17.3 m -171.1 32.33 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.895 0.855 . . . . 1.2 108.894 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.3 m -133.29 148.29 31.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.863 -1.062 . . . . 0.93 109.969 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -169.76 -44.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.46 0.475 . . . . 0.48 111.793 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 8.7 t70 -157.4 153.59 27.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.77 -0.372 . . . . 1.69 111.183 -174.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.17 120.31 8.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.646 -0.502 . . . . 1.14 109.646 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -113.96 112.15 22.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 1.83 111.476 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.879 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.2 tm? -72.87 139.02 46.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.963 -0.562 . . . . 0.94 109.99 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' H ' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -141.99 -100.16 0.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.255 0.835 . . . . 1.33 113.255 -176.305 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.52 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 18.1 m-20 . . . . . 0 CA--C 1.493 -1.229 0 O-C-N 121.911 -0.493 . . . . 2.85 109.809 -154.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 6.3 t . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.94 111.57 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG12 HD21 ' A' ' 31' ' ' LEU . 24.2 t -77.65 156.1 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.566 -0.901 . . . . 0.86 108.566 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.899 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -137.17 145.64 43.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 119.516 -0.874 . . . . 1.19 109.368 -173.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.936 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.7 p90 -143.11 141.53 31.25 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.306 -0.958 . . . . 3.73 112.575 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.1 tm? -82.45 110.88 17.97 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.425 -0.954 . . . . 0.81 108.425 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.5 100.33 13.11 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.42 109.016 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 23.8 ttmm -83.58 126.0 32.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.626 0.727 . . . . 2.63 109.109 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 25' ' ' SER . 37.4 t -109.51 144.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.725 -1.125 . . . . 0.82 110.481 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.456 ' HB3' ' CG ' ' A' ' 87' ' ' MET . 14.7 m -128.85 97.4 4.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.576 -0.898 . . . . 0.72 108.576 165.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.681 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -86.96 130.69 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.676 0.751 . . . . 1.14 111.173 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.5 ' H ' ' HA3' ' A' ' 24' ' ' GLY . 32.1 m -116.88 114.99 24.66 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.344 -1.298 . . . . 0.41 109.447 -173.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.75 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.3 t30 -90.76 133.21 32.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 108.108 -1.071 . . . . 1.48 108.108 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -90.9 8.29 3.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.103 2.536 . . . . 0.73 114.169 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 49.2 t80 -119.0 139.14 52.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.949 -0.76 . . . . 2.08 108.949 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.7 p -79.13 37.81 0.33 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.659 0.614 . . . . 1.51 112.659 -164.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -146.25 130.58 17.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.271 -0.422 . . . . 1.67 110.056 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 m -43.5 100.76 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 124.116 0.966 . . . . 1.39 112.719 172.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.997 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.8 pt -75.55 171.97 10.49 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.431 -0.951 . . . . 1.03 108.431 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 8.0 Cg_endo -87.98 -59.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.498 1.465 . . . . 0.37 114.026 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.883 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 80.0 mt -137.38 155.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.669 0.618 . . . . 1.23 112.669 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -138.0 -178.99 5.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.731 0.777 . . . . 1.15 111.211 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.2 tt0 -141.78 115.5 9.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.99 -1.459 . . . . 1.36 109.982 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.1 109.93 23.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.697 -1.592 . . . . 1.05 109.951 173.542 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 8.5 m -110.97 102.58 11.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.87 -1.514 . . . . 0.83 108.586 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.791 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 3.8 p90 -109.79 122.33 47.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.506 . . . . 0.4 109.733 -168.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 93.9 m -121.03 104.91 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.511 -0.768 . . . . 0.38 109.4 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CE1' HD23 ' A' ' 118' ' ' LEU . 98.9 m-85 -98.14 140.99 31.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.952 -0.567 . . . . 0.96 111.148 -174.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.408 ' CE1' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -132.4 145.23 51.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.636 -1.246 . . . . 1.29 107.636 174.803 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.9 t -110.75 -98.03 0.41 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.317 -0.953 . . . . 1.27 111.062 172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.95 -59.75 4.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.386 -0.598 . . . . 0.36 109.386 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.87 18.05 0.1 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.478 -1.449 . . . . 0.39 109.478 165.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -111.04 -166.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.119 -0.697 . . . . 1.97 109.119 -177.477 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -108.16 98.49 8.03 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.919 0.866 . . . . 2.61 109.689 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -64.57 -41.6 92.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.976 -1.465 . . . . 0.4 111.276 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 164.75 38.25 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.217 -0.992 . . . . 0.49 111.266 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.38 156.84 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.482 0.641 . . . . 1.81 110.991 172.404 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 165.27 160.77 13.02 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.722 -0.951 . . . . 0.43 110.722 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 3.7 ptmm? -136.95 130.74 32.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.968 0.414 . . . . 1.72 110.0 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.0 mt -134.47 120.13 14.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 0.73 110.375 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.87 115.34 3.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.328 2.019 . . . . 0.57 110.537 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.12 143.35 42.33 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.698 -0.852 . . . . 0.79 108.698 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -51.86 90.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.804 2.336 . . . . 0.58 112.16 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.883 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -81.99 24.66 4.49 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.4 112.585 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.997 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 70.7 p -73.81 117.73 15.93 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.438 -0.579 . . . . 0.62 109.438 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.659 HD21 HD22 ' A' ' 49' ' ' ASN . 1.2 pt? -149.41 -171.33 3.86 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.096 -1.442 . . . . 1.1 114.264 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 60.5 mttm -44.77 -96.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.912 -1.04 . . . . 1.84 113.54 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 175.5 105.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.059 -1.089 . . . . 0.99 108.059 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.9 ptpt 41.77 50.44 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.339 1.024 . . . . 1.84 110.842 -170.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 3.5 t0 -143.63 179.93 6.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.907 -1.042 . . . . 0.64 110.122 -170.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.456 ' CG ' ' HB3' ' A' ' 46' ' ' SER . 54.3 ttp -107.74 119.13 38.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.609 -0.723 . . . . 1.35 110.63 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.6 HG22 HG13 ' A' ' 47' ' ' VAL . 5.1 t -106.27 142.82 35.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.05 -0.523 . . . . 0.77 109.633 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 123.77 30.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.549 0.69 . . . . 0.48 110.608 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 91' ' ' ASP . 9.0 tt -124.61 160.73 27.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.897 -1.149 . . . . 0.77 107.897 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.0 m-20 -134.05 122.37 22.88 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.627 -0.67 . . . . 1.81 111.407 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 32.8 mm -92.56 143.27 26.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.65 109.644 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 92' ' ' ILE . 75.8 Cg_exo -51.91 -172.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.924 2.416 . . . . 1.07 113.266 173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.936 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 7.1 m -114.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.72 -0.673 . . . . 0.46 110.549 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 95' ' ' VAL . 4.7 p -125.76 102.51 10.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.144 1.535 . . . . 0.48 115.144 -161.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.659 HG21 ' HG ' ' A' ' 101' ' ' LEU . 2.5 p -152.24 102.74 2.78 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.157 -0.474 . . . . 1.07 111.045 163.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 74.1 Cg_exo -48.89 131.61 25.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.721 1.614 . . . . 0.48 111.398 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.579 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 4.7 t80 -49.43 -35.0 17.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.734 -0.666 . . . . 1.31 111.081 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 12.1 t -62.92 -30.19 71.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 1.2 112.237 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.5 mm -76.78 -54.27 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 121.749 -0.594 . . . . 0.51 110.686 -173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.053 HD23 HD21 ' A' ' 104' ' ' LEU . 36.6 mt -53.84 -26.91 26.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.439 0.638 . . . . 1.0 110.518 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.0 t80 -65.1 -41.45 94.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.466 -1.243 . . . . 0.96 108.877 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' HH21 ' A' ' 106' ' ' ARG . 24.8 m-80 -74.27 -57.88 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.82 112.263 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.053 HD21 HD23 ' A' ' 101' ' ' LEU . 2.1 pp -56.91 -49.66 74.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.23 0.826 . . . . 0.65 113.23 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.538 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.16 -25.7 68.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.883 0.849 . . . . 0.43 110.113 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.492 HH21 ' HA ' ' A' ' 103' ' ' ASN . 6.6 ttp180 -69.62 -50.77 41.19 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.655 -1.157 . . . . 1.81 110.511 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 13.6 t70 -81.74 -54.83 5.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.78 0.8 . . . . 0.8 111.94 -175.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -84.51 -27.67 6.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.594 -0.692 . . . . 0.88 109.964 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.775 ' HA3' HD21 ' A' ' 144' ' ' LEU . . . -73.01 -19.28 79.54 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.308 -0.948 . . . . 0.38 111.457 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -51.86 -44.89 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.794 -1.558 . . . . 1.09 106.794 166.23 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m-20 -69.77 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.529 -0.76 . . . . 1.87 110.025 161.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.817 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.1 p-90 176.91 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.687 0.617 . . . . 1.17 111.715 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.06 129.76 42.02 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 122.304 -0.248 . . . . 2.15 110.581 -174.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.695 HD11 HD23 ' A' ' 144' ' ' LEU . 3.0 mp -117.7 159.19 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.834 0.35 . . . . 0.39 110.415 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 9.3 p-10 -102.96 153.34 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.982 -0.377 . . . . 2.11 109.982 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.8 m-85 -140.09 165.91 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.869 -0.789 . . . . 0.62 108.869 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 35.4 tt0 -156.16 131.98 9.74 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.007 -0.368 . . . . 0.8 110.007 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -103.69 123.85 47.78 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.006 -0.739 . . . . 1.25 109.006 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.79 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 3.4 tp-100 -108.28 99.32 8.74 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.672 -0.862 . . . . 0.63 108.672 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 5.3 tp -106.58 119.36 55.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.259 0.552 . . . . 0.81 110.834 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.53 127.05 8.3 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.879 -0.888 . . . . 0.26 110.879 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.717 ' O ' ' HA ' ' A' ' 133' ' ' THR . 0.4 OUTLIER -98.42 104.32 16.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.457 0.303 . . . . 1.2 111.335 -174.869 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 57.9 m -109.83 95.12 5.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.044 -0.526 . . . . 0.32 109.584 172.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 58' ' ' CYS . 11.5 pt -112.75 128.61 69.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 120.234 -0.586 . . . . 0.98 110.28 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.854 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 22.7 t70 -81.88 106.02 13.47 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.796 -0.816 . . . . 1.52 108.796 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.971 HD23 HG21 ' A' ' 55' ' ' ILE . 29.1 mt -104.82 176.35 1.78 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 114.522 -1.217 . . . . 1.28 109.486 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 9.9 Cg_exo -76.18 -41.93 0.44 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.762 1.642 . . . . 0.74 113.206 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.6 t -59.62 -58.93 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.06 0.763 . . . . 1.12 113.06 -168.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.8 -8.5 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.894 1.33 . . . . 1.35 108.517 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.683 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 88.38 -143.24 17.8 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 112.413 -2.176 . . . . 1.05 108.132 -164.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 -60.74 128.9 38.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.111 0.482 . . . . 1.16 110.02 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 123' ' ' THR . 15.9 t80 -124.31 145.33 49.48 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.826 -0.805 . . . . 1.91 108.826 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 63.1 m -121.86 109.42 14.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.917 0.389 . . . . 1.19 112.042 -173.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -127.33 144.04 49.34 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.021 -0.733 . . . . 0.5 109.021 171.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -93.31 162.45 2.48 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.863 1.709 . . . . 0.45 113.341 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.14 167.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.935 -1.135 . . . . 0.44 107.935 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -133.07 148.67 52.19 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.791 -0.364 . . . . 0.88 111.258 -169.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.1 t -138.34 103.0 4.79 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.683 -1.228 . . . . 0.96 107.683 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.644 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 14.4 ptmt -126.88 156.25 41.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.048 -0.524 . . . . 1.76 111.184 -171.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.92 150.78 17.29 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.594 -0.812 . . . . 0.5 111.634 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.5 mt-10 -98.71 124.88 43.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.741 -0.837 . . . . 2.1 108.741 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.24 165.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.07 -1.085 . . . . 0.76 108.07 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -67.45 178.2 1.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.496 0.665 . . . . 3.53 112.289 -171.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.817 ' HG ' ' O ' ' A' ' 112' ' ' TRP . 5.9 mt -54.05 131.08 59.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.743 -1.117 . . . . 1.23 111.231 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' HD23 ' A' ' 144' ' ' LEU . 32.9 Cg_endo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 123.16 2.573 . . . . 0.71 112.021 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.22 -0.753 0 N-CA-C 116.094 1.198 . . . . 0.54 116.094 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.649 ' O ' HG13 ' A' ' 45' ' ' VAL . 96.2 p -168.99 37.26 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.623 1.169 . . . . 1.2 107.979 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 46' ' ' SER . 4.5 m -134.02 151.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.512 -1.222 . . . . 0.93 110.342 -169.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -167.58 -44.33 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.416 0.447 . . . . 0.48 111.96 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -160.88 164.08 31.52 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.324 0.511 . . . . 1.69 111.313 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.07 135.62 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.284 -0.635 . . . . 1.14 109.284 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -129.0 135.64 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.648 0.261 . . . . 1.83 111.249 -169.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.6 tm? -101.28 139.43 36.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.593 -0.276 . . . . 0.94 111.371 -172.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -144.34 -90.81 0.11 Allowed 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 114.08 1.141 . . . . 1.33 114.08 177.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.841 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.204 -1.334 0 O-C-N 121.587 -0.696 . . . . 2.85 111.404 -155.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 10.8 t . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 122.364 1.078 . . . . 0.94 112.351 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 1.039 HG21 HD12 ' A' ' 101' ' ' LEU . 46.2 t -73.11 155.42 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.636 -1.62 . . . . 0.86 109.08 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 96.8 mt-10 -116.9 134.25 55.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 118.936 -1.106 . . . . 1.19 112.383 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.819 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.36 105.13 10.61 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.905 -1.043 . . . . 3.73 110.718 -175.836 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -81.44 111.58 17.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.341 -0.985 . . . . 0.81 108.341 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.98 117.34 32.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.551 0.691 . . . . 0.42 110.904 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -84.8 120.64 26.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.214 -0.903 . . . . 2.63 108.711 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 25' ' ' SER . 54.2 t -111.11 137.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.643 -0.708 . . . . 0.82 111.033 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.8 m -130.5 100.07 5.21 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.771 -0.372 . . . . 0.72 110.158 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 61.0 t -83.47 130.5 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.938 -0.574 . . . . 1.14 110.737 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -104.74 122.69 46.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.743 -0.383 . . . . 0.41 110.3 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.84 HD22 HD21 ' A' ' 82' ' ' LEU . 13.9 t-20 -88.17 133.52 36.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.86 1.35 . . . . 1.48 109.533 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.92 -17.02 2.15 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.105 2.537 . . . . 0.73 115.746 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.743 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.2 t80 -98.42 -100.46 0.21 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.915 -1.114 . . . . 2.08 111.386 -165.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.465 ' CB ' ' HD2' ' A' ' 85' ' ' LYS . 48.5 t -174.0 29.8 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.551 0.691 . . . . 1.51 109.788 171.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -147.92 133.18 18.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 1.67 110.823 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -40.68 101.93 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.814 0 O-C-N 124.376 1.047 . . . . 1.39 112.194 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 126' ' ' LEU . 7.6 pt -78.93 121.73 83.74 Favored Pre-proline 0 CA--C 1.5 -0.953 0 C-N-CA 120.071 -0.652 . . . . 1.03 109.5 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.945 ' HB2' HD12 ' A' ' 57' ' ' ILE . 28.1 Cg_endo -61.09 -56.5 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.174 1.916 . . . . 0.37 113.51 -157.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.945 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.2 mp -135.02 156.27 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.849 -0.74 . . . . 1.23 111.026 -173.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.646 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.7 p -145.04 178.43 8.05 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.386 1.089 . . . . 1.15 111.856 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.137 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.9 tt0 -131.15 113.84 14.38 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.129 -1.85 . . . . 1.36 109.046 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -98.9 110.62 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.515 1.15 . . . . 1.05 110.151 169.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 79.9 p -111.5 107.12 16.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.051 -1.886 . . . . 0.83 108.228 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.1 p90 -113.92 132.6 55.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.6 0.714 . . . . 0.4 110.222 -168.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 33.6 m -131.6 109.75 10.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.433 -1.258 . . . . 0.38 108.717 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CE1' HD23 ' A' ' 118' ' ' LEU . 94.5 m-85 -97.7 143.08 28.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.691 -0.485 . . . . 0.96 109.691 -175.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -129.64 143.37 50.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.903 -0.777 . . . . 1.29 108.903 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.811 ' CB ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -101.3 -114.79 0.19 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.038 -0.528 . . . . 1.27 111.471 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -57.98 -52.49 65.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.573 -0.899 . . . . 0.36 108.573 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.74 20.74 0.15 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.65 -1.38 . . . . 0.39 109.65 164.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 6.2 ptp180 -117.86 -169.21 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.232 -0.655 . . . . 1.97 109.232 -174.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -107.71 98.33 7.94 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.325 0.583 . . . . 2.61 109.741 -166.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -60.86 -42.96 94.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.404 -1.271 . . . . 0.4 112.19 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.38 154.86 13.18 Favored Glycine 0 C--O 1.219 -0.789 0 C-N-CA 120.339 -0.934 . . . . 0.49 111.686 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 ptmt -158.75 160.29 36.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.935 0.868 . . . . 1.81 112.381 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.02 168.39 34.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.43 111.545 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -127.8 133.35 49.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.944 -0.391 . . . . 1.72 109.944 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 73.8 mt -139.14 112.45 8.05 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.502 -0.317 . . . . 0.73 110.884 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.79 113.53 3.68 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.117 1.878 . . . . 0.57 110.938 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -133.92 144.97 53.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.47 -0.196 . . . . 0.79 110.47 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.72 94.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.3 . . . . 0.58 112.677 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -84.52 21.19 11.22 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.808 -0.633 . . . . 0.4 112.586 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 96.2 p -70.25 118.98 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.452 -0.573 . . . . 0.62 109.452 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD21 HD22 ' A' ' 49' ' ' ASN . 1.9 pt? -141.98 -164.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 120.145 -0.622 . . . . 1.1 112.393 -164.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 94.4 mttt -45.63 -89.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.038 0.755 . . . . 1.84 113.038 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 156.5 111.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.437 -1.319 . . . . 0.99 107.437 -168.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 8.2 ptmm? 45.54 46.07 10.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.003 0.814 . . . . 1.84 111.5 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.2 t70 -155.05 -172.01 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.331 -0.849 . . . . 0.64 109.501 -173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 43.3 ttp -114.79 127.57 55.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.106 0.479 . . . . 1.35 110.831 -172.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.2 t -109.53 142.41 40.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.472 -0.785 . . . . 0.77 110.025 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 108.41 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.38 0.61 . . . . 0.48 110.949 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.782 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.7 tp -100.64 174.89 5.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.094 -0.957 . . . . 0.77 109.131 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.782 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 21.4 t70 -141.71 121.6 13.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.769 -0.372 . . . . 1.81 110.638 -173.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 24.5 mm -107.88 141.92 24.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.3 -0.409 . . . . 0.65 110.324 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 92' ' ' ILE . 61.0 Cg_exo -54.62 -152.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.815 3.01 . . . . 1.07 113.656 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.965 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.5 m -136.76 94.73 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 112.058 0.392 . . . . 0.46 112.058 -165.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -125.38 106.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 113.841 1.052 . . . . 0.48 113.841 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 9.6 t -147.17 102.08 3.82 Favored Pre-proline 0 C--O 1.219 -0.52 0 CA-C-N 115.941 -0.572 . . . . 1.07 110.318 168.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.73 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 31.9 Cg_exo -57.1 124.38 16.08 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 CA-C-N 120.495 1.212 . . . . 0.48 110.757 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.404 ' H ' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -54.03 -29.91 45.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.019 -0.537 . . . . 1.31 111.232 -175.408 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.1 m -53.0 -33.12 50.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 1.2 111.874 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.6 mm -77.65 -54.58 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.528 -0.305 . . . . 0.51 111.28 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 39' ' ' VAL . 11.3 mt -51.03 -26.92 6.8 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.504 0.669 . . . . 1.0 110.848 172.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 99' ' ' SER . 54.8 t80 -63.99 -46.48 84.39 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.391 -1.277 . . . . 0.96 109.056 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 26.1 m-80 -73.27 -55.88 5.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.492 0.553 . . . . 0.82 112.492 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.985 HD21 HD23 ' A' ' 101' ' ' LEU . 1.3 pp -55.47 -57.71 10.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.897 0.702 . . . . 0.65 112.897 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.528 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . -61.26 -24.4 66.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.673 0.749 . . . . 0.43 110.806 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.547 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.4 ttp180 -62.26 -49.62 74.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.781 -1.099 . . . . 1.81 109.86 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -85.21 -53.29 5.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.373 1.082 . . . . 0.8 111.129 -173.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 1.003 HG21 HG23 ' A' ' 114' ' ' ILE . 34.4 m -83.93 -30.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.225 -0.898 . . . . 0.88 110.849 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.58 -20.22 78.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.215 -0.902 . . . . 0.38 111.343 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -47.79 -45.59 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.386 -1.709 . . . . 1.09 106.386 162.385 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 9.3 m-20 -72.84 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.716 -0.674 . . . . 1.87 110.359 162.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 -179.54 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.719 0.408 . . . . 1.17 111.852 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.36 137.92 32.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.018 0.437 . . . . 2.15 111.47 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 1.003 HG23 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -118.36 148.07 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.237 -0.653 . . . . 0.39 109.237 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.3 p-10 -102.65 152.69 20.91 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 87.9 m-85 -137.21 171.48 14.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.636 . . . . 0.62 109.284 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.633 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 34.2 tt0 -160.2 121.33 3.07 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.364 0.415 . . . . 0.8 110.139 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -97.69 137.61 36.33 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.727 -0.471 . . . . 1.25 109.727 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.713 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.3 tp60 -121.37 103.17 8.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.884 -0.598 . . . . 0.63 109.51 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 60' ' ' ILE . 6.8 tp -113.1 121.42 65.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.115 0.483 . . . . 0.81 110.904 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.17 126.48 8.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.333 -0.707 . . . . 0.26 111.333 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.648 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.5 mp -103.77 100.5 10.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.092 0.473 . . . . 1.2 111.393 -172.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.137 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.3 m -104.6 95.59 6.01 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.474 -0.784 . . . . 0.32 109.478 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 58' ' ' CYS . 2.3 pt -106.82 149.89 9.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.716 -0.394 . . . . 0.98 110.602 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -91.12 105.35 17.75 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.52 108.492 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.732 HD12 HG21 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -105.09 148.26 35.88 Favored Pre-proline 0 C--O 1.218 -0.567 0 O-C-N 124.684 1.24 . . . . 1.28 108.995 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.45 -32.15 93.42 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.909 1.739 . . . . 0.74 113.052 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.94 -58.09 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.455 0.539 . . . . 1.12 112.455 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -94.45 -6.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 122.153 0.978 . . . . 1.35 109.952 -175.434 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.82 -31.36 1.27 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 113.716 -1.584 . . . . 1.05 111.59 -171.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.2 pt-20 -171.05 137.15 1.14 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.692 -0.855 . . . . 1.16 108.692 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -143.14 139.55 30.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.372 -0.603 . . . . 1.91 109.372 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.3 t -121.18 112.94 19.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.688 0.756 . . . . 1.19 111.498 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.69 137.05 29.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.205 -0.907 . . . . 0.5 109.66 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 11.1 Cg_endo -91.47 163.64 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.237 1.958 . . . . 0.45 112.758 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.8 166.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.468 -0.938 . . . . 0.44 108.468 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -136.32 147.17 47.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.223 -0.191 . . . . 0.88 110.802 -167.605 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.5 t -140.58 102.88 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.489 -0.93 . . . . 0.96 108.489 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 13.6 ptmt -118.46 152.31 36.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.732 -0.667 . . . . 1.76 111.087 -174.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.11 158.67 30.25 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.6 -0.81 . . . . 0.5 112.231 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.4 mt-10 -102.6 132.79 48.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.409 -0.589 . . . . 2.1 109.409 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.52 172.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.467 -0.568 . . . . 0.76 109.467 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -75.03 167.22 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.006 0.431 . . . . 3.53 111.652 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.699 HD12 HD11 ' A' ' 114' ' ' ILE . 17.8 tp -57.1 132.77 80.48 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.676 -0.693 . . . . 1.23 111.124 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 144' ' ' LEU . 56.1 Cg_endo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 122.611 2.207 . . . . 0.71 112.221 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.505 -0.542 0 N-CA-C 118.348 2.099 . . . . 0.54 118.348 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.614 ' C ' HG13 ' A' ' 45' ' ' VAL . 39.4 m -178.99 34.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 112.618 -1.791 . . . . 1.2 107.525 -170.412 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 120' ' ' ILE . 16.4 m -135.07 150.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.84 -1.073 . . . . 0.93 109.638 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 46' ' ' SER . 1.3 t -160.28 -51.66 0.05 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.988 -0.375 . . . . 0.48 109.988 168.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -158.54 150.14 21.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.294 0.568 . . . . 1.69 112.101 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.13 127.8 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.3 -0.863 . . . . 1.14 108.932 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -119.45 135.27 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.845 0.355 . . . . 1.83 111.303 -169.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -97.33 127.16 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 0.94 111.871 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -129.72 -113.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 1.33 109.679 166.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.82 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.3 p-10 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.05 0.389 . . . . 2.85 112.05 -172.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.676 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 23.0 t . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 106.252 -1.758 . . . . 0.94 106.252 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 33' ' ' ASP . 3.1 t -124.51 161.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.39 -0.967 . . . . 0.86 108.39 166.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.91 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 82.0 mt-10 -114.06 131.93 56.2 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.878 -0.729 . . . . 1.19 112.13 -170.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.791 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.87 103.82 10.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.855 -1.066 . . . . 3.73 109.443 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -72.73 109.18 6.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.081 -1.081 . . . . 0.81 108.081 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -107.31 102.84 12.11 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.288 0.566 . . . . 0.42 109.797 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 18.0 ttpp -83.77 133.55 34.77 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.875 -0.787 . . . . 2.63 108.875 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 25' ' ' SER . 24.3 t -109.7 141.75 24.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.806 -1.088 . . . . 0.82 110.409 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 88' ' ' THR . 1.8 p -120.1 100.52 7.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 119.531 -0.868 . . . . 0.72 109.373 168.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 77.1 t -81.15 112.46 19.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.599 -0.889 . . . . 1.14 108.599 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 2.0 m -102.92 109.89 21.62 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.914 -1.143 . . . . 0.41 107.914 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.777 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 5.1 t30 -87.92 122.52 70.08 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.63 1.206 . . . . 1.48 109.85 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 1.3 Cg_endo -85.34 8.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.988 3.126 . . . . 0.73 114.423 -171.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.704 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 31.4 t80 -96.79 -114.03 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.116 -0.634 . . . . 2.08 110.015 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 18.9 p -168.74 18.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.811 0.3 . . . . 1.51 111.811 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -148.04 143.18 27.04 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.514 -0.55 . . . . 1.67 109.514 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 5.4 m -41.26 98.19 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.256 0.973 . . . . 1.39 112.873 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.942 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.9 pt -74.63 170.54 14.71 Favored Pre-proline 0 C--O 1.21 -0.998 0 N-CA-C 107.685 -1.228 . . . . 1.03 107.685 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.536 ' HB2' HG12 ' A' ' 57' ' ' ILE . 22.9 Cg_endo -91.25 -64.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 120.89 1.06 . . . . 0.37 114.435 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.8 mm -126.4 161.33 32.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.188 -0.605 . . . . 1.23 112.009 -166.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.655 ' HB3' HG22 ' A' ' 124' ' ' ILE . 29.8 p -152.04 175.63 12.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.43 1.11 . . . . 1.15 112.318 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -136.55 114.24 11.12 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.006 -1.907 . . . . 1.36 109.336 175.357 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -98.92 117.74 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.894 -1.048 . . . . 1.05 111.61 174.1 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.657 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.1 p -115.09 109.63 18.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.625 -1.625 . . . . 0.83 109.34 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.0 p90 -114.09 126.86 55.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.428 -0.351 . . . . 0.4 110.13 -168.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.74 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.9 m -119.6 104.64 10.46 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.826 -0.625 . . . . 0.38 109.327 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 94.3 m-85 -97.75 136.04 38.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.957 -0.565 . . . . 0.96 109.783 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.721 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -146.59 140.3 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.734 -0.469 . . . . 1.29 109.734 176.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.594 ' HB2' HD11 ' A' ' 71' ' ' ILE . 48.2 t -102.64 -96.12 0.3 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.603 -0.271 . . . . 1.27 111.588 -173.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.06 5.58 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.546 -0.909 . . . . 0.36 108.546 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.11 16.92 0.18 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 106.69 -2.564 . . . . 0.39 106.69 163.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -105.76 163.25 12.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 112.809 -1.696 . . . . 1.97 108.834 -171.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -97.57 87.89 4.21 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.488 0.661 . . . . 2.61 109.313 -161.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 14.8 mm -44.63 -43.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 113.867 -1.515 . . . . 0.4 111.188 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.23 167.46 36.18 Favored Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 119.9 -1.143 . . . . 0.49 111.622 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.87 161.97 18.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.685 0.743 . . . . 1.81 111.404 173.508 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.47 -178.88 32.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.804 -0.918 . . . . 0.43 110.804 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' SER . 5.1 ptpp? -147.22 141.93 26.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 1.72 111.2 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 92.0 mt -133.47 124.44 18.09 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.73 110.182 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.7 111.34 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.427 2.085 . . . . 0.57 110.678 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.95 144.61 52.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.816 -0.439 . . . . 0.79 109.816 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' A' ' 57' ' ' ILE . 34.2 Cg_exo -62.44 90.53 0.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.146 1.897 . . . . 0.58 112.112 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.51 35.09 2.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.99 -0.55 . . . . 0.4 112.294 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.942 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 52.3 p -73.03 123.73 24.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.396 -0.594 . . . . 0.62 109.396 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -149.54 -159.78 1.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.727 -1.189 . . . . 1.1 113.499 -164.006 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.496 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 86.4 mttt -60.6 -93.61 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.485 0.55 . . . . 1.84 112.485 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.91 110.32 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.85 -1.167 . . . . 0.99 107.85 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 45.2 pttt 41.92 49.43 4.05 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.994 0.902 . . . . 1.84 111.195 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.3 t70 -153.3 -177.97 6.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.706 -1.134 . . . . 0.64 110.118 -172.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.9 ttm -110.35 127.39 55.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.649 -0.705 . . . . 1.35 109.793 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.56 142.24 50.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.77 111.151 -175.062 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.55 114.17 21.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.151 0.501 . . . . 0.48 111.656 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 45' ' ' VAL . 5.9 tt -117.96 171.33 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.533 -0.914 . . . . 0.77 108.533 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.7 133.85 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.477 0.58 . . . . 1.81 112.286 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 46.0 mm -114.06 113.14 46.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.6 -0.889 . . . . 0.65 108.6 168.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.645 ' O ' HD22 ' A' ' 42' ' ' LEU . 45.3 Cg_exo -28.87 -102.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 1 C-N-CA 125.725 4.283 . . . . 1.07 115.415 -170.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.91 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.3 93.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 122.356 -0.215 . . . . 0.46 110.701 -177.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.7 p -127.75 102.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 114.474 1.287 . . . . 0.48 114.474 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 101' ' ' LEU . 2.5 p -153.78 103.61 2.5 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 122.152 -0.343 . . . . 1.07 111.49 159.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.72 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 94.2 Cg_exo -44.37 136.4 8.51 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.405 2.07 . . . . 0.48 113.543 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.676 ' H ' ' HA ' ' A' ' 38' ' ' SER . 2.1 t80 -52.28 -37.84 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.691 -1.141 . . . . 1.31 110.881 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -63.29 -25.89 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 1.2 112.651 -176.047 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.4 mm -71.29 -54.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.694 0.759 . . . . 0.51 110.659 -175.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.629 HD11 HG21 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -54.21 -33.69 58.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.706 -1.588 . . . . 1.0 109.325 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 99' ' ' SER . 56.2 t80 -61.0 -39.85 91.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.29 -1.777 . . . . 0.96 109.032 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 2.9 m120 -74.98 -57.49 3.87 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.82 111.321 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HA ' HH11 ' A' ' 69' ' ' ARG . 3.0 pp -57.99 -50.71 72.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.488 0.922 . . . . 0.65 113.488 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.28 -26.97 66.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 0.43 110.521 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -71.2 -51.71 23.21 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.422 -0.808 . . . . 1.81 110.944 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 35.9 t70 -81.38 -51.96 7.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.776 0.798 . . . . 0.8 111.791 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.5 t -91.01 -22.11 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.734 -0.604 . . . . 0.88 110.431 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.24 -20.09 79.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.393 -0.908 . . . . 0.38 111.043 168.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -51.73 -48.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.635 -1.617 . . . . 1.09 106.635 165.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 14.6 m-20 -69.78 -97.34 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.085 -0.962 . . . . 1.87 110.345 163.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -178.18 -52.69 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.554 0.576 . . . . 1.17 112.554 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -95.65 124.5 39.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.407 -0.361 . . . . 2.15 111.447 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 108' ' ' VAL . 3.0 mp -117.69 155.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.734 0.302 . . . . 0.39 110.218 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -96.0 154.55 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.638 -0.875 . . . . 2.11 108.638 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 60.8 m-85 -140.31 149.36 42.67 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.161 -1.052 . . . . 0.62 108.161 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.828 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 10.5 tt0 -146.29 139.39 25.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.369 -0.532 . . . . 0.8 111.066 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.644 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 10.2 tp -105.67 127.59 53.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.335 -0.848 . . . . 1.25 109.917 170.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.74 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.6 tp60 -113.02 100.34 8.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.456 -0.942 . . . . 0.63 108.456 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.4 tp -112.88 122.34 66.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.124 0.488 . . . . 0.81 111.497 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.62 128.48 9.43 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.978 -0.849 . . . . 0.26 110.978 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.643 HD21 ' HA2' ' A' ' 24' ' ' GLY . 2.2 mp -104.87 97.64 7.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.881 0.372 . . . . 1.2 111.273 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.01 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 78.9 m -97.38 95.37 7.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.93 -0.767 . . . . 0.32 108.93 171.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.86 147.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.032 -0.667 . . . . 0.98 110.013 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 4.5 m-20 -87.99 105.88 17.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 109.374 -0.602 . . . . 1.52 109.374 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 124' ' ' ILE . 1.5 mm? -103.37 162.11 21.03 Favored Pre-proline 0 C--O 1.22 -0.457 0 O-C-N 124.333 1.021 . . . . 1.28 109.611 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.97 -29.83 14.55 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 121.992 1.794 . . . . 0.74 113.053 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -75.38 -57.87 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 113.372 0.879 . . . . 1.12 113.372 -176.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -95.1 -3.35 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.976 0.893 . . . . 1.35 109.857 -176.308 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.84 -36.48 1.44 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 113.951 -1.477 . . . . 1.05 111.217 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.7 pt-20 -174.3 140.09 0.64 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.811 -1.181 . . . . 1.16 107.811 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -140.98 146.2 36.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.83 -0.348 . . . . 1.91 110.113 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.0 t -114.4 112.9 23.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.534 0.683 . . . . 1.19 111.584 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.91 138.48 32.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.624 -0.716 . . . . 0.5 109.76 173.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -93.15 163.65 2.53 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.019 1.813 . . . . 0.45 113.335 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.34 168.09 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.679 -0.86 . . . . 0.44 108.679 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -138.32 156.04 48.01 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.134 0.42 . . . . 0.88 112.134 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 t -145.94 106.87 4.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.63 -0.878 . . . . 0.96 108.63 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.828 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.1 ptmt -120.84 149.69 42.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.629 -0.259 . . . . 1.76 111.099 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.66 146.61 11.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.634 -0.793 . . . . 0.5 112.403 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -107.7 132.02 53.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.067 -0.567 . . . . 2.1 110.797 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.56 172.0 2.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.805 -1.183 . . . . 0.76 107.805 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.6 152.61 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 3.53 111.047 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.87 150.03 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 1.23 112.388 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.346 0.407 0 C-N-CA 123.447 2.765 . . . . 0.71 113.03 -179.61 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.424 -2.166 0 N-CA-C 111.623 -0.591 . . . . 0.54 111.623 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB2' HD11 ' A' ' 122' ' ' LEU . 33.3 m -168.91 29.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.384 -0.969 . . . . 1.2 108.384 170.725 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.47 153.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.865 -1.061 . . . . 0.93 109.723 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -179.5 -46.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.632 0.582 . . . . 0.48 112.099 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 27.2 t70 -155.38 151.89 28.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.69 -0.404 . . . . 1.69 111.603 -174.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.61 120.68 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.393 -0.595 . . . . 1.14 109.393 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 t70 -113.44 110.86 20.99 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.637 -0.256 . . . . 1.83 111.308 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -79.42 130.97 35.93 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.638 -0.134 . . . . 0.94 110.638 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.52 -88.05 0.24 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 114.138 1.162 . . . . 1.33 114.138 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.204 -1.32 0 O-C-N 121.936 -0.478 . . . . 2.85 111.995 -152.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.474 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 6.3 t . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.348 0.594 . . . . 0.94 111.358 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 101' ' ' LEU . 91.4 t -76.89 155.51 5.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.208 -0.905 . . . . 0.86 110.319 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.88 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 48.8 mt-10 -129.35 139.54 51.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.539 -0.864 . . . . 1.19 110.515 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.952 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -139.72 134.62 32.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.582 -0.847 . . . . 3.73 112.293 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -80.41 111.42 16.79 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.824 -0.806 . . . . 0.81 108.824 -174.621 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -90.43 99.9 12.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.374 0.607 . . . . 0.42 110.001 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -83.5 125.04 31.34 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.82 -0.807 . . . . 2.63 108.82 178.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.588 HG13 ' C ' ' A' ' 25' ' ' SER . 52.2 t -115.48 139.19 43.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.169 -0.923 . . . . 0.82 110.445 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.75 104.52 8.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.19 -0.604 . . . . 0.72 109.58 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 83.2 t -83.05 129.89 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.338 -0.846 . . . . 1.14 110.458 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 30.5 m -122.61 113.94 19.95 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.913 -0.585 . . . . 0.41 109.837 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.787 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.5 p-10 -94.87 146.19 30.92 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.628 -0.715 . . . . 1.48 109.172 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.92 8.18 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.13 2.553 . . . . 0.73 113.044 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE1' ' HG2' ' A' ' 127' ' ' PRO . 6.8 t80 -117.11 131.92 56.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.958 -0.386 . . . . 2.08 109.958 -174.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.576 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 38.1 t -87.48 44.7 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.442 0.639 . . . . 1.51 110.655 -169.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -144.07 16.88 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.459 0.911 . . . . 1.67 113.459 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 26.2 t 61.42 98.28 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 111.885 0.328 . . . . 1.39 111.885 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.853 ' O ' ' HA ' ' A' ' 81' ' ' SER . 9.1 pt -78.79 128.87 75.52 Favored Pre-proline 0 C--O 1.207 -1.149 0 O-C-N 121.698 -0.626 . . . . 1.03 111.115 -170.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 28.6 Cg_endo -66.34 -59.21 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.914 1.743 . . . . 0.37 113.106 -163.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 79' ' ' PRO . 10.1 mm -121.65 152.02 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.23 -0.588 . . . . 1.23 110.782 -172.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.589 ' HB3' HG22 ' A' ' 124' ' ' ILE . 10.2 m -148.03 178.23 8.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.147 0.975 . . . . 1.15 111.961 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.097 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 34.7 tt0 -136.8 117.63 14.11 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.587 -1.642 . . . . 1.36 110.618 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -97.89 109.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.783 0.802 . . . . 1.05 109.559 170.029 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.714 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 13.2 p -117.13 102.05 8.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.325 -1.307 . . . . 0.83 109.717 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 p90 -109.92 126.68 54.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.4 110.451 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 8.2 m -120.43 105.3 10.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.525 -0.762 . . . . 0.38 109.312 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 81.6 m-85 -98.67 140.56 32.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.28 -0.418 . . . . 0.96 111.226 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.569 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 2.8 m80 -134.78 143.9 47.36 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.085 -1.08 . . . . 1.29 108.085 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 33.6 t -107.64 -100.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.67 -0.812 . . . . 1.27 111.176 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.53 3.57 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.217 -0.66 . . . . 0.36 109.217 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.51 20.94 0.13 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.292 -1.523 . . . . 0.39 109.292 167.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 69' ' ' ARG . 7.3 ptp180 -116.46 -176.83 3.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.64 -0.874 . . . . 1.97 108.64 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -103.05 96.8 7.04 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.744 0.783 . . . . 2.61 108.935 -167.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.92 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.0 mm -50.77 -42.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 113.762 -1.563 . . . . 0.4 111.153 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 170.0 32.76 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.538 -0.839 . . . . 0.49 111.288 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.44 163.83 27.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.411 0.606 . . . . 1.81 110.396 174.812 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.72 159.71 23.54 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.231 -0.748 . . . . 0.43 111.231 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.714 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 92.3 mttt -133.19 128.53 36.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.238 -0.282 . . . . 1.72 110.238 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.606 ' HB ' HD12 ' A' ' 60' ' ' ILE . 70.3 mt -134.31 111.8 11.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.36 -0.382 . . . . 0.73 110.224 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 111.24 3.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.518 2.146 . . . . 0.57 110.554 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 22.1 t70 -130.88 142.67 46.4 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.738 -0.467 . . . . 0.79 109.738 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' HD13 ' A' ' 57' ' ' ILE . 27.8 Cg_endo -63.84 84.61 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.539 2.159 . . . . 0.58 112.365 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.14 41.74 3.08 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.4 112.147 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 83.9 p -70.48 113.14 7.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.62 109.179 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -142.74 160.82 39.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.447 0.536 . . . . 1.1 112.447 -164.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 90.9 mttt -6.25 -96.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 125.243 1.589 . . . . 1.84 113.796 -172.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 170.5 108.54 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.097 -1.075 . . . . 0.99 108.097 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 9.6 ptpt 42.57 54.32 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.291 0.995 . . . . 1.84 110.844 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t70 -153.53 -167.29 2.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 0.64 110.822 -171.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 52.5 ttm -118.81 125.07 48.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 1.35 110.883 -170.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 47' ' ' VAL . 1.2 t -113.58 143.28 44.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.77 109.309 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.86 106.37 16.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.281 0.563 . . . . 0.48 111.068 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 45' ' ' VAL . 8.5 tt -103.31 160.28 14.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.514 -0.921 . . . . 0.77 108.514 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -136.3 119.56 16.72 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.682 -0.807 . . . . 1.81 111.314 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 31.6 mm -103.36 143.59 26.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.231 -0.895 . . . . 0.65 109.612 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' HG23 ' A' ' 92' ' ' ILE . 17.9 Cg_endo -59.79 -155.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.888 2.392 . . . . 1.07 113.718 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.952 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 5.1 m -126.35 92.3 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 115.602 -0.727 . . . . 0.46 111.411 -162.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -126.29 101.65 8.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 115.633 1.716 . . . . 0.48 115.633 -162.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 39' ' ' VAL . 4.8 p -153.32 123.95 3.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 121.182 -0.949 . . . . 1.07 111.766 162.439 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 49.4 Cg_exo -53.59 135.14 60.88 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.616 1.544 . . . . 0.48 112.071 172.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 38' ' ' SER . 1.2 t80 -50.33 -36.23 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.052 -0.976 . . . . 1.31 110.931 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.7 m -65.62 -25.26 67.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.658 0.614 . . . . 1.2 112.658 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.92 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.5 mm -72.38 -54.46 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 121.73 -0.606 . . . . 0.51 110.043 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.839 HD22 HG11 ' A' ' 39' ' ' VAL . 9.9 mp -60.1 -25.41 65.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.002 -0.999 . . . . 1.0 111.161 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.2 t80 -59.03 -48.49 81.41 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.54 -1.281 . . . . 0.96 107.54 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 91.3 m-20 -75.48 -56.16 4.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.648 -1.16 . . . . 0.82 113.15 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.716 ' HG ' ' HA ' ' A' ' 101' ' ' LEU . 2.8 pp -54.36 -49.76 69.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.255 0.835 . . . . 0.65 113.255 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.92 -24.81 65.24 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 122.066 0.936 . . . . 0.43 110.406 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.6 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 3.3 ttp180 -69.7 -49.57 52.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.226 -1.352 . . . . 1.81 110.238 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 9.0 t70 -81.89 -53.91 5.77 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.73 0.776 . . . . 0.8 111.98 -173.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.751 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.0 t -89.09 -22.69 6.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.88 110.1 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.79 -18.68 78.98 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.43 -0.891 . . . . 0.38 111.228 168.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -51.95 -47.1 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.862 -1.533 . . . . 1.09 106.862 164.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 19.4 m-20 -68.5 -96.22 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.709 -0.678 . . . . 1.87 110.096 159.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -179.34 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.17 111.674 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -94.43 123.73 38.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.064 0.459 . . . . 2.15 110.923 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.751 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.9 mp -110.64 158.76 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.283 -0.636 . . . . 0.39 109.283 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.667 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 4.8 p-10 -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.879 -0.601 . . . . 2.11 109.416 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 40.9 m-85 -137.13 157.9 45.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.903 -1.147 . . . . 0.62 107.903 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.915 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.7 tt0 -145.86 137.97 25.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.146 0.498 . . . . 0.8 109.853 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -110.51 131.49 55.0 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.484 -0.78 . . . . 1.25 109.562 177.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.666 ' N ' HD22 ' A' ' 118' ' ' LEU . 5.3 tp60 -117.56 99.59 7.07 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.772 -0.825 . . . . 0.63 108.772 174.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -114.51 121.06 65.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.441 0.639 . . . . 0.81 110.719 -173.847 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.6 127.75 8.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.26 111.999 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 25' ' ' SER . 1.9 mp -99.05 96.0 7.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.83 0.348 . . . . 1.2 110.624 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.097 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 94.5 m -101.16 95.66 6.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.156 -0.683 . . . . 0.32 109.156 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' A' ' 55' ' ' ILE . 32.7 pt -117.06 137.73 50.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.392 -0.523 . . . . 0.98 110.785 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.678 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -81.66 105.93 13.2 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.224 -0.658 . . . . 1.52 109.224 -176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.574 HD23 HG21 ' A' ' 55' ' ' ILE . 20.0 mt -107.15 141.69 23.45 Favored Pre-proline 0 C--O 1.217 -0.61 0 O-C-N 124.859 1.35 . . . . 1.28 109.69 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 50.3 Cg_exo -55.16 -27.78 57.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.272 1.981 . . . . 0.74 113.536 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.48 -58.21 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 112.584 0.587 . . . . 1.12 112.584 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -99.37 -2.09 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 122.14 0.971 . . . . 1.35 109.774 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.79 -31.14 1.98 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 113.742 -1.572 . . . . 1.05 110.711 -171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.3 pt-20 -169.07 145.12 3.38 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.809 -1.182 . . . . 1.16 107.809 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HB2' HD12 ' A' ' 126' ' ' LEU . 6.6 t80 -134.82 134.63 41.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.048 -0.723 . . . . 1.91 109.048 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 90.9 m -119.0 105.11 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 1.19 111.723 -175.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.3 pp -127.66 132.75 24.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.5 109.838 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 73.6 Cg_endo -84.96 159.29 11.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.682 1.588 . . . . 0.45 112.239 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.43 164.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.198 -1.038 . . . . 0.44 108.198 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -133.42 149.61 51.79 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.854 -0.338 . . . . 0.88 111.528 -168.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.0 t -144.33 103.82 4.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.812 -0.81 . . . . 0.96 108.812 173.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.915 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.7 ptmt -113.44 144.61 42.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.958 -0.565 . . . . 1.76 110.837 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.22 139.73 6.76 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.684 -0.769 . . . . 0.5 111.734 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 12.1 mt-10 -106.33 126.79 52.67 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.922 -0.77 . . . . 2.1 108.922 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.42 173.6 13.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.609 -0.885 . . . . 0.76 108.609 -176.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -68.43 175.83 3.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.03 0.443 . . . . 3.53 111.793 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.4 tp -58.82 129.07 85.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.575 -0.739 . . . . 1.23 112.119 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 144' ' ' LEU . 36.8 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 124.206 3.27 . . . . 0.71 112.85 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.438 -1.22 0 N-CA-C 113.597 0.199 . . . . 0.54 113.597 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG13 ' A' ' 45' ' ' VAL . 76.7 p -166.6 36.98 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.437 1.113 . . . . 1.2 108.308 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.1 m -133.85 154.89 39.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.295 -1.32 . . . . 0.93 110.463 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 t -168.04 -45.34 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.781 0.676 . . . . 0.48 111.387 168.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -162.84 162.9 26.67 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.915 -0.49 . . . . 1.69 111.479 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.49 146.06 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.878 -0.415 . . . . 1.14 109.878 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -129.02 134.92 48.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.582 0.229 . . . . 1.83 111.004 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.542 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.7 tm? -100.85 134.94 43.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.145 -0.317 . . . . 0.94 110.145 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -142.92 -93.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.7 1.0 . . . . 1.33 113.7 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.199 -1.564 0 CA-C-O 118.801 -0.618 . . . . 2.85 111.709 -154.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.242 0.673 0 CA-C-O 121.965 0.888 . . . . 0.94 112.173 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.921 HG21 HD12 ' A' ' 101' ' ' LEU . 48.7 t -71.88 152.49 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.181 -1.372 . . . . 0.86 109.126 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.964 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.2 mt-10 -114.84 133.83 55.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.957 -1.097 . . . . 1.19 112.595 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.829 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.18 105.6 11.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.816 -1.084 . . . . 3.73 110.681 -176.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -81.28 111.15 17.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.32 -0.993 . . . . 0.81 108.32 178.084 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.32 115.61 30.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.528 0.68 . . . . 0.42 110.875 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 39.3 ttmt -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.893 -1.049 . . . . 2.63 108.586 177.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 25' ' ' SER . 51.0 t -108.99 143.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.599 -0.728 . . . . 0.82 110.984 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' THR . 14.2 m -134.59 100.96 4.79 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.227 0.536 . . . . 0.72 110.436 167.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 85.4 t -81.99 124.36 39.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.171 -0.922 . . . . 1.14 110.617 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -103.2 110.67 22.72 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.902 -0.59 . . . . 0.41 110.707 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 9.9 t30 -90.27 128.01 50.95 Favored Pre-proline 0 C--N 1.318 -0.802 0 O-C-N 123.796 0.685 . . . . 1.48 109.748 176.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.31 8.7 3.43 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.51 . . . . 0.73 114.116 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -127.02 147.28 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.588 -0.893 . . . . 2.08 108.588 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.676 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.9 t -79.1 31.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.227 0.454 . . . . 1.51 112.227 -168.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -143.11 128.47 18.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.486 -0.324 . . . . 1.67 110.789 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.538 ' HA ' HD23 ' A' ' 82' ' ' LEU . 47.6 t -38.11 105.05 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 124.577 1.151 . . . . 1.39 112.971 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -77.87 125.11 86.02 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 109.242 -0.651 . . . . 1.03 109.242 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.954 ' HB2' HD12 ' A' ' 57' ' ' ILE . 30.3 Cg_endo -63.09 -58.92 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.048 1.832 . . . . 0.37 113.544 -159.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.5 mp -132.18 154.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.899 -0.72 . . . . 1.23 110.994 -173.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 124' ' ' ILE . 31.4 p -145.83 178.11 8.42 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.504 1.145 . . . . 1.15 112.161 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.099 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.0 tt0 -131.95 114.24 14.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.687 -2.052 . . . . 1.36 109.25 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.86 110.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.334 1.064 . . . . 1.05 110.125 171.415 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -109.1 105.25 14.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.256 -1.793 . . . . 0.83 107.951 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 p90 -115.59 130.71 56.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.416 0.627 . . . . 0.4 110.369 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 32.5 m -131.92 114.56 14.79 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.743 -1.117 . . . . 0.38 109.065 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' HG22 ' A' ' 71' ' ' ILE . 97.3 m-85 -96.77 146.83 24.53 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.508 -0.552 . . . . 0.96 109.508 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -134.09 146.06 49.94 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.392 -1.336 . . . . 1.29 107.392 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . 1.088 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -112.56 -97.2 0.43 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.177 -1.009 . . . . 1.27 110.846 169.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.82 3.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.837 -0.431 . . . . 0.36 109.837 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.2 26.37 0.18 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.964 -1.254 . . . . 0.39 109.964 167.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 8.1 ptp180 -126.17 -174.22 3.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.552 -0.536 . . . . 1.97 109.552 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 100' ' ' ILE . 43.7 mt-10 -101.44 92.06 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.198 0.523 . . . . 2.61 110.391 -164.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -56.85 -32.1 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.4 112.113 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.67 164.94 33.22 Favored Glycine 0 C--O 1.223 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.49 111.245 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.28 160.26 18.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.989 0.895 . . . . 1.81 112.126 175.842 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.77 159.1 21.04 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.076 -0.81 . . . . 0.43 111.076 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.0 mtpt -126.2 128.1 46.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.196 0.498 . . . . 1.72 110.002 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -136.63 122.22 13.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.721 0.296 . . . . 0.73 110.644 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.31 114.53 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.579 2.186 . . . . 0.57 111.022 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 17.9 t70 -129.97 146.0 59.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.074 -0.343 . . . . 0.79 110.074 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 78' ' ' ASP . 12.5 Cg_endo -56.82 91.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.727 2.285 . . . . 0.58 112.17 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -79.88 19.51 6.31 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.497 -0.774 . . . . 0.4 112.82 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 p -70.74 121.32 17.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.006 -0.739 . . . . 0.62 109.006 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -145.23 -161.38 1.29 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.843 0.682 . . . . 1.1 112.843 -162.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 67.5 mttm -53.79 -94.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.83 0.678 . . . . 1.84 112.83 -174.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.629 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 164.51 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.583 -0.895 . . . . 0.99 108.583 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.1 ptmt 46.27 40.86 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.408 1.067 . . . . 1.84 111.088 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.69 -169.75 3.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.907 -1.042 . . . . 0.64 109.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 ttm -116.19 124.5 50.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.305 0.574 . . . . 1.35 110.456 -174.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -111.35 143.48 42.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.352 -0.84 . . . . 0.77 110.863 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.02 138.89 31.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.026 0.441 . . . . 0.48 110.447 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.533 HD22 HG11 ' A' ' 45' ' ' VAL . 1.2 tt -144.15 175.06 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.612 -1.255 . . . . 0.77 107.612 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 4.0 p-10 -142.15 146.5 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.061 0.846 . . . . 1.81 112.217 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.4 mm -114.56 143.25 29.57 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 107.895 -1.15 . . . . 0.65 107.895 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.547 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 85.2 Cg_exo -51.52 -122.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.472 2.781 . . . . 1.07 114.072 175.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -153.82 93.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 O-C-N 121.837 -0.539 . . . . 0.46 111.973 -172.081 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.2 p -126.29 109.03 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.748 1.018 . . . . 0.48 113.748 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 16.9 t -146.86 103.98 3.89 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 115.683 -0.69 . . . . 1.07 109.731 169.246 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.6 Cg_exo -61.26 123.45 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 CA-C-N 120.792 1.319 . . . . 0.48 110.678 171.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.57 -38.34 44.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.56 -0.745 . . . . 1.31 112.176 -171.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.9 m -56.12 -25.52 46.36 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.674 0.25 . . . . 1.2 111.674 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.0 mm -76.34 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 120.252 -0.579 . . . . 0.51 111.116 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.921 HD12 HG21 ' A' ' 39' ' ' VAL . 13.1 mt -51.96 -30.05 23.12 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.488 0.661 . . . . 1.0 110.427 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 99' ' ' SER . 85.3 t80 -62.89 -40.36 97.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.178 -1.374 . . . . 0.96 108.908 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.38 -56.12 5.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.727 -0.67 . . . . 0.82 111.848 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.3 pp -62.14 -51.8 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.57 0.952 . . . . 0.65 113.57 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.424 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -60.3 -25.97 66.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.783 0.801 . . . . 0.43 110.361 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.0 ttp180 -64.28 -50.42 67.96 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.659 -1.155 . . . . 1.81 110.131 173.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.5 t70 -83.24 -53.42 5.77 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.781 0.66 . . . . 0.8 112.781 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 114' ' ' ILE . 4.2 t -84.35 -27.47 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.498 -0.481 . . . . 0.88 110.001 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.44 -21.28 77.72 Favored Glycine 0 C--N 1.328 0.139 0 C-N-CA 120.631 -0.795 . . . . 0.38 111.573 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.8 -46.69 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.98 -1.489 . . . . 1.09 106.98 165.461 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 6.3 m-20 -67.66 -90.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.434 -0.803 . . . . 1.87 109.615 162.039 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -178.16 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.196 0.443 . . . . 1.17 112.196 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -93.63 133.08 37.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.204 0.526 . . . . 2.15 110.991 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD12 ' A' ' 144' ' ' LEU . 2.7 mp -115.87 159.95 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.39 109.962 -171.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' ' 114' ' ' ILE . 10.3 p-10 -98.81 152.83 19.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.59 -0.892 . . . . 2.11 108.59 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.1 m-85 -138.02 163.86 30.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.62 108.339 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.63 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 36.2 tt0 -160.58 128.47 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.8 110.624 -177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -99.83 134.51 42.63 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.314 -0.624 . . . . 1.25 109.314 174.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.642 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.4 tp60 -117.21 102.54 9.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.719 -0.673 . . . . 0.63 109.266 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.584 HD11 HG22 ' A' ' 60' ' ' ILE . 6.4 tp -111.62 120.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.087 0.47 . . . . 0.81 111.154 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -90.85 126.98 8.62 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.114 -0.794 . . . . 0.26 111.114 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.0 mp -106.89 112.93 26.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.673 0.273 . . . . 1.2 111.241 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.099 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.6 m -114.01 96.68 5.94 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.817 -0.629 . . . . 0.32 109.762 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -111.33 144.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.544 -0.462 . . . . 0.98 110.553 -176.853 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -88.57 107.12 18.73 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.163 -1.051 . . . . 1.52 108.163 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.599 HD23 HG21 ' A' ' 55' ' ' ILE . 9.7 mt -106.94 168.08 8.56 Favored Pre-proline 0 C--O 1.222 -0.388 0 O-C-N 125.359 1.662 . . . . 1.28 110.236 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.31 -41.98 0.78 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.189 1.926 . . . . 0.74 112.982 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.02 -57.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.937 0.347 . . . . 1.12 111.937 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -89.19 -8.16 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.697 0.761 . . . . 1.35 109.949 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.64 -33.78 0.71 Allowed Glycine 0 C--N 1.321 -0.291 0 CA-C-N 114.473 -1.239 . . . . 1.05 112.369 -172.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.3 pt-20 -171.99 145.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.419 -1.326 . . . . 1.16 107.419 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 4.4 t80 -153.75 146.11 23.94 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.445 -0.502 . . . . 1.91 110.125 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 31.9 m -120.31 107.07 12.5 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.386 0.429 . . . . 1.19 111.101 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.4 pp -126.37 138.03 31.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.96 -0.564 . . . . 0.5 109.936 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 18.1 Cg_endo -91.69 165.35 3.39 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.386 2.058 . . . . 0.45 112.719 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -164.9 169.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.025 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.3 p -136.52 154.08 50.83 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.375 0.509 . . . . 0.88 112.375 -169.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.4 t -140.58 105.61 4.99 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.716 -1.216 . . . . 0.96 107.716 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.63 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.35 149.7 38.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.577 -0.283 . . . . 1.76 110.834 -172.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.78 135.39 3.9 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.294 -0.723 . . . . 0.5 111.294 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.14 131.84 44.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.652 -0.499 . . . . 2.1 109.652 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.34 172.9 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.512 -0.551 . . . . 0.76 109.512 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 144' ' ' LEU . 0.5 OUTLIER -61.49 167.09 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.172 0.804 . . . . 3.53 113.172 -177.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 ' HD2' ' A' ' 145' ' ' PRO . 32.1 tp -59.19 134.3 87.92 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 114.908 -1.042 . . . . 1.23 111.641 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.847 ' HD2' HD12 ' A' ' 144' ' ' LEU . 31.9 Cg_endo . . . . . 0 C--N 1.351 0.666 0 C-N-CA 123.103 2.535 . . . . 0.71 112.106 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.768 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.437 -1.245 0 CA-C-O 120.368 -0.129 . . . . 0.54 113.35 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 122' ' ' LEU . 40.7 m -172.03 39.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 1.2 108.382 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' SER . 25.1 m -134.87 155.12 37.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.778 -1.101 . . . . 0.93 109.312 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -175.56 -48.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.369 0.507 . . . . 0.48 112.369 168.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -158.5 147.04 18.65 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.049 -0.407 . . . . 1.69 111.128 -174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.876 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.83 138.59 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.954 0.407 . . . . 1.14 110.336 166.17 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.29 135.49 48.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 1.83 111.332 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 39' ' ' VAL . 3.1 tm? -89.9 137.94 31.91 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 0.94 111.202 -172.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -137.45 -91.78 0.23 Allowed 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 113.865 1.061 . . . . 1.33 113.865 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 6.8 m-20 . . . . . 0 C--O 1.207 -1.178 0 O-C-N 121.452 -0.78 . . . . 2.85 111.149 -156.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 35.6 t . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.989 0.423 . . . . 0.94 110.206 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.697 ' HB ' HG13 ' A' ' 96' ' ' VAL . 12.0 t -76.28 158.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.008 -0.542 . . . . 0.86 109.581 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.5 mt-10 -136.91 141.33 42.71 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.451 -0.781 . . . . 1.19 110.932 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -140.73 134.45 30.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.167 -1.013 . . . . 3.73 113.454 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -80.78 110.93 16.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.132 . . . . 0.81 108.624 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.876 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -100.28 106.42 18.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.239 0.542 . . . . 0.42 110.697 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.28 116.99 24.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.161 0.981 . . . . 2.63 109.786 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 25' ' ' SER . 16.1 t -95.97 149.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.214 -1.357 . . . . 0.82 110.069 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.2 m -132.46 104.08 6.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.177 -0.609 . . . . 0.72 110.67 168.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.3 t -83.04 128.43 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.731 -1.122 . . . . 1.14 111.141 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 17.5 m -109.62 109.5 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.962 -0.563 . . . . 0.41 110.323 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.887 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -92.29 133.52 29.86 Favored Pre-proline 0 N--CA 1.466 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 40.6 Cg_endo -104.76 22.28 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.453 2.768 . . . . 0.73 114.656 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.09 -3.45 12.07 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 118.717 -1.193 . . . . 2.08 111.358 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.475 ' CB ' ' HD3' ' A' ' 85' ' ' LYS . 24.6 p 89.89 15.97 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.26 1.024 . . . . 1.51 112.404 161.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -147.6 148.43 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.968 -0.753 . . . . 1.67 108.968 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 41.7 t -54.32 107.16 0.25 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.244 0.965 . . . . 1.39 112.054 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.945 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.0 pt -74.71 173.02 7.42 Favored Pre-proline 0 C--O 1.206 -1.204 0 N-CA-C 107.767 -1.197 . . . . 1.03 107.767 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HB2' HG12 ' A' ' 57' ' ' ILE . 11.0 Cg_endo -90.13 -62.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 CA-C-N 120.192 1.104 . . . . 0.37 114.774 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 79' ' ' PRO . 16.8 mm -131.22 161.35 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.588 -0.445 . . . . 1.23 111.43 -165.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.581 ' CB ' HG22 ' A' ' 124' ' ' ILE . 29.3 p -155.96 -177.3 6.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.38 1.086 . . . . 1.15 111.972 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.5 tt0 -135.96 116.37 13.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.017 -1.902 . . . . 1.36 109.774 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.731 HG22 HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -97.25 110.09 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.238 1.018 . . . . 1.05 109.489 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.475 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.5 p -114.42 102.97 10.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.325 -1.761 . . . . 0.83 108.844 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.3 p90 -113.37 131.65 55.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.517 -0.549 . . . . 0.4 109.517 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 17.6 m -127.94 106.01 8.81 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.736 -1.12 . . . . 0.38 109.067 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 72.1 m-85 -96.99 142.49 28.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 110.232 -0.284 . . . . 0.96 110.232 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.447 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -129.38 144.85 51.41 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.28 -1.378 . . . . 1.29 107.28 176.737 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.885 ' HB3' HD22 ' A' ' 104' ' ' LEU . 39.1 t -107.77 -96.47 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.902 -1.119 . . . . 1.27 111.106 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -63.93 1.1 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.146 -0.687 . . . . 0.36 109.146 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.34 17.21 0.18 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 108.511 -1.836 . . . . 0.39 108.511 167.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.937 HH11 ' HB3' ' A' ' 103' ' ' ASN . 11.8 ptp180 -114.3 177.47 4.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.303 -0.999 . . . . 1.97 108.303 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.13 98.19 8.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.606 0.717 . . . . 2.61 109.486 -163.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.97 -36.43 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 113.979 -1.464 . . . . 0.4 111.912 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.2 161.21 12.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.999 -0.84 . . . . 0.49 110.999 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -159.99 161.77 34.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 117.875 0.837 . . . . 1.81 111.24 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.76 162.43 28.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.753 -0.658 . . . . 0.43 111.456 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.7 mttt -123.47 128.62 50.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.649 -0.5 . . . . 1.72 109.649 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 60' ' ' ILE . 80.4 mt -133.56 116.8 14.03 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.268 -0.271 . . . . 0.73 110.268 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.68 101.49 1.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.753 2.302 . . . . 0.57 111.115 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -112.85 146.13 34.46 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.509 -0.552 . . . . 0.79 109.509 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.694 ' HA ' HD13 ' A' ' 57' ' ' ILE . 35.6 Cg_exo -62.3 86.5 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.028 1.819 . . . . 0.58 112.168 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 36.34 2.58 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.926 -0.579 . . . . 0.4 112.671 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.945 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.2 p -73.95 120.29 19.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.297 -0.631 . . . . 0.62 109.297 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -156.11 161.59 40.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.318 -1.353 . . . . 1.1 114.546 -163.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HG3' ' OG1' ' A' ' 88' ' ' THR . 88.6 mttt -22.28 -97.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.883 1.438 . . . . 1.84 114.883 -164.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.409 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 171.24 109.55 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.252 -1.018 . . . . 0.99 108.252 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.738 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 39.5 pttt 42.15 46.56 3.79 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.008 0.818 . . . . 1.84 110.936 -175.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.9 t70 -150.04 -171.04 3.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.261 -0.881 . . . . 0.64 109.88 -170.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.9 ttm -119.01 117.93 30.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.514 0.673 . . . . 1.35 110.157 -173.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.65 ' CB ' ' HB2' ' A' ' 82' ' ' LEU . 0.8 OUTLIER -106.12 143.31 34.42 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.839 -1.073 . . . . 0.77 111.124 -176.094 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.0 129.9 34.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.463 0.649 . . . . 0.48 110.73 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 45' ' ' VAL . 8.8 tt -135.42 162.05 33.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.398 -1.334 . . . . 0.77 107.398 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.69 138.27 32.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.23 -0.988 . . . . 1.81 112.679 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.9 mm -100.82 149.92 36.59 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.005 -1.452 . . . . 0.65 107.717 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 11.3 Cg_endo -53.96 -116.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.964 2.443 . . . . 1.07 113.686 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.4 m -156.88 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 O-C-N 121.559 -0.713 . . . . 0.46 111.729 -169.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG11 ' HE2' ' A' ' 62' ' ' PHE . 9.1 p -126.27 101.56 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 116.102 1.89 . . . . 0.48 116.102 -163.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.5 p -152.21 110.66 2.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 121.25 -0.906 . . . . 1.07 111.864 163.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.0 Cg_exo -54.43 131.81 47.44 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.794 1.663 . . . . 0.48 110.942 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 24.8 t80 -54.16 -40.64 67.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.53 -0.759 . . . . 1.31 111.523 -172.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 13.4 t -55.88 -26.97 49.66 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.229 0.331 . . . . 1.2 111.785 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 mm -76.11 -55.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.109 -0.636 . . . . 0.51 110.908 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 104' ' ' LEU . 37.9 mt -55.49 -28.48 54.82 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.521 0.677 . . . . 1.0 110.344 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.1 t80 -65.49 -39.72 92.25 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.384 -1.28 . . . . 0.96 108.602 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.937 ' HB3' HH11 ' A' ' 69' ' ' ARG . 11.3 m-80 -74.28 -56.56 4.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.936 . . . . 0.82 112.307 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 101' ' ' LEU . 1.7 pp -60.77 -47.96 83.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.121 0.786 . . . . 0.65 113.121 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.56 -25.02 68.05 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.844 0.83 . . . . 0.43 109.833 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.15 -54.27 36.33 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.529 -1.214 . . . . 1.81 110.274 173.24 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 18.7 t70 -82.41 -53.19 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.998 0.904 . . . . 0.8 111.923 -173.282 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.4 t -87.55 -27.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 121.639 -0.663 . . . . 0.88 110.042 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.16 -19.76 79.76 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.462 -0.875 . . . . 0.38 111.34 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -49.14 -46.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.847 -1.538 . . . . 1.09 106.847 164.743 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 33.3 m-20 -71.32 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.486 -0.779 . . . . 1.87 110.077 162.227 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 179.64 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.192 0.442 . . . . 1.17 112.192 174.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -94.89 131.17 41.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 2.15 111.821 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -120.62 161.33 20.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.954 -0.566 . . . . 0.39 109.89 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 114' ' ' ILE . 14.7 t70 -99.88 154.6 18.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.783 -0.644 . . . . 2.11 109.563 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 83.8 m-85 -140.63 132.14 26.99 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.396 -0.964 . . . . 0.62 108.396 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.758 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 23.2 tt0 -131.22 137.15 48.79 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.082 0.468 . . . . 0.8 110.307 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 14.9 tp -103.16 131.08 50.45 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.775 -0.648 . . . . 1.25 110.256 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 2.2 tp60 -111.7 99.5 8.21 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.57 -1.27 . . . . 0.63 107.57 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.731 HD11 HG22 ' A' ' 60' ' ' ILE . 6.3 tp -113.08 114.89 48.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.348 0.594 . . . . 0.81 111.139 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.41 128.62 8.84 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.212 -0.755 . . . . 0.26 111.212 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 133' ' ' THR . 5.7 mp -105.91 102.05 11.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.983 0.421 . . . . 1.2 110.936 -174.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.3 m -107.86 95.17 5.5 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.272 -0.877 . . . . 0.32 109.514 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.581 HG22 ' CB ' ' A' ' 58' ' ' CYS . 39.3 pt -113.0 141.97 26.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 C-N-CA 120.146 -0.622 . . . . 0.98 110.52 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 53.8 m-20 -85.73 106.16 16.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.752 -0.833 . . . . 1.52 108.752 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 55' ' ' ILE . 45.3 mt -104.02 164.87 14.45 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 124.53 1.143 . . . . 1.28 109.878 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 41.4 Cg_endo -69.91 -40.38 5.15 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.415 1.41 . . . . 0.74 113.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.07 -58.41 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.374 0.509 . . . . 1.12 112.374 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 132' ' ' PHE . 9.7 p -90.21 -7.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.172 0.987 . . . . 1.35 110.05 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.92 -30.9 0.76 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 114.248 -1.342 . . . . 1.05 112.516 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.0 pt-20 -166.86 126.59 1.5 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 1.16 108.716 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HB2' HG11 ' A' ' 129' ' ' VAL . 13.0 t80 -123.71 135.63 53.98 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.428 -0.582 . . . . 1.91 109.428 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.9 t -128.05 103.22 7.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.921 0.867 . . . . 1.19 111.844 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.64 143.9 49.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.236 -0.893 . . . . 0.5 110.227 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 80.9 Cg_endo -92.49 162.74 2.95 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.783 1.656 . . . . 0.45 113.597 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.74 168.54 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.112 -1.44 . . . . 0.44 107.112 178.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 99.1 p -145.64 152.18 39.25 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.335 -0.546 . . . . 0.88 111.845 -168.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -146.98 113.13 5.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.784 -0.821 . . . . 0.96 108.784 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.758 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 6.8 ptmm? -123.88 153.37 41.22 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.08 -0.248 . . . . 1.76 111.378 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.45 143.57 8.65 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.371 -0.692 . . . . 0.5 111.371 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -108.54 132.13 54.14 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.03 -0.585 . . . . 2.1 110.418 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.31 173.45 2.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.473 -1.306 . . . . 0.76 107.473 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -63.94 172.63 2.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.217 0.532 . . . . 3.53 112.332 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 114' ' ' ILE . 15.7 tp -58.97 139.85 87.07 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.316 -0.856 . . . . 1.23 111.306 -175.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 144' ' ' LEU . 37.3 Cg_endo . . . . . 0 C--N 1.349 0.604 0 C-N-CA 122.973 2.449 . . . . 0.71 112.449 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 114.726 0.65 . . . . 0.54 114.726 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.707 ' HB2' HD11 ' A' ' 122' ' ' LEU . 22.5 m -169.83 34.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.841 1.256 . . . . 1.2 108.294 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' SER . 23.1 m -134.94 156.31 39.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.369 -1.287 . . . . 0.93 109.191 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -173.47 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.211 0.448 . . . . 0.48 112.211 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.839 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 15.6 t70 -160.67 157.01 26.38 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.825 -0.35 . . . . 1.69 111.004 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.4 t -142.45 134.97 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.693 -0.855 . . . . 1.14 108.693 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 25.0 t70 -125.2 132.22 53.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 1.83 111.078 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.8 tm? -101.17 127.5 47.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.94 111.55 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.08 -115.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.613 -0.722 . . . . 1.33 110.05 168.667 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.957 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.4 p-10 . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 110.409 -0.219 . . . . 2.85 110.409 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 29.7 t . . . . . 0 N--CA 1.429 -1.501 0 N-CA-C 105.818 -1.919 . . . . 0.94 105.818 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 33' ' ' ASP . 8.2 t -131.33 159.83 42.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.154 -0.684 . . . . 0.86 109.154 170.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 90.9 mt-10 -114.07 134.55 54.79 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.456 0.646 . . . . 1.19 112.386 -169.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.747 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -121.73 106.08 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.841 -1.072 . . . . 3.73 110.237 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -74.11 110.34 8.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.144 -1.058 . . . . 0.81 108.144 175.687 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -98.63 110.17 22.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.468 0.651 . . . . 0.42 110.182 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 22.8 ttmt -87.99 117.35 26.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.692 -1.14 . . . . 2.63 109.342 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 25' ' ' SER . 61.6 t -105.78 143.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.292 -0.867 . . . . 0.82 111.038 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.716 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 4.8 m -134.89 97.39 3.74 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.482 -0.562 . . . . 0.72 109.482 166.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -86.49 126.68 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.454 0.645 . . . . 1.14 110.973 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -101.78 118.01 36.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.886 -1.052 . . . . 0.41 110.159 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 20.4 t30 -89.5 124.07 65.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 O-C-N 124.669 1.231 . . . . 1.48 109.472 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.29 2.27 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.495 2.797 . . . . 0.73 115.34 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.788 ' CE2' ' HB2' ' A' ' 53' ' ' HIS . 7.2 p90 -134.77 163.03 30.72 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.685 -0.634 . . . . 2.08 109.774 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 51.8 p -81.24 21.47 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.848 1.055 . . . . 1.51 113.848 -164.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . 0.788 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 37.0 m80 -131.21 129.97 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.967 -0.693 . . . . 1.67 111.357 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.437 ' HA ' HD23 ' A' ' 82' ' ' LEU . 3.2 m -39.54 110.62 0.15 Allowed 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 124.512 1.125 . . . . 1.39 113.056 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.971 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.5 pt -73.03 170.37 13.97 Favored Pre-proline 0 C--O 1.211 -0.934 0 N-CA-C 107.83 -1.174 . . . . 1.03 107.83 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 7.6 Cg_endo -87.8 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.223 1.282 . . . . 0.37 113.327 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.904 HG12 ' HA ' ' A' ' 79' ' ' PRO . 21.7 mt -142.53 155.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.25 0.463 . . . . 1.23 112.25 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' HG22 ' A' ' 124' ' ' ILE . 21.0 p -142.28 -177.4 5.23 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.042 0.925 . . . . 1.15 110.903 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 1.061 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.1 tt0 -136.4 115.05 11.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.744 -1.571 . . . . 1.36 109.992 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.69 109.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.359 1.076 . . . . 1.05 109.738 167.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 28.7 p -113.55 102.71 10.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.674 -1.603 . . . . 0.83 108.799 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 15.8 p90 -115.49 134.91 54.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.353 0.597 . . . . 0.4 110.478 -164.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 19.5 m -131.65 111.01 11.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.616 -1.174 . . . . 0.38 109.176 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 92.2 m-85 -97.27 139.66 32.9 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.111 -0.495 . . . . 0.96 110.189 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.531 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 1.4 m80 -130.83 145.55 52.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.821 -1.177 . . . . 1.29 107.821 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . 1.021 ' HB3' HD22 ' A' ' 104' ' ' LEU . 29.7 t -107.74 -99.5 0.36 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.642 -0.823 . . . . 1.27 111.206 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -55.86 25.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.01 -0.737 . . . . 0.36 109.01 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.09 18.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.459 -1.856 . . . . 0.39 108.459 164.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 8.4 ptp180 -114.07 171.02 7.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.17 -1.015 . . . . 1.97 108.603 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.72 94.1 7.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.091 0.948 . . . . 2.61 110.324 -166.885 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.1 mm -48.75 -44.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.389 -1.732 . . . . 0.4 112.112 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.81 168.59 41.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.925 -1.131 . . . . 0.49 111.718 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.76 155.57 19.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.211 0.506 . . . . 1.81 110.862 176.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.14 155.11 19.82 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.593 -1.003 . . . . 0.43 110.593 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 95.5 mttt -132.35 119.71 21.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.496 -0.557 . . . . 1.72 109.496 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.617 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.2 mt -133.45 116.05 13.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.73 110.986 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.29 111.8 3.29 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.265 1.977 . . . . 0.57 110.141 168.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.8 t70 -115.87 144.75 33.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.771 -0.455 . . . . 0.79 109.771 -173.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.904 ' HA ' HG12 ' A' ' 57' ' ' ILE . 17.9 Cg_endo -61.34 73.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.815 2.343 . . . . 0.58 111.794 172.305 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -76.47 35.45 1.36 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.333 -0.849 . . . . 0.4 113.605 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.971 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.7 p -73.67 119.7 18.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.272 -0.64 . . . . 0.62 109.272 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 49' ' ' ASN . 1.1 pt? -140.18 -164.47 1.72 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.087 -1.445 . . . . 1.1 114.176 -161.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 90.3 mttt -54.82 -93.89 0.0 OUTLIER 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.735 0.643 . . . . 1.84 112.735 -173.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.32 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.929 -1.137 . . . . 0.99 107.929 -171.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 41.8 pttt 42.32 47.46 4.19 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 124.305 1.003 . . . . 1.84 111.338 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -151.1 -170.41 3.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.282 -0.872 . . . . 0.64 109.596 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' MET . . . . . 0.716 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 12.0 ttt -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.889 -0.596 . . . . 1.35 110.256 -170.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' A' ' 46' ' ' SER . 4.7 t -105.31 142.59 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.093 0.473 . . . . 0.77 110.659 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -89.41 105.91 18.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.709 0.766 . . . . 0.48 110.336 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 45' ' ' VAL . 7.6 tt -104.23 168.29 9.2 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.11 -1.441 . . . . 0.77 107.11 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -141.75 143.22 33.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 119.252 0.933 . . . . 1.81 111.874 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.916 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 33.5 mm -106.4 120.72 47.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.825 -1.176 . . . . 0.65 107.825 170.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.621 ' O ' HD22 ' A' ' 42' ' ' LEU . 46.0 Cg_exo -30.87 -97.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.811 3.674 . . . . 1.07 114.753 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.7 93.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 O-C-N 122.474 -0.141 . . . . 0.46 110.669 -179.066 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -127.17 103.65 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.448 1.277 . . . . 0.48 114.448 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 71' ' ' ILE . 1.8 p -152.14 98.19 2.95 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 122.108 -0.37 . . . . 1.07 110.519 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 69.3 Cg_exo -50.58 128.87 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.265 1.976 . . . . 0.48 111.828 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.695 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.2 t80 -48.63 -40.18 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.398 -0.819 . . . . 1.31 111.609 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 19.9 m -58.92 -28.77 66.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.334 0.494 . . . . 1.2 112.334 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.9 mm -76.32 -55.02 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.095 -0.642 . . . . 0.51 110.001 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 104' ' ' LEU . 35.7 mt -50.25 -28.16 7.24 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.97 0.794 . . . . 1.0 110.8 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.6 t80 -65.11 -44.68 87.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.93 -1.032 . . . . 0.96 109.274 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.794 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.0 m-80 -73.57 -58.08 3.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 0.82 112.197 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 1.021 HD22 ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -59.38 -54.57 45.16 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.135 0.791 . . . . 0.65 113.135 -178.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.5 -24.28 67.75 Favored 'General case' 0 C--O 1.217 -0.605 0 CA-C-O 121.753 0.787 . . . . 0.43 110.532 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.794 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.2 ttp180 -64.69 -44.27 90.85 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.717 -1.129 . . . . 1.81 110.878 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 31.5 t70 -85.16 -52.29 6.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.99 0.9 . . . . 0.8 111.411 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 114' ' ' ILE . 28.7 m -76.71 -30.87 19.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.802 -0.635 . . . . 0.88 110.18 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -79.03 -15.87 79.81 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.869 -1.059 . . . . 0.38 111.681 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.99 -42.15 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.253 -1.758 . . . . 1.09 106.253 162.098 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 37.3 m-20 -75.53 -85.25 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.289 157.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.509 ' O ' HD23 ' A' ' 144' ' ' LEU . 4.4 p-90 173.9 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.092 0.557 . . . . 1.17 112.393 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.39 134.19 35.88 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.408 -0.517 . . . . 2.15 111.941 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -116.68 151.68 18.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.097 0.475 . . . . 0.39 109.807 178.455 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -101.35 154.13 19.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.389 -0.823 . . . . 2.11 108.878 173.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 51.8 m-85 -140.91 160.04 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.198 -0.668 . . . . 0.62 109.198 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 26.4 tt0 -152.08 132.02 13.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.953 -0.388 . . . . 0.8 109.953 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 9.8 tp -101.58 132.35 47.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.184 -0.462 . . . . 1.25 110.399 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLN . . . . . 0.462 ' N ' HD12 ' A' ' 118' ' ' LEU . 6.9 tp60 -117.89 99.55 6.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.971 -0.752 . . . . 0.63 108.971 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.47 121.58 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.557 0.694 . . . . 0.81 110.714 -173.83 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLY . . . . . 0.693 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -89.36 129.23 9.57 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.319 -0.855 . . . . 0.26 111.891 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.1 mp -101.01 109.36 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.841 0.353 . . . . 1.2 110.954 -174.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . 1.061 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.0 m -114.87 96.71 5.85 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.731 -0.668 . . . . 0.32 109.702 175.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.774 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.06 134.35 52.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 120.314 -0.554 . . . . 0.98 111.482 -176.677 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.03 106.81 11.33 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.143 -1.058 . . . . 1.52 108.143 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.533 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 19.5 mt -116.04 170.46 5.74 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.457 1.098 . . . . 1.28 110.705 -171.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 91.0 Cg_endo -84.7 -23.76 2.54 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 121.915 1.744 . . . . 0.74 112.283 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.85 -57.86 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 1.12 111.764 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -107.07 -1.58 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.928 0.871 . . . . 1.35 109.787 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.75 -28.12 0.91 Allowed Glycine 0 C--O 1.225 -0.463 0 CA-C-N 114.207 -1.36 . . . . 1.05 111.833 -171.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 129' ' ' VAL . 9.6 pt-20 -165.58 138.25 4.25 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.344 -1.354 . . . . 1.16 107.344 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.2 t80 -132.41 128.72 38.14 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.664 -0.865 . . . . 1.91 108.664 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 14.0 t -120.97 101.04 7.42 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.293 1.044 . . . . 1.19 111.367 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.2 pp -127.21 132.8 24.49 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.993 -1.003 . . . . 0.5 109.84 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PRO . . . . . 0.693 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 2.5 Cg_endo -85.66 161.76 10.76 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.9 1.733 . . . . 0.45 112.242 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.61 166.6 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.1 m -134.96 148.04 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.788 -0.365 . . . . 0.88 110.987 -170.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 t -141.65 103.5 4.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.228 -1.027 . . . . 0.96 108.228 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -107.99 147.24 31.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.055 -0.52 . . . . 1.76 110.599 -175.416 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.83 135.9 4.45 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.766 -0.73 . . . . 0.5 111.326 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.54 130.05 52.54 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.47 -0.566 . . . . 2.1 109.47 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 174.81 6.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.462 -0.94 . . . . 0.76 108.462 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -68.69 171.65 7.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.375 0.509 . . . . 3.53 112.375 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -56.36 128.93 74.38 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.232 -0.895 . . . . 1.23 110.635 -176.579 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD22 ' A' ' 144' ' ' LEU . 31.7 Cg_endo . . . . . 0 C--N 1.351 0.676 0 C-N-CA 123.544 2.829 . . . . 0.71 113.392 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.939 -0.393 . . . . 12.11 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.84 67.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.675 0.621 . . . . 9.02 112.675 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -71.31 -15.94 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 6.83 111.936 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.04 61.58 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.731 -0.47 . . . . 8.55 109.731 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 5' ' ' LEU . 1.2 tm? -84.09 97.79 9.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.682 -0.69 . . . . 10.47 109.622 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.92 131.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.336 -0.847 . . . . 11.69 111.589 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.547 ' NZ ' ' HB3' ' A' ' 7' ' ' LYS . 9.2 mtpm? -88.78 91.07 8.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.026 0.441 . . . . 11.42 110.825 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.59 170.16 8.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.965 -0.561 . . . . 11.58 110.3 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -107.77 -93.61 0.4 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.468 -0.333 . . . . 15.74 110.214 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 57.47 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.638 0.586 . . . . 12.69 112.552 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.83 -31.13 8.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 13.85 111.048 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.6 m -95.41 172.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.465 0.65 . . . . 8.87 112.643 -167.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.62 -56.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.192 -1.367 . . . . 8.91 107.907 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.29 -11.9 3.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.89 -1.05 . . . . 8.6 109.049 170.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -94.11 133.3 37.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.554 -0.748 . . . . 9.04 110.051 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt 69.89 153.08 0.11 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.99 0.806 . . . . 5.58 111.606 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -154.87 -57.44 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 2.69 109.58 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -161.72 -165.58 1.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.68 110.543 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 126' ' ' LEU . 25.4 pt -90.15 172.21 7.39 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.241 -0.436 . . . . 3.19 110.377 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 21.4 Cg_exo -66.23 -91.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.632 2.221 . . . . 2.42 113.182 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 56.7 tttm 167.43 -45.52 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 122.857 0.463 . . . . 6.38 111.302 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 20' ' ' PRO . 17.5 Cg_exo -68.72 58.46 1.1 Allowed 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.501 2.134 . . . . 2.77 112.669 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 5.5 mp0 -129.04 134.6 48.19 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.617 -2.364 . . . . 3.39 104.617 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.768 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -110.2 -177.35 20.92 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.66 -1.733 . . . . 0.54 116.249 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.746 ' HB2' HD11 ' A' ' 122' ' ' LEU . 23.9 m -169.51 33.14 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.105 -1.548 . . . . 1.2 107.215 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.06 155.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.338 -1.301 . . . . 0.93 109.051 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -174.92 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.182 0.438 . . . . 0.48 112.182 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 9.1 t70 -152.72 153.84 34.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.773 0.26 . . . . 1.69 110.464 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 85.1 t -141.32 123.11 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.797 -0.446 . . . . 1.14 109.797 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 33.0 t70 -113.93 108.72 17.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.757 -0.656 . . . . 1.83 111.017 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.3 tm? -83.06 140.05 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.94 110.488 -177.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -138.68 -91.59 0.2 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.627 0.973 . . . . 1.33 113.627 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.754 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -90.94 -178.62 5.26 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.589 -0.694 . . . . 2.85 111.952 -152.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.836 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.1 p -166.78 -37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 123.708 0.63 . . . . 3.26 110.718 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 8.5 t30 67.16 -81.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.36 -0.836 . . . . 3.16 108.805 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -172.11 14.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.362 0.601 . . . . 5.46 109.636 168.784 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 36' ' ' ARG . 8.6 m-20 -131.33 -39.05 1.17 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.33 -0.85 . . . . 1.92 109.905 -172.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.836 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.7 t -152.63 125.4 8.39 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.926 0.713 . . . . 0.94 112.926 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 61.0 t -75.86 148.85 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.243 -0.89 . . . . 0.86 109.388 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 61.8 mt-10 -124.05 142.75 50.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.299 -0.96 . . . . 1.19 111.209 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.954 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 11.5 p90 -133.51 131.71 40.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.269 -0.972 . . . . 3.73 112.365 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 111.95 23.73 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.213 -1.032 . . . . 0.81 108.213 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.08 118.67 34.01 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.176 -0.61 . . . . 0.42 110.739 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 17.5 tppt? -84.68 116.9 23.47 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.501 -0.925 . . . . 2.63 108.501 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 25' ' ' SER . 37.2 t -100.99 145.42 11.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.82 110.177 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -129.34 100.21 5.5 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.22 0.533 . . . . 0.72 110.05 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -83.02 121.64 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.879 -1.055 . . . . 1.14 110.136 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.768 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.3 m -102.63 113.05 26.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.163 -0.68 . . . . 0.41 109.163 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.772 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 8.7 t30 -88.36 128.93 51.35 Favored Pre-proline 0 N--CA 1.466 0.347 0 O-C-N 124.533 1.146 . . . . 1.48 109.961 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 75.7 Cg_endo -87.58 13.52 2.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.73 114.389 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -130.9 142.42 50.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.392 -0.596 . . . . 2.08 109.392 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.611 ' HB3' ' HD2' ' A' ' 85' ' ' LYS . 56.8 p -74.88 31.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.881 0.697 . . . . 1.51 112.881 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -145.12 128.99 17.37 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.245 -0.284 . . . . 1.67 110.738 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -39.88 110.22 0.14 Allowed 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 124.258 1.023 . . . . 1.39 112.412 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HD11 ' A' ' 82' ' ' LEU . 4.1 pt -79.62 173.31 7.93 Favored Pre-proline 0 C--O 1.201 -1.48 0 N-CA-C 106.111 -1.811 . . . . 1.03 106.111 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.505 ' C ' HD12 ' A' ' 57' ' ' ILE . 9.4 Cg_endo -92.75 -62.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 121.326 1.509 . . . . 0.37 114.408 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.6 HG13 ' HA ' ' A' ' 79' ' ' PRO . 1.4 mp -134.26 153.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.274 -0.421 . . . . 1.23 110.796 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 124' ' ' ILE . 21.0 m -140.76 178.95 6.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.886 0.851 . . . . 1.15 111.503 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.087 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 42.0 tt0 -133.77 115.53 14.65 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.906 -1.497 . . . . 1.36 110.249 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.59 110.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 122.533 1.159 . . . . 1.05 110.378 169.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 120' ' ' ILE . 14.2 t -113.3 102.74 10.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.196 -1.82 . . . . 0.83 108.636 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.536 ' HE1' HG11 ' A' ' 95' ' ' VAL . 6.6 p90 -113.66 133.44 55.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.418 0.628 . . . . 0.4 110.029 -167.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 27.2 m -126.14 104.77 8.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.675 -1.148 . . . . 0.38 108.399 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 4.4 m-85 -95.42 143.17 26.99 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.2 -0.454 . . . . 0.96 110.191 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -132.11 145.63 51.52 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 107.107 -1.442 . . . . 1.29 107.107 175.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.936 ' HB3' HD22 ' A' ' 104' ' ' LEU . 19.9 t -103.84 -91.17 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.631 -1.228 . . . . 1.27 111.158 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -69.07 0.17 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.85 0.357 . . . . 0.36 110.159 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.67 15.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.461 -1.456 . . . . 0.39 109.461 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -100.17 -78.31 0.51 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.516 -0.842 . . . . 1.97 109.041 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.664 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -171.4 -177.34 2.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.141 -1.059 . . . . 2.61 108.141 171.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 96' ' ' VAL . 1.6 mm -135.18 -35.77 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.363 -0.835 . . . . 0.4 109.556 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 160.5 171.98 27.16 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.281 -1.128 . . . . 0.49 110.281 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -161.18 166.13 28.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.124 0.962 . . . . 1.81 110.766 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.01 166.02 32.19 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.359 -0.696 . . . . 0.43 111.359 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -129.33 129.51 44.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.897 -0.409 . . . . 1.72 109.897 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.8 mt -139.23 121.64 10.31 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.782 0.325 . . . . 0.73 110.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.7 115.4 4.32 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.432 2.088 . . . . 0.57 110.76 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.13 141.61 39.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.79 109.375 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 57' ' ' ILE . 23.5 Cg_exo -63.88 82.66 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.593 2.195 . . . . 0.58 112.052 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -87.85 41.97 3.09 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.692 -0.685 . . . . 0.4 112.14 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.801 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 44.4 t -73.45 133.74 43.77 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.208 -1.034 . . . . 0.62 108.208 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.823 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -152.81 -156.93 0.75 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 118.201 -1.4 . . . . 1.1 114.641 -163.812 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 64.9 mttm -63.82 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 1.84 112.173 -173.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.4 106.09 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.75 -0.833 . . . . 0.99 108.75 -171.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 6.5 ptmm? 46.35 46.25 13.65 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.28 0.988 . . . . 1.84 111.348 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.39 -170.68 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.757 -1.11 . . . . 0.64 109.545 -173.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 50.1 ttm -112.0 132.17 54.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 1.35 110.947 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -122.94 146.5 47.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.806 -0.633 . . . . 0.77 110.049 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.05 137.09 32.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.24 0.543 . . . . 0.48 110.696 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 45' ' ' VAL . 7.2 tt -137.72 168.35 19.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.41 -0.959 . . . . 0.77 108.41 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -132.39 140.95 48.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.734 0.642 . . . . 1.81 112.734 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 43.4 mm -110.94 143.51 28.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.65 108.159 172.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.75 -121.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.787 2.991 . . . . 1.07 114.147 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.975 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -157.37 88.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.849 -0.532 . . . . 0.46 111.891 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' HE1' ' A' ' 62' ' ' PHE . 12.3 p -127.39 101.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 115.412 1.634 . . . . 0.48 115.412 -168.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.575 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.2 p -150.96 98.76 3.13 Favored Pre-proline 0 C--N 1.315 -0.898 0 O-C-N 121.501 -0.749 . . . . 1.07 110.489 164.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HB2' HG12 ' A' ' 100' ' ' ILE . 51.9 Cg_exo -52.59 134.02 51.59 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.064 1.842 . . . . 0.48 111.418 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.5 t80 -57.2 -33.28 67.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 1.31 111.204 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 26.5 m -58.04 -32.02 67.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.926 0.343 . . . . 1.2 111.926 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.493 HG21 ' HG2' ' A' ' 70' ' ' GLU . 9.6 mm -76.9 -56.32 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.502 -0.479 . . . . 0.51 110.695 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -51.24 -27.87 10.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.563 171.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 63.2 t80 -65.45 -38.67 90.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.09 -1.413 . . . . 0.96 108.803 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.648 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 36.1 m-80 -74.47 -57.77 3.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.935 -0.575 . . . . 0.82 111.758 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.936 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.2 pp -62.29 -51.42 67.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.56 0.948 . . . . 0.65 113.56 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.24 -24.43 65.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.797 0.808 . . . . 0.43 110.536 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.3 ttm180 -59.1 -52.04 67.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.917 -1.038 . . . . 1.81 110.191 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 22.2 t70 -82.83 -51.34 7.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.6 0.714 . . . . 0.8 111.948 -173.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 2.7 t -86.87 -27.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 121.872 -0.518 . . . . 0.88 110.425 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.0 -20.43 79.43 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.739 -0.743 . . . . 0.38 111.692 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -48.45 -46.33 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.824 -1.547 . . . . 1.09 106.824 163.593 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 12.0 t70 -67.09 -90.41 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.477 -0.783 . . . . 1.87 109.088 160.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 172.44 -45.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.352 0.661 . . . . 1.17 111.17 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.55 127.32 42.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 2.15 111.246 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 144' ' ' LEU . 2.3 mp -124.78 158.54 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.697 -0.483 . . . . 0.39 109.697 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 23.3 t70 -97.58 155.39 16.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.326 -0.99 . . . . 2.11 108.326 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.758 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 47.4 m-85 -136.36 121.83 19.45 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.233 -0.654 . . . . 0.62 109.233 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.868 ' HG3' ' HG2' ' A' ' 139' ' ' LYS . 7.9 tt0 -113.08 132.66 55.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.128 -0.323 . . . . 0.8 110.128 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.739 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 15.8 tp -102.07 128.83 48.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.219 -0.446 . . . . 1.25 110.053 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.552 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.3 tp60 -111.18 99.55 8.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.976 -1.12 . . . . 0.63 107.976 168.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 60' ' ' ILE . 5.4 tp -113.17 117.79 56.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.321 0.582 . . . . 0.81 111.099 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 120.62 5.27 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.104 -0.798 . . . . 0.26 111.104 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 25' ' ' SER . 5.2 mp -97.76 98.55 9.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.123 0.487 . . . . 1.2 111.164 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.087 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.2 m -100.11 121.14 40.95 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.384 -0.969 . . . . 0.32 108.384 169.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.73 HG22 ' SG ' ' A' ' 58' ' ' CYS . 11.0 pt -133.68 132.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.538 -0.465 . . . . 0.98 110.355 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.26 107.03 11.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.194 -1.039 . . . . 1.52 108.194 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 19' ' ' ILE . 11.1 mt -115.73 160.83 33.42 Favored Pre-proline 0 C--O 1.219 -0.522 0 O-C-N 124.715 1.26 . . . . 1.28 110.769 -169.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.75 -23.8 16.32 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.89 1.727 . . . . 0.74 112.152 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -57.59 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.259 -0.428 . . . . 1.12 112.093 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.622 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -109.17 1.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.033 0.921 . . . . 1.35 109.897 -175.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.79 -32.49 0.88 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.09 -1.414 . . . . 1.05 111.682 -171.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -175.75 146.29 0.73 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.456 -1.312 . . . . 1.16 107.456 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 14.6 t80 -150.82 146.32 26.29 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.422 -0.511 . . . . 1.91 110.004 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 37.4 m -121.27 110.39 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.913 0.387 . . . . 1.19 111.221 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.15 133.9 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.5 109.355 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 38.3 Cg_endo -91.54 162.29 3.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.873 1.715 . . . . 0.45 113.28 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.17 167.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.245 -1.02 . . . . 0.44 108.245 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -137.81 150.4 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.662 -0.125 . . . . 0.88 110.662 -167.844 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.7 t -148.6 102.38 3.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.623 -0.51 . . . . 0.96 109.623 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.868 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -99.11 144.5 28.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.847 -0.615 . . . . 1.76 110.936 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.37 130.42 3.07 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.478 -0.649 . . . . 0.5 111.478 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 24.0 mt-10 -98.9 125.29 44.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.662 -0.496 . . . . 2.1 109.662 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 172.68 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.841 -1.17 . . . . 0.76 107.841 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -67.23 141.29 57.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.883 -0.414 . . . . 3.53 109.883 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.2 pp -60.35 163.83 7.87 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.366 -0.379 . . . . 1.23 111.505 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 144' ' ' LEU . 15.9 Cg_endo -55.89 172.26 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.504 2.803 . . . . 0.71 113.804 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.1 t -65.98 133.64 51.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.972 -0.751 . . . . 1.71 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -153.81 -175.53 5.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.824 0.821 . . . . 2.64 112.36 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -176.55 -50.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.835 -1.53 . . . . 3.72 107.534 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -148.45 39.42 0.89 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.491 -1.232 . . . . 4.28 108.141 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 85.2 m-85 -115.24 -43.27 3.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 2.86 110.581 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 89.1 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 117.657 -1.163 . . . . 3.96 109.911 -172.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.989 0.423 . . . . 12.11 109.955 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.87 40.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.988 -0.551 . . . . 9.02 111.492 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 p -144.52 151.41 39.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.573 -0.74 . . . . 6.83 109.568 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.06 103.52 15.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.771 0.319 . . . . 8.55 110.819 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 19' ' ' ILE . 3.1 mm? -92.66 -38.09 12.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.54 . . . . 10.47 109.596 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.08 94.64 6.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 11.69 109.66 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -129.79 -9.12 4.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.836 -0.62 . . . . 11.42 110.755 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 64.11 27.69 14.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 11.58 111.305 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -112.79 131.86 55.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.027 -0.533 . . . . 15.74 110.961 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -136.74 126.19 25.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.096 -0.502 . . . . 12.69 109.936 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -142.74 -58.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.676 -0.861 . . . . 13.85 108.676 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.2 m -137.58 150.99 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.995 -1.002 . . . . 8.87 108.934 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.88 -14.45 21.8 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.799 -0.445 . . . . 8.91 109.799 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.72 -71.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.282 -0.872 . . . . 8.6 111.545 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 50' ' ' PRO . 56.3 mttp -147.19 60.87 1.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.371 . . . . 9.04 110.495 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 41.9 tp -81.59 -32.34 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.192 0.52 . . . . 5.58 110.4 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.464 HG22 HG11 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -84.62 169.61 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.765 -0.652 . . . . 2.69 111.253 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 129' ' ' VAL . . . -80.26 6.9 10.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.819 -0.628 . . . . 1.68 111.347 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.622 HD11 HD11 ' A' ' 5' ' ' LEU . 39.0 pt -136.08 61.57 40.89 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.745 1.017 . . . . 3.19 113.745 -165.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 5.7 Cg_exo -81.71 -94.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.029 1.819 . . . . 2.42 111.995 170.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 3.2 tppp? 167.22 -54.07 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 122.678 0.391 . . . . 6.38 111.86 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 14.4 Cg_endo -90.75 76.01 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.583 2.188 . . . . 2.77 113.116 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' A' ' 48' ' ' THR . 7.6 mp0 -127.96 139.96 52.27 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.249 -2.5 . . . . 3.39 104.249 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -114.05 -178.63 19.14 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 118.092 -2.004 . . . . 0.54 115.881 -165.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG13 ' A' ' 45' ' ' VAL . 93.2 p -166.57 36.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.776 -1.564 . . . . 1.2 106.776 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 46' ' ' SER . 13.4 m -134.52 154.03 36.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.646 -1.615 . . . . 0.93 109.237 -169.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 2.4 t -175.12 -50.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.245 0.461 . . . . 0.48 112.245 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 16.3 t70 -152.19 157.13 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.912 -0.493 . . . . 1.69 111.36 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 75.1 t -147.33 124.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.379 -0.373 . . . . 1.14 110.719 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -107.13 142.03 37.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 1.83 110.454 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.0 tm? -97.85 141.04 31.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.34 -0.615 . . . . 0.94 109.34 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.778 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -135.45 -115.21 0.19 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 114.366 1.247 . . . . 1.33 114.366 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 11.7 m-20 -94.87 178.71 5.48 Favored 'General case' 0 C--O 1.203 -1.368 0 O-C-N 121.653 -0.654 . . . . 2.85 111.823 -156.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.905 ' HB ' HG22 ' A' ' 39' ' ' VAL . 2.7 p -155.49 -34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 112.765 0.654 . . . . 3.26 112.765 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 60.6 m-80 68.34 -77.88 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.285 -0.635 . . . . 3.16 109.285 -170.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.6 10.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.984 -0.553 . . . . 5.46 111.029 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -125.45 -42.39 1.97 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.842 0.83 . . . . 1.92 110.364 -169.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.2 t -161.09 131.77 5.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.361 -1.29 . . . . 0.94 110.556 -171.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.905 HG22 ' HB ' ' A' ' 34' ' ' VAL . 41.8 t -87.64 155.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.606 -0.725 . . . . 0.86 109.495 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.947 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 70.6 mt-10 -118.94 151.12 38.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 122.004 -0.435 . . . . 1.19 110.457 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE2' ' HB2' ' A' ' 43' ' ' ALA . 24.3 p90 -136.89 131.55 33.3 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.122 -0.631 . . . . 3.73 111.833 171.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.32 112.43 20.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.799 -0.815 . . . . 0.81 108.799 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HB2' ' HE2' ' A' ' 41' ' ' TYR . . . -95.32 115.8 27.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.249 0.547 . . . . 0.42 110.936 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 10.8 tppt? -88.39 123.52 33.03 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.518 -0.919 . . . . 2.63 108.518 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 25' ' ' SER . 30.9 t -110.5 140.74 28.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.711 -0.677 . . . . 0.82 110.544 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 1.6 m -129.15 99.32 5.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.25 0.547 . . . . 0.72 110.165 170.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -82.61 125.88 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.308 -0.86 . . . . 1.14 110.483 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.693 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.8 m -108.11 113.97 27.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.465 -0.569 . . . . 0.41 109.465 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.86 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 p30 -89.76 150.53 44.17 Favored Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 108.132 -1.062 . . . . 1.48 108.132 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HB2' ' HB3' ' A' ' 15' ' ' LYS . 54.2 Cg_endo -97.71 -9.34 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.072 2.515 . . . . 0.73 114.48 -175.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.719 ' HE1' HG23 ' A' ' 128' ' ' VAL . 14.2 t80 -89.17 -20.27 24.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.88 -0.728 . . . . 2.08 112.195 -155.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.702 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 24.0 t 84.16 13.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.987 0.804 . . . . 1.51 109.237 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HD1' ' HD2' ' A' ' 51' ' ' TYR . 34.4 m80 -139.65 130.0 25.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.77 . . . . 1.67 109.382 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 14.7 m -41.89 96.7 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 O-C-N 124.102 0.876 . . . . 1.39 112.928 173.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.006 HG21 HD23 ' A' ' 126' ' ' LEU . 6.0 pt -74.75 171.46 11.48 Favored Pre-proline 0 C--O 1.212 -0.889 0 N-CA-C 108.261 -1.015 . . . . 1.03 108.261 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 12.4 Cg_endo -88.91 -59.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.067 1.178 . . . . 0.37 113.993 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.799 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 5.9 mt -138.68 162.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.951 -0.7 . . . . 1.23 112.125 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.708 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.0 p -146.72 177.13 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.251 1.024 . . . . 1.15 111.7 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.111 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 31.8 tt0 -126.4 116.18 20.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.286 -1.779 . . . . 1.36 109.723 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.852 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -98.88 109.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.204 1.002 . . . . 1.05 109.975 172.171 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 5.8 m -112.44 102.89 10.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.597 -1.638 . . . . 0.83 108.465 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 p90 -112.87 127.37 56.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.456 0.646 . . . . 0.4 109.82 -169.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 16.4 m -123.28 106.5 10.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.483 -1.235 . . . . 0.38 108.289 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.34 135.18 39.61 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.646 -0.421 . . . . 0.96 110.514 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.6 OUTLIER -123.05 144.76 49.07 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.034 -1.469 . . . . 1.29 107.034 176.051 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.975 ' HB3' HD22 ' A' ' 104' ' ' LEU . 46.4 t -106.78 -97.53 0.35 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.223 -0.991 . . . . 1.27 110.919 174.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.2 -58.79 6.9 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.212 -0.662 . . . . 0.36 109.212 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 22.41 0.13 Allowed Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.613 -1.395 . . . . 0.39 109.613 164.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.2 ptp180 -122.37 -172.57 2.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.643 -0.503 . . . . 1.97 109.643 -175.058 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -100.46 87.19 3.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.716 0.77 . . . . 2.61 111.46 -161.175 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.671 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.8 mm -53.74 -45.15 61.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.598 -1.183 . . . . 0.4 112.117 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.91 163.62 30.82 Favored Glycine 0 C--O 1.22 -0.74 0 C-N-CA 120.23 -0.986 . . . . 0.49 111.383 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -163.07 157.59 20.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.886 0.843 . . . . 1.81 111.871 -177.758 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.61 28.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.825 -0.51 . . . . 0.43 111.825 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 37.9 mttm -127.3 127.11 43.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.902 -0.407 . . . . 1.72 109.902 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 60' ' ' ILE . 78.4 mt -139.95 124.9 11.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 120.695 0.283 . . . . 0.73 110.55 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.54 116.32 4.64 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.431 2.087 . . . . 0.57 110.801 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 60' ' ' ILE . 10.8 t70 -123.08 141.1 34.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.487 -0.56 . . . . 0.79 109.487 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.7 89.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.719 2.28 . . . . 0.58 112.337 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.799 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -82.69 28.43 3.53 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.4 113.102 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.959 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.9 p -74.91 122.88 24.11 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.985 -0.376 . . . . 0.62 109.985 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.8 pt? -153.41 -167.19 2.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 118.317 -1.353 . . . . 1.1 114.059 -165.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 87.5 mttt -52.57 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.545 0.943 . . . . 1.84 113.545 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . -178.08 105.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.636 -0.876 . . . . 0.99 108.636 -174.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.86 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.7 pttt 36.91 62.97 0.73 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.104 0.877 . . . . 1.84 111.185 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' THR . 5.7 t70 -157.51 -179.3 8.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.789 -1.096 . . . . 0.64 109.015 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.598 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 40.6 ttm -108.73 120.12 41.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.072 -0.513 . . . . 1.35 110.597 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 46' ' ' SER . 6.0 t -105.76 143.68 33.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.621 -0.718 . . . . 0.77 109.917 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.93 26.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.463 0.649 . . . . 0.48 110.708 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.622 HD22 HG11 ' A' ' 45' ' ' VAL . 5.6 tt -116.0 164.58 14.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.982 -1.008 . . . . 0.77 108.985 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.32 132.9 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 1.81 110.951 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 21.7 mm -118.95 140.82 29.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.65 111.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.94 -169.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.059 3.173 . . . . 1.07 113.626 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 18.0 m -126.8 91.01 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.46 112.417 -163.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG13 ' HE1' ' A' ' 41' ' ' TYR . 4.9 p -125.29 104.45 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.885 1.439 . . . . 0.48 114.885 -163.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.47 HG13 HG23 ' A' ' 71' ' ' ILE . 4.8 t -145.79 109.07 4.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.088 -0.382 . . . . 1.07 110.775 170.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.1 Cg_exo -56.87 129.24 33.48 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 120.711 0.94 . . . . 0.48 110.55 169.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.691 ' HD2' HG21 ' A' ' 34' ' ' VAL . 11.8 t80 -53.59 -32.16 49.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.261 -0.427 . . . . 1.31 110.631 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 2.0 m -57.45 -30.73 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 1.2 112.041 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.671 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -76.05 -55.44 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.51 110.52 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 104' ' ' LEU . 42.3 mt -53.49 -27.17 23.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.952 172.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.592 ' HB3' ' O ' ' A' ' 99' ' ' SER . 34.8 t80 -60.77 -46.42 90.54 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.595 -1.184 . . . . 0.96 108.786 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.596 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.3 m-80 -73.44 -56.05 5.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.82 112.217 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.975 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.9 pp -59.85 -46.68 88.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.46 0.911 . . . . 0.65 113.46 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -61.71 -24.06 66.53 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.918 0.866 . . . . 0.43 110.104 178.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.596 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.7 ttp180 -68.61 -49.16 61.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.896 -1.047 . . . . 1.81 110.82 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.667 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -81.85 -54.82 5.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.122 0.963 . . . . 0.8 112.213 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.94 ' HB ' HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -88.72 -20.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 121.348 -0.845 . . . . 0.88 109.883 -176.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.05 -19.93 79.62 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.077 -1.058 . . . . 0.38 110.93 167.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -50.55 -45.86 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.7 -1.222 . . . . 1.09 107.7 167.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 4.6 p-10 -81.16 -84.36 0.1 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.026 -1.07 . . . . 1.87 110.929 163.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.428 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 5.0 p-90 178.1 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.604 0.638 . . . . 1.17 112.665 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.35 121.95 37.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.691 -0.231 . . . . 2.15 111.568 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.94 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.4 mp -113.19 154.81 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.447 -0.575 . . . . 0.39 109.447 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -100.4 153.53 19.26 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.62 -0.718 . . . . 2.11 109.198 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -135.45 151.5 50.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.683 -1.229 . . . . 0.62 107.683 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.805 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 38.3 tt0 -146.07 126.63 14.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.865 0.364 . . . . 0.8 110.032 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.765 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 15.0 tp -97.34 137.13 36.81 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.169 0.509 . . . . 1.25 110.692 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.583 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 5.9 tp60 -115.84 100.52 8.07 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.344 -0.984 . . . . 0.63 108.344 170.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.852 HD11 HG22 ' A' ' 60' ' ' ILE . 4.6 tp -114.01 118.9 59.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.218 0.533 . . . . 0.81 111.091 -173.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.14 124.18 6.91 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.544 -0.622 . . . . 0.26 111.544 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.61 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.5 mp -104.03 100.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.035 0.445 . . . . 1.2 111.108 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 99.9 m -102.62 96.6 6.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.223 -0.899 . . . . 0.32 108.826 172.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.708 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.94 133.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.528 -0.469 . . . . 0.98 110.717 -175.604 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 1.0 OUTLIER -75.22 105.67 6.36 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.93 -0.767 . . . . 1.52 108.93 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 1.006 HD23 HG21 ' A' ' 55' ' ' ILE . 19.2 mt -120.2 143.05 34.82 Favored Pre-proline 0 C--O 1.216 -0.675 0 O-C-N 124.706 1.254 . . . . 1.28 109.925 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 78.0 Cg_exo -53.14 -37.47 79.75 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.905 2.403 . . . . 0.74 115.361 -171.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.719 HG23 ' HE1' ' A' ' 51' ' ' TYR . 97.7 t -73.64 -56.93 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.747 -0.596 . . . . 1.12 112.496 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' ' 132' ' ' PHE . 14.9 p -92.16 -7.97 10.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 122.32 1.057 . . . . 1.35 109.868 -175.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.27 -36.78 2.39 Favored Glycine 0 N--CA 1.462 0.43 0 CA-C-N 114.18 -1.373 . . . . 1.05 112.078 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.5 pt-20 -165.84 122.3 1.36 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.544 -1.28 . . . . 1.16 107.544 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.671 ' HB2' HG11 ' A' ' 129' ' ' VAL . 7.9 t80 -111.98 143.28 43.23 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.241 -0.584 . . . . 1.91 109.801 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 64.7 m -123.75 102.43 7.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.846 -0.615 . . . . 1.19 111.524 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.53 139.19 34.06 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.728 -0.669 . . . . 0.5 110.096 173.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.16 162.26 3.8 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.45 112.557 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 167.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.29 -1.004 . . . . 0.44 108.29 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -137.1 148.78 46.92 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.952 -0.299 . . . . 0.88 110.794 -170.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 t -140.39 107.83 5.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.445 -0.946 . . . . 0.96 108.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.805 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.74 143.93 43.81 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.865 -0.334 . . . . 1.76 110.789 -175.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.73 132.62 3.75 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.812 -0.915 . . . . 0.5 110.812 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 9.3 mt-10 -97.55 126.31 42.76 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.926 -0.768 . . . . 2.1 108.926 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.03 173.3 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.173 -0.677 . . . . 0.76 109.173 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -65.55 168.22 7.76 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.747 0.647 . . . . 3.53 112.747 -173.249 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.915 HD12 ' HD2' ' A' ' 145' ' ' PRO . 22.9 tp -56.21 130.48 74.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.033 -0.985 . . . . 1.23 112.324 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.915 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.8 Cg_endo -58.27 170.9 2.02 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.24 3.293 . . . . 0.71 112.93 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.4 m -63.58 102.9 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 1.71 110.531 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.484 ' HB2' ' H ' ' A' ' 151' ' ' PHE . 7.7 p90 -122.87 -26.84 4.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.511 . . . . 2.64 111.158 -176.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 148' ' ' LYS . 34.5 ttmt 52.09 46.91 25.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.274 0.559 . . . . 3.72 111.386 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 67.12 9.06 6.64 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.508 -0.769 . . . . 4.28 112.504 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -98.4 -46.03 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 2.86 110.643 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.484 ' H ' ' HB2' ' A' ' 147' ' ' PHE . 50.0 m-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 114.754 -1.112 . . . . 3.96 108.767 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 7.6 tpt . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.232 -0.655 . . . . 12.11 109.232 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.485 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -100.01 24.07 9.04 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.732 0.641 . . . . 9.02 112.732 -171.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -86.54 -39.27 16.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.713 -0.477 . . . . 6.83 109.713 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -127.69 22.2 6.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 8.55 110.143 173.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.5 mm? 73.34 150.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.738 -1.119 . . . . 10.47 111.861 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.55 34.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.401 -0.818 . . . . 11.69 111.09 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 62.95 26.63 15.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.546 . . . . 11.42 111.242 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.9 142.64 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.652 . . . . 11.58 109.682 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 50.4 mtpt -130.86 163.45 27.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.466 -0.334 . . . . 15.74 110.94 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 70.93 -56.78 0.61 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.678 0.791 . . . . 12.69 112.432 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -66.12 -35.31 80.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 13.85 110.284 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.99 131.33 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.802 -0.635 . . . . 8.87 110.894 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.69 30.3 2.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.743 -0.662 . . . . 8.91 110.863 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 57.58 41.87 25.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.957 -0.565 . . . . 8.6 110.731 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -56.77 -59.71 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.691 -0.686 . . . . 9.04 110.554 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.33 128.46 39.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.311 -0.404 . . . . 5.58 110.064 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 m -142.27 147.69 36.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.691 -0.485 . . . . 2.69 109.691 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HA ' HG13 ' A' ' 129' ' ' VAL . . . 69.42 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 O-C-N 123.931 0.769 . . . . 1.68 111.003 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.699 HG21 ' HG ' ' A' ' 126' ' ' LEU . 16.9 pt -153.02 170.45 8.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.184 -0.302 . . . . 3.19 110.184 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.21 -160.59 0.06 OUTLIER 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.913 2.409 . . . . 2.42 111.946 172.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 23' ' ' GLU . 33.4 tttp -66.61 105.69 0.91 Allowed Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 110.093 -0.336 . . . . 6.38 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.785 ' HB3' ' HG3' ' A' ' 50' ' ' PRO . 93.6 Cg_endo -100.48 54.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.973 3.115 . . . . 2.77 113.847 -168.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.635 ' HA ' HD11 ' A' ' 134' ' ' ILE . 11.3 pt-20 -123.59 127.48 48.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.46 0.648 . . . . 3.39 110.985 -168.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . 170.77 127.38 0.94 Allowed Glycine 0 N--CA 1.422 -2.294 0 C-N-CA 119.606 -1.283 . . . . 0.54 112.701 171.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.493 ' HB2' HD21 ' A' ' 122' ' ' LEU . 4.9 m -172.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.829 0.851 . . . . 1.2 109.62 167.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 46' ' ' SER . 7.4 p -134.25 147.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.56 -0.746 . . . . 0.93 110.926 -174.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -166.11 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.48 110.899 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 33.3 t70 -167.09 164.78 15.83 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.365 -0.235 . . . . 1.69 110.365 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG21 ' HZ ' ' A' ' 64' ' ' PHE . 69.0 t -142.91 120.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.992 -0.373 . . . . 1.14 109.992 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 9.7 m-20 -92.4 109.86 21.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.83 110.648 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.394 -0.595 . . . . 0.94 109.394 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -124.58 -125.95 0.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.195 -0.457 . . . . 1.33 109.962 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.955 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 p30 179.76 176.67 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.13 0.491 . . . . 2.85 112.1 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 38' ' ' SER . 1.2 t -154.59 132.38 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.816 -1.084 . . . . 3.26 109.549 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.7 t30 51.34 -103.37 0.14 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.504 -1.225 . . . . 3.16 110.605 163.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -175.87 33.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.92 1.343 . . . . 5.46 108.228 169.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -130.4 -39.92 1.29 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.377 -1.738 . . . . 1.92 109.134 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.723 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 39.4 t -143.16 165.4 27.53 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.976 -1.465 . . . . 0.94 107.132 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.105 HG23 HG13 ' A' ' 96' ' ' VAL . 20.4 m -128.69 178.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.377 0.99 . . . . 0.86 111.476 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.949 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 84.4 mt-10 -125.25 151.68 45.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.815 -0.63 . . . . 1.19 111.431 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.884 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 13.5 p90 -136.46 123.42 21.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.897 -0.721 . . . . 3.73 110.197 165.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -86.68 110.82 20.13 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.528 -0.915 . . . . 0.81 108.528 174.511 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.09 115.59 28.13 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.816 0.817 . . . . 0.42 110.211 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 20.8 ttmt -84.72 117.72 23.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.252 -1.34 . . . . 2.63 108.432 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.747 HG21 HG12 ' A' ' 92' ' ' ILE . 39.5 t -111.57 144.9 18.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.435 0.636 . . . . 0.82 111.841 -169.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.672 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 24.7 m -133.57 97.5 3.95 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.22 -0.9 . . . . 0.72 108.735 163.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -85.95 132.16 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.61 0.719 . . . . 1.14 110.893 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 26.8 m -111.33 115.53 29.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.718 -1.128 . . . . 0.41 110.032 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.9 t30 -91.53 132.77 32.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.717 1.26 . . . . 1.48 108.409 174.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.785 ' HG3' ' HB3' ' A' ' 22' ' ' PRO . 42.0 Cg_endo -89.04 3.31 5.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.129 2.553 . . . . 0.73 114.147 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 91.7 t80 -108.33 133.1 53.01 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.152 -0.684 . . . . 2.08 109.152 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.777 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 23.8 p -77.08 30.27 0.14 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.496 0.924 . . . . 1.51 113.496 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 62.2 m80 -146.15 142.81 28.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 1.67 108.597 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -41.01 105.75 0.05 OUTLIER 'General case' 0 C--O 1.208 -1.125 0 O-C-N 123.886 0.741 . . . . 1.39 112.151 171.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.947 ' O ' ' HA ' ' A' ' 81' ' ' SER . 8.4 pt -75.63 171.32 12.26 Favored Pre-proline 0 C--O 1.209 -1.076 0 N-CA-C 107.463 -1.31 . . . . 1.03 107.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 10.2 Cg_endo -89.46 -62.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 120.301 1.143 . . . . 0.37 113.781 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.4 mm -130.3 154.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.401 -0.52 . . . . 1.23 110.919 -167.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.717 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 4.0 m -146.1 -176.52 5.19 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.977 0.894 . . . . 1.15 110.988 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.953 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 43.1 tt0 -138.47 118.14 13.09 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.96 -1.473 . . . . 1.36 111.068 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.63 108.22 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.255 1.026 . . . . 1.05 109.54 166.775 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 15.5 p -113.61 102.62 10.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 113.826 -1.533 . . . . 0.83 108.413 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -112.74 126.89 55.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.488 0.661 . . . . 0.4 110.012 -165.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 20.9 m -120.86 104.25 9.71 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.83 -1.077 . . . . 0.38 108.392 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.814 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.3 130.06 44.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.444 0.64 . . . . 0.96 110.809 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -121.1 145.1 48.16 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 107.104 -1.443 . . . . 1.29 107.104 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 104' ' ' LEU . 33.8 t -101.97 -102.72 0.27 Allowed 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.079 -1.049 . . . . 1.27 110.891 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.66 -54.32 47.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.048 -0.723 . . . . 0.36 109.048 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.19 17.9 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.093 -1.603 . . . . 0.39 109.093 166.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 5.9 ptp180 -106.08 -147.51 0.4 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.859 -0.67 . . . . 1.97 109.561 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -123.82 99.1 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.19 0.45 . . . . 2.61 110.349 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.74 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.5 mm -70.89 -38.95 74.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.544 -0.753 . . . . 0.4 110.231 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.49 171.69 32.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.572 -0.823 . . . . 0.49 111.846 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -159.42 154.7 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.091 0.446 . . . . 1.81 110.367 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.53 155.56 13.6 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.433 -0.667 . . . . 0.43 111.433 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 17.3 ptpt -131.38 134.77 46.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.967 0.413 . . . . 1.72 110.703 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -140.01 122.67 10.11 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.73 109.939 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.94 108.32 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.204 1.936 . . . . 0.57 111.033 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -114.92 141.74 27.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.549 -0.537 . . . . 0.79 109.549 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.8 Cg_endo -60.62 87.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.577 2.185 . . . . 0.58 112.407 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.717 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -88.7 33.99 4.01 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.4 111.905 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.947 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -71.01 118.29 13.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.681 -0.859 . . . . 0.62 108.681 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 HD22 ' A' ' 49' ' ' ASN . 1.4 pt? -148.11 -159.98 1.11 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.07 -1.452 . . . . 1.1 114.73 -158.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 56.2 mttm -52.57 -92.05 0.0 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.131 -0.94 . . . . 1.84 112.778 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 167.02 105.76 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.638 -1.245 . . . . 0.99 107.638 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.0 pttt 41.37 49.47 3.43 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.363 1.039 . . . . 1.84 111.034 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.17 -172.34 3.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.064 -0.971 . . . . 0.64 109.757 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.7 ttm -113.28 118.15 33.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.886 0.374 . . . . 1.35 110.801 -171.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.598 ' CG2' HG13 ' A' ' 47' ' ' VAL . 7.1 t -107.35 143.43 35.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.489 . . . . 0.77 110.19 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.54 136.66 36.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.333 0.587 . . . . 0.48 109.59 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 4.2 tt -133.53 170.48 15.45 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.322 -0.992 . . . . 0.77 108.322 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 t70 -135.2 123.5 23.14 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.012 -0.275 . . . . 1.81 110.647 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -105.18 138.15 19.45 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.616 0.246 . . . . 0.65 110.997 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.79 168.25 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.543 2.829 . . . . 1.07 112.606 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.949 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 4.5 m -110.58 88.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.46 111.364 -166.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG13 ' HE2' ' A' ' 41' ' ' TYR . 4.1 p -128.46 101.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 114.726 1.38 . . . . 0.48 114.726 -165.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.105 HG13 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.3 115.65 3.96 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 119.882 -0.727 . . . . 1.07 110.208 162.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.1 128.52 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.439 1.426 . . . . 0.48 109.746 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.723 ' H ' ' HA ' ' A' ' 38' ' ' SER . 20.5 t80 -57.03 -28.1 62.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.03 0.443 . . . . 1.31 110.112 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -52.44 -30.51 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.563 -0.744 . . . . 1.2 111.892 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.74 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.1 mm -78.2 -54.12 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.409 -0.359 . . . . 0.51 111.209 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 104' ' ' LEU . 22.8 mt -50.44 -27.96 7.39 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.572 0.701 . . . . 1.0 110.218 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 16.7 t80 -68.99 -40.73 78.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.661 -1.609 . . . . 0.96 108.506 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.657 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 18.6 m-80 -74.42 -56.51 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.816 -0.629 . . . . 0.82 112.365 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.1 pp -56.7 -56.35 22.5 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.992 0.738 . . . . 0.65 112.992 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.485 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.34 -21.99 66.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.886 0.85 . . . . 0.43 110.149 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -61.03 -53.99 50.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.481 -1.236 . . . . 1.81 110.147 173.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.617 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.2 t70 -85.4 -52.16 6.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.189 0.995 . . . . 0.8 111.723 -171.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 114' ' ' ILE . 34.3 m -80.03 -31.08 13.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.586 -0.696 . . . . 0.88 110.706 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.03 -16.54 80.67 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.087 -0.961 . . . . 0.38 111.616 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.71 -42.53 13.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.456 -1.683 . . . . 1.09 106.456 161.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 42.0 m-20 -75.74 -86.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.57 -0.741 . . . . 1.87 110.298 159.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.443 ' O ' HD23 ' A' ' 144' ' ' LEU . 17.0 p-90 176.73 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.743 0.417 . . . . 1.17 111.629 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.3 133.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.359 0.599 . . . . 2.15 111.511 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.04 HG23 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -117.95 149.66 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.603 -0.726 . . . . 0.39 109.604 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 10.1 p-10 -104.79 154.98 19.31 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.457 -0.942 . . . . 2.11 108.457 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 48.1 m-85 -134.61 156.98 47.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.526 -0.916 . . . . 0.62 108.526 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.526 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 31.5 tt0 -143.56 129.46 19.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.607 -0.516 . . . . 0.8 109.607 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.814 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -103.79 133.99 47.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.769 -0.65 . . . . 1.25 109.46 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.663 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.1 tp60 -116.7 100.73 8.01 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.02 -0.733 . . . . 0.63 109.02 172.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.589 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.1 tp -110.23 117.58 55.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.305 0.574 . . . . 0.81 110.706 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.65 124.51 7.28 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.0 -0.84 . . . . 0.26 111.0 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.9 mm? -101.1 98.23 8.69 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.529 0.68 . . . . 1.2 111.961 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . 0.953 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 96.5 m -95.83 94.78 7.85 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.32 -1.309 . . . . 0.32 108.954 169.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.808 HG13 HD21 ' A' ' 126' ' ' LEU . 9.7 pt -107.38 141.63 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 120.414 -0.514 . . . . 0.98 109.646 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.55 106.12 18.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 1.52 109.688 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.808 HD21 HG13 ' A' ' 124' ' ' ILE . 1.5 mm? -103.13 141.62 22.86 Favored Pre-proline 0 C--O 1.213 -0.82 0 O-C-N 124.344 1.028 . . . . 1.28 109.586 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 52.5 Cg_exo -57.9 -24.98 67.47 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.082 1.855 . . . . 0.74 113.988 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.82 -58.13 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.984 0.421 . . . . 1.12 111.844 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -102.79 0.67 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.078 0.942 . . . . 1.35 110.789 -177.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.33 -39.45 2.9 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 113.86 -1.518 . . . . 1.05 111.41 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 9.6 pt-20 -167.41 155.44 9.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 1.16 109.285 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.47 142.11 31.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.229 -0.656 . . . . 1.91 109.229 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.7 m -122.66 107.94 12.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.904 0.383 . . . . 1.19 111.777 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.677 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.6 pp -128.0 141.25 40.59 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.5 110.006 172.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.6 Cg_endo -92.42 165.66 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.07 1.847 . . . . 0.45 112.872 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.548 HG23 ' CG2' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -159.03 158.2 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.712 -1.218 . . . . 0.44 107.712 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 76.5 p -131.97 152.41 51.13 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.471 -0.492 . . . . 0.88 111.898 -170.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -139.46 110.73 6.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.835 -0.802 . . . . 0.96 108.835 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.526 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.19 140.92 47.53 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.835 -0.346 . . . . 1.76 110.548 -179.264 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.49 139.16 6.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.868 -0.682 . . . . 0.5 111.971 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 27.9 mt-10 -99.12 129.39 45.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 2.1 109.739 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 pp -139.54 173.59 10.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.638 -0.504 . . . . 0.76 109.638 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -65.59 172.29 3.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.897 0.703 . . . . 3.53 112.897 -171.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.694 HD22 ' HD2' ' A' ' 145' ' ' PRO . 1.7 tm? -61.64 126.59 87.17 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.924 -1.034 . . . . 1.23 109.84 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.694 ' HD2' HD22 ' A' ' 144' ' ' LEU . 72.5 Cg_endo -74.38 175.37 11.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.608 2.872 . . . . 0.71 113.198 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.8 m -55.08 98.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.94 -0.573 . . . . 1.71 110.668 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.72 ' HB2' ' HA ' ' A' ' 151' ' ' PHE . 17.7 p90 -106.15 -29.06 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 2.64 111.113 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 61.36 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.74 -0.664 . . . . 3.72 112.016 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.74 9.17 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.988 0.899 . . . . 4.28 109.202 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.454 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 64.9 m-85 -109.67 -45.69 3.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 2.86 111.652 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.72 ' HA ' ' HB2' ' A' ' 147' ' ' PHE . 60.6 m-85 . . . . . 0 C--O 1.246 0.899 0 O-C-N 124.259 0.974 . . . . 3.96 109.034 -165.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.939 0.399 . . . . 12.11 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.2 38.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.615 -0.513 . . . . 9.02 109.615 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.561 ' HB3' ' HE2' ' A' ' 51' ' ' TYR . 19.5 t -88.25 -76.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.691 -0.404 . . . . 6.83 111.1 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 4' ' ' LEU . 38.7 mt -118.05 88.29 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.557 0.694 . . . . 8.55 112.539 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.76 -134.45 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.938 -1.134 . . . . 10.47 107.938 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -165.12 164.81 20.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.788 -0.449 . . . . 11.69 109.788 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.78 -37.43 0.23 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.362 -0.381 . . . . 11.42 110.989 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.57 -94.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.718 0.294 . . . . 11.58 110.927 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -122.42 175.58 6.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.627 -0.508 . . . . 15.74 109.627 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.9 138.25 32.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.101 0.476 . . . . 12.69 109.846 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -151.12 18.18 0.76 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.751 -0.659 . . . . 13.85 109.47 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 15' ' ' LYS . 15.5 m -125.99 108.05 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.532 -0.758 . . . . 8.87 111.353 -176.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.14 -49.31 2.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 8.91 109.422 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.4 -20.7 13.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 8.6 109.658 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.835 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.3 mmpt? -55.23 -49.94 70.71 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.562 -0.744 . . . . 9.04 111.053 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 tp -107.29 100.16 9.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.123 -0.49 . . . . 5.58 109.828 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -109.57 113.46 26.26 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.449 -0.574 . . . . 2.69 109.449 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . 66.7 -148.01 0.18 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.497 -0.774 . . . . 1.68 111.467 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 19' ' ' ILE . 0.2 OUTLIER -98.48 154.28 37.61 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.826 -0.624 . . . . 3.19 110.854 -170.134 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 -12.9 16.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.836 2.357 . . . . 2.42 114.318 -171.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -129.23 138.44 33.18 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.97 -0.105 . . . . 6.38 110.968 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.35 160.58 48.45 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.334 2.023 . . . . 2.77 111.005 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.769 ' HG2' HD11 ' A' ' 124' ' ' ILE . 1.4 mp0 -118.27 156.56 28.63 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 105.8 -1.926 . . . . 3.39 105.8 -172.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.761 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.24 -177.4 17.03 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 117.653 -2.213 . . . . 0.54 113.798 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB2' HD11 ' A' ' 122' ' ' LEU . 37.7 m -169.47 34.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.642 -1.244 . . . . 1.2 107.642 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 46' ' ' SER . 32.7 m -134.04 155.33 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.347 -1.297 . . . . 0.93 109.786 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -165.15 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.57 -0.53 . . . . 0.48 109.57 166.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 44' ' ' LYS . 4.8 p-10 -167.99 163.0 13.63 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.523 0.677 . . . . 1.69 112.652 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.17 132.98 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.821 -1.082 . . . . 1.14 109.266 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.64 138.26 53.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.484 -0.326 . . . . 1.83 110.796 -173.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 39' ' ' VAL . 3.2 tm? -94.82 138.96 31.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.789 -0.187 . . . . 0.94 111.095 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HE3' ' HB2' ' A' ' 42' ' ' LEU . 6.4 ptpt -145.15 -92.53 0.1 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 114.167 1.173 . . . . 1.33 114.167 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -89.59 178.71 6.21 Favored 'General case' 0 C--O 1.204 -1.304 0 O-C-N 121.308 -0.87 . . . . 2.85 111.262 -155.565 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.861 ' HA ' ' O ' ' A' ' 38' ' ' SER . 6.6 p -168.84 -40.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 120.787 0.327 . . . . 3.26 111.276 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 8.9 t30 67.9 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.756 -1.202 . . . . 3.16 107.756 -170.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.476 ' HD2' ' OD1' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -177.85 25.44 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.229 1.014 . . . . 5.46 109.027 168.666 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.87 -40.46 1.06 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.745 -1.57 . . . . 1.92 109.163 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.861 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 27.1 t -155.75 127.97 7.65 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.628 0.727 . . . . 0.94 112.579 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 101' ' ' LEU . 26.7 t -79.1 155.13 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.967 -1.015 . . . . 0.86 109.216 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 27.4 mt-10 -117.62 131.59 56.63 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.002 -1.079 . . . . 1.19 111.867 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.854 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.84 104.97 11.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.137 -0.938 . . . . 3.73 110.513 -176.457 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.703 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -72.47 109.85 6.45 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.919 -1.141 . . . . 0.81 107.919 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -103.99 107.64 18.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.713 0.768 . . . . 0.42 110.144 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 13.0 ttmt -83.47 126.14 32.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.88 -1.156 . . . . 2.63 107.88 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 90' ' ' LEU . 43.1 t -111.4 141.52 26.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.705 -0.68 . . . . 0.82 109.929 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 88' ' ' THR . 29.8 m -128.82 99.25 5.24 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.289 -0.564 . . . . 0.72 110.225 171.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -81.61 122.82 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 115.63 -0.714 . . . . 1.14 109.748 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.661 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 18.9 m -101.43 116.55 33.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.639 -0.709 . . . . 0.41 110.168 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 15.7 t30 -90.26 126.16 57.7 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.127 -0.694 . . . . 1.48 109.127 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.509 ' CG ' HG13 ' A' ' 19' ' ' ILE . 60.2 Cg_endo -91.84 15.14 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.248 2.632 . . . . 0.73 113.832 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' HE2' ' HB3' ' A' ' 3' ' ' SER . 6.2 t80 -131.5 146.73 52.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.514 -0.921 . . . . 2.08 108.514 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.728 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.7 t -80.96 34.47 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.937 0.399 . . . . 1.51 111.722 -169.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -145.31 133.01 21.0 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.654 -0.248 . . . . 1.67 110.803 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -45.37 100.83 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 124.448 1.099 . . . . 1.39 113.022 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.849 HG21 HD23 ' A' ' 126' ' ' LEU . 5.8 pt -77.34 128.32 80.76 Favored Pre-proline 0 C--O 1.207 -1.182 0 N-CA-C 109.222 -0.659 . . . . 1.03 109.222 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.5 Cg_endo -60.88 -51.97 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.968 1.779 . . . . 0.37 113.691 -160.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.876 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 73.9 mt -138.27 157.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 1.23 112.853 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.837 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -139.92 168.17 20.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.565 1.174 . . . . 1.15 112.245 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.119 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.9 tt0 -120.43 119.37 32.84 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 112.854 -1.976 . . . . 1.36 110.18 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 22.2 mm -94.8 110.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.652 -1.158 . . . . 1.05 110.336 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 64.8 p -121.22 102.4 8.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.99 -0.744 . . . . 0.83 108.99 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' HD1' HG22 ' A' ' 60' ' ' ILE . 17.0 p90 -106.9 135.18 48.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.531 0.681 . . . . 0.4 110.242 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.0 m -130.75 105.85 8.07 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.47 -1.241 . . . . 0.38 108.726 174.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CE1' HD23 ' A' ' 118' ' ' LEU . 96.6 m-85 -96.41 140.75 30.61 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.493 -0.558 . . . . 0.96 109.493 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -127.15 144.43 51.04 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.453 -0.943 . . . . 1.29 108.453 177.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.29 -109.84 0.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 116.531 -0.304 . . . . 1.27 111.457 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.04 -54.3 36.37 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.643 -0.873 . . . . 0.36 108.643 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.3 16.12 0.17 Allowed Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 108.466 -1.853 . . . . 0.39 108.466 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.456 ' NH1' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.98 -171.12 1.78 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.341 -0.985 . . . . 1.97 108.341 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.88 90.9 3.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.174 0.512 . . . . 2.61 111.16 -164.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.986 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -47.88 -42.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.4 111.867 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.12 167.59 39.34 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 119.859 -1.162 . . . . 0.49 111.542 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.81 153.89 9.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.355 0.598 . . . . 1.81 111.343 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.09 -179.06 41.5 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.869 -0.892 . . . . 0.43 110.869 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.71 132.87 26.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.952 0.376 . . . . 1.72 111.34 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.43 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 79.1 mt -130.87 109.16 15.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.963 -0.562 . . . . 0.73 109.877 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.8 128.27 14.86 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.317 2.011 . . . . 0.57 110.401 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -138.96 144.76 42.6 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.758 -0.377 . . . . 0.79 110.128 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.2 Cg_exo -57.24 90.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.578 2.185 . . . . 0.58 111.571 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.876 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -75.7 13.68 6.5 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.176 -0.92 . . . . 0.4 113.557 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 94.3 p -69.69 118.04 12.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.496 -0.557 . . . . 0.62 109.496 -176.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 49' ' ' ASN . 1.5 pt? -143.83 -167.16 2.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 119.931 -0.708 . . . . 1.1 112.631 -163.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 86' ' ' ASP . 92.4 mttt -45.49 -93.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.083 0.771 . . . . 1.84 113.083 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 163.37 107.18 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.307 -0.997 . . . . 0.99 108.307 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptmt 45.43 47.65 10.81 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.218 0.948 . . . . 1.84 111.159 -176.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 5.3 t70 -150.39 -170.03 3.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.226 -0.897 . . . . 0.64 109.514 -173.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.6 ttp -119.2 119.39 33.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.986 0.422 . . . . 1.35 110.874 -171.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.8 t -107.3 144.74 33.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.857 -0.611 . . . . 0.77 110.501 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.52 112.5 23.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.515 0.674 . . . . 0.48 110.887 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 45' ' ' VAL . 4.6 tt -102.72 166.28 10.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.142 -0.936 . . . . 0.77 109.03 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 22.1 t70 -128.93 117.74 21.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.419 -0.512 . . . . 1.81 112.295 -170.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 47.6 mm -110.84 122.72 37.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.738 -0.838 . . . . 0.65 108.738 171.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 84.6 Cg_exo -46.7 -98.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.922 3.081 . . . . 1.07 114.874 -171.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -162.4 94.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 112.124 0.416 . . . . 0.46 112.124 -169.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 62' ' ' PHE . 7.4 p -127.52 103.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.138 1.162 . . . . 0.48 114.138 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.1 p -152.36 98.15 2.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 1.07 110.768 162.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 64.8 Cg_exo -51.4 135.89 47.29 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.924 1.749 . . . . 0.48 112.12 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.426 ' OH ' ' HD1' ' A' ' 150' ' ' PHE . 4.7 t80 -55.56 -30.91 61.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.404 -0.817 . . . . 1.31 111.094 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 50.6 m -56.51 -33.75 66.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.986 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 mm -78.66 -53.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 121.852 -0.53 . . . . 0.51 111.84 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 104' ' ' LEU . 14.5 mt -50.67 -27.47 7.05 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.524 0.678 . . . . 1.0 110.124 170.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' SER . 37.4 t80 -63.69 -42.02 98.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.45 -1.25 . . . . 0.96 108.605 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 69' ' ' ARG . 32.9 m-80 -74.05 -57.92 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 0.82 111.961 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -58.2 -51.99 67.45 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.244 0.831 . . . . 0.65 113.244 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.63 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.48 -26.58 68.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.479 0.657 . . . . 0.43 110.493 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -74.27 -52.5 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.484 -0.78 . . . . 1.81 111.064 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.722 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 8.8 t70 -80.51 -52.42 7.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.826 0.822 . . . . 0.8 111.183 -173.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -92.42 -18.47 7.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 O-C-N 121.912 -0.493 . . . . 0.88 110.581 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.24 -19.09 79.87 Favored Glycine 0 CA--C 1.509 -0.321 0 C-N-CA 120.262 -0.97 . . . . 0.38 110.917 167.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.722 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -54.28 -49.61 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.392 -1.707 . . . . 1.09 106.392 164.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 2.5 m-20 -66.58 -102.84 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.991 -1.004 . . . . 1.87 109.902 162.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.86 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 1.17 111.938 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.7 123.46 38.16 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.361 -0.382 . . . . 2.15 110.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.762 HD11 HD12 ' A' ' 144' ' ' LEU . 3.5 mp -112.82 157.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.899 0.38 . . . . 0.39 110.636 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 114' ' ' ILE . 3.2 m-20 -88.57 152.7 21.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.692 -0.685 . . . . 2.11 109.348 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -145.16 159.97 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.156 -0.683 . . . . 0.62 109.156 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.681 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 33.5 tt0 -154.21 136.0 14.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.779 0.323 . . . . 0.8 110.153 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -108.26 130.07 55.18 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.013 -0.736 . . . . 1.25 109.013 172.402 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.649 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.9 tp60 -118.9 99.68 6.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.151 -0.685 . . . . 0.63 109.151 176.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -112.18 123.46 67.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.349 0.595 . . . . 0.81 110.367 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.14 123.16 6.44 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.595 -0.729 . . . . 0.26 111.552 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 25' ' ' SER . 2.2 mp -96.87 118.55 33.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.781 0.324 . . . . 1.2 110.794 -173.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 95.8 m -124.71 95.71 4.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.596 -0.729 . . . . 0.32 109.524 172.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.837 HG22 ' HB3' ' A' ' 58' ' ' CYS . 14.7 pt -110.88 144.32 19.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.6 -0.44 . . . . 0.98 110.42 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.707 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.8 m-20 -85.59 105.09 15.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.858 -1.164 . . . . 1.52 107.858 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.849 HD23 HG21 ' A' ' 55' ' ' ILE . 28.1 mt -102.47 167.33 10.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 125.0 1.438 . . . . 1.28 110.195 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.17 -29.56 6.35 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 121.825 1.683 . . . . 0.74 112.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.438 HG21 HG22 ' A' ' 19' ' ' ILE . 42.4 t -74.12 -58.95 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 112.543 0.572 . . . . 1.12 112.543 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 18' ' ' ALA . 41.8 t -105.94 2.95 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.528 1.156 . . . . 1.35 109.441 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 74.32 -24.72 1.11 Allowed Glycine 0 C--N 1.318 -0.434 0 CA-C-N 114.217 -1.356 . . . . 1.05 111.945 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 13.3 pt-20 -159.1 170.81 21.19 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.668 -0.864 . . . . 1.16 108.668 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.735 ' O ' ' HA ' ' A' ' 123' ' ' THR . 7.0 t80 -163.57 132.78 3.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.652 -0.869 . . . . 1.91 108.652 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 86.4 m -123.67 95.55 4.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.317 0.58 . . . . 1.19 111.398 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.76 139.12 34.41 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.52 -0.764 . . . . 0.5 110.192 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.606 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.7 Cg_endo -89.15 161.97 5.76 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.778 1.652 . . . . 0.45 112.65 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 167.09 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.386 -0.968 . . . . 0.44 108.386 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.8 p -137.82 151.09 47.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.355 0.598 . . . . 0.88 112.075 -172.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 t -139.98 103.34 4.61 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.29 -1.374 . . . . 0.96 107.29 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.681 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -112.41 152.48 28.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.198 -0.456 . . . . 1.76 110.041 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.53 141.96 7.38 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.342 -0.933 . . . . 0.5 111.564 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -107.29 123.98 49.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.785 -0.707 . . . . 2.1 109.197 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.9 174.39 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.527 -0.916 . . . . 0.76 108.527 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -56.78 160.37 3.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.868 0.692 . . . . 3.53 112.868 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.762 HD12 HD11 ' A' ' 114' ' ' ILE . 19.4 tp -55.84 138.87 70.76 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 114.894 -1.048 . . . . 1.23 111.581 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 144' ' ' LEU . 34.5 Cg_endo -63.61 174.25 3.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.317 2.678 . . . . 0.71 111.911 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -53.63 130.5 36.44 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.375 0.607 . . . . 1.71 110.877 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -146.54 163.93 34.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.706 . . . . 2.64 110.044 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HB3' ' H ' ' A' ' 149' ' ' ASP . 12.8 tppt? -174.69 -84.57 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.008 -0.542 . . . . 3.72 109.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 148' ' ' LYS . 22.4 t70 -98.62 -23.76 15.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.437 -0.801 . . . . 4.28 109.887 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.426 ' HD1' ' OH ' ' A' ' 98' ' ' TYR . 26.6 m-85 -53.43 -66.8 0.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.062 -0.972 . . . . 2.86 110.024 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.443 ' HE2' ' CG ' ' A' ' 102' ' ' PHE . 45.7 m-85 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.568 -0.73 . . . . 3.96 109.292 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HA ' ' CE ' ' A' ' 1' ' ' MET . 2.9 mmt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.477 -0.194 . . . . 12.11 110.477 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.59 119.12 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 O-C-N 124.046 0.841 . . . . 9.02 111.258 -177.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.721 ' HB3' HG21 ' A' ' 128' ' ' VAL . 53.1 m 69.75 20.7 6.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.486 -0.779 . . . . 6.83 111.036 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 2.4 tm? -134.51 99.34 4.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.52 -0.919 . . . . 8.55 108.52 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.9 pt? -150.08 95.84 2.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.326 0.584 . . . . 10.47 111.377 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -170.59 -87.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 11.69 110.215 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? 50.58 31.38 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.156 0.582 . . . . 11.42 111.402 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.564 ' HB3' HG21 ' A' ' 12' ' ' VAL . . . -91.15 113.94 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.971 0.415 . . . . 11.58 110.517 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -77.1 96.6 4.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.852 -0.613 . . . . 15.74 110.301 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 70.22 -175.4 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.193 -0.912 . . . . 12.69 111.342 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 73.77 -46.33 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.818 0.847 . . . . 13.85 113.023 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 8' ' ' ALA . 11.0 m -74.22 84.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.578 0.704 . . . . 8.87 112.601 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -33.12 72.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.661 -0.7 . . . . 8.91 110.015 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.92 -61.42 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.717 . . . . 8.6 110.231 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' HB2' ' NZ ' ' A' ' 15' ' ' LYS . 4.6 ttmp? 62.66 93.84 0.05 OUTLIER 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.92 0.762 . . . . 9.04 111.534 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.8 tp -70.02 108.29 3.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 5.58 109.824 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -113.87 -46.76 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.541 0.571 . . . . 2.69 112.541 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.671 ' HB2' HG11 ' A' ' 129' ' ' VAL . . . -75.8 79.32 2.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.964 0.727 . . . . 1.68 112.964 -170.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.972 HG21 HD13 ' A' ' 126' ' ' LEU . 8.4 pt 55.13 -179.02 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.564 1.146 . . . . 3.19 113.722 166.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.579 ' CD ' ' HB ' ' A' ' 19' ' ' ILE . 23.9 Cg_exo -65.74 -99.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.485 2.123 . . . . 2.42 112.534 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 20' ' ' PRO . 2.1 ttmm 170.27 -53.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 6.38 112.521 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.29 82.23 2.14 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.404 2.069 . . . . 2.77 113.241 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.658 ' HB3' ' O ' ' A' ' 48' ' ' THR . 7.5 mp0 -133.09 149.49 52.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.75 -2.315 . . . . 3.39 104.75 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.51 -175.93 16.59 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 117.725 -2.179 . . . . 0.54 116.579 -162.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 95.7 p -167.91 36.47 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.268 -1.382 . . . . 1.2 107.268 174.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.4 m -133.86 155.66 40.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.365 -1.289 . . . . 0.93 110.037 -170.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.4 HG21 ' HG2' ' A' ' 44' ' ' LYS . 1.7 t -168.65 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.699 -0.482 . . . . 0.48 109.699 169.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.73 172.36 1.11 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.283 -0.417 . . . . 1.69 111.45 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.716 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -142.14 145.91 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.079 -0.711 . . . . 1.14 109.079 168.496 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.43 115.59 30.4 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.762 -0.653 . . . . 1.83 110.378 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.0 tm? -80.29 120.05 23.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 0.94 111.08 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -119.81 -127.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.527 -0.545 . . . . 1.33 109.527 171.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.931 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.1 p30 170.51 166.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.604 0.638 . . . . 2.85 111.919 -168.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 38' ' ' SER . 3.2 m -158.4 106.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.367 0.877 . . . . 3.26 113.367 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.527 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 3.1 t-20 70.42 -91.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 3.16 110.79 169.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.777 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 171.66 28.85 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.22 -1.4 . . . . 5.46 107.22 169.116 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -99.66 -44.77 6.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 106.357 -1.719 . . . . 1.92 106.357 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.689 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 48.1 t -151.97 177.52 10.37 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.669 -2.969 . . . . 0.94 105.235 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.931 HG13 ' HA ' ' A' ' 33' ' ' ASP . 13.4 t -134.63 156.37 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 118.6 0.636 . . . . 0.86 109.743 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.982 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 91.8 mt-10 -119.61 147.59 44.33 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.205 -0.598 . . . . 1.19 111.175 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.935 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.5 p90 -142.29 133.89 26.72 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.095 -1.042 . . . . 3.73 112.039 166.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -79.9 108.99 13.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.189 -0.914 . . . . 0.81 108.715 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.749 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.62 110.16 21.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.585 0.707 . . . . 0.42 109.988 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 35.4 ttmt -84.03 129.77 34.9 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.929 -1.032 . . . . 2.63 109.212 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 25' ' ' SER . 52.5 t -113.57 142.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.69 -0.686 . . . . 0.82 110.335 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 88' ' ' THR . 18.7 m -131.34 98.08 4.44 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.254 0.55 . . . . 0.72 110.077 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.7 t -83.61 128.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.258 -0.883 . . . . 1.14 110.825 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.658 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 6.5 m -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 119.07 -0.491 . . . . 0.41 109.793 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.4 p-10 -91.5 135.21 28.19 Favored Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.859 0.724 . . . . 1.48 110.275 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB3' ' CD ' ' A' ' 23' ' ' GLU . 57.5 Cg_endo -93.63 12.65 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.71 2.94 . . . . 0.73 114.426 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.719 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 29.8 t80 -98.55 -117.86 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.332 -0.618 . . . . 2.08 109.332 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -165.01 19.68 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.51 110.258 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -148.38 151.32 35.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.528 -0.915 . . . . 1.67 108.528 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.61 ' HA ' HD23 ' A' ' 82' ' ' LEU . 28.0 t -44.89 105.57 0.06 Allowed 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.382 1.051 . . . . 1.39 112.295 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.5 pt -78.17 125.34 85.25 Favored Pre-proline 0 CA--C 1.5 -0.951 0 N-CA-C 108.901 -0.777 . . . . 1.03 108.901 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 27.1 Cg_endo -62.49 -54.65 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.777 1.651 . . . . 0.37 112.999 -159.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.5 mm -130.01 159.31 42.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.431 -0.507 . . . . 1.23 111.016 -173.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.608 ' HB3' HG22 ' A' ' 124' ' ' ILE . 27.3 p -150.88 174.7 12.79 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.192 0.996 . . . . 1.15 111.697 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.3 tt0 -130.86 114.05 14.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.362 -1.744 . . . . 1.36 109.673 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.72 111.38 28.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.973 -1.012 . . . . 1.05 110.989 173.77 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 1.6 m -113.7 104.24 12.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.811 -1.541 . . . . 0.83 109.153 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 6.3 p90 -111.98 127.7 55.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.949 -0.389 . . . . 0.4 109.949 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 7.1 m -126.4 104.6 8.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.29 -0.633 . . . . 0.38 109.29 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 94.7 m-85 -98.28 139.23 34.36 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.1 -0.5 . . . . 0.96 111.258 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -128.04 145.43 50.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.667 -1.234 . . . . 1.29 107.667 175.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.685 ' CB ' HD22 ' A' ' 104' ' ' LEU . 41.5 t -107.27 -98.03 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.14 -1.024 . . . . 1.27 111.022 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.56 -60.25 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.674 -0.861 . . . . 0.36 108.674 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.58 15.66 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.227 -1.949 . . . . 0.39 108.227 163.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.94 HH11 ' HB3' ' A' ' 103' ' ' ASN . 10.2 ptp180 -106.09 -175.34 2.77 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.43 -0.952 . . . . 1.97 108.43 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -103.09 97.64 7.7 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.605 0.716 . . . . 2.61 109.589 -166.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.848 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.2 mm -59.04 -43.05 88.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.006 -1.452 . . . . 0.4 110.728 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.78 160.2 22.39 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.402 -0.904 . . . . 0.49 111.179 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -161.77 156.9 23.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.919 0.859 . . . . 1.81 111.446 176.105 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.76 164.88 28.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.758 -0.937 . . . . 0.43 110.758 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -142.13 133.68 26.72 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.097 0.475 . . . . 1.72 111.089 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 63.3 mt -136.1 133.85 19.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.632 -0.713 . . . . 0.73 110.016 -174.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 7.5 Cg_exo -74.26 119.04 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.364 2.042 . . . . 0.57 110.508 170.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.59 139.94 36.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.845 -0.428 . . . . 0.79 109.845 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.0 Cg_endo -61.64 90.82 0.11 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.452 2.101 . . . . 0.58 112.08 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -89.02 30.28 5.56 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.4 112.029 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.1 p -70.49 118.36 13.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.513 -0.921 . . . . 0.62 108.513 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.61 HD23 ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -139.98 -152.11 0.4 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.048 0.759 . . . . 1.1 113.048 -160.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 93.8 mttt -62.35 -96.99 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.937 -0.574 . . . . 1.84 112.304 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.35 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.971 -1.122 . . . . 0.99 107.971 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.719 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 39.5 pttt 42.41 50.41 4.69 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.879 0.847 . . . . 1.84 111.134 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.2 t70 -153.35 -173.38 4.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.894 -1.048 . . . . 0.64 110.726 -169.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.9 ttm -115.77 125.33 52.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 1.35 110.351 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 46' ' ' SER . 3.3 t -116.16 145.05 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.928 -0.578 . . . . 0.77 110.718 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.39 117.07 27.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.514 0.673 . . . . 0.48 110.742 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.666 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.2 tp -115.88 174.86 5.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.775 -1.102 . . . . 0.77 108.106 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.666 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 35.5 m-20 -137.63 130.66 30.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.502 0.592 . . . . 1.81 111.232 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.749 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 30.1 mm -108.6 123.84 36.11 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.666 -0.864 . . . . 0.65 108.666 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 94' ' ' VAL . 24.3 Cg_exo -28.85 -113.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 1 C-N-CA 125.72 4.28 . . . . 1.07 116.22 -171.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.982 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -163.08 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 119.586 -0.245 . . . . 0.46 111.191 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -127.79 101.74 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 115.635 1.717 . . . . 0.48 115.635 -164.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -152.77 107.28 2.7 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 121.326 -0.858 . . . . 1.07 111.607 163.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 53.4 Cg_exo -51.32 129.08 27.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.499 1.466 . . . . 0.48 111.192 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.689 ' H ' ' HA ' ' A' ' 38' ' ' SER . 16.3 t80 -50.17 -35.99 28.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.182 -0.917 . . . . 1.31 111.898 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.8 t -59.9 -27.49 66.77 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.054 0.39 . . . . 1.2 112.054 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.848 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -77.62 -54.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 121.892 -0.505 . . . . 0.51 111.17 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.077 HD23 HD21 ' A' ' 104' ' ' LEU . 53.3 mt -51.89 -30.18 23.0 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.882 0.848 . . . . 1.0 110.129 169.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.523 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 30.4 t80 -69.04 -38.56 79.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.625 -1.625 . . . . 0.96 108.787 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.94 ' HB3' HH11 ' A' ' 69' ' ' ARG . 15.7 m-80 -74.17 -55.95 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.543 -0.753 . . . . 0.82 111.975 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.077 HD21 HD23 ' A' ' 101' ' ' LEU . 2.9 pp -55.04 -50.67 68.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.737 0.643 . . . . 0.65 112.737 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.611 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.21 -24.39 67.2 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.884 0.85 . . . . 0.43 110.551 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.523 ' NH2' ' HD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -70.99 -54.76 10.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.106 -0.952 . . . . 1.81 110.631 175.759 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 16.3 t70 -83.01 -53.88 5.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.814 0.816 . . . . 0.8 111.649 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.0 t -84.12 -26.94 7.2 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 121.505 -0.747 . . . . 0.88 109.959 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -70.5 -17.52 74.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 119.536 -1.316 . . . . 0.38 111.381 170.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -53.74 -47.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.18 -1.415 . . . . 1.09 107.18 166.001 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -107.89 68.53 0.71 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.648 0.737 . . . . 1.87 112.79 164.826 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 23.15 -57.86 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 118.802 2.89 . . . . 1.17 118.802 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' ASP . 13.2 t70 -91.79 122.85 34.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.59 0.632 . . . . 2.15 111.84 -167.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.672 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.8 mp -112.49 158.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.39 110.78 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -104.74 153.87 20.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 2.11 109.934 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 35.3 m-85 -137.51 167.14 22.23 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.957 -0.757 . . . . 0.62 108.957 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.6 tt0 -153.4 139.03 17.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.73 0.3 . . . . 0.8 110.629 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 tp -109.92 129.31 55.67 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.933 -0.576 . . . . 1.25 110.3 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.615 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 7.3 tp60 -112.84 101.32 9.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.048 -0.723 . . . . 0.63 109.048 173.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 60' ' ' ILE . 5.5 tp -112.58 121.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.158 0.504 . . . . 0.81 111.64 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.68 125.41 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.781 -0.528 . . . . 0.26 111.781 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.601 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.0 mp -103.88 106.51 17.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 1.2 111.546 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.8 m -110.16 95.02 5.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.781 -0.645 . . . . 0.32 109.441 174.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 55' ' ' ILE . 10.6 pt -109.53 141.46 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 120.5 -0.48 . . . . 0.98 110.87 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.5 m-20 -84.51 107.47 16.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.714 -0.847 . . . . 1.52 108.714 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.972 HD13 HG21 ' A' ' 19' ' ' ILE . 4.5 mt -115.56 139.65 24.97 Favored Pre-proline 0 C--O 1.216 -0.67 0 O-C-N 124.566 1.166 . . . . 1.28 110.455 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 32.2 Cg_exo -60.74 -16.67 45.23 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.366 2.044 . . . . 0.74 114.105 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 3' ' ' SER . 42.4 t -76.66 -56.45 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.326 0.584 . . . . 1.12 111.524 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -116.91 5.92 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.038 0.923 . . . . 1.35 110.799 -175.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.55 -34.44 2.71 Favored Glycine 0 C--N 1.31 -0.884 0 CA-C-N 113.797 -1.547 . . . . 1.05 111.781 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.3 pt-20 -171.21 162.13 6.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.641 -0.874 . . . . 1.16 108.641 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' THR . 9.3 t80 -159.11 143.13 15.22 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.464 -0.569 . . . . 1.91 109.464 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 75.6 m -112.8 110.67 20.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.148 -0.478 . . . . 1.19 111.359 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -126.16 136.1 28.06 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.59 . . . . 0.5 109.888 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -93.72 162.96 2.28 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.138 1.892 . . . . 0.45 113.21 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.92 168.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.811 -1.181 . . . . 0.44 107.811 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 90.3 p -142.29 149.19 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.513 -0.475 . . . . 0.88 111.484 -169.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.3 t -140.64 103.76 4.59 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.243 -1.021 . . . . 0.96 108.243 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.2 ptmt -123.52 152.49 41.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.676 -0.693 . . . . 1.76 110.454 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.2 155.29 24.18 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.896 -0.668 . . . . 0.5 111.485 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 2.2 mp0 -111.04 132.52 54.16 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.404 -0.398 . . . . 2.1 110.434 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.24 171.98 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.346 -0.613 . . . . 0.76 109.346 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' H ' ' A' ' 144' ' ' LEU . 35.7 ttmt -64.57 174.58 1.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.495 . . . . 3.53 111.653 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.646 HD12 HD11 ' A' ' 114' ' ' ILE . 16.6 tp -55.96 139.28 71.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.612 -0.722 . . . . 1.23 110.901 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo -60.41 170.44 4.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.785 2.324 . . . . 0.71 112.845 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.574 ' HB ' ' HG2' ' A' ' 148' ' ' LYS . 1.4 p -69.51 109.92 4.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.573 -0.739 . . . . 1.71 111.81 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -70.39 61.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 2.64 110.297 172.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.65 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 28.5 mmtp -93.16 -61.27 1.61 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.597 1.189 . . . . 3.72 108.681 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.777 ' HB3' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -79.98 -11.78 59.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.863 -1.971 . . . . 4.28 106.919 166.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 147' ' ' PHE . 63.1 m-85 74.57 107.4 0.07 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 112.718 -2.037 . . . . 2.86 112.632 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.536 ' HD1' ' HB1' ' A' ' 105' ' ' ALA . 93.8 m-85 . . . . . 0 C--O 1.248 1.011 0 CA-C-N 112.967 -1.924 . . . . 3.96 110.846 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.807 0.337 . . . . 12.11 110.404 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.82 8.45 8.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.124 0.488 . . . . 9.02 110.626 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -77.62 -20.3 54.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.642 -0.708 . . . . 6.83 111.186 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 5' ' ' LEU . 35.5 tp -152.11 166.14 32.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.361 . . . . 8.55 110.024 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 87.5 mt -106.86 -163.87 0.95 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.36 -0.382 . . . . 10.47 110.775 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.16 -16.95 48.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.271 0.558 . . . . 11.69 110.211 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -108.66 -155.66 0.56 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.587 -0.733 . . . . 11.42 110.43 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.04 -156.31 0.23 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.609 0.568 . . . . 11.58 110.179 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.0 149.95 25.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.977 0.418 . . . . 15.74 111.245 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.66 -32.85 68.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 12.69 110.912 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -90.54 128.08 36.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 13.85 110.738 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 16' ' ' LEU . 26.8 m -113.46 157.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.057 -0.52 . . . . 8.87 109.769 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.93 49.98 0.69 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.32 0.489 . . . . 8.91 112.32 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 49.42 14.32 0.1 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.131 1.372 . . . . 8.6 114.36 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -129.14 -27.56 2.46 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.023 -0.423 . . . . 9.04 111.3 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 7.1 mp -75.68 94.07 3.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 5.58 110.207 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -149.92 -20.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.803 -0.635 . . . . 2.69 110.999 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.723 ' HA ' HG11 ' A' ' 129' ' ' VAL . . . -65.92 -99.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.302 0.482 . . . . 1.68 112.302 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.022 HG23 ' HD3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -164.87 -63.09 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.021 0.749 . . . . 3.19 113.021 -174.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 1.022 ' HD3' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -104.39 -156.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.364 2.043 . . . . 2.42 114.782 -172.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.611 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 20.8 tptm -175.92 -55.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.334 -1.303 . . . . 6.38 110.412 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 87.8 Cg_endo -82.05 61.87 7.93 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.117 1.878 . . . . 2.77 112.933 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.759 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 7.4 mp0 -128.48 142.69 51.01 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 105.042 -2.207 . . . . 3.39 105.042 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.14 -171.09 15.18 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 117.727 -2.178 . . . . 0.54 116.374 -161.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 45' ' ' VAL . 51.9 p -163.54 37.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.691 1.597 . . . . 1.2 106.814 173.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 46' ' ' SER . 1.5 p -131.05 147.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 113.955 -1.475 . . . . 0.93 110.679 -167.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.22 -36.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.712 -0.677 . . . . 0.48 110.631 166.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -175.89 160.94 2.42 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 109.85 -0.426 . . . . 1.69 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -137.12 145.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.685 -0.857 . . . . 1.14 108.685 162.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.1 146.3 46.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.941 0.4 . . . . 1.83 111.646 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.7 tm? -99.98 135.7 41.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.92 -0.582 . . . . 0.94 111.091 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -143.62 -95.95 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.341 0.867 . . . . 1.33 113.341 176.119 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.77 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 1.6 t70 -91.11 -178.46 5.18 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.723 -0.611 . . . . 2.85 111.613 -154.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.2 p -166.47 -36.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 O-C-N 123.499 0.499 . . . . 3.26 111.08 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 10.1 t30 67.2 -79.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.414 -0.812 . . . . 3.16 109.352 -174.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.81 14.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 5.46 110.009 170.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -140.71 -41.1 0.41 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.928 -0.578 . . . . 1.92 110.264 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.833 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.6 t -141.48 119.65 12.12 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.561 0.696 . . . . 0.94 112.822 -174.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 63.8 t -76.17 151.39 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.017 -0.992 . . . . 0.86 109.647 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.84 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 85.1 mt-10 -109.8 133.34 53.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.223 -0.991 . . . . 1.19 111.853 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.843 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.12 106.15 9.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.767 -1.106 . . . . 3.73 110.555 -176.808 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 94' ' ' VAL . 1.7 tm? -84.78 110.17 18.61 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.821 -0.807 . . . . 0.81 108.821 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -89.97 110.02 21.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.844 0.83 . . . . 0.42 110.247 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 30.6 ttmt -84.43 125.38 32.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.579 -1.192 . . . . 2.63 108.538 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 90' ' ' LEU . 63.5 t -111.78 139.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.219 0.533 . . . . 0.82 112.086 -170.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' THR . 15.7 m -131.82 97.59 4.23 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.72 109.276 162.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 2.3 p -84.62 128.1 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.096 -0.956 . . . . 1.14 110.744 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.669 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 9.8 m -102.25 121.31 42.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.776 -0.647 . . . . 0.41 109.946 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 14.0 t30 -87.57 126.67 61.16 Favored Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 124.722 1.264 . . . . 1.48 109.734 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.759 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 83.4 Cg_endo -83.29 -10.0 10.2 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.951 3.101 . . . . 0.73 115.971 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.0 t80 -96.23 -105.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.595 -0.842 . . . . 2.08 111.264 -171.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 85' ' ' LYS . 47.6 t -175.62 26.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.372 0.606 . . . . 1.51 109.862 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -150.74 139.28 20.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.138 -0.69 . . . . 1.67 109.138 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.862 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 43.5 t -52.19 101.47 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.953 0 O-C-N 124.025 0.828 . . . . 1.39 111.93 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.7 pt -75.24 172.0 10.32 Favored Pre-proline 0 C--O 1.207 -1.173 0 N-CA-C 107.7 -1.222 . . . . 1.03 107.7 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HB2' ' CD1' ' A' ' 57' ' ' ILE . 12.0 Cg_endo -90.08 -58.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.508 0 CA-C-N 120.166 1.095 . . . . 0.37 114.687 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 1.5 mp -130.37 161.87 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 119.727 -0.789 . . . . 1.23 112.768 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 30.1 p -147.64 168.82 21.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.08 0.943 . . . . 1.15 111.77 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.103 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 16.6 tp10 -122.29 118.71 29.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.412 -1.722 . . . . 1.36 110.06 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 13.2 mm -94.58 110.16 23.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 114.618 -1.174 . . . . 1.05 110.567 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 11.0 p -120.61 102.67 8.57 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.615 -0.434 . . . . 0.83 109.864 173.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.556 ' HD1' HG22 ' A' ' 60' ' ' ILE . 11.8 p90 -110.3 126.39 54.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.159 0.504 . . . . 0.4 109.857 -171.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 18.4 m -123.34 112.1 17.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.034 -0.728 . . . . 0.38 109.034 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 93.2 m-85 -97.66 140.99 31.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.979 0.419 . . . . 0.96 110.606 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.518 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -132.93 145.63 51.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.466 -1.309 . . . . 1.29 107.466 176.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -111.52 -97.66 0.42 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.183 -1.007 . . . . 1.27 111.41 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.43 -60.57 3.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.529 -0.545 . . . . 0.36 109.529 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.77 19.63 0.12 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.578 -1.809 . . . . 0.39 108.578 167.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 69' ' ' ARG . 8.5 ptp180 -115.75 -177.85 3.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.332 -0.988 . . . . 1.97 108.332 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.9 98.0 7.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.072 0.939 . . . . 2.61 110.245 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.811 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.37 -43.51 62.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.352 -1.749 . . . . 0.4 111.86 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.23 169.11 42.25 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.077 -1.058 . . . . 0.49 111.355 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.27 155.32 11.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.218 0.509 . . . . 1.81 110.541 174.156 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.22 -175.62 46.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.213 -1.155 . . . . 0.43 110.213 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 11.1 ptpt -152.09 136.64 16.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.321 0.56 . . . . 1.72 112.134 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 68.6 mt -130.78 108.97 15.64 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.289 -0.868 . . . . 0.73 110.312 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 114.34 3.89 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.312 2.008 . . . . 0.57 109.975 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -132.01 146.09 60.21 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.035 -0.357 . . . . 0.79 110.035 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 81' ' ' SER . 9.4 Cg_endo -54.6 90.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.513 2.142 . . . . 0.58 112.17 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -77.09 29.01 1.63 Allowed Glycine 0 C--O 1.225 -0.455 0 CA-C-N 115.278 -0.874 . . . . 0.4 112.493 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.969 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 59.9 p -74.03 119.92 18.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.719 -0.474 . . . . 0.62 109.719 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.862 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -157.95 173.89 16.08 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.833 -1.147 . . . . 1.1 113.646 -164.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 88.6 mttt -33.84 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.578 1.325 . . . . 1.84 114.578 -167.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 168.34 108.87 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.359 -0.978 . . . . 0.99 108.359 -174.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.822 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 47.6 pttt 42.05 48.49 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.168 0.918 . . . . 1.84 110.886 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 4.4 t70 -148.9 -174.37 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.64 -1.164 . . . . 0.64 109.782 -168.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.57 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.1 ttm -117.22 121.67 41.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.33 0.586 . . . . 1.35 110.596 -173.197 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.644 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -115.53 144.55 43.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.158 -0.928 . . . . 0.77 110.743 -175.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -85.92 141.37 29.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.088 0.47 . . . . 0.48 110.043 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.783 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.1 tp -139.32 173.54 11.44 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.25 -1.019 . . . . 0.77 108.25 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.783 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 15.9 m-20 -132.6 124.36 28.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.166 0.508 . . . . 1.81 111.842 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -112.84 138.15 22.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.442 -0.799 . . . . 0.65 109.01 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 92' ' ' ILE . 76.6 Cg_exo -51.96 -159.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.83 3.02 . . . . 1.07 114.58 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 1.4 m -124.08 93.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.371 -0.831 . . . . 0.46 110.873 -167.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 95' ' ' VAL . 5.7 p -128.3 103.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 113.917 1.08 . . . . 0.48 113.917 -168.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 p -152.41 99.64 2.83 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.07 110.924 161.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.4 Cg_exo -52.86 131.05 40.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.94 1.76 . . . . 0.48 111.022 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.434 ' H ' ' HA ' ' A' ' 38' ' ' SER . 10.9 t80 -57.96 -30.59 66.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 1.31 111.559 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.5 m -59.38 -30.57 68.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.783 0.29 . . . . 1.2 111.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.811 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 mm -76.63 -55.15 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.008 -0.677 . . . . 0.51 110.348 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 39' ' ' VAL . 25.3 mt -50.55 -27.38 6.61 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.665 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.431 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 23.7 t80 -64.67 -43.16 94.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.672 -1.149 . . . . 0.96 108.799 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 33.1 m-80 -74.42 -57.73 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.82 112.458 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.991 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -58.24 -49.57 76.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.385 0.883 . . . . 0.65 113.385 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.9 -23.65 67.29 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 121.912 0.863 . . . . 0.43 109.806 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.5 ttp180 -68.03 -47.99 66.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.586 -1.188 . . . . 1.81 110.408 173.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 15.7 t70 -82.59 -55.89 4.19 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.923 0.868 . . . . 0.8 111.871 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.2 t -83.65 -29.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 O-C-N 121.66 -0.65 . . . . 0.88 109.625 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.25 -16.54 80.45 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.522 -0.847 . . . . 0.38 111.693 172.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -49.07 -44.21 16.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.473 -1.677 . . . . 1.09 106.473 165.107 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.64 -81.89 0.08 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.539 -0.755 . . . . 1.87 109.954 163.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 178.44 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.623 0.601 . . . . 1.17 112.623 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.82 128.63 40.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.319 0.58 . . . . 2.15 111.434 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -113.5 161.57 12.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.695 -0.684 . . . . 0.39 109.901 -172.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 3.4 p-10 -101.85 152.74 20.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.768 -0.827 . . . . 2.11 108.768 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 34.5 m-85 -139.52 166.09 25.49 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.637 -0.875 . . . . 0.62 108.637 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.2 tt0 -153.8 135.35 14.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.8 110.142 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -107.37 129.6 54.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.528 -0.76 . . . . 1.25 109.181 173.527 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.698 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.0 tp60 -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.817 -0.809 . . . . 0.63 108.817 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.1 tp -112.92 120.89 64.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.228 0.537 . . . . 0.81 111.399 -173.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.81 119.89 5.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.362 -0.695 . . . . 0.26 111.362 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.617 HD11 ' OG ' ' A' ' 25' ' ' SER . 1.3 mp -98.65 96.11 7.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.007 0.432 . . . . 1.2 110.851 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.103 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 63.2 m -95.98 96.41 8.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.811 -0.631 . . . . 0.32 109.387 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 58' ' ' CYS . 5.7 pt -111.28 138.34 40.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 120.171 -0.612 . . . . 0.98 111.327 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.51 106.14 14.13 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.306 -0.998 . . . . 1.52 108.306 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 55' ' ' ILE . 35.1 mt -116.52 150.3 45.28 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 124.859 1.35 . . . . 1.28 110.344 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.43 -13.98 41.01 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.14 1.894 . . . . 0.74 113.292 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.36 -57.37 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.31 0.576 . . . . 1.12 111.257 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -118.42 6.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.854 0.835 . . . . 1.35 110.74 -177.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.31 -31.93 2.6 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 114.005 -1.452 . . . . 1.05 111.966 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.4 pt-20 -178.55 154.03 0.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.705 -0.85 . . . . 1.16 108.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.725 ' HD2' HG23 ' A' ' 134' ' ' ILE . 11.3 t80 -157.83 144.99 18.17 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.563 -0.455 . . . . 1.91 110.292 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.9 m -101.6 99.56 9.87 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.594 0.559 . . . . 1.19 110.855 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 132' ' ' PHE . 2.3 pp -109.1 124.51 33.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.203 -0.666 . . . . 0.5 109.203 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 95.9 Cg_endo -89.12 162.61 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.559 1.506 . . . . 0.45 112.536 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.7 161.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.056 -1.09 . . . . 0.44 108.056 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -126.84 144.49 50.95 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.168 -0.308 . . . . 0.88 110.168 -171.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 m -136.99 100.82 4.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.338 -0.986 . . . . 0.96 108.338 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 8.9 ptmt -123.72 143.01 50.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.129 -0.487 . . . . 1.76 111.242 -170.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.59 153.63 24.31 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.667 -0.777 . . . . 0.5 111.961 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.559 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 26.1 mt-10 -106.85 132.62 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.774 -0.454 . . . . 2.1 109.774 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.41 174.15 2.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.153 -1.054 . . . . 0.76 108.153 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.23 170.92 1.5 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.302 0.853 . . . . 3.53 113.302 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -68.51 149.8 97.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.91 -1.041 . . . . 1.23 110.739 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo -62.43 169.19 8.5 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.502 2.135 . . . . 0.71 112.091 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.9 m -68.28 104.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 1.71 110.737 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CD1' HD23 ' A' ' 144' ' ' LEU . 22.0 p90 -111.29 156.79 20.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 2.64 111.23 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.583 ' HE2' ' HA ' ' A' ' 148' ' ' LYS . 0.2 OUTLIER -178.8 73.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 3.72 109.993 179.286 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 67.51 9.24 6.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.021 0.439 . . . . 4.28 111.054 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 148' ' ' LYS . 25.1 m-85 -82.59 -41.0 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.163 -0.68 . . . . 2.86 109.163 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' HE2' ' HB3' ' A' ' 147' ' ' PHE . 4.1 p90 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.21 -0.9 . . . . 3.96 109.059 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.524 -0.176 . . . . 12.11 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.22 -145.53 0.61 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.316 -0.402 . . . . 9.02 110.431 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 1.064 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 23.3 m 69.73 -77.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.544 0.527 . . . . 6.83 111.368 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' ' 8' ' ' ALA . 87.7 mt -70.73 117.85 12.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 8.55 110.945 -175.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.97 108.01 10.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.343 -0.614 . . . . 10.47 109.343 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 9.1 t70 71.6 159.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.13 0.894 . . . . 11.69 110.168 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 26.9 mtpp 69.0 5.27 4.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.926 0.49 . . . . 11.42 111.974 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' HB2' ' HB2' ' A' ' 4' ' ' LEU . . . -101.34 94.14 5.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.896 0.379 . . . . 11.58 111.769 -174.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 14.3 mptt -70.52 -55.99 7.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.87 -0.789 . . . . 15.74 108.87 169.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.74 35.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.963 -1.017 . . . . 12.69 108.779 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 9' ' ' LYS . 91.7 m-85 -94.23 137.93 32.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.477 -0.783 . . . . 13.85 110.732 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 31.5 m -89.49 -1.43 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.037 -0.529 . . . . 8.87 110.99 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 15' ' ' LYS . . . 63.66 10.84 5.32 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.6 -0.727 . . . . 8.91 112.144 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 m-20 61.04 22.11 12.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.104 -0.498 . . . . 8.6 111.165 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 47.1 mmtm -117.16 174.65 5.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.057 -0.719 . . . . 9.04 109.057 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.08 102.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.54 -1.281 . . . . 5.58 107.54 170.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' ' 12' ' ' VAL . 1.8 m -77.96 62.46 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.949 0.722 . . . . 2.69 112.949 -166.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.701 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 163.03 -87.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.413 1.071 . . . . 1.68 110.87 168.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 14.2 pt -142.58 139.98 18.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 3.19 110.558 -173.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 4.6 Cg_exo -76.45 -72.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.177 2.585 . . . . 2.42 113.066 -175.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 34.0 mmtp -106.68 161.43 22.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.091 -0.504 . . . . 6.38 109.746 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 18.3 Cg_endo -60.48 157.8 34.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.576 2.184 . . . . 2.77 112.17 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.714 ' HB3' ' O ' ' A' ' 48' ' ' THR . 1.8 mp0 -123.75 152.53 42.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 104.502 -2.407 . . . . 3.39 104.502 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -115.67 179.91 18.15 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 117.55 -2.262 . . . . 0.54 114.624 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 122' ' ' LEU . 89.6 p -169.5 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.195 -1.039 . . . . 1.2 108.195 172.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.91 155.25 41.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.742 -1.117 . . . . 0.93 109.058 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 44' ' ' LYS . 1.6 t -168.94 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.208 0.447 . . . . 0.48 112.208 164.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 22.8 t70 -158.51 156.68 30.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.633 0.651 . . . . 1.69 110.837 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.21 127.07 46.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.573 -0.529 . . . . 1.14 109.573 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -112.49 130.8 55.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 1.83 111.562 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.03 122.75 32.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.94 111.408 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -128.36 -126.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.228 -0.656 . . . . 1.33 109.228 167.231 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 1.029 ' HA ' HG13 ' A' ' 39' ' ' VAL . 7.4 p-10 176.24 170.86 0.42 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 113.267 0.84 . . . . 2.85 113.267 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.94 118.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.181 -1.372 . . . . 3.26 109.995 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' HD3' ' A' ' 36' ' ' ARG . 22.9 t30 54.78 -102.68 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.67 -1.15 . . . . 3.16 109.708 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.531 ' HD3' ' OD1' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -177.47 34.99 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.988 1.375 . . . . 5.46 107.93 168.028 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.98 -41.47 3.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.559 -2.11 . . . . 1.92 108.399 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 t -152.76 107.66 3.21 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.733 -1.121 . . . . 0.94 110.57 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 33' ' ' ASP . 46.5 t -76.75 164.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.911 -0.774 . . . . 0.86 108.911 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.892 ' HG2' ' HB ' ' A' ' 94' ' ' VAL . 4.0 mt-10 -124.76 141.18 52.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.559 -0.856 . . . . 1.19 112.124 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.869 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -122.55 105.4 10.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.106 -0.952 . . . . 3.73 111.012 -177.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -77.74 110.23 12.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.377 -0.971 . . . . 0.81 108.377 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -101.06 98.65 9.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.426 0.632 . . . . 0.42 110.221 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -82.7 106.07 14.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.533 -1.284 . . . . 2.63 107.533 176.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 90' ' ' LEU . 2.0 m -110.83 164.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.702 -1.135 . . . . 0.82 110.632 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.9 m -142.85 105.13 4.44 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.209 0.528 . . . . 0.72 111.665 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.5 t -83.02 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.855 . . . . 1.14 110.851 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.714 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 5.6 m -101.23 122.31 43.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.456 -0.338 . . . . 0.41 110.77 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.934 ' HB2' HD21 ' A' ' 82' ' ' LEU . 7.6 t-20 -88.2 134.73 34.2 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.382 1.051 . . . . 1.48 108.849 173.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.594 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 15.2 Cg_endo -108.23 9.88 0.13 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.191 2.594 . . . . 0.73 115.812 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 52' ' ' SER . 38.5 t80 -118.15 -15.43 9.84 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.089 0.859 . . . . 2.08 113.254 -169.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CE ' ' A' ' 85' ' ' LYS . 17.8 t 87.82 17.59 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.532 0.733 . . . . 1.51 110.412 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -143.43 125.43 15.29 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.163 -0.68 . . . . 1.67 109.163 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -38.85 101.79 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 O-C-N 124.298 0.999 . . . . 1.39 112.969 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.654 HD12 ' HB ' ' A' ' 124' ' ' ILE . 7.3 pt -77.76 118.73 73.98 Favored Pre-proline 0 C--O 1.208 -1.085 0 N-CA-C 109.173 -0.676 . . . . 1.03 109.173 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.939 ' HB2' HD12 ' A' ' 57' ' ' ILE . 29.3 Cg_endo -60.42 -54.01 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.273 1.982 . . . . 0.37 113.651 -157.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.939 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.6 mp -133.83 159.07 42.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.045 -0.662 . . . . 1.23 110.65 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.678 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -145.69 172.41 13.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.158 0.98 . . . . 1.15 111.789 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.048 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.0 tt0 -127.26 114.63 17.88 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.109 -1.86 . . . . 1.36 108.949 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.91 109.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 122.512 1.148 . . . . 1.05 109.78 169.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 13.5 p -112.4 101.64 9.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.216 -1.811 . . . . 0.83 108.184 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 12.0 p90 -114.71 136.56 52.93 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.137 0.494 . . . . 0.4 110.285 -166.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 73' ' ' LYS . 16.9 m -132.45 108.57 9.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.788 -1.097 . . . . 0.38 109.546 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CZ ' HD23 ' A' ' 118' ' ' LEU . 96.4 m-85 -97.22 140.97 30.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.808 -0.633 . . . . 0.96 109.438 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -128.59 145.62 51.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.467 -1.308 . . . . 1.29 107.467 175.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.792 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.8 t -100.99 -102.86 0.25 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.449 -0.9 . . . . 1.27 110.199 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' HH11 ' A' ' 69' ' ' ARG . . . -62.6 -57.05 12.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.889 -0.782 . . . . 0.36 108.889 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.54 15.2 0.16 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 108.599 -1.8 . . . . 0.39 108.599 165.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -109.72 171.86 7.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.368 -0.975 . . . . 1.97 108.368 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.85 95.3 8.17 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.112 0.482 . . . . 2.61 109.913 -164.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.826 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.7 mm -48.08 -41.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.639 -1.164 . . . . 0.4 111.403 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.26 163.38 29.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.211 -0.995 . . . . 0.49 111.608 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.638 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.6 OUTLIER -165.92 155.91 12.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.533 0.667 . . . . 1.81 110.998 174.928 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.66 35.54 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.482 -0.781 . . . . 0.43 111.528 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -123.44 131.71 53.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.09 -0.337 . . . . 1.72 110.09 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.546 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 86.7 mt -137.89 126.18 14.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.441 -0.345 . . . . 0.73 110.123 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.09 115.72 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.468 2.112 . . . . 0.57 111.633 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -125.04 141.29 38.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.084 -0.339 . . . . 0.79 110.084 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.75 87.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.792 2.328 . . . . 0.58 111.963 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -78.73 19.55 4.98 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.4 113.384 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . 91.1 p -70.38 119.71 14.97 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.49 -0.559 . . . . 0.62 109.49 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 49' ' ' ASN . 2.6 pt? -142.41 -165.95 2.15 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.854 0.687 . . . . 1.1 112.854 -165.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 89.9 mttt -43.2 -91.33 0.0 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.777 -1.101 . . . . 1.84 112.949 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 165.02 105.17 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.31 -0.996 . . . . 0.99 108.31 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.1 ptpt 43.84 50.84 6.9 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.363 1.04 . . . . 1.84 111.166 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 87' ' ' MET . 10.8 t70 -151.56 -169.87 3.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.217 -0.901 . . . . 0.64 108.816 -173.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.411 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 48.4 ttm -116.99 121.4 41.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.835 0.35 . . . . 1.35 110.494 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' SER . 12.0 t -104.94 143.36 33.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.754 -0.657 . . . . 0.77 109.739 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.01 106.8 14.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.379 0.609 . . . . 0.48 110.097 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 7.7 tp -100.48 178.23 4.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.085 -0.961 . . . . 0.77 109.246 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.944 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.2 t70 -146.58 127.8 14.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.578 -0.283 . . . . 1.81 111.303 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 1.5 mp -102.61 116.3 62.98 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.645 -1.243 . . . . 0.65 107.645 163.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 33.5 Cg_exo -32.32 -100.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 125.181 3.921 . . . . 1.07 115.477 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.892 ' HB ' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -163.43 93.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 O-C-N 122.275 -0.266 . . . . 0.46 111.336 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -129.03 104.26 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.676 1.361 . . . . 0.48 114.676 -170.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.509 ' CG2' ' HG ' ' A' ' 101' ' ' LEU . 3.0 p -153.79 99.83 2.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 121.867 -0.52 . . . . 1.07 111.949 161.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.5 Cg_exo -53.66 131.71 45.34 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.828 1.685 . . . . 0.48 111.183 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -53.9 -33.23 55.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 1.31 112.356 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -56.17 -32.0 63.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.757 0.313 . . . . 1.2 111.667 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.826 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 mm -76.28 -55.72 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.602 -0.439 . . . . 0.51 110.643 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 104' ' ' LEU . 40.3 mt -51.99 -28.11 15.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.703 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.12 -44.66 95.0 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.028 -0.987 . . . . 0.96 108.99 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.21 -57.15 4.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.799 -0.637 . . . . 0.82 111.889 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.792 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.6 pp -62.07 -53.06 60.82 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.431 0.9 . . . . 0.65 113.431 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.1 -25.97 68.61 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.842 0.83 . . . . 0.43 110.197 -177.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 110' ' ' VAL . 6.7 ttp180 -74.57 -54.7 6.98 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.531 -1.213 . . . . 1.81 110.391 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.88 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.4 t70 -74.06 -52.79 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.883 0.849 . . . . 0.8 111.057 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.608 HG21 HG23 ' A' ' 114' ' ' ILE . 2.3 t -86.93 -17.21 8.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.355 -0.84 . . . . 0.88 109.697 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.738 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -67.91 -25.56 74.22 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.736 -0.745 . . . . 0.38 113.712 168.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 107' ' ' ASP . 11.5 m -63.22 -40.83 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.118 -1.438 . . . . 1.09 107.118 170.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.6 m-20 -59.56 -58.53 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.63 -0.713 . . . . 1.87 110.927 165.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.5 ' CG ' ' N ' ' A' ' 113' ' ' ASP . 3.8 p-90 128.36 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.282 2.233 . . . . 1.17 111.641 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 14.9 t70 -94.44 129.44 41.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.475 -0.329 . . . . 2.15 110.404 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.738 HD11 HD12 ' A' ' 144' ' ' LEU . 2.5 mp -115.32 151.13 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.026 0.441 . . . . 0.39 109.854 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 141' ' ' GLU . 6.1 p-10 -93.73 152.59 18.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.983 -0.747 . . . . 2.11 108.983 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 31.9 m-85 -141.9 165.66 26.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.669 -0.863 . . . . 0.62 108.669 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 22.9 tt0 -152.18 139.92 19.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.751 0.31 . . . . 0.8 110.345 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -113.91 129.94 56.55 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.205 -0.665 . . . . 1.25 109.205 173.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.648 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.9 tp60 -120.59 100.72 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.118 -0.697 . . . . 0.63 109.118 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.07 123.18 71.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.51 0.671 . . . . 0.81 110.773 -174.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.33 124.48 7.07 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.458 -0.792 . . . . 0.26 111.768 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.564 HD12 HD12 ' A' ' 120' ' ' ILE . 6.1 mp -97.4 105.91 18.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.966 0.412 . . . . 1.2 111.055 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.048 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 89.2 m -108.11 95.14 5.47 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.439 -0.801 . . . . 0.32 109.007 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 58' ' ' CYS . 7.0 pt -112.23 140.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 120.555 -0.458 . . . . 0.98 110.281 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.797 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -85.81 105.8 16.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.33 -0.989 . . . . 1.52 108.33 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -125.03 135.54 26.93 Favored Pre-proline 0 C--O 1.22 -0.464 0 O-C-N 124.049 0.843 . . . . 1.28 110.156 178.473 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 53.9 Cg_exo -52.73 -19.38 10.57 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.496 2.797 . . . . 0.74 115.32 -169.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.48 -51.09 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.231 -0.293 . . . . 1.12 111.361 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.064 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 0.2 OUTLIER -103.32 -2.38 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.087 0.946 . . . . 1.35 109.456 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.72 -36.95 1.22 Allowed Glycine 0 C--N 1.314 -0.669 0 CA-C-N 113.558 -1.655 . . . . 1.05 111.151 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.1 pt-20 -177.09 150.57 0.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.554 -1.276 . . . . 1.16 107.554 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HD1' HG11 ' A' ' 129' ' ' VAL . 12.7 t80 -151.97 147.86 27.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.703 -0.399 . . . . 1.91 110.158 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 67.8 m -113.82 104.72 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.506 0.504 . . . . 1.19 111.477 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -124.04 133.09 24.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 0.5 109.608 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 89.6 Cg_endo -87.38 161.28 8.24 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.592 1.528 . . . . 0.45 112.836 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.68 164.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.299 -1.0 . . . . 0.44 108.299 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -135.4 150.21 49.84 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.901 -0.319 . . . . 0.88 111.203 -168.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.3 t -145.8 102.18 3.63 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.649 -1.241 . . . . 0.96 107.649 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 6.0 ptmt -118.12 144.05 45.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.68 -0.489 . . . . 1.76 109.68 -172.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.03 149.55 19.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.021 -1.085 . . . . 0.5 112.443 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 115' ' ' ASP . 31.0 mt-10 -108.06 126.94 53.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.055 -0.572 . . . . 2.1 109.771 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 172.87 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.868 -0.79 . . . . 0.76 108.868 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -54.64 160.81 1.69 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.995 0.739 . . . . 3.53 112.995 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.738 HD12 HD11 ' A' ' 114' ' ' ILE . 25.0 tp -58.88 136.54 87.26 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.056 -0.974 . . . . 1.23 110.57 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.664 ' HD2' HD12 ' A' ' 144' ' ' LEU . 38.1 Cg_endo -66.41 172.57 8.86 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.798 2.332 . . . . 0.71 112.486 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -59.15 128.18 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.528 . . . . 1.71 110.992 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -139.19 145.55 39.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 2.64 110.599 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 150' ' ' PHE . 40.5 ttmt -167.32 97.65 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 3.72 109.893 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 4.9 m-20 73.6 -20.82 0.28 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.443 0.697 . . . . 4.28 111.986 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 148' ' ' LYS . 24.8 m-85 -68.63 -39.31 80.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 2.86 109.697 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.388 -0.815 . . . . 3.96 109.096 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtm . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.874 0.369 . . . . 12.11 110.082 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -98.83 -171.44 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.939 -0.573 . . . . 9.02 111.057 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m 66.29 -78.18 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.778 -0.647 . . . . 6.83 111.369 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.3 138.15 6.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 8.55 110.269 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.69 -20.69 12.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 10.47 109.63 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.04 97.79 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 11.69 110.051 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HB2' ' HE3' ' A' ' 7' ' ' LYS . 40.4 mtmt 65.24 -165.47 0.23 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.662 -0.699 . . . . 11.42 111.018 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -169.38 107.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.798 -0.637 . . . . 11.58 110.151 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 tttm 66.31 93.29 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.377 0.608 . . . . 15.74 111.245 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.65 -176.47 4.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 12.69 109.519 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.61 90.33 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 13.85 109.717 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 m -78.13 93.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.531 -0.759 . . . . 8.87 111.714 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 23.71 2.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.744 0.783 . . . . 8.91 109.2 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.54 -63.92 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.907 -1.042 . . . . 8.6 110.339 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 tttp 68.3 108.41 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.058 0.849 . . . . 9.04 111.587 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.654 ' H ' HD23 ' A' ' 16' ' ' LEU . 2.4 pt? -69.81 152.15 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.739 -0.664 . . . . 5.58 109.42 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.12 135.64 50.61 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 121.185 -0.206 . . . . 2.69 110.947 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . 66.84 -151.67 0.2 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.876 0.735 . . . . 1.68 111.702 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.637 HD12 ' HG3' ' A' ' 50' ' ' PRO . 19.1 pt -111.06 170.6 5.1 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.876 -0.602 . . . . 3.19 110.128 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' ' 2' ' ' ALA . 11.7 Cg_exo -72.54 -148.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.887 2.391 . . . . 2.42 112.488 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.813 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 16.8 ptpt -158.3 -13.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.486 1.291 . . . . 6.38 114.486 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.813 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 14.2 Cg_exo -72.84 45.18 0.86 Allowed 'Trans proline' 0 C--N 1.363 1.337 0 CA-C-N 121.571 1.597 . . . . 2.77 111.848 169.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.694 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 10.8 mp0 -134.39 129.98 36.18 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.828 -2.286 . . . . 3.39 104.828 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -122.2 -161.14 11.18 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 118.508 -1.806 . . . . 0.54 116.282 -154.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 75.5 p -169.01 34.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.47 1.108 . . . . 1.2 108.107 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.21 152.86 36.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 114.48 -1.236 . . . . 0.93 109.701 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 t -168.53 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.135 0.272 . . . . 0.48 110.712 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -174.36 168.08 3.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.554 0.575 . . . . 1.69 112.554 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 67.8 t -142.76 129.36 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.341 -0.845 . . . . 1.14 109.497 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.97 128.12 54.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.619 -0.264 . . . . 1.83 110.98 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 2.7 tm? -92.97 139.54 30.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.801 0.297 . . . . 0.94 111.801 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -139.1 -94.52 0.17 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.047 1.129 . . . . 1.33 114.047 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER -91.11 -174.41 3.97 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 116.182 -0.463 . . . . 2.85 112.182 -153.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.789 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.5 p -165.49 -34.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 123.732 0.645 . . . . 3.26 110.517 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 38.0 m-80 67.34 -65.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.175 -0.92 . . . . 3.16 108.963 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 1.2 tpp180 165.73 18.47 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.874 1.27 . . . . 5.46 110.724 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 98' ' ' TYR . 30.2 m-20 -136.82 -32.56 0.81 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.652 0.739 . . . . 1.92 109.041 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.789 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.1 t -154.39 119.11 4.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.096 -0.956 . . . . 0.94 112.289 -173.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 93.3 t -74.01 147.07 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.578 -1.192 . . . . 0.86 110.056 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -123.55 137.73 54.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.604 -0.838 . . . . 1.19 110.337 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.94 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -141.7 139.61 32.96 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 118.671 -1.212 . . . . 3.73 113.677 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -83.24 109.0 16.86 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.666 -1.235 . . . . 0.81 107.666 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -93.48 107.52 19.35 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.535 -0.913 . . . . 0.42 108.535 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 21.5 ttmm -82.7 131.31 35.21 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.927 -0.768 . . . . 2.63 108.927 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 25' ' ' SER . 45.2 t -111.2 137.81 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.735 -1.12 . . . . 0.82 110.236 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.7 m -126.39 97.87 5.22 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 120.257 -0.577 . . . . 0.72 109.632 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 57.8 t -84.0 124.25 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.651 -0.704 . . . . 1.14 110.812 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.68 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 22.1 m -99.83 121.01 40.66 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.326 -0.991 . . . . 0.41 108.326 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.844 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.9 t30 -89.45 124.37 64.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 124.894 1.371 . . . . 1.48 109.652 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.694 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 89.3 Cg_endo -82.89 11.67 3.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.852 3.035 . . . . 0.73 113.945 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 2.7 t80 -125.54 136.38 53.25 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.717 -0.845 . . . . 2.08 108.717 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.2 p -76.31 34.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.311 0.577 . . . . 1.51 111.161 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 51' ' ' TYR . 52.8 m80 -148.57 132.69 17.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.371 -0.831 . . . . 1.67 109.895 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -45.15 102.07 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.186 0.994 . . . . 1.39 113.459 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 81' ' ' SER . 11.1 pt -75.47 171.65 11.31 Favored Pre-proline 0 C--O 1.208 -1.112 0 N-CA-C 108.535 -0.913 . . . . 1.03 108.535 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 39.6 Cg_endo -89.12 -63.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.455 1.437 . . . . 0.37 114.923 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.2 mm -133.0 162.26 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 121.967 -0.458 . . . . 1.23 111.532 -166.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.809 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.3 p -150.97 -179.85 7.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.165 0.983 . . . . 1.15 111.998 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.064 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.6 tt0 -132.37 116.12 16.44 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.419 -1.719 . . . . 1.36 109.933 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -97.21 108.98 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.362 1.077 . . . . 1.05 109.454 168.573 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 p -114.42 103.03 10.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.454 -1.703 . . . . 0.83 108.807 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 11.8 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.226 0.536 . . . . 0.4 110.294 -165.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 m -137.01 108.81 7.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.873 -1.058 . . . . 0.38 109.626 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 92.7 m-85 -98.54 146.59 25.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.409 -0.359 . . . . 0.96 110.768 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.74 ' HB3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -139.08 128.83 24.75 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 108.098 -1.075 . . . . 1.29 108.098 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . 1.035 ' HB3' HD22 ' A' ' 104' ' ' LEU . 38.1 t -94.06 -89.85 0.21 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.408 -0.917 . . . . 1.27 110.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.55 -67.86 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.387 -0.597 . . . . 0.36 109.387 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.81 18.08 0.17 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.407 -1.077 . . . . 0.39 110.407 167.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' O ' ' HB3' ' A' ' 65' ' ' HIS . 6.7 ptp180 -106.43 -149.47 0.43 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.558 -0.534 . . . . 1.97 109.558 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.35 101.24 7.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 119.068 0.849 . . . . 2.61 109.539 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -73.62 -44.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.645 -0.707 . . . . 0.4 112.417 -171.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.56 140.24 4.43 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.49 111.094 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -154.36 159.08 40.97 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 117.568 0.684 . . . . 1.81 111.222 -174.268 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.74 163.72 26.15 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.886 -0.885 . . . . 0.43 110.886 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.9 mttt -129.85 128.37 42.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.162 -0.31 . . . . 1.72 110.162 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.1 mt -135.67 124.37 15.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.608 -0.269 . . . . 0.73 110.667 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.3 103.0 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.155 1.903 . . . . 0.57 111.234 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HB2' HD11 ' A' ' 60' ' ' ILE . 7.4 t70 -110.43 136.78 20.56 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.79 109.541 -172.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' HD13 ' A' ' 57' ' ' ILE . 25.8 Cg_exo -63.44 88.79 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.546 2.164 . . . . 0.58 112.716 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 82' ' ' LEU . . . -88.24 35.63 3.54 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.885 -0.598 . . . . 0.4 112.379 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.943 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -72.78 117.71 14.82 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.146 -0.687 . . . . 0.62 109.146 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HG ' ' NZ ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -156.41 -155.15 0.52 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.305 -1.358 . . . . 1.1 114.45 -157.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.796 ' CE ' ' HB ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -57.68 -158.2 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.339 1.066 . . . . 1.84 112.305 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.87 80.59 1.72 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.342 -1.355 . . . . 0.99 107.342 -167.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 8.9 mtpt 64.74 68.28 0.53 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.962 -1.472 . . . . 1.84 110.934 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.698 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 9.4 t70 -162.53 -169.59 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.238 -1.346 . . . . 0.64 109.54 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.473 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 41.8 ttp -122.42 118.96 29.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.193 0.521 . . . . 1.35 110.88 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.796 ' HB ' ' CE ' ' A' ' 83' ' ' LYS . 5.6 t -104.04 143.67 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.77 109.018 -172.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.71 109.4 20.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.703 0.763 . . . . 0.48 110.739 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -115.48 175.07 5.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.66 -1.155 . . . . 0.77 108.136 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.588 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 3.1 p30 -144.25 151.22 39.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.011 0.823 . . . . 1.81 112.569 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 40.3 mm -110.16 130.45 22.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.683 -1.144 . . . . 0.65 108.044 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.508 ' O ' HG13 ' A' ' 94' ' ' VAL . 44.6 Cg_exo -35.86 -103.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.687 3.592 . . . . 1.07 115.372 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -164.0 90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 CA-C-O 119.118 -0.468 . . . . 0.46 110.615 -177.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.9 p -124.35 104.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.646 1.721 . . . . 0.48 115.646 -163.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 101' ' ' LEU . 2.5 t -148.9 119.23 4.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 1.07 110.346 164.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 17.9 Cg_exo -65.47 124.9 13.53 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.08 1.064 . . . . 0.48 109.569 164.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.27 -30.85 66.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.31 111.594 -171.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 3.2 p -58.76 -26.54 64.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.311 0.486 . . . . 1.2 112.311 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.2 mm -76.86 -55.31 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 121.818 -0.551 . . . . 0.51 110.995 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 96' ' ' VAL . 26.9 mt -52.24 -26.56 12.09 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.555 0.693 . . . . 1.0 110.392 171.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' SER . 57.6 t80 -64.4 -40.24 95.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.467 -1.242 . . . . 0.96 108.839 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HA ' HH21 ' A' ' 106' ' ' ARG . 22.0 m-80 -73.79 -58.06 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.845 -0.616 . . . . 0.82 112.422 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.035 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -61.04 -50.19 74.31 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.423 0.898 . . . . 0.65 113.423 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.68 -25.05 67.95 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.856 0.836 . . . . 0.43 110.037 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 110' ' ' VAL . 2.7 ttp180 -68.18 -51.11 49.37 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.145 . . . . 1.81 110.728 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 110' ' ' VAL . 24.8 t70 -82.9 -52.07 7.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.545 1.164 . . . . 0.8 112.231 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -84.42 -29.06 6.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.859 -1.151 . . . . 0.88 109.982 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.93 -25.59 73.39 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.923 -0.656 . . . . 0.38 113.786 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -57.65 -40.5 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 118.413 -1.315 . . . . 1.09 108.04 170.78 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 30.6 t70 -64.66 -84.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.504 -1.278 . . . . 1.87 108.097 161.108 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.9 OUTLIER 168.07 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.24 0.83 . . . . 1.17 113.24 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.58 123.78 35.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.87 0.322 . . . . 2.15 111.87 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.578 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.3 mp -117.28 155.55 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.902 0.382 . . . . 0.39 110.032 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' A' ' 141' ' ' GLU . 37.1 t70 -98.91 155.41 17.41 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.067 -0.716 . . . . 2.11 109.067 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 72.9 m-85 -139.08 129.57 25.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.217 -0.66 . . . . 0.62 109.217 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.844 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.5 tt0 -123.78 137.25 54.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.05 0.453 . . . . 0.8 110.068 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.699 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -111.47 129.36 56.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.588 -0.733 . . . . 1.25 109.863 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.699 ' N ' HD22 ' A' ' 118' ' ' LEU . 5.6 tp60 -113.34 101.29 9.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 176.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.654 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 tp -111.88 123.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.146 0.498 . . . . 0.81 111.204 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.76 125.2 7.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.378 -0.689 . . . . 0.26 111.378 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.583 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.3 mp -101.88 94.99 6.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.38 . . . . 1.2 111.131 -174.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.064 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 84.9 m -100.17 95.56 6.89 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.629 -0.714 . . . . 0.32 109.177 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.838 HG13 HD21 ' A' ' 126' ' ' LEU . 3.0 pt -106.89 149.42 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.9 -0.5 . . . . 0.98 109.698 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.527 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.5 m-20 -92.88 107.15 18.99 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -109.93 159.74 30.67 Favored Pre-proline 0 C--O 1.217 -0.63 0 O-C-N 123.996 0.81 . . . . 1.28 109.997 -176.103 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 17.3 Cg_exo -69.88 -13.1 33.93 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.884 1.722 . . . . 0.74 113.358 174.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.63 -59.93 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.769 0.655 . . . . 1.12 112.769 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 18' ' ' ALA . 34.1 t -118.99 9.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 122.915 1.341 . . . . 1.35 109.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.58 -24.78 3.57 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 113.587 -1.642 . . . . 1.05 111.605 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 10.6 pt-20 -172.52 154.77 3.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.628 -0.879 . . . . 1.16 108.628 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -150.0 143.64 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.523 -0.547 . . . . 1.91 109.523 170.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 53.5 m -116.23 108.85 16.64 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.383 0.427 . . . . 1.19 111.352 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.4 pp -124.94 137.38 29.51 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.098 -0.501 . . . . 0.5 109.975 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 73.7 Cg_endo -92.89 159.11 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.047 1.832 . . . . 0.45 113.323 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -156.44 165.38 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.601 -0.888 . . . . 0.44 108.601 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -136.27 151.36 49.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.64 -0.255 . . . . 0.88 111.072 -168.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t -146.11 103.8 3.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.016 -0.735 . . . . 0.96 109.016 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.844 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.8 ptmt -116.11 152.81 32.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 1.76 111.309 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.08 147.02 10.03 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.718 -0.753 . . . . 0.5 112.049 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 115' ' ' ASP . 31.3 mt-10 -98.67 135.09 40.68 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.607 -0.516 . . . . 2.1 109.607 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.13 171.04 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.212 -0.662 . . . . 0.76 109.212 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -60.02 167.01 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 3.53 112.334 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.825 HD12 ' HD2' ' A' ' 145' ' ' PRO . 42.0 tp -56.26 125.44 64.99 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.928 -1.033 . . . . 1.23 109.809 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.825 ' HD2' HD12 ' A' ' 144' ' ' LEU . 28.6 Cg_endo -61.81 173.76 2.76 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.658 2.905 . . . . 0.71 113.197 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.644 HG22 ' HG2' ' A' ' 148' ' ' LYS . 3.9 m -52.1 118.67 3.65 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.18 -0.464 . . . . 1.71 110.003 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.46 ' H ' ' HD1' ' A' ' 147' ' ' PHE . 9.8 m-85 -54.14 -68.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.248 0.342 . . . . 2.64 111.427 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.644 ' HG2' HG22 ' A' ' 146' ' ' THR . 31.4 mmtp 39.68 -103.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.496 0.718 . . . . 3.72 112.635 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.27 7.77 9.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.175 -0.466 . . . . 4.28 110.631 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' N ' ' HD1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -63.07 -34.93 78.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.834 -0.802 . . . . 2.86 108.834 -174.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.653 ' CZ ' HD21 ' A' ' 144' ' ' LEU . 20.9 p90 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 114.545 -1.207 . . . . 3.96 109.189 173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 111.422 0.156 . . . . 12.11 111.422 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.61 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.641 0.588 . . . . 9.02 110.266 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 p 42.14 -86.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.485 1.114 . . . . 6.83 113.685 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -77.39 111.13 12.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.801 0.334 . . . . 8.55 110.701 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.504 ' H ' HD22 ' A' ' 5' ' ' LEU . 2.6 mm? -69.54 -61.62 1.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.206 -0.664 . . . . 10.47 109.206 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -171.8 139.49 1.18 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.172 -0.922 . . . . 11.69 109.481 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -170.07 146.56 3.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.943 0.402 . . . . 11.42 111.118 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.92 139.16 55.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.944 -0.571 . . . . 11.58 110.171 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -87.38 93.19 9.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.319 0.581 . . . . 15.74 111.319 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.09 -58.01 6.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 12.69 109.696 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -175.12 -24.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.796 . . . . 13.85 110.011 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 8.0 m -69.67 72.91 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.521 0.677 . . . . 8.87 112.21 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.33 126.63 34.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 8.91 109.946 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.14 10.36 7.78 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.886 0.741 . . . . 8.6 111.022 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 66.8 mttm -109.74 97.89 7.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.952 -0.567 . . . . 9.04 110.118 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.07 111.32 21.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.316 -0.402 . . . . 5.58 109.917 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -65.74 -26.18 67.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 2.69 111.358 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.637 ' HB1' HG21 ' A' ' 129' ' ' VAL . . . -74.9 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 1.68 111.803 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 39.8 pt -117.48 135.99 23.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 120.591 -0.444 . . . . 3.19 111.551 -171.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 1.2 Cg_endo -84.55 -55.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.964 2.443 . . . . 2.42 112.74 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 49.6 mtpt -140.23 143.6 34.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 6.38 110.043 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HA ' ' OE2' ' A' ' 23' ' ' GLU . 37.2 Cg_exo -58.15 160.97 14.52 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.404 2.736 . . . . 2.77 113.524 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.807 ' HB3' ' O ' ' A' ' 48' ' ' THR . 1.7 mp0 -122.07 158.36 29.42 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.435 -2.061 . . . . 3.39 105.435 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -117.63 -177.07 17.4 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 117.661 -2.209 . . . . 0.54 113.875 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.701 ' O ' HG13 ' A' ' 45' ' ' VAL . 83.6 p -169.31 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.338 1.066 . . . . 1.2 108.561 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 136' ' ' ILE . 14.3 m -134.52 152.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 114.297 -1.32 . . . . 0.93 109.707 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -160.28 -51.52 0.05 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.464 -0.569 . . . . 0.48 109.464 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -157.36 166.16 33.83 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.487 -0.56 . . . . 1.69 109.487 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -145.53 148.34 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.154 -0.684 . . . . 1.14 109.154 165.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -122.37 144.39 49.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.016 0.436 . . . . 1.83 111.215 -169.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.12 118.03 32.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.94 111.126 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HG2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.63 -136.36 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.525 -1.287 . . . . 1.33 107.525 167.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.623 ' HB3' HG13 ' A' ' 39' ' ' VAL . 5.3 p-10 169.81 153.84 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.739 1.755 . . . . 2.85 115.739 -173.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.702 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER -132.12 -28.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 112.842 -1.981 . . . . 3.26 109.263 167.551 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 24.1 t-20 67.8 -62.24 0.35 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.894 1.072 . . . . 3.16 113.894 167.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -49.3 -25.53 2.44 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.021 0.915 . . . . 5.46 111.627 -171.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -134.83 -30.66 1.07 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.811 -1.54 . . . . 1.92 107.695 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 44.1 t -175.3 126.31 0.25 Allowed 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 118.981 -1.088 . . . . 0.94 112.184 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.702 ' HA ' ' H ' ' A' ' 34' ' ' VAL . 44.5 t -70.99 168.48 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.743 -1.206 . . . . 0.86 107.743 168.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.019 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 76.0 mt-10 -128.76 136.18 50.2 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.712 0.768 . . . . 1.19 111.081 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.62 104.21 8.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.637 -1.165 . . . . 3.73 109.886 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.556 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -75.39 109.83 9.24 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.267 -0.973 . . . . 0.81 108.613 176.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.734 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -94.52 109.58 21.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.396 0.617 . . . . 0.42 109.781 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 21.7 ttmt -84.65 130.14 34.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.436 -0.802 . . . . 2.63 109.11 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 90' ' ' LEU . 69.3 t -111.34 136.12 48.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 116.149 -0.478 . . . . 0.82 112.13 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 29.4 m -127.05 95.76 4.4 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.025 -0.731 . . . . 0.72 109.025 160.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -89.48 128.51 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.536 0.684 . . . . 1.14 110.955 -176.45 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.807 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 5.8 m -103.77 117.27 33.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.963 -1.017 . . . . 0.41 109.853 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 6.3 t30 -88.67 128.47 52.46 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 124.146 0.904 . . . . 1.48 108.922 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HG2' ' A' ' 23' ' ' GLU . 41.3 Cg_endo -91.84 11.34 2.39 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.25 2.634 . . . . 0.73 114.218 -174.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -130.49 143.43 50.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.043 -0.725 . . . . 2.08 109.043 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 23.1 t -78.07 34.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.946 0.721 . . . . 1.51 112.946 -164.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -144.5 132.14 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.277 -0.264 . . . . 1.67 110.375 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -39.37 103.6 0.03 OUTLIER 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 124.058 0.943 . . . . 1.39 112.708 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.32 169.45 19.33 Favored Pre-proline 0 C--O 1.21 -1.0 0 N-CA-C 108.097 -1.075 . . . . 1.03 108.097 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.923 ' HB2' HD12 ' A' ' 57' ' ' ILE . 9.9 Cg_endo -91.56 -66.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.504 1.469 . . . . 0.37 114.333 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 56' ' ' PRO . 3.8 mp -134.65 152.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.299 -0.56 . . . . 1.23 111.028 -167.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.68 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 16.5 m -144.23 -178.09 5.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.118 0.961 . . . . 1.15 111.92 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 23.8 tt0 -134.27 116.88 15.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.414 -1.721 . . . . 1.36 109.997 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.571 ' HA ' HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -95.94 108.4 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 115.054 -0.975 . . . . 1.05 108.785 164.215 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 39.5 p -112.76 101.95 10.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.05 -1.432 . . . . 0.83 108.377 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -116.16 134.3 55.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.415 0.626 . . . . 0.4 110.583 -166.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -128.32 111.01 12.9 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.507 -1.224 . . . . 0.38 108.819 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 97.8 m-85 -97.31 140.67 31.44 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.584 -0.524 . . . . 0.96 109.584 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.4 OUTLIER -128.19 144.55 51.13 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.048 -1.464 . . . . 1.29 107.048 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 39.1 t -105.43 -103.86 0.32 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 118.967 -1.093 . . . . 1.27 111.046 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -60.53 -54.31 47.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.115 -0.698 . . . . 0.36 109.115 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 21.22 0.12 Allowed Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 109.116 -1.594 . . . . 0.39 109.116 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 6.6 ptp180 -115.97 -172.25 2.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.568 -0.816 . . . . 1.97 109.014 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -105.11 91.55 3.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.612 0.72 . . . . 2.61 110.555 -165.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 100' ' ' ILE . 6.0 mm -52.07 -44.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.911 -1.041 . . . . 0.4 111.067 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.24 170.54 35.48 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.534 -0.841 . . . . 0.49 111.41 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.89 163.02 21.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.377 0.589 . . . . 1.81 111.043 176.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.83 166.25 35.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.892 -0.595 . . . . 0.43 111.637 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 91.3 mttt -135.74 126.42 27.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.613 0.244 . . . . 1.72 110.456 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.37 115.41 14.94 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.944 -0.391 . . . . 0.73 109.944 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 9.8 Cg_exo -72.24 95.69 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.498 2.132 . . . . 0.57 110.553 170.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -112.24 141.84 25.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.374 -0.602 . . . . 0.79 109.374 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HA ' HG13 ' A' ' 57' ' ' ILE . 19.5 Cg_endo -59.44 88.97 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.519 2.146 . . . . 0.58 112.502 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.68 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -83.21 38.71 2.74 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.261 -0.881 . . . . 0.4 112.29 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.973 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 77.4 p -73.58 125.45 28.02 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.506 -0.553 . . . . 0.62 109.506 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.878 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -156.94 0.77 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.893 1.442 . . . . 1.1 114.893 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 91.5 mttt -62.71 -101.24 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.49 -0.777 . . . . 1.84 112.513 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.23 102.57 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.045 -1.094 . . . . 0.99 108.045 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptpt 43.59 50.43 6.46 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.415 1.072 . . . . 1.84 111.071 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.2 -173.64 4.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.189 -0.914 . . . . 0.64 109.678 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 48.6 ttm -112.59 126.73 55.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.377 -0.374 . . . . 1.35 110.649 -172.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.539 ' CG2' HG13 ' A' ' 47' ' ' VAL . 5.9 t -116.76 144.64 44.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.046 -0.524 . . . . 0.77 110.247 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -90.87 111.36 22.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.737 0.779 . . . . 0.48 110.527 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.746 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -109.85 176.14 5.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.588 -1.187 . . . . 0.77 108.56 -176.498 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.746 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.8 t70 -134.78 131.73 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.365 0.529 . . . . 1.81 111.909 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 19.1 mm -113.62 139.31 23.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.65 110.312 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 92' ' ' ILE . 71.9 Cg_exo -51.3 -177.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.899 . . . . 1.07 113.597 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.019 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.7 m -115.16 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.553 -0.749 . . . . 0.46 110.367 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 p -127.2 102.96 10.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 114.269 1.211 . . . . 0.48 114.269 -164.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.5 p -151.72 98.41 3.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.697 -0.683 . . . . 1.07 110.551 161.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 87.5 Cg_exo -47.67 130.22 18.32 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.994 1.796 . . . . 0.48 111.264 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.513 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -57.86 -31.66 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 1.31 110.998 -173.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 14.9 m -56.6 -28.78 61.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.722 0.296 . . . . 1.2 111.682 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 21.3 mm -76.34 -54.74 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.757 0.313 . . . . 0.51 110.538 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 104' ' ' LEU . 19.9 mt -50.09 -27.84 6.27 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.21 -0.905 . . . . 1.0 110.516 171.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 1.8 t80 -65.66 -42.33 91.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.709 -1.132 . . . . 0.96 109.031 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.649 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 50.7 m-80 -73.59 -56.35 5.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.434 . . . . 0.82 111.946 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 101' ' ' LEU . 1.6 pp -60.94 -51.16 70.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.442 0.904 . . . . 0.65 113.442 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -24.35 66.9 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.718 0.77 . . . . 0.43 109.706 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.649 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -60.32 -53.27 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.654 -1.157 . . . . 1.81 110.143 172.35 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.98 -53.29 6.26 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.301 0.572 . . . . 0.8 112.394 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 2.2 t -89.72 -25.26 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.945 -0.702 . . . . 0.88 110.159 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.35 -24.64 72.63 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.181 -1.009 . . . . 0.38 111.07 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.6 -44.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.448 -1.316 . . . . 1.09 107.448 166.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 7.6 m-20 -68.84 -87.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.78 -0.646 . . . . 1.87 110.179 162.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -179.85 -56.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.313 -0.403 . . . . 1.17 111.631 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 108' ' ' VAL . 1.6 p-10 -94.42 134.38 37.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.802 0.334 . . . . 2.15 110.234 -177.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.653 HD11 HD12 ' A' ' 144' ' ' LEU . 2.3 mp -119.38 156.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.916 -0.772 . . . . 0.39 108.916 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 141' ' ' GLU . 1.6 p-10 -98.0 152.81 18.88 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.714 -0.847 . . . . 2.11 108.714 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 44.0 m-85 -138.07 169.33 17.98 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.737 -1.208 . . . . 0.62 107.737 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.617 ' HA ' ' CB ' ' A' ' 139' ' ' LYS . 3.7 tt0 -160.06 145.04 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.907 0.384 . . . . 0.8 110.224 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -116.59 128.79 55.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.885 -0.598 . . . . 1.25 109.472 174.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.635 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.8 tp60 -117.08 100.37 7.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.465 -0.939 . . . . 0.63 108.465 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -117.14 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.334 0.588 . . . . 0.81 110.846 -173.142 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' N ' HD13 ' A' ' 120' ' ' ILE . . . -86.06 124.15 6.75 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.368 -0.833 . . . . 0.26 111.831 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.555 HD12 HD12 ' A' ' 120' ' ' ILE . 5.9 mp -95.34 106.49 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.11 0.481 . . . . 1.2 110.569 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.08 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.1 m -112.04 94.35 4.9 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.034 -0.985 . . . . 0.32 109.228 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.677 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -117.35 126.17 74.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.481 -0.562 . . . . 0.98 109.481 -175.851 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.847 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 33.3 t70 -81.71 106.86 13.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 120.394 -0.523 . . . . 1.52 110.296 -172.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.672 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 4.5 mm? -98.32 -178.76 0.75 Allowed Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 125.201 1.563 . . . . 1.28 109.994 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 126' ' ' LEU . 15.6 Cg_endo -90.78 -16.4 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.987 1.791 . . . . 0.74 113.445 167.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.8 t -73.53 -59.71 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.481 0.548 . . . . 1.12 112.481 -170.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.637 HG21 ' HB1' ' A' ' 18' ' ' ALA . 2.1 t -113.59 -2.22 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 123.417 1.579 . . . . 1.35 107.026 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 86.95 -133.94 12.15 Favored Glycine 0 N--CA 1.422 -2.248 0 CA-C-N 111.636 -2.529 . . . . 1.05 108.52 -167.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.847 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 7.2 pt-20 -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.796 0.808 . . . . 1.16 110.869 176.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.79 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.2 m-30 -89.68 145.13 25.44 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.524 -0.917 . . . . 1.91 108.524 173.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 21.2 m -129.88 94.16 3.66 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.733 -0.387 . . . . 1.19 111.452 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -128.57 136.16 28.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.23 173.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -89.34 158.23 5.53 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.866 1.711 . . . . 0.45 112.604 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.3 163.94 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.44 109.384 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -132.83 139.95 47.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.376 -0.374 . . . . 0.88 110.133 -170.398 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 50.2 m -147.83 101.02 3.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.715 -0.846 . . . . 0.96 108.715 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 116' ' ' TYR . 13.9 ptmm? -116.53 163.06 16.64 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.45 -0.796 . . . . 1.76 111.66 -171.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.14 138.96 5.61 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.42 -0.895 . . . . 0.5 111.329 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 115' ' ' ASP . 5.0 mp0 -106.55 126.76 52.68 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.715 -0.742 . . . . 2.1 109.416 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.52 174.99 4.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.073 -0.714 . . . . 0.76 109.073 -171.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -57.08 163.13 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.384 0.513 . . . . 3.53 112.384 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.656 HD12 ' HD2' ' A' ' 145' ' ' PRO . 28.5 tp -56.55 127.41 72.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 115.392 -0.822 . . . . 1.23 110.423 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.656 ' HD2' HD12 ' A' ' 144' ' ' LEU . 25.1 Cg_endo -60.74 172.72 2.63 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.401 2.734 . . . . 0.71 113.155 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.59 99.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 1.71 111.837 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -114.58 148.87 37.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.448 -0.796 . . . . 2.64 109.939 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -158.2 80.02 0.83 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.237 -0.438 . . . . 3.72 110.032 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 65.62 1.8 1.86 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.892 -0.595 . . . . 4.28 111.165 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.07 -33.29 61.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.312 -0.625 . . . . 2.86 109.312 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.039 -0.982 . . . . 3.96 109.15 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.286 -0.264 . . . . 12.11 110.286 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.0 95.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 9.02 110.72 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.558 ' HA ' HG13 ' A' ' 128' ' ' VAL . 37.5 m 65.51 -171.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.518 -0.765 . . . . 6.83 110.99 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.704 HD21 ' HE1' ' A' ' 51' ' ' TYR . 3.1 mm? -108.03 139.37 42.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.488 -0.324 . . . . 8.55 110.24 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.76 61.69 6.93 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.162 -0.681 . . . . 10.47 109.162 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 15.8 t70 -171.35 77.04 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.071 -0.968 . . . . 11.69 109.623 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 41.3 ttmt 166.89 -68.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.647 0.592 . . . . 11.42 110.777 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.69 107.95 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.415 0.626 . . . . 11.58 112.564 -168.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -122.27 -20.01 6.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.975 -1.12 . . . . 15.74 107.975 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -110.27 163.41 13.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.685 -1.143 . . . . 12.69 109.527 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 56.16 30.5 16.6 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.637 0.585 . . . . 13.85 112.018 173.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 m -90.86 140.31 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.506 -0.316 . . . . 8.87 110.571 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . -106.92 104.19 13.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 8.91 109.815 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 38.4 m-20 72.94 -58.36 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.506 0.722 . . . . 8.6 111.687 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -172.53 118.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.016 -0.538 . . . . 9.04 109.782 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -76.7 116.62 17.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.749 -0.834 . . . . 5.58 108.749 177.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.1 m -149.08 144.25 26.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.369 -0.378 . . . . 2.69 110.794 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 73.68 -162.13 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 124.121 0.888 . . . . 1.68 111.642 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.771 HG21 HD13 ' A' ' 126' ' ' LEU . 39.2 pt -93.31 174.29 4.06 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.861 -0.609 . . . . 3.19 110.657 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.659 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 48.1 Cg_exo -56.43 -86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.584 2.189 . . . . 2.42 112.515 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 5.1 tmmm? 162.57 -49.27 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.807 0 O-C-N 123.518 0.511 . . . . 6.38 111.791 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 17.0 Cg_exo -69.21 59.09 1.34 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.542 2.162 . . . . 2.77 113.042 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.881 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 8.9 mp0 -134.49 121.04 20.47 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.415 -2.069 . . . . 3.39 105.415 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -132.83 -145.41 5.42 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 118.187 -1.959 . . . . 0.54 116.528 -153.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.817 ' HB2' HD21 ' A' ' 122' ' ' LEU . 58.6 m 179.95 49.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.066 1.747 . . . . 1.2 107.167 -174.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.65 154.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.05 -0.977 . . . . 0.93 109.488 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -175.82 -36.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 O-C-N 123.48 0.487 . . . . 0.48 111.623 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 34.7 t70 -163.73 154.26 15.66 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.078 0.466 . . . . 1.69 110.591 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.719 HG11 ' HZ ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -151.25 144.69 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.604 -0.517 . . . . 1.14 109.604 164.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.35 142.72 51.05 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.023 -0.732 . . . . 1.83 109.023 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.776 HD21 HG11 ' A' ' 96' ' ' VAL . 3.3 tm? -101.17 112.24 24.67 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.713 -0.477 . . . . 0.94 109.713 -170.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.13 147.86 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.03 1.395 . . . . 1.33 112.368 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 1.8 t70 161.65 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.178 -2.737 . . . . 2.85 108.039 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -79.75 -175.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-O 122.37 1.081 . . . . 3.26 108.345 -173.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.553 ' N ' HG13 ' A' ' 34' ' ' VAL . 23.8 t-20 -129.77 -48.99 1.14 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 114.183 -1.371 . . . . 3.16 112.058 -174.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 31.1 ptt180 -50.91 -19.32 0.97 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.882 0.848 . . . . 5.46 111.699 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 m-20 -111.07 -55.62 2.47 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.307 -1.315 . . . . 1.92 107.532 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.534 ' OG ' ' HA ' ' A' ' 97' ' ' PRO . 42.2 t 178.05 140.95 0.09 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 114.185 -1.37 . . . . 0.94 108.274 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 35.9 t -83.95 158.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.533 -1.654 . . . . 0.86 106.533 171.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 12.5 mt-10 -139.19 165.66 26.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.124 -1.065 . . . . 1.19 108.124 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.899 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 30.5 p90 -134.63 126.8 29.91 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.22 -1.392 . . . . 3.73 112.691 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.91 115.17 20.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.566 -0.853 . . . . 0.81 109.364 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . . . -106.39 119.46 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.092 0.472 . . . . 0.42 111.924 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.6 tppt? -87.3 102.31 14.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.216 1.007 . . . . 2.63 109.449 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.999 HG21 HD13 ' A' ' 92' ' ' ILE . 12.4 t -96.36 156.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.766 -1.106 . . . . 0.82 110.33 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.503 ' C ' ' HA ' ' A' ' 25' ' ' SER . 4.1 m -139.45 112.32 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 120.054 -0.659 . . . . 0.72 111.33 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 25.9 t -82.64 124.07 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.975 -1.011 . . . . 1.14 110.372 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 2.4 m -104.09 114.29 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.41 109.267 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 13.0 t30 -89.81 126.26 58.23 Favored Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 124.395 1.059 . . . . 1.48 110.133 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.881 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 91.2 Cg_endo -83.02 3.88 7.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.594 2.863 . . . . 0.73 113.999 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' HE1' HD21 ' A' ' 4' ' ' LEU . 13.0 t80 -122.03 143.72 49.33 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.407 -0.59 . . . . 2.08 109.407 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.624 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 19.8 p -79.2 28.53 0.23 Allowed 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.434 0.531 . . . . 1.51 112.434 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -143.11 131.04 21.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.416 -0.357 . . . . 1.67 110.075 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.5 m -40.76 100.14 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.985 0 C-N-CA 124.212 1.005 . . . . 1.39 112.846 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.957 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.8 pt -74.51 171.14 12.14 Favored Pre-proline 0 C--O 1.21 -1.014 0 N-CA-C 108.073 -1.084 . . . . 1.03 108.073 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 57' ' ' ILE . 13.4 Cg_endo -92.9 -63.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.034 1.156 . . . . 0.37 114.261 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.2 mm -128.38 154.76 39.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 1.23 111.797 -165.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.651 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.5 p -151.02 -177.46 6.03 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.075 0.941 . . . . 1.15 111.78 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.022 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 39.4 tt0 -135.36 115.86 13.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.379 -1.737 . . . . 1.36 109.809 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -98.3 109.52 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.334 1.064 . . . . 1.05 109.619 168.685 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 33.2 p -114.52 102.73 10.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.273 -1.785 . . . . 0.83 108.782 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 p90 -109.69 133.36 53.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.969 0.414 . . . . 0.4 110.116 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 12.2 m -125.53 100.82 6.64 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.185 -0.916 . . . . 0.38 109.546 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.836 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 10.4 m-85 -97.57 143.78 27.91 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.869 -0.605 . . . . 0.96 109.956 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -146.16 143.74 29.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.904 -1.147 . . . . 1.29 107.904 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.882 ' HB3' HD22 ' A' ' 104' ' ' LEU . 33.0 t -102.02 -93.97 0.3 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.987 -0.685 . . . . 1.27 111.421 -174.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.94 10.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.36 109.545 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.44 16.29 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.763 -1.208 . . . . 0.39 110.247 165.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.694 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -99.19 -69.76 0.75 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.998 -0.601 . . . . 1.97 110.532 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 28.1 tt0 -175.75 170.58 2.83 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.523 -1.288 . . . . 2.61 107.523 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.54 ' HB ' ' C ' ' A' ' 64' ' ' PHE . 2.4 mm -136.78 -40.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.146 -1.057 . . . . 0.4 108.146 168.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.42 151.48 6.28 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.783 -0.927 . . . . 0.49 110.783 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -151.89 155.27 37.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.521 0.661 . . . . 1.81 110.771 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.34 177.28 44.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.787 -0.721 . . . . 0.43 112.208 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.65 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 69.4 mttt -128.26 132.71 48.72 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.662 0.272 . . . . 1.72 110.368 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 75' ' ' LYS . 3.2 mp -131.18 110.73 15.39 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 109.463 -0.569 . . . . 0.73 109.463 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.66 105.95 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.276 1.984 . . . . 0.57 110.231 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -120.38 146.27 42.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.216 -0.661 . . . . 0.79 109.216 -172.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 57' ' ' ILE . 39.5 Cg_exo -61.36 91.75 0.1 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.215 1.943 . . . . 0.58 111.917 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.09 31.3 2.86 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.4 111.82 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.957 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 51.4 p -73.33 119.91 18.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.131 -0.692 . . . . 0.62 109.131 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -152.51 -164.91 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 118.847 -1.141 . . . . 1.1 113.328 -162.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 91.3 mttt -51.59 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.312 0.856 . . . . 1.84 113.312 -173.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 161.38 111.19 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.752 -1.203 . . . . 0.99 107.752 -169.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 44.1 pttt 42.6 45.53 4.01 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.271 0.982 . . . . 1.84 111.698 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.7 t70 -151.23 -172.29 4.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.499 -0.773 . . . . 0.64 109.871 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.8 ttm -117.65 122.23 43.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.347 0.594 . . . . 1.35 110.469 -171.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.656 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -112.13 143.66 42.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.77 110.338 -176.096 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.81 130.36 36.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.599 0.714 . . . . 0.48 110.819 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 45' ' ' VAL . 2.1 tm? -125.56 147.75 49.16 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.763 -1.569 . . . . 0.77 106.763 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 90' ' ' LEU . 4.8 p-10 -124.04 123.72 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.162 -1.015 . . . . 1.81 111.573 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.999 HD13 HG21 ' A' ' 45' ' ' VAL . 1.2 mp -90.55 146.53 34.51 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.788 -1.096 . . . . 0.65 109.066 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' O ' HG13 ' A' ' 94' ' ' VAL . 78.0 Cg_exo -52.69 -118.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.121 3.214 . . . . 1.07 113.346 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.6 m -162.97 93.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-O 119.008 -0.52 . . . . 0.46 111.437 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.558 HG11 ' HE1' ' A' ' 62' ' ' PHE . 14.8 p -129.52 103.64 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 119.639 -1.913 . . . . 0.48 115.962 -172.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.776 HG11 HD21 ' A' ' 31' ' ' LEU . 2.4 p -152.98 97.12 2.86 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.312 -0.868 . . . . 1.07 112.122 162.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.747 ' HB2' HG12 ' A' ' 100' ' ' ILE . 75.4 Cg_exo -46.63 136.62 16.08 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 121.823 1.682 . . . . 0.48 112.13 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 3.5 t80 -51.58 -39.54 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.157 -0.474 . . . . 1.31 110.688 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.7 m -62.78 -25.03 68.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.495 -0.32 . . . . 1.2 111.859 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.747 HG12 ' HB2' ' A' ' 97' ' ' PRO . 21.4 mm -76.87 -56.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.77 -0.581 . . . . 0.51 111.453 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.642 HD23 HD11 ' A' ' 104' ' ' LEU . 41.7 mt -53.54 -27.82 28.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.759 0.79 . . . . 1.0 109.942 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 99' ' ' SER . 53.9 t80 -62.45 -42.04 99.18 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.841 -1.527 . . . . 0.96 109.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.628 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.2 m-80 -74.24 -57.6 3.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.946 0.35 . . . . 0.82 111.946 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.882 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -60.62 -49.41 77.65 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.32 0.859 . . . . 0.65 113.32 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 144' ' ' LEU . . . -68.25 -26.18 65.55 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.821 0.819 . . . . 0.43 110.088 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.628 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.8 ttp180 -66.0 -46.09 79.23 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.529 -1.214 . . . . 1.81 110.484 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.9 t0 -82.21 -53.68 5.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.532 0.682 . . . . 0.8 112.317 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 114' ' ' ILE . 6.8 t -85.36 -28.7 6.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.039 -0.664 . . . . 0.88 109.792 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 144' ' ' LEU . . . -75.17 -21.66 77.66 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.575 -0.821 . . . . 0.38 111.607 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -47.84 -44.51 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.976 -1.491 . . . . 1.09 106.976 165.775 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.61 -82.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.517 -0.765 . . . . 1.87 110.284 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 179.94 -58.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.811 0.671 . . . . 1.17 112.811 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 122.97 39.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.505 -0.316 . . . . 2.15 110.634 -172.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 144' ' ' LEU . 2.2 mp -111.21 153.2 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.39 109.941 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.5 p-10 -99.26 154.12 18.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.513 -0.767 . . . . 2.11 109.219 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -139.15 154.22 48.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.732 -0.84 . . . . 0.62 108.732 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.732 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 35.0 tt0 -142.05 135.74 29.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 0.8 110.395 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.836 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -105.31 134.04 49.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.307 -0.86 . . . . 1.25 109.502 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.639 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.8 tp60 -121.93 101.19 7.41 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.533 -0.543 . . . . 0.63 109.533 171.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.478 ' HB ' HD11 ' A' ' 118' ' ' LEU . 7.2 tp -108.04 118.07 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 0.81 110.63 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.59 129.84 10.05 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.98 -0.848 . . . . 0.26 110.98 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 25' ' ' SER . 2.7 mm? -108.9 105.82 15.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.337 0.589 . . . . 1.2 112.348 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.022 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 77.3 m -100.13 95.6 6.94 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.813 -1.085 . . . . 0.32 109.241 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.651 HG22 ' HB3' ' A' ' 58' ' ' CYS . 6.3 pt -109.35 138.12 38.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 120.644 -0.422 . . . . 0.98 111.732 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.18 108.13 16.21 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.45 -0.945 . . . . 1.52 108.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 55' ' ' ILE . 17.7 mt -120.29 156.75 54.87 Favored Pre-proline 0 C--O 1.217 -0.636 0 O-C-N 124.884 1.365 . . . . 1.28 110.273 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.0 Cg_exo -70.87 -21.29 28.52 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.123 1.882 . . . . 0.74 112.24 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 3' ' ' SER . 41.2 t -74.95 -57.1 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.073 -0.512 . . . . 1.12 112.195 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.8 OUTLIER -106.72 -1.63 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 122.007 0.908 . . . . 1.35 109.698 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.52 -32.05 1.19 Allowed Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.163 -1.381 . . . . 1.05 111.264 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.8 pt-20 -174.34 141.39 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.116 -1.438 . . . . 1.16 107.116 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.5 t80 -146.0 135.44 23.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.39 -0.596 . . . . 1.91 109.39 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.3 t -117.38 105.8 12.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.868 0.842 . . . . 1.19 111.347 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.49 138.73 33.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.41 -0.813 . . . . 0.5 110.249 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.509 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 94.7 Cg_endo -95.82 165.62 1.36 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.168 1.912 . . . . 0.45 113.602 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.89 167.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.55 -1.278 . . . . 0.44 107.55 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 83.5 p -140.1 155.83 46.84 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.215 -0.594 . . . . 0.88 112.225 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 t -144.54 103.2 3.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.231 -1.025 . . . . 0.96 108.231 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.732 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -108.17 148.63 29.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.549 -0.296 . . . . 1.76 110.24 -177.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.94 141.5 7.1 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.809 -0.71 . . . . 0.5 111.676 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 1.6 mp0 -104.73 127.82 52.63 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.927 -0.636 . . . . 2.1 109.297 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -147.92 173.02 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.724 0.297 . . . . 0.76 110.314 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.85 159.99 1.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.08 0.77 . . . . 3.53 113.08 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' A' ' 145' ' ' PRO . 25.9 tp -56.82 132.16 78.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.088 -0.96 . . . . 1.23 110.333 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.7 Cg_endo -59.22 172.42 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.055 2.503 . . . . 0.71 112.773 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -49.89 103.84 0.06 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.068 0.461 . . . . 1.71 111.67 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.449 ' HD1' ' O ' ' A' ' 145' ' ' PRO . 28.6 p90 -116.75 125.09 51.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.616 . . . . 2.64 110.876 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.8 mmtt -142.13 78.85 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.87 -0.604 . . . . 3.72 110.086 176.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 t70 70.16 1.28 3.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.85 -0.613 . . . . 4.28 111.073 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -82.17 -50.67 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.294 -0.632 . . . . 2.86 109.294 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.139 -0.937 . . . . 3.96 109.99 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.667 0.27 . . . . 12.11 110.519 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.36 2.88 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 9.02 111.377 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -68.23 -72.73 0.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 6.83 110.979 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 7' ' ' LYS . 45.4 tp -116.81 103.81 10.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.229 -0.441 . . . . 8.55 110.393 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 67.0 tp -146.69 -57.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.933 -0.576 . . . . 10.47 110.339 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.99 -11.47 30.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 11.69 111.009 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.677 ' HB2' HD12 ' A' ' 4' ' ' LEU . 13.4 mptt -68.15 130.67 43.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 11.42 110.787 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.56 -160.4 0.76 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.615 . . . . 11.58 110.147 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -107.15 157.21 18.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.572 -0.285 . . . . 15.74 110.617 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 67.95 -79.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.925 0.765 . . . . 12.69 111.554 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.42 93.65 8.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.234 0.54 . . . . 13.85 110.763 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -108.07 -1.91 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 8.87 110.762 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.13 64.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 8.91 110.917 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.62 -30.79 63.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.679 -0.692 . . . . 8.6 110.436 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' HD2' ' N ' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.11 -42.77 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 9.04 111.64 -174.16 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.4 tp 67.8 109.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.906 0.754 . . . . 5.58 110.017 -172.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.509 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 89.4 m -60.63 -50.15 74.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.863 -0.608 . . . . 2.69 111.796 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 129' ' ' VAL . . . -64.9 157.78 27.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.402 0.62 . . . . 1.68 111.721 -176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.798 HG23 HD13 ' A' ' 126' ' ' LEU . 3.1 tp -91.23 109.12 33.49 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.294 -0.866 . . . . 3.19 109.891 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 58.1 Cg_endo -112.24 109.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 125.377 4.051 . . . . 2.42 115.596 -166.829 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 65.1 mttp -153.01 96.26 2.93 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 107.825 -1.176 . . . . 6.38 107.825 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' LYS . 64.8 Cg_exo -18.09 110.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 125.137 3.891 . . . . 2.77 113.14 -168.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' HB2' HD11 ' A' ' 134' ' ' ILE . 51.3 mp0 -103.01 113.31 26.67 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.024 -1.472 . . . . 3.39 107.024 -161.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.796 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -92.75 179.25 39.88 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.3 -1.429 . . . . 0.54 114.091 -166.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 47' ' ' VAL . 11.4 m -170.78 36.55 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.795 1.238 . . . . 1.2 108.023 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 46' ' ' SER . 27.6 m -133.12 154.3 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.098 -1.41 . . . . 0.93 109.226 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -168.79 -41.3 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.546 0.529 . . . . 0.48 110.595 168.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 1.016 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 27.2 t70 -173.21 160.18 4.01 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.354 -0.239 . . . . 1.69 110.354 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 41' ' ' TYR . 56.0 t -137.66 135.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.143 -0.317 . . . . 1.14 110.143 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 17.6 m-20 -108.18 122.68 47.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.362 -0.381 . . . . 1.83 111.311 -173.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.94 110.335 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -125.53 -122.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.617 -0.512 . . . . 1.33 109.617 169.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.851 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.0 p30 172.28 176.16 0.09 Allowed 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 122.446 0.298 . . . . 2.85 110.296 -173.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.7 97.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 122.358 1.075 . . . . 3.26 111.887 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 67.2 -98.96 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.866 -1.061 . . . . 3.16 109.097 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -169.85 20.65 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.768 1.27 . . . . 5.46 108.968 173.566 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -101.82 -40.21 7.04 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.875 -1.966 . . . . 1.92 107.216 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.597 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 13.8 t -145.58 178.84 7.83 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 112.961 -1.927 . . . . 0.94 106.453 170.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.851 HG13 ' HA ' ' A' ' 33' ' ' ASP . 12.2 t -128.78 162.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.016 -1.105 . . . . 0.86 108.016 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 63.3 mt-10 -123.58 144.55 49.51 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.767 -0.773 . . . . 1.19 112.144 -170.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.855 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -126.33 103.91 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.014 -0.994 . . . . 3.73 110.672 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -81.05 109.15 15.34 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.075 -1.083 . . . . 0.81 108.075 176.508 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -111.0 114.61 28.05 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.673 -0.411 . . . . 0.42 110.518 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 1.016 ' HD3' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -83.62 134.88 34.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.287 -1.005 . . . . 2.63 108.287 173.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.57 ' CG2' HG12 ' A' ' 92' ' ' ILE . 40.8 t -113.18 148.47 16.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.052 -0.976 . . . . 0.82 110.12 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -133.6 101.37 5.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.344 0.592 . . . . 0.72 110.7 170.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 59.6 t -83.42 124.79 39.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 114.901 -1.045 . . . . 1.14 110.721 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.8 m -108.49 118.28 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.251 -0.431 . . . . 0.41 110.206 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 2.8 p30 -96.54 146.21 30.91 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.429 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.622 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 57.5 Cg_endo -90.17 4.51 4.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.921 3.081 . . . . 0.73 114.771 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.69 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 3.8 t80 -95.27 -113.52 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 119.514 -0.874 . . . . 2.08 110.173 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 51' ' ' TYR . 50.0 p -165.32 20.09 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.866 -1.061 . . . . 1.51 108.468 171.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -146.22 158.33 43.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 1.67 110.871 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.707 ' HA ' HD23 ' A' ' 82' ' ' LEU . 31.4 t -55.95 104.11 0.12 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.198 -1.364 . . . . 1.39 111.678 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG21 HD23 ' A' ' 126' ' ' LEU . 8.8 pt -79.06 123.3 84.99 Favored Pre-proline 0 C--O 1.213 -0.848 0 C-N-CA 120.442 -0.503 . . . . 1.03 109.911 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 81' ' ' SER . 29.1 Cg_endo -63.06 -55.12 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.796 1.664 . . . . 0.37 112.942 -159.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.4 mm -130.73 154.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.218 -0.593 . . . . 1.23 111.088 -172.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -147.17 178.19 8.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.106 0.955 . . . . 1.15 111.697 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.045 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 4.5 tm-20 -140.43 112.84 7.91 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.53 -1.668 . . . . 1.36 109.442 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.613 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -99.33 115.09 39.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.536 -1.665 . . . . 1.05 111.373 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -110.33 103.09 11.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.697 -1.592 . . . . 0.83 108.51 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.7 p90 -109.46 132.62 53.96 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.482 0.658 . . . . 0.4 109.546 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 29.0 m -128.41 102.06 6.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.074 -0.967 . . . . 0.38 109.55 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 97.9 m-85 -96.41 139.45 32.51 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.752 -0.833 . . . . 0.96 108.752 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HA ' ' C ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -146.29 138.14 24.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 1.29 109.056 175.357 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.755 ' CB ' HD22 ' A' ' 104' ' ' LEU . 47.6 t -95.5 -98.77 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.458 -0.497 . . . . 1.27 111.384 -173.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -56.78 -60.05 4.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.279 0.562 . . . . 0.36 109.564 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.23 18.21 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.269 -1.533 . . . . 0.39 109.269 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -103.44 -56.04 2.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.233 -0.484 . . . . 1.97 111.069 -173.47 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.734 ' C ' ' HA ' ' A' ' 65' ' ' HIS . 31.1 tt0 171.49 176.96 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.761 -1.57 . . . . 2.61 106.761 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.075 ' HA ' HG21 ' A' ' 100' ' ' ILE . 4.4 mm -145.4 -47.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 C-N-CA 124.425 1.09 . . . . 0.4 108.529 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.33 121.44 0.59 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.229 -0.986 . . . . 0.49 112.011 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -124.49 163.92 20.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.687 0.756 . . . . 1.81 111.901 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.01 169.66 26.76 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.091 -1.204 . . . . 0.43 110.091 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HB2' ' OE2' ' A' ' 59' ' ' GLU . 10.6 ptmm? -144.12 135.02 25.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.632 0.716 . . . . 1.72 111.22 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 52.9 mt -139.98 138.22 19.3 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.723 -0.671 . . . . 0.73 110.152 -173.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 4.2 Cg_exo -78.0 125.9 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.484 2.122 . . . . 0.57 111.208 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -130.86 146.16 60.86 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.47 -0.567 . . . . 0.79 109.47 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' HD13 ' A' ' 57' ' ' ILE . 20.0 Cg_exo -66.61 92.31 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.245 1.963 . . . . 0.58 111.794 174.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.1 25.39 17.43 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.4 112.267 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 82.6 p -70.39 119.84 15.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.741 -0.837 . . . . 0.62 108.741 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -141.18 -159.5 0.97 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.837 1.051 . . . . 1.1 113.837 -159.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 60.5 mttm -52.16 -95.98 0.0 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.821 -1.081 . . . . 1.84 112.801 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 168.84 113.44 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.862 -1.162 . . . . 0.99 107.862 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.69 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 7.7 ptmm? 41.02 51.38 3.28 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.029 0.83 . . . . 1.84 112.02 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.1 t70 -161.83 -171.42 2.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.024 -0.535 . . . . 0.64 111.008 -169.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.635 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.2 ttm -112.27 118.68 35.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 1.35 111.23 -169.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.0 t -106.36 144.45 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 0.77 110.655 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.87 118.0 24.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.546 0.689 . . . . 0.48 111.032 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 45' ' ' VAL . 6.4 tt -119.58 175.7 5.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.765 -1.198 . . . . 0.77 107.765 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.5 m-20 -136.57 143.03 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.739 0.7 . . . . 1.81 111.799 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 41.8 mm -113.66 130.18 24.01 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.173 -1.417 . . . . 0.65 107.173 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.565 ' O ' HD22 ' A' ' 42' ' ' LEU . 62.1 Cg_exo -50.42 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.344 2.696 . . . . 1.07 114.36 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -163.4 91.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 O-C-N 122.112 -0.368 . . . . 0.46 111.375 -176.028 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.3 p -127.34 103.19 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.085 1.143 . . . . 0.48 114.085 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.504 ' CG2' HD23 ' A' ' 101' ' ' LEU . 2.5 p -154.52 99.61 2.45 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 120.718 -0.393 . . . . 1.07 111.473 160.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 5.8 Cg_endo -49.88 137.72 35.15 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.192 1.928 . . . . 0.48 112.506 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.597 ' H ' ' HA ' ' A' ' 38' ' ' SER . 21.6 t80 -53.81 -32.03 51.24 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.769 -0.65 . . . . 1.31 111.45 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.8 m -53.21 -31.6 43.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 1.2 111.882 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 1.075 HG21 ' HA ' ' A' ' 71' ' ' ILE . 37.5 mm -76.27 -57.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.828 0.823 . . . . 0.51 111.501 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.061 HD22 HD21 ' A' ' 104' ' ' LEU . 2.0 mm? -54.23 -26.68 29.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.393 -1.73 . . . . 1.0 110.827 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 99' ' ' SER . 79.1 t80 -64.56 -45.76 85.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.239 -1.346 . . . . 0.96 108.568 177.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.05 -56.72 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.708 -0.678 . . . . 0.82 111.799 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.061 HD21 HD22 ' A' ' 101' ' ' LEU . 2.2 pp -61.08 -52.72 63.75 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.129 0.788 . . . . 0.65 113.129 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.6 -25.48 67.41 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.852 0.834 . . . . 0.43 110.347 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 ttp180 -64.98 -52.15 57.77 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.671 -1.15 . . . . 1.81 110.092 174.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.4 t70 -82.88 -52.83 6.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.55 0.691 . . . . 0.8 112.342 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -85.34 -28.45 6.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 121.714 -0.616 . . . . 0.88 110.035 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.15 -20.67 80.02 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.705 -0.759 . . . . 0.38 111.499 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -49.35 -47.14 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.049 -1.463 . . . . 1.09 107.049 165.17 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.7 m-20 -66.8 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 1.87 109.761 162.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 178.17 -54.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.543 0.527 . . . . 1.17 111.545 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.57 128.87 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.175 0.512 . . . . 2.15 111.067 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.54 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.7 mp -112.67 155.94 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.668 -0.696 . . . . 0.39 110.197 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -98.09 153.43 18.43 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.081 -0.711 . . . . 2.11 109.081 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 61.3 m-85 -140.13 166.13 25.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.639 -0.874 . . . . 0.62 108.639 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.862 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 28.4 tt0 -157.0 137.45 13.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.871 0.367 . . . . 0.8 110.925 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.666 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 14.2 tp -103.65 133.11 49.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.792 -0.64 . . . . 1.25 110.018 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.788 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.9 tp60 -118.8 100.18 7.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.399 -0.963 . . . . 0.63 108.399 172.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 HG22 ' A' ' 60' ' ' ILE . 7.2 tp -112.21 114.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.195 0.521 . . . . 0.81 111.207 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -91.8 142.53 16.1 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.644 -0.982 . . . . 0.26 110.644 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.8 mm? -121.48 122.32 39.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.3 0.571 . . . . 1.2 112.469 -173.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.045 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.9 m -116.37 96.1 5.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.844 -1.071 . . . . 0.32 108.994 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.643 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -108.1 140.86 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.367 -0.533 . . . . 0.98 110.607 -175.275 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.64 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.1 m-20 -84.81 105.87 15.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.406 -0.961 . . . . 1.52 108.406 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.88 HD23 HG21 ' A' ' 55' ' ' ILE . 17.5 mt -111.07 143.38 28.23 Favored Pre-proline 0 C--O 1.219 -0.54 0 O-C-N 125.247 1.592 . . . . 1.28 109.158 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.4 -25.0 71.38 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.158 1.905 . . . . 0.74 114.08 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.524 HG23 ' HE2' ' A' ' 51' ' ' TYR . 60.1 t -74.65 -58.64 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.846 0.684 . . . . 1.12 112.846 -174.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 18' ' ' ALA . 40.1 t -105.37 -2.85 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 122.798 1.285 . . . . 1.35 109.523 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.48 -0.84 53.91 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 113.479 -1.691 . . . . 1.05 111.852 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.6 pt-20 -176.49 174.07 1.96 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.523 -0.547 . . . . 1.16 109.523 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.549 ' HB2' HD12 ' A' ' 126' ' ' LEU . 8.3 t80 -170.74 124.07 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.337 -0.986 . . . . 1.91 108.337 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.8 t -114.16 102.85 10.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.87 0.843 . . . . 1.19 111.687 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 23' ' ' GLU . 2.5 pp -127.96 144.99 53.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 0.5 110.137 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 58.6 Cg_endo -96.44 162.43 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.223 1.948 . . . . 0.45 113.134 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.461 HG23 HG23 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -160.39 167.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.765 -1.198 . . . . 0.44 107.765 179.239 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 137' ' ' SER . . . . . . . . . . . . . 88.7 p -146.17 159.17 43.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.599 0.592 . . . . 0.88 112.599 -168.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -151.0 109.83 3.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.851 -0.796 . . . . 0.96 108.851 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.862 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -107.43 148.0 29.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 1.76 110.217 -179.652 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.38 142.59 8.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.701 -0.762 . . . . 0.5 111.866 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -113.07 133.99 54.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.125 -0.538 . . . . 2.1 110.391 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.49 174.96 7.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.525 -0.917 . . . . 0.76 108.525 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -69.13 175.25 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.87 0.367 . . . . 3.53 111.599 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.704 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.9 tp -57.15 136.37 80.72 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 1.23 111.694 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.704 ' HD2' HD12 ' A' ' 144' ' ' LEU . 72.5 Cg_endo -74.21 174.31 12.69 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.523 2.815 . . . . 0.71 112.902 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.3 m -55.08 114.99 1.98 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.745 -0.661 . . . . 1.71 111.366 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.93 156.23 44.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 2.64 110.086 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 38.6 ttmt -177.32 85.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.176 0.297 . . . . 3.72 110.633 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.6 t70 64.77 4.72 2.49 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.235 0.614 . . . . 4.28 111.6 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.23 -53.24 4.55 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.347 -0.612 . . . . 2.86 109.347 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.04 -0.982 . . . . 3.96 109.385 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.671 -0.122 . . . . 12.11 110.671 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.08 -53.06 0.62 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.576 0.954 . . . . 9.02 113.576 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.478 ' HA ' ' HB ' ' A' ' 17' ' ' THR . 16.9 t 73.38 -49.96 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.468 0.707 . . . . 6.83 110.018 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.76 115.46 30.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.098 -0.704 . . . . 8.55 109.098 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.21 -61.18 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.736 0.303 . . . . 10.47 111.222 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.61 141.69 33.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.325 -0.398 . . . . 11.69 110.088 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.58 -28.57 9.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.653 -0.248 . . . . 11.42 111.38 -173.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 61.1 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.766 0.666 . . . . 11.58 111.731 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -137.15 71.89 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.047 -0.353 . . . . 15.74 110.047 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.16 19.64 10.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.908 -0.587 . . . . 12.69 111.854 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.04 109.77 6.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.815 0.341 . . . . 13.85 110.531 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.665 HG21 ' HB2' ' A' ' 15' ' ' LYS . 16.5 m -88.51 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.2 -0.455 . . . . 8.87 110.419 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.0 -50.81 53.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 8.91 109.888 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -150.24 110.31 4.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.446 -0.797 . . . . 8.6 109.752 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 12' ' ' VAL . 28.4 ttpp -91.3 100.65 13.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.288 -0.415 . . . . 9.04 110.522 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.2 tp -150.05 -101.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 5.58 110.291 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.478 ' HB ' ' HA ' ' A' ' 3' ' ' SER . 24.9 m 57.31 -90.4 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.429 0.456 . . . . 2.69 110.558 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' O ' HG11 ' A' ' 128' ' ' VAL . . . 47.95 -131.27 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.155 0.798 . . . . 1.68 113.155 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.904 HG21 HD13 ' A' ' 126' ' ' LEU . 37.2 pt -130.25 179.56 1.29 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 3.19 111.199 -164.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 30.2 Cg_exo -64.41 -152.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.061 2.507 . . . . 2.42 112.98 172.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.596 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 60.6 tttm -150.57 -49.38 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.069 0.396 . . . . 6.38 112.069 -172.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 Cg_exo -74.79 63.31 5.79 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 2.77 112.855 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.679 ' HG2' ' HG3' ' A' ' 50' ' ' PRO . 2.0 mp0 -130.95 145.03 51.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.365 -2.087 . . . . 3.39 105.365 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -116.36 -177.1 18.13 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 117.956 -2.068 . . . . 0.54 116.973 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.667 ' O ' HG13 ' A' ' 45' ' ' VAL . 99.7 p -161.53 35.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.38 -2.082 . . . . 1.2 105.38 170.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' SER . 10.5 m -133.27 154.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.808 -1.996 . . . . 0.93 108.39 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 7.8 t -173.17 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.365 0.416 . . . . 0.48 111.933 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 4.4 t70 -164.41 156.44 16.34 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.117 -0.364 . . . . 1.69 110.112 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -143.85 132.7 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.57 -0.53 . . . . 1.14 109.57 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 23.2 m-20 -112.94 124.08 51.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.798 0.333 . . . . 1.83 111.121 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -87.69 121.04 29.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.045 -0.525 . . . . 0.94 109.737 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.5 -127.04 0.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.571 -0.529 . . . . 1.33 109.571 171.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.683 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.6 p30 175.7 174.83 0.27 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.419 0.526 . . . . 2.85 112.419 -169.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 34' ' ' VAL . 14.4 p -160.12 100.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.067 -0.97 . . . . 3.26 111.057 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 3.0 t-20 67.1 -103.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.131 -0.692 . . . . 3.16 109.131 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -173.71 30.82 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.391 -1.337 . . . . 5.46 107.391 172.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.37 -43.29 6.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 112.758 -2.019 . . . . 1.92 106.141 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.647 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 36.3 t -149.62 178.33 8.94 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.409 -2.632 . . . . 0.94 105.599 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.113 HG23 HG13 ' A' ' 96' ' ' VAL . 13.8 m -129.29 179.55 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 109.356 -0.609 . . . . 0.86 109.356 164.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 74.5 mt-10 -123.49 142.44 51.0 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.904 -0.718 . . . . 1.19 112.4 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.808 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -123.39 104.16 8.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.124 -0.944 . . . . 3.73 109.726 176.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -75.92 111.29 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.971 -1.122 . . . . 0.81 107.971 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.68 109.7 21.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.697 0.76 . . . . 0.42 109.944 -175.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 28' ' ' ASP . 41.3 mmtm -83.68 123.53 29.92 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.702 -1.136 . . . . 2.63 108.934 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 25' ' ' SER . 55.4 t -111.45 138.92 38.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.625 -0.716 . . . . 0.82 111.118 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.611 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 3.5 m -133.93 100.0 4.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.368 0.604 . . . . 0.72 110.16 168.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.9 t -82.38 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.115 -0.948 . . . . 1.14 111.011 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.539 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.2 m -109.59 109.59 20.4 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.318 -0.623 . . . . 0.41 109.318 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -96.8 125.44 46.6 Favored Pre-proline 0 C--O 1.24 0.563 0 O-C-N 124.28 0.987 . . . . 1.48 109.404 175.147 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.679 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 18.1 Cg_endo -112.32 39.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.4 3.4 . . . . 0.73 116.513 -169.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 10.7 t80 -116.32 -10.82 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.03 1.287 . . . . 2.08 112.18 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.615 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 54.4 p 86.91 26.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.837 1.655 . . . . 1.51 109.401 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -147.46 123.67 10.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.265 -1.334 . . . . 1.67 109.297 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.816 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.0 m -49.03 104.69 0.07 Allowed 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 122.926 0.49 . . . . 1.39 112.045 172.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.944 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.65 170.52 14.85 Favored Pre-proline 0 C--O 1.209 -1.07 0 N-CA-C 108.161 -1.051 . . . . 1.03 108.161 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.6 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.3 Cg_endo -92.87 -63.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.731 1.621 . . . . 0.37 114.395 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 79' ' ' PRO . 12.4 mm -128.29 160.62 38.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 121.079 -0.248 . . . . 1.23 110.721 -167.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.576 ' CB ' HG22 ' A' ' 124' ' ' ILE . 25.6 p -156.58 -177.52 6.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 122.116 0.96 . . . . 1.15 112.772 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.074 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 26.2 tt0 -133.04 117.1 17.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.184 -1.825 . . . . 1.36 109.845 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.746 HG22 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -97.26 109.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 121.997 0.903 . . . . 1.05 109.018 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 19.4 p -112.76 102.76 10.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.005 -1.452 . . . . 0.83 108.908 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 4.6 p90 -112.07 124.9 53.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.467 -0.568 . . . . 0.4 109.467 -168.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 6.6 m -121.9 106.11 10.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.21 -0.904 . . . . 0.38 108.703 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 86.1 m-85 -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.935 -0.395 . . . . 0.96 109.935 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.406 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -126.78 144.53 50.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.569 -0.9 . . . . 1.29 108.569 178.012 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.489 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.48 -112.75 0.16 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.298 177.237 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.31 -51.18 64.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.684 -0.858 . . . . 0.36 108.684 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' H ' HH11 ' A' ' 69' ' ' ARG . . . -161.58 12.74 0.13 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.405 -1.078 . . . . 0.39 110.405 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' HE ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -112.62 -164.99 0.95 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 -175.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.92 98.23 7.74 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.259 0.552 . . . . 2.61 109.868 -169.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.938 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -52.25 -34.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.145 -0.934 . . . . 0.4 110.358 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.74 170.9 27.11 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.823 -0.911 . . . . 0.49 110.823 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.09 163.98 23.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.011 0.906 . . . . 1.81 111.691 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.72 170.42 34.15 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.318 -0.856 . . . . 0.43 110.995 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 133.68 27.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.936 0.398 . . . . 1.72 110.734 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.69 123.13 17.1 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.049 -0.523 . . . . 0.73 110.457 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.8 116.16 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.427 2.084 . . . . 0.57 110.713 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.85 140.48 37.82 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 121.17 -0.212 . . . . 0.79 110.501 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HA ' HD13 ' A' ' 57' ' ' ILE . 21.1 Cg_endo -61.26 88.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.821 2.347 . . . . 0.58 112.46 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.56 43.08 2.77 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.802 -0.636 . . . . 0.4 111.801 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.944 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.6 p -74.08 121.9 21.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.878 -0.415 . . . . 0.62 109.878 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.816 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -164.66 170.69 15.34 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.41 1.633 . . . . 1.1 115.41 -163.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.881 ' HG3' ' HB3' ' A' ' 86' ' ' ASP . 71.4 mmtt 7.57 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.859 1.664 . . . . 1.84 114.031 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . 172.0 -44.23 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.622 -1.992 . . . . 0.99 105.622 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.6 ttpt -159.65 71.08 0.48 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 112.131 -2.304 . . . . 1.84 110.162 173.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.881 ' HB3' ' HG3' ' A' ' 83' ' ' LYS . 6.9 t70 -162.24 -161.66 0.76 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.011 -1.45 . . . . 0.64 108.809 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.601 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 47.9 ttm -121.3 122.16 39.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.858 -0.423 . . . . 1.35 109.858 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 46' ' ' SER . 2.7 t -104.45 143.04 33.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.119 -0.492 . . . . 0.77 109.709 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.93 123.35 31.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.48 110.781 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.604 HD22 HG11 ' A' ' 45' ' ' VAL . 8.7 tt -130.64 164.5 24.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.137 -1.431 . . . . 0.77 107.137 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.65 142.28 32.04 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.173 -1.011 . . . . 1.81 111.764 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 35.3 mm -100.83 143.39 26.49 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.724 -1.213 . . . . 0.65 107.724 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 42' ' ' LEU . 81.9 Cg_exo -48.15 -107.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.212 2.608 . . . . 1.07 114.0 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.41 94.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 O-C-N 121.617 -0.677 . . . . 0.46 111.979 -172.875 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.4 p -127.49 103.02 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.581 1.326 . . . . 0.48 114.581 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 1.113 HG13 HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -151.98 112.89 2.9 Favored Pre-proline 0 C--O 1.219 -0.517 0 O-C-N 121.712 -0.618 . . . . 1.07 110.332 157.582 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 4.8 Cg_endo -53.98 135.16 62.73 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.38 1.387 . . . . 0.48 111.619 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.647 ' H ' ' HA ' ' A' ' 38' ' ' SER . 22.8 t80 -55.58 -30.7 61.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.762 -0.654 . . . . 1.31 110.912 -177.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.687 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.2 p -58.14 -28.78 65.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.995 -0.548 . . . . 1.2 112.32 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 mm -77.51 -52.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.031 -0.418 . . . . 0.51 111.014 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.089 HD23 HD21 ' A' ' 104' ' ' LEU . 21.3 mt -50.75 -27.01 6.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.5 0.666 . . . . 1.0 110.185 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 151' ' ' PHE . 46.9 t80 -63.81 -42.5 97.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.472 -1.24 . . . . 0.96 108.917 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.671 ' HA ' HH21 ' A' ' 106' ' ' ARG . 2.9 m-20 -74.24 -57.59 3.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.665 -0.698 . . . . 0.82 111.789 -179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.089 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -57.36 -50.13 73.93 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.926 0.714 . . . . 0.65 112.926 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 104' ' ' LEU . . . -68.95 -26.72 65.2 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.497 0.665 . . . . 0.43 110.274 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.671 HH21 ' HA ' ' A' ' 103' ' ' ASN . 2.7 ttp180 -68.0 -54.49 18.12 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.238 -0.892 . . . . 1.81 110.222 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.64 -53.93 6.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.8 111.277 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.632 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.6 t -89.05 -28.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.415 -0.514 . . . . 0.88 110.57 -174.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 144' ' ' LEU . . . -68.33 -25.29 74.77 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.063 -1.065 . . . . 0.38 111.416 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -53.7 -46.77 62.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.475 -1.305 . . . . 1.09 107.475 168.791 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 15.2 m-20 -68.01 -61.28 1.94 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.712 0.634 . . . . 1.87 112.712 169.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.435 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER 153.48 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.209 1.004 . . . . 1.17 113.593 -173.166 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -92.5 128.82 38.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.101 0.56 . . . . 2.15 111.006 -173.598 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' HB2' ' A' ' 104' ' ' LEU . 3.3 mp -110.69 155.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.842 -0.429 . . . . 0.39 109.842 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 15.1 p-10 -98.41 153.05 18.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.988 -0.745 . . . . 2.11 108.988 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 74.4 m-85 -143.62 165.44 27.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.62 108.696 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.715 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.5 tt0 -153.16 135.94 15.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 0.8 110.307 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.601 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 11.4 tp -104.72 130.76 52.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.821 -0.437 . . . . 1.25 109.821 171.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.1 tp60 -117.16 100.29 7.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.469 -0.937 . . . . 0.63 108.469 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -119.94 120.42 63.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.617 0.722 . . . . 0.81 111.137 -171.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.77 129.13 9.47 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.228 -0.896 . . . . 0.26 112.101 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.566 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.8 mp -100.84 92.98 5.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 1.2 110.907 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.074 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.5 m -94.18 95.93 9.28 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.942 -0.762 . . . . 0.32 108.942 172.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.576 HG22 ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.93 137.84 43.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.148 -0.621 . . . . 0.98 110.761 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.467 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 7.2 t70 -79.52 106.74 11.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.799 -1.186 . . . . 1.52 107.799 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.904 HD13 HG21 ' A' ' 19' ' ' ILE . 6.7 mt -113.5 166.05 12.07 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.467 -0.788 . . . . 1.28 110.648 -171.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.24 -16.76 15.35 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 121.914 1.743 . . . . 0.74 111.867 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 19' ' ' ILE . 3.0 t -75.18 -59.7 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.433 0.531 . . . . 1.12 112.433 -174.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 131' ' ' GLU . 2.8 t -111.7 -0.2 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 122.643 1.211 . . . . 1.35 108.891 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 80.48 -28.62 2.68 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 113.453 -1.703 . . . . 1.05 111.267 -170.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.8 pt-20 -175.35 143.69 0.66 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.087 -1.079 . . . . 1.16 108.087 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.5 t80 -155.7 145.47 21.28 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.638 -0.504 . . . . 1.91 109.638 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.6 t -113.23 107.94 16.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.581 0.705 . . . . 1.19 110.922 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.5 pp -115.12 128.29 26.07 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.701 -0.852 . . . . 0.5 108.701 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 19.6 Cg_endo -89.3 160.02 5.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 121.759 1.64 . . . . 0.45 112.735 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.53 166.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.972 -1.122 . . . . 0.44 107.972 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.1 m -139.98 153.19 46.81 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.782 -0.367 . . . . 0.88 111.304 -168.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.0 t -143.84 105.72 4.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.269 -1.011 . . . . 0.96 108.269 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.29 149.07 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.627 -0.26 . . . . 1.76 110.788 -176.535 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.04 148.19 16.28 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.517 -0.849 . . . . 0.5 112.131 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -106.1 124.48 49.64 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.807 -0.812 . . . . 2.1 108.807 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.43 173.07 13.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.238 -0.653 . . . . 0.76 109.238 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -55.39 160.3 2.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.543 0.687 . . . . 3.53 112.358 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.716 HD12 ' HD2' ' A' ' 145' ' ' PRO . 24.6 tp -56.29 134.78 75.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.776 -1.102 . . . . 1.23 110.658 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.716 ' HD2' HD12 ' A' ' 144' ' ' LEU . 35.5 Cg_endo -63.2 168.19 11.36 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.787 2.325 . . . . 0.71 111.524 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -78.32 90.1 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.159 0.429 . . . . 1.71 112.159 -172.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.632 ' HB3' ' HB2' ' A' ' 150' ' ' PHE . 96.4 m-85 -137.28 103.78 5.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.305 0.574 . . . . 2.64 110.525 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.641 ' HA ' ' HE3' ' A' ' 148' ' ' LYS . 1.3 tpmt? -72.53 -74.86 0.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 3.72 110.698 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -115.97 22.93 12.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.323 0.582 . . . . 4.28 110.105 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.632 ' HB2' ' HB3' ' A' ' 147' ' ' PHE . 15.4 m-85 -76.99 -47.01 21.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.889 -0.782 . . . . 2.86 108.889 174.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.727 ' CZ ' ' HA ' ' A' ' 102' ' ' PHE . 35.4 m-85 . . . . . 0 C--O 1.243 0.746 0 CA-C-N 115.384 -0.825 . . . . 3.96 109.437 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.93 0.395 . . . . 12.11 110.528 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.846 ' HB1' ' HB3' ' A' ' 14' ' ' ASP . . . -74.62 153.81 38.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 9.02 110.602 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.7 t -169.38 -58.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.975 -0.38 . . . . 6.83 109.975 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.7 tp 178.74 -58.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.345 -0.843 . . . . 8.55 109.044 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 56.56 -102.71 0.16 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.245 -0.889 . . . . 10.47 112.106 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -87.82 156.25 19.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.262 -0.426 . . . . 11.69 110.138 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -104.67 -2.4 25.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 11.42 111.142 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -112.17 21.25 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 11.58 110.987 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' O ' ' HD2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -90.43 109.2 20.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.371 0.605 . . . . 15.74 111.139 178.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.75 -16.75 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 12.69 110.432 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -50.41 -65.07 0.62 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.049 0.452 . . . . 13.85 110.359 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.93 141.46 40.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.481 -0.781 . . . . 8.87 109.408 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 71.4 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.959 -0.385 . . . . 8.91 109.959 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.846 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 3.8 m-20 58.32 88.01 0.07 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.958 0.786 . . . . 8.6 110.69 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 26.0 mmmt 61.16 -92.7 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.596 -0.729 . . . . 9.04 111.152 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.0 mt -140.21 35.55 1.9 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.238 -0.653 . . . . 5.58 109.238 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' HG12 ' A' ' 128' ' ' VAL . 26.3 m 79.43 -23.28 0.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.092 -0.958 . . . . 2.69 110.487 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.812 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -104.5 153.78 20.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.174 -0.466 . . . . 1.68 109.981 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.062 HG23 ' HD3' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -99.43 -63.46 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 114.095 1.146 . . . . 3.19 114.095 -166.205 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 1.062 ' HD3' HG23 ' A' ' 19' ' ' ILE . 7.5 Cg_endo -101.86 -143.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.491 2.128 . . . . 2.42 114.042 -171.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.716 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 9.7 ttmt -168.13 -55.34 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.734 -0.666 . . . . 6.38 111.393 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 42.5 Cg_endo -101.02 95.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.056 2.504 . . . . 2.77 113.5 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.623 ' HB3' ' O ' ' A' ' 48' ' ' THR . 10.3 mp0 -127.97 154.12 45.95 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.389 -2.448 . . . . 3.39 104.389 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -112.1 173.2 15.31 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 117.057 -2.497 . . . . 0.54 115.976 -169.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.67 ' OG ' HD11 ' A' ' 122' ' ' LEU . 79.6 p -162.15 31.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.964 -1.495 . . . . 1.2 106.964 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.7 m -132.79 153.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.209 -1.36 . . . . 0.93 109.665 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.46 -43.89 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.782 0.676 . . . . 0.48 110.407 169.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -169.67 145.27 3.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 122.287 -0.258 . . . . 1.69 110.518 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 96.5 t -119.05 132.74 68.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.387 -0.597 . . . . 1.14 109.387 173.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.92 137.19 54.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.87 0.367 . . . . 1.83 111.147 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.58 126.06 38.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.853 -0.612 . . . . 0.94 111.532 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -130.66 -131.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.774 -0.825 . . . . 1.33 108.774 167.519 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.938 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.2 p-10 171.98 175.76 0.08 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.239 0.927 . . . . 2.85 111.83 -171.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.7 p -156.39 92.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.379 0.609 . . . . 3.26 112.031 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 28.7 t-20 67.92 -62.83 0.34 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.003 0.921 . . . . 3.16 113.033 174.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 137.25 18.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.843 1.657 . . . . 5.46 110.511 -168.64 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.44 -45.14 10.21 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 105.112 -2.181 . . . . 1.92 105.112 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.623 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 14.3 m -148.78 178.46 8.64 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 110.534 -3.03 . . . . 0.94 106.33 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 33' ' ' ASP . 28.4 t -130.64 165.56 30.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.381 -0.97 . . . . 0.86 108.381 167.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.769 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 2.8 mt-10 -125.25 139.37 53.78 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.381 0.61 . . . . 1.19 111.528 -172.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.3 106.57 9.95 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.15 -0.932 . . . . 3.73 109.746 -176.507 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 4.8 tt -88.72 111.8 22.41 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.445 -1.302 . . . . 0.81 109.892 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.71 116.82 30.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.201 -0.909 . . . . 0.42 109.65 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -83.35 131.62 35.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.453 -0.943 . . . . 2.63 108.453 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 25' ' ' SER . 44.5 t -111.17 142.08 24.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.115 -0.948 . . . . 0.82 110.92 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.7 m -131.79 99.45 4.77 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.006 0.431 . . . . 0.72 109.905 167.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 62.2 t -82.46 127.9 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.576 -0.738 . . . . 1.14 110.537 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.639 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.9 m -107.79 113.82 27.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.293 -0.632 . . . . 0.41 109.293 176.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.868 ' HB3' HD21 ' A' ' 82' ' ' LEU . 29.3 p-10 -90.54 140.23 26.7 Favored Pre-proline 0 N--CA 1.461 0.117 0 O-C-N 123.864 0.727 . . . . 1.48 110.164 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' CG ' ' HG3' ' A' ' 20' ' ' PRO . 66.9 Cg_endo -96.36 6.22 1.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.891 3.061 . . . . 0.73 115.399 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.714 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 24.4 t80 -97.18 -113.03 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.855 -0.738 . . . . 2.08 110.08 -172.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.736 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 77.5 p 179.98 19.66 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 117.964 0.347 . . . . 1.51 111.263 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -139.09 19.86 2.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.736 0.643 . . . . 1.67 112.736 -168.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 31.7 t 57.79 96.57 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 111.955 0.354 . . . . 1.39 111.955 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.917 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -73.94 170.71 13.36 Favored Pre-proline 0 C--O 1.209 -1.055 0 N-CA-C 108.62 -0.881 . . . . 1.03 108.62 -172.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.0 Cg_endo -92.79 -61.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.797 1.665 . . . . 0.37 113.935 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.677 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.0 mm -125.95 154.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.217 -0.593 . . . . 1.23 111.479 -166.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 124' ' ' ILE . 26.4 m -145.16 176.43 9.52 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.083 0.944 . . . . 1.15 111.475 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.066 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 2.4 tm-20 -141.86 114.39 8.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.565 -1.652 . . . . 1.36 109.885 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.521 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -103.31 121.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.387 1.089 . . . . 1.05 112.307 173.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.743 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.41 109.66 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.107 -1.861 . . . . 0.83 109.74 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.0 p90 -114.06 122.82 48.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.141 0.496 . . . . 0.4 110.129 -169.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 26.8 m -122.07 109.61 14.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.524 -0.762 . . . . 0.38 109.586 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 118' ' ' LEU . 97.9 m-85 -98.6 141.2 31.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.036 -0.529 . . . . 0.96 110.707 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.431 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -131.94 145.74 51.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.64 -1.245 . . . . 1.29 107.64 175.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.94 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.9 t -109.98 -100.32 0.39 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.196 -1.002 . . . . 1.27 111.025 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.71 -56.8 16.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.231 -0.655 . . . . 0.36 109.231 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 18.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.589 -1.404 . . . . 0.39 109.589 162.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 7.9 ptp180 -105.85 -156.56 0.58 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.738 -0.838 . . . . 1.97 108.738 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.16 94.98 4.78 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.709 0.686 . . . . 2.61 110.098 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.888 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -56.55 -39.25 61.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.904 -1.043 . . . . 0.4 110.892 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.58 169.26 34.25 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.328 -0.939 . . . . 0.49 111.458 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.08 164.63 15.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.668 0.734 . . . . 1.81 111.028 173.607 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.16 167.89 34.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.885 -0.886 . . . . 0.43 110.885 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.743 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.3 mtpt -130.43 131.5 45.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.026 -0.361 . . . . 1.72 110.026 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -133.85 105.14 11.65 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.863 0.363 . . . . 0.73 110.483 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 11.9 Cg_exo -71.25 101.62 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.359 2.039 . . . . 0.57 110.428 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.28 143.57 29.1 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.606 -0.516 . . . . 0.79 109.606 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HA ' HD13 ' A' ' 57' ' ' ILE . 32.5 Cg_exo -62.38 78.78 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.308 2.005 . . . . 0.58 111.957 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.522 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 46.7 3.58 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.4 112.197 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.917 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 92.9 p -73.55 119.23 17.49 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.361 -0.607 . . . . 0.62 109.361 173.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 49' ' ' ASN . 2.2 pt? -153.03 163.9 38.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 119.191 -1.004 . . . . 1.1 113.241 -164.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 54' ' ' SER . 50.5 mttm -16.49 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.756 -1.565 . . . . 1.84 114.417 -168.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 165.5 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.608 -1.256 . . . . 0.99 107.608 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 37.5 pttt 42.32 52.08 4.62 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.197 0.935 . . . . 1.84 110.893 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.5 t70 -152.56 -166.94 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.288 -0.869 . . . . 0.64 110.356 -173.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 47.3 ttm -125.24 117.73 24.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.102 0.477 . . . . 1.35 110.944 -170.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -105.87 144.68 32.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.394 -0.821 . . . . 0.77 110.113 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.75 129.17 35.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.26 0.553 . . . . 0.48 110.927 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -135.25 174.18 10.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.246 -1.02 . . . . 0.77 108.246 -176.314 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 5.8 p-10 -142.72 139.48 31.12 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.736 0.698 . . . . 1.81 112.059 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.5 mm -109.03 115.97 56.18 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.783 -0.821 . . . . 0.65 108.783 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.7 Cg_exo -28.76 -102.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.405 4.07 . . . . 1.07 115.534 -173.169 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -164.88 95.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 O-C-N 122.266 -0.271 . . . . 0.46 111.474 -175.8 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.5 p -128.67 104.8 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.012 1.486 . . . . 0.48 115.012 -172.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -154.4 99.57 2.47 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.601 -0.687 . . . . 1.07 111.335 161.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.9 Cg_exo -51.78 134.65 48.32 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.014 1.809 . . . . 0.48 111.572 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.623 ' H ' ' HA ' ' A' ' 38' ' ' SER . 52.7 t80 -54.93 -36.9 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 1.31 111.635 -172.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 15.0 m -53.88 -30.97 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.377 . . . . 1.2 111.639 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.888 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 mm -76.82 -56.0 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.431 -0.508 . . . . 0.51 110.983 -175.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 104' ' ' LEU . 30.6 mt -53.84 -28.25 34.66 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.699 0.625 . . . . 1.0 110.53 174.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.5 t80 -62.4 -42.45 99.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.413 -1.267 . . . . 0.96 109.206 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.414 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.6 m-80 -74.66 -58.26 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.171 0.434 . . . . 0.82 112.171 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.94 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.8 pp -60.85 -48.83 80.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.665 0.987 . . . . 0.65 113.665 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -66.6 -25.59 66.69 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.852 0.834 . . . . 0.43 109.574 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.414 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.1 ttp180 -68.06 -48.82 64.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.554 -1.203 . . . . 1.81 110.451 172.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.646 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 30.1 t70 -81.36 -54.31 5.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.649 0.738 . . . . 0.8 112.164 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.9 t -87.33 -25.64 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.726 -0.609 . . . . 0.88 110.069 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.03 -20.84 80.13 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.717 -0.754 . . . . 0.38 111.309 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -49.99 -48.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.732 -1.581 . . . . 1.09 106.732 165.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' N ' HG12 ' A' ' 110' ' ' VAL . 30.3 t70 -69.02 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.38 -0.827 . . . . 1.87 109.992 164.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 178.41 -48.19 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.187 0.44 . . . . 1.17 112.187 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -92.76 124.13 36.54 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.012 -0.366 . . . . 2.15 110.012 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -111.7 154.24 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.846 -0.798 . . . . 0.39 108.846 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 152.78 19.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.985 -0.746 . . . . 2.11 108.985 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 57.4 m-85 -140.52 162.73 34.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.915 -0.772 . . . . 0.62 108.915 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.767 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.6 tt0 -151.05 133.57 15.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.947 0.403 . . . . 0.8 110.221 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.6 OUTLIER -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.301 -0.629 . . . . 1.25 109.301 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.642 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.8 tp60 -116.75 103.31 10.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.165 -0.68 . . . . 0.63 109.165 176.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 136' ' ' ILE . 8.4 tp -110.01 120.41 61.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.81 110.934 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.94 131.03 10.52 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.196 -0.762 . . . . 0.26 111.196 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 133' ' ' THR . 7.5 mp -108.23 106.22 16.3 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 120.926 0.393 . . . . 1.2 111.055 -176.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.066 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 81.4 m -109.0 96.6 6.43 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.314 -0.857 . . . . 0.32 109.478 173.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.674 HG22 ' SG ' ' A' ' 58' ' ' CYS . 19.5 pt -112.37 131.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.469 -0.492 . . . . 0.98 110.918 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.83 105.84 9.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.377 -0.601 . . . . 1.52 109.377 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 55' ' ' ILE . 83.3 mt -106.52 160.63 25.56 Favored Pre-proline 0 C--O 1.22 -0.456 0 O-C-N 124.81 1.318 . . . . 1.28 109.971 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.9 Cg_exo -68.97 -34.34 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.832 1.688 . . . . 0.74 113.434 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 17' ' ' THR . 21.5 t -73.34 -57.88 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.316 0.487 . . . . 1.12 112.316 -171.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.812 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -96.19 -7.21 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 122.046 0.927 . . . . 1.35 109.834 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.56 -28.55 2.72 Favored Glycine 0 C--N 1.311 -0.817 0 CA-C-N 113.626 -1.624 . . . . 1.05 111.16 -171.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.677 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.5 pt-20 -162.83 155.83 19.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.473 -0.936 . . . . 1.16 108.473 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.471 ' HB2' HD12 ' A' ' 126' ' ' LEU . 31.2 t80 -143.04 122.19 12.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.222 -0.659 . . . . 1.91 109.222 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.8 m -115.06 102.09 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.139 0.495 . . . . 1.19 111.763 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.08 144.36 50.21 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.015 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.91 164.1 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.885 1.723 . . . . 0.45 113.162 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -156.22 158.53 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.734 -1.21 . . . . 0.44 107.734 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.679 ' H ' HD12 ' A' ' 136' ' ' ILE . 83.0 p -140.59 152.58 45.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.627 -0.429 . . . . 0.88 111.827 -172.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -140.84 102.69 4.34 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.553 -1.276 . . . . 0.96 107.553 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.767 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -114.6 143.99 44.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.1 -0.5 . . . . 1.76 109.986 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.32 151.61 21.62 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.595 -0.812 . . . . 0.5 112.017 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -106.3 130.36 54.16 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.941 -0.763 . . . . 2.1 108.941 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.89 174.1 4.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.24 -1.022 . . . . 0.76 108.24 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' A' ' 143' ' ' LYS . 3.7 mppt? -65.6 163.82 15.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 3.53 112.154 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' ILE . 22.7 tp -55.49 131.23 70.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 114.903 -1.044 . . . . 1.23 111.076 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 144' ' ' LEU . 40.9 Cg_endo -67.11 163.07 35.5 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.093 2.529 . . . . 0.71 112.869 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.2 m -57.03 118.31 4.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 1.71 110.47 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.598 ' HB2' ' H ' ' A' ' 151' ' ' PHE . 8.6 p90 -124.02 -22.45 4.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.158 -0.474 . . . . 2.64 112.03 -172.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 150' ' ' PHE . 35.1 mmtp 57.19 29.23 16.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.62 0.247 . . . . 3.72 111.311 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 73.33 15.03 4.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.774 0.83 . . . . 4.28 111.238 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 94.1 m-85 -102.23 -48.82 4.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.769 -0.65 . . . . 2.86 110.424 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.598 ' H ' ' HB2' ' A' ' 147' ' ' PHE . 96.2 m-85 . . . . . 0 C--O 1.247 0.949 0 O-C-N 124.931 1.394 . . . . 3.96 109.819 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.388 -0.227 . . . . 12.11 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.53 -163.51 0.21 Allowed 'General case' 0 C--O 1.234 0.279 0 O-C-N 123.888 0.743 . . . . 9.02 112.087 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 34.6 t -91.44 154.88 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.727 -0.67 . . . . 6.83 109.782 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 158.42 16.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.314 -0.624 . . . . 8.55 109.314 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 mp 69.84 -66.35 0.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.641 0.588 . . . . 10.47 111.942 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -91.01 -25.15 19.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.31 -0.244 . . . . 11.69 111.245 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 3' ' ' SER . 68.1 mttm 64.82 5.35 2.79 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.907 0.706 . . . . 11.42 112.907 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.19 15.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.45 0.643 . . . . 11.58 110.325 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -84.96 -11.48 55.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 15.74 110.661 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -137.15 140.55 41.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.226 -0.443 . . . . 12.69 110.137 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -78.74 94.16 5.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.48 . . . . 13.85 110.3 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.78 149.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.818 -0.628 . . . . 8.87 111.196 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.31 -26.41 3.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.726 -0.67 . . . . 8.91 110.25 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.38 -15.9 44.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 8.6 110.263 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.59 -176.39 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 9.04 109.642 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 16' ' ' LEU . 1.7 pt? -136.57 91.56 2.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.182 0.515 . . . . 5.58 110.339 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 m -74.42 84.75 1.98 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.998 -0.547 . . . . 2.69 109.986 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . . . -175.24 176.59 2.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.67 -0.695 . . . . 1.68 110.598 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.691 HD11 ' HG3' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -84.65 156.15 61.84 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.497 -0.774 . . . . 3.19 110.373 -175.107 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.89 -64.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.696 2.264 . . . . 2.42 112.844 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 24.0 tptm -154.52 102.5 2.37 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 6.38 110.776 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.715 ' HB3' ' HG3' ' A' ' 50' ' ' PRO . 98.6 Cg_endo -93.68 82.01 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.399 2.733 . . . . 2.77 112.2 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HA ' HD23 ' A' ' 122' ' ' LEU . 8.4 pt-20 -122.17 119.01 30.02 Favored 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 119.453 -0.899 . . . . 3.39 110.812 -169.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.717 ' H ' HD21 ' A' ' 122' ' ' LEU . . . 172.73 119.49 0.53 Allowed Glycine 0 N--CA 1.408 -3.174 0 CA-C-N 114.47 -1.241 . . . . 0.54 111.939 170.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 122' ' ' LEU . 17.3 m -171.1 32.33 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.895 0.855 . . . . 1.2 108.894 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.3 m -133.29 148.29 31.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.863 -1.062 . . . . 0.93 109.969 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -169.76 -44.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.46 0.475 . . . . 0.48 111.793 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 8.7 t70 -157.4 153.59 27.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.77 -0.372 . . . . 1.69 111.183 -174.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.17 120.31 8.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.646 -0.502 . . . . 1.14 109.646 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -113.96 112.15 22.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 1.83 111.476 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.879 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.2 tm? -72.87 139.02 46.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.963 -0.562 . . . . 0.94 109.99 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' H ' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -141.99 -100.16 0.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.255 0.835 . . . . 1.33 113.255 -176.305 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.52 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 18.1 m-20 -93.22 178.71 5.65 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.911 -0.493 . . . . 2.85 109.809 -154.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 39' ' ' VAL . 48.8 t -152.97 -38.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.54 0.686 . . . . 3.26 110.455 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 4.9 t30 71.59 -75.04 0.08 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.142 -1.39 . . . . 3.16 108.617 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 174.21 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 123.847 0.717 . . . . 5.46 111.16 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.46 -25.54 1.02 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.408 0.623 . . . . 1.92 109.833 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 6.3 t -166.94 128.88 1.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.235 -0.893 . . . . 0.94 111.57 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 34' ' ' VAL . 24.2 t -77.65 156.1 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.566 -0.901 . . . . 0.86 108.566 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.899 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -137.17 145.64 43.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 119.516 -0.874 . . . . 1.19 109.368 -173.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.936 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.7 p90 -143.11 141.53 31.25 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.306 -0.958 . . . . 3.73 112.575 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.1 tm? -82.45 110.88 17.97 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.425 -0.954 . . . . 0.81 108.425 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.5 100.33 13.11 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.42 109.016 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 44' ' ' LYS . 23.8 ttmm -83.58 126.0 32.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.626 0.727 . . . . 2.63 109.109 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 25' ' ' SER . 37.4 t -109.51 144.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.725 -1.125 . . . . 0.82 110.481 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.456 ' HB3' ' CG ' ' A' ' 87' ' ' MET . 14.7 m -128.85 97.4 4.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.576 -0.898 . . . . 0.72 108.576 165.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.681 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -86.96 130.69 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.676 0.751 . . . . 1.14 111.173 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 32.1 m -116.88 114.99 24.66 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.344 -1.298 . . . . 0.41 109.447 -173.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.75 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.3 t30 -90.76 133.21 32.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 108.108 -1.071 . . . . 1.48 108.108 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.715 ' HG3' ' HB3' ' A' ' 22' ' ' PRO . 31.3 Cg_endo -90.9 8.29 3.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.103 2.536 . . . . 0.73 114.169 -174.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 49.2 t80 -119.0 139.14 52.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.949 -0.76 . . . . 2.08 108.949 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.7 p -79.13 37.81 0.33 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.659 0.614 . . . . 1.51 112.659 -164.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -146.25 130.58 17.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.271 -0.422 . . . . 1.67 110.056 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 m -43.5 100.76 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 124.116 0.966 . . . . 1.39 112.719 172.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.997 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.8 pt -75.55 171.97 10.49 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.431 -0.951 . . . . 1.03 108.431 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 8.0 Cg_endo -87.98 -59.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.498 1.465 . . . . 0.37 114.026 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.883 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 80.0 mt -137.38 155.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.669 0.618 . . . . 1.23 112.669 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -138.0 -178.99 5.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.731 0.777 . . . . 1.15 111.211 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.2 tt0 -141.78 115.5 9.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.99 -1.459 . . . . 1.36 109.982 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.1 109.93 23.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.697 -1.592 . . . . 1.05 109.951 173.542 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 8.5 m -110.97 102.58 11.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.87 -1.514 . . . . 0.83 108.586 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.791 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 3.8 p90 -109.79 122.33 47.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.506 . . . . 0.4 109.733 -168.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 93.9 m -121.03 104.91 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.511 -0.768 . . . . 0.38 109.4 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CE1' HD23 ' A' ' 118' ' ' LEU . 98.9 m-85 -98.14 140.99 31.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.952 -0.567 . . . . 0.96 111.148 -174.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.408 ' CE1' HG22 ' A' ' 63' ' ' THR . 0.2 OUTLIER -132.4 145.23 51.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.636 -1.246 . . . . 1.29 107.636 174.803 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.9 t -110.75 -98.03 0.41 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.317 -0.953 . . . . 1.27 111.062 172.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.95 -59.75 4.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.386 -0.598 . . . . 0.36 109.386 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.87 18.05 0.1 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.478 -1.449 . . . . 0.39 109.478 165.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -111.04 -166.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.119 -0.697 . . . . 1.97 109.119 -177.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -108.16 98.49 8.03 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.919 0.866 . . . . 2.61 109.689 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -64.57 -41.6 92.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.976 -1.465 . . . . 0.4 111.276 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 164.75 38.25 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.217 -0.992 . . . . 0.49 111.266 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.38 156.84 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.482 0.641 . . . . 1.81 110.991 172.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 165.27 160.77 13.02 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.722 -0.951 . . . . 0.43 110.722 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 3.7 ptmm? -136.95 130.74 32.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.968 0.414 . . . . 1.72 110.0 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.0 mt -134.47 120.13 14.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 0.73 110.375 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.87 115.34 3.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.328 2.019 . . . . 0.57 110.537 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.12 143.35 42.33 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.698 -0.852 . . . . 0.79 108.698 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -51.86 90.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.804 2.336 . . . . 0.58 112.16 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.883 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -81.99 24.66 4.49 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.4 112.585 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.997 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 70.7 p -73.81 117.73 15.93 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.438 -0.579 . . . . 0.62 109.438 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.659 HD21 HD22 ' A' ' 49' ' ' ASN . 1.2 pt? -149.41 -171.33 3.86 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.096 -1.442 . . . . 1.1 114.264 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 60.5 mttm -44.77 -96.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.912 -1.04 . . . . 1.84 113.54 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 175.5 105.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.059 -1.089 . . . . 0.99 108.059 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.9 ptpt 41.77 50.44 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.339 1.024 . . . . 1.84 110.842 -170.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 3.5 t0 -143.63 179.93 6.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.907 -1.042 . . . . 0.64 110.122 -170.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.456 ' CG ' ' HB3' ' A' ' 46' ' ' SER . 54.3 ttp -107.74 119.13 38.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.609 -0.723 . . . . 1.35 110.63 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.6 HG22 HG13 ' A' ' 47' ' ' VAL . 5.1 t -106.27 142.82 35.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.05 -0.523 . . . . 0.77 109.633 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 123.77 30.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.549 0.69 . . . . 0.48 110.608 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 91' ' ' ASP . 9.0 tt -124.61 160.73 27.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.897 -1.149 . . . . 0.77 107.897 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.0 m-20 -134.05 122.37 22.88 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.627 -0.67 . . . . 1.81 111.407 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 32.8 mm -92.56 143.27 26.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.65 109.644 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 92' ' ' ILE . 75.8 Cg_exo -51.91 -172.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.924 2.416 . . . . 1.07 113.266 173.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.936 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 7.1 m -114.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.72 -0.673 . . . . 0.46 110.549 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 95' ' ' VAL . 4.7 p -125.76 102.51 10.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.144 1.535 . . . . 0.48 115.144 -161.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.659 HG21 ' HG ' ' A' ' 101' ' ' LEU . 2.5 p -152.24 102.74 2.78 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.157 -0.474 . . . . 1.07 111.045 163.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 74.1 Cg_exo -48.89 131.61 25.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.721 1.614 . . . . 0.48 111.398 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.579 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 4.7 t80 -49.43 -35.0 17.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.734 -0.666 . . . . 1.31 111.081 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 12.1 t -62.92 -30.19 71.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 1.2 112.237 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.5 mm -76.78 -54.27 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 121.749 -0.594 . . . . 0.51 110.686 -173.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.053 HD23 HD21 ' A' ' 104' ' ' LEU . 36.6 mt -53.84 -26.91 26.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.439 0.638 . . . . 1.0 110.518 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.0 t80 -65.1 -41.45 94.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.466 -1.243 . . . . 0.96 108.877 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' HH21 ' A' ' 106' ' ' ARG . 24.8 m-80 -74.27 -57.88 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.82 112.263 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.053 HD21 HD23 ' A' ' 101' ' ' LEU . 2.1 pp -56.91 -49.66 74.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.23 0.826 . . . . 0.65 113.23 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.538 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.16 -25.7 68.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.883 0.849 . . . . 0.43 110.113 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.492 HH21 ' HA ' ' A' ' 103' ' ' ASN . 6.6 ttp180 -69.62 -50.77 41.19 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.655 -1.157 . . . . 1.81 110.511 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 13.6 t70 -81.74 -54.83 5.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.78 0.8 . . . . 0.8 111.94 -175.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -84.51 -27.67 6.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.594 -0.692 . . . . 0.88 109.964 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.775 ' HA3' HD21 ' A' ' 144' ' ' LEU . . . -73.01 -19.28 79.54 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.308 -0.948 . . . . 0.38 111.457 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -51.86 -44.89 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.794 -1.558 . . . . 1.09 106.794 166.23 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m-20 -69.77 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.529 -0.76 . . . . 1.87 110.025 161.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.817 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.1 p-90 176.91 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.687 0.617 . . . . 1.17 111.715 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.06 129.76 42.02 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 122.304 -0.248 . . . . 2.15 110.581 -174.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.695 HD11 HD23 ' A' ' 144' ' ' LEU . 3.0 mp -117.7 159.19 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.834 0.35 . . . . 0.39 110.415 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 9.3 p-10 -102.96 153.34 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.982 -0.377 . . . . 2.11 109.982 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.8 m-85 -140.09 165.91 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.869 -0.789 . . . . 0.62 108.869 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 35.4 tt0 -156.16 131.98 9.74 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.007 -0.368 . . . . 0.8 110.007 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -103.69 123.85 47.78 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.006 -0.739 . . . . 1.25 109.006 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.79 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 3.4 tp-100 -108.28 99.32 8.74 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.672 -0.862 . . . . 0.63 108.672 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 5.3 tp -106.58 119.36 55.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.259 0.552 . . . . 0.81 110.834 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.53 127.05 8.3 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.879 -0.888 . . . . 0.26 110.879 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.717 HD21 ' H ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -98.42 104.32 16.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.457 0.303 . . . . 1.2 111.335 -174.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 57.9 m -109.83 95.12 5.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.044 -0.526 . . . . 0.32 109.584 172.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.655 HD11 ' HB2' ' A' ' 22' ' ' PRO . 11.5 pt -112.75 128.61 69.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 120.234 -0.586 . . . . 0.98 110.28 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.854 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 22.7 t70 -81.88 106.02 13.47 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.796 -0.816 . . . . 1.52 108.796 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.971 HD23 HG21 ' A' ' 55' ' ' ILE . 29.1 mt -104.82 176.35 1.78 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 114.522 -1.217 . . . . 1.28 109.486 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 9.9 Cg_exo -76.18 -41.93 0.44 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.762 1.642 . . . . 0.74 113.206 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.6 t -59.62 -58.93 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.06 0.763 . . . . 1.12 113.06 -168.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t -109.8 -8.5 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.894 1.33 . . . . 1.35 108.517 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.683 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 88.38 -143.24 17.8 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 112.413 -2.176 . . . . 1.05 108.132 -164.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 -60.74 128.9 38.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.111 0.482 . . . . 1.16 110.02 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 123' ' ' THR . 15.9 t80 -124.31 145.33 49.48 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.826 -0.805 . . . . 1.91 108.826 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 63.1 m -121.86 109.42 14.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.917 0.389 . . . . 1.19 112.042 -173.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.505 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.2 pp -127.33 144.04 49.34 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.021 -0.733 . . . . 0.5 109.021 171.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -93.31 162.45 2.48 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.863 1.709 . . . . 0.45 113.341 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.14 167.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.935 -1.135 . . . . 0.44 107.935 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -133.07 148.67 52.19 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.791 -0.364 . . . . 0.88 111.258 -169.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.1 t -138.34 103.0 4.79 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.683 -1.228 . . . . 0.96 107.683 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.644 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 14.4 ptmt -126.88 156.25 41.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.048 -0.524 . . . . 1.76 111.184 -171.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.92 150.78 17.29 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.594 -0.812 . . . . 0.5 111.634 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.5 mt-10 -98.71 124.88 43.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.741 -0.837 . . . . 2.1 108.741 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.24 165.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.07 -1.085 . . . . 0.76 108.07 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -67.45 178.2 1.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.496 0.665 . . . . 3.53 112.289 -171.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.817 ' HG ' ' O ' ' A' ' 112' ' ' TRP . 5.9 mt -54.05 131.08 59.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.743 -1.117 . . . . 1.23 111.231 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.483 ' O ' ' HD1' ' A' ' 147' ' ' PHE . 32.9 Cg_endo -63.72 173.52 4.55 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.16 2.573 . . . . 0.71 112.021 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -49.76 98.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.927 0.394 . . . . 1.71 111.298 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.483 ' HD1' ' O ' ' A' ' 145' ' ' PRO . 16.0 p90 -124.21 149.28 46.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 2.64 110.501 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -172.8 76.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.615 . . . . 3.72 109.589 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 69.27 4.8 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.587 -0.733 . . . . 4.28 111.355 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -86.34 -38.32 17.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 2.86 108.847 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.7 p90 . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.531 -1.213 . . . . 3.96 108.821 174.774 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.815 0.341 . . . . 12.11 110.161 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.949 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . . . -77.84 0.22 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 9.02 112.03 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.722 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 3.9 p -60.28 -53.78 53.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.156 -0.475 . . . . 6.83 111.04 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.5 -29.6 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 8.55 110.551 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.37 19.42 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.412 . . . . 10.47 111.771 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.949 ' HB2' ' HA ' ' A' ' 2' ' ' ALA . 25.9 t70 -90.86 -37.74 13.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.096 0.474 . . . . 11.69 110.576 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.81 176.18 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.862 -0.608 . . . . 11.42 110.156 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 69.2 -63.38 0.37 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.831 0.707 . . . . 11.58 111.205 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 65.79 15.24 9.97 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.995 0.518 . . . . 15.74 110.965 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -102.21 134.91 44.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.687 -0.688 . . . . 12.69 109.757 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.96 78.13 5.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.959 0.409 . . . . 13.85 110.308 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.62 -68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 8.87 110.722 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.33 31.65 0.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 8.91 110.236 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 24.1 m-20 61.72 21.14 11.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.715 -0.675 . . . . 8.6 110.991 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -145.78 142.63 29.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.812 -0.631 . . . . 9.04 109.772 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 tp -175.01 -57.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.149 -0.685 . . . . 5.58 109.149 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -112.96 -48.07 3.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.858 -0.61 . . . . 2.69 110.237 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.731 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -141.36 -164.59 1.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.282 -0.417 . . . . 1.68 111.196 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG21 ' HG ' ' A' ' 126' ' ' LEU . 2.4 pp -93.8 168.28 12.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 3.19 111.084 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.654 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 17.3 Cg_exo -66.93 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 2.42 113.938 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 64.5 tttp 173.86 -53.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.416 0.525 . . . . 6.38 112.416 -171.092 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 20' ' ' PRO . 86.9 Cg_endo -78.25 65.08 8.48 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.005 1.803 . . . . 2.77 113.298 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HB3' ' A' ' 50' ' ' PRO . 5.6 mp0 -125.01 132.26 53.27 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 104.61 -2.367 . . . . 3.39 104.61 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -112.14 -172.85 19.1 Favored Glycine 0 C--O 1.22 -0.753 0 C-N-CA 118.578 -1.772 . . . . 0.54 116.094 -159.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.649 ' O ' HG13 ' A' ' 45' ' ' VAL . 96.2 p -168.99 37.26 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.623 1.169 . . . . 1.2 107.979 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 46' ' ' SER . 4.5 m -134.02 151.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.512 -1.222 . . . . 0.93 110.342 -169.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -167.58 -44.33 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.416 0.447 . . . . 0.48 111.96 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -160.88 164.08 31.52 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.324 0.511 . . . . 1.69 111.313 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.07 135.62 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.284 -0.635 . . . . 1.14 109.284 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -129.0 135.64 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.648 0.261 . . . . 1.83 111.249 -169.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.6 tm? -101.28 139.43 36.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.593 -0.276 . . . . 0.94 111.371 -172.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -144.34 -90.81 0.11 Allowed 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 114.08 1.141 . . . . 1.33 114.08 177.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.841 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.89 179.52 5.96 Favored 'General case' 0 C--O 1.204 -1.334 0 O-C-N 121.587 -0.696 . . . . 2.85 111.404 -155.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 38' ' ' SER . 6.2 p -168.16 -43.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 112.164 0.431 . . . . 3.26 112.164 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 67.1 -81.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 3.16 109.183 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.12 13.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.652 -0.704 . . . . 5.46 110.178 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 98' ' ' TYR . 8.7 p-10 -132.95 -42.3 0.9 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.321 -0.854 . . . . 1.92 110.257 -172.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.851 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 t -154.83 117.68 4.37 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.364 1.078 . . . . 0.94 112.351 -169.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 1.039 HG21 HD12 ' A' ' 101' ' ' LEU . 46.2 t -73.11 155.42 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.636 -1.62 . . . . 0.86 109.08 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 96.8 mt-10 -116.9 134.25 55.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 118.936 -1.106 . . . . 1.19 112.383 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.819 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.36 105.13 10.61 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.905 -1.043 . . . . 3.73 110.718 -175.836 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.502 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -81.44 111.58 17.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.341 -0.985 . . . . 0.81 108.341 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.98 117.34 32.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.551 0.691 . . . . 0.42 110.904 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -84.8 120.64 26.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.214 -0.903 . . . . 2.63 108.711 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 25' ' ' SER . 54.2 t -111.11 137.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.643 -0.708 . . . . 0.82 111.033 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.8 m -130.5 100.07 5.21 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.771 -0.372 . . . . 0.72 110.158 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 61.0 t -83.47 130.5 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.938 -0.574 . . . . 1.14 110.737 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 4.3 m -104.74 122.69 46.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.743 -0.383 . . . . 0.41 110.3 176.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.84 HD22 HD21 ' A' ' 82' ' ' LEU . 13.9 t-20 -88.17 133.52 36.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.86 1.35 . . . . 1.48 109.533 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 74.5 Cg_endo -88.92 -17.02 2.15 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.105 2.537 . . . . 0.73 115.746 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.743 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.2 t80 -98.42 -100.46 0.21 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.915 -1.114 . . . . 2.08 111.386 -165.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.465 ' CB ' ' HD2' ' A' ' 85' ' ' LYS . 48.5 t -174.0 29.8 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.551 0.691 . . . . 1.51 109.788 171.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -147.92 133.18 18.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 1.67 110.823 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -40.68 101.93 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.814 0 O-C-N 124.376 1.047 . . . . 1.39 112.194 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 126' ' ' LEU . 7.6 pt -78.93 121.73 83.74 Favored Pre-proline 0 CA--C 1.5 -0.953 0 C-N-CA 120.071 -0.652 . . . . 1.03 109.5 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.945 ' HB2' HD12 ' A' ' 57' ' ' ILE . 28.1 Cg_endo -61.09 -56.5 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.174 1.916 . . . . 0.37 113.51 -157.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.945 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.2 mp -135.02 156.27 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.849 -0.74 . . . . 1.23 111.026 -173.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.646 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.7 p -145.04 178.43 8.05 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.386 1.089 . . . . 1.15 111.856 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.137 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.9 tt0 -131.15 113.84 14.38 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.129 -1.85 . . . . 1.36 109.046 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -98.9 110.62 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.515 1.15 . . . . 1.05 110.151 169.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 79.9 p -111.5 107.12 16.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.051 -1.886 . . . . 0.83 108.228 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.1 p90 -113.92 132.6 55.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.6 0.714 . . . . 0.4 110.222 -168.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 33.6 m -131.6 109.75 10.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.433 -1.258 . . . . 0.38 108.717 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CE1' HD23 ' A' ' 118' ' ' LEU . 94.5 m-85 -97.7 143.08 28.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.691 -0.485 . . . . 0.96 109.691 -175.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -129.64 143.37 50.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.903 -0.777 . . . . 1.29 108.903 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.811 ' CB ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -101.3 -114.79 0.19 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.038 -0.528 . . . . 1.27 111.471 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -57.98 -52.49 65.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.573 -0.899 . . . . 0.36 108.573 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.74 20.74 0.15 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.65 -1.38 . . . . 0.39 109.65 164.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 6.2 ptp180 -117.86 -169.21 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.232 -0.655 . . . . 1.97 109.232 -174.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -107.71 98.33 7.94 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.325 0.583 . . . . 2.61 109.741 -166.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -60.86 -42.96 94.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.404 -1.271 . . . . 0.4 112.19 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.38 154.86 13.18 Favored Glycine 0 C--O 1.219 -0.789 0 C-N-CA 120.339 -0.934 . . . . 0.49 111.686 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 ptmt -158.75 160.29 36.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.935 0.868 . . . . 1.81 112.381 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.02 168.39 34.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.43 111.545 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -127.8 133.35 49.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.944 -0.391 . . . . 1.72 109.944 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 73.8 mt -139.14 112.45 8.05 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.502 -0.317 . . . . 0.73 110.884 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.79 113.53 3.68 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.117 1.878 . . . . 0.57 110.938 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -133.92 144.97 53.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.47 -0.196 . . . . 0.79 110.47 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.72 94.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.3 . . . . 0.58 112.677 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -84.52 21.19 11.22 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.808 -0.633 . . . . 0.4 112.586 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 96.2 p -70.25 118.98 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.452 -0.573 . . . . 0.62 109.452 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD21 HD22 ' A' ' 49' ' ' ASN . 1.9 pt? -141.98 -164.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 120.145 -0.622 . . . . 1.1 112.393 -164.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 94.4 mttt -45.63 -89.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.038 0.755 . . . . 1.84 113.038 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 156.5 111.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.437 -1.319 . . . . 0.99 107.437 -168.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 8.2 ptmm? 45.54 46.07 10.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.003 0.814 . . . . 1.84 111.5 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.2 t70 -155.05 -172.01 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.331 -0.849 . . . . 0.64 109.501 -173.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 43.3 ttp -114.79 127.57 55.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.106 0.479 . . . . 1.35 110.831 -172.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.2 t -109.53 142.41 40.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.472 -0.785 . . . . 0.77 110.025 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 108.41 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.38 0.61 . . . . 0.48 110.949 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.782 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.7 tp -100.64 174.89 5.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.094 -0.957 . . . . 0.77 109.131 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.782 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 21.4 t70 -141.71 121.6 13.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.769 -0.372 . . . . 1.81 110.638 -173.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 24.5 mm -107.88 141.92 24.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.3 -0.409 . . . . 0.65 110.324 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 92' ' ' ILE . 61.0 Cg_exo -54.62 -152.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.815 3.01 . . . . 1.07 113.656 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.965 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.5 m -136.76 94.73 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 112.058 0.392 . . . . 0.46 112.058 -165.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -125.38 106.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 113.841 1.052 . . . . 0.48 113.841 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 9.6 t -147.17 102.08 3.82 Favored Pre-proline 0 C--O 1.219 -0.52 0 CA-C-N 115.941 -0.572 . . . . 1.07 110.318 168.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.73 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 31.9 Cg_exo -57.1 124.38 16.08 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 CA-C-N 120.495 1.212 . . . . 0.48 110.757 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.512 ' HE1' ' HB3' ' A' ' 150' ' ' PHE . 1.0 OUTLIER -54.03 -29.91 45.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.019 -0.537 . . . . 1.31 111.232 -175.408 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.1 m -53.0 -33.12 50.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 1.2 111.874 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.6 mm -77.65 -54.58 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.528 -0.305 . . . . 0.51 111.28 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 39' ' ' VAL . 11.3 mt -51.03 -26.92 6.8 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.504 0.669 . . . . 1.0 110.848 172.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 99' ' ' SER . 54.8 t80 -63.99 -46.48 84.39 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.391 -1.277 . . . . 0.96 109.056 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 26.1 m-80 -73.27 -55.88 5.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.492 0.553 . . . . 0.82 112.492 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.985 HD21 HD23 ' A' ' 101' ' ' LEU . 1.3 pp -55.47 -57.71 10.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.897 0.702 . . . . 0.65 112.897 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.528 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . -61.26 -24.4 66.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.673 0.749 . . . . 0.43 110.806 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.547 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.4 ttp180 -62.26 -49.62 74.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.781 -1.099 . . . . 1.81 109.86 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -85.21 -53.29 5.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.373 1.082 . . . . 0.8 111.129 -173.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.003 HG21 HG23 ' A' ' 114' ' ' ILE . 34.4 m -83.93 -30.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.225 -0.898 . . . . 0.88 110.849 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.58 -20.22 78.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.215 -0.902 . . . . 0.38 111.343 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -47.79 -45.59 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.386 -1.709 . . . . 1.09 106.386 162.385 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 9.3 m-20 -72.84 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.716 -0.674 . . . . 1.87 110.359 162.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 -179.54 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.719 0.408 . . . . 1.17 111.852 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.36 137.92 32.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.018 0.437 . . . . 2.15 111.47 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 1.003 HG23 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -118.36 148.07 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.237 -0.653 . . . . 0.39 109.237 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.3 p-10 -102.65 152.69 20.91 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.951 -1.129 . . . . 2.11 107.951 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 87.9 m-85 -137.21 171.48 14.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.636 . . . . 0.62 109.284 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.633 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 34.2 tt0 -160.2 121.33 3.07 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.364 0.415 . . . . 0.8 110.139 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -97.69 137.61 36.33 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.727 -0.471 . . . . 1.25 109.727 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.713 ' N ' HD22 ' A' ' 118' ' ' LEU . 7.3 tp60 -121.37 103.17 8.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.884 -0.598 . . . . 0.63 109.51 176.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 60' ' ' ILE . 6.8 tp -113.1 121.42 65.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.115 0.483 . . . . 0.81 110.904 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.17 126.48 8.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.333 -0.707 . . . . 0.26 111.333 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.648 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.5 mp -103.77 100.5 10.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.092 0.473 . . . . 1.2 111.393 -172.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.137 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.3 m -104.6 95.59 6.01 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.474 -0.784 . . . . 0.32 109.478 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 58' ' ' CYS . 2.3 pt -106.82 149.89 9.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.716 -0.394 . . . . 0.98 110.602 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -91.12 105.35 17.75 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.52 108.492 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.732 HD12 HG21 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -105.09 148.26 35.88 Favored Pre-proline 0 C--O 1.218 -0.567 0 O-C-N 124.684 1.24 . . . . 1.28 108.995 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.45 -32.15 93.42 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.909 1.739 . . . . 0.74 113.052 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.94 -58.09 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.455 0.539 . . . . 1.12 112.455 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.731 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -94.45 -6.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 122.153 0.978 . . . . 1.35 109.952 -175.434 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.82 -31.36 1.27 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 113.716 -1.584 . . . . 1.05 111.59 -171.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.2 pt-20 -171.05 137.15 1.14 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.692 -0.855 . . . . 1.16 108.692 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -143.14 139.55 30.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.372 -0.603 . . . . 1.91 109.372 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.3 t -121.18 112.94 19.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.688 0.756 . . . . 1.19 111.498 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.69 137.05 29.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.205 -0.907 . . . . 0.5 109.66 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 11.1 Cg_endo -91.47 163.64 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.237 1.958 . . . . 0.45 112.758 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.8 166.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.468 -0.938 . . . . 0.44 108.468 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -136.32 147.17 47.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.223 -0.191 . . . . 0.88 110.802 -167.605 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.5 t -140.58 102.88 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.489 -0.93 . . . . 0.96 108.489 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 13.6 ptmt -118.46 152.31 36.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.732 -0.667 . . . . 1.76 111.087 -174.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.11 158.67 30.25 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.6 -0.81 . . . . 0.5 112.231 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.4 mt-10 -102.6 132.79 48.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.409 -0.589 . . . . 2.1 109.409 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.52 172.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.467 -0.568 . . . . 0.76 109.467 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -75.03 167.22 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.006 0.431 . . . . 3.53 111.652 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.699 HD12 HD11 ' A' ' 114' ' ' ILE . 17.8 tp -57.1 132.77 80.48 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.676 -0.693 . . . . 1.23 111.124 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -70.64 172.8 12.8 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.611 2.207 . . . . 0.71 112.221 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 m -70.33 107.8 3.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.039 -0.528 . . . . 1.71 110.429 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -118.52 151.7 37.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.966 0.412 . . . . 2.64 111.102 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 150' ' ' PHE . 40.7 ttmt -172.85 102.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.264 -0.88 . . . . 3.72 109.249 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.51 3.89 2.07 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.573 0.546 . . . . 4.28 110.576 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.512 ' HB3' ' HE1' ' A' ' 98' ' ' TYR . 21.7 m-85 -86.84 -35.19 19.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.917 -0.771 . . . . 2.86 108.917 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.169 -0.923 . . . . 3.96 108.771 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.406 -0.22 . . . . 12.11 110.406 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.85 -12.35 0.22 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.011 1.115 . . . . 9.02 114.011 173.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 p -66.06 -65.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 6.83 111.625 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.724 ' H ' HD23 ' A' ' 4' ' ' LEU . 2.6 pt? -96.92 -0.21 47.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 8.55 110.58 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.4 tp -105.72 29.25 6.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.371 0.605 . . . . 10.47 110.146 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.79 -45.57 10.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.665 -0.698 . . . . 11.69 109.674 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 57.35 67.22 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.302 -0.863 . . . . 11.42 111.492 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.17 143.74 30.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.393 -0.821 . . . . 11.58 110.213 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 18.6 ptpt -133.24 -31.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.453 -0.339 . . . . 15.74 111.087 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -90.71 131.76 36.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.691 -0.231 . . . . 12.69 110.848 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 70.91 -67.17 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.069 0.856 . . . . 13.85 111.22 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.13 137.33 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.344 -0.389 . . . . 8.87 110.585 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.98 -12.27 9.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.282 0.563 . . . . 8.91 110.064 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -97.78 -79.63 0.46 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.537 -0.756 . . . . 8.6 110.212 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' HG2' ' HG ' ' A' ' 16' ' ' LEU . 35.1 ttpt 68.32 -77.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.866 0.729 . . . . 9.04 111.642 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.654 ' HG ' ' HG2' ' A' ' 15' ' ' LYS . 2.8 pp -163.03 163.55 25.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.137 -0.32 . . . . 5.58 110.137 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -152.82 21.13 0.6 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 2.69 110.624 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -122.92 -103.22 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.487 -0.324 . . . . 1.68 111.805 -177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.554 HG21 ' HG ' ' A' ' 126' ' ' LEU . 40.7 pt -147.01 170.5 7.66 Favored Pre-proline 0 N--CA 1.463 0.184 0 C-N-CA 122.145 0.178 . . . . 3.19 110.898 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 50' ' ' PRO . 31.7 Cg_exo -61.97 177.24 1.1 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.856 2.371 . . . . 2.42 111.839 169.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 57.5 mtpt -117.05 -55.25 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.606 0.965 . . . . 6.38 113.606 -171.24 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.669 ' HD3' ' HB2' ' A' ' 21' ' ' LYS . 3.0 Cg_exo -77.85 74.65 5.14 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.018 1.812 . . . . 2.77 113.358 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 48' ' ' THR . 32.3 mt-10 -154.41 131.02 10.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.045 -2.206 . . . . 3.39 105.045 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.665 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -127.62 -144.07 5.86 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 118.348 2.099 . . . . 0.54 118.348 -143.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.614 ' C ' HG13 ' A' ' 45' ' ' VAL . 39.4 m -178.99 34.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 112.618 -1.791 . . . . 1.2 107.525 -170.412 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 120' ' ' ILE . 16.4 m -135.07 150.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.84 -1.073 . . . . 0.93 109.638 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 46' ' ' SER . 1.3 t -160.28 -51.66 0.05 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.988 -0.375 . . . . 0.48 109.988 168.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -158.54 150.14 21.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.294 0.568 . . . . 1.69 112.101 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.13 127.8 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.3 -0.863 . . . . 1.14 108.932 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -119.45 135.27 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.845 0.355 . . . . 1.83 111.303 -169.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -97.33 127.16 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 0.94 111.871 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HE3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -129.72 -113.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 1.33 109.679 166.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.82 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.3 p-10 172.2 176.07 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.05 0.389 . . . . 2.85 112.05 -172.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.4 p -161.7 105.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 122.009 0.909 . . . . 3.26 112.117 174.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t30 59.15 -97.53 0.07 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.149 -0.932 . . . . 3.16 111.101 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.96 24.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.383 1.087 . . . . 5.46 108.512 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.74 -35.51 9.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.41 -1.723 . . . . 1.92 107.434 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.676 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 23.0 t -157.86 179.82 8.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.648 -2.069 . . . . 0.94 106.252 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 33' ' ' ASP . 3.1 t -124.51 161.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.39 -0.967 . . . . 0.86 108.39 166.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.91 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 82.0 mt-10 -114.06 131.93 56.2 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.878 -0.729 . . . . 1.19 112.13 -170.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.791 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.87 103.82 10.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.855 -1.066 . . . . 3.73 109.443 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -72.73 109.18 6.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.081 -1.081 . . . . 0.81 108.081 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -107.31 102.84 12.11 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.288 0.566 . . . . 0.42 109.797 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 18.0 ttpp -83.77 133.55 34.77 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.875 -0.787 . . . . 2.63 108.875 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 25' ' ' SER . 24.3 t -109.7 141.75 24.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.806 -1.088 . . . . 0.82 110.409 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 88' ' ' THR . 1.8 p -120.1 100.52 7.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 119.531 -0.868 . . . . 0.72 109.373 168.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 77.1 t -81.15 112.46 19.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.599 -0.889 . . . . 1.14 108.599 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 2.0 m -102.92 109.89 21.62 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.914 -1.143 . . . . 0.41 107.914 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.777 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 5.1 t30 -87.92 122.52 70.08 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.63 1.206 . . . . 1.48 109.85 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.695 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 1.3 Cg_endo -85.34 8.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.988 3.126 . . . . 0.73 114.423 -171.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 31.4 t80 -96.79 -114.03 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.116 -0.634 . . . . 2.08 110.015 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 18.9 p -168.74 18.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.811 0.3 . . . . 1.51 111.811 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -148.04 143.18 27.04 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.514 -0.55 . . . . 1.67 109.514 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 5.4 m -41.26 98.19 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.256 0.973 . . . . 1.39 112.873 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.942 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.9 pt -74.63 170.54 14.71 Favored Pre-proline 0 C--O 1.21 -0.998 0 N-CA-C 107.685 -1.228 . . . . 1.03 107.685 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.536 ' HB2' HG12 ' A' ' 57' ' ' ILE . 22.9 Cg_endo -91.25 -64.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 120.89 1.06 . . . . 0.37 114.435 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.8 mm -126.4 161.33 32.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.188 -0.605 . . . . 1.23 112.009 -166.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.655 ' HB3' HG22 ' A' ' 124' ' ' ILE . 29.8 p -152.04 175.63 12.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.43 1.11 . . . . 1.15 112.318 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -136.55 114.24 11.12 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.006 -1.907 . . . . 1.36 109.336 175.357 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -98.92 117.74 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.894 -1.048 . . . . 1.05 111.61 174.1 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.657 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.1 p -115.09 109.63 18.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.625 -1.625 . . . . 0.83 109.34 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.0 p90 -114.09 126.86 55.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.428 -0.351 . . . . 0.4 110.13 -168.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.74 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.9 m -119.6 104.64 10.46 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.826 -0.625 . . . . 0.38 109.327 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 94.3 m-85 -97.75 136.04 38.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.957 -0.565 . . . . 0.96 109.783 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.721 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -146.59 140.3 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.734 -0.469 . . . . 1.29 109.734 176.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.594 ' HB2' HD11 ' A' ' 71' ' ' ILE . 48.2 t -102.64 -96.12 0.3 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.603 -0.271 . . . . 1.27 111.588 -173.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.06 5.58 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.546 -0.909 . . . . 0.36 108.546 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.11 16.92 0.18 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 106.69 -2.564 . . . . 0.39 106.69 163.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -105.76 163.25 12.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 112.809 -1.696 . . . . 1.97 108.834 -171.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -97.57 87.89 4.21 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.488 0.661 . . . . 2.61 109.313 -161.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 14.8 mm -44.63 -43.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 113.867 -1.515 . . . . 0.4 111.188 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.23 167.46 36.18 Favored Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 119.9 -1.143 . . . . 0.49 111.622 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.87 161.97 18.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.685 0.743 . . . . 1.81 111.404 173.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.47 -178.88 32.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.804 -0.918 . . . . 0.43 110.804 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' SER . 5.1 ptpp? -147.22 141.93 26.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 1.72 111.2 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 92.0 mt -133.47 124.44 18.09 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.73 110.182 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.7 111.34 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.427 2.085 . . . . 0.57 110.678 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.95 144.61 52.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.816 -0.439 . . . . 0.79 109.816 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' A' ' 57' ' ' ILE . 34.2 Cg_exo -62.44 90.53 0.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.146 1.897 . . . . 0.58 112.112 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.51 35.09 2.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.99 -0.55 . . . . 0.4 112.294 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.942 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 52.3 p -73.03 123.73 24.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.396 -0.594 . . . . 0.62 109.396 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -149.54 -159.78 1.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.727 -1.189 . . . . 1.1 113.499 -164.006 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 86.4 mttt -60.6 -93.61 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.485 0.55 . . . . 1.84 112.485 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.91 110.32 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.85 -1.167 . . . . 0.99 107.85 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 45.2 pttt 41.92 49.43 4.05 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.994 0.902 . . . . 1.84 111.195 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.3 t70 -153.3 -177.97 6.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.706 -1.134 . . . . 0.64 110.118 -172.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.9 ttm -110.35 127.39 55.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.649 -0.705 . . . . 1.35 109.793 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.56 142.24 50.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.77 111.151 -175.062 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.55 114.17 21.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.151 0.501 . . . . 0.48 111.656 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 45' ' ' VAL . 5.9 tt -117.96 171.33 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.533 -0.914 . . . . 0.77 108.533 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.7 133.85 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.477 0.58 . . . . 1.81 112.286 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 46.0 mm -114.06 113.14 46.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.6 -0.889 . . . . 0.65 108.6 168.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' O ' HD22 ' A' ' 42' ' ' LEU . 45.3 Cg_exo -28.87 -102.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 1 C-N-CA 125.725 4.283 . . . . 1.07 115.415 -170.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.91 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.3 93.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 122.356 -0.215 . . . . 0.46 110.701 -177.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.7 p -127.75 102.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 114.474 1.287 . . . . 0.48 114.474 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 101' ' ' LEU . 2.5 p -153.78 103.61 2.5 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 122.152 -0.343 . . . . 1.07 111.49 159.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.72 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 94.2 Cg_exo -44.37 136.4 8.51 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.405 2.07 . . . . 0.48 113.543 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.676 ' H ' ' HA ' ' A' ' 38' ' ' SER . 2.1 t80 -52.28 -37.84 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.691 -1.141 . . . . 1.31 110.881 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -63.29 -25.89 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 1.2 112.651 -176.047 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.4 mm -71.29 -54.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.694 0.759 . . . . 0.51 110.659 -175.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.629 HD11 HG21 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -54.21 -33.69 58.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.706 -1.588 . . . . 1.0 109.325 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 99' ' ' SER . 56.2 t80 -61.0 -39.85 91.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.29 -1.777 . . . . 0.96 109.032 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 2.9 m120 -74.98 -57.49 3.87 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.82 111.321 178.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HA ' HH11 ' A' ' 69' ' ' ARG . 3.0 pp -57.99 -50.71 72.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.488 0.922 . . . . 0.65 113.488 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.28 -26.97 66.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 0.43 110.521 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -71.2 -51.71 23.21 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.422 -0.808 . . . . 1.81 110.944 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 35.9 t70 -81.38 -51.96 7.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.776 0.798 . . . . 0.8 111.791 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.5 t -91.01 -22.11 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.734 -0.604 . . . . 0.88 110.431 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.24 -20.09 79.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.393 -0.908 . . . . 0.38 111.043 168.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -51.73 -48.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.635 -1.617 . . . . 1.09 106.635 165.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 14.6 m-20 -69.78 -97.34 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.085 -0.962 . . . . 1.87 110.345 163.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -178.18 -52.69 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.554 0.576 . . . . 1.17 112.554 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -95.65 124.5 39.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.407 -0.361 . . . . 2.15 111.447 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 108' ' ' VAL . 3.0 mp -117.69 155.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.734 0.302 . . . . 0.39 110.218 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -96.0 154.55 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.638 -0.875 . . . . 2.11 108.638 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 60.8 m-85 -140.31 149.36 42.67 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.161 -1.052 . . . . 0.62 108.161 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.828 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 10.5 tt0 -146.29 139.39 25.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.369 -0.532 . . . . 0.8 111.066 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.644 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 10.2 tp -105.67 127.59 53.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.335 -0.848 . . . . 1.25 109.917 170.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.74 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 6.6 tp60 -113.02 100.34 8.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.456 -0.942 . . . . 0.63 108.456 174.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.4 tp -112.88 122.34 66.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.124 0.488 . . . . 0.81 111.497 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.62 128.48 9.43 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.978 -0.849 . . . . 0.26 110.978 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.643 HD21 ' HA2' ' A' ' 24' ' ' GLY . 2.2 mp -104.87 97.64 7.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.881 0.372 . . . . 1.2 111.273 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.01 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 78.9 m -97.38 95.37 7.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.93 -0.767 . . . . 0.32 108.93 171.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.86 147.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.032 -0.667 . . . . 0.98 110.013 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 4.5 m-20 -87.99 105.88 17.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 109.374 -0.602 . . . . 1.52 109.374 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 124' ' ' ILE . 1.5 mm? -103.37 162.11 21.03 Favored Pre-proline 0 C--O 1.22 -0.457 0 O-C-N 124.333 1.021 . . . . 1.28 109.611 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.97 -29.83 14.55 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 121.992 1.794 . . . . 0.74 113.053 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -75.38 -57.87 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 113.372 0.879 . . . . 1.12 113.372 -176.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.534 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -95.1 -3.35 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.976 0.893 . . . . 1.35 109.857 -176.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.84 -36.48 1.44 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 113.951 -1.477 . . . . 1.05 111.217 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.7 pt-20 -174.3 140.09 0.64 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.811 -1.181 . . . . 1.16 107.811 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -140.98 146.2 36.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.83 -0.348 . . . . 1.91 110.113 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.0 t -114.4 112.9 23.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.534 0.683 . . . . 1.19 111.584 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.91 138.48 32.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.624 -0.716 . . . . 0.5 109.76 173.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -93.15 163.65 2.53 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.019 1.813 . . . . 0.45 113.335 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.34 168.09 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.679 -0.86 . . . . 0.44 108.679 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -138.32 156.04 48.01 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.134 0.42 . . . . 0.88 112.134 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 t -145.94 106.87 4.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.63 -0.878 . . . . 0.96 108.63 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.828 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.1 ptmt -120.84 149.69 42.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.629 -0.259 . . . . 1.76 111.099 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.66 146.61 11.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.634 -0.793 . . . . 0.5 112.403 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -107.7 132.02 53.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.067 -0.567 . . . . 2.1 110.797 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.56 172.0 2.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.805 -1.183 . . . . 0.76 107.805 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.6 152.61 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 3.53 111.047 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.87 150.03 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 1.23 112.388 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 151' ' ' PHE . 35.9 Cg_endo -65.97 174.22 6.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.447 2.765 . . . . 0.71 113.03 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -66.54 102.96 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.723 0.773 . . . . 1.71 110.957 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 151' ' ' PHE . 29.8 p90 -79.1 26.09 0.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.368 -0.833 . . . . 2.64 111.931 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -79.09 81.95 5.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.364 -0.38 . . . . 3.72 109.998 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 77.23 -42.55 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.782 0.833 . . . . 4.28 110.98 -176.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 15.8 m-85 -65.04 -49.32 70.6 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.242 0.339 . . . . 2.86 110.483 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 147' ' ' PHE . 47.4 m-85 . . . . . 0 C--O 1.248 1.016 0 O-C-N 124.791 1.307 . . . . 3.96 110.266 -171.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.804 0.335 . . . . 12.11 110.855 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.13 80.1 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.219 0.533 . . . . 9.02 111.529 -175.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.408 ' HB3' HD22 ' A' ' 4' ' ' LEU . 29.2 t -117.84 -55.01 2.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.768 -0.827 . . . . 6.83 108.768 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.675 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 mm? -104.59 11.58 34.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.184 -0.673 . . . . 8.55 109.184 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 51' ' ' TYR . 3.3 mm? 70.3 -67.87 0.22 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.15 -0.932 . . . . 10.47 110.596 -175.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.94 -161.89 1.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.143 -0.688 . . . . 11.69 109.143 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -154.87 101.44 2.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 11.42 111.324 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.22 -103.57 0.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.205 -0.452 . . . . 11.58 109.839 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 132.06 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.21 -0.292 . . . . 15.74 110.21 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.56 25.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.526 -0.546 . . . . 12.69 109.526 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 61.96 100.11 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.1 -0.955 . . . . 13.85 112.141 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -84.84 -32.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.932 -1.136 . . . . 8.87 107.932 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.6 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.446 -1.252 . . . . 8.91 112.388 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -130.09 5.62 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.295 -0.412 . . . . 8.6 110.714 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.758 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 46.6 mmtm -95.13 39.23 1.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.022 0.439 . . . . 9.04 111.248 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.67 -25.09 64.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.104 -0.498 . . . . 5.58 110.232 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 m -128.33 149.4 50.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 2.69 109.87 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' O ' HG13 ' A' ' 19' ' ' ILE . . . 66.62 35.43 5.32 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.726 0.641 . . . . 1.68 111.251 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 18' ' ' ALA . 1.1 pp 66.21 157.52 0.13 Allowed Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.82 1.248 . . . . 3.19 112.613 172.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.758 ' HA ' ' HB3' ' A' ' 15' ' ' LYS . 6.3 Cg_exo -77.06 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.826 2.351 . . . . 2.42 112.975 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 12.0 ptpt -142.0 116.39 6.73 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.183 0.516 . . . . 6.38 110.887 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.693 ' HG3' ' HD2' ' A' ' 132' ' ' PHE . 86.5 Cg_endo -100.98 48.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.973 3.115 . . . . 2.77 112.25 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.96 114.86 27.09 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.648 0.737 . . . . 3.39 111.253 -168.513 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . 175.27 108.72 0.23 Allowed Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 114.538 -1.21 . . . . 0.54 111.623 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB2' HD11 ' A' ' 122' ' ' LEU . 33.3 m -168.91 29.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.384 -0.969 . . . . 1.2 108.384 170.725 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.47 153.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.865 -1.061 . . . . 0.93 109.723 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -179.5 -46.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.632 0.582 . . . . 0.48 112.099 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 27.2 t70 -155.38 151.89 28.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.69 -0.404 . . . . 1.69 111.603 -174.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.61 120.68 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.393 -0.595 . . . . 1.14 109.393 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 t70 -113.44 110.86 20.99 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.637 -0.256 . . . . 1.83 111.308 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -79.42 130.97 35.93 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.638 -0.134 . . . . 0.94 110.638 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.52 -88.05 0.24 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 114.138 1.162 . . . . 1.33 114.138 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -91.32 -177.35 4.83 Favored 'General case' 0 C--O 1.204 -1.32 0 O-C-N 121.936 -0.478 . . . . 2.85 111.995 -152.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.1 p -164.36 -33.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.973 0.416 . . . . 3.26 111.101 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.71 -69.49 0.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.855 -1.066 . . . . 3.16 110.032 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -174.89 -6.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.819 -0.628 . . . . 5.46 112.191 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -128.15 -30.18 2.45 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.306 0.574 . . . . 1.92 110.159 -164.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 6.3 t -165.59 131.94 2.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.154 -0.93 . . . . 0.94 111.358 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 101' ' ' LEU . 91.4 t -76.89 155.51 5.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.208 -0.905 . . . . 0.86 110.319 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.88 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 48.8 mt-10 -129.35 139.54 51.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.539 -0.864 . . . . 1.19 110.515 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.952 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -139.72 134.62 32.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.582 -0.847 . . . . 3.73 112.293 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -80.41 111.42 16.79 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.824 -0.806 . . . . 0.81 108.824 -174.621 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -90.43 99.9 12.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.374 0.607 . . . . 0.42 110.001 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -83.5 125.04 31.34 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.82 -0.807 . . . . 2.63 108.82 178.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.588 HG13 ' C ' ' A' ' 25' ' ' SER . 52.2 t -115.48 139.19 43.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.169 -0.923 . . . . 0.82 110.445 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.75 104.52 8.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.19 -0.604 . . . . 0.72 109.58 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 83.2 t -83.05 129.89 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.338 -0.846 . . . . 1.14 110.458 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 30.5 m -122.61 113.94 19.95 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.913 -0.585 . . . . 0.41 109.837 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.787 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.5 p-10 -94.87 146.19 30.92 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.628 -0.715 . . . . 1.48 109.172 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HG3' HD13 ' A' ' 19' ' ' ILE . 47.4 Cg_endo -93.92 8.18 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.13 2.553 . . . . 0.73 113.044 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.66 ' HA ' HD21 ' A' ' 5' ' ' LEU . 6.8 t80 -117.11 131.92 56.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.958 -0.386 . . . . 2.08 109.958 -174.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.576 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 38.1 t -87.48 44.7 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.442 0.639 . . . . 1.51 110.655 -169.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -144.07 16.88 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.459 0.911 . . . . 1.67 113.459 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 26.2 t 61.42 98.28 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 111.885 0.328 . . . . 1.39 111.885 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.853 ' O ' ' HA ' ' A' ' 81' ' ' SER . 9.1 pt -78.79 128.87 75.52 Favored Pre-proline 0 C--O 1.207 -1.149 0 O-C-N 121.698 -0.626 . . . . 1.03 111.115 -170.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 28.6 Cg_endo -66.34 -59.21 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.914 1.743 . . . . 0.37 113.106 -163.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 79' ' ' PRO . 10.1 mm -121.65 152.02 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.23 -0.588 . . . . 1.23 110.782 -172.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.589 ' HB3' HG22 ' A' ' 124' ' ' ILE . 10.2 m -148.03 178.23 8.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.147 0.975 . . . . 1.15 111.961 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.097 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 34.7 tt0 -136.8 117.63 14.11 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.587 -1.642 . . . . 1.36 110.618 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -97.89 109.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.783 0.802 . . . . 1.05 109.559 170.029 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.714 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 13.2 p -117.13 102.05 8.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.325 -1.307 . . . . 0.83 109.717 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 p90 -109.92 126.68 54.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.4 110.451 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 8.2 m -120.43 105.3 10.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.525 -0.762 . . . . 0.38 109.312 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 81.6 m-85 -98.67 140.56 32.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.28 -0.418 . . . . 0.96 111.226 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.569 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 2.8 m80 -134.78 143.9 47.36 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.085 -1.08 . . . . 1.29 108.085 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 33.6 t -107.64 -100.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.67 -0.812 . . . . 1.27 111.176 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.53 3.57 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.217 -0.66 . . . . 0.36 109.217 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.51 20.94 0.13 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.292 -1.523 . . . . 0.39 109.292 167.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 69' ' ' ARG . 7.3 ptp180 -116.46 -176.83 3.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.64 -0.874 . . . . 1.97 108.64 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -103.05 96.8 7.04 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.744 0.783 . . . . 2.61 108.935 -167.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.92 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.0 mm -50.77 -42.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 113.762 -1.563 . . . . 0.4 111.153 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 170.0 32.76 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.538 -0.839 . . . . 0.49 111.288 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.44 163.83 27.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.411 0.606 . . . . 1.81 110.396 174.812 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.72 159.71 23.54 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.231 -0.748 . . . . 0.43 111.231 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.714 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 92.3 mttt -133.19 128.53 36.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.238 -0.282 . . . . 1.72 110.238 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.606 ' HB ' HD12 ' A' ' 60' ' ' ILE . 70.3 mt -134.31 111.8 11.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.36 -0.382 . . . . 0.73 110.224 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 111.24 3.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.518 2.146 . . . . 0.57 110.554 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 22.1 t70 -130.88 142.67 46.4 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.738 -0.467 . . . . 0.79 109.738 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' HD13 ' A' ' 57' ' ' ILE . 27.8 Cg_endo -63.84 84.61 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.539 2.159 . . . . 0.58 112.365 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.14 41.74 3.08 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.4 112.147 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 83.9 p -70.48 113.14 7.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.62 109.179 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -142.74 160.82 39.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.447 0.536 . . . . 1.1 112.447 -164.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 90.9 mttt -6.25 -96.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 125.243 1.589 . . . . 1.84 113.796 -172.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 170.5 108.54 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.097 -1.075 . . . . 0.99 108.097 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 9.6 ptpt 42.57 54.32 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.291 0.995 . . . . 1.84 110.844 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t70 -153.53 -167.29 2.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 0.64 110.822 -171.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 52.5 ttm -118.81 125.07 48.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 1.35 110.883 -170.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 47' ' ' VAL . 1.2 t -113.58 143.28 44.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.77 109.309 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.86 106.37 16.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.281 0.563 . . . . 0.48 111.068 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 45' ' ' VAL . 8.5 tt -103.31 160.28 14.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.514 -0.921 . . . . 0.77 108.514 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -136.3 119.56 16.72 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.682 -0.807 . . . . 1.81 111.314 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 31.6 mm -103.36 143.59 26.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.231 -0.895 . . . . 0.65 109.612 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' HG23 ' A' ' 92' ' ' ILE . 17.9 Cg_endo -59.79 -155.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.888 2.392 . . . . 1.07 113.718 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.952 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 5.1 m -126.35 92.3 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 115.602 -0.727 . . . . 0.46 111.411 -162.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -126.29 101.65 8.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 115.633 1.716 . . . . 0.48 115.633 -162.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 39' ' ' VAL . 4.8 p -153.32 123.95 3.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 121.182 -0.949 . . . . 1.07 111.766 162.439 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 49.4 Cg_exo -53.59 135.14 60.88 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.616 1.544 . . . . 0.48 112.071 172.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 38' ' ' SER . 1.2 t80 -50.33 -36.23 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.052 -0.976 . . . . 1.31 110.931 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.7 m -65.62 -25.26 67.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.658 0.614 . . . . 1.2 112.658 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.92 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.5 mm -72.38 -54.46 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 121.73 -0.606 . . . . 0.51 110.043 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.839 HD22 HG11 ' A' ' 39' ' ' VAL . 9.9 mp -60.1 -25.41 65.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.002 -0.999 . . . . 1.0 111.161 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.64 ' HA ' ' CD1' ' A' ' 151' ' ' PHE . 77.2 t80 -59.03 -48.49 81.41 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.54 -1.281 . . . . 0.96 107.54 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 91.3 m-20 -75.48 -56.16 4.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.648 -1.16 . . . . 0.82 113.15 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.716 ' HG ' ' HA ' ' A' ' 101' ' ' LEU . 2.8 pp -54.36 -49.76 69.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.255 0.835 . . . . 0.65 113.255 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.659 ' HB1' ' CZ ' ' A' ' 147' ' ' PHE . . . -67.92 -24.81 65.24 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 122.066 0.936 . . . . 0.43 110.406 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.6 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 3.3 ttp180 -69.7 -49.57 52.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.226 -1.352 . . . . 1.81 110.238 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 9.0 t70 -81.89 -53.91 5.77 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.73 0.776 . . . . 0.8 111.98 -173.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.751 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.0 t -89.09 -22.69 6.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.88 110.1 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.79 -18.68 78.98 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.43 -0.891 . . . . 0.38 111.228 168.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -51.95 -47.1 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.862 -1.533 . . . . 1.09 106.862 164.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 19.4 m-20 -68.5 -96.22 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.709 -0.678 . . . . 1.87 110.096 159.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -179.34 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.17 111.674 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -94.43 123.73 38.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.064 0.459 . . . . 2.15 110.923 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.751 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.9 mp -110.64 158.76 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.283 -0.636 . . . . 0.39 109.283 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.667 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 4.8 p-10 -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.879 -0.601 . . . . 2.11 109.416 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 40.9 m-85 -137.13 157.9 45.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.903 -1.147 . . . . 0.62 107.903 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.915 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.7 tt0 -145.86 137.97 25.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.146 0.498 . . . . 0.8 109.853 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -110.51 131.49 55.0 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.484 -0.78 . . . . 1.25 109.562 177.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.666 ' N ' HD22 ' A' ' 118' ' ' LEU . 5.3 tp60 -117.56 99.59 7.07 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.772 -0.825 . . . . 0.63 108.772 174.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -114.51 121.06 65.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.441 0.639 . . . . 0.81 110.719 -173.847 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.6 127.75 8.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.26 111.999 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.754 HD21 ' H ' ' A' ' 24' ' ' GLY . 1.9 mp -99.05 96.0 7.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.83 0.348 . . . . 1.2 110.624 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.097 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 94.5 m -101.16 95.66 6.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.156 -0.683 . . . . 0.32 109.156 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' A' ' 55' ' ' ILE . 32.7 pt -117.06 137.73 50.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.392 -0.523 . . . . 0.98 110.785 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.678 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -81.66 105.93 13.2 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.224 -0.658 . . . . 1.52 109.224 -176.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.574 HD23 HG21 ' A' ' 55' ' ' ILE . 20.0 mt -107.15 141.69 23.45 Favored Pre-proline 0 C--O 1.217 -0.61 0 O-C-N 124.859 1.35 . . . . 1.28 109.69 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 50.3 Cg_exo -55.16 -27.78 57.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.272 1.981 . . . . 0.74 113.536 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.48 -58.21 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 112.584 0.587 . . . . 1.12 112.584 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -99.37 -2.09 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 122.14 0.971 . . . . 1.35 109.774 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.79 -31.14 1.98 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 113.742 -1.572 . . . . 1.05 110.711 -171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.3 pt-20 -169.07 145.12 3.38 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.809 -1.182 . . . . 1.16 107.809 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.693 ' HD2' ' HG3' ' A' ' 22' ' ' PRO . 6.6 t80 -134.82 134.63 41.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.048 -0.723 . . . . 1.91 109.048 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 90.9 m -119.0 105.11 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 1.19 111.723 -175.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.631 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.3 pp -127.66 132.75 24.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.5 109.838 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 73.6 Cg_endo -84.96 159.29 11.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.682 1.588 . . . . 0.45 112.239 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.43 164.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.198 -1.038 . . . . 0.44 108.198 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -133.42 149.61 51.79 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.854 -0.338 . . . . 0.88 111.528 -168.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.0 t -144.33 103.82 4.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.812 -0.81 . . . . 0.96 108.812 173.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.915 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.7 ptmt -113.44 144.61 42.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.958 -0.565 . . . . 1.76 110.837 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.22 139.73 6.76 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.684 -0.769 . . . . 0.5 111.734 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 12.1 mt-10 -106.33 126.79 52.67 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.922 -0.77 . . . . 2.1 108.922 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.42 173.6 13.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.609 -0.885 . . . . 0.76 108.609 -176.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -68.43 175.83 3.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.03 0.443 . . . . 3.53 111.793 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.4 tp -58.82 129.07 85.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.575 -0.739 . . . . 1.23 112.119 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 144' ' ' LEU . 36.8 Cg_endo -65.07 175.86 3.55 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.206 3.27 . . . . 0.71 112.85 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 136.94 57.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 1.71 112.111 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.659 ' CZ ' ' HB1' ' A' ' 105' ' ' ALA . 17.0 m-85 -125.79 165.74 18.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.145 -0.48 . . . . 2.64 110.511 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.545 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 2.5 tppp? 176.71 55.21 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 O-C-N 123.539 0.525 . . . . 3.72 109.782 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 64.27 28.19 13.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.695 -0.684 . . . . 4.28 110.737 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 148' ' ' LYS . 23.1 m-85 -98.56 -49.86 4.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.682 -0.69 . . . . 2.86 109.387 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 102' ' ' PHE . 6.3 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.993 -1.003 . . . . 3.96 109.698 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.445 -0.206 . . . . 12.11 110.445 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.96 -8.46 57.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.359 0.503 . . . . 9.02 112.359 -172.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 m -123.39 93.97 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.175 -0.306 . . . . 6.83 110.175 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.28 -71.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.426 . . . . 8.55 110.23 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 17' ' ' THR . 57.3 tp 59.71 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.856 0.722 . . . . 10.47 111.488 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -114.39 -45.48 3.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.919 -0.582 . . . . 11.69 110.603 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -100.76 124.38 46.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.998 -0.546 . . . . 11.42 110.849 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -153.56 125.14 7.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.603 -0.726 . . . . 11.58 109.329 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -73.98 -38.29 64.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.907 0.384 . . . . 15.74 110.308 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -93.12 128.81 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.379 -0.6 . . . . 12.69 109.379 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -79.52 178.77 7.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.264 0.554 . . . . 13.85 111.723 -171.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -120.07 158.17 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.681 -0.69 . . . . 8.87 110.51 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.48 -61.01 2.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.125 0.488 . . . . 8.91 110.305 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -147.19 -44.8 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 8.6 111.163 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 8.1 tppt? -143.45 127.25 17.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.487 -0.324 . . . . 9.04 110.413 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.6 tp -143.12 -78.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.111 -0.329 . . . . 5.58 110.111 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.423 ' HA ' HD23 ' A' ' 5' ' ' LEU . 71.6 m 62.4 -85.09 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.575 0.547 . . . . 2.69 110.836 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 60.46 -88.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.382 0.673 . . . . 1.68 112.585 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.424 ' O ' HD12 ' A' ' 19' ' ' ILE . 2.7 pp -137.21 141.44 34.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 3.19 110.57 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.56 -12.86 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.825 2.35 . . . . 2.42 113.0 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 36.9 ttpt -145.78 127.25 7.58 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.917 -0.771 . . . . 6.38 108.917 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -59.32 163.85 11.72 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.684 2.256 . . . . 2.77 112.217 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.723 ' HG3' ' HD3' ' A' ' 50' ' ' PRO . 31.1 mp0 -115.92 148.62 39.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.784 -1.932 . . . . 3.39 105.784 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -113.57 -178.81 19.32 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 118.124 -1.989 . . . . 0.54 113.597 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG13 ' A' ' 45' ' ' VAL . 76.7 p -166.6 36.98 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.437 1.113 . . . . 1.2 108.308 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.1 m -133.85 154.89 39.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.295 -1.32 . . . . 0.93 110.463 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 t -168.04 -45.34 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.781 0.676 . . . . 0.48 111.387 168.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -162.84 162.9 26.67 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.915 -0.49 . . . . 1.69 111.479 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.49 146.06 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.878 -0.415 . . . . 1.14 109.878 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -129.02 134.92 48.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.582 0.229 . . . . 1.83 111.004 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.542 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.7 tm? -100.85 134.94 43.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.145 -0.317 . . . . 0.94 110.145 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -142.92 -93.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.7 1.0 . . . . 1.33 113.7 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -91.06 -178.11 5.1 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-O 118.801 -0.618 . . . . 2.85 111.709 -154.63 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.808 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.5 p -165.56 -36.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 112.46 0.541 . . . . 3.26 112.46 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 66.49 -66.27 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.05 0.844 . . . . 3.16 110.78 -174.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.49 -3.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.663 0.785 . . . . 5.46 109.852 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -127.63 -41.78 1.67 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.349 -0.387 . . . . 1.92 110.21 -168.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.808 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 22.6 t -146.92 122.43 10.4 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.965 0.888 . . . . 0.94 112.173 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.921 HG21 HD12 ' A' ' 101' ' ' LEU . 48.7 t -71.88 152.49 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.181 -1.372 . . . . 0.86 109.126 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.964 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.2 mt-10 -114.84 133.83 55.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.957 -1.097 . . . . 1.19 112.595 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.829 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.18 105.6 11.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.816 -1.084 . . . . 3.73 110.681 -176.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -81.28 111.15 17.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.32 -0.993 . . . . 0.81 108.32 178.084 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.32 115.61 30.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.528 0.68 . . . . 0.42 110.875 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 39.3 ttmt -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.893 -1.049 . . . . 2.63 108.586 177.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 25' ' ' SER . 51.0 t -108.99 143.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.599 -0.728 . . . . 0.82 110.984 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' THR . 14.2 m -134.59 100.96 4.79 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.227 0.536 . . . . 0.72 110.436 167.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 85.4 t -81.99 124.36 39.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.171 -0.922 . . . . 1.14 110.617 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.0 m -103.2 110.67 22.72 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.902 -0.59 . . . . 0.41 110.707 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 9.9 t30 -90.27 128.01 50.95 Favored Pre-proline 0 C--N 1.318 -0.802 0 O-C-N 123.796 0.685 . . . . 1.48 109.748 176.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.723 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 57.3 Cg_endo -90.31 8.7 3.43 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.51 . . . . 0.73 114.116 -175.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -127.02 147.28 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.588 -0.893 . . . . 2.08 108.588 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.676 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.9 t -79.1 31.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.227 0.454 . . . . 1.51 112.227 -168.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -143.11 128.47 18.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.486 -0.324 . . . . 1.67 110.789 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.538 ' HA ' HD23 ' A' ' 82' ' ' LEU . 47.6 t -38.11 105.05 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 124.577 1.151 . . . . 1.39 112.971 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -77.87 125.11 86.02 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 109.242 -0.651 . . . . 1.03 109.242 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.954 ' HB2' HD12 ' A' ' 57' ' ' ILE . 30.3 Cg_endo -63.09 -58.92 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.048 1.832 . . . . 0.37 113.544 -159.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.5 mp -132.18 154.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.899 -0.72 . . . . 1.23 110.994 -173.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 124' ' ' ILE . 31.4 p -145.83 178.11 8.42 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.504 1.145 . . . . 1.15 112.161 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.099 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.0 tt0 -131.95 114.24 14.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.687 -2.052 . . . . 1.36 109.25 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.86 110.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.334 1.064 . . . . 1.05 110.125 171.415 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -109.1 105.25 14.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.256 -1.793 . . . . 0.83 107.951 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 p90 -115.59 130.71 56.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.416 0.627 . . . . 0.4 110.369 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 32.5 m -131.92 114.56 14.79 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.743 -1.117 . . . . 0.38 109.065 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' HG22 ' A' ' 71' ' ' ILE . 97.3 m-85 -96.77 146.83 24.53 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.508 -0.552 . . . . 0.96 109.508 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -134.09 146.06 49.94 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.392 -1.336 . . . . 1.29 107.392 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . 1.088 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -112.56 -97.2 0.43 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.177 -1.009 . . . . 1.27 110.846 169.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.82 3.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.837 -0.431 . . . . 0.36 109.837 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.2 26.37 0.18 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.964 -1.254 . . . . 0.39 109.964 167.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 8.1 ptp180 -126.17 -174.22 3.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.552 -0.536 . . . . 1.97 109.552 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 100' ' ' ILE . 43.7 mt-10 -101.44 92.06 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.198 0.523 . . . . 2.61 110.391 -164.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -56.85 -32.1 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.4 112.113 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.67 164.94 33.22 Favored Glycine 0 C--O 1.223 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.49 111.245 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.28 160.26 18.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.989 0.895 . . . . 1.81 112.126 175.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.77 159.1 21.04 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.076 -0.81 . . . . 0.43 111.076 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.0 mtpt -126.2 128.1 46.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.196 0.498 . . . . 1.72 110.002 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -136.63 122.22 13.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.721 0.296 . . . . 0.73 110.644 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.31 114.53 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.579 2.186 . . . . 0.57 111.022 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 17.9 t70 -129.97 146.0 59.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.074 -0.343 . . . . 0.79 110.074 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 78' ' ' ASP . 12.5 Cg_endo -56.82 91.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.727 2.285 . . . . 0.58 112.17 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -79.88 19.51 6.31 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.497 -0.774 . . . . 0.4 112.82 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 p -70.74 121.32 17.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.006 -0.739 . . . . 0.62 109.006 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -145.23 -161.38 1.29 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.843 0.682 . . . . 1.1 112.843 -162.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 67.5 mttm -53.79 -94.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.83 0.678 . . . . 1.84 112.83 -174.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.629 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 164.51 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.583 -0.895 . . . . 0.99 108.583 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.1 ptmt 46.27 40.86 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.408 1.067 . . . . 1.84 111.088 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.69 -169.75 3.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.907 -1.042 . . . . 0.64 109.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 ttm -116.19 124.5 50.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.305 0.574 . . . . 1.35 110.456 -174.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -111.35 143.48 42.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.352 -0.84 . . . . 0.77 110.863 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.02 138.89 31.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.026 0.441 . . . . 0.48 110.447 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.533 HD22 HG11 ' A' ' 45' ' ' VAL . 1.2 tt -144.15 175.06 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.612 -1.255 . . . . 0.77 107.612 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 4.0 p-10 -142.15 146.5 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.061 0.846 . . . . 1.81 112.217 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.4 mm -114.56 143.25 29.57 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 107.895 -1.15 . . . . 0.65 107.895 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.547 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 85.2 Cg_exo -51.52 -122.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.472 2.781 . . . . 1.07 114.072 175.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -153.82 93.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 O-C-N 121.837 -0.539 . . . . 0.46 111.973 -172.081 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.2 p -126.29 109.03 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.748 1.018 . . . . 0.48 113.748 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 16.9 t -146.86 103.98 3.89 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 115.683 -0.69 . . . . 1.07 109.731 169.246 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.6 Cg_exo -61.26 123.45 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 CA-C-N 120.792 1.319 . . . . 0.48 110.678 171.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' A' ' 150' ' ' PHE . 2.4 t80 -50.57 -38.34 44.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.56 -0.745 . . . . 1.31 112.176 -171.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.9 m -56.12 -25.52 46.36 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.674 0.25 . . . . 1.2 111.674 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.0 mm -76.34 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 120.252 -0.579 . . . . 0.51 111.116 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.921 HD12 HG21 ' A' ' 39' ' ' VAL . 13.1 mt -51.96 -30.05 23.12 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.488 0.661 . . . . 1.0 110.427 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 151' ' ' PHE . 85.3 t80 -62.89 -40.36 97.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.178 -1.374 . . . . 0.96 108.908 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.38 -56.12 5.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.727 -0.67 . . . . 0.82 111.848 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.3 pp -62.14 -51.8 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.57 0.952 . . . . 0.65 113.57 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.424 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -60.3 -25.97 66.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.783 0.801 . . . . 0.43 110.361 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.0 ttp180 -64.28 -50.42 67.96 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.659 -1.155 . . . . 1.81 110.131 173.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.5 t70 -83.24 -53.42 5.77 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.781 0.66 . . . . 0.8 112.781 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 114' ' ' ILE . 4.2 t -84.35 -27.47 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.498 -0.481 . . . . 0.88 110.001 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.44 -21.28 77.72 Favored Glycine 0 C--N 1.328 0.139 0 C-N-CA 120.631 -0.795 . . . . 0.38 111.573 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.8 -46.69 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.98 -1.489 . . . . 1.09 106.98 165.461 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 6.3 m-20 -67.66 -90.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.434 -0.803 . . . . 1.87 109.615 162.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -178.16 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.196 0.443 . . . . 1.17 112.196 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -93.63 133.08 37.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.204 0.526 . . . . 2.15 110.991 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD12 ' A' ' 144' ' ' LEU . 2.7 mp -115.87 159.95 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.39 109.962 -171.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' ' 114' ' ' ILE . 10.3 p-10 -98.81 152.83 19.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.59 -0.892 . . . . 2.11 108.59 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.1 m-85 -138.02 163.86 30.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.62 108.339 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.63 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 36.2 tt0 -160.58 128.47 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.8 110.624 -177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -99.83 134.51 42.63 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.314 -0.624 . . . . 1.25 109.314 174.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.642 ' N ' HD22 ' A' ' 118' ' ' LEU . 6.4 tp60 -117.21 102.54 9.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.719 -0.673 . . . . 0.63 109.266 178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.584 HD11 HG22 ' A' ' 60' ' ' ILE . 6.4 tp -111.62 120.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.087 0.47 . . . . 0.81 111.154 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -90.85 126.98 8.62 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.114 -0.794 . . . . 0.26 111.114 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.0 mp -106.89 112.93 26.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.673 0.273 . . . . 1.2 111.241 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.099 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.6 m -114.01 96.68 5.94 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.817 -0.629 . . . . 0.32 109.762 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -111.33 144.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.544 -0.462 . . . . 0.98 110.553 -176.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -88.57 107.12 18.73 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.163 -1.051 . . . . 1.52 108.163 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD23 HG21 ' A' ' 55' ' ' ILE . 9.7 mt -106.94 168.08 8.56 Favored Pre-proline 0 C--O 1.222 -0.388 0 O-C-N 125.359 1.662 . . . . 1.28 110.236 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.31 -41.98 0.78 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.189 1.926 . . . . 0.74 112.982 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.02 -57.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.937 0.347 . . . . 1.12 111.937 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -89.19 -8.16 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.697 0.761 . . . . 1.35 109.949 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.64 -33.78 0.71 Allowed Glycine 0 C--N 1.321 -0.291 0 CA-C-N 114.473 -1.239 . . . . 1.05 112.369 -172.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.3 pt-20 -171.99 145.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.419 -1.326 . . . . 1.16 107.419 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 4.4 t80 -153.75 146.11 23.94 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.445 -0.502 . . . . 1.91 110.125 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 31.9 m -120.31 107.07 12.5 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.386 0.429 . . . . 1.19 111.101 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.4 pp -126.37 138.03 31.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.96 -0.564 . . . . 0.5 109.936 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 18.1 Cg_endo -91.69 165.35 3.39 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.386 2.058 . . . . 0.45 112.719 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -164.9 169.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.025 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.3 p -136.52 154.08 50.83 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.375 0.509 . . . . 0.88 112.375 -169.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.4 t -140.58 105.61 4.99 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.716 -1.216 . . . . 0.96 107.716 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.63 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.35 149.7 38.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.577 -0.283 . . . . 1.76 110.834 -172.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.78 135.39 3.9 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.294 -0.723 . . . . 0.5 111.294 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.14 131.84 44.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.652 -0.499 . . . . 2.1 109.652 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.34 172.9 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.512 -0.551 . . . . 0.76 109.512 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 144' ' ' LEU . 0.5 OUTLIER -61.49 167.09 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.172 0.804 . . . . 3.53 113.172 -177.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 ' HD2' ' A' ' 145' ' ' PRO . 32.1 tp -59.19 134.3 87.92 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 114.908 -1.042 . . . . 1.23 111.641 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.847 ' HD2' HD12 ' A' ' 144' ' ' LEU . 31.9 Cg_endo -63.56 174.25 3.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.103 2.535 . . . . 0.71 112.106 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.3 m -49.78 96.18 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.298 0.571 . . . . 1.71 111.326 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -100.0 23.41 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 2.64 111.201 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.65 -64.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.282 0.563 . . . . 3.72 110.997 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -140.21 3.38 1.96 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.955 0.884 . . . . 4.28 109.136 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 51.3 m-85 -101.0 -70.4 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.087 -0.961 . . . . 2.86 111.508 -168.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 66.0 m-85 . . . . . 0 C--O 1.245 0.847 0 O-C-N 124.387 1.055 . . . . 3.96 109.277 -164.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.323 -0.251 . . . . 12.11 110.323 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.78 -70.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.07 -0.715 . . . . 9.02 109.07 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.827 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 13.3 p 49.78 -88.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.741 1.385 . . . . 6.83 114.741 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.02 147.21 25.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 8.55 112.14 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.785 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.6 pt? -74.6 -45.63 43.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.56 -0.745 . . . . 10.47 111.126 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 5.3 m-20 -83.89 83.69 7.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.378 0.609 . . . . 11.69 110.277 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 1.048 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -167.03 128.99 1.68 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.127 -0.942 . . . . 11.42 109.633 -175.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.26 -5.77 3.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.099 -0.5 . . . . 11.58 111.455 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.21 -18.28 61.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.379 0.609 . . . . 15.74 110.154 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 1.048 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 3.3 t70 -100.77 146.44 27.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.11 -1.07 . . . . 12.69 108.11 169.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.91 12.51 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.287 1.217 . . . . 13.85 114.287 -163.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG22 ' OD2' ' A' ' 10' ' ' ASP . 19.7 m -130.11 170.01 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.836 -0.431 . . . . 8.87 109.836 171.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.07 -90.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.756 -0.377 . . . . 8.91 110.068 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -146.33 69.14 1.19 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.762 0.792 . . . . 8.6 110.973 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HE2' HG11 ' A' ' 12' ' ' VAL . 54.0 pttt -86.3 -6.97 58.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.051 -0.522 . . . . 9.04 110.435 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.9 mt -135.76 107.5 7.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.977 -0.556 . . . . 5.58 109.583 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -74.84 -35.35 62.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.523 . . . . 2.69 110.194 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.3 -94.43 0.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 1.68 110.906 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.797 HG21 HD13 ' A' ' 126' ' ' LEU . 2.6 pp -146.92 156.33 47.57 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 122.266 -0.271 . . . . 3.19 111.096 -177.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -94.86 -13.98 0.73 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.968 2.446 . . . . 2.42 114.699 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 50' ' ' PRO . 61.3 mttp -131.72 145.55 58.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.311 -0.243 . . . . 6.38 111.009 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.38 155.19 55.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.081 2.52 . . . . 2.77 111.341 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.645 ' HG3' ' HG3' ' A' ' 50' ' ' PRO . 2.6 mp0 -119.57 146.05 45.84 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.275 -1.75 . . . . 3.39 106.275 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.768 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -110.59 178.52 19.9 Favored Glycine 0 C--N 1.303 -1.29 0 C-N-CA 118.392 -1.861 . . . . 0.54 113.35 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 122' ' ' LEU . 40.7 m -172.03 39.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 1.2 108.382 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' SER . 25.1 m -134.87 155.12 37.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.778 -1.101 . . . . 0.93 109.312 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -175.56 -48.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.369 0.507 . . . . 0.48 112.369 168.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -158.5 147.04 18.65 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.049 -0.407 . . . . 1.69 111.128 -174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.876 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.83 138.59 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.954 0.407 . . . . 1.14 110.336 166.17 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.29 135.49 48.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 1.83 111.332 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 39' ' ' VAL . 3.1 tm? -89.9 137.94 31.91 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 0.94 111.202 -172.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -137.45 -91.78 0.23 Allowed 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 113.865 1.061 . . . . 1.33 113.865 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 6.8 m-20 -88.48 177.69 6.74 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 121.452 -0.78 . . . . 2.85 111.149 -156.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.754 HG22 ' H ' ' A' ' 36' ' ' ARG . 4.9 p -165.04 -43.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.787 0.327 . . . . 3.26 111.671 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 5.3 t30 67.33 -10.15 0.36 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.691 0.758 . . . . 3.16 110.755 -176.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.754 ' H ' HG22 ' A' ' 34' ' ' VAL . 10.7 mmt180 82.87 28.73 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.564 1.546 . . . . 5.46 110.313 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -127.75 -33.75 2.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.064 -1.426 . . . . 1.92 109.673 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 35.6 t -168.12 123.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.832 -0.622 . . . . 0.94 110.206 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.697 ' HB ' HG13 ' A' ' 96' ' ' VAL . 12.0 t -76.28 158.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.008 -0.542 . . . . 0.86 109.581 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.5 mt-10 -136.91 141.33 42.71 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.451 -0.781 . . . . 1.19 110.932 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -140.73 134.45 30.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.167 -1.013 . . . . 3.73 113.454 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -80.78 110.93 16.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.132 . . . . 0.81 108.624 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.876 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -100.28 106.42 18.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.239 0.542 . . . . 0.42 110.697 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.28 116.99 24.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.161 0.981 . . . . 2.63 109.786 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 25' ' ' SER . 16.1 t -95.97 149.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.214 -1.357 . . . . 0.82 110.069 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.2 m -132.46 104.08 6.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.177 -0.609 . . . . 0.72 110.67 168.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.3 t -83.04 128.43 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.731 -1.122 . . . . 1.14 111.141 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.737 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 17.5 m -109.62 109.5 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.962 -0.563 . . . . 0.41 110.323 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.887 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -92.29 133.52 29.86 Favored Pre-proline 0 N--CA 1.466 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.645 ' HG3' ' HG3' ' A' ' 23' ' ' GLU . 40.6 Cg_endo -104.76 22.28 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.453 2.768 . . . . 0.73 114.656 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -116.09 -3.45 12.07 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 118.717 -1.193 . . . . 2.08 111.358 -176.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.475 ' CB ' ' HD3' ' A' ' 85' ' ' LYS . 24.6 p 89.89 15.97 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.26 1.024 . . . . 1.51 112.404 161.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -147.6 148.43 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.968 -0.753 . . . . 1.67 108.968 172.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 41.7 t -54.32 107.16 0.25 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.244 0.965 . . . . 1.39 112.054 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.945 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.0 pt -74.71 173.02 7.42 Favored Pre-proline 0 C--O 1.206 -1.204 0 N-CA-C 107.767 -1.197 . . . . 1.03 107.767 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HB2' HG12 ' A' ' 57' ' ' ILE . 11.0 Cg_endo -90.13 -62.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 CA-C-N 120.192 1.104 . . . . 0.37 114.774 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 79' ' ' PRO . 16.8 mm -131.22 161.35 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.588 -0.445 . . . . 1.23 111.43 -165.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.581 ' CB ' HG22 ' A' ' 124' ' ' ILE . 29.3 p -155.96 -177.3 6.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.38 1.086 . . . . 1.15 111.972 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.5 tt0 -135.96 116.37 13.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.017 -1.902 . . . . 1.36 109.774 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.731 HG22 HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -97.25 110.09 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.238 1.018 . . . . 1.05 109.489 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.475 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.5 p -114.42 102.97 10.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.325 -1.761 . . . . 0.83 108.844 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.3 p90 -113.37 131.65 55.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.517 -0.549 . . . . 0.4 109.517 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 17.6 m -127.94 106.01 8.81 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.736 -1.12 . . . . 0.38 109.067 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 72.1 m-85 -96.99 142.49 28.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 110.232 -0.284 . . . . 0.96 110.232 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.447 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -129.38 144.85 51.41 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.28 -1.378 . . . . 1.29 107.28 176.737 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.885 ' HB3' HD22 ' A' ' 104' ' ' LEU . 39.1 t -107.77 -96.47 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.902 -1.119 . . . . 1.27 111.106 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -63.93 1.1 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.146 -0.687 . . . . 0.36 109.146 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.34 17.21 0.18 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 108.511 -1.836 . . . . 0.39 108.511 167.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.937 HH11 ' HB3' ' A' ' 103' ' ' ASN . 11.8 ptp180 -114.3 177.47 4.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.303 -0.999 . . . . 1.97 108.303 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.13 98.19 8.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.606 0.717 . . . . 2.61 109.486 -163.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.97 -36.43 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 113.979 -1.464 . . . . 0.4 111.912 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.2 161.21 12.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.999 -0.84 . . . . 0.49 110.999 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -159.99 161.77 34.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 117.875 0.837 . . . . 1.81 111.24 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.76 162.43 28.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.753 -0.658 . . . . 0.43 111.456 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.7 mttt -123.47 128.62 50.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.649 -0.5 . . . . 1.72 109.649 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 60' ' ' ILE . 80.4 mt -133.56 116.8 14.03 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.268 -0.271 . . . . 0.73 110.268 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.68 101.49 1.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.753 2.302 . . . . 0.57 111.115 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -112.85 146.13 34.46 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.509 -0.552 . . . . 0.79 109.509 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.694 ' HA ' HD13 ' A' ' 57' ' ' ILE . 35.6 Cg_exo -62.3 86.5 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.028 1.819 . . . . 0.58 112.168 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 36.34 2.58 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.926 -0.579 . . . . 0.4 112.671 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.945 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.2 p -73.95 120.29 19.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.297 -0.631 . . . . 0.62 109.297 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -156.11 161.59 40.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.318 -1.353 . . . . 1.1 114.546 -163.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HG3' ' OG1' ' A' ' 88' ' ' THR . 88.6 mttt -22.28 -97.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.883 1.438 . . . . 1.84 114.883 -164.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 171.24 109.55 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.252 -1.018 . . . . 0.99 108.252 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.738 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 39.5 pttt 42.15 46.56 3.79 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.008 0.818 . . . . 1.84 110.936 -175.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.9 t70 -150.04 -171.04 3.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.261 -0.881 . . . . 0.64 109.88 -170.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.9 ttm -119.01 117.93 30.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.514 0.673 . . . . 1.35 110.157 -173.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.65 ' CB ' ' HB2' ' A' ' 82' ' ' LEU . 0.8 OUTLIER -106.12 143.31 34.42 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.839 -1.073 . . . . 0.77 111.124 -176.094 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.0 129.9 34.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.463 0.649 . . . . 0.48 110.73 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 45' ' ' VAL . 8.8 tt -135.42 162.05 33.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.398 -1.334 . . . . 0.77 107.398 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.69 138.27 32.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.23 -0.988 . . . . 1.81 112.679 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.9 mm -100.82 149.92 36.59 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.005 -1.452 . . . . 0.65 107.717 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 11.3 Cg_endo -53.96 -116.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.964 2.443 . . . . 1.07 113.686 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.4 m -156.88 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 O-C-N 121.559 -0.713 . . . . 0.46 111.729 -169.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG11 ' HE2' ' A' ' 62' ' ' PHE . 9.1 p -126.27 101.56 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 116.102 1.89 . . . . 0.48 116.102 -163.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.5 p -152.21 110.66 2.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 121.25 -0.906 . . . . 1.07 111.864 163.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.0 Cg_exo -54.43 131.81 47.44 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.794 1.663 . . . . 0.48 110.942 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.538 ' HE2' ' NH1' ' A' ' 36' ' ' ARG . 24.8 t80 -54.16 -40.64 67.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.53 -0.759 . . . . 1.31 111.523 -172.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 13.4 t -55.88 -26.97 49.66 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.229 0.331 . . . . 1.2 111.785 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 mm -76.11 -55.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.109 -0.636 . . . . 0.51 110.908 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 104' ' ' LEU . 37.9 mt -55.49 -28.48 54.82 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.521 0.677 . . . . 1.0 110.344 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.1 t80 -65.49 -39.72 92.25 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.384 -1.28 . . . . 0.96 108.602 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.937 ' HB3' HH11 ' A' ' 69' ' ' ARG . 11.3 m-80 -74.28 -56.56 4.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.936 . . . . 0.82 112.307 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 101' ' ' LEU . 1.7 pp -60.77 -47.96 83.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.121 0.786 . . . . 0.65 113.121 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.56 -25.02 68.05 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.844 0.83 . . . . 0.43 109.833 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.15 -54.27 36.33 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.529 -1.214 . . . . 1.81 110.274 173.24 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 18.7 t70 -82.41 -53.19 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.998 0.904 . . . . 0.8 111.923 -173.282 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.4 t -87.55 -27.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 121.639 -0.663 . . . . 0.88 110.042 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.16 -19.76 79.76 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.462 -0.875 . . . . 0.38 111.34 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -49.14 -46.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.847 -1.538 . . . . 1.09 106.847 164.743 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 33.3 m-20 -71.32 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.486 -0.779 . . . . 1.87 110.077 162.227 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 179.64 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.192 0.442 . . . . 1.17 112.192 174.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -94.89 131.17 41.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 2.15 111.821 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -120.62 161.33 20.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.954 -0.566 . . . . 0.39 109.89 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 114' ' ' ILE . 14.7 t70 -99.88 154.6 18.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.783 -0.644 . . . . 2.11 109.563 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 83.8 m-85 -140.63 132.14 26.99 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.396 -0.964 . . . . 0.62 108.396 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.758 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 23.2 tt0 -131.22 137.15 48.79 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.082 0.468 . . . . 0.8 110.307 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 14.9 tp -103.16 131.08 50.45 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.775 -0.648 . . . . 1.25 110.256 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.51 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 2.2 tp60 -111.7 99.5 8.21 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.57 -1.27 . . . . 0.63 107.57 170.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.731 HD11 HG22 ' A' ' 60' ' ' ILE . 6.3 tp -113.08 114.89 48.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.348 0.594 . . . . 0.81 111.139 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.41 128.62 8.84 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.212 -0.755 . . . . 0.26 111.212 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 133' ' ' THR . 5.7 mp -105.91 102.05 11.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.983 0.421 . . . . 1.2 110.936 -174.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.3 m -107.86 95.17 5.5 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.272 -0.877 . . . . 0.32 109.514 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 23' ' ' GLU . 39.3 pt -113.0 141.97 26.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 C-N-CA 120.146 -0.622 . . . . 0.98 110.52 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 53.8 m-20 -85.73 106.16 16.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.752 -0.833 . . . . 1.52 108.752 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 19' ' ' ILE . 45.3 mt -104.02 164.87 14.45 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 124.53 1.143 . . . . 1.28 109.878 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 41.4 Cg_endo -69.91 -40.38 5.15 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.415 1.41 . . . . 0.74 113.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.827 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 98.9 t -74.07 -58.41 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.374 0.509 . . . . 1.12 112.374 -173.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 132' ' ' PHE . 9.7 p -90.21 -7.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.172 0.987 . . . . 1.35 110.05 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.92 -30.9 0.76 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 114.248 -1.342 . . . . 1.05 112.516 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.0 pt-20 -166.86 126.59 1.5 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 1.16 108.716 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HB2' HG11 ' A' ' 129' ' ' VAL . 13.0 t80 -123.71 135.63 53.98 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.428 -0.582 . . . . 1.91 109.428 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.9 t -128.05 103.22 7.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.921 0.867 . . . . 1.19 111.844 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.64 143.9 49.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.236 -0.893 . . . . 0.5 110.227 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 80.9 Cg_endo -92.49 162.74 2.95 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.783 1.656 . . . . 0.45 113.597 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.74 168.54 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.112 -1.44 . . . . 0.44 107.112 178.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 99.1 p -145.64 152.18 39.25 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.335 -0.546 . . . . 0.88 111.845 -168.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -146.98 113.13 5.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.784 -0.821 . . . . 0.96 108.784 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.758 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 6.8 ptmm? -123.88 153.37 41.22 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.08 -0.248 . . . . 1.76 111.378 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.45 143.57 8.65 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.371 -0.692 . . . . 0.5 111.371 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -108.54 132.13 54.14 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.03 -0.585 . . . . 2.1 110.418 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.31 173.45 2.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.473 -1.306 . . . . 0.76 107.473 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -63.94 172.63 2.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.217 0.532 . . . . 3.53 112.332 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 114' ' ' ILE . 15.7 tp -58.97 139.85 87.07 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.316 -0.856 . . . . 1.23 111.306 -175.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 144' ' ' LEU . 37.3 Cg_endo -65.9 172.87 7.76 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.973 2.449 . . . . 0.71 112.449 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 t -60.4 125.12 22.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.506 0.669 . . . . 1.71 111.469 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE1' HD23 ' A' ' 144' ' ' LEU . 5.3 p90 -154.11 161.43 41.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 2.64 109.602 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -151.04 75.09 1.18 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.569 -0.53 . . . . 3.72 109.569 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 66.98 11.27 8.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.434 -0.803 . . . . 4.28 110.72 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 26.1 m-85 -108.78 -43.45 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 2.86 110.574 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 59.6 m-85 . . . . . 0 C--O 1.253 1.252 0 CA-C-O 117.652 -1.166 . . . . 3.96 109.122 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . 1.8 mpt? . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.845 0.355 . . . . 12.11 110.269 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.34 145.54 48.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.204 -0.453 . . . . 9.02 110.274 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 20' ' ' PRO . 8.9 m -77.26 8.51 3.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.402 -0.363 . . . . 6.83 111.353 -177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.5 tp 73.0 -54.5 0.69 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.806 0.842 . . . . 8.55 111.36 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.35 -2.69 26.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.174 0.511 . . . . 10.47 110.592 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.82 -20.75 62.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.13 -0.941 . . . . 11.69 111.269 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HG3' ' H ' ' A' ' 8' ' ' ALA . 52.5 pttt -47.55 -63.38 1.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.655 -0.702 . . . . 11.42 112.681 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' H ' ' HG3' ' A' ' 7' ' ' LYS . . . -178.55 163.06 1.49 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 122.206 0.202 . . . . 11.58 110.893 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.17 142.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 O-C-N 124.206 0.941 . . . . 15.74 113.427 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 72.43 127.0 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.757 -1.11 . . . . 12.69 112.354 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.572 ' CD2' HG22 ' A' ' 12' ' ' VAL . 4.2 t80 59.64 -156.19 0.34 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.327 -0.851 . . . . 13.85 109.964 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 15' ' ' LYS . 31.4 m -80.28 -31.98 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.362 0.125 . . . . 8.87 111.222 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.04 -59.87 0.47 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.14 0.793 . . . . 8.91 113.14 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -31.56 62.96 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.681 0.277 . . . . 8.6 111.095 -174.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.676 ' HB2' HG21 ' A' ' 12' ' ' VAL . 44.9 mmtm -75.52 136.69 40.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.256 -0.646 . . . . 9.04 109.256 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.67 88.65 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.239 0.542 . . . . 5.58 110.314 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -74.03 -47.88 33.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 2.69 110.139 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -139.29 176.09 9.01 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.68 110.416 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.771 HG21 HD13 ' A' ' 126' ' ' LEU . 6.9 tp -83.91 149.34 56.25 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.419 -0.81 . . . . 3.19 109.571 -176.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 19' ' ' ILE . 72.4 Cg_exo -43.87 141.66 4.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.849 2.366 . . . . 2.42 113.382 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 63.7 mttm -70.27 -34.18 3.88 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 114.17 1.174 . . . . 6.38 114.17 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 33.8 Cg_endo -65.55 75.94 0.28 Allowed 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.46 1.44 . . . . 2.77 113.808 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 48' ' ' THR . 8.7 mt-10 -123.08 137.09 55.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.414 -2.81 . . . . 3.39 103.414 169.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -108.01 -179.68 21.93 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 117.648 -2.215 . . . . 0.54 114.726 -171.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.707 ' HB2' HD11 ' A' ' 122' ' ' LEU . 22.5 m -169.83 34.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.841 1.256 . . . . 1.2 108.294 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' SER . 23.1 m -134.94 156.31 39.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.369 -1.287 . . . . 0.93 109.191 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -173.47 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.211 0.448 . . . . 0.48 112.211 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.839 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 15.6 t70 -160.67 157.01 26.38 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.825 -0.35 . . . . 1.69 111.004 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.4 t -142.45 134.97 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.693 -0.855 . . . . 1.14 108.693 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 25.0 t70 -125.2 132.22 53.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 1.83 111.078 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.8 tm? -101.17 127.5 47.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.94 111.55 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HE3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.08 -115.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.613 -0.722 . . . . 1.33 110.05 168.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.957 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.4 p-10 171.66 175.31 0.08 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 110.409 -0.219 . . . . 2.85 110.409 -173.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -154.16 96.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.539 0.685 . . . . 3.26 111.105 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . 0.456 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 2.3 t-20 69.47 -97.35 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.696 -0.683 . . . . 3.16 109.267 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.23 32.31 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.246 -1.39 . . . . 5.46 107.246 172.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -101.6 -44.2 5.65 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 112.595 -2.093 . . . . 1.92 105.628 -177.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 29.7 t -147.61 179.07 7.95 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 110.724 -2.944 . . . . 0.94 105.818 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 33' ' ' ASP . 8.2 t -131.33 159.83 42.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.154 -0.684 . . . . 0.86 109.154 170.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 90.9 mt-10 -114.07 134.55 54.79 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.456 0.646 . . . . 1.19 112.386 -169.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.747 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -121.73 106.08 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.841 -1.072 . . . . 3.73 110.237 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -74.11 110.34 8.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.144 -1.058 . . . . 0.81 108.144 175.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -98.63 110.17 22.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.468 0.651 . . . . 0.42 110.182 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 22.8 ttmt -87.99 117.35 26.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.692 -1.14 . . . . 2.63 109.342 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 25' ' ' SER . 61.6 t -105.78 143.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.292 -0.867 . . . . 0.82 111.038 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.716 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 4.8 m -134.89 97.39 3.74 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.482 -0.562 . . . . 0.72 109.482 166.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -86.49 126.68 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.454 0.645 . . . . 1.14 110.973 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.4 m -101.78 118.01 36.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.886 -1.052 . . . . 0.41 110.159 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 20.4 t30 -89.5 124.07 65.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 O-C-N 124.669 1.231 . . . . 1.48 109.472 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' CG ' HG12 ' A' ' 19' ' ' ILE . 67.2 Cg_endo -84.29 2.27 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.495 2.797 . . . . 0.73 115.34 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.788 ' CE2' ' HB2' ' A' ' 53' ' ' HIS . 7.2 p90 -134.77 163.03 30.72 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.685 -0.634 . . . . 2.08 109.774 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 51.8 p -81.24 21.47 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.848 1.055 . . . . 1.51 113.848 -164.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . 0.788 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 37.0 m80 -131.21 129.97 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.967 -0.693 . . . . 1.67 111.357 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.437 ' HA ' HD23 ' A' ' 82' ' ' LEU . 3.2 m -39.54 110.62 0.15 Allowed 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 124.512 1.125 . . . . 1.39 113.056 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.971 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.5 pt -73.03 170.37 13.97 Favored Pre-proline 0 C--O 1.211 -0.934 0 N-CA-C 107.83 -1.174 . . . . 1.03 107.83 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 7.6 Cg_endo -87.8 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.223 1.282 . . . . 0.37 113.327 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.904 HG12 ' HA ' ' A' ' 79' ' ' PRO . 21.7 mt -142.53 155.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.25 0.463 . . . . 1.23 112.25 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' HG22 ' A' ' 124' ' ' ILE . 21.0 p -142.28 -177.4 5.23 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.042 0.925 . . . . 1.15 110.903 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 1.061 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.1 tt0 -136.4 115.05 11.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.744 -1.571 . . . . 1.36 109.992 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.69 109.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.359 1.076 . . . . 1.05 109.738 167.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 28.7 p -113.55 102.71 10.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.674 -1.603 . . . . 0.83 108.799 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 15.8 p90 -115.49 134.91 54.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.353 0.597 . . . . 0.4 110.478 -164.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 19.5 m -131.65 111.01 11.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.616 -1.174 . . . . 0.38 109.176 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 92.2 m-85 -97.27 139.66 32.9 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.111 -0.495 . . . . 0.96 110.189 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.531 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 1.4 m80 -130.83 145.55 52.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.821 -1.177 . . . . 1.29 107.821 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . 1.021 ' HB3' HD22 ' A' ' 104' ' ' LEU . 29.7 t -107.74 -99.5 0.36 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.642 -0.823 . . . . 1.27 111.206 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -55.86 25.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.01 -0.737 . . . . 0.36 109.01 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.09 18.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.459 -1.856 . . . . 0.39 108.459 164.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 8.4 ptp180 -114.07 171.02 7.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.17 -1.015 . . . . 1.97 108.603 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.72 94.1 7.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.091 0.948 . . . . 2.61 110.324 -166.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.1 mm -48.75 -44.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.389 -1.732 . . . . 0.4 112.112 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.81 168.59 41.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.925 -1.131 . . . . 0.49 111.718 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.76 155.57 19.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.211 0.506 . . . . 1.81 110.862 176.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.14 155.11 19.82 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.593 -1.003 . . . . 0.43 110.593 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 95.5 mttt -132.35 119.71 21.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.496 -0.557 . . . . 1.72 109.496 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.617 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.2 mt -133.45 116.05 13.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.73 110.986 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.29 111.8 3.29 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.265 1.977 . . . . 0.57 110.141 168.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.8 t70 -115.87 144.75 33.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.771 -0.455 . . . . 0.79 109.771 -173.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.904 ' HA ' HG12 ' A' ' 57' ' ' ILE . 17.9 Cg_endo -61.34 73.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.815 2.343 . . . . 0.58 111.794 172.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -76.47 35.45 1.36 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.333 -0.849 . . . . 0.4 113.605 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.971 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.7 p -73.67 119.7 18.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.272 -0.64 . . . . 0.62 109.272 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 49' ' ' ASN . 1.1 pt? -140.18 -164.47 1.72 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.087 -1.445 . . . . 1.1 114.176 -161.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 90.3 mttt -54.82 -93.89 0.0 OUTLIER 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.735 0.643 . . . . 1.84 112.735 -173.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.32 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.929 -1.137 . . . . 0.99 107.929 -171.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 41.8 pttt 42.32 47.46 4.19 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 124.305 1.003 . . . . 1.84 111.338 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -151.1 -170.41 3.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.282 -0.872 . . . . 0.64 109.596 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.716 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 12.0 ttt -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.889 -0.596 . . . . 1.35 110.256 -170.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' A' ' 46' ' ' SER . 4.7 t -105.31 142.59 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.093 0.473 . . . . 0.77 110.659 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -89.41 105.91 18.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.709 0.766 . . . . 0.48 110.336 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 45' ' ' VAL . 7.6 tt -104.23 168.29 9.2 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.11 -1.441 . . . . 0.77 107.11 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -141.75 143.22 33.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 119.252 0.933 . . . . 1.81 111.874 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.916 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 33.5 mm -106.4 120.72 47.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.825 -1.176 . . . . 0.65 107.825 170.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.621 ' O ' HD22 ' A' ' 42' ' ' LEU . 46.0 Cg_exo -30.87 -97.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.811 3.674 . . . . 1.07 114.753 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.7 93.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 O-C-N 122.474 -0.141 . . . . 0.46 110.669 -179.066 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -127.17 103.65 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.448 1.277 . . . . 0.48 114.448 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 71' ' ' ILE . 1.8 p -152.14 98.19 2.95 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 122.108 -0.37 . . . . 1.07 110.519 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 69.3 Cg_exo -50.58 128.87 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.265 1.976 . . . . 0.48 111.828 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.695 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.2 t80 -48.63 -40.18 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.398 -0.819 . . . . 1.31 111.609 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 19.9 m -58.92 -28.77 66.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.334 0.494 . . . . 1.2 112.334 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.9 mm -76.32 -55.02 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.095 -0.642 . . . . 0.51 110.001 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 104' ' ' LEU . 35.7 mt -50.25 -28.16 7.24 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.97 0.794 . . . . 1.0 110.8 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.6 t80 -65.11 -44.68 87.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.93 -1.032 . . . . 0.96 109.274 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.794 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.0 m-80 -73.57 -58.08 3.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 0.82 112.197 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 1.021 HD22 ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -59.38 -54.57 45.16 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.135 0.791 . . . . 0.65 113.135 -178.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.5 -24.28 67.75 Favored 'General case' 0 C--O 1.217 -0.605 0 CA-C-O 121.753 0.787 . . . . 0.43 110.532 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.794 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.2 ttp180 -64.69 -44.27 90.85 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.717 -1.129 . . . . 1.81 110.878 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 31.5 t70 -85.16 -52.29 6.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.99 0.9 . . . . 0.8 111.411 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 114' ' ' ILE . 28.7 m -76.71 -30.87 19.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.802 -0.635 . . . . 0.88 110.18 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -79.03 -15.87 79.81 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.869 -1.059 . . . . 0.38 111.681 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.99 -42.15 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.253 -1.758 . . . . 1.09 106.253 162.098 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 37.3 m-20 -75.53 -85.25 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.87 110.289 157.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.509 ' O ' HD23 ' A' ' 144' ' ' LEU . 4.4 p-90 173.9 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.092 0.557 . . . . 1.17 112.393 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.39 134.19 35.88 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.408 -0.517 . . . . 2.15 111.941 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -116.68 151.68 18.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.097 0.475 . . . . 0.39 109.807 178.455 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -101.35 154.13 19.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.389 -0.823 . . . . 2.11 108.878 173.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 51.8 m-85 -140.91 160.04 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.198 -0.668 . . . . 0.62 109.198 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 26.4 tt0 -152.08 132.02 13.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.953 -0.388 . . . . 0.8 109.953 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 9.8 tp -101.58 132.35 47.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.184 -0.462 . . . . 1.25 110.399 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLN . . . . . 0.462 ' N ' HD12 ' A' ' 118' ' ' LEU . 6.9 tp60 -117.89 99.55 6.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.971 -0.752 . . . . 0.63 108.971 175.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.47 121.58 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.557 0.694 . . . . 0.81 110.714 -173.83 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLY . . . . . 0.693 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -89.36 129.23 9.57 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.319 -0.855 . . . . 0.26 111.891 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.1 mp -101.01 109.36 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.841 0.353 . . . . 1.2 110.954 -174.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . 1.061 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.0 m -114.87 96.71 5.85 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.731 -0.668 . . . . 0.32 109.702 175.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.774 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.06 134.35 52.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 120.314 -0.554 . . . . 0.98 111.482 -176.677 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.03 106.81 11.33 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.143 -1.058 . . . . 1.52 108.143 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.771 HD13 HG21 ' A' ' 19' ' ' ILE . 19.5 mt -116.04 170.46 5.74 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.457 1.098 . . . . 1.28 110.705 -171.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 91.0 Cg_endo -84.7 -23.76 2.54 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 121.915 1.744 . . . . 0.74 112.283 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' VAL . . . . . 0.678 HG21 HD13 ' A' ' 19' ' ' ILE . 22.8 t -74.85 -57.86 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 1.12 111.764 -175.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.519 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -107.07 -1.58 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.928 0.871 . . . . 1.35 109.787 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.75 -28.12 0.91 Allowed Glycine 0 C--O 1.225 -0.463 0 CA-C-N 114.207 -1.36 . . . . 1.05 111.833 -171.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 129' ' ' VAL . 9.6 pt-20 -165.58 138.25 4.25 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.344 -1.354 . . . . 1.16 107.344 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.2 t80 -132.41 128.72 38.14 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.664 -0.865 . . . . 1.91 108.664 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 14.0 t -120.97 101.04 7.42 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.293 1.044 . . . . 1.19 111.367 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.2 pp -127.21 132.8 24.49 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.993 -1.003 . . . . 0.5 109.84 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PRO . . . . . 0.693 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 2.5 Cg_endo -85.66 161.76 10.76 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.9 1.733 . . . . 0.45 112.242 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.61 166.6 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.1 m -134.96 148.04 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.788 -0.365 . . . . 0.88 110.987 -170.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 t -141.65 103.5 4.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.228 -1.027 . . . . 0.96 108.228 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -107.99 147.24 31.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.055 -0.52 . . . . 1.76 110.599 -175.416 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.83 135.9 4.45 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.766 -0.73 . . . . 0.5 111.326 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.54 130.05 52.54 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.47 -0.566 . . . . 2.1 109.47 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 174.81 6.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.462 -0.94 . . . . 0.76 108.462 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.469 ' N ' ' HD3' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -68.69 171.65 7.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.375 0.509 . . . . 3.53 112.375 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -56.36 128.93 74.38 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.232 -0.895 . . . . 1.23 110.635 -176.579 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD22 ' A' ' 144' ' ' LEU . 31.7 Cg_endo -63.66 173.82 4.22 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.544 2.829 . . . . 0.71 113.392 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.7 m -47.92 104.23 0.05 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.464 -0.789 . . . . 1.71 111.602 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.509 ' CD1' HD12 ' A' ' 144' ' ' LEU . 10.5 p90 -130.77 162.15 30.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.405 -0.361 . . . . 2.64 110.688 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 23.9 ttmm 174.04 76.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.077 0.861 . . . . 3.72 109.653 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 65.39 7.13 4.07 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.884 -0.598 . . . . 4.28 111.419 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.78 -48.57 9.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.211 -1.033 . . . . 2.86 108.211 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 9.4 p90 . . . . . 0 C--O 1.246 0.913 0 CA-C-N 114.424 -1.262 . . . . 3.96 108.521 172.082 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.718 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.504 -0.626 0 N-CA-C 116.249 1.259 . . . . 0.54000000000000004 116.249 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.746 ' HB2' HD11 ' A' ' 122' ' ' LEU . 23.9 m -169.51 33.14 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.105 -1.548 . . . . 1.2 107.215 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.06 155.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.338 -1.301 . . . . 0.93000000000000005 109.051 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -174.92 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.182 0.438 . . . . 0.47999999999999998 112.182 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 9.1 t70 -152.72 153.84 34.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.773 0.26 . . . . 1.6899999999999999 110.464 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 85.1 t -141.32 123.11 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.797 -0.446 . . . . 1.1399999999999999 109.797 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 33.0 t70 -113.93 108.72 17.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.757 -0.656 . . . . 1.8300000000000001 111.017 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.3 tm? -83.06 140.05 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.93999999999999995 110.488 -177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.605 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -138.68 -91.59 0.2 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.627 0.973 . . . . 1.3300000000000001 113.627 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.754 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.309 -1.189 0 O-C-N 121.589 -0.694 . . . . 2.8500000000000001 111.952 -152.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.432 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 5.7 t . . . . . 0 C--O 1.239 0.544 0 N-CA-C 112.926 0.713 . . . . 0.93999999999999995 112.926 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 61.0 t -75.86 148.85 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.243 -0.89 . . . . 0.85999999999999999 109.388 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 61.8 mt-10 -124.05 142.75 50.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.299 -0.96 . . . . 1.1899999999999999 111.209 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.954 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 11.5 p90 -133.51 131.71 40.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.269 -0.972 . . . . 3.73 112.365 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 111.95 23.73 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.213 -1.032 . . . . 0.81000000000000005 108.213 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.08 118.67 34.01 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.176 -0.61 . . . . 0.41999999999999998 110.739 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 17.5 tppt? -84.68 116.9 23.47 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.501 -0.925 . . . . 2.6299999999999999 108.501 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 25' ' ' SER . 37.2 t -100.99 145.42 11.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.81999999999999995 110.177 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -129.34 100.21 5.5 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.22 0.533 . . . . 0.71999999999999997 110.05 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -83.02 121.64 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.879 -1.055 . . . . 1.1399999999999999 110.136 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.404 ' HB ' ' N ' ' A' ' 24' ' ' GLY . 13.3 m -102.63 113.05 26.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.163 -0.68 . . . . 0.40999999999999998 109.163 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.772 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 8.7 t30 -88.36 128.93 51.35 Favored Pre-proline 0 N--CA 1.466 0.347 0 O-C-N 124.533 1.146 . . . . 1.48 109.961 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -87.58 13.52 2.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.72999999999999998 114.389 -176.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -130.9 142.42 50.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.392 -0.596 . . . . 2.0800000000000001 109.392 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.611 ' HB3' ' HD2' ' A' ' 85' ' ' LYS . 56.8 p -74.88 31.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.881 0.697 . . . . 1.51 112.881 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -145.12 128.99 17.37 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.245 -0.284 . . . . 1.6699999999999999 110.738 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -39.88 110.22 0.14 Allowed 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 124.258 1.023 . . . . 1.3899999999999999 112.412 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HD11 ' A' ' 82' ' ' LEU . 4.1 pt -79.62 173.31 7.93 Favored Pre-proline 0 C--O 1.201 -1.48 0 N-CA-C 106.111 -1.811 . . . . 1.03 106.111 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.505 ' C ' HD12 ' A' ' 57' ' ' ILE . 9.4 Cg_endo -92.75 -62.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 121.326 1.509 . . . . 0.37 114.408 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.6 HG13 ' HA ' ' A' ' 79' ' ' PRO . 1.4 mp -134.26 153.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.274 -0.421 . . . . 1.23 110.796 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 124' ' ' ILE . 21.0 m -140.76 178.95 6.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.886 0.851 . . . . 1.1499999999999999 111.503 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.087 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 42.0 tt0 -133.77 115.53 14.65 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.906 -1.497 . . . . 1.3600000000000001 110.249 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.621 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.59 110.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 122.533 1.159 . . . . 1.05 110.378 169.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 120' ' ' ILE . 14.2 t -113.3 102.74 10.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.196 -1.82 . . . . 0.82999999999999996 108.636 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.536 ' HE1' HG11 ' A' ' 95' ' ' VAL . 6.6 p90 -113.66 133.44 55.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.418 0.628 . . . . 0.40000000000000002 110.029 -167.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 27.2 m -126.14 104.77 8.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.675 -1.148 . . . . 0.38 108.399 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 4.4 m-85 -95.42 143.17 26.99 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.2 -0.454 . . . . 0.95999999999999996 110.191 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 4.0 m170 -132.11 145.63 51.52 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 107.107 -1.442 . . . . 1.29 107.107 175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.936 ' HB3' HD22 ' A' ' 104' ' ' LEU . 19.9 t -103.84 -91.17 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.631 -1.228 . . . . 1.27 111.158 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -69.07 0.17 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.85 0.357 . . . . 0.35999999999999999 110.159 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.67 15.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.461 -1.456 . . . . 0.39000000000000001 109.461 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -100.17 -78.31 0.51 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.516 -0.842 . . . . 1.97 109.041 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.664 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -171.4 -177.34 2.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.141 -1.059 . . . . 2.6099999999999999 108.141 171.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 96' ' ' VAL . 1.6 mm -135.18 -35.77 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.363 -0.835 . . . . 0.40000000000000002 109.556 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 160.5 171.98 27.16 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.281 -1.128 . . . . 0.48999999999999999 110.281 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -161.18 166.13 28.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.124 0.962 . . . . 1.8100000000000001 110.766 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.01 166.02 32.19 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.359 -0.696 . . . . 0.42999999999999999 111.359 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -129.33 129.51 44.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.897 -0.409 . . . . 1.72 109.897 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.8 mt -139.23 121.64 10.31 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.782 0.325 . . . . 0.72999999999999998 110.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.7 115.4 4.32 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.432 2.088 . . . . 0.56999999999999995 110.76 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.13 141.61 39.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.79000000000000004 109.375 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 57' ' ' ILE . 23.5 Cg_exo -63.88 82.66 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.593 2.195 . . . . 0.57999999999999996 112.052 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -87.85 41.97 3.09 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.692 -0.685 . . . . 0.40000000000000002 112.14 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.801 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 44.4 t -73.45 133.74 43.77 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.208 -1.034 . . . . 0.62 108.208 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.823 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -152.81 -156.93 0.75 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 118.201 -1.4 . . . . 1.1000000000000001 114.641 -163.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.521 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 64.9 mttm -63.82 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 1.8400000000000001 112.173 -173.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.4 106.09 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.75 -0.833 . . . . 0.98999999999999999 108.75 -171.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 6.5 ptmm? 46.35 46.25 13.65 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.28 0.988 . . . . 1.8400000000000001 111.348 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.39 -170.68 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.757 -1.11 . . . . 0.64000000000000001 109.545 -173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 50.1 ttm -112.0 132.17 54.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 1.3500000000000001 110.947 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -122.94 146.5 47.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.806 -0.633 . . . . 0.77000000000000002 110.049 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.05 137.09 32.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.24 0.543 . . . . 0.47999999999999998 110.696 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 45' ' ' VAL . 7.2 tt -137.72 168.35 19.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.41 -0.959 . . . . 0.77000000000000002 108.41 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -132.39 140.95 48.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.734 0.642 . . . . 1.8100000000000001 112.734 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 43.4 mm -110.94 143.51 28.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.65000000000000002 108.159 172.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.75 -121.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.787 2.991 . . . . 1.0700000000000001 114.147 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.975 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -157.37 88.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.849 -0.532 . . . . 0.46000000000000002 111.891 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' HE1' ' A' ' 62' ' ' PHE . 12.3 p -127.39 101.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 115.412 1.634 . . . . 0.47999999999999998 115.412 -168.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.575 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.2 p -150.96 98.76 3.13 Favored Pre-proline 0 C--N 1.315 -0.898 0 O-C-N 121.501 -0.749 . . . . 1.0700000000000001 110.489 164.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HB2' HG12 ' A' ' 100' ' ' ILE . 51.9 Cg_exo -52.59 134.02 51.59 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.064 1.842 . . . . 0.47999999999999998 111.418 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.432 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.5 t80 -57.2 -33.28 67.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 1.3100000000000001 111.204 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 26.5 m -58.04 -32.02 67.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.926 0.343 . . . . 1.2 111.926 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.493 HG21 ' HG2' ' A' ' 70' ' ' GLU . 9.6 mm -76.9 -56.32 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.502 -0.479 . . . . 0.51000000000000001 110.695 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -51.24 -27.87 10.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.563 171.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 63.2 t80 -65.45 -38.67 90.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.09 -1.413 . . . . 0.95999999999999996 108.803 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.648 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 36.1 m-80 -74.47 -57.77 3.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.935 -0.575 . . . . 0.81999999999999995 111.758 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.936 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.2 pp -62.29 -51.42 67.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.56 0.948 . . . . 0.65000000000000002 113.56 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.407 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.24 -24.43 65.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.797 0.808 . . . . 0.42999999999999999 110.536 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.3 ttm180 -59.1 -52.04 67.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.917 -1.038 . . . . 1.8100000000000001 110.191 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 22.2 t70 -82.83 -51.34 7.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.6 0.714 . . . . 0.80000000000000004 111.948 -173.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 2.7 t -86.87 -27.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 121.872 -0.518 . . . . 0.88 110.425 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.0 -20.43 79.43 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.739 -0.743 . . . . 0.38 111.692 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -48.45 -46.33 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.824 -1.547 . . . . 1.0900000000000001 106.824 163.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 12.0 t70 -67.09 -90.41 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.477 -0.783 . . . . 1.8700000000000001 109.088 160.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 172.44 -45.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.352 0.661 . . . . 1.1699999999999999 111.17 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.55 127.32 42.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 2.1499999999999999 111.246 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 144' ' ' LEU . 2.3 mp -124.78 158.54 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.697 -0.483 . . . . 0.39000000000000001 109.697 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 23.3 t70 -97.58 155.39 16.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.326 -0.99 . . . . 2.1099999999999999 108.326 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.758 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 47.4 m-85 -136.36 121.83 19.45 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.233 -0.654 . . . . 0.62 109.233 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.868 ' HG3' ' HG2' ' A' ' 139' ' ' LYS . 7.9 tt0 -113.08 132.66 55.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.128 -0.323 . . . . 0.80000000000000004 110.128 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.739 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 15.8 tp -102.07 128.83 48.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.219 -0.446 . . . . 1.25 110.053 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.726 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.18 99.55 8.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.976 -1.12 . . . . 0.63 107.976 168.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 60' ' ' ILE . 5.4 tp -113.17 117.79 56.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.321 0.582 . . . . 0.81000000000000005 111.099 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 120.62 5.27 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.104 -0.798 . . . . 0.26000000000000001 111.104 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 25' ' ' SER . 5.2 mp -97.76 98.55 9.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.123 0.487 . . . . 1.2 111.164 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.087 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.2 m -100.11 121.14 40.95 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.384 -0.969 . . . . 0.32000000000000001 108.384 169.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.73 HG22 ' SG ' ' A' ' 58' ' ' CYS . 11.0 pt -133.68 132.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.538 -0.465 . . . . 0.97999999999999998 110.355 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.26 107.03 11.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.194 -1.039 . . . . 1.52 108.194 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.568 HD23 HG21 ' A' ' 55' ' ' ILE . 11.1 mt -115.73 160.83 33.42 Favored Pre-proline 0 C--O 1.219 -0.522 0 O-C-N 124.715 1.26 . . . . 1.28 110.769 -169.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.75 -23.8 16.32 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.89 1.727 . . . . 0.73999999999999999 112.152 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -57.59 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 112.093 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.504 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -109.17 1.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.033 0.921 . . . . 1.3500000000000001 109.897 -175.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.79 -32.49 0.88 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.09 -1.414 . . . . 1.05 111.682 -171.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -175.75 146.29 0.73 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.456 -1.312 . . . . 1.1599999999999999 107.456 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 14.6 t80 -150.82 146.32 26.29 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.422 -0.511 . . . . 1.9099999999999999 110.004 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 37.4 m -121.27 110.39 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.221 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.15 133.9 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.5 109.355 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 38.3 Cg_endo -91.54 162.29 3.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.873 1.715 . . . . 0.45000000000000001 113.28 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.17 167.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.245 -1.02 . . . . 0.44 108.245 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -137.81 150.4 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.662 -0.125 . . . . 0.88 110.662 -167.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.7 t -148.6 102.38 3.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.623 -0.51 . . . . 0.95999999999999996 109.623 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.868 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -99.11 144.5 28.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.847 -0.615 . . . . 1.76 110.936 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.37 130.42 3.07 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.478 -0.649 . . . . 0.5 111.478 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 24.0 mt-10 -98.9 125.29 44.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.662 -0.496 . . . . 2.1000000000000001 109.662 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 172.68 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.841 -1.17 . . . . 0.76000000000000001 107.841 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -67.23 141.29 57.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.883 -0.414 . . . . 3.5299999999999998 109.883 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.2 pp -60.35 163.83 7.87 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.366 -0.379 . . . . 1.23 111.505 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 144' ' ' LEU . 15.9 Cg_endo . . . . . 0 C--N 1.353 0.808 0 C-N-CA 123.504 2.803 . . . . 0.70999999999999996 113.804 -174.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.549 0 N-CA-C 115.881 1.113 . . . . 0.54000000000000004 115.881 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG13 ' A' ' 45' ' ' VAL . 93.2 p -166.57 36.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.776 -1.564 . . . . 1.2 106.776 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 46' ' ' SER . 13.4 m -134.52 154.03 36.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.646 -1.615 . . . . 0.93000000000000005 109.237 -169.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 2.4 t -175.12 -50.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.245 0.461 . . . . 0.47999999999999998 112.245 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 16.3 t70 -152.19 157.13 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.912 -0.493 . . . . 1.6899999999999999 111.36 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 75.1 t -147.33 124.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.379 -0.373 . . . . 1.1399999999999999 110.719 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -107.13 142.03 37.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 1.8300000000000001 110.454 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.0 tm? -97.85 141.04 31.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.34 -0.615 . . . . 0.93999999999999995 109.34 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.778 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -135.45 -115.21 0.19 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 114.366 1.247 . . . . 1.3300000000000001 114.366 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 11.7 m-20 . . . . . 0 C--O 1.203 -1.368 0 O-C-N 121.653 -0.654 . . . . 2.8500000000000001 111.823 -156.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.402 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 7.2 t . . . . . 0 N--CA 1.441 -0.897 0 CA-C-O 121.15 0.5 . . . . 0.93999999999999995 110.556 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.674 HG21 HD12 ' A' ' 101' ' ' LEU . 41.8 t -87.64 155.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.606 -0.725 . . . . 0.85999999999999999 109.495 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.947 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 70.6 mt-10 -118.94 151.12 38.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 122.004 -0.435 . . . . 1.1899999999999999 110.457 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE2' ' HB2' ' A' ' 43' ' ' ALA . 24.3 p90 -136.89 131.55 33.3 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.122 -0.631 . . . . 3.73 111.833 171.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.32 112.43 20.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.799 -0.815 . . . . 0.81000000000000005 108.799 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HB2' ' HE2' ' A' ' 41' ' ' TYR . . . -95.32 115.8 27.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.249 0.547 . . . . 0.41999999999999998 110.936 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 10.8 tppt? -88.39 123.52 33.03 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.518 -0.919 . . . . 2.6299999999999999 108.518 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 25' ' ' SER . 30.9 t -110.5 140.74 28.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.711 -0.677 . . . . 0.81999999999999995 110.544 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 1.6 m -129.15 99.32 5.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.25 0.547 . . . . 0.71999999999999997 110.165 170.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -82.61 125.88 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.308 -0.86 . . . . 1.1399999999999999 110.483 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.571 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 5.8 m -108.11 113.97 27.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.465 -0.569 . . . . 0.40999999999999998 109.465 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.86 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 p30 -89.76 150.53 44.17 Favored Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 108.132 -1.062 . . . . 1.48 108.132 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -97.71 -9.34 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.072 2.515 . . . . 0.72999999999999998 114.48 -175.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.719 ' HE1' HG23 ' A' ' 128' ' ' VAL . 14.2 t80 -89.17 -20.27 24.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.88 -0.728 . . . . 2.0800000000000001 112.195 -155.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.702 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 24.0 t 84.16 13.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.987 0.804 . . . . 1.51 109.237 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HD1' ' HD2' ' A' ' 51' ' ' TYR . 34.4 m80 -139.65 130.0 25.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.77 . . . . 1.6699999999999999 109.382 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 14.7 m -41.89 96.7 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 O-C-N 124.102 0.876 . . . . 1.3899999999999999 112.928 173.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.006 HG21 HD23 ' A' ' 126' ' ' LEU . 6.0 pt -74.75 171.46 11.48 Favored Pre-proline 0 C--O 1.212 -0.889 0 N-CA-C 108.261 -1.015 . . . . 1.03 108.261 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 12.4 Cg_endo -88.91 -59.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.067 1.178 . . . . 0.37 113.993 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.799 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 5.9 mt -138.68 162.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.951 -0.7 . . . . 1.23 112.125 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.708 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.0 p -146.72 177.13 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.251 1.024 . . . . 1.1499999999999999 111.7 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.111 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 31.8 tt0 -126.4 116.18 20.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.286 -1.779 . . . . 1.3600000000000001 109.723 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.852 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -98.88 109.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.204 1.002 . . . . 1.05 109.975 172.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 5.8 m -112.44 102.89 10.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.597 -1.638 . . . . 0.82999999999999996 108.465 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 p90 -112.87 127.37 56.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.456 0.646 . . . . 0.40000000000000002 109.82 -169.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 16.4 m -123.28 106.5 10.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.483 -1.235 . . . . 0.38 108.289 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.34 135.18 39.61 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.646 -0.421 . . . . 0.95999999999999996 110.514 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 2.2 m170 -123.05 144.76 49.07 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.034 -1.469 . . . . 1.29 107.034 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.975 ' HB3' HD22 ' A' ' 104' ' ' LEU . 46.4 t -106.78 -97.53 0.35 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.223 -0.991 . . . . 1.27 110.919 174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.2 -58.79 6.9 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.212 -0.662 . . . . 0.35999999999999999 109.212 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 22.41 0.13 Allowed Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.613 -1.395 . . . . 0.39000000000000001 109.613 164.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.2 ptp180 -122.37 -172.57 2.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.643 -0.503 . . . . 1.97 109.643 -175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -100.46 87.19 3.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.716 0.77 . . . . 2.6099999999999999 111.46 -161.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.671 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.8 mm -53.74 -45.15 61.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.598 -1.183 . . . . 0.40000000000000002 112.117 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.91 163.62 30.82 Favored Glycine 0 C--O 1.22 -0.74 0 C-N-CA 120.23 -0.986 . . . . 0.48999999999999999 111.383 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -163.07 157.59 20.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.886 0.843 . . . . 1.8100000000000001 111.871 -177.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.61 28.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.825 -0.51 . . . . 0.42999999999999999 111.825 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 37.9 mttm -127.3 127.11 43.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.902 -0.407 . . . . 1.72 109.902 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 60' ' ' ILE . 78.4 mt -139.95 124.9 11.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 120.695 0.283 . . . . 0.72999999999999998 110.55 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.54 116.32 4.64 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.431 2.087 . . . . 0.56999999999999995 110.801 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 60' ' ' ILE . 10.8 t70 -123.08 141.1 34.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.487 -0.56 . . . . 0.79000000000000004 109.487 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.7 89.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.719 2.28 . . . . 0.57999999999999996 112.337 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.799 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -82.69 28.43 3.53 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.40000000000000002 113.102 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.959 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.9 p -74.91 122.88 24.11 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.985 -0.376 . . . . 0.62 109.985 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.8 pt? -153.41 -167.19 2.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 118.317 -1.353 . . . . 1.1000000000000001 114.059 -165.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 87.5 mttt -52.57 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.545 0.943 . . . . 1.8400000000000001 113.545 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . -178.08 105.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.636 -0.876 . . . . 0.98999999999999999 108.636 -174.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.86 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.7 pttt 36.91 62.97 0.73 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.104 0.877 . . . . 1.8400000000000001 111.185 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' THR . 5.7 t70 -157.51 -179.3 8.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.789 -1.096 . . . . 0.64000000000000001 109.015 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.598 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 40.6 ttm -108.73 120.12 41.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.072 -0.513 . . . . 1.3500000000000001 110.597 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 46' ' ' SER . 6.0 t -105.76 143.68 33.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.621 -0.718 . . . . 0.77000000000000002 109.917 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.93 26.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.463 0.649 . . . . 0.47999999999999998 110.708 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.622 HD22 HG11 ' A' ' 45' ' ' VAL . 5.6 tt -116.0 164.58 14.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.982 -1.008 . . . . 0.77000000000000002 108.985 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.32 132.9 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 1.8100000000000001 110.951 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 21.7 mm -118.95 140.82 29.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.65000000000000002 111.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.94 -169.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.059 3.173 . . . . 1.0700000000000001 113.626 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 18.0 m -126.8 91.01 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.46000000000000002 112.417 -163.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.447 HG13 ' HE1' ' A' ' 41' ' ' TYR . 4.9 p -125.29 104.45 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.885 1.439 . . . . 0.47999999999999998 114.885 -163.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.47 HG13 HG23 ' A' ' 71' ' ' ILE . 4.8 t -145.79 109.07 4.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.088 -0.382 . . . . 1.0700000000000001 110.775 170.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.1 Cg_exo -56.87 129.24 33.48 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 120.711 0.94 . . . . 0.47999999999999998 110.55 169.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.548 ' HE1' ' HD2' ' A' ' 102' ' ' PHE . 11.8 t80 -53.59 -32.16 49.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.261 -0.427 . . . . 1.3100000000000001 110.631 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 2.0 m -57.45 -30.73 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 1.2 112.041 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.671 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -76.05 -55.44 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.51000000000000001 110.52 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 104' ' ' LEU . 42.3 mt -53.49 -27.17 23.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.952 172.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.592 ' HB3' ' O ' ' A' ' 99' ' ' SER . 34.8 t80 -60.77 -46.42 90.54 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.595 -1.184 . . . . 0.95999999999999996 108.786 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.596 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.3 m-80 -73.44 -56.05 5.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.81999999999999995 112.217 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.975 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.9 pp -59.85 -46.68 88.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.46 0.911 . . . . 0.65000000000000002 113.46 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -61.71 -24.06 66.53 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.918 0.866 . . . . 0.42999999999999999 110.104 178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.596 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.7 ttp180 -68.61 -49.16 61.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.896 -1.047 . . . . 1.8100000000000001 110.82 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.667 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -81.85 -54.82 5.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.122 0.963 . . . . 0.80000000000000004 112.213 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.94 ' HB ' HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -88.72 -20.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 121.348 -0.845 . . . . 0.88 109.883 -176.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.05 -19.93 79.62 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.077 -1.058 . . . . 0.38 110.93 167.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -50.55 -45.86 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.7 -1.222 . . . . 1.0900000000000001 107.7 167.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 4.6 p-10 -81.16 -84.36 0.1 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.026 -1.07 . . . . 1.8700000000000001 110.929 163.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.428 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 5.0 p-90 178.1 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.604 0.638 . . . . 1.1699999999999999 112.665 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.35 121.95 37.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.691 -0.231 . . . . 2.1499999999999999 111.568 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.94 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.4 mp -113.19 154.81 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.447 -0.575 . . . . 0.39000000000000001 109.447 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -100.4 153.53 19.26 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.62 -0.718 . . . . 2.1099999999999999 109.198 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -135.45 151.5 50.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.683 -1.229 . . . . 0.62 107.683 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.805 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 38.3 tt0 -146.07 126.63 14.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 110.032 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.765 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 15.0 tp -97.34 137.13 36.81 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.169 0.509 . . . . 1.25 110.692 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.737 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -115.84 100.52 8.07 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.344 -0.984 . . . . 0.63 108.344 170.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.852 HD11 HG22 ' A' ' 60' ' ' ILE . 4.6 tp -114.01 118.9 59.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.218 0.533 . . . . 0.81000000000000005 111.091 -173.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.14 124.18 6.91 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.544 -0.622 . . . . 0.26000000000000001 111.544 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.61 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.5 mp -104.03 100.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.035 0.445 . . . . 1.2 111.108 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 99.9 m -102.62 96.6 6.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.223 -0.899 . . . . 0.32000000000000001 108.826 172.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.708 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.94 133.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.528 -0.469 . . . . 0.97999999999999998 110.717 -175.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 1.0 OUTLIER -75.22 105.67 6.36 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.93 -0.767 . . . . 1.52 108.93 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 1.006 HD23 HG21 ' A' ' 55' ' ' ILE . 19.2 mt -120.2 143.05 34.82 Favored Pre-proline 0 C--O 1.216 -0.675 0 O-C-N 124.706 1.254 . . . . 1.28 109.925 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 78.0 Cg_exo -53.14 -37.47 79.75 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.905 2.403 . . . . 0.73999999999999999 115.361 -171.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.719 HG23 ' HE1' ' A' ' 51' ' ' TYR . 97.7 t -73.64 -56.93 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.747 -0.596 . . . . 1.1200000000000001 112.496 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' ' 132' ' ' PHE . 14.9 p -92.16 -7.97 10.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 122.32 1.057 . . . . 1.3500000000000001 109.868 -175.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.27 -36.78 2.39 Favored Glycine 0 N--CA 1.462 0.43 0 CA-C-N 114.18 -1.373 . . . . 1.05 112.078 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.5 pt-20 -165.84 122.3 1.36 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.544 -1.28 . . . . 1.1599999999999999 107.544 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.671 ' HB2' HG11 ' A' ' 129' ' ' VAL . 7.9 t80 -111.98 143.28 43.23 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.241 -0.584 . . . . 1.9099999999999999 109.801 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 64.7 m -123.75 102.43 7.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.846 -0.615 . . . . 1.1899999999999999 111.524 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.53 139.19 34.06 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.728 -0.669 . . . . 0.5 110.096 173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.16 162.26 3.8 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.45000000000000001 112.557 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 167.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.29 -1.004 . . . . 0.44 108.29 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -137.1 148.78 46.92 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.952 -0.299 . . . . 0.88 110.794 -170.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 t -140.39 107.83 5.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.445 -0.946 . . . . 0.95999999999999996 108.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.805 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.74 143.93 43.81 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.865 -0.334 . . . . 1.76 110.789 -175.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.73 132.62 3.75 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.812 -0.915 . . . . 0.5 110.812 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 9.3 mt-10 -97.55 126.31 42.76 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.926 -0.768 . . . . 2.1000000000000001 108.926 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.03 173.3 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.173 -0.677 . . . . 0.76000000000000001 109.173 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -65.55 168.22 7.76 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.747 0.647 . . . . 3.5299999999999998 112.747 -173.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.915 HD12 ' HD2' ' A' ' 145' ' ' PRO . 22.9 tp -56.21 130.48 74.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.033 -0.985 . . . . 1.23 112.324 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.915 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.8 Cg_endo . . . . . 0 C--N 1.354 0.849 0 C-N-CA 124.24 3.293 . . . . 0.70999999999999996 112.93 179.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.422 -2.294 0 CA-C-O 119.788 -0.451 . . . . 0.54000000000000004 112.701 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.493 ' HB2' HD21 ' A' ' 122' ' ' LEU . 4.9 m -172.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.829 0.851 . . . . 1.2 109.62 167.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 46' ' ' SER . 7.4 p -134.25 147.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.56 -0.746 . . . . 0.93000000000000005 110.926 -174.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -166.11 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.47999999999999998 110.899 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 33.3 t70 -167.09 164.78 15.83 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.365 -0.235 . . . . 1.6899999999999999 110.365 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.512 HG21 ' HZ ' ' A' ' 64' ' ' PHE . 69.0 t -142.91 120.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.992 -0.373 . . . . 1.1399999999999999 109.992 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 9.7 m-20 -92.4 109.86 21.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.8300000000000001 110.648 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.394 -0.595 . . . . 0.93999999999999995 109.394 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -124.58 -125.95 0.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.195 -0.457 . . . . 1.3300000000000001 109.962 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.955 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 p30 . . . . . 0 CA--C 1.512 -0.503 0 CA-C-O 121.13 0.491 . . . . 2.8500000000000001 112.1 -171.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.723 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 39.4 t . . . . . 0 C--O 1.212 -0.877 0 N-CA-C 107.132 -1.433 . . . . 0.93999999999999995 107.132 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.105 HG23 HG13 ' A' ' 96' ' ' VAL . 20.4 m -128.69 178.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.377 0.99 . . . . 0.85999999999999999 111.476 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.949 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 84.4 mt-10 -125.25 151.68 45.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.815 -0.63 . . . . 1.1899999999999999 111.431 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.884 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 13.5 p90 -136.46 123.42 21.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.897 -0.721 . . . . 3.73 110.197 165.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -86.68 110.82 20.13 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.528 -0.915 . . . . 0.81000000000000005 108.528 174.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.09 115.59 28.13 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.816 0.817 . . . . 0.41999999999999998 110.211 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 20.8 ttmt -84.72 117.72 23.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.252 -1.34 . . . . 2.6299999999999999 108.432 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.747 HG21 HG12 ' A' ' 92' ' ' ILE . 39.5 t -111.57 144.9 18.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.435 0.636 . . . . 0.81999999999999995 111.841 -169.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.672 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 24.7 m -133.57 97.5 3.95 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.22 -0.9 . . . . 0.71999999999999997 108.735 163.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.619 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -85.95 132.16 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.61 0.719 . . . . 1.1399999999999999 110.893 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.446 ' H ' ' HA3' ' A' ' 24' ' ' GLY . 26.8 m -111.33 115.53 29.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.718 -1.128 . . . . 0.40999999999999998 110.032 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.9 t30 -91.53 132.77 32.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.717 1.26 . . . . 1.48 108.409 174.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -89.04 3.31 5.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.129 2.553 . . . . 0.72999999999999998 114.147 -177.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 91.7 t80 -108.33 133.1 53.01 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.152 -0.684 . . . . 2.0800000000000001 109.152 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.777 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 23.8 p -77.08 30.27 0.14 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.496 0.924 . . . . 1.51 113.496 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 62.2 m80 -146.15 142.81 28.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 1.6699999999999999 108.597 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -41.01 105.75 0.05 OUTLIER 'General case' 0 C--O 1.208 -1.125 0 O-C-N 123.886 0.741 . . . . 1.3899999999999999 112.151 171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.947 ' O ' ' HA ' ' A' ' 81' ' ' SER . 8.4 pt -75.63 171.32 12.26 Favored Pre-proline 0 C--O 1.209 -1.076 0 N-CA-C 107.463 -1.31 . . . . 1.03 107.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.422 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 10.2 Cg_endo -89.46 -62.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 120.301 1.143 . . . . 0.37 113.781 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.4 mm -130.3 154.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.401 -0.52 . . . . 1.23 110.919 -167.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.717 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 4.0 m -146.1 -176.52 5.19 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.977 0.894 . . . . 1.1499999999999999 110.988 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.953 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 43.1 tt0 -138.47 118.14 13.09 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.96 -1.473 . . . . 1.3600000000000001 111.068 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.63 108.22 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.255 1.026 . . . . 1.05 109.54 166.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 15.5 p -113.61 102.62 10.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 113.826 -1.533 . . . . 0.82999999999999996 108.413 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -112.74 126.89 55.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.488 0.661 . . . . 0.40000000000000002 110.012 -165.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 20.9 m -120.86 104.25 9.71 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.83 -1.077 . . . . 0.38 108.392 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.814 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.3 130.06 44.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.444 0.64 . . . . 0.95999999999999996 110.809 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -121.1 145.1 48.16 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 107.104 -1.443 . . . . 1.29 107.104 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 104' ' ' LEU . 33.8 t -101.97 -102.72 0.27 Allowed 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.079 -1.049 . . . . 1.27 110.891 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.66 -54.32 47.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.048 -0.723 . . . . 0.35999999999999999 109.048 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.19 17.9 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.093 -1.603 . . . . 0.39000000000000001 109.093 166.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.552 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 5.9 ptp180 -106.08 -147.51 0.4 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.859 -0.67 . . . . 1.97 109.561 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -123.82 99.1 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.19 0.45 . . . . 2.6099999999999999 110.349 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.74 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.5 mm -70.89 -38.95 74.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.544 -0.753 . . . . 0.40000000000000002 110.231 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.49 171.69 32.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.572 -0.823 . . . . 0.48999999999999999 111.846 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -159.42 154.7 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.091 0.446 . . . . 1.8100000000000001 110.367 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.53 155.56 13.6 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.433 -0.667 . . . . 0.42999999999999999 111.433 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 17.3 ptpt -131.38 134.77 46.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.967 0.413 . . . . 1.72 110.703 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -140.01 122.67 10.11 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.72999999999999998 109.939 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.94 108.32 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.204 1.936 . . . . 0.56999999999999995 111.033 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -114.92 141.74 27.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.549 -0.537 . . . . 0.79000000000000004 109.549 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.8 Cg_endo -60.62 87.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.577 2.185 . . . . 0.57999999999999996 112.407 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.717 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -88.7 33.99 4.01 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.40000000000000002 111.905 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.947 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -71.01 118.29 13.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.681 -0.859 . . . . 0.62 108.681 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 HD22 ' A' ' 49' ' ' ASN . 1.4 pt? -148.11 -159.98 1.11 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.07 -1.452 . . . . 1.1000000000000001 114.73 -158.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 56.2 mttm -52.57 -92.05 0.0 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.131 -0.94 . . . . 1.8400000000000001 112.778 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 167.02 105.76 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.638 -1.245 . . . . 0.98999999999999999 107.638 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.0 pttt 41.37 49.47 3.43 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.363 1.039 . . . . 1.8400000000000001 111.034 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.17 -172.34 3.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.064 -0.971 . . . . 0.64000000000000001 109.757 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.7 ttm -113.28 118.15 33.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.886 0.374 . . . . 1.3500000000000001 110.801 -171.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.598 ' CG2' HG13 ' A' ' 47' ' ' VAL . 7.1 t -107.35 143.43 35.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.489 . . . . 0.77000000000000002 110.19 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.54 136.66 36.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.333 0.587 . . . . 0.47999999999999998 109.59 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 4.2 tt -133.53 170.48 15.45 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.322 -0.992 . . . . 0.77000000000000002 108.322 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.408 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 t70 -135.2 123.5 23.14 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.012 -0.275 . . . . 1.8100000000000001 110.647 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -105.18 138.15 19.45 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.616 0.246 . . . . 0.65000000000000002 110.997 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.79 168.25 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.543 2.829 . . . . 1.0700000000000001 112.606 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.949 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 4.5 m -110.58 88.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.46000000000000002 111.364 -166.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.529 HG13 ' HE2' ' A' ' 41' ' ' TYR . 4.1 p -128.46 101.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 114.726 1.38 . . . . 0.47999999999999998 114.726 -165.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.105 HG13 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.3 115.65 3.96 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 119.882 -0.727 . . . . 1.0700000000000001 110.208 162.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.1 128.52 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.439 1.426 . . . . 0.47999999999999998 109.746 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.723 ' H ' ' HA ' ' A' ' 38' ' ' SER . 20.5 t80 -57.03 -28.1 62.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.03 0.443 . . . . 1.3100000000000001 110.112 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -52.44 -30.51 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.563 -0.744 . . . . 1.2 111.892 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.74 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.1 mm -78.2 -54.12 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.409 -0.359 . . . . 0.51000000000000001 111.209 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 104' ' ' LEU . 22.8 mt -50.44 -27.96 7.39 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.572 0.701 . . . . 1.0 110.218 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 16.7 t80 -68.99 -40.73 78.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.661 -1.609 . . . . 0.95999999999999996 108.506 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.657 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 18.6 m-80 -74.42 -56.51 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.816 -0.629 . . . . 0.81999999999999995 112.365 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.1 pp -56.7 -56.35 22.5 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.992 0.738 . . . . 0.65000000000000002 112.992 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.485 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.34 -21.99 66.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.886 0.85 . . . . 0.42999999999999999 110.149 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -61.03 -53.99 50.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.481 -1.236 . . . . 1.8100000000000001 110.147 173.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.617 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.2 t70 -85.4 -52.16 6.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.189 0.995 . . . . 0.80000000000000004 111.723 -171.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 114' ' ' ILE . 34.3 m -80.03 -31.08 13.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.586 -0.696 . . . . 0.88 110.706 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.03 -16.54 80.67 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.087 -0.961 . . . . 0.38 111.616 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.71 -42.53 13.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.456 -1.683 . . . . 1.0900000000000001 106.456 161.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 42.0 m-20 -75.74 -86.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.57 -0.741 . . . . 1.8700000000000001 110.298 159.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.443 ' O ' HD23 ' A' ' 144' ' ' LEU . 17.0 p-90 176.73 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.743 0.417 . . . . 1.1699999999999999 111.629 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.3 133.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.359 0.599 . . . . 2.1499999999999999 111.511 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.04 HG23 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -117.95 149.66 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.603 -0.726 . . . . 0.39000000000000001 109.604 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 10.1 p-10 -104.79 154.98 19.31 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.457 -0.942 . . . . 2.1099999999999999 108.457 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 48.1 m-85 -134.61 156.98 47.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.526 -0.916 . . . . 0.62 108.526 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.526 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 31.5 tt0 -143.56 129.46 19.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.607 -0.516 . . . . 0.80000000000000004 109.607 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.814 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -103.79 133.99 47.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.769 -0.65 . . . . 1.25 109.46 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.786 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.7 100.73 8.01 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.02 -0.733 . . . . 0.63 109.02 172.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.589 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.1 tp -110.23 117.58 55.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.305 0.574 . . . . 0.81000000000000005 110.706 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.65 124.51 7.28 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.0 -0.84 . . . . 0.26000000000000001 111.0 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.9 mm? -101.1 98.23 8.69 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.529 0.68 . . . . 1.2 111.961 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 0.953 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 96.5 m -95.83 94.78 7.85 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.32 -1.309 . . . . 0.32000000000000001 108.954 169.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.808 HG13 HD21 ' A' ' 126' ' ' LEU . 9.7 pt -107.38 141.63 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 120.414 -0.514 . . . . 0.97999999999999998 109.646 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.55 106.12 18.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 1.52 109.688 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.808 HD21 HG13 ' A' ' 124' ' ' ILE . 1.5 mm? -103.13 141.62 22.86 Favored Pre-proline 0 C--O 1.213 -0.82 0 O-C-N 124.344 1.028 . . . . 1.28 109.586 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 52.5 Cg_exo -57.9 -24.98 67.47 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.082 1.855 . . . . 0.73999999999999999 113.988 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.82 -58.13 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.984 0.421 . . . . 1.1200000000000001 111.844 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -102.79 0.67 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.078 0.942 . . . . 1.3500000000000001 110.789 -177.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.33 -39.45 2.9 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 113.86 -1.518 . . . . 1.05 111.41 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 9.6 pt-20 -167.41 155.44 9.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 1.1599999999999999 109.285 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.47 142.11 31.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.229 -0.656 . . . . 1.9099999999999999 109.229 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.7 m -122.66 107.94 12.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.904 0.383 . . . . 1.1899999999999999 111.777 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.6 pp -128.0 141.25 40.59 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.5 110.006 172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.6 Cg_endo -92.42 165.66 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.07 1.847 . . . . 0.45000000000000001 112.872 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.548 HG23 ' CG2' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -159.03 158.2 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.712 -1.218 . . . . 0.44 107.712 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 76.5 p -131.97 152.41 51.13 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.471 -0.492 . . . . 0.88 111.898 -170.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -139.46 110.73 6.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.835 -0.802 . . . . 0.95999999999999996 108.835 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.526 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.19 140.92 47.53 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.835 -0.346 . . . . 1.76 110.548 -179.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.49 139.16 6.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.868 -0.682 . . . . 0.5 111.971 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 27.9 mt-10 -99.12 129.39 45.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 2.1000000000000001 109.739 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 pp -139.54 173.59 10.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.638 -0.504 . . . . 0.76000000000000001 109.638 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -65.59 172.29 3.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.897 0.703 . . . . 3.5299999999999998 112.897 -171.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.694 HD22 ' HD2' ' A' ' 145' ' ' PRO . 1.7 tm? -61.64 126.59 87.17 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.924 -1.034 . . . . 1.23 109.84 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.694 ' HD2' HD22 ' A' ' 144' ' ' LEU . 72.5 Cg_endo . . . . . 0 C--N 1.349 0.57 0 C-N-CA 123.608 2.872 . . . . 0.70999999999999996 113.198 -175.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.761 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.434 -1.491 0 N-CA-C 113.798 0.279 . . . . 0.54000000000000004 113.798 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB2' HD11 ' A' ' 122' ' ' LEU . 37.7 m -169.47 34.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.642 -1.244 . . . . 1.2 107.642 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 46' ' ' SER . 32.7 m -134.04 155.33 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.347 -1.297 . . . . 0.93000000000000005 109.786 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -165.15 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.57 -0.53 . . . . 0.47999999999999998 109.57 166.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 44' ' ' LYS . 4.8 p-10 -167.99 163.0 13.63 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.523 0.677 . . . . 1.6899999999999999 112.652 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.17 132.98 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.821 -1.082 . . . . 1.1399999999999999 109.266 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.64 138.26 53.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.484 -0.326 . . . . 1.8300000000000001 110.796 -173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 39' ' ' VAL . 3.2 tm? -94.82 138.96 31.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.789 -0.187 . . . . 0.93999999999999995 111.095 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HE3' ' HB2' ' A' ' 42' ' ' LEU . 6.4 ptpt -145.15 -92.53 0.1 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 114.167 1.173 . . . . 1.3300000000000001 114.167 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--O 1.204 -1.304 0 O-C-N 121.308 -0.87 . . . . 2.8500000000000001 111.262 -155.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 27.1 t . . . . . 0 C--O 1.239 0.518 0 CA-C-O 121.628 0.727 . . . . 0.93999999999999995 112.579 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 101' ' ' LEU . 26.7 t -79.1 155.13 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.967 -1.015 . . . . 0.85999999999999999 109.216 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 27.4 mt-10 -117.62 131.59 56.63 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.002 -1.079 . . . . 1.1899999999999999 111.867 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.854 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.84 104.97 11.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.137 -0.938 . . . . 3.73 110.513 -176.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.703 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -72.47 109.85 6.45 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.919 -1.141 . . . . 0.81000000000000005 107.919 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -103.99 107.64 18.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.713 0.768 . . . . 0.41999999999999998 110.144 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 13.0 ttmt -83.47 126.14 32.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.88 -1.156 . . . . 2.6299999999999999 107.88 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 90' ' ' LEU . 43.1 t -111.4 141.52 26.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.705 -0.68 . . . . 0.81999999999999995 109.929 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 88' ' ' THR . 29.8 m -128.82 99.25 5.24 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.289 -0.564 . . . . 0.71999999999999997 110.225 171.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -81.61 122.82 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 115.63 -0.714 . . . . 1.1399999999999999 109.748 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 18.9 m -101.43 116.55 33.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.639 -0.709 . . . . 0.40999999999999998 110.168 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 15.7 t30 -90.26 126.16 57.7 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.127 -0.694 . . . . 1.48 109.127 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -91.84 15.14 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.248 2.632 . . . . 0.72999999999999998 113.832 -177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -131.5 146.73 52.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.514 -0.921 . . . . 2.0800000000000001 108.514 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.728 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.7 t -80.96 34.47 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.937 0.399 . . . . 1.51 111.722 -169.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -145.31 133.01 21.0 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.654 -0.248 . . . . 1.6699999999999999 110.803 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -45.37 100.83 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 124.448 1.099 . . . . 1.3899999999999999 113.022 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.849 HG21 HD23 ' A' ' 126' ' ' LEU . 5.8 pt -77.34 128.32 80.76 Favored Pre-proline 0 C--O 1.207 -1.182 0 N-CA-C 109.222 -0.659 . . . . 1.03 109.222 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.5 Cg_endo -60.88 -51.97 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.968 1.779 . . . . 0.37 113.691 -160.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.876 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 73.9 mt -138.27 157.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 1.23 112.853 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.837 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -139.92 168.17 20.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.565 1.174 . . . . 1.1499999999999999 112.245 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.119 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.9 tt0 -120.43 119.37 32.84 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 112.854 -1.976 . . . . 1.3600000000000001 110.18 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 22.2 mm -94.8 110.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.652 -1.158 . . . . 1.05 110.336 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 64.8 p -121.22 102.4 8.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.99 -0.744 . . . . 0.82999999999999996 108.99 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.612 ' HD1' HG22 ' A' ' 60' ' ' ILE . 17.0 p90 -106.9 135.18 48.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.531 0.681 . . . . 0.40000000000000002 110.242 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.0 m -130.75 105.85 8.07 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.47 -1.241 . . . . 0.38 108.726 174.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CE1' HD23 ' A' ' 118' ' ' LEU . 96.6 m-85 -96.41 140.75 30.61 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.493 -0.558 . . . . 0.95999999999999996 109.493 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.3 m170 -127.15 144.43 51.04 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.453 -0.943 . . . . 1.29 108.453 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.29 -109.84 0.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 116.531 -0.304 . . . . 1.27 111.457 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.04 -54.3 36.37 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.643 -0.873 . . . . 0.35999999999999999 108.643 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.3 16.12 0.17 Allowed Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 108.466 -1.853 . . . . 0.39000000000000001 108.466 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.456 ' NH1' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.98 -171.12 1.78 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.341 -0.985 . . . . 1.97 108.341 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.88 90.9 3.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.174 0.512 . . . . 2.6099999999999999 111.16 -164.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.986 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -47.88 -42.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.40000000000000002 111.867 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.12 167.59 39.34 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 119.859 -1.162 . . . . 0.48999999999999999 111.542 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.81 153.89 9.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.355 0.598 . . . . 1.8100000000000001 111.343 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.09 -179.06 41.5 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.869 -0.892 . . . . 0.42999999999999999 110.869 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.71 132.87 26.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.952 0.376 . . . . 1.72 111.34 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.43 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 79.1 mt -130.87 109.16 15.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.963 -0.562 . . . . 0.72999999999999998 109.877 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.8 128.27 14.86 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.317 2.011 . . . . 0.56999999999999995 110.401 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -138.96 144.76 42.6 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.758 -0.377 . . . . 0.79000000000000004 110.128 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.2 Cg_exo -57.24 90.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.578 2.185 . . . . 0.57999999999999996 111.571 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.876 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -75.7 13.68 6.5 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.176 -0.92 . . . . 0.40000000000000002 113.557 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 94.3 p -69.69 118.04 12.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.496 -0.557 . . . . 0.62 109.496 -176.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 49' ' ' ASN . 1.5 pt? -143.83 -167.16 2.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 119.931 -0.708 . . . . 1.1000000000000001 112.631 -163.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 86' ' ' ASP . 92.4 mttt -45.49 -93.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.083 0.771 . . . . 1.8400000000000001 113.083 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 163.37 107.18 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.307 -0.997 . . . . 0.98999999999999999 108.307 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptmt 45.43 47.65 10.81 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.218 0.948 . . . . 1.8400000000000001 111.159 -176.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 5.3 t70 -150.39 -170.03 3.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.226 -0.897 . . . . 0.64000000000000001 109.514 -173.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.6 ttp -119.2 119.39 33.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.986 0.422 . . . . 1.3500000000000001 110.874 -171.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.8 t -107.3 144.74 33.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.857 -0.611 . . . . 0.77000000000000002 110.501 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.52 112.5 23.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.515 0.674 . . . . 0.47999999999999998 110.887 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 45' ' ' VAL . 4.6 tt -102.72 166.28 10.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.142 -0.936 . . . . 0.77000000000000002 109.03 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.443 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 22.1 t70 -128.93 117.74 21.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.419 -0.512 . . . . 1.8100000000000001 112.295 -170.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 47.6 mm -110.84 122.72 37.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.738 -0.838 . . . . 0.65000000000000002 108.738 171.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 84.6 Cg_exo -46.7 -98.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.922 3.081 . . . . 1.0700000000000001 114.874 -171.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -162.4 94.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 112.124 0.416 . . . . 0.46000000000000002 112.124 -169.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 62' ' ' PHE . 7.4 p -127.52 103.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.138 1.162 . . . . 0.47999999999999998 114.138 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.1 p -152.36 98.15 2.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 1.0700000000000001 110.768 162.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 64.8 Cg_exo -51.4 135.89 47.29 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.924 1.749 . . . . 0.47999999999999998 112.12 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.426 ' O ' ' HB2' ' A' ' 102' ' ' PHE . 4.7 t80 -55.56 -30.91 61.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.404 -0.817 . . . . 1.3100000000000001 111.094 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 50.6 m -56.51 -33.75 66.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.986 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 mm -78.66 -53.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 121.852 -0.53 . . . . 0.51000000000000001 111.84 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 104' ' ' LEU . 14.5 mt -50.67 -27.47 7.05 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.524 0.678 . . . . 1.0 110.124 170.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' SER . 37.4 t80 -63.69 -42.02 98.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.45 -1.25 . . . . 0.95999999999999996 108.605 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 69' ' ' ARG . 32.9 m-80 -74.05 -57.92 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 0.81999999999999995 111.961 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -58.2 -51.99 67.45 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.244 0.831 . . . . 0.65000000000000002 113.244 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.63 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.48 -26.58 68.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.479 0.657 . . . . 0.42999999999999999 110.493 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -74.27 -52.5 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.484 -0.78 . . . . 1.8100000000000001 111.064 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.722 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 8.8 t70 -80.51 -52.42 7.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.826 0.822 . . . . 0.80000000000000004 111.183 -173.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -92.42 -18.47 7.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 O-C-N 121.912 -0.493 . . . . 0.88 110.581 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.24 -19.09 79.87 Favored Glycine 0 CA--C 1.509 -0.321 0 C-N-CA 120.262 -0.97 . . . . 0.38 110.917 167.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.722 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -54.28 -49.61 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.392 -1.707 . . . . 1.0900000000000001 106.392 164.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 2.5 m-20 -66.58 -102.84 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.991 -1.004 . . . . 1.8700000000000001 109.902 162.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.86 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 1.1699999999999999 111.938 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.7 123.46 38.16 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.361 -0.382 . . . . 2.1499999999999999 110.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.762 HD11 HD12 ' A' ' 144' ' ' LEU . 3.5 mp -112.82 157.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.899 0.38 . . . . 0.39000000000000001 110.636 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 114' ' ' ILE . 3.2 m-20 -88.57 152.7 21.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.692 -0.685 . . . . 2.1099999999999999 109.348 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -145.16 159.97 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.156 -0.683 . . . . 0.62 109.156 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.681 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 33.5 tt0 -154.21 136.0 14.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.779 0.323 . . . . 0.80000000000000004 110.153 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -108.26 130.07 55.18 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.013 -0.736 . . . . 1.25 109.013 172.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.649 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -118.9 99.68 6.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.151 -0.685 . . . . 0.63 109.151 176.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -112.18 123.46 67.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.349 0.595 . . . . 0.81000000000000005 110.367 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.14 123.16 6.44 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.595 -0.729 . . . . 0.26000000000000001 111.552 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 25' ' ' SER . 2.2 mp -96.87 118.55 33.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.781 0.324 . . . . 1.2 110.794 -173.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 95.8 m -124.71 95.71 4.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.596 -0.729 . . . . 0.32000000000000001 109.524 172.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.837 HG22 ' HB3' ' A' ' 58' ' ' CYS . 14.7 pt -110.88 144.32 19.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.6 -0.44 . . . . 0.97999999999999998 110.42 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.707 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.8 m-20 -85.59 105.09 15.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.858 -1.164 . . . . 1.52 107.858 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.849 HD23 HG21 ' A' ' 55' ' ' ILE . 28.1 mt -102.47 167.33 10.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 125.0 1.438 . . . . 1.28 110.195 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.17 -29.56 6.35 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 121.825 1.683 . . . . 0.73999999999999999 112.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -74.12 -58.95 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 112.543 0.572 . . . . 1.1200000000000001 112.543 -172.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.546 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 41.8 t -105.94 2.95 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.528 1.156 . . . . 1.3500000000000001 109.441 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 74.32 -24.72 1.11 Allowed Glycine 0 C--N 1.318 -0.434 0 CA-C-N 114.217 -1.356 . . . . 1.05 111.945 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 13.3 pt-20 -159.1 170.81 21.19 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.668 -0.864 . . . . 1.1599999999999999 108.668 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.735 ' O ' ' HA ' ' A' ' 123' ' ' THR . 7.0 t80 -163.57 132.78 3.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.652 -0.869 . . . . 1.9099999999999999 108.652 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 86.4 m -123.67 95.55 4.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.317 0.58 . . . . 1.1899999999999999 111.398 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.76 139.12 34.41 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.52 -0.764 . . . . 0.5 110.192 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.606 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.7 Cg_endo -89.15 161.97 5.76 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.778 1.652 . . . . 0.45000000000000001 112.65 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 167.09 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.386 -0.968 . . . . 0.44 108.386 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.8 p -137.82 151.09 47.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.355 0.598 . . . . 0.88 112.075 -172.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 t -139.98 103.34 4.61 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.29 -1.374 . . . . 0.95999999999999996 107.29 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.681 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -112.41 152.48 28.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.198 -0.456 . . . . 1.76 110.041 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.53 141.96 7.38 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.342 -0.933 . . . . 0.5 111.564 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -107.29 123.98 49.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.785 -0.707 . . . . 2.1000000000000001 109.197 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.9 174.39 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.527 -0.916 . . . . 0.76000000000000001 108.527 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -56.78 160.37 3.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.868 0.692 . . . . 3.5299999999999998 112.868 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.762 HD12 HD11 ' A' ' 114' ' ' ILE . 19.4 tp -55.84 138.87 70.76 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 114.894 -1.048 . . . . 1.23 111.581 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 144' ' ' LEU . 34.5 Cg_endo . . . . . 0 C--N 1.347 0.474 0 C-N-CA 123.317 2.678 . . . . 0.70999999999999996 111.911 176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.57 0 N-CA-C 116.579 1.392 . . . . 0.54000000000000004 116.579 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 95.7 p -167.91 36.47 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.268 -1.382 . . . . 1.2 107.268 174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.4 m -133.86 155.66 40.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.365 -1.289 . . . . 0.93000000000000005 110.037 -170.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.4 HG21 ' HG2' ' A' ' 44' ' ' LYS . 1.7 t -168.65 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.699 -0.482 . . . . 0.47999999999999998 109.699 169.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.73 172.36 1.11 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 111.45 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.716 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -142.14 145.91 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.079 -0.711 . . . . 1.1399999999999999 109.079 168.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.43 115.59 30.4 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.762 -0.653 . . . . 1.8300000000000001 110.378 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.0 tm? -80.29 120.05 23.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 0.93999999999999995 111.08 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -119.81 -127.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.527 -0.545 . . . . 1.3300000000000001 109.527 171.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.931 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.1 p30 . . . . . 0 N--CA 1.469 0.494 0 CA-C-N 118.604 0.638 . . . . 2.8500000000000001 111.919 -168.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.689 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 48.1 t . . . . . 0 N--CA 1.426 -1.651 0 N-CA-C 105.235 -2.135 . . . . 0.93999999999999995 105.235 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.931 HG13 ' HA ' ' A' ' 33' ' ' ASP . 13.4 t -134.63 156.37 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 118.6 0.636 . . . . 0.85999999999999999 109.743 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.982 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 91.8 mt-10 -119.61 147.59 44.33 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.205 -0.598 . . . . 1.1899999999999999 111.175 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.935 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.5 p90 -142.29 133.89 26.72 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.095 -1.042 . . . . 3.73 112.039 166.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -79.9 108.99 13.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.189 -0.914 . . . . 0.81000000000000005 108.715 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.749 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.62 110.16 21.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.585 0.707 . . . . 0.41999999999999998 109.988 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 35.4 ttmt -84.03 129.77 34.9 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.929 -1.032 . . . . 2.6299999999999999 109.212 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 25' ' ' SER . 52.5 t -113.57 142.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.69 -0.686 . . . . 0.81999999999999995 110.335 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 88' ' ' THR . 18.7 m -131.34 98.08 4.44 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.254 0.55 . . . . 0.71999999999999997 110.077 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.7 t -83.61 128.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.258 -0.883 . . . . 1.1399999999999999 110.825 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.563 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.5 m -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 119.07 -0.491 . . . . 0.40999999999999998 109.793 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.4 p-10 -91.5 135.21 28.19 Favored Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.859 0.724 . . . . 1.48 110.275 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 57.5 Cg_endo -93.63 12.65 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.71 2.94 . . . . 0.72999999999999998 114.426 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.719 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 29.8 t80 -98.55 -117.86 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.332 -0.618 . . . . 2.0800000000000001 109.332 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -165.01 19.68 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.51 110.258 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -148.38 151.32 35.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.528 -0.915 . . . . 1.6699999999999999 108.528 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.61 ' HA ' HD23 ' A' ' 82' ' ' LEU . 28.0 t -44.89 105.57 0.06 Allowed 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.382 1.051 . . . . 1.3899999999999999 112.295 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.5 pt -78.17 125.34 85.25 Favored Pre-proline 0 CA--C 1.5 -0.951 0 N-CA-C 108.901 -0.777 . . . . 1.03 108.901 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 27.1 Cg_endo -62.49 -54.65 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.777 1.651 . . . . 0.37 112.999 -159.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.5 mm -130.01 159.31 42.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.431 -0.507 . . . . 1.23 111.016 -173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.608 ' HB3' HG22 ' A' ' 124' ' ' ILE . 27.3 p -150.88 174.7 12.79 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.192 0.996 . . . . 1.1499999999999999 111.697 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.3 tt0 -130.86 114.05 14.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.362 -1.744 . . . . 1.3600000000000001 109.673 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.72 111.38 28.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.973 -1.012 . . . . 1.05 110.989 173.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 1.6 m -113.7 104.24 12.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.811 -1.541 . . . . 0.82999999999999996 109.153 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 6.3 p90 -111.98 127.7 55.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.949 -0.389 . . . . 0.40000000000000002 109.949 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 7.1 m -126.4 104.6 8.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.29 -0.633 . . . . 0.38 109.29 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 94.7 m-85 -98.28 139.23 34.36 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.1 -0.5 . . . . 0.95999999999999996 111.258 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -128.04 145.43 50.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.667 -1.234 . . . . 1.29 107.667 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.685 ' CB ' HD22 ' A' ' 104' ' ' LEU . 41.5 t -107.27 -98.03 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.14 -1.024 . . . . 1.27 111.022 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.56 -60.25 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.674 -0.861 . . . . 0.35999999999999999 108.674 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.58 15.66 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.227 -1.949 . . . . 0.39000000000000001 108.227 163.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.94 HH11 ' HB3' ' A' ' 103' ' ' ASN . 10.2 ptp180 -106.09 -175.34 2.77 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.43 -0.952 . . . . 1.97 108.43 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -103.09 97.64 7.7 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.605 0.716 . . . . 2.6099999999999999 109.589 -166.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.848 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.2 mm -59.04 -43.05 88.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.006 -1.452 . . . . 0.40000000000000002 110.728 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.78 160.2 22.39 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.402 -0.904 . . . . 0.48999999999999999 111.179 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -161.77 156.9 23.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.919 0.859 . . . . 1.8100000000000001 111.446 176.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.76 164.88 28.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.758 -0.937 . . . . 0.42999999999999999 110.758 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -142.13 133.68 26.72 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.097 0.475 . . . . 1.72 111.089 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 63.3 mt -136.1 133.85 19.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.632 -0.713 . . . . 0.72999999999999998 110.016 -174.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 7.5 Cg_exo -74.26 119.04 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.364 2.042 . . . . 0.56999999999999995 110.508 170.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.59 139.94 36.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.845 -0.428 . . . . 0.79000000000000004 109.845 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.0 Cg_endo -61.64 90.82 0.11 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.452 2.101 . . . . 0.57999999999999996 112.08 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.456 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -89.02 30.28 5.56 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.40000000000000002 112.029 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.1 p -70.49 118.36 13.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.513 -0.921 . . . . 0.62 108.513 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.61 HD23 ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -139.98 -152.11 0.4 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.048 0.759 . . . . 1.1000000000000001 113.048 -160.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.534 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 93.8 mttt -62.35 -96.99 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.937 -0.574 . . . . 1.8400000000000001 112.304 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.35 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.971 -1.122 . . . . 0.98999999999999999 107.971 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.719 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 39.5 pttt 42.41 50.41 4.69 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.879 0.847 . . . . 1.8400000000000001 111.134 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.2 t70 -153.35 -173.38 4.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.894 -1.048 . . . . 0.64000000000000001 110.726 -169.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.9 ttm -115.77 125.33 52.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 1.3500000000000001 110.351 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 46' ' ' SER . 3.3 t -116.16 145.05 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.928 -0.578 . . . . 0.77000000000000002 110.718 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.39 117.07 27.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.514 0.673 . . . . 0.47999999999999998 110.742 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.666 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.2 tp -115.88 174.86 5.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.775 -1.102 . . . . 0.77000000000000002 108.106 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.666 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 35.5 m-20 -137.63 130.66 30.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.502 0.592 . . . . 1.8100000000000001 111.232 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.749 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 30.1 mm -108.6 123.84 36.11 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.666 -0.864 . . . . 0.65000000000000002 108.666 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 94' ' ' VAL . 24.3 Cg_exo -28.85 -113.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 1 C-N-CA 125.72 4.28 . . . . 1.0700000000000001 116.22 -171.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.982 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -163.08 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 119.586 -0.245 . . . . 0.46000000000000002 111.191 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -127.79 101.74 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 115.635 1.717 . . . . 0.47999999999999998 115.635 -164.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -152.77 107.28 2.7 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 121.326 -0.858 . . . . 1.0700000000000001 111.607 163.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 53.4 Cg_exo -51.32 129.08 27.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.499 1.466 . . . . 0.47999999999999998 111.192 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.689 ' H ' ' HA ' ' A' ' 38' ' ' SER . 16.3 t80 -50.17 -35.99 28.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.182 -0.917 . . . . 1.3100000000000001 111.898 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.8 t -59.9 -27.49 66.77 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.054 0.39 . . . . 1.2 112.054 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.848 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -77.62 -54.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 121.892 -0.505 . . . . 0.51000000000000001 111.17 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.077 HD23 HD21 ' A' ' 104' ' ' LEU . 53.3 mt -51.89 -30.18 23.0 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.882 0.848 . . . . 1.0 110.129 169.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.523 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 30.4 t80 -69.04 -38.56 79.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.625 -1.625 . . . . 0.95999999999999996 108.787 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.94 ' HB3' HH11 ' A' ' 69' ' ' ARG . 15.7 m-80 -74.17 -55.95 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 111.975 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.077 HD21 HD23 ' A' ' 101' ' ' LEU . 2.9 pp -55.04 -50.67 68.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.737 0.643 . . . . 0.65000000000000002 112.737 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.611 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.21 -24.39 67.2 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.884 0.85 . . . . 0.42999999999999999 110.551 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.523 ' NH2' ' HD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -70.99 -54.76 10.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.106 -0.952 . . . . 1.8100000000000001 110.631 175.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 16.3 t70 -83.01 -53.88 5.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.814 0.816 . . . . 0.80000000000000004 111.649 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.0 t -84.12 -26.94 7.2 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 121.505 -0.747 . . . . 0.88 109.959 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -70.5 -17.52 74.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 119.536 -1.316 . . . . 0.38 111.381 170.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -53.74 -47.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.18 -1.415 . . . . 1.0900000000000001 107.18 166.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -107.89 68.53 0.71 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.648 0.737 . . . . 1.8700000000000001 112.79 164.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 23.15 -57.86 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 118.802 2.89 . . . . 1.1699999999999999 118.802 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' ASP . 13.2 t70 -91.79 122.85 34.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.59 0.632 . . . . 2.1499999999999999 111.84 -167.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.672 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.8 mp -112.49 158.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.39000000000000001 110.78 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -104.74 153.87 20.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.934 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 35.3 m-85 -137.51 167.14 22.23 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.957 -0.757 . . . . 0.62 108.957 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.6 tt0 -153.4 139.03 17.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.73 0.3 . . . . 0.80000000000000004 110.629 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 tp -109.92 129.31 55.67 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.933 -0.576 . . . . 1.25 110.3 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.651 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -112.84 101.32 9.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.048 -0.723 . . . . 0.63 109.048 173.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 60' ' ' ILE . 5.5 tp -112.58 121.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.158 0.504 . . . . 0.81000000000000005 111.64 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.68 125.41 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.781 -0.528 . . . . 0.26000000000000001 111.781 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.601 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.0 mp -103.88 106.51 17.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 1.2 111.546 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.8 m -110.16 95.02 5.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.781 -0.645 . . . . 0.32000000000000001 109.441 174.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 55' ' ' ILE . 10.6 pt -109.53 141.46 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 120.5 -0.48 . . . . 0.97999999999999998 110.87 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.5 m-20 -84.51 107.47 16.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.714 -0.847 . . . . 1.52 108.714 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.589 HD23 HG21 ' A' ' 55' ' ' ILE . 4.5 mt -115.56 139.65 24.97 Favored Pre-proline 0 C--O 1.216 -0.67 0 O-C-N 124.566 1.166 . . . . 1.28 110.455 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 32.2 Cg_exo -60.74 -16.67 45.23 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.366 2.044 . . . . 0.73999999999999999 114.105 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.4 t -76.66 -56.45 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.326 0.584 . . . . 1.1200000000000001 111.524 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.91 5.92 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.038 0.923 . . . . 1.3500000000000001 110.799 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.55 -34.44 2.71 Favored Glycine 0 C--N 1.31 -0.884 0 CA-C-N 113.797 -1.547 . . . . 1.05 111.781 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.3 pt-20 -171.21 162.13 6.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.641 -0.874 . . . . 1.1599999999999999 108.641 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' THR . 9.3 t80 -159.11 143.13 15.22 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.464 -0.569 . . . . 1.9099999999999999 109.464 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 75.6 m -112.8 110.67 20.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.148 -0.478 . . . . 1.1899999999999999 111.359 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -126.16 136.1 28.06 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.59 . . . . 0.5 109.888 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -93.72 162.96 2.28 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.138 1.892 . . . . 0.45000000000000001 113.21 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.92 168.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.811 -1.181 . . . . 0.44 107.811 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 90.3 p -142.29 149.19 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.513 -0.475 . . . . 0.88 111.484 -169.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.3 t -140.64 103.76 4.59 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.243 -1.021 . . . . 0.95999999999999996 108.243 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.2 ptmt -123.52 152.49 41.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.676 -0.693 . . . . 1.76 110.454 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.2 155.29 24.18 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.896 -0.668 . . . . 0.5 111.485 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 2.2 mp0 -111.04 132.52 54.16 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.404 -0.398 . . . . 2.1000000000000001 110.434 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.24 171.98 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.346 -0.613 . . . . 0.76000000000000001 109.346 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' H ' ' A' ' 144' ' ' LEU . 35.7 ttmt -64.57 174.58 1.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.495 . . . . 3.5299999999999998 111.653 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.646 HD12 HD11 ' A' ' 114' ' ' ILE . 16.6 tp -55.96 139.28 71.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.612 -0.722 . . . . 1.23 110.901 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.348 0.513 0 C-N-CA 122.785 2.324 . . . . 0.70999999999999996 112.845 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.221 -0.678 0 N-CA-C 116.374 1.309 . . . . 0.54000000000000004 116.374 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 45' ' ' VAL . 51.9 p -163.54 37.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.691 1.597 . . . . 1.2 106.814 173.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 46' ' ' SER . 1.5 p -131.05 147.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 113.955 -1.475 . . . . 0.93000000000000005 110.679 -167.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.22 -36.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.712 -0.677 . . . . 0.47999999999999998 110.631 166.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -175.89 160.94 2.42 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 109.85 -0.426 . . . . 1.6899999999999999 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -137.12 145.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.685 -0.857 . . . . 1.1399999999999999 108.685 162.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.1 146.3 46.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.941 0.4 . . . . 1.8300000000000001 111.646 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.7 tm? -99.98 135.7 41.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.92 -0.582 . . . . 0.93999999999999995 111.091 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -143.62 -95.95 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.341 0.867 . . . . 1.3300000000000001 113.341 176.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.77 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 1.6 t70 . . . . . 0 C--O 1.208 -1.11 0 O-C-N 121.723 -0.611 . . . . 2.8500000000000001 111.613 -154.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.434 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 8.6 t . . . . . 0 C--O 1.241 0.629 0 CA-C-O 121.561 0.696 . . . . 0.93999999999999995 112.822 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 63.8 t -76.17 151.39 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.017 -0.992 . . . . 0.85999999999999999 109.647 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.84 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 85.1 mt-10 -109.8 133.34 53.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.223 -0.991 . . . . 1.1899999999999999 111.853 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.843 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.12 106.15 9.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.767 -1.106 . . . . 3.73 110.555 -176.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 94' ' ' VAL . 1.7 tm? -84.78 110.17 18.61 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.821 -0.807 . . . . 0.81000000000000005 108.821 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -89.97 110.02 21.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.844 0.83 . . . . 0.41999999999999998 110.247 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 30.6 ttmt -84.43 125.38 32.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.579 -1.192 . . . . 2.6299999999999999 108.538 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 90' ' ' LEU . 63.5 t -111.78 139.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.219 0.533 . . . . 0.81999999999999995 112.086 -170.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' THR . 15.7 m -131.82 97.59 4.23 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.71999999999999997 109.276 162.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 2.3 p -84.62 128.1 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.096 -0.956 . . . . 1.1399999999999999 110.744 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.427 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 9.8 m -102.25 121.31 42.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.776 -0.647 . . . . 0.40999999999999998 109.946 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 14.0 t30 -87.57 126.67 61.16 Favored Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 124.722 1.264 . . . . 1.48 109.734 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -83.29 -10.0 10.2 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.951 3.101 . . . . 0.72999999999999998 115.971 -171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.0 t80 -96.23 -105.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.595 -0.842 . . . . 2.0800000000000001 111.264 -171.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 85' ' ' LYS . 47.6 t -175.62 26.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.372 0.606 . . . . 1.51 109.862 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -150.74 139.28 20.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.138 -0.69 . . . . 1.6699999999999999 109.138 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.862 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 43.5 t -52.19 101.47 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.953 0 O-C-N 124.025 0.828 . . . . 1.3899999999999999 111.93 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.7 pt -75.24 172.0 10.32 Favored Pre-proline 0 C--O 1.207 -1.173 0 N-CA-C 107.7 -1.222 . . . . 1.03 107.7 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HB2' ' CD1' ' A' ' 57' ' ' ILE . 12.0 Cg_endo -90.08 -58.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.508 0 CA-C-N 120.166 1.095 . . . . 0.37 114.687 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 1.5 mp -130.37 161.87 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 119.727 -0.789 . . . . 1.23 112.768 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 30.1 p -147.64 168.82 21.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.08 0.943 . . . . 1.1499999999999999 111.77 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.103 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 16.6 tp10 -122.29 118.71 29.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.412 -1.722 . . . . 1.3600000000000001 110.06 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 13.2 mm -94.58 110.16 23.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 114.618 -1.174 . . . . 1.05 110.567 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 11.0 p -120.61 102.67 8.57 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.615 -0.434 . . . . 0.82999999999999996 109.864 173.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.556 ' HD1' HG22 ' A' ' 60' ' ' ILE . 11.8 p90 -110.3 126.39 54.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.159 0.504 . . . . 0.40000000000000002 109.857 -171.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 18.4 m -123.34 112.1 17.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.034 -0.728 . . . . 0.38 109.034 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 93.2 m-85 -97.66 140.99 31.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.979 0.419 . . . . 0.95999999999999996 110.606 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.518 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 5.2 m170 -132.93 145.63 51.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.466 -1.309 . . . . 1.29 107.466 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -111.52 -97.66 0.42 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.183 -1.007 . . . . 1.27 111.41 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.43 -60.57 3.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.529 -0.545 . . . . 0.35999999999999999 109.529 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.77 19.63 0.12 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.578 -1.809 . . . . 0.39000000000000001 108.578 167.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 69' ' ' ARG . 8.5 ptp180 -115.75 -177.85 3.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.332 -0.988 . . . . 1.97 108.332 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.9 98.0 7.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.072 0.939 . . . . 2.6099999999999999 110.245 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.811 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.37 -43.51 62.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.352 -1.749 . . . . 0.40000000000000002 111.86 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.23 169.11 42.25 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.077 -1.058 . . . . 0.48999999999999999 111.355 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.27 155.32 11.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.218 0.509 . . . . 1.8100000000000001 110.541 174.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.22 -175.62 46.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.213 -1.155 . . . . 0.42999999999999999 110.213 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 11.1 ptpt -152.09 136.64 16.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.321 0.56 . . . . 1.72 112.134 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 68.6 mt -130.78 108.97 15.64 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.289 -0.868 . . . . 0.72999999999999998 110.312 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 114.34 3.89 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.312 2.008 . . . . 0.56999999999999995 109.975 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -132.01 146.09 60.21 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.035 -0.357 . . . . 0.79000000000000004 110.035 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 81' ' ' SER . 9.4 Cg_endo -54.6 90.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.513 2.142 . . . . 0.57999999999999996 112.17 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -77.09 29.01 1.63 Allowed Glycine 0 C--O 1.225 -0.455 0 CA-C-N 115.278 -0.874 . . . . 0.40000000000000002 112.493 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.969 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 59.9 p -74.03 119.92 18.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.719 -0.474 . . . . 0.62 109.719 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.862 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -157.95 173.89 16.08 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.833 -1.147 . . . . 1.1000000000000001 113.646 -164.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 88.6 mttt -33.84 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.578 1.325 . . . . 1.8400000000000001 114.578 -167.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 168.34 108.87 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.359 -0.978 . . . . 0.98999999999999999 108.359 -174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.822 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 47.6 pttt 42.05 48.49 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.168 0.918 . . . . 1.8400000000000001 110.886 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 4.4 t70 -148.9 -174.37 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.64 -1.164 . . . . 0.64000000000000001 109.782 -168.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.57 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.1 ttm -117.22 121.67 41.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.33 0.586 . . . . 1.3500000000000001 110.596 -173.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.644 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -115.53 144.55 43.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.158 -0.928 . . . . 0.77000000000000002 110.743 -175.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -85.92 141.37 29.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.088 0.47 . . . . 0.47999999999999998 110.043 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.783 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.1 tp -139.32 173.54 11.44 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.25 -1.019 . . . . 0.77000000000000002 108.25 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.783 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 15.9 m-20 -132.6 124.36 28.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.166 0.508 . . . . 1.8100000000000001 111.842 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -112.84 138.15 22.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.442 -0.799 . . . . 0.65000000000000002 109.01 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 92' ' ' ILE . 76.6 Cg_exo -51.96 -159.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.83 3.02 . . . . 1.0700000000000001 114.58 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 1.4 m -124.08 93.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.371 -0.831 . . . . 0.46000000000000002 110.873 -167.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 95' ' ' VAL . 5.7 p -128.3 103.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 113.917 1.08 . . . . 0.47999999999999998 113.917 -168.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 p -152.41 99.64 2.83 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.0700000000000001 110.924 161.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.4 Cg_exo -52.86 131.05 40.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.94 1.76 . . . . 0.47999999999999998 111.022 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.434 ' H ' ' HA ' ' A' ' 38' ' ' SER . 10.9 t80 -57.96 -30.59 66.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 1.3100000000000001 111.559 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.5 m -59.38 -30.57 68.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.783 0.29 . . . . 1.2 111.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.811 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 mm -76.63 -55.15 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.008 -0.677 . . . . 0.51000000000000001 110.348 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 39' ' ' VAL . 25.3 mt -50.55 -27.38 6.61 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.665 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.431 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 23.7 t80 -64.67 -43.16 94.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.672 -1.149 . . . . 0.95999999999999996 108.799 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 33.1 m-80 -74.42 -57.73 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.81999999999999995 112.458 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.991 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -58.24 -49.57 76.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.385 0.883 . . . . 0.65000000000000002 113.385 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.9 -23.65 67.29 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 121.912 0.863 . . . . 0.42999999999999999 109.806 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.5 ttp180 -68.03 -47.99 66.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.586 -1.188 . . . . 1.8100000000000001 110.408 173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 15.7 t70 -82.59 -55.89 4.19 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.923 0.868 . . . . 0.80000000000000004 111.871 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.2 t -83.65 -29.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 O-C-N 121.66 -0.65 . . . . 0.88 109.625 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.25 -16.54 80.45 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.522 -0.847 . . . . 0.38 111.693 172.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -49.07 -44.21 16.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.473 -1.677 . . . . 1.0900000000000001 106.473 165.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.64 -81.89 0.08 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.539 -0.755 . . . . 1.8700000000000001 109.954 163.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 178.44 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.623 0.601 . . . . 1.1699999999999999 112.623 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.82 128.63 40.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.319 0.58 . . . . 2.1499999999999999 111.434 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -113.5 161.57 12.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.695 -0.684 . . . . 0.39000000000000001 109.901 -172.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 3.4 p-10 -101.85 152.74 20.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 34.5 m-85 -139.52 166.09 25.49 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.637 -0.875 . . . . 0.62 108.637 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.2 tt0 -153.8 135.35 14.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.80000000000000004 110.142 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -107.37 129.6 54.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.528 -0.76 . . . . 1.25 109.181 173.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.751 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.817 -0.809 . . . . 0.63 108.817 177.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.1 tp -112.92 120.89 64.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.228 0.537 . . . . 0.81000000000000005 111.399 -173.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.81 119.89 5.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.362 -0.695 . . . . 0.26000000000000001 111.362 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.617 HD11 ' OG ' ' A' ' 25' ' ' SER . 1.3 mp -98.65 96.11 7.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.007 0.432 . . . . 1.2 110.851 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.103 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 63.2 m -95.98 96.41 8.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.811 -0.631 . . . . 0.32000000000000001 109.387 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 58' ' ' CYS . 5.7 pt -111.28 138.34 40.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 120.171 -0.612 . . . . 0.97999999999999998 111.327 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.51 106.14 14.13 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.306 -0.998 . . . . 1.52 108.306 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 55' ' ' ILE . 35.1 mt -116.52 150.3 45.28 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 124.859 1.35 . . . . 1.28 110.344 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.43 -13.98 41.01 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.14 1.894 . . . . 0.73999999999999999 113.292 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.36 -57.37 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.31 0.576 . . . . 1.1200000000000001 111.257 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -118.42 6.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.854 0.835 . . . . 1.3500000000000001 110.74 -177.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.31 -31.93 2.6 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 114.005 -1.452 . . . . 1.05 111.966 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.4 pt-20 -178.55 154.03 0.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.705 -0.85 . . . . 1.1599999999999999 108.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.725 ' HD2' HG23 ' A' ' 134' ' ' ILE . 11.3 t80 -157.83 144.99 18.17 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.563 -0.455 . . . . 1.9099999999999999 110.292 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.9 m -101.6 99.56 9.87 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.594 0.559 . . . . 1.1899999999999999 110.855 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 132' ' ' PHE . 2.3 pp -109.1 124.51 33.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.203 -0.666 . . . . 0.5 109.203 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 95.9 Cg_endo -89.12 162.61 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.559 1.506 . . . . 0.45000000000000001 112.536 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.7 161.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.056 -1.09 . . . . 0.44 108.056 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -126.84 144.49 50.95 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.168 -0.308 . . . . 0.88 110.168 -171.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 m -136.99 100.82 4.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.338 -0.986 . . . . 0.95999999999999996 108.338 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 8.9 ptmt -123.72 143.01 50.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.129 -0.487 . . . . 1.76 111.242 -170.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.59 153.63 24.31 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.667 -0.777 . . . . 0.5 111.961 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.559 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 26.1 mt-10 -106.85 132.62 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.774 -0.454 . . . . 2.1000000000000001 109.774 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.41 174.15 2.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.153 -1.054 . . . . 0.76000000000000001 108.153 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.23 170.92 1.5 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.302 0.853 . . . . 3.5299999999999998 113.302 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -68.51 149.8 97.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.91 -1.041 . . . . 1.23 110.739 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo . . . . . 0 C--N 1.35 0.607 0 C-N-CA 122.502 2.135 . . . . 0.70999999999999996 112.091 174.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.765 0 N-CA-C 114.624 0.61 . . . . 0.54000000000000004 114.624 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 122' ' ' LEU . 89.6 p -169.5 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.195 -1.039 . . . . 1.2 108.195 172.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.91 155.25 41.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.742 -1.117 . . . . 0.93000000000000005 109.058 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 44' ' ' LYS . 1.6 t -168.94 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.208 0.447 . . . . 0.47999999999999998 112.208 164.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 22.8 t70 -158.51 156.68 30.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.633 0.651 . . . . 1.6899999999999999 110.837 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.21 127.07 46.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.573 -0.529 . . . . 1.1399999999999999 109.573 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -112.49 130.8 55.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 1.8300000000000001 111.562 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.03 122.75 32.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.93999999999999995 111.408 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -128.36 -126.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.228 -0.656 . . . . 1.3300000000000001 109.228 167.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 1.029 ' HA ' HG13 ' A' ' 39' ' ' VAL . 7.4 p-10 . . . . . 0 CA--C 1.51 -0.594 0 N-CA-C 113.267 0.84 . . . . 2.8500000000000001 113.267 -171.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 t . . . . . 0 N--CA 1.448 -0.566 0 CA-C-O 121.015 0.436 . . . . 0.93999999999999995 110.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 33' ' ' ASP . 46.5 t -76.75 164.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.911 -0.774 . . . . 0.85999999999999999 108.911 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.892 ' HG2' ' HB ' ' A' ' 94' ' ' VAL . 4.0 mt-10 -124.76 141.18 52.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.559 -0.856 . . . . 1.1899999999999999 112.124 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.869 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -122.55 105.4 10.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.106 -0.952 . . . . 3.73 111.012 -177.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -77.74 110.23 12.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.377 -0.971 . . . . 0.81000000000000005 108.377 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -101.06 98.65 9.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.426 0.632 . . . . 0.41999999999999998 110.221 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -82.7 106.07 14.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.533 -1.284 . . . . 2.6299999999999999 107.533 176.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 90' ' ' LEU . 2.0 m -110.83 164.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.702 -1.135 . . . . 0.81999999999999995 110.632 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.9 m -142.85 105.13 4.44 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.209 0.528 . . . . 0.71999999999999997 111.665 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.5 t -83.02 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.855 . . . . 1.1399999999999999 110.851 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 m -101.23 122.31 43.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.456 -0.338 . . . . 0.40999999999999998 110.77 177.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.934 ' HB2' HD21 ' A' ' 82' ' ' LEU . 7.6 t-20 -88.2 134.73 34.2 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.382 1.051 . . . . 1.48 108.849 173.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 15.2 Cg_endo -108.23 9.88 0.13 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.191 2.594 . . . . 0.72999999999999998 115.812 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 52' ' ' SER . 38.5 t80 -118.15 -15.43 9.84 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.089 0.859 . . . . 2.0800000000000001 113.254 -169.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CE ' ' A' ' 85' ' ' LYS . 17.8 t 87.82 17.59 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.532 0.733 . . . . 1.51 110.412 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -143.43 125.43 15.29 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.163 -0.68 . . . . 1.6699999999999999 109.163 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -38.85 101.79 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 O-C-N 124.298 0.999 . . . . 1.3899999999999999 112.969 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.654 HD12 ' HB ' ' A' ' 124' ' ' ILE . 7.3 pt -77.76 118.73 73.98 Favored Pre-proline 0 C--O 1.208 -1.085 0 N-CA-C 109.173 -0.676 . . . . 1.03 109.173 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.939 ' HB2' HD12 ' A' ' 57' ' ' ILE . 29.3 Cg_endo -60.42 -54.01 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.273 1.982 . . . . 0.37 113.651 -157.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.939 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.6 mp -133.83 159.07 42.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.045 -0.662 . . . . 1.23 110.65 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.678 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -145.69 172.41 13.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.158 0.98 . . . . 1.1499999999999999 111.789 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.048 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.0 tt0 -127.26 114.63 17.88 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.109 -1.86 . . . . 1.3600000000000001 108.949 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.91 109.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 122.512 1.148 . . . . 1.05 109.78 169.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 13.5 p -112.4 101.64 9.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.216 -1.811 . . . . 0.82999999999999996 108.184 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 12.0 p90 -114.71 136.56 52.93 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.137 0.494 . . . . 0.40000000000000002 110.285 -166.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 73' ' ' LYS . 16.9 m -132.45 108.57 9.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.788 -1.097 . . . . 0.38 109.546 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CZ ' HD23 ' A' ' 118' ' ' LEU . 96.4 m-85 -97.22 140.97 30.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.808 -0.633 . . . . 0.95999999999999996 109.438 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.4 m170 -128.59 145.62 51.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.467 -1.308 . . . . 1.29 107.467 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.792 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.8 t -100.99 -102.86 0.25 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.449 -0.9 . . . . 1.27 110.199 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' HH11 ' A' ' 69' ' ' ARG . . . -62.6 -57.05 12.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.889 -0.782 . . . . 0.35999999999999999 108.889 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.54 15.2 0.16 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 108.599 -1.8 . . . . 0.39000000000000001 108.599 165.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -109.72 171.86 7.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.368 -0.975 . . . . 1.97 108.368 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.85 95.3 8.17 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.112 0.482 . . . . 2.6099999999999999 109.913 -164.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.826 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.7 mm -48.08 -41.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.639 -1.164 . . . . 0.40000000000000002 111.403 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.26 163.38 29.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.211 -0.995 . . . . 0.48999999999999999 111.608 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.638 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.6 OUTLIER -165.92 155.91 12.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.533 0.667 . . . . 1.8100000000000001 110.998 174.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.66 35.54 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.482 -0.781 . . . . 0.42999999999999999 111.528 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -123.44 131.71 53.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.09 -0.337 . . . . 1.72 110.09 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.546 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 86.7 mt -137.89 126.18 14.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.441 -0.345 . . . . 0.72999999999999998 110.123 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.09 115.72 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.468 2.112 . . . . 0.56999999999999995 111.633 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -125.04 141.29 38.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.084 -0.339 . . . . 0.79000000000000004 110.084 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.75 87.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.792 2.328 . . . . 0.57999999999999996 111.963 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -78.73 19.55 4.98 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.40000000000000002 113.384 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . 91.1 p -70.38 119.71 14.97 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.49 -0.559 . . . . 0.62 109.49 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 49' ' ' ASN . 2.6 pt? -142.41 -165.95 2.15 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.854 0.687 . . . . 1.1000000000000001 112.854 -165.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 89.9 mttt -43.2 -91.33 0.0 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.777 -1.101 . . . . 1.8400000000000001 112.949 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 165.02 105.17 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.31 -0.996 . . . . 0.98999999999999999 108.31 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.1 ptpt 43.84 50.84 6.9 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.363 1.04 . . . . 1.8400000000000001 111.166 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 87' ' ' MET . 10.8 t70 -151.56 -169.87 3.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.217 -0.901 . . . . 0.64000000000000001 108.816 -173.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.411 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 48.4 ttm -116.99 121.4 41.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.835 0.35 . . . . 1.3500000000000001 110.494 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' SER . 12.0 t -104.94 143.36 33.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.754 -0.657 . . . . 0.77000000000000002 109.739 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.01 106.8 14.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.379 0.609 . . . . 0.47999999999999998 110.097 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 7.7 tp -100.48 178.23 4.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.085 -0.961 . . . . 0.77000000000000002 109.246 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.944 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.2 t70 -146.58 127.8 14.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.578 -0.283 . . . . 1.8100000000000001 111.303 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 1.5 mp -102.61 116.3 62.98 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.645 -1.243 . . . . 0.65000000000000002 107.645 163.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 33.5 Cg_exo -32.32 -100.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 125.181 3.921 . . . . 1.0700000000000001 115.477 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.892 ' HB ' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -163.43 93.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 O-C-N 122.275 -0.266 . . . . 0.46000000000000002 111.336 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -129.03 104.26 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.676 1.361 . . . . 0.47999999999999998 114.676 -170.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.509 ' CG2' ' HG ' ' A' ' 101' ' ' LEU . 3.0 p -153.79 99.83 2.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 121.867 -0.52 . . . . 1.0700000000000001 111.949 161.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.5 Cg_exo -53.66 131.71 45.34 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.828 1.685 . . . . 0.47999999999999998 111.183 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -53.9 -33.23 55.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 1.3100000000000001 112.356 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -56.17 -32.0 63.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.757 0.313 . . . . 1.2 111.667 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.826 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 mm -76.28 -55.72 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.602 -0.439 . . . . 0.51000000000000001 110.643 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 104' ' ' LEU . 40.3 mt -51.99 -28.11 15.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.703 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.12 -44.66 95.0 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.028 -0.987 . . . . 0.95999999999999996 108.99 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.21 -57.15 4.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.799 -0.637 . . . . 0.81999999999999995 111.889 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.792 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.6 pp -62.07 -53.06 60.82 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.431 0.9 . . . . 0.65000000000000002 113.431 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.1 -25.97 68.61 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.842 0.83 . . . . 0.42999999999999999 110.197 -177.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 110' ' ' VAL . 6.7 ttp180 -74.57 -54.7 6.98 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.531 -1.213 . . . . 1.8100000000000001 110.391 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.88 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.4 t70 -74.06 -52.79 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.883 0.849 . . . . 0.80000000000000004 111.057 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.608 HG21 HG23 ' A' ' 114' ' ' ILE . 2.3 t -86.93 -17.21 8.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.355 -0.84 . . . . 0.88 109.697 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.738 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -67.91 -25.56 74.22 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.736 -0.745 . . . . 0.38 113.712 168.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 107' ' ' ASP . 11.5 m -63.22 -40.83 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.118 -1.438 . . . . 1.0900000000000001 107.118 170.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.6 m-20 -59.56 -58.53 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.63 -0.713 . . . . 1.8700000000000001 110.927 165.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.5 ' CG ' ' N ' ' A' ' 113' ' ' ASP . 3.8 p-90 128.36 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.282 2.233 . . . . 1.1699999999999999 111.641 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 14.9 t70 -94.44 129.44 41.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.475 -0.329 . . . . 2.1499999999999999 110.404 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.738 HD11 HD12 ' A' ' 144' ' ' LEU . 2.5 mp -115.32 151.13 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.026 0.441 . . . . 0.39000000000000001 109.854 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 141' ' ' GLU . 6.1 p-10 -93.73 152.59 18.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.983 -0.747 . . . . 2.1099999999999999 108.983 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 31.9 m-85 -141.9 165.66 26.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.669 -0.863 . . . . 0.62 108.669 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 22.9 tt0 -152.18 139.92 19.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.751 0.31 . . . . 0.80000000000000004 110.345 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -113.91 129.94 56.55 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.205 -0.665 . . . . 1.25 109.205 173.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.648 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -120.59 100.72 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.118 -0.697 . . . . 0.63 109.118 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.07 123.18 71.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.51 0.671 . . . . 0.81000000000000005 110.773 -174.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.33 124.48 7.07 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.458 -0.792 . . . . 0.26000000000000001 111.768 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.564 HD12 HD12 ' A' ' 120' ' ' ILE . 6.1 mp -97.4 105.91 18.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.966 0.412 . . . . 1.2 111.055 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.048 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 89.2 m -108.11 95.14 5.47 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.439 -0.801 . . . . 0.32000000000000001 109.007 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 58' ' ' CYS . 7.0 pt -112.23 140.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 120.555 -0.458 . . . . 0.97999999999999998 110.281 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.797 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -85.81 105.8 16.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.33 -0.989 . . . . 1.52 108.33 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -125.03 135.54 26.93 Favored Pre-proline 0 C--O 1.22 -0.464 0 O-C-N 124.049 0.843 . . . . 1.28 110.156 178.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 53.9 Cg_exo -52.73 -19.38 10.57 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.496 2.797 . . . . 0.73999999999999999 115.32 -169.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.48 -51.09 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.231 -0.293 . . . . 1.1200000000000001 111.361 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.692 HG11 ' HD1' ' A' ' 132' ' ' PHE . 0.2 OUTLIER -103.32 -2.38 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.087 0.946 . . . . 1.3500000000000001 109.456 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.72 -36.95 1.22 Allowed Glycine 0 C--N 1.314 -0.669 0 CA-C-N 113.558 -1.655 . . . . 1.05 111.151 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.1 pt-20 -177.09 150.57 0.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.554 -1.276 . . . . 1.1599999999999999 107.554 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HD1' HG11 ' A' ' 129' ' ' VAL . 12.7 t80 -151.97 147.86 27.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.703 -0.399 . . . . 1.9099999999999999 110.158 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 67.8 m -113.82 104.72 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.506 0.504 . . . . 1.1899999999999999 111.477 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -124.04 133.09 24.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 0.5 109.608 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 89.6 Cg_endo -87.38 161.28 8.24 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.592 1.528 . . . . 0.45000000000000001 112.836 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.68 164.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.299 -1.0 . . . . 0.44 108.299 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -135.4 150.21 49.84 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.901 -0.319 . . . . 0.88 111.203 -168.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.3 t -145.8 102.18 3.63 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.649 -1.241 . . . . 0.95999999999999996 107.649 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 6.0 ptmt -118.12 144.05 45.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.68 -0.489 . . . . 1.76 109.68 -172.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.03 149.55 19.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.021 -1.085 . . . . 0.5 112.443 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 115' ' ' ASP . 31.0 mt-10 -108.06 126.94 53.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.055 -0.572 . . . . 2.1000000000000001 109.771 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 172.87 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.868 -0.79 . . . . 0.76000000000000001 108.868 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -54.64 160.81 1.69 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.995 0.739 . . . . 3.5299999999999998 112.995 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.738 HD12 HD11 ' A' ' 114' ' ' ILE . 25.0 tp -58.88 136.54 87.26 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.056 -0.974 . . . . 1.23 110.57 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.664 ' HD2' HD12 ' A' ' 144' ' ' LEU . 38.1 Cg_endo . . . . . 0 C--N 1.345 0.364 0 C-N-CA 122.798 2.332 . . . . 0.70999999999999996 112.486 177.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.22 -0.729 0 N-CA-C 116.282 1.273 . . . . 0.54000000000000004 116.282 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 75.5 p -169.01 34.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.47 1.108 . . . . 1.2 108.107 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.21 152.86 36.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 114.48 -1.236 . . . . 0.93000000000000005 109.701 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 t -168.53 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.135 0.272 . . . . 0.47999999999999998 110.712 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -174.36 168.08 3.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.554 0.575 . . . . 1.6899999999999999 112.554 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 67.8 t -142.76 129.36 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.341 -0.845 . . . . 1.1399999999999999 109.497 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.97 128.12 54.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.619 -0.264 . . . . 1.8300000000000001 110.98 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 2.7 tm? -92.97 139.54 30.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.801 0.297 . . . . 0.93999999999999995 111.801 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -139.1 -94.52 0.17 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.047 1.129 . . . . 1.3300000000000001 114.047 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--O 1.205 -1.272 0 CA-C-N 116.182 -0.463 . . . . 2.8500000000000001 112.182 -153.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.471 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 45.1 t . . . . . 0 C--O 1.24 0.586 0 CA-C-O 121.83 0.824 . . . . 0.93999999999999995 112.289 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 93.3 t -74.01 147.07 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.578 -1.192 . . . . 0.85999999999999999 110.056 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -123.55 137.73 54.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.604 -0.838 . . . . 1.1899999999999999 110.337 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.94 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -141.7 139.61 32.96 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 118.671 -1.212 . . . . 3.73 113.677 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -83.24 109.0 16.86 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.666 -1.235 . . . . 0.81000000000000005 107.666 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -93.48 107.52 19.35 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.535 -0.913 . . . . 0.41999999999999998 108.535 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 21.5 ttmm -82.7 131.31 35.21 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.927 -0.768 . . . . 2.6299999999999999 108.927 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 25' ' ' SER . 45.2 t -111.2 137.81 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.735 -1.12 . . . . 0.81999999999999995 110.236 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.7 m -126.39 97.87 5.22 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 120.257 -0.577 . . . . 0.71999999999999997 109.632 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 57.8 t -84.0 124.25 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.651 -0.704 . . . . 1.1399999999999999 110.812 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.631 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 22.1 m -99.83 121.01 40.66 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.326 -0.991 . . . . 0.40999999999999998 108.326 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.844 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.9 t30 -89.45 124.37 64.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 124.894 1.371 . . . . 1.48 109.652 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.89 11.67 3.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.852 3.035 . . . . 0.72999999999999998 113.945 -175.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 2.7 t80 -125.54 136.38 53.25 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.717 -0.845 . . . . 2.0800000000000001 108.717 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.2 p -76.31 34.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.311 0.577 . . . . 1.51 111.161 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 51' ' ' TYR . 52.8 m80 -148.57 132.69 17.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.371 -0.831 . . . . 1.6699999999999999 109.895 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -45.15 102.07 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.186 0.994 . . . . 1.3899999999999999 113.459 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 81' ' ' SER . 11.1 pt -75.47 171.65 11.31 Favored Pre-proline 0 C--O 1.208 -1.112 0 N-CA-C 108.535 -0.913 . . . . 1.03 108.535 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 39.6 Cg_endo -89.12 -63.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.455 1.437 . . . . 0.37 114.923 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.2 mm -133.0 162.26 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 121.967 -0.458 . . . . 1.23 111.532 -166.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.809 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.3 p -150.97 -179.85 7.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.165 0.983 . . . . 1.1499999999999999 111.998 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.064 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.6 tt0 -132.37 116.12 16.44 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.419 -1.719 . . . . 1.3600000000000001 109.933 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -97.21 108.98 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.362 1.077 . . . . 1.05 109.454 168.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 p -114.42 103.03 10.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.454 -1.703 . . . . 0.82999999999999996 108.807 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 11.8 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.226 0.536 . . . . 0.40000000000000002 110.294 -165.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 m -137.01 108.81 7.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.873 -1.058 . . . . 0.38 109.626 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 92.7 m-85 -98.54 146.59 25.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.409 -0.359 . . . . 0.95999999999999996 110.768 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.74 ' HB3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -139.08 128.83 24.75 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 108.098 -1.075 . . . . 1.29 108.098 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 1.035 ' HB3' HD22 ' A' ' 104' ' ' LEU . 38.1 t -94.06 -89.85 0.21 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.408 -0.917 . . . . 1.27 110.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.55 -67.86 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.387 -0.597 . . . . 0.35999999999999999 109.387 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.81 18.08 0.17 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.407 -1.077 . . . . 0.39000000000000001 110.407 167.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.74 ' O ' ' HB3' ' A' ' 65' ' ' HIS . 6.7 ptp180 -106.43 -149.47 0.43 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.558 -0.534 . . . . 1.97 109.558 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.35 101.24 7.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 119.068 0.849 . . . . 2.6099999999999999 109.539 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -73.62 -44.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.645 -0.707 . . . . 0.40000000000000002 112.417 -171.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.56 140.24 4.43 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.48999999999999999 111.094 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -154.36 159.08 40.97 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 117.568 0.684 . . . . 1.8100000000000001 111.222 -174.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.74 163.72 26.15 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.886 -0.885 . . . . 0.42999999999999999 110.886 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.9 mttt -129.85 128.37 42.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.162 -0.31 . . . . 1.72 110.162 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.1 mt -135.67 124.37 15.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.608 -0.269 . . . . 0.72999999999999998 110.667 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.3 103.0 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.155 1.903 . . . . 0.56999999999999995 111.234 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HB2' HD11 ' A' ' 60' ' ' ILE . 7.4 t70 -110.43 136.78 20.56 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.79000000000000004 109.541 -172.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' HD13 ' A' ' 57' ' ' ILE . 25.8 Cg_exo -63.44 88.79 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.546 2.164 . . . . 0.57999999999999996 112.716 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 82' ' ' LEU . . . -88.24 35.63 3.54 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.885 -0.598 . . . . 0.40000000000000002 112.379 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.943 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -72.78 117.71 14.82 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.146 -0.687 . . . . 0.62 109.146 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HG ' ' NZ ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -156.41 -155.15 0.52 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.305 -1.358 . . . . 1.1000000000000001 114.45 -157.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.796 ' CE ' ' HB ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -57.68 -158.2 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.339 1.066 . . . . 1.8400000000000001 112.305 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.87 80.59 1.72 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.342 -1.355 . . . . 0.98999999999999999 107.342 -167.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 8.9 mtpt 64.74 68.28 0.53 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.962 -1.472 . . . . 1.8400000000000001 110.934 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.698 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 9.4 t70 -162.53 -169.59 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.238 -1.346 . . . . 0.64000000000000001 109.54 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.473 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 41.8 ttp -122.42 118.96 29.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.193 0.521 . . . . 1.3500000000000001 110.88 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.796 ' HB ' ' CE ' ' A' ' 83' ' ' LYS . 5.6 t -104.04 143.67 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.77000000000000002 109.018 -172.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.71 109.4 20.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.703 0.763 . . . . 0.47999999999999998 110.739 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -115.48 175.07 5.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.66 -1.155 . . . . 0.77000000000000002 108.136 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.588 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 3.1 p30 -144.25 151.22 39.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.011 0.823 . . . . 1.8100000000000001 112.569 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 40.3 mm -110.16 130.45 22.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.683 -1.144 . . . . 0.65000000000000002 108.044 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.508 ' O ' HG13 ' A' ' 94' ' ' VAL . 44.6 Cg_exo -35.86 -103.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.687 3.592 . . . . 1.0700000000000001 115.372 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -164.0 90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 CA-C-O 119.118 -0.468 . . . . 0.46000000000000002 110.615 -177.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.9 p -124.35 104.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.646 1.721 . . . . 0.47999999999999998 115.646 -163.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 101' ' ' LEU . 2.5 t -148.9 119.23 4.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 1.0700000000000001 110.346 164.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 17.9 Cg_exo -65.47 124.9 13.53 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.08 1.064 . . . . 0.47999999999999998 109.569 164.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.471 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -58.27 -30.85 66.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.3100000000000001 111.594 -171.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 3.2 p -58.76 -26.54 64.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.311 0.486 . . . . 1.2 112.311 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.2 mm -76.86 -55.31 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 121.818 -0.551 . . . . 0.51000000000000001 110.995 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 96' ' ' VAL . 26.9 mt -52.24 -26.56 12.09 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.555 0.693 . . . . 1.0 110.392 171.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' SER . 57.6 t80 -64.4 -40.24 95.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.467 -1.242 . . . . 0.95999999999999996 108.839 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HA ' HH21 ' A' ' 106' ' ' ARG . 22.0 m-80 -73.79 -58.06 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.845 -0.616 . . . . 0.81999999999999995 112.422 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.035 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -61.04 -50.19 74.31 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.423 0.898 . . . . 0.65000000000000002 113.423 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.68 -25.05 67.95 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.856 0.836 . . . . 0.42999999999999999 110.037 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 110' ' ' VAL . 2.7 ttp180 -68.18 -51.11 49.37 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.145 . . . . 1.8100000000000001 110.728 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 110' ' ' VAL . 24.8 t70 -82.9 -52.07 7.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.545 1.164 . . . . 0.80000000000000004 112.231 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -84.42 -29.06 6.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.859 -1.151 . . . . 0.88 109.982 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.93 -25.59 73.39 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.923 -0.656 . . . . 0.38 113.786 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -57.65 -40.5 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 118.413 -1.315 . . . . 1.0900000000000001 108.04 170.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 30.6 t70 -64.66 -84.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.504 -1.278 . . . . 1.8700000000000001 108.097 161.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.9 OUTLIER 168.07 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.24 0.83 . . . . 1.1699999999999999 113.24 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.58 123.78 35.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.87 0.322 . . . . 2.1499999999999999 111.87 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.578 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.3 mp -117.28 155.55 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.902 0.382 . . . . 0.39000000000000001 110.032 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' A' ' 141' ' ' GLU . 37.1 t70 -98.91 155.41 17.41 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.067 -0.716 . . . . 2.1099999999999999 109.067 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 72.9 m-85 -139.08 129.57 25.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.217 -0.66 . . . . 0.62 109.217 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.844 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.5 tt0 -123.78 137.25 54.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.05 0.453 . . . . 0.80000000000000004 110.068 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.699 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -111.47 129.36 56.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.588 -0.733 . . . . 1.25 109.863 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.721 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.34 101.29 9.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 176.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.654 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 tp -111.88 123.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.146 0.498 . . . . 0.81000000000000005 111.204 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.76 125.2 7.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.378 -0.689 . . . . 0.26000000000000001 111.378 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.583 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.3 mp -101.88 94.99 6.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.38 . . . . 1.2 111.131 -174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.064 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 84.9 m -100.17 95.56 6.89 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.629 -0.714 . . . . 0.32000000000000001 109.177 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.838 HG13 HD21 ' A' ' 126' ' ' LEU . 3.0 pt -106.89 149.42 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.9 -0.5 . . . . 0.97999999999999998 109.698 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.527 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.5 m-20 -92.88 107.15 18.99 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -109.93 159.74 30.67 Favored Pre-proline 0 C--O 1.217 -0.63 0 O-C-N 123.996 0.81 . . . . 1.28 109.997 -176.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 17.3 Cg_exo -69.88 -13.1 33.93 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.884 1.722 . . . . 0.73999999999999999 113.358 174.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.63 -59.93 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.769 0.655 . . . . 1.1200000000000001 112.769 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 129' ' ' VAL . 34.1 t -118.99 9.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 122.915 1.341 . . . . 1.3500000000000001 109.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.58 -24.78 3.57 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 113.587 -1.642 . . . . 1.05 111.605 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 10.6 pt-20 -172.52 154.77 3.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.628 -0.879 . . . . 1.1599999999999999 108.628 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -150.0 143.64 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.523 -0.547 . . . . 1.9099999999999999 109.523 170.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 53.5 m -116.23 108.85 16.64 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.383 0.427 . . . . 1.1899999999999999 111.352 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.4 pp -124.94 137.38 29.51 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.098 -0.501 . . . . 0.5 109.975 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 73.7 Cg_endo -92.89 159.11 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.047 1.832 . . . . 0.45000000000000001 113.323 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -156.44 165.38 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.601 -0.888 . . . . 0.44 108.601 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -136.27 151.36 49.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.64 -0.255 . . . . 0.88 111.072 -168.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t -146.11 103.8 3.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.016 -0.735 . . . . 0.95999999999999996 109.016 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.844 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.8 ptmt -116.11 152.81 32.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 1.76 111.309 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.08 147.02 10.03 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.718 -0.753 . . . . 0.5 112.049 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 115' ' ' ASP . 31.3 mt-10 -98.67 135.09 40.68 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.607 -0.516 . . . . 2.1000000000000001 109.607 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.13 171.04 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.212 -0.662 . . . . 0.76000000000000001 109.212 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -60.02 167.01 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 3.5299999999999998 112.334 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.825 HD12 ' HD2' ' A' ' 145' ' ' PRO . 42.0 tp -56.26 125.44 64.99 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.928 -1.033 . . . . 1.23 109.809 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.825 ' HD2' HD12 ' A' ' 144' ' ' LEU . 28.6 Cg_endo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 123.658 2.905 . . . . 0.70999999999999996 113.197 -176.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.733 0 N-CA-C 113.875 0.31 . . . . 0.54000000000000004 113.875 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.701 ' O ' HG13 ' A' ' 45' ' ' VAL . 83.6 p -169.31 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.338 1.066 . . . . 1.2 108.561 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 136' ' ' ILE . 14.3 m -134.52 152.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 114.297 -1.32 . . . . 0.93000000000000005 109.707 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -160.28 -51.52 0.05 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.464 -0.569 . . . . 0.47999999999999998 109.464 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -157.36 166.16 33.83 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.487 -0.56 . . . . 1.6899999999999999 109.487 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -145.53 148.34 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.154 -0.684 . . . . 1.1399999999999999 109.154 165.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -122.37 144.39 49.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.016 0.436 . . . . 1.8300000000000001 111.215 -169.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.12 118.03 32.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.93999999999999995 111.126 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HG2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.63 -136.36 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.525 -1.287 . . . . 1.3300000000000001 107.525 167.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.623 ' HB3' HG13 ' A' ' 39' ' ' VAL . 5.3 p-10 . . . . . 0 N--CA 1.48 1.058 0 N-CA-C 115.739 1.755 . . . . 2.8500000000000001 115.739 -173.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 44.1 t . . . . . 0 CA--C 1.504 -0.825 0 CA-C-O 121.046 0.451 . . . . 0.93999999999999995 112.184 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.623 HG13 ' HB3' ' A' ' 33' ' ' ASP . 44.5 t -70.99 168.48 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.743 -1.206 . . . . 0.85999999999999999 107.743 168.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.019 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 76.0 mt-10 -128.76 136.18 50.2 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.712 0.768 . . . . 1.1899999999999999 111.081 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.62 104.21 8.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.637 -1.165 . . . . 3.73 109.886 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.556 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -75.39 109.83 9.24 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.267 -0.973 . . . . 0.81000000000000005 108.613 176.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.734 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -94.52 109.58 21.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.396 0.617 . . . . 0.41999999999999998 109.781 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 21.7 ttmt -84.65 130.14 34.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.436 -0.802 . . . . 2.6299999999999999 109.11 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 90' ' ' LEU . 69.3 t -111.34 136.12 48.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 116.149 -0.478 . . . . 0.81999999999999995 112.13 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.561 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 29.4 m -127.05 95.76 4.4 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.025 -0.731 . . . . 0.71999999999999997 109.025 160.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -89.48 128.51 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.536 0.684 . . . . 1.1399999999999999 110.955 -176.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.8 m -103.77 117.27 33.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.963 -1.017 . . . . 0.40999999999999998 109.853 -175.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 6.3 t30 -88.67 128.47 52.46 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 124.146 0.904 . . . . 1.48 108.922 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -91.84 11.34 2.39 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.25 2.634 . . . . 0.72999999999999998 114.218 -174.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -130.49 143.43 50.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.043 -0.725 . . . . 2.0800000000000001 109.043 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 23.1 t -78.07 34.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.946 0.721 . . . . 1.51 112.946 -164.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -144.5 132.14 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.277 -0.264 . . . . 1.6699999999999999 110.375 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -39.37 103.6 0.03 OUTLIER 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 124.058 0.943 . . . . 1.3899999999999999 112.708 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.32 169.45 19.33 Favored Pre-proline 0 C--O 1.21 -1.0 0 N-CA-C 108.097 -1.075 . . . . 1.03 108.097 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.923 ' HB2' HD12 ' A' ' 57' ' ' ILE . 9.9 Cg_endo -91.56 -66.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.504 1.469 . . . . 0.37 114.333 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 56' ' ' PRO . 3.8 mp -134.65 152.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.299 -0.56 . . . . 1.23 111.028 -167.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.68 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 16.5 m -144.23 -178.09 5.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.118 0.961 . . . . 1.1499999999999999 111.92 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 23.8 tt0 -134.27 116.88 15.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.414 -1.721 . . . . 1.3600000000000001 109.997 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.571 ' HA ' HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -95.94 108.4 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 115.054 -0.975 . . . . 1.05 108.785 164.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 39.5 p -112.76 101.95 10.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.05 -1.432 . . . . 0.82999999999999996 108.377 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -116.16 134.3 55.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.415 0.626 . . . . 0.40000000000000002 110.583 -166.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -128.32 111.01 12.9 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.507 -1.224 . . . . 0.38 108.819 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 97.8 m-85 -97.31 140.67 31.44 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.584 -0.524 . . . . 0.95999999999999996 109.584 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -128.19 144.55 51.13 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.048 -1.464 . . . . 1.29 107.048 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 39.1 t -105.43 -103.86 0.32 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 118.967 -1.093 . . . . 1.27 111.046 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -60.53 -54.31 47.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.115 -0.698 . . . . 0.35999999999999999 109.115 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 21.22 0.12 Allowed Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 109.116 -1.594 . . . . 0.39000000000000001 109.116 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 6.6 ptp180 -115.97 -172.25 2.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.568 -0.816 . . . . 1.97 109.014 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -105.11 91.55 3.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.612 0.72 . . . . 2.6099999999999999 110.555 -165.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 100' ' ' ILE . 6.0 mm -52.07 -44.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.911 -1.041 . . . . 0.40000000000000002 111.067 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.24 170.54 35.48 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.534 -0.841 . . . . 0.48999999999999999 111.41 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.89 163.02 21.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.377 0.589 . . . . 1.8100000000000001 111.043 176.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.83 166.25 35.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.892 -0.595 . . . . 0.42999999999999999 111.637 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 91.3 mttt -135.74 126.42 27.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.613 0.244 . . . . 1.72 110.456 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.37 115.41 14.94 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.944 -0.391 . . . . 0.72999999999999998 109.944 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 9.8 Cg_exo -72.24 95.69 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.498 2.132 . . . . 0.56999999999999995 110.553 170.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -112.24 141.84 25.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.374 -0.602 . . . . 0.79000000000000004 109.374 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HA ' HG13 ' A' ' 57' ' ' ILE . 19.5 Cg_endo -59.44 88.97 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.519 2.146 . . . . 0.57999999999999996 112.502 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.68 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -83.21 38.71 2.74 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.261 -0.881 . . . . 0.40000000000000002 112.29 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.973 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 77.4 p -73.58 125.45 28.02 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.506 -0.553 . . . . 0.62 109.506 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.878 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -156.94 0.77 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.893 1.442 . . . . 1.1000000000000001 114.893 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.545 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 91.5 mttt -62.71 -101.24 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.49 -0.777 . . . . 1.8400000000000001 112.513 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.23 102.57 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.045 -1.094 . . . . 0.98999999999999999 108.045 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptpt 43.59 50.43 6.46 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.415 1.072 . . . . 1.8400000000000001 111.071 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.2 -173.64 4.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.189 -0.914 . . . . 0.64000000000000001 109.678 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 48.6 ttm -112.59 126.73 55.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.377 -0.374 . . . . 1.3500000000000001 110.649 -172.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.539 ' CG2' HG13 ' A' ' 47' ' ' VAL . 5.9 t -116.76 144.64 44.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.046 -0.524 . . . . 0.77000000000000002 110.247 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -90.87 111.36 22.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.737 0.779 . . . . 0.47999999999999998 110.527 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.746 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -109.85 176.14 5.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.588 -1.187 . . . . 0.77000000000000002 108.56 -176.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.746 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.8 t70 -134.78 131.73 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.365 0.529 . . . . 1.8100000000000001 111.909 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 19.1 mm -113.62 139.31 23.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.65000000000000002 110.312 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 92' ' ' ILE . 71.9 Cg_exo -51.3 -177.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.899 . . . . 1.0700000000000001 113.597 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.019 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.7 m -115.16 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.553 -0.749 . . . . 0.46000000000000002 110.367 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 p -127.2 102.96 10.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 114.269 1.211 . . . . 0.47999999999999998 114.269 -164.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.5 p -151.72 98.41 3.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.697 -0.683 . . . . 1.0700000000000001 110.551 161.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 87.5 Cg_exo -47.67 130.22 18.32 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.994 1.796 . . . . 0.47999999999999998 111.264 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.513 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -57.86 -31.66 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 1.3100000000000001 110.998 -173.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 14.9 m -56.6 -28.78 61.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.722 0.296 . . . . 1.2 111.682 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 21.3 mm -76.34 -54.74 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.757 0.313 . . . . 0.51000000000000001 110.538 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 104' ' ' LEU . 19.9 mt -50.09 -27.84 6.27 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.21 -0.905 . . . . 1.0 110.516 171.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 1.8 t80 -65.66 -42.33 91.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.709 -1.132 . . . . 0.95999999999999996 109.031 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.649 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 50.7 m-80 -73.59 -56.35 5.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.434 . . . . 0.81999999999999995 111.946 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 101' ' ' LEU . 1.6 pp -60.94 -51.16 70.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.442 0.904 . . . . 0.65000000000000002 113.442 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -24.35 66.9 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.718 0.77 . . . . 0.42999999999999999 109.706 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.649 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -60.32 -53.27 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.654 -1.157 . . . . 1.8100000000000001 110.143 172.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.98 -53.29 6.26 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.301 0.572 . . . . 0.80000000000000004 112.394 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 2.2 t -89.72 -25.26 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.945 -0.702 . . . . 0.88 110.159 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.35 -24.64 72.63 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.181 -1.009 . . . . 0.38 111.07 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.6 -44.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.448 -1.316 . . . . 1.0900000000000001 107.448 166.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 7.6 m-20 -68.84 -87.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.78 -0.646 . . . . 1.8700000000000001 110.179 162.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -179.85 -56.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.313 -0.403 . . . . 1.1699999999999999 111.631 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 108' ' ' VAL . 1.6 p-10 -94.42 134.38 37.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.802 0.334 . . . . 2.1499999999999999 110.234 -177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.653 HD11 HD12 ' A' ' 144' ' ' LEU . 2.3 mp -119.38 156.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.916 -0.772 . . . . 0.39000000000000001 108.916 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 141' ' ' GLU . 1.6 p-10 -98.0 152.81 18.88 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.714 -0.847 . . . . 2.1099999999999999 108.714 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 44.0 m-85 -138.07 169.33 17.98 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.737 -1.208 . . . . 0.62 107.737 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.617 ' HA ' ' CB ' ' A' ' 139' ' ' LYS . 3.7 tt0 -160.06 145.04 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.907 0.384 . . . . 0.80000000000000004 110.224 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -116.59 128.79 55.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.885 -0.598 . . . . 1.25 109.472 174.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.635 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -117.08 100.37 7.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.465 -0.939 . . . . 0.63 108.465 176.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -117.14 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.334 0.588 . . . . 0.81000000000000005 110.846 -173.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.402 ' N ' HD13 ' A' ' 120' ' ' ILE . . . -86.06 124.15 6.75 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.368 -0.833 . . . . 0.26000000000000001 111.831 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.555 HD12 HD12 ' A' ' 120' ' ' ILE . 5.9 mp -95.34 106.49 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.11 0.481 . . . . 1.2 110.569 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.08 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.1 m -112.04 94.35 4.9 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.034 -0.985 . . . . 0.32000000000000001 109.228 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.677 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -117.35 126.17 74.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.481 -0.562 . . . . 0.97999999999999998 109.481 -175.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.847 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 33.3 t70 -81.71 106.86 13.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 120.394 -0.523 . . . . 1.52 110.296 -172.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.672 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 4.5 mm? -98.32 -178.76 0.75 Allowed Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 125.201 1.563 . . . . 1.28 109.994 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 126' ' ' LEU . 15.6 Cg_endo -90.78 -16.4 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.987 1.791 . . . . 0.73999999999999999 113.445 167.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.8 t -73.53 -59.71 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.481 0.548 . . . . 1.1200000000000001 112.481 -170.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.595 ' H ' ' HE1' ' A' ' 132' ' ' PHE . 2.1 t -113.59 -2.22 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 123.417 1.579 . . . . 1.3500000000000001 107.026 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 86.95 -133.94 12.15 Favored Glycine 0 N--CA 1.422 -2.248 0 CA-C-N 111.636 -2.529 . . . . 1.05 108.52 -167.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.847 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 7.2 pt-20 -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.796 0.808 . . . . 1.1599999999999999 110.869 176.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.79 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.2 m-30 -89.68 145.13 25.44 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.524 -0.917 . . . . 1.9099999999999999 108.524 173.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 21.2 m -129.88 94.16 3.66 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.733 -0.387 . . . . 1.1899999999999999 111.452 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -128.57 136.16 28.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.23 173.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -89.34 158.23 5.53 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.866 1.711 . . . . 0.45000000000000001 112.604 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.3 163.94 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.44 109.384 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -132.83 139.95 47.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.376 -0.374 . . . . 0.88 110.133 -170.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 50.2 m -147.83 101.02 3.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.715 -0.846 . . . . 0.95999999999999996 108.715 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 116' ' ' TYR . 13.9 ptmm? -116.53 163.06 16.64 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.45 -0.796 . . . . 1.76 111.66 -171.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.14 138.96 5.61 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.42 -0.895 . . . . 0.5 111.329 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 115' ' ' ASP . 5.0 mp0 -106.55 126.76 52.68 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.715 -0.742 . . . . 2.1000000000000001 109.416 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.52 174.99 4.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.073 -0.714 . . . . 0.76000000000000001 109.073 -171.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -57.08 163.13 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.384 0.513 . . . . 3.5299999999999998 112.384 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.656 HD12 ' HD2' ' A' ' 145' ' ' PRO . 28.5 tp -56.55 127.41 72.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 115.392 -0.822 . . . . 1.23 110.423 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.656 ' HD2' HD12 ' A' ' 144' ' ' LEU . 25.1 Cg_endo . . . . . 0 C--N 1.347 0.481 0 C-N-CA 123.401 2.734 . . . . 0.70999999999999996 113.155 -177.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.501 -0.808 0 N-CA-C 116.528 1.371 . . . . 0.54000000000000004 116.528 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.817 ' HB2' HD21 ' A' ' 122' ' ' LEU . 58.6 m 179.95 49.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.066 1.747 . . . . 1.2 107.167 -174.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.65 154.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.05 -0.977 . . . . 0.93000000000000005 109.488 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -175.82 -36.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 O-C-N 123.48 0.487 . . . . 0.47999999999999998 111.623 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 34.7 t70 -163.73 154.26 15.66 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.078 0.466 . . . . 1.6899999999999999 110.591 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.719 HG11 ' HZ ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -151.25 144.69 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.604 -0.517 . . . . 1.1399999999999999 109.604 164.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.35 142.72 51.05 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.023 -0.732 . . . . 1.8300000000000001 109.023 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.776 HD21 HG11 ' A' ' 96' ' ' VAL . 3.3 tm? -101.17 112.24 24.67 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.713 -0.477 . . . . 0.93999999999999995 109.713 -170.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.13 147.86 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.03 1.395 . . . . 1.3300000000000001 112.368 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 1.8 t70 . . . . . 0 C--N 1.294 -1.826 0 CA-C-N 111.178 -2.737 . . . . 2.8500000000000001 108.039 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.534 ' OG ' ' HA ' ' A' ' 97' ' ' PRO . 42.2 t . . . . . 0 CA--C 1.494 -1.193 0 N-CA-C 108.274 -1.01 . . . . 0.93999999999999995 108.274 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.409 ' HB ' HD12 ' A' ' 101' ' ' LEU . 35.9 t -83.95 158.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.533 -1.654 . . . . 0.85999999999999999 106.533 171.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 12.5 mt-10 -139.19 165.66 26.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.124 -1.065 . . . . 1.1899999999999999 108.124 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.899 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 30.5 p90 -134.63 126.8 29.91 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.22 -1.392 . . . . 3.73 112.691 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.91 115.17 20.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.566 -0.853 . . . . 0.81000000000000005 109.364 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . . . -106.39 119.46 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.092 0.472 . . . . 0.41999999999999998 111.924 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.6 tppt? -87.3 102.31 14.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.216 1.007 . . . . 2.6299999999999999 109.449 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.999 HG21 HD13 ' A' ' 92' ' ' ILE . 12.4 t -96.36 156.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.766 -1.106 . . . . 0.81999999999999995 110.33 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.503 ' C ' ' HA ' ' A' ' 25' ' ' SER . 4.1 m -139.45 112.32 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 120.054 -0.659 . . . . 0.71999999999999997 111.33 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 25.9 t -82.64 124.07 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.975 -1.011 . . . . 1.1399999999999999 110.372 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.4 m -104.09 114.29 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.40999999999999998 109.267 174.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 13.0 t30 -89.81 126.26 58.23 Favored Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 124.395 1.059 . . . . 1.48 110.133 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -83.02 3.88 7.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.594 2.863 . . . . 0.72999999999999998 113.999 -176.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 13.0 t80 -122.03 143.72 49.33 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.407 -0.59 . . . . 2.0800000000000001 109.407 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.624 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 19.8 p -79.2 28.53 0.23 Allowed 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.434 0.531 . . . . 1.51 112.434 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -143.11 131.04 21.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.416 -0.357 . . . . 1.6699999999999999 110.075 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.5 m -40.76 100.14 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.985 0 C-N-CA 124.212 1.005 . . . . 1.3899999999999999 112.846 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.957 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.8 pt -74.51 171.14 12.14 Favored Pre-proline 0 C--O 1.21 -1.014 0 N-CA-C 108.073 -1.084 . . . . 1.03 108.073 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 57' ' ' ILE . 13.4 Cg_endo -92.9 -63.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.034 1.156 . . . . 0.37 114.261 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.2 mm -128.38 154.76 39.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 1.23 111.797 -165.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.651 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.5 p -151.02 -177.46 6.03 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.075 0.941 . . . . 1.1499999999999999 111.78 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.022 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 39.4 tt0 -135.36 115.86 13.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.379 -1.737 . . . . 1.3600000000000001 109.809 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -98.3 109.52 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.334 1.064 . . . . 1.05 109.619 168.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 33.2 p -114.52 102.73 10.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.273 -1.785 . . . . 0.82999999999999996 108.782 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 p90 -109.69 133.36 53.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.969 0.414 . . . . 0.40000000000000002 110.116 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 12.2 m -125.53 100.82 6.64 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.185 -0.916 . . . . 0.38 109.546 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.836 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 10.4 m-85 -97.57 143.78 27.91 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.869 -0.605 . . . . 0.95999999999999996 109.956 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -146.16 143.74 29.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.904 -1.147 . . . . 1.29 107.904 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.882 ' HB3' HD22 ' A' ' 104' ' ' LEU . 33.0 t -102.02 -93.97 0.3 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.987 -0.685 . . . . 1.27 111.421 -174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.94 10.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.35999999999999999 109.545 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.44 16.29 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.763 -1.208 . . . . 0.39000000000000001 110.247 165.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.694 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -99.19 -69.76 0.75 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.998 -0.601 . . . . 1.97 110.532 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 28.1 tt0 -175.75 170.58 2.83 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.523 -1.288 . . . . 2.6099999999999999 107.523 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.54 ' HB ' ' C ' ' A' ' 64' ' ' PHE . 2.4 mm -136.78 -40.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.146 -1.057 . . . . 0.40000000000000002 108.146 168.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.42 151.48 6.28 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.783 -0.927 . . . . 0.48999999999999999 110.783 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -151.89 155.27 37.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.521 0.661 . . . . 1.8100000000000001 110.771 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.34 177.28 44.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.787 -0.721 . . . . 0.42999999999999999 112.208 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.65 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 69.4 mttt -128.26 132.71 48.72 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.662 0.272 . . . . 1.72 110.368 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 75' ' ' LYS . 3.2 mp -131.18 110.73 15.39 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 109.463 -0.569 . . . . 0.72999999999999998 109.463 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.66 105.95 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.276 1.984 . . . . 0.56999999999999995 110.231 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -120.38 146.27 42.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -172.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 57' ' ' ILE . 39.5 Cg_exo -61.36 91.75 0.1 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.215 1.943 . . . . 0.57999999999999996 111.917 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.09 31.3 2.86 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.40000000000000002 111.82 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.957 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 51.4 p -73.33 119.91 18.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.131 -0.692 . . . . 0.62 109.131 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -152.51 -164.91 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 118.847 -1.141 . . . . 1.1000000000000001 113.328 -162.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 91.3 mttt -51.59 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.312 0.856 . . . . 1.8400000000000001 113.312 -173.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 161.38 111.19 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.752 -1.203 . . . . 0.98999999999999999 107.752 -169.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 44.1 pttt 42.6 45.53 4.01 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.271 0.982 . . . . 1.8400000000000001 111.698 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.7 t70 -151.23 -172.29 4.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.499 -0.773 . . . . 0.64000000000000001 109.871 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.8 ttm -117.65 122.23 43.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.347 0.594 . . . . 1.3500000000000001 110.469 -171.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.656 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -112.13 143.66 42.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.77000000000000002 110.338 -176.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.81 130.36 36.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.599 0.714 . . . . 0.47999999999999998 110.819 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 45' ' ' VAL . 2.1 tm? -125.56 147.75 49.16 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.763 -1.569 . . . . 0.77000000000000002 106.763 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 90' ' ' LEU . 4.8 p-10 -124.04 123.72 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.162 -1.015 . . . . 1.8100000000000001 111.573 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.999 HD13 HG21 ' A' ' 45' ' ' VAL . 1.2 mp -90.55 146.53 34.51 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.788 -1.096 . . . . 0.65000000000000002 109.066 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.405 ' O ' HG13 ' A' ' 94' ' ' VAL . 78.0 Cg_exo -52.69 -118.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.121 3.214 . . . . 1.0700000000000001 113.346 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.6 m -162.97 93.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-O 119.008 -0.52 . . . . 0.46000000000000002 111.437 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.558 HG11 ' HE1' ' A' ' 62' ' ' PHE . 14.8 p -129.52 103.64 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 119.639 -1.913 . . . . 0.47999999999999998 115.962 -172.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.776 HG11 HD21 ' A' ' 31' ' ' LEU . 2.4 p -152.98 97.12 2.86 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.312 -0.868 . . . . 1.0700000000000001 112.122 162.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.747 ' HB2' HG12 ' A' ' 100' ' ' ILE . 75.4 Cg_exo -46.63 136.62 16.08 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 121.823 1.682 . . . . 0.47999999999999998 112.13 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 3.5 t80 -51.58 -39.54 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.157 -0.474 . . . . 1.3100000000000001 110.688 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.7 m -62.78 -25.03 68.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.495 -0.32 . . . . 1.2 111.859 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.747 HG12 ' HB2' ' A' ' 97' ' ' PRO . 21.4 mm -76.87 -56.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.77 -0.581 . . . . 0.51000000000000001 111.453 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.642 HD23 HD11 ' A' ' 104' ' ' LEU . 41.7 mt -53.54 -27.82 28.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.759 0.79 . . . . 1.0 109.942 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 99' ' ' SER . 53.9 t80 -62.45 -42.04 99.18 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.841 -1.527 . . . . 0.95999999999999996 109.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.628 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.2 m-80 -74.24 -57.6 3.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.946 0.35 . . . . 0.81999999999999995 111.946 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.882 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -60.62 -49.41 77.65 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.32 0.859 . . . . 0.65000000000000002 113.32 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 144' ' ' LEU . . . -68.25 -26.18 65.55 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.821 0.819 . . . . 0.42999999999999999 110.088 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.628 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.8 ttp180 -66.0 -46.09 79.23 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.529 -1.214 . . . . 1.8100000000000001 110.484 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.9 t0 -82.21 -53.68 5.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.532 0.682 . . . . 0.80000000000000004 112.317 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 114' ' ' ILE . 6.8 t -85.36 -28.7 6.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.039 -0.664 . . . . 0.88 109.792 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 144' ' ' LEU . . . -75.17 -21.66 77.66 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.575 -0.821 . . . . 0.38 111.607 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -47.84 -44.51 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.976 -1.491 . . . . 1.0900000000000001 106.976 165.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.61 -82.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.517 -0.765 . . . . 1.8700000000000001 110.284 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 179.94 -58.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.811 0.671 . . . . 1.1699999999999999 112.811 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 122.97 39.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.505 -0.316 . . . . 2.1499999999999999 110.634 -172.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 144' ' ' LEU . 2.2 mp -111.21 153.2 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.39000000000000001 109.941 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.5 p-10 -99.26 154.12 18.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.513 -0.767 . . . . 2.1099999999999999 109.219 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -139.15 154.22 48.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.732 -0.84 . . . . 0.62 108.732 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.732 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 35.0 tt0 -142.05 135.74 29.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 0.80000000000000004 110.395 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.836 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -105.31 134.04 49.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.307 -0.86 . . . . 1.25 109.502 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.763 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.93 101.19 7.41 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.533 -0.543 . . . . 0.63 109.533 171.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.478 ' HB ' HD11 ' A' ' 118' ' ' LEU . 7.2 tp -108.04 118.07 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 0.81000000000000005 110.63 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.59 129.84 10.05 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.98 -0.848 . . . . 0.26000000000000001 110.98 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 25' ' ' SER . 2.7 mm? -108.9 105.82 15.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.337 0.589 . . . . 1.2 112.348 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.022 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 77.3 m -100.13 95.6 6.94 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.813 -1.085 . . . . 0.32000000000000001 109.241 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.651 HG22 ' HB3' ' A' ' 58' ' ' CYS . 6.3 pt -109.35 138.12 38.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 120.644 -0.422 . . . . 0.97999999999999998 111.732 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.18 108.13 16.21 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.45 -0.945 . . . . 1.52 108.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 55' ' ' ILE . 17.7 mt -120.29 156.75 54.87 Favored Pre-proline 0 C--O 1.217 -0.636 0 O-C-N 124.884 1.365 . . . . 1.28 110.273 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.0 Cg_exo -70.87 -21.29 28.52 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.123 1.882 . . . . 0.73999999999999999 112.24 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 41.2 t -74.95 -57.1 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.073 -0.512 . . . . 1.1200000000000001 112.195 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.8 OUTLIER -106.72 -1.63 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 122.007 0.908 . . . . 1.3500000000000001 109.698 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.52 -32.05 1.19 Allowed Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.163 -1.381 . . . . 1.05 111.264 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.8 pt-20 -174.34 141.39 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.116 -1.438 . . . . 1.1599999999999999 107.116 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.5 t80 -146.0 135.44 23.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.39 -0.596 . . . . 1.9099999999999999 109.39 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.3 t -117.38 105.8 12.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.868 0.842 . . . . 1.1899999999999999 111.347 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.49 138.73 33.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.41 -0.813 . . . . 0.5 110.249 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.509 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 94.7 Cg_endo -95.82 165.62 1.36 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.168 1.912 . . . . 0.45000000000000001 113.602 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.89 167.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.55 -1.278 . . . . 0.44 107.55 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.557 ' HB3' HE22 ' A' ' 119' ' ' GLN . 83.5 p -140.1 155.83 46.84 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.215 -0.594 . . . . 0.88 112.225 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 t -144.54 103.2 3.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.231 -1.025 . . . . 0.95999999999999996 108.231 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.732 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -108.17 148.63 29.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.549 -0.296 . . . . 1.76 110.24 -177.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.94 141.5 7.1 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.809 -0.71 . . . . 0.5 111.676 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 1.6 mp0 -104.73 127.82 52.63 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.927 -0.636 . . . . 2.1000000000000001 109.297 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -147.92 173.02 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.724 0.297 . . . . 0.76000000000000001 110.314 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.85 159.99 1.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.08 0.77 . . . . 3.5299999999999998 113.08 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' A' ' 145' ' ' PRO . 25.9 tp -56.82 132.16 78.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.088 -0.96 . . . . 1.23 110.333 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.7 Cg_endo . . . . . 0 C--N 1.345 0.386 0 C-N-CA 123.055 2.503 . . . . 0.70999999999999996 112.773 179.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.796 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.432 -1.61 0 N-CA-C 114.091 0.397 . . . . 0.54000000000000004 114.091 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 47' ' ' VAL . 11.4 m -170.78 36.55 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.795 1.238 . . . . 1.2 108.023 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 46' ' ' SER . 27.6 m -133.12 154.3 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.098 -1.41 . . . . 0.93000000000000005 109.226 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -168.79 -41.3 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.546 0.529 . . . . 0.47999999999999998 110.595 168.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 1.016 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 27.2 t70 -173.21 160.18 4.01 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.354 -0.239 . . . . 1.6899999999999999 110.354 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 41' ' ' TYR . 56.0 t -137.66 135.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.143 -0.317 . . . . 1.1399999999999999 110.143 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 17.6 m-20 -108.18 122.68 47.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.362 -0.381 . . . . 1.8300000000000001 111.311 -173.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.93999999999999995 110.335 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -125.53 -122.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.617 -0.512 . . . . 1.3300000000000001 109.617 169.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.851 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.0 p30 . . . . . 0 CA--C 1.507 -0.683 0 C-N-CA 122.446 0.298 . . . . 2.8500000000000001 110.296 -173.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.597 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 13.8 t . . . . . 0 N--CA 1.436 -1.138 0 N-CA-C 106.453 -1.684 . . . . 0.93999999999999995 106.453 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.851 HG13 ' HA ' ' A' ' 33' ' ' ASP . 12.2 t -128.78 162.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.016 -1.105 . . . . 0.85999999999999999 108.016 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 63.3 mt-10 -123.58 144.55 49.51 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.767 -0.773 . . . . 1.1899999999999999 112.144 -170.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.855 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -126.33 103.91 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.014 -0.994 . . . . 3.73 110.672 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -81.05 109.15 15.34 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.075 -1.083 . . . . 0.81000000000000005 108.075 176.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -111.0 114.61 28.05 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.673 -0.411 . . . . 0.41999999999999998 110.518 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 1.016 ' HD3' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -83.62 134.88 34.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.287 -1.005 . . . . 2.6299999999999999 108.287 173.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.57 ' CG2' HG12 ' A' ' 92' ' ' ILE . 40.8 t -113.18 148.47 16.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.052 -0.976 . . . . 0.81999999999999995 110.12 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -133.6 101.37 5.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.344 0.592 . . . . 0.71999999999999997 110.7 170.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 59.6 t -83.42 124.79 39.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 114.901 -1.045 . . . . 1.1399999999999999 110.721 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.8 m -108.49 118.28 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.251 -0.431 . . . . 0.40999999999999998 110.206 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 2.8 p30 -96.54 146.21 30.91 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.429 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -90.17 4.51 4.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.921 3.081 . . . . 0.72999999999999998 114.771 -174.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.69 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 3.8 t80 -95.27 -113.52 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 119.514 -0.874 . . . . 2.0800000000000001 110.173 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 51' ' ' TYR . 50.0 p -165.32 20.09 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.866 -1.061 . . . . 1.51 108.468 171.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -146.22 158.33 43.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 1.6699999999999999 110.871 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.707 ' HA ' HD23 ' A' ' 82' ' ' LEU . 31.4 t -55.95 104.11 0.12 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.198 -1.364 . . . . 1.3899999999999999 111.678 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.88 HG21 HD23 ' A' ' 126' ' ' LEU . 8.8 pt -79.06 123.3 84.99 Favored Pre-proline 0 C--O 1.213 -0.848 0 C-N-CA 120.442 -0.503 . . . . 1.03 109.911 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 81' ' ' SER . 29.1 Cg_endo -63.06 -55.12 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.796 1.664 . . . . 0.37 112.942 -159.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.4 mm -130.73 154.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.218 -0.593 . . . . 1.23 111.088 -172.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -147.17 178.19 8.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.106 0.955 . . . . 1.1499999999999999 111.697 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.045 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 4.5 tm-20 -140.43 112.84 7.91 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.53 -1.668 . . . . 1.3600000000000001 109.442 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.613 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -99.33 115.09 39.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.536 -1.665 . . . . 1.05 111.373 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -110.33 103.09 11.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.697 -1.592 . . . . 0.82999999999999996 108.51 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.7 p90 -109.46 132.62 53.96 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.482 0.658 . . . . 0.40000000000000002 109.546 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 29.0 m -128.41 102.06 6.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.074 -0.967 . . . . 0.38 109.55 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 97.9 m-85 -96.41 139.45 32.51 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.752 -0.833 . . . . 0.95999999999999996 108.752 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HA ' ' C ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -146.29 138.14 24.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 1.29 109.056 175.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.755 ' CB ' HD22 ' A' ' 104' ' ' LEU . 47.6 t -95.5 -98.77 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.458 -0.497 . . . . 1.27 111.384 -173.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -56.78 -60.05 4.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.279 0.562 . . . . 0.35999999999999999 109.564 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.23 18.21 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.269 -1.533 . . . . 0.39000000000000001 109.269 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -103.44 -56.04 2.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.233 -0.484 . . . . 1.97 111.069 -173.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.734 ' C ' ' HA ' ' A' ' 65' ' ' HIS . 31.1 tt0 171.49 176.96 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.761 -1.57 . . . . 2.6099999999999999 106.761 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.075 ' HA ' HG21 ' A' ' 100' ' ' ILE . 4.4 mm -145.4 -47.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 C-N-CA 124.425 1.09 . . . . 0.40000000000000002 108.529 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.33 121.44 0.59 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.229 -0.986 . . . . 0.48999999999999999 112.011 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -124.49 163.92 20.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.687 0.756 . . . . 1.8100000000000001 111.901 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.01 169.66 26.76 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.091 -1.204 . . . . 0.42999999999999999 110.091 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HB2' ' OE2' ' A' ' 59' ' ' GLU . 10.6 ptmm? -144.12 135.02 25.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.632 0.716 . . . . 1.72 111.22 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 52.9 mt -139.98 138.22 19.3 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.723 -0.671 . . . . 0.72999999999999998 110.152 -173.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 4.2 Cg_exo -78.0 125.9 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.484 2.122 . . . . 0.56999999999999995 111.208 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -130.86 146.16 60.86 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.47 -0.567 . . . . 0.79000000000000004 109.47 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' HD13 ' A' ' 57' ' ' ILE . 20.0 Cg_exo -66.61 92.31 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.245 1.963 . . . . 0.57999999999999996 111.794 174.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.1 25.39 17.43 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.40000000000000002 112.267 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 82.6 p -70.39 119.84 15.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.741 -0.837 . . . . 0.62 108.741 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -141.18 -159.5 0.97 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.837 1.051 . . . . 1.1000000000000001 113.837 -159.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.46 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 60.5 mttm -52.16 -95.98 0.0 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.821 -1.081 . . . . 1.8400000000000001 112.801 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 168.84 113.44 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.862 -1.162 . . . . 0.98999999999999999 107.862 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.69 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 7.7 ptmm? 41.02 51.38 3.28 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.029 0.83 . . . . 1.8400000000000001 112.02 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.1 t70 -161.83 -171.42 2.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.024 -0.535 . . . . 0.64000000000000001 111.008 -169.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.635 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.2 ttm -112.27 118.68 35.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 1.3500000000000001 111.23 -169.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.0 t -106.36 144.45 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 0.77000000000000002 110.655 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.87 118.0 24.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.546 0.689 . . . . 0.47999999999999998 111.032 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 45' ' ' VAL . 6.4 tt -119.58 175.7 5.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.765 -1.198 . . . . 0.77000000000000002 107.765 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.402 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.5 m-20 -136.57 143.03 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.739 0.7 . . . . 1.8100000000000001 111.799 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 41.8 mm -113.66 130.18 24.01 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.173 -1.417 . . . . 0.65000000000000002 107.173 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.565 ' O ' HD22 ' A' ' 42' ' ' LEU . 62.1 Cg_exo -50.42 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.344 2.696 . . . . 1.0700000000000001 114.36 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -163.4 91.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 O-C-N 122.112 -0.368 . . . . 0.46000000000000002 111.375 -176.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.3 p -127.34 103.19 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.085 1.143 . . . . 0.47999999999999998 114.085 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.504 ' CG2' HD23 ' A' ' 101' ' ' LEU . 2.5 p -154.52 99.61 2.45 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 120.718 -0.393 . . . . 1.0700000000000001 111.473 160.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 5.8 Cg_endo -49.88 137.72 35.15 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.192 1.928 . . . . 0.47999999999999998 112.506 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.597 ' H ' ' HA ' ' A' ' 38' ' ' SER . 21.6 t80 -53.81 -32.03 51.24 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.769 -0.65 . . . . 1.3100000000000001 111.45 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.8 m -53.21 -31.6 43.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 1.2 111.882 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 1.075 HG21 ' HA ' ' A' ' 71' ' ' ILE . 37.5 mm -76.27 -57.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.828 0.823 . . . . 0.51000000000000001 111.501 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.061 HD22 HD21 ' A' ' 104' ' ' LEU . 2.0 mm? -54.23 -26.68 29.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.393 -1.73 . . . . 1.0 110.827 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 99' ' ' SER . 79.1 t80 -64.56 -45.76 85.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.239 -1.346 . . . . 0.95999999999999996 108.568 177.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.05 -56.72 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.708 -0.678 . . . . 0.81999999999999995 111.799 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.061 HD21 HD22 ' A' ' 101' ' ' LEU . 2.2 pp -61.08 -52.72 63.75 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.129 0.788 . . . . 0.65000000000000002 113.129 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.431 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.6 -25.48 67.41 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.852 0.834 . . . . 0.42999999999999999 110.347 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 ttp180 -64.98 -52.15 57.77 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.671 -1.15 . . . . 1.8100000000000001 110.092 174.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.4 t70 -82.88 -52.83 6.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.55 0.691 . . . . 0.80000000000000004 112.342 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -85.34 -28.45 6.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 121.714 -0.616 . . . . 0.88 110.035 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.15 -20.67 80.02 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.705 -0.759 . . . . 0.38 111.499 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -49.35 -47.14 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.049 -1.463 . . . . 1.0900000000000001 107.049 165.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.7 m-20 -66.8 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 1.8700000000000001 109.761 162.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 178.17 -54.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.543 0.527 . . . . 1.1699999999999999 111.545 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.57 128.87 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.175 0.512 . . . . 2.1499999999999999 111.067 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.54 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.7 mp -112.67 155.94 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.668 -0.696 . . . . 0.39000000000000001 110.197 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -98.09 153.43 18.43 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.081 -0.711 . . . . 2.1099999999999999 109.081 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 61.3 m-85 -140.13 166.13 25.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.639 -0.874 . . . . 0.62 108.639 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.862 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 28.4 tt0 -157.0 137.45 13.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.871 0.367 . . . . 0.80000000000000004 110.925 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.666 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 14.2 tp -103.65 133.11 49.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.792 -0.64 . . . . 1.25 110.018 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.788 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -118.8 100.18 7.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.399 -0.963 . . . . 0.63 108.399 172.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 HG22 ' A' ' 60' ' ' ILE . 7.2 tp -112.21 114.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.195 0.521 . . . . 0.81000000000000005 111.207 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -91.8 142.53 16.1 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.644 -0.982 . . . . 0.26000000000000001 110.644 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.8 mm? -121.48 122.32 39.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.3 0.571 . . . . 1.2 112.469 -173.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.045 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.9 m -116.37 96.1 5.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.844 -1.071 . . . . 0.32000000000000001 108.994 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.643 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -108.1 140.86 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.367 -0.533 . . . . 0.97999999999999998 110.607 -175.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.64 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.1 m-20 -84.81 105.87 15.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.406 -0.961 . . . . 1.52 108.406 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.88 HD23 HG21 ' A' ' 55' ' ' ILE . 17.5 mt -111.07 143.38 28.23 Favored Pre-proline 0 C--O 1.219 -0.54 0 O-C-N 125.247 1.592 . . . . 1.28 109.158 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.4 -25.0 71.38 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.158 1.905 . . . . 0.73999999999999999 114.08 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.524 HG23 ' HE2' ' A' ' 51' ' ' TYR . 60.1 t -74.65 -58.64 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.846 0.684 . . . . 1.1200000000000001 112.846 -174.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.432 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 40.1 t -105.37 -2.85 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 122.798 1.285 . . . . 1.3500000000000001 109.523 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.48 -0.84 53.91 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 113.479 -1.691 . . . . 1.05 111.852 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.6 pt-20 -176.49 174.07 1.96 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.523 -0.547 . . . . 1.1599999999999999 109.523 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.549 ' HB2' HD12 ' A' ' 126' ' ' LEU . 8.3 t80 -170.74 124.07 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.337 -0.986 . . . . 1.9099999999999999 108.337 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.8 t -114.16 102.85 10.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.87 0.843 . . . . 1.1899999999999999 111.687 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.42 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.5 pp -127.96 144.99 53.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 0.5 110.137 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 58.6 Cg_endo -96.44 162.43 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.223 1.948 . . . . 0.45000000000000001 113.134 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.461 HG23 HG23 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -160.39 167.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.765 -1.198 . . . . 0.44 107.765 179.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.542 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 88.7 p -146.17 159.17 43.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.599 0.592 . . . . 0.88 112.599 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -151.0 109.83 3.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.851 -0.796 . . . . 0.95999999999999996 108.851 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.862 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -107.43 148.0 29.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 1.76 110.217 -179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.38 142.59 8.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.701 -0.762 . . . . 0.5 111.866 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -113.07 133.99 54.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.125 -0.538 . . . . 2.1000000000000001 110.391 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.49 174.96 7.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.525 -0.917 . . . . 0.76000000000000001 108.525 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -69.13 175.25 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.87 0.367 . . . . 3.5299999999999998 111.599 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.704 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.9 tp -57.15 136.37 80.72 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 1.23 111.694 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.704 ' HD2' HD12 ' A' ' 144' ' ' LEU . 72.5 Cg_endo . . . . . 0 CA--C 1.53 0.293 0 C-N-CA 123.523 2.815 . . . . 0.70999999999999996 112.902 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.223 -0.55 0 N-CA-C 116.973 1.549 . . . . 0.54000000000000004 116.973 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.667 ' O ' HG13 ' A' ' 45' ' ' VAL . 99.7 p -161.53 35.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.38 -2.082 . . . . 1.2 105.38 170.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' SER . 10.5 m -133.27 154.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.808 -1.996 . . . . 0.93000000000000005 108.39 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 7.8 t -173.17 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.365 0.416 . . . . 0.47999999999999998 111.933 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 4.4 t70 -164.41 156.44 16.34 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.117 -0.364 . . . . 1.6899999999999999 110.112 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -143.85 132.7 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.57 -0.53 . . . . 1.1399999999999999 109.57 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 23.2 m-20 -112.94 124.08 51.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.798 0.333 . . . . 1.8300000000000001 111.121 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -87.69 121.04 29.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.045 -0.525 . . . . 0.93999999999999995 109.737 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.5 -127.04 0.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.571 -0.529 . . . . 1.3300000000000001 109.571 171.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.683 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.6 p30 . . . . . 0 CA--C 1.515 -0.377 0 N-CA-C 112.419 0.526 . . . . 2.8500000000000001 112.419 -169.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.647 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 36.3 t . . . . . 0 N--CA 1.432 -1.362 0 N-CA-C 105.599 -2.0 . . . . 0.93999999999999995 105.599 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.113 HG23 HG13 ' A' ' 96' ' ' VAL . 13.8 m -129.29 179.55 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 109.356 -0.609 . . . . 0.85999999999999999 109.356 164.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 74.5 mt-10 -123.49 142.44 51.0 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.904 -0.718 . . . . 1.1899999999999999 112.4 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.808 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -123.39 104.16 8.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.124 -0.944 . . . . 3.73 109.726 176.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -75.92 111.29 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.971 -1.122 . . . . 0.81000000000000005 107.971 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.68 109.7 21.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.697 0.76 . . . . 0.41999999999999998 109.944 -175.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 28' ' ' ASP . 41.3 mmtm -83.68 123.53 29.92 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.702 -1.136 . . . . 2.6299999999999999 108.934 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 25' ' ' SER . 55.4 t -111.45 138.92 38.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.625 -0.716 . . . . 0.81999999999999995 111.118 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.611 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 3.5 m -133.93 100.0 4.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.368 0.604 . . . . 0.71999999999999997 110.16 168.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.9 t -82.38 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.115 -0.948 . . . . 1.1399999999999999 111.011 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 3.2 m -109.59 109.59 20.4 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.318 -0.623 . . . . 0.40999999999999998 109.318 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -96.8 125.44 46.6 Favored Pre-proline 0 C--O 1.24 0.563 0 O-C-N 124.28 0.987 . . . . 1.48 109.404 175.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 18.1 Cg_endo -112.32 39.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.4 3.4 . . . . 0.72999999999999998 116.513 -169.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 10.7 t80 -116.32 -10.82 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.03 1.287 . . . . 2.0800000000000001 112.18 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.615 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 54.4 p 86.91 26.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.837 1.655 . . . . 1.51 109.401 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -147.46 123.67 10.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.265 -1.334 . . . . 1.6699999999999999 109.297 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.816 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.0 m -49.03 104.69 0.07 Allowed 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 122.926 0.49 . . . . 1.3899999999999999 112.045 172.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.944 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.65 170.52 14.85 Favored Pre-proline 0 C--O 1.209 -1.07 0 N-CA-C 108.161 -1.051 . . . . 1.03 108.161 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.6 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.3 Cg_endo -92.87 -63.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.731 1.621 . . . . 0.37 114.395 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 79' ' ' PRO . 12.4 mm -128.29 160.62 38.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 121.079 -0.248 . . . . 1.23 110.721 -167.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.576 ' CB ' HG22 ' A' ' 124' ' ' ILE . 25.6 p -156.58 -177.52 6.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 122.116 0.96 . . . . 1.1499999999999999 112.772 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.074 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 26.2 tt0 -133.04 117.1 17.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.184 -1.825 . . . . 1.3600000000000001 109.845 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.746 HG22 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -97.26 109.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 121.997 0.903 . . . . 1.05 109.018 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 19.4 p -112.76 102.76 10.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.005 -1.452 . . . . 0.82999999999999996 108.908 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 4.6 p90 -112.07 124.9 53.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.467 -0.568 . . . . 0.40000000000000002 109.467 -168.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 6.6 m -121.9 106.11 10.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.21 -0.904 . . . . 0.38 108.703 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 86.1 m-85 -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.935 -0.395 . . . . 0.95999999999999996 109.935 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.406 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 8.2 m170 -126.78 144.53 50.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.569 -0.9 . . . . 1.29 108.569 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.489 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.48 -112.75 0.16 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.298 177.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.31 -51.18 64.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.684 -0.858 . . . . 0.35999999999999999 108.684 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.456 ' H ' HH11 ' A' ' 69' ' ' ARG . . . -161.58 12.74 0.13 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.405 -1.078 . . . . 0.39000000000000001 110.405 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.613 ' HE ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -112.62 -164.99 0.95 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 -175.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.92 98.23 7.74 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.259 0.552 . . . . 2.6099999999999999 109.868 -169.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.938 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -52.25 -34.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.145 -0.934 . . . . 0.40000000000000002 110.358 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.74 170.9 27.11 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.823 -0.911 . . . . 0.48999999999999999 110.823 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.09 163.98 23.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.011 0.906 . . . . 1.8100000000000001 111.691 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.72 170.42 34.15 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.318 -0.856 . . . . 0.42999999999999999 110.995 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 133.68 27.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.936 0.398 . . . . 1.72 110.734 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.69 123.13 17.1 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.049 -0.523 . . . . 0.72999999999999998 110.457 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.8 116.16 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.427 2.084 . . . . 0.56999999999999995 110.713 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.85 140.48 37.82 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 121.17 -0.212 . . . . 0.79000000000000004 110.501 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HA ' HD13 ' A' ' 57' ' ' ILE . 21.1 Cg_endo -61.26 88.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.821 2.347 . . . . 0.57999999999999996 112.46 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.56 43.08 2.77 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.802 -0.636 . . . . 0.40000000000000002 111.801 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.944 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.6 p -74.08 121.9 21.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.878 -0.415 . . . . 0.62 109.878 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.816 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -164.66 170.69 15.34 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.41 1.633 . . . . 1.1000000000000001 115.41 -163.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.881 ' HG3' ' HB3' ' A' ' 86' ' ' ASP . 71.4 mmtt 7.57 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.859 1.664 . . . . 1.8400000000000001 114.031 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . 172.0 -44.23 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.622 -1.992 . . . . 0.98999999999999999 105.622 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.6 ttpt -159.65 71.08 0.48 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 112.131 -2.304 . . . . 1.8400000000000001 110.162 173.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.881 ' HB3' ' HG3' ' A' ' 83' ' ' LYS . 6.9 t70 -162.24 -161.66 0.76 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.011 -1.45 . . . . 0.64000000000000001 108.809 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.601 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 47.9 ttm -121.3 122.16 39.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.858 -0.423 . . . . 1.3500000000000001 109.858 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 46' ' ' SER . 2.7 t -104.45 143.04 33.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.119 -0.492 . . . . 0.77000000000000002 109.709 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.93 123.35 31.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.47999999999999998 110.781 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.604 HD22 HG11 ' A' ' 45' ' ' VAL . 8.7 tt -130.64 164.5 24.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.137 -1.431 . . . . 0.77000000000000002 107.137 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.65 142.28 32.04 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.173 -1.011 . . . . 1.8100000000000001 111.764 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 35.3 mm -100.83 143.39 26.49 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.724 -1.213 . . . . 0.65000000000000002 107.724 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 42' ' ' LEU . 81.9 Cg_exo -48.15 -107.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.212 2.608 . . . . 1.0700000000000001 114.0 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.41 94.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 O-C-N 121.617 -0.677 . . . . 0.46000000000000002 111.979 -172.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.504 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.4 p -127.49 103.02 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.581 1.326 . . . . 0.47999999999999998 114.581 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 1.113 HG13 HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -151.98 112.89 2.9 Favored Pre-proline 0 C--O 1.219 -0.517 0 O-C-N 121.712 -0.618 . . . . 1.0700000000000001 110.332 157.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 4.8 Cg_endo -53.98 135.16 62.73 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.38 1.387 . . . . 0.47999999999999998 111.619 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.647 ' H ' ' HA ' ' A' ' 38' ' ' SER . 22.8 t80 -55.58 -30.7 61.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.762 -0.654 . . . . 1.3100000000000001 110.912 -177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.687 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.2 p -58.14 -28.78 65.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.995 -0.548 . . . . 1.2 112.32 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 mm -77.51 -52.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.031 -0.418 . . . . 0.51000000000000001 111.014 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.089 HD23 HD21 ' A' ' 104' ' ' LEU . 21.3 mt -50.75 -27.01 6.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.5 0.666 . . . . 1.0 110.185 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.687 ' HB3' ' O ' ' A' ' 99' ' ' SER . 46.9 t80 -63.81 -42.5 97.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.472 -1.24 . . . . 0.95999999999999996 108.917 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.671 ' HA ' HH21 ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.24 -57.59 3.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.665 -0.698 . . . . 0.81999999999999995 111.789 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.089 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -57.36 -50.13 73.93 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.926 0.714 . . . . 0.65000000000000002 112.926 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 104' ' ' LEU . . . -68.95 -26.72 65.2 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.497 0.665 . . . . 0.42999999999999999 110.274 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.671 HH21 ' HA ' ' A' ' 103' ' ' ASN . 2.7 ttp180 -68.0 -54.49 18.12 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.238 -0.892 . . . . 1.8100000000000001 110.222 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.64 -53.93 6.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.80000000000000004 111.277 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.632 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.6 t -89.05 -28.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.415 -0.514 . . . . 0.88 110.57 -174.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 144' ' ' LEU . . . -68.33 -25.29 74.77 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.063 -1.065 . . . . 0.38 111.416 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -53.7 -46.77 62.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.475 -1.305 . . . . 1.0900000000000001 107.475 168.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 15.2 m-20 -68.01 -61.28 1.94 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.712 0.634 . . . . 1.8700000000000001 112.712 169.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.435 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER 153.48 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.209 1.004 . . . . 1.1699999999999999 113.593 -173.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -92.5 128.82 38.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.101 0.56 . . . . 2.1499999999999999 111.006 -173.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' HB2' ' A' ' 104' ' ' LEU . 3.3 mp -110.69 155.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.842 -0.429 . . . . 0.39000000000000001 109.842 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 15.1 p-10 -98.41 153.05 18.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.988 -0.745 . . . . 2.1099999999999999 108.988 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 74.4 m-85 -143.62 165.44 27.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.62 108.696 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.715 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.5 tt0 -153.16 135.94 15.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 0.80000000000000004 110.307 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.601 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 11.4 tp -104.72 130.76 52.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.821 -0.437 . . . . 1.25 109.821 171.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -117.16 100.29 7.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.469 -0.937 . . . . 0.63 108.469 176.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -119.94 120.42 63.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.617 0.722 . . . . 0.81000000000000005 111.137 -171.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.77 129.13 9.47 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.228 -0.896 . . . . 0.26000000000000001 112.101 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.566 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.8 mp -100.84 92.98 5.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 1.2 110.907 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.074 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.5 m -94.18 95.93 9.28 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.942 -0.762 . . . . 0.32000000000000001 108.942 172.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.576 HG22 ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.93 137.84 43.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.148 -0.621 . . . . 0.97999999999999998 110.761 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.467 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 7.2 t70 -79.52 106.74 11.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.799 -1.186 . . . . 1.52 107.799 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.458 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 6.7 mt -113.5 166.05 12.07 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.467 -0.788 . . . . 1.28 110.648 -171.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.24 -16.76 15.35 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 121.914 1.743 . . . . 0.73999999999999999 111.867 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.416 HG22 ' CZ ' ' A' ' 51' ' ' TYR . 3.0 t -75.18 -59.7 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.433 0.531 . . . . 1.1200000000000001 112.433 -174.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 131' ' ' GLU . 2.8 t -111.7 -0.2 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 122.643 1.211 . . . . 1.3500000000000001 108.891 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 80.48 -28.62 2.68 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 113.453 -1.703 . . . . 1.05 111.267 -170.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.8 pt-20 -175.35 143.69 0.66 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.087 -1.079 . . . . 1.1599999999999999 108.087 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.5 t80 -155.7 145.47 21.28 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.638 -0.504 . . . . 1.9099999999999999 109.638 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.6 t -113.23 107.94 16.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.581 0.705 . . . . 1.1899999999999999 110.922 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.5 pp -115.12 128.29 26.07 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.701 -0.852 . . . . 0.5 108.701 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 19.6 Cg_endo -89.3 160.02 5.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 121.759 1.64 . . . . 0.45000000000000001 112.735 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.53 166.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.972 -1.122 . . . . 0.44 107.972 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.1 m -139.98 153.19 46.81 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.782 -0.367 . . . . 0.88 111.304 -168.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.0 t -143.84 105.72 4.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.269 -1.011 . . . . 0.95999999999999996 108.269 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.29 149.07 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.627 -0.26 . . . . 1.76 110.788 -176.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.04 148.19 16.28 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.517 -0.849 . . . . 0.5 112.131 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -106.1 124.48 49.64 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.807 -0.812 . . . . 2.1000000000000001 108.807 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.43 173.07 13.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.238 -0.653 . . . . 0.76000000000000001 109.238 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -55.39 160.3 2.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.543 0.687 . . . . 3.5299999999999998 112.358 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.716 HD12 ' HD2' ' A' ' 145' ' ' PRO . 24.6 tp -56.29 134.78 75.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.776 -1.102 . . . . 1.23 110.658 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.716 ' HD2' HD12 ' A' ' 144' ' ' LEU . 35.5 Cg_endo . . . . . 0 C--N 1.344 0.297 0 C-N-CA 122.787 2.325 . . . . 0.70999999999999996 111.524 176.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.445 -0.712 0 N-CA-C 115.976 1.151 . . . . 0.54000000000000004 115.976 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.67 ' OG ' HD11 ' A' ' 122' ' ' LEU . 79.6 p -162.15 31.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.964 -1.495 . . . . 1.2 106.964 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.7 m -132.79 153.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.209 -1.36 . . . . 0.93000000000000005 109.665 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.46 -43.89 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.782 0.676 . . . . 0.47999999999999998 110.407 169.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -169.67 145.27 3.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 122.287 -0.258 . . . . 1.6899999999999999 110.518 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 96.5 t -119.05 132.74 68.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.387 -0.597 . . . . 1.1399999999999999 109.387 173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.92 137.19 54.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.87 0.367 . . . . 1.8300000000000001 111.147 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.58 126.06 38.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.853 -0.612 . . . . 0.93999999999999995 111.532 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -130.66 -131.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.774 -0.825 . . . . 1.3300000000000001 108.774 167.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.938 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.2 p-10 . . . . . 0 N--CA 1.471 0.615 0 CA-C-N 119.239 0.927 . . . . 2.8500000000000001 111.83 -171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.623 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 14.3 m . . . . . 0 N--CA 1.425 -1.705 0 N-CA-C 106.33 -1.73 . . . . 0.93999999999999995 106.33 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 33' ' ' ASP . 28.4 t -130.64 165.56 30.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.381 -0.97 . . . . 0.85999999999999999 108.381 167.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.769 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 2.8 mt-10 -125.25 139.37 53.78 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.381 0.61 . . . . 1.1899999999999999 111.528 -172.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.3 106.57 9.95 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.15 -0.932 . . . . 3.73 109.746 -176.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 4.8 tt -88.72 111.8 22.41 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.445 -1.302 . . . . 0.81000000000000005 109.892 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.71 116.82 30.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.201 -0.909 . . . . 0.41999999999999998 109.65 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -83.35 131.62 35.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.453 -0.943 . . . . 2.6299999999999999 108.453 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 25' ' ' SER . 44.5 t -111.17 142.08 24.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.115 -0.948 . . . . 0.81999999999999995 110.92 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.7 m -131.79 99.45 4.77 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.006 0.431 . . . . 0.71999999999999997 109.905 167.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 62.2 t -82.46 127.9 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.576 -0.738 . . . . 1.1399999999999999 110.537 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 5.9 m -107.79 113.82 27.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.293 -0.632 . . . . 0.40999999999999998 109.293 176.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.868 ' HB3' HD21 ' A' ' 82' ' ' LEU . 29.3 p-10 -90.54 140.23 26.7 Favored Pre-proline 0 N--CA 1.461 0.117 0 O-C-N 123.864 0.727 . . . . 1.48 110.164 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.52 ' HD2' HD21 ' A' ' 126' ' ' LEU . 66.9 Cg_endo -96.36 6.22 1.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.891 3.061 . . . . 0.72999999999999998 115.399 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.714 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 24.4 t80 -97.18 -113.03 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.855 -0.738 . . . . 2.0800000000000001 110.08 -172.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.736 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 77.5 p 179.98 19.66 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 117.964 0.347 . . . . 1.51 111.263 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -139.09 19.86 2.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.736 0.643 . . . . 1.6699999999999999 112.736 -168.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 31.7 t 57.79 96.57 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 111.955 0.354 . . . . 1.3899999999999999 111.955 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.917 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -73.94 170.71 13.36 Favored Pre-proline 0 C--O 1.209 -1.055 0 N-CA-C 108.62 -0.881 . . . . 1.03 108.62 -172.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.0 Cg_endo -92.79 -61.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.797 1.665 . . . . 0.37 113.935 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.677 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.0 mm -125.95 154.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.217 -0.593 . . . . 1.23 111.479 -166.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 124' ' ' ILE . 26.4 m -145.16 176.43 9.52 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.083 0.944 . . . . 1.1499999999999999 111.475 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.066 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 2.4 tm-20 -141.86 114.39 8.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.565 -1.652 . . . . 1.3600000000000001 109.885 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.521 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -103.31 121.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.387 1.089 . . . . 1.05 112.307 173.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.743 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.41 109.66 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.107 -1.861 . . . . 0.82999999999999996 109.74 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.0 p90 -114.06 122.82 48.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.141 0.496 . . . . 0.40000000000000002 110.129 -169.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 26.8 m -122.07 109.61 14.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.524 -0.762 . . . . 0.38 109.586 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 118' ' ' LEU . 97.9 m-85 -98.6 141.2 31.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.036 -0.529 . . . . 0.95999999999999996 110.707 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.431 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.3 m170 -131.94 145.74 51.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.64 -1.245 . . . . 1.29 107.64 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.94 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.9 t -109.98 -100.32 0.39 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.196 -1.002 . . . . 1.27 111.025 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.71 -56.8 16.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.231 -0.655 . . . . 0.35999999999999999 109.231 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 18.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.589 -1.404 . . . . 0.39000000000000001 109.589 162.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 7.9 ptp180 -105.85 -156.56 0.58 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.738 -0.838 . . . . 1.97 108.738 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.16 94.98 4.78 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.709 0.686 . . . . 2.6099999999999999 110.098 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.888 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -56.55 -39.25 61.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.904 -1.043 . . . . 0.40000000000000002 110.892 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.58 169.26 34.25 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.328 -0.939 . . . . 0.48999999999999999 111.458 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.08 164.63 15.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.668 0.734 . . . . 1.8100000000000001 111.028 173.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.16 167.89 34.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.885 -0.886 . . . . 0.42999999999999999 110.885 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.743 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.3 mtpt -130.43 131.5 45.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.026 -0.361 . . . . 1.72 110.026 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -133.85 105.14 11.65 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.863 0.363 . . . . 0.72999999999999998 110.483 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 11.9 Cg_exo -71.25 101.62 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.359 2.039 . . . . 0.56999999999999995 110.428 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.28 143.57 29.1 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.606 -0.516 . . . . 0.79000000000000004 109.606 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HA ' HD13 ' A' ' 57' ' ' ILE . 32.5 Cg_exo -62.38 78.78 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.308 2.005 . . . . 0.57999999999999996 111.957 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.522 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 46.7 3.58 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.40000000000000002 112.197 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.917 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 92.9 p -73.55 119.23 17.49 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.361 -0.607 . . . . 0.62 109.361 173.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 49' ' ' ASN . 2.2 pt? -153.03 163.9 38.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 119.191 -1.004 . . . . 1.1000000000000001 113.241 -164.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 54' ' ' SER . 50.5 mttm -16.49 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.756 -1.565 . . . . 1.8400000000000001 114.417 -168.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 165.5 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.608 -1.256 . . . . 0.98999999999999999 107.608 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 37.5 pttt 42.32 52.08 4.62 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.197 0.935 . . . . 1.8400000000000001 110.893 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.5 t70 -152.56 -166.94 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.288 -0.869 . . . . 0.64000000000000001 110.356 -173.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 47.3 ttm -125.24 117.73 24.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.102 0.477 . . . . 1.3500000000000001 110.944 -170.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -105.87 144.68 32.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.394 -0.821 . . . . 0.77000000000000002 110.113 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.75 129.17 35.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.26 0.553 . . . . 0.47999999999999998 110.927 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -135.25 174.18 10.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.246 -1.02 . . . . 0.77000000000000002 108.246 -176.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 5.8 p-10 -142.72 139.48 31.12 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.736 0.698 . . . . 1.8100000000000001 112.059 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.5 mm -109.03 115.97 56.18 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.783 -0.821 . . . . 0.65000000000000002 108.783 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.7 Cg_exo -28.76 -102.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.405 4.07 . . . . 1.0700000000000001 115.534 -173.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -164.88 95.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 O-C-N 122.266 -0.271 . . . . 0.46000000000000002 111.474 -175.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.541 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.5 p -128.67 104.8 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.012 1.486 . . . . 0.47999999999999998 115.012 -172.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -154.4 99.57 2.47 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.601 -0.687 . . . . 1.0700000000000001 111.335 161.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.9 Cg_exo -51.78 134.65 48.32 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.014 1.809 . . . . 0.47999999999999998 111.572 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.623 ' H ' ' HA ' ' A' ' 38' ' ' SER . 52.7 t80 -54.93 -36.9 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 1.3100000000000001 111.635 -172.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 15.0 m -53.88 -30.97 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.377 . . . . 1.2 111.639 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.888 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 mm -76.82 -56.0 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.431 -0.508 . . . . 0.51000000000000001 110.983 -175.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 104' ' ' LEU . 30.6 mt -53.84 -28.25 34.66 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.699 0.625 . . . . 1.0 110.53 174.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.5 t80 -62.4 -42.45 99.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.413 -1.267 . . . . 0.95999999999999996 109.206 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.414 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.6 m-80 -74.66 -58.26 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.171 0.434 . . . . 0.81999999999999995 112.171 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.94 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.8 pp -60.85 -48.83 80.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.665 0.987 . . . . 0.65000000000000002 113.665 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -66.6 -25.59 66.69 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.852 0.834 . . . . 0.42999999999999999 109.574 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.414 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.1 ttp180 -68.06 -48.82 64.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.554 -1.203 . . . . 1.8100000000000001 110.451 172.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.646 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 30.1 t70 -81.36 -54.31 5.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.649 0.738 . . . . 0.80000000000000004 112.164 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.9 t -87.33 -25.64 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.726 -0.609 . . . . 0.88 110.069 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.03 -20.84 80.13 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.717 -0.754 . . . . 0.38 111.309 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -49.99 -48.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.732 -1.581 . . . . 1.0900000000000001 106.732 165.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.4 ' N ' HG12 ' A' ' 110' ' ' VAL . 30.3 t70 -69.02 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.38 -0.827 . . . . 1.8700000000000001 109.992 164.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 178.41 -48.19 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.187 0.44 . . . . 1.1699999999999999 112.187 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -92.76 124.13 36.54 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.012 -0.366 . . . . 2.1499999999999999 110.012 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -111.7 154.24 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.846 -0.798 . . . . 0.39000000000000001 108.846 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 152.78 19.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.985 -0.746 . . . . 2.1099999999999999 108.985 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 57.4 m-85 -140.52 162.73 34.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.915 -0.772 . . . . 0.62 108.915 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.767 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.6 tt0 -151.05 133.57 15.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.947 0.403 . . . . 0.80000000000000004 110.221 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.6 OUTLIER -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.301 -0.629 . . . . 1.25 109.301 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.687 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.75 103.31 10.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.165 -0.68 . . . . 0.63 109.165 176.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 136' ' ' ILE . 8.4 tp -110.01 120.41 61.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.81000000000000005 110.934 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.94 131.03 10.52 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.196 -0.762 . . . . 0.26000000000000001 111.196 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 133' ' ' THR . 7.5 mp -108.23 106.22 16.3 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 120.926 0.393 . . . . 1.2 111.055 -176.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.066 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 81.4 m -109.0 96.6 6.43 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.314 -0.857 . . . . 0.32000000000000001 109.478 173.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.674 HG22 ' SG ' ' A' ' 58' ' ' CYS . 19.5 pt -112.37 131.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.469 -0.492 . . . . 0.97999999999999998 110.918 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.83 105.84 9.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.377 -0.601 . . . . 1.52 109.377 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 55' ' ' ILE . 83.3 mt -106.52 160.63 25.56 Favored Pre-proline 0 C--O 1.22 -0.456 0 O-C-N 124.81 1.318 . . . . 1.28 109.971 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.9 Cg_exo -68.97 -34.34 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.832 1.688 . . . . 0.73999999999999999 113.434 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.34 -57.88 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.316 0.487 . . . . 1.1200000000000001 112.316 -171.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.677 ' HB ' ' O ' ' A' ' 131' ' ' GLU . 0.1 OUTLIER -96.19 -7.21 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 122.046 0.927 . . . . 1.3500000000000001 109.834 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.56 -28.55 2.72 Favored Glycine 0 C--N 1.311 -0.817 0 CA-C-N 113.626 -1.624 . . . . 1.05 111.16 -171.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.677 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.5 pt-20 -162.83 155.83 19.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.473 -0.936 . . . . 1.1599999999999999 108.473 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.471 ' HB2' HD12 ' A' ' 126' ' ' LEU . 31.2 t80 -143.04 122.19 12.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.222 -0.659 . . . . 1.9099999999999999 109.222 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.8 m -115.06 102.09 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.139 0.495 . . . . 1.1899999999999999 111.763 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.08 144.36 50.21 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.015 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.91 164.1 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.885 1.723 . . . . 0.45000000000000001 113.162 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -156.22 158.53 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.734 -1.21 . . . . 0.44 107.734 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.679 ' H ' HD12 ' A' ' 136' ' ' ILE . 83.0 p -140.59 152.58 45.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.627 -0.429 . . . . 0.88 111.827 -172.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -140.84 102.69 4.34 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.553 -1.276 . . . . 0.95999999999999996 107.553 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.767 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -114.6 143.99 44.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.1 -0.5 . . . . 1.76 109.986 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.32 151.61 21.62 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.595 -0.812 . . . . 0.5 112.017 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -106.3 130.36 54.16 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.941 -0.763 . . . . 2.1000000000000001 108.941 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.89 174.1 4.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.24 -1.022 . . . . 0.76000000000000001 108.24 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 3.7 mppt? -65.6 163.82 15.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 3.5299999999999998 112.154 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' ILE . 22.7 tp -55.49 131.23 70.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 114.903 -1.044 . . . . 1.23 111.076 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 144' ' ' LEU . 40.9 Cg_endo . . . . . 0 C--N 1.343 0.261 0 C-N-CA 123.093 2.529 . . . . 0.70999999999999996 112.869 -179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.681 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.408 -3.174 0 N-CA-C 111.939 -0.465 . . . . 0.54000000000000004 111.939 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 122' ' ' LEU . 17.3 m -171.1 32.33 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.895 0.855 . . . . 1.2 108.894 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.3 m -133.29 148.29 31.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.863 -1.062 . . . . 0.93000000000000005 109.969 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -169.76 -44.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.46 0.475 . . . . 0.47999999999999998 111.793 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 8.7 t70 -157.4 153.59 27.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.77 -0.372 . . . . 1.6899999999999999 111.183 -174.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.17 120.31 8.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.646 -0.502 . . . . 1.1399999999999999 109.646 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -113.96 112.15 22.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 1.8300000000000001 111.476 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.879 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.2 tm? -72.87 139.02 46.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.963 -0.562 . . . . 0.93999999999999995 109.99 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.54 ' H ' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -141.99 -100.16 0.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.255 0.835 . . . . 1.3300000000000001 113.255 -176.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.52 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 18.1 m-20 . . . . . 0 CA--C 1.493 -1.229 0 O-C-N 121.911 -0.493 . . . . 2.8500000000000001 109.809 -154.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 6.3 t . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 120.913 0.387 . . . . 0.93999999999999995 111.57 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.565 HG12 HD21 ' A' ' 31' ' ' LEU . 24.2 t -77.65 156.1 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.566 -0.901 . . . . 0.85999999999999999 108.566 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.899 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -137.17 145.64 43.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 119.516 -0.874 . . . . 1.1899999999999999 109.368 -173.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.936 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.7 p90 -143.11 141.53 31.25 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.306 -0.958 . . . . 3.73 112.575 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.1 tm? -82.45 110.88 17.97 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.425 -0.954 . . . . 0.81000000000000005 108.425 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.5 100.33 13.11 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.41999999999999998 109.016 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 23.8 ttmm -83.58 126.0 32.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.626 0.727 . . . . 2.6299999999999999 109.109 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 25' ' ' SER . 37.4 t -109.51 144.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.725 -1.125 . . . . 0.81999999999999995 110.481 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.456 ' HB3' ' CG ' ' A' ' 87' ' ' MET . 14.7 m -128.85 97.4 4.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.576 -0.898 . . . . 0.71999999999999997 108.576 165.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.681 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -86.96 130.69 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.676 0.751 . . . . 1.1399999999999999 111.173 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.5 ' H ' ' HA3' ' A' ' 24' ' ' GLY . 32.1 m -116.88 114.99 24.66 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.344 -1.298 . . . . 0.40999999999999998 109.447 -173.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.75 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.3 t30 -90.76 133.21 32.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 108.108 -1.071 . . . . 1.48 108.108 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -90.9 8.29 3.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.103 2.536 . . . . 0.72999999999999998 114.169 -174.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 49.2 t80 -119.0 139.14 52.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.949 -0.76 . . . . 2.0800000000000001 108.949 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.7 p -79.13 37.81 0.33 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.659 0.614 . . . . 1.51 112.659 -164.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -146.25 130.58 17.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.271 -0.422 . . . . 1.6699999999999999 110.056 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 m -43.5 100.76 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 124.116 0.966 . . . . 1.3899999999999999 112.719 172.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.997 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.8 pt -75.55 171.97 10.49 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.431 -0.951 . . . . 1.03 108.431 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 8.0 Cg_endo -87.98 -59.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.498 1.465 . . . . 0.37 114.026 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.883 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 80.0 mt -137.38 155.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.669 0.618 . . . . 1.23 112.669 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -138.0 -178.99 5.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.731 0.777 . . . . 1.1499999999999999 111.211 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.2 tt0 -141.78 115.5 9.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.99 -1.459 . . . . 1.3600000000000001 109.982 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.1 109.93 23.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.697 -1.592 . . . . 1.05 109.951 173.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 8.5 m -110.97 102.58 11.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.87 -1.514 . . . . 0.82999999999999996 108.586 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.791 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 3.8 p90 -109.79 122.33 47.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.506 . . . . 0.40000000000000002 109.733 -168.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 93.9 m -121.03 104.91 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.511 -0.768 . . . . 0.38 109.4 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CE1' HD23 ' A' ' 118' ' ' LEU . 98.9 m-85 -98.14 140.99 31.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.952 -0.567 . . . . 0.95999999999999996 111.148 -174.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -132.4 145.23 51.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.636 -1.246 . . . . 1.29 107.636 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.9 t -110.75 -98.03 0.41 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.317 -0.953 . . . . 1.27 111.062 172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.95 -59.75 4.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.386 -0.598 . . . . 0.35999999999999999 109.386 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.87 18.05 0.1 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.478 -1.449 . . . . 0.39000000000000001 109.478 165.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -111.04 -166.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.119 -0.697 . . . . 1.97 109.119 -177.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -108.16 98.49 8.03 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.919 0.866 . . . . 2.6099999999999999 109.689 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -64.57 -41.6 92.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.976 -1.465 . . . . 0.40000000000000002 111.276 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 164.75 38.25 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.217 -0.992 . . . . 0.48999999999999999 111.266 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.38 156.84 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.482 0.641 . . . . 1.8100000000000001 110.991 172.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 165.27 160.77 13.02 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.722 -0.951 . . . . 0.42999999999999999 110.722 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 3.7 ptmm? -136.95 130.74 32.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.968 0.414 . . . . 1.72 110.0 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.0 mt -134.47 120.13 14.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 0.72999999999999998 110.375 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.87 115.34 3.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.328 2.019 . . . . 0.56999999999999995 110.537 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.12 143.35 42.33 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.698 -0.852 . . . . 0.79000000000000004 108.698 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -51.86 90.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.804 2.336 . . . . 0.57999999999999996 112.16 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.883 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -81.99 24.66 4.49 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.40000000000000002 112.585 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.997 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 70.7 p -73.81 117.73 15.93 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.438 -0.579 . . . . 0.62 109.438 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.659 HD21 HD22 ' A' ' 49' ' ' ASN . 1.2 pt? -149.41 -171.33 3.86 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.096 -1.442 . . . . 1.1000000000000001 114.264 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 60.5 mttm -44.77 -96.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.912 -1.04 . . . . 1.8400000000000001 113.54 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 175.5 105.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.059 -1.089 . . . . 0.98999999999999999 108.059 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.9 ptpt 41.77 50.44 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.339 1.024 . . . . 1.8400000000000001 110.842 -170.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 3.5 t0 -143.63 179.93 6.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 110.122 -170.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.456 ' CG ' ' HB3' ' A' ' 46' ' ' SER . 54.3 ttp -107.74 119.13 38.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.609 -0.723 . . . . 1.3500000000000001 110.63 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.6 HG22 HG13 ' A' ' 47' ' ' VAL . 5.1 t -106.27 142.82 35.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.05 -0.523 . . . . 0.77000000000000002 109.633 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 123.77 30.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.549 0.69 . . . . 0.47999999999999998 110.608 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 91' ' ' ASP . 9.0 tt -124.61 160.73 27.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.897 -1.149 . . . . 0.77000000000000002 107.897 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.412 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.0 m-20 -134.05 122.37 22.88 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.627 -0.67 . . . . 1.8100000000000001 111.407 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 32.8 mm -92.56 143.27 26.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.65000000000000002 109.644 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 92' ' ' ILE . 75.8 Cg_exo -51.91 -172.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.924 2.416 . . . . 1.0700000000000001 113.266 173.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.936 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 7.1 m -114.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.72 -0.673 . . . . 0.46000000000000002 110.549 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 95' ' ' VAL . 4.7 p -125.76 102.51 10.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.144 1.535 . . . . 0.47999999999999998 115.144 -161.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.659 HG21 ' HG ' ' A' ' 101' ' ' LEU . 2.5 p -152.24 102.74 2.78 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.157 -0.474 . . . . 1.0700000000000001 111.045 163.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 74.1 Cg_exo -48.89 131.61 25.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.721 1.614 . . . . 0.47999999999999998 111.398 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.579 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 4.7 t80 -49.43 -35.0 17.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.734 -0.666 . . . . 1.3100000000000001 111.081 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 12.1 t -62.92 -30.19 71.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 1.2 112.237 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.5 mm -76.78 -54.27 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 121.749 -0.594 . . . . 0.51000000000000001 110.686 -173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.053 HD23 HD21 ' A' ' 104' ' ' LEU . 36.6 mt -53.84 -26.91 26.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.439 0.638 . . . . 1.0 110.518 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.0 t80 -65.1 -41.45 94.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.466 -1.243 . . . . 0.95999999999999996 108.877 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' HH21 ' A' ' 106' ' ' ARG . 24.8 m-80 -74.27 -57.88 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.81999999999999995 112.263 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.053 HD21 HD23 ' A' ' 101' ' ' LEU . 2.1 pp -56.91 -49.66 74.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.23 0.826 . . . . 0.65000000000000002 113.23 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.538 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.16 -25.7 68.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.883 0.849 . . . . 0.42999999999999999 110.113 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.492 HH21 ' HA ' ' A' ' 103' ' ' ASN . 6.6 ttp180 -69.62 -50.77 41.19 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.655 -1.157 . . . . 1.8100000000000001 110.511 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 13.6 t70 -81.74 -54.83 5.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.78 0.8 . . . . 0.80000000000000004 111.94 -175.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -84.51 -27.67 6.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.594 -0.692 . . . . 0.88 109.964 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.775 ' HA3' HD21 ' A' ' 144' ' ' LEU . . . -73.01 -19.28 79.54 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.308 -0.948 . . . . 0.38 111.457 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -51.86 -44.89 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.794 -1.558 . . . . 1.0900000000000001 106.794 166.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m-20 -69.77 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.529 -0.76 . . . . 1.8700000000000001 110.025 161.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.817 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.1 p-90 176.91 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.687 0.617 . . . . 1.1699999999999999 111.715 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.06 129.76 42.02 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 122.304 -0.248 . . . . 2.1499999999999999 110.581 -174.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.695 HD11 HD23 ' A' ' 144' ' ' LEU . 3.0 mp -117.7 159.19 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.834 0.35 . . . . 0.39000000000000001 110.415 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 9.3 p-10 -102.96 153.34 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.982 -0.377 . . . . 2.1099999999999999 109.982 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.8 m-85 -140.09 165.91 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.869 -0.789 . . . . 0.62 108.869 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 35.4 tt0 -156.16 131.98 9.74 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.007 -0.368 . . . . 0.80000000000000004 110.007 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -103.69 123.85 47.78 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.006 -0.739 . . . . 1.25 109.006 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.79 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 8.4 tp60 -108.28 99.32 8.74 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.672 -0.862 . . . . 0.63 108.672 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 5.3 tp -106.58 119.36 55.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.259 0.552 . . . . 0.81000000000000005 110.834 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.53 127.05 8.3 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.879 -0.888 . . . . 0.26000000000000001 110.879 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.717 ' O ' ' HA ' ' A' ' 133' ' ' THR . 0.4 OUTLIER -98.42 104.32 16.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.457 0.303 . . . . 1.2 111.335 -174.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 57.9 m -109.83 95.12 5.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.044 -0.526 . . . . 0.32000000000000001 109.584 172.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 58' ' ' CYS . 11.5 pt -112.75 128.61 69.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 120.234 -0.586 . . . . 0.97999999999999998 110.28 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.854 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 22.7 t70 -81.88 106.02 13.47 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.796 -0.816 . . . . 1.52 108.796 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.971 HD23 HG21 ' A' ' 55' ' ' ILE . 29.1 mt -104.82 176.35 1.78 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 114.522 -1.217 . . . . 1.28 109.486 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 9.9 Cg_exo -76.18 -41.93 0.44 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.762 1.642 . . . . 0.73999999999999999 113.206 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.6 t -59.62 -58.93 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.06 0.763 . . . . 1.1200000000000001 113.06 -168.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . . . . . . . . . 2.4 t -109.8 -8.5 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.894 1.33 . . . . 1.3500000000000001 108.517 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.683 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 88.38 -143.24 17.8 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 112.413 -2.176 . . . . 1.05 108.132 -164.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 -60.74 128.9 38.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.111 0.482 . . . . 1.1599999999999999 110.02 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 123' ' ' THR . 15.9 t80 -124.31 145.33 49.48 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.826 -0.805 . . . . 1.9099999999999999 108.826 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 63.1 m -121.86 109.42 14.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.917 0.389 . . . . 1.1899999999999999 112.042 -173.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.5 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -127.33 144.04 49.34 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.021 -0.733 . . . . 0.5 109.021 171.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -93.31 162.45 2.48 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.863 1.709 . . . . 0.45000000000000001 113.341 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.14 167.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.935 -1.135 . . . . 0.44 107.935 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -133.07 148.67 52.19 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.791 -0.364 . . . . 0.88 111.258 -169.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.1 t -138.34 103.0 4.79 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.683 -1.228 . . . . 0.95999999999999996 107.683 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.644 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 14.4 ptmt -126.88 156.25 41.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.048 -0.524 . . . . 1.76 111.184 -171.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.92 150.78 17.29 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.594 -0.812 . . . . 0.5 111.634 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.5 mt-10 -98.71 124.88 43.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.741 -0.837 . . . . 2.1000000000000001 108.741 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.24 165.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.07 -1.085 . . . . 0.76000000000000001 108.07 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -67.45 178.2 1.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.496 0.665 . . . . 3.5299999999999998 112.289 -171.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.817 ' HG ' ' O ' ' A' ' 112' ' ' TRP . 5.9 mt -54.05 131.08 59.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.743 -1.117 . . . . 1.23 111.231 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.449 ' HD2' HD23 ' A' ' 144' ' ' LEU . 32.9 Cg_endo . . . . . 0 C--N 1.344 0.296 0 C-N-CA 123.16 2.573 . . . . 0.70999999999999996 112.021 178.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 C--O 1.22 -0.753 0 N-CA-C 116.094 1.198 . . . . 0.54000000000000004 116.094 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.649 ' O ' HG13 ' A' ' 45' ' ' VAL . 96.2 p -168.99 37.26 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.623 1.169 . . . . 1.2 107.979 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 46' ' ' SER . 4.5 m -134.02 151.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.512 -1.222 . . . . 0.93000000000000005 110.342 -169.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -167.58 -44.33 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.416 0.447 . . . . 0.47999999999999998 111.96 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -160.88 164.08 31.52 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.324 0.511 . . . . 1.6899999999999999 111.313 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.07 135.62 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.284 -0.635 . . . . 1.1399999999999999 109.284 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -129.0 135.64 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.648 0.261 . . . . 1.8300000000000001 111.249 -169.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.6 tm? -101.28 139.43 36.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.593 -0.276 . . . . 0.93999999999999995 111.371 -172.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -144.34 -90.81 0.11 Allowed 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 114.08 1.141 . . . . 1.3300000000000001 114.08 177.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.841 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.204 -1.334 0 O-C-N 121.587 -0.696 . . . . 2.8500000000000001 111.404 -155.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.404 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 10.8 t . . . . . 0 N--CA 1.434 -1.232 0 CA-C-O 122.364 1.078 . . . . 0.93999999999999995 112.351 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 1.039 HG21 HD12 ' A' ' 101' ' ' LEU . 46.2 t -73.11 155.42 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.636 -1.62 . . . . 0.85999999999999999 109.08 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 96.8 mt-10 -116.9 134.25 55.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 118.936 -1.106 . . . . 1.1899999999999999 112.383 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.819 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.36 105.13 10.61 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.905 -1.043 . . . . 3.73 110.718 -175.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.502 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -81.44 111.58 17.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.341 -0.985 . . . . 0.81000000000000005 108.341 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.98 117.34 32.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.551 0.691 . . . . 0.41999999999999998 110.904 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -84.8 120.64 26.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.214 -0.903 . . . . 2.6299999999999999 108.711 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 25' ' ' SER . 54.2 t -111.11 137.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.643 -0.708 . . . . 0.81999999999999995 111.033 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.8 m -130.5 100.07 5.21 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.771 -0.372 . . . . 0.71999999999999997 110.158 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 61.0 t -83.47 130.5 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.938 -0.574 . . . . 1.1399999999999999 110.737 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -104.74 122.69 46.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.743 -0.383 . . . . 0.40999999999999998 110.3 176.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.84 HD22 HD21 ' A' ' 82' ' ' LEU . 13.9 t-20 -88.17 133.52 36.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.86 1.35 . . . . 1.48 109.533 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -88.92 -17.02 2.15 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.105 2.537 . . . . 0.72999999999999998 115.746 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.743 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.2 t80 -98.42 -100.46 0.21 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.915 -1.114 . . . . 2.0800000000000001 111.386 -165.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.465 ' CB ' ' HD2' ' A' ' 85' ' ' LYS . 48.5 t -174.0 29.8 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.551 0.691 . . . . 1.51 109.788 171.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -147.92 133.18 18.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 1.6699999999999999 110.823 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -40.68 101.93 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.814 0 O-C-N 124.376 1.047 . . . . 1.3899999999999999 112.194 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 126' ' ' LEU . 7.6 pt -78.93 121.73 83.74 Favored Pre-proline 0 CA--C 1.5 -0.953 0 C-N-CA 120.071 -0.652 . . . . 1.03 109.5 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.945 ' HB2' HD12 ' A' ' 57' ' ' ILE . 28.1 Cg_endo -61.09 -56.5 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.174 1.916 . . . . 0.37 113.51 -157.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.945 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.2 mp -135.02 156.27 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.849 -0.74 . . . . 1.23 111.026 -173.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.646 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.7 p -145.04 178.43 8.05 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.386 1.089 . . . . 1.1499999999999999 111.856 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.137 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.9 tt0 -131.15 113.84 14.38 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.129 -1.85 . . . . 1.3600000000000001 109.046 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -98.9 110.62 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.515 1.15 . . . . 1.05 110.151 169.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 79.9 p -111.5 107.12 16.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.051 -1.886 . . . . 0.82999999999999996 108.228 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.1 p90 -113.92 132.6 55.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.6 0.714 . . . . 0.40000000000000002 110.222 -168.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 33.6 m -131.6 109.75 10.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.433 -1.258 . . . . 0.38 108.717 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CE1' HD23 ' A' ' 118' ' ' LEU . 94.5 m-85 -97.7 143.08 28.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.691 -0.485 . . . . 0.95999999999999996 109.691 -175.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -129.64 143.37 50.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.903 -0.777 . . . . 1.29 108.903 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.811 ' CB ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -101.3 -114.79 0.19 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.038 -0.528 . . . . 1.27 111.471 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -57.98 -52.49 65.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.573 -0.899 . . . . 0.35999999999999999 108.573 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.74 20.74 0.15 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.65 -1.38 . . . . 0.39000000000000001 109.65 164.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 6.2 ptp180 -117.86 -169.21 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.232 -0.655 . . . . 1.97 109.232 -174.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -107.71 98.33 7.94 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.325 0.583 . . . . 2.6099999999999999 109.741 -166.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -60.86 -42.96 94.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.404 -1.271 . . . . 0.40000000000000002 112.19 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.38 154.86 13.18 Favored Glycine 0 C--O 1.219 -0.789 0 C-N-CA 120.339 -0.934 . . . . 0.48999999999999999 111.686 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 ptmt -158.75 160.29 36.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.935 0.868 . . . . 1.8100000000000001 112.381 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.02 168.39 34.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.42999999999999999 111.545 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -127.8 133.35 49.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.944 -0.391 . . . . 1.72 109.944 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 73.8 mt -139.14 112.45 8.05 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.502 -0.317 . . . . 0.72999999999999998 110.884 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.79 113.53 3.68 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.117 1.878 . . . . 0.56999999999999995 110.938 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -133.92 144.97 53.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.47 -0.196 . . . . 0.79000000000000004 110.47 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.72 94.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.3 . . . . 0.57999999999999996 112.677 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -84.52 21.19 11.22 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.808 -0.633 . . . . 0.40000000000000002 112.586 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 96.2 p -70.25 118.98 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.452 -0.573 . . . . 0.62 109.452 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.84 HD21 HD22 ' A' ' 49' ' ' ASN . 1.9 pt? -141.98 -164.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 120.145 -0.622 . . . . 1.1000000000000001 112.393 -164.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 94.4 mttt -45.63 -89.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.038 0.755 . . . . 1.8400000000000001 113.038 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 156.5 111.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.437 -1.319 . . . . 0.98999999999999999 107.437 -168.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 8.2 ptmm? 45.54 46.07 10.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.003 0.814 . . . . 1.8400000000000001 111.5 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.2 t70 -155.05 -172.01 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.331 -0.849 . . . . 0.64000000000000001 109.501 -173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 43.3 ttp -114.79 127.57 55.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.106 0.479 . . . . 1.3500000000000001 110.831 -172.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.2 t -109.53 142.41 40.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.472 -0.785 . . . . 0.77000000000000002 110.025 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 108.41 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.38 0.61 . . . . 0.47999999999999998 110.949 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.782 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.7 tp -100.64 174.89 5.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.094 -0.957 . . . . 0.77000000000000002 109.131 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.782 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 21.4 t70 -141.71 121.6 13.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.769 -0.372 . . . . 1.8100000000000001 110.638 -173.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 24.5 mm -107.88 141.92 24.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.3 -0.409 . . . . 0.65000000000000002 110.324 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 92' ' ' ILE . 61.0 Cg_exo -54.62 -152.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.815 3.01 . . . . 1.0700000000000001 113.656 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.965 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.5 m -136.76 94.73 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 112.058 0.392 . . . . 0.46000000000000002 112.058 -165.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -125.38 106.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 113.841 1.052 . . . . 0.47999999999999998 113.841 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 9.6 t -147.17 102.08 3.82 Favored Pre-proline 0 C--O 1.219 -0.52 0 CA-C-N 115.941 -0.572 . . . . 1.0700000000000001 110.318 168.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.73 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 31.9 Cg_exo -57.1 124.38 16.08 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 CA-C-N 120.495 1.212 . . . . 0.47999999999999998 110.757 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.404 ' H ' ' HA ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -54.03 -29.91 45.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.019 -0.537 . . . . 1.3100000000000001 111.232 -175.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.1 m -53.0 -33.12 50.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 1.2 111.874 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.6 mm -77.65 -54.58 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.528 -0.305 . . . . 0.51000000000000001 111.28 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 39' ' ' VAL . 11.3 mt -51.03 -26.92 6.8 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.504 0.669 . . . . 1.0 110.848 172.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 99' ' ' SER . 54.8 t80 -63.99 -46.48 84.39 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.391 -1.277 . . . . 0.95999999999999996 109.056 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 26.1 m-80 -73.27 -55.88 5.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.492 0.553 . . . . 0.81999999999999995 112.492 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.985 HD21 HD23 ' A' ' 101' ' ' LEU . 1.3 pp -55.47 -57.71 10.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.897 0.702 . . . . 0.65000000000000002 112.897 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.528 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . -61.26 -24.4 66.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.673 0.749 . . . . 0.42999999999999999 110.806 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.547 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.4 ttp180 -62.26 -49.62 74.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.781 -1.099 . . . . 1.8100000000000001 109.86 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -85.21 -53.29 5.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.373 1.082 . . . . 0.80000000000000004 111.129 -173.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 1.003 HG21 HG23 ' A' ' 114' ' ' ILE . 34.4 m -83.93 -30.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.225 -0.898 . . . . 0.88 110.849 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.58 -20.22 78.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.215 -0.902 . . . . 0.38 111.343 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -47.79 -45.59 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.386 -1.709 . . . . 1.0900000000000001 106.386 162.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 9.3 m-20 -72.84 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.716 -0.674 . . . . 1.8700000000000001 110.359 162.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 -179.54 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.719 0.408 . . . . 1.1699999999999999 111.852 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.36 137.92 32.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.018 0.437 . . . . 2.1499999999999999 111.47 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 1.003 HG23 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -118.36 148.07 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.237 -0.653 . . . . 0.39000000000000001 109.237 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.3 p-10 -102.65 152.69 20.91 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.951 -1.129 . . . . 2.1099999999999999 107.951 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 87.9 m-85 -137.21 171.48 14.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.636 . . . . 0.62 109.284 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.633 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 34.2 tt0 -160.2 121.33 3.07 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.364 0.415 . . . . 0.80000000000000004 110.139 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -97.69 137.61 36.33 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.727 -0.471 . . . . 1.25 109.727 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.768 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.37 103.17 8.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.884 -0.598 . . . . 0.63 109.51 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 60' ' ' ILE . 6.8 tp -113.1 121.42 65.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.115 0.483 . . . . 0.81000000000000005 110.904 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.17 126.48 8.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.333 -0.707 . . . . 0.26000000000000001 111.333 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.648 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.5 mp -103.77 100.5 10.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.092 0.473 . . . . 1.2 111.393 -172.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.137 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.3 m -104.6 95.59 6.01 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.474 -0.784 . . . . 0.32000000000000001 109.478 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 58' ' ' CYS . 2.3 pt -106.82 149.89 9.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.716 -0.394 . . . . 0.97999999999999998 110.602 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -91.12 105.35 17.75 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.52 108.492 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.732 HD12 HG21 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -105.09 148.26 35.88 Favored Pre-proline 0 C--O 1.218 -0.567 0 O-C-N 124.684 1.24 . . . . 1.28 108.995 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.45 -32.15 93.42 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.909 1.739 . . . . 0.73999999999999999 113.052 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.94 -58.09 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.455 0.539 . . . . 1.1200000000000001 112.455 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.475 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -94.45 -6.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 122.153 0.978 . . . . 1.3500000000000001 109.952 -175.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.82 -31.36 1.27 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 113.716 -1.584 . . . . 1.05 111.59 -171.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.2 pt-20 -171.05 137.15 1.14 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.692 -0.855 . . . . 1.1599999999999999 108.692 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -143.14 139.55 30.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.372 -0.603 . . . . 1.9099999999999999 109.372 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.3 t -121.18 112.94 19.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.688 0.756 . . . . 1.1899999999999999 111.498 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.69 137.05 29.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.205 -0.907 . . . . 0.5 109.66 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 11.1 Cg_endo -91.47 163.64 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.237 1.958 . . . . 0.45000000000000001 112.758 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.8 166.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.468 -0.938 . . . . 0.44 108.468 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -136.32 147.17 47.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.223 -0.191 . . . . 0.88 110.802 -167.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.5 t -140.58 102.88 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.489 -0.93 . . . . 0.95999999999999996 108.489 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 13.6 ptmt -118.46 152.31 36.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.732 -0.667 . . . . 1.76 111.087 -174.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.11 158.67 30.25 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.6 -0.81 . . . . 0.5 112.231 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.4 mt-10 -102.6 132.79 48.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.409 -0.589 . . . . 2.1000000000000001 109.409 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.52 172.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.467 -0.568 . . . . 0.76000000000000001 109.467 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -75.03 167.22 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.006 0.431 . . . . 3.5299999999999998 111.652 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.699 HD12 HD11 ' A' ' 114' ' ' ILE . 17.8 tp -57.1 132.77 80.48 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.676 -0.693 . . . . 1.23 111.124 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 144' ' ' LEU . 56.1 Cg_endo . . . . . 0 C--O 1.235 0.34 0 C-N-CA 122.611 2.207 . . . . 0.70999999999999996 112.221 177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.656 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 CA--C 1.505 -0.542 0 N-CA-C 118.348 2.099 . . . . 0.54000000000000004 118.348 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.614 ' C ' HG13 ' A' ' 45' ' ' VAL . 39.4 m -178.99 34.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 112.618 -1.791 . . . . 1.2 107.525 -170.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 120' ' ' ILE . 16.4 m -135.07 150.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.84 -1.073 . . . . 0.93000000000000005 109.638 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 46' ' ' SER . 1.3 t -160.28 -51.66 0.05 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.988 -0.375 . . . . 0.47999999999999998 109.988 168.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -158.54 150.14 21.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.294 0.568 . . . . 1.6899999999999999 112.101 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.13 127.8 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.3 -0.863 . . . . 1.1399999999999999 108.932 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -119.45 135.27 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 111.303 -169.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -97.33 127.16 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 0.93999999999999995 111.871 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -129.72 -113.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 1.3300000000000001 109.679 166.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.82 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.3 p-10 . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 112.05 0.389 . . . . 2.8500000000000001 112.05 -172.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.676 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 23.0 t . . . . . 0 N--CA 1.441 -0.888 0 N-CA-C 106.252 -1.758 . . . . 0.93999999999999995 106.252 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 33' ' ' ASP . 3.1 t -124.51 161.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.39 -0.967 . . . . 0.85999999999999999 108.39 166.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.91 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 82.0 mt-10 -114.06 131.93 56.2 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.878 -0.729 . . . . 1.1899999999999999 112.13 -170.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.791 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.87 103.82 10.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.855 -1.066 . . . . 3.73 109.443 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -72.73 109.18 6.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.081 -1.081 . . . . 0.81000000000000005 108.081 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -107.31 102.84 12.11 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.288 0.566 . . . . 0.41999999999999998 109.797 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 18.0 ttpp -83.77 133.55 34.77 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.875 -0.787 . . . . 2.6299999999999999 108.875 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 25' ' ' SER . 24.3 t -109.7 141.75 24.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.806 -1.088 . . . . 0.81999999999999995 110.409 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 88' ' ' THR . 1.8 p -120.1 100.52 7.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 119.531 -0.868 . . . . 0.71999999999999997 109.373 168.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 77.1 t -81.15 112.46 19.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.599 -0.889 . . . . 1.1399999999999999 108.599 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 2.0 m -102.92 109.89 21.62 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.914 -1.143 . . . . 0.40999999999999998 107.914 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.777 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 5.1 t30 -87.92 122.52 70.08 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.63 1.206 . . . . 1.48 109.85 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 1.3 Cg_endo -85.34 8.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.988 3.126 . . . . 0.72999999999999998 114.423 -171.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.704 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 31.4 t80 -96.79 -114.03 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.116 -0.634 . . . . 2.0800000000000001 110.015 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 18.9 p -168.74 18.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.811 0.3 . . . . 1.51 111.811 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -148.04 143.18 27.04 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.514 -0.55 . . . . 1.6699999999999999 109.514 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 5.4 m -41.26 98.19 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.256 0.973 . . . . 1.3899999999999999 112.873 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.942 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.9 pt -74.63 170.54 14.71 Favored Pre-proline 0 C--O 1.21 -0.998 0 N-CA-C 107.685 -1.228 . . . . 1.03 107.685 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.536 ' HB2' HG12 ' A' ' 57' ' ' ILE . 22.9 Cg_endo -91.25 -64.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 120.89 1.06 . . . . 0.37 114.435 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.8 mm -126.4 161.33 32.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.188 -0.605 . . . . 1.23 112.009 -166.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.655 ' HB3' HG22 ' A' ' 124' ' ' ILE . 29.8 p -152.04 175.63 12.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.43 1.11 . . . . 1.1499999999999999 112.318 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -136.55 114.24 11.12 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.006 -1.907 . . . . 1.3600000000000001 109.336 175.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -98.92 117.74 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.894 -1.048 . . . . 1.05 111.61 174.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.657 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.1 p -115.09 109.63 18.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.625 -1.625 . . . . 0.82999999999999996 109.34 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.0 p90 -114.09 126.86 55.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.428 -0.351 . . . . 0.40000000000000002 110.13 -168.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.74 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.9 m -119.6 104.64 10.46 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.826 -0.625 . . . . 0.38 109.327 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 94.3 m-85 -97.75 136.04 38.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.957 -0.565 . . . . 0.95999999999999996 109.783 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.721 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -146.59 140.3 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.734 -0.469 . . . . 1.29 109.734 176.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.594 ' HB2' HD11 ' A' ' 71' ' ' ILE . 48.2 t -102.64 -96.12 0.3 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.603 -0.271 . . . . 1.27 111.588 -173.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.06 5.58 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.546 -0.909 . . . . 0.35999999999999999 108.546 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.11 16.92 0.18 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 106.69 -2.564 . . . . 0.39000000000000001 106.69 163.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -105.76 163.25 12.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 112.809 -1.696 . . . . 1.97 108.834 -171.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -97.57 87.89 4.21 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.488 0.661 . . . . 2.6099999999999999 109.313 -161.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 14.8 mm -44.63 -43.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 113.867 -1.515 . . . . 0.40000000000000002 111.188 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.23 167.46 36.18 Favored Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 119.9 -1.143 . . . . 0.48999999999999999 111.622 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.87 161.97 18.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.685 0.743 . . . . 1.8100000000000001 111.404 173.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.47 -178.88 32.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.804 -0.918 . . . . 0.42999999999999999 110.804 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' SER . 5.1 ptpp? -147.22 141.93 26.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 1.72 111.2 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 92.0 mt -133.47 124.44 18.09 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.72999999999999998 110.182 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.7 111.34 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.427 2.085 . . . . 0.56999999999999995 110.678 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.95 144.61 52.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.816 -0.439 . . . . 0.79000000000000004 109.816 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' A' ' 57' ' ' ILE . 34.2 Cg_exo -62.44 90.53 0.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.146 1.897 . . . . 0.57999999999999996 112.112 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.51 35.09 2.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.99 -0.55 . . . . 0.40000000000000002 112.294 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.942 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 52.3 p -73.03 123.73 24.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.396 -0.594 . . . . 0.62 109.396 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -149.54 -159.78 1.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.727 -1.189 . . . . 1.1000000000000001 113.499 -164.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.496 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 86.4 mttt -60.6 -93.61 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.485 0.55 . . . . 1.8400000000000001 112.485 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.91 110.32 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.85 -1.167 . . . . 0.98999999999999999 107.85 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 45.2 pttt 41.92 49.43 4.05 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.994 0.902 . . . . 1.8400000000000001 111.195 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.3 t70 -153.3 -177.97 6.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.706 -1.134 . . . . 0.64000000000000001 110.118 -172.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.9 ttm -110.35 127.39 55.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.649 -0.705 . . . . 1.3500000000000001 109.793 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.56 142.24 50.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.77000000000000002 111.151 -175.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.55 114.17 21.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.151 0.501 . . . . 0.47999999999999998 111.656 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 45' ' ' VAL . 5.9 tt -117.96 171.33 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.533 -0.914 . . . . 0.77000000000000002 108.533 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.7 133.85 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.477 0.58 . . . . 1.8100000000000001 112.286 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 46.0 mm -114.06 113.14 46.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.6 -0.889 . . . . 0.65000000000000002 108.6 168.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.645 ' O ' HD22 ' A' ' 42' ' ' LEU . 45.3 Cg_exo -28.87 -102.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 1 C-N-CA 125.725 4.283 . . . . 1.0700000000000001 115.415 -170.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.91 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.3 93.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 122.356 -0.215 . . . . 0.46000000000000002 110.701 -177.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.7 p -127.75 102.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 114.474 1.287 . . . . 0.47999999999999998 114.474 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 101' ' ' LEU . 2.5 p -153.78 103.61 2.5 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 122.152 -0.343 . . . . 1.0700000000000001 111.49 159.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.72 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 94.2 Cg_exo -44.37 136.4 8.51 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.405 2.07 . . . . 0.47999999999999998 113.543 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.676 ' H ' ' HA ' ' A' ' 38' ' ' SER . 2.1 t80 -52.28 -37.84 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.691 -1.141 . . . . 1.3100000000000001 110.881 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -63.29 -25.89 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 1.2 112.651 -176.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.4 mm -71.29 -54.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.694 0.759 . . . . 0.51000000000000001 110.659 -175.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.629 HD11 HG21 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -54.21 -33.69 58.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.706 -1.588 . . . . 1.0 109.325 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 99' ' ' SER . 56.2 t80 -61.0 -39.85 91.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.29 -1.777 . . . . 0.95999999999999996 109.032 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -74.98 -57.49 3.87 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.81999999999999995 111.321 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HA ' HH11 ' A' ' 69' ' ' ARG . 3.0 pp -57.99 -50.71 72.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.488 0.922 . . . . 0.65000000000000002 113.488 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.28 -26.97 66.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 0.42999999999999999 110.521 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -71.2 -51.71 23.21 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.422 -0.808 . . . . 1.8100000000000001 110.944 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 35.9 t70 -81.38 -51.96 7.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.776 0.798 . . . . 0.80000000000000004 111.791 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.5 t -91.01 -22.11 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.734 -0.604 . . . . 0.88 110.431 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.24 -20.09 79.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.393 -0.908 . . . . 0.38 111.043 168.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -51.73 -48.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.635 -1.617 . . . . 1.0900000000000001 106.635 165.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 14.6 m-20 -69.78 -97.34 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.085 -0.962 . . . . 1.8700000000000001 110.345 163.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -178.18 -52.69 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.554 0.576 . . . . 1.1699999999999999 112.554 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -95.65 124.5 39.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.407 -0.361 . . . . 2.1499999999999999 111.447 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 108' ' ' VAL . 3.0 mp -117.69 155.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.734 0.302 . . . . 0.39000000000000001 110.218 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -96.0 154.55 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.638 -0.875 . . . . 2.1099999999999999 108.638 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 60.8 m-85 -140.31 149.36 42.67 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.161 -1.052 . . . . 0.62 108.161 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.828 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 10.5 tt0 -146.29 139.39 25.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.369 -0.532 . . . . 0.80000000000000004 111.066 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.644 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 10.2 tp -105.67 127.59 53.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.335 -0.848 . . . . 1.25 109.917 170.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.74 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -113.02 100.34 8.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.456 -0.942 . . . . 0.63 108.456 174.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.4 tp -112.88 122.34 66.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.124 0.488 . . . . 0.81000000000000005 111.497 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.62 128.48 9.43 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.978 -0.849 . . . . 0.26000000000000001 110.978 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.643 HD21 ' HA2' ' A' ' 24' ' ' GLY . 2.2 mp -104.87 97.64 7.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.881 0.372 . . . . 1.2 111.273 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.01 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 78.9 m -97.38 95.37 7.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.93 -0.767 . . . . 0.32000000000000001 108.93 171.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.86 147.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.032 -0.667 . . . . 0.97999999999999998 110.013 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 4.5 m-20 -87.99 105.88 17.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 109.374 -0.602 . . . . 1.52 109.374 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 124' ' ' ILE . 1.5 mm? -103.37 162.11 21.03 Favored Pre-proline 0 C--O 1.22 -0.457 0 O-C-N 124.333 1.021 . . . . 1.28 109.611 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.97 -29.83 14.55 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 121.992 1.794 . . . . 0.73999999999999999 113.053 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -75.38 -57.87 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 113.372 0.879 . . . . 1.1200000000000001 113.372 -176.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -95.1 -3.35 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.976 0.893 . . . . 1.3500000000000001 109.857 -176.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.84 -36.48 1.44 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 113.951 -1.477 . . . . 1.05 111.217 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.7 pt-20 -174.3 140.09 0.64 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.811 -1.181 . . . . 1.1599999999999999 107.811 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -140.98 146.2 36.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.83 -0.348 . . . . 1.9099999999999999 110.113 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.0 t -114.4 112.9 23.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.534 0.683 . . . . 1.1899999999999999 111.584 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.91 138.48 32.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.624 -0.716 . . . . 0.5 109.76 173.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -93.15 163.65 2.53 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.019 1.813 . . . . 0.45000000000000001 113.335 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.34 168.09 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.679 -0.86 . . . . 0.44 108.679 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -138.32 156.04 48.01 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.134 0.42 . . . . 0.88 112.134 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 t -145.94 106.87 4.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.63 -0.878 . . . . 0.95999999999999996 108.63 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.828 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.1 ptmt -120.84 149.69 42.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.629 -0.259 . . . . 1.76 111.099 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.66 146.61 11.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.634 -0.793 . . . . 0.5 112.403 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -107.7 132.02 53.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.067 -0.567 . . . . 2.1000000000000001 110.797 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.56 172.0 2.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.805 -1.183 . . . . 0.76000000000000001 107.805 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.6 152.61 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 3.5299999999999998 111.047 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.87 150.03 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 1.23 112.388 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--N 1.346 0.407 0 C-N-CA 123.447 2.765 . . . . 0.70999999999999996 113.03 -179.61 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.424 -2.166 0 N-CA-C 111.623 -0.591 . . . . 0.54000000000000004 111.623 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB2' HD11 ' A' ' 122' ' ' LEU . 33.3 m -168.91 29.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.384 -0.969 . . . . 1.2 108.384 170.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.47 153.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.865 -1.061 . . . . 0.93000000000000005 109.723 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -179.5 -46.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.632 0.582 . . . . 0.47999999999999998 112.099 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 27.2 t70 -155.38 151.89 28.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.69 -0.404 . . . . 1.6899999999999999 111.603 -174.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.61 120.68 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.393 -0.595 . . . . 1.1399999999999999 109.393 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 t70 -113.44 110.86 20.99 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.637 -0.256 . . . . 1.8300000000000001 111.308 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -79.42 130.97 35.93 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.638 -0.134 . . . . 0.93999999999999995 110.638 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.52 -88.05 0.24 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 114.138 1.162 . . . . 1.3300000000000001 114.138 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.204 -1.32 0 O-C-N 121.936 -0.478 . . . . 2.8500000000000001 111.995 -152.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.474 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 6.3 t . . . . . 0 C--O 1.234 0.259 0 CA-C-O 121.348 0.594 . . . . 0.93999999999999995 111.358 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 101' ' ' LEU . 91.4 t -76.89 155.51 5.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.208 -0.905 . . . . 0.85999999999999999 110.319 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.88 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 48.8 mt-10 -129.35 139.54 51.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.539 -0.864 . . . . 1.1899999999999999 110.515 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.952 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -139.72 134.62 32.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.582 -0.847 . . . . 3.73 112.293 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.512 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -80.41 111.42 16.79 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.824 -0.806 . . . . 0.81000000000000005 108.824 -174.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -90.43 99.9 12.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.374 0.607 . . . . 0.41999999999999998 110.001 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -83.5 125.04 31.34 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.82 -0.807 . . . . 2.6299999999999999 108.82 178.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.588 HG13 ' C ' ' A' ' 25' ' ' SER . 52.2 t -115.48 139.19 43.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.169 -0.923 . . . . 0.81999999999999995 110.445 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.75 104.52 8.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.19 -0.604 . . . . 0.71999999999999997 109.58 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 83.2 t -83.05 129.89 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.338 -0.846 . . . . 1.1399999999999999 110.458 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 30.5 m -122.61 113.94 19.95 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.913 -0.585 . . . . 0.40999999999999998 109.837 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.787 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.5 p-10 -94.87 146.19 30.92 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.628 -0.715 . . . . 1.48 109.172 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -93.92 8.18 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.13 2.553 . . . . 0.72999999999999998 113.044 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' CE1' ' HG2' ' A' ' 127' ' ' PRO . 6.8 t80 -117.11 131.92 56.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.958 -0.386 . . . . 2.0800000000000001 109.958 -174.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.576 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 38.1 t -87.48 44.7 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.442 0.639 . . . . 1.51 110.655 -169.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -144.07 16.88 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.459 0.911 . . . . 1.6699999999999999 113.459 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 26.2 t 61.42 98.28 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 111.885 0.328 . . . . 1.3899999999999999 111.885 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.853 ' O ' ' HA ' ' A' ' 81' ' ' SER . 9.1 pt -78.79 128.87 75.52 Favored Pre-proline 0 C--O 1.207 -1.149 0 O-C-N 121.698 -0.626 . . . . 1.03 111.115 -170.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 28.6 Cg_endo -66.34 -59.21 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.914 1.743 . . . . 0.37 113.106 -163.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 79' ' ' PRO . 10.1 mm -121.65 152.02 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.23 -0.588 . . . . 1.23 110.782 -172.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.589 ' HB3' HG22 ' A' ' 124' ' ' ILE . 10.2 m -148.03 178.23 8.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.147 0.975 . . . . 1.1499999999999999 111.961 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.097 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 34.7 tt0 -136.8 117.63 14.11 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.587 -1.642 . . . . 1.3600000000000001 110.618 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -97.89 109.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.783 0.802 . . . . 1.05 109.559 170.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.714 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 13.2 p -117.13 102.05 8.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.325 -1.307 . . . . 0.82999999999999996 109.717 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 p90 -109.92 126.68 54.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.40000000000000002 110.451 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 8.2 m -120.43 105.3 10.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.525 -0.762 . . . . 0.38 109.312 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 81.6 m-85 -98.67 140.56 32.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.28 -0.418 . . . . 0.95999999999999996 111.226 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.569 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 10.9 m170 -134.78 143.9 47.36 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.085 -1.08 . . . . 1.29 108.085 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 33.6 t -107.64 -100.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.67 -0.812 . . . . 1.27 111.176 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.53 3.57 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.217 -0.66 . . . . 0.35999999999999999 109.217 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.51 20.94 0.13 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.292 -1.523 . . . . 0.39000000000000001 109.292 167.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 69' ' ' ARG . 7.3 ptp180 -116.46 -176.83 3.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.64 -0.874 . . . . 1.97 108.64 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -103.05 96.8 7.04 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.744 0.783 . . . . 2.6099999999999999 108.935 -167.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.92 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.0 mm -50.77 -42.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 113.762 -1.563 . . . . 0.40000000000000002 111.153 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 170.0 32.76 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.538 -0.839 . . . . 0.48999999999999999 111.288 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.44 163.83 27.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.411 0.606 . . . . 1.8100000000000001 110.396 174.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.72 159.71 23.54 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.231 -0.748 . . . . 0.42999999999999999 111.231 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.714 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 92.3 mttt -133.19 128.53 36.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.238 -0.282 . . . . 1.72 110.238 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.606 ' HB ' HD12 ' A' ' 60' ' ' ILE . 70.3 mt -134.31 111.8 11.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.36 -0.382 . . . . 0.72999999999999998 110.224 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 111.24 3.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.518 2.146 . . . . 0.56999999999999995 110.554 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 22.1 t70 -130.88 142.67 46.4 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.738 -0.467 . . . . 0.79000000000000004 109.738 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' HD13 ' A' ' 57' ' ' ILE . 27.8 Cg_endo -63.84 84.61 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.539 2.159 . . . . 0.57999999999999996 112.365 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.14 41.74 3.08 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.40000000000000002 112.147 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 83.9 p -70.48 113.14 7.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.62 109.179 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -142.74 160.82 39.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.447 0.536 . . . . 1.1000000000000001 112.447 -164.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 90.9 mttt -6.25 -96.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 125.243 1.589 . . . . 1.8400000000000001 113.796 -172.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 170.5 108.54 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.097 -1.075 . . . . 0.98999999999999999 108.097 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 9.6 ptpt 42.57 54.32 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.291 0.995 . . . . 1.8400000000000001 110.844 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t70 -153.53 -167.29 2.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 0.64000000000000001 110.822 -171.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 52.5 ttm -118.81 125.07 48.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 1.3500000000000001 110.883 -170.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 47' ' ' VAL . 1.2 t -113.58 143.28 44.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.77000000000000002 109.309 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.86 106.37 16.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.281 0.563 . . . . 0.47999999999999998 111.068 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 45' ' ' VAL . 8.5 tt -103.31 160.28 14.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.514 -0.921 . . . . 0.77000000000000002 108.514 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -136.3 119.56 16.72 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.682 -0.807 . . . . 1.8100000000000001 111.314 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 31.6 mm -103.36 143.59 26.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.231 -0.895 . . . . 0.65000000000000002 109.612 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' HG23 ' A' ' 92' ' ' ILE . 17.9 Cg_endo -59.79 -155.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.888 2.392 . . . . 1.0700000000000001 113.718 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.952 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 5.1 m -126.35 92.3 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 115.602 -0.727 . . . . 0.46000000000000002 111.411 -162.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -126.29 101.65 8.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 115.633 1.716 . . . . 0.47999999999999998 115.633 -162.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 39' ' ' VAL . 4.8 p -153.32 123.95 3.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 121.182 -0.949 . . . . 1.0700000000000001 111.766 162.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 49.4 Cg_exo -53.59 135.14 60.88 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.616 1.544 . . . . 0.47999999999999998 112.071 172.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 38' ' ' SER . 1.2 t80 -50.33 -36.23 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.052 -0.976 . . . . 1.3100000000000001 110.931 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.7 m -65.62 -25.26 67.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.658 0.614 . . . . 1.2 112.658 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.92 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.5 mm -72.38 -54.46 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 121.73 -0.606 . . . . 0.51000000000000001 110.043 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.839 HD22 HG11 ' A' ' 39' ' ' VAL . 9.9 mp -60.1 -25.41 65.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.002 -0.999 . . . . 1.0 111.161 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.2 t80 -59.03 -48.49 81.41 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.54 -1.281 . . . . 0.95999999999999996 107.54 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 91.3 m-20 -75.48 -56.16 4.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.648 -1.16 . . . . 0.81999999999999995 113.15 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.716 ' HG ' ' HA ' ' A' ' 101' ' ' LEU . 2.8 pp -54.36 -49.76 69.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.255 0.835 . . . . 0.65000000000000002 113.255 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.567 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.92 -24.81 65.24 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 122.066 0.936 . . . . 0.42999999999999999 110.406 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.6 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 3.3 ttp180 -69.7 -49.57 52.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.226 -1.352 . . . . 1.8100000000000001 110.238 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 9.0 t70 -81.89 -53.91 5.77 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.73 0.776 . . . . 0.80000000000000004 111.98 -173.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.751 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.0 t -89.09 -22.69 6.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.88 110.1 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.79 -18.68 78.98 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.43 -0.891 . . . . 0.38 111.228 168.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -51.95 -47.1 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.862 -1.533 . . . . 1.0900000000000001 106.862 164.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 19.4 m-20 -68.5 -96.22 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.709 -0.678 . . . . 1.8700000000000001 110.096 159.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -179.34 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.1699999999999999 111.674 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -94.43 123.73 38.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.064 0.459 . . . . 2.1499999999999999 110.923 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.751 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.9 mp -110.64 158.76 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.283 -0.636 . . . . 0.39000000000000001 109.283 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.667 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 4.8 p-10 -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.879 -0.601 . . . . 2.1099999999999999 109.416 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 40.9 m-85 -137.13 157.9 45.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.903 -1.147 . . . . 0.62 107.903 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.915 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.7 tt0 -145.86 137.97 25.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.146 0.498 . . . . 0.80000000000000004 109.853 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -110.51 131.49 55.0 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.484 -0.78 . . . . 1.25 109.562 177.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.666 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -117.56 99.59 7.07 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.772 -0.825 . . . . 0.63 108.772 174.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -114.51 121.06 65.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.441 0.639 . . . . 0.81000000000000005 110.719 -173.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.6 127.75 8.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.26000000000000001 111.999 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.634 HD11 ' HB2' ' A' ' 25' ' ' SER . 1.9 mp -99.05 96.0 7.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.83 0.348 . . . . 1.2 110.624 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.097 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 94.5 m -101.16 95.66 6.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.156 -0.683 . . . . 0.32000000000000001 109.156 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' A' ' 55' ' ' ILE . 32.7 pt -117.06 137.73 50.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.392 -0.523 . . . . 0.97999999999999998 110.785 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.678 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -81.66 105.93 13.2 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.224 -0.658 . . . . 1.52 109.224 -176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.574 HD23 HG21 ' A' ' 55' ' ' ILE . 20.0 mt -107.15 141.69 23.45 Favored Pre-proline 0 C--O 1.217 -0.61 0 O-C-N 124.859 1.35 . . . . 1.28 109.69 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 50.3 Cg_exo -55.16 -27.78 57.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.272 1.981 . . . . 0.73999999999999999 113.536 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.48 -58.21 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 112.584 0.587 . . . . 1.1200000000000001 112.584 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.484 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -99.37 -2.09 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 122.14 0.971 . . . . 1.3500000000000001 109.774 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.79 -31.14 1.98 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 113.742 -1.572 . . . . 1.05 110.711 -171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.3 pt-20 -169.07 145.12 3.38 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.809 -1.182 . . . . 1.1599999999999999 107.809 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.482 ' HB2' HD12 ' A' ' 126' ' ' LEU . 6.6 t80 -134.82 134.63 41.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.048 -0.723 . . . . 1.9099999999999999 109.048 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 90.9 m -119.0 105.11 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 1.1899999999999999 111.723 -175.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.444 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.3 pp -127.66 132.75 24.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.5 109.838 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 73.6 Cg_endo -84.96 159.29 11.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.682 1.588 . . . . 0.45000000000000001 112.239 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.43 164.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.198 -1.038 . . . . 0.44 108.198 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -133.42 149.61 51.79 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.854 -0.338 . . . . 0.88 111.528 -168.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.0 t -144.33 103.82 4.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.812 -0.81 . . . . 0.95999999999999996 108.812 173.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.915 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.7 ptmt -113.44 144.61 42.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.958 -0.565 . . . . 1.76 110.837 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.22 139.73 6.76 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.684 -0.769 . . . . 0.5 111.734 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 12.1 mt-10 -106.33 126.79 52.67 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.922 -0.77 . . . . 2.1000000000000001 108.922 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.42 173.6 13.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.609 -0.885 . . . . 0.76000000000000001 108.609 -176.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -68.43 175.83 3.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.03 0.443 . . . . 3.5299999999999998 111.793 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.4 tp -58.82 129.07 85.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.575 -0.739 . . . . 1.23 112.119 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 144' ' ' LEU . 36.8 Cg_endo . . . . . 0 C--N 1.349 0.6 0 C-N-CA 124.206 3.27 . . . . 0.70999999999999996 112.85 178.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.438 -1.22 0 N-CA-C 113.597 0.199 . . . . 0.54000000000000004 113.597 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG13 ' A' ' 45' ' ' VAL . 76.7 p -166.6 36.98 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.437 1.113 . . . . 1.2 108.308 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.1 m -133.85 154.89 39.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.295 -1.32 . . . . 0.93000000000000005 110.463 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 t -168.04 -45.34 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.781 0.676 . . . . 0.47999999999999998 111.387 168.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -162.84 162.9 26.67 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.915 -0.49 . . . . 1.6899999999999999 111.479 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.49 146.06 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.878 -0.415 . . . . 1.1399999999999999 109.878 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -129.02 134.92 48.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.582 0.229 . . . . 1.8300000000000001 111.004 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.542 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.7 tm? -100.85 134.94 43.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.145 -0.317 . . . . 0.93999999999999995 110.145 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -142.92 -93.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.7 1.0 . . . . 1.3300000000000001 113.7 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER . . . . . 0 C--O 1.199 -1.564 0 CA-C-O 118.801 -0.618 . . . . 2.8500000000000001 111.709 -154.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 22.6 t . . . . . 0 C--O 1.242 0.673 0 CA-C-O 121.965 0.888 . . . . 0.93999999999999995 112.173 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.921 HG21 HD12 ' A' ' 101' ' ' LEU . 48.7 t -71.88 152.49 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.181 -1.372 . . . . 0.85999999999999999 109.126 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.964 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.2 mt-10 -114.84 133.83 55.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.957 -1.097 . . . . 1.1899999999999999 112.595 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.829 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.18 105.6 11.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.816 -1.084 . . . . 3.73 110.681 -176.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -81.28 111.15 17.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.32 -0.993 . . . . 0.81000000000000005 108.32 178.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.32 115.61 30.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.528 0.68 . . . . 0.41999999999999998 110.875 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 39.3 ttmt -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.893 -1.049 . . . . 2.6299999999999999 108.586 177.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 25' ' ' SER . 51.0 t -108.99 143.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.599 -0.728 . . . . 0.81999999999999995 110.984 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' THR . 14.2 m -134.59 100.96 4.79 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.227 0.536 . . . . 0.71999999999999997 110.436 167.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 85.4 t -81.99 124.36 39.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.171 -0.922 . . . . 1.1399999999999999 110.617 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.0 m -103.2 110.67 22.72 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.902 -0.59 . . . . 0.40999999999999998 110.707 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 9.9 t30 -90.27 128.01 50.95 Favored Pre-proline 0 C--N 1.318 -0.802 0 O-C-N 123.796 0.685 . . . . 1.48 109.748 176.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -90.31 8.7 3.43 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.51 . . . . 0.72999999999999998 114.116 -175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -127.02 147.28 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.588 -0.893 . . . . 2.0800000000000001 108.588 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.676 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.9 t -79.1 31.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.227 0.454 . . . . 1.51 112.227 -168.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -143.11 128.47 18.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.486 -0.324 . . . . 1.6699999999999999 110.789 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.538 ' HA ' HD23 ' A' ' 82' ' ' LEU . 47.6 t -38.11 105.05 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 124.577 1.151 . . . . 1.3899999999999999 112.971 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -77.87 125.11 86.02 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 109.242 -0.651 . . . . 1.03 109.242 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.954 ' HB2' HD12 ' A' ' 57' ' ' ILE . 30.3 Cg_endo -63.09 -58.92 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.048 1.832 . . . . 0.37 113.544 -159.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.5 mp -132.18 154.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.899 -0.72 . . . . 1.23 110.994 -173.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 124' ' ' ILE . 31.4 p -145.83 178.11 8.42 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.504 1.145 . . . . 1.1499999999999999 112.161 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.099 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.0 tt0 -131.95 114.24 14.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.687 -2.052 . . . . 1.3600000000000001 109.25 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.86 110.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.334 1.064 . . . . 1.05 110.125 171.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -109.1 105.25 14.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.256 -1.793 . . . . 0.82999999999999996 107.951 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 p90 -115.59 130.71 56.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.416 0.627 . . . . 0.40000000000000002 110.369 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 32.5 m -131.92 114.56 14.79 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.743 -1.117 . . . . 0.38 109.065 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' HG22 ' A' ' 71' ' ' ILE . 97.3 m-85 -96.77 146.83 24.53 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.508 -0.552 . . . . 0.95999999999999996 109.508 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -134.09 146.06 49.94 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.392 -1.336 . . . . 1.29 107.392 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 1.088 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -112.56 -97.2 0.43 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.177 -1.009 . . . . 1.27 110.846 169.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.82 3.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.837 -0.431 . . . . 0.35999999999999999 109.837 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.2 26.37 0.18 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.964 -1.254 . . . . 0.39000000000000001 109.964 167.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 8.1 ptp180 -126.17 -174.22 3.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.552 -0.536 . . . . 1.97 109.552 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 100' ' ' ILE . 43.7 mt-10 -101.44 92.06 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.198 0.523 . . . . 2.6099999999999999 110.391 -164.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -56.85 -32.1 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.40000000000000002 112.113 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.67 164.94 33.22 Favored Glycine 0 C--O 1.223 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.48999999999999999 111.245 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.28 160.26 18.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.989 0.895 . . . . 1.8100000000000001 112.126 175.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.77 159.1 21.04 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.076 -0.81 . . . . 0.42999999999999999 111.076 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.0 mtpt -126.2 128.1 46.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.196 0.498 . . . . 1.72 110.002 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -136.63 122.22 13.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.721 0.296 . . . . 0.72999999999999998 110.644 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.31 114.53 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.579 2.186 . . . . 0.56999999999999995 111.022 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 17.9 t70 -129.97 146.0 59.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.074 -0.343 . . . . 0.79000000000000004 110.074 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 78' ' ' ASP . 12.5 Cg_endo -56.82 91.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.727 2.285 . . . . 0.57999999999999996 112.17 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -79.88 19.51 6.31 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.497 -0.774 . . . . 0.40000000000000002 112.82 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 p -70.74 121.32 17.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.006 -0.739 . . . . 0.62 109.006 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -145.23 -161.38 1.29 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.843 0.682 . . . . 1.1000000000000001 112.843 -162.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 67.5 mttm -53.79 -94.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.83 0.678 . . . . 1.8400000000000001 112.83 -174.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.629 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 164.51 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.583 -0.895 . . . . 0.98999999999999999 108.583 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.1 ptmt 46.27 40.86 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.408 1.067 . . . . 1.8400000000000001 111.088 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.69 -169.75 3.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 109.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 ttm -116.19 124.5 50.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.305 0.574 . . . . 1.3500000000000001 110.456 -174.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -111.35 143.48 42.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.352 -0.84 . . . . 0.77000000000000002 110.863 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.02 138.89 31.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.026 0.441 . . . . 0.47999999999999998 110.447 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.533 HD22 HG11 ' A' ' 45' ' ' VAL . 1.2 tt -144.15 175.06 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.612 -1.255 . . . . 0.77000000000000002 107.612 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 4.0 p-10 -142.15 146.5 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.061 0.846 . . . . 1.8100000000000001 112.217 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.4 mm -114.56 143.25 29.57 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 107.895 -1.15 . . . . 0.65000000000000002 107.895 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.547 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 85.2 Cg_exo -51.52 -122.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.472 2.781 . . . . 1.0700000000000001 114.072 175.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -153.82 93.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 O-C-N 121.837 -0.539 . . . . 0.46000000000000002 111.973 -172.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.2 p -126.29 109.03 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.748 1.018 . . . . 0.47999999999999998 113.748 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 16.9 t -146.86 103.98 3.89 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 115.683 -0.69 . . . . 1.0700000000000001 109.731 169.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.6 Cg_exo -61.26 123.45 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 CA-C-N 120.792 1.319 . . . . 0.47999999999999998 110.678 171.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -50.57 -38.34 44.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.56 -0.745 . . . . 1.3100000000000001 112.176 -171.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.9 m -56.12 -25.52 46.36 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.674 0.25 . . . . 1.2 111.674 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.0 mm -76.34 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 120.252 -0.579 . . . . 0.51000000000000001 111.116 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.921 HD12 HG21 ' A' ' 39' ' ' VAL . 13.1 mt -51.96 -30.05 23.12 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.488 0.661 . . . . 1.0 110.427 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.406 ' HB3' ' O ' ' A' ' 99' ' ' SER . 85.3 t80 -62.89 -40.36 97.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.178 -1.374 . . . . 0.95999999999999996 108.908 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.38 -56.12 5.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.727 -0.67 . . . . 0.81999999999999995 111.848 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.3 pp -62.14 -51.8 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.57 0.952 . . . . 0.65000000000000002 113.57 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.424 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -60.3 -25.97 66.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.783 0.801 . . . . 0.42999999999999999 110.361 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.0 ttp180 -64.28 -50.42 67.96 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.659 -1.155 . . . . 1.8100000000000001 110.131 173.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.5 t70 -83.24 -53.42 5.77 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.781 0.66 . . . . 0.80000000000000004 112.781 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 114' ' ' ILE . 4.2 t -84.35 -27.47 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.498 -0.481 . . . . 0.88 110.001 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.44 -21.28 77.72 Favored Glycine 0 C--N 1.328 0.139 0 C-N-CA 120.631 -0.795 . . . . 0.38 111.573 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.8 -46.69 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.98 -1.489 . . . . 1.0900000000000001 106.98 165.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 6.3 m-20 -67.66 -90.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.434 -0.803 . . . . 1.8700000000000001 109.615 162.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -178.16 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.196 0.443 . . . . 1.1699999999999999 112.196 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -93.63 133.08 37.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.204 0.526 . . . . 2.1499999999999999 110.991 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD12 ' A' ' 144' ' ' LEU . 2.7 mp -115.87 159.95 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.39000000000000001 109.962 -171.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' ' 114' ' ' ILE . 10.3 p-10 -98.81 152.83 19.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.59 -0.892 . . . . 2.1099999999999999 108.59 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.1 m-85 -138.02 163.86 30.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.62 108.339 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.63 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 36.2 tt0 -160.58 128.47 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.80000000000000004 110.624 -177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -99.83 134.51 42.63 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.314 -0.624 . . . . 1.25 109.314 174.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.707 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -117.21 102.54 9.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.719 -0.673 . . . . 0.63 109.266 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.584 HD11 HG22 ' A' ' 60' ' ' ILE . 6.4 tp -111.62 120.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.087 0.47 . . . . 0.81000000000000005 111.154 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -90.85 126.98 8.62 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.114 -0.794 . . . . 0.26000000000000001 111.114 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.0 mp -106.89 112.93 26.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.673 0.273 . . . . 1.2 111.241 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.099 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.6 m -114.01 96.68 5.94 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.817 -0.629 . . . . 0.32000000000000001 109.762 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -111.33 144.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.544 -0.462 . . . . 0.97999999999999998 110.553 -176.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -88.57 107.12 18.73 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.163 -1.051 . . . . 1.52 108.163 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.599 HD23 HG21 ' A' ' 55' ' ' ILE . 9.7 mt -106.94 168.08 8.56 Favored Pre-proline 0 C--O 1.222 -0.388 0 O-C-N 125.359 1.662 . . . . 1.28 110.236 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.31 -41.98 0.78 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.189 1.926 . . . . 0.73999999999999999 112.982 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.02 -57.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.937 0.347 . . . . 1.1200000000000001 111.937 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.51 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.2 OUTLIER -89.19 -8.16 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.697 0.761 . . . . 1.3500000000000001 109.949 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.64 -33.78 0.71 Allowed Glycine 0 C--N 1.321 -0.291 0 CA-C-N 114.473 -1.239 . . . . 1.05 112.369 -172.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.3 pt-20 -171.99 145.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.419 -1.326 . . . . 1.1599999999999999 107.419 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 4.4 t80 -153.75 146.11 23.94 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.445 -0.502 . . . . 1.9099999999999999 110.125 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 31.9 m -120.31 107.07 12.5 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.386 0.429 . . . . 1.1899999999999999 111.101 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.4 pp -126.37 138.03 31.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.96 -0.564 . . . . 0.5 109.936 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 18.1 Cg_endo -91.69 165.35 3.39 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.386 2.058 . . . . 0.45000000000000001 112.719 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -164.9 169.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.3 p -136.52 154.08 50.83 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.375 0.509 . . . . 0.88 112.375 -169.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.4 t -140.58 105.61 4.99 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.716 -1.216 . . . . 0.95999999999999996 107.716 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.63 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.35 149.7 38.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.577 -0.283 . . . . 1.76 110.834 -172.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.78 135.39 3.9 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.294 -0.723 . . . . 0.5 111.294 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.14 131.84 44.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.652 -0.499 . . . . 2.1000000000000001 109.652 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.34 172.9 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.512 -0.551 . . . . 0.76000000000000001 109.512 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 144' ' ' LEU . 0.5 OUTLIER -61.49 167.09 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.172 0.804 . . . . 3.5299999999999998 113.172 -177.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 ' HD2' ' A' ' 145' ' ' PRO . 32.1 tp -59.19 134.3 87.92 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 114.908 -1.042 . . . . 1.23 111.641 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.847 ' HD2' HD12 ' A' ' 144' ' ' LEU . 31.9 Cg_endo . . . . . 0 C--N 1.351 0.666 0 C-N-CA 123.103 2.535 . . . . 0.70999999999999996 112.106 176.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.768 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.437 -1.245 0 CA-C-O 120.368 -0.129 . . . . 0.54000000000000004 113.35 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 122' ' ' LEU . 40.7 m -172.03 39.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 1.2 108.382 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' SER . 25.1 m -134.87 155.12 37.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.778 -1.101 . . . . 0.93000000000000005 109.312 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -175.56 -48.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.369 0.507 . . . . 0.47999999999999998 112.369 168.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -158.5 147.04 18.65 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.049 -0.407 . . . . 1.6899999999999999 111.128 -174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.876 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.83 138.59 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.954 0.407 . . . . 1.1399999999999999 110.336 166.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.29 135.49 48.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 1.8300000000000001 111.332 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 39' ' ' VAL . 3.1 tm? -89.9 137.94 31.91 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 0.93999999999999995 111.202 -172.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -137.45 -91.78 0.23 Allowed 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 113.865 1.061 . . . . 1.3300000000000001 113.865 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 6.8 m-20 . . . . . 0 C--O 1.207 -1.178 0 O-C-N 121.452 -0.78 . . . . 2.8500000000000001 111.149 -156.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.478 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 35.6 t . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.989 0.423 . . . . 0.93999999999999995 110.206 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.697 ' HB ' HG13 ' A' ' 96' ' ' VAL . 12.0 t -76.28 158.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 109.581 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.5 mt-10 -136.91 141.33 42.71 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.451 -0.781 . . . . 1.1899999999999999 110.932 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -140.73 134.45 30.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.167 -1.013 . . . . 3.73 113.454 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -80.78 110.93 16.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.132 . . . . 0.81000000000000005 108.624 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.876 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -100.28 106.42 18.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.239 0.542 . . . . 0.41999999999999998 110.697 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.28 116.99 24.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.161 0.981 . . . . 2.6299999999999999 109.786 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 25' ' ' SER . 16.1 t -95.97 149.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.214 -1.357 . . . . 0.81999999999999995 110.069 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.572 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 2.2 m -132.46 104.08 6.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.177 -0.609 . . . . 0.71999999999999997 110.67 168.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.3 t -83.04 128.43 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.731 -1.122 . . . . 1.1399999999999999 111.141 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 17.5 m -109.62 109.5 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.962 -0.563 . . . . 0.40999999999999998 110.323 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.887 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -92.29 133.52 29.86 Favored Pre-proline 0 N--CA 1.466 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 49' ' ' ASN . 40.6 Cg_endo -104.76 22.28 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.453 2.768 . . . . 0.72999999999999998 114.656 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.599 ' HD2' ' HE1' ' A' ' 53' ' ' HIS . 4.1 t80 -116.09 -3.45 12.07 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 118.717 -1.193 . . . . 2.0800000000000001 111.358 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.475 ' CB ' ' HD3' ' A' ' 85' ' ' LYS . 24.6 p 89.89 15.97 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.26 1.024 . . . . 1.51 112.404 161.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.599 ' HE1' ' HD2' ' A' ' 51' ' ' TYR . 48.7 p-80 -147.6 148.43 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.968 -0.753 . . . . 1.6699999999999999 108.968 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 41.7 t -54.32 107.16 0.25 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.244 0.965 . . . . 1.3899999999999999 112.054 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.945 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.0 pt -74.71 173.02 7.42 Favored Pre-proline 0 C--O 1.206 -1.204 0 N-CA-C 107.767 -1.197 . . . . 1.03 107.767 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HB2' HG12 ' A' ' 57' ' ' ILE . 11.0 Cg_endo -90.13 -62.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 CA-C-N 120.192 1.104 . . . . 0.37 114.774 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 79' ' ' PRO . 16.8 mm -131.22 161.35 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.588 -0.445 . . . . 1.23 111.43 -165.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.581 ' CB ' HG22 ' A' ' 124' ' ' ILE . 29.3 p -155.96 -177.3 6.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.38 1.086 . . . . 1.1499999999999999 111.972 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.5 tt0 -135.96 116.37 13.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.017 -1.902 . . . . 1.3600000000000001 109.774 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.731 HG22 HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -97.25 110.09 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.238 1.018 . . . . 1.05 109.489 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.475 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.5 p -114.42 102.97 10.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.325 -1.761 . . . . 0.82999999999999996 108.844 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.3 p90 -113.37 131.65 55.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.517 -0.549 . . . . 0.40000000000000002 109.517 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 17.6 m -127.94 106.01 8.81 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.736 -1.12 . . . . 0.38 109.067 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 72.1 m-85 -96.99 142.49 28.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 110.232 -0.284 . . . . 0.95999999999999996 110.232 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.447 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -129.38 144.85 51.41 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.28 -1.378 . . . . 1.29 107.28 176.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.885 ' HB3' HD22 ' A' ' 104' ' ' LEU . 39.1 t -107.77 -96.47 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.902 -1.119 . . . . 1.27 111.106 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -63.93 1.1 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.146 -0.687 . . . . 0.35999999999999999 109.146 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.34 17.21 0.18 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 108.511 -1.836 . . . . 0.39000000000000001 108.511 167.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.937 HH11 ' HB3' ' A' ' 103' ' ' ASN . 11.8 ptp180 -114.3 177.47 4.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.303 -0.999 . . . . 1.97 108.303 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.13 98.19 8.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.606 0.717 . . . . 2.6099999999999999 109.486 -163.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.97 -36.43 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 113.979 -1.464 . . . . 0.40000000000000002 111.912 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.2 161.21 12.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.999 -0.84 . . . . 0.48999999999999999 110.999 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -159.99 161.77 34.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 117.875 0.837 . . . . 1.8100000000000001 111.24 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.76 162.43 28.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.753 -0.658 . . . . 0.42999999999999999 111.456 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.7 mttt -123.47 128.62 50.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.649 -0.5 . . . . 1.72 109.649 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 60' ' ' ILE . 80.4 mt -133.56 116.8 14.03 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.268 -0.271 . . . . 0.72999999999999998 110.268 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.68 101.49 1.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.753 2.302 . . . . 0.56999999999999995 111.115 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -112.85 146.13 34.46 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.509 -0.552 . . . . 0.79000000000000004 109.509 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.694 ' HA ' HD13 ' A' ' 57' ' ' ILE . 35.6 Cg_exo -62.3 86.5 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.028 1.819 . . . . 0.57999999999999996 112.168 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 36.34 2.58 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.926 -0.579 . . . . 0.40000000000000002 112.671 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.945 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.2 p -73.95 120.29 19.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.297 -0.631 . . . . 0.62 109.297 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -156.11 161.59 40.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.318 -1.353 . . . . 1.1000000000000001 114.546 -163.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HG3' ' OG1' ' A' ' 88' ' ' THR . 88.6 mttt -22.28 -97.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.883 1.438 . . . . 1.8400000000000001 114.883 -164.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.409 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 171.24 109.55 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.252 -1.018 . . . . 0.98999999999999999 108.252 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.738 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 39.5 pttt 42.15 46.56 3.79 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.008 0.818 . . . . 1.8400000000000001 110.936 -175.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.9 t70 -150.04 -171.04 3.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.261 -0.881 . . . . 0.64000000000000001 109.88 -170.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.9 ttm -119.01 117.93 30.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.514 0.673 . . . . 1.3500000000000001 110.157 -173.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.65 ' CB ' ' HB2' ' A' ' 82' ' ' LEU . 0.8 OUTLIER -106.12 143.31 34.42 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.839 -1.073 . . . . 0.77000000000000002 111.124 -176.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.0 129.9 34.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.463 0.649 . . . . 0.47999999999999998 110.73 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 45' ' ' VAL . 8.8 tt -135.42 162.05 33.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.398 -1.334 . . . . 0.77000000000000002 107.398 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.69 138.27 32.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.23 -0.988 . . . . 1.8100000000000001 112.679 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.9 mm -100.82 149.92 36.59 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.005 -1.452 . . . . 0.65000000000000002 107.717 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 11.3 Cg_endo -53.96 -116.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.964 2.443 . . . . 1.0700000000000001 113.686 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.4 m -156.88 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 O-C-N 121.559 -0.713 . . . . 0.46000000000000002 111.729 -169.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.539 HG11 ' HE2' ' A' ' 62' ' ' PHE . 9.1 p -126.27 101.56 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 116.102 1.89 . . . . 0.47999999999999998 116.102 -163.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.5 p -152.21 110.66 2.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 121.25 -0.906 . . . . 1.0700000000000001 111.864 163.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.0 Cg_exo -54.43 131.81 47.44 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.794 1.663 . . . . 0.47999999999999998 110.942 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.478 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 24.8 t80 -54.16 -40.64 67.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.53 -0.759 . . . . 1.3100000000000001 111.523 -172.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 13.4 t -55.88 -26.97 49.66 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.229 0.331 . . . . 1.2 111.785 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 mm -76.11 -55.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.109 -0.636 . . . . 0.51000000000000001 110.908 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 104' ' ' LEU . 37.9 mt -55.49 -28.48 54.82 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.521 0.677 . . . . 1.0 110.344 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.1 t80 -65.49 -39.72 92.25 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.384 -1.28 . . . . 0.95999999999999996 108.602 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.937 ' HB3' HH11 ' A' ' 69' ' ' ARG . 11.3 m-80 -74.28 -56.56 4.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.936 . . . . 0.81999999999999995 112.307 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 101' ' ' LEU . 1.7 pp -60.77 -47.96 83.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.121 0.786 . . . . 0.65000000000000002 113.121 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.56 -25.02 68.05 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.844 0.83 . . . . 0.42999999999999999 109.833 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.15 -54.27 36.33 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.529 -1.214 . . . . 1.8100000000000001 110.274 173.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 18.7 t70 -82.41 -53.19 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.998 0.904 . . . . 0.80000000000000004 111.923 -173.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.4 t -87.55 -27.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 121.639 -0.663 . . . . 0.88 110.042 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.16 -19.76 79.76 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.462 -0.875 . . . . 0.38 111.34 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -49.14 -46.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.847 -1.538 . . . . 1.0900000000000001 106.847 164.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 33.3 m-20 -71.32 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.486 -0.779 . . . . 1.8700000000000001 110.077 162.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 179.64 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.192 0.442 . . . . 1.1699999999999999 112.192 174.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -94.89 131.17 41.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 2.1499999999999999 111.821 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -120.62 161.33 20.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.954 -0.566 . . . . 0.39000000000000001 109.89 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 114' ' ' ILE . 14.7 t70 -99.88 154.6 18.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.783 -0.644 . . . . 2.1099999999999999 109.563 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 83.8 m-85 -140.63 132.14 26.99 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.396 -0.964 . . . . 0.62 108.396 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.758 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 23.2 tt0 -131.22 137.15 48.79 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.082 0.468 . . . . 0.80000000000000004 110.307 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 14.9 tp -103.16 131.08 50.45 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.775 -0.648 . . . . 1.25 110.256 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.7 99.5 8.21 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.57 -1.27 . . . . 0.63 107.57 170.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.731 HD11 HG22 ' A' ' 60' ' ' ILE . 6.3 tp -113.08 114.89 48.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.348 0.594 . . . . 0.81000000000000005 111.139 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.41 128.62 8.84 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.212 -0.755 . . . . 0.26000000000000001 111.212 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 133' ' ' THR . 5.7 mp -105.91 102.05 11.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.983 0.421 . . . . 1.2 110.936 -174.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.3 m -107.86 95.17 5.5 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.272 -0.877 . . . . 0.32000000000000001 109.514 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.581 HG22 ' CB ' ' A' ' 58' ' ' CYS . 39.3 pt -113.0 141.97 26.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 C-N-CA 120.146 -0.622 . . . . 0.97999999999999998 110.52 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 53.8 m-20 -85.73 106.16 16.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.752 -0.833 . . . . 1.52 108.752 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 55' ' ' ILE . 45.3 mt -104.02 164.87 14.45 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 124.53 1.143 . . . . 1.28 109.878 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.58 ' HG3' ' CE1' ' A' ' 53' ' ' HIS . 41.4 Cg_endo -69.91 -40.38 5.15 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.415 1.41 . . . . 0.73999999999999999 113.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 98.9 t -74.07 -58.41 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.374 0.509 . . . . 1.1200000000000001 112.374 -173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 132' ' ' PHE . 9.7 p -90.21 -7.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.172 0.987 . . . . 1.3500000000000001 110.05 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.92 -30.9 0.76 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 114.248 -1.342 . . . . 1.05 112.516 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.0 pt-20 -166.86 126.59 1.5 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 1.1599999999999999 108.716 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HB2' HG11 ' A' ' 129' ' ' VAL . 13.0 t80 -123.71 135.63 53.98 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.428 -0.582 . . . . 1.9099999999999999 109.428 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.9 t -128.05 103.22 7.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.921 0.867 . . . . 1.1899999999999999 111.844 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.64 143.9 49.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.236 -0.893 . . . . 0.5 110.227 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 80.9 Cg_endo -92.49 162.74 2.95 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.783 1.656 . . . . 0.45000000000000001 113.597 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.74 168.54 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.112 -1.44 . . . . 0.44 107.112 178.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 99.1 p -145.64 152.18 39.25 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.335 -0.546 . . . . 0.88 111.845 -168.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -146.98 113.13 5.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.784 -0.821 . . . . 0.95999999999999996 108.784 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.758 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 6.8 ptmm? -123.88 153.37 41.22 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.08 -0.248 . . . . 1.76 111.378 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.45 143.57 8.65 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.371 -0.692 . . . . 0.5 111.371 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -108.54 132.13 54.14 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.03 -0.585 . . . . 2.1000000000000001 110.418 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.31 173.45 2.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.473 -1.306 . . . . 0.76000000000000001 107.473 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -63.94 172.63 2.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.217 0.532 . . . . 3.5299999999999998 112.332 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 114' ' ' ILE . 15.7 tp -58.97 139.85 87.07 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.316 -0.856 . . . . 1.23 111.306 -175.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 144' ' ' LEU . 37.3 Cg_endo . . . . . 0 C--N 1.349 0.604 0 C-N-CA 122.973 2.449 . . . . 0.70999999999999996 112.449 176.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . . . . . . 0 N--CA 1.446 -0.655 0 N-CA-C 114.726 0.65 . . . . 0.54000000000000004 114.726 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.707 ' HB2' HD11 ' A' ' 122' ' ' LEU . 22.5 m -169.83 34.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.841 1.256 . . . . 1.2 108.294 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' SER . 23.1 m -134.94 156.31 39.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.369 -1.287 . . . . 0.93000000000000005 109.191 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -173.47 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.211 0.448 . . . . 0.47999999999999998 112.211 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.839 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 15.6 t70 -160.67 157.01 26.38 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.825 -0.35 . . . . 1.6899999999999999 111.004 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.4 t -142.45 134.97 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.693 -0.855 . . . . 1.1399999999999999 108.693 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 25.0 t70 -125.2 132.22 53.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 111.078 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.8 tm? -101.17 127.5 47.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.93999999999999995 111.55 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.08 -115.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.613 -0.722 . . . . 1.3300000000000001 110.05 168.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.957 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.4 p-10 . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 110.409 -0.219 . . . . 2.8500000000000001 110.409 -173.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 29.7 t . . . . . 0 N--CA 1.429 -1.501 0 N-CA-C 105.818 -1.919 . . . . 0.93999999999999995 105.818 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 33' ' ' ASP . 8.2 t -131.33 159.83 42.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 170.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 90.9 mt-10 -114.07 134.55 54.79 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.456 0.646 . . . . 1.1899999999999999 112.386 -169.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.747 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -121.73 106.08 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.841 -1.072 . . . . 3.73 110.237 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -74.11 110.34 8.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.144 -1.058 . . . . 0.81000000000000005 108.144 175.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -98.63 110.17 22.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.468 0.651 . . . . 0.41999999999999998 110.182 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 22.8 ttmt -87.99 117.35 26.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.692 -1.14 . . . . 2.6299999999999999 109.342 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 25' ' ' SER . 61.6 t -105.78 143.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.292 -0.867 . . . . 0.81999999999999995 111.038 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.716 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 4.8 m -134.89 97.39 3.74 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.482 -0.562 . . . . 0.71999999999999997 109.482 166.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -86.49 126.68 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.454 0.645 . . . . 1.1399999999999999 110.973 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 13.4 m -101.78 118.01 36.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.886 -1.052 . . . . 0.40999999999999998 110.159 -175.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 20.4 t30 -89.5 124.07 65.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 O-C-N 124.669 1.231 . . . . 1.48 109.472 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -84.29 2.27 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.495 2.797 . . . . 0.72999999999999998 115.34 -171.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.788 ' CE2' ' HB2' ' A' ' 53' ' ' HIS . 7.2 p90 -134.77 163.03 30.72 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.685 -0.634 . . . . 2.0800000000000001 109.774 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 51.8 p -81.24 21.47 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.848 1.055 . . . . 1.51 113.848 -164.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . 0.788 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 37.0 m80 -131.21 129.97 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.967 -0.693 . . . . 1.6699999999999999 111.357 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.437 ' HA ' HD23 ' A' ' 82' ' ' LEU . 3.2 m -39.54 110.62 0.15 Allowed 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 124.512 1.125 . . . . 1.3899999999999999 113.056 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.971 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.5 pt -73.03 170.37 13.97 Favored Pre-proline 0 C--O 1.211 -0.934 0 N-CA-C 107.83 -1.174 . . . . 1.03 107.83 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 7.6 Cg_endo -87.8 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.223 1.282 . . . . 0.37 113.327 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.904 HG12 ' HA ' ' A' ' 79' ' ' PRO . 21.7 mt -142.53 155.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.25 0.463 . . . . 1.23 112.25 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' HG22 ' A' ' 124' ' ' ILE . 21.0 p -142.28 -177.4 5.23 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.042 0.925 . . . . 1.1499999999999999 110.903 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 1.061 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.1 tt0 -136.4 115.05 11.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.744 -1.571 . . . . 1.3600000000000001 109.992 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.69 109.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.359 1.076 . . . . 1.05 109.738 167.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 28.7 p -113.55 102.71 10.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.674 -1.603 . . . . 0.82999999999999996 108.799 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 15.8 p90 -115.49 134.91 54.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.353 0.597 . . . . 0.40000000000000002 110.478 -164.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 19.5 m -131.65 111.01 11.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.616 -1.174 . . . . 0.38 109.176 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 92.2 m-85 -97.27 139.66 32.9 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.111 -0.495 . . . . 0.95999999999999996 110.189 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.531 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 7.6 m170 -130.83 145.55 52.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.821 -1.177 . . . . 1.29 107.821 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 1.021 ' HB3' HD22 ' A' ' 104' ' ' LEU . 29.7 t -107.74 -99.5 0.36 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.642 -0.823 . . . . 1.27 111.206 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -55.86 25.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.01 -0.737 . . . . 0.35999999999999999 109.01 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.09 18.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.459 -1.856 . . . . 0.39000000000000001 108.459 164.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 8.4 ptp180 -114.07 171.02 7.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.17 -1.015 . . . . 1.97 108.603 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.72 94.1 7.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.091 0.948 . . . . 2.6099999999999999 110.324 -166.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.1 mm -48.75 -44.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.389 -1.732 . . . . 0.40000000000000002 112.112 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.81 168.59 41.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.925 -1.131 . . . . 0.48999999999999999 111.718 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.76 155.57 19.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.211 0.506 . . . . 1.8100000000000001 110.862 176.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.14 155.11 19.82 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.593 -1.003 . . . . 0.42999999999999999 110.593 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 95.5 mttt -132.35 119.71 21.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.496 -0.557 . . . . 1.72 109.496 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.617 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.2 mt -133.45 116.05 13.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.72999999999999998 110.986 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.29 111.8 3.29 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.265 1.977 . . . . 0.56999999999999995 110.141 168.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.8 t70 -115.87 144.75 33.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.771 -0.455 . . . . 0.79000000000000004 109.771 -173.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.904 ' HA ' HG12 ' A' ' 57' ' ' ILE . 17.9 Cg_endo -61.34 73.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.815 2.343 . . . . 0.57999999999999996 111.794 172.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -76.47 35.45 1.36 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.333 -0.849 . . . . 0.40000000000000002 113.605 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.971 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.7 p -73.67 119.7 18.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.272 -0.64 . . . . 0.62 109.272 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 49' ' ' ASN . 1.1 pt? -140.18 -164.47 1.72 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.087 -1.445 . . . . 1.1000000000000001 114.176 -161.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.444 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 90.3 mttt -54.82 -93.89 0.0 OUTLIER 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.735 0.643 . . . . 1.8400000000000001 112.735 -173.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.32 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.929 -1.137 . . . . 0.98999999999999999 107.929 -171.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 41.8 pttt 42.32 47.46 4.19 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 124.305 1.003 . . . . 1.8400000000000001 111.338 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -151.1 -170.41 3.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.282 -0.872 . . . . 0.64000000000000001 109.596 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' MET . . . . . 0.716 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 12.0 ttt -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.889 -0.596 . . . . 1.3500000000000001 110.256 -170.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' A' ' 46' ' ' SER . 4.7 t -105.31 142.59 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.093 0.473 . . . . 0.77000000000000002 110.659 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -89.41 105.91 18.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.709 0.766 . . . . 0.47999999999999998 110.336 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 45' ' ' VAL . 7.6 tt -104.23 168.29 9.2 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.11 -1.441 . . . . 0.77000000000000002 107.11 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -141.75 143.22 33.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 119.252 0.933 . . . . 1.8100000000000001 111.874 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.916 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 33.5 mm -106.4 120.72 47.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.825 -1.176 . . . . 0.65000000000000002 107.825 170.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.621 ' O ' HD22 ' A' ' 42' ' ' LEU . 46.0 Cg_exo -30.87 -97.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.811 3.674 . . . . 1.0700000000000001 114.753 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.7 93.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 O-C-N 122.474 -0.141 . . . . 0.46000000000000002 110.669 -179.066 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -127.17 103.65 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.448 1.277 . . . . 0.47999999999999998 114.448 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 71' ' ' ILE . 1.8 p -152.14 98.19 2.95 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 122.108 -0.37 . . . . 1.0700000000000001 110.519 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 69.3 Cg_exo -50.58 128.87 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.265 1.976 . . . . 0.47999999999999998 111.828 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.695 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.2 t80 -48.63 -40.18 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.398 -0.819 . . . . 1.3100000000000001 111.609 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 19.9 m -58.92 -28.77 66.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.334 0.494 . . . . 1.2 112.334 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.9 mm -76.32 -55.02 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.095 -0.642 . . . . 0.51000000000000001 110.001 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 104' ' ' LEU . 35.7 mt -50.25 -28.16 7.24 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.97 0.794 . . . . 1.0 110.8 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.6 t80 -65.11 -44.68 87.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.93 -1.032 . . . . 0.95999999999999996 109.274 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.794 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.0 m-80 -73.57 -58.08 3.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 0.81999999999999995 112.197 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 1.021 HD22 ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -59.38 -54.57 45.16 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.135 0.791 . . . . 0.65000000000000002 113.135 -178.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.5 -24.28 67.75 Favored 'General case' 0 C--O 1.217 -0.605 0 CA-C-O 121.753 0.787 . . . . 0.42999999999999999 110.532 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.794 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.2 ttp180 -64.69 -44.27 90.85 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.717 -1.129 . . . . 1.8100000000000001 110.878 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 31.5 t70 -85.16 -52.29 6.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.99 0.9 . . . . 0.80000000000000004 111.411 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 114' ' ' ILE . 28.7 m -76.71 -30.87 19.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.802 -0.635 . . . . 0.88 110.18 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -79.03 -15.87 79.81 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.869 -1.059 . . . . 0.38 111.681 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.99 -42.15 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.253 -1.758 . . . . 1.0900000000000001 106.253 162.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 37.3 m-20 -75.53 -85.25 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.8700000000000001 110.289 157.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.509 ' O ' HD23 ' A' ' 144' ' ' LEU . 4.4 p-90 173.9 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.092 0.557 . . . . 1.1699999999999999 112.393 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.39 134.19 35.88 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.408 -0.517 . . . . 2.1499999999999999 111.941 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -116.68 151.68 18.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.097 0.475 . . . . 0.39000000000000001 109.807 178.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -101.35 154.13 19.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.389 -0.823 . . . . 2.1099999999999999 108.878 173.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 51.8 m-85 -140.91 160.04 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.198 -0.668 . . . . 0.62 109.198 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 26.4 tt0 -152.08 132.02 13.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.953 -0.388 . . . . 0.80000000000000004 109.953 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 9.8 tp -101.58 132.35 47.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.184 -0.462 . . . . 1.25 110.399 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -117.89 99.55 6.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.971 -0.752 . . . . 0.63 108.971 175.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.47 121.58 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.557 0.694 . . . . 0.81000000000000005 110.714 -173.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . 0.693 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -89.36 129.23 9.57 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.319 -0.855 . . . . 0.26000000000000001 111.891 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.1 mp -101.01 109.36 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.841 0.353 . . . . 1.2 110.954 -174.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . 1.061 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.0 m -114.87 96.71 5.85 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.731 -0.668 . . . . 0.32000000000000001 109.702 175.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.774 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.06 134.35 52.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 120.314 -0.554 . . . . 0.97999999999999998 111.482 -176.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.03 106.81 11.33 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.143 -1.058 . . . . 1.52 108.143 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.533 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 19.5 mt -116.04 170.46 5.74 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.457 1.098 . . . . 1.28 110.705 -171.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 91.0 Cg_endo -84.7 -23.76 2.54 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 121.915 1.744 . . . . 0.73999999999999999 112.283 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 22.8 t -74.85 -57.86 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 1.1200000000000001 111.764 -175.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.515 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.5 OUTLIER -107.07 -1.58 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.928 0.871 . . . . 1.3500000000000001 109.787 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.75 -28.12 0.91 Allowed Glycine 0 C--O 1.225 -0.463 0 CA-C-N 114.207 -1.36 . . . . 1.05 111.833 -171.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 129' ' ' VAL . 9.6 pt-20 -165.58 138.25 4.25 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.344 -1.354 . . . . 1.1599999999999999 107.344 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.2 t80 -132.41 128.72 38.14 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.664 -0.865 . . . . 1.9099999999999999 108.664 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 14.0 t -120.97 101.04 7.42 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.293 1.044 . . . . 1.1899999999999999 111.367 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.2 pp -127.21 132.8 24.49 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.993 -1.003 . . . . 0.5 109.84 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PRO . . . . . 0.693 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 2.5 Cg_endo -85.66 161.76 10.76 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.9 1.733 . . . . 0.45000000000000001 112.242 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.61 166.6 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.1 m -134.96 148.04 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.788 -0.365 . . . . 0.88 110.987 -170.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 t -141.65 103.5 4.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.228 -1.027 . . . . 0.95999999999999996 108.228 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -107.99 147.24 31.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.055 -0.52 . . . . 1.76 110.599 -175.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.83 135.9 4.45 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.766 -0.73 . . . . 0.5 111.326 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.54 130.05 52.54 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.47 -0.566 . . . . 2.1000000000000001 109.47 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 174.81 6.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.462 -0.94 . . . . 0.76000000000000001 108.462 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -68.69 171.65 7.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.375 0.509 . . . . 3.5299999999999998 112.375 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -56.36 128.93 74.38 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.232 -0.895 . . . . 1.23 110.635 -176.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD22 ' A' ' 144' ' ' LEU . 31.7 Cg_endo . . . . . 0 C--N 1.351 0.676 0 C-N-CA 123.544 2.829 . . . . 0.70999999999999996 113.392 -177.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 ttm . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.939 -0.393 . . . . 12.109999999999999 109.939 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -63.0 -23.84 67.64 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.675 0.621 . . . . 9.0199999999999996 112.675 -173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.2 p -71.31 -15.94 62.43 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.862 0.363 . . . . 6.8300000000000001 111.936 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.04 61.58 0.61 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.731 -0.47 . . . . 8.5500000000000007 109.731 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.432 HD22 ' HA ' ' A' ' 5' ' ' LEU . 1.2 tm? -84.09 97.79 9.52 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.682 -0.69 . . . . 10.470000000000001 109.622 -178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.8 t70 69.92 131.17 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 115.336 -0.847 . . . . 11.69 111.589 -178.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.547 ' HB3' ' NZ ' ' A' ' 7' ' ' LYS . 9.2 mtpm? -88.78 91.07 8.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.026 0.441 . . . . 11.42 110.825 179.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -107.59 170.16 8.15 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.965 -0.561 . . . . 11.58 110.3 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -107.77 -93.61 0.4 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.468 -0.333 . . . . 15.74 110.214 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 57.47 -85.35 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.638 0.586 . . . . 12.69 112.552 178.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -107.83 -31.13 8.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.992 0.425 . . . . 13.85 111.048 -176.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 22.6 m -95.41 172.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.465 0.65 . . . . 8.8699999999999992 112.643 -167.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.62 -56.35 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.192 -1.367 . . . . 8.9100000000000001 107.907 176.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -131.29 -11.9 3.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.89 -1.05 . . . . 8.5999999999999996 109.049 170.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -94.11 133.3 37.74 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.554 -0.748 . . . . 9.0399999999999991 110.051 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 87.1 mt 69.89 153.08 0.11 Allowed 'General case' 0 N--CA 1.466 0.326 0 O-C-N 123.99 0.806 . . . . 5.5800000000000001 111.606 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 39.5 m -154.87 -57.44 0.1 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.66 -0.7 . . . . 2.6899999999999999 109.58 175.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.622 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -161.72 -165.58 1.3 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.884 -0.598 . . . . 1.6799999999999999 110.543 179.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.67 HG21 HD13 ' A' ' 126' ' ' LEU . 25.4 pt -90.15 172.21 7.39 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.241 -0.436 . . . . 3.1899999999999999 110.377 -176.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.528 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 21.4 Cg_exo -66.23 -91.19 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.632 2.221 . . . . 2.4199999999999999 113.182 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 56.7 tttm 167.43 -45.52 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.591 0 C-N-CA 122.857 0.463 . . . . 6.3799999999999999 111.302 -176.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.485 ' HD2' ' HB2' ' A' ' 20' ' ' PRO . 17.5 Cg_exo -68.72 58.46 1.1 Allowed 'Trans proline' 0 C--N 1.362 1.289 0 C-N-CA 122.501 2.134 . . . . 2.77 112.669 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.659 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 5.5 mp0 -129.04 134.6 48.19 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 104.617 -2.364 . . . . 3.3900000000000001 104.617 -178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.768 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -110.2 -177.35 20.92 Favored Glycine 0 C--N 1.313 -0.719 0 C-N-CA 118.66 -1.733 . . . . 0.54000000000000004 116.249 -157.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.746 ' HB2' HD11 ' A' ' 122' ' ' LEU . 23.9 m -169.51 33.14 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 113.105 -1.548 . . . . 1.2 107.215 174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -134.06 155.02 38.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.338 -1.301 . . . . 0.93000000000000005 109.051 -175.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.5 t -174.92 -45.31 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.182 0.438 . . . . 0.47999999999999998 112.182 168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 9.1 t70 -152.72 153.84 34.04 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 117.773 0.26 . . . . 1.6899999999999999 110.464 -177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.435 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 85.1 t -141.32 123.11 13.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.797 -0.446 . . . . 1.1399999999999999 109.797 175.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.468 ' O ' ' HE3' ' A' ' 32' ' ' LYS . 33.0 t70 -113.93 108.72 17.43 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.757 -0.656 . . . . 1.8300000000000001 111.017 -173.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.605 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.3 tm? -83.06 140.05 32.89 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.338 -0.392 . . . . 0.93999999999999995 110.488 -177.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.605 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -138.68 -91.59 0.2 Allowed 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 113.627 0.973 . . . . 1.3300000000000001 113.627 -179.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.754 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -90.94 -178.62 5.26 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 121.589 -0.694 . . . . 2.8500000000000001 111.952 -152.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.836 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.1 p -166.78 -37.93 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 O-C-N 123.708 0.63 . . . . 3.2599999999999998 110.718 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 8.5 t30 67.16 -81.92 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.36 -0.836 . . . . 3.1600000000000001 108.805 -175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.427 ' HG2' ' OD1' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -172.11 14.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.362 0.601 . . . . 5.46 109.636 168.784 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD1' ' HG2' ' A' ' 36' ' ' ARG . 8.6 m-20 -131.33 -39.05 1.17 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.33 -0.85 . . . . 1.9199999999999999 109.905 -172.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.836 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 5.7 t -152.63 125.4 8.39 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 112.926 0.713 . . . . 0.93999999999999995 112.926 -176.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.754 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 61.0 t -75.86 148.85 7.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.243 -0.89 . . . . 0.85999999999999999 109.388 175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.975 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 61.8 mt-10 -124.05 142.75 50.91 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 119.299 -0.96 . . . . 1.1899999999999999 111.209 -176.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.954 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 11.5 p90 -133.51 131.71 40.14 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 119.269 -0.972 . . . . 3.73 112.365 177.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.79 111.95 23.73 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.213 -1.032 . . . . 0.81000000000000005 108.213 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.822 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.08 118.67 34.01 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.176 -0.61 . . . . 0.41999999999999998 110.739 -178.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 17.5 tppt? -84.68 116.9 23.47 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 108.501 -0.925 . . . . 2.6299999999999999 108.501 173.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 25' ' ' SER . 37.2 t -100.99 145.42 11.29 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.243 0 CA-C-N 115.142 -0.936 . . . . 0.81999999999999995 110.177 -177.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -129.34 100.21 5.5 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-O 121.22 0.533 . . . . 0.71999999999999997 110.05 168.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.718 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 41.8 t -83.02 121.64 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.399 0 CA-C-N 114.879 -1.055 . . . . 1.1399999999999999 110.136 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.768 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.3 m -102.63 113.05 26.1 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.163 -0.68 . . . . 0.40999999999999998 109.163 177.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.772 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 8.7 t30 -88.36 128.93 51.35 Favored Pre-proline 0 N--CA 1.466 0.347 0 O-C-N 124.533 1.146 . . . . 1.48 109.961 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.659 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 75.7 Cg_endo -87.58 13.52 2.62 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.492 2.795 . . . . 0.72999999999999998 114.389 -176.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 27.3 t80 -130.9 142.42 50.36 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.392 -0.596 . . . . 2.0800000000000001 109.392 -177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.611 ' HB3' ' HD2' ' A' ' 85' ' ' LYS . 56.8 p -74.88 31.1 0.09 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.881 0.697 . . . . 1.51 112.881 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -145.12 128.99 17.37 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 122.245 -0.284 . . . . 1.6699999999999999 110.738 178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.8 m -39.88 110.22 0.14 Allowed 'General case' 0 C--O 1.206 -1.223 0 C-N-CA 124.258 1.023 . . . . 1.3899999999999999 112.412 170.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.823 HG12 HD11 ' A' ' 82' ' ' LEU . 4.1 pt -79.62 173.31 7.93 Favored Pre-proline 0 C--O 1.201 -1.48 0 N-CA-C 106.111 -1.811 . . . . 1.03 106.111 -175.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.505 ' C ' HD12 ' A' ' 57' ' ' ILE . 9.4 Cg_endo -92.75 -62.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.145 0 CA-C-N 121.326 1.509 . . . . 0.37 114.408 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.6 HG13 ' HA ' ' A' ' 79' ' ' PRO . 1.4 mp -134.26 153.23 35.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 116.274 -0.421 . . . . 1.23 110.796 -168.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.73 ' SG ' HG22 ' A' ' 124' ' ' ILE . 21.0 m -140.76 178.95 6.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.886 0.851 . . . . 1.1499999999999999 111.503 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.087 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 42.0 tt0 -133.77 115.53 14.65 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.906 -1.497 . . . . 1.3600000000000001 110.249 176.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.621 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.59 110.41 25.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-O 122.533 1.159 . . . . 1.05 110.378 169.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.438 ' C ' HD12 ' A' ' 120' ' ' ILE . 14.2 t -113.3 102.74 10.63 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 113.196 -1.82 . . . . 0.82999999999999996 108.636 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.536 ' HE1' HG11 ' A' ' 95' ' ' VAL . 6.6 p90 -113.66 133.44 55.31 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 121.418 0.628 . . . . 0.40000000000000002 110.029 -167.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.552 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 27.2 m -126.14 104.77 8.42 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 114.675 -1.148 . . . . 0.38 108.399 173.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.739 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 4.4 m-85 -95.42 143.17 26.99 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.2 -0.454 . . . . 0.95999999999999996 110.191 -177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 4.0 m170 -132.11 145.63 51.52 Favored 'General case' 0 C--O 1.217 -0.609 0 N-CA-C 107.107 -1.442 . . . . 1.29 107.107 175.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.936 ' HB3' HD22 ' A' ' 104' ' ' LEU . 19.9 t -103.84 -91.17 0.37 Allowed 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 118.631 -1.228 . . . . 1.27 111.158 173.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.07 -69.07 0.17 Allowed 'General case' 0 CA--C 1.516 -0.351 0 CA-C-O 120.85 0.357 . . . . 0.35999999999999999 110.159 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.67 15.52 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 109.461 -1.456 . . . . 0.39000000000000001 109.461 171.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.664 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -100.17 -78.31 0.51 Allowed 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.516 -0.842 . . . . 1.97 109.041 -177.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.664 ' H ' ' HG3' ' A' ' 69' ' ' ARG . 0.8 OUTLIER -171.4 -177.34 2.07 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 108.141 -1.059 . . . . 2.6099999999999999 108.141 171.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.575 HG23 ' HB ' ' A' ' 96' ' ' VAL . 1.6 mm -135.18 -35.77 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 CA-C-N 115.363 -0.835 . . . . 0.40000000000000002 109.556 170.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 160.5 171.98 27.16 Favored Glycine 0 N--CA 1.449 -0.467 0 N-CA-C 110.281 -1.128 . . . . 0.48999999999999999 110.281 -178.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -161.18 166.13 28.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 118.124 0.962 . . . . 1.8100000000000001 110.766 -179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.01 166.02 32.19 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.359 -0.696 . . . . 0.42999999999999999 111.359 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -129.33 129.51 44.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.897 -0.409 . . . . 1.72 109.897 178.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.569 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.8 mt -139.23 121.64 10.31 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-O 120.782 0.325 . . . . 0.72999999999999998 110.721 -179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.7 115.4 4.32 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.432 2.088 . . . . 0.56999999999999995 110.76 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -125.13 141.61 39.02 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 109.375 -0.602 . . . . 0.79000000000000004 109.375 -175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.6 ' HA ' HG13 ' A' ' 57' ' ' ILE . 23.5 Cg_exo -63.88 82.66 0.14 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.593 2.195 . . . . 0.57999999999999996 112.052 177.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.6 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -87.85 41.97 3.09 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.692 -0.685 . . . . 0.40000000000000002 112.14 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.801 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 44.4 t -73.45 133.74 43.77 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.208 -1.034 . . . . 0.62 108.208 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.823 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -152.81 -156.93 0.75 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 118.201 -1.4 . . . . 1.1000000000000001 114.641 -163.812 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 64.9 mttm -63.82 -97.54 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.507 -0.77 . . . . 1.8400000000000001 112.173 -173.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.621 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.4 106.09 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 108.75 -0.833 . . . . 0.98999999999999999 108.75 -171.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.772 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 6.5 ptmm? 46.35 46.25 13.65 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 124.28 0.988 . . . . 1.8400000000000001 111.348 -177.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -154.39 -170.68 3.61 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 114.757 -1.11 . . . . 0.64000000000000001 109.545 -173.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.503 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 50.1 ttm -112.0 132.17 54.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.867 0.365 . . . . 1.3500000000000001 110.947 -171.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.517 ' O ' ' HA ' ' A' ' 46' ' ' SER . 0.8 OUTLIER -122.94 146.5 47.54 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.806 -0.633 . . . . 0.77000000000000002 110.049 -178.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.05 137.09 32.64 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 121.24 0.543 . . . . 0.47999999999999998 110.696 179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.522 HD22 HG11 ' A' ' 45' ' ' VAL . 7.2 tt -137.72 168.35 19.86 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.41 -0.959 . . . . 0.77000000000000002 108.41 -176.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -132.39 140.95 48.68 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.734 0.642 . . . . 1.8100000000000001 112.734 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.822 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 43.4 mm -110.94 143.51 28.45 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 114.819 -1.082 . . . . 0.65000000000000002 108.159 172.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.75 -121.15 0.0 OUTLIER 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 123.787 2.991 . . . . 1.0700000000000001 114.147 176.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.975 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.4 m -157.37 88.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.699 0 O-C-N 121.849 -0.532 . . . . 0.46000000000000002 111.891 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.536 HG11 ' HE1' ' A' ' 62' ' ' PHE . 12.3 p -127.39 101.76 8.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 115.412 1.634 . . . . 0.47999999999999998 115.412 -168.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.575 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.2 p -150.96 98.76 3.13 Favored Pre-proline 0 C--N 1.315 -0.898 0 O-C-N 121.501 -0.749 . . . . 1.0700000000000001 110.489 164.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.414 ' HB2' HG12 ' A' ' 100' ' ' ILE . 51.9 Cg_exo -52.59 134.02 51.59 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.064 1.842 . . . . 0.47999999999999998 111.418 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.432 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.5 t80 -57.2 -33.28 67.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 1.3100000000000001 111.204 -173.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.444 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 26.5 m -58.04 -32.02 67.58 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 111.926 0.343 . . . . 1.2 111.926 -179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.493 HG21 ' HG2' ' A' ' 70' ' ' GLU . 9.6 mm -76.9 -56.32 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 120.502 -0.479 . . . . 0.51000000000000001 110.695 -174.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.684 HD23 HD11 ' A' ' 104' ' ' LEU . 0.8 OUTLIER -51.24 -27.87 10.2 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-N 115.042 -0.981 . . . . 1.0 110.563 171.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 63.2 t80 -65.45 -38.67 90.53 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 114.09 -1.413 . . . . 0.95999999999999996 108.803 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.648 ' HB3' ' NH1' ' A' ' 69' ' ' ARG . 36.1 m-80 -74.47 -57.77 3.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.935 -0.575 . . . . 0.81999999999999995 111.758 178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.936 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.2 pp -62.29 -51.42 67.78 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.56 0.948 . . . . 0.65000000000000002 113.56 -177.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.24 -24.43 65.81 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.797 0.808 . . . . 0.42999999999999999 110.536 -178.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 2.3 ttm180 -59.1 -52.04 67.45 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 114.917 -1.038 . . . . 1.8100000000000001 110.191 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.572 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 22.2 t70 -82.83 -51.34 7.74 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.6 0.714 . . . . 0.80000000000000004 111.948 -173.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.564 ' O ' ' HB3' ' A' ' 111' ' ' ASP . 2.7 t -86.87 -27.31 5.89 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 O-C-N 121.872 -0.518 . . . . 0.88 110.425 -175.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.407 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.0 -20.43 79.43 Favored Glycine 0 N--CA 1.46 0.273 0 C-N-CA 120.739 -0.743 . . . . 0.38 111.692 170.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -48.45 -46.33 14.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 106.824 -1.547 . . . . 1.0900000000000001 106.824 163.593 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.564 ' HB3' ' O ' ' A' ' 108' ' ' VAL . 12.0 t70 -67.09 -90.41 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.477 -0.783 . . . . 1.8700000000000001 109.088 160.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.9 p-90 172.44 -45.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.352 0.661 . . . . 1.1699999999999999 111.17 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -96.55 127.32 42.43 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.192 -0.458 . . . . 2.1499999999999999 111.246 -174.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.557 ' CD1' ' HB3' ' A' ' 144' ' ' LEU . 2.3 mp -124.78 158.54 32.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 N-CA-C 109.697 -0.483 . . . . 0.39000000000000001 109.697 -178.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 23.3 t70 -97.58 155.39 16.99 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.326 -0.99 . . . . 2.1099999999999999 108.326 178.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.758 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 47.4 m-85 -136.36 121.83 19.45 Favored 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 109.233 -0.654 . . . . 0.62 109.233 178.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.868 ' HG3' ' HG2' ' A' ' 139' ' ' LYS . 7.9 tt0 -113.08 132.66 55.33 Favored 'General case' 0 C--N 1.308 -1.222 0 N-CA-C 110.128 -0.323 . . . . 0.80000000000000004 110.128 -174.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.739 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 15.8 tp -102.07 128.83 48.35 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 116.219 -0.446 . . . . 1.25 110.053 172.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.726 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.18 99.55 8.37 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.976 -1.12 . . . . 0.63 107.976 168.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.621 HD11 HG22 ' A' ' 60' ' ' ILE . 5.4 tp -113.17 117.79 56.31 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.154 0 CA-C-O 121.321 0.582 . . . . 0.81000000000000005 111.099 -172.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -83.84 120.62 5.27 Favored Glycine 0 N--CA 1.441 -0.97 0 N-CA-C 111.104 -0.798 . . . . 0.26000000000000001 111.104 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.746 HD11 ' HB2' ' A' ' 25' ' ' SER . 5.2 mp -97.76 98.55 9.95 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.123 0.487 . . . . 1.2 111.164 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.087 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.2 m -100.11 121.14 40.95 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.384 -0.969 . . . . 0.32000000000000001 108.384 169.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.73 HG22 ' SG ' ' A' ' 58' ' ' CYS . 11.0 pt -133.68 132.58 57.11 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 C-N-CA 120.538 -0.465 . . . . 0.97999999999999998 110.355 178.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -79.26 107.03 11.71 Favored 'General case' 0 CA--C 1.51 -0.596 0 N-CA-C 108.194 -1.039 . . . . 1.52 108.194 -177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.67 HD13 HG21 ' A' ' 19' ' ' ILE . 11.1 mt -115.73 160.83 33.42 Favored Pre-proline 0 C--O 1.219 -0.522 0 O-C-N 124.715 1.26 . . . . 1.28 110.769 -169.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -73.75 -23.8 16.32 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 121.89 1.727 . . . . 0.73999999999999999 112.152 173.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.37 -57.59 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-N 116.259 -0.428 . . . . 1.1200000000000001 112.093 -175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.622 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -109.17 1.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 122.033 0.921 . . . . 1.3500000000000001 109.897 -175.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.429 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.79 -32.49 0.88 Allowed Glycine 0 C--N 1.314 -0.682 0 CA-C-N 114.09 -1.414 . . . . 1.05 111.682 -171.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.504 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.3 pt-20 -175.75 146.29 0.73 Allowed 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 107.456 -1.312 . . . . 1.1599999999999999 107.456 177.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 14.6 t80 -150.82 146.32 26.29 Favored 'General case' 0 C--N 1.314 -0.943 0 C-N-CA 120.422 -0.511 . . . . 1.9099999999999999 110.004 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 37.4 m -121.27 110.39 16.08 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 120.913 0.387 . . . . 1.1899999999999999 111.221 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.507 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.15 133.9 25.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.843 -0.617 . . . . 0.5 109.355 172.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 38.3 Cg_endo -91.54 162.29 3.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.873 1.715 . . . . 0.45000000000000001 113.28 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.404 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -158.17 167.74 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 108.245 -1.02 . . . . 0.44 108.245 179.395 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.0 OUTLIER -137.81 150.4 47.16 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.662 -0.125 . . . . 0.88 110.662 -167.844 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.7 t -148.6 102.38 3.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 109.623 -0.51 . . . . 0.95999999999999996 109.623 176.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.868 ' HG2' ' HG3' ' A' ' 117' ' ' GLU . 0.9 OUTLIER -99.11 144.5 28.18 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.847 -0.615 . . . . 1.76 110.936 178.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.37 130.42 3.07 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 111.478 -0.649 . . . . 0.5 111.478 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.413 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 24.0 mt-10 -98.9 125.29 44.28 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.662 -0.496 . . . . 2.1000000000000001 109.662 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -149.02 172.68 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 107.841 -1.17 . . . . 0.76000000000000001 107.841 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 53.5 mttm -67.23 141.29 57.32 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.883 -0.414 . . . . 3.5299999999999998 109.883 178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.731 ' HB2' ' HD2' ' A' ' 145' ' ' PRO . 3.2 pp -60.35 163.83 7.87 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 116.366 -0.379 . . . . 1.23 111.505 -176.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.731 ' HD2' ' HB2' ' A' ' 144' ' ' LEU . 15.9 Cg_endo -55.89 172.26 0.59 Allowed 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 123.504 2.803 . . . . 0.70999999999999996 113.804 -174.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 11.1 t -65.98 133.64 51.27 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.972 -0.751 . . . . 1.71 108.972 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -153.81 -175.53 5.42 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-O 121.824 0.821 . . . . 2.6400000000000001 112.36 -165.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -176.55 -50.9 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 113.835 -1.53 . . . . 3.7200000000000002 107.534 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -148.45 39.42 0.89 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.491 -1.232 . . . . 4.2800000000000002 108.141 173.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 85.2 m-85 -115.24 -43.27 3.09 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.088 -0.96 . . . . 2.8599999999999999 110.581 -177.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 89.1 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 117.657 -1.163 . . . . 3.96 109.911 -172.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.0 ttp . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 120.989 0.423 . . . . 12.109999999999999 109.955 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -101.33 120.87 40.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.988 -0.551 . . . . 9.0199999999999996 111.492 -175.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.0 p -144.52 151.41 39.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.573 -0.74 . . . . 6.8300000000000001 109.568 176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.1 tp -96.06 103.52 15.41 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.771 0.319 . . . . 8.5500000000000007 110.819 -178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.622 HD11 HD11 ' A' ' 19' ' ' ILE . 3.1 mm? -92.66 -38.09 12.05 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.233 0.54 . . . . 10.470000000000001 109.596 177.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -81.08 94.64 6.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.535 -0.757 . . . . 11.69 109.66 177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.1 tttp -129.79 -9.12 4.48 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.836 -0.62 . . . . 11.42 110.755 -174.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 64.11 27.69 14.11 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.968 -0.56 . . . . 11.58 111.305 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt -112.79 131.86 55.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.027 -0.533 . . . . 15.74 110.961 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -136.74 126.19 25.08 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.096 -0.502 . . . . 12.69 109.936 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -142.74 -58.64 0.44 Allowed 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.676 -0.861 . . . . 13.85 108.676 178.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.404 ' O ' ' HB2' ' A' ' 16' ' ' LEU . 17.2 m -137.58 150.99 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.995 -1.002 . . . . 8.8699999999999992 108.934 171.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.88 -14.45 21.8 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.799 -0.445 . . . . 8.9100000000000001 109.799 178.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -54.72 -71.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.282 -0.872 . . . . 8.5999999999999996 111.545 179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.542 ' HB3' ' HB2' ' A' ' 50' ' ' PRO . 56.3 mttp -147.19 60.87 1.18 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.88 0.371 . . . . 9.0399999999999991 110.495 -177.408 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.404 ' HB2' ' O ' ' A' ' 12' ' ' VAL . 41.9 tp -81.59 -32.34 32.13 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.192 0.52 . . . . 5.5800000000000001 110.4 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.464 HG22 HG11 ' A' ' 128' ' ' VAL . 0.0 OUTLIER -84.62 169.61 14.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.765 -0.652 . . . . 2.6899999999999999 111.253 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.606 ' HB1' HG12 ' A' ' 129' ' ' VAL . . . -80.26 6.9 10.63 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.819 -0.628 . . . . 1.6799999999999999 111.347 177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.622 HD11 HD11 ' A' ' 5' ' ' LEU . 39.0 pt -136.08 61.57 40.89 Favored Pre-proline 0 CA--C 1.543 0.674 0 N-CA-C 113.745 1.017 . . . . 3.1899999999999999 113.745 -165.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.537 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 5.7 Cg_exo -81.71 -94.96 0.0 OUTLIER 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.029 1.819 . . . . 2.4199999999999999 111.995 170.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 3.2 tppp? 167.22 -54.07 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.616 0 C-N-CA 122.678 0.391 . . . . 6.3799999999999999 111.86 -178.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 14.4 Cg_endo -90.75 76.01 0.79 Allowed 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 122.583 2.188 . . . . 2.77 113.116 -175.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HB3' ' O ' ' A' ' 48' ' ' THR . 7.6 mp0 -127.96 139.96 52.27 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 104.249 -2.5 . . . . 3.3900000000000001 104.249 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.729 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -114.05 -178.63 19.14 Favored Glycine 0 C--N 1.312 -0.758 0 C-N-CA 118.092 -2.004 . . . . 0.54000000000000004 115.881 -165.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.65 ' O ' HG13 ' A' ' 45' ' ' VAL . 93.2 p -166.57 36.94 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.776 -1.564 . . . . 1.2 106.776 174.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 46' ' ' SER . 13.4 m -134.52 154.03 36.4 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.301 0 CA-C-N 113.646 -1.615 . . . . 0.93000000000000005 109.237 -169.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 2.4 t -175.12 -50.71 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.245 0.461 . . . . 0.47999999999999998 112.245 171.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.443 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 16.3 t70 -152.19 157.13 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.912 -0.493 . . . . 1.6899999999999999 111.36 -174.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG21 ' CZ ' ' A' ' 64' ' ' PHE . 75.1 t -147.33 124.54 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.379 -0.373 . . . . 1.1399999999999999 110.719 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -107.13 142.03 37.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.286 -0.415 . . . . 1.8300000000000001 110.454 176.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.778 HD13 ' N ' ' A' ' 32' ' ' LYS . 3.0 tm? -97.85 141.04 31.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.34 -0.615 . . . . 0.93999999999999995 109.34 173.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.778 ' N ' HD13 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -135.45 -115.21 0.19 Allowed 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 114.366 1.247 . . . . 1.3300000000000001 114.366 -178.054 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.609 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 11.7 m-20 -94.87 178.71 5.48 Favored 'General case' 0 C--O 1.203 -1.368 0 O-C-N 121.653 -0.654 . . . . 2.8500000000000001 111.823 -156.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.905 ' HB ' HG22 ' A' ' 39' ' ' VAL . 2.7 p -155.49 -34.3 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.498 0 N-CA-C 112.765 0.654 . . . . 3.2599999999999998 112.765 -176.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.414 ' HB2' ' O ' ' A' ' 34' ' ' VAL . 60.6 m-80 68.34 -77.88 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.285 -0.635 . . . . 3.1600000000000001 109.285 -170.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.6 10.14 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.984 -0.553 . . . . 5.46 111.029 177.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -125.45 -42.39 1.97 Allowed 'General case' 0 CA--C 1.506 -0.748 0 CA-C-O 121.842 0.83 . . . . 1.9199999999999999 110.364 -169.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.666 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.2 t -161.09 131.77 5.25 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.361 -1.29 . . . . 0.93999999999999995 110.556 -171.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.905 HG22 ' HB ' ' A' ' 34' ' ' VAL . 41.8 t -87.64 155.89 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.606 -0.725 . . . . 0.85999999999999999 109.495 -178.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.947 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 70.6 mt-10 -118.94 151.12 38.75 Favored 'General case' 0 N--CA 1.434 -1.23 0 O-C-N 122.004 -0.435 . . . . 1.1899999999999999 110.457 -177.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.908 ' HE2' ' HB2' ' A' ' 43' ' ' ALA . 24.3 p90 -136.89 131.55 33.3 Favored 'General case' 0 C--N 1.318 -0.798 0 C-N-CA 120.122 -0.631 . . . . 3.73 111.833 171.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -85.32 112.43 20.79 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.799 -0.815 . . . . 0.81000000000000005 108.799 176.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.908 ' HB2' ' HE2' ' A' ' 41' ' ' TYR . . . -95.32 115.8 27.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.249 0.547 . . . . 0.41999999999999998 110.936 179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 10.8 tppt? -88.39 123.52 33.03 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 108.518 -0.919 . . . . 2.6299999999999999 108.518 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.65 HG13 ' O ' ' A' ' 25' ' ' SER . 30.9 t -110.5 140.74 28.26 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 CA-C-N 115.711 -0.677 . . . . 0.81999999999999995 110.544 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.598 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 1.6 m -129.15 99.32 5.2 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-O 121.25 0.547 . . . . 0.71999999999999997 110.165 170.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.729 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -82.61 125.88 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-N 115.308 -0.86 . . . . 1.1399999999999999 110.483 -175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.693 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.8 m -108.11 113.97 27.52 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 109.465 -0.569 . . . . 0.40999999999999998 109.465 177.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.86 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.5 p30 -89.76 150.53 44.17 Favored Pre-proline 0 CA--C 1.512 -0.483 0 N-CA-C 108.132 -1.062 . . . . 1.48 108.132 174.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.542 ' HB2' ' HB3' ' A' ' 15' ' ' LYS . 54.2 Cg_endo -97.71 -9.34 0.64 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.072 2.515 . . . . 0.72999999999999998 114.48 -175.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.719 ' HE1' HG23 ' A' ' 128' ' ' VAL . 14.2 t80 -89.17 -20.27 24.44 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 119.88 -0.728 . . . . 2.0800000000000001 112.195 -155.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.702 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 24.0 t 84.16 13.86 0.29 Allowed 'General case' 0 C--N 1.327 -0.386 0 O-C-N 123.987 0.804 . . . . 1.51 109.237 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.403 ' HD1' ' HD2' ' A' ' 51' ' ' TYR . 34.4 m80 -139.65 130.0 25.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.507 -0.77 . . . . 1.6699999999999999 109.382 178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 14.7 m -41.89 96.7 0.01 OUTLIER 'General case' 0 C--O 1.212 -0.881 0 O-C-N 124.102 0.876 . . . . 1.3899999999999999 112.928 173.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.006 HG21 HD23 ' A' ' 126' ' ' LEU . 6.0 pt -74.75 171.46 11.48 Favored Pre-proline 0 C--O 1.212 -0.889 0 N-CA-C 108.261 -1.015 . . . . 1.03 108.261 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.491 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 12.4 Cg_endo -88.91 -59.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.411 0 C-N-CA 121.067 1.178 . . . . 0.37 113.993 -177.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.799 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 5.9 mt -138.68 162.01 29.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 C-N-CA 119.951 -0.7 . . . . 1.23 112.125 -168.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.708 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.0 p -146.72 177.13 9.33 Favored 'General case' 0 N--CA 1.44 -0.938 0 CA-C-O 122.251 1.024 . . . . 1.1499999999999999 111.7 178.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.111 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 31.8 tt0 -126.4 116.18 20.78 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 113.286 -1.779 . . . . 1.3600000000000001 109.723 176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.852 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -98.88 109.44 24.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.891 0 CA-C-O 122.204 1.002 . . . . 1.05 109.975 172.171 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.554 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 5.8 m -112.44 102.89 10.98 Favored 'General case' 0 N--CA 1.443 -0.824 0 CA-C-N 113.597 -1.638 . . . . 0.82999999999999996 108.465 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.694 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.8 p90 -112.87 127.37 56.17 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.456 0.646 . . . . 0.40000000000000002 109.82 -169.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 16.4 m -123.28 106.5 10.76 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 114.483 -1.235 . . . . 0.38 108.289 175.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.765 ' CZ ' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.34 135.18 39.61 Favored 'General case' 0 N--CA 1.436 -1.174 0 C-N-CA 120.646 -0.421 . . . . 0.95999999999999996 110.514 -175.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 2.2 m170 -123.05 144.76 49.07 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 107.034 -1.469 . . . . 1.29 107.034 176.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.975 ' HB3' HD22 ' A' ' 104' ' ' LEU . 46.4 t -106.78 -97.53 0.35 Allowed 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 119.223 -0.991 . . . . 1.27 110.919 174.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.2 -58.79 6.9 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 109.212 -0.662 . . . . 0.35999999999999999 109.212 -176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 22.41 0.13 Allowed Glycine 0 N--CA 1.443 -0.897 0 N-CA-C 109.613 -1.395 . . . . 0.39000000000000001 109.613 164.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 9.2 ptp180 -122.37 -172.57 2.49 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 109.643 -0.503 . . . . 1.97 109.643 -175.058 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -100.46 87.19 3.33 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.716 0.77 . . . . 2.6099999999999999 111.46 -161.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.671 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.8 mm -53.74 -45.15 61.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 114.598 -1.183 . . . . 0.40000000000000002 112.117 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.91 163.62 30.82 Favored Glycine 0 C--O 1.22 -0.74 0 C-N-CA 120.23 -0.986 . . . . 0.48999999999999999 111.383 -176.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.694 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -163.07 157.59 20.94 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 117.886 0.843 . . . . 1.8100000000000001 111.871 -177.758 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.45 163.61 28.63 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 111.825 -0.51 . . . . 0.42999999999999999 111.825 174.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.513 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 37.9 mttm -127.3 127.11 43.79 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.902 -0.407 . . . . 1.72 109.902 177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.477 ' HB ' HD12 ' A' ' 60' ' ' ILE . 78.4 mt -139.95 124.9 11.32 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-O 120.695 0.283 . . . . 0.72999999999999998 110.55 -177.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_exo -73.54 116.32 4.64 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.431 2.087 . . . . 0.56999999999999995 110.801 170.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' HB2' HD11 ' A' ' 60' ' ' ILE . 10.8 t70 -123.08 141.1 34.94 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.487 -0.56 . . . . 0.79000000000000004 109.487 -175.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -55.7 89.16 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.719 2.28 . . . . 0.57999999999999996 112.337 175.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.799 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -82.69 28.43 3.53 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.363 -0.835 . . . . 0.40000000000000002 113.102 -178.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.959 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.9 p -74.91 122.88 24.11 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.985 -0.376 . . . . 0.62 109.985 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.8 pt? -153.41 -167.19 2.63 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 118.317 -1.353 . . . . 1.1000000000000001 114.059 -165.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.439 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 87.5 mttt -52.57 -101.58 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.545 0.943 . . . . 1.8400000000000001 113.545 -173.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.43 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . -178.08 105.22 0.05 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.636 -0.876 . . . . 0.98999999999999999 108.636 -174.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.86 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.7 pttt 36.91 62.97 0.73 Allowed 'General case' 0 N--CA 1.468 0.438 0 O-C-N 124.104 0.877 . . . . 1.8400000000000001 111.185 -169.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.571 ' O ' ' HA ' ' A' ' 48' ' ' THR . 5.7 t70 -157.51 -179.3 8.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.789 -1.096 . . . . 0.64000000000000001 109.015 -171.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.598 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 40.6 ttm -108.73 120.12 41.54 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.072 -0.513 . . . . 1.3500000000000001 110.597 -171.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 46' ' ' SER . 6.0 t -105.76 143.68 33.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.621 -0.718 . . . . 0.77000000000000002 109.917 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.64 115.93 26.52 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.463 0.649 . . . . 0.47999999999999998 110.708 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.622 HD22 HG11 ' A' ' 45' ' ' VAL . 5.6 tt -116.0 164.58 14.23 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.982 -1.008 . . . . 0.77000000000000002 108.985 -177.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -131.32 132.9 44.85 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.318 -0.553 . . . . 1.8100000000000001 110.951 -172.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.666 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 21.7 mm -118.95 140.82 29.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 115.872 -0.604 . . . . 0.65000000000000002 111.048 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.94 -169.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 124.059 3.173 . . . . 1.0700000000000001 113.626 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.947 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 18.0 m -126.8 91.01 1.67 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.892 0 CA-C-N 115.885 -0.598 . . . . 0.46000000000000002 112.417 -163.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.447 HG13 ' HE1' ' A' ' 41' ' ' TYR . 4.9 p -125.29 104.45 13.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 N-CA-C 114.885 1.439 . . . . 0.47999999999999998 114.885 -163.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.47 HG13 HG23 ' A' ' 71' ' ' ILE . 4.8 t -145.79 109.07 4.4 Favored Pre-proline 0 C--N 1.328 -0.36 0 O-C-N 122.088 -0.382 . . . . 1.0700000000000001 110.775 170.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 32.1 Cg_exo -56.87 129.24 33.48 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 120.711 0.94 . . . . 0.47999999999999998 110.55 169.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.691 ' HD2' HG21 ' A' ' 34' ' ' VAL . 11.8 t80 -53.59 -32.16 49.88 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.261 -0.427 . . . . 1.3100000000000001 110.631 -175.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.592 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 2.0 m -57.45 -30.73 65.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.194 -0.457 . . . . 1.2 112.041 -178.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.671 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -76.05 -55.44 11.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 C-N-CA 120.248 -0.581 . . . . 0.51000000000000001 110.52 -175.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.908 HD23 HD21 ' A' ' 104' ' ' LEU . 42.3 mt -53.49 -27.17 23.82 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.524 -0.762 . . . . 1.0 110.952 172.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.592 ' HB3' ' O ' ' A' ' 99' ' ' SER . 34.8 t80 -60.77 -46.42 90.54 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.595 -1.184 . . . . 0.95999999999999996 108.786 178.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.596 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.3 m-80 -73.44 -56.05 5.56 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.358 -0.837 . . . . 0.81999999999999995 112.217 -177.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.975 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.9 pp -59.85 -46.68 88.5 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.46 0.911 . . . . 0.65000000000000002 113.46 -179.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -61.71 -24.06 66.53 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.918 0.866 . . . . 0.42999999999999999 110.104 178.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.596 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.7 ttp180 -68.61 -49.16 61.44 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-N 114.896 -1.047 . . . . 1.8100000000000001 110.82 174.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.667 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -81.85 -54.82 5.03 Favored 'General case' 0 C--O 1.241 0.644 0 CA-C-O 122.122 0.963 . . . . 0.80000000000000004 112.213 -176.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.94 ' HB ' HG13 ' A' ' 114' ' ' ILE . 0.6 OUTLIER -88.72 -20.97 7.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 O-C-N 121.348 -0.845 . . . . 0.88 109.883 -176.211 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.597 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.05 -19.93 79.62 Favored Glycine 0 CA--C 1.51 -0.267 0 C-N-CA 120.077 -1.058 . . . . 0.38 110.93 167.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.667 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -50.55 -45.86 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.7 -1.222 . . . . 1.0900000000000001 107.7 167.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 4.6 p-10 -81.16 -84.36 0.1 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 119.026 -1.07 . . . . 1.8700000000000001 110.929 163.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.428 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 5.0 p-90 178.1 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.604 0.638 . . . . 1.1699999999999999 112.665 175.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -95.35 121.95 37.55 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 116.691 -0.231 . . . . 2.1499999999999999 111.568 -175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.94 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.4 mp -113.19 154.81 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 109.447 -0.575 . . . . 0.39000000000000001 109.447 -175.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.522 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -100.4 153.53 19.26 Favored 'General case' 0 C--N 1.309 -1.16 0 CA-C-N 115.62 -0.718 . . . . 2.1099999999999999 109.198 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.665 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -135.45 151.5 50.47 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 107.683 -1.229 . . . . 0.62 107.683 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.805 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 38.3 tt0 -146.07 126.63 14.18 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.865 0.364 . . . . 0.80000000000000004 110.032 -177.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.765 ' HB2' ' CZ ' ' A' ' 64' ' ' PHE . 15.0 tp -97.34 137.13 36.81 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.169 0.509 . . . . 1.25 110.692 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.737 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -115.84 100.52 8.07 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.344 -0.984 . . . . 0.63 108.344 170.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.852 HD11 HG22 ' A' ' 60' ' ' ILE . 4.6 tp -114.01 118.9 59.72 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 CA-C-O 121.218 0.533 . . . . 0.81000000000000005 111.091 -173.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.14 124.18 6.91 Favored Glycine 0 N--CA 1.447 -0.591 0 N-CA-C 111.544 -0.622 . . . . 0.26000000000000001 111.544 175.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.61 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.5 mp -104.03 100.71 10.48 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-O 121.035 0.445 . . . . 1.2 111.108 -174.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.111 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 99.9 m -102.62 96.6 6.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.223 -0.899 . . . . 0.32000000000000001 108.826 172.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.708 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.94 133.12 58.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.049 0 C-N-CA 120.528 -0.469 . . . . 0.97999999999999998 110.717 -175.604 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.481 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 1.0 OUTLIER -75.22 105.67 6.36 Favored 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.93 -0.767 . . . . 1.52 108.93 -177.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 1.006 HD23 HG21 ' A' ' 55' ' ' ILE . 19.2 mt -120.2 143.05 34.82 Favored Pre-proline 0 C--O 1.216 -0.675 0 O-C-N 124.706 1.254 . . . . 1.28 109.925 -175.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.411 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 78.0 Cg_exo -53.14 -37.47 79.75 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.905 2.403 . . . . 0.73999999999999999 115.361 -171.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.719 HG23 ' HE1' ' A' ' 51' ' ' TYR . 97.7 t -73.64 -56.93 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 121.747 -0.596 . . . . 1.1200000000000001 112.496 -175.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' ' 132' ' ' PHE . 14.9 p -92.16 -7.97 10.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 122.32 1.057 . . . . 1.3500000000000001 109.868 -175.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.27 -36.78 2.39 Favored Glycine 0 N--CA 1.462 0.43 0 CA-C-N 114.18 -1.373 . . . . 1.05 112.078 -178.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.5 pt-20 -165.84 122.3 1.36 Allowed 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.544 -1.28 . . . . 1.1599999999999999 107.544 177.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.671 ' HB2' HG11 ' A' ' 129' ' ' VAL . 7.9 t80 -111.98 143.28 43.23 Favored 'General case' 0 C--N 1.315 -0.91 0 C-N-CA 120.241 -0.584 . . . . 1.9099999999999999 109.801 -177.457 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.501 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 64.7 m -123.75 102.43 7.82 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.846 -0.615 . . . . 1.1899999999999999 111.524 -175.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.411 HD12 ' O ' ' A' ' 134' ' ' ILE . 2.2 pp -126.53 139.19 34.06 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.728 -0.669 . . . . 0.5 110.096 173.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -91.16 162.26 3.8 Favored 'Trans proline' 0 N--CA 1.447 -1.25 0 C-N-CA 122.021 1.814 . . . . 0.45000000000000001 112.557 177.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -161.5 167.9 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 108.29 -1.004 . . . . 0.44 108.29 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -137.1 148.78 46.92 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.952 -0.299 . . . . 0.88 110.794 -170.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.3 t -140.39 107.83 5.56 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.445 -0.946 . . . . 0.95999999999999996 108.445 177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.805 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.74 143.93 43.81 Favored 'General case' 0 C--N 1.315 -0.896 0 C-N-CA 120.865 -0.334 . . . . 1.76 110.789 -175.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -152.73 132.62 3.75 Favored Glycine 0 N--CA 1.438 -1.225 0 N-CA-C 110.812 -0.915 . . . . 0.5 110.812 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 9.3 mt-10 -97.55 126.31 42.76 Favored 'General case' 0 C--N 1.312 -1.036 0 N-CA-C 108.926 -0.768 . . . . 2.1000000000000001 108.926 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.7 pp -144.03 173.3 5.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 109.173 -0.677 . . . . 0.76000000000000001 109.173 -173.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -65.55 168.22 7.76 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.747 0.647 . . . . 3.5299999999999998 112.747 -173.249 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.915 HD12 ' HD2' ' A' ' 145' ' ' PRO . 22.9 tp -56.21 130.48 74.74 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-N 115.033 -0.985 . . . . 1.23 112.324 -173.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.915 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.8 Cg_endo -58.27 170.9 2.02 Favored 'Trans proline' 0 C--N 1.354 0.849 0 C-N-CA 124.24 3.293 . . . . 0.70999999999999996 112.93 179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.4 m -63.58 102.9 0.48 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.272 -0.422 . . . . 1.71 110.531 176.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.484 ' HB2' ' H ' ' A' ' 151' ' ' PHE . 7.7 p90 -122.87 -26.84 4.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.075 -0.511 . . . . 2.6400000000000001 111.158 -176.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.401 ' HE3' ' HB2' ' A' ' 148' ' ' LYS . 34.5 ttmt 52.09 46.91 25.8 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-O 121.274 0.559 . . . . 3.7200000000000002 111.386 177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 67.12 9.06 6.64 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 115.508 -0.769 . . . . 4.2800000000000002 112.504 178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -98.4 -46.03 5.92 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.871 0.367 . . . . 2.8599999999999999 110.643 -179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.484 ' H ' ' HB2' ' A' ' 147' ' ' PHE . 50.0 m-85 . . . . . 0 C--O 1.249 1.075 0 CA-C-N 114.754 -1.112 . . . . 3.96 108.767 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HG3' ' H ' ' A' ' 2' ' ' ALA . 7.6 tpt . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.232 -0.655 . . . . 12.109999999999999 109.232 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.485 ' H ' ' HG3' ' A' ' 1' ' ' MET . . . -100.01 24.07 9.04 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.732 0.641 . . . . 9.0199999999999996 112.732 -171.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.1 t -86.54 -39.27 16.38 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.713 -0.477 . . . . 6.8300000000000001 109.713 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.474 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -127.69 22.2 6.39 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 8.5500000000000007 110.143 173.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 4' ' ' LEU . 3.5 mm? 73.34 150.75 0.11 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 114.738 -1.119 . . . . 10.470000000000001 111.861 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -84.55 34.66 0.53 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.401 -0.818 . . . . 11.69 111.09 -179.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 62.95 26.63 15.62 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.0 -0.546 . . . . 11.42 111.242 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -94.9 142.64 27.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.767 -0.652 . . . . 11.58 109.682 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 9' ' ' LYS . 50.4 mtpt -130.86 163.45 27.39 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.466 -0.334 . . . . 15.74 110.94 -176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 62.2 m-20 70.93 -56.78 0.61 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.678 0.791 . . . . 12.69 112.432 173.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -66.12 -35.31 80.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 13.85 110.284 -178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 23.0 m -68.99 131.33 33.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.802 -0.635 . . . . 8.8699999999999992 110.894 179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -95.69 30.3 2.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.743 -0.662 . . . . 8.9100000000000001 110.863 -177.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 57.58 41.87 25.05 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.957 -0.565 . . . . 8.5999999999999996 110.731 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 tmtm? -56.77 -59.71 4.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.691 -0.686 . . . . 9.0399999999999991 110.554 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.5 tp -131.33 128.46 39.76 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.311 -0.404 . . . . 5.5800000000000001 110.064 -179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.2 m -142.27 147.69 36.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.691 -0.485 . . . . 2.6899999999999999 109.691 178.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.461 ' HA ' HG13 ' A' ' 129' ' ' VAL . . . 69.42 -90.53 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 O-C-N 123.931 0.769 . . . . 1.6799999999999999 111.003 -178.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.699 HG21 ' HG ' ' A' ' 126' ' ' LEU . 16.9 pt -153.02 170.45 8.15 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.184 -0.302 . . . . 3.1899999999999999 110.184 -173.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_exo -69.21 -160.59 0.06 OUTLIER 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.913 2.409 . . . . 2.4199999999999999 111.946 172.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' HE3' ' OE1' ' A' ' 23' ' ' GLU . 33.4 tttp -66.61 105.69 0.91 Allowed Pre-proline 0 CA--C 1.537 0.448 0 N-CA-C 110.093 -0.336 . . . . 6.3799999999999999 110.093 179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.785 ' HB3' ' HG3' ' A' ' 50' ' ' PRO . 93.6 Cg_endo -100.48 54.4 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 123.973 3.115 . . . . 2.77 113.847 -168.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.635 ' HA ' HD11 ' A' ' 134' ' ' ILE . 11.3 pt-20 -123.59 127.48 48.34 Favored 'General case' 0 N--CA 1.431 -1.416 0 CA-C-O 121.46 0.648 . . . . 3.3900000000000001 110.985 -168.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.619 ' C ' ' HA ' ' A' ' 47' ' ' VAL . . . 170.77 127.38 0.94 Allowed Glycine 0 N--CA 1.422 -2.294 0 C-N-CA 119.606 -1.283 . . . . 0.54000000000000004 112.701 171.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.493 ' HB2' HD21 ' A' ' 122' ' ' LEU . 4.9 m -172.92 37.45 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.829 0.851 . . . . 1.2 109.62 167.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 46' ' ' SER . 7.4 p -134.25 147.42 30.21 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.56 -0.746 . . . . 0.93000000000000005 110.926 -174.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -166.11 -35.67 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.839 -0.619 . . . . 0.47999999999999998 110.899 165.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 33.3 t70 -167.09 164.78 15.83 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 110.365 -0.235 . . . . 1.6899999999999999 110.365 179.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.512 HG21 ' HZ ' ' A' ' 64' ' ' PHE . 69.0 t -142.91 120.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.992 -0.373 . . . . 1.1399999999999999 109.992 172.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.439 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 9.7 m-20 -92.4 109.86 21.25 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.8300000000000001 110.648 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -87.33 118.3 26.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.394 -0.595 . . . . 0.93999999999999995 109.394 177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -124.58 -125.95 0.25 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.195 -0.457 . . . . 1.3300000000000001 109.962 177.721 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.955 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 2.7 p30 179.76 176.67 0.67 Allowed 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 121.13 0.491 . . . . 2.8500000000000001 112.1 -171.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.539 HG12 ' O ' ' A' ' 38' ' ' SER . 1.2 t -154.59 132.38 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 CA-C-N 114.816 -1.084 . . . . 3.2599999999999998 109.549 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 56.7 t30 51.34 -103.37 0.14 Allowed 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 114.504 -1.225 . . . . 3.1600000000000001 110.605 163.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -175.87 33.86 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 122.92 1.343 . . . . 5.46 108.228 169.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -130.4 -39.92 1.29 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 113.377 -1.738 . . . . 1.9199999999999999 109.134 -172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.723 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 39.4 t -143.16 165.4 27.53 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 113.976 -1.465 . . . . 0.93999999999999995 107.132 174.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.105 HG23 HG13 ' A' ' 96' ' ' VAL . 20.4 m -128.69 178.95 4.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 119.377 0.99 . . . . 0.85999999999999999 111.476 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.949 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 84.4 mt-10 -125.25 151.68 45.61 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.815 -0.63 . . . . 1.1899999999999999 111.431 -173.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.884 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 13.5 p90 -136.46 123.42 21.45 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.897 -0.721 . . . . 3.73 110.197 165.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.443 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.5 OUTLIER -86.68 110.82 20.13 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.528 -0.915 . . . . 0.81000000000000005 108.528 174.511 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.911 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.09 115.59 28.13 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 121.816 0.817 . . . . 0.41999999999999998 110.211 178.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 20.8 ttmt -84.72 117.72 23.98 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.252 -1.34 . . . . 2.6299999999999999 108.432 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.747 HG21 HG12 ' A' ' 92' ' ' ILE . 39.5 t -111.57 144.9 18.52 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-O 121.435 0.636 . . . . 0.81999999999999995 111.841 -169.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.672 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 24.7 m -133.57 97.5 3.95 Favored 'General case' 0 N--CA 1.428 -1.561 0 CA-C-N 115.22 -0.9 . . . . 0.71999999999999997 108.735 163.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.619 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -85.95 132.16 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 CA-C-O 121.61 0.719 . . . . 1.1399999999999999 110.893 -177.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 26.8 m -111.33 115.53 29.45 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 114.718 -1.128 . . . . 0.40999999999999998 110.032 -174.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.775 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.9 t30 -91.53 132.77 32.58 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.717 1.26 . . . . 1.48 108.409 174.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.785 ' HG3' ' HB3' ' A' ' 22' ' ' PRO . 42.0 Cg_endo -89.04 3.31 5.66 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 123.129 2.553 . . . . 0.72999999999999998 114.147 -177.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.616 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 91.7 t80 -108.33 133.1 53.01 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.152 -0.684 . . . . 2.0800000000000001 109.152 -173.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.777 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 23.8 p -77.08 30.27 0.14 Allowed 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 113.496 0.924 . . . . 1.51 113.496 -165.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.572 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 62.2 m80 -146.15 142.81 28.83 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.597 -0.89 . . . . 1.6699999999999999 108.597 172.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.5 t -41.01 105.75 0.05 OUTLIER 'General case' 0 C--O 1.208 -1.125 0 O-C-N 123.886 0.741 . . . . 1.3899999999999999 112.151 171.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.947 ' O ' ' HA ' ' A' ' 81' ' ' SER . 8.4 pt -75.63 171.32 12.26 Favored Pre-proline 0 C--O 1.209 -1.076 0 N-CA-C 107.463 -1.31 . . . . 1.03 107.463 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.422 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 10.2 Cg_endo -89.46 -62.58 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.393 0 CA-C-N 120.301 1.143 . . . . 0.37 113.781 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.649 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.4 mm -130.3 154.77 40.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 C-N-CA 120.401 -0.52 . . . . 1.23 110.919 -167.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.717 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 4.0 m -146.1 -176.52 5.19 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-O 121.977 0.894 . . . . 1.1499999999999999 110.988 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.953 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 43.1 tt0 -138.47 118.14 13.09 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.96 -1.473 . . . . 1.3600000000000001 111.068 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.513 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.63 108.22 21.02 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-O 122.255 1.026 . . . . 1.05 109.54 166.775 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 15.5 p -113.61 102.62 10.44 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 113.826 -1.533 . . . . 0.82999999999999996 108.413 177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.597 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -112.74 126.89 55.91 Favored 'General case' 0 N--CA 1.441 -0.903 0 CA-C-O 121.488 0.661 . . . . 0.40000000000000002 110.012 -165.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.64 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 20.9 m -120.86 104.25 9.71 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.83 -1.077 . . . . 0.38 108.392 175.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.814 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 1.8 m-85 -97.3 130.06 44.52 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.444 0.64 . . . . 0.95999999999999996 110.809 -175.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.7 m170 -121.1 145.1 48.16 Favored 'General case' 0 C--N 1.315 -0.932 0 N-CA-C 107.104 -1.443 . . . . 1.29 107.104 176.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.788 ' CB ' HD22 ' A' ' 104' ' ' LEU . 33.8 t -101.97 -102.72 0.27 Allowed 'General case' 0 C--N 1.313 -1.018 0 C-N-CA 119.079 -1.049 . . . . 1.27 110.891 176.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.66 -54.32 47.78 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 109.048 -0.723 . . . . 0.35999999999999999 109.048 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.19 17.9 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.716 0 N-CA-C 109.093 -1.603 . . . . 0.39000000000000001 109.093 166.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.552 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 5.9 ptp180 -106.08 -147.51 0.4 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 114.859 -0.67 . . . . 1.97 109.561 -174.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -123.82 99.1 6.11 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 118.19 0.45 . . . . 2.6099999999999999 110.349 -170.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.74 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.5 mm -70.89 -38.95 74.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.544 -0.753 . . . . 0.40000000000000002 110.231 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.49 171.69 32.92 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.572 -0.823 . . . . 0.48999999999999999 111.846 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -159.42 154.7 25.36 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.091 0.446 . . . . 1.8100000000000001 110.367 177.503 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.53 155.56 13.6 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 111.433 -0.667 . . . . 0.42999999999999999 111.433 175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.473 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 17.3 ptpt -131.38 134.77 46.61 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.967 0.413 . . . . 1.72 110.703 178.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 82.0 mt -140.01 122.67 10.11 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.866 -0.606 . . . . 0.72999999999999998 109.939 -178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -68.94 108.32 1.9 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.204 1.936 . . . . 0.56999999999999995 111.033 172.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -114.92 141.74 27.34 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 109.549 -0.537 . . . . 0.79000000000000004 109.549 -174.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.649 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.8 Cg_endo -60.62 87.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.577 2.185 . . . . 0.57999999999999996 112.407 176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.717 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -88.7 33.99 4.01 Favored Glycine 0 N--CA 1.447 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.40000000000000002 111.905 178.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.947 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -71.01 118.29 13.59 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 108.681 -0.859 . . . . 0.62 108.681 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.773 HD21 HD22 ' A' ' 49' ' ' ASN . 1.4 pt? -148.11 -159.98 1.11 Allowed 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 118.07 -1.452 . . . . 1.1000000000000001 114.73 -158.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.519 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 56.2 mttm -52.57 -92.05 0.0 OUTLIER 'General case' 0 C--O 1.234 0.281 0 CA-C-N 115.131 -0.94 . . . . 1.8400000000000001 112.778 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 167.02 105.76 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 107.638 -1.245 . . . . 0.98999999999999999 107.638 -174.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HG2' ' HA ' ' A' ' 52' ' ' SER . 37.0 pttt 41.37 49.47 3.43 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.363 1.039 . . . . 1.8400000000000001 111.034 -175.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -146.17 -172.34 3.91 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.064 -0.971 . . . . 0.64000000000000001 109.757 -172.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.672 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.7 ttm -113.28 118.15 33.83 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.886 0.374 . . . . 1.3500000000000001 110.801 -171.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.598 ' CG2' HG13 ' A' ' 47' ' ' VAL . 7.1 t -107.35 143.43 35.66 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.125 -0.489 . . . . 0.77000000000000002 110.19 -179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -80.54 136.66 36.32 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.333 0.587 . . . . 0.47999999999999998 109.59 178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.729 ' HB3' ' HB ' ' A' ' 45' ' ' VAL . 4.2 tt -133.53 170.48 15.45 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.322 -0.992 . . . . 0.77000000000000002 108.322 -176.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.408 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.2 t70 -135.2 123.5 23.14 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 121.012 -0.275 . . . . 1.8100000000000001 110.647 -173.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.911 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -105.18 138.15 19.45 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.616 0.246 . . . . 0.65000000000000002 110.997 -178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.79 168.25 0.23 Allowed 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 123.543 2.829 . . . . 1.0700000000000001 112.606 174.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.949 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 4.5 m -110.58 88.81 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.774 -0.648 . . . . 0.46000000000000002 111.364 -166.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.529 HG13 ' HE2' ' A' ' 41' ' ' TYR . 4.1 p -128.46 101.21 6.59 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 114.726 1.38 . . . . 0.47999999999999998 114.726 -165.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.105 HG13 HG23 ' A' ' 39' ' ' VAL . 0.5 OUTLIER -148.3 115.65 3.96 Favored Pre-proline 0 C--N 1.317 -0.845 0 C-N-CA 119.882 -0.727 . . . . 1.0700000000000001 110.208 162.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.1 128.52 30.54 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 121.439 1.426 . . . . 0.47999999999999998 109.746 173.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.723 ' H ' ' HA ' ' A' ' 38' ' ' SER . 20.5 t80 -57.03 -28.1 62.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.03 0.443 . . . . 1.3100000000000001 110.112 -175.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.5 m -52.44 -30.51 29.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.563 -0.744 . . . . 1.2 111.892 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.74 HG21 ' HA ' ' A' ' 71' ' ' ILE . 28.1 mm -78.2 -54.12 12.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.409 -0.359 . . . . 0.51000000000000001 111.209 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.787 HD23 HD21 ' A' ' 104' ' ' LEU . 22.8 mt -50.44 -27.96 7.39 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-O 121.572 0.701 . . . . 1.0 110.218 170.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.551 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 16.7 t80 -68.99 -40.73 78.6 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.661 -1.609 . . . . 0.95999999999999996 108.506 -178.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.657 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 18.6 m-80 -74.42 -56.51 4.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.816 -0.629 . . . . 0.81999999999999995 112.365 178.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.788 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.1 pp -56.7 -56.35 22.5 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.992 0.738 . . . . 0.65000000000000002 112.992 178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.485 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.34 -21.99 66.6 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.886 0.85 . . . . 0.42999999999999999 110.149 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.657 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.0 OUTLIER -61.03 -53.99 50.36 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.481 -1.236 . . . . 1.8100000000000001 110.147 173.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.617 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.2 t70 -85.4 -52.16 6.06 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 122.189 0.995 . . . . 0.80000000000000004 111.723 -171.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.04 HG21 HG23 ' A' ' 114' ' ' ILE . 34.3 m -80.03 -31.08 13.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 O-C-N 121.586 -0.696 . . . . 0.88 110.706 -179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.485 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.03 -16.54 80.67 Favored Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.087 -0.961 . . . . 0.38 111.616 173.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.617 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.71 -42.53 13.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 106.456 -1.683 . . . . 1.0900000000000001 106.456 161.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 42.0 m-20 -75.74 -86.51 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 115.57 -0.741 . . . . 1.8700000000000001 110.298 159.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.443 ' O ' HD23 ' A' ' 144' ' ' LEU . 17.0 p-90 176.73 -39.92 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 122.743 0.417 . . . . 1.1699999999999999 111.629 175.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -93.3 133.35 36.62 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.359 0.599 . . . . 2.1499999999999999 111.511 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.04 HG23 HG21 ' A' ' 108' ' ' VAL . 0.7 OUTLIER -117.95 149.66 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.534 0 CA-C-N 115.603 -0.726 . . . . 0.39000000000000001 109.604 179.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.553 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 10.1 p-10 -104.79 154.98 19.31 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 108.457 -0.942 . . . . 2.1099999999999999 108.457 175.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 48.1 m-85 -134.61 156.98 47.76 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.526 -0.916 . . . . 0.62 108.526 176.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.526 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 31.5 tt0 -143.56 129.46 19.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.607 -0.516 . . . . 0.80000000000000004 109.607 177.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.814 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.5 OUTLIER -103.79 133.99 47.85 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.769 -0.65 . . . . 1.25 109.46 177.291 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.786 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.7 100.73 8.01 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.02 -0.733 . . . . 0.63 109.02 172.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.589 ' HB ' HD11 ' A' ' 118' ' ' LEU . 6.1 tp -110.23 117.58 55.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.305 0.574 . . . . 0.81000000000000005 110.706 -176.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.494 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.65 124.51 7.28 Favored Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 111.0 -0.84 . . . . 0.26000000000000001 111.0 176.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.9 mm? -101.1 98.23 8.69 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.529 0.68 . . . . 1.2 111.961 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 0.953 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 96.5 m -95.83 94.78 7.85 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-N 114.32 -1.309 . . . . 0.32000000000000001 108.954 169.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.808 HG13 HD21 ' A' ' 126' ' ' LEU . 9.7 pt -107.38 141.63 22.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 C-N-CA 120.414 -0.514 . . . . 0.97999999999999998 109.646 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -88.55 106.12 18.09 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.688 -0.486 . . . . 1.52 109.688 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.808 HD21 HG13 ' A' ' 124' ' ' ILE . 1.5 mm? -103.13 141.62 22.86 Favored Pre-proline 0 C--O 1.213 -0.82 0 O-C-N 124.344 1.028 . . . . 1.28 109.586 -179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.616 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 52.5 Cg_exo -57.9 -24.98 67.47 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.082 1.855 . . . . 0.73999999999999999 113.988 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 24.7 t -76.82 -58.13 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-O 120.984 0.421 . . . . 1.1200000000000001 111.844 -173.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.461 HG13 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -102.79 0.67 10.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 122.078 0.942 . . . . 1.3500000000000001 110.789 -177.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 84.33 -39.45 2.9 Favored Glycine 0 C--N 1.31 -0.873 0 CA-C-N 113.86 -1.518 . . . . 1.05 111.41 -177.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 9.6 pt-20 -167.41 155.44 9.24 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.285 -0.635 . . . . 1.1599999999999999 109.285 176.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -143.47 142.11 31.05 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.229 -0.656 . . . . 1.9099999999999999 109.229 173.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.505 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.7 m -122.66 107.94 12.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.904 0.383 . . . . 1.1899999999999999 111.777 -174.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.677 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.6 pp -128.0 141.25 40.59 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.19 -0.459 . . . . 0.5 110.006 172.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.494 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.6 Cg_endo -92.42 165.66 2.91 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 C-N-CA 122.07 1.847 . . . . 0.45000000000000001 112.872 177.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.548 HG23 ' CG2' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -159.03 158.2 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.712 -1.218 . . . . 0.44 107.712 179.046 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.628 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 76.5 p -131.97 152.41 51.13 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.471 -0.492 . . . . 0.88 111.898 -170.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.5 t -139.46 110.73 6.97 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.835 -0.802 . . . . 0.95999999999999996 108.835 176.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.526 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -113.19 140.92 47.53 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 120.835 -0.346 . . . . 1.76 110.548 -179.264 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.49 139.16 6.34 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.868 -0.682 . . . . 0.5 111.971 -179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 27.9 mt-10 -99.12 129.39 45.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.739 -0.467 . . . . 2.1000000000000001 109.739 179.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.0 pp -139.54 173.59 10.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 109.638 -0.504 . . . . 0.76000000000000001 109.638 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 34.5 mtmm -65.59 172.29 3.49 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.897 0.703 . . . . 3.5299999999999998 112.897 -171.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.694 HD22 ' HD2' ' A' ' 145' ' ' PRO . 1.7 tm? -61.64 126.59 87.17 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 114.924 -1.034 . . . . 1.23 109.84 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.694 ' HD2' HD22 ' A' ' 144' ' ' LEU . 72.5 Cg_endo -74.38 175.37 11.09 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 123.608 2.872 . . . . 0.70999999999999996 113.198 -175.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.8 m -55.08 98.46 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 115.94 -0.573 . . . . 1.71 110.668 173.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.72 ' HB2' ' HA ' ' A' ' 151' ' ' PHE . 17.7 p90 -106.15 -29.06 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.433 -0.349 . . . . 2.6400000000000001 111.113 -177.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt 61.36 -80.41 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.74 -0.664 . . . . 3.7200000000000002 112.016 -178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -145.74 9.17 1.16 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.988 0.899 . . . . 4.2800000000000002 109.202 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.454 ' HB3' ' CE2' ' A' ' 102' ' ' PHE . 64.9 m-85 -109.67 -45.69 3.63 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.209 -0.905 . . . . 2.8599999999999999 111.652 -170.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.72 ' HA ' ' HB2' ' A' ' 147' ' ' PHE . 60.6 m-85 . . . . . 0 C--O 1.246 0.899 0 O-C-N 124.259 0.974 . . . . 3.96 109.034 -165.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.6 mmm . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.939 0.399 . . . . 12.109999999999999 109.968 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -78.44 141.2 38.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.615 -0.513 . . . . 9.0199999999999996 109.615 174.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.561 ' HB3' ' HE2' ' A' ' 51' ' ' TYR . 19.5 t -88.25 -76.07 0.4 Allowed 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 120.691 -0.404 . . . . 6.8300000000000001 111.1 -175.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 4' ' ' LEU . 38.7 mt -118.05 88.29 2.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.557 0.694 . . . . 8.5500000000000007 112.539 -176.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.76 -134.45 0.29 Allowed 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 107.938 -1.134 . . . . 10.470000000000001 107.938 170.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -165.12 164.81 20.25 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.788 -0.449 . . . . 11.69 109.788 171.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -146.78 -37.43 0.23 Allowed 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.362 -0.381 . . . . 11.42 110.989 -179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -146.57 -94.97 0.09 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.718 0.294 . . . . 11.58 110.927 177.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -122.42 175.58 6.36 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.627 -0.508 . . . . 15.74 109.627 177.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -84.9 138.25 32.63 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.101 0.476 . . . . 12.69 109.846 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -151.12 18.18 0.76 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.751 -0.659 . . . . 13.85 109.47 176.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.479 HG12 ' HB2' ' A' ' 15' ' ' LYS . 15.5 m -125.99 108.05 18.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.532 -0.758 . . . . 8.8699999999999992 111.353 -176.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -114.14 -49.31 2.86 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.754 -0.657 . . . . 8.9100000000000001 109.422 174.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -108.4 -20.7 13.03 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.467 -0.788 . . . . 8.5999999999999996 109.658 176.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.835 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 9.3 mmpt? -55.23 -49.94 70.71 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 115.562 -0.744 . . . . 9.0399999999999991 111.053 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 60.9 tp -107.29 100.16 9.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.123 -0.49 . . . . 5.5800000000000001 109.828 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 18.8 m -109.57 113.46 26.26 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.449 -0.574 . . . . 2.6899999999999999 109.449 176.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.635 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . 66.7 -148.01 0.18 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.497 -0.774 . . . . 1.6799999999999999 111.467 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.664 ' H ' HD13 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -98.48 154.28 37.61 Favored Pre-proline 0 C--N 1.317 -0.816 0 CA-C-N 115.826 -0.624 . . . . 3.1899999999999999 110.854 -170.134 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -77.89 -12.9 16.16 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.836 2.357 . . . . 2.4199999999999999 114.318 -171.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 51.9 mmtt -129.23 138.44 33.18 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.97 -0.105 . . . . 6.3799999999999999 110.968 -177.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -68.35 160.58 48.45 Favored 'Trans proline' 0 C--O 1.238 0.492 0 C-N-CA 122.334 2.023 . . . . 2.77 111.005 174.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.769 ' HG2' HD11 ' A' ' 124' ' ' ILE . 1.4 mp0 -118.27 156.56 28.63 Favored 'General case' 0 N--CA 1.419 -2.022 0 N-CA-C 105.8 -1.926 . . . . 3.3900000000000001 105.8 -172.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.761 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.24 -177.4 17.03 Favored Glycine 0 N--CA 1.434 -1.491 0 C-N-CA 117.653 -2.213 . . . . 0.54000000000000004 113.798 175.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.659 ' HB2' HD11 ' A' ' 122' ' ' LEU . 37.7 m -169.47 34.6 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.642 -1.244 . . . . 1.2 107.642 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 46' ' ' SER . 32.7 m -134.04 155.33 39.42 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.347 -1.297 . . . . 0.93000000000000005 109.786 -174.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -165.15 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 109.57 -0.53 . . . . 0.47999999999999998 109.57 166.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.499 ' OD1' ' HD2' ' A' ' 44' ' ' LYS . 4.8 p-10 -167.99 163.0 13.63 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.523 0.677 . . . . 1.6899999999999999 112.652 -179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 53.9 t -139.17 132.98 39.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 114.821 -1.082 . . . . 1.1399999999999999 109.266 176.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.64 138.26 53.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.484 -0.326 . . . . 1.8300000000000001 110.796 -173.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.523 HD21 ' CG1' ' A' ' 39' ' ' VAL . 3.2 tm? -94.82 138.96 31.94 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.789 -0.187 . . . . 0.93999999999999995 111.095 -174.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.703 ' HE3' ' HB2' ' A' ' 42' ' ' LEU . 6.4 ptpt -145.15 -92.53 0.1 Allowed 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 114.167 1.173 . . . . 1.3300000000000001 114.167 177.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.672 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.8 OUTLIER -89.59 178.71 6.21 Favored 'General case' 0 C--O 1.204 -1.304 0 O-C-N 121.308 -0.87 . . . . 2.8500000000000001 111.262 -155.565 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.861 ' HA ' ' O ' ' A' ' 38' ' ' SER . 6.6 p -168.84 -40.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 CA-C-O 120.787 0.327 . . . . 3.2599999999999998 111.276 179.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 8.9 t30 67.9 -84.87 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.756 -1.202 . . . . 3.1600000000000001 107.756 -170.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.476 ' HD2' ' OD1' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -177.85 25.44 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 122.229 1.014 . . . . 5.46 109.027 168.666 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.87 -40.46 1.06 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.745 -1.57 . . . . 1.9199999999999999 109.163 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.861 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 27.1 t -155.75 127.97 7.65 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-O 121.628 0.727 . . . . 0.93999999999999995 112.579 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 101' ' ' LEU . 26.7 t -79.1 155.13 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 114.967 -1.015 . . . . 0.85999999999999999 109.216 178.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.833 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 27.4 mt-10 -117.62 131.59 56.63 Favored 'General case' 0 N--CA 1.442 -0.857 0 C-N-CA 119.002 -1.079 . . . . 1.1899999999999999 111.867 -176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.854 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.84 104.97 11.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.137 -0.938 . . . . 3.73 110.513 -176.457 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.703 ' HB2' ' HE3' ' A' ' 32' ' ' LYS . 0.4 OUTLIER -72.47 109.85 6.45 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.919 -1.141 . . . . 0.81000000000000005 107.919 178.289 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.558 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -103.99 107.64 18.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.713 0.768 . . . . 0.41999999999999998 110.144 -177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HD2' ' OD1' ' A' ' 28' ' ' ASP . 13.0 ttmt -83.47 126.14 32.45 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 107.88 -1.156 . . . . 2.6299999999999999 107.88 176.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.647 HG11 HD22 ' A' ' 90' ' ' LEU . 43.1 t -111.4 141.52 26.54 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 115.705 -0.68 . . . . 0.81999999999999995 109.929 -176.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 88' ' ' THR . 29.8 m -128.82 99.25 5.24 Favored 'General case' 0 N--CA 1.432 -1.337 0 C-N-CA 120.289 -0.564 . . . . 0.71999999999999997 110.225 171.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.761 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 48.7 t -81.61 122.82 37.18 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.256 0 CA-C-N 115.63 -0.714 . . . . 1.1399999999999999 109.748 -177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.661 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 18.9 m -101.43 116.55 33.04 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.639 -0.709 . . . . 0.40999999999999998 110.168 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.77 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 15.7 t30 -90.26 126.16 57.7 Favored Pre-proline 0 C--N 1.319 -0.757 0 N-CA-C 109.127 -0.694 . . . . 1.48 109.127 176.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.509 ' CG ' HG13 ' A' ' 19' ' ' ILE . 60.2 Cg_endo -91.84 15.14 1.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 123.248 2.632 . . . . 0.72999999999999998 113.832 -177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.561 ' HE2' ' HB3' ' A' ' 3' ' ' SER . 6.2 t80 -131.5 146.73 52.37 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.514 -0.921 . . . . 2.0800000000000001 108.514 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.728 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.7 t -80.96 34.47 0.35 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.937 0.399 . . . . 1.51 111.722 -169.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 36.9 m80 -145.31 133.01 21.0 Favored 'General case' 0 CA--C 1.522 -0.129 0 CA-C-N 116.654 -0.248 . . . . 1.6699999999999999 110.803 177.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.6 m -45.37 100.83 0.02 OUTLIER 'General case' 0 C--O 1.217 -0.653 0 C-N-CA 124.448 1.099 . . . . 1.3899999999999999 113.022 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.849 HG21 HD23 ' A' ' 126' ' ' LEU . 5.8 pt -77.34 128.32 80.76 Favored Pre-proline 0 C--O 1.207 -1.182 0 N-CA-C 109.222 -0.659 . . . . 1.03 109.222 -177.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.707 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 29.5 Cg_endo -60.88 -51.97 4.16 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.968 1.779 . . . . 0.37 113.691 -160.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.876 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 73.9 mt -138.27 157.61 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 C-N-CA 119.651 -0.82 . . . . 1.23 112.853 -173.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.837 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -139.92 168.17 20.42 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 122.565 1.174 . . . . 1.1499999999999999 112.245 178.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.119 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.9 tt0 -120.43 119.37 32.84 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 112.854 -1.976 . . . . 1.3600000000000001 110.18 178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 22.2 mm -94.8 110.5 23.95 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-N 114.652 -1.158 . . . . 1.05 110.336 172.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 64.8 p -121.22 102.4 8.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 108.99 -0.744 . . . . 0.82999999999999996 108.99 171.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.612 ' HD1' HG22 ' A' ' 60' ' ' ILE . 17.0 p90 -106.9 135.18 48.9 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.531 0.681 . . . . 0.40000000000000002 110.242 -171.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.605 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.0 m -130.75 105.85 8.07 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.47 -1.241 . . . . 0.38 108.726 174.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.532 ' CE1' HD23 ' A' ' 118' ' ' LEU . 96.6 m-85 -96.41 140.75 30.61 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.493 -0.558 . . . . 0.95999999999999996 109.493 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.445 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 6.3 m170 -127.15 144.43 51.04 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.453 -0.943 . . . . 1.29 108.453 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.576 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.29 -109.84 0.17 Allowed 'General case' 0 N--CA 1.43 -1.443 0 CA-C-N 116.531 -0.304 . . . . 1.27 111.457 177.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.479 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.04 -54.3 36.37 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.643 -0.873 . . . . 0.35999999999999999 108.643 -177.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.3 16.12 0.17 Allowed Glycine 0 N--CA 1.432 -1.625 0 N-CA-C 108.466 -1.853 . . . . 0.39000000000000001 108.466 167.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.456 ' NH1' ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -111.98 -171.12 1.78 Allowed 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.341 -0.985 . . . . 1.97 108.341 -178.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -108.88 90.9 3.43 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.174 0.512 . . . . 2.6099999999999999 111.16 -164.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.986 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -47.88 -42.02 9.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 114.987 -1.006 . . . . 0.40000000000000002 111.867 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -176.12 167.59 39.34 Favored Glycine 0 CA--C 1.503 -0.682 0 C-N-CA 119.859 -1.162 . . . . 0.48999999999999999 111.542 -177.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.584 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.81 153.89 9.03 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.355 0.598 . . . . 1.8100000000000001 111.343 175.294 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 168.09 -179.06 41.5 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.869 -0.892 . . . . 0.42999999999999999 110.869 178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.638 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -141.71 132.87 26.31 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.952 0.376 . . . . 1.72 111.34 -179.624 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.43 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 79.1 mt -130.87 109.16 15.54 Favored Pre-proline 0 N--CA 1.45 -0.469 0 CA-C-N 115.963 -0.562 . . . . 0.72999999999999998 109.877 179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.8 128.27 14.86 Favored 'Trans proline' 0 N--CA 1.462 -0.37 0 C-N-CA 122.317 2.011 . . . . 0.56999999999999995 110.401 173.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -138.96 144.76 42.6 Favored Pre-proline 0 C--N 1.324 -0.531 0 C-N-CA 120.758 -0.377 . . . . 0.79000000000000004 110.128 -174.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 57' ' ' ILE . 47.2 Cg_exo -57.24 90.41 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.578 2.185 . . . . 0.57999999999999996 111.571 172.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.876 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -75.7 13.68 6.5 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.176 -0.92 . . . . 0.40000000000000002 113.557 -177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.698 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 94.3 p -69.69 118.04 12.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.496 -0.557 . . . . 0.62 109.496 -176.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.59 HD21 ' HB2' ' A' ' 49' ' ' ASN . 1.5 pt? -143.83 -167.16 2.52 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 119.931 -0.708 . . . . 1.1000000000000001 112.631 -163.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.459 ' HD2' ' HB3' ' A' ' 86' ' ' ASP . 92.4 mttt -45.49 -93.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 113.083 0.771 . . . . 1.8400000000000001 113.083 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 163.37 107.18 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.512 0 N-CA-C 108.307 -0.997 . . . . 0.98999999999999999 108.307 -172.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.77 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptmt 45.43 47.65 10.81 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.218 0.948 . . . . 1.8400000000000001 111.159 -176.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.459 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 5.3 t70 -150.39 -170.03 3.54 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.226 -0.897 . . . . 0.64000000000000001 109.514 -173.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.474 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.6 ttp -119.2 119.39 33.98 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.986 0.422 . . . . 1.3500000000000001 110.874 -171.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 46' ' ' SER . 5.8 t -107.3 144.74 33.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.857 -0.611 . . . . 0.77000000000000002 110.501 -177.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.52 112.5 23.7 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.515 0.674 . . . . 0.47999999999999998 110.887 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.647 HD22 HG11 ' A' ' 45' ' ' VAL . 4.6 tt -102.72 166.28 10.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.142 -0.936 . . . . 0.77000000000000002 109.03 178.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.443 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 22.1 t70 -128.93 117.74 21.47 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.419 -0.512 . . . . 1.8100000000000001 112.295 -170.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 47.6 mm -110.84 122.72 37.36 Favored Pre-proline 0 C--N 1.327 -0.373 0 N-CA-C 108.738 -0.838 . . . . 0.65000000000000002 108.738 171.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.65 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 84.6 Cg_exo -46.7 -98.24 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.922 3.081 . . . . 1.0700000000000001 114.874 -171.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.854 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.3 OUTLIER -162.4 94.6 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.492 0 N-CA-C 112.124 0.416 . . . . 0.46000000000000002 112.124 -169.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.46 HG11 ' CE2' ' A' ' 62' ' ' PHE . 7.4 p -127.52 103.54 10.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.138 1.162 . . . . 0.47999999999999998 114.138 -172.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.687 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.1 p -152.36 98.15 2.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.254 -0.43 . . . . 1.0700000000000001 110.768 162.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 64.8 Cg_exo -51.4 135.89 47.29 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.924 1.749 . . . . 0.47999999999999998 112.12 176.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.426 ' OH ' ' HD1' ' A' ' 150' ' ' PHE . 4.7 t80 -55.56 -30.91 61.65 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 115.404 -0.817 . . . . 1.3100000000000001 111.094 -176.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.59 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 50.6 m -56.51 -33.75 66.33 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.39 0.515 . . . . 1.2 112.39 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.986 HG21 ' HA ' ' A' ' 71' ' ' ILE . 9.0 mm -78.66 -53.67 13.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 O-C-N 121.852 -0.53 . . . . 0.51000000000000001 111.84 -174.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.044 HD23 HD21 ' A' ' 104' ' ' LEU . 14.5 mt -50.67 -27.47 7.05 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-O 121.524 0.678 . . . . 1.0 110.124 170.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.59 ' HB3' ' O ' ' A' ' 99' ' ' SER . 37.4 t80 -63.69 -42.02 98.06 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.45 -1.25 . . . . 0.95999999999999996 108.605 -179.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.423 ' HB3' ' CZ ' ' A' ' 69' ' ' ARG . 32.9 m-80 -74.05 -57.92 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.699 -0.682 . . . . 0.81999999999999995 111.961 178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.044 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -58.2 -51.99 67.45 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.244 0.831 . . . . 0.65000000000000002 113.244 -178.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.63 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.48 -26.58 68.6 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.479 0.657 . . . . 0.42999999999999999 110.493 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 1.3 ttp180 -74.27 -52.5 12.12 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.484 -0.78 . . . . 1.8100000000000001 111.064 175.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.722 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 8.8 t70 -80.51 -52.42 7.64 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.826 0.822 . . . . 0.80000000000000004 111.183 -173.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.622 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -92.42 -18.47 7.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 O-C-N 121.912 -0.493 . . . . 0.88 110.581 -177.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.63 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.24 -19.09 79.87 Favored Glycine 0 CA--C 1.509 -0.321 0 C-N-CA 120.262 -0.97 . . . . 0.38 110.917 167.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.722 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -54.28 -49.61 62.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.392 -1.707 . . . . 1.0900000000000001 106.392 164.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 2.5 m-20 -66.58 -102.84 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 114.991 -1.004 . . . . 1.8700000000000001 109.902 162.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -179.86 -48.96 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 122.813 0.445 . . . . 1.1699999999999999 111.938 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -94.7 123.46 38.16 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 116.361 -0.382 . . . . 2.1499999999999999 110.108 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.762 HD11 HD12 ' A' ' 144' ' ' LEU . 3.5 mp -112.82 157.04 13.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 CA-C-O 120.899 0.38 . . . . 0.39000000000000001 110.636 -173.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.418 ' N ' HG22 ' A' ' 114' ' ' ILE . 3.2 m-20 -88.57 152.7 21.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.692 -0.685 . . . . 2.1099999999999999 109.348 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -145.16 159.97 42.17 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.156 -0.683 . . . . 0.62 109.156 173.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.681 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 33.5 tt0 -154.21 136.0 14.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.779 0.323 . . . . 0.80000000000000004 110.153 -179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -108.26 130.07 55.18 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.013 -0.736 . . . . 1.25 109.013 172.402 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.649 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -118.9 99.68 6.9 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.151 -0.685 . . . . 0.63 109.151 176.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.583 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -112.18 123.46 67.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 CA-C-O 121.349 0.595 . . . . 0.81000000000000005 110.367 -176.213 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.606 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.14 123.16 6.44 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 115.595 -0.729 . . . . 0.26000000000000001 111.552 178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.659 HD11 ' HB2' ' A' ' 25' ' ' SER . 2.2 mp -96.87 118.55 33.55 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.781 0.324 . . . . 1.2 110.794 -173.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.119 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 95.8 m -124.71 95.71 4.62 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.596 -0.729 . . . . 0.32000000000000001 109.524 172.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.837 HG22 ' HB3' ' A' ' 58' ' ' CYS . 14.7 pt -110.88 144.32 19.07 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 C-N-CA 120.6 -0.44 . . . . 0.97999999999999998 110.42 -178.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.707 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.8 m-20 -85.59 105.09 15.91 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.858 -1.164 . . . . 1.52 107.858 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.849 HD23 HG21 ' A' ' 55' ' ' ILE . 28.1 mt -102.47 167.33 10.54 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 125.0 1.438 . . . . 1.28 110.195 -174.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -76.17 -29.56 6.35 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 121.825 1.683 . . . . 0.73999999999999999 112.677 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.438 HG21 HG22 ' A' ' 19' ' ' ILE . 42.4 t -74.12 -58.95 3.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 112.543 0.572 . . . . 1.1200000000000001 112.543 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.635 HG23 ' HA ' ' A' ' 18' ' ' ALA . 41.8 t -105.94 2.95 10.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 122.528 1.156 . . . . 1.3500000000000001 109.441 -178.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.517 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 74.32 -24.72 1.11 Allowed Glycine 0 C--N 1.318 -0.434 0 CA-C-N 114.217 -1.356 . . . . 1.05 111.945 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.546 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 13.3 pt-20 -159.1 170.81 21.19 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 108.668 -0.864 . . . . 1.1599999999999999 108.668 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.735 ' O ' ' HA ' ' A' ' 123' ' ' THR . 7.0 t80 -163.57 132.78 3.98 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.652 -0.869 . . . . 1.9099999999999999 108.652 174.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 86.4 m -123.67 95.55 4.62 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.317 0.58 . . . . 1.1899999999999999 111.398 -177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.76 139.12 34.41 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.52 -0.764 . . . . 0.5 110.192 175.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.606 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 96.7 Cg_endo -89.15 161.97 5.76 Favored 'Trans proline' 0 N--CA 1.45 -1.042 0 C-N-CA 121.778 1.652 . . . . 0.45000000000000001 112.65 177.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -152.75 167.09 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 108.386 -0.968 . . . . 0.44 108.386 179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.8 p -137.82 151.09 47.74 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.355 0.598 . . . . 0.88 112.075 -172.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 t -139.98 103.34 4.61 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.29 -1.374 . . . . 0.95999999999999996 107.29 173.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.681 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -112.41 152.48 28.62 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.198 -0.456 . . . . 1.76 110.041 -174.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -165.53 141.96 7.38 Favored Glycine 0 N--CA 1.434 -1.435 0 C-N-CA 120.342 -0.933 . . . . 0.5 111.564 178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -107.29 123.98 49.11 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-N 114.785 -0.707 . . . . 2.1000000000000001 109.197 -179.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -145.9 174.39 2.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 108.527 -0.916 . . . . 0.76000000000000001 108.527 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 36.1 tttp -56.78 160.37 3.44 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.868 0.692 . . . . 3.5299999999999998 112.868 -175.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.762 HD12 HD11 ' A' ' 114' ' ' ILE . 19.4 tp -55.84 138.87 70.76 Favored Pre-proline 0 C--O 1.234 0.283 0 CA-C-N 114.894 -1.048 . . . . 1.23 111.581 -177.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.634 ' HD2' HD12 ' A' ' 144' ' ' LEU . 34.5 Cg_endo -63.61 174.25 3.79 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.317 2.678 . . . . 0.70999999999999996 111.911 176.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 8.8 t -53.63 130.5 36.44 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.375 0.607 . . . . 1.71 110.877 179.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -146.54 163.93 34.18 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.648 -0.706 . . . . 2.6400000000000001 110.044 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' HB3' ' H ' ' A' ' 149' ' ' ASP . 12.8 tppt? -174.69 -84.57 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.008 -0.542 . . . . 3.7200000000000002 109.578 -178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.426 ' H ' ' HB3' ' A' ' 148' ' ' LYS . 22.4 t70 -98.62 -23.76 15.35 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.437 -0.801 . . . . 4.2800000000000002 109.887 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.426 ' HD1' ' OH ' ' A' ' 98' ' ' TYR . 26.6 m-85 -53.43 -66.8 0.33 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.062 -0.972 . . . . 2.8599999999999999 110.024 179.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.443 ' HE2' ' CG ' ' A' ' 102' ' ' PHE . 45.7 m-85 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.568 -0.73 . . . . 3.96 109.292 172.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' CE ' ' HA ' ' A' ' 1' ' ' MET . 2.9 mmt . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 110.477 -0.194 . . . . 12.109999999999999 110.477 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 69.59 119.12 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 O-C-N 124.046 0.841 . . . . 9.0199999999999996 111.258 -177.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.721 ' HB3' HG21 ' A' ' 128' ' ' VAL . 53.1 m 69.75 20.7 6.75 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.486 -0.779 . . . . 6.8300000000000001 111.036 -179.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.446 ' HB3' ' HB3' ' A' ' 1' ' ' MET . 2.4 tm? -134.51 99.34 4.33 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.52 -0.919 . . . . 8.5500000000000007 108.52 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 5' ' ' LEU . 1.9 pt? -150.08 95.84 2.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.326 0.584 . . . . 10.470000000000001 111.377 -176.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -170.59 -87.75 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.5 -0.773 . . . . 11.69 110.215 175.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.3 mtpm? 50.58 31.38 5.62 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 123.156 0.582 . . . . 11.42 111.402 -177.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.564 ' HB3' HG21 ' A' ' 12' ' ' VAL . . . -91.15 113.94 26.34 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.971 0.415 . . . . 11.58 110.517 -177.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -77.1 96.6 4.5 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.852 -0.613 . . . . 15.74 110.301 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 70.22 -175.4 0.19 Allowed 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.193 -0.912 . . . . 12.69 111.342 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 73.77 -46.33 0.63 Allowed 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.818 0.847 . . . . 13.85 113.023 175.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.564 HG21 ' HB3' ' A' ' 8' ' ' ALA . 11.0 m -74.22 84.98 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.578 0.704 . . . . 8.8699999999999992 112.601 -175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -69.35 -33.12 72.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.661 -0.7 . . . . 8.9100000000000001 110.015 174.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -66.92 -61.42 1.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.624 -0.717 . . . . 8.5999999999999996 110.231 177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.499 ' NZ ' ' HB2' ' A' ' 15' ' ' LYS . 4.6 ttmp? 62.66 93.84 0.05 OUTLIER 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.92 0.762 . . . . 9.0399999999999991 111.534 174.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.8 tp -70.02 108.29 3.99 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.819 -0.628 . . . . 5.5800000000000001 109.824 -179.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.8 m -113.87 -46.76 3.0 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.541 0.571 . . . . 2.6899999999999999 112.541 -172.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.671 ' HB2' HG11 ' A' ' 129' ' ' VAL . . . -75.8 79.32 2.73 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.964 0.727 . . . . 1.6799999999999999 112.964 -170.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.972 HG21 HD13 ' A' ' 126' ' ' LEU . 8.4 pt 55.13 -179.02 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.0 0 C-N-CA 124.564 1.146 . . . . 3.1899999999999999 113.722 166.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.579 ' CD ' ' HB ' ' A' ' 19' ' ' ILE . 23.9 Cg_exo -65.74 -99.88 0.0 OUTLIER 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.485 2.123 . . . . 2.4199999999999999 112.534 172.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' H ' ' HB2' ' A' ' 20' ' ' PRO . 2.1 ttmm 170.27 -53.18 0.0 OUTLIER Pre-proline 0 CA--C 1.541 0.603 0 N-CA-C 112.521 0.563 . . . . 6.3799999999999999 112.521 -177.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.29 82.23 2.14 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.404 2.069 . . . . 2.77 113.241 -177.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.658 ' HB3' ' O ' ' A' ' 48' ' ' THR . 7.5 mp0 -133.09 149.49 52.14 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 104.75 -2.315 . . . . 3.3900000000000001 104.75 -178.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.51 -175.93 16.59 Favored Glycine 0 C--N 1.314 -0.662 0 C-N-CA 117.725 -2.179 . . . . 0.54000000000000004 116.579 -162.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.681 ' O ' HG13 ' A' ' 45' ' ' VAL . 95.7 p -167.91 36.47 0.03 OUTLIER 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 107.268 -1.382 . . . . 1.2 107.268 174.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.4 m -133.86 155.66 40.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 114.365 -1.289 . . . . 0.93000000000000005 110.037 -170.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.4 HG21 ' HG2' ' A' ' 44' ' ' LYS . 1.7 t -168.65 -46.33 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.699 -0.482 . . . . 0.47999999999999998 109.699 169.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -179.73 172.36 1.11 Allowed 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 111.45 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.716 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -142.14 145.91 23.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.079 -0.711 . . . . 1.1399999999999999 109.079 168.496 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -108.43 115.59 30.4 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.762 -0.653 . . . . 1.8300000000000001 110.378 -176.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.0 tm? -80.29 120.05 23.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.142 -0.481 . . . . 0.93999999999999995 111.08 -174.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.61 ' HD2' ' HA ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -119.81 -127.63 0.28 Allowed 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.527 -0.545 . . . . 1.3300000000000001 109.527 171.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.931 ' HA ' HG13 ' A' ' 39' ' ' VAL . 3.1 p30 170.51 166.73 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.604 0.638 . . . . 2.8500000000000001 111.919 -168.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 38' ' ' SER . 3.2 m -158.4 106.16 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 113.367 0.877 . . . . 3.2599999999999998 113.367 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.625 HD22 ' HB2' ' A' ' 37' ' ' ASP . 16.5 t30 70.42 -91.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.487 -0.779 . . . . 3.1600000000000001 110.79 169.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.777 ' HA ' ' HB3' ' A' ' 149' ' ' ASP . 0.0 OUTLIER 171.66 28.85 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 107.22 -1.4 . . . . 5.46 107.22 169.116 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.625 ' HB2' HD22 ' A' ' 35' ' ' ASN . 0.9 OUTLIER -99.66 -44.77 6.0 Favored 'General case' 0 CA--C 1.488 -1.418 0 N-CA-C 106.357 -1.719 . . . . 1.9199999999999999 106.357 -174.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.689 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 48.1 t -151.97 177.52 10.37 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 110.669 -2.969 . . . . 0.93999999999999995 105.235 178.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.931 HG13 ' HA ' ' A' ' 33' ' ' ASP . 13.4 t -134.63 156.37 40.05 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.207 0 CA-C-N 118.6 0.636 . . . . 0.85999999999999999 109.743 175.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.982 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 91.8 mt-10 -119.61 147.59 44.33 Favored 'General case' 0 C--N 1.317 -0.815 0 C-N-CA 120.205 -0.598 . . . . 1.1899999999999999 111.175 -172.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.935 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.5 p90 -142.29 133.89 26.72 Favored 'General case' 0 C--N 1.321 -0.647 0 C-N-CA 119.095 -1.042 . . . . 3.73 112.039 166.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.8 OUTLIER -79.9 108.99 13.91 Favored 'General case' 0 C--N 1.31 -1.151 0 CA-C-N 115.189 -0.914 . . . . 0.81000000000000005 108.715 -177.395 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.749 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.62 110.16 21.48 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-O 121.585 0.707 . . . . 0.41999999999999998 109.988 -178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 35.4 ttmt -84.03 129.77 34.9 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-N 114.929 -1.032 . . . . 2.6299999999999999 109.212 -178.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 25' ' ' SER . 52.5 t -113.57 142.44 26.07 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.192 0 CA-C-N 115.69 -0.686 . . . . 0.81999999999999995 110.335 -175.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.64 ' HA ' ' O ' ' A' ' 88' ' ' THR . 18.7 m -131.34 98.08 4.44 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.254 0.55 . . . . 0.71999999999999997 110.077 168.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.7 t -83.61 128.44 38.8 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.154 0 CA-C-N 115.258 -0.883 . . . . 1.1399999999999999 110.825 -175.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.658 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 6.5 m -107.66 116.09 31.32 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 119.07 -0.491 . . . . 0.40999999999999998 109.793 176.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.714 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.4 p-10 -91.5 135.21 28.19 Favored Pre-proline 0 N--CA 1.467 0.39 0 O-C-N 123.859 0.724 . . . . 1.48 110.275 176.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.518 ' HB3' ' CD ' ' A' ' 23' ' ' GLU . 57.5 Cg_endo -93.63 12.65 1.75 Allowed 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.71 2.94 . . . . 0.72999999999999998 114.426 -174.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.719 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 29.8 t80 -98.55 -117.86 0.14 Allowed 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.332 -0.618 . . . . 2.0800000000000001 109.332 -177.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 12.9 p -165.01 19.68 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.111 0.481 . . . . 1.51 110.258 173.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.8 m80 -148.38 151.32 35.1 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.528 -0.915 . . . . 1.6699999999999999 108.528 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.61 ' HA ' HD23 ' A' ' 82' ' ' LEU . 28.0 t -44.89 105.57 0.06 Allowed 'General case' 0 C--N 1.312 -1.023 0 O-C-N 124.382 1.051 . . . . 1.3899999999999999 112.295 172.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.681 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.5 pt -78.17 125.34 85.25 Favored Pre-proline 0 CA--C 1.5 -0.951 0 N-CA-C 108.901 -0.777 . . . . 1.03 108.901 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.657 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 27.1 Cg_endo -62.49 -54.65 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.06 0 C-N-CA 121.777 1.651 . . . . 0.37 112.999 -159.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.676 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.5 mm -130.01 159.31 42.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 C-N-CA 120.431 -0.507 . . . . 1.23 111.016 -173.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.608 ' HB3' HG22 ' A' ' 124' ' ' ILE . 27.3 p -150.88 174.7 12.79 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.192 0.996 . . . . 1.1499999999999999 111.697 178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 40.3 tt0 -130.86 114.05 14.81 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 113.362 -1.744 . . . . 1.3600000000000001 109.673 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.67 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.72 111.38 28.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 CA-C-N 114.973 -1.012 . . . . 1.05 110.989 173.77 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.651 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 1.6 m -113.7 104.24 12.02 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 113.811 -1.541 . . . . 0.82999999999999996 109.153 -178.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 6.3 p90 -111.98 127.7 55.95 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 109.949 -0.389 . . . . 0.40000000000000002 109.949 -169.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.615 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 7.1 m -126.4 104.6 8.26 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.29 -0.633 . . . . 0.38 109.29 175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.718 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 94.7 m-85 -98.28 139.23 34.36 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 116.1 -0.5 . . . . 0.95999999999999996 111.258 -174.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.2 m170 -128.04 145.43 50.99 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.667 -1.234 . . . . 1.29 107.667 175.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.685 ' CB ' HD22 ' A' ' 104' ' ' LEU . 41.5 t -107.27 -98.03 0.36 Allowed 'General case' 0 C--N 1.319 -0.745 0 C-N-CA 119.14 -1.024 . . . . 1.27 111.022 174.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.56 -60.25 3.81 Favored 'General case' 0 CA--C 1.512 -0.494 0 N-CA-C 108.674 -0.861 . . . . 0.35999999999999999 108.674 -176.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.58 15.66 0.1 OUTLIER Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 108.227 -1.949 . . . . 0.39000000000000001 108.227 163.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.94 HH11 ' HB3' ' A' ' 103' ' ' ASN . 10.2 ptp180 -106.09 -175.34 2.77 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.43 -0.952 . . . . 1.97 108.43 -175.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -103.09 97.64 7.7 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-O 121.605 0.716 . . . . 2.6099999999999999 109.589 -166.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.848 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.2 mm -59.04 -43.05 88.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 114.006 -1.452 . . . . 0.40000000000000002 110.728 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.78 160.2 22.39 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.402 -0.904 . . . . 0.48999999999999999 111.179 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.621 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -161.77 156.9 23.44 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 117.919 0.859 . . . . 1.8100000000000001 111.446 176.105 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.76 164.88 28.1 Favored Glycine 0 N--CA 1.444 -0.795 0 N-CA-C 110.758 -0.937 . . . . 0.42999999999999999 110.758 178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -142.13 133.68 26.72 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.097 0.475 . . . . 1.72 111.089 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.405 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 63.3 mt -136.1 133.85 19.91 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.632 -0.713 . . . . 0.72999999999999998 110.016 -174.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 7.5 Cg_exo -74.26 119.04 5.61 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.364 2.042 . . . . 0.56999999999999995 110.508 170.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -131.59 139.94 36.81 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.845 -0.428 . . . . 0.79000000000000004 109.845 -176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.676 ' HA ' HD13 ' A' ' 57' ' ' ILE . 18.0 Cg_endo -61.64 90.82 0.11 Allowed 'Trans proline' 0 CA--C 1.528 0.219 0 C-N-CA 122.452 2.101 . . . . 0.57999999999999996 112.08 175.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.456 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -89.02 30.28 5.56 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.40000000000000002 112.029 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.681 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.1 p -70.49 118.36 13.2 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 108.513 -0.921 . . . . 0.62 108.513 178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.61 HD23 ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -139.98 -152.11 0.4 Allowed 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 113.048 0.759 . . . . 1.1000000000000001 113.048 -160.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.534 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 93.8 mttt -62.35 -96.99 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 115.937 -0.574 . . . . 1.8400000000000001 112.304 -176.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 169.35 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 107.971 -1.122 . . . . 0.98999999999999999 107.971 -171.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.719 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 39.5 pttt 42.41 50.41 4.69 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.879 0.847 . . . . 1.8400000000000001 111.134 -176.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.563 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.2 t70 -153.35 -173.38 4.56 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.894 -1.048 . . . . 0.64000000000000001 110.726 -169.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.435 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.9 ttm -115.77 125.33 52.61 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.009 -0.542 . . . . 1.3500000000000001 110.351 -174.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.64 ' O ' ' HA ' ' A' ' 46' ' ' SER . 3.3 t -116.16 145.05 43.38 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.928 -0.578 . . . . 0.77000000000000002 110.718 -176.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -88.39 117.07 27.06 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.514 0.673 . . . . 0.47999999999999998 110.742 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.666 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.2 tp -115.88 174.86 5.8 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.775 -1.102 . . . . 0.77000000000000002 108.106 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.666 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 35.5 m-20 -137.63 130.66 30.41 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 118.502 0.592 . . . . 1.8100000000000001 111.232 -176.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.749 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 30.1 mm -108.6 123.84 36.11 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 108.666 -0.864 . . . . 0.65000000000000002 108.666 171.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.473 ' O ' HG13 ' A' ' 94' ' ' VAL . 24.3 Cg_exo -28.85 -113.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.354 0.847 1 C-N-CA 125.72 4.28 . . . . 1.0700000000000001 116.22 -171.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.982 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -163.08 89.32 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.882 0 CA-C-O 119.586 -0.245 . . . . 0.46000000000000002 111.191 -176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.501 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -127.79 101.74 7.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 N-CA-C 115.635 1.717 . . . . 0.47999999999999998 115.635 -164.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.579 ' HB ' ' CE2' ' A' ' 41' ' ' TYR . 2.7 p -152.77 107.28 2.7 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 121.326 -0.858 . . . . 1.0700000000000001 111.607 163.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.56 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 53.4 Cg_exo -51.32 129.08 27.67 Favored 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.499 1.466 . . . . 0.47999999999999998 111.192 173.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.689 ' H ' ' HA ' ' A' ' 38' ' ' SER . 16.3 t80 -50.17 -35.99 28.5 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.182 -0.917 . . . . 1.3100000000000001 111.898 -173.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 12.8 t -59.9 -27.49 66.77 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.054 0.39 . . . . 1.2 112.054 -178.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.848 HG21 ' HA ' ' A' ' 71' ' ' ILE . 11.0 mm -77.62 -54.09 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 O-C-N 121.892 -0.505 . . . . 0.51000000000000001 111.17 -174.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.077 HD23 HD21 ' A' ' 104' ' ' LEU . 53.3 mt -51.89 -30.18 23.0 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-O 121.882 0.848 . . . . 1.0 110.129 169.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.523 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 30.4 t80 -69.04 -38.56 79.22 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.625 -1.625 . . . . 0.95999999999999996 108.787 -177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.94 ' HB3' HH11 ' A' ' 69' ' ' ARG . 15.7 m-80 -74.17 -55.95 5.48 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.543 -0.753 . . . . 0.81999999999999995 111.975 178.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.077 HD21 HD23 ' A' ' 101' ' ' LEU . 2.9 pp -55.04 -50.67 68.51 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 112.737 0.643 . . . . 0.65000000000000002 112.737 177.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.611 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.21 -24.39 67.2 Favored 'General case' 0 C--O 1.22 -0.46 0 CA-C-O 121.884 0.85 . . . . 0.42999999999999999 110.551 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.523 ' NH2' ' HD1' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -70.99 -54.76 10.11 Favored 'General case' 0 C--N 1.304 -1.383 0 CA-C-N 115.106 -0.952 . . . . 1.8100000000000001 110.631 175.759 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 16.3 t70 -83.01 -53.88 5.49 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.814 0.816 . . . . 0.80000000000000004 111.649 -175.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.0 t -84.12 -26.94 7.2 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.064 0 O-C-N 121.505 -0.747 . . . . 0.88 109.959 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.611 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -70.5 -17.52 74.66 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 119.536 -1.316 . . . . 0.38 111.381 170.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -53.74 -47.4 62.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 107.18 -1.415 . . . . 1.0900000000000001 107.18 166.001 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' N ' ' A' ' 113' ' ' ASP . 1.0 OUTLIER -107.89 68.53 0.71 Allowed 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 121.648 0.737 . . . . 1.8700000000000001 112.79 164.826 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.0 p-90 23.15 -57.86 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 118.802 2.89 . . . . 1.1699999999999999 118.802 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.435 ' N ' ' O ' ' A' ' 111' ' ' ASP . 13.2 t70 -91.79 122.85 34.71 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 118.59 0.632 . . . . 2.1499999999999999 111.84 -167.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.672 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.8 mp -112.49 158.58 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 121.23 0.538 . . . . 0.39000000000000001 110.78 -172.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 12.9 p-10 -104.74 153.87 20.74 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.744 -0.662 . . . . 2.1099999999999999 109.934 176.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.63 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 35.3 m-85 -137.51 167.14 22.23 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.957 -0.757 . . . . 0.62 108.957 178.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.559 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.6 tt0 -153.4 139.03 17.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.73 0.3 . . . . 0.80000000000000004 110.629 178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.718 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 11.0 tp -109.92 129.31 55.67 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.933 -0.576 . . . . 1.25 110.3 171.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.651 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -112.84 101.32 9.4 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.048 -0.723 . . . . 0.63 109.048 173.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.67 HD11 HG22 ' A' ' 60' ' ' ILE . 5.5 tp -112.58 121.62 65.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.158 0.504 . . . . 0.81000000000000005 111.64 -172.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.68 125.41 8.13 Favored Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.781 -0.528 . . . . 0.26000000000000001 111.781 175.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.601 HD11 ' OG ' ' A' ' 25' ' ' SER . 5.0 mp -103.88 106.51 17.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.029 0.442 . . . . 1.2 111.546 -172.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.8 m -110.16 95.02 5.32 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.781 -0.645 . . . . 0.32000000000000001 109.441 174.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.659 ' HB ' HD12 ' A' ' 55' ' ' ILE . 10.6 pt -109.53 141.46 24.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.137 0 C-N-CA 120.5 -0.48 . . . . 0.97999999999999998 110.87 -175.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.657 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.5 m-20 -84.51 107.47 16.77 Favored 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.714 -0.847 . . . . 1.52 108.714 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.972 HD13 HG21 ' A' ' 19' ' ' ILE . 4.5 mt -115.56 139.65 24.97 Favored Pre-proline 0 C--O 1.216 -0.67 0 O-C-N 124.566 1.166 . . . . 1.28 110.455 -171.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 32.2 Cg_exo -60.74 -16.67 45.23 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.366 2.044 . . . . 0.73999999999999999 114.105 -176.203 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.721 HG21 ' HB3' ' A' ' 3' ' ' SER . 42.4 t -76.66 -56.45 8.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-O 121.326 0.584 . . . . 1.1200000000000001 111.524 -176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.671 HG11 ' HB2' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -116.91 5.92 7.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 122.038 0.923 . . . . 1.3500000000000001 110.799 -175.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 82.55 -34.44 2.71 Favored Glycine 0 C--N 1.31 -0.884 0 CA-C-N 113.797 -1.547 . . . . 1.05 111.781 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.476 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.3 pt-20 -171.21 162.13 6.84 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.641 -0.874 . . . . 1.1599999999999999 108.641 177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' THR . 9.3 t80 -159.11 143.13 15.22 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.464 -0.569 . . . . 1.9099999999999999 109.464 174.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.557 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 75.6 m -112.8 110.67 20.92 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.148 -0.478 . . . . 1.1899999999999999 111.359 -177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.486 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -126.16 136.1 28.06 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 115.901 -0.59 . . . . 0.5 109.888 174.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -93.72 162.96 2.28 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.138 1.892 . . . . 0.45000000000000001 113.21 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.92 168.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 107.811 -1.181 . . . . 0.44 107.811 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 90.3 p -142.29 149.19 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 C-N-CA 120.513 -0.475 . . . . 0.88 111.484 -169.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 21.3 t -140.64 103.76 4.59 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.243 -1.021 . . . . 0.95999999999999996 108.243 179.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.559 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.2 ptmt -123.52 152.49 41.71 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.676 -0.693 . . . . 1.76 110.454 -172.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.2 155.29 24.18 Favored Glycine 0 N--CA 1.44 -1.057 0 C-N-CA 120.896 -0.668 . . . . 0.5 111.485 -176.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 2.2 mp0 -111.04 132.52 54.16 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.404 -0.398 . . . . 2.1000000000000001 110.434 -176.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 1.9 pp -144.24 171.98 6.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 109.346 -0.613 . . . . 0.76000000000000001 109.346 -176.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.559 ' HG2' ' H ' ' A' ' 144' ' ' LEU . 35.7 ttmt -64.57 174.58 1.69 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.141 0.495 . . . . 3.5299999999999998 111.653 -173.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.646 HD12 HD11 ' A' ' 114' ' ' ILE . 16.6 tp -55.96 139.28 71.06 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.612 -0.722 . . . . 1.23 110.901 -178.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.5 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo -60.41 170.44 4.21 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 122.785 2.324 . . . . 0.70999999999999996 112.845 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.574 ' HB ' ' HG2' ' A' ' 148' ' ' LYS . 1.4 p -69.51 109.92 4.5 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.573 -0.739 . . . . 1.71 111.81 -176.229 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 150' ' ' PHE . 0.4 OUTLIER -70.39 61.63 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.613 0.72 . . . . 2.6400000000000001 110.297 172.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.65 ' HG3' ' OD2' ' A' ' 33' ' ' ASP . 28.5 mmtp -93.16 -61.27 1.61 Allowed 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 122.597 1.189 . . . . 3.7200000000000002 108.681 175.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.777 ' HB3' ' HA ' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -79.98 -11.78 59.76 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 112.863 -1.971 . . . . 4.2800000000000002 106.919 166.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.767 ' HA ' ' HA ' ' A' ' 147' ' ' PHE . 63.1 m-85 74.57 107.4 0.07 Allowed 'General case' 0 N--CA 1.435 -1.199 0 CA-C-N 112.718 -2.037 . . . . 2.8599999999999999 112.632 178.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.536 ' HD1' ' HB1' ' A' ' 105' ' ' ALA . 93.8 m-85 . . . . . 0 C--O 1.248 1.011 0 CA-C-N 112.967 -1.924 . . . . 3.96 110.846 177.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.807 0.337 . . . . 12.109999999999999 110.404 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -124.82 8.45 8.15 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.124 0.488 . . . . 9.0199999999999996 110.626 -179.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.1 m -77.62 -20.3 54.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.642 -0.708 . . . . 6.8300000000000001 111.186 -177.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.401 ' HG ' ' N ' ' A' ' 5' ' ' LEU . 35.5 tp -152.11 166.14 32.59 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.024 -0.361 . . . . 8.5500000000000007 110.024 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.401 ' N ' ' HG ' ' A' ' 4' ' ' LEU . 87.5 mt -106.86 -163.87 0.95 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.36 -0.382 . . . . 10.470000000000001 110.775 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -82.16 -16.95 48.0 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.271 0.558 . . . . 11.69 110.211 179.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 60.2 pttt -108.66 -155.66 0.56 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.587 -0.733 . . . . 11.42 110.43 -177.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 67.04 -156.31 0.23 Allowed 'General case' 0 C--O 1.236 0.344 0 O-C-N 123.609 0.568 . . . . 11.58 110.179 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -105.0 149.95 25.34 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.977 0.418 . . . . 15.74 111.245 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -71.66 -32.85 68.33 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.422 -0.808 . . . . 12.69 110.912 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -90.54 128.08 36.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.04 -0.527 . . . . 13.85 110.738 -178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.467 ' HB ' ' HB2' ' A' ' 16' ' ' LEU . 26.8 m -113.46 157.26 14.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.057 -0.52 . . . . 8.8699999999999992 109.769 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.93 49.98 0.69 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.32 0.489 . . . . 8.9100000000000001 112.32 -176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 49.42 14.32 0.1 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 125.131 1.372 . . . . 8.5999999999999996 114.36 174.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm -129.14 -27.56 2.46 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 122.023 -0.423 . . . . 9.0399999999999991 111.3 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.467 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 7.1 mp -75.68 94.07 3.18 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.112 0.482 . . . . 5.5800000000000001 110.207 -179.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.5 m -149.92 -20.57 0.26 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.803 -0.635 . . . . 2.6899999999999999 110.999 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.723 ' HA ' HG11 ' A' ' 129' ' ' VAL . . . -65.92 -99.67 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.302 0.482 . . . . 1.6799999999999999 112.302 -176.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.022 HG23 ' HD3' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -164.87 -63.09 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.055 0 N-CA-C 113.021 0.749 . . . . 3.1899999999999999 113.021 -174.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 1.022 ' HD3' HG23 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -104.39 -156.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 122.364 2.043 . . . . 2.4199999999999999 114.782 -172.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.611 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 20.8 tptm -175.92 -55.12 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.535 0 CA-C-N 114.334 -1.303 . . . . 6.3799999999999999 110.412 175.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.611 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 87.8 Cg_endo -82.05 61.87 7.93 Favored 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 122.117 1.878 . . . . 2.77 112.933 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.759 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 7.4 mp0 -128.48 142.69 51.01 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 105.042 -2.207 . . . . 3.3900000000000001 105.042 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.719 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -118.14 -171.09 15.18 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 117.727 -2.178 . . . . 0.54000000000000004 116.374 -161.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.646 ' O ' HG13 ' A' ' 45' ' ' VAL . 51.9 p -163.54 37.38 0.09 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.691 1.597 . . . . 1.2 106.814 173.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.56 ' O ' ' HB2' ' A' ' 46' ' ' SER . 1.5 p -131.05 147.75 33.03 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 113.955 -1.475 . . . . 0.93000000000000005 110.679 -167.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.22 -36.12 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.712 -0.677 . . . . 0.47999999999999998 110.631 166.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -175.89 160.94 2.42 Favored 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 109.85 -0.426 . . . . 1.6899999999999999 109.85 179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.9 OUTLIER -137.12 145.76 29.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.685 -0.857 . . . . 1.1399999999999999 108.685 162.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -121.1 146.3 46.89 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.941 0.4 . . . . 1.8300000000000001 111.646 -165.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.7 tm? -99.98 135.7 41.01 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.92 -0.582 . . . . 0.93999999999999995 111.091 -174.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' N ' HD22 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -143.62 -95.95 0.11 Allowed 'General case' 0 C--O 1.222 -0.388 0 N-CA-C 113.341 0.867 . . . . 1.3300000000000001 113.341 176.119 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.77 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 1.6 t70 -91.11 -178.46 5.18 Favored 'General case' 0 C--O 1.208 -1.11 0 O-C-N 121.723 -0.611 . . . . 2.8500000000000001 111.613 -154.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.833 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.2 p -166.47 -36.86 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.893 0 O-C-N 123.499 0.499 . . . . 3.2599999999999998 111.08 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 10.1 t30 67.2 -79.26 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.414 -0.812 . . . . 3.1600000000000001 109.352 -174.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -171.81 14.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.159 0.504 . . . . 5.46 110.009 170.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -140.71 -41.1 0.41 Allowed 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.928 -0.578 . . . . 1.9199999999999999 110.264 -173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.833 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 8.6 t -141.48 119.65 12.12 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 121.561 0.696 . . . . 0.93999999999999995 112.822 -174.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.77 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 63.8 t -76.17 151.39 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-N 115.017 -0.992 . . . . 0.85999999999999999 109.647 176.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.84 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 85.1 mt-10 -109.8 133.34 53.26 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 119.223 -0.991 . . . . 1.1899999999999999 111.853 -178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.843 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.12 106.15 9.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.767 -1.106 . . . . 3.73 110.555 -176.808 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 94' ' ' VAL . 1.7 tm? -84.78 110.17 18.61 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.821 -0.807 . . . . 0.81000000000000005 108.821 -177.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.703 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -89.97 110.02 21.01 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.844 0.83 . . . . 0.41999999999999998 110.247 -179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 30.6 ttmt -84.43 125.38 32.29 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 114.579 -1.192 . . . . 2.6299999999999999 108.538 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.758 HG21 HD23 ' A' ' 90' ' ' LEU . 63.5 t -111.78 139.06 37.96 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-O 121.219 0.533 . . . . 0.81999999999999995 112.086 -170.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 88' ' ' THR . 15.7 m -131.82 97.59 4.23 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.568 -0.742 . . . . 0.71999999999999997 109.276 162.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.719 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 2.3 p -84.62 128.1 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 CA-C-N 115.096 -0.956 . . . . 1.1399999999999999 110.744 -177.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.669 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 9.8 m -102.25 121.31 42.01 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.776 -0.647 . . . . 0.40999999999999998 109.946 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.822 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 14.0 t30 -87.57 126.67 61.16 Favored Pre-proline 0 N--CA 1.467 0.383 0 O-C-N 124.722 1.264 . . . . 1.48 109.734 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.759 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 83.4 Cg_endo -83.29 -10.0 10.2 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.951 3.101 . . . . 0.72999999999999998 115.971 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.718 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.0 t80 -96.23 -105.61 0.16 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 119.595 -0.842 . . . . 2.0800000000000001 111.264 -171.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.451 ' HB2' ' HD3' ' A' ' 85' ' ' LYS . 47.6 t -175.62 26.76 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.372 0.606 . . . . 1.51 109.862 174.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -150.74 139.28 20.55 Favored 'General case' 0 CA--C 1.511 -0.552 0 N-CA-C 109.138 -0.69 . . . . 1.6699999999999999 109.138 -178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.862 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 43.5 t -52.19 101.47 0.04 OUTLIER 'General case' 0 C--O 1.211 -0.953 0 O-C-N 124.025 0.828 . . . . 1.3899999999999999 111.93 174.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.969 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.7 pt -75.24 172.0 10.32 Favored Pre-proline 0 C--O 1.207 -1.173 0 N-CA-C 107.7 -1.222 . . . . 1.03 107.7 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.576 ' HB2' ' CD1' ' A' ' 57' ' ' ILE . 12.0 Cg_endo -90.08 -58.73 0.02 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.508 0 CA-C-N 120.166 1.095 . . . . 0.37 114.687 -176.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.581 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 1.5 mp -130.37 161.87 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 119.727 -0.789 . . . . 1.23 112.768 -168.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 30.1 p -147.64 168.82 21.06 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 122.08 0.943 . . . . 1.1499999999999999 111.77 177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.103 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 16.6 tp10 -122.29 118.71 29.16 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 113.412 -1.722 . . . . 1.3600000000000001 110.06 178.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.658 ' O ' ' HA ' ' A' ' 75' ' ' LYS . 13.2 mm -94.58 110.16 23.33 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.078 0 CA-C-N 114.618 -1.174 . . . . 1.05 110.567 175.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.604 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 11.0 p -120.61 102.67 8.57 Favored 'General case' 0 C--N 1.312 -1.024 0 C-N-CA 120.615 -0.434 . . . . 0.82999999999999996 109.864 173.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.556 ' HD1' HG22 ' A' ' 60' ' ' ILE . 11.8 p90 -110.3 126.39 54.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.159 0.504 . . . . 0.40000000000000002 109.857 -171.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.569 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 18.4 m -123.34 112.1 17.19 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.034 -0.728 . . . . 0.38 109.034 174.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.475 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 93.2 m-85 -97.66 140.99 31.25 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-O 120.979 0.419 . . . . 0.95999999999999996 110.606 -176.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.518 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 5.2 m170 -132.93 145.63 51.07 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.466 -1.309 . . . . 1.29 107.466 176.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.991 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -111.52 -97.66 0.42 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.183 -1.007 . . . . 1.27 111.41 173.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.43 -60.57 3.59 Favored 'General case' 0 CA--C 1.515 -0.386 0 N-CA-C 109.529 -0.545 . . . . 0.35999999999999999 109.529 -174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.77 19.63 0.12 Allowed Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 108.578 -1.809 . . . . 0.39000000000000001 108.578 167.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 69' ' ' ARG . 8.5 ptp180 -115.75 -177.85 3.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.332 -0.988 . . . . 1.97 108.332 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -104.9 98.0 7.78 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-O 122.072 0.939 . . . . 2.6099999999999999 110.245 -168.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.811 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.37 -43.51 62.88 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 113.352 -1.749 . . . . 0.40000000000000002 111.86 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -172.23 169.11 42.25 Favored Glycine 0 CA--C 1.502 -0.775 0 C-N-CA 120.077 -1.058 . . . . 0.48999999999999999 111.355 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -166.27 155.32 11.26 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 117.218 0.509 . . . . 1.8100000000000001 110.541 174.156 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.22 -175.62 46.63 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.213 -1.155 . . . . 0.42999999999999999 110.213 176.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.658 ' HA ' ' O ' ' A' ' 60' ' ' ILE . 11.1 ptpt -152.09 136.64 16.9 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 117.321 0.56 . . . . 1.72 112.134 178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.416 ' O ' ' HB ' ' A' ' 60' ' ' ILE . 68.6 mt -130.78 108.97 15.64 Favored Pre-proline 0 N--CA 1.449 -0.517 0 CA-C-N 115.289 -0.868 . . . . 0.72999999999999998 110.312 -176.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.23 114.34 3.89 Favored 'Trans proline' 0 N--CA 1.46 -0.444 0 C-N-CA 122.312 2.008 . . . . 0.56999999999999995 109.975 172.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -132.01 146.09 60.21 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 110.035 -0.357 . . . . 0.79000000000000004 110.035 -171.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' C ' ' H ' ' A' ' 81' ' ' SER . 9.4 Cg_endo -54.6 90.9 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.513 2.142 . . . . 0.57999999999999996 112.17 173.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.581 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -77.09 29.01 1.63 Allowed Glycine 0 C--O 1.225 -0.455 0 CA-C-N 115.278 -0.874 . . . . 0.40000000000000002 112.493 177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.969 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 59.9 p -74.03 119.92 18.9 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 109.719 -0.474 . . . . 0.62 109.719 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.862 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -157.95 173.89 16.08 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 118.833 -1.147 . . . . 1.1000000000000001 113.646 -164.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 88.6 mttt -33.84 -93.94 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.578 1.325 . . . . 1.8400000000000001 114.578 -167.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 168.34 108.87 0.01 OUTLIER 'General case' 0 CA--C 1.509 -0.621 0 N-CA-C 108.359 -0.978 . . . . 0.98999999999999999 108.359 -174.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.822 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 47.6 pttt 42.05 48.49 4.06 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.168 0.918 . . . . 1.8400000000000001 110.886 -175.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 4.4 t70 -148.9 -174.37 4.61 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.64 -1.164 . . . . 0.64000000000000001 109.782 -168.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.57 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 45.1 ttm -117.22 121.67 41.87 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.33 0.586 . . . . 1.3500000000000001 110.596 -173.197 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.644 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -115.53 144.55 43.7 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.158 -0.928 . . . . 0.77000000000000002 110.743 -175.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -85.92 141.37 29.61 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.088 0.47 . . . . 0.47999999999999998 110.043 -179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.783 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.1 tp -139.32 173.54 11.44 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.25 -1.019 . . . . 0.77000000000000002 108.25 -177.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.783 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 15.9 m-20 -132.6 124.36 28.2 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.166 0.508 . . . . 1.8100000000000001 111.842 -175.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.703 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.7 mm -112.84 138.15 22.06 Favored Pre-proline 0 C--N 1.318 -0.78 0 CA-C-N 115.442 -0.799 . . . . 0.65000000000000002 109.01 171.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.407 ' HD2' HG23 ' A' ' 92' ' ' ILE . 76.6 Cg_exo -51.96 -159.1 0.0 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 123.83 3.02 . . . . 1.0700000000000001 114.58 178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.843 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 1.4 m -124.08 93.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 CA-C-N 115.371 -0.831 . . . . 0.46000000000000002 110.873 -167.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.455 ' O ' HG13 ' A' ' 95' ' ' VAL . 5.7 p -128.3 103.55 10.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 113.917 1.08 . . . . 0.47999999999999998 113.917 -168.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.634 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.0 p -152.41 99.64 2.83 Favored Pre-proline 0 C--N 1.319 -0.729 0 CA-C-N 116.204 -0.453 . . . . 1.0700000000000001 110.924 161.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.638 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.4 Cg_exo -52.86 131.05 40.34 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 121.94 1.76 . . . . 0.47999999999999998 111.022 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.434 ' H ' ' HA ' ' A' ' 38' ' ' SER . 10.9 t80 -57.96 -30.59 66.11 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.967 -0.56 . . . . 1.3100000000000001 111.559 -171.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 19.5 m -59.38 -30.57 68.52 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 111.783 0.29 . . . . 1.2 111.783 -179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.811 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.8 mm -76.63 -55.15 11.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 C-N-CA 120.008 -0.677 . . . . 0.51000000000000001 110.348 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.701 HD12 HG21 ' A' ' 39' ' ' VAL . 25.3 mt -50.55 -27.38 6.61 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 115.654 -0.703 . . . . 1.0 110.665 170.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.431 ' HD1' ' NH2' ' A' ' 106' ' ' ARG . 23.7 t80 -64.67 -43.16 94.49 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 114.672 -1.149 . . . . 0.95999999999999996 108.799 -178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.495 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 33.1 m-80 -74.42 -57.73 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.962 -0.563 . . . . 0.81999999999999995 112.458 -179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.991 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -58.24 -49.57 76.64 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 113.385 0.883 . . . . 0.65000000000000002 113.385 179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.442 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.9 -23.65 67.29 Favored 'General case' 0 C--O 1.218 -0.566 0 CA-C-O 121.912 0.863 . . . . 0.42999999999999999 109.806 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.495 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.5 ttp180 -68.03 -47.99 66.87 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 114.586 -1.188 . . . . 1.8100000000000001 110.408 173.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.506 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 15.7 t70 -82.59 -55.89 4.19 Favored 'General case' 0 C--O 1.24 0.564 0 CA-C-O 121.923 0.868 . . . . 0.80000000000000004 111.871 -176.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.2 t -83.65 -29.38 7.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 O-C-N 121.66 -0.65 . . . . 0.88 109.625 -175.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -77.25 -16.54 80.45 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.522 -0.847 . . . . 0.38 111.693 172.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.506 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.5 OUTLIER -49.07 -44.21 16.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 N-CA-C 106.473 -1.677 . . . . 1.0900000000000001 106.473 165.107 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -76.64 -81.89 0.08 Allowed 'General case' 0 CA--C 1.547 0.828 0 CA-C-N 115.539 -0.755 . . . . 1.8700000000000001 109.954 163.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 178.44 -59.73 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 112.623 0.601 . . . . 1.1699999999999999 112.623 174.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -93.82 128.63 40.17 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.319 0.58 . . . . 2.1499999999999999 111.434 -173.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.847 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -113.5 161.57 12.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 CA-C-N 115.695 -0.684 . . . . 0.39000000000000001 109.901 -172.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 3.4 p-10 -101.85 152.74 20.54 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.768 -0.827 . . . . 2.1099999999999999 108.768 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 34.5 m-85 -139.52 166.09 25.49 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.637 -0.875 . . . . 0.62 108.637 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.689 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.2 tt0 -153.8 135.35 14.32 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.264 0.554 . . . . 0.80000000000000004 110.142 177.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.698 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -107.37 129.6 54.89 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.528 -0.76 . . . . 1.25 109.181 173.527 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.751 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.817 -0.809 . . . . 0.63 108.817 177.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.604 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.1 tp -112.92 120.89 64.07 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-O 121.228 0.537 . . . . 0.81000000000000005 111.399 -173.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.409 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.81 119.89 5.54 Favored Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 111.362 -0.695 . . . . 0.26000000000000001 111.362 174.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.617 HD11 ' OG ' ' A' ' 25' ' ' SER . 1.3 mp -98.65 96.11 7.71 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.007 0.432 . . . . 1.2 110.851 -174.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.103 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 63.2 m -95.98 96.41 8.87 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.811 -0.631 . . . . 0.32000000000000001 109.387 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.61 HG22 ' HB3' ' A' ' 58' ' ' CYS . 5.7 pt -111.28 138.34 40.07 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.134 0 C-N-CA 120.171 -0.612 . . . . 0.97999999999999998 111.327 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.51 106.14 14.13 Favored 'General case' 0 CA--C 1.513 -0.461 0 N-CA-C 108.306 -0.998 . . . . 1.52 108.306 -177.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.947 HD23 HG21 ' A' ' 55' ' ' ILE . 35.1 mt -116.52 150.3 45.28 Favored Pre-proline 0 C--O 1.215 -0.734 0 O-C-N 124.859 1.35 . . . . 1.28 110.344 -172.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_exo -67.43 -13.98 41.01 Favored 'Trans proline' 0 CA--C 1.536 0.611 0 C-N-CA 122.14 1.894 . . . . 0.73999999999999999 113.292 178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 37.9 t -76.36 -57.37 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-O 121.31 0.576 . . . . 1.1200000000000001 111.257 -174.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.723 HG11 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -118.42 6.85 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.854 0.835 . . . . 1.3500000000000001 110.74 -177.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.31 -31.93 2.6 Favored Glycine 0 C--N 1.311 -0.845 0 CA-C-N 114.005 -1.452 . . . . 1.05 111.966 -177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.4 pt-20 -178.55 154.03 0.75 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.705 -0.85 . . . . 1.1599999999999999 108.705 -178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.725 ' HD2' HG23 ' A' ' 134' ' ' ILE . 11.3 t80 -157.83 144.99 18.17 Favored 'General case' 0 C--N 1.319 -0.746 0 C-N-CA 120.563 -0.455 . . . . 1.9099999999999999 110.292 171.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 26.9 m -101.6 99.56 9.87 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.594 0.559 . . . . 1.1899999999999999 110.855 175.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.725 HG23 ' HD2' ' A' ' 132' ' ' PHE . 2.3 pp -109.1 124.51 33.87 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 109.203 -0.666 . . . . 0.5 109.203 172.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.409 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 95.9 Cg_endo -89.12 162.61 5.79 Favored 'Trans proline' 0 N--CA 1.443 -1.451 0 C-N-CA 121.559 1.506 . . . . 0.45000000000000001 112.536 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.7 161.45 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 108.056 -1.09 . . . . 0.44 108.056 -179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -126.84 144.49 50.95 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 110.168 -0.308 . . . . 0.88 110.168 -171.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.9 m -136.99 100.82 4.39 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.338 -0.986 . . . . 0.95999999999999996 108.338 178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.689 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 8.9 ptmt -123.72 143.01 50.54 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.129 -0.487 . . . . 1.76 111.242 -170.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.59 153.63 24.31 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.667 -0.777 . . . . 0.5 111.961 -177.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.559 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 26.1 mt-10 -106.85 132.62 52.61 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.774 -0.454 . . . . 2.1000000000000001 109.774 178.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -146.41 174.15 2.54 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 108.153 -1.054 . . . . 0.76000000000000001 108.153 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -61.23 170.92 1.5 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.302 0.853 . . . . 3.5299999999999998 113.302 -177.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 HD11 ' A' ' 114' ' ' ILE . 15.9 tp -68.51 149.8 97.89 Favored Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 114.91 -1.041 . . . . 1.23 110.739 -175.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 144' ' ' LEU . 20.3 Cg_endo -62.43 169.19 8.5 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.502 2.135 . . . . 0.70999999999999996 112.091 174.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 29.9 m -68.28 104.95 1.97 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.179 0.514 . . . . 1.71 110.737 -178.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' CD1' HD23 ' A' ' 144' ' ' LEU . 22.0 p90 -111.29 156.79 20.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.605 -0.725 . . . . 2.6400000000000001 111.23 -174.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.583 ' HA ' ' HE2' ' A' ' 148' ' ' LYS . 0.2 OUTLIER -178.8 73.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.859 -0.609 . . . . 3.7200000000000002 109.993 179.286 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 67.51 9.24 6.89 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.021 0.439 . . . . 4.2800000000000002 111.054 176.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.469 ' CE2' ' HB3' ' A' ' 148' ' ' LYS . 25.1 m-85 -82.59 -41.0 20.09 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.163 -0.68 . . . . 2.8599999999999999 109.163 178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' HE2' ' HB3' ' A' ' 147' ' ' PHE . 4.1 p90 . . . . . 0 C--O 1.254 1.29 0 CA-C-O 118.21 -0.9 . . . . 3.96 109.059 173.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 mmt . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 110.524 -0.176 . . . . 12.109999999999999 110.524 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.22 -145.53 0.61 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.316 -0.402 . . . . 9.0199999999999996 110.431 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 1.064 ' HA ' ' HA ' ' A' ' 129' ' ' VAL . 23.3 m 69.73 -77.53 0.05 Allowed 'General case' 0 C--N 1.33 -0.251 0 O-C-N 123.544 0.527 . . . . 6.8300000000000001 111.368 178.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.69 ' HB2' ' HB2' ' A' ' 8' ' ' ALA . 87.7 mt -70.73 117.85 12.77 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.926 0.393 . . . . 8.5500000000000007 110.945 -175.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -77.97 108.01 10.93 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.343 -0.614 . . . . 10.470000000000001 109.343 174.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 9.1 t70 71.6 159.37 0.21 Allowed 'General case' 0 N--CA 1.467 0.395 0 O-C-N 124.13 0.894 . . . . 11.69 110.168 -177.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 26.9 mtpp 69.0 5.27 4.96 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 122.926 0.49 . . . . 11.42 111.974 178.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.69 ' HB2' ' HB2' ' A' ' 4' ' ' LEU . . . -101.34 94.14 5.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.896 0.379 . . . . 11.58 111.769 -174.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.5 ' HB2' ' CE2' ' A' ' 11' ' ' PHE . 14.3 mptt -70.52 -55.99 7.62 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.87 -0.789 . . . . 15.74 108.87 169.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.74 35.97 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 114.963 -1.017 . . . . 12.69 108.779 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.5 ' CE2' ' HB2' ' A' ' 9' ' ' LYS . 91.7 m-85 -94.23 137.93 32.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.477 -0.783 . . . . 13.85 110.732 -175.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.502 ' HB ' ' OG1' ' A' ' 17' ' ' THR . 31.5 m -89.49 -1.43 9.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.037 -0.529 . . . . 8.8699999999999992 110.99 176.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.417 ' O ' ' HG2' ' A' ' 15' ' ' LYS . . . 63.66 10.84 5.32 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.6 -0.727 . . . . 8.9100000000000001 112.144 176.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.484 ' H ' HG23 ' A' ' 12' ' ' VAL . 3.4 m-20 61.04 22.11 12.4 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.104 -0.498 . . . . 8.5999999999999996 111.165 -178.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 47.1 mmtm -117.16 174.65 5.99 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.057 -0.719 . . . . 9.0399999999999991 109.057 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.6 OUTLIER -66.08 102.79 0.85 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 107.54 -1.281 . . . . 5.5800000000000001 107.54 170.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.502 ' OG1' ' HB ' ' A' ' 12' ' ' VAL . 1.8 m -77.96 62.46 2.76 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.949 0.722 . . . . 2.6899999999999999 112.949 -166.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.701 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 163.03 -87.75 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.384 0 O-C-N 124.413 1.071 . . . . 1.6799999999999999 110.87 168.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.442 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 14.2 pt -142.58 139.98 18.08 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.567 -0.288 . . . . 3.1899999999999999 110.558 -173.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 4.6 Cg_exo -76.45 -72.08 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.177 2.585 . . . . 2.4199999999999999 113.066 -175.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HB3' ' HD2' ' A' ' 22' ' ' PRO . 34.0 mmtp -106.68 161.43 22.9 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 116.091 -0.504 . . . . 6.3799999999999999 109.746 -179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 18.3 Cg_endo -60.48 157.8 34.74 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.576 2.184 . . . . 2.77 112.17 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.714 ' HB3' ' O ' ' A' ' 48' ' ' THR . 1.8 mp0 -123.75 152.53 42.05 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 104.502 -2.407 . . . . 3.3900000000000001 104.502 -176.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -115.67 179.91 18.15 Favored Glycine 0 C--N 1.303 -1.28 0 C-N-CA 117.55 -2.262 . . . . 0.54000000000000004 114.624 -176.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.558 ' OG ' HD11 ' A' ' 122' ' ' LEU . 89.6 p -169.5 34.74 0.02 OUTLIER 'General case' 0 CA--C 1.505 -0.781 0 N-CA-C 108.195 -1.039 . . . . 1.2 108.195 172.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.6 m -132.91 155.25 41.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 CA-C-N 114.742 -1.117 . . . . 0.93000000000000005 109.058 -174.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 44' ' ' LYS . 1.6 t -168.94 -42.74 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.208 0.447 . . . . 0.47999999999999998 112.208 164.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.58 ' HB3' ' CG ' ' A' ' 44' ' ' LYS . 22.8 t70 -158.51 156.68 30.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.633 0.651 . . . . 1.6899999999999999 110.837 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 77.0 t -135.21 127.07 46.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 N-CA-C 109.573 -0.529 . . . . 1.1399999999999999 109.573 173.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -112.49 130.8 55.87 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.095 0.474 . . . . 1.8300000000000001 111.562 -171.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -88.03 122.75 32.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.657 -0.701 . . . . 0.93999999999999995 111.408 -176.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.458 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -128.36 -126.54 0.22 Allowed 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.228 -0.656 . . . . 1.3300000000000001 109.228 167.231 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 1.029 ' HA ' HG13 ' A' ' 39' ' ' VAL . 7.4 p-10 176.24 170.86 0.42 Allowed 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 113.267 0.84 . . . . 2.8500000000000001 113.267 -171.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.94 118.53 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 CA-C-N 114.181 -1.372 . . . . 3.2599999999999998 109.995 171.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.531 ' OD1' ' HD3' ' A' ' 36' ' ' ARG . 22.9 t30 54.78 -102.68 0.15 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.67 -1.15 . . . . 3.1600000000000001 109.708 169.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.531 ' HD3' ' OD1' ' A' ' 35' ' ' ASN . 0.0 OUTLIER -177.47 34.99 0.0 OUTLIER 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 122.988 1.375 . . . . 5.46 107.93 168.028 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -114.98 -41.47 3.34 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 112.559 -2.11 . . . . 1.9199999999999999 108.399 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 47.8 t -152.76 107.66 3.21 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 114.733 -1.121 . . . . 0.93999999999999995 110.57 175.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.029 HG13 ' HA ' ' A' ' 33' ' ' ASP . 46.5 t -76.75 164.2 3.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.911 -0.774 . . . . 0.85999999999999999 108.911 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.892 ' HG2' ' HB ' ' A' ' 94' ' ' VAL . 4.0 mt-10 -124.76 141.18 52.29 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 119.559 -0.856 . . . . 1.1899999999999999 112.124 -170.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.869 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -122.55 105.4 10.09 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.106 -0.952 . . . . 3.73 111.012 -177.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.9 OUTLIER -77.74 110.23 12.42 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.377 -0.971 . . . . 0.81000000000000005 108.377 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -101.06 98.65 9.07 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.426 0.632 . . . . 0.41999999999999998 110.221 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.58 ' CG ' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -82.7 106.07 14.25 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 107.533 -1.284 . . . . 2.6299999999999999 107.533 176.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.582 HG23 ' HB3' ' A' ' 90' ' ' LEU . 2.0 m -110.83 164.41 6.86 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 114.702 -1.135 . . . . 0.81999999999999995 110.632 -171.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.9 m -142.85 105.13 4.44 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 121.209 0.528 . . . . 0.71999999999999997 111.665 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 67.5 t -83.02 125.37 40.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.318 -0.855 . . . . 1.1399999999999999 110.851 -175.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.714 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 5.6 m -101.23 122.31 43.43 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.456 -0.338 . . . . 0.40999999999999998 110.77 177.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.934 ' HB2' HD21 ' A' ' 82' ' ' LEU . 7.6 t-20 -88.2 134.73 34.2 Favored Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.382 1.051 . . . . 1.48 108.849 173.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.594 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 15.2 Cg_endo -108.23 9.88 0.13 Allowed 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.191 2.594 . . . . 0.72999999999999998 115.812 -178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.408 ' O ' ' HB3' ' A' ' 52' ' ' SER . 38.5 t80 -118.15 -15.43 9.84 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 119.089 0.859 . . . . 2.0800000000000001 113.254 -169.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.424 ' HB2' ' CE ' ' A' ' 85' ' ' LYS . 17.8 t 87.82 17.59 0.07 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 123.532 0.733 . . . . 1.51 110.412 173.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -143.43 125.43 15.29 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.163 -0.68 . . . . 1.6699999999999999 109.163 179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.7 m -38.85 101.79 0.02 OUTLIER 'General case' 0 C--O 1.215 -0.762 0 O-C-N 124.298 0.999 . . . . 1.3899999999999999 112.969 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.654 HD12 ' HB ' ' A' ' 124' ' ' ILE . 7.3 pt -77.76 118.73 73.98 Favored Pre-proline 0 C--O 1.208 -1.085 0 N-CA-C 109.173 -0.676 . . . . 1.03 109.173 -176.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.939 ' HB2' HD12 ' A' ' 57' ' ' ILE . 29.3 Cg_endo -60.42 -54.01 2.46 Favored 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 122.273 1.982 . . . . 0.37 113.651 -157.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.939 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.6 mp -133.83 159.07 42.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 C-N-CA 120.045 -0.662 . . . . 1.23 110.65 -175.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.678 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -145.69 172.41 13.32 Favored 'General case' 0 N--CA 1.436 -1.168 0 CA-C-O 122.158 0.98 . . . . 1.1499999999999999 111.789 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.048 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.0 tt0 -127.26 114.63 17.88 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 113.109 -1.86 . . . . 1.3600000000000001 108.949 175.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -97.91 109.17 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.033 0 CA-C-O 122.512 1.148 . . . . 1.05 109.78 169.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.575 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 13.5 p -112.4 101.64 9.82 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 113.216 -1.811 . . . . 0.82999999999999996 108.184 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 12.0 p90 -114.71 136.56 52.93 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.137 0.494 . . . . 0.40000000000000002 110.285 -166.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 73' ' ' LYS . 16.9 m -132.45 108.57 9.23 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.788 -1.097 . . . . 0.38 109.546 175.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.432 ' CZ ' HD23 ' A' ' 118' ' ' LEU . 96.4 m-85 -97.22 140.97 30.92 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.808 -0.633 . . . . 0.95999999999999996 109.438 -178.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.486 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.4 m170 -128.59 145.62 51.08 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 107.467 -1.308 . . . . 1.29 107.467 175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.792 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.8 t -100.99 -102.86 0.25 Allowed 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 119.449 -0.9 . . . . 1.27 110.199 173.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.471 ' HB3' HH11 ' A' ' 69' ' ' ARG . . . -62.6 -57.05 12.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 108.889 -0.782 . . . . 0.35999999999999999 108.889 -175.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.54 15.2 0.16 Allowed Glycine 0 N--CA 1.435 -1.401 0 N-CA-C 108.599 -1.8 . . . . 0.39000000000000001 108.599 165.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.471 HH11 ' HB3' ' A' ' 67' ' ' ALA . 0.0 OUTLIER -109.72 171.86 7.19 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.368 -0.975 . . . . 1.97 108.368 -179.079 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -95.85 95.3 8.17 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.112 0.482 . . . . 2.6099999999999999 109.913 -164.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.826 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.7 mm -48.08 -41.41 9.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 114.639 -1.164 . . . . 0.40000000000000002 111.403 177.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.26 163.38 29.18 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.211 -0.995 . . . . 0.48999999999999999 111.608 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.638 ' HB3' HG23 ' A' ' 63' ' ' THR . 0.6 OUTLIER -165.92 155.91 12.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 117.533 0.667 . . . . 1.8100000000000001 110.998 174.928 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 176.6 167.66 35.54 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.482 -0.781 . . . . 0.42999999999999999 111.528 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -123.44 131.71 53.73 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.09 -0.337 . . . . 1.72 110.09 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.546 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 86.7 mt -137.89 126.18 14.29 Favored Pre-proline 0 C--N 1.317 -0.815 0 CA-C-N 116.441 -0.345 . . . . 0.72999999999999998 110.123 178.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -85.09 115.72 1.72 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.468 2.112 . . . . 0.56999999999999995 111.633 174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -125.04 141.29 38.04 Favored Pre-proline 0 C--N 1.326 -0.438 0 N-CA-C 110.084 -0.339 . . . . 0.79000000000000004 110.084 -175.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -59.75 87.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.792 2.328 . . . . 0.57999999999999996 111.963 175.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.502 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -78.73 19.55 4.98 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.359 -0.837 . . . . 0.40000000000000002 113.384 -176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.646 ' HB3' ' HA ' ' A' ' 56' ' ' PRO . 91.1 p -70.38 119.71 14.97 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.49 -0.559 . . . . 0.62 109.49 -176.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.934 HD21 ' HB2' ' A' ' 49' ' ' ASN . 2.6 pt? -142.41 -165.95 2.15 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.854 0.687 . . . . 1.1000000000000001 112.854 -165.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 89.9 mttt -43.2 -91.33 0.0 OUTLIER 'General case' 0 C--O 1.234 0.265 0 CA-C-N 114.777 -1.101 . . . . 1.8400000000000001 112.949 -175.093 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 165.02 105.17 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.527 0 N-CA-C 108.31 -0.996 . . . . 0.98999999999999999 108.31 -172.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.1 ptpt 43.84 50.84 6.9 Favored 'General case' 0 N--CA 1.465 0.298 0 O-C-N 124.363 1.04 . . . . 1.8400000000000001 111.166 -176.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 87' ' ' MET . 10.8 t70 -151.56 -169.87 3.49 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.217 -0.901 . . . . 0.64000000000000001 108.816 -173.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.411 ' H ' ' CG ' ' A' ' 86' ' ' ASP . 48.4 ttm -116.99 121.4 41.28 Favored 'General case' 0 C--N 1.312 -1.043 0 CA-C-O 120.835 0.35 . . . . 1.3500000000000001 110.494 -171.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 46' ' ' SER . 12.0 t -104.94 143.36 33.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.754 -0.657 . . . . 0.77000000000000002 109.739 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -82.01 106.8 14.21 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.379 0.609 . . . . 0.47999999999999998 110.097 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.944 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 7.7 tp -100.48 178.23 4.8 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.085 -0.961 . . . . 0.77000000000000002 109.246 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.944 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 6.2 t70 -146.58 127.8 14.77 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.578 -0.283 . . . . 1.8100000000000001 111.303 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.634 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 1.5 mp -102.61 116.3 62.98 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 107.645 -1.243 . . . . 0.65000000000000002 107.645 163.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.586 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 33.5 Cg_exo -32.32 -100.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 125.181 3.921 . . . . 1.0700000000000001 115.477 -172.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.892 ' HB ' ' HG2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -163.43 93.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.883 0 O-C-N 122.275 -0.266 . . . . 0.46000000000000002 111.336 -172.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.454 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.6 p -129.03 104.26 10.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 114.676 1.361 . . . . 0.47999999999999998 114.676 -170.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.509 ' CG2' ' HG ' ' A' ' 101' ' ' LEU . 3.0 p -153.79 99.83 2.57 Favored Pre-proline 0 C--N 1.327 -0.389 0 O-C-N 121.867 -0.52 . . . . 1.0700000000000001 111.949 161.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.556 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.5 Cg_exo -53.66 131.71 45.34 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 121.828 1.685 . . . . 0.47999999999999998 111.183 175.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -53.9 -33.23 55.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.047 -0.524 . . . . 1.3100000000000001 112.356 -173.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 13.3 m -56.17 -32.0 63.92 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.757 0.313 . . . . 1.2 111.667 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.826 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.2 mm -76.28 -55.72 10.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 C-N-CA 120.602 -0.439 . . . . 0.51000000000000001 110.643 -176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.634 HD23 HD21 ' A' ' 104' ' ' LEU . 40.3 mt -51.99 -28.11 15.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.565 -0.743 . . . . 1.0 110.703 173.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -63.12 -44.66 95.0 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.028 -0.987 . . . . 0.95999999999999996 108.99 -179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -71.21 -57.15 4.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.799 -0.637 . . . . 0.81999999999999995 111.889 -178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.792 HD22 ' CB ' ' A' ' 66' ' ' SER . 1.6 pp -62.07 -53.06 60.82 Favored 'General case' 0 C--O 1.221 -0.418 0 N-CA-C 113.431 0.9 . . . . 0.65000000000000002 113.431 -177.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.738 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.1 -25.97 68.61 Favored 'General case' 0 C--O 1.22 -0.499 0 CA-C-O 121.842 0.83 . . . . 0.42999999999999999 110.197 -177.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.764 ' O ' HG13 ' A' ' 110' ' ' VAL . 6.7 ttp180 -74.57 -54.7 6.98 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 114.531 -1.213 . . . . 1.8100000000000001 110.391 173.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.88 ' O ' HG22 ' A' ' 110' ' ' VAL . 14.4 t70 -74.06 -52.79 11.56 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.883 0.849 . . . . 0.80000000000000004 111.057 -173.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.608 HG21 HG23 ' A' ' 114' ' ' ILE . 2.3 t -86.93 -17.21 8.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 O-C-N 121.355 -0.84 . . . . 0.88 109.697 -178.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.738 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -67.91 -25.56 74.22 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 120.736 -0.745 . . . . 0.38 113.712 168.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 107' ' ' ASP . 11.5 m -63.22 -40.83 90.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 N-CA-C 107.118 -1.438 . . . . 1.0900000000000001 107.118 170.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.6 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.6 m-20 -59.56 -58.53 8.19 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.63 -0.713 . . . . 1.8700000000000001 110.927 165.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.5 ' CG ' ' N ' ' A' ' 113' ' ' ASP . 3.8 p-90 128.36 -64.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 127.282 2.233 . . . . 1.1699999999999999 111.641 -176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 14.9 t70 -94.44 129.44 41.18 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.475 -0.329 . . . . 2.1499999999999999 110.404 -175.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.738 HD11 HD12 ' A' ' 144' ' ' LEU . 2.5 mp -115.32 151.13 17.1 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.275 0 CA-C-O 121.026 0.441 . . . . 0.39000000000000001 109.854 -174.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 141' ' ' GLU . 6.1 p-10 -93.73 152.59 18.84 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 108.983 -0.747 . . . . 2.1099999999999999 108.983 176.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.564 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 31.9 m-85 -141.9 165.66 26.84 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.669 -0.863 . . . . 0.62 108.669 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 22.9 tt0 -152.18 139.92 19.87 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.751 0.31 . . . . 0.80000000000000004 110.345 -178.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.648 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -113.91 129.94 56.55 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.205 -0.665 . . . . 1.25 109.205 173.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.648 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -120.59 100.72 7.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.118 -0.697 . . . . 0.63 109.118 175.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.07 123.18 71.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 CA-C-O 121.51 0.671 . . . . 0.81000000000000005 110.773 -174.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.554 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -87.33 124.48 7.07 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.458 -0.792 . . . . 0.26000000000000001 111.768 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.564 HD12 HD12 ' A' ' 120' ' ' ILE . 6.1 mp -97.4 105.91 18.13 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.966 0.412 . . . . 1.2 111.055 -175.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.048 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 89.2 m -108.11 95.14 5.47 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 115.439 -0.801 . . . . 0.32000000000000001 109.007 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.678 HG22 ' HB3' ' A' ' 58' ' ' CYS . 7.0 pt -112.23 140.05 33.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 C-N-CA 120.555 -0.458 . . . . 0.97999999999999998 110.281 -178.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.797 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -85.81 105.8 16.58 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.33 -0.989 . . . . 1.52 108.33 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.424 ' HA ' HG22 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -125.03 135.54 26.93 Favored Pre-proline 0 C--O 1.22 -0.464 0 O-C-N 124.049 0.843 . . . . 1.28 110.156 178.473 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 126' ' ' LEU . 53.9 Cg_exo -52.73 -19.38 10.57 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 123.496 2.797 . . . . 0.73999999999999999 115.32 -169.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 3.4 t -73.48 -51.09 26.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 O-C-N 122.231 -0.293 . . . . 1.1200000000000001 111.361 -177.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.064 ' HA ' ' HA ' ' A' ' 3' ' ' SER . 0.2 OUTLIER -103.32 -2.38 9.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 122.087 0.946 . . . . 1.3500000000000001 109.456 178.58 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.72 -36.95 1.22 Allowed Glycine 0 C--N 1.314 -0.669 0 CA-C-N 113.558 -1.655 . . . . 1.05 111.151 -169.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.523 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.1 pt-20 -177.09 150.57 0.76 Allowed 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 107.554 -1.276 . . . . 1.1599999999999999 107.554 178.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HD1' HG11 ' A' ' 129' ' ' VAL . 12.7 t80 -151.97 147.86 27.05 Favored 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.703 -0.399 . . . . 1.9099999999999999 110.158 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 67.8 m -113.82 104.72 12.47 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.506 0.504 . . . . 1.1899999999999999 111.477 -178.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.3 pp -124.04 133.09 24.41 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 0.5 109.608 172.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.554 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 89.6 Cg_endo -87.38 161.28 8.24 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 121.592 1.528 . . . . 0.45000000000000001 112.836 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.68 164.68 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 108.299 -1.0 . . . . 0.44 108.299 178.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -135.4 150.21 49.84 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 120.901 -0.319 . . . . 0.88 111.203 -168.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.3 t -145.8 102.18 3.63 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 107.649 -1.241 . . . . 0.95999999999999996 107.649 174.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 6.0 ptmt -118.12 144.05 45.98 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.68 -0.489 . . . . 1.76 109.68 -172.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.03 149.55 19.15 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.021 -1.085 . . . . 0.5 112.443 -174.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.525 ' HG2' ' HA ' ' A' ' 115' ' ' ASP . 31.0 mt-10 -108.06 126.94 53.33 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.055 -0.572 . . . . 2.1000000000000001 109.771 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 172.87 7.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 108.868 -0.79 . . . . 0.76000000000000001 108.868 -176.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.2 pttp -54.64 160.81 1.69 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.995 0.739 . . . . 3.5299999999999998 112.995 -177.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.738 HD12 HD11 ' A' ' 114' ' ' ILE . 25.0 tp -58.88 136.54 87.26 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 115.056 -0.974 . . . . 1.23 110.57 176.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.664 ' HD2' HD12 ' A' ' 144' ' ' LEU . 38.1 Cg_endo -66.41 172.57 8.86 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.798 2.332 . . . . 0.70999999999999996 112.486 177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 30.9 m -59.15 128.18 35.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.037 -0.528 . . . . 1.71 110.992 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -139.19 145.55 39.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 2.6400000000000001 110.599 -175.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.426 ' C ' ' H ' ' A' ' 150' ' ' PHE . 40.5 ttmt -167.32 97.65 0.5 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.213 -0.449 . . . . 3.7200000000000002 109.893 176.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . 0.402 ' HB2' ' O ' ' A' ' 148' ' ' LYS . 4.9 m-20 73.6 -20.82 0.28 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 123.443 0.697 . . . . 4.2800000000000002 111.986 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.426 ' H ' ' C ' ' A' ' 148' ' ' LYS . 24.8 m-85 -68.63 -39.31 80.82 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.133 0.492 . . . . 2.8599999999999999 109.697 177.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.388 -0.815 . . . . 3.96 109.096 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtm . . . . . 0 N--CA 1.482 1.16 0 CA-C-O 120.874 0.369 . . . . 12.109999999999999 110.082 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.551 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -98.83 -171.44 2.1 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.939 -0.573 . . . . 9.0199999999999996 111.057 -176.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.8 m 66.29 -78.18 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.778 -0.647 . . . . 6.8300000000000001 111.369 -176.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -163.3 138.15 6.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.911 0.386 . . . . 8.5500000000000007 110.269 -178.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 96.3 mt -110.69 -20.69 12.43 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.967 -0.56 . . . . 10.470000000000001 109.63 175.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -79.04 97.79 6.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.533 -0.758 . . . . 11.69 110.051 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.499 ' HE3' ' HB2' ' A' ' 7' ' ' LYS . 40.4 mtmt 65.24 -165.47 0.23 Allowed 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.662 -0.699 . . . . 11.42 111.018 -179.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -169.38 107.65 0.41 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.798 -0.637 . . . . 11.58 110.151 177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.4 tttm 66.31 93.29 0.07 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.377 0.608 . . . . 15.74 111.245 178.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -164.65 -176.47 4.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.511 -0.768 . . . . 12.69 109.519 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -81.61 90.33 6.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.408 0.623 . . . . 13.85 109.717 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.5 m -78.13 93.26 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.531 -0.759 . . . . 8.8699999999999992 111.714 -176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -89.04 23.71 2.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.744 0.783 . . . . 8.9100000000000001 109.2 172.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -124.54 -63.92 1.15 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 114.907 -1.042 . . . . 8.5999999999999996 110.339 -176.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 65.2 tttp 68.3 108.41 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.252 0 O-C-N 124.058 0.849 . . . . 9.0399999999999991 111.587 177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 16' ' ' LEU . 2.4 pt? -69.81 152.15 44.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.739 -0.664 . . . . 5.5800000000000001 109.42 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 87.6 m -110.12 135.64 50.61 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 121.185 -0.206 . . . . 2.6899999999999999 110.947 -178.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.547 ' HA ' HG23 ' A' ' 129' ' ' VAL . . . 66.84 -151.67 0.2 Allowed 'General case' 0 C--O 1.234 0.258 0 O-C-N 123.876 0.735 . . . . 1.6799999999999999 111.702 175.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.637 HD12 ' HG3' ' A' ' 50' ' ' PRO . 19.1 pt -111.06 170.6 5.1 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.876 -0.602 . . . . 3.1899999999999999 110.128 -173.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.551 ' HG2' ' HA ' ' A' ' 2' ' ' ALA . 11.7 Cg_exo -72.54 -148.82 0.03 OUTLIER 'Trans proline' 0 CA--C 1.535 0.539 0 C-N-CA 122.887 2.391 . . . . 2.4199999999999999 112.488 175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.813 ' H ' ' CD ' ' A' ' 22' ' ' PRO . 16.8 ptpt -158.3 -13.58 0.0 OUTLIER Pre-proline 0 CA--C 1.544 0.74 0 N-CA-C 114.486 1.291 . . . . 6.3799999999999999 114.486 -176.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.813 ' CD ' ' H ' ' A' ' 21' ' ' LYS . 14.2 Cg_exo -72.84 45.18 0.86 Allowed 'Trans proline' 0 C--N 1.363 1.337 0 CA-C-N 121.571 1.597 . . . . 2.77 111.848 169.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.694 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 10.8 mp0 -134.39 129.98 36.18 Favored 'General case' 0 N--CA 1.434 -1.245 0 N-CA-C 104.828 -2.286 . . . . 3.3900000000000001 104.828 -176.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.724 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -122.2 -161.14 11.18 Favored Glycine 0 C--O 1.22 -0.729 0 C-N-CA 118.508 -1.806 . . . . 0.54000000000000004 116.282 -154.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.641 ' O ' HG13 ' A' ' 45' ' ' VAL . 75.5 p -169.01 34.25 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 124.47 1.108 . . . . 1.2 108.107 177.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.4 m -133.21 152.86 36.42 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 CA-C-N 114.48 -1.236 . . . . 0.93000000000000005 109.701 -169.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 2.2 t -168.53 -41.83 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.599 0 O-C-N 123.135 0.272 . . . . 0.47999999999999998 110.712 170.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -174.36 168.08 3.94 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 112.554 0.575 . . . . 1.6899999999999999 112.554 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 67.8 t -142.76 129.36 18.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 CA-C-N 115.341 -0.845 . . . . 1.1399999999999999 109.497 176.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -117.97 128.12 54.49 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.619 -0.264 . . . . 1.8300000000000001 110.98 -175.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.615 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 2.7 tm? -92.97 139.54 30.41 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 111.801 0.297 . . . . 0.93999999999999995 111.801 -169.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -139.1 -94.52 0.17 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 114.047 1.129 . . . . 1.3300000000000001 114.047 176.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.744 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER -91.11 -174.41 3.97 Favored 'General case' 0 C--O 1.205 -1.272 0 CA-C-N 116.182 -0.463 . . . . 2.8500000000000001 112.182 -153.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.789 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.5 p -165.49 -34.79 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.0 0 O-C-N 123.732 0.645 . . . . 3.2599999999999998 110.517 -177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.565 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 38.0 m-80 67.34 -65.0 0.24 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.175 -0.92 . . . . 3.1600000000000001 108.963 -172.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 1.2 tpp180 165.73 18.47 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.157 0 C-N-CA 124.874 1.27 . . . . 5.46 110.724 170.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 98' ' ' TYR . 30.2 m-20 -136.82 -32.56 0.81 Allowed 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.652 0.739 . . . . 1.9199999999999999 109.041 -177.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.789 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.1 t -154.39 119.11 4.9 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.096 -0.956 . . . . 0.93999999999999995 112.289 -173.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 33' ' ' ASP . 93.3 t -74.01 147.07 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 114.578 -1.192 . . . . 0.85999999999999999 110.056 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.905 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -123.55 137.73 54.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 C-N-CA 119.604 -0.838 . . . . 1.1899999999999999 110.337 -173.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.94 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -141.7 139.61 32.96 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 118.671 -1.212 . . . . 3.73 113.677 173.694 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -83.24 109.0 16.86 Favored 'General case' 0 C--N 1.313 -1.009 0 N-CA-C 107.666 -1.235 . . . . 0.81000000000000005 107.666 179.906 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -93.48 107.52 19.35 Favored 'General case' 0 C--N 1.313 -1.011 0 N-CA-C 108.535 -0.913 . . . . 0.41999999999999998 108.535 176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 21.5 ttmm -82.7 131.31 35.21 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 108.927 -0.768 . . . . 2.6299999999999999 108.927 -176.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 25' ' ' SER . 45.2 t -111.2 137.81 42.17 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-N 114.735 -1.12 . . . . 0.81999999999999995 110.236 -173.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.593 ' HA ' ' O ' ' A' ' 88' ' ' THR . 2.7 m -126.39 97.87 5.22 Favored 'General case' 0 N--CA 1.432 -1.366 0 C-N-CA 120.257 -0.577 . . . . 0.71999999999999997 109.632 168.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.724 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 57.8 t -84.0 124.25 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 CA-C-N 115.651 -0.704 . . . . 1.1399999999999999 110.812 -177.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.68 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 22.1 m -99.83 121.01 40.66 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.326 -0.991 . . . . 0.40999999999999998 108.326 172.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.844 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 4.9 t30 -89.45 124.37 64.54 Favored Pre-proline 0 C--N 1.329 -0.323 0 O-C-N 124.894 1.371 . . . . 1.48 109.652 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.694 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 89.3 Cg_endo -82.89 11.67 3.18 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 123.852 3.035 . . . . 0.72999999999999998 113.945 -175.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 2.7 t80 -125.54 136.38 53.25 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.717 -0.845 . . . . 2.0800000000000001 108.717 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.2 p -76.31 34.36 0.13 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.311 0.577 . . . . 1.51 111.161 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.457 ' H ' ' C ' ' A' ' 51' ' ' TYR . 52.8 m80 -148.57 132.69 17.3 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.371 -0.831 . . . . 1.6699999999999999 109.895 178.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.0 m -45.15 102.07 0.03 OUTLIER 'General case' 0 C--O 1.213 -0.86 0 C-N-CA 124.186 0.994 . . . . 1.3899999999999999 113.459 173.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.943 ' O ' ' HA ' ' A' ' 81' ' ' SER . 11.1 pt -75.47 171.65 11.31 Favored Pre-proline 0 C--O 1.208 -1.112 0 N-CA-C 108.535 -0.913 . . . . 1.03 108.535 -178.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.527 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 39.6 Cg_endo -89.12 -63.28 0.01 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 121.455 1.437 . . . . 0.37 114.923 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.563 HD13 ' HA ' ' A' ' 79' ' ' PRO . 18.2 mm -133.0 162.26 40.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 O-C-N 121.967 -0.458 . . . . 1.23 111.532 -166.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.809 ' HB3' HG22 ' A' ' 124' ' ' ILE . 22.3 p -150.97 -179.85 7.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-O 122.165 0.983 . . . . 1.1499999999999999 111.998 176.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.064 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.6 tt0 -132.37 116.12 16.44 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 113.419 -1.719 . . . . 1.3600000000000001 109.933 177.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.61 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -97.21 108.98 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 CA-C-O 122.362 1.077 . . . . 1.05 109.454 168.573 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.0 p -114.42 103.03 10.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 113.454 -1.703 . . . . 0.82999999999999996 108.807 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.465 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 11.8 p90 -113.23 137.97 50.68 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.226 0.536 . . . . 0.40000000000000002 110.294 -165.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.7 m -137.01 108.81 7.05 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 114.873 -1.058 . . . . 0.38 109.626 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.459 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 92.7 m-85 -98.54 146.59 25.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.409 -0.359 . . . . 0.95999999999999996 110.768 -175.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.74 ' HB3' ' O ' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -139.08 128.83 24.75 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 108.098 -1.075 . . . . 1.29 108.098 176.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 1.035 ' HB3' HD22 ' A' ' 104' ' ' LEU . 38.1 t -94.06 -89.85 0.21 Allowed 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 119.408 -0.917 . . . . 1.27 110.829 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.55 -67.86 0.36 Allowed 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 109.387 -0.597 . . . . 0.35999999999999999 109.387 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.81 18.08 0.17 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 110.407 -1.077 . . . . 0.39000000000000001 110.407 167.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.74 ' O ' ' HB3' ' A' ' 65' ' ' HIS . 6.7 ptp180 -106.43 -149.47 0.43 Allowed 'General case' 0 C--O 1.221 -0.43 0 N-CA-C 109.558 -0.534 . . . . 1.97 109.558 -175.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -120.35 101.24 7.66 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 119.068 0.849 . . . . 2.6099999999999999 109.539 -173.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.856 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.7 OUTLIER -73.62 -44.93 52.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.645 -0.707 . . . . 0.40000000000000002 112.417 -171.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -178.56 140.24 4.43 Favored Glycine 0 CA--C 1.502 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.48999999999999999 111.094 -175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -154.36 159.08 40.97 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 117.568 0.684 . . . . 1.8100000000000001 111.222 -174.268 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 171.74 163.72 26.15 Favored Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.886 -0.885 . . . . 0.42999999999999999 110.886 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.9 mttt -129.85 128.37 42.13 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.162 -0.31 . . . . 1.72 110.162 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.435 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.1 mt -135.67 124.37 15.72 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.608 -0.269 . . . . 0.72999999999999998 110.667 -176.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -75.3 103.0 1.66 Allowed 'Trans proline' 0 N--CA 1.459 -0.525 0 C-N-CA 122.155 1.903 . . . . 0.56999999999999995 111.234 172.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.458 ' HB2' HD11 ' A' ' 60' ' ' ILE . 7.4 t70 -110.43 136.78 20.56 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.541 -0.54 . . . . 0.79000000000000004 109.541 -172.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HA ' HD13 ' A' ' 57' ' ' ILE . 25.8 Cg_exo -63.44 88.79 0.14 Allowed 'Trans proline' 0 CA--C 1.531 0.35 0 C-N-CA 122.546 2.164 . . . . 0.57999999999999996 112.716 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HD22 ' A' ' 82' ' ' LEU . . . -88.24 35.63 3.54 Favored Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.885 -0.598 . . . . 0.40000000000000002 112.379 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.943 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 86.0 p -72.78 117.71 14.82 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.146 -0.687 . . . . 0.62 109.146 175.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.558 ' HG ' ' NZ ' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -156.41 -155.15 0.52 Allowed 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 118.305 -1.358 . . . . 1.1000000000000001 114.45 -157.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.796 ' CE ' ' HB ' ' A' ' 88' ' ' THR . 0.1 OUTLIER -57.68 -158.2 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 122.339 1.066 . . . . 1.8400000000000001 112.305 179.898 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -141.87 80.59 1.72 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.342 -1.355 . . . . 0.98999999999999999 107.342 -167.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.844 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 8.9 mtpt 64.74 68.28 0.53 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 113.962 -1.472 . . . . 1.8400000000000001 110.934 -169.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.698 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 9.4 t70 -162.53 -169.59 2.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.238 -1.346 . . . . 0.64000000000000001 109.54 -178.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.473 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 41.8 ttp -122.42 118.96 29.61 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.193 0.521 . . . . 1.3500000000000001 110.88 -171.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.796 ' HB ' ' CE ' ' A' ' 83' ' ' LYS . 5.6 t -104.04 143.67 32.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.493 -0.776 . . . . 0.77000000000000002 109.018 -172.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -90.71 109.4 20.59 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.703 0.763 . . . . 0.47999999999999998 110.739 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.588 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.6 OUTLIER -115.48 175.07 5.68 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.66 -1.155 . . . . 0.77000000000000002 108.136 179.738 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.588 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 3.1 p30 -144.25 151.22 39.13 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 119.011 0.823 . . . . 1.8100000000000001 112.569 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 40.3 mm -110.16 130.45 22.84 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 114.683 -1.144 . . . . 0.65000000000000002 108.044 170.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.508 ' O ' HG13 ' A' ' 94' ' ' VAL . 44.6 Cg_exo -35.86 -103.22 0.0 OUTLIER 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 124.687 3.592 . . . . 1.0700000000000001 115.372 -173.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.94 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.2 OUTLIER -164.0 90.46 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.057 0 CA-C-O 119.118 -0.468 . . . . 0.46000000000000002 110.615 -177.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.502 ' O ' HG13 ' A' ' 95' ' ' VAL . 14.9 p -124.35 104.25 13.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 N-CA-C 115.646 1.721 . . . . 0.47999999999999998 115.646 -163.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.684 HG11 ' HG ' ' A' ' 101' ' ' LEU . 2.5 t -148.9 119.23 4.11 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.176 -0.466 . . . . 1.0700000000000001 110.346 164.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.676 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 17.9 Cg_exo -65.47 124.9 13.53 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 CA-C-N 120.08 1.064 . . . . 0.47999999999999998 109.569 164.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 0.2 OUTLIER -58.27 -30.85 66.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.03 -0.532 . . . . 1.3100000000000001 111.594 -171.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 3.2 p -58.76 -26.54 64.1 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.311 0.486 . . . . 1.2 112.311 178.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.856 HG21 ' HA ' ' A' ' 71' ' ' ILE . 20.2 mm -76.86 -55.31 11.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 121.818 -0.551 . . . . 0.51000000000000001 110.995 -177.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.684 ' HG ' HG11 ' A' ' 96' ' ' VAL . 26.9 mt -52.24 -26.56 12.09 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.555 0.693 . . . . 1.0 110.392 171.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.471 ' HB3' ' O ' ' A' ' 99' ' ' SER . 57.6 t80 -64.4 -40.24 95.42 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.467 -1.242 . . . . 0.95999999999999996 108.839 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.464 ' HA ' HH21 ' A' ' 106' ' ' ARG . 22.0 m-80 -73.79 -58.06 3.56 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.845 -0.616 . . . . 0.81999999999999995 112.422 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.035 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.4 pp -61.04 -50.19 74.31 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.423 0.898 . . . . 0.65000000000000002 113.423 -179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -62.68 -25.05 67.95 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.856 0.836 . . . . 0.42999999999999999 110.037 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 110' ' ' VAL . 2.7 ttp180 -68.18 -51.11 49.37 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 114.68 -1.145 . . . . 1.8100000000000001 110.728 173.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.406 ' O ' HG22 ' A' ' 110' ' ' VAL . 24.8 t70 -82.9 -52.07 7.04 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 122.545 1.164 . . . . 0.80000000000000004 112.231 -175.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.578 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.1 t -84.42 -29.06 6.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 120.859 -1.151 . . . . 0.88 109.982 -177.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.93 -25.59 73.39 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.923 -0.656 . . . . 0.38 113.786 175.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -57.65 -40.5 75.67 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 C-N-CA 118.413 -1.315 . . . . 1.0900000000000001 108.04 170.78 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 30.6 t70 -64.66 -84.12 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 118.504 -1.278 . . . . 1.8700000000000001 108.097 161.108 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.426 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.9 OUTLIER 168.07 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 113.24 0.83 . . . . 1.1699999999999999 113.24 170.045 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -91.58 123.78 35.24 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 111.87 0.322 . . . . 2.1499999999999999 111.87 -175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.578 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.3 mp -117.28 155.55 18.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 CA-C-O 120.902 0.382 . . . . 0.39000000000000001 110.032 -178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.576 ' HB2' ' HG2' ' A' ' 141' ' ' GLU . 37.1 t70 -98.91 155.41 17.41 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.067 -0.716 . . . . 2.1099999999999999 109.067 177.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.649 ' O ' ' HA ' ' A' ' 139' ' ' LYS . 72.9 m-85 -139.08 129.57 25.78 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.217 -0.66 . . . . 0.62 109.217 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.844 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 17.5 tt0 -123.78 137.25 54.71 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.05 0.453 . . . . 0.80000000000000004 110.068 -177.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.699 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.8 OUTLIER -111.47 129.36 56.06 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.588 -0.733 . . . . 1.25 109.863 176.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.721 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -113.34 101.29 9.25 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.854 -0.795 . . . . 0.63 108.854 176.129 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.654 ' HB ' HD11 ' A' ' 118' ' ' LEU . 5.9 tp -111.88 123.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 121.146 0.498 . . . . 0.81000000000000005 111.204 -174.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -88.76 125.2 7.62 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 111.378 -0.689 . . . . 0.26000000000000001 111.378 173.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.583 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.3 mp -101.88 94.99 6.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.899 0.38 . . . . 1.2 111.131 -174.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.064 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 84.9 m -100.17 95.56 6.89 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.629 -0.714 . . . . 0.32000000000000001 109.177 173.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.838 HG13 HD21 ' A' ' 126' ' ' LEU . 3.0 pt -106.89 149.42 10.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 121.9 -0.5 . . . . 0.97999999999999998 109.698 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.527 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 18.5 m-20 -92.88 107.15 18.99 Favored 'General case' 0 CA--C 1.515 -0.397 0 N-CA-C 109.132 -0.692 . . . . 1.52 109.132 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.838 HD21 HG13 ' A' ' 124' ' ' ILE . 0.9 OUTLIER -109.93 159.74 30.67 Favored Pre-proline 0 C--O 1.217 -0.63 0 O-C-N 123.996 0.81 . . . . 1.28 109.997 -176.103 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 17.3 Cg_exo -69.88 -13.1 33.93 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.884 1.722 . . . . 0.73999999999999999 113.358 174.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 40.4 t -75.63 -59.93 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.477 0 N-CA-C 112.769 0.655 . . . . 1.1200000000000001 112.769 -175.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.547 HG23 ' HA ' ' A' ' 18' ' ' ALA . 34.1 t -118.99 9.88 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-O 122.915 1.341 . . . . 1.3500000000000001 109.029 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.58 -24.78 3.57 Favored Glycine 0 C--N 1.313 -0.747 0 CA-C-N 113.587 -1.642 . . . . 1.05 111.605 -177.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 10.6 pt-20 -172.52 154.77 3.21 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.628 -0.879 . . . . 1.1599999999999999 108.628 177.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -150.0 143.64 25.31 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 109.523 -0.547 . . . . 1.9099999999999999 109.523 170.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.506 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 53.5 m -116.23 108.85 16.64 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.383 0.427 . . . . 1.1899999999999999 111.352 -177.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.43 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.4 pp -124.94 137.38 29.51 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.098 -0.501 . . . . 0.5 109.975 174.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 134' ' ' ILE . 73.7 Cg_endo -92.89 159.11 2.74 Favored 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 122.047 1.832 . . . . 0.45000000000000001 113.323 -179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.4 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -156.44 165.38 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 N-CA-C 108.601 -0.888 . . . . 0.44 108.601 178.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.7 OUTLIER -136.27 151.36 49.57 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.64 -0.255 . . . . 0.88 111.072 -168.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t -146.11 103.8 3.76 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 109.016 -0.735 . . . . 0.95999999999999996 109.016 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.844 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.8 ptmt -116.11 152.81 32.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.893 -0.594 . . . . 1.76 111.309 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.08 147.02 10.03 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.718 -0.753 . . . . 0.5 112.049 -178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.576 ' HG2' ' HB2' ' A' ' 115' ' ' ASP . 31.3 mt-10 -98.67 135.09 40.68 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 109.607 -0.516 . . . . 2.1000000000000001 109.607 -178.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.13 171.04 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.212 -0.662 . . . . 0.76000000000000001 109.212 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 14.5 ptmm? -60.02 167.01 2.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.396 0.617 . . . . 3.5299999999999998 112.334 -174.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.825 HD12 ' HD2' ' A' ' 145' ' ' PRO . 42.0 tp -56.26 125.44 64.99 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 114.928 -1.033 . . . . 1.23 109.809 176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.825 ' HD2' HD12 ' A' ' 144' ' ' LEU . 28.6 Cg_endo -61.81 173.76 2.76 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.658 2.905 . . . . 0.70999999999999996 113.197 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.644 HG22 ' HG2' ' A' ' 148' ' ' LYS . 3.9 m -52.1 118.67 3.65 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 116.18 -0.464 . . . . 1.71 110.003 176.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.46 ' H ' ' HD1' ' A' ' 147' ' ' PHE . 9.8 m-85 -54.14 -68.75 0.16 Allowed 'General case' 0 C--N 1.33 -0.271 0 O-C-N 123.248 0.342 . . . . 2.6400000000000001 111.427 -174.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.644 ' HG2' HG22 ' A' ' 146' ' ' THR . 31.4 mmtp 39.68 -103.79 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.496 0.718 . . . . 3.7200000000000002 112.635 -178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -122.27 7.77 9.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.175 -0.466 . . . . 4.2800000000000002 110.631 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' N ' ' HD1' ' A' ' 150' ' ' PHE . 0.9 OUTLIER -63.07 -34.93 78.64 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.834 -0.802 . . . . 2.8599999999999999 108.834 -174.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.653 ' CZ ' HD21 ' A' ' 144' ' ' LEU . 20.9 p90 . . . . . 0 C--O 1.248 0.975 0 CA-C-N 114.545 -1.207 . . . . 3.96 109.189 173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.483 1.187 0 N-CA-C 111.422 0.156 . . . . 12.109999999999999 111.422 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.61 -88.8 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 O-C-N 123.641 0.588 . . . . 9.0199999999999996 110.266 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 32.6 p 42.14 -86.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.485 1.114 . . . . 6.8300000000000001 113.685 176.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 83.6 mt -77.39 111.13 12.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.801 0.334 . . . . 8.5500000000000007 110.701 -178.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.504 ' H ' HD22 ' A' ' 5' ' ' LEU . 2.6 mm? -69.54 -61.62 1.71 Allowed 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.206 -0.664 . . . . 10.470000000000001 109.206 176.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -171.8 139.49 1.18 Allowed 'General case' 0 C--O 1.235 0.34 0 CA-C-N 115.172 -0.922 . . . . 11.69 109.481 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -170.07 146.56 3.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.943 0.402 . . . . 11.42 111.118 -178.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.92 139.16 55.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.944 -0.571 . . . . 11.58 110.171 176.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 48.5 pttt -87.38 93.19 9.33 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.319 0.581 . . . . 15.74 111.319 -176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -66.09 -58.01 6.42 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.909 -0.587 . . . . 12.69 109.696 175.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -175.12 -24.2 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.45 -0.796 . . . . 13.85 110.011 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.436 ' HB ' ' HB2' ' A' ' 15' ' ' LYS . 8.0 m -69.67 72.91 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.343 0 CA-C-O 121.521 0.677 . . . . 8.8699999999999992 112.21 -179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -86.33 126.63 34.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.753 -0.658 . . . . 8.9100000000000001 109.946 177.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 68.14 10.36 7.78 Favored 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.886 0.741 . . . . 8.5999999999999996 111.022 -178.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.436 ' HB2' ' HB ' ' A' ' 12' ' ' VAL . 66.8 mttm -109.74 97.89 7.34 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.952 -0.567 . . . . 9.0399999999999991 110.118 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 38.2 tp -114.07 111.32 21.43 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.316 -0.402 . . . . 5.5800000000000001 109.917 177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.6 m -65.74 -26.18 67.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.867 -0.606 . . . . 2.6899999999999999 111.358 -177.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.637 ' HB1' HG21 ' A' ' 129' ' ' VAL . . . -74.9 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.139 -0.482 . . . . 1.6799999999999999 111.803 -177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.5 ' HA ' ' HD3' ' A' ' 20' ' ' PRO . 39.8 pt -117.48 135.99 23.4 Favored Pre-proline 0 C--N 1.318 -0.762 0 C-N-CA 120.591 -0.444 . . . . 3.1899999999999999 111.551 -171.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.5 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 1.2 Cg_endo -84.55 -55.23 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.964 2.443 . . . . 2.4199999999999999 112.74 -178.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 49.6 mtpt -140.23 143.6 34.24 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.117 -0.492 . . . . 6.3799999999999999 110.043 -174.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.429 ' HA ' ' OE2' ' A' ' 23' ' ' GLU . 37.2 Cg_exo -58.15 160.97 14.52 Favored 'Trans proline' 0 C--O 1.237 0.47 0 C-N-CA 123.404 2.736 . . . . 2.77 113.524 -176.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.807 ' HB3' ' O ' ' A' ' 48' ' ' THR . 1.7 mp0 -122.07 158.36 29.42 Favored 'General case' 0 N--CA 1.421 -1.92 0 N-CA-C 105.435 -2.061 . . . . 3.3900000000000001 105.435 -174.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.648 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -117.63 -177.07 17.4 Favored Glycine 0 C--N 1.304 -1.219 0 C-N-CA 117.661 -2.209 . . . . 0.54000000000000004 113.875 176.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.701 ' O ' HG13 ' A' ' 45' ' ' VAL . 83.6 p -169.31 31.85 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 122.338 1.066 . . . . 1.2 108.561 173.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 136' ' ' ILE . 14.3 m -134.52 152.63 33.84 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 CA-C-N 114.297 -1.32 . . . . 0.93000000000000005 109.707 -170.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.3 t -160.28 -51.52 0.05 Allowed 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.464 -0.569 . . . . 0.47999999999999998 109.464 170.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -157.36 166.16 33.83 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.487 -0.56 . . . . 1.6899999999999999 109.487 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.637 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.7 OUTLIER -145.53 148.34 17.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.154 -0.684 . . . . 1.1399999999999999 109.154 165.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -122.37 144.39 49.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.016 0.436 . . . . 1.8300000000000001 111.215 -169.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -97.12 118.03 32.63 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.821 -0.627 . . . . 0.93999999999999995 111.126 -173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.687 ' HG2' ' HB2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -128.63 -136.36 0.23 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 107.525 -1.287 . . . . 1.3300000000000001 107.525 167.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.623 ' HB3' HG13 ' A' ' 39' ' ' VAL . 5.3 p-10 169.81 153.84 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.739 1.755 . . . . 2.8500000000000001 115.739 -173.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.702 ' H ' ' HA ' ' A' ' 39' ' ' VAL . 0.9 OUTLIER -132.12 -28.94 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.455 0 CA-C-N 112.842 -1.981 . . . . 3.2599999999999998 109.263 167.551 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.459 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 5.0 t30 67.8 -62.24 0.35 Allowed 'General case' 0 C--O 1.221 -0.405 0 N-CA-C 113.894 1.072 . . . . 3.1600000000000001 113.894 167.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 81.9 mtp180 -49.3 -25.53 2.44 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-O 122.021 0.915 . . . . 5.46 111.627 -171.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -134.83 -30.66 1.07 Allowed 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 113.811 -1.54 . . . . 1.9199999999999999 107.695 176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.513 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 44.1 t -175.3 126.31 0.25 Allowed 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 118.981 -1.088 . . . . 0.93999999999999995 112.184 -172.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.702 ' HA ' ' H ' ' A' ' 34' ' ' VAL . 44.5 t -70.99 168.48 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 N-CA-C 107.743 -1.206 . . . . 0.85999999999999999 107.743 168.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.019 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 76.0 mt-10 -128.76 136.18 50.2 Favored 'General case' 0 C--N 1.311 -1.093 0 CA-C-O 121.712 0.768 . . . . 1.1899999999999999 111.081 -165.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.823 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -124.62 104.21 8.56 Favored 'General case' 0 C--N 1.308 -1.209 0 CA-C-N 114.637 -1.165 . . . . 3.73 109.886 -178.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.556 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.0 OUTLIER -75.39 109.83 9.24 Favored 'General case' 0 C--N 1.314 -0.958 0 C-N-CA 119.267 -0.973 . . . . 0.81000000000000005 108.613 176.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.734 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -94.52 109.58 21.46 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 121.396 0.617 . . . . 0.41999999999999998 109.781 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 21.7 ttmt -84.65 130.14 34.75 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.436 -0.802 . . . . 2.6299999999999999 109.11 -177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.734 HG21 HD23 ' A' ' 90' ' ' LEU . 69.3 t -111.34 136.12 48.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 116.149 -0.478 . . . . 0.81999999999999995 112.13 -171.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.561 ' HB3' ' SD ' ' A' ' 87' ' ' MET . 29.4 m -127.05 95.76 4.4 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 109.025 -0.731 . . . . 0.71999999999999997 109.025 160.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.698 ' HA ' ' HA ' ' A' ' 25' ' ' SER . 0.3 OUTLIER -89.48 128.51 41.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-O 121.536 0.684 . . . . 1.1399999999999999 110.955 -176.45 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.807 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 5.8 m -103.77 117.27 33.98 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.963 -1.017 . . . . 0.40999999999999998 109.853 -175.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 6.3 t30 -88.67 128.47 52.46 Favored Pre-proline 0 C--N 1.319 -0.76 0 O-C-N 124.146 0.904 . . . . 1.48 108.922 174.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.415 ' HD3' ' HG2' ' A' ' 23' ' ' GLU . 41.3 Cg_endo -91.84 11.34 2.39 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.25 2.634 . . . . 0.72999999999999998 114.218 -174.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.6 t80 -130.49 143.43 50.75 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.043 -0.725 . . . . 2.0800000000000001 109.043 -178.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.485 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 23.1 t -78.07 34.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.946 0.721 . . . . 1.51 112.946 -164.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -144.5 132.14 21.11 Favored 'General case' 0 C--N 1.328 -0.348 0 O-C-N 122.277 -0.264 . . . . 1.6699999999999999 110.375 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.4 m -39.37 103.6 0.03 OUTLIER 'General case' 0 C--O 1.209 -1.064 0 C-N-CA 124.058 0.943 . . . . 1.3899999999999999 112.708 170.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.973 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.32 169.45 19.33 Favored Pre-proline 0 C--O 1.21 -1.0 0 N-CA-C 108.097 -1.075 . . . . 1.03 108.097 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.923 ' HB2' HD12 ' A' ' 57' ' ' ILE . 9.9 Cg_endo -91.56 -66.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.386 0 C-N-CA 121.504 1.469 . . . . 0.37 114.333 -177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.923 HD12 ' HB2' ' A' ' 56' ' ' PRO . 3.8 mp -134.65 152.47 33.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 C-N-CA 120.299 -0.56 . . . . 1.23 111.028 -167.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.68 ' SG ' ' HA3' ' A' ' 80' ' ' GLY . 16.5 m -144.23 -178.09 5.78 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 122.118 0.961 . . . . 1.1499999999999999 111.92 -173.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.08 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 23.8 tt0 -134.27 116.88 15.8 Favored 'General case' 0 C--N 1.31 -1.131 0 CA-C-N 113.414 -1.721 . . . . 1.3600000000000001 109.997 176.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.571 ' HA ' HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -95.94 108.4 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.099 0 CA-C-N 115.054 -0.975 . . . . 1.05 108.785 164.215 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.598 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 39.5 p -112.76 101.95 10.02 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.05 -1.432 . . . . 0.82999999999999996 108.377 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.1 p90 -116.16 134.3 55.08 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-O 121.415 0.626 . . . . 0.40000000000000002 110.583 -166.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.4 m -128.32 111.01 12.9 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-N 114.507 -1.224 . . . . 0.38 108.819 176.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.496 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 97.8 m-85 -97.31 140.67 31.44 Favored 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.584 -0.524 . . . . 0.95999999999999996 109.584 -176.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.5 OUTLIER -128.19 144.55 51.13 Favored 'General case' 0 C--O 1.216 -0.706 0 N-CA-C 107.048 -1.464 . . . . 1.29 107.048 178.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.762 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 39.1 t -105.43 -103.86 0.32 Allowed 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 118.967 -1.093 . . . . 1.27 111.046 175.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.43 ' HA ' ' OD1' ' A' ' 115' ' ' ASP . . . -60.53 -54.31 47.03 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.115 -0.698 . . . . 0.35999999999999999 109.115 -175.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.65 21.22 0.12 Allowed Glycine 0 N--CA 1.441 -0.997 0 N-CA-C 109.116 -1.594 . . . . 0.39000000000000001 109.116 164.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 103' ' ' ASN . 6.6 ptp180 -115.97 -172.25 2.13 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 114.568 -0.816 . . . . 1.97 109.014 -174.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 70' ' ' GLU . 0.3 OUTLIER -105.11 91.55 3.84 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-O 121.612 0.72 . . . . 2.6099999999999999 110.555 -165.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.824 ' HA ' HG21 ' A' ' 100' ' ' ILE . 6.0 mm -52.07 -44.71 40.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 114.911 -1.041 . . . . 0.40000000000000002 111.067 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.24 170.54 35.48 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.534 -0.841 . . . . 0.48999999999999999 111.41 -177.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.582 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.89 163.02 21.1 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 117.377 0.589 . . . . 1.8100000000000001 111.043 176.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.83 166.25 35.1 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.892 -0.595 . . . . 0.42999999999999999 111.637 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.598 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 91.3 mttt -135.74 126.42 27.21 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.613 0.244 . . . . 1.72 110.456 179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 4.9 mp -132.37 115.41 14.94 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 109.944 -0.391 . . . . 0.72999999999999998 109.944 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.406 ' HA ' ' O ' ' A' ' 58' ' ' CYS . 9.8 Cg_exo -72.24 95.69 0.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.498 2.132 . . . . 0.56999999999999995 110.553 170.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -112.24 141.84 25.8 Favored Pre-proline 0 C--N 1.324 -0.537 0 N-CA-C 109.374 -0.602 . . . . 0.79000000000000004 109.374 -173.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.546 ' HA ' HG13 ' A' ' 57' ' ' ILE . 19.5 Cg_endo -59.44 88.97 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.519 2.146 . . . . 0.57999999999999996 112.502 177.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.68 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -83.21 38.71 2.74 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.261 -0.881 . . . . 0.40000000000000002 112.29 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.973 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 77.4 p -73.58 125.45 28.02 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 109.506 -0.553 . . . . 0.62 109.506 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.878 HD11 HG12 ' A' ' 55' ' ' ILE . 0.3 OUTLIER -149.73 -156.94 0.77 Allowed 'General case' 0 N--CA 1.48 1.068 0 N-CA-C 114.893 1.442 . . . . 1.1000000000000001 114.893 -163.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.545 ' H ' ' HB2' ' A' ' 82' ' ' LEU . 91.5 mttt -62.71 -101.24 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 115.49 -0.777 . . . . 1.8400000000000001 112.513 -172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 177.23 102.57 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.686 0 N-CA-C 108.045 -1.094 . . . . 0.98999999999999999 108.045 -173.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.781 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.2 ptpt 43.59 50.43 6.46 Favored 'General case' 0 CA--C 1.535 0.393 0 O-C-N 124.415 1.072 . . . . 1.8400000000000001 111.071 -173.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -149.2 -173.64 4.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.189 -0.914 . . . . 0.64000000000000001 109.678 -174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.561 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 48.6 ttm -112.59 126.73 55.67 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.377 -0.374 . . . . 1.3500000000000001 110.649 -172.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.539 ' CG2' HG13 ' A' ' 47' ' ' VAL . 5.9 t -116.76 144.64 44.22 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.046 -0.524 . . . . 0.77000000000000002 110.247 -178.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.425 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -90.87 111.36 22.74 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.737 0.779 . . . . 0.47999999999999998 110.527 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.746 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 0.9 OUTLIER -109.85 176.14 5.18 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.588 -1.187 . . . . 0.77000000000000002 108.56 -176.498 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.746 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 27.8 t70 -134.78 131.73 37.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 118.365 0.529 . . . . 1.8100000000000001 111.909 -174.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.734 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 19.1 mm -113.62 139.31 23.22 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.78 -0.646 . . . . 0.65000000000000002 110.312 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.441 ' HD2' HG23 ' A' ' 92' ' ' ILE . 71.9 Cg_exo -51.3 -177.73 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.648 2.899 . . . . 1.0700000000000001 113.597 175.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.019 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.7 m -115.16 93.58 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-N 115.553 -0.749 . . . . 0.46000000000000002 110.367 -168.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.2 p -127.2 102.96 10.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 114.269 1.211 . . . . 0.47999999999999998 114.269 -164.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.513 ' HB ' HG23 ' A' ' 71' ' ' ILE . 1.5 p -151.72 98.41 3.01 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.697 -0.683 . . . . 1.0700000000000001 110.551 161.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.699 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 87.5 Cg_exo -47.67 130.22 18.32 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 121.994 1.796 . . . . 0.47999999999999998 111.264 175.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.513 ' H ' ' HA ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -57.86 -31.66 66.9 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.974 -0.557 . . . . 1.3100000000000001 110.998 -173.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 14.9 m -56.6 -28.78 61.13 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.722 0.296 . . . . 1.2 111.682 177.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.824 HG21 ' HA ' ' A' ' 71' ' ' ILE . 21.3 mm -76.34 -54.74 12.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.757 0.313 . . . . 0.51000000000000001 110.538 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.806 HD23 HD21 ' A' ' 104' ' ' LEU . 19.9 mt -50.09 -27.84 6.27 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 115.21 -0.905 . . . . 1.0 110.516 171.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.492 ' O ' ' HB2' ' A' ' 106' ' ' ARG . 1.8 t80 -65.66 -42.33 91.49 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.709 -1.132 . . . . 0.95999999999999996 109.031 -178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.649 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 50.7 m-80 -73.59 -56.35 5.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.434 . . . . 0.81999999999999995 111.946 178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.806 HD21 HD23 ' A' ' 101' ' ' LEU . 1.6 pp -60.94 -51.16 70.44 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.442 0.904 . . . . 0.65000000000000002 113.442 -178.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -65.79 -24.35 66.9 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.718 0.77 . . . . 0.42999999999999999 109.706 -178.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.649 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.7 OUTLIER -60.32 -53.27 59.58 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 114.654 -1.157 . . . . 1.8100000000000001 110.143 172.35 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -81.98 -53.29 6.26 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.301 0.572 . . . . 0.80000000000000004 112.394 -174.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 111' ' ' ASP . 2.2 t -89.72 -25.26 5.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 C-N-CA 119.945 -0.702 . . . . 0.88 110.159 -174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.35 -24.64 72.63 Favored Glycine 0 CA--C 1.511 -0.159 0 C-N-CA 120.181 -1.009 . . . . 0.38 111.07 171.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -48.6 -44.25 14.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 107.448 -1.316 . . . . 1.0900000000000001 107.448 166.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 7.6 m-20 -68.84 -87.58 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 115.78 -0.646 . . . . 1.8700000000000001 110.179 162.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.8 p-90 -179.85 -56.32 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.313 -0.403 . . . . 1.1699999999999999 111.631 173.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.479 ' O ' HG12 ' A' ' 108' ' ' VAL . 1.6 p-10 -94.42 134.38 37.0 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.802 0.334 . . . . 2.1499999999999999 110.234 -177.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.653 HD11 HD12 ' A' ' 144' ' ' LEU . 2.3 mp -119.38 156.71 21.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 108.916 -0.772 . . . . 0.39000000000000001 108.916 -175.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.483 ' HA ' ' HG3' ' A' ' 141' ' ' GLU . 1.6 p-10 -98.0 152.81 18.88 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.714 -0.847 . . . . 2.1099999999999999 108.714 177.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.762 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 44.0 m-85 -138.07 169.33 17.98 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.737 -1.208 . . . . 0.62 107.737 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.617 ' HA ' ' CB ' ' A' ' 139' ' ' LYS . 3.7 tt0 -160.06 145.04 14.96 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.907 0.384 . . . . 0.80000000000000004 110.224 -178.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.635 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -116.59 128.79 55.72 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.885 -0.598 . . . . 1.25 109.472 174.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.635 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -117.08 100.37 7.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.465 -0.939 . . . . 0.63 108.465 176.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.571 HD11 ' HA ' ' A' ' 60' ' ' ILE . 0.0 OUTLIER -117.14 124.11 72.62 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.315 0 CA-C-O 121.334 0.588 . . . . 0.81000000000000005 110.846 -173.142 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.402 ' N ' HD13 ' A' ' 120' ' ' ILE . . . -86.06 124.15 6.75 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 115.368 -0.833 . . . . 0.26000000000000001 111.831 176.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.555 HD12 HD12 ' A' ' 120' ' ' ILE . 5.9 mp -95.34 106.49 18.54 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.11 0.481 . . . . 1.2 110.569 -176.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.08 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.1 m -112.04 94.35 4.9 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.034 -0.985 . . . . 0.32000000000000001 109.228 172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.677 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -117.35 126.17 74.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.209 0 N-CA-C 109.481 -0.562 . . . . 0.97999999999999998 109.481 -175.851 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.847 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 33.3 t70 -81.71 106.86 13.98 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 120.394 -0.523 . . . . 1.52 110.296 -172.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.672 ' O ' ' HA2' ' A' ' 130' ' ' GLY . 4.5 mm? -98.32 -178.76 0.75 Allowed Pre-proline 0 C--N 1.331 -0.235 0 O-C-N 125.201 1.563 . . . . 1.28 109.994 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.416 ' CD ' ' HB3' ' A' ' 126' ' ' LEU . 15.6 Cg_endo -90.78 -16.4 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 C-N-CA 121.987 1.791 . . . . 0.73999999999999999 113.445 167.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 6.8 t -73.53 -59.71 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 112.481 0.548 . . . . 1.1200000000000001 112.481 -170.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.637 HG21 ' HB1' ' A' ' 18' ' ' ALA . 2.1 t -113.59 -2.22 10.24 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.767 0 CA-C-O 123.417 1.579 . . . . 1.3500000000000001 107.026 172.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.672 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 86.95 -133.94 12.15 Favored Glycine 0 N--CA 1.422 -2.248 0 CA-C-N 111.636 -2.529 . . . . 1.05 108.52 -167.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.847 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 7.2 pt-20 -57.63 122.16 12.08 Favored 'General case' 0 C--N 1.293 -1.886 0 CA-C-O 121.796 0.808 . . . . 1.1599999999999999 110.869 176.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.79 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.2 m-30 -89.68 145.13 25.44 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 108.524 -0.917 . . . . 1.9099999999999999 108.524 173.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.552 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 21.2 m -129.88 94.16 3.66 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.733 -0.387 . . . . 1.1899999999999999 111.452 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 122' ' ' LEU . 2.2 pp -128.57 136.16 28.69 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.972 -0.558 . . . . 0.5 110.23 173.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -89.34 158.23 5.53 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 121.866 1.711 . . . . 0.45000000000000001 112.604 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -152.3 163.94 2.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.384 -0.598 . . . . 0.44 109.384 179.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.579 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -132.83 139.95 47.72 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.376 -0.374 . . . . 0.88 110.133 -170.398 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 118' ' ' LEU . 50.2 m -147.83 101.02 3.27 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 108.715 -0.846 . . . . 0.95999999999999996 108.715 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.744 ' HB2' ' O ' ' A' ' 116' ' ' TYR . 13.9 ptmm? -116.53 163.06 16.64 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.45 -0.796 . . . . 1.76 111.66 -171.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -163.14 138.96 5.61 Favored Glycine 0 N--CA 1.435 -1.392 0 C-N-CA 120.42 -0.895 . . . . 0.5 111.329 178.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.483 ' HG3' ' HA ' ' A' ' 115' ' ' ASP . 5.0 mp0 -106.55 126.76 52.68 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.715 -0.742 . . . . 2.1000000000000001 109.416 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.52 174.99 4.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 109.073 -0.714 . . . . 0.76000000000000001 109.073 -171.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -57.08 163.13 2.2 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.384 0.513 . . . . 3.5299999999999998 112.384 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.656 HD12 ' HD2' ' A' ' 145' ' ' PRO . 28.5 tp -56.55 127.41 72.65 Favored Pre-proline 0 C--O 1.236 0.388 0 CA-C-N 115.392 -0.822 . . . . 1.23 110.423 178.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.656 ' HD2' HD12 ' A' ' 144' ' ' LEU . 25.1 Cg_endo -60.74 172.72 2.63 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.401 2.734 . . . . 0.70999999999999996 113.155 -177.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.59 99.28 0.21 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.707 -0.679 . . . . 1.71 111.837 -177.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 9.2 p90 -114.58 148.87 37.41 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.448 -0.796 . . . . 2.6400000000000001 109.939 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -158.2 80.02 0.83 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.237 -0.438 . . . . 3.7200000000000002 110.032 177.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 65.62 1.8 1.86 Allowed 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.892 -0.595 . . . . 4.2800000000000002 111.165 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 21.4 m-85 -75.07 -33.29 61.66 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.312 -0.625 . . . . 2.8599999999999999 109.312 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.411 ' CE1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.154 0 CA-C-O 118.039 -0.982 . . . . 3.96 109.15 176.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.2 mtt . . . . . 0 N--CA 1.483 1.194 0 N-CA-C 110.286 -0.264 . . . . 12.109999999999999 110.286 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.0 95.95 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.195 -0.457 . . . . 9.0199999999999996 110.72 178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.558 ' HA ' HG13 ' A' ' 128' ' ' VAL . 37.5 m 65.51 -171.83 0.19 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.518 -0.765 . . . . 6.8300000000000001 110.99 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.704 HD21 ' HE1' ' A' ' 51' ' ' TYR . 3.1 mm? -108.03 139.37 42.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.488 -0.324 . . . . 8.5500000000000007 110.24 -178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.76 61.69 6.93 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.162 -0.681 . . . . 10.470000000000001 109.162 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.505 ' O ' ' HB2' ' A' ' 7' ' ' LYS . 15.8 t70 -171.35 77.04 0.06 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.071 -0.968 . . . . 11.69 109.623 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.505 ' HB2' ' O ' ' A' ' 6' ' ' ASP . 41.3 ttmt 166.89 -68.11 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.647 0.592 . . . . 11.42 110.777 177.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -103.69 107.95 19.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.415 0.626 . . . . 11.58 112.564 -168.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.6 pttm -122.27 -20.01 6.31 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 107.975 -1.12 . . . . 15.74 107.975 168.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -110.27 163.41 13.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-N 114.685 -1.143 . . . . 12.69 109.527 -178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 56.16 30.5 16.6 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 123.637 0.585 . . . . 13.85 112.018 173.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 21.9 m -90.86 140.31 16.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.506 -0.316 . . . . 8.8699999999999992 110.571 178.057 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 14' ' ' ASP . . . -106.92 104.19 13.81 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.184 -0.462 . . . . 8.9100000000000001 109.815 177.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 13' ' ' ALA . 38.4 m-20 72.94 -58.36 0.6 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.506 0.722 . . . . 8.5999999999999996 111.687 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -172.53 118.65 0.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.016 -0.538 . . . . 9.0399999999999991 109.782 -172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 16' ' ' LEU . 0.4 OUTLIER -76.7 116.62 17.54 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.749 -0.834 . . . . 5.5800000000000001 108.749 177.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 90.1 m -149.08 144.25 26.55 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.369 -0.378 . . . . 2.6899999999999999 110.794 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.501 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 73.68 -162.13 0.09 Allowed 'General case' 0 C--O 1.234 0.27 0 O-C-N 124.121 0.888 . . . . 1.6799999999999999 111.642 175.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.771 HG21 HD13 ' A' ' 126' ' ' LEU . 39.2 pt -93.31 174.29 4.06 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 115.861 -0.609 . . . . 3.1899999999999999 110.657 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.659 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 48.1 Cg_exo -56.43 -86.72 0.01 OUTLIER 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.584 2.189 . . . . 2.4199999999999999 112.515 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.659 ' HB2' ' O ' ' A' ' 20' ' ' PRO . 5.1 tmmm? 162.57 -49.27 0.0 OUTLIER Pre-proline 0 N--CA 1.475 0.807 0 O-C-N 123.518 0.511 . . . . 6.3799999999999999 111.791 177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.445 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 17.0 Cg_exo -69.21 59.09 1.34 Allowed 'Trans proline' 0 C--N 1.361 1.23 0 C-N-CA 122.542 2.162 . . . . 2.77 113.042 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.881 ' HG2' ' HB3' ' A' ' 50' ' ' PRO . 8.9 mp0 -134.49 121.04 20.47 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 105.415 -2.069 . . . . 3.3900000000000001 105.415 -176.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.727 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -132.83 -145.41 5.42 Favored Glycine 0 CA--C 1.501 -0.808 0 C-N-CA 118.187 -1.959 . . . . 0.54000000000000004 116.528 -153.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.817 ' HB2' HD21 ' A' ' 122' ' ' LEU . 58.6 m 179.95 49.51 0.0 OUTLIER 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 126.066 1.747 . . . . 1.2 107.167 -174.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.1 m -134.65 154.27 36.63 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-N 115.05 -0.977 . . . . 0.93000000000000005 109.488 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.2 t -175.82 -36.58 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 O-C-N 123.48 0.487 . . . . 0.47999999999999998 111.623 164.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.488 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 34.7 t70 -163.73 154.26 15.66 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-O 121.078 0.466 . . . . 1.6899999999999999 110.591 177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.719 HG11 ' HZ ' ' A' ' 64' ' ' PHE . 0.2 OUTLIER -151.25 144.69 16.57 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.604 -0.517 . . . . 1.1399999999999999 109.604 164.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -124.35 142.72 51.05 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 109.023 -0.732 . . . . 1.8300000000000001 109.023 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.776 HD21 HG11 ' A' ' 96' ' ' VAL . 3.3 tm? -101.17 112.24 24.67 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.713 -0.477 . . . . 0.93999999999999995 109.713 -170.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.581 ' HG2' ' O ' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -175.13 147.86 0.95 Allowed 'General case' 0 N--CA 1.432 -1.362 0 CA-C-O 123.03 1.395 . . . . 1.3300000000000001 112.368 176.189 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.605 ' HB2' ' HB2' ' A' ' 40' ' ' GLU . 1.8 t70 161.65 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 111.178 -2.737 . . . . 2.8500000000000001 108.039 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -79.75 -175.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.416 -2.161 0 CA-C-O 122.37 1.081 . . . . 3.2599999999999998 108.345 -173.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.553 ' N ' HG13 ' A' ' 34' ' ' VAL . 2.6 t30 -129.77 -48.99 1.14 Allowed 'General case' 0 C--N 1.27 -2.854 0 CA-C-N 114.183 -1.371 . . . . 3.1600000000000001 112.058 -174.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.417 ' HG3' ' OD1' ' A' ' 37' ' ' ASP . 31.1 ptt180 -50.91 -19.32 0.97 Allowed 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.882 0.848 . . . . 5.46 111.699 -173.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.417 ' OD1' ' HG3' ' A' ' 36' ' ' ARG . 5.4 m-20 -111.07 -55.62 2.47 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-N 114.307 -1.315 . . . . 1.9199999999999999 107.532 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.534 ' OG ' ' HA ' ' A' ' 97' ' ' PRO . 42.2 t 178.05 140.95 0.09 Allowed 'General case' 0 CA--C 1.494 -1.193 0 CA-C-N 114.185 -1.37 . . . . 0.93999999999999995 108.274 -165.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 35.9 t -83.95 158.05 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.387 0 N-CA-C 106.533 -1.654 . . . . 0.85999999999999999 106.533 171.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.027 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 12.5 mt-10 -139.19 165.66 26.58 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.124 -1.065 . . . . 1.1899999999999999 108.124 -178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.899 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 30.5 p90 -134.63 126.8 29.91 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 118.22 -1.392 . . . . 3.73 112.691 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -81.91 115.17 20.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.566 -0.853 . . . . 0.81000000000000005 109.364 173.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.49 ' HB2' ' CE1' ' A' ' 41' ' ' TYR . . . -106.39 119.46 39.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.092 0.472 . . . . 0.41999999999999998 111.924 -177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 16.6 tppt? -87.3 102.31 14.38 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 122.216 1.007 . . . . 2.6299999999999999 109.449 173.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.999 HG21 HD13 ' A' ' 92' ' ' ILE . 12.4 t -96.36 156.19 3.37 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 CA-C-N 114.766 -1.106 . . . . 0.81999999999999995 110.33 -175.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.503 ' C ' ' HA ' ' A' ' 25' ' ' SER . 4.1 m -139.45 112.32 7.96 Favored 'General case' 0 N--CA 1.444 -0.758 0 C-N-CA 120.054 -0.659 . . . . 0.71999999999999997 111.33 171.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.727 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 25.9 t -82.64 124.07 39.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 114.975 -1.011 . . . . 1.1399999999999999 110.372 -176.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 23' ' ' GLU . 2.4 m -104.09 114.29 28.43 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.267 -0.642 . . . . 0.40999999999999998 109.267 174.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.705 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 13.0 t30 -89.81 126.26 58.23 Favored Pre-proline 0 N--CA 1.464 0.241 0 O-C-N 124.395 1.059 . . . . 1.48 110.133 177.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.881 ' HB3' ' HG2' ' A' ' 23' ' ' GLU . 91.2 Cg_endo -83.02 3.88 7.5 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 123.594 2.863 . . . . 0.72999999999999998 113.999 -176.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' HE1' HD21 ' A' ' 4' ' ' LEU . 13.0 t80 -122.03 143.72 49.33 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 109.407 -0.59 . . . . 2.0800000000000001 109.407 -174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.624 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 19.8 p -79.2 28.53 0.23 Allowed 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 112.434 0.531 . . . . 1.51 112.434 -170.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 42.3 m80 -143.11 131.04 21.63 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.416 -0.357 . . . . 1.6699999999999999 110.075 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.5 m -40.76 100.14 0.02 OUTLIER 'General case' 0 C--O 1.21 -0.985 0 C-N-CA 124.212 1.005 . . . . 1.3899999999999999 112.846 171.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.957 ' O ' ' HA ' ' A' ' 81' ' ' SER . 6.8 pt -74.51 171.14 12.14 Favored Pre-proline 0 C--O 1.21 -1.014 0 N-CA-C 108.073 -1.084 . . . . 1.03 108.073 -177.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.484 ' HB2' HG12 ' A' ' 57' ' ' ILE . 13.4 Cg_endo -92.9 -63.74 0.01 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.512 0 C-N-CA 121.034 1.156 . . . . 0.37 114.261 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.637 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.2 mm -128.38 154.76 39.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 C-N-CA 120.335 -0.546 . . . . 1.23 111.797 -165.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.651 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.5 p -151.02 -177.46 6.03 Favored 'General case' 0 N--CA 1.443 -0.795 0 CA-C-O 122.075 0.941 . . . . 1.1499999999999999 111.78 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.022 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 39.4 tt0 -135.36 115.86 13.69 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 113.379 -1.737 . . . . 1.3600000000000001 109.809 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.466 HG22 HD11 ' A' ' 120' ' ' ILE . 0.7 OUTLIER -98.3 109.52 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 CA-C-O 122.334 1.064 . . . . 1.05 109.619 168.685 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.65 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 33.2 p -114.52 102.73 10.34 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 113.273 -1.785 . . . . 0.82999999999999996 108.782 -178.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.654 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.2 p90 -109.69 133.36 53.21 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.969 0.414 . . . . 0.40000000000000002 110.116 -167.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.599 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 12.2 m -125.53 100.82 6.64 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.185 -0.916 . . . . 0.38 109.546 175.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.836 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 10.4 m-85 -97.57 143.78 27.91 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 115.869 -0.605 . . . . 0.95999999999999996 109.956 177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -146.16 143.74 29.49 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 107.904 -1.147 . . . . 1.29 107.904 174.447 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.882 ' HB3' HD22 ' A' ' 104' ' ' LEU . 33.0 t -102.02 -93.97 0.3 Allowed 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 119.987 -0.685 . . . . 1.27 111.421 -174.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.71 -57.94 10.54 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.545 -0.539 . . . . 0.35999999999999999 109.545 -175.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.44 16.29 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 119.763 -1.208 . . . . 0.39000000000000001 110.247 165.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.694 ' HG3' ' H ' ' A' ' 70' ' ' GLU . 7.7 ptp180 -99.19 -69.76 0.75 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 114.998 -0.601 . . . . 1.97 110.532 -174.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.734 ' HA ' ' HB3' ' A' ' 65' ' ' HIS . 28.1 tt0 -175.75 170.58 2.83 Favored 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 107.523 -1.288 . . . . 2.6099999999999999 107.523 -178.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.54 ' HB ' ' C ' ' A' ' 64' ' ' PHE . 2.4 mm -136.78 -40.41 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 N-CA-C 108.146 -1.057 . . . . 0.40000000000000002 108.146 168.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.42 151.48 6.28 Favored Glycine 0 N--CA 1.447 -0.608 0 N-CA-C 110.783 -0.927 . . . . 0.48999999999999999 110.783 177.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.654 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -151.89 155.27 37.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 117.521 0.661 . . . . 1.8100000000000001 110.771 -177.744 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.34 177.28 44.29 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.787 -0.721 . . . . 0.42999999999999999 112.208 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.65 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 69.4 mttt -128.26 132.71 48.72 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 123.662 0.272 . . . . 1.72 110.368 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.411 HD12 ' C ' ' A' ' 75' ' ' LYS . 3.2 mp -131.18 110.73 15.39 Favored Pre-proline 0 C--N 1.317 -0.84 0 N-CA-C 109.463 -0.569 . . . . 0.72999999999999998 109.463 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -67.66 105.95 1.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.276 1.984 . . . . 0.56999999999999995 110.231 171.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -120.38 146.27 42.47 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -172.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.637 ' HA ' HD13 ' A' ' 57' ' ' ILE . 39.5 Cg_exo -61.36 91.75 0.1 Allowed 'Trans proline' 0 N--CA 1.463 -0.287 0 C-N-CA 122.215 1.943 . . . . 0.57999999999999996 111.917 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.441 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.09 31.3 2.86 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.805 -0.634 . . . . 0.40000000000000002 111.82 177.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.957 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 51.4 p -73.33 119.91 18.22 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 109.131 -0.692 . . . . 0.62 109.131 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.656 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -152.51 -164.91 2.06 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 118.847 -1.141 . . . . 1.1000000000000001 113.328 -162.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 91.3 mttt -51.59 -93.36 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.312 0.856 . . . . 1.8400000000000001 113.312 -173.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 161.38 111.19 0.0 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 107.752 -1.203 . . . . 0.98999999999999999 107.752 -169.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.705 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 44.1 pttt 42.6 45.53 4.01 Favored 'General case' 0 N--CA 1.466 0.356 0 O-C-N 124.271 0.982 . . . . 1.8400000000000001 111.698 -177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.405 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.7 t70 -151.23 -172.29 4.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.499 -0.773 . . . . 0.64000000000000001 109.871 -174.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.492 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 43.8 ttm -117.65 122.23 43.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.347 0.594 . . . . 1.3500000000000001 110.469 -171.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.656 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -112.13 143.66 42.8 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.08 -0.964 . . . . 0.77000000000000002 110.338 -176.096 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -77.81 130.36 36.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.599 0.714 . . . . 0.47999999999999998 110.819 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.813 ' HB3' HG12 ' A' ' 45' ' ' VAL . 2.1 tm? -125.56 147.75 49.16 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 106.763 -1.569 . . . . 0.77000000000000002 106.763 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.6 ' N ' HD13 ' A' ' 90' ' ' LEU . 4.8 p-10 -124.04 123.72 40.97 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 119.162 -1.015 . . . . 1.8100000000000001 111.573 179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.999 HD13 HG21 ' A' ' 45' ' ' VAL . 1.2 mp -90.55 146.53 34.51 Favored Pre-proline 0 N--CA 1.444 -0.768 0 CA-C-N 114.788 -1.096 . . . . 0.65000000000000002 109.066 173.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.405 ' O ' HG13 ' A' ' 94' ' ' VAL . 78.0 Cg_exo -52.69 -118.2 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.121 3.214 . . . . 1.0700000000000001 113.346 177.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.027 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 1.6 m -162.97 93.47 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.197 -1.71 0 CA-C-O 119.008 -0.52 . . . . 0.46000000000000002 111.437 -171.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.558 HG11 ' HE1' ' A' ' 62' ' ' PHE . 14.8 p -129.52 103.64 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 O-C-N 119.639 -1.913 . . . . 0.47999999999999998 115.962 -172.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.776 HG11 HD21 ' A' ' 31' ' ' LEU . 2.4 p -152.98 97.12 2.86 Favored Pre-proline 0 N--CA 1.465 0.318 0 O-C-N 121.312 -0.868 . . . . 1.0700000000000001 112.122 162.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.747 ' HB2' HG12 ' A' ' 100' ' ' ILE . 75.4 Cg_exo -46.63 136.62 16.08 Favored 'Trans proline' 0 C--O 1.233 0.256 0 C-N-CA 121.823 1.682 . . . . 0.47999999999999998 112.13 -179.404 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.518 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 3.5 t80 -51.58 -39.54 58.11 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.157 -0.474 . . . . 1.3100000000000001 110.688 -174.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.534 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.7 m -62.78 -25.03 68.03 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.495 -0.32 . . . . 1.2 111.859 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.747 HG12 ' HB2' ' A' ' 97' ' ' PRO . 21.4 mm -76.87 -56.84 7.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 121.77 -0.581 . . . . 0.51000000000000001 111.453 -174.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.642 HD23 HD11 ' A' ' 104' ' ' LEU . 41.7 mt -53.54 -27.82 28.09 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.759 0.79 . . . . 1.0 109.942 171.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.534 ' HB3' ' O ' ' A' ' 99' ' ' SER . 53.9 t80 -62.45 -42.04 99.18 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 113.841 -1.527 . . . . 0.95999999999999996 109.215 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.628 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.2 m-80 -74.24 -57.6 3.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 111.946 0.35 . . . . 0.81999999999999995 111.946 178.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.882 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.6 pp -60.62 -49.41 77.65 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 113.32 0.859 . . . . 0.65000000000000002 113.32 -176.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.442 ' HB1' HD11 ' A' ' 144' ' ' LEU . . . -68.25 -26.18 65.55 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.821 0.819 . . . . 0.42999999999999999 110.088 -178.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.628 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.8 ttp180 -66.0 -46.09 79.23 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.529 -1.214 . . . . 1.8100000000000001 110.484 173.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.437 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.9 t0 -82.21 -53.68 5.87 Favored 'General case' 0 C--O 1.239 0.537 0 CA-C-O 121.532 0.682 . . . . 0.80000000000000004 112.317 -175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 114' ' ' ILE . 6.8 t -85.36 -28.7 6.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 C-N-CA 120.039 -0.664 . . . . 0.88 109.792 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.491 ' HA3' HD13 ' A' ' 144' ' ' LEU . . . -75.17 -21.66 77.66 Favored Glycine 0 C--N 1.328 0.11 0 C-N-CA 120.575 -0.821 . . . . 0.38 111.607 173.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.6 OUTLIER -47.84 -44.51 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 106.976 -1.491 . . . . 1.0900000000000001 106.976 165.775 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -74.61 -82.63 0.06 Allowed 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.517 -0.765 . . . . 1.8700000000000001 110.284 164.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.6 p-90 179.94 -58.69 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.811 0.671 . . . . 1.1699999999999999 112.811 173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -96.09 122.97 39.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.505 -0.316 . . . . 2.1499999999999999 110.634 -172.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.552 HD11 HD12 ' A' ' 144' ' ' LEU . 2.2 mp -111.21 153.2 13.01 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 CA-C-O 121.116 0.484 . . . . 0.39000000000000001 109.941 -174.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.454 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.5 p-10 -99.26 154.12 18.41 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.513 -0.767 . . . . 2.1099999999999999 109.219 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.563 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 42.6 m-85 -139.15 154.22 48.06 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.732 -0.84 . . . . 0.62 108.732 178.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.732 ' HG3' ' HE3' ' A' ' 139' ' ' LYS . 35.0 tt0 -142.05 135.74 29.5 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.113 0.482 . . . . 0.80000000000000004 110.395 175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.836 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 1.0 OUTLIER -105.31 134.04 49.09 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.307 -0.86 . . . . 1.25 109.502 177.133 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.763 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.93 101.19 7.41 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.533 -0.543 . . . . 0.63 109.533 171.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.478 ' HB ' HD11 ' A' ' 118' ' ' LEU . 7.2 tp -108.04 118.07 54.93 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 0.81000000000000005 110.63 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.509 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.59 129.84 10.05 Favored Glycine 0 N--CA 1.442 -0.937 0 N-CA-C 110.98 -0.848 . . . . 0.26000000000000001 110.98 175.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 25' ' ' SER . 2.7 mm? -108.9 105.82 15.53 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.337 0.589 . . . . 1.2 112.348 -176.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.022 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 77.3 m -100.13 95.6 6.94 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 114.813 -1.085 . . . . 0.32000000000000001 109.241 172.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.651 HG22 ' HB3' ' A' ' 58' ' ' CYS . 6.3 pt -109.35 138.12 38.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 C-N-CA 120.644 -0.422 . . . . 0.97999999999999998 111.732 -175.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.18 108.13 16.21 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.45 -0.945 . . . . 1.52 108.45 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 55' ' ' ILE . 17.7 mt -120.29 156.75 54.87 Favored Pre-proline 0 C--O 1.217 -0.636 0 O-C-N 124.884 1.365 . . . . 1.28 110.273 -173.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.434 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.0 Cg_exo -70.87 -21.29 28.52 Favored 'Trans proline' 0 CA--C 1.534 0.494 0 C-N-CA 122.123 1.882 . . . . 0.73999999999999999 112.24 175.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.558 HG13 ' HA ' ' A' ' 3' ' ' SER . 41.2 t -74.95 -57.1 7.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-N 116.073 -0.512 . . . . 1.1200000000000001 112.195 -176.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' C ' ' H ' ' A' ' 131' ' ' GLU . 0.8 OUTLIER -106.72 -1.63 9.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 122.007 0.908 . . . . 1.3500000000000001 109.698 -175.236 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.52 -32.05 1.19 Allowed Glycine 0 C--N 1.317 -0.505 0 CA-C-N 114.163 -1.381 . . . . 1.05 111.264 -170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.527 ' H ' ' C ' ' A' ' 129' ' ' VAL . 11.8 pt-20 -174.34 141.39 0.71 Allowed 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 107.116 -1.438 . . . . 1.1599999999999999 107.116 178.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.403 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.5 t80 -146.0 135.44 23.05 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.39 -0.596 . . . . 1.9099999999999999 109.39 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.3 t -117.38 105.8 12.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.868 0.842 . . . . 1.1899999999999999 111.347 -176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.513 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.49 138.73 33.0 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.41 -0.813 . . . . 0.5 110.249 177.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.509 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 94.7 Cg_endo -95.82 165.62 1.36 Allowed 'Trans proline' 0 N--CA 1.449 -1.127 0 C-N-CA 122.168 1.912 . . . . 0.45000000000000001 113.602 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -160.89 167.73 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 N-CA-C 107.55 -1.278 . . . . 0.44 107.55 177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.557 ' HB3' HE22 ' A' ' 119' ' ' GLN . 83.5 p -140.1 155.83 46.84 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 120.215 -0.594 . . . . 0.88 112.225 -167.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 15.5 t -144.54 103.2 3.92 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 108.231 -1.025 . . . . 0.95999999999999996 108.231 175.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.732 ' HE3' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -108.17 148.63 29.63 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.549 -0.296 . . . . 1.76 110.24 -177.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.94 141.5 7.1 Favored Glycine 0 N--CA 1.438 -1.187 0 C-N-CA 120.809 -0.71 . . . . 0.5 111.676 -178.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 1.6 mp0 -104.73 127.82 52.63 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 114.927 -0.636 . . . . 2.1000000000000001 109.297 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -147.92 173.02 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-O 120.724 0.297 . . . . 0.76000000000000001 110.314 -172.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -53.85 159.99 1.54 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.08 0.77 . . . . 3.5299999999999998 113.08 -176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.625 HD12 ' HD2' ' A' ' 145' ' ' PRO . 25.9 tp -56.82 132.16 78.97 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.088 -0.96 . . . . 1.23 110.333 176.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.625 ' HD2' HD12 ' A' ' 144' ' ' LEU . 18.7 Cg_endo -59.22 172.42 1.83 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.055 2.503 . . . . 0.70999999999999996 112.773 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 17.9 p -49.89 103.84 0.06 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.068 0.461 . . . . 1.71 111.67 -178.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.449 ' HD1' ' O ' ' A' ' 145' ' ' PRO . 28.6 p90 -116.75 125.09 51.14 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.844 -0.616 . . . . 2.6400000000000001 110.876 -174.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 148' ' ' LYS . 71.8 mmtt -142.13 78.85 1.64 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.87 -0.604 . . . . 3.7200000000000002 110.086 176.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.0 t70 70.16 1.28 3.48 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 115.85 -0.613 . . . . 4.2800000000000002 111.073 178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 29.1 m-85 -82.17 -50.67 8.76 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.294 -0.632 . . . . 2.8599999999999999 109.294 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-N 115.139 -0.937 . . . . 3.96 109.99 176.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.667 0.27 . . . . 12.109999999999999 110.519 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.36 2.88 53.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.907 0.384 . . . . 9.0199999999999996 111.377 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.8 p -68.23 -72.73 0.16 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 6.8300000000000001 110.979 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.677 HD12 ' HB2' ' A' ' 7' ' ' LYS . 45.4 tp -116.81 103.81 10.69 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.229 -0.441 . . . . 8.5500000000000007 110.393 -179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 67.0 tp -146.69 -57.39 0.28 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.933 -0.576 . . . . 10.470000000000001 110.339 177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -93.99 -11.47 30.75 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.018 -0.537 . . . . 11.69 111.009 -178.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.677 ' HB2' HD12 ' A' ' 4' ' ' LEU . 13.4 mptt -68.15 130.67 43.62 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 11.42 110.787 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -104.56 -160.4 0.76 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.846 -0.615 . . . . 11.58 110.147 178.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -107.15 157.21 18.04 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.572 -0.285 . . . . 15.74 110.617 178.466 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 67.95 -79.37 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 O-C-N 123.925 0.765 . . . . 12.69 111.554 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -92.42 93.65 8.7 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.234 0.54 . . . . 13.85 110.763 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 30.8 m -108.07 -1.91 9.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.744 -0.662 . . . . 8.8699999999999992 110.762 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.36 -26.13 64.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.102 0.477 . . . . 8.9100000000000001 110.917 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -73.62 -30.79 63.19 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.679 -0.692 . . . . 8.5999999999999996 110.436 178.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.432 ' N ' ' HD2' ' A' ' 15' ' ' LYS . 0.0 OUTLIER -97.11 -42.77 7.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.429 -0.35 . . . . 9.0399999999999991 111.64 -174.16 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 54.4 tp 67.8 109.25 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.276 0 O-C-N 123.906 0.754 . . . . 5.5800000000000001 110.017 -172.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.509 ' HA ' ' HE2' ' A' ' 7' ' ' LYS . 89.4 m -60.63 -50.15 74.68 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.863 -0.608 . . . . 2.6899999999999999 111.796 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.458 ' HB2' HG21 ' A' ' 129' ' ' VAL . . . -64.9 157.78 27.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.402 0.62 . . . . 1.6799999999999999 111.721 -176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.798 HG23 HD13 ' A' ' 126' ' ' LEU . 3.1 tp -91.23 109.12 33.49 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 115.294 -0.866 . . . . 3.1899999999999999 109.891 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HD3' ' HA ' ' A' ' 19' ' ' ILE . 58.1 Cg_endo -112.24 109.05 0.02 OUTLIER 'Trans proline' 0 CA--C 1.541 0.859 1 C-N-CA 125.377 4.051 . . . . 2.4199999999999999 115.596 -166.829 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 50' ' ' PRO . 65.1 mttp -153.01 96.26 2.93 Favored Pre-proline 0 C--N 1.319 -0.721 0 N-CA-C 107.825 -1.176 . . . . 6.3799999999999999 107.825 169.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.4 ' C ' ' O ' ' A' ' 21' ' ' LYS . 64.8 Cg_exo -18.09 110.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 125.137 3.891 . . . . 2.77 113.14 -168.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.517 ' HB2' HD11 ' A' ' 134' ' ' ILE . 51.3 mp0 -103.01 113.31 26.67 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 107.024 -1.472 . . . . 3.3900000000000001 107.024 -161.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.796 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -92.75 179.25 39.88 Favored Glycine 0 N--CA 1.432 -1.61 0 C-N-CA 119.3 -1.429 . . . . 0.54000000000000004 114.091 -166.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.613 ' OG ' HG22 ' A' ' 47' ' ' VAL . 11.4 m -170.78 36.55 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 124.795 1.238 . . . . 1.2 108.023 175.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.567 ' O ' ' HB2' ' A' ' 46' ' ' SER . 27.6 m -133.12 154.3 39.21 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 114.098 -1.41 . . . . 0.93000000000000005 109.226 -175.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -168.79 -41.3 0.02 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.546 0.529 . . . . 0.47999999999999998 110.595 168.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 1.016 ' HB3' ' HD3' ' A' ' 44' ' ' LYS . 27.2 t70 -173.21 160.18 4.01 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 110.354 -0.239 . . . . 1.6899999999999999 110.354 174.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.415 HG12 ' CD1' ' A' ' 41' ' ' TYR . 56.0 t -137.66 135.73 46.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 110.143 -0.317 . . . . 1.1399999999999999 110.143 178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.432 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 17.6 m-20 -108.18 122.68 47.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.362 -0.381 . . . . 1.8300000000000001 111.311 -173.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -88.26 118.04 27.58 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.066 -0.516 . . . . 0.93999999999999995 110.335 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -125.53 -122.8 0.25 Allowed 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.617 -0.512 . . . . 1.3300000000000001 109.617 169.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.851 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.0 p30 172.28 176.16 0.09 Allowed 'General case' 0 CA--C 1.507 -0.683 0 C-N-CA 122.446 0.298 . . . . 2.8500000000000001 110.296 -173.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 34' ' ' VAL . 13.9 p -156.7 97.64 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 CA-C-O 122.358 1.075 . . . . 3.2599999999999998 111.887 176.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 47.6 m-20 67.2 -98.96 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.866 -1.061 . . . . 3.1600000000000001 109.097 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 36' ' ' ARG . 0.0 OUTLIER -169.85 20.65 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 122.768 1.27 . . . . 5.46 108.968 173.566 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -101.82 -40.21 7.04 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 112.875 -1.966 . . . . 1.9199999999999999 107.216 -170.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.597 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 13.8 t -145.58 178.84 7.83 Favored 'General case' 0 N--CA 1.436 -1.138 0 CA-C-N 112.961 -1.927 . . . . 0.93999999999999995 106.453 170.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.851 HG13 ' HA ' ' A' ' 33' ' ' ASP . 12.2 t -128.78 162.64 35.43 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.016 -1.105 . . . . 0.85999999999999999 108.016 167.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.793 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 63.3 mt-10 -123.58 144.55 49.51 Favored 'General case' 0 C--N 1.312 -1.032 0 C-N-CA 119.767 -0.773 . . . . 1.1899999999999999 112.144 -170.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.855 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.1 OUTLIER -126.33 103.91 7.9 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.014 -0.994 . . . . 3.73 110.672 179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.565 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -81.05 109.15 15.34 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.075 -1.083 . . . . 0.81000000000000005 108.075 176.508 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.677 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -111.0 114.61 28.05 Favored 'General case' 0 C--N 1.309 -1.173 0 C-N-CA 120.673 -0.411 . . . . 0.41999999999999998 110.518 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 1.016 ' HD3' ' HB3' ' A' ' 28' ' ' ASP . 0.0 OUTLIER -83.62 134.88 34.78 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 108.287 -1.005 . . . . 2.6299999999999999 108.287 173.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.57 ' CG2' HG12 ' A' ' 92' ' ' ILE . 40.8 t -113.18 148.47 16.1 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 CA-C-N 115.052 -0.976 . . . . 0.81999999999999995 110.12 -173.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 88' ' ' THR . 3.6 m -133.6 101.37 5.1 Favored 'General case' 0 N--CA 1.436 -1.133 0 CA-C-O 121.344 0.592 . . . . 0.71999999999999997 110.7 170.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.796 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 59.6 t -83.42 124.79 39.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 CA-C-N 114.901 -1.045 . . . . 1.1399999999999999 110.721 -176.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 6.8 m -108.49 118.28 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.251 -0.431 . . . . 0.40999999999999998 110.206 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.543 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 2.8 p30 -96.54 146.21 30.91 Favored Pre-proline 0 C--O 1.24 0.559 0 C-N-CA 120.564 -0.454 . . . . 1.48 110.429 177.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.622 ' HB3' ' HB2' ' A' ' 21' ' ' LYS . 57.5 Cg_endo -90.17 4.51 4.69 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.921 3.081 . . . . 0.72999999999999998 114.771 -174.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.69 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 3.8 t80 -95.27 -113.52 0.12 Allowed 'General case' 0 CA--C 1.513 -0.445 0 C-N-CA 119.514 -0.874 . . . . 2.0800000000000001 110.173 -170.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' H ' ' HB3' ' A' ' 51' ' ' TYR . 50.0 p -165.32 20.09 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.993 0 CA-C-N 114.866 -1.061 . . . . 1.51 108.468 171.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -146.22 158.33 43.87 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.282 0.563 . . . . 1.6699999999999999 110.871 -175.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.707 ' HA ' HD23 ' A' ' 82' ' ' LEU . 31.4 t -55.95 104.11 0.12 Allowed 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 114.198 -1.364 . . . . 1.3899999999999999 111.678 173.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.88 HG21 HD23 ' A' ' 126' ' ' LEU . 8.8 pt -79.06 123.3 84.99 Favored Pre-proline 0 C--O 1.213 -0.848 0 C-N-CA 120.442 -0.503 . . . . 1.03 109.911 178.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 81' ' ' SER . 29.1 Cg_endo -63.06 -55.12 0.85 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 121.796 1.664 . . . . 0.37 112.942 -159.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.535 HD13 ' HA ' ' A' ' 79' ' ' PRO . 23.4 mm -130.73 154.35 40.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.218 -0.593 . . . . 1.23 111.088 -172.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.602 ' HB3' HG22 ' A' ' 124' ' ' ILE . 26.6 p -147.17 178.19 8.59 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 122.106 0.955 . . . . 1.1499999999999999 111.697 179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.045 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 4.5 tm-20 -140.43 112.84 7.91 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-N 113.53 -1.668 . . . . 1.3600000000000001 109.442 -177.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.613 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -99.33 115.09 39.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.111 0 CA-C-N 113.536 -1.665 . . . . 1.05 111.373 178.502 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.4 OUTLIER -110.33 103.09 11.7 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 113.697 -1.592 . . . . 0.82999999999999996 108.51 179.131 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.7 p90 -109.46 132.62 53.96 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-O 121.482 0.658 . . . . 0.40000000000000002 109.546 -169.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.788 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 29.0 m -128.41 102.06 6.48 Favored 'General case' 0 C--N 1.299 -1.594 0 CA-C-N 115.074 -0.967 . . . . 0.38 109.55 175.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.666 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 97.9 m-85 -96.41 139.45 32.51 Favored 'General case' 0 C--N 1.308 -1.201 0 N-CA-C 108.752 -0.833 . . . . 0.95999999999999996 108.752 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.734 ' HA ' ' C ' ' A' ' 70' ' ' GLU . 0.1 OUTLIER -146.29 138.14 24.9 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.056 -0.72 . . . . 1.29 109.056 175.357 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.755 ' CB ' HD22 ' A' ' 104' ' ' LEU . 47.6 t -95.5 -98.77 0.17 Allowed 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.458 -0.497 . . . . 1.27 111.384 -173.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.484 ' HB3' ' HD2' ' A' ' 69' ' ' ARG . . . -56.78 -60.05 4.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-O 121.279 0.562 . . . . 0.35999999999999999 109.564 -174.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -175.23 18.21 0.05 OUTLIER Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.269 -1.533 . . . . 0.39000000000000001 109.269 169.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.557 ' HG2' ' H ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -103.44 -56.04 2.29 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.233 -0.484 . . . . 1.97 111.069 -173.47 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.734 ' C ' ' HA ' ' A' ' 65' ' ' HIS . 31.1 tt0 171.49 176.96 0.07 Allowed 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.761 -1.57 . . . . 2.6099999999999999 106.761 -177.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.075 ' HA ' HG21 ' A' ' 100' ' ' ILE . 4.4 mm -145.4 -47.75 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.104 0 C-N-CA 124.425 1.09 . . . . 0.40000000000000002 108.529 166.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.33 121.44 0.59 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.229 -0.986 . . . . 0.48999999999999999 112.011 -178.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.553 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -124.49 163.92 20.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.687 0.756 . . . . 1.8100000000000001 111.901 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 163.01 169.66 26.76 Favored Glycine 0 N--CA 1.444 -0.768 0 N-CA-C 110.091 -1.204 . . . . 0.42999999999999999 110.091 -178.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.497 ' HB2' ' OE2' ' A' ' 59' ' ' GLU . 10.6 ptmm? -144.12 135.02 25.23 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 117.632 0.716 . . . . 1.72 111.22 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . 52.9 mt -139.98 138.22 19.3 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-N 115.723 -0.671 . . . . 0.72999999999999998 110.152 -173.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 76' ' ' ILE . 4.2 Cg_exo -78.0 125.9 7.56 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.484 2.122 . . . . 0.56999999999999995 111.208 171.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -130.86 146.16 60.86 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.47 -0.567 . . . . 0.79000000000000004 109.47 -176.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.535 ' HA ' HD13 ' A' ' 57' ' ' ILE . 20.0 Cg_exo -66.61 92.31 0.3 Allowed 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.245 1.963 . . . . 0.57999999999999996 111.794 174.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -92.1 25.39 17.43 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.949 -0.569 . . . . 0.40000000000000002 112.267 -178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.692 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 82.6 p -70.39 119.84 15.16 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.741 -0.837 . . . . 0.62 108.741 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.743 ' HB2' ' HB ' ' A' ' 88' ' ' THR . 1.4 pt? -141.18 -159.5 0.97 Allowed 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.837 1.051 . . . . 1.1000000000000001 113.837 -159.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 60.5 mttm -52.16 -95.98 0.0 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-N 114.821 -1.081 . . . . 1.8400000000000001 112.801 -179.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.589 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 168.84 113.44 0.01 OUTLIER 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.862 -1.162 . . . . 0.98999999999999999 107.862 -171.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.69 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 7.7 ptmm? 41.02 51.38 3.28 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 124.029 0.83 . . . . 1.8400000000000001 112.02 -175.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.598 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.1 t70 -161.83 -171.42 2.89 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.024 -0.535 . . . . 0.64000000000000001 111.008 -169.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.635 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.2 ttm -112.27 118.68 35.96 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.647 -0.706 . . . . 1.3500000000000001 111.23 -169.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.743 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.0 t -106.36 144.45 33.03 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.807 -0.633 . . . . 0.77000000000000002 110.655 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.87 118.0 24.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.546 0.689 . . . . 0.47999999999999998 111.032 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.556 HD22 HG11 ' A' ' 45' ' ' VAL . 6.4 tt -119.58 175.7 5.72 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.765 -1.198 . . . . 0.77000000000000002 107.765 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.402 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.5 m-20 -136.57 143.03 43.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 118.739 0.7 . . . . 1.8100000000000001 111.799 -177.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.677 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 41.8 mm -113.66 130.18 24.01 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 107.173 -1.417 . . . . 0.65000000000000002 107.173 165.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.565 ' O ' HD22 ' A' ' 42' ' ' LEU . 62.1 Cg_exo -50.42 -99.41 0.0 OUTLIER 'Trans proline' 0 CA--C 1.533 0.454 0 C-N-CA 123.344 2.696 . . . . 1.0700000000000001 114.36 -172.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.855 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -163.4 91.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.545 0 O-C-N 122.112 -0.368 . . . . 0.46000000000000002 111.375 -176.028 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.47 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.3 p -127.34 103.19 10.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 114.085 1.143 . . . . 0.47999999999999998 114.085 -170.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.504 ' CG2' HD23 ' A' ' 101' ' ' LEU . 2.5 p -154.52 99.61 2.45 Favored Pre-proline 0 N--CA 1.452 -0.335 0 C-N-CA 120.718 -0.393 . . . . 1.0700000000000001 111.473 160.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 5.8 Cg_endo -49.88 137.72 35.15 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.192 1.928 . . . . 0.47999999999999998 112.506 178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.597 ' H ' ' HA ' ' A' ' 38' ' ' SER . 21.6 t80 -53.81 -32.03 51.24 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.769 -0.65 . . . . 1.3100000000000001 111.45 -177.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.416 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 51.8 m -53.21 -31.6 43.92 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.888 -0.596 . . . . 1.2 111.882 178.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 1.075 HG21 ' HA ' ' A' ' 71' ' ' ILE . 37.5 mm -76.27 -57.01 6.77 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 CA-C-O 121.828 0.823 . . . . 0.51000000000000001 111.501 -173.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.061 HD22 HD21 ' A' ' 104' ' ' LEU . 2.0 mm? -54.23 -26.68 29.99 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 113.393 -1.73 . . . . 1.0 110.827 175.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.416 ' HB3' ' O ' ' A' ' 99' ' ' SER . 79.1 t80 -64.56 -45.76 85.68 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.239 -1.346 . . . . 0.95999999999999996 108.568 177.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -73.05 -56.72 4.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.708 -0.678 . . . . 0.81999999999999995 111.799 -178.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.061 HD21 HD22 ' A' ' 101' ' ' LEU . 2.2 pp -61.08 -52.72 63.75 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 113.129 0.788 . . . . 0.65000000000000002 113.129 -177.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.431 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -65.6 -25.48 67.41 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 121.852 0.834 . . . . 0.42999999999999999 110.347 -177.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.453 ' HE ' ' HB3' ' A' ' 106' ' ' ARG . 9.9 ttp180 -64.98 -52.15 57.77 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 114.671 -1.15 . . . . 1.8100000000000001 110.092 174.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.583 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 26.4 t70 -82.88 -52.83 6.35 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.55 0.691 . . . . 0.80000000000000004 112.342 -175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -85.34 -28.45 6.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 O-C-N 121.714 -0.616 . . . . 0.88 110.035 -175.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.431 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.15 -20.67 80.02 Favored Glycine 0 C--O 1.229 -0.192 0 C-N-CA 120.705 -0.759 . . . . 0.38 111.499 171.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.583 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.9 OUTLIER -49.35 -47.14 19.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 107.049 -1.463 . . . . 1.0900000000000001 107.049 165.17 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.525 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 1.7 m-20 -66.8 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.471 -0.786 . . . . 1.8700000000000001 109.761 162.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 178.17 -54.72 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 O-C-N 123.543 0.527 . . . . 1.1699999999999999 111.545 171.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -94.57 128.87 41.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.175 0.512 . . . . 2.1499999999999999 111.067 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.54 ' HA ' HG11 ' A' ' 108' ' ' VAL . 2.7 mp -112.67 155.94 13.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-N 115.668 -0.696 . . . . 0.39000000000000001 110.197 -173.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -98.09 153.43 18.43 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.081 -0.711 . . . . 2.1099999999999999 109.081 178.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.682 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 61.3 m-85 -140.13 166.13 25.5 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.639 -0.874 . . . . 0.62 108.639 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.862 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 28.4 tt0 -157.0 137.45 13.0 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 120.871 0.367 . . . . 0.80000000000000004 110.925 177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.666 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 14.2 tp -103.65 133.11 49.21 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.792 -0.64 . . . . 1.25 110.018 172.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.788 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.0 OUTLIER -118.8 100.18 7.23 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.399 -0.963 . . . . 0.63 108.399 172.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.613 HD11 HG22 ' A' ' 60' ' ' ILE . 7.2 tp -112.21 114.72 47.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 CA-C-O 121.195 0.521 . . . . 0.81000000000000005 111.207 -173.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -91.8 142.53 16.1 Favored Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.644 -0.982 . . . . 0.26000000000000001 110.644 175.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.744 ' O ' ' HA ' ' A' ' 133' ' ' THR . 2.8 mm? -121.48 122.32 39.47 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.3 0.571 . . . . 1.2 112.469 -173.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.045 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 88.9 m -116.37 96.1 5.37 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.844 -1.071 . . . . 0.32000000000000001 108.994 171.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.643 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -108.1 140.86 24.97 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 C-N-CA 120.367 -0.533 . . . . 0.97999999999999998 110.607 -175.275 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.64 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.1 m-20 -84.81 105.87 15.92 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 108.406 -0.961 . . . . 1.52 108.406 -178.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.88 HD23 HG21 ' A' ' 55' ' ' ILE . 17.5 mt -111.07 143.38 28.23 Favored Pre-proline 0 C--O 1.219 -0.54 0 O-C-N 125.247 1.592 . . . . 1.28 109.158 -176.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.4 -25.0 71.38 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 122.158 1.905 . . . . 0.73999999999999999 114.08 -175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.524 HG23 ' HE2' ' A' ' 51' ' ' TYR . 60.1 t -74.65 -58.64 4.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 112.846 0.684 . . . . 1.1200000000000001 112.846 -174.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.458 HG21 ' HB2' ' A' ' 18' ' ' ALA . 40.1 t -105.37 -2.85 9.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-O 122.798 1.285 . . . . 1.3500000000000001 109.523 -176.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 74.48 -0.84 53.91 Favored Glycine 0 C--N 1.311 -0.83 0 CA-C-N 113.479 -1.691 . . . . 1.05 111.852 -174.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.6 pt-20 -176.49 174.07 1.96 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.523 -0.547 . . . . 1.1599999999999999 109.523 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.549 ' HB2' HD12 ' A' ' 126' ' ' LEU . 8.3 t80 -170.74 124.07 0.65 Allowed 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.337 -0.986 . . . . 1.9099999999999999 108.337 174.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.8 t -114.16 102.85 10.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.87 0.843 . . . . 1.1899999999999999 111.687 -177.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.517 HD11 ' HB2' ' A' ' 23' ' ' GLU . 2.5 pp -127.96 144.99 53.48 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.358 -0.837 . . . . 0.5 110.137 176.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 58.6 Cg_endo -96.44 162.43 1.21 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.223 1.948 . . . . 0.45000000000000001 113.134 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.461 HG23 HG23 ' A' ' 120' ' ' ILE . 0.0 OUTLIER -160.39 167.53 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.765 -1.198 . . . . 0.44 107.765 179.239 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.542 ' HB3' ' NE2' ' A' ' 119' ' ' GLN . 88.7 p -146.17 159.17 43.67 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 112.599 0.592 . . . . 0.88 112.599 -168.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.3 t -151.0 109.83 3.87 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 108.851 -0.796 . . . . 0.95999999999999996 108.851 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.862 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -107.43 148.0 29.7 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 110.217 -0.29 . . . . 1.76 110.217 -179.652 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.38 142.59 8.29 Favored Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.701 -0.762 . . . . 0.5 111.866 -177.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -113.07 133.99 54.74 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.125 -0.538 . . . . 2.1000000000000001 110.391 -177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -140.49 174.96 7.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.525 -0.917 . . . . 0.76000000000000001 108.525 -179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -69.13 175.25 3.93 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.87 0.367 . . . . 3.5299999999999998 111.599 -175.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.704 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.9 tp -57.15 136.37 80.72 Favored Pre-proline 0 CA--C 1.537 0.446 0 CA-C-N 115.847 -0.615 . . . . 1.23 111.694 -172.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.704 ' HD2' HD12 ' A' ' 144' ' ' LEU . 72.5 Cg_endo -74.21 174.31 12.69 Favored 'Trans proline' 0 CA--C 1.53 0.293 0 C-N-CA 123.523 2.815 . . . . 0.70999999999999996 112.902 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 25.3 m -55.08 114.99 1.98 Allowed 'General case' 0 CA--C 1.534 0.331 0 CA-C-N 115.745 -0.661 . . . . 1.71 111.366 177.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 30.5 p90 -128.93 156.23 44.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.197 -0.456 . . . . 2.6400000000000001 110.086 -178.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HB2' ' HE3' ' A' ' 148' ' ' LYS . 38.6 ttmt -177.32 85.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 123.176 0.297 . . . . 3.7200000000000002 110.633 177.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 33.6 t70 64.77 4.72 2.49 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.235 0.614 . . . . 4.2800000000000002 111.6 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.9 m-85 -90.23 -53.24 4.55 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.347 -0.612 . . . . 2.8599999999999999 109.347 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.249 1.045 0 CA-C-N 115.04 -0.982 . . . . 3.96 109.385 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ttt . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 110.671 -0.122 . . . . 12.109999999999999 110.671 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 76.08 -53.06 0.62 Allowed 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.576 0.954 . . . . 9.0199999999999996 113.576 169.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.478 ' HA ' ' HB ' ' A' ' 17' ' ' THR . 16.9 t 73.38 -49.96 0.69 Allowed 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.468 0.707 . . . . 6.8300000000000001 110.018 -173.716 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.0 mp -100.76 115.46 30.34 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.098 -0.704 . . . . 8.5500000000000007 109.098 173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -74.21 -61.18 1.95 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.736 0.303 . . . . 10.470000000000001 111.222 -175.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -141.61 141.69 33.44 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.325 -0.398 . . . . 11.69 110.088 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -107.58 -28.57 9.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.653 -0.248 . . . . 11.42 111.38 -173.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 61.1 -85.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 O-C-N 123.766 0.666 . . . . 11.58 111.731 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 38.5 ttmt -137.15 71.89 1.41 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.047 -0.353 . . . . 15.74 110.047 177.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 61.16 19.64 10.21 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.908 -0.587 . . . . 12.69 111.854 174.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -139.04 109.77 6.67 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.815 0.341 . . . . 13.85 110.531 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.665 HG21 ' HB2' ' A' ' 15' ' ' LYS . 16.5 m -88.51 142.41 12.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 116.2 -0.455 . . . . 8.8699999999999992 110.419 177.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.0 -50.81 53.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.953 -0.567 . . . . 8.9100000000000001 109.888 176.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -150.24 110.31 4.14 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.446 -0.797 . . . . 8.5999999999999996 109.752 176.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.665 ' HB2' HG21 ' A' ' 12' ' ' VAL . 28.4 ttpp -91.3 100.65 13.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.288 -0.415 . . . . 9.0399999999999991 110.522 178.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.2 tp -150.05 -101.73 0.07 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.138 -0.483 . . . . 5.5800000000000001 110.291 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.478 ' HB ' ' HA ' ' A' ' 3' ' ' SER . 24.9 m 57.31 -90.4 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.228 0 O-C-N 123.429 0.456 . . . . 2.6899999999999999 110.558 -175.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.463 ' O ' HG11 ' A' ' 128' ' ' VAL . . . 47.95 -131.27 1.55 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.155 0.798 . . . . 1.6799999999999999 113.155 176.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.904 HG21 HD13 ' A' ' 126' ' ' LEU . 37.2 pt -130.25 179.56 1.29 Allowed Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 3.1899999999999999 111.199 -164.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 19' ' ' ILE . 30.2 Cg_exo -64.41 -152.02 0.02 OUTLIER 'Trans proline' 0 C--N 1.354 0.818 0 C-N-CA 123.061 2.507 . . . . 2.4199999999999999 112.98 172.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.596 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 60.6 tttm -150.57 -49.38 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.492 0 N-CA-C 112.069 0.396 . . . . 6.3799999999999999 112.069 -172.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 7.4 Cg_exo -74.79 63.31 5.79 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 122.262 1.975 . . . . 2.77 112.855 178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.679 ' HG2' ' HG3' ' A' ' 50' ' ' PRO . 2.0 mp0 -130.95 145.03 51.9 Favored 'General case' 0 N--CA 1.429 -1.52 0 N-CA-C 105.365 -2.087 . . . . 3.3900000000000001 105.365 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -116.36 -177.1 18.13 Favored Glycine 0 C--N 1.31 -0.887 0 C-N-CA 117.956 -2.068 . . . . 0.54000000000000004 116.973 -160.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.667 ' O ' HG13 ' A' ' 45' ' ' VAL . 99.7 p -161.53 35.51 0.13 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 105.38 -2.082 . . . . 1.2 105.38 170.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.422 ' O ' ' HB2' ' A' ' 46' ' ' SER . 10.5 m -133.27 154.15 38.68 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 CA-C-N 112.808 -1.996 . . . . 0.93000000000000005 108.39 -170.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.611 ' HB ' ' HB2' ' A' ' 46' ' ' SER . 7.8 t -173.17 -33.63 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.625 0 O-C-N 123.365 0.416 . . . . 0.47999999999999998 111.933 172.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.513 ' HB3' ' HB2' ' A' ' 44' ' ' LYS . 4.4 t70 -164.41 156.44 16.34 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 122.117 -0.364 . . . . 1.6899999999999999 110.112 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 89.3 t -143.85 132.7 19.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.57 -0.53 . . . . 1.1399999999999999 109.57 174.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.746 ' HB2' ' HB3' ' A' ' 42' ' ' LEU . 23.2 m-20 -112.94 124.08 51.8 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.798 0.333 . . . . 1.8300000000000001 111.121 -173.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.548 HD21 HD11 ' A' ' 101' ' ' LEU . 3.2 tm? -87.69 121.04 29.62 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.045 -0.525 . . . . 0.93999999999999995 109.737 176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.49 ' HE2' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -133.5 -127.04 0.17 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.571 -0.529 . . . . 1.3300000000000001 109.571 171.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.683 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 3.6 p30 175.7 174.83 0.27 Allowed 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 112.419 0.526 . . . . 2.8500000000000001 112.419 -169.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.561 HG13 ' O ' ' A' ' 34' ' ' VAL . 14.4 p -160.12 100.24 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 CA-C-N 115.067 -0.97 . . . . 3.2599999999999998 111.057 175.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.428 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 15.5 t30 67.1 -103.23 0.07 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.131 -0.692 . . . . 3.1600000000000001 109.131 176.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -173.71 30.82 0.01 OUTLIER 'General case' 0 N--CA 1.44 -0.937 0 N-CA-C 107.391 -1.337 . . . . 5.46 107.391 172.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.37 -43.29 6.3 Favored 'General case' 0 CA--C 1.493 -1.213 0 CA-C-N 112.758 -2.019 . . . . 1.9199999999999999 106.141 -177.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.647 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 36.3 t -149.62 178.33 8.94 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 111.409 -2.632 . . . . 0.93999999999999995 105.599 174.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.113 HG23 HG13 ' A' ' 96' ' ' VAL . 13.8 m -129.29 179.55 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.436 0 N-CA-C 109.356 -0.609 . . . . 0.85999999999999999 109.356 164.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.927 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 74.5 mt-10 -123.49 142.44 51.0 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.904 -0.718 . . . . 1.1899999999999999 112.4 -172.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.808 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -123.39 104.16 8.93 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.124 -0.944 . . . . 3.73 109.726 176.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.746 ' HB3' ' HB2' ' A' ' 30' ' ' ASP . 0.3 OUTLIER -75.92 111.29 11.14 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 107.971 -1.122 . . . . 0.81000000000000005 107.971 175.575 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.797 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.68 109.7 21.76 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 121.697 0.76 . . . . 0.41999999999999998 109.944 -175.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 28' ' ' ASP . 41.3 mmtm -83.68 123.53 29.92 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 114.702 -1.136 . . . . 2.6299999999999999 108.934 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.667 HG13 ' O ' ' A' ' 25' ' ' SER . 55.4 t -111.45 138.92 38.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 CA-C-N 115.625 -0.716 . . . . 0.81999999999999995 111.118 -173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.611 ' HB2' ' HB ' ' A' ' 27' ' ' THR . 3.5 m -133.93 100.0 4.61 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.368 0.604 . . . . 0.71999999999999997 110.16 168.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.744 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.9 t -82.38 128.04 39.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.115 -0.948 . . . . 1.1399999999999999 111.011 -174.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.539 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.2 m -109.59 109.59 20.4 Favored 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 109.318 -0.623 . . . . 0.40999999999999998 109.318 177.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.701 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -96.8 125.44 46.6 Favored Pre-proline 0 C--O 1.24 0.563 0 O-C-N 124.28 0.987 . . . . 1.48 109.404 175.147 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.679 ' HG3' ' HG2' ' A' ' 23' ' ' GLU . 18.1 Cg_endo -112.32 39.28 0.02 OUTLIER 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.4 3.4 . . . . 0.72999999999999998 116.513 -169.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.416 ' CZ ' HG22 ' A' ' 128' ' ' VAL . 10.7 t80 -116.32 -10.82 11.32 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.03 1.287 . . . . 2.0800000000000001 112.18 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.615 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 54.4 p 86.91 26.85 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.837 1.655 . . . . 1.51 109.401 174.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 46.7 m80 -147.46 123.67 10.86 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.265 -1.334 . . . . 1.6699999999999999 109.297 179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.816 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 2.0 m -49.03 104.69 0.07 Allowed 'General case' 0 C--O 1.214 -0.808 0 C-N-CA 122.926 0.49 . . . . 1.3899999999999999 112.045 172.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.944 ' O ' ' HA ' ' A' ' 81' ' ' SER . 4.7 pt -74.65 170.52 14.85 Favored Pre-proline 0 C--O 1.209 -1.07 0 N-CA-C 108.161 -1.051 . . . . 1.03 108.161 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.6 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.3 Cg_endo -92.87 -63.66 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 121.731 1.621 . . . . 0.37 114.395 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.601 HD13 ' HA ' ' A' ' 79' ' ' PRO . 12.4 mm -128.29 160.62 38.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 C-N-CA 121.079 -0.248 . . . . 1.23 110.721 -167.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.576 ' CB ' HG22 ' A' ' 124' ' ' ILE . 25.6 p -156.58 -177.52 6.67 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 122.116 0.96 . . . . 1.1499999999999999 112.772 -178.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.074 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 26.2 tt0 -133.04 117.1 17.17 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 113.184 -1.825 . . . . 1.3600000000000001 109.845 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.746 HG22 HD11 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -97.26 109.73 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 CA-C-O 121.997 0.903 . . . . 1.05 109.018 169.818 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.661 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 19.4 p -112.76 102.76 10.78 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.005 -1.452 . . . . 0.82999999999999996 108.908 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.587 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 4.6 p90 -112.07 124.9 53.41 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 109.467 -0.568 . . . . 0.40000000000000002 109.467 -168.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.661 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 6.6 m -121.9 106.11 10.95 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 115.21 -0.904 . . . . 0.38 108.703 176.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.601 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 86.1 m-85 -95.95 140.12 31.16 Favored 'General case' 0 C--N 1.31 -1.116 0 N-CA-C 109.935 -0.395 . . . . 0.95999999999999996 109.935 -175.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.406 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 8.2 m170 -126.78 144.53 50.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 108.569 -0.9 . . . . 1.29 108.569 178.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.489 ' HB3' HD22 ' A' ' 104' ' ' LEU . 0.1 OUTLIER -98.48 -112.75 0.16 Allowed 'General case' 0 N--CA 1.426 -1.654 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.298 177.237 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -64.31 -51.18 64.71 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.684 -0.858 . . . . 0.35999999999999999 108.684 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.456 ' H ' HH11 ' A' ' 69' ' ' ARG . . . -161.58 12.74 0.13 Allowed Glycine 0 N--CA 1.437 -1.287 0 N-CA-C 110.405 -1.078 . . . . 0.39000000000000001 110.405 168.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.613 ' HE ' ' HB3' ' A' ' 103' ' ' ASN . 0.0 OUTLIER -112.62 -164.99 0.95 Allowed 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 108.715 -0.846 . . . . 1.97 108.715 -175.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -108.92 98.23 7.74 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 121.259 0.552 . . . . 2.6099999999999999 109.868 -169.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.938 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -52.25 -34.82 18.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.145 -0.934 . . . . 0.40000000000000002 110.358 176.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.74 170.9 27.11 Favored Glycine 0 CA--C 1.504 -0.61 0 N-CA-C 110.823 -0.911 . . . . 0.48999999999999999 110.823 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.587 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -164.09 163.98 23.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 118.011 0.906 . . . . 1.8100000000000001 111.691 178.104 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 169.72 170.42 34.15 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.318 -0.856 . . . . 0.42999999999999999 110.995 179.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.474 ' HB3' ' HE3' ' A' ' 75' ' ' LYS . 0.0 OUTLIER -141.86 133.68 27.2 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-O 120.936 0.398 . . . . 1.72 110.734 179.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 79.9 mt -133.69 123.13 17.1 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.049 -0.523 . . . . 0.72999999999999998 110.457 -176.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_exo -70.8 116.16 4.55 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 122.427 2.084 . . . . 0.56999999999999995 110.713 172.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -132.85 140.48 37.82 Favored Pre-proline 0 C--N 1.322 -0.592 0 C-N-CA 121.17 -0.212 . . . . 0.79000000000000004 110.501 -175.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.601 ' HA ' HD13 ' A' ' 57' ' ' ILE . 21.1 Cg_endo -61.26 88.64 0.09 OUTLIER 'Trans proline' 0 C--O 1.233 0.248 0 C-N-CA 122.821 2.347 . . . . 0.57999999999999996 112.46 175.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.542 ' O ' HD12 ' A' ' 82' ' ' LEU . . . -91.56 43.08 2.77 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.802 -0.636 . . . . 0.40000000000000002 111.801 179.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.944 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 79.6 p -74.08 121.9 21.84 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.878 -0.415 . . . . 0.62 109.878 177.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.816 ' O ' ' HA ' ' A' ' 54' ' ' SER . 0.0 OUTLIER -164.66 170.69 15.34 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 115.41 1.633 . . . . 1.1000000000000001 115.41 -163.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.881 ' HG3' ' HB3' ' A' ' 86' ' ' ASP . 71.4 mmtt 7.57 -98.92 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.859 1.664 . . . . 1.8400000000000001 114.031 -177.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.406 ' H ' ' HB2' ' A' ' 83' ' ' LYS . . . 172.0 -44.23 0.01 OUTLIER 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 105.622 -1.992 . . . . 0.98999999999999999 105.622 179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 5.6 ttpt -159.65 71.08 0.48 Allowed 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 112.131 -2.304 . . . . 1.8400000000000001 110.162 173.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.881 ' HB3' ' HG3' ' A' ' 83' ' ' LYS . 6.9 t70 -162.24 -161.66 0.76 Allowed 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.011 -1.45 . . . . 0.64000000000000001 108.809 -177.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.601 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 47.9 ttm -121.3 122.16 39.27 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.858 -0.423 . . . . 1.3500000000000001 109.858 -171.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 46' ' ' SER . 2.7 t -104.45 143.04 33.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.119 -0.492 . . . . 0.77000000000000002 109.709 -177.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -85.93 123.35 31.17 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.715 0.769 . . . . 0.47999999999999998 110.781 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.604 HD22 HG11 ' A' ' 45' ' ' VAL . 8.7 tt -130.64 164.5 24.85 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 107.137 -1.431 . . . . 0.77000000000000002 107.137 -179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.65 142.28 32.04 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 119.173 -1.011 . . . . 1.8100000000000001 111.764 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.797 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 35.3 mm -100.83 143.39 26.49 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 107.724 -1.213 . . . . 0.65000000000000002 107.724 173.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.551 ' O ' HD22 ' A' ' 42' ' ' LEU . 81.9 Cg_exo -48.15 -107.19 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.212 2.608 . . . . 1.0700000000000001 114.0 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.927 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.41 94.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.532 0 O-C-N 121.617 -0.677 . . . . 0.46000000000000002 111.979 -172.875 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.504 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.4 p -127.49 103.02 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 114.581 1.326 . . . . 0.47999999999999998 114.581 -170.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 1.113 HG13 HG23 ' A' ' 39' ' ' VAL . 0.7 OUTLIER -151.98 112.89 2.9 Favored Pre-proline 0 C--O 1.219 -0.517 0 O-C-N 121.712 -0.618 . . . . 1.0700000000000001 110.332 157.582 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.738 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 4.8 Cg_endo -53.98 135.16 62.73 Favored 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 121.38 1.387 . . . . 0.47999999999999998 111.619 173.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.647 ' H ' ' HA ' ' A' ' 38' ' ' SER . 22.8 t80 -55.58 -30.7 61.3 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 115.762 -0.654 . . . . 1.3100000000000001 110.912 -177.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.687 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.2 p -58.14 -28.78 65.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.995 -0.548 . . . . 1.2 112.32 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.938 HG21 ' HA ' ' A' ' 71' ' ' ILE . 8.3 mm -77.51 -52.86 15.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 O-C-N 122.031 -0.418 . . . . 0.51000000000000001 111.014 -177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.089 HD23 HD21 ' A' ' 104' ' ' LEU . 21.3 mt -50.75 -27.01 6.3 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 121.5 0.666 . . . . 1.0 110.185 170.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.727 ' HA ' ' CZ ' ' A' ' 151' ' ' PHE . 46.9 t80 -63.81 -42.5 97.68 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.472 -1.24 . . . . 0.95999999999999996 108.917 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.671 ' HA ' HH21 ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.24 -57.59 3.85 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.665 -0.698 . . . . 0.81999999999999995 111.789 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.089 HD21 HD23 ' A' ' 101' ' ' LEU . 3.2 pp -57.36 -50.13 73.93 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 112.926 0.714 . . . . 0.65000000000000002 112.926 -177.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' N ' HD12 ' A' ' 104' ' ' LEU . . . -68.95 -26.72 65.2 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 121.497 0.665 . . . . 0.42999999999999999 110.274 -176.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.671 HH21 ' HA ' ' A' ' 103' ' ' ASN . 2.7 ttp180 -68.0 -54.49 18.12 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.238 -0.892 . . . . 1.8100000000000001 110.222 175.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -79.64 -53.93 6.36 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.476 0.655 . . . . 0.80000000000000004 111.277 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.632 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.6 t -89.05 -28.46 5.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 C-N-CA 120.415 -0.514 . . . . 0.88 110.57 -174.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' HA2' HD13 ' A' ' 144' ' ' LEU . . . -68.33 -25.29 74.77 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.063 -1.065 . . . . 0.38 111.416 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.487 ' HB ' ' O ' ' A' ' 106' ' ' ARG . 0.6 OUTLIER -53.7 -46.77 62.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.475 -1.305 . . . . 1.0900000000000001 107.475 168.791 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.435 ' O ' ' HB3' ' A' ' 112' ' ' TRP . 15.2 m-20 -68.01 -61.28 1.94 Allowed 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.712 0.634 . . . . 1.8700000000000001 112.712 169.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.435 ' HB3' ' O ' ' A' ' 111' ' ' ASP . 0.2 OUTLIER 153.48 -79.81 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 C-N-CA 124.209 1.004 . . . . 1.1699999999999999 113.593 -173.166 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . 0.433 ' N ' ' CG ' ' A' ' 112' ' ' TRP . 0.6 OUTLIER -92.5 128.82 38.49 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.101 0.56 . . . . 2.1499999999999999 111.006 -173.598 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.792 HG21 ' HB2' ' A' ' 104' ' ' LEU . 3.3 mp -110.69 155.36 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 109.842 -0.429 . . . . 0.39000000000000001 109.842 -174.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.425 ' OD1' ' HA ' ' A' ' 67' ' ' ALA . 15.1 p-10 -98.41 153.05 18.86 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.988 -0.745 . . . . 2.1099999999999999 108.988 178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.416 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 74.4 m-85 -143.62 165.44 27.62 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.696 -0.853 . . . . 0.62 108.696 177.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.715 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.5 tt0 -153.16 135.94 15.34 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.845 0.355 . . . . 0.80000000000000004 110.307 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.601 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 11.4 tp -104.72 130.76 52.73 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.821 -0.437 . . . . 1.25 109.821 171.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.661 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -117.16 100.29 7.62 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 108.469 -0.937 . . . . 0.63 108.469 176.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.746 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -119.94 120.42 63.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-O 121.617 0.722 . . . . 0.81000000000000005 111.137 -171.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.54 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -88.77 129.13 9.47 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.228 -0.896 . . . . 0.26000000000000001 112.101 177.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.566 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.8 mp -100.84 92.98 5.31 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.014 0.435 . . . . 1.2 110.907 -177.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.074 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.5 m -94.18 95.93 9.28 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.942 -0.762 . . . . 0.32000000000000001 108.942 172.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.576 HG22 ' CB ' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.93 137.84 43.04 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.167 0 C-N-CA 120.148 -0.621 . . . . 0.97999999999999998 110.761 -177.07 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.467 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 7.2 t70 -79.52 106.74 11.77 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 107.799 -1.186 . . . . 1.52 107.799 -179.017 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.904 HD13 HG21 ' A' ' 19' ' ' ILE . 6.7 mt -113.5 166.05 12.07 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.467 -0.788 . . . . 1.28 110.648 -171.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -77.24 -16.76 15.35 Favored 'Trans proline' 0 CA--C 1.532 0.417 0 C-N-CA 121.914 1.743 . . . . 0.73999999999999999 111.867 171.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.494 HG21 HG22 ' A' ' 19' ' ' ILE . 3.0 t -75.18 -59.7 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 112.433 0.531 . . . . 1.1200000000000001 112.433 -174.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.447 ' C ' ' H ' ' A' ' 131' ' ' GLU . 2.8 t -111.7 -0.2 9.38 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 CA-C-O 122.643 1.211 . . . . 1.3500000000000001 108.891 -177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.458 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 80.48 -28.62 2.68 Favored Glycine 0 C--N 1.312 -0.763 0 CA-C-N 113.453 -1.703 . . . . 1.05 111.267 -170.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.8 pt-20 -175.35 143.69 0.66 Allowed 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.087 -1.079 . . . . 1.1599999999999999 108.087 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.469 ' O ' ' HA ' ' A' ' 123' ' ' THR . 13.5 t80 -155.7 145.47 21.28 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.638 -0.504 . . . . 1.9099999999999999 109.638 176.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.515 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.6 t -113.23 107.94 16.59 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.581 0.705 . . . . 1.1899999999999999 110.922 -179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.48 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.5 pp -115.12 128.29 26.07 Favored Pre-proline 0 C--N 1.322 -0.614 0 N-CA-C 108.701 -0.852 . . . . 0.5 108.701 171.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.54 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 19.6 Cg_endo -89.3 160.02 5.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 121.759 1.64 . . . . 0.45000000000000001 112.735 -177.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.53 166.75 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.852 0 N-CA-C 107.972 -1.122 . . . . 0.44 107.972 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.1 m -139.98 153.19 46.81 Favored 'General case' 0 C--N 1.313 -0.983 0 C-N-CA 120.782 -0.367 . . . . 0.88 111.304 -168.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 39.0 t -143.84 105.72 4.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.269 -1.011 . . . . 0.95999999999999996 108.269 174.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.715 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.29 149.07 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.627 -0.26 . . . . 1.76 110.788 -176.535 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -160.04 148.19 16.28 Favored Glycine 0 N--CA 1.441 -1.008 0 C-N-CA 120.517 -0.849 . . . . 0.5 112.131 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -106.1 124.48 49.64 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 108.807 -0.812 . . . . 2.1000000000000001 108.807 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.43 173.07 13.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 109.238 -0.653 . . . . 0.76000000000000001 109.238 -177.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 49.0 mttp -55.39 160.3 2.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.543 0.687 . . . . 3.5299999999999998 112.358 -177.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.716 HD12 ' HD2' ' A' ' 145' ' ' PRO . 24.6 tp -56.29 134.78 75.71 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.776 -1.102 . . . . 1.23 110.658 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.716 ' HD2' HD12 ' A' ' 144' ' ' LEU . 35.5 Cg_endo -63.2 168.19 11.36 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.787 2.325 . . . . 0.70999999999999996 111.524 176.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.2 m -78.32 90.1 4.36 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 112.159 0.429 . . . . 1.71 112.159 -172.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.632 ' HB3' ' HB2' ' A' ' 150' ' ' PHE . 96.4 m-85 -137.28 103.78 5.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.305 0.574 . . . . 2.6400000000000001 110.525 178.619 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.641 ' HE3' ' HA ' ' A' ' 148' ' ' LYS . 1.3 tpmt? -72.53 -74.86 0.15 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.132 -0.94 . . . . 3.7200000000000002 110.698 -177.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -115.97 22.93 12.62 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.323 0.582 . . . . 4.2800000000000002 110.105 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.632 ' HB2' ' HB3' ' A' ' 147' ' ' PHE . 15.4 m-85 -76.99 -47.01 21.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.889 -0.782 . . . . 2.8599999999999999 108.889 174.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.727 ' CZ ' ' HA ' ' A' ' 102' ' ' PHE . 35.4 m-85 . . . . . 0 C--O 1.243 0.746 0 CA-C-N 115.384 -0.825 . . . . 3.96 109.437 177.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.2 ttm . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 120.93 0.395 . . . . 12.109999999999999 110.528 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.846 ' HB1' ' HB3' ' A' ' 14' ' ' ASP . . . -74.62 153.81 38.81 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.929 -0.578 . . . . 9.0199999999999996 110.602 178.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 39.7 t -169.38 -58.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.975 -0.38 . . . . 6.8300000000000001 109.975 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 42.7 tp 178.74 -58.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.345 -0.843 . . . . 8.5500000000000007 109.044 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.4 mm? 56.56 -102.71 0.16 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.245 -0.889 . . . . 10.470000000000001 112.106 177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -87.82 156.25 19.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.262 -0.426 . . . . 11.69 110.138 -174.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -104.67 -2.4 25.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.781 0.324 . . . . 11.42 111.142 -175.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -112.17 21.25 16.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 11.58 110.987 -178.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.526 ' HD2' ' O ' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -90.43 109.2 20.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.371 0.605 . . . . 15.74 111.139 178.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -107.75 -16.75 14.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.801 -0.636 . . . . 12.69 110.432 178.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -50.41 -65.07 0.62 Allowed 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.049 0.452 . . . . 13.85 110.359 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.8 m -136.93 141.46 40.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.481 -0.781 . . . . 8.8699999999999992 109.408 174.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.22 71.4 8.2 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.959 -0.385 . . . . 8.9100000000000001 109.959 177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.846 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 3.8 m-20 58.32 88.01 0.07 Allowed 'General case' 0 N--CA 1.462 0.174 0 O-C-N 123.958 0.786 . . . . 8.5999999999999996 110.69 -176.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.414 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 26.0 mmmt 61.16 -92.7 0.04 OUTLIER 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.596 -0.729 . . . . 9.0399999999999991 111.152 -176.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.0 mt -140.21 35.55 1.9 Allowed 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.238 -0.653 . . . . 5.5800000000000001 109.238 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.426 ' O ' HG12 ' A' ' 128' ' ' VAL . 26.3 m 79.43 -23.28 0.25 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.092 -0.958 . . . . 2.6899999999999999 110.487 -177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.812 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -104.5 153.78 20.72 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.174 -0.466 . . . . 1.6799999999999999 109.981 173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.062 HG23 ' HD3' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -99.43 -63.46 0.09 OUTLIER Pre-proline 0 CA--C 1.551 0.999 0 N-CA-C 114.095 1.146 . . . . 3.1899999999999999 114.095 -166.205 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 1.062 ' HD3' HG23 ' A' ' 19' ' ' ILE . 7.5 Cg_endo -101.86 -143.45 0.01 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 122.491 2.128 . . . . 2.4199999999999999 114.042 -171.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.716 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 9.7 ttmt -168.13 -55.34 0.0 OUTLIER Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.734 -0.666 . . . . 6.3799999999999999 111.393 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.716 ' HD3' ' HB3' ' A' ' 21' ' ' LYS . 42.5 Cg_endo -101.02 95.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 123.056 2.504 . . . . 2.77 113.5 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.623 ' HB3' ' O ' ' A' ' 48' ' ' THR . 10.3 mp0 -127.97 154.12 45.95 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 104.389 -2.448 . . . . 3.3900000000000001 104.389 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.769 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -112.1 173.2 15.31 Favored Glycine 0 C--N 1.304 -1.246 0 C-N-CA 117.057 -2.497 . . . . 0.54000000000000004 115.976 -169.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.67 ' OG ' HD11 ' A' ' 122' ' ' LEU . 79.6 p -162.15 31.6 0.12 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.964 -1.495 . . . . 1.2 106.964 169.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.444 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.7 m -132.79 153.55 38.17 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.268 0 CA-C-N 114.209 -1.36 . . . . 0.93000000000000005 109.665 -171.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -162.46 -43.89 0.04 OUTLIER 'General case' 0 C--N 1.318 -0.795 0 O-C-N 123.782 0.676 . . . . 0.47999999999999998 110.407 169.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -169.67 145.27 3.06 Favored 'General case' 0 CA--C 1.514 -0.441 0 O-C-N 122.287 -0.258 . . . . 1.6899999999999999 110.518 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 ' HA ' ' HA ' ' A' ' 43' ' ' ALA . 96.5 t -119.05 132.74 68.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.844 0 N-CA-C 109.387 -0.597 . . . . 1.1399999999999999 109.387 173.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -119.92 137.19 54.18 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.87 0.367 . . . . 1.8300000000000001 111.147 -168.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -93.58 126.06 38.53 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.853 -0.612 . . . . 0.93999999999999995 111.532 -172.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -130.66 -131.69 0.2 Allowed 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.774 -0.825 . . . . 1.3300000000000001 108.774 167.519 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.938 ' HA ' HG13 ' A' ' 39' ' ' VAL . 4.2 p-10 171.98 175.76 0.08 Allowed 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 119.239 0.927 . . . . 2.8500000000000001 111.83 -171.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.494 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.7 p -156.39 92.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.293 0 CA-C-O 121.379 0.609 . . . . 3.2599999999999998 112.031 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.61 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 9.5 t30 67.92 -62.83 0.34 Allowed 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.003 0.921 . . . . 3.1600000000000001 113.033 174.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.61 ' HB2' ' O ' ' A' ' 35' ' ' ASN . 0.0 OUTLIER 137.25 18.11 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.843 1.657 . . . . 5.46 110.511 -168.64 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.44 -45.14 10.21 Favored 'General case' 0 CA--C 1.49 -1.341 0 N-CA-C 105.112 -2.181 . . . . 1.9199999999999999 105.112 172.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.623 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 14.3 m -148.78 178.46 8.64 Favored 'General case' 0 N--CA 1.425 -1.705 0 CA-C-N 110.534 -3.03 . . . . 0.93999999999999995 106.33 178.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.938 HG13 ' HA ' ' A' ' 33' ' ' ASP . 28.4 t -130.64 165.56 30.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.381 -0.97 . . . . 0.85999999999999999 108.381 167.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.769 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 2.8 mt-10 -125.25 139.37 53.78 Favored 'General case' 0 N--CA 1.433 -1.307 0 CA-C-O 121.381 0.61 . . . . 1.1899999999999999 111.528 -172.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.779 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -125.3 106.57 9.95 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-N 115.15 -0.932 . . . . 3.73 109.746 -176.507 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.503 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 4.8 tt -88.72 111.8 22.41 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 118.445 -1.302 . . . . 0.81000000000000005 109.892 176.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.71 116.82 30.67 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.201 -0.909 . . . . 0.41999999999999998 109.65 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -83.35 131.62 35.05 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.453 -0.943 . . . . 2.6299999999999999 108.453 176.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.665 HG13 ' O ' ' A' ' 25' ' ' SER . 44.5 t -111.17 142.08 24.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 CA-C-N 115.115 -0.948 . . . . 0.81999999999999995 110.92 -173.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.7 m -131.79 99.45 4.77 Favored 'General case' 0 N--CA 1.44 -0.948 0 CA-C-O 121.006 0.431 . . . . 0.71999999999999997 109.905 167.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.769 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 62.2 t -82.46 127.9 39.22 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 CA-C-N 115.576 -0.738 . . . . 1.1399999999999999 110.537 -175.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.639 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 5.9 m -107.79 113.82 27.34 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 109.293 -0.632 . . . . 0.40999999999999998 109.293 176.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.868 ' HB3' HD21 ' A' ' 82' ' ' LEU . 29.3 p-10 -90.54 140.23 26.7 Favored Pre-proline 0 N--CA 1.461 0.117 0 O-C-N 123.864 0.727 . . . . 1.48 110.164 176.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.581 ' CG ' ' HG3' ' A' ' 20' ' ' PRO . 66.9 Cg_endo -96.36 6.22 1.77 Allowed 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 123.891 3.061 . . . . 0.72999999999999998 115.399 -169.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.714 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 24.4 t80 -97.18 -113.03 0.14 Allowed 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.855 -0.738 . . . . 2.0800000000000001 110.08 -172.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.736 ' HA ' ' HG2' ' A' ' 85' ' ' LYS . 77.5 p 179.98 19.66 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 117.964 0.347 . . . . 1.51 111.263 174.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -139.09 19.86 2.62 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.736 0.643 . . . . 1.6699999999999999 112.736 -168.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.821 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 31.7 t 57.79 96.57 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.778 0 N-CA-C 111.955 0.354 . . . . 1.3899999999999999 111.955 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.917 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -73.94 170.71 13.36 Favored Pre-proline 0 C--O 1.209 -1.055 0 N-CA-C 108.62 -0.881 . . . . 1.03 108.62 -172.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.547 ' HB2' HG12 ' A' ' 57' ' ' ILE . 10.0 Cg_endo -92.79 -61.77 0.01 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 121.797 1.665 . . . . 0.37 113.935 -178.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.677 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.0 mm -125.95 154.39 34.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.217 -0.593 . . . . 1.23 111.479 -166.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.674 ' SG ' HG22 ' A' ' 124' ' ' ILE . 26.4 m -145.16 176.43 9.52 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 122.083 0.944 . . . . 1.1499999999999999 111.475 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.066 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 2.4 tm-20 -141.86 114.39 8.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 113.565 -1.652 . . . . 1.3600000000000001 109.885 175.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.521 HD12 ' HB ' ' A' ' 76' ' ' ILE . 0.9 OUTLIER -103.31 121.62 54.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 122.387 1.089 . . . . 1.05 112.307 173.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.743 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.1 OUTLIER -115.41 109.66 18.19 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 113.107 -1.861 . . . . 0.82999999999999996 109.74 -179.16 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.661 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.0 p90 -114.06 122.82 48.05 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.141 0.496 . . . . 0.40000000000000002 110.129 -169.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.534 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 26.8 m -122.07 109.61 14.76 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 115.524 -0.762 . . . . 0.38 109.586 177.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.514 ' CE1' HD23 ' A' ' 118' ' ' LEU . 97.9 m-85 -98.6 141.2 31.73 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.036 -0.529 . . . . 0.95999999999999996 110.707 -176.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.431 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 6.3 m170 -131.94 145.74 51.67 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.64 -1.245 . . . . 1.29 107.64 175.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.94 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.9 t -109.98 -100.32 0.39 Allowed 'General case' 0 C--N 1.32 -0.717 0 C-N-CA 119.196 -1.002 . . . . 1.27 111.025 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -56.71 -56.8 16.81 Favored 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.231 -0.655 . . . . 0.35999999999999999 109.231 -174.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.03 18.71 0.08 OUTLIER Glycine 0 N--CA 1.44 -1.045 0 N-CA-C 109.589 -1.404 . . . . 0.39000000000000001 109.589 162.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.461 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 7.9 ptp180 -105.85 -156.56 0.58 Allowed 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.738 -0.838 . . . . 1.97 108.738 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.16 94.98 4.78 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 118.709 0.686 . . . . 2.6099999999999999 110.098 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.888 ' HA ' HG21 ' A' ' 100' ' ' ILE . 2.8 mm -56.55 -39.25 61.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 114.904 -1.043 . . . . 0.40000000000000002 110.892 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.58 169.26 34.25 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 120.328 -0.939 . . . . 0.48999999999999999 111.458 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.08 164.63 15.84 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 117.668 0.734 . . . . 1.8100000000000001 111.028 173.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.16 167.89 34.31 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.885 -0.886 . . . . 0.42999999999999999 110.885 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.743 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.3 mtpt -130.43 131.5 45.25 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 110.026 -0.361 . . . . 1.72 110.026 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.521 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -133.85 105.14 11.65 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-O 120.863 0.363 . . . . 0.72999999999999998 110.483 -179.196 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.507 ' HA ' ' HA ' ' A' ' 59' ' ' GLU . 11.9 Cg_exo -71.25 101.62 1.14 Allowed 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.359 2.039 . . . . 0.56999999999999995 110.428 172.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -112.28 143.57 29.1 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 109.606 -0.516 . . . . 0.79000000000000004 109.606 -173.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.677 ' HA ' HD13 ' A' ' 57' ' ' ILE . 32.5 Cg_exo -62.38 78.78 0.1 Allowed 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.308 2.005 . . . . 0.57999999999999996 111.957 174.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.522 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 46.7 3.58 Favored Glycine 0 N--CA 1.445 -0.755 0 CA-C-N 115.8 -0.636 . . . . 0.40000000000000002 112.197 -178.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.917 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 92.9 p -73.55 119.23 17.49 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 109.361 -0.607 . . . . 0.62 109.361 173.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 49' ' ' ASN . 2.2 pt? -153.03 163.9 38.99 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 119.191 -1.004 . . . . 1.1000000000000001 113.241 -164.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 54' ' ' SER . 50.5 mttm -16.49 -92.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 113.756 -1.565 . . . . 1.8400000000000001 114.417 -168.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 165.5 110.41 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 107.608 -1.256 . . . . 0.98999999999999999 107.608 -176.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.747 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 37.5 pttt 42.32 52.08 4.62 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 124.197 0.935 . . . . 1.8400000000000001 110.893 -175.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.564 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.5 t70 -152.56 -166.94 2.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.288 -0.869 . . . . 0.64000000000000001 110.356 -173.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 47.3 ttm -125.24 117.73 24.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.102 0.477 . . . . 1.3500000000000001 110.944 -170.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.561 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -105.87 144.68 32.26 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.394 -0.821 . . . . 0.77000000000000002 110.113 -176.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -87.75 129.17 35.26 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.26 0.553 . . . . 0.47999999999999998 110.927 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.534 HD22 HG11 ' A' ' 45' ' ' VAL . 1.0 OUTLIER -135.25 174.18 10.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.246 -1.02 . . . . 0.77000000000000002 108.246 -176.314 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.507 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 5.8 p-10 -142.72 139.48 31.12 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 118.736 0.698 . . . . 1.8100000000000001 112.059 -177.059 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.5 mm -109.03 115.97 56.18 Favored Pre-proline 0 C--N 1.325 -0.466 0 N-CA-C 108.783 -0.821 . . . . 0.65000000000000002 108.783 171.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.503 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 24.7 Cg_exo -28.76 -102.37 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.728 1 C-N-CA 125.405 4.07 . . . . 1.0700000000000001 115.534 -173.169 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.779 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 0.0 OUTLIER -164.88 95.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.212 -0.902 0 O-C-N 122.266 -0.271 . . . . 0.46000000000000002 111.474 -175.8 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.541 ' N ' ' H ' ' A' ' 41' ' ' TYR . 7.5 p -128.67 104.8 12.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 115.012 1.486 . . . . 0.47999999999999998 115.012 -172.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 1.7 p -154.4 99.57 2.47 Favored Pre-proline 0 CA--C 1.533 0.293 0 O-C-N 121.601 -0.687 . . . . 1.0700000000000001 111.335 161.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.57 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 50.9 Cg_exo -51.78 134.65 48.32 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.014 1.809 . . . . 0.47999999999999998 111.572 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.623 ' H ' ' HA ' ' A' ' 38' ' ' SER . 52.7 t80 -54.93 -36.9 65.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.792 -0.64 . . . . 1.3100000000000001 111.635 -172.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.401 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 15.0 m -53.88 -30.97 48.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.891 0.377 . . . . 1.2 111.639 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.888 HG21 ' HA ' ' A' ' 71' ' ' ILE . 10.1 mm -76.82 -56.0 9.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 C-N-CA 120.431 -0.508 . . . . 0.51000000000000001 110.983 -175.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.653 HD23 HD21 ' A' ' 104' ' ' LEU . 30.6 mt -53.84 -28.25 34.66 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 123.699 0.625 . . . . 1.0 110.53 174.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.401 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.5 t80 -62.4 -42.45 99.44 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 114.413 -1.267 . . . . 0.95999999999999996 109.206 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.414 ' HA ' HH21 ' A' ' 106' ' ' ARG . 29.6 m-80 -74.66 -58.26 3.4 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.171 0.434 . . . . 0.81999999999999995 112.171 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.94 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.8 pp -60.85 -48.83 80.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.665 0.987 . . . . 0.65000000000000002 113.665 -177.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -66.6 -25.59 66.69 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.852 0.834 . . . . 0.42999999999999999 109.574 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.414 HH21 ' HA ' ' A' ' 103' ' ' ASN . 3.1 ttp180 -68.06 -48.82 64.55 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 114.554 -1.203 . . . . 1.8100000000000001 110.451 172.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.646 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 30.1 t70 -81.36 -54.31 5.58 Favored 'General case' 0 C--O 1.239 0.512 0 CA-C-O 121.649 0.738 . . . . 0.80000000000000004 112.164 -174.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.553 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.9 t -87.33 -25.64 6.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 O-C-N 121.726 -0.609 . . . . 0.88 110.069 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.03 -20.84 80.13 Favored Glycine 0 CA--C 1.509 -0.288 0 C-N-CA 120.717 -0.754 . . . . 0.38 111.309 171.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.646 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -49.99 -48.36 22.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.732 -1.581 . . . . 1.0900000000000001 106.732 165.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.4 ' N ' HG12 ' A' ' 110' ' ' VAL . 30.3 t70 -69.02 -93.67 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 115.38 -0.827 . . . . 1.8700000000000001 109.992 164.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER 178.41 -48.19 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 112.187 0.44 . . . . 1.1699999999999999 112.187 174.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -92.76 124.13 36.54 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 110.012 -0.366 . . . . 2.1499999999999999 110.012 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.651 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -111.7 154.24 13.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.259 0 N-CA-C 108.846 -0.798 . . . . 0.39000000000000001 108.846 -179.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 152.78 19.17 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.985 -0.746 . . . . 2.1099999999999999 108.985 178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.648 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 57.4 m-85 -140.52 162.73 34.64 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.915 -0.772 . . . . 0.62 108.915 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.767 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 34.6 tt0 -151.05 133.57 15.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.947 0.403 . . . . 0.80000000000000004 110.221 -178.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.6 OUTLIER -111.65 130.55 55.73 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 109.301 -0.629 . . . . 1.25 109.301 174.084 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.687 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -116.75 103.31 10.21 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 109.165 -0.68 . . . . 0.63 109.165 176.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 136' ' ' ILE . 8.4 tp -110.01 120.41 61.0 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-O 121.184 0.516 . . . . 0.81000000000000005 110.934 -175.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -89.94 131.03 10.52 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.196 -0.762 . . . . 0.26000000000000001 111.196 174.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 133' ' ' THR . 7.5 mp -108.23 106.22 16.3 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-O 120.926 0.393 . . . . 1.2 111.055 -176.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.066 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 81.4 m -109.0 96.6 6.43 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.314 -0.857 . . . . 0.32000000000000001 109.478 173.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.674 HG22 ' SG ' ' A' ' 58' ' ' CYS . 19.5 pt -112.37 131.05 64.94 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 C-N-CA 120.469 -0.492 . . . . 0.97999999999999998 110.918 -176.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -77.83 105.84 9.27 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.377 -0.601 . . . . 1.52 109.377 -177.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.743 HD23 HG21 ' A' ' 55' ' ' ILE . 83.3 mt -106.52 160.63 25.56 Favored Pre-proline 0 C--O 1.22 -0.456 0 O-C-N 124.81 1.318 . . . . 1.28 109.971 -176.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.408 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 16.9 Cg_exo -68.97 -34.34 17.52 Favored 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 121.832 1.688 . . . . 0.73999999999999999 113.434 176.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 17' ' ' THR . 21.5 t -73.34 -57.88 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 112.316 0.487 . . . . 1.1200000000000001 112.316 -171.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.812 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.1 OUTLIER -96.19 -7.21 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 122.046 0.927 . . . . 1.3500000000000001 109.834 -176.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.56 -28.55 2.72 Favored Glycine 0 C--N 1.311 -0.817 0 CA-C-N 113.626 -1.624 . . . . 1.05 111.16 -171.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.677 ' O ' ' HB ' ' A' ' 129' ' ' VAL . 12.5 pt-20 -162.83 155.83 19.48 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.473 -0.936 . . . . 1.1599999999999999 108.473 178.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.471 ' HB2' HD12 ' A' ' 126' ' ' LEU . 31.2 t80 -143.04 122.19 12.92 Favored 'General case' 0 C--N 1.311 -1.087 0 N-CA-C 109.222 -0.659 . . . . 1.9099999999999999 109.222 177.226 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.712 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 87.8 m -115.06 102.09 9.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.139 0.495 . . . . 1.1899999999999999 111.763 -177.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.08 144.36 50.21 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.805 -0.634 . . . . 0.5 110.015 175.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -92.91 164.1 2.65 Favored 'Trans proline' 0 N--CA 1.448 -1.177 0 C-N-CA 121.885 1.723 . . . . 0.45000000000000001 113.162 178.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.894 HG23 HG23 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -156.22 158.53 3.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 107.734 -1.21 . . . . 0.44 107.734 178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.679 ' H ' HD12 ' A' ' 136' ' ' ILE . 83.0 p -140.59 152.58 45.59 Favored 'General case' 0 C--N 1.309 -1.157 0 C-N-CA 120.627 -0.429 . . . . 0.88 111.827 -172.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 22.7 t -140.84 102.69 4.34 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.553 -1.276 . . . . 0.95999999999999996 107.553 176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.767 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -114.6 143.99 44.11 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.1 -0.5 . . . . 1.76 109.986 -177.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -162.32 151.61 21.62 Favored Glycine 0 N--CA 1.439 -1.113 0 C-N-CA 120.595 -0.812 . . . . 0.5 112.017 -177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -106.3 130.36 54.16 Favored 'General case' 0 C--N 1.314 -0.959 0 N-CA-C 108.941 -0.763 . . . . 2.1000000000000001 108.941 178.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -143.89 174.1 4.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.24 -1.022 . . . . 0.76000000000000001 108.24 -178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 3.7 mppt? -65.6 163.82 15.47 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.242 0.544 . . . . 3.5299999999999998 112.154 -176.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.651 HD12 HD11 ' A' ' 114' ' ' ILE . 22.7 tp -55.49 131.23 70.8 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 114.903 -1.044 . . . . 1.23 111.076 -175.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD12 ' A' ' 144' ' ' LEU . 40.9 Cg_endo -67.11 163.07 35.5 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.093 2.529 . . . . 0.70999999999999996 112.869 -179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 24.2 m -57.03 118.31 4.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.813 -0.63 . . . . 1.71 110.47 177.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.598 ' HB2' ' H ' ' A' ' 151' ' ' PHE . 8.6 p90 -124.02 -22.45 4.83 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.158 -0.474 . . . . 2.6400000000000001 112.03 -172.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.438 ' HB2' ' HD2' ' A' ' 150' ' ' PHE . 35.1 mmtp 57.19 29.23 16.33 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.62 0.247 . . . . 3.7200000000000002 111.311 178.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.8 t70 73.33 15.03 4.38 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 123.774 0.83 . . . . 4.2800000000000002 111.238 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 94.1 m-85 -102.23 -48.82 4.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.769 -0.65 . . . . 2.8599999999999999 110.424 177.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.598 ' H ' ' HB2' ' A' ' 147' ' ' PHE . 96.2 m-85 . . . . . 0 C--O 1.247 0.949 0 O-C-N 124.931 1.394 . . . . 3.96 109.819 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptm . . . . . 0 N--CA 1.48 1.07 0 N-CA-C 110.388 -0.227 . . . . 12.109999999999999 110.388 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 58.53 -163.51 0.21 Allowed 'General case' 0 C--O 1.234 0.279 0 O-C-N 123.888 0.743 . . . . 9.0199999999999996 112.087 175.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.642 ' O ' ' HA ' ' A' ' 7' ' ' LYS . 34.6 t -91.44 154.88 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.727 -0.67 . . . . 6.8300000000000001 109.782 177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -90.92 158.42 16.76 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.314 -0.624 . . . . 8.5500000000000007 109.314 176.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 mp 69.84 -66.35 0.27 Allowed 'General case' 0 N--CA 1.47 0.54 0 O-C-N 123.641 0.588 . . . . 10.470000000000001 111.942 -179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -91.01 -25.15 19.84 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.31 -0.244 . . . . 11.69 111.245 -176.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.642 ' HA ' ' O ' ' A' ' 3' ' ' SER . 68.1 mttm 64.82 5.35 2.79 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.907 0.706 . . . . 11.42 112.907 176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 58.97 27.19 15.98 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.45 0.643 . . . . 11.58 110.325 -173.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 53.1 tttm -84.96 -11.48 55.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.37 -0.832 . . . . 15.74 110.661 -177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -137.15 140.55 41.91 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.226 -0.443 . . . . 12.69 110.137 -177.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -78.74 94.16 5.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.109 0.48 . . . . 13.85 110.3 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 32.5 m -90.78 149.75 3.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.818 -0.628 . . . . 8.8699999999999992 111.196 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -127.31 -26.41 3.07 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.726 -0.67 . . . . 8.9100000000000001 110.25 176.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -84.38 -15.9 44.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 8.5999999999999996 110.263 178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.4 mtpm? -109.59 -176.39 3.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.89 -0.596 . . . . 9.0399999999999991 109.642 178.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 16' ' ' LEU . 1.7 pt? -136.57 91.56 2.67 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.182 0.515 . . . . 5.5800000000000001 110.339 178.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 m -74.42 84.75 1.98 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.998 -0.547 . . . . 2.6899999999999999 109.986 176.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.55 ' HA ' ' CG2' ' A' ' 129' ' ' VAL . . . -175.24 176.59 2.02 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.67 -0.695 . . . . 1.6799999999999999 110.598 178.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.691 HD11 ' HG3' ' A' ' 22' ' ' PRO . 0.2 OUTLIER -84.65 156.15 61.84 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 115.497 -0.774 . . . . 3.1899999999999999 110.373 -175.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -60.89 -64.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.696 2.264 . . . . 2.4199999999999999 112.844 -177.396 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 24.0 tptm -154.52 102.5 2.37 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.104 0.478 . . . . 6.3799999999999999 110.776 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.715 ' HB3' ' HG3' ' A' ' 50' ' ' PRO . 98.6 Cg_endo -93.68 82.01 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.399 2.733 . . . . 2.77 112.2 178.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.62 ' HA ' HD23 ' A' ' 122' ' ' LEU . 8.4 pt-20 -122.17 119.01 30.02 Favored 'General case' 0 N--CA 1.425 -1.709 0 C-N-CA 119.453 -0.899 . . . . 3.3900000000000001 110.812 -169.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.717 ' H ' HD21 ' A' ' 122' ' ' LEU . . . 172.73 119.49 0.53 Allowed Glycine 0 N--CA 1.408 -3.174 0 CA-C-N 114.47 -1.241 . . . . 0.54000000000000004 111.939 170.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.696 ' HB2' HD11 ' A' ' 122' ' ' LEU . 17.3 m -171.1 32.33 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.895 0.855 . . . . 1.2 108.894 165.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.441 ' O ' ' HB2' ' A' ' 46' ' ' SER . 33.3 m -133.29 148.29 31.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 CA-C-N 114.863 -1.062 . . . . 0.93000000000000005 109.969 -173.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 t -169.76 -44.16 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.749 0 O-C-N 123.46 0.475 . . . . 0.47999999999999998 111.793 165.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 8.7 t70 -157.4 153.59 27.49 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.77 -0.372 . . . . 1.6899999999999999 111.183 -174.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 73.6 t -142.17 120.31 8.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.646 -0.502 . . . . 1.1399999999999999 109.646 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -113.96 112.15 22.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.356 -0.384 . . . . 1.8300000000000001 111.476 -176.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.879 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.2 tm? -72.87 139.02 46.62 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.963 -0.562 . . . . 0.93999999999999995 109.99 178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.54 ' H ' HD22 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -141.99 -100.16 0.13 Allowed 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 113.255 0.835 . . . . 1.3300000000000001 113.255 -176.305 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.52 ' H ' ' HG3' ' A' ' 32' ' ' LYS . 18.1 m-20 -93.22 178.71 5.65 Favored 'General case' 0 CA--C 1.493 -1.229 0 O-C-N 121.911 -0.493 . . . . 2.8500000000000001 109.809 -154.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 39' ' ' VAL . 48.8 t -152.97 -38.4 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-O 121.54 0.686 . . . . 3.2599999999999998 110.455 -174.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.512 ' HB3' ' O ' ' A' ' 34' ' ' VAL . 4.9 t30 71.59 -75.04 0.08 Allowed 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.142 -1.39 . . . . 3.1600000000000001 108.617 -174.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 174.21 13.77 0.0 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 O-C-N 123.847 0.717 . . . . 5.46 111.16 176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -137.46 -25.54 1.02 Allowed 'General case' 0 CA--C 1.504 -0.789 0 CA-C-O 121.408 0.623 . . . . 1.9199999999999999 109.833 -173.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.579 ' HA ' ' HB2' ' A' ' 98' ' ' TYR . 6.3 t -166.94 128.88 1.7 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.235 -0.893 . . . . 0.93999999999999995 111.57 -175.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.772 HG22 HG22 ' A' ' 34' ' ' VAL . 24.2 t -77.65 156.1 5.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 108.566 -0.901 . . . . 0.85999999999999999 108.566 178.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.899 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 45.3 mt-10 -137.17 145.64 43.99 Favored 'General case' 0 N--CA 1.437 -1.101 0 C-N-CA 119.516 -0.874 . . . . 1.1899999999999999 109.368 -173.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.936 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 5.7 p90 -143.11 141.53 31.25 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 119.306 -0.958 . . . . 3.73 112.575 176.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.418 ' N ' HG12 ' A' ' 94' ' ' VAL . 1.1 tm? -82.45 110.88 17.97 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.425 -0.954 . . . . 0.81000000000000005 108.425 -178.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.702 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -91.5 100.33 13.11 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.016 -0.735 . . . . 0.41999999999999998 109.016 177.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . 23.8 ttmm -83.58 126.0 32.37 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-O 121.626 0.727 . . . . 2.6299999999999999 109.109 -176.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.622 HG13 ' CA ' ' A' ' 25' ' ' SER . 37.4 t -109.51 144.95 16.83 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 114.725 -1.125 . . . . 0.81999999999999995 110.481 -173.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.456 ' HB3' ' CG ' ' A' ' 87' ' ' MET . 14.7 m -128.85 97.4 4.64 Favored 'General case' 0 N--CA 1.428 -1.55 0 N-CA-C 108.576 -0.898 . . . . 0.71999999999999997 108.576 165.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.681 ' HA ' ' C ' ' A' ' 24' ' ' GLY . 0.3 OUTLIER -86.96 130.69 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 CA-C-O 121.676 0.751 . . . . 1.1399999999999999 111.173 -176.14 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.601 ' HB ' ' O ' ' A' ' 23' ' ' GLU . 32.1 m -116.88 114.99 24.66 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.344 -1.298 . . . . 0.40999999999999998 109.447 -173.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.75 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 1.3 t30 -90.76 133.21 32.85 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 108.108 -1.071 . . . . 1.48 108.108 175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.715 ' HG3' ' HB3' ' A' ' 22' ' ' PRO . 31.3 Cg_endo -90.9 8.29 3.37 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.103 2.536 . . . . 0.72999999999999998 114.169 -174.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CE2' ' HG2' ' A' ' 127' ' ' PRO . 49.2 t80 -119.0 139.14 52.19 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.949 -0.76 . . . . 2.0800000000000001 108.949 -175.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 85' ' ' LYS . 10.7 p -79.13 37.81 0.33 Allowed 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.659 0.614 . . . . 1.51 112.659 -164.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -146.25 130.58 17.61 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.271 -0.422 . . . . 1.6699999999999999 110.056 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 6.7 m -43.5 100.76 0.02 OUTLIER 'General case' 0 C--O 1.21 -1.012 0 C-N-CA 124.116 0.966 . . . . 1.3899999999999999 112.719 172.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.997 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.8 pt -75.55 171.97 10.49 Favored Pre-proline 0 C--O 1.213 -0.861 0 N-CA-C 108.431 -0.951 . . . . 1.03 108.431 -176.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 8.0 Cg_endo -87.98 -59.25 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 121.498 1.465 . . . . 0.37 114.026 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.883 ' HA ' ' H ' ' A' ' 80' ' ' GLY . 80.0 mt -137.38 155.47 31.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 112.669 0.618 . . . . 1.23 112.669 -170.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.61 ' HB3' HG22 ' A' ' 124' ' ' ILE . 25.6 p -138.0 -178.99 5.51 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 121.731 0.777 . . . . 1.1499999999999999 111.211 179.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.083 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.2 tt0 -141.78 115.5 9.12 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 113.99 -1.459 . . . . 1.3600000000000001 109.982 178.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.709 HG22 HD11 ' A' ' 120' ' ' ILE . 0.2 OUTLIER -96.1 109.93 23.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-N 113.697 -1.592 . . . . 1.05 109.951 173.542 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.615 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 8.5 m -110.97 102.58 11.05 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 113.87 -1.514 . . . . 0.82999999999999996 108.586 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.791 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 3.8 p90 -109.79 122.33 47.25 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-O 121.164 0.506 . . . . 0.40000000000000002 109.733 -168.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.79 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 93.9 m -121.03 104.91 10.15 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.511 -0.768 . . . . 0.38 109.4 178.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.534 ' CE1' HD23 ' A' ' 118' ' ' LEU . 98.9 m-85 -98.14 140.99 31.63 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-N 115.952 -0.567 . . . . 0.95999999999999996 111.148 -174.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 m170 -132.4 145.23 51.07 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 107.636 -1.246 . . . . 1.29 107.636 174.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.79 ' CB ' HD22 ' A' ' 104' ' ' LEU . 46.9 t -110.75 -98.03 0.41 Allowed 'General case' 0 C--N 1.319 -0.741 0 C-N-CA 119.317 -0.953 . . . . 1.27 111.062 172.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.95 -59.75 4.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.386 -0.598 . . . . 0.35999999999999999 109.386 -173.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.87 18.05 0.1 Allowed Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 109.478 -1.449 . . . . 0.39000000000000001 109.478 165.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 69' ' ' ARG . 0.0 OUTLIER -111.04 -166.32 1.07 Allowed 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.119 -0.697 . . . . 1.97 109.119 -177.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -108.16 98.49 8.03 Favored 'General case' 0 N--CA 1.437 -1.101 0 CA-C-O 121.919 0.866 . . . . 2.6099999999999999 109.689 -170.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.9 mm -64.57 -41.6 92.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 113.976 -1.465 . . . . 0.40000000000000002 111.276 -177.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 164.75 38.25 Favored Glycine 0 N--CA 1.444 -0.778 0 C-N-CA 120.217 -0.992 . . . . 0.48999999999999999 111.266 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.791 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -167.38 156.84 10.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.482 0.641 . . . . 1.8100000000000001 110.991 172.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 165.27 160.77 13.02 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 110.722 -0.951 . . . . 0.42999999999999999 110.722 176.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 3.7 ptmm? -136.95 130.74 32.02 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.968 0.414 . . . . 1.72 110.0 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 71.0 mt -134.47 120.13 14.51 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.956 -0.565 . . . . 0.72999999999999998 110.375 -174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_exo -66.87 115.34 3.54 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.328 2.019 . . . . 0.56999999999999995 110.537 172.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -124.12 143.35 42.33 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 108.698 -0.852 . . . . 0.79000000000000004 108.698 -176.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_endo -51.86 90.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.804 2.336 . . . . 0.57999999999999996 112.16 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.883 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -81.99 24.66 4.49 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 114.887 -1.051 . . . . 0.40000000000000002 112.585 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.997 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 70.7 p -73.81 117.73 15.93 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 109.438 -0.579 . . . . 0.62 109.438 -178.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.659 HD21 HD22 ' A' ' 49' ' ' ASN . 1.2 pt? -149.41 -171.33 3.86 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 118.096 -1.442 . . . . 1.1000000000000001 114.264 -163.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.576 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 60.5 mttm -44.77 -96.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 114.912 -1.04 . . . . 1.8400000000000001 113.54 -172.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . 175.5 105.3 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 N-CA-C 108.059 -1.089 . . . . 0.98999999999999999 108.059 -178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.75 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 13.9 ptpt 41.77 50.44 4.0 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 124.339 1.024 . . . . 1.8400000000000001 110.842 -170.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 83' ' ' LYS . 3.5 t0 -143.63 179.93 6.83 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 110.122 -170.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.456 ' CG ' ' HB3' ' A' ' 46' ' ' SER . 54.3 ttp -107.74 119.13 38.58 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.609 -0.723 . . . . 1.3500000000000001 110.63 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.6 HG22 HG13 ' A' ' 47' ' ' VAL . 5.1 t -106.27 142.82 35.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.05 -0.523 . . . . 0.77000000000000002 109.633 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.32 123.77 30.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.549 0.69 . . . . 0.47999999999999998 110.608 178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.412 HD23 ' N ' ' A' ' 91' ' ' ASP . 9.0 tt -124.61 160.73 27.78 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.897 -1.149 . . . . 0.77000000000000002 107.897 -178.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.412 ' N ' HD23 ' A' ' 90' ' ' LEU . 11.0 m-20 -134.05 122.37 22.88 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 121.627 -0.67 . . . . 1.8100000000000001 111.407 -177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.702 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 32.8 mm -92.56 143.27 26.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.269 -0.878 . . . . 0.65000000000000002 109.644 176.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' HG23 ' A' ' 92' ' ' ILE . 75.8 Cg_exo -51.91 -172.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 122.924 2.416 . . . . 1.0700000000000001 113.266 173.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.936 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 7.1 m -114.33 92.15 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.947 0 CA-C-N 115.72 -0.673 . . . . 0.46000000000000002 110.549 -165.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.423 ' O ' HG13 ' A' ' 95' ' ' VAL . 4.7 p -125.76 102.51 10.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 115.144 1.535 . . . . 0.47999999999999998 115.144 -161.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.659 HG21 ' HG ' ' A' ' 101' ' ' LEU . 2.5 p -152.24 102.74 2.78 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 116.157 -0.474 . . . . 1.0700000000000001 111.045 163.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 74.1 Cg_exo -48.89 131.61 25.42 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 121.721 1.614 . . . . 0.47999999999999998 111.398 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.579 ' HB2' ' HA ' ' A' ' 38' ' ' SER . 4.7 t80 -49.43 -35.0 17.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.734 -0.666 . . . . 1.3100000000000001 111.081 -175.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 12.1 t -62.92 -30.19 71.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.144 -0.48 . . . . 1.2 112.237 -177.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.5 mm -76.78 -54.27 13.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 O-C-N 121.749 -0.594 . . . . 0.51000000000000001 110.686 -173.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.053 HD23 HD21 ' A' ' 104' ' ' LEU . 36.6 mt -53.84 -26.91 26.64 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.439 0.638 . . . . 1.0 110.518 170.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' HB3' ' O ' ' A' ' 99' ' ' SER . 59.0 t80 -65.1 -41.45 94.95 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 114.466 -1.243 . . . . 0.95999999999999996 108.877 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.492 ' HA ' HH21 ' A' ' 106' ' ' ARG . 24.8 m-80 -74.27 -57.88 3.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.001 -0.545 . . . . 0.81999999999999995 112.263 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.053 HD21 HD23 ' A' ' 101' ' ' LEU . 2.1 pp -56.91 -49.66 74.91 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 113.23 0.826 . . . . 0.65000000000000002 113.23 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.538 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -64.16 -25.7 68.2 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.883 0.849 . . . . 0.42999999999999999 110.113 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.492 HH21 ' HA ' ' A' ' 103' ' ' ASN . 6.6 ttp180 -69.62 -50.77 41.19 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 114.655 -1.157 . . . . 1.8100000000000001 110.511 174.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.563 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 13.6 t70 -81.74 -54.83 5.05 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 121.78 0.8 . . . . 0.80000000000000004 111.94 -175.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HA ' ' A' ' 114' ' ' ILE . 3.3 t -84.51 -27.67 6.92 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 O-C-N 121.594 -0.692 . . . . 0.88 109.964 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.775 ' HA3' HD21 ' A' ' 144' ' ' LEU . . . -73.01 -19.28 79.54 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.308 -0.948 . . . . 0.38 111.457 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.563 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -51.86 -44.89 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 106.794 -1.558 . . . . 1.0900000000000001 106.794 166.23 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 4.5 m-20 -69.77 -88.91 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.529 -0.76 . . . . 1.8700000000000001 110.025 161.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.817 ' O ' ' HG ' ' A' ' 144' ' ' LEU . 6.1 p-90 176.91 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.691 0 O-C-N 123.687 0.617 . . . . 1.1699999999999999 111.715 171.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -95.06 129.76 42.02 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 122.304 -0.248 . . . . 2.1499999999999999 110.581 -174.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.695 HD11 HD23 ' A' ' 144' ' ' LEU . 3.0 mp -117.7 159.19 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 120.834 0.35 . . . . 0.39000000000000001 110.415 -171.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.655 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 9.3 p-10 -102.96 153.34 20.32 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.982 -0.377 . . . . 2.1099999999999999 109.982 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.64 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.8 m-85 -140.09 165.91 26.08 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.869 -0.789 . . . . 0.62 108.869 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.644 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 35.4 tt0 -156.16 131.98 9.74 Favored 'General case' 0 CA--C 1.517 -0.303 0 N-CA-C 110.007 -0.368 . . . . 0.80000000000000004 110.007 176.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.649 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -103.69 123.85 47.78 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 109.006 -0.739 . . . . 1.25 109.006 172.776 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.79 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 8.4 tp60 -108.28 99.32 8.74 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.672 -0.862 . . . . 0.63 108.672 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.709 HD11 HG22 ' A' ' 60' ' ' ILE . 5.3 tp -106.58 119.36 55.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-O 121.259 0.552 . . . . 0.81000000000000005 110.834 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -87.53 127.05 8.3 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 110.879 -0.888 . . . . 0.26000000000000001 110.879 175.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.717 HD21 ' H ' ' A' ' 24' ' ' GLY . 0.4 OUTLIER -98.42 104.32 16.35 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 122.457 0.303 . . . . 1.2 111.335 -174.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.083 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 57.9 m -109.83 95.12 5.4 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.044 -0.526 . . . . 0.32000000000000001 109.584 172.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.655 HD11 ' HB2' ' A' ' 22' ' ' PRO . 11.5 pt -112.75 128.61 69.36 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 120.234 -0.586 . . . . 0.97999999999999998 110.28 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.854 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 22.7 t70 -81.88 106.02 13.47 Favored 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 108.796 -0.816 . . . . 1.52 108.796 -175.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.971 HD23 HG21 ' A' ' 55' ' ' ILE . 29.1 mt -104.82 176.35 1.78 Allowed Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 114.522 -1.217 . . . . 1.28 109.486 -174.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' A' ' 51' ' ' TYR . 9.9 Cg_exo -76.18 -41.93 0.44 Allowed 'Trans proline' 0 CA--C 1.535 0.573 0 C-N-CA 121.762 1.642 . . . . 0.73999999999999999 113.206 172.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 59.6 t -59.62 -58.93 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.57 0 N-CA-C 113.06 0.763 . . . . 1.1200000000000001 113.06 -168.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.55 ' CG2' ' HA ' ' A' ' 18' ' ' ALA . 2.4 t -109.8 -8.5 11.43 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.579 0 CA-C-O 122.894 1.33 . . . . 1.3500000000000001 108.517 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.683 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 88.38 -143.24 17.8 Favored Glycine 0 N--CA 1.426 -2.0 0 CA-C-N 112.413 -2.176 . . . . 1.05 108.132 -164.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.854 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 11.0 pt-20 -60.74 128.9 38.84 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.111 0.482 . . . . 1.1599999999999999 110.02 174.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 123' ' ' THR . 15.9 t80 -124.31 145.33 49.48 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 108.826 -0.805 . . . . 1.9099999999999999 108.826 175.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.717 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 63.1 m -121.86 109.42 14.63 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.917 0.389 . . . . 1.1899999999999999 112.042 -173.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.505 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.2 pp -127.33 144.04 49.34 Favored Pre-proline 0 C--N 1.326 -0.455 0 N-CA-C 109.021 -0.733 . . . . 0.5 109.021 171.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -93.31 162.45 2.48 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.863 1.709 . . . . 0.45000000000000001 113.341 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -157.14 167.18 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 107.935 -1.135 . . . . 0.44 107.935 175.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.8 OUTLIER -133.07 148.67 52.19 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.791 -0.364 . . . . 0.88 111.258 -169.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 25.1 t -138.34 103.0 4.79 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 107.683 -1.228 . . . . 0.95999999999999996 107.683 172.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.644 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 14.4 ptmt -126.88 156.25 41.7 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.048 -0.524 . . . . 1.76 111.184 -171.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -167.92 150.78 17.29 Favored Glycine 0 N--CA 1.437 -1.293 0 C-N-CA 120.594 -0.812 . . . . 0.5 111.634 175.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.5 mt-10 -98.71 124.88 43.82 Favored 'General case' 0 C--N 1.315 -0.894 0 N-CA-C 108.741 -0.837 . . . . 2.1000000000000001 108.741 175.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -141.24 165.6 18.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.07 -1.085 . . . . 0.76000000000000001 108.07 -173.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 7.6 ptpp? -67.45 178.2 1.67 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.496 0.665 . . . . 3.5299999999999998 112.289 -171.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.817 ' HG ' ' O ' ' A' ' 112' ' ' TRP . 5.9 mt -54.05 131.08 59.23 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 114.743 -1.117 . . . . 1.23 111.231 -178.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.483 ' O ' ' HD1' ' A' ' 147' ' ' PHE . 32.9 Cg_endo -63.72 173.52 4.55 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.16 2.573 . . . . 0.70999999999999996 112.021 178.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.1 m -49.76 98.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 120.927 0.394 . . . . 1.71 111.298 179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.483 ' HD1' ' O ' ' A' ' 145' ' ' PRO . 16.0 p90 -124.21 149.28 46.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.194 -0.457 . . . . 2.6400000000000001 110.501 -176.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 37.8 ttmt -172.8 76.5 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.615 . . . . 3.7200000000000002 109.589 175.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 69.27 4.8 4.78 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.587 -0.733 . . . . 4.2800000000000002 111.355 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -86.34 -38.32 17.58 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.847 -0.798 . . . . 2.8599999999999999 108.847 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 2.7 p90 . . . . . 0 C--O 1.248 1.022 0 CA-C-N 114.531 -1.213 . . . . 3.96 108.821 174.774 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 120.815 0.341 . . . . 12.109999999999999 110.161 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.949 ' HA ' ' HB2' ' A' ' 6' ' ' ASP . . . -77.84 0.22 24.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.236 -0.438 . . . . 9.0199999999999996 112.03 -175.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.722 ' HA ' ' HB3' ' A' ' 18' ' ' ALA . 3.9 p -60.28 -53.78 53.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.156 -0.475 . . . . 6.8300000000000001 111.04 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.0 tp -151.5 -29.6 0.18 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.545 -0.752 . . . . 8.5500000000000007 110.551 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 97.7 mt -84.37 19.42 1.91 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.295 -0.412 . . . . 10.470000000000001 111.771 -176.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.949 ' HB2' ' HA ' ' A' ' 2' ' ' ALA . 25.9 t70 -90.86 -37.74 13.39 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.096 0.474 . . . . 11.69 110.576 178.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.81 176.18 12.79 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.862 -0.608 . . . . 11.42 110.156 -178.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . 69.2 -63.38 0.37 Allowed 'General case' 0 N--CA 1.464 0.252 0 O-C-N 123.831 0.707 . . . . 11.58 111.205 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp 65.79 15.24 9.97 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 122.995 0.518 . . . . 15.74 110.965 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -102.21 134.91 44.71 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.687 -0.688 . . . . 12.69 109.757 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -78.96 78.13 5.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.959 0.409 . . . . 13.85 110.308 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 41.8 t -65.62 -68.42 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 8.8699999999999992 110.722 -179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -164.33 31.65 0.07 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.935 -0.575 . . . . 8.9100000000000001 110.236 -179.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.447 ' HB3' ' HG3' ' A' ' 20' ' ' PRO . 24.1 m-20 61.72 21.14 11.95 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 115.715 -0.675 . . . . 8.5999999999999996 110.991 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -145.78 142.63 29.07 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.812 -0.631 . . . . 9.0399999999999991 109.772 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 35.4 tp -175.01 -57.12 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.149 -0.685 . . . . 5.5800000000000001 109.149 177.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 m -112.96 -48.07 3.0 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.858 -0.61 . . . . 2.6899999999999999 110.237 176.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.731 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -141.36 -164.59 1.79 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.282 -0.417 . . . . 1.6799999999999999 111.196 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.642 HG21 ' HG ' ' A' ' 126' ' ' LEU . 2.4 pp -93.8 168.28 12.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.069 -0.514 . . . . 3.1899999999999999 111.084 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.654 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 17.3 Cg_exo -66.93 -89.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 122.856 2.371 . . . . 2.4199999999999999 113.938 -176.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HB3' ' HD3' ' A' ' 22' ' ' PRO . 64.5 tttp 173.86 -53.2 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 112.416 0.525 . . . . 6.3799999999999999 112.416 -171.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.654 ' HD2' ' HB2' ' A' ' 20' ' ' PRO . 86.9 Cg_endo -78.25 65.08 8.48 Favored 'Trans proline' 0 C--N 1.354 0.85 0 C-N-CA 122.005 1.803 . . . . 2.77 113.298 -175.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.481 ' CG ' ' HB3' ' A' ' 50' ' ' PRO . 5.6 mp0 -125.01 132.26 53.27 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 104.61 -2.367 . . . . 3.3900000000000001 104.61 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.75 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -112.14 -172.85 19.1 Favored Glycine 0 C--O 1.22 -0.753 0 C-N-CA 118.578 -1.772 . . . . 0.54000000000000004 116.094 -159.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.649 ' O ' HG13 ' A' ' 45' ' ' VAL . 96.2 p -168.99 37.26 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 124.623 1.169 . . . . 1.2 107.979 174.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.44 ' O ' ' HB2' ' A' ' 46' ' ' SER . 4.5 m -134.02 151.22 32.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 114.512 -1.222 . . . . 0.93000000000000005 110.342 -169.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -167.58 -44.33 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.757 0 O-C-N 123.416 0.447 . . . . 0.47999999999999998 111.96 168.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -160.88 164.08 31.52 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 118.324 0.511 . . . . 1.6899999999999999 111.313 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.4 t -143.07 135.62 24.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 109.284 -0.635 . . . . 1.1399999999999999 109.284 174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -129.0 135.64 49.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.648 0.261 . . . . 1.8300000000000001 111.249 -169.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.6 tm? -101.28 139.43 36.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.593 -0.276 . . . . 0.93999999999999995 111.371 -172.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.473 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -144.34 -90.81 0.11 Allowed 'General case' 0 C--O 1.219 -0.523 0 N-CA-C 114.08 1.141 . . . . 1.3300000000000001 114.08 177.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.841 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -89.89 179.52 5.96 Favored 'General case' 0 C--O 1.204 -1.334 0 O-C-N 121.587 -0.696 . . . . 2.8500000000000001 111.404 -155.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.851 ' HA ' ' O ' ' A' ' 38' ' ' SER . 6.2 p -168.16 -43.19 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.237 0.401 0 N-CA-C 112.164 0.431 . . . . 3.2599999999999998 112.164 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 67.1 -81.8 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.365 -0.834 . . . . 3.1600000000000001 109.183 -170.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -171.12 13.26 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.652 -0.704 . . . . 5.46 110.178 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 98' ' ' TYR . 8.7 p-10 -132.95 -42.3 0.9 Allowed 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.321 -0.854 . . . . 1.9199999999999999 110.257 -172.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.851 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 10.8 t -154.83 117.68 4.37 Favored 'General case' 0 N--CA 1.434 -1.232 0 CA-C-O 122.364 1.078 . . . . 0.93999999999999995 112.351 -169.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 1.039 HG21 HD12 ' A' ' 101' ' ' LEU . 46.2 t -73.11 155.42 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-N 113.636 -1.62 . . . . 0.85999999999999999 109.08 175.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.965 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 96.8 mt-10 -116.9 134.25 55.0 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 118.936 -1.106 . . . . 1.1899999999999999 112.383 -176.278 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.819 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.36 105.13 10.61 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 114.905 -1.043 . . . . 3.73 110.718 -175.836 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.502 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.6 OUTLIER -81.44 111.58 17.91 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.341 -0.985 . . . . 0.81000000000000005 108.341 178.559 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.693 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -97.98 117.34 32.1 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.551 0.691 . . . . 0.41999999999999998 110.904 -177.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.715 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -84.8 120.64 26.68 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.214 -0.903 . . . . 2.6299999999999999 108.711 177.112 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 25' ' ' SER . 54.2 t -111.11 137.46 43.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 115.643 -0.708 . . . . 0.81999999999999995 111.033 -176.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 88' ' ' THR . 5.8 m -130.5 100.07 5.21 Favored 'General case' 0 N--CA 1.439 -1.003 0 C-N-CA 120.771 -0.372 . . . . 0.71999999999999997 110.158 169.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.75 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 61.0 t -83.47 130.5 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.212 0 CA-C-N 115.938 -0.574 . . . . 1.1399999999999999 110.737 -176.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 4.3 m -104.74 122.69 46.23 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 120.743 -0.383 . . . . 0.40999999999999998 110.3 176.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.84 HD22 HD21 ' A' ' 82' ' ' LEU . 13.9 t-20 -88.17 133.52 36.79 Favored Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.86 1.35 . . . . 1.48 109.533 174.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.481 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . 74.5 Cg_endo -88.92 -17.02 2.15 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 123.105 2.537 . . . . 0.72999999999999998 115.746 -175.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.743 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 9.2 t80 -98.42 -100.46 0.21 Allowed 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 118.915 -1.114 . . . . 2.0800000000000001 111.386 -165.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.465 ' CB ' ' HD2' ' A' ' 85' ' ' LYS . 48.5 t -174.0 29.8 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.112 0 CA-C-O 121.551 0.691 . . . . 1.51 109.788 171.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 39.9 m80 -147.92 133.18 18.44 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.88 -0.6 . . . . 1.6699999999999999 110.823 -179.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 m -40.68 101.93 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.814 0 O-C-N 124.376 1.047 . . . . 1.3899999999999999 112.194 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.732 HG21 HD12 ' A' ' 126' ' ' LEU . 7.6 pt -78.93 121.73 83.74 Favored Pre-proline 0 CA--C 1.5 -0.953 0 C-N-CA 120.071 -0.652 . . . . 1.03 109.5 -175.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.945 ' HB2' HD12 ' A' ' 57' ' ' ILE . 28.1 Cg_endo -61.09 -56.5 0.88 Allowed 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.174 1.916 . . . . 0.37 113.51 -157.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.945 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.2 mp -135.02 156.27 39.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 C-N-CA 119.849 -0.74 . . . . 1.23 111.026 -173.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.646 ' HB3' HG22 ' A' ' 124' ' ' ILE . 28.7 p -145.04 178.43 8.05 Favored 'General case' 0 N--CA 1.437 -1.078 0 CA-C-O 122.386 1.089 . . . . 1.1499999999999999 111.856 -177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.137 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 36.9 tt0 -131.15 113.84 14.38 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 113.129 -1.85 . . . . 1.3600000000000001 109.046 176.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.532 HG22 HD11 ' A' ' 120' ' ' ILE . 0.8 OUTLIER -98.9 110.62 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 CA-C-O 122.515 1.15 . . . . 1.05 110.151 169.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 79.9 p -111.5 107.12 16.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.051 -1.886 . . . . 0.82999999999999996 108.228 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.544 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 7.1 p90 -113.92 132.6 55.88 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.6 0.714 . . . . 0.40000000000000002 110.222 -168.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 33.6 m -131.6 109.75 10.45 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.433 -1.258 . . . . 0.38 108.717 175.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.536 ' CE1' HD23 ' A' ' 118' ' ' LEU . 94.5 m-85 -97.7 143.08 28.71 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 109.691 -0.485 . . . . 0.95999999999999996 109.691 -175.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -129.64 143.37 50.79 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 108.903 -0.777 . . . . 1.29 108.903 179.668 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.811 ' CB ' HD22 ' A' ' 104' ' ' LEU . 0.3 OUTLIER -101.3 -114.79 0.19 Allowed 'General case' 0 N--CA 1.426 -1.633 0 CA-C-N 116.038 -0.528 . . . . 1.27 111.471 178.189 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 66' ' ' SER . . . -57.98 -52.49 65.29 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.573 -0.899 . . . . 0.35999999999999999 108.573 -174.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.74 20.74 0.15 Allowed Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.65 -1.38 . . . . 0.39000000000000001 109.65 164.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 6.2 ptp180 -117.86 -169.21 1.64 Allowed 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 109.232 -0.655 . . . . 1.97 109.232 -174.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -107.71 98.33 7.94 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-O 121.325 0.583 . . . . 2.6099999999999999 109.741 -166.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.776 ' HA ' HG21 ' A' ' 100' ' ' ILE . 0.9 OUTLIER -60.86 -42.96 94.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 114.404 -1.271 . . . . 0.40000000000000002 112.19 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.38 154.86 13.18 Favored Glycine 0 C--O 1.219 -0.789 0 C-N-CA 120.339 -0.934 . . . . 0.48999999999999999 111.686 -174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 17.5 ptmt -158.75 160.29 36.17 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 117.935 0.868 . . . . 1.8100000000000001 112.381 -174.003 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 174.02 168.39 34.88 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.643 -0.708 . . . . 0.42999999999999999 111.545 172.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -127.8 133.35 49.43 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 109.944 -0.391 . . . . 1.72 109.944 177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.51 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 73.8 mt -139.14 112.45 8.05 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.502 -0.317 . . . . 0.72999999999999998 110.884 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -71.79 113.53 3.68 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.117 1.878 . . . . 0.56999999999999995 110.938 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -133.92 144.97 53.9 Favored Pre-proline 0 C--N 1.326 -0.421 0 N-CA-C 110.47 -0.196 . . . . 0.79000000000000004 110.47 -171.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.72 94.09 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.751 2.3 . . . . 0.57999999999999996 112.677 175.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.427 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -84.52 21.19 11.22 Favored Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.808 -0.633 . . . . 0.40000000000000002 112.586 175.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.623 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 96.2 p -70.25 118.98 13.76 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.452 -0.573 . . . . 0.62 109.452 -177.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.84 HD21 HD22 ' A' ' 49' ' ' ASN . 1.9 pt? -141.98 -164.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 120.145 -0.622 . . . . 1.1000000000000001 112.393 -164.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 94.4 mttt -45.63 -89.81 0.0 OUTLIER 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.038 0.755 . . . . 1.8400000000000001 113.038 -178.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.662 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 156.5 111.27 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 107.437 -1.319 . . . . 0.98999999999999999 107.437 -168.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.743 ' HB3' ' O ' ' A' ' 51' ' ' TYR . 8.2 ptmm? 45.54 46.07 10.86 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 124.003 0.814 . . . . 1.8400000000000001 111.5 -179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.421 ' HB3' ' HD2' ' A' ' 83' ' ' LYS . 6.2 t70 -155.05 -172.01 4.03 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.331 -0.849 . . . . 0.64000000000000001 109.501 -173.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.445 ' SD ' ' HB3' ' A' ' 46' ' ' SER . 43.3 ttp -114.79 127.57 55.81 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.106 0.479 . . . . 1.3500000000000001 110.831 -172.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.536 ' HB ' ' HB2' ' A' ' 82' ' ' LEU . 5.2 t -109.53 142.41 40.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.472 -0.785 . . . . 0.77000000000000002 110.025 -177.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -89.58 108.41 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.38 0.61 . . . . 0.47999999999999998 110.949 178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.782 ' HG ' ' H ' ' A' ' 91' ' ' ASP . 1.7 tp -100.64 174.89 5.86 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.094 -0.957 . . . . 0.77000000000000002 109.131 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.782 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 21.4 t70 -141.71 121.6 13.6 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.769 -0.372 . . . . 1.8100000000000001 110.638 -173.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.693 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 24.5 mm -107.88 141.92 24.13 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.3 -0.409 . . . . 0.65000000000000002 110.324 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 92' ' ' ILE . 61.0 Cg_exo -54.62 -152.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.815 3.01 . . . . 1.0700000000000001 113.656 175.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.965 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.5 m -136.76 94.73 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.219 -0.543 0 N-CA-C 112.058 0.392 . . . . 0.46000000000000002 112.058 -165.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.1 p -125.38 106.78 16.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 113.841 1.052 . . . . 0.47999999999999998 113.841 -168.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.695 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 9.6 t -147.17 102.08 3.82 Favored Pre-proline 0 C--O 1.219 -0.52 0 CA-C-N 115.941 -0.572 . . . . 1.0700000000000001 110.318 168.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.73 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 31.9 Cg_exo -57.1 124.38 16.08 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 CA-C-N 120.495 1.212 . . . . 0.47999999999999998 110.757 169.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.512 ' HE1' ' HB3' ' A' ' 150' ' ' PHE . 1.0 OUTLIER -54.03 -29.91 45.6 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.019 -0.537 . . . . 1.3100000000000001 111.232 -175.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.522 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 18.1 m -53.0 -33.12 50.14 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.882 -0.599 . . . . 1.2 111.874 177.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.776 HG21 ' HA ' ' A' ' 71' ' ' ILE . 12.6 mm -77.65 -54.58 12.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.528 -0.305 . . . . 0.51000000000000001 111.28 -175.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 1.039 HD12 HG21 ' A' ' 39' ' ' VAL . 11.3 mt -51.03 -26.92 6.8 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-O 121.504 0.669 . . . . 1.0 110.848 172.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 99' ' ' SER . 54.8 t80 -63.99 -46.48 84.39 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.391 -1.277 . . . . 0.95999999999999996 109.056 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.547 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 26.1 m-80 -73.27 -55.88 5.83 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 112.492 0.553 . . . . 0.81999999999999995 112.492 -177.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.985 HD21 HD23 ' A' ' 101' ' ' LEU . 1.3 pp -55.47 -57.71 10.76 Favored 'General case' 0 CA--C 1.536 0.417 0 N-CA-C 112.897 0.702 . . . . 0.65000000000000002 112.897 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.528 ' H ' ' HG ' ' A' ' 104' ' ' LEU . . . -61.26 -24.4 66.35 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.673 0.749 . . . . 0.42999999999999999 110.806 -177.15 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.547 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 1.4 ttp180 -62.26 -49.62 74.98 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 114.781 -1.099 . . . . 1.8100000000000001 109.86 175.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.578 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 10.2 t70 -85.21 -53.29 5.34 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 122.373 1.082 . . . . 0.80000000000000004 111.129 -173.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.003 HG21 HG23 ' A' ' 114' ' ' ILE . 34.4 m -83.93 -30.86 7.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.225 -0.898 . . . . 0.88 110.849 -175.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.58 -20.22 78.59 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.215 -0.902 . . . . 0.38 111.343 174.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.578 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.0 OUTLIER -47.79 -45.59 11.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 106.386 -1.709 . . . . 1.0900000000000001 106.386 162.385 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 9.3 m-20 -72.84 -88.73 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 115.716 -0.674 . . . . 1.8700000000000001 110.359 162.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 4.0 p-90 -179.54 -45.8 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 122.719 0.408 . . . . 1.1699999999999999 111.852 176.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -94.36 137.92 32.94 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.018 0.437 . . . . 2.1499999999999999 111.47 -173.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 1.003 HG23 HG21 ' A' ' 108' ' ' VAL . 0.8 OUTLIER -118.36 148.07 21.44 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 109.237 -0.653 . . . . 0.39000000000000001 109.237 -179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 141' ' ' GLU . 4.3 p-10 -102.65 152.69 20.91 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.951 -1.129 . . . . 2.1099999999999999 107.951 174.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.457 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 87.9 m-85 -137.21 171.48 14.43 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.284 -0.636 . . . . 0.62 109.284 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.633 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 34.2 tt0 -160.2 121.33 3.07 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.364 0.415 . . . . 0.80000000000000004 110.139 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.3 OUTLIER -97.69 137.61 36.33 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.727 -0.471 . . . . 1.25 109.727 179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.768 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -121.37 103.17 8.76 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.884 -0.598 . . . . 0.63 109.51 176.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.532 HD11 HG22 ' A' ' 60' ' ' ILE . 6.8 tp -113.1 121.42 65.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-O 121.115 0.483 . . . . 0.81000000000000005 110.904 -177.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -92.17 126.48 8.53 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 111.333 -0.707 . . . . 0.26000000000000001 111.333 175.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.648 HD11 ' OG ' ' A' ' 25' ' ' SER . 4.5 mp -103.77 100.5 10.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.092 0.473 . . . . 1.2 111.393 -172.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.137 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 86.3 m -104.6 95.59 6.01 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.474 -0.784 . . . . 0.32000000000000001 109.478 174.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.646 HG22 ' HB3' ' A' ' 58' ' ' CYS . 2.3 pt -106.82 149.89 9.86 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.153 0 C-N-CA 120.716 -0.394 . . . . 0.97999999999999998 110.602 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.692 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 0.5 OUTLIER -91.12 105.35 17.75 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.52 108.492 179.222 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.732 HD12 HG21 ' A' ' 55' ' ' ILE . 0.6 OUTLIER -105.09 148.26 35.88 Favored Pre-proline 0 C--O 1.218 -0.567 0 O-C-N 124.684 1.24 . . . . 1.28 108.995 -178.524 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -60.45 -32.15 93.42 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 121.909 1.739 . . . . 0.73999999999999999 113.052 178.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 42.9 t -73.94 -58.09 5.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.455 0.539 . . . . 1.1200000000000001 112.455 -174.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.731 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -94.45 -6.81 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 CA-C-O 122.153 0.978 . . . . 1.3500000000000001 109.952 -175.434 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 75.82 -31.36 1.27 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 113.716 -1.584 . . . . 1.05 111.59 -171.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.475 ' H ' ' C ' ' A' ' 129' ' ' VAL . 12.2 pt-20 -171.05 137.15 1.14 Allowed 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.692 -0.855 . . . . 1.1599999999999999 108.692 -178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -143.14 139.55 30.44 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.372 -0.603 . . . . 1.9099999999999999 109.372 173.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.639 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 8.3 t -121.18 112.94 19.28 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 121.688 0.756 . . . . 1.1899999999999999 111.498 -176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.481 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.69 137.05 29.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.205 -0.907 . . . . 0.5 109.66 176.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.466 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 11.1 Cg_endo -91.47 163.64 3.58 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 122.237 1.958 . . . . 0.45000000000000001 112.758 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -158.8 166.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 108.468 -0.938 . . . . 0.44 108.468 178.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -136.32 147.17 47.31 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 121.223 -0.191 . . . . 0.88 110.802 -167.605 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.5 t -140.58 102.88 4.42 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.489 -0.93 . . . . 0.95999999999999996 108.489 176.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.633 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 13.6 ptmt -118.46 152.31 36.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.732 -0.667 . . . . 1.76 111.087 -174.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -171.11 158.67 30.25 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.6 -0.81 . . . . 0.5 112.231 178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 115' ' ' ASP . 22.4 mt-10 -102.6 132.79 48.45 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.409 -0.589 . . . . 2.1000000000000001 109.409 178.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.52 172.05 14.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.467 -0.568 . . . . 0.76000000000000001 109.467 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 4.0 mppt? -75.03 167.22 22.35 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.006 0.431 . . . . 3.5299999999999998 111.652 -173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.699 HD12 HD11 ' A' ' 114' ' ' ILE . 17.8 tp -57.1 132.77 80.48 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 115.676 -0.693 . . . . 1.23 111.124 -176.158 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.616 ' HD2' HD12 ' A' ' 144' ' ' LEU . 56.1 Cg_endo -70.64 172.8 12.8 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.611 2.207 . . . . 0.70999999999999996 112.221 177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 19.4 m -70.33 107.8 3.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.039 -0.528 . . . . 1.71 110.429 -179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 21.1 p90 -118.52 151.7 37.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.966 0.412 . . . . 2.6400000000000001 111.102 -176.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 150' ' ' PHE . 40.7 ttmt -172.85 102.62 0.14 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.264 -0.88 . . . . 3.7200000000000002 109.249 177.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.51 3.89 2.07 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 123.573 0.546 . . . . 4.2800000000000002 110.576 -175.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.512 ' HB3' ' HE1' ' A' ' 98' ' ' TYR . 21.7 m-85 -86.84 -35.19 19.19 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.917 -0.771 . . . . 2.8599999999999999 108.917 176.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.465 ' CD1' ' HA ' ' A' ' 106' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.999 0 CA-C-N 115.169 -0.923 . . . . 3.96 108.771 171.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mpp? . . . . . 0 N--CA 1.481 1.103 0 N-CA-C 110.406 -0.22 . . . . 12.109999999999999 110.406 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 66.85 -12.35 0.22 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 114.011 1.115 . . . . 9.0199999999999996 114.011 173.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.8 p -66.06 -65.85 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.1 0.476 . . . . 6.8300000000000001 111.625 -177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 4' ' ' LEU . 2.6 pt? -96.92 -0.21 47.98 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.04 -0.527 . . . . 8.5500000000000007 110.58 -179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 20.4 tp -105.72 29.25 6.75 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.371 0.605 . . . . 10.470000000000001 110.146 -175.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -86.79 -45.57 10.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.665 -0.698 . . . . 11.69 109.674 178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 57.35 67.22 1.0 Allowed 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.302 -0.863 . . . . 11.42 111.492 176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -101.17 143.74 30.9 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.393 -0.821 . . . . 11.58 110.213 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.409 ' HG3' ' OD1' ' A' ' 10' ' ' ASP . 18.6 ptpt -133.24 -31.09 1.27 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.453 -0.339 . . . . 15.74 111.087 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.409 ' OD1' ' HG3' ' A' ' 9' ' ' LYS . 0.8 OUTLIER -90.71 131.76 36.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.691 -0.231 . . . . 12.69 110.848 -178.732 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 70.91 -67.17 0.26 Allowed 'General case' 0 N--CA 1.468 0.448 0 O-C-N 124.069 0.856 . . . . 13.85 111.22 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 19.0 m -123.13 137.33 56.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.344 -0.389 . . . . 8.8699999999999992 110.585 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -118.98 -12.27 9.56 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.282 0.563 . . . . 8.9100000000000001 110.064 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -97.78 -79.63 0.46 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.537 -0.756 . . . . 8.5999999999999996 110.212 179.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.654 ' HG2' ' HG ' ' A' ' 16' ' ' LEU . 35.1 ttpt 68.32 -77.27 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 O-C-N 123.866 0.729 . . . . 9.0399999999999991 111.642 176.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.654 ' HG ' ' HG2' ' A' ' 15' ' ' LYS . 2.8 pp -163.03 163.55 25.93 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.137 -0.32 . . . . 5.5800000000000001 110.137 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.8 m -152.82 21.13 0.6 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.22 0.533 . . . . 2.6899999999999999 110.624 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.534 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -122.92 -103.22 0.39 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.487 -0.324 . . . . 1.6799999999999999 111.805 -177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.554 HG21 ' HG ' ' A' ' 126' ' ' LEU . 40.7 pt -147.01 170.5 7.66 Favored Pre-proline 0 N--CA 1.463 0.184 0 C-N-CA 122.145 0.178 . . . . 3.1899999999999999 110.898 -175.12 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 50' ' ' PRO . 31.7 Cg_exo -61.97 177.24 1.1 Allowed 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.856 2.371 . . . . 2.4199999999999999 111.839 169.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.669 ' HB2' ' HD3' ' A' ' 22' ' ' PRO . 57.5 mtpt -117.05 -55.25 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 113.606 0.965 . . . . 6.3799999999999999 113.606 -171.24 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.669 ' HD3' ' HB2' ' A' ' 21' ' ' LYS . 3.0 Cg_exo -77.85 74.65 5.14 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.018 1.812 . . . . 2.77 113.358 -177.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HB3' ' O ' ' A' ' 48' ' ' THR . 32.3 mt-10 -154.41 131.02 10.65 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 105.045 -2.206 . . . . 3.3900000000000001 105.045 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.665 ' H ' ' HB ' ' A' ' 48' ' ' THR . . . -127.62 -144.07 5.86 Favored Glycine 0 CA--C 1.505 -0.542 0 N-CA-C 118.348 2.099 . . . . 0.54000000000000004 118.348 -143.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.614 ' C ' HG13 ' A' ' 45' ' ' VAL . 39.4 m -178.99 34.31 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 112.618 -1.791 . . . . 1.2 107.525 -170.412 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG13 HG21 ' A' ' 120' ' ' ILE . 16.4 m -135.07 150.23 29.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 CA-C-N 114.84 -1.073 . . . . 0.93000000000000005 109.638 -176.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.481 ' HB ' ' HB3' ' A' ' 46' ' ' SER . 1.3 t -160.28 -51.66 0.05 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.988 -0.375 . . . . 0.47999999999999998 109.988 168.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.5 ' OD2' ' HB3' ' A' ' 44' ' ' LYS . 0.8 OUTLIER -158.54 150.14 21.07 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.294 0.568 . . . . 1.6899999999999999 112.101 179.8 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -132.13 127.8 58.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.3 -0.863 . . . . 1.1399999999999999 108.932 176.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -119.45 135.27 54.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.845 0.355 . . . . 1.8300000000000001 111.303 -169.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -97.33 127.16 43.06 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.109 -0.496 . . . . 0.93999999999999995 111.871 -171.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.489 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -129.72 -113.93 0.25 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.764 -0.653 . . . . 1.3300000000000001 109.679 166.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.82 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.3 p-10 172.2 176.07 0.09 Allowed 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 112.05 0.389 . . . . 2.8500000000000001 112.05 -172.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.541 HG13 ' O ' ' A' ' 34' ' ' VAL . 11.4 p -161.7 105.16 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-O 122.009 0.909 . . . . 3.2599999999999998 112.117 174.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 43.6 t30 59.15 -97.53 0.07 Allowed 'General case' 0 N--CA 1.439 -1.003 0 CA-C-N 115.149 -0.932 . . . . 3.1600000000000001 111.101 173.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -172.96 24.12 0.01 OUTLIER 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 122.383 1.087 . . . . 5.46 108.512 174.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -100.74 -35.51 9.43 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 113.41 -1.723 . . . . 1.9199999999999999 107.434 -174.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.676 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 23.0 t -157.86 179.82 8.84 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 112.648 -2.069 . . . . 0.93999999999999995 106.252 173.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.82 HG13 ' HA ' ' A' ' 33' ' ' ASP . 3.1 t -124.51 161.55 27.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.39 -0.967 . . . . 0.85999999999999999 108.39 166.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.91 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 82.0 mt-10 -114.06 131.93 56.2 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 119.878 -0.729 . . . . 1.1899999999999999 112.13 -170.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.791 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -117.87 103.82 10.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.855 -1.066 . . . . 3.73 109.443 179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.645 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.6 OUTLIER -72.73 109.18 6.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.081 -1.081 . . . . 0.81000000000000005 108.081 176.537 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.659 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -107.31 102.84 12.11 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.288 0.566 . . . . 0.41999999999999998 109.797 -179.144 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.5 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 18.0 ttpp -83.77 133.55 34.77 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 108.875 -0.787 . . . . 2.6299999999999999 108.875 177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.614 HG13 ' C ' ' A' ' 25' ' ' SER . 24.3 t -109.7 141.75 24.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.274 0 CA-C-N 114.806 -1.088 . . . . 0.81999999999999995 110.409 -172.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 88' ' ' THR . 1.8 p -120.1 100.52 7.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 C-N-CA 119.531 -0.868 . . . . 0.71999999999999997 109.373 168.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 77.1 t -81.15 112.46 19.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 N-CA-C 108.599 -0.889 . . . . 1.1399999999999999 108.599 -177.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 2.0 m -102.92 109.89 21.62 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.914 -1.143 . . . . 0.40999999999999998 107.914 179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.777 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 5.1 t30 -87.92 122.52 70.08 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 124.63 1.206 . . . . 1.48 109.85 -176.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.695 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 1.3 Cg_endo -85.34 8.93 4.33 Favored 'Trans proline' 0 N--CA 1.459 -0.551 0 C-N-CA 123.988 3.126 . . . . 0.72999999999999998 114.423 -171.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.704 ' O ' ' HB3' ' A' ' 85' ' ' LYS . 31.4 t80 -96.79 -114.03 0.14 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.116 -0.634 . . . . 2.0800000000000001 110.015 -179.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.442 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 18.9 p -168.74 18.05 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 111.811 0.3 . . . . 1.51 111.811 175.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.2 m80 -148.04 143.18 27.04 Favored 'General case' 0 CA--C 1.515 -0.399 0 N-CA-C 109.514 -0.55 . . . . 1.6699999999999999 109.514 -179.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 5.4 m -41.26 98.19 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.922 0 O-C-N 124.256 0.973 . . . . 1.3899999999999999 112.873 171.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.942 ' O ' ' HA ' ' A' ' 81' ' ' SER . 7.9 pt -74.63 170.54 14.71 Favored Pre-proline 0 C--O 1.21 -0.998 0 N-CA-C 107.685 -1.228 . . . . 1.03 107.685 -177.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.536 ' HB2' HG12 ' A' ' 57' ' ' ILE . 22.9 Cg_endo -91.25 -64.29 0.01 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.494 0 C-N-CA 120.89 1.06 . . . . 0.37 114.435 -178.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 79' ' ' PRO . 17.8 mm -126.4 161.33 32.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 C-N-CA 120.188 -0.605 . . . . 1.23 112.009 -166.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.655 ' HB3' HG22 ' A' ' 124' ' ' ILE . 29.8 p -152.04 175.63 12.35 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 122.43 1.11 . . . . 1.1499999999999999 112.318 177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.01 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 1.0 OUTLIER -136.55 114.24 11.12 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-N 113.006 -1.907 . . . . 1.3600000000000001 109.336 175.357 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -98.92 117.74 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 CA-C-N 114.894 -1.048 . . . . 1.05 111.61 174.1 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.657 ' HB3' ' HB3' ' A' ' 75' ' ' LYS . 1.1 p -115.09 109.63 18.33 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 113.625 -1.625 . . . . 0.82999999999999996 109.34 179.034 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.759 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 6.0 p90 -114.09 126.86 55.57 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.428 -0.351 . . . . 0.40000000000000002 110.13 -168.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.74 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 11.9 m -119.6 104.64 10.46 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.826 -0.625 . . . . 0.38 109.327 174.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 94.3 m-85 -97.75 136.04 38.66 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.957 -0.565 . . . . 0.95999999999999996 109.783 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.721 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -146.59 140.3 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.734 -0.469 . . . . 1.29 109.734 176.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.594 ' HB2' HD11 ' A' ' 71' ' ' ILE . 48.2 t -102.64 -96.12 0.3 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.603 -0.271 . . . . 1.27 111.588 -173.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -62.25 -59.06 5.58 Favored 'General case' 0 CA--C 1.506 -0.717 0 N-CA-C 108.546 -0.909 . . . . 0.35999999999999999 108.546 -177.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.11 16.92 0.18 Allowed Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 106.69 -2.564 . . . . 0.39000000000000001 106.69 163.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 104' ' ' LEU . 0.1 OUTLIER -105.76 163.25 12.85 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 112.809 -1.696 . . . . 1.97 108.834 -171.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -97.57 87.89 4.21 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.488 0.661 . . . . 2.6099999999999999 109.313 -161.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.958 ' HA ' HG21 ' A' ' 100' ' ' ILE . 14.8 mm -44.63 -43.66 2.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 113.867 -1.515 . . . . 0.40000000000000002 111.188 176.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 178.23 167.46 36.18 Favored Glycine 0 CA--C 1.503 -0.708 0 C-N-CA 119.9 -1.143 . . . . 0.48999999999999999 111.622 176.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.759 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.87 161.97 18.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.685 0.743 . . . . 1.8100000000000001 111.404 173.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 156.47 -178.88 32.72 Favored Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.804 -0.918 . . . . 0.42999999999999999 110.804 179.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 61' ' ' SER . 5.1 ptpp? -147.22 141.93 26.71 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.076 0.465 . . . . 1.72 111.2 179.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.403 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 92.0 mt -133.47 124.44 18.09 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.508 -0.769 . . . . 0.72999999999999998 110.182 -178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.7 111.34 3.22 Favored 'Trans proline' 0 N--CA 1.459 -0.51 0 C-N-CA 122.427 2.085 . . . . 0.56999999999999995 110.678 171.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -127.95 144.61 52.1 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.816 -0.439 . . . . 0.79000000000000004 109.816 -173.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.604 ' HA ' HD13 ' A' ' 57' ' ' ILE . 34.2 Cg_exo -62.44 90.53 0.12 Allowed 'Trans proline' 0 N--CA 1.463 -0.282 0 C-N-CA 122.146 1.897 . . . . 0.57999999999999996 112.112 175.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -83.51 35.09 2.85 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.99 -0.55 . . . . 0.40000000000000002 112.294 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.942 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 52.3 p -73.03 123.73 24.1 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.396 -0.594 . . . . 0.62 109.396 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.563 HD12 ' HB ' ' A' ' 88' ' ' THR . 1.0 OUTLIER -149.54 -159.78 1.08 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 118.727 -1.189 . . . . 1.1000000000000001 113.499 -164.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.496 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 86.4 mttt -60.6 -93.61 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.485 0.55 . . . . 1.8400000000000001 112.485 -174.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.91 110.32 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.517 0 N-CA-C 107.85 -1.167 . . . . 0.98999999999999999 107.85 -170.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 45.2 pttt 41.92 49.43 4.05 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 121.994 0.902 . . . . 1.8400000000000001 111.195 -175.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 48' ' ' THR . 3.3 t70 -153.3 -177.97 6.67 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 114.706 -1.134 . . . . 0.64000000000000001 110.118 -172.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 50.9 ttm -110.35 127.39 55.04 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.649 -0.705 . . . . 1.3500000000000001 109.793 -172.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.563 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -121.56 142.24 50.28 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 116.045 -0.525 . . . . 0.77000000000000002 111.151 -175.062 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.55 114.17 21.32 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.151 0.501 . . . . 0.47999999999999998 111.656 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.594 HD22 HG11 ' A' ' 45' ' ' VAL . 5.9 tt -117.96 171.33 8.15 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.533 -0.914 . . . . 0.77000000000000002 108.533 177.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -134.7 133.85 40.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 118.477 0.58 . . . . 1.8100000000000001 112.286 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.659 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 46.0 mm -114.06 113.14 46.78 Favored Pre-proline 0 C--N 1.326 -0.423 0 N-CA-C 108.6 -0.889 . . . . 0.65000000000000002 108.6 168.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.645 ' O ' HD22 ' A' ' 42' ' ' LEU . 45.3 Cg_exo -28.87 -102.48 0.0 OUTLIER 'Trans proline' 0 C--N 1.352 0.743 1 C-N-CA 125.725 4.283 . . . . 1.0700000000000001 115.415 -170.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.91 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -162.3 93.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 122.356 -0.215 . . . . 0.46000000000000002 110.701 -177.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.7 p -127.75 102.58 9.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 114.474 1.287 . . . . 0.47999999999999998 114.474 -168.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 101' ' ' LEU . 2.5 p -153.78 103.61 2.5 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 122.152 -0.343 . . . . 1.0700000000000001 111.49 159.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.72 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 94.2 Cg_exo -44.37 136.4 8.51 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.405 2.07 . . . . 0.47999999999999998 113.543 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.676 ' H ' ' HA ' ' A' ' 38' ' ' SER . 2.1 t80 -52.28 -37.84 56.64 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.691 -1.141 . . . . 1.3100000000000001 110.881 -176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.0 OUTLIER -63.29 -25.89 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.828 -0.624 . . . . 1.2 112.651 -176.047 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.958 HG21 ' HA ' ' A' ' 71' ' ' ILE . 16.4 mm -71.29 -54.76 16.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.694 0.759 . . . . 0.51000000000000001 110.659 -175.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.629 HD11 HG21 ' A' ' 96' ' ' VAL . 0.5 OUTLIER -54.21 -33.69 58.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 113.706 -1.588 . . . . 1.0 109.325 175.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.483 ' HB3' ' O ' ' A' ' 99' ' ' SER . 56.2 t80 -61.0 -39.85 91.27 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 113.29 -1.777 . . . . 0.95999999999999996 109.032 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.558 ' HB2' ' HD3' ' A' ' 69' ' ' ARG . 0.9 OUTLIER -74.98 -57.49 3.87 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.289 -0.414 . . . . 0.81999999999999995 111.321 178.045 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.634 ' HA ' HH11 ' A' ' 69' ' ' ARG . 3.0 pp -57.99 -50.71 72.45 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.488 0.922 . . . . 0.65000000000000002 113.488 -177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.556 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -67.28 -26.97 66.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 0.42999999999999999 110.521 -178.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.4 ttp180 -71.2 -51.71 23.21 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.422 -0.808 . . . . 1.8100000000000001 110.944 175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 35.9 t70 -81.38 -51.96 7.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.776 0.798 . . . . 0.80000000000000004 111.791 -174.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.709 ' HB ' HG13 ' A' ' 114' ' ' ILE . 2.5 t -91.01 -22.11 6.33 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 O-C-N 121.734 -0.604 . . . . 0.88 110.431 -176.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.556 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -73.24 -20.09 79.82 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.393 -0.908 . . . . 0.38 111.043 168.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.2 t -51.73 -48.52 37.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 106.635 -1.617 . . . . 1.0900000000000001 106.635 165.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 14.6 m-20 -69.78 -97.34 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 115.085 -0.962 . . . . 1.8700000000000001 110.345 163.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 3.2 p-90 -178.18 -52.69 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 112.554 0.576 . . . . 1.1699999999999999 112.554 175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -95.65 124.5 39.7 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.407 -0.361 . . . . 2.1499999999999999 111.447 -175.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.709 HG13 ' HB ' ' A' ' 108' ' ' VAL . 3.0 mp -117.69 155.76 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 120.734 0.302 . . . . 0.39000000000000001 110.218 -177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -96.0 154.55 17.18 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.638 -0.875 . . . . 2.1099999999999999 108.638 179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.58 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 60.8 m-85 -140.31 149.36 42.67 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.161 -1.052 . . . . 0.62 108.161 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.828 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 10.5 tt0 -146.29 139.39 25.7 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.369 -0.532 . . . . 0.80000000000000004 111.066 -178.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.644 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 10.2 tp -105.67 127.59 53.15 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 115.335 -0.848 . . . . 1.25 109.917 170.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.74 ' HB3' ' HB ' ' A' ' 63' ' ' THR . 0.1 OUTLIER -113.02 100.34 8.55 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.456 -0.942 . . . . 0.63 108.456 174.28 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.591 ' HA ' ' O ' ' A' ' 61' ' ' SER . 5.4 tp -112.88 122.34 66.85 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.072 0 CA-C-O 121.124 0.488 . . . . 0.81000000000000005 111.497 -171.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -92.62 128.48 9.43 Favored Glycine 0 N--CA 1.445 -0.75 0 N-CA-C 110.978 -0.849 . . . . 0.26000000000000001 110.978 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.643 HD21 ' HA2' ' A' ' 24' ' ' GLY . 2.2 mp -104.87 97.64 7.48 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.881 0.372 . . . . 1.2 111.273 -173.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.01 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 78.9 m -97.38 95.37 7.63 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 108.93 -0.767 . . . . 0.32000000000000001 108.93 171.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.655 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -111.86 147.57 15.64 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 C-N-CA 120.032 -0.667 . . . . 0.97999999999999998 110.013 -177.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.46 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 4.5 m-20 -87.99 105.88 17.76 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 109.374 -0.602 . . . . 1.52 109.374 -179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.639 HD21 HG12 ' A' ' 124' ' ' ILE . 1.5 mm? -103.37 162.11 21.03 Favored Pre-proline 0 C--O 1.22 -0.457 0 O-C-N 124.333 1.021 . . . . 1.28 109.611 -178.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -71.97 -29.83 14.55 Favored 'Trans proline' 0 CA--C 1.515 -0.472 0 C-N-CA 121.992 1.794 . . . . 0.73999999999999999 113.053 176.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.43 ' H ' HG22 ' A' ' 128' ' ' VAL . 0.1 OUTLIER -75.38 -57.87 5.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 113.372 0.879 . . . . 1.1200000000000001 113.372 -176.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.534 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -95.1 -3.35 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.976 0.893 . . . . 1.3500000000000001 109.857 -176.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 76.84 -36.48 1.44 Allowed Glycine 0 C--N 1.312 -0.757 0 CA-C-N 113.951 -1.477 . . . . 1.05 111.217 -171.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 11.7 pt-20 -174.3 140.09 0.64 Allowed 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 107.811 -1.181 . . . . 1.1599999999999999 107.811 176.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 16.2 t80 -140.98 146.2 36.99 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 120.83 -0.348 . . . . 1.9099999999999999 110.113 179.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.62 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 4.0 t -114.4 112.9 23.76 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.534 0.683 . . . . 1.1899999999999999 111.584 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.435 ' O ' HD12 ' A' ' 134' ' ' ILE . 2.2 pp -126.91 138.48 32.72 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.624 -0.716 . . . . 0.5 109.76 173.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -93.15 163.65 2.53 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.019 1.813 . . . . 0.45000000000000001 113.335 -179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -163.34 168.09 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.679 -0.86 . . . . 0.44 108.679 177.318 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.2 m -138.32 156.04 48.01 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.134 0.42 . . . . 0.88 112.134 -169.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.4 t -145.94 106.87 4.13 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.63 -0.878 . . . . 0.95999999999999996 108.63 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.828 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 9.1 ptmt -120.84 149.69 42.19 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.629 -0.259 . . . . 1.76 111.099 -175.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.66 146.61 11.52 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.634 -0.793 . . . . 0.5 112.403 -175.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -107.7 132.02 53.79 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.067 -0.567 . . . . 2.1000000000000001 110.797 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.56 172.0 2.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.805 -1.183 . . . . 0.76000000000000001 107.805 177.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.6 152.61 38.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.969 0.414 . . . . 3.5299999999999998 111.047 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.87 150.03 40.29 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 115.726 -0.67 . . . . 1.23 112.388 -177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.422 ' HG2' ' O ' ' A' ' 151' ' ' PHE . 35.9 Cg_endo -65.97 174.22 6.07 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 123.447 2.765 . . . . 0.70999999999999996 113.03 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.3 t -66.54 102.96 0.96 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.723 0.773 . . . . 1.71 110.957 -179.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 151' ' ' PHE . 29.8 p90 -79.1 26.09 0.27 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.368 -0.833 . . . . 2.6400000000000001 111.931 -177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp -79.09 81.95 5.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.364 -0.38 . . . . 3.7200000000000002 109.998 176.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.6 t70 77.23 -42.55 0.41 Allowed 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.782 0.833 . . . . 4.2800000000000002 110.98 -176.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.466 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 15.8 m-85 -65.04 -49.32 70.6 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.242 0.339 . . . . 2.8599999999999999 110.483 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.681 ' HA ' ' HA ' ' A' ' 147' ' ' PHE . 47.4 m-85 . . . . . 0 C--O 1.248 1.016 0 O-C-N 124.791 1.307 . . . . 3.96 110.266 -171.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.481 1.105 0 CA-C-O 120.804 0.335 . . . . 12.109999999999999 110.855 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -82.13 80.1 8.45 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.219 0.533 . . . . 9.0199999999999996 111.529 -175.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.408 ' HB3' HD22 ' A' ' 4' ' ' LEU . 29.2 t -117.84 -55.01 2.3 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.768 -0.827 . . . . 6.8300000000000001 108.768 172.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.675 HD12 ' HG3' ' A' ' 20' ' ' PRO . 1.3 mm? -104.59 11.58 34.05 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.184 -0.673 . . . . 8.5500000000000007 109.184 175.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.66 HD21 ' HA ' ' A' ' 51' ' ' TYR . 3.3 mm? 70.3 -67.87 0.22 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 115.15 -0.932 . . . . 10.470000000000001 110.596 -175.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.94 -161.89 1.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.143 -0.688 . . . . 11.69 109.143 178.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -154.87 101.44 2.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.94 0.4 . . . . 11.42 111.324 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.22 -103.57 0.33 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.205 -0.452 . . . . 11.58 109.839 173.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.74 132.06 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 110.21 -0.292 . . . . 15.74 110.21 175.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -179.56 25.33 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.526 -0.546 . . . . 12.69 109.526 175.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 61.96 100.11 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.1 -0.955 . . . . 13.85 112.141 -174.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.8 t -84.84 -32.53 7.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.932 -1.136 . . . . 8.8699999999999992 107.932 172.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 63.6 -82.62 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 114.446 -1.252 . . . . 8.9100000000000001 112.388 174.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -130.09 5.62 4.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.295 -0.412 . . . . 8.5999999999999996 110.714 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.758 ' HB3' ' HA ' ' A' ' 20' ' ' PRO . 46.6 mmtm -95.13 39.23 1.11 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.022 0.439 . . . . 9.0399999999999991 111.248 -173.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -68.67 -25.09 64.63 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.104 -0.498 . . . . 5.5800000000000001 110.232 178.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 m -128.33 149.4 50.53 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.675 -0.693 . . . . 2.6899999999999999 109.87 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.768 ' O ' HG13 ' A' ' 19' ' ' ILE . . . 66.62 35.43 5.32 Favored 'General case' 0 N--CA 1.463 0.205 0 O-C-N 123.726 0.641 . . . . 1.6799999999999999 111.251 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.768 HG13 ' O ' ' A' ' 18' ' ' ALA . 1.1 pp 66.21 157.52 0.13 Allowed Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 124.82 1.248 . . . . 3.1899999999999999 112.613 172.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.758 ' HA ' ' HB3' ' A' ' 15' ' ' LYS . 6.3 Cg_exo -77.06 -77.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.826 2.351 . . . . 2.4199999999999999 112.975 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 12.0 ptpt -142.0 116.39 6.73 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.183 0.516 . . . . 6.3799999999999999 110.887 179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.693 ' HG3' ' HD2' ' A' ' 132' ' ' PHE . 86.5 Cg_endo -100.98 48.71 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.973 3.115 . . . . 2.77 112.25 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.445 ' HA ' ' CD2' ' A' ' 122' ' ' LEU . 0.0 OUTLIER -97.96 114.86 27.09 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 121.648 0.737 . . . . 3.3900000000000001 111.253 -168.513 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.773 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . 175.27 108.72 0.23 Allowed Glycine 0 N--CA 1.424 -2.166 0 CA-C-N 114.538 -1.21 . . . . 0.54000000000000004 111.623 174.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.634 ' HB2' HD11 ' A' ' 122' ' ' LEU . 33.3 m -168.91 29.82 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.384 -0.969 . . . . 1.2 108.384 170.725 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.47 153.65 35.79 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.105 0 CA-C-N 114.865 -1.061 . . . . 0.93000000000000005 109.723 -173.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.8 t -179.5 -46.41 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.398 0 O-C-N 123.632 0.582 . . . . 0.47999999999999998 112.099 169.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.706 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 27.2 t70 -155.38 151.89 28.43 Favored 'General case' 0 CA--C 1.516 -0.359 0 C-N-CA 120.69 -0.404 . . . . 1.6899999999999999 111.603 -174.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 94.2 t -144.61 120.68 4.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.393 -0.595 . . . . 1.1399999999999999 109.393 173.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.513 ' O ' ' HD2' ' A' ' 32' ' ' LYS . 6.2 t70 -113.44 110.86 20.99 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 116.637 -0.256 . . . . 1.8300000000000001 111.308 -172.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.687 ' HA ' ' HB3' ' A' ' 41' ' ' TYR . 3.1 tm? -79.42 130.97 35.93 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.638 -0.134 . . . . 0.93999999999999995 110.638 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.593 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -138.52 -88.05 0.24 Allowed 'General case' 0 C--O 1.22 -0.492 0 N-CA-C 114.138 1.162 . . . . 1.3300000000000001 114.138 179.464 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.656 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.4 OUTLIER -91.32 -177.35 4.83 Favored 'General case' 0 C--O 1.204 -1.32 0 O-C-N 121.936 -0.478 . . . . 2.8500000000000001 111.995 -152.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.693 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.1 p -164.36 -33.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 120.973 0.416 . . . . 3.2599999999999998 111.101 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.71 -69.49 0.11 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.855 -1.066 . . . . 3.1600000000000001 110.032 -176.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.4 tpp180 -174.89 -6.81 0.01 OUTLIER 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.819 -0.628 . . . . 5.46 112.191 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -128.15 -30.18 2.45 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.306 0.574 . . . . 1.9199999999999999 110.159 -164.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.693 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 6.3 t -165.59 131.94 2.69 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.154 -0.93 . . . . 0.93999999999999995 111.358 -173.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.839 HG11 HD22 ' A' ' 101' ' ' LEU . 91.4 t -76.89 155.51 5.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.208 -0.905 . . . . 0.85999999999999999 110.319 -178.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.88 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 48.8 mt-10 -129.35 139.54 51.69 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 119.539 -0.864 . . . . 1.1899999999999999 110.515 -174.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.952 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -139.72 134.62 32.16 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 119.582 -0.847 . . . . 3.73 112.293 175.143 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.512 ' N ' HG12 ' A' ' 94' ' ' VAL . 0.9 OUTLIER -80.41 111.42 16.79 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 108.824 -0.806 . . . . 0.81000000000000005 108.824 -174.621 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -90.43 99.9 12.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.374 0.607 . . . . 0.41999999999999998 110.001 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.706 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 0.1 OUTLIER -83.5 125.04 31.34 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.82 -0.807 . . . . 2.6299999999999999 108.82 178.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.588 HG13 ' C ' ' A' ' 25' ' ' SER . 52.2 t -115.48 139.19 43.12 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 115.169 -0.923 . . . . 0.81999999999999995 110.445 -173.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -124.75 104.52 8.69 Favored 'General case' 0 N--CA 1.433 -1.309 0 C-N-CA 120.19 -0.604 . . . . 0.71999999999999997 109.58 171.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.773 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 83.2 t -83.05 129.89 36.67 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.502 0 CA-C-N 115.338 -0.846 . . . . 1.1399999999999999 110.458 -176.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' ASP . 30.5 m -122.61 113.94 19.95 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.913 -0.585 . . . . 0.40999999999999998 109.837 176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.787 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 27.5 p-10 -94.87 146.19 30.92 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 115.628 -0.715 . . . . 1.48 109.172 176.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.574 ' HG3' HD13 ' A' ' 19' ' ' ILE . 47.4 Cg_endo -93.92 8.18 2.38 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 123.13 2.553 . . . . 0.72999999999999998 113.044 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.66 ' HA ' HD21 ' A' ' 5' ' ' LEU . 6.8 t80 -117.11 131.92 56.79 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.958 -0.386 . . . . 2.0800000000000001 109.958 -174.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.576 ' HB2' ' HE3' ' A' ' 85' ' ' LYS . 38.1 t -87.48 44.7 1.2 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.442 0.639 . . . . 1.51 110.655 -169.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 45.0 m80 -144.07 16.88 1.74 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.459 0.911 . . . . 1.6699999999999999 113.459 -179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.712 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 26.2 t 61.42 98.28 0.03 OUTLIER 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 111.885 0.328 . . . . 1.3899999999999999 111.885 177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.853 ' O ' ' HA ' ' A' ' 81' ' ' SER . 9.1 pt -78.79 128.87 75.52 Favored Pre-proline 0 C--O 1.207 -1.149 0 O-C-N 121.698 -0.626 . . . . 1.03 111.115 -170.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.678 ' HD2' ' O ' ' A' ' 125' ' ' ASP . 28.6 Cg_endo -66.34 -59.21 0.14 Allowed 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 121.914 1.743 . . . . 0.37 113.106 -163.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.477 HD13 ' HA ' ' A' ' 79' ' ' PRO . 10.1 mm -121.65 152.02 25.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 C-N-CA 120.23 -0.588 . . . . 1.23 110.782 -172.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.589 ' HB3' HG22 ' A' ' 124' ' ' ILE . 10.2 m -148.03 178.23 8.71 Favored 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.147 0.975 . . . . 1.1499999999999999 111.961 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.097 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 34.7 tt0 -136.8 117.63 14.11 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 113.587 -1.642 . . . . 1.3600000000000001 110.618 177.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 120' ' ' ILE . 0.4 OUTLIER -97.89 109.43 23.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-O 121.783 0.802 . . . . 1.05 109.559 170.029 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.714 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 13.2 p -117.13 102.05 8.98 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.325 -1.307 . . . . 0.82999999999999996 109.717 -179.307 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.613 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 5.1 p90 -109.92 126.68 54.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.008 0.432 . . . . 0.40000000000000002 110.451 -168.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.593 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 8.2 m -120.43 105.3 10.74 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.525 -0.762 . . . . 0.38 109.312 177.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.691 ' CE1' ' HB2' ' A' ' 118' ' ' LEU . 81.6 m-85 -98.67 140.56 32.7 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.28 -0.418 . . . . 0.95999999999999996 111.226 -174.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.569 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 10.9 m170 -134.78 143.9 47.36 Favored 'General case' 0 C--O 1.219 -0.531 0 N-CA-C 108.085 -1.08 . . . . 1.29 108.085 175.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.618 ' HA ' ' HA ' ' A' ' 116' ' ' TYR . 33.6 t -107.64 -100.8 0.36 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 119.67 -0.812 . . . . 1.27 111.176 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -57.94 -60.53 3.57 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 109.217 -0.66 . . . . 0.35999999999999999 109.217 -175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.51 20.94 0.13 Allowed Glycine 0 N--CA 1.44 -1.085 0 N-CA-C 109.292 -1.523 . . . . 0.39000000000000001 109.292 167.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 69' ' ' ARG . 7.3 ptp180 -116.46 -176.83 3.04 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 108.64 -0.874 . . . . 1.97 108.64 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -103.05 96.8 7.04 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-O 121.744 0.783 . . . . 2.6099999999999999 108.935 -167.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.92 ' HA ' HG21 ' A' ' 100' ' ' ILE . 5.0 mm -50.77 -42.58 23.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 113.762 -1.563 . . . . 0.40000000000000002 111.153 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.64 170.0 32.76 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.538 -0.839 . . . . 0.48999999999999999 111.288 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.44 163.83 27.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.411 0.606 . . . . 1.8100000000000001 110.396 174.812 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.72 159.71 23.54 Favored Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 111.231 -0.748 . . . . 0.42999999999999999 111.231 -179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.714 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 92.3 mttt -133.19 128.53 36.19 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 110.238 -0.282 . . . . 1.72 110.238 -179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.606 ' HB ' HD12 ' A' ' 60' ' ' ILE . 70.3 mt -134.31 111.8 11.89 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.36 -0.382 . . . . 0.72999999999999998 110.224 -178.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo -74.29 111.24 3.26 Favored 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.518 2.146 . . . . 0.56999999999999995 110.554 172.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.404 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 22.1 t70 -130.88 142.67 46.4 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 109.738 -0.467 . . . . 0.79000000000000004 109.738 -172.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.477 ' HA ' HD13 ' A' ' 57' ' ' ILE . 27.8 Cg_endo -63.84 84.61 0.14 Allowed 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.539 2.159 . . . . 0.57999999999999996 112.365 178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.14 41.74 3.08 Favored Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.813 -0.63 . . . . 0.40000000000000002 112.147 -177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.853 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 83.9 p -70.48 113.14 7.31 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.179 -0.674 . . . . 0.62 109.179 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.712 ' O ' ' HA ' ' A' ' 54' ' ' SER . 1.4 pt? -142.74 160.82 39.59 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 112.447 0.536 . . . . 1.1000000000000001 112.447 -164.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 86' ' ' ASP . 90.9 mttt -6.25 -96.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 O-C-N 125.243 1.589 . . . . 1.8400000000000001 113.796 -172.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 85' ' ' LYS . . . 170.5 108.54 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.637 0 N-CA-C 108.097 -1.075 . . . . 0.98999999999999999 108.097 -179.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.787 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 9.6 ptpt 42.57 54.32 4.5 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 124.291 0.995 . . . . 1.8400000000000001 110.844 -172.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.648 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.6 t70 -153.53 -167.29 2.65 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.926 -1.034 . . . . 0.64000000000000001 110.822 -171.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.505 ' HA ' ' O ' ' A' ' 47' ' ' VAL . 52.5 ttm -118.81 125.07 48.74 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.035 0.445 . . . . 1.3500000000000001 110.883 -170.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.672 HG22 ' HB ' ' A' ' 47' ' ' VAL . 1.2 t -113.58 143.28 44.83 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.319 -0.855 . . . . 0.77000000000000002 109.309 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.86 106.37 16.33 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.281 0.563 . . . . 0.47999999999999998 111.068 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.507 HD22 HG11 ' A' ' 45' ' ' VAL . 8.5 tt -103.31 160.28 14.82 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.514 -0.921 . . . . 0.77000000000000002 108.514 179.005 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -136.3 119.56 16.72 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 119.682 -0.807 . . . . 1.8100000000000001 111.314 -172.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.636 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 31.6 mm -103.36 143.59 26.93 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.231 -0.895 . . . . 0.65000000000000002 109.612 177.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.536 ' HD2' HG23 ' A' ' 92' ' ' ILE . 17.9 Cg_endo -59.79 -155.59 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.888 2.392 . . . . 1.0700000000000001 113.718 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.952 ' HA ' ' O ' ' A' ' 41' ' ' TYR . 5.1 m -126.35 92.3 1.98 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.74 0 CA-C-N 115.602 -0.727 . . . . 0.46000000000000002 111.411 -162.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.521 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.5 p -126.29 101.65 8.44 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.512 0 N-CA-C 115.633 1.716 . . . . 0.47999999999999998 115.633 -162.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.664 HG13 ' HB ' ' A' ' 39' ' ' VAL . 4.8 p -153.32 123.95 3.49 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 121.182 -0.949 . . . . 1.0700000000000001 111.766 162.439 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.595 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 49.4 Cg_exo -53.59 135.14 60.88 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 121.616 1.544 . . . . 0.47999999999999998 112.071 172.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 38' ' ' SER . 1.2 t80 -50.33 -36.23 31.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.052 -0.976 . . . . 1.3100000000000001 110.931 -179.346 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.515 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 5.7 m -65.62 -25.26 67.3 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.658 0.614 . . . . 1.2 112.658 -175.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.92 HG21 ' HA ' ' A' ' 71' ' ' ILE . 6.5 mm -72.38 -54.46 16.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.368 0 O-C-N 121.73 -0.606 . . . . 0.51000000000000001 110.043 -177.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.839 HD22 HG11 ' A' ' 39' ' ' VAL . 9.9 mp -60.1 -25.41 65.41 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-N 115.002 -0.999 . . . . 1.0 111.161 174.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.64 ' HA ' ' CD1' ' A' ' 151' ' ' PHE . 77.2 t80 -59.03 -48.49 81.41 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 107.54 -1.281 . . . . 0.95999999999999996 107.54 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.6 ' HA ' ' HE ' ' A' ' 106' ' ' ARG . 91.3 m-20 -75.48 -56.16 4.97 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 114.648 -1.16 . . . . 0.81999999999999995 113.15 -178.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.716 ' HG ' ' HA ' ' A' ' 101' ' ' LEU . 2.8 pp -54.36 -49.76 69.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.255 0.835 . . . . 0.65000000000000002 113.255 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.659 ' HB1' ' CZ ' ' A' ' 147' ' ' PHE . . . -67.92 -24.81 65.24 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-O 122.066 0.936 . . . . 0.42999999999999999 110.406 -178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.6 ' HE ' ' HA ' ' A' ' 103' ' ' ASN . 3.3 ttp180 -69.7 -49.57 52.11 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.226 -1.352 . . . . 1.8100000000000001 110.238 175.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.705 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 9.0 t70 -81.89 -53.91 5.77 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.73 0.776 . . . . 0.80000000000000004 111.98 -173.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.751 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.0 t -89.09 -22.69 6.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 C-N-CA 119.404 -0.918 . . . . 0.88 110.1 -177.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.567 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -72.79 -18.68 78.98 Favored Glycine 0 C--N 1.329 0.185 0 C-N-CA 120.43 -0.891 . . . . 0.38 111.228 168.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.705 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 1.1 t -51.95 -47.1 42.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 106.862 -1.533 . . . . 1.0900000000000001 106.862 164.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.426 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 19.4 m-20 -68.5 -96.22 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.709 -0.678 . . . . 1.8700000000000001 110.096 159.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 1.4 p-90 -179.34 -52.72 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.094 -0.503 . . . . 1.1699999999999999 111.674 176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -94.43 123.73 38.02 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.064 0.459 . . . . 2.1499999999999999 110.923 -179.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.751 HG13 ' HB ' ' A' ' 108' ' ' VAL . 2.9 mp -110.64 158.76 10.9 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 109.283 -0.636 . . . . 0.39000000000000001 109.283 -174.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.667 ' CB ' ' HG2' ' A' ' 141' ' ' GLU . 4.8 p-10 -106.88 153.82 21.96 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.879 -0.601 . . . . 2.1099999999999999 109.416 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 40.9 m-85 -137.13 157.9 45.64 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.903 -1.147 . . . . 0.62 107.903 178.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.915 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 19.7 tt0 -145.86 137.97 25.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.146 0.498 . . . . 0.80000000000000004 109.853 176.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.691 ' HB2' ' CE1' ' A' ' 64' ' ' PHE . 0.6 OUTLIER -110.51 131.49 55.0 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.484 -0.78 . . . . 1.25 109.562 177.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.666 ' N ' HD22 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -117.56 99.59 7.07 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 108.772 -0.825 . . . . 0.63 108.772 174.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.706 ' HA ' ' O ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -114.51 121.06 65.86 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 CA-C-O 121.441 0.639 . . . . 0.81000000000000005 110.719 -173.847 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.635 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.6 127.75 8.42 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.682 -0.69 . . . . 0.26000000000000001 111.999 178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.754 HD21 ' H ' ' A' ' 24' ' ' GLY . 1.9 mp -99.05 96.0 7.51 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.83 0.348 . . . . 1.2 110.624 -177.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.097 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 94.5 m -101.16 95.66 6.7 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 109.156 -0.683 . . . . 0.32000000000000001 109.156 172.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.783 ' HB ' HD12 ' A' ' 55' ' ' ILE . 32.7 pt -117.06 137.73 50.01 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.199 0 C-N-CA 120.392 -0.523 . . . . 0.97999999999999998 110.785 -176.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.678 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 2.2 m-20 -81.66 105.93 13.2 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.224 -0.658 . . . . 1.52 109.224 -176.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.574 HD23 HG21 ' A' ' 55' ' ' ILE . 20.0 mt -107.15 141.69 23.45 Favored Pre-proline 0 C--O 1.217 -0.61 0 O-C-N 124.859 1.35 . . . . 1.28 109.69 -177.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HG2' ' CE1' ' A' ' 51' ' ' TYR . 50.3 Cg_exo -55.16 -27.78 57.85 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 122.272 1.981 . . . . 0.73999999999999999 113.536 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 58.3 t -74.48 -58.21 5.16 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.331 0 N-CA-C 112.584 0.587 . . . . 1.1200000000000001 112.584 -176.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -99.37 -2.09 9.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-O 122.14 0.971 . . . . 1.3500000000000001 109.774 -175.166 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 78.79 -31.14 1.98 Allowed Glycine 0 C--N 1.316 -0.571 0 CA-C-N 113.742 -1.572 . . . . 1.05 110.711 -171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.524 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.3 pt-20 -169.07 145.12 3.38 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 107.809 -1.182 . . . . 1.1599999999999999 107.809 176.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.693 ' HD2' ' HG3' ' A' ' 22' ' ' PRO . 6.6 t80 -134.82 134.63 41.03 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 109.048 -0.723 . . . . 1.9099999999999999 109.048 176.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 90.9 m -119.0 105.11 11.11 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.176 0.512 . . . . 1.1899999999999999 111.723 -175.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.631 HG12 ' HG2' ' A' ' 22' ' ' PRO . 2.3 pp -127.66 132.75 24.49 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.893 -0.594 . . . . 0.5 109.838 173.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.635 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 73.6 Cg_endo -84.96 159.29 11.71 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.682 1.588 . . . . 0.45000000000000001 112.239 176.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.43 164.69 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 108.198 -1.038 . . . . 0.44 108.198 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.622 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 0.9 OUTLIER -133.42 149.61 51.79 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 120.854 -0.338 . . . . 0.88 111.528 -168.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.0 t -144.33 103.82 4.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 108.812 -0.81 . . . . 0.95999999999999996 108.812 173.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.915 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 12.7 ptmt -113.44 144.61 42.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.958 -0.565 . . . . 1.76 110.837 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -156.22 139.73 6.76 Favored Glycine 0 N--CA 1.441 -0.991 0 C-N-CA 120.684 -0.769 . . . . 0.5 111.734 -178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.667 ' HG2' ' CB ' ' A' ' 115' ' ' ASP . 12.1 mt-10 -106.33 126.79 52.67 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.922 -0.77 . . . . 2.1000000000000001 108.922 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.42 173.6 13.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.609 -0.885 . . . . 0.76000000000000001 108.609 -176.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -68.43 175.83 3.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.03 0.443 . . . . 3.5299999999999998 111.793 -175.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.7 HD12 ' HD2' ' A' ' 145' ' ' PRO . 21.4 tp -58.82 129.07 85.06 Favored Pre-proline 0 CA--C 1.534 0.353 0 CA-C-N 115.575 -0.739 . . . . 1.23 112.119 -171.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.7 ' HD2' HD12 ' A' ' 144' ' ' LEU . 36.8 Cg_endo -65.07 175.86 3.55 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 124.206 3.27 . . . . 0.70999999999999996 112.85 178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 2.2 m -64.11 136.94 57.7 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.918 -0.583 . . . . 1.71 112.111 -178.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.659 ' CZ ' ' HB1' ' A' ' 105' ' ' ALA . 17.0 m-85 -125.79 165.74 18.1 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.145 -0.48 . . . . 2.6400000000000001 110.511 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.545 ' HB3' ' CE2' ' A' ' 150' ' ' PHE . 2.5 tppp? 176.71 55.21 0.0 OUTLIER 'General case' 0 C--O 1.233 0.206 0 O-C-N 123.539 0.525 . . . . 3.7200000000000002 109.782 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 64.27 28.19 13.87 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 115.695 -0.684 . . . . 4.2800000000000002 110.737 -177.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.545 ' CE2' ' HB3' ' A' ' 148' ' ' LYS . 23.1 m-85 -98.56 -49.86 4.48 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.682 -0.69 . . . . 2.8599999999999999 109.387 179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.64 ' CD1' ' HA ' ' A' ' 102' ' ' PHE . 6.3 m-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-N 114.993 -1.003 . . . . 3.96 109.698 -175.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.089 0 N-CA-C 110.445 -0.206 . . . . 12.109999999999999 110.445 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -76.96 -8.46 57.43 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 112.359 0.503 . . . . 9.0199999999999996 112.359 -172.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.4 m -123.39 93.97 4.11 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 110.175 -0.306 . . . . 6.8300000000000001 110.175 175.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -154.28 -71.54 0.13 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.426 . . . . 8.5500000000000007 110.23 -178.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 17' ' ' THR . 57.3 tp 59.71 100.21 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.856 0.722 . . . . 10.470000000000001 111.488 -176.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -114.39 -45.48 3.03 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.919 -0.582 . . . . 11.69 110.603 179.195 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 87.0 mttt -100.76 124.38 46.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.998 -0.546 . . . . 11.42 110.849 -175.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -153.56 125.14 7.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.603 -0.726 . . . . 11.58 109.329 178.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -73.98 -38.29 64.19 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.907 0.384 . . . . 15.74 110.308 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -93.12 128.81 39.18 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.379 -0.6 . . . . 12.69 109.379 174.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -79.52 178.77 7.89 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.264 0.554 . . . . 13.85 111.723 -171.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 33.6 m -120.07 158.17 22.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.681 -0.69 . . . . 8.8699999999999992 110.51 -179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.48 -61.01 2.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.125 0.488 . . . . 8.9100000000000001 110.305 177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -147.19 -44.8 0.17 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.018 -0.537 . . . . 8.5999999999999996 111.163 176.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.468 ' HB2' ' HE2' ' A' ' 15' ' ' LYS . 8.1 tppt? -143.45 127.25 17.19 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.487 -0.324 . . . . 9.0399999999999991 110.413 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 47.6 tp -143.12 -78.79 0.22 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.111 -0.329 . . . . 5.5800000000000001 110.111 177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.423 ' HA ' HD23 ' A' ' 5' ' ' LEU . 71.6 m 62.4 -85.09 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.149 0 O-C-N 123.575 0.547 . . . . 2.6899999999999999 110.836 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.557 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . 60.46 -88.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.382 0.673 . . . . 1.6799999999999999 112.585 176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.424 HD12 ' O ' ' A' ' 19' ' ' ILE . 2.7 pp -137.21 141.44 34.28 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 3.1899999999999999 110.57 -176.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.56 -12.86 2.94 Favored 'Trans proline' 0 N--CA 1.462 -0.34 0 C-N-CA 122.825 2.35 . . . . 2.4199999999999999 113.0 -177.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 22' ' ' PRO . 36.9 ttpt -145.78 127.25 7.58 Favored Pre-proline 0 C--N 1.322 -0.612 0 N-CA-C 108.917 -0.771 . . . . 6.3799999999999999 108.917 -176.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 32.2 Cg_exo -59.32 163.85 11.72 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.684 2.256 . . . . 2.77 112.217 -179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.723 ' HG3' ' HD3' ' A' ' 50' ' ' PRO . 31.1 mp0 -115.92 148.62 39.84 Favored 'General case' 0 N--CA 1.422 -1.845 0 N-CA-C 105.784 -1.932 . . . . 3.3900000000000001 105.784 -174.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.785 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -113.57 -178.81 19.32 Favored Glycine 0 C--N 1.3 -1.424 0 C-N-CA 118.124 -1.989 . . . . 0.54000000000000004 113.597 176.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG13 ' A' ' 45' ' ' VAL . 76.7 p -166.6 36.98 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.437 1.113 . . . . 1.2 108.308 176.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.554 ' O ' ' HB2' ' A' ' 46' ' ' SER . 3.1 m -133.85 154.89 39.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-N 114.295 -1.32 . . . . 0.93000000000000005 110.463 -170.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 t -168.04 -45.34 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.724 0 O-C-N 123.781 0.676 . . . . 0.47999999999999998 111.387 168.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -162.84 162.9 26.67 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.915 -0.49 . . . . 1.6899999999999999 111.479 -178.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 60.5 t -144.49 146.06 20.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 N-CA-C 109.878 -0.415 . . . . 1.1399999999999999 109.878 177.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -129.02 134.92 48.32 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.582 0.229 . . . . 1.8300000000000001 111.004 -176.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.542 HD21 ' CG1' ' A' ' 39' ' ' VAL . 2.7 tm? -100.85 134.94 43.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 110.145 -0.317 . . . . 0.93999999999999995 110.145 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.448 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -142.92 -93.41 0.12 Allowed 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.7 1.0 . . . . 1.3300000000000001 113.7 179.688 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.848 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 0.5 OUTLIER -91.06 -178.11 5.1 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-O 118.801 -0.618 . . . . 2.8500000000000001 111.709 -154.63 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.808 ' HA ' ' O ' ' A' ' 38' ' ' SER . 7.5 p -165.56 -36.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 N-CA-C 112.46 0.541 . . . . 3.2599999999999998 112.46 -179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 66.49 -66.27 0.18 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.05 0.844 . . . . 3.1600000000000001 110.78 -174.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.49 -3.2 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 123.663 0.785 . . . . 5.46 109.852 176.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -127.63 -41.78 1.67 Allowed 'General case' 0 CA--C 1.509 -0.599 0 CA-C-N 116.349 -0.387 . . . . 1.9199999999999999 110.21 -168.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.808 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 22.6 t -146.92 122.43 10.4 Favored 'General case' 0 C--O 1.242 0.673 0 CA-C-O 121.965 0.888 . . . . 0.93999999999999995 112.173 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.921 HG21 HD12 ' A' ' 101' ' ' LEU . 48.7 t -71.88 152.49 8.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 CA-C-N 114.181 -1.372 . . . . 0.85999999999999999 109.126 173.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.964 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.2 mt-10 -114.84 133.83 55.63 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 118.957 -1.097 . . . . 1.1899999999999999 112.595 -175.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.829 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -120.18 105.6 11.13 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 114.816 -1.084 . . . . 3.73 110.681 -176.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.547 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.4 OUTLIER -81.28 111.15 17.41 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.32 -0.993 . . . . 0.81000000000000005 108.32 178.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.733 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -105.32 115.61 30.56 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.528 0.68 . . . . 0.41999999999999998 110.875 -177.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 44' ' ' LYS . 39.3 ttmt -84.82 125.3 32.47 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 114.893 -1.049 . . . . 2.6299999999999999 108.586 177.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.656 HG13 ' O ' ' A' ' 25' ' ' SER . 51.0 t -108.99 143.31 19.45 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 115.599 -0.728 . . . . 0.81999999999999995 110.984 -173.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' THR . 14.2 m -134.59 100.96 4.79 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 121.227 0.536 . . . . 0.71999999999999997 110.436 167.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.785 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 85.4 t -81.99 124.36 39.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.171 -0.922 . . . . 1.1399999999999999 110.617 -176.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 3.0 m -103.2 110.67 22.72 Favored 'General case' 0 C--O 1.217 -0.609 0 CA-C-N 115.902 -0.59 . . . . 0.40999999999999998 110.707 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.65 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 9.9 t30 -90.27 128.01 50.95 Favored Pre-proline 0 C--N 1.318 -0.802 0 O-C-N 123.796 0.685 . . . . 1.48 109.748 176.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.723 ' HD3' ' HG3' ' A' ' 23' ' ' GLU . 57.3 Cg_endo -90.31 8.7 3.43 Favored 'Trans proline' 0 CA--C 1.531 0.37 0 C-N-CA 123.064 2.51 . . . . 0.72999999999999998 114.116 -175.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -127.02 147.28 50.14 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.588 -0.893 . . . . 2.0800000000000001 108.588 -176.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.676 ' HB2' ' HD2' ' A' ' 85' ' ' LYS . 33.9 t -79.1 31.58 0.21 Allowed 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.227 0.454 . . . . 1.51 112.227 -168.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -143.11 128.47 18.88 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.486 -0.324 . . . . 1.6699999999999999 110.789 176.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.538 ' HA ' HD23 ' A' ' 82' ' ' LEU . 47.6 t -38.11 105.05 0.04 OUTLIER 'General case' 0 C--O 1.215 -0.711 0 C-N-CA 124.577 1.151 . . . . 1.3899999999999999 112.971 172.38 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.659 ' O ' ' HA ' ' A' ' 81' ' ' SER . 5.6 pt -77.87 125.11 86.02 Favored Pre-proline 0 C--O 1.209 -1.049 0 N-CA-C 109.242 -0.651 . . . . 1.03 109.242 -178.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.954 ' HB2' HD12 ' A' ' 57' ' ' ILE . 30.3 Cg_endo -63.09 -58.92 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.048 1.832 . . . . 0.37 113.544 -159.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.954 HD12 ' HB2' ' A' ' 56' ' ' PRO . 4.5 mp -132.18 154.57 40.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 C-N-CA 119.899 -0.72 . . . . 1.23 110.994 -173.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.599 ' HB3' HG22 ' A' ' 124' ' ' ILE . 31.4 p -145.83 178.11 8.42 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 122.504 1.145 . . . . 1.1499999999999999 112.161 -178.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.099 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.0 tt0 -131.95 114.24 14.39 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 112.687 -2.052 . . . . 1.3600000000000001 109.25 177.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.584 HG22 HD11 ' A' ' 120' ' ' ILE . 0.6 OUTLIER -98.86 110.63 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 CA-C-O 122.334 1.064 . . . . 1.05 110.125 171.415 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.511 ' HB3' ' HG2' ' A' ' 75' ' ' LYS . 0.9 OUTLIER -109.1 105.25 14.65 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 113.256 -1.793 . . . . 0.82999999999999996 107.951 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.652 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 8.1 p90 -115.59 130.71 56.97 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.416 0.627 . . . . 0.40000000000000002 110.369 -167.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.428 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 32.5 m -131.92 114.56 14.79 Favored 'General case' 0 C--N 1.301 -1.538 0 CA-C-N 114.743 -1.117 . . . . 0.38 109.065 176.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.542 ' HB2' HG22 ' A' ' 71' ' ' ILE . 97.3 m-85 -96.77 146.83 24.53 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 109.508 -0.552 . . . . 0.95999999999999996 109.508 -177.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.503 ' HA ' ' O ' ' A' ' 69' ' ' ARG . 0.2 OUTLIER -134.09 146.06 49.94 Favored 'General case' 0 C--N 1.313 -0.978 0 N-CA-C 107.392 -1.336 . . . . 1.29 107.392 179.292 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 1.088 ' HB3' HD22 ' A' ' 104' ' ' LEU . 47.7 t -112.56 -97.2 0.43 Allowed 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 119.177 -1.009 . . . . 1.27 110.846 169.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.64 -60.82 3.23 Favored 'General case' 0 CA--C 1.515 -0.384 0 N-CA-C 109.837 -0.431 . . . . 0.35999999999999999 109.837 -175.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.2 26.37 0.18 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 109.964 -1.254 . . . . 0.39000000000000001 109.964 167.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 65' ' ' HIS . 8.1 ptp180 -126.17 -174.22 3.05 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.552 -0.536 . . . . 1.97 109.552 -178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.417 ' C ' HG21 ' A' ' 100' ' ' ILE . 43.7 mt-10 -101.44 92.06 4.75 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 121.198 0.523 . . . . 2.6099999999999999 110.391 -164.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.796 HD11 HD21 ' A' ' 104' ' ' LEU . 0.9 OUTLIER -56.85 -32.1 37.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.539 -1.21 . . . . 0.40000000000000002 112.113 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -179.67 164.94 33.22 Favored Glycine 0 C--O 1.223 -0.544 0 C-N-CA 120.664 -0.779 . . . . 0.48999999999999999 111.245 179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.652 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -165.28 160.26 18.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.989 0.895 . . . . 1.8100000000000001 112.126 175.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 175.77 159.1 21.04 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.076 -0.81 . . . . 0.42999999999999999 111.076 176.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HG2' ' HB3' ' A' ' 61' ' ' SER . 51.0 mtpt -126.2 128.1 46.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 117.196 0.498 . . . . 1.72 110.002 179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.402 ' HB ' HD12 ' A' ' 60' ' ' ILE . 75.5 mt -136.63 122.22 13.26 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-O 120.721 0.296 . . . . 0.72999999999999998 110.644 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -78.31 114.53 3.55 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.579 2.186 . . . . 0.56999999999999995 111.022 171.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 17.9 t70 -129.97 146.0 59.56 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 110.074 -0.343 . . . . 0.79000000000000004 110.074 -173.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.403 ' HD2' ' OD1' ' A' ' 78' ' ' ASP . 12.5 Cg_endo -56.82 91.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.727 2.285 . . . . 0.57999999999999996 112.17 175.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.4 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -79.88 19.51 6.31 Favored Glycine 0 N--CA 1.451 -0.355 0 CA-C-N 115.497 -0.774 . . . . 0.40000000000000002 112.82 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.6 p -70.74 121.32 17.77 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 109.006 -0.739 . . . . 0.62 109.006 -176.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.671 HD12 ' HB ' ' A' ' 88' ' ' THR . 0.9 OUTLIER -145.23 -161.38 1.29 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.843 0.682 . . . . 1.1000000000000001 112.843 -162.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' ALA . 67.5 mttm -53.79 -94.75 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.83 0.678 . . . . 1.8400000000000001 112.83 -174.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.629 ' O ' ' HG2' ' A' ' 85' ' ' LYS . . . 164.51 108.54 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.639 0 N-CA-C 108.583 -0.895 . . . . 0.98999999999999999 108.583 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.676 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 13.1 ptmt 46.27 40.86 8.19 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 124.408 1.067 . . . . 1.8400000000000001 111.088 -178.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -147.69 -169.75 3.4 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 114.907 -1.042 . . . . 0.64000000000000001 109.7 -172.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 46.2 ttm -116.19 124.5 50.45 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.305 0.574 . . . . 1.3500000000000001 110.456 -174.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.671 ' HB ' HD12 ' A' ' 82' ' ' LEU . 0.6 OUTLIER -111.35 143.48 42.07 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.352 -0.84 . . . . 0.77000000000000002 110.863 -177.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -86.02 138.89 31.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.026 0.441 . . . . 0.47999999999999998 110.447 178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.533 HD22 HG11 ' A' ' 45' ' ' VAL . 1.2 tt -144.15 175.06 10.35 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.612 -1.255 . . . . 0.77000000000000002 107.612 -178.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.484 ' H ' ' HG ' ' A' ' 90' ' ' LEU . 4.0 p-10 -142.15 146.5 35.38 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 119.061 0.846 . . . . 1.8100000000000001 112.217 -175.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.733 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 50.4 mm -114.56 143.25 29.57 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 107.895 -1.15 . . . . 0.65000000000000002 107.895 170.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.547 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 85.2 Cg_exo -51.52 -122.91 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.472 2.781 . . . . 1.0700000000000001 114.072 175.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.964 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -153.82 93.96 0.09 OUTLIER 'Isoleucine or valine' 0 C--O 1.215 -0.743 0 O-C-N 121.837 -0.539 . . . . 0.46000000000000002 111.973 -172.081 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.2 p -126.29 109.03 20.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 113.748 1.018 . . . . 0.47999999999999998 113.748 -169.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.727 ' HB ' ' HB ' ' A' ' 39' ' ' VAL . 16.9 t -146.86 103.98 3.89 Favored Pre-proline 0 C--O 1.218 -0.558 0 CA-C-N 115.683 -0.69 . . . . 1.0700000000000001 109.731 169.246 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.585 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 23.6 Cg_exo -61.26 123.45 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 CA-C-N 120.792 1.319 . . . . 0.47999999999999998 110.678 171.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.406 ' OH ' ' HA ' ' A' ' 150' ' ' PHE . 2.4 t80 -50.57 -38.34 44.68 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 115.56 -0.745 . . . . 1.3100000000000001 112.176 -171.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.406 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 1.9 m -56.12 -25.52 46.36 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 111.674 0.25 . . . . 1.2 111.674 -177.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.646 HG21 ' HA ' ' A' ' 71' ' ' ILE . 19.0 mm -76.34 -55.55 10.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 C-N-CA 120.252 -0.579 . . . . 0.51000000000000001 111.116 -176.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.921 HD12 HG21 ' A' ' 39' ' ' VAL . 13.1 mt -51.96 -30.05 23.12 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-O 121.488 0.661 . . . . 1.0 110.427 172.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 151' ' ' PHE . 85.3 t80 -62.89 -40.36 97.31 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.178 -1.374 . . . . 0.95999999999999996 108.908 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.571 ' O ' ' HB3' ' A' ' 106' ' ' ARG . 0.9 OUTLIER -74.38 -56.12 5.22 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.727 -0.67 . . . . 0.81999999999999995 111.848 -178.491 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 66' ' ' SER . 1.3 pp -62.14 -51.8 66.4 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.57 0.952 . . . . 0.65000000000000002 113.57 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.424 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -60.3 -25.97 66.17 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.783 0.801 . . . . 0.42999999999999999 110.361 178.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.571 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 3.0 ttp180 -64.28 -50.42 67.96 Favored 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.659 -1.155 . . . . 1.8100000000000001 110.131 173.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 38.5 t70 -83.24 -53.42 5.77 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 112.781 0.66 . . . . 0.80000000000000004 112.781 -175.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.522 HG11 ' HA ' ' A' ' 114' ' ' ILE . 4.2 t -84.35 -27.47 7.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 C-N-CA 120.498 -0.481 . . . . 0.88 110.001 -176.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.424 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -75.44 -21.28 77.72 Favored Glycine 0 C--N 1.328 0.139 0 C-N-CA 120.631 -0.795 . . . . 0.38 111.573 171.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.513 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.8 -46.69 16.09 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 106.98 -1.489 . . . . 1.0900000000000001 106.98 165.461 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 6.3 m-20 -67.66 -90.28 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.434 -0.803 . . . . 1.8700000000000001 109.615 162.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 7.0 p-90 -178.16 -62.69 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.196 0.443 . . . . 1.1699999999999999 112.196 173.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -93.63 133.08 37.34 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.204 0.526 . . . . 2.1499999999999999 110.991 -175.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.583 HD11 HD12 ' A' ' 144' ' ' LEU . 2.7 mp -115.87 159.95 15.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 115.367 -0.833 . . . . 0.39000000000000001 109.962 -171.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.423 ' N ' HG22 ' A' ' 114' ' ' ILE . 10.3 p-10 -98.81 152.83 19.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 108.59 -0.892 . . . . 2.1099999999999999 108.59 177.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.774 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 41.1 m-85 -138.02 163.86 30.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.339 -0.986 . . . . 0.62 108.339 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.63 ' HG3' ' HE2' ' A' ' 139' ' ' LYS . 36.2 tt0 -160.58 128.47 4.5 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.881 0.372 . . . . 0.80000000000000004 110.624 -177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.642 HD22 ' N ' ' A' ' 119' ' ' GLN . 0.5 OUTLIER -99.83 134.51 42.63 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 109.314 -0.624 . . . . 1.25 109.314 174.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.707 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -117.21 102.54 9.37 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.719 -0.673 . . . . 0.63 109.266 178.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.584 HD11 HG22 ' A' ' 60' ' ' ILE . 6.4 tp -111.62 120.21 61.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.087 0.47 . . . . 0.81000000000000005 111.154 -175.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -90.85 126.98 8.62 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 111.114 -0.794 . . . . 0.26000000000000001 111.114 173.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.67 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.0 mp -106.89 112.93 26.13 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.673 0.273 . . . . 1.2 111.241 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.099 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 92.6 m -114.01 96.68 5.94 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.817 -0.629 . . . . 0.32000000000000001 109.762 173.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.635 ' HB ' HD12 ' A' ' 55' ' ' ILE . 0.1 OUTLIER -111.33 144.01 20.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 C-N-CA 120.544 -0.462 . . . . 0.97999999999999998 110.553 -176.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.701 ' O ' ' HD2' ' A' ' 56' ' ' PRO . 1.0 OUTLIER -88.57 107.12 18.73 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.163 -1.051 . . . . 1.52 108.163 179.441 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.599 HD23 HG21 ' A' ' 55' ' ' ILE . 9.7 mt -106.94 168.08 8.56 Favored Pre-proline 0 C--O 1.222 -0.388 0 O-C-N 125.359 1.662 . . . . 1.28 110.236 -173.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_exo -74.31 -41.98 0.78 Allowed 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.189 1.926 . . . . 0.73999999999999999 112.982 173.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.02 -57.73 6.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 111.937 0.347 . . . . 1.1200000000000001 111.937 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.557 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.2 OUTLIER -89.19 -8.16 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 121.697 0.761 . . . . 1.3500000000000001 109.949 -177.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.64 -33.78 0.71 Allowed Glycine 0 C--N 1.321 -0.291 0 CA-C-N 114.473 -1.239 . . . . 1.05 112.369 -172.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.516 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 12.3 pt-20 -171.99 145.7 1.88 Allowed 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 107.419 -1.326 . . . . 1.1599999999999999 107.419 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.617 ' O ' ' HA ' ' A' ' 123' ' ' THR . 4.4 t80 -153.75 146.11 23.94 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 120.445 -0.502 . . . . 1.9099999999999999 110.125 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.67 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 31.9 m -120.31 107.07 12.5 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 123.386 0.429 . . . . 1.1899999999999999 111.101 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.432 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.4 pp -126.37 138.03 31.49 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 115.96 -0.564 . . . . 0.5 109.936 173.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.447 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 18.1 Cg_endo -91.69 165.35 3.39 Favored 'Trans proline' 0 N--CA 1.447 -1.217 0 C-N-CA 122.386 2.058 . . . . 0.45000000000000001 112.719 178.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.416 HG12 ' H ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -164.9 169.11 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 108.691 -0.855 . . . . 0.44 108.691 178.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.521 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.3 p -136.52 154.08 50.83 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 112.375 0.509 . . . . 0.88 112.375 -169.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 32.4 t -140.58 105.61 4.99 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.716 -1.216 . . . . 0.95999999999999996 107.716 172.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.63 ' HE2' ' HG3' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -116.35 149.7 38.9 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.577 -0.283 . . . . 1.76 110.834 -172.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -161.78 135.39 3.9 Favored Glycine 0 N--CA 1.44 -1.047 0 N-CA-C 111.294 -0.723 . . . . 0.5 111.294 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -99.14 131.84 44.88 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 109.652 -0.499 . . . . 2.1000000000000001 109.652 -178.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 2.1 pp -146.34 172.9 3.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.512 -0.551 . . . . 0.76000000000000001 109.512 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.431 ' HE3' ' O ' ' A' ' 144' ' ' LEU . 0.5 OUTLIER -61.49 167.09 3.58 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 113.172 0.804 . . . . 3.5299999999999998 113.172 -177.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.847 HD12 ' HD2' ' A' ' 145' ' ' PRO . 32.1 tp -59.19 134.3 87.92 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 114.908 -1.042 . . . . 1.23 111.641 -177.069 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.847 ' HD2' HD12 ' A' ' 144' ' ' LEU . 31.9 Cg_endo -63.56 174.25 3.74 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.103 2.535 . . . . 0.70999999999999996 112.106 176.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 5.3 m -49.78 96.18 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 121.298 0.571 . . . . 1.71 111.326 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -100.0 23.41 9.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.035 -0.529 . . . . 2.6400000000000001 111.201 -171.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 33.1 mmtp -52.65 -64.65 0.75 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.282 0.563 . . . . 3.7200000000000002 110.997 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -140.21 3.38 1.96 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.955 0.884 . . . . 4.2800000000000002 109.136 -179.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.513 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 51.3 m-85 -101.0 -70.4 0.74 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.087 -0.961 . . . . 2.8599999999999999 111.508 -168.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.513 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 66.0 m-85 . . . . . 0 C--O 1.245 0.847 0 O-C-N 124.387 1.055 . . . . 3.96 109.277 -164.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptt? . . . . . 0 N--CA 1.482 1.169 0 N-CA-C 110.323 -0.251 . . . . 12.109999999999999 110.323 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.78 -70.41 0.21 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.07 -0.715 . . . . 9.0199999999999996 109.07 176.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.827 ' HB3' ' HA ' ' A' ' 128' ' ' VAL . 13.3 p 49.78 -88.53 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.741 1.385 . . . . 6.8300000000000001 114.741 167.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.02 147.21 25.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.988 0.423 . . . . 8.5500000000000007 112.14 -168.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 5' ' ' LEU . 1.6 pt? -74.6 -45.63 43.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.56 -0.745 . . . . 10.470000000000001 111.126 -179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.443 ' N ' ' HG ' ' A' ' 5' ' ' LEU . 5.3 m-20 -83.89 83.69 7.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.378 0.609 . . . . 11.69 110.277 178.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 1.048 ' HD3' ' HB3' ' A' ' 10' ' ' ASP . 0.2 OUTLIER -167.03 128.99 1.68 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.127 -0.942 . . . . 11.42 109.633 -175.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -131.26 -5.77 3.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.099 -0.5 . . . . 11.58 111.455 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.21 -18.28 61.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.379 0.609 . . . . 15.74 110.154 177.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 1.048 ' HB3' ' HD3' ' A' ' 7' ' ' LYS . 3.3 t70 -100.77 146.44 27.26 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.11 -1.07 . . . . 12.69 108.11 169.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -83.91 12.51 6.06 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 114.287 1.217 . . . . 13.85 114.287 -163.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.424 HG22 ' OD2' ' A' ' 10' ' ' ASP . 19.7 m -130.11 170.01 20.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 109.836 -0.431 . . . . 8.8699999999999992 109.836 171.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -93.07 -90.9 0.18 Allowed 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.756 -0.377 . . . . 8.9100000000000001 110.068 177.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -146.33 69.14 1.19 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.762 0.792 . . . . 8.5999999999999996 110.973 -179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HE2' HG11 ' A' ' 12' ' ' VAL . 54.0 pttt -86.3 -6.97 58.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.051 -0.522 . . . . 9.0399999999999991 110.435 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.9 mt -135.76 107.5 7.02 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.977 -0.556 . . . . 5.5800000000000001 109.583 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.4 m -74.84 -35.35 62.39 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.197 0.523 . . . . 2.6899999999999999 110.194 -179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -133.3 -94.43 0.32 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.861 -0.609 . . . . 1.6799999999999999 110.906 175.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.797 HG21 HD13 ' A' ' 126' ' ' LEU . 2.6 pp -146.92 156.33 47.57 Favored Pre-proline 0 CA--C 1.533 0.308 0 O-C-N 122.266 -0.271 . . . . 3.1899999999999999 111.096 -177.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -94.86 -13.98 0.73 Allowed 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 122.968 2.446 . . . . 2.4199999999999999 114.699 -174.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.611 ' HB2' ' HB2' ' A' ' 50' ' ' PRO . 61.3 mttp -131.72 145.55 58.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 O-C-N 122.311 -0.243 . . . . 6.3799999999999999 111.009 -176.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.38 155.19 55.85 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 123.081 2.52 . . . . 2.77 111.341 175.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.645 ' HG3' ' HG3' ' A' ' 50' ' ' PRO . 2.6 mp0 -119.57 146.05 45.84 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 106.275 -1.75 . . . . 3.3900000000000001 106.275 -173.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.768 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -110.59 178.52 19.9 Favored Glycine 0 C--N 1.303 -1.29 0 C-N-CA 118.392 -1.861 . . . . 0.54000000000000004 113.35 177.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.672 ' HB2' HD11 ' A' ' 122' ' ' LEU . 40.7 m -172.03 39.96 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 124.534 1.134 . . . . 1.2 108.382 -178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 46' ' ' SER . 25.1 m -134.87 155.12 37.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 CA-C-N 114.778 -1.101 . . . . 0.93000000000000005 109.312 -175.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.5 t -175.56 -48.58 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.369 0.507 . . . . 0.47999999999999998 112.369 168.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -158.5 147.04 18.65 Favored 'General case' 0 C--O 1.214 -0.792 0 O-C-N 122.049 -0.407 . . . . 1.6899999999999999 111.128 -174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.876 ' HB ' ' HA ' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -149.83 138.59 15.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 120.954 0.407 . . . . 1.1399999999999999 110.336 166.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.29 135.49 48.84 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.939 -0.573 . . . . 1.8300000000000001 111.332 -171.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.67 HD21 HG12 ' A' ' 39' ' ' VAL . 3.1 tm? -89.9 137.94 31.91 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.084 -0.507 . . . . 0.93999999999999995 111.202 -172.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.564 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -137.45 -91.78 0.23 Allowed 'General case' 0 C--O 1.223 -0.322 0 N-CA-C 113.865 1.061 . . . . 1.3300000000000001 113.865 178.769 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.596 ' O ' ' HA ' ' A' ' 39' ' ' VAL . 6.8 m-20 -88.48 177.69 6.74 Favored 'General case' 0 C--O 1.207 -1.178 0 O-C-N 121.452 -0.78 . . . . 2.8500000000000001 111.149 -156.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.754 HG22 ' H ' ' A' ' 36' ' ' ARG . 4.9 p -165.04 -43.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-O 120.787 0.327 . . . . 3.2599999999999998 111.671 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 36' ' ' ARG . 5.3 t30 67.33 -10.15 0.36 Allowed 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.691 0.758 . . . . 3.1600000000000001 110.755 -176.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.754 ' H ' HG22 ' A' ' 34' ' ' VAL . 10.7 mmt180 82.87 28.73 0.1 Allowed 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 125.564 1.546 . . . . 5.46 110.313 -178.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -127.75 -33.75 2.25 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.064 -1.426 . . . . 1.9199999999999999 109.673 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.734 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 35.6 t -168.12 123.86 1.01 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.832 -0.622 . . . . 0.93999999999999995 110.206 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.697 ' HB ' HG13 ' A' ' 96' ' ' VAL . 12.0 t -76.28 158.46 5.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 109.581 -178.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 1.051 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 56.5 mt-10 -136.91 141.33 42.71 Favored 'General case' 0 CA--C 1.508 -0.649 0 O-C-N 121.451 -0.781 . . . . 1.1899999999999999 110.932 -173.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.919 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 7.9 p90 -140.73 134.45 30.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 119.167 -1.013 . . . . 3.73 113.454 178.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.618 ' HA ' ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -80.78 110.93 16.76 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 114.711 -1.132 . . . . 0.81000000000000005 108.624 -177.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.876 ' HA ' ' HB ' ' A' ' 29' ' ' VAL . . . -100.28 106.42 18.06 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.239 0.542 . . . . 0.41999999999999998 110.697 -177.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 ttmm -86.28 116.99 24.8 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 122.161 0.981 . . . . 2.6299999999999999 109.786 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.579 HG13 ' C ' ' A' ' 25' ' ' SER . 16.1 t -95.97 149.72 4.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 CA-C-N 114.214 -1.357 . . . . 0.81999999999999995 110.069 178.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.572 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 2.2 m -132.46 104.08 6.51 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.177 -0.609 . . . . 0.71999999999999997 110.67 168.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.768 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 47.3 t -83.04 128.43 38.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 114.731 -1.122 . . . . 1.1399999999999999 111.141 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.737 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 17.5 m -109.62 109.5 20.27 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.962 -0.563 . . . . 0.40999999999999998 110.323 178.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.887 ' HB3' HD11 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -92.29 133.52 29.86 Favored Pre-proline 0 N--CA 1.466 0.325 0 N-CA-C 108.527 -0.916 . . . . 1.48 108.527 174.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.645 ' HG3' ' HG3' ' A' ' 23' ' ' GLU . 40.6 Cg_endo -104.76 22.28 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.453 2.768 . . . . 0.72999999999999998 114.656 -174.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.599 ' HD2' ' HE1' ' A' ' 53' ' ' HIS . 4.1 t80 -116.09 -3.45 12.07 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 118.717 -1.193 . . . . 2.0800000000000001 111.358 -176.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.475 ' CB ' ' HD3' ' A' ' 85' ' ' LYS . 24.6 p 89.89 15.97 0.05 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.26 1.024 . . . . 1.51 112.404 161.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.599 ' HE1' ' HD2' ' A' ' 51' ' ' TYR . 48.7 p-80 -147.6 148.43 31.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.968 -0.753 . . . . 1.6699999999999999 108.968 172.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.84 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 41.7 t -54.32 107.16 0.25 Allowed 'General case' 0 C--N 1.308 -1.206 0 O-C-N 124.244 0.965 . . . . 1.3899999999999999 112.054 176.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.945 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.0 pt -74.71 173.02 7.42 Favored Pre-proline 0 C--O 1.206 -1.204 0 N-CA-C 107.767 -1.197 . . . . 1.03 107.767 177.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.502 ' HB2' HG12 ' A' ' 57' ' ' ILE . 11.0 Cg_endo -90.13 -62.13 0.01 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.297 0 CA-C-N 120.192 1.104 . . . . 0.37 114.774 -177.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.694 HD13 ' HA ' ' A' ' 79' ' ' PRO . 16.8 mm -131.22 161.35 41.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.588 -0.445 . . . . 1.23 111.43 -165.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.581 ' CB ' HG22 ' A' ' 124' ' ' ILE . 29.3 p -155.96 -177.3 6.48 Favored 'General case' 0 N--CA 1.443 -0.813 0 CA-C-O 122.38 1.086 . . . . 1.1499999999999999 111.972 -179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.085 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 37.5 tt0 -135.96 116.37 13.67 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 113.017 -1.902 . . . . 1.3600000000000001 109.774 177.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.731 HG22 HD11 ' A' ' 120' ' ' ILE . 0.5 OUTLIER -97.25 110.09 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-O 122.238 1.018 . . . . 1.05 109.489 170.208 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.475 ' CB ' ' HG2' ' A' ' 75' ' ' LYS . 10.5 p -114.42 102.97 10.59 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 113.325 -1.761 . . . . 0.82999999999999996 108.844 -178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.545 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 9.3 p90 -113.37 131.65 55.9 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 109.517 -0.549 . . . . 0.40000000000000002 109.517 -167.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.51 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 17.6 m -127.94 106.01 8.81 Favored 'General case' 0 C--N 1.303 -1.449 0 CA-C-N 114.736 -1.12 . . . . 0.38 109.067 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 118' ' ' LEU . 72.1 m-85 -96.99 142.49 28.89 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 110.232 -0.284 . . . . 0.95999999999999996 110.232 -175.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.447 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 0.2 OUTLIER -129.38 144.85 51.41 Favored 'General case' 0 C--O 1.217 -0.651 0 N-CA-C 107.28 -1.378 . . . . 1.29 107.28 176.737 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.885 ' HB3' HD22 ' A' ' 104' ' ' LEU . 39.1 t -107.77 -96.47 0.37 Allowed 'General case' 0 C--N 1.315 -0.906 0 C-N-CA 118.902 -1.119 . . . . 1.27 111.106 175.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.37 -63.93 1.1 Allowed 'General case' 0 CA--C 1.512 -0.495 0 N-CA-C 109.146 -0.687 . . . . 0.35999999999999999 109.146 -177.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.34 17.21 0.18 Allowed Glycine 0 N--CA 1.437 -1.251 0 N-CA-C 108.511 -1.836 . . . . 0.39000000000000001 108.511 167.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.937 HH11 ' HB3' ' A' ' 103' ' ' ASN . 11.8 ptp180 -114.3 177.47 4.63 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.303 -0.999 . . . . 1.97 108.303 -176.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -101.13 98.19 8.64 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-O 121.606 0.717 . . . . 2.6099999999999999 109.486 -163.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.858 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.4 mm -54.97 -36.43 38.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 113.979 -1.464 . . . . 0.40000000000000002 111.912 -177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 163.2 161.21 12.18 Favored Glycine 0 N--CA 1.445 -0.735 0 N-CA-C 110.999 -0.84 . . . . 0.48999999999999999 110.999 -179.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.545 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.3 OUTLIER -159.99 161.77 34.17 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 117.875 0.837 . . . . 1.8100000000000001 111.24 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 179.76 162.43 28.75 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.753 -0.658 . . . . 0.42999999999999999 111.456 178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 61' ' ' SER . 95.7 mttt -123.47 128.62 50.07 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.649 -0.5 . . . . 1.72 109.649 178.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.475 ' HB ' HD12 ' A' ' 60' ' ' ILE . 80.4 mt -133.56 116.8 14.03 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 110.268 -0.271 . . . . 0.72999999999999998 110.268 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -72.68 101.49 1.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.366 0 C-N-CA 122.753 2.302 . . . . 0.56999999999999995 111.115 173.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -112.85 146.13 34.46 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 109.509 -0.552 . . . . 0.79000000000000004 109.509 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.694 ' HA ' HD13 ' A' ' 57' ' ' ILE . 35.6 Cg_exo -62.3 86.5 0.11 Allowed 'Trans proline' 0 N--CA 1.463 -0.294 0 C-N-CA 122.028 1.819 . . . . 0.57999999999999996 112.168 174.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.5 ' HA3' ' SG ' ' A' ' 58' ' ' CYS . . . -82.28 36.34 2.58 Favored Glycine 0 N--CA 1.453 -0.201 0 CA-C-N 115.926 -0.579 . . . . 0.40000000000000002 112.671 -179.048 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.945 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 85.2 p -73.95 120.29 19.34 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 109.297 -0.631 . . . . 0.62 109.297 176.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.887 HD11 ' HB3' ' A' ' 49' ' ' ASN . 0.0 OUTLIER -156.11 161.59 40.35 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 118.318 -1.353 . . . . 1.1000000000000001 114.546 -163.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HG3' ' OG1' ' A' ' 88' ' ' THR . 88.6 mttt -22.28 -97.1 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 114.883 1.438 . . . . 1.8400000000000001 114.883 -164.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.409 ' C ' ' HG2' ' A' ' 85' ' ' LYS . . . 171.24 109.55 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 108.252 -1.018 . . . . 0.98999999999999999 108.252 -172.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.738 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 39.5 pttt 42.15 46.56 3.79 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 124.008 0.818 . . . . 1.8400000000000001 110.936 -175.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 48' ' ' THR . 2.9 t70 -150.04 -171.04 3.8 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.261 -0.881 . . . . 0.64000000000000001 109.88 -170.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.572 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 46.9 ttm -119.01 117.93 30.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.514 0.673 . . . . 1.3500000000000001 110.157 -173.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.65 ' CB ' ' HB2' ' A' ' 82' ' ' LEU . 0.8 OUTLIER -106.12 143.31 34.42 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.839 -1.073 . . . . 0.77000000000000002 111.124 -176.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -84.0 129.9 34.9 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.463 0.649 . . . . 0.47999999999999998 110.73 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.434 ' CD2' ' HB ' ' A' ' 45' ' ' VAL . 8.8 tt -135.42 162.05 33.73 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 107.398 -1.334 . . . . 0.77000000000000002 107.398 -178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -141.69 138.27 32.31 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 119.23 -0.988 . . . . 1.8100000000000001 112.679 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.695 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 27.9 mm -100.82 149.92 36.59 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 114.005 -1.452 . . . . 0.65000000000000002 107.717 174.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.618 ' O ' ' HA ' ' A' ' 42' ' ' LEU . 11.3 Cg_endo -53.96 -116.11 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.077 0 C-N-CA 122.964 2.443 . . . . 1.0700000000000001 113.686 175.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 1.051 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 2.4 m -156.88 91.96 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.209 -1.073 0 O-C-N 121.559 -0.713 . . . . 0.46000000000000002 111.729 -169.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.539 HG11 ' HE2' ' A' ' 62' ' ' PHE . 9.1 p -126.27 101.56 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 116.102 1.89 . . . . 0.47999999999999998 116.102 -163.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.697 HG13 ' HB ' ' A' ' 39' ' ' VAL . 2.5 p -152.21 110.66 2.83 Favored Pre-proline 0 C--N 1.327 -0.387 0 O-C-N 121.25 -0.906 . . . . 1.0700000000000001 111.864 163.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 52.0 Cg_exo -54.43 131.81 47.44 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 121.794 1.663 . . . . 0.47999999999999998 110.942 173.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.538 ' HE2' ' NH1' ' A' ' 36' ' ' ARG . 24.8 t80 -54.16 -40.64 67.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.53 -0.759 . . . . 1.3100000000000001 111.523 -172.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.403 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 13.4 t -55.88 -26.97 49.66 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.229 0.331 . . . . 1.2 111.785 -176.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.858 HG21 ' HA ' ' A' ' 71' ' ' ILE . 13.3 mm -76.11 -55.38 11.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.109 -0.636 . . . . 0.51000000000000001 110.908 -176.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.948 HD23 HD21 ' A' ' 104' ' ' LEU . 37.9 mt -55.49 -28.48 54.82 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.521 0.677 . . . . 1.0 110.344 172.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.403 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.1 t80 -65.49 -39.72 92.25 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.384 -1.28 . . . . 0.95999999999999996 108.602 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.937 ' HB3' HH11 ' A' ' 69' ' ' ARG . 11.3 m-80 -74.28 -56.56 4.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.142 -0.936 . . . . 0.81999999999999995 112.307 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.948 HD21 HD23 ' A' ' 101' ' ' LEU . 1.7 pp -60.77 -47.96 83.95 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 113.121 0.786 . . . . 0.65000000000000002 113.121 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.45 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.56 -25.02 68.05 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.844 0.83 . . . . 0.42999999999999999 109.833 179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.666 ' HB3' ' O ' ' A' ' 103' ' ' ASN . 0.8 OUTLIER -64.15 -54.27 36.33 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.529 -1.214 . . . . 1.8100000000000001 110.274 173.24 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.56 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 18.7 t70 -82.41 -53.19 6.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.998 0.904 . . . . 0.80000000000000004 111.923 -173.282 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 ' HB ' HG13 ' A' ' 114' ' ' ILE . 3.4 t -87.55 -27.09 5.72 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 O-C-N 121.639 -0.663 . . . . 0.88 110.042 -176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -74.16 -19.76 79.76 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.462 -0.875 . . . . 0.38 111.34 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.56 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -49.14 -46.14 17.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 106.847 -1.538 . . . . 1.0900000000000001 106.847 164.743 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 33.3 m-20 -71.32 -89.96 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.486 -0.779 . . . . 1.8700000000000001 110.077 162.227 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . . . . . . . . . 6.3 p-90 179.64 -55.42 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 112.192 0.442 . . . . 1.1699999999999999 112.192 174.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -94.89 131.17 41.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.081 0.467 . . . . 2.1499999999999999 111.821 -174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.689 HD11 HD12 ' A' ' 144' ' ' LEU . 2.4 mp -120.62 161.33 20.48 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-N 115.954 -0.566 . . . . 0.39000000000000001 109.89 -176.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.434 ' N ' HG22 ' A' ' 114' ' ' ILE . 14.7 t70 -99.88 154.6 18.23 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.783 -0.644 . . . . 2.1099999999999999 109.563 176.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 83.8 m-85 -140.63 132.14 26.99 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 108.396 -0.964 . . . . 0.62 108.396 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.758 ' HG3' ' HB3' ' A' ' 139' ' ' LYS . 23.2 tt0 -131.22 137.15 48.79 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.082 0.468 . . . . 0.80000000000000004 110.307 -174.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.723 ' HB2' ' CE2' ' A' ' 64' ' ' PHE . 14.9 tp -103.16 131.08 50.45 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.775 -0.648 . . . . 1.25 110.256 174.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.533 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.0 OUTLIER -111.7 99.5 8.21 Favored 'General case' 0 C--N 1.312 -1.038 0 N-CA-C 107.57 -1.27 . . . . 0.63 107.57 170.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.731 HD11 HG22 ' A' ' 60' ' ' ILE . 6.3 tp -113.08 114.89 48.24 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 CA-C-O 121.348 0.594 . . . . 0.81000000000000005 111.139 -170.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.455 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -85.41 128.62 8.84 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 111.212 -0.755 . . . . 0.26000000000000001 111.212 176.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.705 ' O ' ' HA ' ' A' ' 133' ' ' THR . 5.7 mp -105.91 102.05 11.51 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.983 0.421 . . . . 1.2 110.936 -174.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.085 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 49.3 m -107.86 95.17 5.5 Favored 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 115.272 -0.877 . . . . 0.32000000000000001 109.514 175.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.617 HD11 ' HG2' ' A' ' 23' ' ' GLU . 39.3 pt -113.0 141.97 26.88 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 C-N-CA 120.146 -0.622 . . . . 0.97999999999999998 110.52 -177.445 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 131' ' ' GLU . 53.8 m-20 -85.73 106.16 16.79 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 108.752 -0.833 . . . . 1.52 108.752 -177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.797 HD13 HG21 ' A' ' 19' ' ' ILE . 45.3 mt -104.02 164.87 14.45 Favored Pre-proline 0 N--CA 1.45 -0.427 0 O-C-N 124.53 1.143 . . . . 1.28 109.878 -176.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.58 ' HG3' ' CE1' ' A' ' 53' ' ' HIS . 41.4 Cg_endo -69.91 -40.38 5.15 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 121.415 1.41 . . . . 0.73999999999999999 113.136 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.827 ' HA ' ' HB3' ' A' ' 3' ' ' SER . 98.9 t -74.07 -58.41 4.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 112.374 0.509 . . . . 1.1200000000000001 112.374 -173.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.692 HG11 ' HB2' ' A' ' 132' ' ' PHE . 9.7 p -90.21 -7.34 10.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 122.172 0.987 . . . . 1.3500000000000001 110.05 -175.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 72.92 -30.9 0.76 Allowed Glycine 0 C--O 1.227 -0.291 0 CA-C-N 114.248 -1.342 . . . . 1.05 112.516 -176.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.482 ' HA ' ' HA ' ' A' ' 125' ' ' ASP . 12.0 pt-20 -166.86 126.59 1.5 Allowed 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 1.1599999999999999 108.716 178.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.692 ' HB2' HG11 ' A' ' 129' ' ' VAL . 13.0 t80 -123.71 135.63 53.98 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 109.428 -0.582 . . . . 1.9099999999999999 109.428 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 9.9 t -128.05 103.22 7.1 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.921 0.867 . . . . 1.1899999999999999 111.844 -176.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 2.0 pp -127.64 143.9 49.15 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.236 -0.893 . . . . 0.5 110.227 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.455 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 80.9 Cg_endo -92.49 162.74 2.95 Favored 'Trans proline' 0 N--CA 1.45 -1.052 0 C-N-CA 121.783 1.656 . . . . 0.45000000000000001 113.597 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.408 HD13 ' N ' ' A' ' 137' ' ' SER . 0.0 OUTLIER -157.74 168.54 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 N-CA-C 107.112 -1.44 . . . . 0.44 107.112 178.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 99.1 p -145.64 152.18 39.25 Favored 'General case' 0 C--N 1.315 -0.911 0 C-N-CA 120.335 -0.546 . . . . 0.88 111.845 -168.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 33.3 t -146.98 113.13 5.84 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.784 -0.821 . . . . 0.95999999999999996 108.784 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.758 ' HB3' ' HG3' ' A' ' 117' ' ' GLU . 6.8 ptmm? -123.88 153.37 41.22 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.08 -0.248 . . . . 1.76 111.378 -176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -164.45 143.57 8.65 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.371 -0.692 . . . . 0.5 111.371 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.0 mp0 -108.54 132.13 54.14 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.03 -0.585 . . . . 2.1000000000000001 110.418 -176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.31 173.45 2.29 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 N-CA-C 107.473 -1.306 . . . . 0.76000000000000001 107.473 -178.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -63.94 172.63 2.21 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.217 0.532 . . . . 3.5299999999999998 112.332 -177.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.689 HD12 HD11 ' A' ' 114' ' ' ILE . 15.7 tp -58.97 139.85 87.07 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.316 -0.856 . . . . 1.23 111.306 -175.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.561 ' HD2' HD12 ' A' ' 144' ' ' LEU . 37.3 Cg_endo -65.9 172.87 7.76 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.973 2.449 . . . . 0.70999999999999996 112.449 176.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.8 t -60.4 125.12 22.48 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.506 0.669 . . . . 1.71 111.469 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.58 ' CE1' HD23 ' A' ' 144' ' ' LEU . 5.3 p90 -154.11 161.43 41.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.777 -0.647 . . . . 2.6400000000000001 109.602 -176.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 12.0 tppt? -151.04 75.09 1.18 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.569 -0.53 . . . . 3.7200000000000002 109.569 173.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 66.98 11.27 8.28 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.434 -0.803 . . . . 4.2800000000000002 110.72 -177.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 151' ' ' PHE . 26.1 m-85 -108.78 -43.45 4.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 2.8599999999999999 110.574 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.422 ' HB2' ' O ' ' A' ' 150' ' ' PHE . 59.6 m-85 . . . . . 0 C--O 1.253 1.252 0 CA-C-O 117.652 -1.166 . . . . 3.96 109.122 -166.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' HB3' ' HG2' ' A' ' 20' ' ' PRO . 1.8 mpt? . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 120.845 0.355 . . . . 12.109999999999999 110.269 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.34 145.54 48.16 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.204 -0.453 . . . . 9.0199999999999996 110.274 179.778 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 20' ' ' PRO . 8.9 m -77.26 8.51 3.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.402 -0.363 . . . . 6.8300000000000001 111.353 -177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.5 tp 73.0 -54.5 0.69 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.806 0.842 . . . . 8.5500000000000007 111.36 178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.5 mt -74.35 -2.69 26.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.174 0.511 . . . . 10.470000000000001 110.592 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.82 -20.75 62.24 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 115.13 -0.941 . . . . 11.69 111.269 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.506 ' HG3' ' H ' ' A' ' 8' ' ' ALA . 52.5 pttt -47.55 -63.38 1.07 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.655 -0.702 . . . . 11.42 112.681 -176.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.506 ' H ' ' HG3' ' A' ' 7' ' ' LYS . . . -178.55 163.06 1.49 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 122.206 0.202 . . . . 11.58 110.893 -177.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.9 mttm 68.17 142.74 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.504 0 O-C-N 124.206 0.941 . . . . 15.74 113.427 174.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.1 t70 72.43 127.0 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 114.757 -1.11 . . . . 12.69 112.354 174.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.572 ' CD2' HG22 ' A' ' 12' ' ' VAL . 4.2 t80 59.64 -156.19 0.34 Allowed 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.327 -0.851 . . . . 13.85 109.964 178.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.676 HG21 ' HB2' ' A' ' 15' ' ' LYS . 31.4 m -80.28 -31.98 13.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.362 0.125 . . . . 8.8699999999999992 111.222 -179.577 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 69.04 -59.87 0.47 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.14 0.793 . . . . 8.9100000000000001 113.14 176.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.03 -31.56 62.96 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.681 0.277 . . . . 8.5999999999999996 111.095 -174.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.676 ' HB2' HG21 ' A' ' 12' ' ' VAL . 44.9 mmtm -75.52 136.69 40.59 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.256 -0.646 . . . . 9.0399999999999991 109.256 177.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -68.67 88.65 0.36 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.239 0.542 . . . . 5.5800000000000001 110.314 -176.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 m -74.03 -47.88 33.85 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.569 -0.741 . . . . 2.6899999999999999 110.139 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.519 ' HA ' HG22 ' A' ' 129' ' ' VAL . . . -139.29 176.09 9.01 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.577 -0.738 . . . . 1.6799999999999999 110.416 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.771 HG21 HD13 ' A' ' 126' ' ' LEU . 6.9 tp -83.91 149.34 56.25 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 115.419 -0.81 . . . . 3.1899999999999999 109.571 -176.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 19' ' ' ILE . 72.4 Cg_exo -43.87 141.66 4.1 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 122.849 2.366 . . . . 2.4199999999999999 113.382 172.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.587 ' N ' ' HD2' ' A' ' 22' ' ' PRO . 63.7 mttm -70.27 -34.18 3.88 Favored Pre-proline 0 CA--C 1.54 0.594 0 N-CA-C 114.17 1.174 . . . . 6.3799999999999999 114.17 -177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 21' ' ' LYS . 33.8 Cg_endo -65.55 75.94 0.28 Allowed 'Trans proline' 0 C--N 1.359 1.095 0 C-N-CA 121.46 1.44 . . . . 2.77 113.808 178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 48' ' ' THR . 8.7 mt-10 -123.08 137.09 55.02 Favored 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 103.414 -2.81 . . . . 3.3900000000000001 103.414 169.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.73 ' O ' ' HA ' ' A' ' 47' ' ' VAL . . . -108.01 -179.68 21.93 Favored Glycine 0 C--N 1.304 -1.207 0 C-N-CA 117.648 -2.215 . . . . 0.54000000000000004 114.726 -171.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.707 ' HB2' HD11 ' A' ' 122' ' ' LEU . 22.5 m -169.83 34.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 124.841 1.256 . . . . 1.2 108.294 172.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.419 ' O ' ' HB2' ' A' ' 46' ' ' SER . 23.1 m -134.94 156.31 39.55 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.096 0 CA-C-N 114.369 -1.287 . . . . 0.93000000000000005 109.191 -175.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.2 t -173.47 -37.62 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.211 0.448 . . . . 0.47999999999999998 112.211 169.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.839 ' HB3' ' HB3' ' A' ' 44' ' ' LYS . 15.6 t70 -160.67 157.01 26.38 Favored 'General case' 0 C--O 1.222 -0.348 0 C-N-CA 120.825 -0.35 . . . . 1.6899999999999999 111.004 -173.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 69.4 t -142.45 134.97 26.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 108.693 -0.855 . . . . 1.1399999999999999 108.693 171.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.601 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 25.0 t70 -125.2 132.22 53.04 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.874 0.369 . . . . 1.8300000000000001 111.078 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.423 HD22 ' N ' ' A' ' 32' ' ' LYS . 2.8 tm? -101.17 127.5 47.71 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.062 -0.517 . . . . 0.93999999999999995 111.55 -173.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.477 ' HB3' ' HE3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -132.08 -115.27 0.23 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.613 -0.722 . . . . 1.3300000000000001 110.05 168.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.957 ' HA ' HG13 ' A' ' 39' ' ' VAL . 6.4 p-10 171.66 175.31 0.08 Allowed 'General case' 0 CA--C 1.513 -0.466 0 N-CA-C 110.409 -0.219 . . . . 2.8500000000000001 110.409 -173.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.518 HG13 ' O ' ' A' ' 34' ' ' VAL . 7.5 p -154.16 96.41 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.558 0 CA-C-O 121.539 0.685 . . . . 3.2599999999999998 111.105 174.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . 0.548 HD22 ' HB2' ' A' ' 37' ' ' ASP . 11.0 t30 69.47 -97.35 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.696 -0.683 . . . . 3.1600000000000001 109.267 175.059 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 179.23 32.31 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 107.246 -1.39 . . . . 5.46 107.246 172.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.548 ' HB2' HD22 ' A' ' 35' ' ' ASN . 2.0 t70 -101.6 -44.2 5.65 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 112.595 -2.093 . . . . 1.9199999999999999 105.628 -177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.695 ' HA ' ' H ' ' A' ' 98' ' ' TYR . 29.7 t -147.61 179.07 7.95 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 110.724 -2.944 . . . . 0.93999999999999995 105.818 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.957 HG13 ' HA ' ' A' ' 33' ' ' ASP . 8.2 t -131.33 159.83 42.76 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 N-CA-C 109.154 -0.684 . . . . 0.85999999999999999 109.154 170.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.849 ' HB3' ' HB ' ' A' ' 94' ' ' VAL . 90.9 mt-10 -114.07 134.55 54.79 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.456 0.646 . . . . 1.1899999999999999 112.386 -169.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.747 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 0.0 OUTLIER -121.73 106.08 10.98 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.841 -1.072 . . . . 3.73 110.237 -179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.621 HD22 ' O ' ' A' ' 93' ' ' PRO . 0.5 OUTLIER -74.11 110.34 8.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.144 -1.058 . . . . 0.81000000000000005 108.144 175.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.916 ' HB3' ' HB ' ' A' ' 92' ' ' ILE . . . -98.63 110.17 22.81 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.468 0.651 . . . . 0.41999999999999998 110.182 179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.839 ' HB3' ' HB3' ' A' ' 28' ' ' ASP . 22.8 ttmt -87.99 117.35 26.79 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.692 -1.14 . . . . 2.6299999999999999 109.342 -176.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.701 HG13 ' O ' ' A' ' 25' ' ' SER . 61.6 t -105.78 143.69 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 115.292 -0.867 . . . . 0.81999999999999995 111.038 -173.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.716 ' HB3' ' HG2' ' A' ' 87' ' ' MET . 4.8 m -134.89 97.39 3.74 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 109.482 -0.562 . . . . 0.71999999999999997 109.482 166.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.73 ' HA ' ' O ' ' A' ' 24' ' ' GLY . 0.2 OUTLIER -86.49 126.68 40.72 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-O 121.454 0.645 . . . . 1.1399999999999999 110.973 -179.237 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.665 ' HB ' ' H ' ' A' ' 24' ' ' GLY . 13.4 m -101.78 118.01 36.04 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 114.886 -1.052 . . . . 0.40999999999999998 110.159 -175.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . 0.7 ' O ' ' HA ' ' A' ' 85' ' ' LYS . 20.4 t30 -89.5 124.07 65.18 Favored Pre-proline 0 C--N 1.327 -0.378 0 O-C-N 124.669 1.231 . . . . 1.48 109.472 176.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' CG ' HG12 ' A' ' 19' ' ' ILE . 67.2 Cg_endo -84.29 2.27 8.24 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.495 2.797 . . . . 0.72999999999999998 115.34 -171.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.788 ' CE2' ' HB2' ' A' ' 53' ' ' HIS . 7.2 p90 -134.77 163.03 30.72 Favored 'General case' 0 CA--C 1.511 -0.557 0 O-C-N 121.685 -0.634 . . . . 2.0800000000000001 109.774 176.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.577 ' HB3' ' HD3' ' A' ' 85' ' ' LYS . 51.8 p -81.24 21.47 0.74 Allowed 'General case' 0 C--N 1.311 -1.107 0 N-CA-C 113.848 1.055 . . . . 1.51 113.848 -164.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . 0.788 ' HB2' ' CE2' ' A' ' 51' ' ' TYR . 37.0 m80 -131.21 129.97 42.34 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 119.967 -0.693 . . . . 1.6699999999999999 111.357 175.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.437 ' HA ' HD23 ' A' ' 82' ' ' LEU . 3.2 m -39.54 110.62 0.15 Allowed 'General case' 0 C--O 1.207 -1.158 0 C-N-CA 124.512 1.125 . . . . 1.3899999999999999 113.056 170.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.971 ' O ' ' HA ' ' A' ' 81' ' ' SER . 3.5 pt -73.03 170.37 13.97 Favored Pre-proline 0 C--O 1.211 -0.934 0 N-CA-C 107.83 -1.174 . . . . 1.03 107.83 177.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' CD ' ' HB ' ' A' ' 55' ' ' ILE . 7.6 Cg_endo -87.8 -57.3 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 121.223 1.282 . . . . 0.37 113.327 -179.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.904 HG12 ' HA ' ' A' ' 79' ' ' PRO . 21.7 mt -142.53 155.88 18.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 112.25 0.463 . . . . 1.23 112.25 -171.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' CYS . . . . . 0.774 ' HB3' HG22 ' A' ' 124' ' ' ILE . 21.0 p -142.28 -177.4 5.23 Favored 'General case' 0 N--CA 1.438 -1.045 0 CA-C-O 122.042 0.925 . . . . 1.1499999999999999 110.903 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 1.061 ' HB3' ' HB ' ' A' ' 123' ' ' THR . 41.1 tt0 -136.4 115.05 11.99 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.744 -1.571 . . . . 1.3600000000000001 109.992 176.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.747 HG22 HD11 ' A' ' 120' ' ' ILE . 1.0 OUTLIER -96.69 109.52 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 CA-C-O 122.359 1.076 . . . . 1.05 109.738 167.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.531 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 28.7 p -113.55 102.71 10.54 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 113.674 -1.603 . . . . 0.82999999999999996 108.799 -179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.468 ' O ' ' HA ' ' A' ' 73' ' ' LYS . 15.8 p90 -115.49 134.91 54.63 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.353 0.597 . . . . 0.40000000000000002 110.478 -164.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.445 ' HB ' ' HB3' ' A' ' 119' ' ' GLN . 19.5 m -131.65 111.01 11.33 Favored 'General case' 0 C--N 1.301 -1.521 0 CA-C-N 114.616 -1.174 . . . . 0.38 109.176 176.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.573 ' CZ ' HD13 ' A' ' 118' ' ' LEU . 92.2 m-85 -97.27 139.66 32.9 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 116.111 -0.495 . . . . 0.95999999999999996 110.189 -176.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.531 ' HA ' ' H ' ' A' ' 71' ' ' ILE . 7.6 m170 -130.83 145.55 52.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.821 -1.177 . . . . 1.29 107.821 175.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 1.021 ' HB3' HD22 ' A' ' 104' ' ' LEU . 29.7 t -107.74 -99.5 0.36 Allowed 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 119.642 -0.823 . . . . 1.27 111.206 176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.91 -55.86 25.19 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.01 -0.737 . . . . 0.35999999999999999 109.01 -174.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.09 18.02 0.1 Allowed Glycine 0 N--CA 1.444 -0.77 0 N-CA-C 108.459 -1.856 . . . . 0.39000000000000001 108.459 164.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.418 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 8.4 ptp180 -114.07 171.02 7.85 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 114.17 -1.015 . . . . 1.97 108.603 -176.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -96.72 94.1 7.1 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 122.091 0.948 . . . . 2.6099999999999999 110.324 -166.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.76 ' HA ' HG21 ' A' ' 100' ' ' ILE . 1.1 mm -48.75 -44.87 15.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 113.389 -1.732 . . . . 0.40000000000000002 112.112 179.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -173.81 168.59 41.49 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 119.925 -1.131 . . . . 0.48999999999999999 111.718 -176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -162.76 155.57 19.35 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.211 0.506 . . . . 1.8100000000000001 110.862 176.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -175.14 155.11 19.82 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.593 -1.003 . . . . 0.42999999999999999 110.593 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.416 ' HA ' ' HA ' ' A' ' 61' ' ' SER . 95.5 mttt -132.35 119.71 21.08 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 109.496 -0.557 . . . . 1.72 109.496 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.617 ' HB ' ' CD1' ' A' ' 60' ' ' ILE . 68.2 mt -133.45 116.05 13.91 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 116.408 -0.36 . . . . 0.72999999999999998 110.986 -171.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_exo -72.29 111.8 3.29 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.265 1.977 . . . . 0.56999999999999995 110.141 168.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 57' ' ' ILE . 20.8 t70 -115.87 144.75 33.29 Favored Pre-proline 0 C--N 1.322 -0.6 0 N-CA-C 109.771 -0.455 . . . . 0.79000000000000004 109.771 -173.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.904 ' HA ' HG12 ' A' ' 57' ' ' ILE . 17.9 Cg_endo -61.34 73.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 122.815 2.343 . . . . 0.57999999999999996 111.794 172.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.603 ' H ' ' HA ' ' A' ' 57' ' ' ILE . . . -76.47 35.45 1.36 Allowed Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 115.333 -0.849 . . . . 0.40000000000000002 113.605 -175.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.971 ' HA ' ' O ' ' A' ' 55' ' ' ILE . 93.7 p -73.67 119.7 18.26 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.272 -0.64 . . . . 0.62 109.272 177.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.671 HD11 ' HB2' ' A' ' 49' ' ' ASN . 1.1 pt? -140.18 -164.47 1.72 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 118.087 -1.445 . . . . 1.1000000000000001 114.176 -161.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' N ' ' HG ' ' A' ' 82' ' ' LEU . 90.3 mttt -54.82 -93.89 0.0 OUTLIER 'General case' 0 C--O 1.233 0.184 0 N-CA-C 112.735 0.643 . . . . 1.8400000000000001 112.735 -173.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 83' ' ' LYS . . . 162.32 111.84 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.643 0 N-CA-C 107.929 -1.137 . . . . 0.98999999999999999 107.929 -171.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.7 ' HA ' ' O ' ' A' ' 49' ' ' ASN . 41.8 pttt 42.32 47.46 4.19 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 124.305 1.003 . . . . 1.8400000000000001 111.338 -178.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -151.1 -170.41 3.65 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.282 -0.872 . . . . 0.64000000000000001 109.596 -173.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.716 ' HG2' ' HB3' ' A' ' 46' ' ' SER . 12.0 ttt -122.68 116.23 23.43 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-N 115.889 -0.596 . . . . 1.3500000000000001 110.256 -170.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.663 ' O ' ' HA ' ' A' ' 46' ' ' SER . 4.7 t -105.31 142.59 34.8 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.093 0.473 . . . . 0.77000000000000002 110.659 -174.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 45' ' ' VAL . . . -89.41 105.91 18.1 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-O 121.709 0.766 . . . . 0.47999999999999998 110.336 -176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.551 HD22 HG11 ' A' ' 45' ' ' VAL . 7.6 tt -104.23 168.29 9.2 Favored 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 107.11 -1.441 . . . . 0.77000000000000002 107.11 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -141.75 143.22 33.39 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 119.252 0.933 . . . . 1.8100000000000001 111.874 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.916 ' HB ' ' HB3' ' A' ' 43' ' ' ALA . 33.5 mm -106.4 120.72 47.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 107.825 -1.176 . . . . 0.65000000000000002 107.825 170.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.621 ' O ' HD22 ' A' ' 42' ' ' LEU . 46.0 Cg_exo -30.87 -97.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 124.811 3.674 . . . . 1.0700000000000001 114.753 -171.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.849 ' HB ' ' HB3' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -164.7 93.9 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.508 0 O-C-N 122.474 -0.141 . . . . 0.46000000000000002 110.669 -179.066 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 95' ' ' VAL . 7.4 p -127.17 103.65 11.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 114.448 1.277 . . . . 0.47999999999999998 114.448 -168.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.453 ' CG2' HD12 ' A' ' 71' ' ' ILE . 1.8 p -152.14 98.19 2.95 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 122.108 -0.37 . . . . 1.0700000000000001 110.519 160.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.704 ' HD2' ' O ' ' A' ' 71' ' ' ILE . 69.3 Cg_exo -50.58 128.87 24.97 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.265 1.976 . . . . 0.47999999999999998 111.828 178.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.695 ' H ' ' HA ' ' A' ' 38' ' ' SER . 8.2 t80 -48.63 -40.18 26.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.398 -0.819 . . . . 1.3100000000000001 111.609 -175.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.405 ' O ' ' HB3' ' A' ' 102' ' ' PHE . 19.9 m -58.92 -28.77 66.54 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.334 0.494 . . . . 1.2 112.334 -175.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.76 HG21 ' HA ' ' A' ' 71' ' ' ILE . 5.9 mm -76.32 -55.02 12.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 120.095 -0.642 . . . . 0.51000000000000001 110.001 -177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.69 HD23 HD11 ' A' ' 104' ' ' LEU . 35.7 mt -50.25 -28.16 7.24 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 123.97 0.794 . . . . 1.0 110.8 172.4 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 99' ' ' SER . 77.6 t80 -65.11 -44.68 87.95 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 114.93 -1.032 . . . . 0.95999999999999996 109.274 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.794 ' HA ' HH21 ' A' ' 106' ' ' ARG . 30.0 m-80 -73.57 -58.08 3.55 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.151 -0.477 . . . . 0.81999999999999995 112.197 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 1.021 HD22 ' HB3' ' A' ' 66' ' ' SER . 0.8 OUTLIER -59.38 -54.57 45.16 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 113.135 0.791 . . . . 0.65000000000000002 113.135 -178.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.498 ' O ' ' HA3' ' A' ' 109' ' ' GLY . . . -63.5 -24.28 67.75 Favored 'General case' 0 C--O 1.217 -0.605 0 CA-C-O 121.753 0.787 . . . . 0.42999999999999999 110.532 -175.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.794 HH21 ' HA ' ' A' ' 103' ' ' ASN . 8.2 ttp180 -64.69 -44.27 90.85 Favored 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 114.717 -1.129 . . . . 1.8100000000000001 110.878 175.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . 0.666 ' O ' ' HB ' ' A' ' 110' ' ' VAL . 31.5 t70 -85.16 -52.29 6.03 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.99 0.9 . . . . 0.80000000000000004 111.411 -174.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.981 HG21 HG23 ' A' ' 114' ' ' ILE . 28.7 m -76.71 -30.87 19.09 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.802 -0.635 . . . . 0.88 110.18 -178.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' O ' ' A' ' 105' ' ' ALA . . . -79.03 -15.87 79.81 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 114.869 -1.059 . . . . 0.38 111.681 175.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.666 ' HB ' ' O ' ' A' ' 107' ' ' ASP . 0.8 OUTLIER -48.99 -42.15 14.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 106.253 -1.758 . . . . 1.0900000000000001 106.253 162.098 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . 0.507 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 37.3 m-20 -75.53 -85.25 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.488 -0.778 . . . . 1.8700000000000001 110.289 157.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.509 ' O ' HD23 ' A' ' 144' ' ' LEU . 4.4 p-90 173.9 -37.88 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.092 0.557 . . . . 1.1699999999999999 112.393 173.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -93.39 134.19 35.88 Favored 'General case' 0 C--N 1.316 -0.861 0 C-N-CA 120.408 -0.517 . . . . 2.1499999999999999 111.941 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.981 HG23 HG21 ' A' ' 108' ' ' VAL . 0.2 OUTLIER -116.68 151.68 18.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.097 0.475 . . . . 0.39000000000000001 109.807 178.455 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.0 p-10 -101.35 154.13 19.05 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.389 -0.823 . . . . 2.1099999999999999 108.878 173.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.655 ' HA ' ' HA ' ' A' ' 66' ' ' SER . 51.8 m-85 -140.91 160.04 40.92 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.198 -0.668 . . . . 0.62 109.198 -179.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.577 ' HA ' ' HA ' ' A' ' 139' ' ' LYS . 26.4 tt0 -152.08 132.02 13.36 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.953 -0.388 . . . . 0.80000000000000004 109.953 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.573 HD13 ' CZ ' ' A' ' 64' ' ' PHE . 9.8 tp -101.58 132.35 47.29 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.184 -0.462 . . . . 1.25 110.399 174.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLN . . . . . 0.64 HE21 ' HA ' ' A' ' 119' ' ' GLN . 0.1 OUTLIER -117.89 99.55 6.99 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.971 -0.752 . . . . 0.63 108.971 175.182 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.747 HD11 HG22 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -118.47 121.58 67.42 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 CA-C-O 121.557 0.694 . . . . 0.81000000000000005 110.714 -173.83 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . 0.693 ' HA2' ' HA ' ' A' ' 135' ' ' PRO . . . -89.36 129.23 9.57 Favored Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.319 -0.855 . . . . 0.26000000000000001 111.891 178.073 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.721 ' O ' ' HA ' ' A' ' 133' ' ' THR . 6.1 mp -101.01 109.36 21.26 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.841 0.353 . . . . 1.2 110.954 -174.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . 1.061 ' HB ' ' HB3' ' A' ' 59' ' ' GLU . 91.0 m -114.87 96.71 5.85 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.731 -0.668 . . . . 0.32000000000000001 109.702 175.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.774 HG22 ' HB3' ' A' ' 58' ' ' CYS . 0.1 OUTLIER -110.06 134.35 52.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 C-N-CA 120.314 -0.554 . . . . 0.97999999999999998 111.482 -176.677 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -79.03 106.81 11.33 Favored 'General case' 0 CA--C 1.512 -0.487 0 N-CA-C 108.143 -1.058 . . . . 1.52 108.143 178.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.771 HD13 HG21 ' A' ' 19' ' ' ILE . 19.5 mt -116.04 170.46 5.74 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 124.457 1.098 . . . . 1.28 110.705 -171.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 126' ' ' LEU . 91.0 Cg_endo -84.7 -23.76 2.54 Favored 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 121.915 1.744 . . . . 0.73999999999999999 112.283 173.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' VAL . . . . . 0.678 HG21 HD13 ' A' ' 19' ' ' ILE . 22.8 t -74.85 -57.86 5.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.93 -0.577 . . . . 1.1200000000000001 111.764 -175.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.519 HG22 ' HA ' ' A' ' 18' ' ' ALA . 0.5 OUTLIER -107.07 -1.58 9.96 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-O 121.928 0.871 . . . . 1.3500000000000001 109.787 -177.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.533 ' HA2' ' O ' ' A' ' 126' ' ' LEU . . . 73.75 -28.12 0.91 Allowed Glycine 0 C--O 1.225 -0.463 0 CA-C-N 114.207 -1.36 . . . . 1.05 111.833 -171.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.515 ' H ' ' C ' ' A' ' 129' ' ' VAL . 9.6 pt-20 -165.58 138.25 4.25 Favored 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 107.344 -1.354 . . . . 1.1599999999999999 107.344 177.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . 0.436 ' O ' ' HA ' ' A' ' 123' ' ' THR . 6.2 t80 -132.41 128.72 38.14 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 108.664 -0.865 . . . . 1.9099999999999999 108.664 174.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.721 ' HA ' ' O ' ' A' ' 122' ' ' LEU . 14.0 t -120.97 101.04 7.42 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 122.293 1.044 . . . . 1.1899999999999999 111.367 -177.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.478 ' HA ' ' HD3' ' A' ' 135' ' ' PRO . 2.2 pp -127.21 132.8 24.49 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.993 -1.003 . . . . 0.5 109.84 176.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PRO . . . . . 0.693 ' HA ' ' HA2' ' A' ' 121' ' ' GLY . 2.5 Cg_endo -85.66 161.76 10.76 Favored 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.9 1.733 . . . . 0.45000000000000001 112.242 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -155.61 166.6 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.695 0 N-CA-C 108.114 -1.069 . . . . 0.44 108.114 179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 1.1 m -134.96 148.04 49.91 Favored 'General case' 0 C--N 1.316 -0.854 0 C-N-CA 120.788 -0.365 . . . . 0.88 110.987 -170.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.1 t -141.65 103.5 4.38 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 108.228 -1.027 . . . . 0.95999999999999996 108.228 174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.577 ' HA ' ' HA ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -107.99 147.24 31.36 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.055 -0.52 . . . . 1.76 110.599 -175.416 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . . . . . . . . . . . -158.83 135.9 4.45 Favored Glycine 0 N--CA 1.441 -0.978 0 C-N-CA 120.766 -0.73 . . . . 0.5 111.326 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -104.54 130.05 52.54 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.47 -0.566 . . . . 2.1000000000000001 109.47 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.26 174.81 6.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.462 -0.94 . . . . 0.76000000000000001 108.462 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.469 ' HD3' ' N ' ' A' ' 143' ' ' LYS . 0.0 OUTLIER -68.69 171.65 7.43 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 112.375 0.509 . . . . 3.5299999999999998 112.375 -175.105 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 HD11 ' A' ' 114' ' ' ILE . 1.0 OUTLIER -56.36 128.93 74.38 Favored Pre-proline 0 CA--C 1.537 0.478 0 CA-C-N 115.232 -0.895 . . . . 1.23 110.635 -176.579 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' PRO . . . . . 0.604 ' HD2' HD22 ' A' ' 144' ' ' LEU . 31.7 Cg_endo -63.66 173.82 4.22 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.544 2.829 . . . . 0.70999999999999996 113.392 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 15.7 m -47.92 104.23 0.05 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.464 -0.789 . . . . 1.71 111.602 178.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.509 ' CD1' HD12 ' A' ' 144' ' ' LEU . 10.5 p90 -130.77 162.15 30.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.405 -0.361 . . . . 2.6400000000000001 110.688 -175.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 147' ' ' PHE . 23.9 ttmm 174.04 76.04 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 O-C-N 124.077 0.861 . . . . 3.7200000000000002 109.653 175.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 38.7 t70 65.39 7.13 4.07 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 115.884 -0.598 . . . . 4.2800000000000002 111.419 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -83.78 -48.57 9.96 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.211 -1.033 . . . . 2.8599999999999999 108.211 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 9.4 p90 . . . . . 0 C--O 1.246 0.913 0 CA-C-N 114.424 -1.262 . . . . 3.96 108.521 172.082 . . . . . . . . 0 0 . 1 stop_ save_